PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhou, QH; Li, HM; Li, HZ; Nakagawa, A; Lin, JLJ; Lee, ES; Harry, BL; Skeen-Gaar, RR; Suehiro, Y; William, D; Mitani, S; Yuan, HS; Kang, BH; Xue, D				Zhou, Qinghua; Li, Haimin; Li, Hanzeng; Nakagawa, Akihisa; Lin, Jason L. J.; Lee, Eui-Seung; Harry, Brian L.; Skeen-Gaar, Riley Robert; Suehiro, Yuji; William, Donna; Mitani, Shohei; Yuan, Hanna S.; Kang, Byung-Ho; Xue, Ding			Mitochondrial endonuclease G mediates breakdown of paternal mitochondria upon fertilization	SCIENCE			English	Article							C. ELEGANS; DNA; AUTOPHAGY; INHERITANCE; DEGRADATION; HETEROPLASMY; TRANSMISSION; APOPTOSIS; DISEASE; MTDNA	Mitochondria are inherited maternally in most animals, but the mechanisms of selective paternal mitochondrial elimination (PME) are unknown. While examining fertilization in Caenorhabditis elegans, we observed that paternal mitochondria rapidly lose their inner membrane integrity. CPS-6, a mitochondrial endonuclease G, serves as a paternal mitochondrial factor that is critical for PME. We found that CPS-6 relocates from the intermembrane space of paternal mitochondria to the matrix after fertilization to degrade mitochondrial DNA. It acts with maternal autophagy and proteasome machineries to promote PME. Loss of cps-6 delays breakdown of mitochondrial inner membranes, autophagosome enclosure of paternal mitochondria, and PME. Delayed removal of paternal mitochondria causes increased embryonic lethality, demonstrating that PME is important for normal animal development. Thus, CPS-6 functions as a paternal mitochondrial degradation factor during animal development.	[Zhou, Qinghua; Li, Haimin; Li, Hanzeng; Nakagawa, Akihisa; Lee, Eui-Seung; Harry, Brian L.; Skeen-Gaar, Riley Robert; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Li, Hanzeng] Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA; [Lin, Jason L. J.; Yuan, Hanna S.] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Harry, Brian L.] Univ Colorado, Med Scientist Training Program, Aurora, CO 80045 USA; [Suehiro, Yuji; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Suehiro, Yuji; Mitani, Shohei] Japan Sci & Technol Agcy, CREST, Tokyo 1628666, Japan; [William, Donna] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Kang, Byung-Ho] Chinese Univ Hong Kong, Sch Life Sci, Ctr Cell & Dev Biol, Hong Kong, Hong Kong, Peoples R China; [Kang, Byung-Ho] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Zhou, Qinghua] Jinan Univ, Biomed Translat Res Inst, Affiliated Hosp 1, Guangzhou 510630, Guangdong, Peoples R China	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Academia Sinica - Taiwan; University of Colorado System; University of Colorado Anschutz Medical Campus; Tokyo Women's Medical University; Japan Science & Technology Agency (JST); State University System of Florida; University of Florida; Chinese University of Hong Kong; Chinese University of Hong Kong; Jinan University	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.; Kang, BH (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Cell & Dev Biol, Hong Kong, Hong Kong, Peoples R China.; Kang, BH (corresponding author), Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China.	bkang@cuhk.edu.hk; ding.xue@colorado.edu	Yuan, Hanna S./AAA-4005-2021; Li, Hanzeng/T-7473-2019; Zhou, Qinghua/I-2484-2014; Kang, Byung-Ho/G-9312-2017	Yuan, Hanna S./0000-0001-9671-6967; Zhou, Qinghua/0000-0003-0468-9266; Kang, Byung-Ho/0000-0002-4299-2170	March of Dimes [1-FY14-300]; NIH [GM59083, GM79097, GM118188]; Research Grants Council of Hong Kong [AoE/M-05/12]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088241, R01GM066262, R35GM118188, R01GM059083, R01GM079097, T32GM008497] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Blumenthal, R. Poyton, and K. Krauter for comments and H. Zhang for strains and antibodies. Supported by March of Dimes grant 1-FY14-300 and NIH grants GM59083, GM79097, and GM118188 (D.X.) and Research Grants Council of Hong Kong grant AoE/M-05/12 (B.-H.K.).	Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Cummins J M, 2000, Hum Reprod, V15 Suppl 2, P92; DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021; Jia KL, 2010, ADV EXP MED BIOL, V694, P47; Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051; Levine B, 2011, SCIENCE, V334, P1069, DOI 10.1126/science.1215480; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lin JLJ, 2012, J BIOL CHEM, V287, P7110, DOI 10.1074/jbc.M111.316075; Madura K, 2004, TRENDS BIOCHEM SCI, V29, P637, DOI 10.1016/j.tibs.2004.10.008; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI [10.1139/o02-135, 10.1139/O02-135]; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wang XD, 2001, GENE DEV, V15, P2922; Zhou QH, 2011, CELL RES, V21, P1662, DOI 10.1038/cr.2011.182	22	103	109	6	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2016	353	6297					394	399		10.1126/science.aaf4777	http://dx.doi.org/10.1126/science.aaf4777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HB	27338704	Green Accepted			2022-12-28	WOS:000380583400044
J	Frankland, PW; Josselyn, SA				Frankland, Paul W.; Josselyn, Sheena A.			NEUROSCIENCE In search of the memory molecule	NATURE			English	Editorial Material							KINASE M-ZETA; LTP; MAINTENANCE		[Frankland, Paul W.; Josselyn, Sheena A.] Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Frankland, PW (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.							Attardo A, 2015, NATURE, V523, P592, DOI 10.1038/nature14467; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; LeBlancq MJ, 2016, J NEUROSCI, V36, P6193, DOI 10.1523/JNEUROSCI.4563-14.2016; Lee AM, 2013, NATURE, V493, P416, DOI 10.1038/nature11803; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Rubin A, 2015, ELIFE, V4, DOI 10.7554/eLife.12247; Shema R, 2011, SCIENCE, V331, P1207, DOI 10.1126/science.1200215; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Tsokas P, 2016, ELIFE, V5, DOI 10.7554/eLife.14846; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802	12	5	6	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					41	42		10.1038/nature18903	http://dx.doi.org/10.1038/nature18903			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362229				2022-12-28	WOS:000379015600022
J	Kay-Stacey, M; Attarian, H				Kay-Stacey, Margaret; Attarian, Hrayr			Advances in the management of chronic insomnia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; OREXIN RECEPTOR ANTAGONIST; SUBLINGUAL ZOLPIDEM TARTRATE; PLACEBO-CONTROLLED TRIAL; DWELLING OLDER-ADULTS; TERM-CARE FACILITIES; SLEEP QUALITY; TAI-CHI	Chronic insomnia is a common condition that affects people worldwide and has negative effects on patients' health and wellbeing. The treatment of insomnia can be complex and time consuming for patients and providers. Although behavioral interventions are the first line therapy, there are barriers to access for these treatments. However, in recent years, alternative ways of providing these behavioral therapies that make them more widely available have been investigated. Drugs also play an important role in the treatment of insomnia and new drugs have been introduced as options for treating patients with sleep initiation and sleep maintenance insomnia. In this review, we will discuss advances in the past six years in both non-pharmacologic and pharmacologic treatments for patients with chronic insomnia. We will also review the controversies surrounding some of the current drug treatments, as well as the role that technology and personal activity monitoring devices may play in treating insomnia.	[Kay-Stacey, Margaret; Attarian, Hrayr] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Kay-Stacey, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	margaret-stacey@northwestern.edu						Afonso RF, 2012, MENOPAUSE, V19, P186, DOI 10.1097/gme.0b013e318228225f; Amaral Odete, 2014, Aten Primaria, V46 Suppl 5, P191, DOI 10.1016/S0212-6567(14)70090-3; American Academy of Sleep Medicine, 2014, INTERNATIONAL CLASSI; Bakken MS, 2014, EUR J CLIN PHARMACOL, V70, P873, DOI 10.1007/s00228-014-1684-z; Bei B, 2015, J CLIN SLEEP MED, V11, P1021, DOI 10.5664/jcsm.5018; Benbir G, 2015, PSYCHIAT CLIN NEUROS, V69, P543, DOI 10.1111/pcn.12252; Blank M, 2015, SLEEP, V38, P197, DOI 10.5665/sleep.4396; Blom K, 2015, BEHAV RES THER, V70, P47, DOI 10.1016/j.brat.2015.05.002; Borison R., 2014, WEARABLES AWARENESS; Bostock ECS, 2015, J AFFECT DISORDERS, V183, P57, DOI 10.1016/j.jad.2015.04.057; Bothelius K, 2013, J SLEEP RES, V22, P688, DOI 10.1111/jsr.12067; Bower JE, 2012, CANCER-AM CANCER SOC, V118, P3766, DOI 10.1002/cncr.26702; Brand S, 2014, SLEEP MED, V15, P1031, DOI 10.1016/j.sleep.2014.05.016; Buman MP, 2014, SLEEP MED, V15, P755, DOI 10.1016/j.sleep.2014.01.008; Canivet C, 2014, J PSYCHOSOM RES, V76, P292, DOI 10.1016/j.jpsychores.2014.02.001; Cape J, 2016, PSYCHOL MED, V46, P1015, DOI 10.1017/S0033291715002561; Castro LS, 2013, ANN NEUROL, V74, P537, DOI 10.1002/ana.23945; Cervena K, 2004, J SLEEP RES, V13, P385, DOI 10.1111/j.1365-2869.2004.00431.x; Chen HC, 2013, SLEEP, V36, P1187, DOI 10.5665/sleep.2884; Chen KM, 2009, INT J NURS STUD, V46, P154, DOI 10.1016/j.ijnurstu.2008.09.005; Chen MC, 2012, INT J NURS STUD, V49, P265, DOI 10.1016/j.ijnurstu.2011.09.009; Cheng SK, 2012, PSYCHOTHER PSYCHOSOM, V81, P206, DOI 10.1159/000335379; Chung KF, 2015, SLEEP MED, V16, P477, DOI 10.1016/j.sleep.2014.10.018; Citrome L, 2014, INT J CLIN PRACT, V68, P1429, DOI 10.1111/ijcp.12568; Clancy Megan, 2015, Int J MS Care, V17, P261, DOI 10.7224/1537-2073.2014-071; Clarke G, 2015, BEHAV RES THER, V69, P111, DOI 10.1016/j.brat.2015.04.009; Cohen L, 2004, CANCER-AM CANCER SOC, V100, P2253, DOI 10.1002/cncr.20236; Connor KM, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw022; Constantino Michael J, 2007, Behav Sleep Med, V5, P210; de Bruin EJ, 2014, BEHAV SLEEP MED, V12, P235, DOI 10.1080/15402002.2013.784703; de Gage SB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6231; de Zambotti M, 2015, SLEEP, V38, P1461, DOI 10.5665/sleep.4990; Dhruva A, 2012, J ALTERN COMPLEM MED, V18, P473, DOI 10.1089/acm.2011.0555; Dubey AK, 2015, J PHARMACOL PHARMACO, V6, P118, DOI 10.4103/0976-500X.155496; Ellis JG, 2012, J PSYCHIATR RES, V46, P1278, DOI 10.1016/j.jpsychires.2012.07.001; Equihua AC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00163; Espie CA, 2007, SLEEP, V30, P574, DOI 10.1093/sleep/30.5.574; Espie CA, 2014, SLEEP MED, V15, P913, DOI 10.1016/j.sleep.2014.03.001; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; Falloon K, 2015, BRIT J GEN PRACT, V65, pE508, DOI 10.3399/bjgp15X686137; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; Fernandez-Mendoza J, 2015, J SLEEP RES, V24, P390, DOI 10.1111/jsr.12285; Finan PH, 2014, SLEEP MED CLIN, V9, P261, DOI 10.1016/j.jsmc.2014.02.007; Ford ES, 2015, SLEEP MED, V16, P372, DOI 10.1016/j.sleep.2014.12.008; Garde AH, 2013, SCAND J WORK ENV HEA, V39, P550, DOI 10.5271/sjweh.3372; Garland SN, 2015, EXPLORE-NY, V11, P445, DOI 10.1016/j.explore.2015.08.004; Gindin J, 2014, J AM GERIATR SOC, V62, P2033, DOI 10.1111/jgs.13099; Godet-Cayre V, 2006, SLEEP, V29, P179, DOI 10.1093/sleep/29.2.179; Greenblatt DJ, 2014, DRUG AGING, V31, P731, DOI 10.1007/s40266-014-0211-3; Greenblatt DJ, 2014, J CLIN PHARMACOL, V54, P282, DOI 10.1002/jcph.220; Greenblatt DJ, 2013, CLIN THER, V35, P604, DOI 10.1016/j.clinthera.2013.03.007; Gross CR, 2011, EXPLORE-NY, V7, P76, DOI 10.1016/j.explore.2010.12.003; Haaramo P, 2014, J SLEEP RES, V23, P281, DOI 10.1111/jsr.12116; Halpern J, 2014, ALTERN THER HEALTH M, V20, P37; Hariprasad VR, 2013, INDIAN J PSYCHIAT, V55, pS364, DOI 10.4103/0019-5545.116310; Heckler CE, 2016, SUPPORT CARE CANCER, V24, P2059, DOI 10.1007/s00520-015-2996-y; Heidenreich T, 2006, PSYCHOTHER PSYCHOSOM, V75, P188, DOI 10.1159/000091778; Herring WJ, 2016, BIOL PSYCHIAT, V79, P136, DOI 10.1016/j.biopsych.2014.10.003; Herring WJ, 2012, NEUROLOGY, V79, P2265, DOI 10.1212/WNL.0b013e31827688ee; Holmqvist M, 2014, SLEEP MED, V15, P187, DOI 10.1016/j.sleep.2013.10.013; Horoszok L, 2014, HUM PSYCHOPHARM CLIN, V29, P266, DOI 10.1002/hup.2395; Hsu HM, 2015, BEHAV RES THER, V73, P143, DOI 10.1016/j.brat.2015.07.016; Hsu YW, 2013, SLEEP MED, V14, P843, DOI 10.1016/j.sleep.2013.02.017; Irwin MR, 2015, BIOL PSYCHIAT, V78, P721, DOI 10.1016/j.biopsych.2015.01.010; Irwin MR, 2014, SLEEP, V37, P1543, DOI 10.5665/sleep.4008; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Jarnefelt H, 2014, BEHAV RES THER, V56, P16, DOI 10.1016/j.brat.2014.02.007; Jarnefelt H, 2012, J OCCUP REHABIL, V22, P511, DOI 10.1007/s10926-012-9365-1; Jaussent I, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-212; Jiang XL, 2015, PUBLIC HEALTH, V129, P1579, DOI 10.1016/j.puhe.2015.07.030; Johnson JA, 2016, SLEEP MED REV, V27, P20, DOI 10.1016/j.smrv.2015.07.001; Jones KD, 2012, CLIN RHEUMATOL, V31, P1205, DOI 10.1007/s10067-012-1996-2; Kao CH, 2012, MAYO CLIN PROC, V87, P430, DOI 10.1016/j.mayocp.2012.02.012; Kapella MC, 2011, INT J CHRONIC OBSTR, V6, P625, DOI 10.2147/COPD.S24858; Kaplan KA, 2013, AM J PSYCHIAT, V170, P716, DOI 10.1176/appi.ajp.2013.12050708; Karlin BE, 2013, J CONSULT CLIN PSYCH, V81, P912, DOI 10.1037/a0032554; Kishi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136910; Kolla BP, 2013, J HOSP MED, V8, P1, DOI 10.1002/jhm.1985; Kriegbaum M, 2015, PHARMACOEPIDEM DR S, V24, P779, DOI 10.1002/pds.3745; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Kronholm E, 2016, J SLEEP RES, V25, P454, DOI 10.1111/jsr.12398; Krystal AD, 2011, SLEEP, V34, P1433, DOI 10.5665/SLEEP.1294; Krystal AD, 2010, SLEEP, V33, P1553, DOI 10.1093/sleep/33.11.1553; Lallukka T, 2015, J SLEEP RES; Lancee J, 2016, SLEEP, V39, P183, DOI 10.5665/sleep.5344; Lancee J, 2015, COGN BEHAV THERAPY, V44, P406, DOI 10.1080/16506073.2015.1026386; Lankford A, 2012, SLEEP MED, V13, P133, DOI 10.1016/j.sleep.2011.09.006; Larkey LK, 2015, ANN BEHAV MED, V49, P165, DOI 10.1007/s12160-014-9645-4; Larouche M, 2014, PATHOL BIOL, V62, P284, DOI 10.1016/j.patbio.2014.07.002; Laugsand LE, 2014, EUR HEART J, V35, P1382, DOI 10.1093/eurheartj/eht019; LeBlanc M, 2009, SLEEP, V32, P1027, DOI 10.1093/sleep/32.8.1027; Lee J, 2015, STUD HEALTH TECHNOL, V210, P458, DOI 10.3233/978-1-61499-512-8-458; Leger D, 2014, J SLEEP RES, V23, P143, DOI 10.1111/jsr.12104; Leger D, 2010, SLEEP MED, V11, P987, DOI 10.1016/j.sleep.2010.04.019; Li FZ, 2004, J AM GERIATR SOC, V52, P892, DOI 10.1111/j.1532-5415.2004.52255.x; Li Y, 2015, HYPERTENSION, V65, P644, DOI 10.1161/HYPERTENSIONAHA.114.04604; Lichstein KL, 2013, J CLIN PSYCHOL, V69, P1056, DOI 10.1002/jclp.22030; Lovato N, 2013, SLEEP MED, V14, P888, DOI 10.1016/j.sleep.2013.05.008; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; MCCLUSKY HY, 1991, AM J PSYCHIAT, V148, P121; Michelson D, 2014, LANCET NEUROL, V13, P461, DOI 10.1016/S1474-4422(14)70053-5; Min Y, 2016, DRUG AGING, V33, P151, DOI 10.1007/s40266-015-0339-9; Montgomery P, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858; Morgenthaler T, 2006, SLEEP, V29, P1415; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Mustian KM, 2013, J CLIN ONCOL, V31, P3233, DOI 10.1200/JCO.2012.43.7707; Nicolau ZFM, 2014, CONTEMP CLIN TRIALS, V39, P166, DOI 10.1016/j.cct.2014.08.006; Norell-Clarke A, 2015, BEHAV RES THER, V74, P80, DOI 10.1016/j.brat.2015.09.005; Okajima I, 2012, J CLIN PSYCHIAT, V73, P377, DOI 10.4088/JCP.10m06286; Omvik S, 2008, BEHAV RES THER, V46, P623, DOI 10.1016/j.brat.2008.02.013; Ong J, 2010, J CLIN PSYCHOL, V66, P1175, DOI 10.1002/jclp.20736; Ong JC, 2008, BEHAV THER, V39, P171, DOI 10.1016/j.beth.2007.07.002; Ong JC, 2008, J PSYCHOSOM RES, V64, P419, DOI 10.1016/j.jpsychores.2007.10.009; Ong JC, 2014, SLEEP, V37, P1553, DOI 10.5665/sleep.4010; Ong JC, 2009, EXPLORE-NY, V5, P30, DOI 10.1016/j.explore.2008.10.004; Parthasarathy S, 2015, AM J MED, V128, P268, DOI 10.1016/j.amjmed.2014.10.015; Passos GS, 2010, J CLIN SLEEP MED, V6, P270; Passos GS, 2011, SLEEP MED, V12, P1018, DOI 10.1016/j.sleep.2011.02.007; Pergolizzi Joseph V Jr, 2014, Sleep Disord, V2014, P527109, DOI 10.1155/2014/527109; Perlis ML, 2008, J CLIN SLEEP MED, V4, P11; Reid KJ, 2010, SLEEP MED, V11, P934, DOI 10.1016/j.sleep.2010.04.014; Ritterband LM, 2012, PSYCHO-ONCOLOGY, V21, P695, DOI 10.1002/pon.1969; Rosenberger ME, 2016, MED SCI SPORT EXER, V48, P457, DOI 10.1249/MSS.0000000000000778; Roth T, 2014, HUM PSYCHOPHARM CLIN, V29, P25, DOI 10.1002/hup.2364; Roth T, 2013, SLEEP, V36, P189, DOI 10.5665/sleep.2370; Sarsour K, 2011, SLEEP, V34, P443, DOI 10.1093/sleep/34.4.443; SCHARF MB, 1994, J CLIN PSYCHIAT, V55, P192; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; Sivertsen B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-720; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI [10.1111/jsr.12102, 10.1111/jsr.12254]; Smith MT, 2015, ARTHRITIS RHEUMATOL, V67, P1221, DOI 10.1002/art.39048; Smitherman TA, 2016, HEADACHE, V56, P276, DOI 10.1111/head.12760; Sun H, 2013, SLEEP, V36, P259, DOI 10.5665/sleep.2386; Taipale HT, 2009, DRUG AGING, V26, P871, DOI 10.2165/11317080-000000000-00000; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Taylor-Piliae RE, 2014, ARCH PHYS MED REHAB, V95, P816, DOI 10.1016/j.apmr.2014.01.001; Thorndike FP, 2013, J CLIN PSYCHOL, V69, P1078, DOI 10.1002/jclp.22032; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; Uemura N, 2015, J CLIN PHARMACOL, V55, P1093, DOI 10.1002/jcph.523; Valente KD, 2013, SLEEP MED, V14, P20, DOI 10.1016/j.sleep.2012.09.003; Vermeeren A, 2014, SLEEP, V37, P489, DOI 10.5665/sleep.3482; Verster JC, 2014, CURR DRUG SAF, V9, P205, DOI 10.2174/1574886309666140601210422; Vitiello MV, 2013, J AM GERIATR SOC, V61, P947, DOI 10.1111/jgs.12275; Vozoris NT, 2014, J CLIN PSYCHIAT, V75, P616, DOI 10.4088/JCP.13m08818; Walsh JK, 2009, SLEEP MED, V10, P859, DOI 10.1016/j.sleep.2008.10.005; Wang F, 2016, SLEEP MED REV, V30, P43, DOI 10.1016/j.smrv.2015.12.001; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307; Wong MY, 2016, CLIN PSYCHOL PSYCHOT, V23, P377, DOI 10.1002/cpp.1980; Wu JQ, 2015, JAMA INTERN MED, V175, P1461, DOI 10.1001/jamainternmed.2015.3006; Wu MP, 2014, STROKE, V45, P1349, DOI 10.1161/STROKEAHA.113.003675; Wu RG, 2006, PSYCHOTHER PSYCHOSOM, V75, P220, DOI 10.1159/000092892; Yamadera W, 2013, SLEEP BIOL RHYTHMS, V11, P176, DOI 10.1111/sbr.12019; Ye YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142258; Yeung WF, 2015, SLEEP MED REV, V19, P75, DOI 10.1016/j.smrv.2014.06.001; Zachariae R, 2016, SLEEP MED REV, V30, P1, DOI 10.1016/j.smrv.2015.10.004; Zhan YQ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1050; Zhang JX, 2015, EXPLORE-NY, V11, P180, DOI 10.1016/j.explore.2015.02.005; Zhuang J, 2016, CLIN EXP HYPERTENS, V38, P51, DOI 10.3109/10641963.2015.1060983; Zisapel N, 2015, EXPERT OPIN INV DRUG, V24, P401, DOI 10.1517/13543784.2015.987340	159	72	79	1	45	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2016	354								i2123	10.1136/bmj.i2123	http://dx.doi.org/10.1136/bmj.i2123			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR0EP	27383400				2022-12-28	WOS:000379581100001
J	Chaurasia, A				Chaurasia, Anurag			Stop teaching Indians to copy and paste	NATURE			English	Editorial Material									[Chaurasia, Anurag] Natl Bur Agr Important Microorganisms, Kushmaur, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Agriculturally Important Microorganisms	Chaurasia, A (corresponding author), Natl Bur Agr Important Microorganisms, Kushmaur, India.	anurag_vns1@yahoo.co.in		Chaurasia, Anurag/0000-0003-4622-0642					0	4	5	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					591	591		10.1038/534591a	http://dx.doi.org/10.1038/534591a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357759	Bronze			2022-12-28	WOS:000378676000004
J	Han, PD; Bloomekatz, J; Ren, J; Zhang, RL; Grinstein, JD; Zhao, L; Burns, CG; Burns, CE; Anderson, RM; Chi, NC				Han, Peidong; Bloomekatz, Joshua; Ren, Jie; Zhang, Ruilin; Grinstein, Jonathan D.; Zhao, Long; Burns, C. Geoffrey; Burns, Caroline E.; Anderson, Ryan M.; Chi, Neil C.			Coordinating cardiomyocyte interactions to direct ventricular chamber morphogenesis	NATURE			English	Article							REVEALS; TRANSGENESIS; INHIBITION; EXPRESSION; MUTATIONS; MIGRATION; PROMOTER; BEHAVIOR; GROWTH; CELLS	Many organs are composed of complex tissue walls that are structurally organized to optimize organ function. In particular, the ventricular myocardial wall of the heart comprises an outer compact layer that concentrically encircles the ridge-like inner trabecular layer. Although disruption in the morphogenesis of this myocardial wall can lead to various forms of congenital heart disease(1) and non-compaction cardiomyopathies(2), it remains unclear how embryonic cardiomyocytes assemble to form ventricular wall layers of appropriate spatial dimensions and myocardial mass. Here we use advanced genetic and imaging tools in zebrafish to reveal an interplay between myocardial Notch and Erbb2 signalling that directs the spatial allocation of myocardial cells to their proper morphological positions in the ventricular wall. Although previous studies have shown that endocardial Notch signalling non-cell-autonomously promotes myocardial trabeculation through Erbb2 and bone morphogenetic protein (BMP) signalling(3), we discover that distinct ventricular cardiomyocyte clusters exhibit myocardial Notch activity that cell-autonomously inhibits Erbb2 signalling and prevents cardiomyocyte sprouting and trabeculation. Myocardial-specific Notch inactivation leads to ventricles of reduced size and increased wall thickness because of excessive trabeculae, whereas widespread myocardial Notch activity results in ventricles of increased size with a single-cell-thick wall but no trabeculae. Notably, this myocardial Notch signalling is activated non-cell-autonomously by neighbouring Erbb2-activated cardiomyocytes that sprout and form nascent trabeculae. Thus, these findings support an interactive cellular feedback process that guides the assembly of cardiomyocytes to morphologically create the ventricular myocardial wall and more broadly provide insight into the cellular dynamics of how diverse cell lineages organize to create form.	[Han, Peidong; Bloomekatz, Joshua; Ren, Jie; Zhang, Ruilin; Grinstein, Jonathan D.; Chi, Neil C.] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Zhao, Long; Burns, C. Geoffrey; Burns, Caroline E.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Div Cardiol, Dept Med, Charlestown, MA 02129 USA; [Zhao, Long; Burns, C. Geoffrey; Burns, Caroline E.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Anderson, Ryan M.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Dept Pediat, Indianapolis, IN 46202 USA; [Anderson, Ryan M.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Chi, Neil C.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; Harvard University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of California System; University of California San Diego	Chi, NC (corresponding author), Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA.; Chi, NC (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.	nchi@ucsd.edu	Zhao, Long/A-6439-2014; Ren, Jie/AAB-5475-2019	Zhao, Long/0000-0003-2691-7055; Zhang, Ruilin/0000-0002-6594-450X; Grinstein, Jonathan/0000-0003-2911-4506	American Heart Association [14POST20380738]; March of Dimes [1-FY14-327]; NIH/NHLBI [5R01HL127067]; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069305, R01HD085902] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL128773, R01HL127067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); March of Dimes(March of Dimes); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Tedeschi for fish care: B. Le for experimental assistance; S. Evans, D. Yelon, and Chi laboratory members for comments on the manuscript; N. Ninov and D. Stainier for plasmids; B. Link for the d2GFP BMP and d2GFP Notch reporter lines: N. Lawson for the eGFP Notch reporter line; B. Appel for the myomrdial Cerulean line; K. Poss for the myocardial CreFR and Brainbow/priZm lines; and W. Talbot for the erbb2 mutant. This work was supported in part by grants from American Heart Association (14POST20380738) to L.Z.; the March of Dimes (1-FY14-327) to RAM.; the NIH/NHLBI (5R01HL127067) to C.G.B. and C.E.B.; and the National Institutes of Health to N.C.C.	Anderson RM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003650; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Clark BS, 2012, DEVELOPMENT, V139, P1599, DOI 10.1242/dev.078097; Collery RF, 2011, DEV DYNAM, V240, P712, DOI 10.1002/dvdy.22567; D'Amico L, 2007, CURR BIOL, V17, P252, DOI 10.1016/j.cub.2006.12.023; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Gupta V, 2012, NATURE, V484, P479, DOI 10.1038/nature11045; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Liu JD, 2010, DEVELOPMENT, V137, P3867, DOI 10.1242/dev.053736; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Mathews ES, 2014, J NEUROSCI, V34, P3402, DOI 10.1523/JNEUROSCI.4587-13.2014; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Ong LL, 1998, DEV BIOL, V193, P1, DOI 10.1006/dbio.1997.8775; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Peshkovsky C, 2011, DEV DYNAM, V240, P446, DOI 10.1002/dvdy.22526; Rentschler S, 2011, J CLIN INVEST, V121, P525, DOI 10.1172/JCI44470; Samsa LA, 2015, DEVELOPMENT, V142, P4080, DOI 10.1242/dev.125724; Schumacher JA, 2013, DEV BIOL, V383, P214, DOI 10.1016/j.ydbio.2013.09.019; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Staudt DW, 2014, DEVELOPMENT, V141, P585, DOI 10.1242/dev.098632; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Yang JW, 2012, CARDIOVASC RES, V96, P276, DOI 10.1093/cvr/cvs250; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zemrak F, 2014, J AM COLL CARDIOL, V64, P1971, DOI 10.1016/j.jacc.2014.08.035; Zhang RL, 2013, NATURE, V498, P497, DOI 10.1038/nature12322; Zhao C, 2014, DEVELOPMENT, V141, P281, DOI 10.1242/dev.093690; Zhao L, 2014, P NATL ACAD SCI USA, V111, P1403, DOI 10.1073/pnas.1311705111; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	41	49	49	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					700	+		10.1038/nature18310	http://dx.doi.org/10.1038/nature18310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357797	Green Submitted, Green Accepted			2022-12-28	WOS:000378676000040
J	Liesa, M; Shirihai, OS				Liesa, Marc; Shirihai, Orian S.			Mitochondrial Networking in T Cell Memory	CELL			English	Editorial Material							ENERGY-EXPENDITURE; AUTOPHAGY; FISSION	T-lymphocytes show large changes in ATP demand and nutrient utilization, imposed by their different roles as T memory and T effector cells. Therefore, T cell remodeling represents a bioenergetic challenge to mitochondria. New work from Buck et al. links changes in mitochondrial shape to T cell fate choice.	[Liesa, Marc; Shirihai, Orian S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Liesa, M; Shirihai, OS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol, Los Angeles, CA 90095 USA.	mliesa@mednet.ucla.edu; oshirihai@mednet.ucla.edu	Liesa, Marc/K-8590-2019	Liesa, Marc/0000-0002-5909-8570				Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753	8	12	13	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					9	10		10.1016/j.cell.2016.06.035	http://dx.doi.org/10.1016/j.cell.2016.06.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368094	Bronze			2022-12-28	WOS:000380254400004
J	Jain, V				Jain, Vageesh			Medical research in India and the rise of non-communicable disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; CHINA		[Jain, Vageesh] Kings Coll London, London SE1 1UL, England	University of London; King's College London	Jain, V (corresponding author), Kings Coll London, London SE1 1UL, England.	vageesh.jain@kcl.ac.uk						[Anonymous], INT J EPIDEMIOL, DOI DOI 10.1093/IJE/DYL098; [Anonymous], FUND PROGR ANN REP D; [Anonymous], MIN SCI TECHN ANN RE; [Anonymous], HLTH EXP TOT GDP; [Anonymous], 2009, VALUE IMPORTANCE OVE; [Anonymous], PUBL HLTH RES EUR FU; [Anonymous], MIN HLTH FAM WELF AN; [Anonymous], NATIONAL AMBIENT AIR; [Anonymous], 2015, WORLD EC OUTLOOK DAT; [Anonymous], CHRONIC NONCOMMUNICA; [Anonymous], COUNTR PROF ENV BURD; [Anonymous], INT J MED SCI PUBLIC; [Anonymous], GLOBOCAN 2012 V1 0 C; [Anonymous], BUDG ALL NET REC; [Anonymous], HLTH EXP PUBL GDP; [Anonymous], MIN SCI TECHN ANN RE; [Anonymous], GLOB BURD DIS 2013; Chatterji S, 2008, HEALTH AFFAIR, V27, P1052, DOI 10.1377/hlthaff.27.4.1052; Dikid T, 2013, INDIAN J MED RES, V138, P18; Kan HD, 2009, ENVIRON HEALTH PERSP, V117, pA530, DOI 10.1289/ehp.0901615; Pandav CS, 2013, INDIAN J MED RES, V138, P418; Pandve Harshal T, 2009, Indian J Occup Environ Med, V13, P17, DOI 10.4103/0019-5278.50718; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Upadhyay RP, 2012, IRAN J PUBLIC HEALTH, V41, P1; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; WHO, 2016, WHO GLOB URB AMB AIR; World Health Organization, 2005, WORLD HLTH REP 2005	30	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2016	353								i3371	10.1136/bmj.i3371	http://dx.doi.org/10.1136/bmj.i3371			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FV	27358280				2022-12-28	WOS:000379018700001
J	Matthews, A; Herrett, E; Gasparrini, A; Van Staa, T; Goldacre, B; Smeeth, L; Bhaskaran, K				Matthews, Anthony; Herrett, Emily; Gasparrini, Antonio; Van Staa, Tjeerd; Goldacre, Ben; Smeeth, Liam; Bhaskaran, Krishnan			Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; LDL CHOLESTEROL; HEART-DISEASE; LOW-RISK; METAANALYSIS; BENEFITS; MEDICATION; PEOPLE; HEALTH	OBJECTIVE To quantify how a period of intense media coverage of controversy over the risk: benefit balance of statins affected their use. DESIGN Interrupted time series analysis of prospectively collected electronic data from primary care. SETTING Clinical Practice Research Datalink (CPRD) in the United Kingdom. PARTICIPANTS Patients newly eligible for or currently taking statins for primary and secondary cardiovascular disease prevention in each month in January 2011-March 2015. Main outcom e measures Adjusted odds ratios for starting/stopping taking statins after the media coverage (October 2013-March 2014). RESULTS There was no evidence that the period of high media coverage was associated with changes in statin initiation among patients with a high recorded risk score for cardiovascular disease (primary prevention) or a recent cardiovascular event (secondary prevention) (odds ratio 0.99 (95% confidence interval 0.87 to 1.13; P = 0.92) and 1.04 (0.92 to 1.18; P = 0.54), respectively), though there was a decrease in the overall proportion of patients with a recorded risk score. Patients already taking statins were more likely to stop taking them for both primary and secondary prevention after the high media coverage period (1.11 (1.05 to 1.18; P < 0.001) and 1.12 (1.04 to 1.21; P = 0.003), respectively). Stratified analyses showed that older patients and those with a longer continuous prescription were more likely to stop taking statins after the media coverage. In post hoc analyses, the increased rates of cessation were no longer observed after six months. CONCLUSIONS A period of intense public discussion over the risks: benefit balance of statins, covered widely in the media, was followed by a transient rise in the proportion of people who stopped taking statins. This research highlights the potential for widely covered health stories in the lay media to impact on healthcare related behaviour.	[Matthews, Anthony; Herrett, Emily; Goldacre, Ben; Smeeth, Liam; Bhaskaran, Krishnan] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England; [Gasparrini, Antonio] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Keppel St, London WC1E 7HT, England; [Van Staa, Tjeerd] Univ Manchester, Farr Inst Hlth Informat Res, Hlth eRes Ctr, Manchester, Lancs, England; [Van Staa, Tjeerd] Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Manchester; Utrecht University	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	Gasparrini, Antonio/F-7627-2012; Matthews, Anthony/H-9441-2019; Smeeth, Liam/X-5862-2018	Gasparrini, Antonio/0000-0002-2271-3568; Matthews, Anthony/0000-0002-1290-271X; van Staa, Tjeerd/0000-0001-9363-742X; Smeeth, Liam/0000-0002-9168-6022; Bhaskaran, Krishnan/0000-0001-5364-8757	British Heart Foundation; Wellcome Trust; Royal Society [107731/Z/15/Z]; British Heart Foundation [PG/15/80/31781] Funding Source: researchfish; Medical Research Council [MR/K006665/1, MC_PC_13042, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [14/49/159] Funding Source: researchfish; Wellcome Trust [107731/Z/15/Z] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the British Heart Foundation. KB holds a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant No 107731/Z/15/Z). LS is funded by a Wellcome Trust senior fellowship in clinical science. The British Heart Foundation, the Wellcome Trust, and the Royal Society had no role in the design, analysis, or writing up of this study.	Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; [Anonymous], 2014, DAILY MAIL; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Boseley S., 2014, GUARDIAN; British Cardiovascular Association, 2014, STAT MED SURV RES; BRUGTS JJ, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B2376; Campbell J, 2013, PHARMACOEPIDEM DR S, V22, P280; Casey GM, 2013, BRIT J CANCER, V109, P1192, DOI 10.1038/bjc.2013.444; Chapman S, 2005, MED J AUSTRALIA, V183, P247, DOI 10.5694/j.1326-5377.2005.tb07029.x; Denaxas Spiros C, 2012, Int J Epidemiol, V41, P1625, DOI 10.1093/ije/dys188; Faasse K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001607; Fontana M, 2014, CIRCULATION, V129, P2539, DOI 10.1161/CIRCULATIONAHA.113.007595; Fung Vicki, 2010, Perm J, V14, P4; Gale NK, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-59; Grilli R, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000389; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Kelaher M, 2008, INT J EPIDEMIOL, V37, P1326, DOI 10.1093/ije/dyn090; Kocas C, 2015, INT J CARDIOL, V201, P139, DOI 10.1016/j.ijcard.2015.07.095; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Kravitz RL, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S3-S5; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; MacArthur GJ, 2011, J MED SCREEN, V18, P204, DOI 10.1258/jms.2011.011092; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; McCullagh P., 1989, GEN LINEAR MODELS, DOI [10. 1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6, 10.1007/978-1-4899-3242-6]; McDowall D., 1980, INTERRUPTED TIME SER; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Nielsen SF, 2016, EUR HEART J, V37, P908, DOI 10.1093/eurheartj/ehv641; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Saib A, 2013, ARCH CARDIOVASC DIS, V106, P511, DOI 10.1016/j.acvd.2013.06.053; Schaffer AL, 2015, MED J AUSTRALIA, V202, P591, DOI 10.5694/mja15.00103; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; van Hunsel F, 2009, BRIT J CLIN PHARMACO, V67, P558, DOI 10.1111/j.1365-2125.2009.03400.x; Wennberg J E, 1984, Health Manage Q, P6, DOI 10.1377/hlthaff.3.2.6; Will CM, 2015, SOC SCI MED, V131, P280, DOI 10.1016/j.socscimed.2014.04.033; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	38	125	125	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2016	353								i3283	10.1136/bmj.i3283	http://dx.doi.org/10.1136/bmj.i3283			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FP	27353418	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000379018000002
J	Marcos, V; Stephens, AJ; Jaramillo-Garcia, J; Nussbaumer, AL; Woltering, SL; Valero, A; Lemonnier, JF; Vitorica-Yrezabal, IJ; Leigh, DA				Marcos, Vanesa; Stephens, Alexander J.; Jaramillo-Garcia, Javier; Nussbaumer, Alina L.; Woltering, Steffen L.; Valero, Alberto; Lemonnier, Jean-Francois; Vitorica-Yrezabal, Inigo J.; Leigh, David A.			ORGANIC CHEMISTRY Allosteric initiation and regulation of catalysis with a molecular knot	SCIENCE			English	Article							TREFOIL KNOT; TEMPLATE SYNTHESIS; SOLOMON LINK; BINDING; TOPOLOGY	Molecular knots occur in DNA, proteins, and other macromolecules. However, the benefits that can potentially arise from tying molecules in knots are, for the most part, unclear. Here, we report on a synthetic molecular pentafoil knot that allosterically initiates or regulates catalyzed chemical reactions by controlling the in situ generation of a carbocation formed through the knot-promoted cleavage of a carbon-halogen bond. The knot architecture is crucial to this function because it restricts the conformations that the molecular chain can adopt and prevents the formation of catalytically inactive species upon metal ion binding. Unknotted analogs are not catalytically active. Our results suggest that knotting molecules may be a useful strategy for reducing the degrees of freedom of flexible chains, enabling them to adopt what are otherwise thermodynamically inaccessible functional conformations.	[Marcos, Vanesa; Stephens, Alexander J.; Jaramillo-Garcia, Javier; Nussbaumer, Alina L.; Woltering, Steffen L.; Valero, Alberto; Lemonnier, Jean-Francois; Vitorica-Yrezabal, Inigo J.; Leigh, David A.] Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England	University of Manchester	Leigh, DA (corresponding author), Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England.	david.leigh@manchester.ac.uk	Marcos, Vanesa/J-7539-2016; Leigh, David/K-5965-2015; Vitorica-Yrezabal, Inigo/AAD-6983-2022; Stephens, Alexander/J-4105-2018	Leigh, David/0000-0002-1202-4507; Vitorica-Yrezabal, Inigo/0000-0001-8806-150X; Stephens, Alexander/0000-0001-5264-2126; Jaramillo-Garcia, Javier/0000-0001-7222-2727; Lemonnier, Jean-Francois/0000-0002-2201-2788; Woltering, Steffen/0000-0002-9697-9019	European Research Council [339019]; European Union [FP7-PEOPLE-2013-ITN-607602]; Engineering and Physical Sciences Research Council [EP/P001386/1] Funding Source: researchfish; EPSRC [EP/P001386/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded by the European Research Council (advanced grant no. 339019) and the European Union's Seventh Framework Program (FP7-PEOPLE-2013-ITN-607602 'Hierarchical Self Assembly of Polymeric Soft Systems' SASSYPOL). The authors thank the Engineering and Physical Sciences Research Council National Mass Spectrometry Service Centre (Swansea, UK) for high-resolution mass spectrometry. CCDC-1443084 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via https://summary.ccdc.cam.ac.uk/structure-summary-form [or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB21EZ, UK; fax: (+44)1223-336-033; or deposit@ccdc.cam.ac.uk].	Alexander J. W., 1926, ANN MATH, V28, P562, DOI 10.2307/1968399; Arai Y, 1999, NATURE, V399, P446, DOI 10.1038/20894; Ayme JF, 2015, J AM CHEM SOC, V137, P9812, DOI 10.1021/jacs.5b06340; Ayme JF, 2014, J AM CHEM SOC, V136, P13142, DOI 10.1021/ja506886p; Ayme JF, 2013, CHEM SOC REV, V42, P1700, DOI 10.1039/c2cs35229j; Ayme JF, 2012, J AM CHEM SOC, V134, P9488, DOI 10.1021/ja303355v; Ayme JF, 2012, NAT CHEM, V4, P15, DOI 10.1038/nchem.1193; Bah J, 2014, CHEM-EUR J, V20, P1066, DOI 10.1002/chem.201304160; Barran PE, 2011, ANGEW CHEM INT EDIT, V50, P12280, DOI 10.1002/anie.201105012; Brak K, 2013, ANGEW CHEM INT EDIT, V52, P534, DOI 10.1002/anie.201205449; Busschaert N, 2015, CHEM REV, V115, P8038, DOI 10.1021/acs.chemrev.5b00099; de Jong RM, 2003, CURR OPIN STRUC BIOL, V13, P722, DOI 10.1016/j.sbi.2003.10.009; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; DIETRICHBUCHECKER CO, 1989, ANGEW CHEM INT EDIT, V28, P189, DOI 10.1002/anie.198901891; Feigel M, 2006, ANGEW CHEM INT EDIT, V45, P5698, DOI 10.1002/anie.200601111; FRANKKAMENETSKII MD, 1975, NATURE, V258, P398, DOI 10.1038/258398a0; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; Guo J, 2010, NAT CHEM, V2, P218, DOI [10.1038/NCHEM.544, 10.1038/nchem.544]; Hasenknopf B, 1996, ANGEW CHEM INT EDIT, V35, P1838, DOI 10.1002/anie.199618381; Hasenknopf B, 1998, ANGEW CHEM INT EDIT, V37, P3265, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3265::AID-ANIE3265>3.0.CO;2-B; Leigh DA, 2014, NAT CHEM, V6, P978, DOI [10.1038/NCHEM.2056, 10.1038/nchem.2056]; Liu YZ, 2016, SCIENCE, V351, P365, DOI 10.1126/science.aad4011; McGuirk CM, 2014, J AM CHEM SOC, V136, P16594, DOI 10.1021/ja508804n; Naidu VR, 2015, CHEMCATCHEM, V7, P1896, DOI 10.1002/cctc.201500225; Ponnuswamy N, 2014, J AM CHEM SOC, V136, P8243, DOI 10.1021/ja4125884; Ponnuswamy N, 2012, SCIENCE, V338, P783, DOI 10.1126/science.1227032; Prakasam T, 2013, ANGEW CHEM INT EDIT, V52, P9956, DOI 10.1002/anie.201302425; Safarowsky O, 2000, ANGEW CHEM INT EDIT, V39, P1616, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1616::AID-ANIE1616>3.0.CO;2-Y; Saitta AM, 1999, NATURE, V399, P46, DOI 10.1038/19935; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Tang LX, 2005, BIOCHEMISTRY-US, V44, P6609, DOI 10.1021/bi047613z; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Traut T.W., 2008, ALLOSTERIC REGULATOR; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WASSERMAN SA, 1986, SCIENCE, V232, P951, DOI 10.1126/science.3010458	35	156	155	7	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1555	1559		10.1126/science.aaf3673	http://dx.doi.org/10.1126/science.aaf3673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339983	Green Submitted			2022-12-28	WOS:000378346500038
J	Lorenzo, ME; Carter, JB; Barnes, JA; Nazarian, RM				Lorenzo, Mayra E.; Carter, Joi B.; Barnes, Jeffrey A.; Nazarian, Rosalynn M.			Case 19-2016: A 65-Year-Old Man with End-Stage Renal Disease and a Pruritic Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELL LEUKEMIA/LYMPHOMA; CUTANEOUS MANIFESTATIONS; LYMPHOMA; SKIN; FEATURES		[Lorenzo, Mayra E.; Carter, Joi B.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Barnes, Jeffrey A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Nazarian, Rosalynn M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lorenzo, Mayra E.; Carter, Joi B.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Barnes, Jeffrey A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Nazarian, Rosalynn M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lorenzo, ME (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.; Lorenzo, ME (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA.		Nazarian, Rosalynn/AFL-3176-2022	Nazarian, Rosalynn/0000-0003-4003-7193				Basavaraj KH, 2010, INT J DERMATOL, V49, P1351, DOI 10.1111/j.1365-4632.2010.04570.x; Bazarbachi A, 2010, J CLIN ONCOL, V28, P4177, DOI 10.1200/JCO.2010.28.0669; Bittencourt AL, 2007, AM J CLIN PATHOL, V128, P875, DOI 10.1309/2YGD1P0QCVCWBLDX; Bittencourt AL, 2010, INT J DERMATOL, V49, P1099, DOI 10.1111/j.1365-4632.2010.04568.x; Bittencourt A, 2009, ACTA ONCOL, V48, P598, DOI 10.1080/02841860802657235; Gorouhi F, 2014, SCI WORLD J, DOI 10.1155/2014/742826; Goyal A, 2015, ATLAS CUTANEOUS LYMP, P73; Hinds GA, 2009, J AM ACAD DERMATOL, V60, P359, DOI 10.1016/j.jaad.2008.10.031; Jawed SI, 2014, J AM ACAD DERMATOL, V70, DOI 10.1016/j.jaad.2013.07.049; Kamath S, 2014, J AM ACAD DERMATOL, V71, P795, DOI 10.1016/j.jaad.2014.03.034; Kudo H, 2012, CLIN EXP DERMATOL, V37, P183, DOI 10.1111/j.1365-2230.2011.04141.x; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Mahieux Renaud, 2007, Curr Hematol Malig Rep, V2, P257, DOI 10.1007/s11899-007-0035-x; Marchetti MA, 2015, J AM ACAD DERMATOL, V72, P293, DOI 10.1016/j.jaad.2014.10.006; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Ohshima K., 2008, WHO CLASSIFICATION T, P281; Ralfkiaer E, 2008, WHO CLASSIFICATION T, P296; Sawada Y, 2011, BLOOD, V117, P3961, DOI 10.1182/blood-2010-11-316794; Sugaya M, 2013, J DERMATOL, V40, P2, DOI 10.1111/j.1346-8138.2012.01639.x; Takemori N, 1995, BRIT J DERMATOL, V133, P955, DOI 10.1111/j.1365-2133.1995.tb06933.x; Theoharides TC, 2015, NEW ENGL J MED, V373, P1885, DOI 10.1056/NEJMc1510021; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Yamaguchi T, 2005, BRIT J DERMATOL, V152, P76, DOI 10.1111/J.1365-2133.2004.06274.X	25	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2478	2488		10.1056/NEJMcpc1512457	http://dx.doi.org/10.1056/NEJMcpc1512457			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1TG	27332907				2022-12-28	WOS:000378271700012
J	Quinn, T				Quinn, Terry			Review: Evidence is insufficient to determine the risk-benefit ratio for vision acuity screening in older adults Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Quinn, Terry] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Glasgow	Quinn, T (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.		Quinn, Terence Joseph/H-7000-2019	Quinn, Terence Joseph/0000-0003-1401-0181	Stroke Association [PPA2015/01_CSO, TSA15LECT05] Funding Source: researchfish	Stroke Association			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					JC64	JC64		10.7326/ACPJC-2016-164-12-064	http://dx.doi.org/10.7326/ACPJC-2016-164-12-064			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323260	Green Accepted			2022-12-28	WOS:000379343000003
J	Sacks, HS				Sacks, Henry S.			In older adults, macrolide antibiotics were not linked to increased risk for ventricular arrhythmia Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sacks, Henry S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sacks, HS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Jespersen CM, 2006, BRIT MED J, V332, P22, DOI 10.1136/bmj.38666.653600.55; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					JC68	JC68		10.7326/ACPJC-2016-164-12-068	http://dx.doi.org/10.7326/ACPJC-2016-164-12-068			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323264				2022-12-28	WOS:000379343000007
J	Mayer, KH; Shisana, O; Beyrer, C				Mayer, Kenneth H.; Shisana, Olive; Beyrer, Chris			AIDS 2016: from aspiration to implementation	LANCET			English	Editorial Material							HIV-INFECTION; PREVENTION		[Mayer, Kenneth H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA 02215 USA; [Mayer, Kenneth H.; Shisana, Olive; Beyrer, Chris] Int AIDS Soc, Geneva, Switzerland; [Shisana, Olive] Evidence Based Solut, Cape Town, South Africa; [Shisana, Olive] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Hlth & Human Rights, Baltimore, MD USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Fenway Health; University of Cape Town; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mayer, KH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.; Mayer, KH (corresponding author), Fenway Hlth, Fenway Inst, Boston, MA 02215 USA.	kmayer@fenwayhealth.org						Beyrer C, 2015, LANCET, V386, P505, DOI 10.1016/S0140-6736(15)61458-1; Case KK, 2012, B WORLD HEALTH ORGAN, V90, P831, DOI 10.2471/BLT.12.102574; Cohen MS, 2012, CURR OPIN HIV AIDS, V7, P99, DOI 10.1097/COH.0b013e32834f5cf2; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Risher K, 2015, CURR OPIN HIV AIDS, V10, P420, DOI 10.1097/COH.0000000000000200; Sheena M, 2016, LANCET, V387, P53; Shisana O, 2014, S AFRICAN NATL HIV P; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Wang HB, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/503978; World Health Organization, 2015, GUID START ANT THER	12	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2484	2485		10.1016/S0140-6736(16)30621-3	http://dx.doi.org/10.1016/S0140-6736(16)30621-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO7FG	27353669				2022-12-28	WOS:000377947200006
J	Arbore, G; West, EE; Spolski, R; Robertson, AAB; Klos, A; Rheinheimer, C; Dutow, P; Woodruff, TM; Yu, ZX; O'Neill, LA; Coll, RC; Sher, A; Leonard, WJ; Kohl, J; Monk, P; Cooper, MA; Arno, M; Afzali, B; Lachmann, HJ; Cope, AP; Mayer-Barber, KD; Kemper, C				Arbore, Giuseppina; West, Erin E.; Spolski, Rosanne; Robertson, Avril A. B.; Klos, Andreas; Rheinheimer, Claudia; Dutow, Pavel; Woodruff, Trent M.; Yu, Zu Xi; O'Neill, Luke A.; Coll, Rebecca C.; Sher, Alan; Leonard, Warren J.; Koehl, Jorg; Monk, Pete; Cooper, Matthew A.; Arno, Matthew; Afzali, Behdad; Lachmann, Helen J.; Cope, Andrew P.; Mayer-Barber, Katrin D.; Kemper, Claudia			T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells	SCIENCE			English	Article							INNATE LYMPHOID-CELLS; C5A RECEPTOR CD88; INTESTINAL INFLAMMATION; IFN-GAMMA; DIFFERENTIATION; ACTIVATION; C5L2; CYTOKINE; DISEASE; ANTAGONISTS		[Arbore, Giuseppina; Afzali, Behdad; Kemper, Claudia] Kings Coll London, Div Transplant Immunol & Mucosal Biol, MRC Ctr Transplantat, London SE1 9RT, England; [West, Erin E.; Spolski, Rosanne; Leonard, Warren J.; Kemper, Claudia] NHLBI, Lab Mol Immunol, Bldg 10, Bethesda, MD 20892 USA; [Robertson, Avril A. B.; Woodruff, Trent M.; Coll, Rebecca C.; Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Klos, Andreas; Rheinheimer, Claudia; Dutow, Pavel] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, D-30625 Hannover, Germany; [Yu, Zu Xi] NHLBI, Pathol Core, Bldg 10, Bethesda, MD 20892 USA; [O'Neill, Luke A.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Sher, Alan] NIAID, Parasit Dis Lab, Bethesda, MD 20892 USA; [Koehl, Jorg] Med Univ Lubeck, Inst Syst Inflammat Res, D-23538 Lubeck, Germany; [Koehl, Jorg] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Koehl, Jorg] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Monk, Pete] Univ Sheffield, Dept Infect & Immun, Sheffield S10 2RX, S Yorkshire, England; [Arno, Matthew] Kings Coll London, Fac Life Sci & Med, Genom Ctr, London SE1 9NH, England; [Afzali, Behdad] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; [Lachmann, Helen J.] UCL, Div Med, UK Natl Amyloidosis Ctr, Royal Free Campus, London NW3 2PF, England; [Cope, Andrew P.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, Acad Dept Rheumatol, London SE1 1UL, England; [Mayer-Barber, Katrin D.] NIAID, Lab Clin Infect Dis, Inflammat & Innate Immun Unit, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Queensland; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Trinity College Dublin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Lubeck; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Sheffield; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of London; University College London; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kemper, C (corresponding author), Kings Coll London, Div Transplant Immunol & Mucosal Biol, MRC Ctr Transplantat, London SE1 9RT, England.; Kemper, C (corresponding author), NHLBI, Lab Mol Immunol, Bldg 10, Bethesda, MD 20892 USA.	claudia.kemper@kcl.ac.uk	Arbore, Giuseppina/AAN-1899-2020; Coll, Rebecca/J-2124-2014; Leonard, Warren/AAA-1397-2022; Cooper, Matthew A./C-7988-2009; Woodruff, Trent/AAS-4629-2020; Robertson, Avril/A-4043-2012; Koehl, Joerg/C-8531-2011; Afzali, Behdad/H-8565-2013; Woodruff, Trent M/B-4861-2009; Monk, Peter/C-6155-2008	Arbore, Giuseppina/0000-0002-8318-7557; Coll, Rebecca/0000-0002-7359-6023; Cooper, Matthew A./0000-0003-3147-3460; Woodruff, Trent/0000-0003-1382-911X; Robertson, Avril/0000-0002-9652-8357; Koehl, Joerg/0000-0003-1121-3178; Afzali, Behdad/0000-0003-2968-1156; Woodruff, Trent M/0000-0003-1382-911X; Monk, Peter/0000-0003-4637-3059; Kemper, Claudia/0000-0003-4196-1417; Cope, Andrew/0000-0001-6735-5496; Lachmann, Helen/0000-0001-8378-2498; O'Neill, Luke/0000-0002-4333-2748	British Heart Foundation [PG/09/018/25279] Funding Source: Medline; Intramural NIH HHS [ZIA AI001207-01, Z99 AI999999] Funding Source: Medline; Medical Research Council [MR/J006742/1] Funding Source: Medline; Wellcome Trust [109443/Z/15/Z] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005409, ZIGHL006020, ZICHL005904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001207, ZIAAI001044] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bauer C, 2012, DIGEST DIS, V30, P82, DOI 10.1159/000341681; Ben-Sasson SZ, 2013, J EXP MED, V210, P491, DOI 10.1084/jem.20122006; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bock D, 1997, EUR J IMMUNOL, V27, P1522, DOI 10.1002/eji.1830270631; Bruchard M, 2015, NAT IMMUNOL, V16, P859, DOI 10.1038/ni.3202; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Carta S, 2015, P NATL ACAD SCI USA, V112, P2835, DOI 10.1073/pnas.1424741112; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Croker DE, 2013, IMMUNOL CELL BIOL, V91, P625, DOI 10.1038/icb.2013.48; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; Dunkelberger J, 2012, J IMMUNOL, V188, P4032, DOI 10.4049/jimmunol.1103141; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Ghannam A, 2008, J IMMUNOL, V181, P5158, DOI 10.4049/jimmunol.181.7.5158; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; Kastbom A, 2008, RHEUMATOLOGY, V47, P415, DOI 10.1093/rheumatology/kem372; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Le Friec G, 2012, NAT IMMUNOL, V13, P1213, DOI 10.1038/ni.2454; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Monkl PN, 2012, IMMUNOBIOLOGY, V217, P1162, DOI 10.1016/j.imbio.2012.08.097; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Otto M, 2004, J BIOL CHEM, V279, P142, DOI 10.1074/jbc.M310078200; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Samstad EO, 2014, J IMMUNOL, V192, P2837, DOI 10.4049/jimmunol.1302484; Sarma JV, 2012, CELL HEALTH CYTOSKEL, V4, P73, DOI 10.2147/CHC.S27233; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Valatas V, 2013, MUCOSAL IMMUNOL, V6, P601, DOI 10.1038/mi.2012.102; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com; Yamamoto H, 2013, INT J BIOCHEM CELL B, V45, P2808, DOI 10.1016/j.biocel.2013.09.016; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	59	274	277	5	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292							aad1210	10.1126/science.aad1210	http://dx.doi.org/10.1126/science.aad1210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313051	Green Submitted, Green Accepted			2022-12-28	WOS:000377975400040
J	Huybers, P; Langmuir, C; Katz, RF; Ferguson, D; Proistosescu, C; Carbotte, S				Huybers, Peter; Langmuir, Charles; Katz, Richard F.; Ferguson, David; Proistosescu, Cristian; Carbotte, Suzanne			Comment on "Sensitivity of seafloor bathymetry to climate-driven fluctuations in mid-ocean ridge magma supply"	SCIENCE			English	Editorial Material							GALAPAGOS-SPREADING-CENTER; MID-ATLANTIC-RIDGE; DE-FUCA RIDGE; CRUSTAL THICKNESS; OCEANIC-CRUST; MORPHOLOGY	Olive et al. (Reports, 16 October 2015, p. 310) argue that similar to 10% fluctuations in melt supply do not produce appreciable changes in ocean ridge bathymetry on time scales less than 100,000 years and thus cannot reflect sea level forcing. Spectral analysis of bathymetry in a region they highlight as being fault controlled, however, shows strong evidence for a signal from sea level variation.	[Huybers, Peter; Langmuir, Charles; Ferguson, David; Proistosescu, Cristian] Harvard Univ, Cambridge, MA 02138 USA; [Carbotte, Suzanne] Lamont Doherty Earth Observ, Palisades, NY USA; [Katz, Richard F.] Univ Oxford, Oxford, England	Harvard University; Columbia University; University of Oxford	Huybers, P (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	phuybers@fas.harvard.edu	; Katz, Richard/D-3364-2009	Proistosescu, Cristian/0000-0002-1717-124X; Huybers, Peter/0000-0002-3734-8145; Katz, Richard/0000-0001-8746-5430; Ferguson, David/0000-0003-0612-6512	Directorate For Geosciences [1338832] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Canales JP, 2002, EARTH PLANET SC LETT, V203, P311, DOI 10.1016/S0012-821X(02)00843-9; Carbotte SM, 2006, GEOLOGY, V34, P209, DOI 10.1130/G21969.1; Clague DA, 2014, GEOCHEM GEOPHY GEOSY, V15, P3364, DOI 10.1002/2014GC005415; Crowley JW, 2015, SCIENCE, V347, P1237, DOI 10.1126/science.1261508; DETRICK RS, 1995, J GEOPHYS RES-SOL EA, V100, P3767, DOI 10.1029/94JB02649; GOFF JA, 1991, J GEOPHYS RES-SOL EA, V96, P21713, DOI 10.1029/91JB02275; Goff JA, 2015, SCIENCE, V349, DOI 10.1126/science.aab2350; Holmes RC, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002152; Huybers P, 2009, EARTH PLANET SC LETT, V286, P479, DOI 10.1016/j.epsl.2009.07.014; Olive JA, 2015, SCIENCE, V350, P310, DOI 10.1126/science.aad0715; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Perfit MR, 1998, GEOPH MONOG SERIES, V106, P59; Searle RC, 2010, EARTH PLANET SC LETT, V299, P228, DOI 10.1016/j.epsl.2010.09.003; Sempere JC, 1997, J GEOPHYS RES-SOL EA, V102, P15489, DOI 10.1029/97JB00171; Siddall M, 2010, QUATERNARY SCI REV, V29, P170, DOI 10.1016/j.quascirev.2009.05.011; Sinton J, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000609; SINTON JM, 1992, J GEOPHYS RES-SOL EA, V97, P197, DOI 10.1029/91JB02508	17	10	10	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292								10.1126/science.aae0451	http://dx.doi.org/10.1126/science.aae0451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313034	Green Submitted			2022-12-28	WOS:000377975400034
J	Raaijmakers, JM; Mazzola, M				Raaijmakers, Jos M.; Mazzola, Mark			Soil immune responses Soil microbiomes may be harnessed for plant health	SCIENCE			English	Editorial Material							RHIZOSPHERE MICROBIOME; FUSARIUM-WILT; SUPPRESSION; POPULATIONS		[Raaijmakers, Jos M.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Ecol, Wageningen, Netherlands; [Raaijmakers, Jos M.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Mazzola, Mark] USDA ARS, Wenatchee, WA USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Leiden University; Leiden University - Excl LUMC; United States Department of Agriculture (USDA)	Raaijmakers, JM (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Inst Ecol, Wageningen, Netherlands.; Raaijmakers, JM (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	j.raaijmakers@nioo.knaw.nl	Mazzola, Mark/AAW-1929-2021; Raaijmakers, Jos M/D-1574-2014; KNAW, NIOO-KNAW/A-4320-2012	Raaijmakers, Jos M/0000-0003-1608-6614; KNAW, NIOO-KNAW/0000-0002-3835-159X				Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; Cha JY, 2016, ISME J, V10, P119, DOI 10.1038/ismej.2015.95; Chapelle E, 2016, ISME J, V10, P265, DOI 10.1038/ismej.2015.82; HENRY A. W., 1931, CANADIAN JOUR RES, V4, P69; Kinkel LL, 2012, RES MICROBIOL, V163, P490, DOI 10.1016/j.resmic.2012.07.005; Larkin RP, 1996, PHYTOPATHOLOGY, V86, P812, DOI 10.1094/Phyto-86-812; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; LEMANCEAU P, 1993, BIOCONTROL SCI TECHN, V3, P219, DOI 10.1080/09583159309355278; Mazzola M, 2004, MICROB ECOL, V48, P338, DOI 10.1007/s00248-003-1067-y; Mazzola M, 2015, PHYTOPATHOLOGY, V105, P460, DOI 10.1094/PHYTO-09-14-0247-R; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Mueller UG, 2015, TRENDS MICROBIOL, V23, P606, DOI 10.1016/j.tim.2015.07.009; Olatinwo R, 2006, PHYTOPATHOLOGY, V96, P111, DOI 10.1094/PHYTO-96-0111; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010	14	191	211	15	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1392	1393		10.1126/science.aaf3252	http://dx.doi.org/10.1126/science.aaf3252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313024				2022-12-28	WOS:000377975400021
J	Hofer, K; Jaschke, A				Hoefer, Katharina; Jaeschke, Andres			MOLECULAR BIOLOGY A surprise beginning for RNA	NATURE			English	Editorial Material							LINKED RNA; COA; CAP		[Hoefer, Katharina; Jaeschke, Andres] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Jaschke, A (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany.	jaeschke@uni-hd.de	Jäschke, Andres/F-1575-2010	Jäschke, Andres/0000-0002-4625-2655; Hofer, Katharina/0000-0002-7472-9887				Bird JG, 2016, NATURE, V535, P444, DOI 10.1038/nature18622; Jaschke A, 2016, CURR OPIN MICROBIOL, V30, P44, DOI 10.1016/j.mib.2015.12.009; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Martinez-Rucobo FW, 2015, MOL CELL, V58, P1079, DOI 10.1016/j.molcel.2015.04.004; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52	8	6	6	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					359	360		10.1038/nature18908	http://dx.doi.org/10.1038/nature18908			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27383782				2022-12-28	WOS:000380344200025
J	Lyman, GH; Moses, HL				Lyman, Gary H.; Moses, Harold L.			Biomarker Tests for Molecularly Targeted Therapies - The Key to Unlocking Precision Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIANS		[Lyman, Gary H.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Lyman, Gary H.] Univ Washington, Seattle, WA 98195 USA; [Lyman, Gary H.; Moses, Harold L.] Natl Acad Sci Engn & Med, Comm Policy Issues Clin Dev & Use Biomarkers Mole, Washington, DC 20418 USA; [Moses, Harold L.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; National Academies of Sciences, Engineering & Medicine; Vanderbilt University	Lyman, GH (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.; Lyman, GH (corresponding author), Univ Washington, Seattle, WA 98195 USA.; Lyman, GH (corresponding author), Natl Acad Sci Engn & Med, Comm Policy Issues Clin Dev & Use Biomarkers Mole, Washington, DC 20418 USA.		Lyman, Gary H/K-5227-2019	Lyman, Gary H/0000-0002-0823-8086				Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Gray SW, 2014, J CLIN ONCOL, V32, P1317, DOI 10.1200/JCO.2013.52.4298; Hayes DF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005950; Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104; Vassy JL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2401	5	60	61	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2016	375	1					4	6		10.1056/NEJMp1604033	http://dx.doi.org/10.1056/NEJMp1604033			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL8VA	27353537				2022-12-28	WOS:000394897200002
J	Kronzer, VL				Kronzer, Vanessa L.			Screening for health literacy is not the answer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SHAME		[Kronzer, Vanessa L.] Washington Univ, Sch Med, 660 South Euclid Ave,Campus Box 8054, St Louis, MO 63110 USA	Washington University (WUSTL)	Kronzer, VL (corresponding author), Washington Univ, Sch Med, 660 South Euclid Ave,Campus Box 8054, St Louis, MO 63110 USA.	vkronzer@wustl.edu	Kronzer, Vanessa/Y-4687-2019	Kronzer, Vanessa/0000-0002-7489-3134				Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Brown Daniel R, 2004, J Allied Health, V33, P150; Cawthon C, 2014, JT COMM J QUAL PATIE, V40, P68, DOI 10.1016/S1553-7250(14)40008-4; Centers for Disease Control and Prevention, 2009, SIMPL PUT GUID CREAT; DeWalt D, 2010, HLTH LITERACY UNIVER; Ilona Kickbusch I., 2013, HLTH LITERACY SOLID; Miller MJ, 2008, J AM PHARM ASSOC, V48, P784, DOI 10.1331/JAPhA.2008.07073; National Center for Education Statistics, 2006, HLTH LITERACY AM ADU; *OECD, 2013, OECD SKILLS OUTL 201; Parikh NS, 1996, PATIENT EDUC COUNS, V27, P33, DOI 10.1016/0738-3991(95)00787-3; Pelikan JM, 2012, COMP REPORT HLTH LIT; Weiss B, 2007, HLTH LITERACY PATIEN; Wolf MS, 2007, J HEALTH COMMUN, V12, P721, DOI 10.1080/10810730701672173	13	5	5	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2016	354								i3699	10.1136/bmj.i3699	http://dx.doi.org/10.1136/bmj.i3699			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EG	27381740				2022-12-28	WOS:000379580200007
J	Banik, SM; Medley, JW; Jacobsen, EN				Banik, Steven M.; Medley, Jonathan William; Jacobsen, Eric N.			Catalytic, asymmetric difluorination of alkenes to generate difluoromethylated stereocenters	SCIENCE			English	Article							MEDICINAL CHEMISTRY; NUCLEOPHILIC DIFLUOROMETHYLATION; ORGANIC-COMPOUNDS; AMINO-ACIDS; FLUORINE; REAGENTS; TRIFLUOROMETHYLATION; REARRANGEMENT; DIFLUORIDES; OLEFINS	Difluoromethyl groups possess specific steric and electronic properties that invite their use as chemically inert surrogates of alcohols, thiols, and other polar functional groups important in a wide assortment of molecular recognition processes. We report here a method for the catalytic, asymmetric, migratory geminal difluorination of beta-substituted styrenes to access a variety of products bearing difluoromethylated tertiary or quaternary stereocenters. The reaction uses commercially available reagents (m-chloroperbenzoic acid and hydrogen fluoride pyridine) and a simple chiral aryl iodide catalyst and is carried out readily on a gram scale. Substituent effects and temperature-dependent variations in enantioselectivity suggest that cation-p interactions play an important role in stereodifferentiation by the catalyst.	[Banik, Steven M.; Medley, Jonathan William; Jacobsen, Eric N.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Jacobsen, EN (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	jacobsen@chemistry.harvard.edu			NIH [GM043214]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043214, R37GM043214] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Complete experimental and characterization data are provided in the supplementary materials. This work was supported by NIH (GM043214), by an NSF predoctoral fellowship to S.M.B., and by an NIH postdoctoral fellowship to J.W.M. We thank S.-L. Zheng (Harvard) for determination of the x-ray crystal structures of 3h and 10. Metrical parameters are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-1480097 and CCDC-1480098.	Aikawa K, 2015, ORG LETT, V17, P5108, DOI 10.1021/acs.orglett.5b02617; Banik SM, 2016, J AM CHEM SOC, V138, P5000, DOI 10.1021/jacs.6b02391; CARPENTER W, 1966, J ORG CHEM, V31, P2688, DOI 10.1021/jo01346a512; DMOWSKI W, 1986, J FLUORINE CHEM, V32, P255; DREW MGB, 1985, J CHEM SOC CHEM COMM, P1191, DOI 10.1039/c39850001191; ERICKSON JA, 1995, J ORG CHEM, V60, P1626, DOI 10.1021/jo00111a021; Farid U, 2013, ANGEW CHEM INT EDIT, V52, P7018, DOI 10.1002/anie.201302358; Gillis EP, 2015, J MED CHEM, V58, P8315, DOI 10.1021/acs.jmedchem.5b00258; Grassi D, 2012, CHEM COMMUN, V48, P11404, DOI 10.1039/c2cc36513h; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Hara S, 1998, TETRAHEDRON LETT, V39, P2589, DOI 10.1016/S0040-4039(98)00276-7; Hu JB, 2009, CHEM COMMUN, P7465, DOI 10.1039/b916463d; Hudlicky M., 1988, ORG REACTIONS, V35, P513, DOI DOI 10.1002/0471264180.0R035.03; Hugenberg V, 2012, J FLUORINE CHEM, V143, P238, DOI 10.1016/j.jfluchem.2012.06.015; Ilchenko NO, 2014, ANGEW CHEM INT EDIT, V53, P12897, DOI 10.1002/anie.201408812; KITA Y, 1994, J AM CHEM SOC, V116, P3684, DOI 10.1021/ja00088a003; Kitamura T, 2015, J ORG CHEM, V80, P10431, DOI 10.1021/acs.joc.5b01929; Knowles RR, 2010, P NATL ACAD SCI USA, V107, P20678, DOI 10.1073/pnas.1006402107; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Liu YL, 2011, ORG LETT, V13, P3826, DOI 10.1021/ol201316z; Mann J., 1987, J CHEM SOC P1, V1987, P385; Romero RM, 2014, CHEM-ASIAN J, V9, P972, DOI 10.1002/asia.201301637; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; MIDDLETON WJ, 1975, J ORG CHEM, V40, P574, DOI 10.1021/jo00893a007; Molnar IG, 2016, J AM CHEM SOC, V138, P5004, DOI 10.1021/jacs.6b01183; Ni CF, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.21; PATRICK TB, 1980, J ORG CHEM, V45, P4492, DOI 10.1021/jo01310a043; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Rozen S, 2005, ACCOUNTS CHEM RES, V38, P803, DOI 10.1021/ar040270c; SABOL JS, 1994, TETRAHEDRON LETT, V35, P1821, DOI 10.1016/S0040-4039(00)73169-8; Shibata N, 2008, TETRAHEDRON-ASYMMETR, V19, P2633, DOI 10.1016/j.tetasy.2008.11.011; Singh RP, 2002, SYNTHESIS-STUTTGART, P2561; Smits R, 2008, CHEM SOC REV, V37, P1727, DOI 10.1039/b800310f; Truong AP, 2010, BIOORG MED CHEM LETT, V20, P6231, DOI 10.1016/j.bmcl.2010.08.102; Uyanik M, 2013, ANGEW CHEM INT EDIT, V52, P9215, DOI 10.1002/anie.201303559; Uyanik M, 2010, ANGEW CHEM INT EDIT, V49, P2175, DOI 10.1002/anie.200907352; Uyeda C, 2011, J AM CHEM SOC, V133, P5062, DOI 10.1021/ja110842s; Wang J, 2014, CHEM REV, V114, P2432, DOI 10.1021/cr4002879; Yang XY, 2015, CHEM REV, V115, P826, DOI 10.1021/cr500277b; Yoshimura A, 2016, CHEM REV, V116, P3328, DOI 10.1021/acs.chemrev.5b00547; Zhao YC, 2011, ORG LETT, V13, P5342, DOI 10.1021/ol202208b; ZUPAN M, 1975, J CHEM SOC CHEM COMM, P715, DOI 10.1039/c39750000715	42	194	196	9	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					51	54		10.1126/science.aaf8078	http://dx.doi.org/10.1126/science.aaf8078			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365443	Green Accepted			2022-12-28	WOS:000378816200032
J	Petry, WK; Soule, JD; Iler, AM; Chicas-Mosier, A; Inouye, DW; Miller, TEX; Mooney, KA				Petry, William K.; Soule, Judith D.; Iler, Amy M.; Chicas-Mosier, Ana; Inouye, David W.; Miller, Tom E. X.; Mooney, Kailen A.			Sex-specific responses to climate change in plants alter population sex ratio and performance	SCIENCE			English	Article							POLLEN LIMITATION; EVOLUTION; DIMORPHISM; CONSEQUENCES; INVASIONS	Males and females are ecologically distinct in many species, but whether responses to climate change are sex-specific is unknown. We document sex-specific responses to climate change in the plant Valeriana edulis (valerian) over four decades and across its 1800-meter elevation range. Increased elevation was associated with increased water availability and female frequency, likely owing to sex-specific water use efficiency and survival. Recent aridification caused male frequency to move upslope at 175 meters per decade, a rate of trait shift outpacing reported species' range shifts by an order of magnitude. This increase in male frequency reduced pollen limitation and increased seedset. Coupled with previous studies reporting sex-specific arthropod communities, these results underscore the importance of ecological differences between the sexes in mediating biological responses to climate change.	[Petry, William K.; Mooney, Kailen A.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Petry, William K.; Soule, Judith D.; Iler, Amy M.; Chicas-Mosier, Ana; Inouye, David W.; Mooney, Kailen A.] Rocky Mt Biol Labs, Crested Butte, CO 81224 USA; [Iler, Amy M.] Aarhus Univ, Aarhus Inst Adv Studies, Hoegh Guldbergs Gade 6B, DK-8000 Aarhus C, Denmark; [Chicas-Mosier, Ana] Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA; [Inouye, David W.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Miller, Tom E. X.] Rice Univ, Dept BioSci, Program Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Petry, William K.] ETH, Swiss Fed Inst Technol, Inst Integrat Biol, Univ Str 16, Zurich, Switzerland	University of California System; University of California Irvine; Aarhus University; Oklahoma State University System; Oklahoma State University - Stillwater; University System of Maryland; University of Maryland College Park; Rice University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Petry, WK (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.; Petry, WK (corresponding author), Rocky Mt Biol Labs, Crested Butte, CO 81224 USA.; Petry, WK (corresponding author), ETH, Swiss Fed Inst Technol, Inst Integrat Biol, Univ Str 16, Zurich, Switzerland.	william.petry@usys.ethz.ch	Inouye, David W./C-2997-2011; Iler, Amy Marie/Y-7201-2019	Inouye, David W./0000-0003-2076-7834; Iler, Amy Marie/0000-0002-3354-7593; Petry, William/0000-0002-5230-5987	Direct For Biological Sciences [1457029, 1354104, 1407318] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Calabrese JM, 2008, J ANIM ECOL, V77, P746, DOI 10.1111/j.1365-2656.2008.01385.x; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Dawson T.E., 1999, CONFORMAL INVARIANCE, P175, DOI [DOI 10.1007/978-3-662-03937-3, 10.1007/978-3-662-03937-3]; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Geber MA, 1999, GENDER SEXUAL DIMORP; Hultine KR, 2007, OECOLOGIA, V154, P85, DOI 10.1007/s00442-007-0813-0; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Maurer E. P., 2007, EOS T AM GEOPHYS UN, V88, P504, DOI DOI 10.1029/2007EO470006; MEURMAN O, 1925, SOC SCI FENN COMM BI, V0002, P00001; Miller TEX, 2013, ECOL LETT, V16, P354, DOI 10.1111/ele.12049; Miller TEX, 2011, AM NAT, V177, P549, DOI 10.1086/659628; Mooney KA, 2012, ARTHROPOD-PLANT INTE, V6, P553, DOI 10.1007/s11829-012-9204-5; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Petry WK, 2013, ECOLOGY, V94, P2055, DOI 10.1890/12-2170.1; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Shelton AO, 2008, ECOLOGY, V89, P3020, DOI 10.1890/07-1835.1; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Soule J. D., 1981, THESIS; Thompson J, 2013, P NATL ACAD SCI USA, V110, P2893, DOI 10.1073/pnas.1215833110	25	54	55	8	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					69	71		10.1126/science.aaf2588	http://dx.doi.org/10.1126/science.aaf2588			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365446				2022-12-28	WOS:000378816200037
J	Mertens, SFL; Hemmi, A; Muff, S; Groning, O; De Feyter, S; Osterwalder, J; Greber, T				Mertens, Stijn F. L.; Hemmi, Adrian; Muff, Stefan; Groning, Oliver; De Feyter, Steven; Osterwalder, Jurg; Greber, Thomas			Switching stiction and adhesion of a liquid on a solid	NATURE			English	Article							HEXAGONAL BORON-NITRIDE; UNDERPOTENTIAL DEPOSITION; CONTACT-ANGLE; HYDROGEN; RHODIUM; ADSORPTION; DEPENDENCE; NANOMESH; KINETICS; PROTON	When a gecko moves on a ceiling it makes use of adhesion and stiction. Stiction-static friction-is experienced on microscopic and macroscopic scales and is related to adhesion and sliding friction(1). Although important for most locomotive processes, the concepts of adhesion, stiction and sliding friction are often only empirically correlated. A more detailed understanding of these concepts will, for example, help to improve the design of increasingly smaller devices such as micro-and nanoelectromechanical switches(2). Here we show how stiction and adhesion are related for a liquid drop on a hexagonal boron nitride monolayer on rhodium(3), by measuring dynamic contact angles in two distinct states of the solid-liquid interface: a corrugated state in the absence of hydrogen intercalation and an intercalation-induced flat state. Stiction and adhesion can be reversibly switched by applying different electrochemical potentials to the sample, causing atomic hydrogen to be intercalated or not. We ascribe the change in adhesion to a change in lateral electric field of in-plane two-nanometre dipole rings(4), because it cannot be explained by the change in surface roughness known from the Wenzel model(5). Although the change in adhesion can be calculated for the system we study(6), it is not yet possible to determine the stiction at such a solid-liquid interface using ab initio methods. The inorganic hybrid of hexagonal boron nitride and rhodium is very stable and represents a new class of switchable surfaces with the potential for application in the study of adhesion, friction and lubrication.	[Mertens, Stijn F. L.; De Feyter, Steven] Katholieke Univ Leuven, Dept Chem, Celestijnenlaan 200F, B-3001 Leuven, Belgium; [Mertens, Stijn F. L.] Vienna Univ Technol, Inst Angew Phys, Wiedner Hauptstr 8-10-E134, A-1040 Vienna, Austria; [Hemmi, Adrian; Muff, Stefan; Osterwalder, Jurg; Greber, Thomas] Univ Zurich, Phys Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Groning, Oliver] Empa, Swiss Fed Labs Mat Sci & Technol, Uberlandstr 129, CH-8600 Dubendorf, Switzerland	KU Leuven; Technische Universitat Wien; University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Mertens, SFL (corresponding author), Katholieke Univ Leuven, Dept Chem, Celestijnenlaan 200F, B-3001 Leuven, Belgium.; Mertens, SFL (corresponding author), Vienna Univ Technol, Inst Angew Phys, Wiedner Hauptstr 8-10-E134, A-1040 Vienna, Austria.; Greber, T (corresponding author), Univ Zurich, Phys Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	stmerten@gmail.com; greber@physik.uzh.ch	Greber, Thomas/D-9509-2015; Gröning, Oliver/J-9727-2012; De Feyter, Steven/K-7245-2014; Mertens, Stijn/B-1266-2012; Muff, Stefan/T-9202-2017	Greber, Thomas/0000-0002-5234-1937; De Feyter, Steven/0000-0002-0909-9292; Mertens, Stijn/0000-0002-5715-0486; 	Swiss National Science Foundation; FP7 Marie Curie European reintegration grant, ERC grant OxideSurfaces; FWO-Vlaanderen	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); FP7 Marie Curie European reintegration grant, ERC grant OxideSurfaces; FWO-Vlaanderen(FWO)	We acknowledge financial support by the Swiss National Science Foundation within the funding instrument 'Sinergia'. S.F.L.M. acknowledges the receipt of an FP7 Marie Curie European reintegration grant, ERC grant OxideSurfaces and, together with S.D.F., support by FWO-Vlaanderen. We thank M. Schmid for help with the depiction of the STM images, G. Schutz for discussions and A. P Seitsonen for the artwork in Fig. 1g.	Amirfazli A, 2000, LANGMUIR, V16, P2024, DOI 10.1021/la990609h; Berner S, 2007, ANGEW CHEM INT EDIT, V46, P5115, DOI 10.1002/anie.200700234; Brugger T, 2010, ANGEW CHEM INT EDIT, V49, P6120, DOI 10.1002/anie.201001064; Colonell JI, 1996, SURF SCI, V366, P19, DOI 10.1016/0039-6028(96)00807-2; Corso M, 2004, SCIENCE, V303, P217, DOI 10.1126/science.1091979; Cun H, 2014, ACS NANO, V8, P7423, DOI 10.1021/nn502645w; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; Dil H, 2008, SCIENCE, V319, P1824, DOI 10.1126/science.1154179; Ding Y, 2011, J PHYS CHEM C, V115, P13685, DOI 10.1021/jp110235y; EHRLICH G, 1966, J CHEM PHYS, V44, P1039, DOI 10.1063/1.1726787; Evans MG, 1938, T FARADAY SOC, V34, P0011, DOI 10.1039/tf9383400011; Golze D, 2015, PHYS CHEM CHEM PHYS, V17, P14307, DOI 10.1039/c4cp04638b; HANSEN WN, 1979, J ELECTROANAL CHEM, V100, P493, DOI 10.1016/0368-1874(79)85131-X; Hemmi A, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4866648; HOLZSCHUH E, 1992, PHYS LETT B, V287, P381, DOI 10.1016/0370-2693(92)91000-Y; Hu S, 2014, NATURE, V516, P227, DOI 10.1038/nature14015; Iannuzzi M, 2014, PHYS CHEM CHEM PHYS, V16, P12374, DOI 10.1039/c4cp01466a; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; Jerkiewicz G, 1996, J PHYS CHEM-US, V100, P8454, DOI 10.1021/jp960130n; King SW, 2015, SURF INTERFACE ANAL, V47, P798, DOI 10.1002/sia.5781; Koper MTM, 2011, ELECTROCHIM ACTA, V56, P10645, DOI 10.1016/j.electacta.2011.02.001; KRIM J, 1991, PHYS REV LETT, V66, P181, DOI 10.1103/PhysRevLett.66.181; Kwok DY, 1999, ADV COLLOID INTERFAC, V81, P167, DOI 10.1016/S0001-8686(98)00087-6; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Losiewicz B, 2011, ELECTROCHIM ACTA, V56, P5746, DOI 10.1016/j.electacta.2011.04.048; Ma HF, 2012, LANGMUIR, V28, P15246, DOI 10.1021/la302561r; Manukyan G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.014501; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Persson B. N. J., 1998, NANOSCI TECHNOL; Schneemilch M, 2000, LANGMUIR, V16, P2924, DOI 10.1021/1a990524g; SCHRADER ME, 1995, LANGMUIR, V11, P3585, DOI 10.1021/la00009a049; Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565; SUNG YE, 1995, J PHYS CHEM-US, V99, P13513, DOI 10.1021/j100036a031; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288; Wagner TJW, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/27/275501; WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015; Widmer R, 2007, ELECTROCHEM COMMUN, V9, P2484, DOI 10.1016/j.elecom.2007.07.019; WILLMAN KW, 1983, ANAL CHEM, V55, P1139, DOI 10.1021/ac00258a036; Zhang Q, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.144114; Zolfaghari A, 1997, J ELECTROCHEM SOC, V144, P3034, DOI 10.1149/1.1837955	40	56	57	5	276	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					676	+		10.1038/nature18275	http://dx.doi.org/10.1038/nature18275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357755	Green Accepted			2022-12-28	WOS:000378676000034
J	Yozwiak, NL; Happi, CT; Grant, DS; Schieffelin, JS; Garry, RF; Sabeti, PC; Andersen, KG				Yozwiak, Nathan L.; Happi, Christian T.; Grant, Donald S.; Schieffelin, John S.; Garry, Robert F.; Sabeti, Pardis C.; Andersen, Kristian G.			Roots, Not Parachutes: Research Collaborations Combat Outbreaks	CELL			English	Editorial Material							SIERRA-LEONE; EBOLA; TRANSMISSION	Recent infectious disease epidemics illustrate how health systems failures anywhere can create disease vulnerabilities everywhere. We must therefore prioritize investments in health care infrastructure in outbreak-prone regions of the world. We describe how "rooted" research collaborations can establish capacity for pathogen surveillance and facilitate rapid outbreak responses.	[Yozwiak, Nathan L.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Yozwiak, Nathan L.; Sabeti, Pardis C.; Andersen, Kristian G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Happi, Christian T.] Redeemers Univ, Dept Biol Sci, Ede, Osun State, Nigeria; [Happi, Christian T.] Redeemers Univ, African Ctr Excellence Genom Infect Dis, Ede, Osun State, Nigeria; [Grant, Donald S.] Kenema Govt Hosp, Kenema, Sierra Leone; [Schieffelin, John S.; Garry, Robert F.] Tulane Univ, Med Ctr, New Orleans, LA 70112 USA; [Sabeti, Pardis C.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Redeemers University; Redeemers University; Kenema Government Hospital; Tulane University; Howard Hughes Medical Institute; Scripps Research Institute; Scripps Research Institute	Yozwiak, NL (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Yozwiak, NL; Andersen, KG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.	nyozwiak@broadinstitute.org; kristian@andersen-lab.com	Sabeti, Pardis/GQH-8610-2022	Happi, Christian/0000-0002-3056-6705; Garry, Robert/0000-0002-5683-3250	NCATS NIH HHS [UL1 TR001114] Funding Source: Medline; NHGRI NIH HHS [U01 HG007480] Funding Source: Medline; NIAID NIH HHS [U19 AI110818, HHSN272201400048C, R01 AI114855, U19 AI115589, R01 AI104621, U19 AI109762] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI115589, R01AI114855, U19AI110818, R01AI104621, U19AI109762] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ariasa A., 2016, VIRUS EVOLUTION; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Blackley DJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600378; Currie J, 2016, SCIENCE, V351, P815, DOI 10.1126/science.aad8521; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Heymann DL, 2016, NEW ENGL J MED, V374, P1504, DOI 10.1056/NEJMp1602278; Marsh K, 2016, AFRICA CAN CLOSE ITS; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; UNESCO, 2015, GLOBAL CITIZENSHIP E	10	35	35	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					5	8		10.1016/j.cell.2016.06.029	http://dx.doi.org/10.1016/j.cell.2016.06.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368093	Green Accepted, Bronze			2022-12-28	WOS:000380254400003
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: The forgotten problem of incontinence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							URINARY-TRACT SYMPTOMS					davidoliver372@googlemail.com						[Anonymous], 2007, HELP AGED INCONTINEN; Department of Health, 2014, HARD TRUTHS JOURN PU; Owen C., 1989, Thatcheria, V24, P1; Hyde N., 2016, GET READING; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Lievesley N, 2011, CHANGING ROLE CARE H; Manchester City Council, SUMM MANCH GREAT PLA; National Institute for Health and Care Excellence, 2016, URINARY INCONTINENCE; NHS England, 2015, EXC CONT CAR PRACT G; Perry S, 2000, J PUBLIC HEALTH MED, V22, P427, DOI 10.1093/pubmed/22.3.427; Rees J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3861; Royal College of Physicians, 2015, NAT AUD CONT CAR NAC; Steel N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a957; West Berkshire Council, 2016, BUDG PROP 2016 17 PH; Wood LN, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4531	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2016	353								i3557	10.1136/bmj.i3557	http://dx.doi.org/10.1136/bmj.i3557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FV	27358208	Green Published, Bronze			2022-12-28	WOS:000379018700002
J	MacDonell-Yilmaz, RE				MacDonell-Yilmaz, Rebecca E.			The Hunger Games	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DURATION		[MacDonell-Yilmaz, Rebecca E.] Brown Univ, Hasbro Childrens Hosp, Providence, RI 02912 USA	Brown University; Hasbro Children's Hospital	MacDonell-Yilmaz, RE (corresponding author), Brown Univ, Hasbro Childrens Hosp, Providence, RI 02912 USA.	rmacdonellyilmaz@gmail.com						Eidelman AI, 2012, PEDIATRICS, V129, pE827, DOI 10.1542/peds.2011-3552; Flaherman VJ, 2013, PEDIATRICS, V131, P1059, DOI 10.1542/peds.2012-2809; Lebel C, 2016, BIOL PSYCHIAT, V80, P859, DOI 10.1016/j.biopsych.2015.12.004; O'Brien M, 2009, J HUM LACT, V25, P55, DOI 10.1177/0890334408326071	4	0	0	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2667	2668		10.1001/jama.2016.2060	http://dx.doi.org/10.1001/jama.2016.2060			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27367875				2022-12-28	WOS:000378709300015
J	Zohar, E				Zohar, Erez			PARTICLE PHYSICS Quantum simulation of fundamental physics	NATURE			English	Editorial Material							LATTICE GAUGE-THEORIES	Gauge theories underpin the standard model of particle physics, but are difficult to study using conventional computational methods. An experimental quantum system opens up fresh avenues of investigation. SEE LETTER p. 516	[Zohar, Erez] Max Planck Inst Quantum Opt, Div Theory, D-85748 Garching, Germany	Max Planck Society	Zohar, E (corresponding author), Max Planck Inst Quantum Opt, Div Theory, D-85748 Garching, Germany.	erez.zohar@mpq.mpg.de	Zohar, Erez/Q-1858-2019	Zohar, Erez/0000-0001-6993-6569				[Anonymous], 2012, NATURE PHYS; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Tagliacozzo L, 2013, ANN PHYS-NEW YORK, V330, P160, DOI 10.1016/j.aop.2012.11.009; WILSON KG, 1974, PHYS REV D, V10, P2445, DOI 10.1103/PhysRevD.10.2445	7	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					480	481		10.1038/534480a	http://dx.doi.org/10.1038/534480a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27337336				2022-12-28	WOS:000378270300037
J	Perkins, G; Brace-McDonnell, S				Perkins, Gavin; Brace-McDonnell, Samantha			Carl McQueen OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item													Perkins, Gavin/E-7613-2010; McDonnell, Samantha/K-4720-2016	Perkins, Gavin/0000-0003-3027-7548; McDonnell, Samantha/0000-0001-6547-2867				MCQUEEN C, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2016	353								i3332	10.1136/bmj.i3332	http://dx.doi.org/10.1136/bmj.i3332			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HJ	27311314				2022-12-28	WOS:000378240800007
J	Watts, G				Watts, Geoff			Thomas Herald Rea Obituary	LANCET			English	Biographical-Item																		REA TH, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2086	2086		10.1016/S0140-6736(16)30533-5	http://dx.doi.org/10.1016/S0140-6736(16)30533-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	27308675	Bronze			2022-12-28	WOS:000376450800019
J	Zhu, JM; Li, WK; Chen, L				Zhu, Jiming; Li, Wenkai; Chen, Lincoln			Doctors in China: improving quality through modernisation of residency education	LANCET			English	Review							HEALTH-CARE; PROFESSIONALS	There is growing recognition that the ultimate success of China's ambitious health reform (enacted in 2009) and higher education reform (1998) depends on well educated health professionals who have the clinical, ethical, and human competencies necessary for the provision of quality services. In this Review, we describe and analyse graduate education of doctors in China by discussing the country's health workforce and their clinical residency education. China has launched a new system called the 5 + 3 (5 year undergraduate and 3 year residency [standardised residency training]), which aims to set national quality standards. To improve understanding for the Chinese model, we present a comparative perspective with systems from the UK and USA. To succeed, the 5 + 3 model will need to overcome major challenges of accreditation and certification, alternative education pathways, and China's unique degree and credentialing system. We conclude by reviewing the challenges of clinical competencies in China, especially the complementarity of specialist training and general practitioner training, which are essential for the quality and equity of China's health-care system.	[Zhu, Jiming; Li, Wenkai] China Med Board, Beijing Off, Beijing 100730, Peoples R China; [Zhu, Jiming] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Chen, Lincoln] China Med Board, Cambridge, MA USA	Nokia Corporation; Pfizer; University of Oxford	Zhu, JM (corresponding author), China Med Board, Beijing Off, Beijing 100730, Peoples R China.	jzhu@cmbfound.org						[Anonymous], BAREFOOT DOCTOR VILL; Aranda V, 2012, NAT MED, V18, P639, DOI 10.1038/nm0512-639; Blumenthal D, 2015, NEW ENGL J MED, V372, P1281, DOI 10.1056/NEJMp1410425; Chen L, 2013, J SHANGHAI JIAOTONG, V8, P1150; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; China State Council, 2011, STAT COUNC GUID EST; Crisp N, 2014, NEW ENGL J MED, V370, P950, DOI 10.1056/NEJMra1111610; Hou JL, 2014, LANCET, V384, P819, DOI 10.1016/S0140-6736(14)61307-6; Ludmerer KM., 2015, LET ME HEAL OPPORTUN; Ministry of Education and Ministry of Health, 2012, SEV SUGG IMPL COMPR; Ministry of Education National Health and Family Planning Commission State Administration of Traditional Chinese Medicine National Development and Reform Commission Ministry of Finance Ministry of Human Resources and Social Security, 2014, OP COORD HLTH ED SEC; National Health and Family Planning Commission, 2014, DEV REP CHIN STAND R; National Health and Family Planning Commission, 2014, REG SRT MAN TRIAL; National Health and Family Planning Commission of China, 2015, CHIN HLTH FAM PLANN; National Health and Family Planning Commission State Commission Office for Public Sector Reform (SCOPSR) National Development and Reform Commission, 2013, GUID OP EST STAND RE; Owens B, 2015, LANCET, V386, P1433, DOI 10.1016/S0140-6736(15)00455-9; Roberts M., 2008, GETTING HLTH REFORM, DOI DOI 10.1093/ACPROF:OSO/9780195371505.001.0001; Tang JL, 2008, LANCET, V372, P1938, DOI 10.1016/S0140-6736(08)61354-9; Yang T, 2013, LANCET, V382, P1703, DOI 10.1016/S0140-6736(13)62401-0; Zhou LJ, 2015, LANCET, V386, P27	20	65	71	8	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2016	388	10054					1922	1929		10.1016/S0140-6736(16)00582-1	http://dx.doi.org/10.1016/S0140-6736(16)00582-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ0AM	27339756				2022-12-28	WOS:000385499000037
J	Owens, DK; Whitlock, EP; Henderson, J; Pignone, MP; Krist, AH; Bibbins-Domingo, K; Curry, SJ; Davidson, KW; Ebel, M; Gillman, MW; Grossman, DC; Kemper, AR; Kurth, AE; Maciosek, M; Siu, AL; LeFevre, ML				Owens, Douglas K.; Whitlock, Evelyn P.; Henderson, Jillian; Pignone, Michael P.; Krist, Alex H.; Bibbins-Domingo, Kirsten; Curry, Susan J.; Davidson, Karim W.; Ebel, Mark; Gillman, Matthew W.; Grossman, David C.; Kemper, Alex R.; Kurth, Ann E.; Maciosek, Michael; Siu, Albert L.; LeFevre, Michael L.		US Preventive Serv Task Force	Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations: Methods of the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							SYSTEMATIC REVIEWS	The U.S. Preventive Services Task Force (USPSTF) develops evidence-based recommendations about preventive care based on comprehensive systematic reviews of the best available evidence. Decision models provide a complementary, quantitative approach to support the USPSTF as it deliberates about the evidence and develops recommendations for clinical and policy use. This article describes the rationale for using modeling, an approach to selecting topics for modeling, and how modeling may inform recommendations about clinical preventive services. Decision modeling is useful when clinical questions remain about how to target an empirically established clinical preventive service at the individual or program level or when complex determinations of magnitude of net benefit, overall or among important subpopulations, are required. Before deciding whether to use decision modeling, the USPSTF assesses whether the benefits and harms of the preventive service have been established empirically, assesses whether there are key issues about applicability or implementation that modeling could address, and then defines the decision problem and key questions to address through modeling. Decision analyses conducted for the USPSTF are expected to follow best practices for modeling. For chosen topics, the USPSTF assesses the strengths and limitations of the systematically reviewed evidence and the modeling analyses and integrates the results of each to make preventive service recommendations.	[Owens, Douglas K.] Stanford Univ, Sch Med, 291 Campus Dr,Room LK3C02, Stanford, CA 94305 USA; [Whitlock, Evelyn P.] Patient Ctr Outcomes Res Inst, 1828 L St NW,Suite 900, Washington, DC 20036 USA; [Henderson, Jillian] Kaiser Permanente Northwest, Kaiser Permanente Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA; [Pignone, Michael P.] Univ North Carolina Chapel Hill, Sch Med, 5045 Old Clin Bldg, Chapel Hill, NC 27707 USA; [Krist, Alex H.] VCU Fairfax Family Med Residency, 3650 Joseph Siewick Dr,Suite 400, Fairfax, VA 22033 USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Gen Internal Med, Box 1364, San Francisco, CA 94143 USA; [Curry, Susan J.] Univ Iowa, Coll Publ Hlth, 105 River St, Iowa City, IA 52242 USA; [Davidson, Karim W.] Cornell Univ, Med Ctr, 622 East 168th St, New York, NY 10032 USA; [Ebel, Mark] Univ Georgia, BS Miller Hall Room 233,Hlth Sci Campus, Athens, GA 30602 USA; [Gillman, Matthew W.] Harvard Med Sch, Dept Populat Med, 401 Pk Dr,Suite 401, Boston, MA 02215 USA; [Grossman, David C.] Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA; [Kemper, Alex R.] Duke Univ, Dept Pediat, 4020 North Roxboro St, Durham, NC 27704 USA; [Kurth, Ann E.] Yale Univ, Yale Sch Nursing, West Campus,POB 27399, West Haven, CT 06516 USA; [Maciosek, Michael] Hlth Partners Inst, POB 1524, Minneapolis, MN 55440 USA; [Siu, Albert L.] Mt Sinai Sch Med, One Gustave L Levy Pl,Box 1070, New York, NY 10029 USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, 1 Hosp Dr,Med Sci Bldg, Columbia, MO 65212 USA	Stanford University; Kaiser Permanente; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California San Francisco; University of Iowa; Cornell University; University System of Georgia; University of Georgia; Harvard University; Harvard Medical School; Duke University; Yale University; Icahn School of Medicine at Mount Sinai; University of Missouri System; University of Missouri Columbia	Owens, DK (corresponding author), Stanford Univ, Sch Med, 291 Campus Dr,Room LK3C02, Stanford, CA 94305 USA.		Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Kemper, Alex/0000-0001-5491-3997; Maciosek, Michael/0000-0002-8164-8858	AHRQ; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Whitlock reports other (contract to perform support services for the USPSTF that resulted in the background paper supporting this manuscript) from AHRQ during the conduct of the study. Dr. Henderson reports grants from AHRQ during the conduct of this work. Dr. Pignone reports having developed and revised decision models for preventive services (including aspirin to prevent cardiovascular disease and CRC screening) that are considered by the USPSTF. Dr. Maciosek reports grants from AHRQ during the conduct of this work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-2531.	Ades AE, 2013, MED DECIS MAKING, V33, P679, DOI 10.1177/0272989X13485156; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Caro JJ, 2012, VALUE HEALTH, V15, P796, DOI 10.1016/j.jval.2012.06.012; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Dehmer SP, 2015, AHRQ PUBLICATION, V15-05229-EF-1; Eddy DM, 2012, VALUE HEALTH, V15, P843, DOI 10.1016/j.jval.2012.04.012; Habbema JDF, 2014, ANN INTERN MED, V161, P812, DOI 10.7326/M14-0845; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Karnon J, 2012, VALUE HEALTH, V15, P821, DOI 10.1016/j.jval.2012.04.013; Kuntz K, 2013, DECISION SIMULATION; LeFevre ML, 2015, ANN INTERN MED, V162, P641, DOI 10.7326/M15-0483; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; Pignone M, 2005, ANN INTERN MED, V142, P1073, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00007; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Pitman R, 2012, VALUE HEALTH, V15, P828, DOI 10.1016/j.jval.2012.06.011; Roberts M, 2012, VALUE HEALTH, V15, P804, DOI 10.1016/j.jval.2012.06.016; Saha S, 2001, AM J PREV MED, V20, P36, DOI 10.1016/S0749-3797(01)00260-4; Sainfort F, 2013, VALUE HEALTH, V16, P133, DOI 10.1016/j.jval.2012.09.009; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023; Sox HC, 2013, MED DECISION MAKING; U.S. Preventive Services Task Force, 2020, PROC MAN; Whitlock EP, 2015, AHRQ PUBLICATION, V13-05193-EF-1; Zauber A, 2015, AHRQ PUBLICATION	32	21	23	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2016	165	7					501	+		10.7326/M15-2531	http://dx.doi.org/10.7326/M15-2531			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY0EY	27379742				2022-12-28	WOS:000384771300008
J	Corcoran, EB; Pirnot, MT; Lin, SS; Dreher, SD; DiRocco, DA; Davies, IW; Buchwald, SL; MacMillan, DWC				Corcoran, Emily B.; Pirnot, Michael T.; Lin, Shishi; Dreher, Spencer D.; DiRocco, Daniel A.; Davies, Ian W.; Buchwald, Stephen L.; MacMillan, David W. C.			Aryl amination using ligand-free Ni(II) salts and photoredox catalysis	SCIENCE			English	Article							REDUCTIVE-ELIMINATION; DUAL CATALYSIS; OXIDATIVE-ADDITION; BOND FORMATION; COMPLEXES; CHLORIDES; HALIDES; AMINES; MECHANISM; MESYLATES	Over the past two decades, there have been major developments in transition metal-catalyzed aminations of aryl halides to form anilines, a common structure found in drug agents, natural product isolates, and fine chemicals. Many of these approaches have enabled highly efficient and selective coupling through the design of specialized ligands, which facilitate reductive elimination from a destabilized metal center. We postulated that a general and complementary method for carbon-nitrogen bond formation could be developed through the destabilization of a metal amido complex via photoredox catalysis, thus providing an alternative approach to the use of structurally complex ligand systems. Here, we report the development of a distinct mechanistic paradigm for aryl amination using ligand-free nickel(II) salts, in which facile reductive elimination from the nickel metal center is induced via a photoredox-catalyzed electron-transfer event.	[Corcoran, Emily B.; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA; [Pirnot, Michael T.; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Lin, Shishi; Dreher, Spencer D.; DiRocco, Daniel A.; Davies, Ian W.] Merck Res Labs, Dept Proc Chem, Rahway, NJ 07065 USA	Princeton University; Massachusetts Institute of Technology (MIT); Merck & Company	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.; Buchwald, SL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	sbuchwal@mit.edu; dmacmill@princeton.edu			NIH [GM58160, RO1-GM078201-05, GM113311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM113311, R01GM078201, R01GM058160] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the NIH under award numbers GM58160 and RO1-GM078201-05. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. M.T.P. thanks the NIH for a postdoctoral fellowship (GM113311).	Brusoe AT, 2015, J AM CHEM SOC, V137, P8460, DOI 10.1021/jacs.5b02512; Chan DMT, 1996, TETRAHEDRON LETT, V37, P9013, DOI 10.1016/S0040-4039(96)02116-8; Driver MS, 1996, J AM CHEM SOC, V118, P7217, DOI 10.1021/ja960937t; Fors BP, 2008, J AM CHEM SOC, V130, P13552, DOI 10.1021/ja8055358; Gao CY, 2008, J ORG CHEM, V73, P1624, DOI 10.1021/jo7022558; Ge SZ, 2014, J AM CHEM SOC, V136, P1617, DOI 10.1021/ja411911s; Goldberg I., 1906, BER DTSCH CHEM GES, V39, P1691, DOI [10.1002/cber.19060390298, DOI 10.1002/CBER.19060390298]; Gupta AK, 2012, TETRAHEDRON LETT, V53, P2218, DOI 10.1016/j.tetlet.2012.02.081; GURAM AS, 1994, J AM CHEM SOC, V116, P7901, DOI 10.1021/ja00096a059; Hartwig JF, 1997, SYNLETT, P329, DOI 10.1055/s-1997-789; Illies L, 2012, ORG LETT, V14, P5570, DOI 10.1021/ol302688u; Jouffroy M, 2016, ORG LETT, V18, P876, DOI 10.1021/acs.orglett.6b00208; KOO K, 1995, ORGANOMETALLICS, V14, P4421, DOI 10.1021/om00009a054; KOSUGI M, 1983, CHEM LETT, P927, DOI 10.1246/cl.1983.927; Kutchukian PS, 2016, CHEM SCI, V7, P2604, DOI 10.1039/c5sc04751j; Lin BL, 2002, J AM CHEM SOC, V124, P2890, DOI 10.1021/ja017652n; Lowry MS, 2005, CHEM MATER, V17, P5712, DOI 10.1021/cm051312+; Macgregor SA, 2003, FARADAY DISCUSS, V124, P111, DOI 10.1039/b212309f; Oderinde MS, 2016, J AM CHEM SOC, V138, P1760, DOI 10.1021/jacs.5b11244; Park NH, 2014, ORG LETT, V16, P220, DOI 10.1021/ol403209k; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Shimasaki T, 2010, ANGEW CHEM INT EDIT, V49, P2929, DOI 10.1002/anie.200907287; Surry DS, 2011, CHEM SCI, V2, P27, DOI 10.1039/c0sc00331j; Tasker SZ, 2015, J AM CHEM SOC, V137, P9531, DOI 10.1021/jacs.5b05597; Tellis JC, 2014, SCIENCE, V345, P433, DOI 10.1126/science.1253647; Terrett JA, 2015, NATURE, V524, P330, DOI 10.1038/nature14875; TSOU TT, 1979, J AM CHEM SOC, V101, P6319, DOI 10.1021/ja00515a028; Ullmann F., 1903, BER DTSCH CHEM GES 2, V36, P2382, DOI DOI 10.1002/CBER.190303602174; Wolfe JP, 1997, J AM CHEM SOC, V119, P6054, DOI 10.1021/ja964391m; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	30	336	340	18	365	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2016	353	6296					279	283		10.1126/science.aag0209	http://dx.doi.org/10.1126/science.aag0209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0EM	27338703	Green Published, Green Accepted			2022-12-28	WOS:000379580800046
J	Stafford, N				Stafford, Ned			Ann Ward OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.de							0	0	0	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2016	354								i3765	10.1136/bmj.i3765	http://dx.doi.org/10.1136/bmj.i3765			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EP	27383075				2022-12-28	WOS:000379581100024
J	Braillon, A				Braillon, Alain			Moderate Alcohol Intake and Cardiometabolic Risk in Adults With Type 2 Diabetes	ANNALS OF INTERNAL MEDICINE			English	Letter							TRIAL		[Braillon, Alain] Univ Hosp, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Braillon, A (corresponding author), Univ Hosp, Amiens, France.							[Anonymous], 2015, ANN INTERN MED, V163, DOI 10.7326/P15-9031; Braillon A, 2015, AM J CARDIOL, V116, P1646, DOI 10.1016/j.amjcard.2015.09.002; Gepner Y, 2015, ANN INTERN MED, V163, P569, DOI 10.7326/M14-1650; Goulden R, 2016, AM J MED, V129, P180, DOI 10.1016/j.amjmed.2015.10.013; Whitman IR, 2015, AM J CARDIOL, V116, P642, DOI 10.1016/j.amjcard.2015.05.029	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					68	68		10.7326/L16-5014	http://dx.doi.org/10.7326/L16-5014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380290				2022-12-28	WOS:000379215800016
J	Tsutsumi, Y; Tsujimoto, Y; Kataoka, Y; Ikenoue, T				Tsutsumi, Yusuke; Tsujimoto, Yasushi; Kataoka, Yuki; Ikenoue, Tatsuyoshi			Outcomes of Basic Versus Advanced Life Support for Out-of-Hospital Medical Emergencies	ANNALS OF INTERNAL MEDICINE			English	Letter									[Tsutsumi, Yusuke; Tsujimoto, Yasushi; Kataoka, Yuki; Ikenoue, Tatsuyoshi] Kyoto Univ, Grad Sch Med & Publ Hlth, Kyoto, Japan	Kyoto University	Tsutsumi, Y (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Kyoto, Japan.		Ikenoue, Tatsuyoshi/AFV-4648-2022; Tsutsumi, Yusuke/AAO-4750-2021; KATAOKA, Yuki/GRR-4808-2022; KATAOKA, Yuki/I-6026-2019	Ikenoue, Tatsuyoshi/0000-0003-3717-8788; Tsutsumi, Yusuke/0000-0002-9160-0241; KATAOKA, Yuki/0000-0001-7982-5213; KATAOKA, Yuki/0000-0001-7982-5213; Tsujimoto, Yasushi/0000-0002-7214-5589				Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Sanghavi P, 2015, ANN INTERN MED, V163, P681, DOI 10.7326/M15-0557; Stock J.H., 2014, INTRO ECONOMETRICS	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					69	69		10.7326/L15-0626	http://dx.doi.org/10.7326/L15-0626			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380155				2022-12-28	WOS:000379215800018
J	Blanchette, ML				Blanchette, Melanie L.			The measure of success	SCIENCE			English	Editorial Material									[Blanchette, Melanie L.] Edith Cowan Univ, Perth, WA, Australia	Edith Cowan University	Blanchette, ML (corresponding author), Edith Cowan Univ, Perth, WA, Australia.	SciCareerEditor@aaas.org		Blanchette, Melanie/0000-0003-2138-2864					0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					94	94		10.1126/science.353.6294.94	http://dx.doi.org/10.1126/science.353.6294.94			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP9KX	27365451				2022-12-28	WOS:000378816200042
J	Gao, H; Chakraborty, G; Zhang, ZG; Akalay, I; Gadiya, M; Gao, YQ; Sinha, S; Hu, J; Jiang, CZ; Akram, M; Brogi, E; Leitinger, B; Giancotti, FG				Gao, Hua; Chakraborty, Goutam; Zhang, Zhanguo; Akalay, Intissar; Gadiya, Mayur; Gao, Yaquan; Sinha, Surajit; Hu, Jian; Jiang, Cizhong; Akram, Muzaffar; Brogi, Edi; Leitinger, Birgit; Giancotti, Filippo G.			Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling	CELL			English	Article							L6 ANTIGEN; CANCER; ACTIVATION; MECHANISMS; PROTEIN; INHIBITION; DORMANCY; TARGET; CELLS; BONE	Genetic screening identifies the atypical tetraspanin TM4SF1 as a strong mediator of metastatic reactivation of breast cancer. Intriguingly, TM4SF1 couples the collagen receptor tyrosine kinase DDR1 to the cortical adaptor syntenin 2 and, hence, to PKC alpha. The latter kinase phosphorylates and activates JAK2, leading to the activation of STAT3. This non-canonical mechanism of signaling induces the expression of SOX2 and NANOG; sustains the manifestation of cancer stem cell traits; and drives metastatic reactivation in the lung, bone, and brain. Bioinformatic analyses and pathological studies corroborate the clinical relevance of these findings. We conclude that non-canonical DDR1 signaling enables breast cancer cells to exploit the ubiquitous interstitial matrix component collagen I to undergo metastatic reactivation in multiple target organs.	[Gao, Hua; Gao, Yaquan] Tongji Univ, Shanghai East Hosp, Res Ctr Translat Med,Metastasis Res Inst, Key Lab Arrhythmias,Minist Educ China,Breast Canc, Shanghai 200092, Peoples R China; [Gao, Hua; Gao, Yaquan] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China; [Gao, Hua; Chakraborty, Goutam; Zhang, Zhanguo; Akalay, Intissar; Gadiya, Mayur; Sinha, Surajit; Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Gao, Hua; Chakraborty, Goutam; Zhang, Zhanguo; Akalay, Intissar; Gadiya, Mayur; Sinha, Surajit; Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Ctr Metastasis Res, Sloan Kettering Inst Canc Res, New York, NY 10065 USA; [Gadiya, Mayur] Cornell Univ, Weill Cornell Grad Sch Med Sci, Sloan Kettering Div, New York, NY 10065 USA; [Hu, Jian; Jiang, Cizhong] Tongji Univ, Collaborat Innovat Ctr Brain Sci, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China; [Akram, Muzaffar; Brogi, Edi] Mem Hosp, Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Leitinger, Birgit] Imperial Coll London, Natl Heart & Lung Inst, Mol Med Sect, London SW7 2AZ, England; [Giancotti, Filippo G.] UT MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77054 USA; [Giancotti, Filippo G.] UT MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Houston, TX 77054 USA; [Zhang, Zhanguo] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan 430030, Peoples R China	Ministry of Education, China; Tongji University; Tongji University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Tongji University; Memorial Sloan Kettering Cancer Center; Imperial College London; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Huazhong University of Science & Technology	Gao, H (corresponding author), Tongji Univ, Shanghai East Hosp, Res Ctr Translat Med,Metastasis Res Inst, Key Lab Arrhythmias,Minist Educ China,Breast Canc, Shanghai 200092, Peoples R China.; Gao, H (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China.; Gao, H; Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA.; Gao, H; Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Metastasis Res, Sloan Kettering Inst Canc Res, New York, NY 10065 USA.; Giancotti, FG (corresponding author), UT MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77054 USA.; Giancotti, FG (corresponding author), UT MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Houston, TX 77054 USA.	gaoh@tongji.edu.cn; fggiancotti@mdanderson.org	SINHA, SURAJIT/AAE-9200-2020; Chakraborty, Goutam/U-5559-2019; Gadiya, Mayur/ABB-3418-2020	Gao, Hua/0000-0002-9698-5830	NIH [R01 CA175712, R35 CA197566, P01 CA094060]; Geoffrey Beene Cancer Center of MSKCC; National Basic Research program of China (973 Program) [2015CB964800]; National Natural Science Foundation of China [81372840]; One Thousand Talents Program of Shanghai [SH04020]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81221001]; Program for Professors of Special Appointment at Shanghai Institutions of Higher Learning; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA175712, P30CA008748, R35CA197566, P01CA094060] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Cancer Center of MSKCC; National Basic Research program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Thousand Talents Program of Shanghai; Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professors of Special Appointment at Shanghai Institutions of Higher Learning; China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Levine, J. Massague, C. McCilloch, F. Miller, and M.J. Tang for reagents, A. Barlas, N. Fan, and M. Turkekul for help with some of the staining experiments, H. Erdjument-Bromage for mass spectrometric analyses, the staff of the Genomics Core and the Molecular Cytology Core of MSKCC for their services, and members of the Giancotti laboratory for discussions. This work was supported primarily by grants from the NIH (R01 CA175712, R35 CA197566, and P01 CA094060 Project 4, to F.G.G.). Additional funding was provided by the Geoffrey Beene Cancer Center of MSKCC (to F.G.G.), the National Basic Research program of China (973 Program, 2015CB964800, to H.G.), the National Natural Science Foundation of China (81372840, to H.G.) and the One Thousand Talents Program of Shanghai (SH04020, to H.G.), and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81221001). H.G. received an Eastern Scholarship from the Program for Professors of Special Appointment at Shanghai Institutions of Higher Learning (2013-14), and Z.Z. was partially supported by the China Scholarship Council.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Borrell-Pages M, 2000, MOL BIOL CELL, V11, P4217, DOI 10.1091/mbc.11.12.4217; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Canning P, 2014, J MOL BIOL, V426, P2457, DOI 10.1016/j.jmb.2014.04.014; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Gao D, 2015, CURR OPIN GENET DEV, V30, P42, DOI 10.1016/j.gde.2015.02.007; Gao H, 2014, P NATL ACAD SCI USA, V111, P16532, DOI 10.1073/pnas.1403234111; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Ghajar CM, 2015, NAT REV CANCER, V15, P238, DOI 10.1038/nrc3910; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; HELLSTROM I, 1986, P NATL ACAD SCI USA, V83, P7059, DOI 10.1073/pnas.83.18.7059; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; MARKEN JS, 1992, P NATL ACAD SCI USA, V89, P3503, DOI 10.1073/pnas.89.8.3503; MARKEN JS, 1994, J BIOL CHEM, V269, P7397; Mihai C, 2009, J MOL BIOL, V385, P432, DOI 10.1016/j.jmb.2008.10.067; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sarkar D, 2008, CANCER RES, V68, P3087, DOI 10.1158/0008-5472.CAN-07-6210; Shan YB, 2014, NAT STRUCT MOL BIOL, V21, P579, DOI 10.1038/nsmb.2849; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Toms AV, 2013, NAT STRUCT MOL BIOL, V20, P1221, DOI 10.1038/nsmb.2673; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhao D, 2015, ONCOGENE, V34, P3107, DOI 10.1038/onc.2014.257	42	143	146	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					47	62		10.1016/j.cell.2016.06.009	http://dx.doi.org/10.1016/j.cell.2016.06.009			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368100	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000380254400010
J	Wise, J				Wise, Jacqui			Targeted campaigns must help ethnic minorities spot cancer signs, researchers say	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Niksic M, 2016, BR J CANC, V2016	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2016	353								i3612	10.1136/bmj.i3612	http://dx.doi.org/10.1136/bmj.i3612			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FV	27357846				2022-12-28	WOS:000379018700006
J	Hwang, TJ; Sokolov, E; Franklin, JM; Kesselheim, AS				Hwang, Thomas J.; Sokolov, Elisaveta; Franklin, Jessica M.; Kesselheim, Aaron S.			Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREMARKET APPROVAL; CARDIOVASCULAR DEVICES; CLINICAL-EVALUATION; ELUTING STENT; EVIDENCE BASE; FDA APPROVAL; RISK; REPLACEMENT; HIP; RECALLS	OBJECTIVE To evaluate safety alerts and recalls, publication of key trial outcomes, and subsequent US approval of high profile medical devices introduced in the European Union. DESIGN Cohort study. SETTING Novel cardiovascular, orthopedic, and neurologic devices approved in the EU through Conformite Europeenne marking between 2005 and 2010. DATA SOURCES Public and commercial databases searched up to January 2016 for press releases and announcements of approvals; public Food and Drug Administration and European regulatory authority databases for US approvals and safety alerts and recalls; and Medline, Embase, and Web of Science for peer reviewed publications. MAIN OUTCOME MEASURES We categorized the novelty of the devices in the study sample as a "major innovation" or an "other change," and extracted descriptive data about the devices and information on any safety alerts and withdrawals. Linear regression models examined factors associated with differential EU and US approvals. Cox proportional hazards regression models were used to evaluate factors associated with safety alerts and recalls and the publication of trial outcomes for devices categorized as major innovations. Models controlled for time, therapeutic category, regulatory pathway, size of sponsoring company, and indicator variables for devices approved first in the EU and devices approved only in the EU. RESULTS 67% (206/309) of devices identified were approved in both the US and the EU, of which 63% (129/206) were approved first in the EU. The unadjusted rate of safety alerts and recalls for devices approved first in the EU was 27% (62/232) compared with 14% (11/77) for devices approved first in the US. The adjusted hazard ratio for safety alerts and recalls was 2.9 (95% confidence interval 1.4 to 6.2) for devices approved first in the EU. The results of pivotal trials were published for 49% (37/75) of devices categorized as major innovations, with an overall publication rate of 37% five years after approval. CONCLUSIONS Devices approved first in the EU are associated with an increased risk of post-marketing safety alerts and recalls. Poor trial publication rates mean that patients and clinicians need greater regulatory transparency to make informed decisions about treatment.	[Hwang, Thomas J.] Harvard Univ, Fac Arts & Sci, Cambridge, MA USA; [Sokolov, Elisaveta] Kings Coll London, Dept Neurol & Neurophysiol, London, England; [Hwang, Thomas J.; Franklin, Jessica M.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Program Regulat Therapeut & Law PORTAL, Boston, MA USA; [Hwang, Thomas J.; Franklin, Jessica M.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hwang, TJ (corresponding author), Harvard Univ, Fac Arts & Sci, Cambridge, MA USA.; Hwang, TJ; Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Program Regulat Therapeut & Law PORTAL, Boston, MA USA.; Hwang, TJ; Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	tjhwang@post.harvard.edu; akesselheim@partners.org	Sokolov, Elisaveta/AAD-5231-2020	Sokolov, Elisaveta/0000-0002-1509-9416; Hwang, Thomas/0000-0003-0717-1497	Harvard University; Interfaculty Initiative in Health Policy; Patient-Centered Outcomes Research Institute; Merck; Harvard program in therapeutic science; Laura and John Arnold Foundation; FDA Office of Generic Drugs and Division of Health Communication	Harvard University; Interfaculty Initiative in Health Policy; Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Merck(Merck & Company); Harvard program in therapeutic science; Laura and John Arnold Foundation; FDA Office of Generic Drugs and Division of Health Communication	All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare that (within the past three years): TJH has received funding from Harvard University and the Interfaculty Initiative in Health Policy and was employed by Blackstone and Bain Capital; JMF has received funding from the Patient-Centered Outcomes Research Institute and Merck, and has consulted for Aetion, a software company; and ASK is a Greenwall faculty scholar and has received funding from the Harvard program in therapeutic science, the Laura and John Arnold Foundation, and the FDA Office of Generic Drugs and Division of Health Communication.	[Anonymous], PREM APPR PMA DAT; Basu S, 2012, NEW ENGL J MED, V367, P485, DOI 10.1056/NEJMp1204170; Boulton AJM, 2013, LANCET DIABETES ENDO, V1, P270, DOI 10.1016/S2213-8587(13)70178-5; California Healthcare Institute, 2014, TAK PULS MED DEV REG; Campillo-Artero C, 2013, HEALTH POLICY, V113, P38, DOI 10.1016/j.healthpol.2013.03.017; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Chang L, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2613; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Cohen D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6446; Cohen D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7221; Cohen D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7090; Cohen D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2748; Curfman GD, 2011, NEW ENGL J MED, V365, P975, DOI 10.1056/NEJMp1109094; Davis S, 2011, EU MED DEVICE APPROV; Day CS, 2016, J BONE JOINT SURG AM, V98, P517, DOI 10.2106/JBJS.15.00286; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; Eikermann M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2771; Food and Drug Administration, 2012, UNSAFE AND INEFFECTI; Fox DM, 2014, MILBANK Q, V92, P151, DOI 10.1111/1468-0009.12044; Fraser AG, 2011, EUR HEART J, V32, P1673, DOI 10.1093/eurheartj/ehr171; Fraser AG, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2952; Freemantle N, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2839; Gartenberg AJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g93; Godlee F, 2012, BMJ-BRIT MED J, V344, pe1539; Grennan M, 2015, WORKING PAPER; Heneghan C, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000155; Hines JZ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000280; Horton R, 2012, LANCET, V379, P106, DOI 10.1016/S0140-6736(12)60032-4; Hulstaert F, 2012, INT J TECHNOL ASSESS, V28, P278, DOI 10.1017/S0266462312000335; Hwang TJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g217; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; Kesselheim AS, 2016, ANN INTERN MED, V164, P500, DOI 10.7326/M15-1906; Kramer DB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001276; Kramer DB, 2012, NEW ENGL J MED, V366, P848, DOI 10.1056/NEJMhle1113918; Kramer DB, 2010, AM J THER, V17, P2, DOI 10.1097/MJT.0b013e3181ca8105; Krucoff MW, 2008, J AM COLL CARDIOL, V51, P1543, DOI 10.1016/j.jacc.2008.01.020; Kynaston-Pearson F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6956; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Lieberman JR, 2004, CLIN ORTHOP RELAT R, P338, DOI 10.1097/01.blo.0000146540.62612.7d; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1901, DOI 10.1001/jama.295.16.1901; Maisel WH, 2008, NEW ENGL J MED, V358, P985, DOI 10.1056/NEJMp0800495; Maisel WH, 2007, NEW ENGL J MED, V356, P981, DOI 10.1056/NEJMp068305; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; McCulloch P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7126; Mercer NSG, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2923; Mitka M, 2008, JAMA-J AM MED ASSOC, V300, P1985, DOI 10.1001/jama.2008.528; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Nieuwenhuijse MJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5133; Pinto F, 2016, EUR HEART J, V37, P140, DOI 10.1093/eurheartj/ehv275; Rathi VK, 2015, JAMA-J AM MED ASSOC, V314, P604, DOI 10.1001/jama.2015.8761; Reinohl J, 2015, NEW ENGL J MED, V373, P2438, DOI 10.1056/NEJMoa1500893; Rising JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117235; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Rockoff JD., 2010, WALL STREET J; Rome BN, 2014, JAMA-J AM MED ASSOC, V311, P385, DOI 10.1001/jama.2013.284986; Ross S, 2008, J OBSTET GYNAECOL CA, V30, P508, DOI 10.1016/S1701-2163(16)32867-5; Sedrakyan A, 2012, LANCET, V379, P1174, DOI 10.1016/S0140-6736(12)60372-9; Sorenson C, 2014, MILBANK Q, V92, P114, DOI 10.1111/1468-0009.12043; Stordeur S, 2013, REV EPIDEMIOL SANTE, V61, P105, DOI 10.1016/j.respe.2012.08.004; Storz-Pfennig P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1646; Thompson M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2973; Walter JR, 2016, OBSTET GYNECOL, V127, P1110, DOI 10.1097/AOG.0000000000001430; Wentholt IME, 2005, DIABETOLOGIA, V48, P1055, DOI 10.1007/s00125-005-1754-y; Wild C, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-154; Williams N, 2012, LANCET, V379, P1789, DOI 10.1016/S0140-6736(12)60759-4; Zhon C, 2008, J GEN INTERN MED, V23, P13, DOI 10.1007/s11606-007-0392-0; Zuckerman D, 2014, JAMA INTERN MED, V174, P1781, DOI 10.1001/jamainternmed.2014.4193; Zuckerman DM, 2011, ARCH INTERN MED, V171, P1006, DOI 10.1001/archinternmed.2011.30	70	38	37	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2016	353								i3323	10.1136/bmj.i3323	http://dx.doi.org/10.1136/bmj.i3323			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FP	27352914	Green Published, hybrid			2022-12-28	WOS:000379018000004
J	Morris, PE; Berry, MJ; Files, DC; Thompson, JC; Hauser, J; Flores, L; Dhar, S; Chmelo, E; Lovato, J; Case, LD; Bakhru, RN; Sarwal, A; Parry, SM; Campbell, P; Mote, A; Winkelman, C; Hite, RD; Nicklas, B; Chatterjee, A; Young, MP				Morris, Peter E.; Berry, Michael J.; Files, D. Clark; Thompson, J. Clifton; Hauser, Jordan; Flores, Lori; Dhar, Sanjay; Chmelo, Elizabeth; Lovato, James; Case, L. Douglas; Bakhru, Rita N.; Sarwal, Aarti; Parry, Selina M.; Campbell, Pamela; Mote, Arthur; Winkelman, Chris; Hite, Robert D.; Nicklas, Barbara; Chatterjee, Arjun; Young, Michael P.			Standardized Rehabilitation and Hospital Length of Stay Among Patients With Acute Respiratory Failure A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; ACUTE LUNG INJURY; PHYSICAL-THERAPY; CRITICAL ILLNESS; DISTRESS-SYNDROME; POINT-PREVALENCE; MORTALITY; VENTILATION; DISABILITY	IMPORTANCE Physical rehabilitation in the intensive care unit (ICU) may improve the outcomes of patients with acute respiratory failure. OBJECTIVE To compare standardized rehabilitation therapy (SRT) to usual ICU care in acute respiratory failure. DESIGN, SETTING, AND PARTICIPANTS Single-center, randomized clinical trial at Wake Forest Baptist Medical Center, North Carolina. Adult patients (mean age, 58 years; women, 55%) admitted to the ICU with acute respiratory failure requiring mechanical ventilation were randomized to SRT (n = 150) or usual care (n = 150) from October 2009 through May 2014 with 6-month follow-up. INTERVENTIONS Patients in the SRT group received daily therapy until hospital discharge, consisting of passive range of motion, physical therapy, and progressive resistance exercise. The usual care group received weekday physical therapy when ordered by the clinical team. For the SRT group, the median (interquartile range [IQR]) days of delivery of therapy were 8.0 (5.0-14.0) for passive range of motion, 5.0 (3.0-8.0) for physical therapy, and 3.0 (1.0-5.0) for progressive resistance exercise. The median days of delivery of physical therapy for the usual care group was 1.0 (IQR, 0.0-8.0). MAIN OUTCOMES AND MEASURES Both groups underwent assessor-blinded testing at ICU and hospital discharge and at 2, 4, and 6 months. The primary outcome was hospital length of stay (LOS). Secondary outcomes were ventilator days, ICU days, Short Physical Performance Battery (SPPB) score, 36-item Short-Form Health Surveys (SF-36) for physical and mental health and physical function scale score, Functional Performance Inventory (FPI) score, Mini-Mental State Examination (MMSE) score, and handgrip and handheld dynamometer strength. RESULTS Among 300 randomized patients, the median hospital LOS was 10 days (IQR, 6 to 17) for the SRT group and 10 days (IQR, 7 to 16) for the usual care group (median difference, 0 [95% CI, -1.5 to 3], P=.41). There was no difference in duration of ventilation or ICU care. There was no effect at 6 months for handgrip (difference, 2.0 kg [95% CI, -1.3 to 5.4], P=.23) and handheld dynamometer strength (difference, 0.4 lb [95% CI, -2.9 to 3.7], P=.82), SF-36 physical health score (difference, 3.4 [95% CI, -0.02 to 7.0], P=.05), SF-36 mental health score (difference, 2.4 [95% CI, -1.2 to 6.0], P=.19), or MMSE score (difference, 0.6 [95% CI, -0.2 to 1.4], P=.17). There were higher scores at 6 months in the SRT group for the SPPB score (difference, 1.1 [95% CI, 0.04 to 2.1, P =.04), SF-36 physical function scale score (difference, 12.2 [95% CI, 3.8 to 20.7], P=.001), and the FPI score (difference, 0.2 [95% CI, 0.04 to 0.4], P=.02). CONCLUSIONS AND RELEVANCE Among patients hospitalized with acute respiratory failure, SRT compared with usual care did not decrease hospital LOS.	[Morris, Peter E.] Univ Kentucky, Div Pulm Crit Care & Sleep Med, Lexington, KY 40536 USA; [Berry, Michael J.; Hauser, Jordan] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Files, D. Clark; Thompson, J. Clifton; Flores, Lori; Dhar, Sanjay; Chmelo, Elizabeth; Bakhru, Rita N.; Campbell, Pamela; Mote, Arthur; Chatterjee, Arjun; Young, Michael P.] Wake Forest Univ, Sect Pulm Crit Care Allergy & Immunol Dis, Winston Salem, NC 27109 USA; [Lovato, James; Case, L. Douglas] Wake Forest Univ, Dept Biostat Sci, Winston Salem, NC 27109 USA; [Sarwal, Aarti] Wake Forest Univ, Dept Neurol, Winston Salem, NC 27109 USA; [Parry, Selina M.] Univ Melbourne, Physiotherapy Dept, Melbourne, Vic, Australia; [Winkelman, Chris] Case Western Reserve Univ, Francis Payne Bolton Sch Nursing, Cleveland, OH 44106 USA; [Hite, Robert D.] Cleveland Clin, Resp Inst, Dept Crit Care, Cleveland, OH 44106 USA; [Nicklas, Barbara] Wake Forest Univ, Div Geriatr, Winston Salem, NC 27109 USA	University of Kentucky; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; University of Melbourne; Case Western Reserve University; Cleveland Clinic Foundation; Wake Forest University	Morris, PE (corresponding author), Univ Kentucky, Div Pulm Crit Care & Sleep Med, Kentucky Clin, 740 S Limestone,L-543, Lexington, KY 40536 USA.	peter.morris@uky.edu	chatterjee, arjun B/H-2689-2013; Sarwal, A./I-2139-2019; Nicklas, Barbara/AAA-2781-2020; Winkelman, Chris/AAB-7818-2019	chatterjee, arjun B/0000-0001-8221-873X; Winkelman, Chris/0000-0002-2988-9304; Hite, Robert Duncan/0000-0002-2625-8750; Parry, Selina/0000-0003-2204-3143; Files, Daniel Clark/0000-0002-1595-4080	National Institutes of Health; National Institute of Nursing Research; National Heart, Lung, and Blood Institute; NATIONAL INSTITUTE ON AGING [P30AG021332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health, National Institute of Nursing Research, and National Heart, Lung, and Blood Institute.	Bailey P, 2007, CRIT CARE MED, V35, P139, DOI 10.1097/01.CCM.0000251130.69568.87; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Berney SC, 2013, CRIT CARE RESUSC, V15, P260; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brummel NE, 2014, INTENS CARE MED, V40, P370, DOI 10.1007/s00134-013-3136-0; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Denehy L, 2013, CRIT CARE, V17, DOI 10.1186/cc12835; Elliott D, 2014, CRIT CARE MED, V42, P2518, DOI 10.1097/CCM.0000000000000525; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Fan E, 2014, CRIT CARE MED, V42, P849, DOI 10.1097/CCM.0000000000000040; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Hermans G, 2014, AM J RESP CRIT CARE, V190, P410, DOI 10.1164/rccm.201312-2257OC; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hodgin KE, 2009, CRIT CARE MED, V37, P561, DOI 10.1097/CCM.0b013e3181957449; Hudson LD, 2003, NEW ENGL J MED, V348, P745, DOI 10.1056/NEJMe020180; Iwashyna TJ, 2012, AM J RESP CRIT CARE, V186, P302, DOI 10.1164/rccm.201206-1138ED; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Leidy NK, 2012, INT J CHRONIC OBSTR, V7, P543, DOI 10.2147/COPD.S32032; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Moss M, 2016, AM J RESP CRIT CARE, V193, P1101, DOI 10.1164/rccm.201505-1039OC; Needham DM, 2010, ARCH PHYS MED REHAB, V91, P536, DOI 10.1016/j.apmr.2010.01.002; Nydahl P, 2014, CRIT CARE MED, V42, P1178, DOI 10.1097/CCM.0000000000000149; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Parry SM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001891; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Ratitch B, IMPLEMENTATION PATTE; SAS Institute, 2011, SAS STAT 9 3 SAS US; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; TEAM Study Investigators, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0765-4; Walsh TS, 2015, JAMA INTERN MED, V175, P901, DOI 10.1001/jamainternmed.2015.0822	36	191	210	4	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2694	2702		10.1001/jama.2016.7201	http://dx.doi.org/10.1001/jama.2016.7201			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27367766	Green Accepted, Bronze			2022-12-28	WOS:000378709300020
J	Ainsworth, TD; Gates, RD				Ainsworth, Tracy D.; Gates, Ruth D.			Corals' microbial sentinels The coral microbiome will be key to future reef health	SCIENCE			English	Editorial Material									[Ainsworth, Tracy D.] James Cook Univ, IARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Gates, Ruth D.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA	James Cook University; University of Hawaii System; University of Hawaii Manoa	Ainsworth, TD (corresponding author), James Cook Univ, IARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	tracy.ainsworth@jcu.edu.au	Ainsworth, Tracy D/L-7309-2016	Ainsworth, Tracy D/0000-0001-6476-9263				Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Glasl B, 2016, ISME J, V10, P2280, DOI 10.1038/ismej.2016.9; Goodrich JK, 2016, SCIENCE, V352, P532, DOI 10.1126/science.aad9379; Knowlton N., 2015, CORAL REEFS ANTHROPO, DOI [DOI 10.1007/978-94-017-7249-5_6, 10.1007/978-94-017-7249-5_6]; Krause S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00251; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Meyer JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100316; Ogawa D., 2014, THESIS; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; van de Leemput IA, 2016, CORAL REEFS, V35, P857, DOI 10.1007/s00338-016-1439-7; Zaneveld JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11833; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163	15	50	50	9	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1518	1519		10.1126/science.aad9957	http://dx.doi.org/10.1126/science.aad9957			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339969				2022-12-28	WOS:000378346500020
J	Choi, JY; Hild, S; Zeiher, J; Schauss, P; Rubio-Abadal, A; Yefsah, T; Khemani, V; Huse, DA; Bloch, I; Gross, C				Choi, Jae-yoon; Hild, Sebastian; Zeiher, Johannes; Schauss, Peter; Rubio-Abadal, Antonio; Yefsah, Tarik; Khemani, Vedika; Huse, David A.; Bloch, Immanuel; Gross, Christian			QUANTUM SIMULATION Exploring the many-body localization transition in two dimensions	SCIENCE			English	Article							ANDERSON LOCALIZATION; THERMALIZATION; INSULATOR; DYNAMICS; SYSTEM	A fundamental assumption in statistical physics is that generic closed quantum many-body systems thermalize under their own dynamics. Recently, the emergence of many-body localized systems has questioned this concept and challenged our understanding of the connection between statistical physics and quantum mechanics. Here we report on the observation of a many-body localization transition between thermal and localized phases for bosons in a two-dimensional disordered optical lattice. With our single-site-resolved measurements, we track the relaxation dynamics of an initially prepared out-of-equilibrium density pattern and find strong evidence for a diverging length scale when approaching the localization transition. Our experiments represent a demonstration and in-depth characterization of many-body localization in a regime not accessible with state-of-the-art simulations on classical computers.	[Choi, Jae-yoon; Hild, Sebastian; Zeiher, Johannes; Schauss, Peter; Rubio-Abadal, Antonio; Yefsah, Tarik; Bloch, Immanuel; Gross, Christian] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Khemani, Vedika; Huse, David A.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Huse, David A.] Inst Adv Study, Olden Lane, Princeton, NJ 08540 USA; [Bloch, Immanuel] Univ Munich, Fak Phys, D-80799 Munich, Germany; [Schauss, Peter] Princeton Univ, Dept Phys, Princeton, NJ 08540 USA; [Schauss, Peter; Yefsah, Tarik] Ecole Normale Super, CNRS, Lab Kastler Brossel, F-75005 Paris, France	Max Planck Society; Princeton University; Institute for Advanced Study - USA; University of Munich; Princeton University; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Choi, JY (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.	jae-yoon.choi@mpq.mpg.de	Yefsah, Tarik/AAA-1429-2019; Rubio-Abadal, Antonio/ABG-1268-2020; Bloch, Immanuel/N-9169-2019; Zeiher, Johannes/AAU-6102-2021; Schauss, Peter/AAV-1298-2020; Bloch, Immanuel/G-3174-2010; Gross, Christian/P-5475-2014; Choi, Jae-yoon/Q-8472-2018	Yefsah, Tarik/0000-0002-6024-5611; Zeiher, Johannes/0000-0002-8466-1863; Schauss, Peter/0000-0002-8505-5195; Bloch, Immanuel/0000-0002-0679-4759; Gross, Christian/0000-0003-2292-5234; Choi, Jae-yoon/0000-0003-1208-3395; Rubio-Abadal, Antonio/0000-0001-9887-132X	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft; European Union (UQUAM, Marie Curie Fellowship)	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (UQUAM, Marie Curie Fellowship)	We thank M. Fischer, E. Altman, M. Knap, P. Bordia, H. Luschen, A. Rosch, E. Demler, and S. Sondhi for discussions. D.A.H. is the A. and H. Broitman Member at the Institute for Advanced Study. We acknowledge funding by Max-Planck-Gesellschaft, Deutsche Forschungsgemeinschaft, the European Union (UQUAM, Marie Curie Fellowship to J.C.).	Agarwal K, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.160401; Aleiner IL, 2010, NAT PHYS, V6, P900, DOI [10.1038/nphys1758, 10.1038/NPHYS1758]; Altman E, 2015, ANNU REV CONDEN MA P, V6, P383, DOI 10.1146/annurev-conmatphys-031214-014701; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Bar Lev Y, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/46001; Bar Lev Y, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.100601; Bardarson JH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.017202; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; Billy J, 2008, NATURE, V453, P891, DOI 10.1038/nature07000; Bordia P, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.140401; Chandran A, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.085425; D'Errico C, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.095301; Deissler B, 2010, NAT PHYS, V6, P354, DOI 10.1038/NPHYS1635; DEUTSCH JM, 1991, PHYS REV A, V43, P2046, DOI 10.1103/PhysRevA.43.2046; Eisert J, 2015, NAT PHYS, V11, P124, DOI [10.1038/nphys3215, 10.1038/NPHYS3215]; Endres M, 2011, SCIENCE, V334, P200, DOI [10.1126/science.1209284, 10.1126/science.1210268]; Fischer MH, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.160401; Gadway B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.145306; Gornyi IV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.206603; Huse DA, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.174202; Islam R, 2015, NATURE, V528, P77, DOI 10.1038/nature15750; Jendrzejewski F, 2012, NAT PHYS, V8, P398, DOI [10.1038/NPHYS2256, 10.1038/nphys2256]; Johri S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.117401; Kjall JA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.107204; Kondov SS, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.083002; Kondov SS, 2011, SCIENCE, V334, P66, DOI 10.1126/science.1209019; Levi E, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.237203; Medvedyeva MV, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.094205; Meldgin C, 2016, NAT PHYS, V12, P646, DOI [10.1038/nphys3695, 10.1038/NPHYS3695]; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Nandkishore R, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.064203; Nanduri A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.064201; Oganesyan V, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155111; Ovadia M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13503; Pal A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174411; Pasienski M, 2010, NAT PHYS, V6, P677, DOI 10.1038/NPHYS1726; Potter AC, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031033; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Roati G, 2008, NATURE, V453, P895, DOI 10.1038/nature07071; Schreiber M, 2015, SCIENCE, V349, P842, DOI 10.1126/science.aaa7432; Schwartz T, 2007, NATURE, V446, P52, DOI 10.1038/nature05623; Semeghini G, 2015, NAT PHYS, V11, P554, DOI 10.1038/NPHYS3339; Serbyn M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.147204; Serbyn M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.127201; Serbyn M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.260601; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Smith J, 2016, NAT PHYS, V12, P907, DOI [10.1038/nphys3783, 10.1038/NPHYS3783]; SREDNICKI M, 1994, PHYS REV E, V50, P888, DOI 10.1103/PhysRevE.50.888; Tanzi L, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.115301; Tasaki H, 1998, PHYS REV LETT, V80, P1373, DOI 10.1103/PhysRevLett.80.1373; Vosk R, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031032; Vosk R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.067204; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Znidaric M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.064426	54	557	558	7	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1547	1552		10.1126/science.aaf8834	http://dx.doi.org/10.1126/science.aaf8834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339981	Green Submitted			2022-12-28	WOS:000378346500036
J	De Breuck, C				De Breuck, Carlos			When the universe became dusty Observations from high-redshift galaxies reveal details of early universe evolution	SCIENCE			English	Editorial Material							STAR-FORMING GALAXIES; C II EMISSION; SIMILAR-TO 7; ALMA; STARBURST; LINE		[De Breuck, Carlos] European So Observ, D-85748 Garching, Germany; [De Breuck, Carlos] Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	European Southern Observatory	De Breuck, C (corresponding author), European So Observ, D-85748 Garching, Germany.; De Breuck, C (corresponding author), Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA.	cdebreuc@eso.org						Capak PL, 2015, NATURE, V522, P455, DOI 10.1038/nature14500; Cormier D, 2015, ASTRON ASTROPHYS, V578, DOI 10.1051/0004-6361/201425207; Ferkinhoff C, 2010, ASTROPHYS J LETT, V714, pL147, DOI 10.1088/2041-8205/714/1/L147; Gullberg B, 2015, MON NOT R ASTRON SOC, V449, P2883, DOI 10.1093/mnras/stv372; Inoue AK, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L18; Inoue AK, 2016, SCIENCE, V352, P1559, DOI 10.1126/science.aaf0714; Maiolino R, 2015, MON NOT R ASTRON SOC, V452, P54, DOI 10.1093/mnras/stv1194; Mancini M, 2015, MON NOT R ASTRON SOC, V451, pL70, DOI 10.1093/mnrasl/slv070; Ouchi M, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/102; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Schaerer D, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201424649; Vallini L, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/1/36; Venemans BP, 2016, ASTROPHYS J, V816, DOI 10.3847/0004-637X/816/1/37	13	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1520	1520		10.1126/science.aaf9761	http://dx.doi.org/10.1126/science.aaf9761			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339970				2022-12-28	WOS:000378346500021
J	Hosten, O; Krishnakumar, R; Engelsen, NJ; Kasevich, MA				Hosten, O.; Krishnakumar, R.; Engelsen, N. J.; Kasevich, M. A.			Quantum phase magnification	SCIENCE			English	Article							SPIN STATES; ENTANGLEMENT; LIMIT; ATOM; GENERATION; CAVITY; TIMES	Quantum metrology exploits entangled states of particles to improve sensing precision beyond the limit achievable with uncorrelated particles. All previous methods required detection noise levels below this standard quantum limit to realize the benefits of the intrinsic sensitivity provided by these states. We experimentally demonstrate a widely applicable method for entanglement-enhanced measurements without low-noise detection. The method involves an intermediate quantum phase magnification step that eases implementation complexity. We used it to perform squeezed-state metrology 8 decibels below the standard quantum limit with a detection system that has a noise floor 10 decibels above the standard quantum limit.	[Hosten, O.; Krishnakumar, R.; Engelsen, N. J.; Kasevich, M. A.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University	Kasevich, MA (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	kasevich@stanford.edu	Engelsen, Nils Johan/L-5865-2017	Engelsen, Nils Johan/0000-0001-8044-4629	Defense Threat Reduction Agency; Office of Naval Research	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Office of Naval Research(Office of Naval Research)	Supported by grants from the Defense Threat Reduction Agency and the Office of Naval Research. We thank M. Schleier-Smith for crucial discussions over the course of this work.	Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; Bohnet JG, 2014, NAT PHOTONICS, V8, P731, DOI [10.1038/nphoton.2014.151, 10.1038/NPHOTON.2014.151]; Bohnet JG, 2016, SCIENCE, V352, P1297, DOI 10.1126/science.aad9958; Cox KC, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.093602; Davis E, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.053601; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Haas F, 2014, SCIENCE, V344, P180, DOI 10.1126/science.1248905; Hamley CD, 2012, NAT PHYS, V8, P305, DOI [10.1038/nphys2245, 10.1038/NPHYS2245]; Hosten O, 2016, NATURE, V529, P505, DOI 10.1038/nature16176; Hume DB, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.253001; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Lee J, 2014, OPT LETT, V39, P4005, DOI 10.1364/OL.39.004005; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.250801; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073602; Lucke B, 2011, SCIENCE, V334, P773, DOI 10.1126/science.1208798; Lucke B, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.155304; Massar S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.060401; McConnell R, 2015, NATURE, V519, P439, DOI 10.1038/nature14293; McConnell R, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.063802; Muessel W, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.023603; Muessel W, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.103004; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988; Schleier-Smith MH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073604; Sewell RJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.253605; Strobel H, 2014, SCIENCE, V345, P424, DOI 10.1126/science.1250147; Stroescu I, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.013412; Takano T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.033601; Volz J, 2011, NATURE, V475, P210, DOI 10.1038/nature10225; Zhang H, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.133603	29	102	102	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1552	1555		10.1126/science.aaf3397	http://dx.doi.org/10.1126/science.aaf3397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339982	Green Submitted			2022-12-28	WOS:000378346500037
J	Donato, AA				Donato, Anthony A.			In patients with new suspected angina, the 7-item PISA model predicted 10-year risk for coronary mortality Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Donato, Anthony A.] Reading Hlth Syst, Reading, PA 19611 USA		Donato, AA (corresponding author), Reading Hlth Syst, Reading, PA 19611 USA.							Jensen JM, 2012, ATHEROSCLEROSIS, V220, P557, DOI 10.1016/j.atherosclerosis.2011.11.027	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					JC70	JC70		10.7326/ACPJC-2016-164-12-070	http://dx.doi.org/10.7326/ACPJC-2016-164-12-070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323266				2022-12-28	WOS:000379343000009
J	Gilbert, WV; Bell, TA; Schaening, C				Gilbert, Wendy V.; Bell, Tristan A.; Schaening, Cassandra			Messenger RNA modifications: Form, distribution, and function	SCIENCE			English	Review							SINGLE-NUCLEOTIDE-RESOLUTION; MAPPING REVEALS; NUCLEAR-RNA; WIDESPREAD OCCURRENCE; N-6-METHYLADENOSINE; METHYLATION; YEAST; PSEUDOURIDYLATION; N6-METHYLADENOSINE; IDENTIFICATION	RNA contains more than 100 distinct modifications that promote the functions of stable noncoding RNAs in translation and splicing. Recent technical advances have revealed widespread and sparse modification of messenger RNAs with N-6-methyladenosine (m(6)A), 5-methylcytosine (m(5)C), and pseudouridine (psi). Here we discuss the rapidly evolving understanding of the location, regulation, and function of these dynamic mRNA marks, collectively termed the epitranscriptome. We highlight differences among modifications and between species that could instruct ongoing efforts to understand how specific mRNA target sites are selected and how their modification is regulated. Diverse molecular consequences of individual m(6)A modifications are beginning to be revealed, but the effects of m(5)C and psi remain largely unknown. Future work linking molecular effects to organismal phenotypes will broaden our understanding of mRNA modifications as cell and developmental regulators.	[Gilbert, Wendy V.; Bell, Tristan A.; Schaening, Cassandra] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bell, Tristan A.] MIT, Grad Program Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Schaening, Cassandra] MIT, Grad Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Gilbert, WV (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	wgilbert@mit.edu		Schaening Burgos, Cassandra/0000-0003-4793-5033	NCI NIH HHS [CA187236, R21 CA187236] Funding Source: Medline; NIGMS NIH HHS [GM101316, T32GM007287, T32 GM087237, T32 GM007287, R01 GM101316] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA187236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101316, T32GM007287, T32GM087237] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Chen K, 2015, ANGEW CHEM INT EDIT, V54, P1587, DOI 10.1002/anie.201410647; DAVIS FF, 1957, J BIOL CHEM, V227, P907; Delatte B, 2016, SCIENCE, V351, P282, DOI 10.1126/science.aac5253; Deng X, 2015, NUCLEIC ACIDS RES, V43, P6557, DOI 10.1093/nar/gkv596; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; Hoernes TP, 2016, NUCLEIC ACIDS RES, V44, P852, DOI 10.1093/nar/gkv1182; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; Li XY, 2016, NAT CHEM BIOL, V12, P311, DOI [10.1038/NCHEMBIO.2040, 10.1038/nchembio.2040]; Li XY, 2015, NAT CHEM BIOL, V11, P592, DOI [10.1038/nchembio.1836, 10.1038/NCHEMBIO.1836]; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu NA, 2015, METHOD ENZYMOL, V560, P149, DOI 10.1016/bs.mie.2015.03.005; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Lovejoy AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110799; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Meyer B, 2011, NUCLEIC ACIDS RES, V39, P1526, DOI 10.1093/nar/gkq931; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Shen L, 2014, ANNU REV BIOCHEM, V83, P585, DOI 10.1146/annurev-biochem-060713-035513; SHIMBA S, 1995, NUCLEIC ACIDS RES, V23, P2421, DOI 10.1093/nar/23.13.2421; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Urban A, 2009, J BIOL CHEM, V284, P5845, DOI 10.1074/jbc.M807986200; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Zhang R, 2014, NAT METHODS, V11, P51, DOI 10.1038/nmeth.2736; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	50	338	350	15	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1408	1412		10.1126/science.aad8711	http://dx.doi.org/10.1126/science.aad8711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313037	Green Accepted, Green Submitted			2022-12-28	WOS:000377975400037
J	Marchalik, D; Jurecic, A				Marchalik, Daniel; Jurecic, Ann			The surgical theatre	LANCET			English	Editorial Material									[Marchalik, Daniel] Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA; [Jurecic, Ann] Rutgers State Univ, Dept English, New Brunswick, NJ 08903 USA	Georgetown University; Rutgers State University New Brunswick	Marchalik, D (corresponding author), Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA.	dan.marchalik@gmail.com		Marchalik, Daniel/0000-0002-6912-1252					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2371	2371		10.1016/S0140-6736(16)30741-3	http://dx.doi.org/10.1016/S0140-6736(16)30741-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1ST	27312296				2022-12-28	WOS:000377560100016
J	Frokjaer-Jensen, C; Jain, N; Hansen, L; Davis, MW; Li, YB; Zhao, D; Rebora, K; Millet, JRM; Liu, X; Kim, SK; Dupuy, D; Jorgensen, EM; Fire, AZ				Frokjaer-Jensen, Christian; Jain, Nimit; Hansen, Loren; Davis, M. Wayne; Li, Yongbin; Zhao, Di; Rebora, Karine; Millet, Jonathan R. M.; Liu, Xiao; Kim, Stuart K.; Dupuy, Denis; Jorgensen, Erik M.; Fire, Andrew Z.			An Abundant Class of Non-coding DNA Can Prevent Stochastic Gene Silencing in the C. elegans Germline	CELL			English	Article							MESSENGER-RNA; X-CHROMOSOMES; EXPRESSION; INTERFERENCE; DYNAMICS; MEIOSIS; HOMOLOG; PATHWAY; SMU-1; ARMS	Cells benefit from silencing foreign genetic elements but must simultaneously avoid inactivating endogenous genes. Although chromatin modifications and RNAs contribute to maintenance of silenced states, the establishment of silenced regions will inevitably reflect underlying DNA sequence and/or structure. Here, we demonstrate that a pervasive non-coding DNA feature in Caenorhabditis elegans, characterized by 10-base pair periodic A(n)/T-n-clusters ( PATCs), can license transgenes for germline expression within repressive chromatin domains. Transgenes containing natural or synthetic PATCs are resistant to position effect variegation and stochastic silencing in the germline. Among endogenous genes, intron length and PATC-character undergo dramatic changes as orthologs move from active to repressive chromatin over evolutionary time, indicating a dynamic character to the A(n)/T-n periodicity. We propose that PATCs form the basis of a cellular immune system, identifying certain endogenous genes in heterochromatic contexts as privileged while foreign DNA can be suppressed with no requirement for a cellular memory of prior exposure.	[Frokjaer-Jensen, Christian; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA; [Frokjaer-Jensen, Christian; Hansen, Loren; Fire, Andrew Z.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Frokjaer-Jensen, Christian] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Frokjaer-Jensen, Christian] Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, DK-2200 Copenhagen N, Denmark; [Jain, Nimit] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Liu, Xiao; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Rebora, Karine; Millet, Jonathan R. M.; Dupuy, Denis] Univ Bordeaux, IECB, Lab ARNA, INSERM,U869, F-33600 Pessac, France; [Kim, Stuart K.; Fire, Andrew Z.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Li, Yongbin; Zhao, Di; Liu, Xiao] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Stanford University; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; Stanford University; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Stanford University; Tsinghua University	Jorgensen, EM (corresponding author), Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA.; Fire, AZ (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Fire, AZ (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	jorgensen@biology.utah.edu; afire@stanford.edu	Dupuy, Denis/M-7299-2014; Jain, Nimit/HIK-2809-2022; Frøkjær-Jensen, Christian/ABB-4637-2020	Millet, Jonathan/0000-0003-4359-9132; Li, Yongbin/0000-0002-0686-0883; , Nimit/0000-0001-8759-2456; Frokjaer-Jensen, Christian/0000-0002-3178-0906; Fire, Andrew/0000-0001-6217-8312; Dupuy, Denis/0000-0002-4781-5595	Carlsberg Foundation; Direktor Ib Henriksens Foundation; Stanford Graduate Fellowship; NIH [R01GM095817, R01GM37706]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095817, R01GM037706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	Carlsberg Foundation(Carlsberg Foundation); Direktor Ib Henriksens Foundation; Stanford Graduate Fellowship(Stanford University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Feldman, A. Villeneuve, S. Strome, A. Rechtsteiner, J. Lieb, K. Ikegami, C. Engert, S. Klemm, T. Machacek, V. Jantsch, C. Girard, G. Maro, D. Nix, the A.Z.F. and E.M.J. lab members, and K. Hoe for expert technical assistance. This work was supported by the Carlsberg Foundation (C.F.J.), Direktor Ib Henriksens Foundation (C.F.J.), a Stanford Graduate Fellowship (N.J.), NIH grants R01GM095817 (E.M.J) and R01GM37706 (A.Z.F.), and the Howard Hughes Medical Institute (E.M.J.).	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BRENNER S, 1974, GENETICS, V77, P71; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Elgin SCR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017780; Fire A, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P153; Fire A, 2006, GENETICS, V173, P1259, DOI 10.1534/genetics.106.057364; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Garrigues JM, 2015, GENOME RES, V25, P76, DOI 10.1101/gr.180489.114; Guoping S, 2010, CHROMOSOMA, V119, P73, DOI 10.1007/s00412-009-0235-3; Heger P, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-84; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; HOLMQUIST GP, 1994, J MOL EVOL, V39, P436; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Johnson CL, 2011, SCIENCE, V333, P1311, DOI 10.1126/science.1208178; Kelly WG, 1997, GENETICS, V146, P227; Kelly WG, 2002, DEVELOPMENT, V129, P479; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Leopold LE, 2015, P NATL ACAD SCI USA, V112, pE2667, DOI 10.1073/pnas.1501979112; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Ortiz MA, 2014, G3-GENES GENOM GENET, V4, P1765, DOI 10.1534/g3.114.012351; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Spartz AK, 2004, MOL CELL BIOL, V24, P6811, DOI 10.1128/MCB.24.15.6811-6823.2004; Spike CA, 2001, MOL CELL BIOL, V21, P4985, DOI 10.1128/MCB.21.15.4985-4995.2001; Stoeckius M, 2014, EMBO J, V33, P1751, DOI 10.15252/embj.201488769; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; VANWYE JD, 1991, NUCLEIC ACIDS RES, V19, P5253, DOI 10.1093/nar/19.19.5253; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	45	49	51	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					343	357		10.1016/j.cell.2016.05.072	http://dx.doi.org/10.1016/j.cell.2016.05.072			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27374334	Green Accepted, Bronze			2022-12-28	WOS:000380255400013
J	Chitty, LS; Wright, D; Hill, M; Verhoef, TI; Daley, R; Lewis, C; Mason, S; McKay, F; Jenkins, L; Howarth, A; Cameron, L; McEwan, A; Fisher, J; Kroese, M; Morris, S				Chitty, Lyn S.; Wright, David; Hill, Melissa; Verhoef, Talitha I.; Daley, Rebecca; Lewis, Celine; Mason, Sarah; McKay, Fiona; Jenkins, Lucy; Howarth, Abigail; Cameron, Louise; McEwan, Alec; Fisher, Jane; Kroese, Mark; Morris, Stephen			Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CELL-FREE DNA; FETAL TRISOMIES; DIAGNOSIS; WOMEN; VIEWS; CONSEQUENCES; TRISOMY-21; ANEUPLOIDY; STATEMENT; IMPACT	OBJECTIVE To investigate the benefits and costs of implementing non-invasive prenatal testing (NIPT) for Down's syndrome into the NHS maternity care pathway. DESIGN Prospective cohort study. SETTING Eight maternity units across the United Kingdom between 1 November 2013 and 28 February 2015. PARTICIPANTS All pregnant women with a current Down's syndrome risk on screening of at least 1/1000. MAIN OUTCOME MEASURES Outcomes were uptake of NIPT, number of cases of Down's syndrome detected, invasive tests performed, and miscarriages avoided. Pregnancy outcomes and costs associated with implementation of NIPT, compared with current screening, were determined using study data on NIPT uptake and invasive testing in combination with national datasets. Results NIPT was prospectively offered to 3175 pregnant women. In 934 women with a Down's syndrome risk greater than 1/150, 695 (74.4%) chose NIPT, 166 (17.8%) chose invasive testing, and 73 (7.8%) declined further testing. Of 2241 women with risks between 1/151 and 1/1000, 1799 (80.3%) chose NIPT. Of 71 pregnancies with a confirmed diagnosis of Down's syndrome, 13/42 (31%) with the diagnosis after NIPT and 2/29 (7%) after direct invasive testing continued, resulting in 12 live births. In an annual screening population of 698 500, offering NIPT as a contingent test to women with a Down's syndrome screening risk of at least 1/150 would increase detection by 195 (95% uncertainty interval -34 to 480) cases with 3368 (2279 to 4027) fewer invasive tests and 17 (7 to 30) fewer procedure related miscarriages, for a non-significant difference in total costs (-46 pound 000, -1802 pound 000 to 2 pound 661 000). The marginal cost of NIPT testing strategies versus current screening is very sensitive to NIPT costs; at a screening threshold of 1/150, NIPT would be cheaper than current screening if it cost less than 256 pound. Lowering the risk threshold increases the number of Down's syndrome cases detected and overall costs, while maintaining the reduction in invasive tests and procedure related miscarriages. CONCLUSIONS Implementation of NIPT as a contingent test within a public sector Down's syndrome screening programme can improve quality of care, choices for women, and overall performance within the current budget. As some women use NIPT for information only, the Down's syndrome live birth rate may not change significantly. Future research should consider NIPT uptake and informed decision making outside of a research setting.	[Chitty, Lyn S.; Hill, Melissa; Lewis, Celine] UCL Inst Child Hlth, Genet & Genom Med, London WC1N 3BH, England; [Chitty, Lyn S.; Daley, Rebecca; Lewis, Celine; Howarth, Abigail] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Wright, David] Univ Plymouth, Dept Stat, Plymouth, Devon, England; [Verhoef, Talitha I.; Morris, Stephen] UCL, Dept Appl Hlth Res, London, England; [Mason, Sarah; McKay, Fiona; Jenkins, Lucy] Great Ormond St Hosp Children NHS Fdn Trust, North East Thames Reg Genet Lab, London, England; [Cameron, Louise; Kroese, Mark] PHG Fdn, Cambridge, England; [McEwan, Alec] Univ Nottingham Hosp, Dept Obstet & Gynaecol, Nottingham, England; [Fisher, Jane] AFRC, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Plymouth; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Nottingham	Chitty, LS (corresponding author), UCL Inst Child Hlth, Genet & Genom Med, London WC1N 3BH, England.; Chitty, LS (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, London, England.	l.chitty@ucl.ac.uk	Hill, Melissa/AIC-6192-2022	Kroese, Mark/0000-0002-4280-108X; Morris, Stephen/0000-0002-5828-3563; chitty, lyn/0000-0002-4857-7138; Hill, Melissa/0000-0003-3900-1425; Daley, Rebecca/0000-0002-5137-7639	National Institute for Health Research (NIHR) [RP-PG-0707-10107]; NIHR Comprehensive Local Research Network; Great Ormond Street Hospital Children's Charity; NIHR Comprehensive Biomedical Research Centre at Great Ormond Street Hospital (GOSH); NIHR Efficacy and Mechanism Evaluation (EME) Programme; National Institute for Health Research [RP-PG-0707-10107, NF-SI-0513-10141] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Comprehensive Local Research Network; Great Ormond Street Hospital Children's Charity; NIHR Comprehensive Biomedical Research Centre at Great Ormond Street Hospital (GOSH); NIHR Efficacy and Mechanism Evaluation (EME) Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by National Institute for Health Research (NIHR) programme grants for applied research (RP-PG-0707-10107). Additional funding to support the study came from the NIHR Comprehensive Local Research Network, the Great Ormond Street Hospital Children's Charity, the NIHR Comprehensive Biomedical Research Centre at Great Ormond Street Hospital (GOSH), and the NIHR Efficacy and Mechanism Evaluation (EME) Programme. The research funded is independent, and the views expressed in the paper are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	[Anonymous], 2015, Obstet Gynecol, V126, pe31, DOI 10.1097/AOG.0000000000001051; Ayres AC, 2014, AUST NZ J OBSTET GYN, V54, P412, DOI 10.1111/ajo.12223; Benn P, 2015, PRENATAL DIAG, V35, P725, DOI 10.1002/pd.4608; Beulen L, 2014, EUR J OBSTET GYN R B, V182, P53, DOI 10.1016/j.ejogrb.2014.08.028; Chetty S, 2013, PRENATAL DIAG, V33, P542, DOI 10.1002/pd.4125; Cuckle H, 2015, CLIN BIOCHEM, V48, P932, DOI 10.1016/j.clinbiochem.2015.02.011; Cuckle H, 2013, PRENATAL DIAG, V33, P636, DOI 10.1002/pd.4157; Curtis L, 2013, UNIT COSTS HLTH SOCI; Department of Health, 2013, NHS REF COSTS 2012 2; Fetal Anomaly Screening Programme NHS, 2012, DEC PLANN TOOL; Garfield SS, 2012, J MANAGED CARE MED, V15, P34; Gil MM, 2016, ULTRASOUND OBST GYN, V47, P45, DOI 10.1002/uog.15783; Gil MM, 2015, ULTRASOUND OBST GYN, V45, P249, DOI 10.1002/uog.14791; Gil MM, 2015, ULTRASOUND OBST GYN, V45, P67, DOI 10.1002/uog.14683; Grody WW, 2013, GENET MED, V15, P482, DOI 10.1038/gim.2013.47; Hill M, 2016, EUR J HUM GENET, V24, P968, DOI 10.1038/ejhg.2015.249; Hill M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-229; Johnson J, 2013, PRENATAL DIAG, V33, P1044, DOI 10.1002/pd.4194; Langlois S, 2013, J OBSTET GYNAECOL CA, V35, P177, DOI 10.1016/S1701-2163(15)31025-2; Lewis C, 2014, BJOG-INT J OBSTET GY, V121, P582, DOI 10.1111/1471-0528.12579; Lewis C, 2013, PUBLIC HEALTH GENOM, V16, P223, DOI 10.1159/000353523; Lewis C, 2016, EUR J HUM GENET, V24, P809, DOI 10.1038/ejhg.2015.207; Lo KK, 2014, BIOINFORMATICS, V30, P2965, DOI 10.1093/bioinformatics/btu419; Minear MA, 2015, PRENATAL DIAG, V35, P959, DOI 10.1002/pd.4637; Morris S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093559; National Institute for Health and Care Excellence, 2014, DEV NICE GUID MAN; Neyt M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005922; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; O'Leary P, 2013, AUST NZ J OBSTET GYN, V53, P425, DOI 10.1111/ajo.12136; Office of National Statistics, 2014, STAT B BIRTHS ENGL W; Ohno M, 2013, PRENATAL DIAG, V33, P630, DOI 10.1002/pd.4156; Okun N, 2014, PRENATAL DIAG, V34, P350, DOI 10.1002/pd.4311; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Petersen OB, 2014, ULTRASOUND OBST GYN, V43, P265, DOI 10.1002/uog.13270; Public Health England, 2014, SYNDR SCREEN QUAL AS; Royal College of Obsetricians and Gynaecologists, 2014, 15 ROYAL COLL OBS GY; Song K, 2013, J MATERN-FETAL NEO M, V26, P1180, DOI 10.3109/14767058.2013.770464; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Tischler R, 2011, PRENATAL DIAG, V31, P1292, DOI 10.1002/pd.2888; Wagner P, 2016, ULTRASOUND OBST GYN, V48, P446, DOI 10.1002/uog.15829; Wald NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058732; Walker BS, 2015, PRENATAL DIAG, V35, P440, DOI 10.1002/pd.4511; Warsof SL, 2015, PRENATAL DIAG, V35, P972, DOI 10.1002/pd.4601; Wax JR, 2015, J CLIN ULTRASOUND, V43, P1, DOI 10.1002/jcu.22243; Zhang H, 2015, ULTRASOUND OBST GYN, V45, P530, DOI 10.1002/uog.14792	45	100	105	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2016	354								i3426	10.1136/bmj.i3426	http://dx.doi.org/10.1136/bmj.i3426			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EA	27378786	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000379579600002
J	Alonso-Coello, P; Oxman, AD; Moberg, J; Brignardello-Petersen, R; Akl, EA; Davoli, M; Treweek, S; Mustafa, RA; Vandvik, PO; Meerpohl, J; Guyatt, GH; Schunemann, HJ				Alonso-Coello, Pablo; Oxman, Andrew D.; Moberg, Jenny; Brignardello-Petersen, Romina; Akl, Elie A.; Davoli, Marina; Treweek, Shaun; Mustafa, Reem A.; Vandvik, Per O.; Meerpohl, Joerg; Guyatt, Gordon H.; Schunemann, Holger J.		GRADE Working Grp	GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WARFARIN; DABIGATRAN; RECOMMENDATIONS; DETERMINANTS; PREVENTION; CHECKLIST; STROKE		[Alonso-Coello, Pablo] CIBERESP IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain; [Alonso-Coello, Pablo; Brignardello-Petersen, Romina; Akl, Elie A.; Mustafa, Reem A.; Guyatt, Gordon H.; Schunemann, Holger J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Oxman, Andrew D.; Moberg, Jenny; Vandvik, Per O.] Norwegian Inst Publ Hlth, Global Hlth Unit, Oslo, Norway; [Brignardello-Petersen, Romina] Univ Chile, Fac Dent, Evidence Based Dent Unit, Santiago, Chile; [Akl, Elie A.] Amer Univ Beirut, Dept Internal Med, Med Ctr, Clin Epidemiol Unit, Beirut, Lebanon; [Davoli, Marina] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Treweek, Shaun] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Mustafa, Reem A.] Univ Missouri, Dept Med, Kansas City, MO USA; [Meerpohl, Joerg] Univ Freiburg, Fac Med, Med Ctr, Cochrane Germany, Freiburg, Germany; [Guyatt, Gordon H.; Schunemann, Holger J.] McMaster Univ, Dept Med, Hamilton, ON, Canada	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; McMaster University; Norwegian Institute of Public Health (NIPH); Universidad de Chile; American University of Beirut; University of Aberdeen; University of Missouri System; University of Missouri Kansas City; University of Freiburg; McMaster University	Alonso-Coello, P (corresponding author), CIBERESP IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain.; Alonso-Coello, P (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	palonso@santpau.cat	Akl, Elie A/R-2079-2016; Meerpohl, Joerg J/J-4224-2013; Oxman, Andrew/Y-3004-2019; Treweek, Shaun/AAE-8006-2019; Davoli, Marina/K-1975-2016; ETXEANDIA-IKOBALTZETA, ITZIAR/AAG-3519-2022; Singh, Jasvinder/R-6172-2019; ETXEANDIA-IKOBALTZETA, ITZIAR/AFK-4845-2022; Akl, Elie/K-5269-2019	Akl, Elie A/0000-0002-3444-8618; Meerpohl, Joerg J/0000-0002-1333-5403; Oxman, Andrew/0000-0002-5608-5061; Treweek, Shaun/0000-0002-7239-7241; Davoli, Marina/0000-0003-4521-032X; ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; Singh, Jasvinder/0000-0003-3485-0006; ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; 	European Commission FP7 Program as part of the DECIDE project [258583]; Chief Scientist Office [HSRU2] Funding Source: researchfish	European Commission FP7 Program as part of the DECIDE project; Chief Scientist Office	Work on this article has been partially funded by the European Commission FP7 Program (grant agreement 258583) as part of the DECIDE project. Sole responsibility lies with the authors; the European Commission is not responsible for any use that may be made of the information contained therein.	Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2016; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Beauchamp Tom L., 2019, PRINCIPLES BIOMEDICA, V8th; Brunetti M, 2013, J CLIN EPIDEMIOL, V66, P140, DOI 10.1016/j.jclinepi.2012.04.012; Connolly SJ, 2009, N ENGL J MED, V361, P1139, DOI [10.1056/NEJMoa0905561, DOI 10.1056/NEJM0A0905561]; Dans AM, 2007, J CLIN EPIDEMIOL, V60, P540, DOI 10.1016/j.jclinepi.2006.10.008; Earle CC, 2000, J CLIN ONCOL, V18, P3302, DOI 10.1200/JCO.2000.18.18.3302; Flottorp SA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-35; Fretheim A, 2009, HEALTH RES POLICY SY, V7, DOI 10.1186/1478-4505-7-S1-S18; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Guyatt G, 2013, J CLIN EPIDEMIOL, V66, P151, DOI 10.1016/j.jclinepi.2012.01.006; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; HALL J, 1992, SOC SCI MED, V34, P993, DOI 10.1016/0277-9536(92)90130-I; Hamidi V, 2010, RAPPORT FRA KUNNSKAP; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Laine C, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00011; MacLean S, 2012, CHEST, V141, pE1S, DOI 10.1378/chest.11-2290; Morville P, 2004, USER EXPERIENCE DESI; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P24, DOI 10.1186/1478-4505-4-24; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Richardson WS, 1995, ACP J CLUB, V123, pA12, DOI DOI 10.7326/ACPJC-1995-123-3-A12; Rosenbaum SE, 2010, IMPROVING USER EXPER, P108; Saarni SI, 2011, INT J TECHNOL ASSESS, V27, P305, DOI 10.1017/S0266462311000444; Schunemann HJ, 2014, CAN MED ASSOC J, V186, pE123, DOI 10.1503/cmaj.131237; Sorensen SV, 2013, PHARMACOECONOMICS, V31, P589, DOI 10.1007/s40273-013-0035-8; Sun X, 2014, JAMA-J AM MED ASSOC, V311, P405, DOI 10.1001/jama.2013.285063; Treweek S, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-6; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4	32	149	150	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i2089	10.1136/bmj.i2089	http://dx.doi.org/10.1136/bmj.i2089			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27365494	Green Published, Bronze			2022-12-28	WOS:000379019700001
J	Geitmann, A				Geitmann, Anja			Actuators Acting without Actin	CELL			English	Editorial Material							PLANT	Plant actuators move organs, allowing the plant to respond to environmental cues or perform other mechanical tasks. In Cardamine hursuta the dispersal of seeds is accomplished by explosive opening of the fruit. The biomechanical mechanism relies on a complex interplay between turgor regulation and cell wall mechanical properties.	[Geitmann, Anja] McGill Univ, Fac Agr & Environm Sci, Dept Plant Sci, Macdonald Campus,21111 Lakeshore, Ste Anne De Bellevue, PQ H9X 3V9, Canada	McGill University	Geitmann, A (corresponding author), McGill Univ, Fac Agr & Environm Sci, Dept Plant Sci, Macdonald Campus,21111 Lakeshore, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	anja.geitmann@mcgill.ca	Geitmann, Anja/D-4696-2012	Geitmann, Anja/0000-0003-0390-0517				Armon S, 2011, SCIENCE, V333, P1726, DOI 10.1126/science.1203874; Dumais J, 2012, ANNU REV FLUID MECH, V44, P453, DOI 10.1146/annurev-fluid-120710-101200; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Hofhuis H, 2016, CELL, V166, P222, DOI 10.1016/j.cell.2016.05.002; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Stolarz M, 2009, PLANT SIGNAL BEHAV, V4, P380, DOI 10.4161/psb.4.5.8293; Vincent O, 2011, P ROY SOC B-BIOL SCI, V278, P2909, DOI 10.1098/rspb.2010.2292	7	11	11	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					15	17		10.1016/j.cell.2016.06.030	http://dx.doi.org/10.1016/j.cell.2016.06.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368097	Bronze			2022-12-28	WOS:000380254400007
J	Hallegatte, S; Mach, KJ				Hallegatte, Stephane; Mach, Katharine J.			Make climate-change assessments more relevant	NATURE			English	Editorial Material									[Hallegatte, Stephane] World Bank, Climate Change Policy Team, 1818 H St NW, Washington, DC 20433 USA; [Mach, Katharine J.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA	The World Bank; Carnegie Institution for Science	Hallegatte, S (corresponding author), World Bank, Climate Change Policy Team, 1818 H St NW, Washington, DC 20433 USA.	shallegatte@worldbank.org		Oppenheimer, Michael/0000-0002-9708-5914				Clark PU, 2016, NAT CLIM CHANGE, V6, P360, DOI 10.1038/NCLIMATE2923; Hallegatte S., 2016, CLIMATE CHANGE DEV S; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Kriegler E, 2015, TECHNOL FORECAST SOC, V90, P1, DOI 10.1016/j.techfore.2014.10.012; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Otto FEL, 2015, NAT CLIM CHANGE, V5, P917, DOI 10.1038/NCLIMATE2716; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Rogelj J, 2014, P NATL ACAD SCI USA, V111, P16325, DOI 10.1073/pnas.1415631111; Steinacher M, 2013, NATURE, V499, P197, DOI 10.1038/nature12269; van Vuuren DP, 2011, CLIMATIC CHANGE, V104, P793, DOI 10.1007/s10584-010-0004-6	10	26	26	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					613	615		10.1038/534613a	http://dx.doi.org/10.1038/534613a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP7JV	27357778	Bronze			2022-12-28	WOS:000378676000012
J	Orwoll, E				Orwoll, Eric			Passing the Baton - Harnessing the Full Value of Older Scientists	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Orwoll, Eric] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Orwoll, E (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.							Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Kaiser J, 2008, SCIENCE, V322, P848, DOI 10.1126/science.322.5903.848; Lawrence P, 2008, NATURE, V453, P588, DOI 10.1038/453588a; National Institute of Health, 2014, PHYS SCI WORKF WORK; Rockey S., 2012, AGE DISTRIBUTION NIH	5	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2514	2517		10.1056/NEJMp1603666	http://dx.doi.org/10.1056/NEJMp1603666			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP8DD	27355531				2022-12-28	WOS:000378727200003
J	Rosenthal, AK; Ryan, LM				Rosenthal, Ann K.; Ryan, Lawrence M.			Calcium Pyrophosphate Deposition Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CRYSTAL DEPOSITION; ARTICULAR-CARTILAGE; INORGANIC PYROPHOSPHATE; EXTRACELLULAR ATP; MONOSODIUM URATE; CHONDROCALCINOSIS; PSEUDOGOUT; DIHYDRATE; OSTEOARTHRITIS; PREVALENCE		[Rosenthal, Ann K.; Ryan, Lawrence M.] Med Coll Wisconsin, Dept Med, Div Rheumatol, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Rosenthal, Ann K.] Zablocki Vet Affairs Med Ctr, Dept Med, Milwaukee, WI USA	Medical College of Wisconsin	Rosenthal, AK (corresponding author), Med Coll Wisconsin, Dept Med, Div Rheumatol, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	arosenthal@mcw.edu			Veterans Affairs [I01CX001143] Funding Source: NIH RePORTER; CSRD VA [I01 CX001143] Funding Source: Medline	Veterans Affairs(US Department of Veterans Affairs); CSRD VA		Abhishek A, 2014, ANN RHEUM DIS, V73, P1997, DOI 10.1136/annrheumdis-2013-203400; ALVARELLOS A, 1986, J RHEUMATOL, V13, P804; Ames Paul R J, 2007, Mod Rheumatol, V17, P445, DOI 10.1007/s10165-007-0601-z; BILEZIKIAN J P, 1973, Lancet, V1, P445; Chollet-Janin A, 2007, ARTHRITIS RHEUM-US, V56, P688, DOI 10.1002/art.22389; Costello JC, 2011, CONNECT TISSUE RES, V52, P139, DOI 10.3109/03008207.2010.491928; DERFUS BA, 1992, ARTHRITIS RHEUM, V35, P231, DOI 10.1002/art.1780350218; Derfus BA, 2002, J RHEUMATOL, V29, P570; DOHERTY M, 1982, LANCET, V1, P1207; Ea HK, 2005, J RHEUMATOL, V32, P1840; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Finckh A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0458-4; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Fuerst M, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-166; GLASS JS, 1976, ANN RHEUM DIS, V35, P521, DOI 10.1136/ard.35.6.521; Godfrin-Valnet M, 2013, NEUROCHIRURGIE, V59, P115, DOI 10.1016/j.neuchi.2013.03.003; Hammesfahr J F Rick, 2003, Am J Orthop (Belle Mead NJ), V32, P277; Harato K, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-014-0145-9; Jaccard YB, 1996, REV RHUM, V63, P331; JONES AC, 1992, SEMIN ARTHRITIS RHEU, V22, P188, DOI 10.1016/0049-0172(92)90019-A; Kumar V, 2015, KNEE SURG SPORTS TRA; Lee RS, 2006, J ANAT, V208, P13, DOI 10.1111/j.1469-7580.2006.00504.x; Liu-Bryan R, 2005, J IMMUNOL, V174, P5016, DOI 10.4049/jimmunol.174.8.5016; Loffler C, 2015, J RHEUMATOL, V42, P513, DOI 10.3899/jrheum.140634; LUST G, 1981, ARTHRITIS RHEUM, V24, P1517, DOI 10.1002/art.1780241210; Malnick SDH, 1997, ANN PHARMACOTHER, V31, P499, DOI 10.1177/106002809703100422; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MASUDA I, 1988, CLIN ORTHOP RELAT R, P173; MCCARTY DJ, 1972, J LAB CLIN MED, V79, P277; MCCARTY DJ, 1966, J BONE JOINT SURG AM, VA 48, P309, DOI 10.2106/00004623-196648020-00009; MCCARTY DJ, 1962, ANN INTERN MED, V56, P711, DOI 10.7326/0003-4819-56-5-711; MCCARTY DJ, 1975, B RHEUM DIS, V25, P804; Miksanek J, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0496-1; Muehleman C, 2008, J RHEUMATOL, V35, P1108; Neame RL, 2003, ANN RHEUM DIS, V62, P513, DOI 10.1136/ard.62.6.513; Ottaviani S, 2013, JOINT BONE SPINE, V80, P178, DOI 10.1016/j.jbspin.2012.07.018; Pang L, 2013, J IMMUNOL, V190, P6488, DOI 10.4049/jimmunol.1203215; Pawlotsky Y, 1999, ARTHRITIS RHEUM, V42, P799; Punzi L, 1998, REV RHUM, V65, P571; Ramos YFM, 2015, ANN RHEUM DIS, V74, P1756, DOI 10.1136/annrheumdis-2013-205149; Reuben PM, 2001, CONNECT TISSUE RES, V42, P1, DOI 10.3109/03008200109014244; Rho YH, 2012, RHEUMATOLOGY, V51, P2070, DOI 10.1093/rheumatology/kes204; Richette P, 2005, J RHEUMATOL, V32, P2434; Rosenthal AK, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4337; Rothschild Bruce, 1997, Comprehensive Therapy, V23, P327; Ryan L., 1985, ARTHRITIS ALLIED CON, V10th ed., P1515; Ryan L, 1989, ARTHRITIS ALLIED CON, P1711; Ryan LM, 2003, CURR OPIN RHEUMATOL, V15, P311, DOI 10.1097/00002281-200305000-00020; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; WILKINS E, 1983, ANN RHEUM DIS, V42, P280, DOI 10.1136/ard.42.3.280; Williams CJ, 2003, ARTHRITIS RHEUM, V48, P2627, DOI 10.1002/art.11133; Yamakawa K, 2001, PATHOL RES PRACT, V197, P499, DOI 10.1078/0344-0338-00118; Yayama T, 2008, CLIN RHEUMATOL, V27, P597, DOI 10.1007/s10067-007-0754-3; Zhang W, 2011, ANN RHEUM DIS, V70, P571, DOI 10.1136/ard.2010.139360; Zhang W, 2011, ANN RHEUM DIS, V70, P563, DOI 10.1136/ard.2010.139105; ZITNAN D, 1963, ANN RHEUM DIS, V22, P142, DOI 10.1136/ard.22.3.142	56	157	171	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2575	2584		10.1056/NEJMra1511117	http://dx.doi.org/10.1056/NEJMra1511117			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8DD	27355536	Green Accepted			2022-12-28	WOS:000378727200009
J	Sana, TG; Monack, DM				Sana, Thibault G.; Monack, Denise M.			MICROBIOLOGY The dark side of antibiotics	NATURE			English	Editorial Material							ETHANOLAMINE; SALMONELLA; PATHOGENS; DIARRHEA		[Sana, Thibault G.; Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University	Sana, TG (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	tsana@stanford.edu; dmonack@stanford.edu	Sana, Thibault G/B-1599-2013	Monack, Denise/0000-0003-3804-2209; Sana, Thibault/0000-0003-0723-6924	NIAID NIH HHS [R01 AI116059] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116059] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2016, TACKL DRUG RES INF G; Bergogne-Berezin E, 2000, INT J ANTIMICROB AG, V16, P521, DOI 10.1016/S0924-8579(00)00293-4; BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; Faber F, 2016, NATURE, V534, P697, DOI 10.1038/nature18597; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Hogenauer C, 1998, CLIN INFECT DIS, V27, P702, DOI 10.1086/514958; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Lamichhane-Khadka R, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130146; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; PAVIA AT, 1990, J INFECT DIS, V161, P255, DOI 10.1093/infdis/161.2.255; Songhet P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013804; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108	13	22	22	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					624	625		10.1038/nature18449	http://dx.doi.org/10.1038/nature18449			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27309812				2022-12-28	WOS:000378676000022
J	Simonich, CA; Williams, KL; Verkerke, HP; Williams, JA; Nduati, R; Lee, KK; Overbaugh, J				Simonich, Cassandra A.; Williams, Katherine L.; Verkerke, Hans P.; Williams, James A.; Nduati, Ruth; Lee, Kelly K.; Overbaugh, Julie			HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; B-CELL RESPONSES; AFFINITY MATURATION; POTENT; BROAD; VACCINE; GLYCOPROTEIN; BINDING; EPITOPE	HIV-1 broadly neutralizing antibodies (bnAbs) develop in a subset of infected adults and exhibit high levels of somatic hypermutation (SHM) due to years of affinity maturation. There is no precedent for eliciting highly mutated antibodies by vaccination, nor is it practical to wait years for a desired response. Infants develop broad responses early, which may suggest a more direct path to generating bnAbs. Here, we isolated ten neutralizing antibodies (nAbs) contributing to plasma breadth of an infant at similar to 1 year post-infection, including one with cross-clade breadth. The nAbs bind to envelope trimer from the transmitted virus, suggesting that this interaction may have initiated development of the infant nAbs. The infant cross-clade bnAb targets the N332 supersite on envelope but, unlike adult bnAbs targeting this site, lacks indels and has low SHM. The identification of this infant bnAb illustrates that HIV-1-specific neutralization breadth can develop without prolonged affinity maturation and extensive SHM.	[Simonich, Cassandra A.; Williams, Katherine L.; Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Simonich, Cassandra A.; Overbaugh, Julie] Univ Washington, Sch Med, Med Scientist Training Program, Seattle, WA 98195 USA; [Verkerke, Hans P.; Williams, James A.; Lee, Kelly K.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Nduati, Ruth] Univ Nairobi, Dept Pediat & Child Hlth, Nairobi, Kenya	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi	Overbaugh, J (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.; Overbaugh, J (corresponding author), Univ Washington, Sch Med, Med Scientist Training Program, Seattle, WA 98195 USA.	joverbau@fredhutch.org		Simonich, Cassandra/0000-0001-6100-4652; Williams, James/0000-0003-4998-6571	NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH [12670]; NIH [R01 AI076105, R01 AI103981, R01 AI120961, R21 AI112389, F30 AI122866, T32 AI083203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI122866, T32AI083203, R01AI076105, R01AI120961, R21AI112389, R01AI103981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the participants and staff of the Nairobi Breastfeeding Trial. We are grateful to Justin Taylor for helpful discussions regarding flow cytometry, John McNevin for help with cell sorting, Stephanie Rainwater and Brianna Hennessy for assistance preparing pseudoviruses and constructing BF520 envelope clones, Stanley Riddell for providing 3T3/CD40L cells, and David Veesler for advice regarding analysis of EM data. Panel of Global HIV-1 Env Clones (cat# 12670) was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH from David Montefiori. This work was supported by NIH grants R01 AI076105, R01 AI103981, R01 AI120961, R21 AI112389, F30 AI122866, and T32 AI083203.	Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Doria-Rose NA, 2015, CURR OPIN VIROL, V11, P137, DOI 10.1016/j.coviro.2015.04.002; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Eroshkin AM, 2014, NUCLEIC ACIDS RES, V42, pD1133, DOI 10.1093/nar/gkt1083; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; Goo L, 2014, NAT MED, V20, P655, DOI 10.1038/nm.3565; Goo L, 2012, J VIROL, V86, P10857, DOI 10.1128/JVI.01414-12; Goo L, 2012, J VIROL, V86, P9566, DOI 10.1128/JVI.00953-12; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Kepler TB, 2014, CELL HOST MICROBE, V16, P304, DOI 10.1016/j.chom.2014.08.006; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Lee JH, 2015, STRUCTURE, V23, P1943, DOI 10.1016/j.str.2015.07.020; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li LD, 2016, IEEE T CYBERNETICS, V46, P39, DOI 10.1109/TCYB.2015.2392129; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lovelace E, 2011, VIROLOGY, V421, P235, DOI 10.1016/j.virol.2011.09.032; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Milligan C, 2016, MBIO, V7, DOI 10.1128/mBio.02221-15; Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12; Mouquet H, 2014, TRENDS IMMUNOL, V35, P549, DOI 10.1016/j.it.2014.08.007; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scherer EM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004461; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153; Williams KL, 2015, EBIOMEDICINE, V2, P1464, DOI 10.1016/j.ebiom.2015.09.001; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Yu L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00250; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11	58	91	95	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					77	87		10.1016/j.cell.2016.05.055	http://dx.doi.org/10.1016/j.cell.2016.05.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27345369	Bronze, Green Accepted			2022-12-28	WOS:000380254400012
J	Shin, HJR; Kim, H; Oh, S; Lee, JG; Kee, M; Ko, HJ; Kweon, MN; Won, KJ; Baek, SH				Shin, Hi-Jai R.; Kim, Hyunkyung; Oh, Sungryong; Lee, Jun-Gi; Kee, Minjung; Ko, Hyun-Jeong; Kweon, Mi-Na; Won, Kyoung-Jae; Baek, Sung Hee			AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; AMPK; COACTIVATOR; DEGRADATION; HOMEOSTASIS; EXPRESSION; INHIBITOR; COMPLEXES; DISEASE; TFEB	Autophagy is a highly conserved self-digestion process, which is essential for maintaining homeostasis and viability in response to nutrient starvation(1-4). Although the components of autophagy in the cytoplasm have been well studied(5,6), the molecular basis for the transcriptional and epigenetic regulation of autophagy is poorly understood. Here we identify co-activator-associated arginine methyltransferase 1 (CARM1) as a crucial component of autophagy in mammals. Notably, CARM1 stability is regulated by the SKP2-containing SCF (SKP1-cullin1-F-box protein) E3 ubiquitin ligase in the nucleus, but not in the cytoplasm, under nutrient-rich conditions. Furthermore, we show that nutrient starvation results in AMP-activated protein kinase (AMPK)-dependent phosphorylation of FOXO3a in the nucleus, which in turn transcriptionally represses SKP2. This repression leads to increased levels of CARM1 protein and subsequent increases in histone H3 Arg17 dimethylation. Genome-wide analyses reveal that CARM1 exerts transcriptional co-activator function on autophagy-related and lysosomal genes through transcription factor EB (TFEB). Our findings demonstrate that CARM1-dependent histone arginine methylation is a crucial nuclear event in autophagy, and identify a new signalling axis of AMPK-SKP2-CARM1 in the regulation of autophagy induction after nutrient starvation.	[Shin, Hi-Jai R.; Kim, Hyunkyung; Oh, Sungryong; Lee, Jun-Gi; Kee, Minjung; Baek, Sung Hee] Seoul Natl Univ, Sch Biol Sci, Creat Res Initiat Ctr Chromatin Dynam, Seoul, South Korea; [Ko, Hyun-Jeong] Kangwon Natl Univ, Coll Pharm, Lab Microbiol & Immunol, Chunchon, South Korea; [Kweon, Mi-Na] Univ Ulsan, Coll Med, Asan Med Ctr, Mucosal Immunol Lab,Dept Convergence Med, Seoul, South Korea; [Won, Kyoung-Jae] Univ Penn, Perelman Sch Med, Dept Genet, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	Seoul National University (SNU); Kangwon National University; University of Ulsan; Asan Medical Center; University of Pennsylvania; Pennsylvania Medicine	Baek, SH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Creat Res Initiat Ctr Chromatin Dynam, Seoul, South Korea.	sbaek@snu.ac.kr		Shin, Hijai Regina/0000-0001-5642-4441; Won, Kyoung Jae/0000-0002-2924-9630; Ko, Hyun-Jeong/0000-0002-3844-928X; Kim, Hyunkyung/0000-0001-7678-6087	Creative Research Initiatives Program (Research Center for Chromatin Dynamics) [2009-0081563]; National Junior Research Fellowship [NRF-2011-A01496-0001806]; National Research Foundation (NRF) - South Korean government (MSIP) [NRF-2014R1A6A3A0405 7910]; NIH [R01DK106027]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106027] Funding Source: NIH RePORTER	Creative Research Initiatives Program (Research Center for Chromatin Dynamics); National Junior Research Fellowship; National Research Foundation (NRF) - South Korean government (MSIP); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Chromatin Dynamics Research Center for technical assistance and discussions and J. Kim and J. Chung for valuable reagents and discussions. We thank Y. S. Yu for illustrations. The TEM data were analysed in the Korean Basic Science Institute. Carm1 knockout and knock-in MEFs were provided by M. T. Bedford. Ampk DKO MEFs was a gift from B. Viollet, and Foxo1.3.4<SUP>f/f</SUP> MEFs were a gift from R. DePinho and J.-H. Paik. This work was supported by Creative Research Initiatives Program (Research Center for Chromatin Dynamics, 2009-0081563) to S.H.B.; the National Junior Research Fellowship (NRF-2011-A01496-0001806) to H.-J.R.S.; the Basic Science Research Program (NRF-2014R1A6A3A0405 7910) to H.K. from the National Research Foundation (NRF) grant funded by the South Korean government (MSIP); NIH grant (R01DK106027) to K.-J.W.	Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Boo K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7810; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen Z, 2013, BBA-PROTEINS PROTEOM, V1834, P1461, DOI 10.1016/j.bbapap.2013.04.006; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hardie DG, 2011, EMBO J, V30, P634, DOI 10.1038/emboj.2011.12; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim H, 2011, MOL CELL, V44, P797, DOI 10.1016/j.molcel.2011.09.023; Kim IS, 2012, MOL CELL, V46, P260, DOI 10.1016/j.molcel.2012.03.021; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Selvi BR, 2010, J BIOL CHEM, V285, P7143, DOI 10.1074/jbc.M109.063933; Settembre C, 2015, METHOD CELL BIOL, V126, P45, DOI 10.1016/bs.mcb.2014.11.011; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Wang K, 2010, J BIOL CHEM, V285, P16958, DOI 10.1074/jbc.M109.093005; Yang YC, 2014, J THORAC ONCOL, V9, P1305, DOI 10.1097/JTO.0000000000000240; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814	32	270	280	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					553	+		10.1038/nature18014	http://dx.doi.org/10.1038/nature18014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309807	Green Accepted			2022-12-28	WOS:000378270300054
J	Vasek, MJ; Garber, C; Dorsey, D; Durrant, DM; Bollman, B; Soung, A; Yu, JS; Perez-Torres, C; Frouin, A; Wilton, DK; Funk, K; DeMasters, BK; Jiang, XP; Bowen, JR; Mennerick, S; Robinson, JK; Garbow, JR; Tyler, KL; Suthar, MS; Schmidt, RE; Stevens, B; Klein, RS				Vasek, Michael J.; Garber, Charise; Dorsey, Denise; Durrant, Douglas M.; Bollman, Bryan; Soung, Allison; Yu, Jinsheng; Perez-Torres, Carlos; Frouin, Arnaud; Wilton, Daniel K.; Funk, Kristen; DeMasters, Bette K.; Jiang, Xiaoping; Bowen, James R.; Mennerick, Steven; Robinson, John K.; Garbow, Joel R.; Tyler, Kenneth L.; Suthar, Mehul S.; Schmidt, Robert E.; Stevens, Beth; Klein, Robyn S.			A complement-microglial axis drives synapse loss during virus-induced memory impairment	NATURE			English	Article							WEST-NILE-VIRUS; INFECTION; ACTIVATION; CNS; TRAFFICKING; PROTECTS; DEATH	Over 50% of patients who survive neuroinvasive infection with West Nile virus (WNV) exhibit chronic cognitive sequelae(1,2). Although thousands of cases of WNV-mediated memory dysfunction accrue annually(3), the mechanisms responsible for these impairments are unknown. The classical complement cascade, a key component of innate immune pathogen defence, mediates synaptic pruning by microglia during early postnatal development(4,5). Here we show that viral infection of adult hippocampal neurons induces complement-mediated elimination of presynaptic terminals in a murine WNV neuroinvasive disease model. Inoculation of WNV-NS5-E218A, a WNV with a mutant NS5(E218A) protein(6,7) leads to survival rates and cognitive dysfunction that mirror human WNV neuroinvasive disease. WNV-NS5-E218A-recovered mice (recovery defined as survival after acute infection) display impaired spatial learning and persistence of phagocytic microglia without loss of hippocampal neurons or volume. Hippocampi from WNV-NS5-E218A-recovered mice with poor spatial learning show increased expression of genes that drive synaptic remodelling by microglia via complement. C1QA was upregulated and localized to microglia, infected neurons and presynaptic terminals during WNV neuroinvasive disease. Murine and human WNV neuroinvasive disease post-mortem samples exhibit loss of hippocampal CA3 presynaptic terminals, and murine studies revealed microglial engulfment of presynaptic terminals during acute infection and after recovery. Mice with fewer microglia (Il34(-/-) mice with a deficiency in IL-34 production) or deficiency in complement C3 or C3a receptor were protected from WNV-induced synaptic terminal loss. Our study provides a new murine model of WNV-induced spatial memory impairment, and identifies a potential mechanism underlying neurocognitive impairment in patients recovering from WNV neuroinvasive disease.	[Vasek, Michael J.; Garber, Charise; Dorsey, Denise; Durrant, Douglas M.; Bollman, Bryan; Soung, Allison; Funk, Kristen; Klein, Robyn S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Durrant, Douglas M.] Calif State Polytech Univ Pomona, Dept Biol Sci, 3801 West Temple Ave, Pomona, CA 91768 USA; [Yu, Jinsheng] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Perez-Torres, Carlos; Garbow, Joel R.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Frouin, Arnaud; Wilton, Daniel K.; Stevens, Beth] Harvard Univ, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Sch Med,Dept Neurol, Boston, MA 02115 USA; [DeMasters, Bette K.; Tyler, Kenneth L.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO 80045 USA; [Jiang, Xiaoping; Mennerick, Steven] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Bowen, James R.; Suthar, Mehul S.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30329 USA; [Bowen, James R.; Suthar, Mehul S.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Emory Vaccine Ctr,Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Robinson, John K.] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Schmidt, Robert E.; Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); California State University System; California State Polytechnic University Pomona; Washington University (WUSTL); Washington University (WUSTL); Harvard University; Boston Children's Hospital; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; Washington University (WUSTL); Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL); Washington University (WUSTL)	Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	rklein@dom.wustl.edu	Tyler, Kenneth L./J-2420-2019; Mennerick, Steven/O-2806-2017; Funk, Kristen/AAC-6334-2020	Tyler, Kenneth L./0000-0003-3294-5888; Mennerick, Steven/0000-0003-0868-0664; Funk, Kristen/0000-0002-1912-1430; Perez-Torres, Carlos/0000-0003-3352-011X; Soung, Allison/0000-0002-1590-6038; Vasek, Michael/0000-0002-1112-4346	NIH [F31 NS077640, R01 NS052632, U19 AI083019]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052066, U19AI083019, R01AI101400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077640, R01NS052632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F30AA023685] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding for this research was provided by the NIH F31 NS077640 (M.J.V.), R01 NS052632 (R.S.K.), and U19 AI083019 (R.S.K. and M.S.S.). The authors would like to thank J. Atkinson and X. Wu for reagents and M. Diamond for critical reading of the manuscript.	Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Clarke P, 2014, MBIO, V5, DOI 10.1128/mBio.00902-14; Clarke P, 2014, J VIROL, V88, P1080, DOI 10.1128/JVI.02944-13; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Durrant DM, 2013, J EXP MED, V210, P503, DOI 10.1084/jem.20121897; EBENBICHLER CF, 1991, J EXP MED, V174, P1417, DOI 10.1084/jem.174.6.1417; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879; Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016; McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105; Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; Menard C, 2015, NEUROBIOL AGING, V36, P1471, DOI 10.1016/j.neurobiolaging.2014.11.013; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Sadek JR, 2010, J CLIN EXP NEUROPSYC, V32, P81, DOI 10.1080/13803390902881918; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Samuel MA, 2007, J VIROL, V81, P2614, DOI 10.1128/JVI.02311-06; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096442; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Veerhuis R, 1999, EXP NEUROL, V160, P289, DOI 10.1006/exnr.1999.7199; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360	33	340	344	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					538	+		10.1038/nature18283	http://dx.doi.org/10.1038/nature18283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27337340	Green Accepted			2022-12-28	WOS:000378270300051
J	Mayor, S				Mayor, Susan			Moderate LDL cholesterol reduction with statins shows similar benefit to aggressive lipid lowering in ischaemic heart disease	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ascher SB, 2016, JAMA INTERN MED, V176, P1113, DOI 10.1001/jamainternmed.2016.2784; Leibowitz M, 2016, JAMA INTERN MED, V176, P1105, DOI 10.1001/jamainternmed.2016.2751	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i3437	10.1136/bmj.i3437	http://dx.doi.org/10.1136/bmj.i3437			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27335335				2022-12-28	WOS:000378723500013
J	Timmis, A; Rapsomaniki, E; Chung, SC; Pujades-Rodriguez, M; Moayyeri, A; Stogiannis, D; Shah, AD; Pasea, L; Denaxas, S; Emmas, C; Hemingway, H				Timmis, A.; Rapsomaniki, E.; Chung, S. C.; Pujades-Rodriguez, M.; Moayyeri, A.; Stogiannis, D.; Shah, A. D.; Pasea, L.; Denaxas, S.; Emmas, C.; Hemingway, H.			Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; 12 CARDIOVASCULAR-DISEASES; ST-SEGMENT ELEVATION; CLINICAL-TRIALS; LIFETIME RISKS; PRIMARY-CARE; CLOPIDOGREL; ASSOCIATIONS; COHORT; AGE	OBJECTIVE To estimate the potential magnitude in unselected patients of the benefits and harms of prolonged dual antiplatelet therapy after acute myocardial infarction seen in selected patients with high risk characteristics in trials. DESIGN Observational population based cohort study. SETTING PEGASUS-TIMI-54 trial population and CALIBER (ClinicAl research using LInked Bespoke studies and Electronic health Records). PARTICIPANTS 7238 patients who survived a year or more after acute myocardial infarction. Interventions Prolonged dual antiplatelet therapy after acute myocardial infarction. MAIN OUTCOME MEASURES Recurrent acute myocardial infarction, stroke, or fatal cardiovascular disease. Fatal, severe, or intracranial bleeding. RESULTS 1676/7238 (23.1%) patients met trial inclusion and exclusion criteria ("target" population). Compared with the placebo arm in the trial population, in the target population the median age was 12 years higher, there were more women (48.6% v 24.3%), and there was a substantially higher cumulative three year risk of both the primary (benefit) trial endpoint of recurrent acute myocardial infarction, stroke, or fatal cardiovascular disease (18.8% (95% confidence interval 16.3% to 21.8%) v 9.04%) and the primary (harm) endpoint of fatal, severe, or intracranial bleeding (3.0% (2.0% to 4.4%) v 1.26% (TIMI major bleeding)). Application of intention to treat relative risks from the trial (ticagrelor 60 mg daily arm) to CALIBER's target population showed an estimated 101 (95% confidence interval 87 to 117) ischaemic events prevented per 10 000 treated per year and an estimated 75 (50 to 110) excess fatal, severe, or intracranial bleeds caused per 10 000 patients treated per year. Generalisation from CALIBER's target subgroup to all 7238 real world patients who were stable at least one year after acute myocardial infarction showed similar three year risks of ischaemic events (17.2%, 16.0% to 18.5%), with an estimated 92 (86 to 99) events prevented per 10 000 patients treated per year, and similar three year risks of bleeding events (2.3%, 1.8% to 2.9%), with an estimated 58 (45 to 73) events caused per 10 000 patients treated per year. CONCLUSIONS This novel use of primary-secondary care linked electronic health records allows characterisation of "healthy trial participant" effects and confirms the potential absolute benefits and harms of dual antiplatelet therapy in representative patients a year or more after acute myocardial infarction.	[Timmis, A.; Rapsomaniki, E.; Chung, S. C.; Pujades-Rodriguez, M.; Moayyeri, A.; Shah, A. D.; Pasea, L.; Denaxas, S.; Hemingway, H.] UCL, Farr Inst Hlth Informat Res, London, England; [Timmis, A.] Barts Heart Ctr, Cardiovasc Biomed Res Unit, Barts & London Natl Inst Hlth Res, London, England; [Stogiannis, D.] Univ Athens, Dept Math, Athens, Greece; [Emmas, C.] AstraZeneca, Luton, Beds, England	University of London; University College London; University of London; Queen Mary University London; National & Kapodistrian University of Athens; AstraZeneca	Timmis, A (corresponding author), UCL, Farr Inst Hlth Informat Res, London, England.; Timmis, A (corresponding author), Barts Heart Ctr, Cardiovasc Biomed Res Unit, Barts & London Natl Inst Hlth Res, London, England.	a.d.timmis@qmul.ac.uk	Pujades-Rodriguez, Mar/T-1129-2018; Shah, Anoop Dinesh/D-4396-2014; Hemingway, Harry/C-1219-2009	Pujades-Rodriguez, Mar/0000-0002-1375-1028; Shah, Anoop Dinesh/0000-0002-8907-5724; Denaxas, Spiros/0000-0001-9612-7791; Chung, Sheng-Chia/0000-0001-6025-9207; Hemingway, Harry/0000-0003-2279-0624	AstraZeneca; National Institute for Health Research [RP-PG-0407-10315]; Wellcome Trust [086091/Z/08/Z, MR/K006584/1, 0938/30/Z/10/Z]; Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership [G0902393/99558]; Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research; Barts; London NIHR Cardiovascular Biomedical Research Unit; UCL Provost's Strategic Development Fund; ESRC [ES/L007517/1] Funding Source: UKRI; MRC [MR/L01629X/1, MR/M015084/1] Funding Source: UKRI; Economic and Social Research Council [ES/L007517/1] Funding Source: researchfish; Medical Research Council [MR/L01629X/1, MR/M015084/1, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10314] Funding Source: researchfish	AstraZeneca(AstraZeneca); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; Barts; London NIHR Cardiovascular Biomedical Research Unit; UCL Provost's Strategic Development Fund; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by AstraZeneca, the National Institute for Health Research (RP-PG-0407-10315), Wellcome Trust (086091/Z/08/Z), and the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (G0902393/99558), and by awards to establish the Fair Institute of Health Informatics Research at UCL Partners, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (Al and HH, grant MR/K006584/1). Al was supported by Barts and The London NIHR Cardiovascular Biomedical Research Unit, funded by the National Institute for Health Research. SD was support by a UCL Provost's Strategic Development Fund fellowship. ADS is supported by a Wellcome Trust clinical research training fellowship (0938/30/Z/10/Z). The sponsors had no role in the collection of data.	Alexandrescu R, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-468; Alzuhairi KS, 2015, EUR HEART J-QUAL CAR, V1, P72, DOI 10.1093/ehjqcco/qcv016; [Anonymous], 1995, J Clin Epidemiol, V48, P1441; Boggon R, 2011, EUR HEART J, V32, P2376, DOI 10.1093/eurheartj/ehr340; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Budaj A, 2002, CIRCULATION, V106, P1622, DOI 10.1161/01.CIR.0000029926.71825.E2; Chung SC, 2014, LANCET, V383, P1305, DOI 10.1016/S0140-6736(13)62070-X; Denaxas Spiros C, 2012, Int J Epidemiol, V41, P1625, DOI 10.1093/ije/dys188; Denaxas SC, 2015, EUR HEART J-QUAL CAR, V1, P9, DOI 10.1093/ehjqcco/qcv005; Fath-Ordoubadi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088577; Ford I, 2016, CIRCULATION, V133, P1073, DOI 10.1161/CIRCULATIONAHA.115.019014; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; George J, 2015, CIRCULATION, V132, P1320, DOI 10.1161/CIRCULATIONAHA.114.013797; Gray HH, 2010, HEART, V96, P1662, DOI 10.1136/hrt.2010.204511; Hemingway H, 2006, JAMA-J AM MED ASSOC, V295, P1404, DOI 10.1001/jama.295.12.1404; HERRETT E, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F2350; Jackevicius CA, 2008, CIRCULATION, V117, P1028, DOI 10.1161/CIRCULATIONAHA.107.706820; Jernberg T, 2014, ANN REPORT; Jernberg T, 2015, EUR HEART J, V36, P1163, DOI 10.1093/eurheartj/ehu505; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Myocardial Ischaemia National Audit Project, NHS CAR PAT HEART AT; Nallamothu BK, 2008, CIRCULATION, V118, P1294, DOI 10.1161/CIRCULATIONAHA.107.703579; Navarese EP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1618; Pujades-Rodriguez M, 2015, INT J EPIDEMIOL, V44, P129, DOI 10.1093/ije/dyu218; Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Schoenmaker N, 2004, LANCET NEUROL, V3, P627, DOI 10.1016/S1474-4422(04)00884-1; Sekhri N, 2007, HEART, V93, P458, DOI 10.1136/hrt.2006.090894; Dinesh Shah Anoop, 2015, Lancet, V385 Suppl 1, pS86, DOI [10.1016/S2213-8587(14)70219-0, 10.1016/S0140-6736(15)60401-9]; Udell JA, 2016, EUR HEART J, V37, P390, DOI 10.1093/eurheartj/ehv443; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Weng C, 2014, APPL CLIN INFORM, V5, P463, DOI 10.4338/ACI-2013-12-RA-0105; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	38	11	11	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i3163	10.1136/bmj.i3163	http://dx.doi.org/10.1136/bmj.i3163			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27334486	Green Published, hybrid			2022-12-28	WOS:000378723500007
J	Bell, JS				Bell, Joseph S.			Osler in Jail	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bell, Joseph S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Bell, JS (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	joe_bell@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Osler, 1922, AEQUANIMITAS OTHER A	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2523	2524		10.1001/jama.2016.1823	http://dx.doi.org/10.1001/jama.2016.1823			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27327797	Green Accepted			2022-12-28	WOS:000378306700013
J	Wise, J				Wise, Jacqui			Newer tests for hepatitis C virus could transform screening	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Freiman JM, 2016, ANN INTERN MED, V165, P345, DOI 10.7326/M16-0065	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2016	353								i3420	10.1136/bmj.i3420	http://dx.doi.org/10.1136/bmj.i3420			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BP	27330017				2022-12-28	WOS:000378723200002
J	Parry, J				Parry, Jane			A prescription for poverty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janeparry.net						Centre for Effective Practice, POV CLIN TOOL PRIM C; Ontario Coalition Against Poverty, SHORT HIST OCAP	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2016	353								i3370	10.1136/bmj.i3370	http://dx.doi.org/10.1136/bmj.i3370			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BK	27325618				2022-12-28	WOS:000378722700001
J	Forbes, JC; Krumholz, MR; Goldbaum, NJ; Dekel, A				Forbes, John C.; Krumholz, Mark R.; Goldbaum, Nathan J.; Dekel, Avishai			Suppression of star formation in dwarf galaxies by photoelectric grain heating feedback	NATURE			English	Article							ADAPTIVE MESH REFINEMENT; COLD DARK-MATTER; INTERSTELLAR-MEDIUM; MOLECULAR-HYDROGEN; STELLAR FEEDBACK; FORMATION LAW; MASS FUNCTION; HIGH-REDSHIFT; H I; EVOLUTION	Photoelectric heating-heating of dust grains by far-ultraviolet photons-has long been recognized as the primary source of heating for the neutral interstellar medium(1). Simulations of spiral galaxies(2) have shown some indication that photoelectric heating could suppress star formation; however, simulations that include photoelectric heating have typically shown that it has little effect on the rate of star formation in either spiral galaxies(3,4) or dwarf galaxies(5), which suggests that supernovae are responsible for setting the gas depletion time in galaxies(6-8). This result is in contrast with recent work(9-13) indicating that a star formation law that depends on galaxy metallicity-as is expected with photoelectric heating, but not with supernovae-reproduces the present-day galaxy population better than does a metallicity-independent one. Here we report a series of simulations of dwarf galaxies, the class of galaxy in which the effects of both photoelectric heating and supernovae are expected to be strongest. We simultaneously include space-and time-dependent photoelectric heating in our simulations, and we resolve the energy-conserving phase of every supernova blast wave, which allows us to directly measure the relative importance of feedback by supernovae and photoelectric heating in suppressing star formation. We find that supernovae are unable to account for the observed(14) large gas depletion times in dwarf galaxies. Instead, photoelectric heating is the dominant means by which dwarf galaxies regulate their star formation rate at any given time, suppressing the rate by more than an order of magnitude relative to simulations with only supernovae.	[Forbes, John C.; Krumholz, Mark R.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Krumholz, Mark R.] Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT 2611, Australia; [Goldbaum, Nathan J.] Univ Illinois, Natl Ctr Supercomp Applicat, 1205 West Clark St, Urbana, IL 61820 USA; [Dekel, Avishai] Hebrew Univ Jerusalem, Racah Inst Phys, Ctr Astrophys & Planetary Sci, IL-91904 Jerusalem, Israel	University of California System; University of California Santa Cruz; Australian National University; University of Illinois System; University of Illinois Urbana-Champaign; Hebrew University of Jerusalem	Forbes, JC (corresponding author), Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA.	jcforbes@ucsc.edu	Dekel, Avishai/ABF-9516-2021	Dekel, Avishai/0000-0003-4174-0374; Forbes, John/0000-0002-1975-4449; Krumholz, Mark/0000-0003-3893-854X	Hubble Archival Research grant [HST-AR-13909]; NSF [AST-09553300, AST-1405962, AST-1229745]; NASA ATP grant [NNX13AB84G]; NASA TCAN grant [NNX14AB52G]; Australian Research Council [DP160100695]; ISF [124/12]; I-CORE Program of the PBC/ISF [1829/12]; BSF [2014-273]; Direct For Computer & Info Scie & Enginr [1535651] Funding Source: National Science Foundation; Direct For Mathematical & Physical Scien [1405962] Funding Source: National Science Foundation	Hubble Archival Research grant; NSF(National Science Foundation (NSF)); NASA ATP grant; NASA TCAN grant; Australian Research Council(Australian Research Council); ISF(Israel Science Foundation); I-CORE Program of the PBC/ISF; BSF(US-Israel Binational Science Foundation); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	J.C.F. and M.R.K. acknowledge support from Hubble Archival Research grant HST-AR-13909. This work was also supported by NSF grants AST-09553300 and AST-1405962, NASA ATP grant NNX13AB84G and NASA TCAN grant NNX14AB52G (J.C.F., M.R.K. and N.J.G.), and by Australian Research Council grant DP160100695. A.D. acknowledges support from the grants ISF 124/12, I-CORE Program of the PBC/ISF 1829/12, BSF 2014-273 and NSF AST-1405962. Simulations were carried out on NASA Pleiades and the UCSC supercomputer Hyades, supported by NSF grant AST-1229745.	Bekki K, 2015, MON NOT R ASTRON SOC, V454, pL41, DOI 10.1093/mnrasl/slv117; Bekki K, 2015, ASTROPHYS J LETT, V812, DOI 10.1088/2041-8205/812/1/L14; Bigiel F, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/2/L13; Broeils AH, 1997, ASTRON ASTROPHYS, V324, P877; Bryan GL, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/2/19; Cannon JM, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/2/72; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Chomiuk L, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/6/197; Christensen C, 2012, MON NOT R ASTRON SOC, V425, P3058, DOI 10.1111/j.1365-2966.2012.21628.x; Dave R, 2012, MON NOT R ASTRON SOC, V421, P98, DOI 10.1111/j.1365-2966.2011.20148.x; DRAINE BT, 1978, ASTROPHYS J SUPPL S, V36, P595, DOI 10.1086/190513; Forbes JC, 2014, MON NOT R ASTRON SOC, V443, P168, DOI 10.1093/mnras/stu1142; Geha M, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/29; Goldbaum NJ, 2015, ASTROPHYS J, V814, DOI 10.1088/0004-637X/814/2/131; HABING HJ, 1968, B ASTRON I NETH, V19, P421; Hayward C. C., 2015, STELLAR FEEDBACK SIM; Hopkins PF, 2013, MON NOT R ASTRON SOC, V432, P2647, DOI 10.1093/mnras/stt723; Hopkins PF, 2011, MON NOT R ASTRON SOC, V417, P950, DOI 10.1111/j.1365-2966.2011.19306.x; Hu CY, 2016, MON NOT R ASTRON SOC, V458, P3528, DOI 10.1093/mnras/stw544; Hunter DA, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/134; Janowiecki S, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/96; KATZ N, 1992, ASTROPHYS J, V391, P502, DOI 10.1086/171366; Kim JH, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/1/14; Krumholz MR, 2007, ASTROPHYS J, V654, P304, DOI 10.1086/509101; Krumholz MR, 2013, MON NOT R ASTRON SOC, V436, P2747, DOI 10.1093/mnras/stt1780; Krumholz MR, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/16; Krumholz MR, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/69; Krumholz MR, 2009, ASTROPHYS J, V693, P216, DOI 10.1088/0004-637X/693/1/216; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Lilly SJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/119; Makiya R, 2014, MON NOT R ASTRON SOC, V441, P63, DOI 10.1093/mnras/stu561; Okamoto T, 2008, MON NOT R ASTRON SOC, V390, P920, DOI 10.1111/j.1365-2966.2008.13830.x; Onorbe J, 2015, MON NOT R ASTRON SOC, V454, P2092, DOI 10.1093/mnras/stv2072; Papastergis E, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/138; Springel V, 1999, MON NOT R ASTRON SOC, V307, P162, DOI 10.1046/j.1365-8711.1999.02613.x; Tasker EJ, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/1/33; Tasker EJ, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/11; Thornton K, 1998, ASTROPHYS J, V500, P95, DOI 10.1086/305704; Truelove JK, 1998, ASTROPHYS J, V495, P821, DOI 10.1086/305329; Turk MJ, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/1/9	43	43	43	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					523	+		10.1038/nature18292	http://dx.doi.org/10.1038/nature18292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27350244	Green Submitted			2022-12-28	WOS:000380856600022
J	Badalyan, A; Stahl, SS				Badalyan, Artavazd; Stahl, Shannon S.			Cooperative electrocatalytic alcohol oxidation with electron-proton-transfer mediators	NATURE			English	Article							MECHANISM; ELECTROOXIDATION; CATALYSIS; ALDEHYDES; AMINES; CELLS	The electrochemical oxidation of alcohols is a major focus of energy and chemical conversion efforts, with potential applications ranging from fuel cells to biomass utilization and fine-chemical synthesis(1-7). Small-molecule electrocatalysts for processes of this type are promising targets for further development(8), as demonstrated by recent advances in nickel catalysts for electrochemical production and oxidation of hydrogen(9-11). Complexes with tethered amines that resemble the active site of hydrogenases(12) have been shown both to catalyse hydrogen production (from protons and electrons) with rates far exceeding those of such enzymes(11,13) and to mediate reversible electrocatalytic hydrogen production and oxidation with enzyme-like performance(14). Progress in electrocatalytic alcohol oxidation has been more modest. Nickel complexes similar to those used for hydrogen oxidation have been shown to mediate efficient electrochemical oxidation of benzyl alcohol, with a turnover frequency of 2.1 per second. These compounds exhibit poor reactivity with ethanol and methanol, however(15). Organic nitroxyls, such as TEMPO (2,2,6,6-tetramethyl-1-piperidine N-oxyl), are the most widely studied electrocatalysts for alcohol oxidation(5-7,16-19). These catalysts exhibit good activity (1-2 turnovers per second) with a wide range of alcohols(18) and have great promise for electro-organic synthesis(7). Their use in energy-conversion applications, however, is limited by the high electrode potentials required to generate the reactive oxoammonium species. Here we report (2,2'-bipyridine) Cu/nitroxyl co-catalyst systems for electrochemical alcohol oxidation that proceed with much faster rates, while operating at an electrode potential a half-volt lower than that used for the TEMPO-only process. The (2,2'-bipyridine) Cu(II) and TEMPO redox partners exhibit cooperative reactivity and exploit the low-potential, proton-coupled TEMPO/TEMPOH redox process rather than the high-potential TEMPO/TEMPO+ process. The results show how electron-proton-transfer mediators, such as TEMPO, may be used in combination with first-row transition metals, such as copper, to achieve efficient two-electron electrochemical processes, thereby introducing a new concept for the development of non-precious-metal electrocatalysts.	[Badalyan, Artavazd; Stahl, Shannon S.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Stahl, SS (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	stahl@chem.wisc.edu	Badalyan, Artavazd/W-2162-2019	Badalyan, Artavazd/0000-0002-6933-6181	Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science) [DE-FC02-07ER64494]	Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science)(United States Department of Energy (DOE))	Financial support for this project was provided by the Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science DE-FC02-07ER64494).	Bianchini C, 2009, CHEM REV, V109, P4183, DOI 10.1021/cr9000995; Bobbitt J.M., 2009, ORGANIC REACTIONS, P103, DOI [DOI 10.1002/0471264180.OR074.02, 10.1002/0471264180.or074.02]; Cha HG, 2015, NAT CHEM, V7, P328, DOI [10.1038/NCHEM.2194, 10.1038/nchem.2194]; Cheung KC, 2007, COORDIN CHEM REV, V251, P2367, DOI 10.1016/j.ccr.2007.04.004; Chirik PJ, 2010, SCIENCE, V327, P794, DOI 10.1126/science.1183281; Ciriminna R, 2015, CHEMCATCHEM, V7, P552, DOI 10.1002/cctc.201402896; Costentin C, 2014, CHEMELECTROCHEM, V1, P1226, DOI 10.1002/celc.201300263; Dijksman A, 2003, ORG BIOMOL CHEM, V1, P3232, DOI 10.1039/b305941c; Dubois MR, 2009, ACCOUNTS CHEM RES, V42, P1974, DOI 10.1021/ar900110c; Francke R, 2014, CHEM SOC REV, V43, P2492, DOI 10.1039/c3cs60464k; Helm ML, 2011, SCIENCE, V333, P863, DOI 10.1126/science.1205864; Hickey DP, 2015, J AM CHEM SOC, V137, P16179, DOI 10.1021/jacs.5b11252; Hickey DP, 2014, J AM CHEM SOC, V136, P15917, DOI 10.1021/ja5098379; Hoover JM, 2013, J AM CHEM SOC, V135, P2357, DOI 10.1021/ja3117203; Huynh MHV, 2007, CHEM REV, V107, P5004, DOI 10.1021/cr0500030; Kakati N, 2014, CHEM REV, V114, P12397, DOI 10.1021/cr400389f; Le Goff A, 2009, SCIENCE, V326, P1384, DOI 10.1126/science.1179773; Rafiee M, 2015, J AM CHEM SOC, V137, P14751, DOI 10.1021/jacs.5b09672; Rauchfuss TB, 2015, ACCOUNTS CHEM RES, V48, P2107, DOI 10.1021/acs.accounts.5b00177; Raugei S, 2016, INORG CHEM, V55, P445, DOI 10.1021/acs.inorgchem.5b02262; Rodriguez-Macia P, 2015, ANGEW CHEM INT EDIT, V54, P12303, DOI 10.1002/anie.201502364; Ryland BL, 2014, J AM CHEM SOC, V136, P12166, DOI 10.1021/ja5070137; Ryland BL, 2014, ANGEW CHEM INT EDIT, V53, P8824, DOI 10.1002/anie.201403110; SEMMELHACK MF, 1986, TETRAHEDRON LETT, V27, P1119, DOI 10.1016/S0040-4039(00)84193-3; SEMMELHACK MF, 1983, J AM CHEM SOC, V105, P4492, DOI 10.1021/ja00351a070; SEMMELHACK MF, 1984, J AM CHEM SOC, V106, P3374, DOI 10.1021/ja00323a064; Trincado M, 2014, ENERG ENVIRON SCI, V7, P2464, DOI 10.1039/c4ee00389f; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Weiss CJ, 2015, CHEM COMMUN, V51, P6172, DOI 10.1039/c5cc01107h; Whittaker JW, 2003, CHEM REV, V103, P2347, DOI 10.1021/cr020425z	30	277	279	49	784	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					406	410		10.1038/nature18008	http://dx.doi.org/10.1038/nature18008			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27350245				2022-12-28	WOS:000380344200037
J	Igarashi, M; Guarente, L				Igarashi, Masaki; Guarente, Leonard			mTORC1 and SIRT1 Cooperate to Foster Expansion of Gut Adult Stem Cells during Calorie Restriction	CELL			English	Article							S6 KINASE; LIFE-SPAN; PHOSPHORYLATION; NAD(+); DIFFERENTIATION; METABOLISM; ACTIVATION; EXPRESSION; STRATEGIES; P70(S6K)	Longevity-promoting caloric restriction is thought to trigger downregulation of mammalian target of rapamycin complex 1 ( mTORC1) signaling and upregulation of SIRT1 activity with associated health benefits. Here, we show that mTORC1 signaling in intestinal stem cells ( ISCs) is instead upregulated during calorie restriction ( CR). SIRT1 deacetylates S6K1, thereby enhancing its phosphorylation by mTORC1, which leads to an increase in protein synthesis and an increase in ISC number. Paneth cells in the ISC niche secrete cyclic ADP ribose that triggers SIRT1 activity and mTORC1 signaling in neighboring ISCs. Notably, the mTOR inhibitor rapamycin, previously reported to mimic effects of CR, abolishes this expansion of ISCs. We suggest that Paneth cell signaling overrides any direct nutrient sensing in ISCs to sculpt the observed response to CR. Moreover, drugs that modulate pathways important in CR may exert opposing effects on different cell types.	[Igarashi, Masaki; Guarente, Leonard] MIT, Dept Biol, Glenn Labs Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Igarashi, Masaki; Guarente, Leonard] MIT, Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, Glenn Labs Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Guarente, L (corresponding author), MIT, Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu			Manpei Suzuki Diabetes Foundation; NIH; Glenn Foundation for Medical Research	Manpei Suzuki Diabetes Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research	We wish to thank Angeliki Chalkiadaki and Eric Williams for comments on the manuscript. We also thank Dr. Inoki (University of Michigan) for S6K1 acetylation mutant expression vector. M.I. was supported by the Manpei Suzuki Diabetes Foundation. L.G. was supported by grants from NIH and the Glenn Foundation for Medical Research. L.G. is a founder of Elysium Health and consults for GSK, Sibelius, and Segterra.	Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brandauer J, 2013, J PHYSIOL-LONDON, V591, P5207, DOI 10.1113/jphysiol.2013.259515; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Fenton TR, 2010, INT J BIOCHEM CELL B, V42, P359, DOI 10.1016/j.biocel.2009.11.022; Fenton TR, 2010, BIOCHEM BIOPH RES CO, V398, P400, DOI 10.1016/j.bbrc.2010.06.081; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gregorieff A, 2010, CURR PROTOC STEM CEL; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hasty P, 2014, CANCER PREV RES, V7, P169, DOI 10.1158/1940-6207.CAPR-13-0299; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hong SK, 2014, J BIOL CHEM, V289, P13132, DOI 10.1074/jbc.M113.520734; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; De Bonis ML, 2014, STEM CELL REP, V2, P690, DOI 10.1016/j.stemcr.2014.03.002; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wen L, 2013, P NATL ACAD SCI USA, V110, pE2420, DOI 10.1073/pnas.1309354110; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	44	166	176	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					436	450		10.1016/j.cell.2016.05.044	http://dx.doi.org/10.1016/j.cell.2016.05.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27345368	Bronze			2022-12-28	WOS:000380255400020
J	Schuster, MA; Reisner, SL; Onorato, SE				Schuster, Mark A.; Reisner, Sari L.; Onorato, Sarah E.			Beyond Bathrooms - Meeting the Health Needs of Transgender People	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schuster, Mark A.; Reisner, Sari L.; Onorato, Sarah E.] Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA; [Schuster, Mark A.; Reisner, Sari L.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Reisner, Sari L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Reisner, Sari L.] Fenway Hlth, Fenway Inst, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Fenway Health	Schuster, MA (corresponding author), Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA.; Schuster, MA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.							[Committee on Federal and State Affairs Kansas State Legislature], 2016, HOUS BILL 2737; Gates G, 2011, MANY PEOPLE ARE LESB; General Assembly of North Carolina, 2016, HOUS BILL DRH40005 T; Grant J.M., 2011, INJUSTICE EVERY TURN; Reisner SL, 2016, LANCET IN PRESS	5	49	50	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2016	375	2					101	103		10.1056/NEJMp1605912	http://dx.doi.org/10.1056/NEJMp1605912			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ9KY	27376582				2022-12-28	WOS:000379530000001
J	Sokol, D				Sokol, Daniel			ETHICS MAN Embracing the ethically complicated patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel] 12 Kings Bench Walk, London, England		Sokol, D (corresponding author), 12 Kings Bench Walk, London, England.	Sokol@12kbw.co.uk						Furfari Kristin, 2016, J Clin Ethics, V27, P39; Sokol DK, 2005, BRIT MED J, V330, P741, DOI 10.1136/bmj.330.7494.741; SOKOL DK, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G5342	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2016	354								i3727	10.1136/bmj.i3727	http://dx.doi.org/10.1136/bmj.i3727			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EG	27380924				2022-12-28	WOS:000379580200010
J	Wang, YL; Zhao, XQ; Lin, JX; Li, H; Johnston, SC; Lin, Y; Pan, YS; Liu, LP; Wang, D; Wang, CX; Meng, X; Xu, JF; Wang, YJ				Wang, Yilong; Zhao, Xingquan; Lin, Jinxi; Li, Hao; Johnston, S. Claiborne; Lin, Yi; Pan, Yuesong; Liu, Liping; Wang, David; Wang, Chunxue; Meng, Xia; Xu, Jianfeng; Wang, Yongjun		CHANCE Investigators	Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPLEMENTATION CONSORTIUM GUIDELINES; ANTIPLATELET TREATMENT; PLATELET-FUNCTION; POLYMORPHISMS; GENOTYPE; METABOLISM; PREVALENCE; GENE	IMPORTANCE Data are limited regarding the association between CYP2C19 genetic variants and clinical outcomes of patients with minor stroke or transient ischemic attack treated with clopidogrel. OBJECTIVE To estimate the association between CYP2C19 genetic variants and clinical outcomes of clopidogrel-treated patients with minor stroke or transient ischemic attack. DESIGN, SETTING, AND PARTICIPANTS Three CYP2C19 major alleles (*2, *3, *17) were genotyped among 2933 Chinese patients from 73 sites who were enrolled in the Clopidogrel in High-Risk Patients with Acute Nondisabling Cerebrovascular Events (CHANCE) randomized trial conducted from January 2, 2010, to March 20, 2012. INTERVENTIONS Patients with acute minor ischemic stroke or transient ischemic attack in the trial were randomized to treatment with clopidogrel combined with aspirin or to aspirin alone. MAIN OUTCOMES AND MEASURES The primary efficacy outcome was new stroke. The secondary efficacy outcome was a composite of new composite vascular events (ischemic stroke, hemorrhagic stroke, myocardial infarction, or vascular death). Bleeding was the safety outcome. RESULTS Among 2933 patients, 1948 (66.4%) were men, with a mean age of 62.4 years. Overall, 1207 patients (41.2%) were noncarriers and 1726 patients (58.8%) were carriers of loss-of-function alleles (*2, *3). After day 90 follow-up, clopidogrel-aspirin reduced the rate of new stroke in the noncarriers but not in the carriers of the loss-of-function alleles (P = .02 for interaction; events among noncarriers, 41 [6.7%] with clopidogrel-aspirin vs 74 [12.4%] with aspirin; hazard ratio [HR], 0.51 [95% CI, 0.35-0.75]; events among carriers, 80 [9.4%] with clopidogrel-aspirin vs 94 [10.8%] with aspirin; HR, 0.93 [95% CI, 0.69 to 1.26]). Similar results were observed for the secondary composite efficacy outcome (noncarriers: 41 [6.7%] with clopidogrel-aspirin vs 75 [12.5%] with aspirin; HR, 0.50 [95% CI, 0.34-0.74]; carriers: 80 [9.4%] with clopidogrel-aspirin vs 95 [10.9%] with aspirin; HR, 0.92 [95% CI, 0.68-1.24]; P = .02 for interaction). The effect of treatment assignment on bleeding did not vary significantly between the carriers and the noncarriers of the loss-of-function alleles (2.3% for carriers and 2.5% for noncarriers in the clopidogrel-aspirin group vs 1.4% for carriers and 1.7% for noncarriers in the aspirin only group; P = .78 for interaction). CONCLUSIONS AND RELEVANCE Among patients with minor ischemic stroke or transient ischemic attack, the use of clopidogrel plus aspirin compared with aspirin alone reduced the risk of a new stroke only in the subgroup of patients who were not carriers of the CYP2C19 loss-of-function alleles. These findings support a role of CYP2C19 genotype in the efficacy of this treatment.	[Wang, Yilong; Zhao, Xingquan; Lin, Jinxi; Li, Hao; Pan, Yuesong; Liu, Liping; Wang, Chunxue; Meng, Xia; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Yilong; Zhao, Xingquan; Lin, Jinxi; Li, Hao; Pan, Yuesong; Liu, Liping; Wang, Chunxue; Meng, Xia; Wang, Yongjun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Wang, Yilong; Zhao, Xingquan; Lin, Jinxi; Li, Hao; Pan, Yuesong; Liu, Liping; Wang, Chunxue; Meng, Xia; Wang, Yongjun] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Wang, Yilong; Zhao, Xingquan; Lin, Jinxi; Li, Hao; Pan, Yuesong; Liu, Liping; Wang, Chunxue; Meng, Xia; Wang, Yongjun] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Johnston, S. Claiborne] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA; [Lin, Yi] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China; [Lin, Yi] Fujian Med Univ, Affiliated Hosp 1, Inst Neurol, Fuzhou, Peoples R China; [Wang, David] Univ Illinois, Coll Med, Illinois Neurol Inst Stroke Network, OSF Healthcare Syst, Peoria, IL 61656 USA; [Xu, Jianfeng] Fudan Univ, Hushan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] NorthShore Univ HealthSyst, Program Personalized Canc Care, Evanston, IL USA	Capital Medical University; University of Texas System; University of Texas Austin; Fujian Medical University; Fujian Medical University; University of Illinois System; University of Illinois Peoria; Fudan University; NorthShore University Health System	Wang, YJ (corresponding author), 6 Tiantanxili, Beijing 100050, Peoples R China.	yongjunwang1962@gmail.com	Li, Hao/GPS-9834-2022; Pan, Yuesong/AAI-6303-2020	Pan, Yuesong/0000-0003-3082-6789; Wang, Yilong/0000-0003-2725-2788	Ministry of Science and Technology of the People's Republic of China [2006BAI01A11, 2011BAI08B01, 2011BAI08B02, 2012ZX09303-005-001, 2013BAI09B03]; Beijing Biobank of Cerebral Vascular Disease [D131100005313003]; Beijing Institute for Brain Disorders [BIBD-PXM2013_014226_07_000084]; National Natural Science Foundation of China [81322019]; China Postdoctoral Science Foundation [2014T70093]; Natural Science Foundation of Fujian Province [2015J01394]; Beijing Municipal Science and Technology Commission [Z141107002514125]; Shanghai Municipal Commission of Health and Family Planning [20124035]; Ellrodt-Schweighauser Family Chair of Cancer Genomic Research of NorthShore University HealthSystem	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Beijing Biobank of Cerebral Vascular Disease; Beijing Institute for Brain Disorders; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Shanghai Municipal Commission of Health and Family Planning; Ellrodt-Schweighauser Family Chair of Cancer Genomic Research of NorthShore University HealthSystem	The study is supported by grants from the Ministry of Science and Technology of the People's Republic of China (2006BAI01A11, 2011BAI08B01, 2011BAI08B02, 2012ZX09303-005-001, and 2013BAI09B03), the Beijing Biobank of Cerebral Vascular Disease (D131100005313003), the Beijing Institute for Brain Disorders (BIBD-PXM2013_014226_07_000084), the National Natural Science Foundation of China (No. 81322019), the China Postdoctoral Science Foundation (No. 2014T70093), the Natural Science Foundation of Fujian Province (No. 2015J01394), the Beijing Municipal Science and Technology Commission (No. Z141107002514125), and the Shanghai Municipal Commission of Health and Family Planning (No. 20124035) and supported from the Ellrodt-Schweighauser Family Chair of Cancer Genomic Research of NorthShore University HealthSystem (Dr Xu).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bauer T, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4588; Collet JP, 2009, J CARDIOVASC PHARM T, V14, P157, DOI 10.1177/1074248409339309; Hasan MS, 2013, INT J NEUROSCI, V123, P143, DOI 10.3109/00207454.2012.744308; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Jia DM, 2013, STROKE, V44, P1717, DOI 10.1161/STROKEAHA.113.000823; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kitzmiller JP, 2011, CLEV CLIN J MED, V78, P243, DOI 10.3949/ccjm.78a.10145; Li ZX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003038; McDonough CW, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001652; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Osnabrugge RL, 2015, GENET MED, V17, P3, DOI 10.1038/gim.2014.76; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5; Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105; Scott SA, 2011, CLIN PHARMACOL THER, V90, P328, DOI 10.1038/clpt.2011.132; Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Sun WS, 2015, PLATELETS, V26, P558, DOI 10.3109/09537104.2014.953044; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Trenk D, 2014, BRIT J CLIN PHARMACO, V77, P642, DOI 10.1111/bcp.12230; Wang YL, 2007, INT J STROKE, V2, P211, DOI 10.1111/j.1747-4949.2007.00142.x; Wang YL, 2015, NEUROLOGY, V84, P2354, DOI 10.1212/WNL.0000000000001665; Wang YJ, 2014, CHIN J NEUROL, V48, P258; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wei Wei, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P420, DOI 10.3760/cma.j.issn.1003-9406.2012.04.009; Yang J, 2013, PHARMAZIE, V68, P183, DOI 10.1691/ph.2013.2703; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807	29	195	208	7	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					70	78		10.1001/jama.2016.8662	http://dx.doi.org/10.1001/jama.2016.8662			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2MY	27348249	Bronze			2022-12-28	WOS:000379037600020
J	Terrer, C; Vicca, S; Hungate, BA; Phillips, RP; Prentice, IC				Terrer, Cesar; Vicca, Sara; Hungate, Bruce A.; Phillips, Richard P.; Prentice, I. Colin			Mycorrhizal association as a primary control of the CO2 fertilization effect	SCIENCE			English	Article							ELEVATED CO2; FOREST PRODUCTIVITY; ATMOSPHERIC CO2; ENRICHMENT FACE; CARBON-DIOXIDE; SOIL CARBON; NITROGEN; RESPONSES; GROWTH; ENHANCEMENT	Plants buffer increasing atmospheric carbon dioxide (CO2) concentrations through enhanced growth, but the question whether nitrogen availability constrains the magnitude of this ecosystem service remains unresolved. Synthesizing experiments from around the world, we show that CO2 fertilization is best explained by a simple interaction between nitrogen availability and mycorrhizal association. Plant species that associate with ectomycorrhizal fungi show a strong biomass increase (30 +/- 3%, P < 0.001) in response to elevated CO2 regardless of nitrogen availability, whereas low nitrogen availability limits CO2 fertilization (0 +/- 5%, P = 0.946) in plants that associate with arbuscular mycorrhizal fungi. The incorporation of mycorrhizae in global carbon cyclemodels is feasible, and crucial if we are to accurately project ecosystem responses and feedbacks to climate change.	[Terrer, Cesar; Prentice, I. Colin] Univ London Imperial Coll Sci Technol & Med, AXA Chair Programme Biosphere & Climate Impacts, Dept Life Sci, Silwood Pk Campus, London SW7 2AZ, England; [Vicca, Sara] Univ Antwerp, Dept Biol, Ctr Excellence PLECO Plant & Vegetat Ecol, B-2610 Antwerp, Belgium; [Hungate, Bruce A.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [Hungate, Bruce A.] No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA; [Phillips, Richard P.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Prentice, I. Colin] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia	Imperial College London; University of Antwerp; Northern Arizona University; Northern Arizona University; Indiana University System; Indiana University Bloomington; Macquarie University	Terrer, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, AXA Chair Programme Biosphere & Climate Impacts, Dept Life Sci, Silwood Pk Campus, London SW7 2AZ, England.	c.terrer@imperial.ac.uk	Vicca, Sara/I-3637-2012; Phillips, Richard P/C-6429-2009; Terrer, Cesar/R-1103-2018	Vicca, Sara/0000-0001-9812-5837; Phillips, Richard P/0000-0002-1345-4138; Terrer, Cesar/0000-0002-5479-3486	Imperial College; ClimMani COST Action [ES1308]; European Research Council [ERC-SyG-610028 IMBALANCE-P]; Biological and Environmental Research program, Office of Science, U.S. Department of Energy (DOE) [DE SC0008270]; NSF (Ecosystem Studies Program) [1153401]; DOE (Environmental System Science Program); Royal Netherlands Academy of Arts and Sciences; DOE; INTERFACE; New Phytologist trust; Division Of Environmental Biology [0955771, 1234162] Funding Source: National Science Foundation	Imperial College; ClimMani COST Action(European Cooperation in Science and Technology (COST)); European Research Council(European Research Council (ERC)European Commission); Biological and Environmental Research program, Office of Science, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NSF (Ecosystem Studies Program)(National Science Foundation (NSF)); DOE (Environmental System Science Program)(United States Department of Energy (DOE)); Royal Netherlands Academy of Arts and Sciences; DOE(United States Department of Energy (DOE)); INTERFACE; New Phytologist trust; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Talhelm, A. Finzi, L. Andresen, I. Kappel, C. Calfapietra, B. Sigurdsson, J. Dukes, P. Newton, D. Blumenthal, B. Kimball, J. Heath, P. Reich, R. Norby, C. Korner, N. Chiariello, C. Field, and M. Schneider, who provided additional data and advice. This research is a contribution to the Imperial College initiative Grand Challenges in Ecosystems and the Environment and the AXA Chair Programme in Biosphere and Climate Impacts. C.T. is supported by an Imperial College Ph.D. studentship within this program. C.T. and S.V. acknowledge support of ClimMani COST Action (ES1308). S.V. is a postdoctoral fellow of the Research Foundation-Flanders (FWO) and acknowledges support from the European Research Council grant ERC-SyG-610028 IMBALANCE-P. B.A.H. was supported by the Biological and Environmental Research program, Office of Science, U.S. Department of Energy (DOE) grant DE SC0008270. R.P. acknowledges support from NSF (Ecosystem Studies Program 1153401) and DOE (Environmental System Science Program). R.P. and C.T. thank the Royal Netherlands Academy of Arts and Sciences, DOE, INTERFACE, and the New Phytologist trust for funding the Workshop "Climate models revisited: the biogeochemical consequences of mycorrhizal dynamics." The data reported in this paper are available online as supplementary materials. C.T. conceived the initial idea, collected the data, and conducted the data synthesis and meta-analysis. S.V. developed the nitrogen classification. B.A.H. refined model selection, meta-analysis, and framework. All authors contributed to the development of the conceptual framework and to the writing of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Alberton O, 2005, NEW PHYTOL, V167, P859, DOI 10.1111/j.1469-8137.2005.01458.x; Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Baig S, 2015, GLOBAL CHANGE BIOL, V21, P4303, DOI 10.1111/gcb.12962; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Chaudhary VB, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.28; Ciais P., 2013, CLIMATE CHANGE 2013, P465, DOI [10.1017/CBO9781107415324.015, DOI 10.1017/CBO9781107415324.015]; Cornelissen JHC, 2001, OECOLOGIA, V129, P611, DOI 10.1007/s004420100752; Cotrufo MF, 2015, NAT GEOSCI, V8, P776, DOI [10.1038/ngeo2520, 10.1038/NGEO2520]; de Graaff MA, 2006, GLOBAL CHANGE BIOL, V12, P2077, DOI 10.1111/j.1365-2486.2006.01240.x; Drake JE, 2011, ECOL LETT, V14, P349, DOI 10.1111/j.1461-0248.2011.01593.x; Hovenden MJ, 2014, NATURE, V511, P583, DOI 10.1038/nature13281; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Hungate BA, 2013, NEW PHYTOL, V200, P767, DOI 10.1111/nph.12409; Johnson NC, 2015, NEW PHYTOL, V205, P1473, DOI 10.1111/nph.13172; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P349, DOI 10.5194/essd-7-349-2015; McCarthy HR, 2010, NEW PHYTOL, V185, P514, DOI 10.1111/j.1469-8137.2009.03078.x; Newingham BA, 2013, GLOBAL CHANGE BIOL, V19, P2168, DOI 10.1111/gcb.12177; Norby RJ, 2016, NEW PHYTOL, V209, P17, DOI 10.1111/nph.13593; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Perez-Moreno J, 2000, NEW PHYTOL, V145, P301, DOI 10.1046/j.1469-8137.2000.00569.x; Phillips RP, 2013, NEW PHYTOL, V199, P41, DOI 10.1111/nph.12221; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reich PB, 2013, NAT CLIM CHANGE, V3, P278, DOI [10.1038/nclimate1694, 10.1038/NCLIMATE1694]; Shi M, 2016, GLOBAL CHANGE BIOL, V22, P1299, DOI 10.1111/gcb.13131; Sulman BN, 2014, NAT CLIM CHANGE, V4, P1099, DOI [10.1038/nclimate2436, 10.1038/NCLIMATE2436]; Talhelm AF, 2014, GLOBAL CHANGE BIOL, V20, P2492, DOI 10.1111/gcb.12564; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vicca S, 2012, ECOL LETT, V15, P520, DOI 10.1111/j.1461-0248.2012.01775.x; Wieder WR, 2015, NAT GEOSCI, V8, P441, DOI 10.1038/NGEO2413; Zhu ZC, 2016, NAT CLIM CHANGE, V6, P791, DOI [10.1038/NCLIMATE3004, 10.1038/nclimate3004]	34	295	311	52	609	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					72	74		10.1126/science.aaf4610	http://dx.doi.org/10.1126/science.aaf4610			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365447	Green Accepted, Green Submitted			2022-12-28	WOS:000378816200038
J	Eliott, D; Papaliodis, GN; Durand, ML; Turbett, SE				Eliott, Dean; Papaliodis, George N.; Durand, Marlene L.; Turbett, Sarah E.			Case 20-2016: A 50-Year-Old Man with Cloudy Vision, Hearing Loss, and Unsteadiness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Eliott, Dean; Papaliodis, George N.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Ophthalmol,Massachusetts Eye & Ear Infirm, Boston, MA USA; [Durand, Marlene L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Turbett, Sarah E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA USA; [Eliott, Dean; Papaliodis, George N.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Durand, Marlene L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Turbett, Sarah E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Eliott, D (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Ophthalmol,Massachusetts Eye & Ear Infirm, Boston, MA USA.				Acucela; ThromboGenics; Neurotech; Ocata Therapeutics; Alcon; Alimera; Allergan; Arctic; Avalanche; Bausch Lomb; Biogen; Dutch Ophthalmic; Ophthotech; MacuLogix	Acucela; ThromboGenics; Neurotech; Ocata Therapeutics; Alcon(Novartis); Alimera; Allergan(AbbVieAllergan); Arctic; Avalanche; Bausch Lomb; Biogen(Biogen); Dutch Ophthalmic; Ophthotech; MacuLogix	Dr. Eliott reports receiving fees for serving on an advisory board from Acucela, fees for conducting an educational seminar from ThromboGenics, grant support to his institution from Neurotech and Ocata Therapeutics, and consulting fees from Alcon, Alimera, Allergan, Arctic, Avalanche, Bausch & Lomb, Biogen, Dutch Ophthalmic, Ophthotech, MacuLogix, and ThromboGenics. No other potential conflict of interest relevant to this article was reported.	Centre for Disease Control and Prevention, 2015, SEXUALLY; Fraga NAD, 2012, AN BRAS DERMATOL, V87, P877, DOI 10.1590/S0365-05962012000600009; Fu EX, 2010, RETINA-J RET VIT DIS, V30, P1135, DOI 10.1097/IAE.0b013e3181cdf3ae; Otiti-Sengeri J, 2008, CURR OPIN HIV AIDS, V3, P432, DOI 10.1097/COH.0b013e328302cc3d	4	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2586	2593		10.1056/NEJMcpc1600611	http://dx.doi.org/10.1056/NEJMcpc1600611			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8DD	27355538				2022-12-28	WOS:000378727200012
J	Estrada, J; Wong, F; DePace, A; Gunawardena, J				Estrada, Javier; Wong, Felix; DePace, Angela; Gunawardena, Jeremy			Information Integration and Energy Expenditure in Gene Regulation	CELL			English	Article							TRANSCRIPTION FACTORS; MEDIATOR COMPLEX; EXPRESSION; PRECISION; BIOLOGY; BINDING; MODEL	The quantitative concepts used to reason about gene regulation largely derive from bacterial studies. We show that this bacterial paradigm cannot explain the sharp expression of a canonical developmental gene in response to a regulating transcription factor (TF). In the absence of energy expenditure, with regulatory DNA at thermodynamic equilibrium, information integration across multiple TF binding sites can generate the required sharpness, but with strong constraints on the resultant "higher-order cooperativities." Even with such integration, there is a "Hopfield barrier" to sharpness; for n TF binding sites, this barrier is represented by the Hill function with the Hill coefficient n. If, however, energy is expended to maintain regulatory DNA away from thermodynamic equilibrium, as in kinetic proofreading, this barrier can be breached and greater sharpness achieved. Our approach is grounded in fundamental physics, leads to testable experimental predictions, and suggests how a quantitative paradigm for eukaryotic gene regulation can be formulated.	[Estrada, Javier; Wong, Felix; DePace, Angela; Gunawardena, Jeremy] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Wong, Felix] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Gunawardena, J (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	jeremy@hms.harvard.edu		Estrada, Javier/0000-0003-3646-204X; Estrada Diez, Francisco Javier/0000-0001-8918-2573	National Science Foundation (NSF) [GRF DGE1144152]; NIH [U01 GM103804]; NSF CAREER [1452557]; NSF [1462629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM103804] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the editor, Robert Kruger, and the anonymous reviewers for their help. We thank Rebecca Ward for editorial assistance. We gratefully acknowledge the Department of Systems Biology for supporting J.E. F.W. was supported by a National Science Foundation (NSF) grant (GRF DGE1144152); A.D. was supported by an NIH grant (U01 GM103804) and NSF CAREER grant (1452557); and J.G. was supported by an NSF grant (1462629).	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Ahsendorf T, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0102-4; Bialek W., 2015, ARXIV151208954; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Bosveld F, 2008, DEV BIOL, V313, P802, DOI 10.1016/j.ydbio.2007.11.019; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; Davidson EH, 2006, REG GEN GEN REG; Engel P.C., 2013, BIOCHEM J, V2013, P1; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gunawardena J, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-29; Gunawardena J, 2013, MOL BIOL CELL, V24, P1827, DOI 10.1091/mbc.E12-03-0227; Hammar P, 2014, NAT GENET, V46, P405, DOI 10.1038/ng.2905; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Keung AJ, 2015, NAT REV GENET, V16, P159, DOI 10.1038/nrg3900; Lebrecht D, 2005, P NATL ACAD SCI USA, V102, P13176, DOI 10.1073/pnas.0506462102; MAHAN BH, 1975, J CHEM EDUC, V52, P299, DOI 10.1021/ed052p299; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Nussinov R, 2013, ANNU REV BIOPHYS, V42, P169, DOI 10.1146/annurev-biophys-083012-130257; Park JM, 2001, MOL CELL BIOL, V21, P2312, DOI 10.1128/MCB.21.7.2312-2323.2001; Perry MW, 2012, CURR BIOL, V22, P2247, DOI 10.1016/j.cub.2012.09.051; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Ptashne M, 2004, GENETIC SWITCH PHAGE; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Sherman MS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002407; Singh N, 2005, DEV BIOL, V278, P242, DOI 10.1016/j.ydbio.2004.11.011; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003	36	70	70	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					234	244		10.1016/j.cell.2016.06.012	http://dx.doi.org/10.1016/j.cell.2016.06.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368104	Bronze, Green Accepted			2022-12-28	WOS:000380254400024
J	Lenzer, J				Lenzer, Jeanne			Physician health programs under fire	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jlenzer@bmj.com						Anderson P, 2016, MEDSCAPE; Anderson P, 2015, MEDSCAPE; Benjamin M, 2009, CAMP LEJEUNE WHISTLE; Benjamin M, 2010, SALON; Bourne T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006687; Boyd JW, 2015, J ADDICT MED, V9, P431, DOI 10.1097/ADM.0000000000000174; Boyd JW, 2012, J ADDICT MED, V6, P243, DOI 10.1097/ADM.0b013e318262ab09; Federation of State Physician Health Programs, 2008, PUBL POL STAT POS IL; Glaser G, 2015, ATLANTIC; Goldsmith RJ, 2015, MEDSCAPE; Hampton T, 2005, JAMA-J AM MED ASSOC, V294, P1189, DOI 10.1001/jama.294.10.1189; Katz A, 2016, EMERG MED NEWS, V38, P20, DOI [10.1097/01.EEM.0000480794.97823.49, DOI 10.1097/01.EEM.0000480794.97823.49]; Leape LL, 2006, ANN INTERN MED, V144, P107, DOI 10.7326/0003-4819-144-2-200601170-00008; McLellan AT, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2038; Miles S, 1997, Minn Med, V80, P42; Miles SH, 1998, JAMA-J AM MED ASSOC, V280, P865, DOI 10.1001/jama.280.10.865; Platman S, 2013, J ADDICT MED, V7, P435, DOI 10.1097/01.ADM.0000434988.43332.dc; Szalavitz M, 2016, HUFFINGTON POST; Tjia J, 2005, J AM COLL HEALTH, V53, P219, DOI 10.3200/JACH.53.5.219-224; Wible PL, 2015, MEDSCAPE; Williams D, 1999, FLORIDA TIMES U 0525; Wood BA, 2016, STATE N CAROLINA PER	22	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3568	10.1136/bmj.i3568	http://dx.doi.org/10.1136/bmj.i3568			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27364761				2022-12-28	WOS:000379019700005
J	Mooney, H				Mooney, Helen			A third of British describe NHS funding crisis as "severe"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Curtice J, 2016, LATEST REPORT PUBLIS	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3666	10.1136/bmj.i3666	http://dx.doi.org/10.1136/bmj.i3666			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27365491				2022-12-28	WOS:000379019700021
J	Abrahamsen, B; Eiken, P; Prieto-Alhambra, D; Eastell, R				Abrahamsen, Bo; Eiken, Pia; Prieto-Alhambra, Daniel; Eastell, Richard			Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FEMUR FRACTURES; DIAPHYSEAL FRACTURES; ATYPICAL FRACTURES; BISPHOSPHONATE USE; OSTEOPOROSIS; MORTALITY; EXTENSION; ADHERENCE; THERAPY; RATES	OBJECTIVES To determine the skeletal safety and efficacy of long term (>= 10 years) alendronate use in patients with osteoporosis. DESIGN Open register based cohort study containing two nested case control studies. SETTING Nationwide study of population of Denmark. PARTICIPANTS 61 990 men and women aged 50-94 at the start of treatment, who had not previously taken alendronate, 1996-2007. INTERVENTIONS Treatment with alendronate. MAIN OUTCOME MEASURES Incident fracture of the subtrochanteric femur or femoral shaft (ST/FS) or the hip. Non-fracture controls from the cohort were matched to fracture cases by sex, year of birth, and year of initiation of alendronate treatment. Conditional logistic regression models were fitted to calculate odds ratios with and without adjustment for comorbidity and comedications. Sensitivity analyses investigated subsequent treatment with other drugs for osteoporosis. RESULTS 1428 participants sustained a ST/FS (incidence rate 3.4/1000 person years, 95% confidence interval 3.2 to 3.6), and 6784 sustained a hip fracture (16.2/1000 person years, 15.8 to 16.6). The risk of ST/FS was lower with high adherence to treatment with alendronate (medication possession ratio (MPR, a proxy for compliance) >80%) compared with poor adherence (MPR <50%; odds ratio 0.88, 0.77 to 0.99; P = 0.05). Multivariable adjustment attenuated this association (adjusted odds ratio 0.88, 0.77 to 1.01; P = 0.08). The risk was no higher in long term users (>= 10 dose years; 0.70, 0.44 to 1.11; P = 0.13) or in current compared with past users (0.91, 0.79 to 1.06; P = 0.22). Similarly, MPR >80% was associated with a decreased risk of hip fracture (0.73, 0.68 to 0.78; P < 0.001) as was longer term cumulative use for 5-10 dose years (0.74, 0.67 to 0.83; P < 0.001) or >= 10 dose years (0.74, 0.56 to 0.97; P = 0.03). CONCLUSIONS These findings support an acceptable balance between benefit and risk with treatment with alendronate in terms of fracture outcomes, even for over 10 years of continuous use.	[Abrahamsen, Bo] Univ Southern Denmark, Odense Patient Data Explorat Network, Dept Clin Res, JB Winslows Vej 9 A,3 Sal, DK-5000 Odense, Denmark; [Abrahamsen, Bo] Holbaek Cent Hosp, Dept Med, Smedelundsgade 60, DK-4300 Holbaek, Denmark; [Eiken, Pia] Hillerod Hosp, Dept Cardiol Nephrol & Endocrinol, Dyrehavevej 29, DK-3400 Hillerod, Denmark; [Eiken, Pia] Univ Copenhagen, Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Prieto-Alhambra, Daniel] Univ Oxford, Oxford NIHR Musculoskeletal Biomed Res Unit, NDORMS, Botnar Res Ctr, Oxford OX3 7LD, England; [Prieto-Alhambra, Daniel] Univ Autonoma Barcelona, IMIM Parc Salut Mar, Musculoskeletal Res Unit, Passeig Maritim 25-29, Barcelona 08003, Spain; [Prieto-Alhambra, Daniel] Univ Autonoma Barcelona, RETICEF, Passeig Maritim 25-29, Barcelona 08003, Spain; [Prieto-Alhambra, Daniel] Inst Carlos III FEDER Res Funds, Passeig Maritim 25-29, Barcelona 08003, Spain; [Eastell, Richard] No Gen Hosp, Acad Unit Bone Metab AUBM, Sheffield S5 7AU, S Yorkshire, England; [Eastell, Richard] Univ Sheffield, Sheffield S5 7AU, S Yorkshire, England	University of Southern Denmark; Holbaek Hospital; University of Copenhagen; University of Copenhagen; University of Oxford; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; Northern General Hospital; University of Sheffield	Prieto-Alhambra, D (corresponding author), Univ Oxford, Botnar Res Ctr, NDORMS, Nuffield Orthopaed Ctr, Oxford OX3 7LD, England.	Daniel.prietoalhambra@ndorms.ox.ac.uk	Eastell, Richard/G-5851-2011	Eastell, Richard/0000-0002-0323-3366; Prieto-Alhambra, Daniel/0000-0002-3950-6346; Abrahamsen, Bo/0000-0002-2730-6080	Novartis; UCB; Amgen; NPS Pharmaceuticals; Nycomed; Merck; Eli Lilly; Servier; IDS; Alexian; Roche; Astra Zeneca; Bayer; Fonterra; Janssen; Ono Pharma; Alere; Teijin Pharm; D-STAR; GSK nutrition; Medical Research Council [MR/K006312/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10073] Funding Source: researchfish; MRC [MR/K006312/1] Funding Source: UKRI	Novartis(Novartis); UCB(UCB Pharma SA); Amgen(Amgen); NPS Pharmaceuticals; Nycomed; Merck(Merck & Company); Eli Lilly(Eli Lilly); Servier(Servier); IDS; Alexian; Roche(Roche Holding); Astra Zeneca(AstraZeneca); Bayer(Bayer AG); Fonterra(Fonterra); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Ono Pharma; Alere; Teijin Pharm; D-STAR; GSK nutrition; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; BA receives institutional research grants and has contracts with Novartis and UCB, past institutional research contracts with Amgen and NPS Pharmaceuticals, and past payment for membership of advisory boards from Nycomed, Merck, and Amgen; PE reports grant support from Eli Lilly and payment for educational presentations for Amgen and Eli Lilly, pro bono educational presentations for Boehringer Ingelheim, payment for membership of advisory boards from Amgen, Eli Lilly, and Merck, and stock ownership in Novo Nordisk; DP-A reports institutional research grants from Amgen and Servier and support for conference attendance and speaker fees paid to his institution; RE reports institutional research grants and personal fees from Amgen, IDS, Alexian, and Roche, institutional research grants from Astra Zeneca, and speaker or consulting fees from Bayer, Fonterra, Janssen, Eli Lilly, Ono Pharma, Alere, Teijin Pharm, D-STAR, and GSK nutrition.	Abrahamsen B, 2016, J BONE MINER RES, V31, P488, DOI 10.1002/jbmr.2801; Abrahamsen B, 2010, J CLIN ENDOCR METAB, V95, P5258, DOI 10.1210/jc.2010-1571; Black DM, 2015, J BONE MINER RES, V30, P934, DOI 10.1002/jbmr.2442; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Caro JJ, 2004, OSTEOPOROSIS INT, V15, P1003, DOI 10.1007/s00198-004-1652-z; Chatellier G, 1996, BRIT MED J, V312, P426; Chiang CY, 2013, BONE, V52, P360, DOI 10.1016/j.bone.2012.10.006; Dell RM, 2012, J BONE MINER RES, V27, P2544, DOI 10.1002/jbmr.1719; Feldstein AC, 2012, J BONE MINER RES, V27, P977, DOI 10.1002/jbmr.1550; Gallagher AM, 2008, J BONE MINER RES, V23, P1569, DOI [10.1359/jbmr.080510, 10.1359/JBMR.080510]; Girgis CM, 2010, NEW ENGL J MED, V362, P1848, DOI 10.1056/NEJMc0910389; Giusti A, 2011, BONE, V48, P966, DOI 10.1016/j.bone.2010.12.033; Jarvinen TLN, 2015, J INTERN MED, V277, P662, DOI 10.1111/joim.12366; Jarvinen TLN, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2088; Jha S, 2015, J BONE MINER RES, V30, P2179, DOI 10.1002/jbmr.2565; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; Kharazmi M, 2016, J BONE MINER RES, V31, P491, DOI 10.1002/jbmr.2767; Lalmohamed A, 2012, ARCH INTERN MED, V172, P1229, DOI 10.1001/archinternmed.2012.2713; Meier RPH, 2012, ARCH INTERN MED, V172, P930, DOI 10.1001/archinternmed.2012.1796; Muschitz C, 2015, J CLIN DENSITOM, VS1094-6950, P00126; Napoli N, 2013, J CLIN ENDOCR METAB, V98, P659, DOI 10.1210/jc.2012-1896; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reyes C, 2016, J CELL BIOCHEM, V117, P20, DOI 10.1002/jcb.25266; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Saita Y, 2014, BONE, V66, P105, DOI 10.1016/j.bone.2014.06.008; Schilcher J, 2015, J BONE MINER RES, V30, P2127, DOI 10.1002/jbmr.2547; Schilcher J, 2015, ACTA ORTHOP, V86, P100, DOI 10.3109/17453674.2015.1004149; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Selga J, 2016, OSTEOPOROSIS INT, V27, P827, DOI 10.1007/s00198-015-3355-z; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Siris ES, 2006, MAYO CLIN PROC, V81, P1013, DOI 10.4065/81.8.1013; Svedbom A, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0137-0; Taormina DP, 2014, BONE, V63, P1, DOI 10.1016/j.bone.2014.02.006; Wang Z, 2014, OSTEOPOROSIS INT, V25, P2109, DOI 10.1007/s00198-014-2738-x; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2	35	59	61	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2016	353								i3365	10.1136/bmj.i3365	http://dx.doi.org/10.1136/bmj.i3365			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FP	27353596	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000379018000005
J	Shanti, SD				Shanti, S. D.			PERSONAL VIEW Tampon makers could help reduce violence against women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shanti, S. D.] AT Still Univ Hlth Sci, 8535 East Still Circle, Mesa, AZ 85206 USA	A.T. Still University of Health Sciences	Shanti, SD (corresponding author), AT Still Univ Hlth Sci, 8535 East Still Circle, Mesa, AZ 85206 USA.	sshanti@atsu.edu						Day T, 2005, UN EC COSTS VIOLENCE; Hemenway D, 2010, NEW ENGL J MED, V362, P1657, DOI 10.1056/NEJMp1001784; PRWEB, 2012, GLOB MARK FEM HYG PR; United Nations Office on Drugs and Crime, 2013, GLOB STUD HOM; United Nations Trust Fund to End Violence Against Women, 2013, ANN REP 2012, P28; World Bank, 2015, VIOL WOM GIRLS	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2016	353								i3465	10.1136/bmj.i3465	http://dx.doi.org/10.1136/bmj.i3465			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FP	27352947				2022-12-28	WOS:000379018000009
J	Albuquerque, RPP; Richards, A				Albuquerque, Rui P. P.; Richards, Andrea			Squamous-Cell Carcinoma of the Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Albuquerque, Rui P. P.; Richards, Andrea] Univ Birmingham, Birmingham, W Midlands, England	University of Birmingham	Albuquerque, RPP (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	r.p.p.d.albuquerque@bham.ac.uk		Albuquerque, Rui/0000-0002-1741-8871	National Institute for Health Research [CL-2012-09-008] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	1	1	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					E32	E32		10.1056/NEJMicm1513456	http://dx.doi.org/10.1056/NEJMicm1513456			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1TG	27332922	Green Published			2022-12-28	WOS:000378271700001
J	Jepson, PD; Law, RJ				Jepson, Paul D.; Law, Robin J.			MARINE ENVIRONMENT Persistent pollutants, persistent threats	SCIENCE			English	Editorial Material							CONTAMINANTS; WATERS; PCB		[Jepson, Paul D.; Law, Robin J.] Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England; [Law, Robin J.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Pakefield Rd, Lowestoft NR33 0HT, Suffolk, England	Zoological Society of London; Centre for Environment Fisheries & Aquaculture Science	Jepson, PD (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	paul.jepson@ioz.ac.uk						Carson Rachel, 1994, SILENT SPRING; Convention S, 2001, STOCKHOLM CONVENTION; Forney KA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P145; Henry TB, 2015, CRIT REV TOXICOL, V45, P643, DOI 10.3109/10408444.2015.1038498; Houde M, 2005, REV ENVIRON CONTAM T, V184, P1, DOI 10.1007/0-387-27565-7_1; International Council for the Exploration of the Sea, 2016, REP WORK GROUP MAR M; International Union for Conservation of Nature, 2015, IUCN RED LIST THREAT; JENSEN S, 1969, NATURE, V224, P247, DOI 10.1038/224247a0; Jepson PD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18573; Letcher RJ, 2010, SCI TOTAL ENVIRON, V408, P2995, DOI 10.1016/j.scitotenv.2009.10.038; Ma JM, 2011, NAT CLIM CHANGE, V1, P255, DOI 10.1038/NCLIMATE1167; Pinzone M, 2015, ENVIRON RES, V142, P185, DOI 10.1016/j.envres.2015.06.021; Riget F, 2016, ENVIRON POLLUT, V217, P114, DOI 10.1016/j.envpol.2015.11.006; Roos AM, 2012, ENVIRON POLLUT, V170, P268, DOI 10.1016/j.envpol.2012.07.017	14	92	94	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1388	1389		10.1126/science.aaf9075	http://dx.doi.org/10.1126/science.aaf9075			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313021	Green Submitted			2022-12-28	WOS:000377975400018
J	Buffington, SA; Di Prisco, GV; Auchtung, TA; Ajami, NJ; Petrosino, JF; Costa-Mattioli, M				Buffington, Shelly A.; Di Prisco, Gonzalo Viana; Auchtung, Thomas A.; Ajami, Nadim J.; Petrosino, Joseph F.; Costa-Mattioli, Mauro			Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring	CELL			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; GUT MICROBIOME; OXYTOCIN; AUTISM; BEHAVIOR; BRAIN; ASSOCIATION; OBESITY; MOUSE	Maternal obesity during pregnancy has been associated with increased risk of neurodevelopmental disorders, including autism spectrum disorder (ASD), in offspring. Here, we report that maternal high-fat diet (MHFD) induces a shift in microbial ecology that negatively impacts offspring social behavior. Social deficits and gut microbiota dysbiosis in MHFD offspring are prevented by co-housing with offspring of mothers on a regular diet (MRD) and transferable to germ-free mice. In addition, social interaction induces synaptic potentiation (LTP) in the ventral tegmental area (VTA) of MRD, but not MHFD offspring. Moreover, MHFD offspring had fewer oxytocin immunoreactive neurons in the hypothalamus. Using metagenomics and precision microbiota reconstitution, we identified a single commensal strain that corrects oxytocin levels, LTP, and social deficits in MHFD offspring. Our findings causally link maternal diet, gut microbial imbalance, VTA plasticity, and behavior and suggest that probiotic treatment may relieve specific behavioral abnormalities associated with neurodevelopmental disorders.	[Buffington, Shelly A.; Di Prisco, Gonzalo Viana; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Buffington, Shelly A.; Di Prisco, Gonzalo Viana; Costa-Mattioli, Mauro] Baylor Coll Med, Memory & Brain Res Ctr, Houston, TX 77030 USA; [Auchtung, Thomas A.; Ajami, Nadim J.; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Auchtung, Thomas A.; Ajami, Nadim J.; Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Costa-Mattioli, M (corresponding author), Baylor Coll Med, Memory & Brain Res Ctr, Houston, TX 77030 USA.	costamat@bcm.edu	Petrosino, Joseph F./AAF-1621-2019; Buffington, Shelly Alexandra/AAD-7637-2022	Buffington, Shelly Alexandra/0000-0001-7133-0064; Auchtung, Thomas/0000-0002-0135-6266	NIH [NIMH 096816, NINDS 076708]; Alkek Foundation; Baylor College of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alkek Foundation; Baylor College of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Costa-Mattioli laboratory, K. Krnjevic, M. Beauchamp, and H. Dierick for comments on the manuscript; A. Swennes, J. Garcia, D. Quach and J. Auchtung for technical advice. This work was supported by funding from the NIH (NIMH 096816, NINDS 076708) to M. C.-M and the Alkek Foundation and Baylor College of Medicine to the Alkek Center for Meta-genomics and Microbiome Research to J.F.P.	Aye ILMH, 2015, P NATL ACAD SCI USA, V112, P12858, DOI 10.1073/pnas.1515484112; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bilder DA, 2013, PEDIATRICS, V132, pE1276, DOI 10.1542/peds.2013-1188; Bolton JL, 2014, DIALOGUES CLIN NEURO, V16, P307; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Bresnahan M, 2015, JAMA PSYCHIAT, V72, P466, DOI 10.1001/jamapsychiatry.2014.3034; Connolly N., 2016, AUTISM RES; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Davari S, 2013, NEUROSCIENCE, V240, P287, DOI 10.1016/j.neuroscience.2013.02.055; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Galley JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113026; Groppe SE, 2013, BIOL PSYCHIAT, V74, P172, DOI 10.1016/j.biopsych.2012.12.023; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huang W, 2016, ELIFE, V5, DOI 10.7554/eLife.12052; Huang YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003281; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; Ma J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4889; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mathers JC, 2009, ADV EXP MED BIOL, V646, P119, DOI 10.1007/978-1-4020-9173-5_13; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; Mayer EA, 2014, BIOESSAYS, V36, P933, DOI 10.1002/bies.201400075; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Melis MR, 2007, EUR J NEUROSCI, V26, P1026, DOI 10.1111/j.1460-9568.2007.05721.x; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Modi ME, 2012, HORM BEHAV, V61, P340, DOI 10.1016/j.yhbeh.2011.12.010; Moss BG, 2014, AM J HEALTH PROMOT, V28, P181, DOI 10.4278/ajhp.120705-QUAN-325; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; PEDERSEN CA, 1994, BEHAV NEUROSCI, V108, P1163, DOI 10.1037/0735-7044.108.6.1163; Penagarikano O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010257; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078898; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Sabatier Nancy, 2013, Front Endocrinol (Lausanne), V4, P35, DOI 10.3389/fendo.2013.00035; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Sullivan EL, 2014, PHYSIOL BEHAV, V123, P236, DOI 10.1016/j.physbeh.2012.07.014; Tang YM, 2014, NEUROPHARMACOLOGY, V77, P277, DOI 10.1016/j.neuropharm.2013.10.004; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uvnas-Moberg K, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01529; Wang X, 2002, WORLD J GASTROENTERO, V8, P540, DOI 10.3748/wjg.v8.i3.540; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	55	589	619	11	231	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1762	1775		10.1016/j.cell.2016.06.001	http://dx.doi.org/10.1016/j.cell.2016.06.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315483	Bronze, Green Accepted			2022-12-28	WOS:000378062000025
J	Mafi, JN; Wee, CC; Davis, RB; Landon, BE				Mafi, John N.; Wee, Christina C.; Davis, Roger B.; Landon, Bruce E.			Comparing Use of Low-Value Health Care Services Among US Advanced Practice Clinicians and Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							RESPIRATORY-TRACT INFECTIONS; QUALITY-OF-CARE; NURSE-PRACTITIONERS; UNITED-STATES; ACUTE BRONCHITIS; ANTIBIOTIC USE; BACK-PAIN; ADULTS; ASSISTANTS; TRENDS	Background: Many physicians believe that advanced practice clinicians (APCs [nurse practitioners and physician assistants]) provide care of relatively lower value. Objective: To compare use of low-value services among U.S. APCs and physicians. Design: Service use after primary care visits was evaluated for 3 conditions after adjustment for patient and provider characteristics and year. Patients with guideline-based red flags were excluded and analyses stratified by office-versus hospital-based visits, acute versus nonacute presentations, and whether clinicians self-identified as the patient's primary care provider (PCP). Setting: National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 1997 to 2011 Patients: Patients presenting with upper respiratory infections (URIs), back pain, or headache. Measurements: Use of guideline-discordant antibiotics (for URIs), radiography (for URIs and back pain), computed tomography (CT) or magnetic resonance imaging (MRI) (for headache and back pain), and referrals to other physicians (for all 3 conditions). Results: 12 170 physician and 473 APC office-based visits and 13 359 physician and 2947 APC hospital-based visits were identified. Although office-based clinicians saw similar patients, hospital-based APCs saw younger patients (mean age, 42.6 vs. 45.0 years; P < 0.001), and practiced in urban settings less frequently (49.7% vs. 81.7% of visits; P < 0.001) than hospital-based physicians. Unadjusted and adjusted results revealed that APCs ordered antibiotics, CT or MRI, radiography, and referrals as often as physicians in both settings. Stratification suggested that self-identified PCP APCs ordered more services than PCP physicians in the hospital-based setting. Limitation: NHAMCS reflects hospital-based APC care; NAMCS samples physician practices and likely underrepresents office-based APCs. Conclusion: APCs and physicians provided an equivalent amount of low-value health services, dispelling physicians' perceptions that APCs provide lower-value care than physicians for these common conditions.	Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; RAND Corp, Santa Monica, CA USA; [Wee, Christina C.; Davis, Roger B.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave, Boston, MA 02215 USA; [Landon, Bruce E.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Mafi, John N.] UCLA, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, 911 Broxton Ave 301, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mafi, JN (corresponding author), Ronald Reagan UCLA Med Ctr, Dept Med, Div Gen Internal Med & Hlth Serv Res, 911 Broxton Ave 301, Los Angeles, CA 90024 USA.	jmafi@mednet.ucla.edu			U.S. Health Services and Research Administration; Ryoichi Sasakawa Fellowship Fund; National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK087932] Funding Source: NIH RePORTER	U.S. Health Services and Research Administration; Ryoichi Sasakawa Fellowship Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	U.S. Health Services and Research Administration, Ryoichi Sasakawa Fellowship Fund, and National Institutes of Health.	Atwater A, 2008, DM-DIS MON, V54, P728, DOI 10.1016/j.disamonth.2008.08.002; Barnett ML, 2014, JAMA-J AM MED ASSOC, V311, P2020, DOI 10.1001/jama.2013.286141; Barnett ML, 2014, JAMA INTERN MED, V174, P138, DOI 10.1001/jamainternmed.2013.11673; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; Bodenheimer TS, 2013, HEALTH AFFAIR, V32, P1881, DOI 10.1377/hlthaff.2013.0234; Centers for Disease Control and Prevention, 2004, US ULT CLUST MOD NAM; Chenoweth D, 2008, J OCCUP ENVIRON MED, V50, P1293, DOI 10.1097/JOM.0b013e318184563a; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; CHRISTIAN S, 2007, OVERVIEW NURSE PRACT; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; Donelan K, 2013, NEW ENGL J MED, V368, P1898, DOI 10.1056/NEJMsa1212938; Edwards ST, 2014, J GEN INTERN MED, V29, P947, DOI 10.1007/s11606-014-2808-y; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Gadbois EA, 2015, MED CARE RES REV, V72, P200, DOI 10.1177/1077558714563763; Goertz MTD., 2012, I CLIN SYSTEMS IMPRO; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Gonzales R, 1998, J GEN INTERN MED, V13, P541, DOI 10.1046/j.1525-1497.1998.00165.x; Hainer BL, 2013, AM FAM PHYSICIAN, V87, P682; Hemani A, 1999, Eff Clin Pract, V2, P258; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; Hsiao C.J., 2010, UNDERSTANDING USING; Hughes DR, 2015, JAMA INTERN MED, V175, P101, DOI 10.1001/jamainternmed.2014.6349; Iglehart JK, 2013, NEW ENGL J MED, V368, P1935, DOI 10.1056/NEJMhpr1301084; Kuo YF, 2013, HEALTH AFFAIR, V32, P1236, DOI 10.1377/hlthaff.2013.0072; Landon BE, 2006, MED CARE, V44, P234, DOI 10.1097/01.mlr.0000199848.17133.9b; Linder JA, 2003, CLIN THER, V25, P2419, DOI 10.1016/S0149-2918(03)80284-9; Lipner RS, 2006, ANN INTERN MED, V144, P29, DOI 10.7326/0003-4819-144-1-200601030-00007; Mafi JN, 2015, J GEN INTERN MED, V30, P548, DOI 10.1007/s11606-014-3107-3; Mafi JN, 2013, JAMA INTERN MED, V173, P1573, DOI 10.1001/jamainternmed.2013.8992; Martin-Misener R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007167; Martinez-Gonzalez NA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-214; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; Morgan PA, 2007, HEALTH SERV RES, V42, P2022, DOI 10.1111/j.1475-6773.2007.00700.x; Mundinger MO, 2000, JAMA-J AM MED ASSOC, V283, P59, DOI 10.1001/jama.283.1.59; National Committee for Quality Assurance, 2015, SUMM TABL MEAS CHANG; Naylor MD, 2010, HEALTH AFFAIR, V29, P893, DOI 10.1377/hlthaff.2010.0440; Peek ME, 2008, J GEN INTERN MED, V23, P1858, DOI 10.1007/s11606-008-0737-3; Petterson SM, 2012, ANN FAM MED, V10, P503, DOI 10.1370/afm.1431; Roblin DW, 2004, HEALTH SERV RES, V39, P607, DOI 10.1111/j.1475-6773.2004.00247.x; Schwartz AL, 2014, JAMA INTERN MED, V174, P1067, DOI 10.1001/jamainternmed.2014.1541; Schwartz MD, 2012, J GEN INTERN MED, V27, P469, DOI 10.1007/s11606-011-1921-4; Stange K, 2014, J HEALTH ECON, V33, P1, DOI 10.1016/j.jhealeco.2013.10.009; US Department of Health and Human Services, 2013, PROJ SUPPL DEM PRIM; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010	44	42	42	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					237	+		10.7326/M15-2152	http://dx.doi.org/10.7326/M15-2152			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UI	27322541	Green Accepted			2022-12-28	WOS:000381267200012
J	Mackintosh, M; Channon, A; Karan, A; Selvaraj, S; Zhao, HW; Cavagnero, E				Mackintosh, Maureen; Channon, Amos; Karan, Anup; Selvaraj, Sakthivel; Zhao, Hongwen; Cavagnero, Eleonora			What is the private sector? Understanding private provision in the health systems of low-income and middle-income countries	LANCET			English	Article							SOUTH-AFRICA; UNIVERSAL COVERAGE; PROVIDERS; POOR; ARGENTINA; SERVICES; ACCESS; MALAWI; INDIA; FEVER	Private health care in low-income and middle-income countries is very extensive and very heterogeneous, ranging from itinerant medicine sellers, through millions of independent practitioners-both unlicensed and licensed-to corporate hospital chains and large private insurers. Policies for universal health coverage (UHC) must address this complex private sector. However, no agreed measures exist to assess the scale and scope of the private health sector in these countries, and policy makers tasked with managing and regulating mixed health systems struggle to identify the key features of their private sectors. In this report, we propose a set of metrics, drawn from existing data that can form a starting point for policy makers to identify the structure and dynamics of private provision in their particular mixed health systems; that is, to identify the consequences of specific structures, the drivers of change, and levers available to improve efficiency and outcomes. The central message is that private sectors cannot be understood except within their context of mixed health systems since private and public sectors interact. We develop an illustrative and partial country typology, using the metrics and other country information, to illustrate how the scale and operation of the public sector can shape the private sector's structure and behaviour, and vice versa.	[Mackintosh, Maureen] Open Univ, Fac Social Sci, Dept Econ, Walton Hall, Milton Keynes, Bucks, England; [Channon, Amos] Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England; [Karan, Anup; Selvaraj, Sakthivel] Publ Hlth Fdn India, New Delhi, India; [Cavagnero, Eleonora] World Bank, Hlth Nutr & Populat Global Practice, Washington, DC USA	Open University - UK; University of Southampton; Public Health Foundation of India; The World Bank	Mackintosh, M (corresponding author), Open Univ, Fac Social Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	maureen.mackintosh@open.ac.uk	Selvaraj, Sakthivel/ABE-6897-2020; Karan, Anup/AAK-2060-2020; Selvaraj, Sakthivel/ABD-5873-2021	Selvaraj, Sakthivel/0000-0001-5940-1958; Channon, Andrew/0000-0003-4855-0418	ESRC [ES/F028180/1] Funding Source: UKRI; Economic and Social Research Council [ES/F028180/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Abiiro GA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-234; Alaba OA, 2012, DEV SO AFR, V29, P704, DOI 10.1080/0376835X.2012.730973; [Anonymous], 2012, HLTH FINANCING GHANA; [Anonymous], 1996, PEOPLES DAILY; Argentina Ministry of Health, 2012, ENC UT GAST SERV SAL; Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9; B Shrestha, 2012, NEPAL NATL HLTH ACCO; Balabanova D, 2011, GOOD HLTH LOW COST 2; BARU RV, 1998, PRIVATE HLTH CARE IN; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Bhat R, 1999, HEALTH POLICY PLANN, V14, P26, DOI 10.1093/heapol/14.1.26; Bloom G, 2011, HEALTH POLICY PLANN, V26, pi45, DOI 10.1093/heapol/czr025; Cavagnero E, 2008, HEALTH POLICY, V88, P88, DOI 10.1016/j.healthpol.2008.02.009; China Ministry of Health, 2009, CHIN NAT HLTH YB; China Ministry of Health, 2003, 3 NAT HLTH SERV SURV; Chudnovsky, 2002, SISTEMA SALUD ARGENT; Class D, 2014, ARGENTINA HLTH FINAN; Dai D., 1993, CHINESE HLTH EC, V2, P26; Department of Census and Statistics, 2011, HOUS INC EXP SURV 20; Fernando T, 2009, SRI LANKA HLTH ACCOU; Filmer D, 2005, HEALTH POLICY PLANN, V20, P337, DOI 10.1093/heapol/czi043; Filmer D., 1998, ESTIMATING WEALTH EF; [Government of India Ministry of Health and Family Welfare], 2009, NAT HLTH ACC CELL; Govindaraj R., 2014, HLTH CARE SRI LANKA; Hanson K, 1998, HEALTH POLICY PLANN, V13, P195, DOI 10.1093/heapol/13.3.195; Hurtado J., 2007, ARGENTINA MED PREPAG; ICF International, 2013, MEAS DHS; INDEC, 2001, ENC COND VID 2001 I; Kazembe LN, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-40; Lloyd-Sherlock P, 2005, SOC SCI MED, V60, P1893, DOI 10.1016/j.socscimed.2004.08.032; Mackintosh M, 2005, COMMERCIALIZATION HL; Mackintosh M, 2010, J AFR ECON, V19, piii166, DOI 10.1093/jae/ejq017; Marten R, 2014, LANCET, V384, P2164, DOI 10.1016/S0140-6736(14)60075-1; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; McIntyre D, 2007, HLTH CARE FINANCING; McPake B, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-46; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ministry of Health and Social Welfare, 2012, NAT HLTH ACC YEAR 20; Ministry of Health of the People's Republic of China, 2009, CHIN HLTH STAT YB 20; Ministry of Health Sri Lanka, 2008, MIN HLTH ANN HLTH B; Ministry of Statistics and Programme Implementation, 2013, NAT SAMPL SURV REP; Ministry of Statistics and Programme Implementation, 2015, NAT SAMPL SURV REP; Montagu D, 2013, PRIVATE HEALTHCARE D; MURALEEDHARAN VR, 1999, CHARACTERISTICS STRU; Onwujekwe O, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-50; Planning Commission, 2012, REP STEER COMM HLTH; Public Health Foundation of India, 2011, CRIT ASS EX HLTH INS; Rannan-Eliya RP, 2010, OECD WORKING PAPERS, V52; Rutstein S. O., 2004, DHS WEALTH INDEX; Saksena P., 2010, WORLD HLTH REP, VVolume 20; Sakthivel Selvaraj, 2009, Economic and Political Weekly, V44, P55; Soyibo A., 2009, NATL HLTH ACCO UNPUB, VI; Stallworthy G, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-55; Sussmuth-Dyckerhoff C, 2010, IDENTIFYING PRIVATE; Tanzania National Bureau of Statistics, 2009, TANZ HOUS BUDG SURV; Thailand Ministry of Public Health, 2009, THAI NAT HLTH ACC SU; Thailand National Statistical Office, 2011, 2011 SURV HLTH WELF; The Global Fund, 2008, MAL NAT HLTH ACC SUB; Tung E, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-52; van den Heever AM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S5; van Doorslaer E, 2005, PAYING OUT OF POCKET; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Wang S., LEARNING MECH ADAPTA; Witter S., 2010, MAPPING USER FEES HL; World Bank, 2013, WORLD BANK GROUP IMPACT EVALUATIONS: RELEVANCE AND EFFECTIVENESS, P1, DOI 10.1596/978-0-8213-9717-6; World Health Organisation, 2013, GLOB HLTH EXP DAT; World Health Organization, 2012, WORLD HLTH STAT 2012; Yazbeck A., 2003, HLTH POLICY RES S AS; Zhao H., 2008, GOVERNING HEALTHCARE; [No title captured]	71	114	116	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					596	605		10.1016/S0140-6736(16)00342-1	http://dx.doi.org/10.1016/S0140-6736(16)00342-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27358253	Green Accepted			2022-12-28	WOS:000380756600032
J	Reisner, S; Keatley, J; Baral, S				Reisner, Sari; Keatley, JoAnne; Baral, Stefan			Transgender community voices: a participatory population perspective	LANCET			English	Editorial Material									[Reisner, Sari] Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA; [Reisner, Sari] Harvard Med Sch, Boston, MA 02115 USA; [Reisner, Sari] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Reisner, Sari] Fenway Hlth, Fenway Inst, Boston, MA USA; [Keatley, JoAnne] Univ Calif San Francisco, Ctr Excellence Transgender Hlth, San Francisco, CA 94143 USA; [Baral, Stefan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Fenway Health; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Reisner, S (corresponding author), Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA.; Reisner, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Reisner, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.; Reisner, S (corresponding author), Fenway Hlth, Fenway Inst, Boston, MA USA.	sari.reisner@childrens.harvard.edu	Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419					0	29	29	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					327	327		10.1016/S0140-6736(16)30709-7	http://dx.doi.org/10.1016/S0140-6736(16)30709-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR6MV	27323922				2022-12-28	WOS:000380016900015
J	Katz, LN; Ates, JLY; Pillow, JW; Huk, AC				Katz, Leor N.; Ates, Jacob L. Y.; Pillow, Jonathan W.; Huk, Alexander C.			Dissociated functional significance of decision-related activity in the primate dorsal stream	NATURE			English	Article							LATERAL INTRAPARIETAL AREA; PARIETAL CORTEX; PERCEPTUAL DECISION; VISUAL-CORTEX; MOTION SIGNALS; MACAQUE MONKEY; NEURAL BASIS; NEURONS; MT; INACTIVATION	During decision making, neurons in multiple brain regions exhibit responses that are correlated with decisions(1-6). However, it remains uncertain whether or not various forms of decision-related activity are causally related to decision making(7-9). Here we address this question by recording and reversibly inactivating the lateral intraparietal (LIP) and middle temporal (MT) areas of rhesus macaques performing a motion direction discrimination task. Neurons in area LIP exhibited firing rate patterns that directly resembled the evidence accumulation process posited to govern decision making(2,10), with strong correlations between their response fluctuations and the animal's choices. Neurons in area MT, in contrast, exhibited weak correlations between their response fluctuations and choices, and had firing rate patterns consistent with their sensory role in motion encoding(1). The behavioural impact of pharmacological inactivation of each area was inversely related to their degree of decision-related activity: while inactivation of neurons in MT profoundly impaired psychophysical performance, inactivation in LIP had no measurable impact on decision-making performance, despite having silenced the very clusters that exhibited strong decision-related activity. Although LIP inactivation did not impair psychophysical behaviour, it did influence spatial selection and oculomotor metrics in a free-choice control task. The absence of an effect on perceptual decision making was stable over trials and sessions and was robust to changes in stimulus type and task geometry, arguing against several forms of compensation. Thus, decision-related signals in LIP do not appear to be critical for computing perceptual decisions, and may instead reflect secondary processes. Our findings highlight a dissociation between decision correlation and causation, showing that strong neuron-decision correlations do not necessarily offer direct access to the neural computations underlying decisions.	[Katz, Leor N.; Ates, Jacob L. Y.; Huk, Alexander C.] Univ Texas Austin, Dept Neurosci, Ctr Perceptual Syst, Austin, TX 78712 USA; [Katz, Leor N.; Ates, Jacob L. Y.; Huk, Alexander C.] Univ Texas Austin, Dept Psychol, Ctr Perceptual Syst, Austin, TX 78712 USA; [Pillow, Jonathan W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA; [Pillow, Jonathan W.] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Princeton University; Princeton University	Katz, LN (corresponding author), Univ Texas Austin, Dept Neurosci, Ctr Perceptual Syst, Austin, TX 78712 USA.; Katz, LN (corresponding author), Univ Texas Austin, Dept Psychol, Ctr Perceptual Syst, Austin, TX 78712 USA.	leor.katz@utexas.edu	Huk, Alexander/A-8031-2016	Huk, Alexander/0000-0003-1430-6935; Pillow, Jonathan/0000-0002-3638-8831	Howard Hughes Medical Institute International Student Research Fellowship; McKnight Foundation; National Eye Institute [R01-EY017366]; National Institutes of Health from the National Institute on Drug Abuse [T32DA018926]; National Institutes of Health from the National Eye Institute [T32EY021462]; NATIONAL EYE INSTITUTE [R01EY017366, T32EY021462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA018926] Funding Source: NIH RePORTER	Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); McKnight Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health from the National Institute on Drug Abuse; National Institutes of Health from the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Krauzlis, C. Brody, E. Seidemann, L. Cormack, and R. Aldrich for comments on the manuscript. We thank the Brody laboratory (particularly C. Brody and J. Erlich) for inspiring the experiments, the Mauk laboratory (particularly M. Mauk. F. Riusech, and H. Halverson) for assistance with muscimol preparation, and K. Mitchell for animal support. This research was supported by the Howard Hughes Medical Institute International Student Research Fellowship to L.N.K.. the McKnight Foundation grant to J.W.P, the National Eye Institute (R01-EY017366) grant to both J.W.P, and A.C.H., and the National Institutes of Health under Ruth L. Kirschstein National Research Service Awards T32DA018926 from the National Institute on Drug Abuse and T32EY021462 from the National Eye Institute.	Arikan R, 2002, J NEUROSCI METH, V118, P51, DOI 10.1016/S0165-0270(02)00143-7; Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chowdhury SA, 2008, NEURON, V60, P367, DOI 10.1016/j.neuron.2008.08.023; Crowe DA, 2013, NAT NEUROSCI, V16, P1484, DOI 10.1038/nn.3509; Cumming BG, 2016, CURR OPIN NEUROBIOL, V37, P126, DOI 10.1016/j.conb.2016.01.009; Ding L, 2013, NEURON, V79, P640, DOI 10.1016/j.neuron.2013.07.042; Eastman KM, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00001; Erlich J. C., 2015, ELIFE, V4, P8166; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Heiss JD, 2010, J NEUROSURG, V112, P790, DOI 10.3171/2009.7.JNS09652; Heitz RP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0071; HESS R, 1974, EXP BRAIN RES, V21, P285; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kubanek J, 2015, P NATL ACAD SCI USA, V112, pE2067, DOI 10.1073/pnas.1418324112; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Li N, 2016, NATURE, V532, P459, DOI 10.1038/nature17643; Liu S, 2013, NAT NEUROSCI, V16, P89, DOI 10.1038/nn.3267; Liu YQ, 2010, NAT NEUROSCI, V13, P495, DOI 10.1038/nn.2496; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Noudoost B, 2011, J NEUROSCI METH, V194, P218, DOI 10.1016/j.jneumeth.2010.10.009; Patel GH, 2010, P NATL ACAD SCI USA, V107, P4728, DOI 10.1073/pnas.0908092107; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pillow JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062123; Pitkow X, 2015, NEURON, V87, P411, DOI 10.1016/j.neuron.2015.06.033; Raposo D, 2014, NAT NEUROSCI, V17, P1784, DOI 10.1038/nn.3865; Sarma A, 2016, NAT NEUROSCI, V19, P143, DOI 10.1038/nn.4168; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Siegel M, 2015, SCIENCE, V348, P1352, DOI 10.1126/science.aab0551; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; Wardak C, 2004, NEURON, V42, P501, DOI 10.1016/S0896-6273(04)00185-0; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilke M, 2012, P NATL ACAD SCI USA, V109, P8274, DOI 10.1073/pnas.1204789109; Yttri EA, 2014, J NEUROPHYSIOL, V111, P520, DOI 10.1152/jn.00058.2013; Zirnsak M., 2015, P C SOC NEUR	51	156	157	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					285	+		10.1038/nature18617	http://dx.doi.org/10.1038/nature18617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27376476	Green Accepted			2022-12-28	WOS:000379912600057
J	Matheoud, D; Sugiura, A; Bellemare-Pelletier, A; Laplante, A; Rondeau, C; Chemali, M; Fazel, A; Bergeron, JJ; Trudeau, LE; Burelle, Y; Gagnon, E; McBride, HM; Desjardins, M				Matheoud, Diana; Sugiura, Ayumu; Bellemare-Pelletier, Angelique; Laplante, Annie; Rondeau, Christiane; Chemali, Magali; Fazel, Ali; Bergeron, John J.; Trudeau, Louis-Eric; Burelle, Yan; Gagnon, Etienne; McBride, Heidi M.; Desjardins, Michel			Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation	CELL			English	Article							PRIMARY BILIARY-CIRRHOSIS; REGULATORY T-CELLS; CLASS-I MOLECULES; MAMMALIAN-CELLS; HEAT-SHOCK; AUTOPHAGY; MITOPHAGY; TRANSPORT; CARGO; RAB9	Antigen presentation is essential for establishing immune tolerance and for immune responses against infectious disease and cancer. Although antigen presentation can be mediated by autophagy, here we demonstrate a pathway for mitochondrial antigen presentation ( MitAP) that relies on the generation and trafficking of mitochondrial-derived vesicles ( MDVs) rather than on autophagy/mitophagy. We find that PINK1 and Parkin, two mitochondrial proteins linked to Parkinson's disease ( PD), actively inhibit MDV formation and MitAP. In absence of PINK1 or Parkin, inflammatory conditions trigger MitAP in immune cells, both in vitro and in vivo. MitAP and the formation of MDVs require Rab9 and Sorting nexin 9, whose recruitment to mitochondria is inhibited by Parkin. The identification of PINK1 and Parkin as suppressors of an immune-response-eliciting pathway provoked by inflammation suggests new insights into PD pathology.	[Matheoud, Diana; Bellemare-Pelletier, Angelique; Laplante, Annie; Rondeau, Christiane; Chemali, Magali; Desjardins, Michel] Univ Montreal, Dept Pathol & Biol Cellulaire, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Sugiura, Ayumu; McBride, Heidi M.] McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada; [Fazel, Ali; Bergeron, John J.] McGill Univ, Dept Med, Hosp Res Inst, Montreal, PQ H4A 3J1, Canada; [Trudeau, Louis-Eric] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Trudeau, Louis-Eric] Univ Montreal, Dept Neurosci, Montreal, PQ H3C 3J7, Canada; [Burelle, Yan] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Gagnon, Etienne] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Gagnon, Etienne] Univ Montreal, Dept Immunol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Desjardins, M (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.; McBride, HM (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	heidi.mcbride@mcgill.ca; michel.desjardins@umontreal.ca	McBride, Heidi M/C-1162-2008; Bergeron, John/AAW-1893-2021; Burelle, Yan/AAF-8104-2021; Sugiura, Ayumu/G-3648-2018; McBride, Heidi M./ABD-5774-2021; Trudeau, Louis-Eric/AAE-4782-2020	McBride, Heidi M/0000-0003-4666-2280; Burelle, Yan/0000-0001-9379-146X; Sugiura, Ayumu/0000-0002-4776-1478; McBride, Heidi M./0000-0003-4666-2280; Trudeau, Louis-Eric/0000-0003-4684-1377; Desjardins, Michel/0000-0002-5684-5980	Canadian Institutes for Health Research (MOP) [133653, 114869, 5605, 133549]; Canada Research Chair; Japan Society for the Promotion of Science	Canadian Institutes for Health Research (MOP)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank F. Carbone, W. Heath (University of Melbourne), and N. Shastri (University of California) for the hybridomas. We thank J. Boulais, H. Soudeyns, and the Fondation Centre de cancerologie Charles-Bruneau for technical support. This work was supported by the Canadian Institutes for Health Research (MOP#133653, MOP#114869, MOP#5605, and MOP#133549), the Canada Research Chair, and the Japan Society for the Promotion of Science.	Baba Y, 2005, PARKINSONISM RELAT D, V11, P493, DOI 10.1016/j.parkreldis.2005.07.005; BAUM H, 1995, BBA-MOL BASIS DIS, V1271, P111, DOI 10.1016/0925-4439(95)00017-X; Bell C, 2013, MOL CELL PROTEOMICS, V12, P2394, DOI 10.1074/mcp.M112.025775; BJORKLAND A, 1991, SCAND J IMMUNOL, V33, P749, DOI 10.1111/j.1365-3083.1991.tb02549.x; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Cebrian C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4633; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Dawson TM, 2008, LANCET NEUROL, V7, P474, DOI 10.1016/S1474-4422(08)70099-1; Dong B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2347; DUTZ JP, 1994, MOL IMMUNOL, V31, P967, DOI 10.1016/0161-5890(94)90091-4; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hasday JD, 2000, CELL STRESS CHAPERON, V5, P471, DOI 10.1379/1466-1268(2000)005<0471:FATHSR>2.0.CO;2; Hernandez D.G., 2016, J NEUROCHEM, DOI 10/1111/jnc.13593; Hirschfield GM, 2013, ANNU REV PATHOL-MECH, V8, P303, DOI 10.1146/annurev-pathol-020712-164014; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Kucera A, 2016, TRAFFIC, V17, P211, DOI 10.1111/tra.12357; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Martin HL, 2016, GLIA, V64, P386, DOI 10.1002/glia.22935; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Mosley RL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009381; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Nivon M, 2009, AUTOPHAGY, V5, P766, DOI 10.4161/auto.8788; Norton M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004374; Olson KE, 2016, CURR OPIN PHARMACOL, V26, P87, DOI 10.1016/j.coph.2015.10.006; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Pisani V, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-188; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Tanaka H, 2014, CLIN EXP IMMUNOL, V178, P253, DOI 10.1111/cei.12415; Tang FL, 2015, CELL REP, V12, P1631, DOI 10.1016/j.celrep.2015.08.001; Tran TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023660; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wang W., 2015, EUR POLYM J, V1, P1, DOI DOI 10.1016/J.IJCARD.2014.10.148; Xu XM, 2013, J BIOL CHEM, V288, P18077, DOI 10.1074/jbc.M113.474650; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014	53	298	307	3	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					314	327		10.1016/j.cell.2016.05.039	http://dx.doi.org/10.1016/j.cell.2016.05.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27345367	Bronze			2022-12-28	WOS:000380255400011
J	Butt, CA				Butt, Carrie A.			Frog Pond Larry Bell	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					16	17		10.1001/jama.2015.14356	http://dx.doi.org/10.1001/jama.2015.14356			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2MY	27380329				2022-12-28	WOS:000379037600001
J	Sanghavi, P; Jena, AB; Newhouse, JP; Zaslavsky, AM				Sanghavi, Prachi; Jena, Anupam B.; Newhouse, Joseph P.; Zaslavsky, Alan M.			Is Prehospital Advanced Life Support Harmful?	ANNALS OF INTERNAL MEDICINE			English	Letter									[Sanghavi, Prachi] Univ Chicago, Chicago, IL 60637 USA; [Jena, Anupam B.; Newhouse, Joseph P.; Zaslavsky, Alan M.] Harvard Univ, Cambridge, MA 02138 USA	University of Chicago; Harvard University	Sanghavi, P (corresponding author), Univ Chicago, Chicago, IL 60637 USA.		Newhouse, Joseph/AAD-9763-2019; Newhouse, Joseph/AGJ-5632-2022					Sanghavi P, 2015, ANN INTERN MED, V163, P681, DOI 10.7326/M15-0557; Sasson C, 2015, ANN INTERN MED, V163, P721, DOI 10.7326/M15-2192	2	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					70	71		10.7326/L16-0010	http://dx.doi.org/10.7326/L16-0010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380157				2022-12-28	WOS:000379215800020
J	Kiper, POS; Saito, H; Gori, F; Unger, S; Hesse, E; Yamana, K; Kiviranta, R; Solban, N; Liu, J; Brommage, R; Boduroglu, K; Bonafe, L; Campos-Xavier, B; Dikoglu, E; Eastell, R; Gossiel, F; Harshman, K; Nishimura, G; Girisha, KM; Stevenson, BJ; Takita, H; Rivolta, C; Superti-Furga, A; Baron, R				Kiper, Pelin O. Simsek; Saito, Hiroaki; Gori, Francesca; Unger, Sheila; Hesse, Eric; Yamana, Kei; Kiviranta, Riku; Solban, Nicolas; Liu, Jeff; Brommage, Robert; Boduroglu, Koray; Bonafe, Luisa; Campos-Xavier, Belinda; Dikoglu, Esra; Eastell, Richard; Gossiel, Fatma; Harshman, Keith; Nishimura, Gen; Girisha, Katta M.; Stevenson, Brian J.; Takita, Hiroyuki; Rivolta, Carlo; Superti-Furga, Andrea; Baron, Roland			Cortical-Bone Fragility - Insights from sFRP4 Deficiency in Pyle's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WNT SIGNALING PATHWAY; MINERAL DENSITY; METAPHYSEAL DYSPLASIA; BMP ANTAGONIST; BETA-CATENIN; WOMEN; OSTEOCLASTOGENESIS; CLASSIFICATION; OSTEOPOROSIS; ASSOCIATION	BACKGROUND Cortical-bone fragility is a common feature in osteoporosis that is linked to non-vertebral fractures. Regulation of cortical-bone homeostasis has proved elusive. The study of genetic disorders of the skeleton can yield insights that fuel experimental therapeutic approaches to the treatment of rare disorders and common skeletal ailments. METHODS We evaluated four patients with Pyle's disease, a genetic disorder that is characterized by cortical-bone thinning, limb deformity, and fractures; two patients were examined by means of exome sequencing, and two were examined by means of Sanger sequencing. After a candidate gene was identified, we generated a knockout mouse model that manifested the phenotype and studied the mechanisms responsible for altered bone architecture. RESULTS In all affected patients, we found biallelic truncating mutations in SFRP4, the gene encoding secreted frizzled-related protein 4, a soluble Wnt inhibitor. Mice deficient in Sfrp4, like persons with Pyle's disease, have increased amounts of trabecular bone and unusually thin cortical bone, as a result of differential regulation of Wnt and bone morphogenetic protein (BMP) signaling in these two bone compartments. Treatment of Sfrp4-deficient mice with a soluble Bmp2 receptor (RAP-661) or with antibodies to sclerostin corrected the cortical-bone defect. CONCLUSIONS Our study showed that Pyle's disease was caused by a deficiency of sFRP4, that cortical-bone and trabecular-bone homeostasis were governed by different mechanisms, and that sFRP4-mediated cross-regulation between Wnt and BMP signaling was critical for achieving proper cortical-bone thickness and stability.	[Kiper, Pelin O. Simsek; Bonafe, Luisa; Campos-Xavier, Belinda; Dikoglu, Esra] Univ Lausanne, Ctr Mol Dis, Lausanne, Switzerland; [Unger, Sheila] Univ Lausanne, Med Genet Serv, Lausanne, Switzerland; [Superti-Furga, Andrea] Univ Lausanne, Dept Pediat, Lausanne, Switzerland; [Harshman, Keith] Univ Lausanne, Univ Lausanne Hosp, Genom Technol Facil, Ctr Integrat Genom, Lausanne, Switzerland; [Rivolta, Carlo] Univ Lausanne, Dept Computat Biol, Unit Med Genet, Lausanne, Switzerland; [Stevenson, Brian J.] Swiss Inst Bioinformat, Lausanne, Switzerland; [Kiper, Pelin O. Simsek; Boduroglu, Koray] Hacettepe Univ, Fac Med, Dept Pediat, Unit Pediat Genet, TR-06100 Ankara, Turkey; [Saito, Hiroaki; Gori, Francesca; Hesse, Eric; Yamana, Kei; Kiviranta, Riku; Baron, Roland] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA; [Baron, Roland] Harvard Univ, Sch Med, Dept Med, Endocrine Unit,Massachusetts Gen Hosp, 188 Longwood Ave, Boston, MA 02115 USA; [Solban, Nicolas] Acceleron Pharma, Cambridge, MA USA; [Liu, Jeff; Brommage, Robert] Lexicon Pharmaceut, The Woodlands, TX USA; [Eastell, Richard; Gossiel, Fatma] No Gen Hosp, Metab Bone Ctr, Acad Unit Bone Metab, Sheffield S5 7AU, S Yorkshire, England; [Nishimura, Gen] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Radiol & Med Imaging, Kiyose, Japan; [Takita, Hiroyuki] Saga Hosp, Natl Hosp Org, Dept Orthoped, Saga, Japan; [Girisha, Katta M.] Manipal Univ, Kasturba Med Coll, Dept Med Genet, Manipal, India	University of Lausanne; University of Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Institute of Bioinformatics; Hacettepe University; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Acceleron Pharma; Lexicon Pharmaceuticals; Northern General Hospital; University of Sheffield; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Baron, R (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med, 188 Longwood Ave, Boston, MA 02115 USA.; Superti-Furga, A (corresponding author), Lausanne Univ Hosp CHUV, Div Med Genet, CH-1011 Lausanne, Switzerland.	asuperti@unil.ch; roland_baron@hms.harvard.edu	Brommage, Robert/J-5670-2019; Eastell, Richard/G-5851-2011; Gori, Francesca/S-9422-2019; Simsek-Kiper, Pelin Ozlem/AAI-3010-2021; KM, Girisha/AAK-6867-2020; superti-furga, andrea/E-9162-2015; BODUROGLU, KORAY O/I-9094-2013; Campos-Xavier, Belinda/P-9917-2019	Brommage, Robert/0000-0002-9947-3822; Eastell, Richard/0000-0002-0323-3366; KM, Girisha/0000-0002-0139-8239; superti-furga, andrea/0000-0002-3543-7531; Campos-Xavier, Belinda/0000-0002-6271-0724; Saito, Hiroaki/0000-0002-8130-0624; Boduroglu, Koray/0000-0001-6260-1942; Unger, Sheila/0000-0002-9539-8941; Rivolta, Carlo/0000-0002-0733-9950	Swiss National Foundation; National Institutes of Health; Medical Research Council [MR/K006312/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10073] Funding Source: researchfish; MRC [MR/K006312/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064724] Funding Source: NIH RePORTER	Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by the Swiss National Foundation and the National Institutes of Health.	Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; BEIGHTON P, 1987, J MED GENET, V24, P321, DOI 10.1136/jmg.24.6.321; Bhat RA, 2007, J CELL BIOCHEM, V102, P1519, DOI 10.1002/jcb.21372; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Bonafe L, 2015, AM J MED GENET A, V167, P2869, DOI 10.1002/ajmg.a.37365; Boudin E, 2013, BONE, V52, P292, DOI 10.1016/j.bone.2012.09.034; Briggs MD, 2015, EXPERT OPIN ORPHAN D, V3, P1137, DOI 10.1517/21678707.2015.1083853; Canalis E, 2012, ENDOCRINOLOGY, V153, P1616, DOI 10.1210/en.2011-1604; Cheung AM, 2013, CURR OSTEOPOROS REP, V11, P136, DOI 10.1007/s11914-013-0140-9; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Christov M, 2011, ENDOCRINOLOGY, V152, P2031, DOI 10.1210/en.2010-1351; Cohn M, 1933, ROFO FORTSCHR RONTG, V47, P293; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; HESELSON NG, 1979, BRIT J RADIOL, V52, P431, DOI 10.1259/0007-1285-52-618-431; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Karasik D, 2003, BONE, V33, P308, DOI 10.1016/S8756-3282(03)00173-X; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim BJ, 2015, BONE, V81, P435, DOI 10.1016/j.bone.2015.08.014; Lee DY, 2010, MENOPAUSE, V17, P1064, DOI 10.1097/gme.0b013e3181da4da3; Li XD, 2010, J BONE MINER RES, V25, P2371, DOI 10.1002/jbmr.182; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Mulivor A, 2011, BONE, V48, pS98, DOI 10.1016/j.bone.2011.03.147; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Pyle E, 1931, J BONE JOINT SURG, V13, P874; Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.0.CO;2-L; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	37	85	90	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2553	2562		10.1056/NEJMoa1509342	http://dx.doi.org/10.1056/NEJMoa1509342			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8DD	27355534	Bronze, Green Accepted			2022-12-28	WOS:000378727200007
J	Moberly, T				Moberly, Tom			What does Brexit mean for doctors working in the UK?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3611	10.1136/bmj.i3611	http://dx.doi.org/10.1136/bmj.i3611			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27363998				2022-12-28	WOS:000379019700009
J	Murchison, EP				Murchison, Elizabeth P.			CANCER Transmissible tumours under the sea	NATURE			English	Editorial Material							NEOPLASTIC DISEASES; MARINE BIVALVES		[Murchison, Elizabeth P.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of Cambridge	Murchison, EP (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England.	epm27@cam.ac.uk		Murchison, Elizabeth Proby/0000-0001-7462-8907	Wellcome Trust [102942/Z/13/A] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barber BJ, 2004, AQUAT LIVING RESOUR, V17, P449, DOI 10.1051/alr:2004052; Carballal ML, 2015, J INVERTEBR PATHOL, V131, P83, DOI 10.1016/j.jip.2015.06.004; Fanley C A, 1969, Natl Cancer Inst Monogr, V31, P541; Metzger MJ, 2015, CELL, V161, P255, DOI 10.1016/j.cell.2015.02.042; Muehlenbachs A, 2015, NEW ENGL J MED, V373, P1845, DOI 10.1056/NEJMoa1505892; Murchison E P, 2008, Oncogene, V27 Suppl 2, pS19, DOI 10.1038/onc.2009.350; Pye RJ, 2016, P NATL ACAD SCI USA, V113, P374, DOI 10.1073/pnas.1519691113; Strakova A, 2015, CURR OPIN GENET DEV, V30, P49, DOI 10.1016/j.gde.2015.03.005	8	5	5	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					628	629		10.1038/nature18455	http://dx.doi.org/10.1038/nature18455			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27350242				2022-12-28	WOS:000378676000025
J	Wang, Y; Kumar, A; Wu, TY; Weiss, DS				Wang, Yang; Kumar, Aishwarya; Wu, Tsung-Yao; Weiss, David S.			QUANTUM INFORMATION Single-qubit gates based on targeted phase shifts in a 3D neutral atom array	SCIENCE			English	Article							ERROR-CORRECTION; LATTICE; IONS	Although the quality of individual quantum bits (qubits) and quantum gates has been steadily improving, the number of qubits in a single system has increased quite slowly. Here, we demonstrate arbitrary single-qubit gates based on targeted phase shifts, an approach that can be applied to atom, ion, or other atom-like systems. These gates are highly insensitive to addressing beam imperfections and have little cross-talk, allowing for a dramatic scaling up of qubit number. We have performed gates in series on 48 individually targeted sites in a 40% full 5 by 5 by 5 three-dimensional array created by an optical lattice. Using randomized benchmarking, we demonstrate an average gate fidelity of 0.9962(16), with an average cross-talk fidelity of 0.9979(2) (numbers in parentheses indicate the one standard deviation uncertainty in the final digits).	[Wang, Yang; Kumar, Aishwarya; Wu, Tsung-Yao; Weiss, David S.] Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Weiss, DS (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	dsweiss@phys.psu.edu	Wang, Yang/R-8921-2019; Weiss, David S/B-7886-2010; Kumar, Aishwarya/T-1294-2017	Wang, Yang/0000-0001-6881-5212; Kumar, Aishwarya/0000-0001-7787-6367	U.S. National Science Foundation [PHY-1520976]	U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by the U.S. National Science Foundation grant PHY-1520976. The data presented in this report are available on request to D.S.W.	Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; Bravyi S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022316; Brown KR, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.030303; Chiaverini J, 2004, NATURE, V432, P602, DOI 10.1038/nature03074; Corcoles AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7979; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Harty TP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.220501; Keating T, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.012337; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Knoernschild C, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3494526; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Lake K, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.012319; Lee JH, 2013, NAT COMMUN, V4, DOI [10.1038/ncomms3186, 10.1038/ncomms3027]; Li X, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.103001; Maller KM, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.022336; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Olmschenk S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113007; Piltz C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5679; Ryan CA, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013034; Schindler P, 2011, SCIENCE, V332, P1059, DOI 10.1126/science.1203329; Senko C, 2014, SCIENCE, V345, P430, DOI 10.1126/science.1251422; Souza AM, 2012, PHILOS T R SOC A, V370, P4748, DOI 10.1098/rsta.2011.0355; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; Vala J, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.032324; Veldhorst M, 2014, NAT NANOTECHNOL, V9, P981, DOI [10.1038/nnano.2014.216, 10.1038/NNANO.2014.216]; Wang Y, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.043003; Weiss DS, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.040302; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Wilk T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010502; Wilson AC, 2014, NATURE, V512, P57, DOI 10.1038/nature13565; Xia T, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.100503	34	91	93	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1562	1565		10.1126/science.aaf2581	http://dx.doi.org/10.1126/science.aaf2581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339984	Green Submitted			2022-12-28	WOS:000378346500040
J	Menard, D; Khim, N; Beghain, J; Adegnika, AA; Shafiul-Alam, M; Amodu, O; Rahim-Awab, G; Barnadas, C; Berry, A; Boum, Y; Bustos, MD; Cao, J; Chen, JH; Collet, L; Cui, L; Thakur, GD; Dieye, A; Djalle, D; Dorkenoo, MA; Eboumbou-Moukoko, CE; Espino, FEC; Fandeur, T; Ferreira-Da-Cruz, MF; Fola, AA; Fuehrer, HP; Hassan, AM; Herrera, S; Hongvanthong, B; Houze, S; Ibrahim, ML; Jahirul-Karim, M; Jiang, L; Kano, S; Ali-Khan, W; Khanthavong, M; Kremsner, PG; Lacerda, M; Leang, R; Leelawong, M; Li, M; Lin, K; Mazarati, JB; Menard, S; Morlais, I; Muhindo-Mavoko, H; Musset, L; Na-Bangchang, K; Nambozi, M; Niare, K; Noedl, H; Ouedraogo, JB; Pillai, DR; Pradines, B; Quang-Phuc, B; Ramharter, M; Randrianarivelojosia, M; Sattabongkot, J; Sheikh-Omar, A; Silue, KD; Sirima, SB; Sutherland, C; Syafruddin, D; Tahar, R; Tang, LH; Toure, OA; Tshibangu-wa-Tshibangu, P; Vigan-Womas, I; Warsame, M; Wini, L; Zakeri, S; Kim, S; Earn, R; Berne, L; Khean, C; Chy, S; Ken, M; Loch, K; Canier, L; Duru, V; Legrand, E; Barale, JC; Stokes, B; Straimer, J; Witkowski, B; Fidock, DA; Rogier, C; Ringwald, P; Ariey, F; Mercereau-Puijalon, O				Menard, D.; Khim, N.; Beghain, J.; Adegnika, A. A.; Shafiul-Alam, M.; Amodu, O.; Rahim-Awab, G.; Barnadas, C.; Berry, A.; Boum, Y.; Bustos, M. D.; Cao, J.; Chen, J. -H.; Collet, L.; Cui, L.; Thakur, G. -D.; Dieye, A.; Djalle, D.; Dorkenoo, M. A.; Eboumbou-Moukoko, C. E.; Espino, F. -E. -C. J.; Fandeur, T.; Ferreira-da-Cruz, M. -F; Fola, A. A.; Fuehrer, H-P.; Hassan, A. M.; Herrera, S.; Hongvanthong, B.; Houze, S.; Ibrahim, M. L.; Jahirul-Karim, M.; Jiang, L.; Kano, S.; Ali-Khan, W.; Khanthavong, M.; Kremsner, P. G.; Lacerda, M.; Leang, R.; Leelawong, M.; Li, M.; Lin, K.; Mazarati, J. -B.; Menard, S.; Morlais, I.; Muhindo-Mavoko, H.; Musset, L.; Na-Bangchang, K.; Nambozi, M.; Niare, K.; Noedl, H.; Ouedraogo, J. -B.; Pillai, D. R.; Pradines, B.; Quang-Phuc, B.; Ramharter, M.; Randrianarivelojosia, M.; Sattabongkot, J.; Sheikh-Omar, A.; Silue, K. D.; Sirima, S. B.; Sutherland, C.; Syafruddin, D.; Tahar, R.; Tang, L. -H.; Toure, O. A.; Tshibangu-wa-Tshibangu, P.; Vigan-Womas, I.; Warsame, M.; Wini, L.; Zakeri, S.; Kim, S.; Earn, R.; Berne, L.; Khean, C.; Chy, S.; Ken, M.; Loch, K.; Canier, L.; Duru, V.; Legrand, E.; Barale, J. -C.; Stokes, B.; Straimer, J.; Witkowski, B.; Fidock, D. A.; Rogier, C.; Ringwald, P.; Ariey, F.; Mercereau-Puijalon, O.		KARMA Consortium	A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTEMISININ RESISTANCE MUTATIONS; CHINA-MYANMAR BORDER; K13 PROPELLER GENE; SUB-SAHARAN AFRICA; WESTERN CAMBODIA; MOLECULAR MARKER; DRUG-RESISTANCE; IN-VITRO; MALARIA; CLEARANCE	BACKGROUND Recent gains in reducing the global burden of malaria are threatened by the emergence of Plasmodium falciparum resistance to artemisinins. The discovery that mutations in portions of a P. falciparum gene encoding kelch (K13)-propeller domains are the major determinant of resistance has provided opportunities for monitoring such resistance on a global scale. METHODS We analyzed the K13-propeller sequence polymorphism in 14,037 samples collected in 59 countries in which malaria is endemic. Most of the samples (84.5%) were obtained from patients who were treated at sentinel sites used for nationwide surveillance of antimalarial resistance. We evaluated the emergence and dissemination of mutations by haplotyping neighboring loci. RESULTS We identified 108 nonsynonymous K13 mutations, which showed marked geographic disparity in their frequency and distribution. In Asia, 36.5% of the K13 mutations were distributed within two areas - one in Cambodia, Vietnam, and Laos and the other in western Thailand, Myanmar, and China - with no overlap. In Africa, we observed a broad array of rare nonsynonymous mutations that were not associated with delayed parasite clearance. The gene-edited Dd2 transgenic line with the A578S mutation, which expresses the most frequently observed African allele, was found to be susceptible to artemisinin in vitro on a ring-stage survival assay. CONCLUSIONS No evidence of artemisinin resistance was found outside Southeast Asia and China, where resistance-associated K13 mutations were confined. The common African A578S allele was not associated with clinical or in vitro resistance to artemisinin, and many African mutations appear to be neutral.	[Menard, D.] Inst Pasteur Cambodia, 5 Monivong Blvd,POB 983, Phnom Penh, Cambodia; [Menard, D.; Khim, N.; Kim, S.; Earn, R.; Berne, L.; Khean, C.; Chy, S.; Ken, M.; Loch, K.; Canier, L.; Duru, V.; Witkowski, B.] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Leang, R.] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Beghain, J.; Legrand, E.; Ariey, F.; Mercereau-Puijalon, O.] Inst Pasteur, Dept Parasites & Insect Vectors, Paris, France; [Barale, J. -C.] Inst Pasteur, Dept Struct Biol & Chem, Biol Malaria Targets Grp, Struct Microbiol Unit, Paris, France; [Barale, J. -C.] Inst Pasteur, CNRS, UMR3528, Paris, France; [Houze, S.] Inst Pasteur, Ctr Natl Reference Paludisme, Hop Bichat Claude Bernard, Paris, France; [Houze, S.] PRES Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, Paris, France; [Houze, S.; Tahar, R.] Inst Rech Dev, UMR Mere & Enfant Face Infect Trop 216, Paris, France; [Ariey, F.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Ariey, F.] Lab Parasitol Mycol, Hop Cochin, Paris, France; [Pradines, B.] Aix Marseille Univ, Unite Rech Malad Infect Trop & Emergentes, Marseille, France; [Pradines, B.] Ctr Natl Reference Paludisme Marseille, Marseille, France; [Rogier, C.] URMITE, UMR 6236, Marseille, France; [Pradines, B.; Rogier, C.] Inst Rech Biomed Armees, Bretigny-sur-Orge, France; [Menard, S.] Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Berry, A.] Ctr Hosp Univ Toulouse, Toulouse, France; [Collet, L.] Ctr Hospitalier Mayotte, Mayotte, France; [Adegnika, A. A.; Kremsner, P. G.; Ramharter, M.] Ctr Rec Med Lambarene, Hop Albert Schweitzer, Lambarene, Gabon; [Adegnika, A. A.; Kremsner, P. G.; Ramharter, M.] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Adegnika, A. A.] Leiden Med Univ Ctr, Dept Parasitol, Albinusdreef, Leiden, Netherlands; [Shafiul-Alam, M.; Ali-Khan, W.] Parasitol Res Grp, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Jahirul-Karim, M.] Directorate Gen Hlth Serv, Dhaka, Bangladesh; [Amodu, O.] Univ Ibadan, Ibadan, Nigeria; [Rahim-Awab, G.] Nangarhar Univ, Jalalabad, Afghanistan; [Rahim-Awab, G.] Mahidol Univ, Mahidol Oxford Res Unit, Bangkok, Thailand; [Na-Bangchang, K.] Thammasat Univ, Chulabhorn Int Coll Med, Ctr Excellence Pharmacol & Mol Biol Malaria & Cho, Pathum Thani, Thailand; [Sattabongkot, J.] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok, Thailand; [Bustos, M. D.] World Hlth Org WHO, Country Off Thailand, Bangkok, Thailand; [Barnadas, C.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Barnadas, C.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Barnadas, C.; Fola, A. A.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Boum, Y.] Epicentre Mbarara Res Ctr, Mbarara, Uganda; [Boum, Y.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Cao, J.] Jiangnan Univ, Publ Hlth Res Ctr, Shanghai, Peoples R China; [Cao, J.] Jiangsu Inst Parasit Dis, Shanghai, Peoples R China; [Chen, J. -H.; Li, M.; Tang, L. -H.] Chinese Minist Hlth, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol, Shanghai, Peoples R China; [Jiang, L.] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Cui, L.] Penn State Univ, Dept Entomol, State Coll, PA USA; [Thakur, G. -D.] Minist Publ Hlth, Epidemiol & Dis Control Div, Kathmandu, Nepal; [Dieye, A.] Univ Cheikh Anta DIOP Dakar, Inst Pasteur Dakar & Immunol Dept, Dakar, Senegal; [Djalle, D.] Inst Pasteur, Bangui, Cent Afr Republ; [Dorkenoo, M. A.] Univ Lome, Fac Scie Sante, Lome, Togo; [Eboumbou-Moukoko, C. E.] Ctr Pasteur Cameroun, Pole Excellence Epidemiol Paludisme, Yaounde, Cameroon; [Morlais, I.] Inst Rech Dev, Yaounde, Cameroon; [Eboumbou-Moukoko, C. E.] Univ Douala, Fac Med & Pharmaceut Sci, Biol Sci Unit, Douala, Cameroon; [Espino, F. -E. -C. J.] Res Inst Trop Med, Dept Hlth, Muntinlupa, Philippines; [Fandeur, T.] Ctr Int Rech Med Franceville, Franceville, Gabon; [Ferreira-da-Cruz, M. -F] FioCruz Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Lacerda, M.] Fundacao Med Trop Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Lacerda, M.] Inst Pesquisas Leonidas Maria Deane, Fiocruz Amazonia, Manaus, Amazonas, Brazil; [Fola, A. A.] Univ Gondar, Sch Biomed & Lab Sci, Coll Med & Hlth Sci, Gondar, Ethiopia; [Fuehrer, H-P.] Univ Vet Med, Inst Parasitol, Dept Pathobiol, Vienna, Austria; [Noedl, H.] Malaria Res Initiat Bandarban, Vienna, Austria; [Noedl, H.] Specif Prophylaxis & Trop Med, Vienna, Austria; [Noedl, H.; Ramharter, M.] Univ Vienna, Dept Med I, Div Infect Dis & Trop Med, Vienna, Austria; [Hassan, A. M.] World Hlth Org, Country Off Somalia, Mogadishu, Somalia; [Sheikh-Omar, A.] Minist Hlth & Human Serv, Mogadishu, Somalia; [Herrera, S.] Caucaseco Sci Res Ctr, Cali, Colombia; [Hongvanthong, B.; Khanthavong, M.] Ctr Malariol Parasitol & Entomol, Viangchan, Laos; [Kano, S.] Inst Pasteur Laos, Viangchan, Laos; [Kano, S.] SATREPS Project Parasit Dis, Viangchan, Laos; [Leelawong, M.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Leelawong, M.] US Naval Med Res Unit 6, Lima, Peru; [Lin, K.] Parasitol Res Div, Dept Med Res, Pyin Oo Lwin, Myanmar; [Ibrahim, M. L.] Ctr Rech Med & Sanitaire, Niamey, Niger; [Mazarati, J. -B.] Rwanda BioMed Ctr, Kigali, Rwanda; [Muhindo-Mavoko, H.; Tshibangu-wa-Tshibangu, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Muhindo-Mavoko, H.] Univ Antwerp, Antwerp, Belgium; [Musset, L.; Legrand, E.] Inst Pasteur, WHO Collaborat Ctr Surveillance Antimalarial Drug, Laboratoire Parasitol, Cayenne, French Guiana; [Nambozi, M.] Trop Dis Res Ctr, Clin Sci, Ndola, Zambia; [Na-Bangchang, K.] Univ Sci Techn & Technol Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Ouedraogo, J. -B.] Inst Rech Sci Sante, Ctr Muraz, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso; [Sirima, S. B.] Grp Rech Act Sante, Ouagadougou, Burkina Faso; [Pillai, D. R.] Med Malaria Venture, Geneva, Switzerland; [Warsame, M.; Ringwald, P.] WHO, Global Malaria Programme, Geneva, Switzerland; [Pillai, D. R.] Univ Calgary, Calgary, AB, Canada; [Quang-Phuc, B.] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Randrianarivelojosia, M.; Vigan-Womas, I.; Rogier, C.] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Silue, K. D.] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Silue, K. D.] Univ Felix Houphouet Boigny, UFR Biosciences, Abidjan, Cote Ivoire; [Toure, O. A.] Inst Pasteur Cote Ivoire, Abidjan, Cote Ivoire; [Sutherland, C.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Malaria Reference Lab, London, England; [Syafruddin, D.] Hasanuddin Univ, Dept Parasitol, Jalan Perintis Kemerdekaan, Makassar, Indonesia; [Syafruddin, D.] Eijkman Inst Mol Biol, Jalan Diponegoro, Jakarta, Indonesia; [Wini, L.] Minist Hlth & Med Serv, Natl Vector Borne Dis Control Program, Point Cruz, Honiara, Solomon Islands; [Zakeri, S.] Pasteur Inst Iran, Malaria & Vector Res Grp, Biotechnol Res Ctr, Tehran, Iran; [Kano, S.] Res Inst, Natl Ctr Global Hlth & Med, Toyama, Shinjuku, Japan; [Stokes, B.; Straimer, J.; Fidock, D. A.] Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY 10027 USA; [Fidock, D. A.] Columbia Univ, Med Ctr, Div Infect Dis, Dept Med, New York, NY USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; National Center Parasitology, Entomology & Malaria Control; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Eberhard Karls University of Tubingen; Leiden University; Leiden University Medical Center (LUMC); International Centre for Diarrhoeal Disease Research (ICDDR); University of Ibadan; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Chulabhorn Research Institute; Thammasat University; Mahidol University; World Health Organization; PNG Institute Of Medical Research; University of Melbourne; Walter & Eliza Hall Institute; Mbarara University of Science & Technology; Jiangnan University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University Cheikh Anta Diop Dakar; Centre Pasteur du Cameroun; Institut de Recherche pour le Developpement (IRD); Philippine Department Health; Research Institute for Tropical Medicine - Philippines; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of Gondar; University of Veterinary Medicine Vienna; University of Vienna; World Health Organization; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); Rwanda Biomedical Center; Universite de Kinshasa; University of Antwerp; University of Science & Technology of Bamako; Centre Muraz; World Health Organization; University of Calgary; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; University of London; London School of Hygiene & Tropical Medicine; Universitas Hasanuddin; Eijkman Institute; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; National Center for Global Health & Medicine - Japan; Columbia University; Columbia University	Menard, D (corresponding author), Inst Pasteur Cambodia, 5 Monivong Blvd,POB 983, Phnom Penh, Cambodia.	dmenard@pasteur-kh.org	Rachida, Tahar/ABF-1506-2021; Laminou, IBRAHIM Maman/AAA-2748-2019; ariey, frederic/P-1185-2017; Morlais, Isabelle/F-5078-2014; Van geertruyden, Jean-Pierre/S-3254-2019; durand, salomon/G-7804-2018; Fola, Abebe/AAV-8048-2021; Sutherland, Colin/AAN-3939-2020; Witkowski, Benoit/T-1118-2019; Prachumsri, Jetsumon/AAZ-7732-2021; Alam, Mohammad Shafiul/C-2285-2011; Fuehrer, Hans-Peter/J-9055-2019; Ines, VIGAN-WOMAS/I-8604-2012; Van geertruyden, Jean-Pierre/K-6425-2014; Mercereau-Puijalon, Odile/AAA-2242-2020; Menard, Didier/O-3294-2013; Morlais, Isabelle/Q-2171-2019; ADEGNIKA, Ayola Akim/AAK-7307-2020; Ines, VIGAN-WOMAS/A-7846-2017; Zakeri, Sedigheh/L-1274-2017; Berry, Antoine/J-9352-2014; SOULAMA, Issiaka/Z-1254-2019; sandrine, houze/M-3260-2017; Ramharter, Michael/C-5273-2013	Laminou, IBRAHIM Maman/0000-0001-5059-5370; ariey, frederic/0000-0002-0680-1090; Morlais, Isabelle/0000-0002-2962-7670; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; durand, salomon/0000-0002-5923-8879; Sutherland, Colin/0000-0003-1592-6407; Alam, Mohammad Shafiul/0000-0001-8330-5499; Fuehrer, Hans-Peter/0000-0002-4178-0133; Ines, VIGAN-WOMAS/0000-0001-7848-9297; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Menard, Didier/0000-0003-1357-4495; Morlais, Isabelle/0000-0002-2962-7670; Ines, VIGAN-WOMAS/0000-0001-7848-9297; Zakeri, Sedigheh/0000-0003-0933-0981; SOULAMA, Issiaka/0000-0002-0993-0525; Legrand, Eric/0000-0003-4725-0712; Fidock, David/0000-0001-6753-8938; Ouedraogo, Alphonse/0000-0002-3520-6637; Pradines, Bruno/0000-0002-2360-3803; sandrine, houze/0000-0001-9016-3847; Berry, Antoine/0000-0002-6626-7766; Kano, Shigeyuki/0000-0001-9050-4955; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; SOME, Anyirekun Fabrice/0000-0002-1530-1493; Hetzel, Manuel W./0000-0002-5285-3254; Lotsch, Felix/0000-0002-6938-9523; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Ramharter, Michael/0000-0002-9259-1885; Fola, Abebe Alemu/0000-0001-5392-2859; Mohamed Elhassan, Ahmed/0000-0003-0740-0499; Sattabongkot, Jetsumon/0000-0002-3938-4588; Menard, sandie/0000-0001-6972-3598; DORKENOO, Monique Ameyo/0000-0002-1030-7757; Amodu, Olukemi/0000-0003-1477-4229; Syafruddin, din/0000-0001-7141-2545; HONKPEHEDJI, Yabo/0000-0002-9726-6643; Randrianarivelojosia, Milijaona/0000-0003-2767-0349; /0000-0001-7338-8745; TAHAR, Rachida/0000-0003-1799-231X	Institut Pasteur Paris; FOGARTY INTERNATIONAL CENTER [D43TW007393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109023, U19AI089702, T32AI106711, U19AI089672] Funding Source: NIH RePORTER	Institut Pasteur Paris; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by Institut Pasteur Paris and others.	Abdulla S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0445-x; Amaratunga C, 2014, ANTIMICROB AGENTS CH, V58, P4935, DOI 10.1128/AAC.03055-14; Amaratunga C, 2014, LANCET INFECT DIS, V14, P449, DOI 10.1016/S1473-3099(14)70777-7; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Borrmann S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03318; Carter TE, 2015, AM J TROP MED HYG, V92, P552, DOI 10.4269/ajtmh.14-0664; Cheeseman IH, 2015, MOL BIOL EVOL, V32, P1080, DOI 10.1093/molbev/msu397; Conrad MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105690; Cooper RA, 2015, ANTIMICROB AGENTS CH, V59, P5061, DOI 10.1128/AAC.00921-15; Denis MB, 2006, TROP MED INT HEALTH, V11, P1800, DOI 10.1111/j.1365-3156.2006.01739.x; Denis MB, 2006, TROP MED INT HEALTH, V11, P1360, DOI 10.1111/j.1365-3156.2006.01690.x; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Escobar C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119215; Feng J, 2015, ANTIMICROB AGENTS CH, V59, P2554, DOI 10.1128/AAC.04843-14; Feng J, 2015, ANTIMICROB AGENTS CH, V59, P326, DOI 10.1128/AAC.04144-14; Hawkes M, 2015, EMERG INFECT DIS, V21, P1237, DOI 10.3201/eid2107.150213; Henriques G, 2014, J INFECT DIS, V210, P2001, DOI 10.1093/infdis/jiu358; Huang F, 2015, J INFECT DIS, V212, P1629, DOI 10.1093/infdis/jiv249; Huang F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-243; Isozumi R, 2015, EMERG INFECT DIS, V21, P490, DOI 10.3201/eid2103.140898; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; Kimura M., 1983, NEUTRAL THEORY MOL E; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopera-Mesa TM, 2013, J INFECT DIS, V207, P1655, DOI 10.1093/infdis/jit082; MalariaGen, 2015, P FALC COMM PROJ DAT; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; Menard D, 2015, LANCET INFECT DIS, V15, P367, DOI 10.1016/S1473-3099(15)70046-0; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mishra N, 2015, ANTIMICROB AGENTS CH, V59, P2548, DOI 10.1128/AAC.04632-14; Mohon A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-431; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nei M., 1987, MOL EVOLUTIONARY GEN; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nyunt MH, 2015, CLIN INFECT DIS, V60, P1208, DOI 10.1093/cid/ciu1160; Ouattara A, 2015, AM J TROP MED HYG, V92, P1202, DOI 10.4269/ajtmh.14-0605; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Roper C, 2014, LANCET INFECT DIS, V14, P668, DOI 10.1016/S1473-3099(14)70826-6; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Talundzic E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004789; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Torrentino-Madamet M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-472; TPhrietner K, 2014, ANTIMICROB AGENTS CH, V58, P7049; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; Trape JF, 2002, TRENDS PARASITOL, V18, P224, DOI 10.1016/S1471-4922(02)02249-3; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830; Wang ZL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0672-9; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; Witkowski B, 2013, ANTIMICROB AGENTS CH, V57, P914, DOI 10.1128/AAC.01868-12; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2015, STAT REP ART ACT RES; World Health Organization, 2015, GUID TREATM MAL, Vthird	62	336	347	1	114	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2453	2464		10.1056/NEJMoa1513137	http://dx.doi.org/10.1056/NEJMoa1513137			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1TG	27332904	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000378271700009
J	Usher-Smith, JA; Sharp, SJ; Griffin, SJ				Usher-Smith, Juliet A.; Sharp, Stephen J.; Griffin, Simon J.			The spectrum effect in tests for risk prediction, screening, and diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROGNOSIS RESEARCH; TEST ACCURACY; SPECIFICITY; SENSITIVITY; BIAS	The spectrum effect describes the variation between settings in performance of tests used to predict, screen for, and diagnose disease. In particular, the predictive use of a test may be different when it is applied in a general population rather than in the study sample in which it was first developed. This article discusses the impact of the spectrum effect on measures of test performance, and its implications for the development, evaluation, application, and implementation of such tests.	[Usher-Smith, Juliet A.; Griffin, Simon J.] Univ Cambridge, Strangeways Res Lab, Primary Care Unit, Cambridge CB1 8RN, England; [Sharp, Stephen J.; Griffin, Simon J.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB1 8RN, England	University of Cambridge; University of Cambridge	Usher-Smith, JA (corresponding author), Univ Cambridge, Strangeways Res Lab, Primary Care Unit, Cambridge CB1 8RN, England.	jau20@medschl.cam.ac.uk		Usher-Smith, Juliet/0000-0002-8501-2531	National Institute of Health; Medical Research Council [MC_UU_12015/1]; MRC [MC_UU_12015/1, MC_U106179474, MC_UU_12015/4] Funding Source: UKRI; Medical Research Council [MC_U106179474, MC_UU_12015/4] Funding Source: researchfish; National Institute for Health Research [CL-2012-14-007] Funding Source: researchfish	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	JUS is supported by a National Institute of Health Research clinical lectureship. The views expressed in this publication are those of the authors and not necessarily those of the NHS, National Institute of Health Research, or the UK Department of Health. SJS is supported by the Medical Research Council (unit programme no MC_UU_12015/1). All researchers were independent of the funding body and the funders had no role in study design; data collection, analysis, and interpretation of data; in the writing of the report; or decision to submit the article, for publication.	ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; COUGHLIN SS, 1992, J CLIN EPIDEMIOL, V45, P1, DOI 10.1016/0895-4356(92)90180-U; DIAMOND GA, 1986, AM J CARDIOL, V57, P1175, DOI 10.1016/0002-9149(86)90694-6; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Hingorani AD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5793; Irwig L, 2002, BRIT MED J, V324, P669, DOI 10.1136/bmj.324.7338.669; Leeflang MMG, 2013, CAN MED ASSOC J, V185, pE537, DOI 10.1503/cmaj.121286; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; MCNEIL BJ, 1984, MED DECIS MAKING, V4, P137, DOI 10.1177/0272989X8400400203; Moons KGM, 1997, EPIDEMIOLOGY, V8, P12, DOI 10.1097/00001648-199701000-00002; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; National Institute for Health and Care Excellence, 2014, LIPID MODIFICATION C; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381	17	120	121	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i3139	10.1136/bmj.i3139	http://dx.doi.org/10.1136/bmj.i3139			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27334281	Green Published, hybrid			2022-12-28	WOS:000378723500005
J	Schwarze, M; Tress, W; Beyer, B; Gao, F; Scholz, R; Poelking, C; Ortstein, K; Gunther, AA; Kasemann, D; Andrienko, D; Leo, K				Schwarze, Martin; Tress, Wolfgang; Beyer, Beatrice; Gao, Feng; Scholz, Reinhard; Poelking, Carl; Ortstein, Katrin; Guenther, Alrun A.; Kasemann, Daniel; Andrienko, Denis; Leo, Karl			Band structure engineering in organic semiconductors	SCIENCE			English	Article							OPEN-CIRCUIT VOLTAGE; DONOR-ACCEPTOR HETEROJUNCTIONS; SOLAR-CELLS; THIN-FILMS; PHTHALOCYANINES; ENERGY; POLYMER; DEVICES; ALLOYS; STATES	A key breakthrough in modern electronics was the introduction of band structure engineering, the design of almost arbitrary electronic potential structures by alloying different semiconductors to continuously tune the band gap and band-edge energies. Implementation of this approach in organic semiconductors has been hindered by strong localization of the electronic states in these materials. We show that the influence of so far largely ignored long-range Coulomb interactions provides a workaround. Photoelectron spectroscopy confirms that the ionization energies of crystalline organic semiconductors can be continuously tuned over a wide range by blending them with their halogenated derivatives. Correspondingly, the photovoltaic gap and open-circuit voltage of organic solar cells can be continuously tuned by the blending ratio of these donors.	[Schwarze, Martin; Scholz, Reinhard; Ortstein, Katrin; Guenther, Alrun A.; Kasemann, Daniel; Leo, Karl] Tech Univ Dresden, Inst Angew Photophys, D-01069 Dresden, Germany; [Tress, Wolfgang; Gao, Feng] Linkoping Univ, Biomol & Organ Elect, IFM, S-58183 Linkoping, Sweden; [Beyer, Beatrice] Fraunhofer Inst Electron Beam Plasma Technol & CO, D-01109 Dresden, Germany; [Scholz, Reinhard] Tech Univ Dresden, Dresden Ctr Computat Mat Sci, D-01062 Dresden, Germany; [Poelking, Carl; Andrienko, Denis] Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany; [Tress, Wolfgang] Swiss Fed Inst Technol EPFL, Lab Photon & Interfaces, Stn 6, CH-1015 Lausanne, Switzerland	Technische Universitat Dresden; Linkoping University; Fraunhofer Gesellschaft; Technische Universitat Dresden; Max Planck Society; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Leo, K (corresponding author), Tech Univ Dresden, Inst Angew Photophys, D-01069 Dresden, Germany.	leo@iapp.de	Hauke, Alrun Aline/AAE-9092-2020; Andrienko, Denis/B-7721-2008; Gao, Feng/AAF-6971-2019; Gao, Feng/C-8797-2014; Tress, Wolfgang/B-7171-2017	Hauke, Alrun Aline/0000-0003-1835-0407; Andrienko, Denis/0000-0002-1541-1377; Gao, Feng/0000-0002-2582-1740; Gao, Feng/0000-0002-2582-1740; Beyer, Beatrice/0000-0002-7850-209X; Tress, Wolfgang/0000-0002-4010-239X; Schwarze, Martin/0000-0003-1286-1011	DFG [LE-747/44-1]; European Community's Seventh Framework Programme [EP7-267995]; Knut and Alice Wallenberg Foundation through a Wallenberg Scholar grant; Swedish Research Council (VR) [330-2014-6433]; European Commission, Made Sklodowska-Curie Actions [INCA 600398]; Bundesministerium fur Bildung und Forschung [FKZ 03EK3503B]; Dr Isolde-Dietrich-Stiftung	DFG(German Research Foundation (DFG)); European Community's Seventh Framework Programme(European Commission); Knut and Alice Wallenberg Foundation through a Wallenberg Scholar grant; Swedish Research Council (VR)(Swedish Research Council); European Commission, Made Sklodowska-Curie Actions; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Dr Isolde-Dietrich-Stiftung	We thank O. Inganas for his support and insightful discussions, D. Wohrle for supplying FgZnPc, O. Kaveh for conductivity measurements, D. Schutze for building OFETs, L. Wilde for performing GIXRD measurements, and F. Holzmuller for evaluating and discussing GIXRD measurements. The research in Dresden was funded by the DFG project MatWorldNet LE-747/44-1, as well as the European Community's Seventh Framework Programme under grant agreement EP7-267995 (NUDES). The research at Linkoping was supported by the Knut and Alice Wallenberg Foundation through a Wallenberg Scholar grant to O. Inganas, the Swedish Research Council (VR, 330-2014-6433), and the European Commission, Made Sklodowska-Curie Actions (INCA 600398). Also supported by Bundesministerium fur Bildung und Forschung project MEDOS grant FKZ 03EK3503B (C.P. and D.A) and by the Dr Isolde-Dietrich-Stiftung (A.A.G.). K.L. is a fellow of the Canadian Institute for Advanced Research (CIFAR). Author contributions: M.S. and K.O. acquired. UPS data; W.T., B.B., and F.G. acquired and evaluated solar cell data; M.S. evaluated UPS and conductivity data; R.S. performed OFT calculations; C.P. performed molecular simulations; A.A.G. obtained mobility values; M.S., K.L., C.P., R.S., and D.A. wrote the manuscript; all authors contributed to discussions and finalizing the manuscript. There are no competing financial interests.	Anger F, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3677839; Barret M, 2008, ORG ELECTRON, V9, P1093, DOI 10.1016/j.orgel.2008.08.018; Brendel M, 2015, ADV FUNCT MATER, V25, P1565, DOI 10.1002/adfm.201404434; Brinkmann H, 2008, PHYS STATUS SOLIDI A, V205, P409, DOI 10.1002/pssa.200723391; CAPASSO F, 1987, SCIENCE, V235, P172, DOI 10.1126/science.235.4785.172; Cheng YC, 2003, J CHEM PHYS, V118, P3764, DOI 10.1063/1.1539090; Duhm S, 2008, NAT MATER, V7, P326, DOI 10.1038/nmat2119; GHOSH A, 1994, J AM CHEM SOC, V116, P1932, DOI 10.1021/ja00084a038; Gisslen L, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.115309; HILL R, 1974, J PHYS C SOLID STATE, V7, P521, DOI 10.1088/0022-3719/7/3/009; HIRAMOTO M, 1991, APPL PHYS LETT, V58, P1062, DOI 10.1063/1.104423; Hwang J, 2009, MAT SCI ENG R, V64, P1, DOI 10.1016/j.mser.2008.12.001; Khlyabich PP, 2012, J AM CHEM SOC, V134, P9074, DOI 10.1021/ja302935n; Khlyabich PP, 2011, J AM CHEM SOC, V133, P14534, DOI 10.1021/ja205977z; KIDO J, 1994, APPL PHYS LETT, V64, P815, DOI 10.1063/1.111023; Koch N, 2003, APPL PHYS LETT, V82, P2281, DOI 10.1063/1.1565506; Lee JH, 2014, ORG ELECTRON, V15, P16, DOI 10.1016/j.orgel.2013.10.011; Marom N, 2010, J CHEM THEORY COMPUT, V6, P81, DOI 10.1021/ct900410j; Meiss J, 2012, ADV FUNCT MATER, V22, P405, DOI 10.1002/adfm.201101799; Opitz A, 2009, ORG ELECTRON, V10, P1259, DOI 10.1016/j.orgel.2009.07.004; Poelking C, 2015, J AM CHEM SOC, V137, P6320, DOI 10.1021/jacs.5b02130; Poelking C, 2015, NAT MATER, V14, P434, DOI [10.1038/nmat4167, 10.1038/NMAT4167]; Polander LE, 2014, APL MATER, V2, DOI 10.1063/1.4889843; Reineke S, 2009, NATURE, V459, P234, DOI 10.1038/nature08003; Salzmann I, 2008, J AM CHEM SOC, V130, P12870, DOI 10.1021/ja804793a; Schlettwein D, 2001, J PHYS CHEM B, V105, P4791, DOI 10.1021/jp001912q; Schober M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165326; Schunemann C, 2011, THIN SOLID FILMS, V519, P3939, DOI 10.1016/j.tsf.2011.01.356; Tang ML, 2011, CHEM MATER, V23, P446, DOI 10.1021/cm102182x; Tietze ML, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.085119; Topham BJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165405; Tress W, 2011, ADV FUNCT MATER, V21, P2140, DOI 10.1002/adfm.201002669; VANVECHTEN JA, 1970, PHYS REV B-SOLID ST, V1, P3351, DOI 10.1103/PhysRevB.1.3351; Veldman D, 2009, ADV FUNCT MATER, V19, P1939, DOI 10.1002/adfm.200900090; Widmer J, 2013, ADV FUNCT MATER, V23, P5814, DOI 10.1002/adfm.201301048; Yoshida H, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.075145; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789	37	189	190	20	447	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1446	1449		10.1126/science.aaf0590	http://dx.doi.org/10.1126/science.aaf0590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313043				2022-12-28	WOS:000377975400045
J	Stark, L				Stark, Laura			The unintended ethics of Henry K Beecher	LANCET			English	Editorial Material									[Stark, Laura] Vanderbilt Univ, Ctr Med Hlth & Soc, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University	Stark, L (corresponding author), Vanderbilt Univ, Ctr Med Hlth & Soc, 221 Kirkland Hall, Nashville, TN 37235 USA.	laura.stark@vanderbilt.edu						Beecher HK, 1966, NEW ENGL J MED, V274, P1354; Freidenfelds L, 2007, INT ANESTHESIOL CLIN, V45, P79, DOI 10.1097/AIA.0b013e31812e56de; Gaw A, 2012, ANN INTERN MED, V156, P150, DOI 10.7326/0003-4819-156-2-201201170-00012; Harkness J, 2001, B WORLD HEALTH ORGAN, V79, P365; Rothman D., 1991, STRANGERS BEDSIDE HI, DOI DOI 10.4324/9781315130286; Stark L., 2012, CLOSED DOORS IRBS MA	6	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2374	2375		10.1016/S0140-6736(16)30743-7	http://dx.doi.org/10.1016/S0140-6736(16)30743-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1ST	27312298				2022-12-28	WOS:000377560100018
J	Heukelbach, J; Werneck, GL				Heukelbach, Joerg; Werneck, Guilherme Loureiro			Surveillance of Zika virus infection and microcephaly in Brazil	LANCET			English	Editorial Material									[Heukelbach, Joerg] Univ Fed Ceara, Sch Med, Dept Community Hlth, BR-60430140 Fortaleza, CE, Brazil; [Heukelbach, Joerg] James Cook Univ, Anton Breinl Ctr Publ Hlth, Townsville, Qld, Australia; [Heukelbach, Joerg] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia; [Werneck, Guilherme Loureiro] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, RJ, Brazil	Universidade Federal do Ceara; James Cook University; James Cook University; Universidade do Estado do Rio de Janeiro	Heukelbach, J (corresponding author), Univ Fed Ceara, Sch Med, Dept Community Hlth, BR-60430140 Fortaleza, CE, Brazil.; Heukelbach, J (corresponding author), James Cook Univ, Anton Breinl Ctr Publ Hlth, Townsville, Qld, Australia.; Heukelbach, J (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia.	heukelbach@web.de	Werneck, Guilherme/A-2841-2013	Werneck, Guilherme/0000-0003-1169-1436; Heukelbach, Jorg/0000-0002-7845-5510				[Anonymous], 2016, WHO DIRECTOR GEN SUM; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Franca GVA, 2016, LANCET; Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338	8	15	15	0	46	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					846	847		10.1016/S0140-6736(16)30931-X	http://dx.doi.org/10.1016/S0140-6736(16)30931-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU0RI	27372396	hybrid			2022-12-28	WOS:000381911800006
J	Brangwynne, CP; Marko, JF				Brangwynne, Clifford P.; Marko, John F.			A sticky problem for chromosomes	NATURE			English	Editorial Material							SURFACTANT	The role of Ki-67 in mitotic cell division has been a mystery. Extensive imaging reveals that this highly positively charged protein coats chromosomes to prevent them from coalescing. SEE LETTER R308	[Brangwynne, Clifford P.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Marko, John F.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Marko, John F.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	Princeton University; Northwestern University; Northwestern University	Brangwynne, CP (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	cbrangwy@princeton.edu; john-marko@northwestern.edu	Marko, John F./AAY-7111-2021	Marko, John F./0000-0003-4151-9530	NATIONAL CANCER INSTITUTE [U54CA193419] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA193419] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bergeron-Sandoval LP, 2016, CELL, V165, P1067, DOI 10.1016/j.cell.2016.05.026; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Goloborodko A, 2016, ELIFE, V5, DOI 10.7554/eLife.14864; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1034/j.1399-3003.1999.13f36.x; Rosen M. J., 1978, SURFACTANTS INTERFAC, DOI DOI 10.1002/0471670561; VERHEIJEN R, 1989, J CELL SCI, V92, P531	7	3	3	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					234	235		10.1038/nature18904	http://dx.doi.org/10.1038/nature18904			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR4ZN	27362225				2022-12-28	WOS:000379912600042
J	Frank, S; Testa, CM; Stamler, D; Kayson, E; Davis, C; Edmondson, MC; Kinel, S; Leavitt, B; Oakes, D; O'Neill, C; Vaughan, C; Goldstein, J; Herzog, M; Snively, V; Whaley, J; Wong, C; Suter, G; Jankovic, J; Jimenez-Shahed, J; Hunter, C; Claassen, DO; Roman, OC; Sung, V; Smith, J; Janicki, S; Clouse, R; Saint-Hilaire, M; Hohler, A; Turpin, D; James, RC; Rodriguez, R; Rizer, K; Anderson, KE; Heller, H; Carlson, A; Criswell, S; Racette, BA; Revilla, FJ; Nucifora, F; Margolis, RL; Ong, M; Mendis, T; Mendis, N; Singer, C; Quesada, M; Paulsen, JS; Brashers-Krug, T; Miller, A; Kerr, J; Dubinsky, RM; Gray, C; Factor, SA; Sperin, E; Molho, E; Eglow, M; Evans, S; Kumar, R; Reeves, C; Samii, A; Chouinard, S; Beland, M; Scott, BL; Hickey, PT; Esmail, S; Fung, WLA; Gibbons, C; Qi, L; Colcher, A; Hackmyer, C; McGarry, A; Klos, K; Gudesblatt, M; Fafard, L; Graffitti, L; Schneider, DP; Dhall, R; Wojcieszek, JM; LaFaver, K; Duker, A; Neefus, E; Wilson-Perez, H; Shprecher, D; Wall, P; Blindauer, KA; Wheeler, L; Boyd, JT; Houston, E; Farbman, ES; Agarwal, P; Eberly, SW; Watts, A; Tariot, PN; Feigin, A; Evans, S; Beck, C; Orme, C; Edicola, J; Christopher, E				Frank, Samuel; Testa, Claudia M.; Stamler, David; Kayson, Elise; Davis, Charles; Edmondson, Mary C.; Kinel, Shari; Leavitt, Blair; Oakes, David; O'Neill, Christine; Vaughan, Christina; Goldstein, Jody; Herzog, Margaret; Snively, Victoria; Whaley, Jacquelyn; Wong, Cynthia; Suter, Greg; Jankovic, Joseph; Jimenez-Shahed, Joohi; Hunter, Christine; Claassen, Daniel O.; Roman, Olivia C.; Sung, Victor; Smith, Jenna; Janicki, Sarah; Clouse, Ronda; Saint-Hilaire, Marie; Hohler, Anna; Turpin, Denyse; James, Raymond C.; Rodriguez, Ramon; Rizer, Kyle; Anderson, Karen E.; Heller, Hope; Carlson, Alexis; Criswell, Susan; Racette, Brad A.; Revilla, Fredy J.; Nucifora, Frederick, Jr.; Margolis, Russell L.; Ong, MaryJane; Mendis, Tilak; Mendis, Neila; Singer, Carlos; Quesada, Monica; Paulsen, Jane S.; Brashers-Krug, Thomas; Miller, Amanda; Kerr, Jane; Dubinsky, Richard M.; Gray, Carolyn; Factor, Stewart A.; Sperin, Elaine; Molho, Eric; Eglow, Mary; Evans, Sharon; Kumar, Rajeev; Reeves, Christina; Samii, Ali; Chouinard, Sylvain; Beland, Monica; Scott, Burton L.; Hickey, Patrick T.; Esmail, Sherali; Fung, Wai Lun Alan; Gibbons, Clare; Qi, Lina; Colcher, Amy; Hackmyer, Cory; McGarry, Andrew; Klos, Kevin; Gudesblatt, Mark; Fafard, Lori; Graffitti, Laura; Schneider, Daniel P.; Dhall, Rohit; Wojcieszek, Joanne M.; LaFaver, Kathrin; Duker, Andrew; Neefus, Erin; Wilson-Perez, Hilary; Shprecher, David; Wall, Paola; Blindauer, Karen A.; Wheeler, Lynn; Boyd, James T.; Houston, Emily; Farbman, Eric S.; Agarwal, Pinky; Eberly, Shirley W.; Watts, Arthur; Tariot, Pierre N.; Feigin, Andrew; Evans, Scott; Beck, Chris; Orme, Constance; Edicola, Jon; Christopher, Emily		Huntington Study Grp	Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RATING-SCALE; DEUTERIUM; DRUG; VALIDITY	IMPORTANCE Deutetrabenazine is a novel molecule containing deuterium, which attenuates CYP2D6 metabolism and increases activemetabolite half-lives and may therefore lead to stable systemic exposure while preserving key pharmacological activity. OBJECTIVE To evaluate efficacy and safety of deutetrabenazine treatment to control chorea associated with Huntington disease. DESIGN, SETTING, AND PARTICIPANTS Ninety ambulatory adults diagnosed with manifest Huntington disease and a baseline total maximal chorea score of 8 or higher (range, 0-28; lower score indicates less chorea) were enrolled from August 2013 to August 2014 and randomized to receive deutetrabenazine (n = 45) or placebo (n = 45) in a double-blind fashion at 34 Huntington Study Group sites. INTERVENTIONS Deutetrabenazine or placebo was titrated to optimal dose level over 8 weeks and maintained for 4 weeks, followed by a 1-week washout. MAIN OUTCOMES AND MEASURES Primary end point was the total maximal chorea score change from baseline (the average of values from the screening and day-0 visits) to maintenance therapy (the average of values from the week 9 and 12 visits) obtained by in-person visits. This study was designed to detect a 2.7-unit treatment difference in scores. The secondary end points, assessed hierarchically, were the proportion of patients who achieved treatment success on the Patient Global Impression of Change (PGIC) and on the Clinical Global Impression of Change (CGIC), the change in 36-Item Short Form-physical functioning subscale score (SF-36), and the change in the Berg Balance Test. RESULTS Ninety patients with Huntington disease (mean age, 53.7 years; 40 women [ 44.4%]) were enrolled. In the deutetrabenazine group, the mean total maximal chorea scores improved from 12.1 (95% CI, 11.2-12.9) to 7.7 (95% CI, 6.5-8.9), whereas in the placebo group, scores improved from 13.2 (95% CI, 12.2-14.3) to11.3(95% CI, 10.0-12.5); the mean between-group difference was -2.5 units (95% CI, -3.7 to -1.3) (P < .001). Treatment success, as measured by the PGIC, occurred in 23 patients (51%) in the deutetrabenazine group vs 9 (20%) in the placebo group (P =.002). As measured by the CGIC, treatment success occurred in 19 patients (42%) in the deutetrabenazine group vs 6(13%) in the placebo group(P =.002). In the deutetrabenazine group, the mean SF-36 physical functioning subscale scores decreased from 47.5 (95% CI, 44.3-50.8) to 47.4 (44.3-50.5), where as in the placebo group, scores decreased from 43.2 (95% CI, 40.2-46.3) to 39.9(95% CI, 36.2-43.6), for a treatment benefit of 4.3 (95% CI, 0.4 to 8.3) (P = .03). There was no difference between groups (mean difference of 1.0 unit; 95% CI, -0.3 to 2.3; P = .14), for improvement in the Berg Balance Test, which improved by 2.2 units (95% CI, 1.3-3.1) in the deutetrabenazine group and by 1.3 units(95% CI, 0.4-2.2) in the placebo group. Adverseeventrates were similar for deutetrabenazine and placebo, including depression, anxiety, and akathisia. CONCLUSIONS AND RELEVANCE Among patients with chorea associated with Huntington disease, the use of deutetrabenazine compared with placebo resulted in improved motor signs at 12 weeks. Further research is needed to assess the clinical importance of the effect size and to determine longer-term efficacy and safety.	[Frank, Samuel] Harvard Univ, Sch Med, Boston, MA USA; [Testa, Claudia M.] Virginia Commonwealth Univ, Richmond, VA USA; [Stamler, David; Wong, Cynthia] Teva Pharmaceut Ltd, Frazer, PA USA; [Kayson, Elise; Goldstein, Jody; Herzog, Margaret; Snively, Victoria; Whaley, Jacquelyn] Univ Rochester, Ctr Human Expt Therapeut, Rochester, NY USA; [Davis, Charles] CSD Biostatist, Tucson, AZ USA; [Edmondson, Mary C.; Scott, Burton L.; Hickey, Patrick T.] Duke Univ, Durham, NC USA; [Kinel, Shari] Huntington Study Grp, Rochester, NY USA; [Leavitt, Blair] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Oakes, David; Eberly, Shirley W.; Watts, Arthur; Beck, Chris; Orme, Constance; Edicola, Jon] Univ Rochester, Rochester, NY USA; [O'Neill, Christine] Wake Forest Sch Med, Winston Salem, NC USA; [Vaughan, Christina] Med Univ S Carolina, Charleston, SC 29425 USA; [Suter, Greg] Hereditary Neurol Dis Ctr, Wichita, KS USA; [Jankovic, Joseph; Jimenez-Shahed, Joohi; Hunter, Christine] Baylor Coll Med, Houston, TX 77030 USA; [Claassen, Daniel O.; Roman, Olivia C.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Sung, Victor; Smith, Jenna] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Janicki, Sarah; Clouse, Ronda; Carlson, Alexis] Columbia Univ, New York, NY USA; [Saint-Hilaire, Marie; Hohler, Anna; Turpin, Denyse; James, Raymond C.] Boston Univ, Med Campus, Boston, MA 02215 USA; [Rodriguez, Ramon; Rizer, Kyle] Univ Florida, Coll Med, Gainesville, FL USA; [Anderson, Karen E.; Heller, Hope] Georgetown Univ, Washington, DC USA; [Criswell, Susan; Racette, Brad A.] Washington Univ, Sch Med, St Louis, MO USA; [Revilla, Fredy J.] Greenville Hlth Syst, Greenville, SC USA; [Revilla, Fredy J.] Univ S Carolina, Sch Med, Greenville, SC USA; [Nucifora, Frederick, Jr.; Margolis, Russell L.; Ong, MaryJane] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Mendis, Tilak; Mendis, Neila] Ottowa Parkinsons & Neurodegenerat Disorders Clin, Ottawa, ON, Canada; [Singer, Carlos; Quesada, Monica] Univ Miami Hlth, Miami, FL USA; [Paulsen, Jane S.; Brashers-Krug, Thomas; Miller, Amanda; Kerr, Jane] Univ Iowa Carver, Coll Med, Iowa City, IA USA; [Dubinsky, Richard M.; Gray, Carolyn] Univ Kansas, Med Ctr, Lawrence, KS USA; [Factor, Stewart A.; Sperin, Elaine] Emory Univ, Atlanta, GA 30322 USA; [Molho, Eric; Eglow, Mary; Evans, Sharon] Albany Med Coll, Albany, NY 12208 USA; [Kumar, Rajeev; Reeves, Christina] Rocky Mt Movement Disorders Ctr, Englewood, CO USA; [Samii, Ali] Univ Washington, Seattle, WA 98195 USA; [Chouinard, Sylvain] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada; [Beland, Monica] Hop Notre Dame de Bon Secours, Montreal, PQ H2L 4K8, Canada; [Esmail, Sherali; Fung, Wai Lun Alan; Gibbons, Clare; Qi, Lina] North York Gen Hosp, Toronto, ON, Canada; [Fung, Wai Lun Alan; Gibbons, Clare] Univ Toronto, Toronto, ON, Canada; [Fung, Wai Lun Alan] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Colcher, Amy; Hackmyer, Cory; McGarry, Andrew] Cooper Univ Hosp, Camden, NJ 08103 USA; [Klos, Kevin] Movement Disorders Clin, Tulsa, OK USA; [Gudesblatt, Mark; Fafard, Lori; Graffitti, Laura] South Shore Neurol Associates, Islip, NY USA; [Schneider, Daniel P.] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Dhall, Rohit] Parkinsons Inst & Clin Ctr, Sunnyvale, CA USA; [Wojcieszek, Joanne M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [LaFaver, Kathrin] Univ Louisville, Louisville, KY 40292 USA; [Duker, Andrew; Neefus, Erin; Wilson-Perez, Hilary] Univ Cincinnati, Cincinnati, OH USA; [Shprecher, David] Univ Utah Hlth Care, Salt Lake City, UT USA; [Shprecher, David] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Wall, Paola; Blindauer, Karen A.; Wheeler, Lynn] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Boyd, James T.; Houston, Emily] Univ Vermont, Med Ctr, Burlington, VT USA; [Farbman, Eric S.] Univ Nevada, Sch Med, Reno, NV 89557 USA; [Agarwal, Pinky] Evergreen Neurosci Inst, Kirkland, WA USA; [Tariot, Pierre N.] Banner Alzheimers Inst, Phoenix, AZ USA; [Feigin, Andrew] Feinstein Inst Med Res, Manhasset, NY USA; [Evans, Scott; Christopher, Emily] Harvard Univ, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Virginia Commonwealth University; University of Rochester; Duke University; University of British Columbia; University of Rochester; Wake Forest University; Medical University of South Carolina; Baylor College of Medicine; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; Columbia University; Boston University; State University System of Florida; University of Florida; Georgetown University; Washington University (WUSTL); Greenville Health System; University of South Carolina; Johns Hopkins University; University of Iowa; University of Kansas; University of Kansas Medical Center; Emory University; Albany Medical College; University of Washington; University of Washington Seattle; Universite de Montreal; Universite de Montreal; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Cooper University Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Indiana University System; Indiana University Bloomington; University of Louisville; University System of Ohio; University of Cincinnati; Utah System of Higher Education; University of Utah; University of Utah Hospital; Banner Research; Banner Health; Banner Sun Health Research Institute; Medical College of Wisconsin; University of Vermont; University of Vermont Medical Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; Banner Research; Banner Health; Banner Alzheimer's Institute; Northwell Health; Harvard University	Frank, S (corresponding author), 330 Brookline Ave,KS 228, Boston, MA 02215 USA.	sfrank2@bidmc.harvard.edu	LaFaver, Kathrin/ABE-3189-2020; Singer, Carlos/AAI-6643-2020; jimenez-shahed, joohi/ABD-3632-2020; Anderson, Karen E./AAR-1228-2020; Leavitt, Blair R/G-1934-2012; NUCIFORA, FREDERICK/X-2364-2019; Scott, Burton/L-3951-2019; Paulsen, Jane/AAQ-2932-2020	jimenez-shahed, joohi/0000-0002-9772-7569; Paulsen, Jane/0000-0002-0983-228X; Dhall, Rohit/0000-0001-9436-1920	Huntington Study Group (HGS); Auspex Pharmaceuticals; Teva Pharmaceuticals; CHDI Foundation; Lundbeck Pharmaceuticals; Auspex Pharmaceuticals Inc.; LifeMax Pharmaceuticals; Raptor Pharmaceuticals; Roche; HSG for Auspex Pharmaceuticals; Auspex; Teva; Lundbeck Inc; National Institutes of Health (NIH); Michael J. Fox Foundation; Lundbeck; Teva Neuroscience; University of Florida; Teva/Auspex	Huntington Study Group (HGS); Auspex Pharmaceuticals; Teva Pharmaceuticals(Teva Pharmaceutical Industries); CHDI Foundation; Lundbeck Pharmaceuticals(Lundbeck Corporation); Auspex Pharmaceuticals Inc.; LifeMax Pharmaceuticals; Raptor Pharmaceuticals; Roche(Roche Holding); HSG for Auspex Pharmaceuticals; Auspex; Teva(Teva Pharmaceutical Industries); Lundbeck Inc(Lundbeck Corporation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Lundbeck(Lundbeck Corporation); Teva Neuroscience(Teva Pharmaceutical Industries); University of Florida(University of Florida); Teva/Auspex(Teva Pharmaceutical Industries)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Samuel Dr Frank reports receiving grants from Huntington Study Group (HGS). Dr Testa reports receiving grants paid to the Virginia Commonwealth University from Huntington Study Group and Auspex Pharmaceuticals for serving as coprincipal investigator for this study; honorarium for participating on the scientific advisory board of Lundbeck Pharmaceuticals; and grants from Teva Pharmaceuticals and the CHDI Foundation, and other support from Auspex Pharmaceuticals and Lundbeck Pharmaceuticals. Dr Stamler reports receiving personal fees from Auspex Pharmaceuticals and is an employee of Auspex Pharmaceuticals Inc. Dr Davis reports receiving personal fees from Auspex Pharmaceuticals. Ms Kinel reports receiving other support from Auspex Pharmaceuticals and Teva Pharmaceuticals. Dr Leavitt reports receiving personal fees and nonfinancial support from Ionis Pharmaceuticals, grants and personal fees from LifeMax Pharmaceuticals and Teva Pharmaceuticals, and personal fees from Raptor Pharmaceuticals, Roche, and the Huntington Study Group. Dr Oakes reports receiving grants from HSG for Auspex Pharmaceuticals and personal fees from Raptor Pharmaceuticals. Ms O'Neill reports receiving personal fees from the Hunter Study Group for Auspex Pharmaceuticals. Ms Herzog reports receiving other support from HSG for Auspex Pharmaceuticals. Ms Snively reports receiving other support from HSG for Auspex Pharmaceuticals. Ms Whaley reports receiving grants from Auspex Pharmaceuticals. MsWong reports that she is an employee of Auspex Pharmaceuticals Inc. Mr Suter reports receiving other support from HSG for Auspex Pharmaceuticals. Dr Jankovic reports receiving grants and personal fees from Auspex and Teva. Dr Jimenez-Shahed reports receiving personal fees from Lundbeck Inc and Teva Pharmaceuticals. Dr Claassen reports receiving grants from the National Institutes of Health (NIH), the Michael J. Fox Foundation, and Lundbeck and personal fees from Teva Neuroscience and Lundbeck. Ms Roman reports receiving other support from HSG for Auspex Pharmaceuticals. Dr Janicki reports receiving personal fees from HSG for Auspex Pharmaceuticals. Victor Sung reports receiving personal fees from Lundbeck Inc. Dr Saint-Hilaire reports receiving grants from Auspex pharmaceuticals. Dr Rodriguez reports receiving grants from the University of Florida and personal fees from Auspex Pharmaceuticals and Teva Pharmaceuticals. Anderson reports receiving support and personal fees from Teva/Auspex and that Teva and Auspex have both contributed to a and Erin Squindo, Rutgers RobertWood Johnson Medical School; Edith Simpson, Barrow Neurological Clinical, Phoenix; Andrea Hurt, LPN, Indiana University School of Medicine; Barbara Blaney, Medical College of Wisconsin; Marjorie Leahy, Shamine Poynor, and Christine Zades, University of Nevada School of Medicine; Julissa Leon, Booth Gardner Parkinson's Care Center, Kirkland, Washington; Kim Higdon, RN, Myassar Zarif, MD, South Shore Neurologic Associates, Islip, New York; and Irenita Gardner, GNP, formerly with the University of Rochester, New York, New York; and Carol Moskowitz, MS, formerly Columbia University, New York, New York.	Armstrong MJ, 2012, NEUROLOGY, V79, P597, DOI 10.1212/WNL.0b013e318263c443; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; BERG K, 1989, Physiotherapy Canada, V41, P304; Dorsey ER, 2013, JAMA NEUROL, V70, P1520, DOI 10.1001/jamaneurol.2013.4408; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; FOSTER AB, 1984, TRENDS PHARMACOL SCI, V5, P524, DOI 10.1016/0165-6147(84)90534-0; Frank S, 2010, DRUGS, V70, P561, DOI 10.2165/11534430-000000000-00000; Gant TG, 2014, J MED CHEM, V57, P3595, DOI 10.1021/jm4007998; Guengerich FP, 2013, J LABELLED COMPD RAD, V56, P428, DOI 10.1002/jlcr.3031; Hurst H, 2004, J MANIP PHYSIOL THER, V27, P26, DOI 10.1016/j.jmpt.2003.11.003; Jankovic J, 2014, MOVEMENT DISORD, V29, P1414, DOI 10.1002/mds.25996; Jankovic J, 2011, EXPERT REV NEUROTHER, V11, P1509, DOI [10.1586/ERN.11.149, 10.1586/ern.11.149]; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kushner DJ, 1999, CAN J PHYSIOL PHARM, V77, P79, DOI 10.1139/cjpp-77-2-79; Lloret SP, 2007, MOVEMENT DISORD, V22, P107, DOI 10.1002/mds.21152; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marder K, 2013, JAMA NEUROL, V70, P1382, DOI 10.1001/jamaneurol.2013.3487; Marshall FJ, 2006, NEUROLOGY, V66, P366, DOI 10.1212/01.wnl.0000198586.85250.13; Mehanna R, 2013, MOVEMENT DISORD, V28, P210, DOI 10.1002/mds.25278; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Schneider LS, 1997, ALZ DIS ASSOC DIS, V11, pS22; Shen Vivienne, 2013, Tremor Other Hyperkinet Mov (N Y), V3, DOI 10.7916/D8BK1B2D; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Stamler D, 2013, NEUROLOGY, V80; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; YOUNG AB, 1986, NEUROLOGY, V36, P244, DOI 10.1212/WNL.36.2.244; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	114	122	2	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					40	50		10.1001/jama.2016.8655	http://dx.doi.org/10.1001/jama.2016.8655			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2MY	27380342	Green Published, Bronze			2022-12-28	WOS:000379037600017
J	Kumar, PD				Kumar, P. Dileep			Why Physicians Hate "Patient Satisfaction": The Real Reasons	ANNALS OF INTERNAL MEDICINE			English	Letter									[Kumar, P. Dileep] East Michigan Hospitalists, Port Huron, MI 48060 USA		Kumar, PD (corresponding author), East Michigan Hospitalists, Port Huron, MI 48060 USA.							Briggs N., 2015, SCARSDALE DAILY 1118; Nash IS, 2015, ANN INTERN MED, V163, P792, DOI 10.7326/M15-1087; Reponen E, 2015, NEUROSURGERY, V77, P769, DOI 10.1227/NEU.0000000000000931	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					71	72		10.7326/L16-0008	http://dx.doi.org/10.7326/L16-0008			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380158				2022-12-28	WOS:000379215800022
J	Sinkins, SP				Sinkins, Steven P.			Yob makes mosquitoes male	SCIENCE			English	Editorial Material							Y-CHROMOSOME; SEX-RATIO; GENE; DISTORTION; SYSTEM		[Sinkins, Steven P.] Univ Lancaster, Lancaster LA1 4YQ, England	Lancaster University	Sinkins, SP (corresponding author), Univ Lancaster, Lancaster LA1 4YQ, England.	s.sinkins@lancaster.ac.uk			MRC [MC_UU_12014/8] Funding Source: UKRI; Medical Research Council [MC_UU_12014/8] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Criscione F, 2013, INSECT MOL BIOL, V22, P433, DOI 10.1111/imb.12034; Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977; Hall AB, 2016, P NATL ACAD SCI USA, V113, pE2114, DOI 10.1073/pnas.1525164113; Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850; Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; HICKEY WA, 1966, GENETICS, V53, P1177; Krzywinska E, 2016, SCIENCE, V353, P67, DOI 10.1126/science.aaf5605; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Rose NH, 2016, GENOME BIOL EVOL, V8, P243, DOI 10.1093/gbe/evv258; Scali C, 2005, J EXP BIOL, V208, P3701, DOI 10.1242/jeb.01819	12	1	1	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					33	34		10.1126/science.aag1012	http://dx.doi.org/10.1126/science.aag1012			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365441				2022-12-28	WOS:000378816200024
J	Kaschula, R; Salecker, I				Kaschula, Richard; Salecker, Iris			Neuronal Computations Made Visible with Subcellular Resolution	CELL			English	Editorial Material							MOTION DETECTION; DROSOPHILA	Sensory information is gradually processed within dedicated neural circuits to generate specific behaviors. In this issue, Yang et al. push technology boundaries to measure both voltage and calcium signals from subcellular compartments of genetically defined interconnected neurons and shed light on local neural computations critical for motion detection.	[Kaschula, Richard; Salecker, Iris] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England	Francis Crick Institute	Salecker, I (corresponding author), Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England.	iris.salecker@crick.ac.uk	Salecker, Iris/V-1228-2018	Salecker, Iris/0000-0003-3775-7763	MRC [MC_U117581332] Funding Source: UKRI; The Francis Crick Institute [10151] Funding Source: researchfish; Medical Research Council [MC_U117581332] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Francis Crick Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Behnia R, 2014, NATURE, V512, P427, DOI 10.1038/nature13427; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Fisher YE, 2015, NEURON, V88, P390, DOI 10.1016/j.neuron.2015.09.033; Gjorgjieva J, 2014, J NEUROSCI, V34, P12127, DOI 10.1523/JNEUROSCI.1032-14.2014; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Leonhardt A, 2016, NAT NEUROSCI, V19, P706, DOI 10.1038/nn.4262; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Yang HH, 2016, CELL, V166, P245, DOI 10.1016/j.cell.2016.05.031	9	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					18	20		10.1016/j.cell.2016.06.022	http://dx.doi.org/10.1016/j.cell.2016.06.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368098	Bronze			2022-12-28	WOS:000380254400008
J	Schmidt, K; Worrack, S; Von Korff, M; Davydow, D; Brunkhorst, F; Ehlert, U; Pausch, C; Mehlhorn, J; Schneider, N; Scherag, A; Freytag, A; Reinhart, K; Wensing, M; Gensichen, J				Schmidt, Konrad; Worrack, Susanne; Von Korff, Michael; Davydow, Dimitry; Brunkhorst, Frank; Ehlert, Ulrike; Pausch, Christine; Mehlhorn, Juliane; Schneider, Nico; Scherag, Andre; Freytag, Antje; Reinhart, Konrad; Wensing, Michel; Gensichen, Jochen		SMOOTH Study Grp	Effect of a Primary Care Management Intervention on Mental Health-Related Quality of Life Among Survivors of Sepsis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CRITICALLY-ILL PATIENTS; SHORT-FORM 36; CRITICAL ILLNESS; FOLLOW-UP; PHYSICAL REHABILITATION; PATIENT ASSESSMENT; SEPTIC SHOCK; SYMPTOMS; QUESTIONNAIRE	IMPORTANCE Survivors of sepsis face long-term sequelae that diminish health-related quality of life and result in increased care needs in the primary care setting, such as medication, physiotherapy, or mental health care. OBJECTIVE To examine if a primary care-based intervention improves mental health-related quality of life. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial conducted between February 2011 and December 2014, enrolling 291 patients 18 years or older who survived sepsis (including septic shock), recruited from 9 intensive care units (ICUs) across Germany. INTERVENTIONS Participants were randomized to usual care (n = 143) or to a 12-month intervention (n = 148). Usual care was provided by their primary care physician (PCP) and included periodic contacts, referrals to specialists, and prescription of medication, other treatment, or both. The intervention additionally included PCP and patient training, case management provided by trained nurses, and clinical decision support for PCPs by consulting physicians. MAIN OUTCOMES AND MEASURES The primary outcome was change in mental health-related quality of life between ICU discharge and 6 months after ICU discharge using the Mental Component Summary (MCS) of the 36-Item Short-Form Health Survey (SF-36 [range, 0-100; higher ratings indicate lower impairment; minimal clinically important difference, 5 score points]). RESULTS The mean age of the 291 patients was 61.6 years (SD, 14.4); 66.2%(n = 192) were men, and 84.4%(n = 244) required mechanical ventilation during their ICU stay (median duration of ventilation, 12 days [range, 0-134]). At 6 and 12 months after ICU discharge, 75.3% (n = 219 [112 intervention, 107 control]) and 69.4%(n = 202 [107 intervention, 95 control]), respectively, completed follow-up. Overall mortality was 13.7% at 6 months (40 deaths [21 intervention, 19 control]) and 18.2% at 12 months (53 deaths [27 intervention, 26 control]). Among patients in the intervention group, 104 (70.3%) received the intervention at high levels of integrity. Therewas no significant difference in change of mean MCS scores (intervention group mean at baseline, 49.1; at 6 months, 52.9; change, 3.79 score points [95% CI, 1.05 to 6.54] vs control group mean at baseline, 49.3; at 6 months, 51.0; change, 1.64 score points [95% CI, -1.22 to 4.51]; mean treatment effect, 2.15 [95% CI, -1.79 to 6.09]; P = .28). CONCLUSIONS AND RELEVANCE Among survivors of sepsis and septic shock, the use of a primary care-focused team-based intervention, compared with usual care, did not improve mental health-related quality of life 6 months after ICU discharge. Further research is needed to determine if modified approaches to primary care management may be more effective.	[Schmidt, Konrad; Worrack, Susanne; Mehlhorn, Juliane; Schneider, Nico; Freytag, Antje; Wensing, Michel; Gensichen, Jochen] Jena Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany; [Schmidt, Konrad; Worrack, Susanne; Brunkhorst, Frank; Pausch, Christine; Scherag, Andre; Reinhart, Konrad; Gensichen, Jochen] Jena Univ Hosp, Ctr Sepsis Control & Care CSCC, Jena, Germany; [Von Korff, Michael] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Davydow, Dimitry] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Brunkhorst, Frank] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Ctr Clin Studies, Jena, Germany; [Ehlert, Ulrike] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Pausch, Christine] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Reinhart, Konrad] Jena Univ Hosp, Dept Anaesthesiol & Intens Care Med, Jena, Germany; [Wensing, Michel] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv, Heidelberg, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Group Health Cooperative; University of Washington; University of Washington Seattle; Friedrich Schiller University of Jena; University of Zurich; Leipzig University; Friedrich Schiller University of Jena; Ruprecht Karls University Heidelberg	Gensichen, J (corresponding author), Univ Jena, Inst Gen Practice & Family Med, Jena Univ Hosp, Bachstr 18, D-07740 Jena, Germany.	jochen.gensichen@med.uni-jena.de	Wensing, Michel/H-8113-2014; Mueller, Friederike/E-6492-2019; Schmidt, Konrad/V-5469-2017	Wensing, Michel/0000-0001-6569-8137; Schmidt, Konrad/0000-0001-5879-0664; Engel, Christoph/0000-0002-7247-282X; Freytag, Antje/0000-0001-8288-2729; VonKorff, Michael/0000-0001-5386-8477; Spies, Claudia/0000-0002-1062-0495	Center for Sepsis Control and Care (CSCC) - German Federal Ministry of Education and Research [01 E0 1002]; German Sepsis Society; National Institutes of Health [KL2 TR000421]; Thuringian Ministry of Education, Science and Culture [PE 108-2]; Thuringian Foundation for Technology, Innovation and Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000421, KL2TR002317] Funding Source: NIH RePORTER	Center for Sepsis Control and Care (CSCC) - German Federal Ministry of Education and Research; German Sepsis Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thuringian Ministry of Education, Science and Culture; Thuringian Foundation for Technology, Innovation and Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was supported by the Center for Sepsis Control and Care (CSCC), funded by the German Federal Ministry of Education and Research (grant 01 E0 1002) and the German Sepsis Society. Dr Davydow is supported by the National Institutes of Health (grant KL2 TR000421). Dr Brunkhorst is supported by the Thuringian Ministry of Education, Science and Culture (grant PE 108-2) and the Thuringian Foundation for Technology, Innovation and Research.	Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; [Anonymous], CRIT CARE S1; Battle CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116304; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; Bullinger M, 1998, SF36 FRAGEBOGEN ZUM; Burns KEA, 2013, AM J RESP CRIT CARE, V187, P1212, DOI 10.1164/rccm.201208-1537OC; Chrispin PS, 1997, ANAESTHESIA, V52, P15, DOI 10.1111/j.1365-2044.1997.015-az014.x; Cronlein T, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-65; Cuijpers P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-39; Cuthbertson BH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3723; Czerwonka AI, 2015, J CRIT CARE, V30, P242, DOI 10.1016/j.jcrc.2014.10.017; Davydow DS, 2013, AM J GERIAT PSYCHIAT, V21, P887, DOI 10.1016/j.jagp.2013.01.017; Davydow DS, 2013, GEN HOSP PSYCHIAT, V35, P226, DOI 10.1016/j.genhosppsych.2012.12.005; Day SJ, 2000, BRIT MED J, V321, P504, DOI 10.1136/bmj.321.7259.504; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Douglas SL, 2007, AM J CRIT CARE, V16, P447; Egerod I, 2013, INTENS CRIT CARE NUR, V29, P103, DOI 10.1016/j.iccn.2012.10.005; Elliott D, 2014, CRIT CARE MED, V42, P2518, DOI 10.1097/CCM.0000000000000525; Elliott D, 2011, CRIT CARE, V15, DOI 10.1186/cc10265; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Fonda S., 2004, HRS AHEAD DOCUMENTAT; Garrouste-Orgeas M, 2004, INTENS CARE MED, V30, P437, DOI 10.1007/s00134-003-2095-2; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Goodwin AJ, 2015, CRIT CARE MED, V43, P738, DOI 10.1097/CCM.0000000000000859; Griffiths J, 2007, INTENS CARE MED, V33, P1506, DOI 10.1007/s00134-007-0730-z; Hall Margaret Jean, 2011, NCHS Data Brief, P1; Haslbeck M, 2007, DIABETOLOGIE, V2, P150, DOI [10.1055/s-2007-960632, DOI 10.1055/S-2007-960632]; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; Hofhuis JGM, 2008, ANESTH ANALG, V107, P1957, DOI 10.1213/ane.0b013e318187bbd8; Iwashyna TJ, 2014, JAMA-J AM MED ASSOC, V311, P1295, DOI 10.1001/jama.2014.2639; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jackson JC, 2012, CRIT CARE MED, V40, P1088, DOI 10.1097/CCM.0b013e3182373115; Jones C, 2010, CRIT CARE, V14, DOI 10.1186/cc9260; Karlsson S, 2007, INTENS CARE MED, V33, P435, DOI 10.1007/s00134-006-0504-z; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Lee H, 2004, CRIT CARE MED, V32, P981, DOI 10.1097/01.CCM.0000120053.98734.2C; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Marinos E, 2003, MUST REPORT NUTR SCR; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; McGovern M, 2011, BRIT J GEN PRACT, V61, P714, DOI 10.3399/bjgp11X612945; Mehlhorn J, 2014, CRIT CARE MED, V42, P1263, DOI 10.1097/CCM.0000000000000148; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Parker AM, 2015, CRIT CARE MED, V43, P1121, DOI 10.1097/CCM.0000000000000882; Prescott HC, 2015, JAMA-J AM MED ASSOC, V313, P1055, DOI 10.1001/jama.2015.1410; R Core Team, R LANG ENV STAT COMP; Richardson W S, 1995, ACP J Club, V123, pA12; Rosemann T, 2007, J EVAL CLIN PRACT, V13, P806, DOI 10.1111/j.1365-2753.2007.00786.x; Schmidt K, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-283; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54; Van der Schaaf M, 2015, MINERVA ANESTESIOL, V81, P135; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Ware JE, 2000, SF 36 VERSION HLTH S; WATZL H, 1991, SUCHT PSYCHOSOMATIK; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Wollmerstedt N, 2003, Z ORTHOP GRENZGEB, V141, P718, DOI 10.1055/s-2003-812406; Zentralinstitut fur die kassenarztliche Versorgung in Deutschland, ZI PRAX PAN JAHR 201	61	79	84	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2703	2711		10.1001/jama.2016.7207	http://dx.doi.org/10.1001/jama.2016.7207			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP7WG	27367877	Green Accepted, Bronze			2022-12-28	WOS:000378709300021
J	Groves, T				Groves, Trish			MEDICINE AND THE MEDIA Tweeting and rule breaking at conferences	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tgroves@bmj.com	Groves, Trish/A-9119-2009	Groves, Trish/0000-0001-7915-6419				Groves T., 2015, UCL EARLY CAREERS NE; RELMAN AS, 1981, NEW ENGL J MED, V305, P824, DOI 10.1056/NEJM198110013051408; Tennant J., 2014, LETS HAV DISC LIV TW	3	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2016	353								i3556	10.1136/bmj.i3556	http://dx.doi.org/10.1136/bmj.i3556			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FG	27352951				2022-12-28	WOS:000379017000005
J	Qian, L				Qian, Li			Hope for the brokenhearted Cellular reprogramming improves cardiac function in a mouse model of myocardial infarction	SCIENCE			English	Editorial Material							INDUCED CARDIOMYOCYTES; FIBROBLASTS		[Qian, Li] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Qian, L (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	li_qian@med.unc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128331] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Liu ZQ, 2016, STEM CELL RES, V16, P507, DOI 10.1016/j.scr.2016.02.037; Ma H, 2015, CARDIOVASC RES, V108, P217, DOI 10.1093/cvr/cvv223; Qian L, 2013, CIRC RES, V113, P915, DOI 10.1161/CIRCRESAHA.112.300625; Qian L, 2013, NAT PROTOC, V8, P1204, DOI 10.1038/nprot.2013.067; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Wang L., 2015, JOVE-J VIS EXP, V105; Wang L, 2015, CIRC RES, V116, P237, DOI 10.1161/CIRCRESAHA.116.305547; Zhou Y, 2016, CELL STEM CELL, V18, P382, DOI 10.1016/j.stem.2016.02.003	8	2	2	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1400	1401		10.1126/science.aag1213	http://dx.doi.org/10.1126/science.aag1213			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313029				2022-12-28	WOS:000377975400026
J	Bournazos, S; Gazumyan, A; Seaman, MS; Nussenzweig, MC; Ravetch, JV				Bournazos, Stylianos; Gazumyan, Anna; Seaman, Michael S.; Nussenzweig, Michel C.; Ravetch, Jeffrey V.			Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency	CELL			English	Article							BROADLY NEUTRALIZING ANTIBODIES; HIV-ANTIBODIES; HUMANIZED MICE; CONFORMATIONAL EPITOPE; GP41-GP120 INTERFACE; CD4 BINDING; IGG; MACAQUES; THERAPY; VIREMIA	Broadly neutralizing antibodies (bNAbs) against the HIV-1 envelope glycoprotein (Env) suppress viremia in animal models of HIV-1 and humans. To achieve potent activity without the emergence of viral escape mutants, co-administration of different bNAbs is necessary to target distinct epitopes essential for viral fitness. Here, we report the development of bispecific anti-Env neutralizing antibodies (biNAbs) with potent activity. Synergistic activity of biNAbs was achieved by combining an engineered hinge domain of IgG3 to increase Fab domain flexibility necessary for hetero-bivalent binding to the Env trimer while retaining the functional properties of the IgG1-Fc. Compared to unmodified biNAbs, hinge domain variants exhibited substantially improved neutralization activity, with particular combinations showing evidence of synergistic neutralization potency in vitro and enhanced in vivo therapeutic activity in HIV-1-infected humanized mice. These findings suggest innovative strategies for generating biNAbs with enhanced neutralization breadth and potency, representing ideal candidate molecules for the control of HIV-1 infection.	[Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Seaman, Michael S.] Harvard Univ, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Nussenzweig, Michel/AAE-7292-2019; Bournazos, Stylianos/ABH-1578-2021	Ravetch, Jeffrey/0000-0003-2024-9041; 	NIAID [AI081677, AI100148]; Bill & Melinda Gates Foundation [OPP1033115, OPP1124068, OPP1032144]; amfAR Mathilde Krim Fellowship in Basic Biomedical Research [108977-57-RKVA]; NIH AIDS Reagent Program [T251-18]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148, P01AI081677] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); amfAR Mathilde Krim Fellowship in Basic Biomedical Research; NIH AIDS Reagent Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank P. Smith, H. Lee, M. Saito, M. Ye, E. Lam, P. Bartel, T. Schoofs, J. Cetrulo-Lorenzi, and L. Nogueira (Rockefeller University) for technical help and advice; M. Louder and J. Mascola (VRC, National Institute of Allergy and Infectious Diseases [NIAID]) for providing the raw neutralization data for the bNAb combinations (Figure S4); and the NIH AIDS Reagent Program for obtaining the T251-18 env construct. Research reported in this publication was supported in part by the NIAID under award numbers AI081677 and AI100148 (to J.V.R. and M.C.N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Research support was also provided by the Bill & Melinda Gates Foundation grants OPP1033115 and OPP1124068 to J.V.R. and M.C.N. and grant OPP1032144 to M.S.S. S.B. was supported by an amfAR Mathilde Krim Fellowship in Basic Biomedical Research (108977-57-RKVA).	Asokan M, 2015, J VIROL, V89, P12501, DOI 10.1128/JVI.02097-15; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chames P, 2009, MABS-AUSTIN, V1, P539, DOI 10.4161/mabs.1.6.10015; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Galimidi RP, 2015, CELL, V160, P433, DOI 10.1016/j.cell.2015.01.016; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14; Lee JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9167; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; MONTEFIORI DC, 2005, CURR PROTOC IMMUNOL, V12; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Pace CS, 2013, P NATL ACAD SCI USA, V110, P13540, DOI 10.1073/pnas.1304985110; Pegu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9447; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Roux KH, 1998, J IMMUNOL, V161, P4083; Roux KH, 1997, J IMMUNOL, V159, P3372; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Sung JAM, 2015, J CLIN INVEST, V125, P4077, DOI 10.1172/JCI82314; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	52	107	108	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1609	1620		10.1016/j.cell.2016.04.050	http://dx.doi.org/10.1016/j.cell.2016.04.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315478	Green Accepted, Bronze			2022-12-28	WOS:000378062000013
J	Branco, T; Tozer, A; Magnus, CJ; Sugino, K; Tanaka, S; Lee, AK; Wood, JN; Sternson, SM				Branco, Tiago; Tozer, Adam; Magnus, Christopher J.; Sugino, Ken; Tanaka, Shinsuke; Lee, Albert K.; Wood, John N.; Sternson, Scott M.			Near-Perfect Synaptic Integration by Na(v)1.7 in Hypothalamic Neurons Regulates Body Weight	CELL			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; SODIUM-CHANNELS; HIPPOCAMPAL-NEURONS; RNA INTERFERENCE; AGRP NEURONS; TIME-COURSE; CURRENTS; NUCLEUS; CIRCUIT; HUNGER	Neurons are well suited for computations on millisecond timescales, but some neuronal circuits set behavioral states over long time periods, such as those involved in energy homeostasis. We found that multiple types of hypothalamic neurons, including those that oppositely regulate body weight, are specialized as near-perfect synaptic integrators that summate inputs over extended timescales. Excitatory postsynaptic potentials (EPSPs) are greatly prolonged, outlasting the neuronal membrane time-constant up to 10-fold. This is due to the voltage-gated sodium channel Na(v)1.7 (Scn9a), previously associated with pain-sensation but not synaptic integration. Scn9a deletion in AGRP, POMC, or paraventricular hypothalamic neurons reduced EPSP duration, synaptic integration, and altered body weight in mice. In vivo whole-cell recordings in the hypothalamus confirmed near-perfect synaptic integration. These experiments show that integration of synaptic inputs over time by Na(v)1.7 is critical for body weight regulation and reveal a mechanism for synaptic control of circuits regulating long term homeostatic functions.	[Branco, Tiago; Magnus, Christopher J.; Sugino, Ken; Tanaka, Shinsuke; Lee, Albert K.; Sternson, Scott M.] Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA; [Branco, Tiago; Tozer, Adam] MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 0QH, England; [Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, Mortimer St, London WC1E 6BT, England	Howard Hughes Medical Institute; MRC Laboratory Molecular Biology; University of London; University College London	Branco, T; Sternson, SM (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.; Branco, T (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 0QH, England.	tbranco@mrc-lmb.cam.ac.uk; sternsons@janelia.hhmi.org		Sternson, Scott/0000-0002-0835-444X	Howard Hughes Medical Institute; HHMI Janelia Research Campus Visitor program; NeuroSeq Project Team; Wellcome Trust/Royal Society Henry Dale Fellowship [098400/Z/12/Z]; Medical Research Council (MRC) grant [MC-UP-1201/1]; MRC grant [G091905]; Wellcome Trust Grant [10154]; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [MC_UP_1201/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [MC_UP_1201/1] Funding Source: researchfish; Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish	Howard Hughes Medical Institute(Howard Hughes Medical Institute); HHMI Janelia Research Campus Visitor program; NeuroSeq Project Team; Wellcome Trust/Royal Society Henry Dale Fellowship; Medical Research Council (MRC) grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Grant(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by the Howard Hughes Medical Institute (to S.M.S.), the HHMI Janelia Research Campus Visitor program (to T.B.), the NeuroSeq Project Team (to K.S.), a Wellcome Trust/Royal Society Henry Dale Fellowship (098400/Z/12/Z) and Medical Research Council (MRC) grant MC-UP-1201/1 (to T.B.), and MRC grant G091905 and Wellcome Trust Grant 10154 (to J.N.W.). We thank H. Su for molecular biology; M. Copeland for RNA-FISH; K. Ritola for virus production; A. Zeladonis and S. Lindo for mouse breeding, genotyping, and histology; L. Jin for mouse weight measurements; and S. Eddy, B. Clark, M. Hausser, A. Roth, and C. Schmidt-Hieber for comments on the manuscript. This paper is dedicated to Professor Stuart L. Schreiber on the occasion of his 60th birthday.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Carter BC, 2012, NEURON, V75, P1081, DOI 10.1016/j.neuron.2012.08.033; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1998, J NEUROSCI, V18, P9607; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Farries MA, 2010, J NEUROSCI, V30, P13180, DOI 10.1523/JNEUROSCI.1909-10.2010; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Henry FE, 2015, ELIFE, V4, DOI 10.7554/eLife.09800; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; IANSEK R, 1973, J PHYSIOL-LONDON, V234, P665, DOI 10.1113/jphysiol.1973.sp010366; Jack J.J.B., 1975, ELECT CURRENT FLOW E; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Matveeva Olga V., 2012, Frontiers in Genetics, V3, P163, DOI 10.3389/fgene.2012.00163; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Prescott SA, 2005, J NEUROSCI, V25, P4743, DOI 10.1523/JNEUROSCI.0356-05.2005; Pressley J, 2009, BIOL CYBERN, V101, P63, DOI 10.1007/s00422-009-0317-6; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Tolson KP, 2010, J NEUROSCI, V30, P3803, DOI 10.1523/JNEUROSCI.5444-09.2010; Uebachs M, 2010, J NEUROSCI, V30, P8489, DOI 10.1523/JNEUROSCI.1534-10.2010; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Vega AV, 2008, NEUROSCI LETT, V442, P69, DOI 10.1016/j.neulet.2008.06.065; Wang DQ, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00040; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039	47	49	50	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1749	1761		10.1016/j.cell.2016.05.019	http://dx.doi.org/10.1016/j.cell.2016.05.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315482	Green Published, hybrid			2022-12-28	WOS:000378062000024
J	Martines, RB; Bhatnagar, J; Ramos, AMD; Davi, HPF; Iglezias, SD; Kanamura, CT; Keating, MK; Hale, G; Silva-Flannery, L; Muehlenbachs, A; Ritter, J; Gary, J; Rollin, D; Goldsmith, CS; Reagan-Steiner, S; Ermias, Y; Suzuki, T; Luz, KG; de Oliveira, WK; Lanciotti, R; Lambert, A; Shieh, WJ; Zaki, SR				Martines, Roosecelis Brasil; Bhatnagar, Julu; de Oliveira Ramos, Ana Maria; Freire Davi, Helaine Pompeia; Iglezias, Silvia D'Andretta; Kanamura, Cristina Takami; Keating, M. Kelly; Hale, Gillian; Silva-Flannery, Luciana; Muehlenbachs, Atis; Ritter, Jana; Gary, Joy; Rollin, Dominique; Goldsmith, Cynthia S.; Reagan-Steiner, Sarah; Ermias, Yokabed; Suzuki, Tadaki; Luz, Kleber G.; de Oliveira, Wanderson Kleber; Lanciotti, Robert; Lambert, Amy; Shieh, Wun-Ju; Zaki, Sherif R.			Pathology of congenital Zika syndrome in Brazil: a case series	LANCET			English	Article							VIRUS-INFECTION; ARTHROGRYPOSIS; ETIOLOGY; TISSUES; UPDATE; STATES; BRAIN; PCR	Background Zika virus is an arthropod-borne virus that is a member of the family Flaviviridae transmitted mainly by mosquitoes of the genus Aedes. Although usually asymptomatic, infection can result in a mild and self-limiting illness characterised by fever, rash, arthralgia, and conjunctivitis. An increase in the number of children born with microcephaly was noted in 2015 in regions of Brazil with high transmission of Zika virus. More recently, evidence has been accumulating supporting a link between Zika virus and microcephaly. Here, we describe findings from three fatal cases and two spontaneous abortions associated with Zika virus infection. Methods In this case series, formalin-fixed paraffin-embedded tissue samples from five cases, including two newborn babies with microcephaly and severe arthrogryposis who died shortly after birth, one 2-month-old baby, and two placentas from spontaneous abortions, from Brazil were submitted to the Infectious Diseases Pathology Branch at the US Centers for Disease Control and Prevention (Atlanta, GA, USA) between December, 2015, and March, 2016. Specimens were assessed by histopathological examination, immunohistochemical assays using a mouse anti-Zika virus antibody, and RT-PCR assays targeting the NS5 and envelope genes. Amplicons of RT-PCR positive cases were sequenced for characterisation of strains. Findings Viral antigens were localised to glial cells and neurons and associated with microcalcifications in all three fatal cases with microcephaly. Antigens were also seen in chorionic villi of one of the first trimester placentas. Tissues from all five cases were positive for Zika virus RNA by RT-PCR, and sequence analyses showed highest identities with Zika virus strains isolated from Brazil during 2015. Interpretation These findings provide strong evidence of a link between Zika virus infection and different congenital central nervous system malformations, including microcephaly as well as arthrogryposis and spontaneous abortions.	[Martines, Roosecelis Brasil; Bhatnagar, Julu; Keating, M. Kelly; Hale, Gillian; Silva-Flannery, Luciana; Muehlenbachs, Atis; Ritter, Jana; Gary, Joy; Rollin, Dominique; Goldsmith, Cynthia S.; Ermias, Yokabed; Shieh, Wun-Ju; Zaki, Sherif R.] NCEZID, Div High Consequence Pathogens & Pathol, Infect Dis Pathol Branch, Atlanta, GA USA; [Reagan-Steiner, Sarah] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Immunizat Serv Div, Atlanta, GA USA; [de Oliveira Ramos, Ana Maria] Univ Fed Rio Grande do Norte, Dept Pathol, Natal, RN, Brazil; [de Oliveira Ramos, Ana Maria; Freire Davi, Helaine Pompeia] Serv Ascertaining Death State Rio Grande Norte SV, Natal, RN, Brazil; [Iglezias, Silvia D'Andretta; Kanamura, Cristina Takami] Adolfo Lutz Inst, Sao Paulo, Brazil; [Suzuki, Tadaki] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Luz, Kleber G.] Univ Fed Rio Grande do Norte, Dept Infect Dis, Natal, RN, Brazil; [de Oliveira, Wanderson Kleber] Minist Hlth, Brasilia, DF, Brazil; [Lanciotti, Robert; Lambert, Amy] Ctr Dis Control & Prevent, NCEZID, Div Vector Borne Dis, Arboviral Dis Branch, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA; Universidade Federal do Rio Grande do Norte; Instituto Adolfo Lutz; National Institute of Infectious Diseases (NIID); Universidade Federal do Rio Grande do Norte; Centers for Disease Control & Prevention - USA	Zaki, SR (corresponding author), Ctr Dis Control & Prevent, NCEZID, Div High Consequence Pathogens & Pathol, Infect Dis Pathol Branch, Atlanta, GA 30329 USA.	szaki@cdc.gov	Oliveira, Wanderson/AAF-5182-2019; Suzuki, Tadaki/ABH-2661-2020	Oliveira, Wanderson/0000-0002-9662-1930; Kanamura, Cristina/0000-0003-2537-2356; Ramos, Ana Maria/0000-0001-7542-4973				Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751; Bhatnagar J, 2016, 32 CLIN VIR S; Bhatnagar J, 2012, AM J TROP MED HYG, V86, P335, DOI 10.4269/ajtmh.2012.11-0346; Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Franca GVA, 2016, LANCET; FRASER SH, 1994, J PAEDIATR CHILD H, V30, P450, DOI 10.1111/j.1440-1754.1994.tb00701.x; Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Hall JG, 2014, EUR J MED GENET, V57, P464, DOI 10.1016/j.ejmg.2014.03.008; Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5; Kowalczyk B, 2016, ARCH MED SCI, V12, P10, DOI 10.5114/aoms.2016.57578; Lazar M, 2016, EBIOMEDICINE, V3, P86, DOI 10.1016/j.ebiom.2015.11.050; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2; Oehler E, 2014, EUROSURVEILLANCE, V19, P4; PASTUSZAK AL, 1994, NEW ENGL J MED, V330, P901, DOI 10.1056/NEJM199403313301305; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	29	211	218	4	104	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					898	904		10.1016/S0140-6736(16)30883-2	http://dx.doi.org/10.1016/S0140-6736(16)30883-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU0RI	27372395	Bronze			2022-12-28	WOS:000381911800028
J	Scheid, JF; Horwitz, JA; Bar-On, Y; Kreider, EF; Lu, CL; Lorenzi, JCC; Feldmann, A; Braunschweig, M; Nogueira, L; Oliveira, T; Shimeliovich, I; Patel, R; Burke, L; Cohen, YZ; Hadrigan, S; Settler, A; Witmer-Pack, M; West, AP; Juelg, B; Keler, T; Hawthorne, T; Zingman, B; Gulick, RM; Pfeifer, N; Learn, GH; Seaman, MS; Bjorkman, PJ; Klein, F; Schlesinger, SJ; Walker, BD; Hahn, BH; Nussenzweig, MC; Caskey, M				Scheid, Johannes F.; Horwitz, Joshua A.; Bar-On, Yotam; Kreider, Edward F.; Lu, Ching-Lan; Lorenzi, Julio C. C.; Feldmann, Anna; Braunschweig, Malte; Nogueira, Lilian; Oliveira, Thiago; Shimeliovich, Irina; Patel, Roshni; Burke, Leah; Cohen, Yehuda Z.; Hadrigan, Sonya; Settler, Allison; Witmer-Pack, Maggi; West, Anthony P., Jr.; Juelg, Boris; Keler, Tibor; Hawthorne, Thomas; Zingman, Barry; Gulick, Roy M.; Pfeifer, Nico; Learn, Gerald H.; Seaman, Michael S.; Bjorkman, Pamela J.; Klein, Florian; Schlesinger, Sarah J.; Walker, Bruce D.; Hahn, Beatrice H.; Nussenzweig, Michel C.; Caskey, Marina			HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption	NATURE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; ANTIRETROVIRAL THERAPY; MONOCLONAL-ANTIBODIES; GENETIC-DETERMINANTS; PASSIVE TRANSFER; POTENT; SEQUENCE; REPLICATION; RESPONSES; IMMUNOTHERAPY	Interruption of combination antiretroviral therapy in HIV-1-infected individuals leads to rapid viral rebound. Here we report the results of a phase IIa open label clinical trial evaluating 3BNC117, a broad and potent neutralizing antibody against the CD4 binding site of the HIV-1 Env protein(1), during analytical treatment interruption in 13 HIV-1-infected individuals. Participants with 3BNC117-sensitive virus outgrowth cultures were enrolled. Results show that two or four 30 mg kg(-1) 3BNC117 infusions, separated by 3 or 2 weeks, respectively, are generally well tolerated. Infusions are associated with a delay in viral rebound of 5-9 weeks after two infusions, and up to 19 weeks after four infusions, or an average of 6.7 and 9.9 weeks, respectively, compared with 2.6 weeks for historical controls (P < 0.00001). Rebound viruses arise predominantly from a single provirus. In most individuals, emerging viruses show increased resistance, indicating escape. However, 30% of participants remained suppressed until antibody concentrations waned below 20 mu g ml(-1), and the viruses emerging in all but one of these individuals showed no apparent resistance to 3BCN117, suggesting failure to escape over a period of 9-19 weeks. We conclude that the administration of 3BNC117 exerts strong selective pressure on HIV-1 emerging from latent reservoirs during analytical treatment interruption in humans.	[Scheid, Johannes F.; Horwitz, Joshua A.; Bar-On, Yotam; Lu, Ching-Lan; Lorenzi, Julio C. C.; Braunschweig, Malte; Nogueira, Lilian; Oliveira, Thiago; Shimeliovich, Irina; Patel, Roshni; Cohen, Yehuda Z.; Hadrigan, Sonya; Settler, Allison; Witmer-Pack, Maggi; Klein, Florian; Schlesinger, Sarah J.; Nussenzweig, Michel C.; Caskey, Marina] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Scheid, Johannes F.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Scheid, Johannes F.] Harvard Med Sch, Boston, MA 02114 USA; [Kreider, Edward F.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kreider, Edward F.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Feldmann, Anna; Pfeifer, Nico] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Campus E1 4, D-66123 Saarbrcken, Germany; [Burke, Leah; Gulick, Roy M.] Cornell Univ, Div Infect Dis, Weill Med Coll, New York, NY 10065 USA; [West, Anthony P., Jr.; Bjorkman, Pamela J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Juelg, Boris; Walker, Bruce D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Keler, Tibor; Hawthorne, Thomas] Celldex Therapeut Inc, Hampton, NJ 08827 USA; [Zingman, Barry] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Klein, Florian] Univ Cologne, Ctr Mol Med Cologne CMMC, Lab Expt Immunol, D-50931 Cologne, Germany; [Klein, Florian] Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Dept Internal Med 1, D-50937 Cologne, Germany; [Walker, Bruce D.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Max Planck Society; Cornell University; California Institute of Technology; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; University of Cologne; University of Cologne; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC; Caskey, M (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	nussen@rockefeller.edu; mcaskey@rockefeller.edu	Oliveira, Thiago Y/ABF-5186-2020; Pfeifer, Nico/G-1559-2016; Lorenzi, Julio/S-2394-2019; Juelg, Boris/ABA-1955-2020; Learn, Jerry/E-3356-2012; Lorenzi, Julio Cesar C.C. Cetrulo/B-5264-2008; Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019; Kreider, Edward/GSD-5998-2022	Oliveira, Thiago Y/0000-0002-2654-0879; Lorenzi, Julio/0000-0003-2492-3961; Juelg, Boris/0000-0002-4687-9626; Lorenzi, Julio Cesar C.C. Cetrulo/0000-0003-2492-3961; Oliveira, Thiago Y/0000-0002-2654-0879; Caskey, Marina/0000-0003-1727-8693; Cohen, Yehuda/0000-0001-6987-1478; Pfeifer, Nico/0000-0002-4647-8566; Kreider, Edward/0000-0003-2330-8430; Hahn, Beatrice/0000-0002-9400-9887	Rockefeller University Hospital Clinical Research Support Office; AIDS Clinical Trials Group grant [UM1 AI068636]; Statistical and Data Management Center [UM1 AI068634]; Collaboration for AIDS Vaccine Discovery grant [OPP1033115, OPP1032144]; National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000043]; NIH Clinical and Translational Science Award (CTSA) program; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663-01, 5UM1 AI100645-03, 1UM1 AI00645]; Bill and Melinda Gates Foundation [OPP1092074, OPP1124068]; NIH HIVRAD [P01 AI100148]; Robertson Foundation; Ruth L. Kirschstein National Research Service Award [F30 AI112426, F31 AI118555]; University of Pennsylvania Center for AIDS Research (CFAR) Single Genome Amplification Service Center [P30 AI045008]; NIH Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1-AI100663]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001866, UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, UM1AI068634, F30AI112426, K08AI106408, Z01AI000645, UM1AI100663, P30AI045008, UM1AI068636, F31AI118555, P01AI100148] Funding Source: NIH RePORTER	Rockefeller University Hospital Clinical Research Support Office; AIDS Clinical Trials Group grant; Statistical and Data Management Center; Collaboration for AIDS Vaccine Discovery grant; National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH HIVRAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for AIDS Research (CFAR) Single Genome Amplification Service Center; NIH Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank the trial participants for their invaluable support. We thank the Rockefeller University Hospital Clinical Research Support Office and nursing staff for help with recruitment and study implementation, especially N. Buckley, A. Hurley, S. B. A. Shulman and L. Corregano; all members of the Nussenzweig laboratory, especially T. Schoofs, A. Halper-Stromberg, M. and Z. Jankovic; C. Unson-O'Brien, J. Dizon, R. Baptiste and R. Levin for sample processing and study coordination; A. Louie for regulatory support; P. Fast and H. Park for clinical monitoring; E. Giorgi and W. Fischer from Los Alamos National Laboratory; R. T. Gandhi, J. Li and The AIDS Clinical Trials Group (grant UM1 AI068636) and its Statistical and Data Management Center (grant UM1 AI068634). This study was supported by the following grants: Collaboration for AIDS Vaccine Discovery grant OPP1033115 (M. C. N.) and OPP1032144 (M. S. S.). Grant 8 UL1 TR000043 from the National Center for Advancing Translational Sciences (NCATS); NIH Clinical and Translational Science Award (CTSA) program; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) 1UM1 AI100663-01 (M. C. N.) and 5UM1 AI100645-03 (B. H. H.); Bill and Melinda Gates Foundation grants OPP1092074 and OPP1124068 (M. C. N.); NIH HIVRAD P01 AI100148 (P. J. B. and M. C. N.); the Robertson Foundation to M. C. N. M. C. N. is a Howard Hughes Medical Institute Investigator. Ruth L. Kirschstein National Research Service Award F30 AI112426 (E.F.K.); F31 AI118555 (J. A. H.); The NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) 1UM1 AI00645 (B. H. H.); The University of Pennsylvania Center for AIDS Research (CFAR) Single Genome Amplification Service Center P30 AI045008 (B. H. H.); The NIH Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID and 1UM1-AI100663) (B.D.W.).	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Altfeld MA, 2000, J VIROL, V74, P8541, DOI 10.1128/JVI.74.18.8541-8549.2000; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Giorgi EE, 2012, BIOMETRICS, V68, P1323, DOI 10.1111/j.1541-0420.2012.01775.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Jacobson JM, 2006, J INFECT DIS, V194, P623, DOI 10.1086/506364; Kearney MF, 2016, J VIROL, V90, P1369, DOI 10.1128/JVI.02139-15; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kilby JM, 2006, J INFECT DIS, V194, P1672, DOI 10.1086/509508; Kirchherr JL, 2007, J VIROL METHODS, V143, P104, DOI 10.1016/j.jviromet.2007.02.015; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JZ, 2016, AIDS, V30, P343, DOI 10.1097/QAD.0000000000000953; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; MADDISON W.P., 2001, MACCLADE ANAL PHYLOG; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Rothenberger MK, 2015, P NATL ACAD SCI USA, V112, pE1126, DOI 10.1073/pnas.1414926112; Salantes B. S. B, 2016, CROI C; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Volberding P, 2009, AIDS, V23, P1987, DOI 10.1097/QAD.0b013e32832eb285; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Xie J, 2005, STAT MED, V24, P3089, DOI 10.1002/sim.2174	52	308	314	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					556	+		10.1038/nature18929	http://dx.doi.org/10.1038/nature18929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27338952	Green Accepted			2022-12-28	WOS:000380856600030
J	Kirby, T				Kirby, Tony			Sari Reisner-making transgender health visible	LANCET			English	Biographical-Item																		REISNER S, PUBLICATION LIST	1	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					332	332		10.1016/S0140-6736(16)30839-X	http://dx.doi.org/10.1016/S0140-6736(16)30839-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR6MV	27323920				2022-12-28	WOS:000380016900022
J	Carson, SS; Cox, CE; Wallenstein, S; Hanson, LC; Danis, M; Tulsky, JA; Chai, E; Nelson, JE				Carson, Shannon S.; Cox, Christopher E.; Wallenstein, Sylvan; Hanson, Laura C.; Danis, Marion; Tulsky, James A.; Chai, Emily; Nelson, Judith E.			Effect of Palliative Care-Led Meetings for Families of Patients With Chronic Critical Illness A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROLONGED MECHANICAL VENTILATION; RESOURCE UTILIZATION; COMMUNICATION; UNIT; VALIDATION; ICU; OUTCOMES; CONSULTATION; INFORMATION; DEPRESSION	IMPORTANCE Family caregivers of patients with chronic critical illness experience significant psychological distress. OBJECTIVE To determine whether family informational and emotional support meetings led by palliative care clinicians improve family anxiety and depression. DESIGN, SETTING, AND PARTICIPANTS A multicenter randomized clinical trial conducted from October 2010 through November 2014 in 4 medical intensive care units (ICUs). Adult patients (aged >= 21 years) requiring 7 days of mechanical ventilation were randomized and their family surrogate decision makers were enrolled in the study. Observers were blinded to group allocation for the measurement of the primary outcomes. INTERVENTIONS At least 2 structured family meetings led by palliative care specialists and provision of an informational brochure (intervention) compared with provision of an informational brochure and routine family meetings conducted by ICU teams (control). There were 130 patients with 184 family surrogate decision makers in the intervention group and 126 patients with 181 family surrogate decision makers in the control group. MAIN OUTCOMES AND MEASURES The primary outcome was Hospital Anxiety and Depression Scale symptom score (HADS; score range, 0[best] to 42[worst]; minimal clinically important difference, 1.5) obtained during 3-month follow-up interviews with the surrogate decision makers. Secondary outcomes included posttraumatic stress disorder experienced by the family and measured by the Impact of Events Scale-Revised (IES-R; total score range, 0 [best] to 88 [worst]), discussion of patient preferences, hospital length of stay, and 90-day survival. RESULTS Among 365 family surrogate decision makers (mean age, 51 years; 71% female), 312 completed the study. At 3 months, there was no significant difference in anxiety and depression symptoms between surrogate decision makers in the intervention group and the control group (adjusted mean HADS score, 12.2 vs 11.4, respectively; between-group difference, 0.8 [95% CI, -0.9 to 2.6]; P = .34). Posttraumatic stress disorder symptoms were higher in the intervention group (adjusted mean IES-R score, 25.9) compared with the control group (adjusted mean IES-R score, 21.3) (between-group difference, 4.60 [95% CI, 0.01 to 9.10]; P = .0495). There was no difference between groups regarding the discussion of patient preferences (intervention, 75%; control, 83%; odds ratio, 0.63[95% CI, 0.34 to 1.16; P = .14]). The median number of hospital days for patients in the intervention vs the control group (19 days vs 23 days, respectively; between-group difference, -4 days [95% CI, -6 to 3 days]; P = .51) and 90-day survival (hazard ratio, 0.95 [95% CI, 0.65 to 1.38], P = .96) were not significantly different. CONCLUSIONS AND RELEVANCE Among families of patients with chronic critical illness, the use of palliative care-led informational and emotional support meetings compared with usual care did not reduce anxiety or depression symptoms and may have increased posttraumatic stress disorder symptoms. These findings do not support routine or mandatory palliative care-led discussion of goals of care for all families of patients with chronic critical illness.	[Carson, Shannon S.; Hanson, Laura C.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Cox, Christopher E.] Duke Univ, Med Ctr, Durham, NC USA; [Wallenstein, Sylvan; Chai, Emily] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Danis, Marion] NIH, Bldg 10, Bethesda, MD 20892 USA; [Tulsky, James A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA; [Tulsky, James A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Nelson, Judith E.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Nelson, Judith E.] Weill Cornell Med Coll, New York, NY USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Cornell University	Carson, SS (corresponding author), Univ N Carolina, Sch Med, Div Pulm & Crit Care Med, Marsico Lung Inst,Cecil B Sheps Ctr Hlth Serv Res, 4125 Bioinformat Bldg,CB 7020, Chapel Hill, NC 27599 USA.	scarson@med.unc.edu	Cox, Christopher/ABH-7957-2020	Cox, Christopher/0000-0002-4486-0681; , Laura/0000-0003-3737-9926; Hanson, Laura/0000-0001-5120-6058	National Institute of Nursing Research [R01-NR012413]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012413] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This project was funded by grant R01-NR012413 from the National Institute of Nursing Research.	Arnold RM, 2015, J CRIT CARE, V30, P250, DOI 10.1016/j.jcrc.2014.11.016; Aslakson R, 2014, J PALLIAT MED, V17, P219, DOI 10.1089/jpm.2013.0409; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Cameron JI, 2016, NEW ENGL J MED, V374, P1831, DOI 10.1056/NEJMoa1511160; Carson SS, 2012, CRIT CARE MED, V40, P73, DOI 10.1097/CCM.0b013e31822d7901; Cox CE, 2007, CRIT CARE, V11, DOI 10.1186/cc5667; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Curtis JR, 2016, AM J RESP CRIT CARE, V193, P154, DOI 10.1164/rccm.201505-0900OC; Curtis JR, 2013, JAMA-J AM MED ASSOC, V310, P2271, DOI 10.1001/jama.2013.282081; Curtis JR, 2004, EUR RESPIR J, V24, P200, DOI 10.1183/09031936.04.00010104; Dunlop DD, 2003, AM J PUBLIC HEALTH, V93, P1945, DOI 10.2105/AJPH.93.11.1945; Hough CL, 2015, CRIT CARE MED, V43, P2339, DOI 10.1097/CCM.0000000000001205; Hua MS, 2014, AM J RESP CRIT CARE, V189, P428, DOI 10.1164/rccm.201307-1229OC; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kelley AS, 2015, NEW ENGL J MED, V373, P747, DOI 10.1056/NEJMra1404684; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Lupu D, 2010, J PAIN SYMPTOM MANAG, V40, P899, DOI 10.1016/j.jpainsymman.2010.07.004; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Nelson JE, 2005, J CRIT CARE, V20, P79, DOI 10.1016/j.jcrc.2004.11.003; Nelson JE, 2007, ARCH INTERN MED, V167, P2509, DOI 10.1001/archinte.167.22.2509; Nelson JE, 2013, CRIT CARE MED, V41, P2318, DOI 10.1097/CCM.0b013e31828cf12c; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Rose S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000560; Sihra L, 2011, J PAIN SYMPTOM MANAG, V42, P672, DOI 10.1016/j.jpainsymman.2011.08.002; Sullivan AM, 2016, ANN AM THORAC SOC, V13, P512, DOI 10.1513/AnnalsATS.201508-495OC; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P752, DOI 10.1016/S0885-3924(01)00331-1; Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007; Wall RJ, 2007, CRIT CARE MED, V35, P271, DOI 10.1097/01.CCM.0000251122.15053.50; Weiss D.S., 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000; Weissman DE, 2011, J PALLIAT MED, V14, P17, DOI 10.1089/jpm.2010.0347; Zier LS, 2012, ANN INTERN MED, V156, P360, DOI 10.7326/0003-4819-156-5-201203060-00008; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	191	192	1	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					51	62		10.1001/jama.2016.8474	http://dx.doi.org/10.1001/jama.2016.8474			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ2MY	27380343	Bronze, Green Accepted			2022-12-28	WOS:000379037600018
J	Taurog, JD; Chhabra, A; Colbert, RA				Taurog, Joel D.; Chhabra, Avneesh; Colbert, Robert A.			Ankylosing Spondylitis and Axial Spondyloarthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SOCIETY CLASSIFICATION CRITERIA; INFLAMMATORY BACK-PAIN; JUVENILE SPONDYLOARTHRITIS; SACROILIAC JOINTS; AMERICAN-COLLEGE; RECOMMENDATIONS; DIAGNOSIS; CELLS; SUBTYPES; PART		[Taurog, Joel D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Rheumat Dis, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Chhabra, Avneesh] Univ Texas SW Med Ctr Dallas, Dept Radiol, Musculoskeletal Imaging Div, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Colbert, Robert A.] NIAMSD, Pediat Translat Res Branch, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Taurog, JD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Rheumat Dis, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joel.taurog@utsouthwestern.edu	Caruso, Pier Francesco/ABA-2455-2021	Caruso, Pier Francesco/0000-0002-0839-4396; Campochiaro, Corrado/0000-0001-6806-3794	UT Southwestern; AbbVie Pharmaceuticals; Siemens; General Electric-Association of University Radiologists; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041184] Funding Source: NIH RePORTER	UT Southwestern; AbbVie Pharmaceuticals(AbbVie); Siemens(Siemens AG); General Electric-Association of University Radiologists; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Taurog reports receiving laboratory funding and discretionary funding through a license agreement between UT Southwestern and AbbVie Pharmaceuticals, through which AbbVie has acquired access to HLA-B27 transgenic rats from Dr. Taurog's laboratory; Dr. Chhabra, receiving fees for the development of computer-aided detection technology from Siemens and grant support from the General Electric-Association of University Radiologists; and Dr. Colbert, being principal investigator in a cooperative research and development agreement between his institution and Eli Lilly. No other potential conflict of interest relevant to this article was reported.	Akgol G, 2014, RHEUMATOLOGY, V53, P497, DOI 10.1093/rheumatology/ket385; Appel H, 2010, J RHEUMATOL, V37, P823, DOI 10.3899/jrheum.090986; Araujo LM, 2014, ARTHRITIS RHEUMATOL, V66, P2412, DOI 10.1002/art.38737; Baeten D, 2015, NEW ENGL J MED, V373, P2534, DOI 10.1056/NEJMoa1505066; Beukelman T, 2011, ARTHRIT CARE RES, V63, P465, DOI 10.1002/acr.20460; Boulman N, 2012, CLIN EXP RHEUMATOL, V30, P453; Bowness P, 2015, ANNU REV IMMUNOL, V33, P29, DOI 10.1146/annurev-immunol-032414-112110; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Callhoff J, 2015, ANN RHEUM DIS, V74, P1241, DOI 10.1136/annrheumdis-2014-205322; Coffre M, 2013, ARTHRITIS RHEUM-US, V65, P1510, DOI 10.1002/art.37936; Colbert RA, 2010, NAT REV RHEUMATOL, V6, P477, DOI 10.1038/nrrheum.2010.103; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; Davey-Ranasinghe N, 2013, CURR OPIN RHEUMATOL, V25, P509, DOI 10.1097/BOR.0b013e3283620777; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Deodhar A, 2014, ARTHRITIS RHEUMATOL, V66, P2649, DOI 10.1002/art.38776; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; Feldtkeller E, 2013, RHEUMATOLOGY, V52, P1648, DOI 10.1093/rheumatology/ket176; Fernandez-Espartero C, 2014, ANN RHEUM DIS, V73, P1350, DOI 10.1136/annrheumdis-2012-202976; Fert I, 2008, ARTHRITIS RHEUM-US, V58, P3425, DOI 10.1002/art.24023; Fert I, 2014, ARTHRITIS RHEUMATOL, V66, P841, DOI 10.1002/art.38318; Galocha B, 2008, ARTHRITIS RHEUM-US, V58, P401, DOI 10.1002/art.23164; Gill T, 2015, CURR OPIN RHEUMATOL, V27, P319, DOI 10.1097/BOR.0000000000000187; Gladman DD, 2015, ARTHRITIS RHEUMATOL, V67, P865, DOI 10.1002/art.39014; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Jeanty C, 2014, ARTHRITIS RHEUMATOL, V66, P2113, DOI 10.1002/art.38644; Kennedy LG, 1998, SPONDYLARTHRITIDES, P239; Khan MA, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0362-y; Larbi A, 2014, SKELETAL RADIOL, V43, P351, DOI 10.1007/s00256-013-1789-y; Lin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105684; Loll B, 2016, ARTHRITIS RHEUMATOL, V68, P1172, DOI 10.1002/art.39567; Machado P, 2010, ANN RHEUM DIS, V69, P1465, DOI 10.1136/ard.2009.124206; Machado PM, 2015, ANN RHEUM DIS; McGonagle D, 2014, ANN RHEUM DIS, V73, P321, DOI 10.1136/annrheumdis-2013-203924; Mothes K., 1980, ENCY PLANT PHYSL, V8, P1; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pedersen SJ, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0531-2; Poddubnyy D, 2014, CURR OPIN RHEUMATOL, V26, P377, DOI 10.1097/BOR.0000000000000071; Poddubnyy D, 2012, CURR OPIN RHEUMATOL, V24, P363, DOI 10.1097/BOR.0b013e328352b7bd; Reveille JD, 2012, ARTHRIT CARE RES, V64, P905, DOI 10.1002/acr.21621; Reveille JD, 2012, NAT REV RHEUMATOL, V8, P296, DOI 10.1038/nrrheum.2012.41; Robinson PC, 2013, ANN RHEUM DIS, V72, P162, DOI 10.1136/annrheumdis-2012-202073; Rohekar S, 2015, J RHEUMATOL, V42, P665, DOI 10.3899/jrheum.141001; Rosenbaum JT, 2015, CLIN RHEUMATOL, V34, P999, DOI 10.1007/s10067-015-2960-8; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P1520, DOI 10.1136/ard.2009.110767; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Sieper J, 2009, ANN RHEUM DIS, V68, P784, DOI 10.1136/ard.2008.101501; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Sieper J, 2013, ARTHRITIS RHEUM-US, V65, P543, DOI 10.1002/art.37803; Smith JA, 2014, ARTHRITIS RHEUMATOL, V66, P231, DOI 10.1002/art.38291; Soker G, 2016, DIAGN INTERV IMAG, V97, P419, DOI 10.1016/j.diii.2015.10.003; Song IH, 2016, SEMIN ARTHRITIS RHEU, V45, P404, DOI 10.1016/j.semarthrit.2015.08.005; Stoll ML, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0486-0; Talpin A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0417-0; Tan S, 2015, CURR OPIN RHEUMATOL, V27, P326, DOI 10.1097/BOR.0000000000000179; Tran TM, 2015, CURR OPIN RHEUMATOL, V27, P357, DOI 10.1097/BOR.0000000000000188; Uddin M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10314; van den Berg R, 2013, ANN RHEUM DIS, V72, P1646, DOI 10.1136/annrheumdis-2012-201884; van der Linden S, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0535-y; van Hoeven L, 2014, ARTHRIT CARE RES, V66, P446, DOI 10.1002/acr.22180; Van Praet L, 2013, ANN RHEUM DIS, V72, P414, DOI 10.1136/annrheumdis-2012-202135; Vander Cruyssen B, 2013, CURR OPIN RHEUMATOL, V25, P448, DOI 10.1097/BOR.0b013e3283620e04; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Venken K, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0507-2; Vieira-Sousa E, 2015, ARTHRITIS RHEUMATOL, V67, P2813, DOI 10.1002/art.39282; Wallis D, 2013, J RHEUMATOL, V40, P2038, DOI 10.3899/jrheum.130588; Wang RS, 2016, ARTHRITIS RHEUMATOL, V68, P1415, DOI 10.1002/art.39542; Ward MM, 2016, ARTHRITIS RHEUMATOL, V68, P282, DOI 10.1002/art.39298; Weber U, 2015, ANN RHEUM DIS, V74, P1976, DOI 10.1136/annrheumdis-2014-205408; Weiss PF, 2016, ARTHRIT CARE RES, V68, P187, DOI 10.1002/acr.22665; Wendling D, 2013, J RHEUMATOL, V40, P1148, DOI 10.3899/jrheum.121460; Yeremenko N, 2014, CURR OPIN RHEUMATOL, V26, P361, DOI 10.1097/BOR.0000000000000069; Zhao YH, 2015, EUR RADIOL, V25, P2754, DOI 10.1007/s00330-015-3634-2	76	379	401	9	97	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2563	2574		10.1056/NEJMra1406182	http://dx.doi.org/10.1056/NEJMra1406182			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8DD	27355535				2022-12-28	WOS:000378727200008
J	Booth, DS; King, N				Booth, David S.; King, Nicole			EVOLUTION Gene regulation in transition	NATURE			English	Editorial Material							MULTICELLULARITY; ORIGINS	An in-depth analysis of a close relative of animals, Capsaspora owczarzaki, provides clues to the changes in gene regulation that occurred during the transition to multicellularity.	[Booth, David S.; King, Nicole] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Booth, David S.; King, Nicole] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Booth, DS (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Booth, DS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dbooth@berkeley.edu; nking@berkeley.edu		Booth, David/0000-0002-4724-4702				ERWIN DH, 1993, BIOL J LINN SOC, V50, P255, DOI 10.1006/bijl.1993.1058; Hurlin PJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014332; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levin TC, 2014, ELIFE, V3, DOI 10.7554/eLife.04070; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Lolas M, 2014, P NATL ACAD SCI USA, V111, P4478, DOI 10.1073/pnas.1402612111; Richter DJ, 2013, ANNU REV GENET, V47, P509, DOI 10.1146/annurev-genet-111212-133456; Sebe-Pedros A, 2016, CELL, V165, P1224, DOI 10.1016/j.cell.2016.03.034; Sebe-Pedros A, 2013, ELIFE, V2, DOI 10.7554/eLife.01287	10	2	2	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					482	483		10.1038/nature18447	http://dx.doi.org/10.1038/nature18447			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309804				2022-12-28	WOS:000378270300038
J							Drug & Therapeutics Bulletin	QT interval and drug therapy (Reprinted from Drug and Therapeutics Bulletin, vol 54, pg 33-36, 2016)	BMJ-BRITISH MEDICAL JOURNAL			English	Reprint							TORSADE-DE-POINTES; PROLONGATION; RISK		[Drug & Therapeutics Bulletin] Drug & Therapeut Bulletin, Editorial Off, London WC1H 9JR, England		Drug & Therapeut Bulletin, Editorial Off, London WC1H 9JR, England.							Astrom-Lilja C, 2008, PHARMACOEPIDEM DR S, V17, P587, DOI 10.1002/pds.1607; Drew BJ, 2010, J AM COLL CARDIOL, V55, P934, DOI [10.1016/j.jacc.2010.01.001, 10.1161/CIRCULATIONAHA.109.192704]; *DRUG THER BULL ED, 2016, DRUG THER BULL, V54, P33; European Medicines Agency, 2005, E14 ICH EUR MED AG; European Medicines Agency, 2005, S7B ICH EUR MED AG; Isbister GK, 2013, BRIT J CLIN PHARMACO, V76, P48, DOI 10.1111/bcp.12040; Joint Formulary Committee, 2015, BRIT NATL FORMULARY; Medicines and Healthcare products Regulatory Agency, 2011, DRUG SAF UPDATE, V5, pA1; Moss A, 1999, DRUG SAFETY, V21, P81, DOI 10.2165/00002018-199921001-00010; Moss AJ, 1999, DRUG SAFETY, V21, P5, DOI 10.2165/00002018-199921001-00002; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; Nachimuthu S, 2012, THER ADV DRUG SAF, V3, P241, DOI 10.1177/2042098612454283; Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Rodday AM, 2012, PEDIATRICS, V129, pE999, DOI 10.1542/peds.2011-0643; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Rubinstein E, 2002, J ANTIMICROB CHEMOTH, V49, P593, DOI 10.1093/jac/49.4.593; Schwartz PJ, 2013, EUR HEART J, V34, P3109, DOI 10.1093/eurheartj/eht089; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Shah AA, 2014, J PSYCHIATR PRACT, V20, P196, DOI 10.1097/01.pra.0000450319.21859.6d; Trinkley KE, 2013, CURR MED RES OPIN, V29, P1719, DOI 10.1185/03007995.2013.840568; Yang T, 2001, J CARDIOVASC PHARM, V38, P737, DOI 10.1097/00005344-200111000-00010; Zeltser D, 2003, MEDICINE, V82, P282, DOI 10.1097/00005792-200307000-00007	24	8	8	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i2732	10.1136/bmj.i2732	http://dx.doi.org/10.1136/bmj.i2732			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27334640				2022-12-28	WOS:000378723500001
J	Fekete, T				Fekete, Thomas			Oral fluoroquinolone treatment was not associated with serious arrhythmia Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AZITHROMYCIN		[Fekete, Thomas] Temple Univ, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fekete, T (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.		Fekete, Thomas/AFI-5367-2022					Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					JC67	JC67		10.7326/ACPJC-2016-164-12-067	http://dx.doi.org/10.7326/ACPJC-2016-164-12-067			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323263				2022-12-28	WOS:000379343000006
J	Garg, S; Sharp, PA				Garg, Salil; Sharp, Phillip A.			GENE EXPRESSION Single-cell variability guided by microRNAs	SCIENCE			English	Editorial Material							STEM-CELLS; PLURIPOTENCY		[Garg, Salil] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Garg, Salil; Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu	Garg, Salil/GXH-2201-2022	Garg, Salil/0000-0002-7198-1833	NATIONAL CANCER INSTITUTE [P01CA042063, R01CA133404] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA042063, R01 CA133404] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Schmiedel JM, 2015, SCIENCE, V348, P128, DOI 10.1126/science.aaa1738; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	6	13	14	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1390	1391		10.1126/science.aag1097	http://dx.doi.org/10.1126/science.aag1097			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313022				2022-12-28	WOS:000377975400019
J	Abramson, JS; Mason, E				Abramson, Jon S.; Mason, Elizabeth			Strengthening maternal immunisation to improve the health of mothers and infants	LANCET			English	Editorial Material									[Abramson, Jon S.] Wake Forest Sch Med, Dept Pediat, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Mason, Elizabeth] UCL, Inst Global Hlth, London, England	Wake Forest University; University of London; University College London	Abramson, JS (corresponding author), Wake Forest Sch Med, Dept Pediat, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jabrams@wakehealth.edu						[Anonymous], 2013, Wkly Epidemiol Rec, V88, P269; [Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P337; [Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P461; Gruber MF, 2014, CLIN INFECT DIS, V59, pS395, DOI 10.1093/cid/ciu707; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Madjarrad K., 2015, WHO PROD DEV VACC AD; Margarit I, WHO PROD DEV VACC AD; Ropero-Alvarez AM, 2016, HUM VACC IMMUNOTHER, V12, P2206, DOI 10.1080/21645515.2016.1157240; Sobjano-ter Meulen A, 2015, MATERNAL IMMUNIZATIO; UNAIDS, 2014, 2014 PROGR REP GLOB; United Nations Department of Economic and Social Affairs, 2015, SUST DEV KNOWL PLATF; WHO, PROD DEV VACC ADV CO PROD DEV VACC ADV CO; WHO (World Health Organization), 2015, STRAT END PREV MAT M; World Health Organization, 2015, PREGN CHILDB POSTP N; World Health Organization, 2016, MAT NEON TET MNT EL; World Health Organization, 2015, WHO REC ROUT IMM SUM; World Health Organization, 2014, EV NEWB ACT PLAN END	17	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2562	2564		10.1016/S0140-6736(16)30882-0	http://dx.doi.org/10.1016/S0140-6736(16)30882-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC5IA	27372397				2022-12-28	WOS:000388166300032
J	Bennett, J; Wellman, J; Marshall, KA; McCague, S; Ashtari, M; DiStefano-Pappas, J; Elci, OU; Chung, DC; Sun, JW; Wright, JF; Cross, DR; Aravand, P; Cyckowski, LL; Bennicelli, JL; Mingozzi, F; Auricchio, A; Pierce, EA; Ruggiero, J; Leroy, BP; Simonelli, F; High, KA; Maguire, AM				Bennett, Jean; Wellman, Jennifer; Marshall, Kathleen A.; McCague, Sarah; Ashtari, Manzar; DiStefano-Pappas, Julie; Elci, Okan U.; Chung, Daniel C.; Sun, Junwei; Wright, J. Fraser; Cross, Dominique R.; Aravand, Puya; Cyckowski, Laura L.; Bennicelli, Jeannette L.; Mingozzi, Federico; Auricchio, Alberto; Pierce, Eric A.; Ruggiero, Jason; Leroy, Bart P.; Simonelli, Francesca; High, Katherine A.; Maguire, Albert M.			Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial	LANCET			English	Article							LEBER CONGENITAL AMAUROSIS; ADENOASSOCIATED VIRUS; RETINAL DEGENERATION; CANINE MODEL; VISUAL CYCLE; VISION; IMPROVEMENT; ROD	Background Safety and efficacy have been shown in a phase 1 dose-escalation study involving a unilateral subretinal injection of a recombinant adeno-associated virus (AAV) vector containing the RPE65 gene (AAV2-hRPE65v2) in individuals with inherited retinal dystrophy caused by RPE65 mutations. This finding, along with the bilateral nature of the disease and intended use in treatment, prompted us to determine the safety of administration of AAV2-hRPE65v2 to the contralateral eye in patients enrolled in the phase 1 study. Methods In this follow-on phase 1 trial, one dose of AAV2-hRPE65v2 (1.5 x 10(11) vector genomes) in a total volume of 300 mu L was subretinally injected into the contralateral, previously uninjected, eyes of 11 children and adults (aged 11-46 years at second administration) with inherited retinal dystrophy caused by RPE65 mutations, 1.71-4.58 years after the initial subretinal injection. We assessed safety, immune response, retinal and visual function, functional vision, and activation of the visual cortex from baseline until 3 year follow-up, with observations ongoing. This study is registered with ClinicalTrials.gov, number NCT01208389. Findings No adverse events related to the AAV were reported, and those related to the procedure were mostly mild (dellen formation in three patients and cataracts in two). One patient developed bacterial endophthalmitis and was excluded from analyses. We noted improvements in efficacy outcomes in most patients without significant immunogenicity. Compared with baseline, pooled analysis of ten participants showed improvements in mean mobility and full-field light sensitivity in the injected eye by day 30 that persisted to year 3 (mobility p=0.0003, white light full-field sensitivity p<0.0001), but no significant change was seen in the previously injected eyes over the same time period (mobility p=0.7398, white light full-field sensitivity p=0.6709). Changes in visual acuity from baseline to year 3 were not significant in pooled analysis in the second eyes or the previously injected eyes (p>0.49 for all time-points compared with baseline). Interpretation To our knowledge, AAV2-hRPE65v2 is the first successful gene therapy administered to the contralateral eye. The results highlight the use of several outcome measures and help to delineate the variables that contribute to maximal benefit from gene augmentation therapy in this disease.	[Bennett, Jean; Ashtari, Manzar; Chung, Daniel C.; Sun, Junwei; Aravand, Puya; Bennicelli, Jeannette L.; Maguire, Albert M.] Univ Penn, Ctr Adv Retinal & Ocular Therapeut, Philadelphia, PA 19104 USA; [Bennett, Jean; Ashtari, Manzar; Chung, Daniel C.; Bennicelli, Jeannette L.; Pierce, Eric A.; Maguire, Albert M.] Univ Penn, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Pierce, Eric A.; Ruggiero, Jason; Maguire, Albert M.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Bennett, Jean; Wellman, Jennifer; Marshall, Kathleen A.; McCague, Sarah; Sun, Junwei; Wright, J. Fraser; Cross, Dominique R.; Mingozzi, Federico; Leroy, Bart P.; High, Katherine A.; Maguire, Albert M.] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Ashtari, Manzar; Cyckowski, Laura L.] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA; [DiStefano-Pappas, Julie; Elci, Okan U.] Childrens Hosp Philadelphia, Westat Biostat & Data Management Core, Philadelphia, PA 19104 USA; [Pierce, Eric A.; Leroy, Bart P.; Maguire, Albert M.] Childrens Hosp Philadelphia, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Wellman, Jennifer; Chung, Daniel C.; Wright, J. Fraser; High, Katherine A.] Spark Therapeut, Philadelphia, PA USA; [Mingozzi, Federico] Genethon, Immunol & Liver Gene Therapy, Evry, France; [Auricchio, Alberto] Telethon Inst Genet & Med, Naples, Italy; [Auricchio, Alberto] Univ Naples Federico II, Med Genet, Dept Pediat, Naples, Italy; [Pierce, Eric A.] Harvard Med Sch, Ocular Genom Inst, Massachusetts Eye & Ear Infirm, Boston, MA USA; [Leroy, Bart P.] Ghent Univ Hosp, Dept Ophthalmol, Ghent, Belgium; [Leroy, Bart P.] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Leroy, Bart P.] Univ Ghent, Ghent, Belgium; [Simonelli, Francesca] Univ Naples 2, Eye Clin, Multidisciplinary Dept Med Surg & Dent Sci, Naples, Italy; [High, Katherine A.] Howard Hughes Med Inst, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Universita della Campania Vanvitelli; Howard Hughes Medical Institute	Bennett, J (corresponding author), Univ Penn, Ctr Adv Retinal & Ocular Therapeut, Stellar Chance Labs 309c, 422 Curie Blvd, Philadelphia, PA 19104 USA.	jebennet@mail.med.upenn.edu	Simonelli, Francesca/AHE-7571-2022; High, Katherine A./AAB-9322-2020	Simonelli, Francesca/0000-0001-8520-6769; Pierce, Eric/0000-0002-2354-4102; High, Katherine/0000-0002-0805-6223	Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia; Spark Therapeutics; US National Institutes of Health; Foundation Fighting Blindness; Institute for Translational Medicine and Therapeutics; Research to Prevent Blindness; Center for Advanced Retinal and Ocular Therapeutics; Mackall Foundation Trust; F M Kirby Foundation; Research Foundation-Flanders; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY019861, R01EY025287, R21EY020662, DP1EY023177] Funding Source: NIH RePORTER	Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia; Spark Therapeutics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Institute for Translational Medicine and Therapeutics; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Center for Advanced Retinal and Ocular Therapeutics; Mackall Foundation Trust; F M Kirby Foundation; Research Foundation-Flanders(FWO); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia, Spark Therapeutics, US National Institutes of Health, Foundation Fighting Blindness, Institute for Translational Medicine and Therapeutics, Research to Prevent Blindness, Center for Advanced Retinal and Ocular Therapeutics, Mackall Foundation Trust, F M Kirby Foundation, and The Research Foundation-Flanders.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Amado D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000659; Ashtari M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8791; Ashtari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086068; Ashtari M, 2011, J CLIN INVEST, V121, P2160, DOI 10.1172/JCI57377; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Davson H., 1990, PHYSL EYE, P395; Dejneka NS, 2004, MOL THER, V9, P182, DOI 10.1016/j.ymthe.2003.11.013; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Holladay JT, 2004, J CATARACT REFR SURG, V30, P287, DOI 10.1016/j.jcrs.2004.01.014; Jacobson SG, 2015, NEW ENGL J MED, V372, P1920, DOI 10.1056/NEJMoa1412965; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P137, DOI 10.1007/s00417-008-0926-0; Maguire A, 2015, PHASE 3 TRIAL AAV2 H; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Russell S, 2015, PHASE 3 TRIAL AAV2 H; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Testa F, 2013, OPHTHALMOLOGY, V120, P1283, DOI 10.1016/j.ophtha.2012.11.048; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Vardas E, 2010, AIDS RES HUM RETROV, V26, P933, DOI 10.1089/aid.2009.0242	30	263	279	1	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					661	672		10.1016/S0140-6736(16)30371-3	http://dx.doi.org/10.1016/S0140-6736(16)30371-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UX	27375040	Green Accepted			2022-12-28	WOS:000381268700026
J	Wang, H; Avican, K; Fahlgren, A; Erttmann, SF; Nuss, AM; Dersch, P; Fallman, M; Edgren, T; Wolf-Watz, H				Wang, He; Avican, Kemal; Fahlgren, Anna; Erttmann, Saskia F.; Nuss, Aaron M.; Dersch, Petra; Fallman, Maria; Edgren, Tomas; Wolf-Watz, Hans			Increased plasmid copy number is essential for Yersinia T3SS function and virulence	SCIENCE			English	Article							OUTER-MEMBRANE PROTEINS; TARGET-CELL CONTACT; SALMONELLA-TYPHIMURIUM; PSEUDOTUBERCULOSIS; TRANSLOCATION; EXPRESSION; SECRETION; AMPLIFICATION; TEMPERATURE; RESISTANCE	Pathogenic bacteria have evolved numerous virulence mechanisms that are essential for establishing infections. The enterobacterium Yersinia uses a type III secretion system (T3SS) encoded by a 70-kilobase, low-copy, IncFII-class virulence plasmid. We report a novel virulence strategy in Y. pseudotuberculosis in which this pathogen up-regulates the plasmid copy number during infection. We found that an increased dose of plasmid-encoded genes is indispensable for virulence and substantially elevates the expression and function of the T3SS. Remarkably, we observed direct, tight coupling between plasmid replication and T3SS function. This regulatory pathway provides a framework for further exploration of the environmental sensing mechanisms of pathogenic bacteria.	[Wang, He; Avican, Kemal; Fahlgren, Anna; Erttmann, Saskia F.; Fallman, Maria; Edgren, Tomas; Wolf-Watz, Hans] Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, SE-90187 Umea, Sweden; [Wang, He; Avican, Kemal; Erttmann, Saskia F.; Fallman, Maria; Wolf-Watz, Hans] Umea Univ, Lab Mol Infect Med Sweden MIMS, Dept Mol Biol, SE-90187 Umea, Sweden; [Nuss, Aaron M.; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Germany	Umea University; Umea University; Helmholtz Association; Helmholtz-Center for Infection Research	Edgren, T; Wolf-Watz, H (corresponding author), Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, SE-90187 Umea, Sweden.; Wolf-Watz, H (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, Dept Mol Biol, SE-90187 Umea, Sweden.	tomas.edgren@umu.se; hans.wolf-watz@umu.se		Erttmann, Saskia Friederike/0000-0003-2398-8405; Avican, Kemal/0000-0003-0707-2050	Stiftelsen JC Kempes Minnes Stipendiefond; EMBO grant [ALTF 1629-2011]; Swedish Research Council [2015-02874, 2011-4937, K2014-56X-11222-20-5]; Carl Tryggers Stiftelse for Naturvetenskaplig Forskning; German Center for Infection Research	Stiftelsen JC Kempes Minnes Stipendiefond; EMBO grant(European Molecular Biology Organization (EMBO)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse for Naturvetenskaplig Forskning; German Center for Infection Research	Sequence data used in this study have been deposited in the European Nucleotide Archive with accession number PRJEB13406. Supported by Stiftelsen JC Kempes Minnes Stipendiefond (H.W.-W.), EMBO grant ALTF 1629-2011 (H.W.), the Swedish Research Council (grant 2015-02874, H.W.-W.; grant 2011-4937, T.E.; grant K2014-56X-11222-20-5, M.F.), Carl Tryggers Stiftelse for Naturvetenskaplig Forskning (T.E.), and the German Center for Infection Research (P.D.). This work traces back to Kurt Nordstrom (mentor to H.W.-W.), to whom this paper is dedicated.	Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Amer AAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077767; BERGMAN T, 1994, J BACTERIOL, V176, P2619, DOI 10.1128/JB.176.9.2619-2626.1994; BOLIN I, 1985, INFECT IMMUN, V48, P234; BRUBAKER RR, 1983, REV INFECT DIS, V5, pS748; CORNELIS GR, 1989, MOL MICROBIOL, V3, P1455, DOI 10.1111/j.1365-2958.1989.tb00129.x; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Fahlgren A, 2014, INFECT IMMUN, V82, P3471, DOI 10.1128/IAI.01793-14; FORSBERG A, 1988, MOL MICROBIOL, V2, P121, DOI 10.1111/j.1365-2958.1988.tb00013.x; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; MEYER J, 1979, MOL GEN GENET, V176, P209, DOI 10.1007/BF00273215; MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; Nuss AM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005087; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; PORTNOY DA, 1984, INFECT IMMUN, V43, P108, DOI 10.1128/IAI.43.1.108-114.1984; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; STRALEY SC, 1993, MOL MICROBIOL, V8, P1005, DOI 10.1111/j.1365-2958.1993.tb01644.x; Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998	23	37	40	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					492	495		10.1126/science.aaf7501	http://dx.doi.org/10.1126/science.aaf7501			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27365311	Green Submitted			2022-12-28	WOS:000380583600042
J	Chen, YNP; LaMarche, MJ; Chan, HM; Fekkes, P; Garcia-Fortanet, J; Acker, MG; Antonakos, B; Chen, CHT; Chen, ZL; Cooke, VG; Dobson, JR; Deng, Z; Fei, F; Firestone, B; Fodor, M; Fridrich, C; Gao, H; Grunenfelder, D; Hao, HX; Jacob, J; Ho, S; Hsiao, K; Kang, ZB; Karki, R; Kato, M; Larrow, J; La Bonte, LR; Lenoir, F; Liu, G; Liu, SM; Majumdar, D; Meyer, MJ; Palermo, M; Perez, L; Pu, MY; Price, E; Quinn, C; Shakya, S; Shultz, MD; Slisz, J; Venkatesan, K; Wang, P; Warmuth, M; Williams, S; Yang, GZ; Yuan, J; Zhang, JH; Zhu, P; Ramsey, T; Keen, NJ; Sellers, WR; Stams, T; Fortin, PD				Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.			Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases	NATURE			English	Article							PTPN11; PROTOONCOGENE; TARGET; POTENT	The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase(1). Activating mutations of SHP2 have been associated with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukaemia, lung and breast cancer and neuroblastoma(1-5). SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway(2,3). It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways(6,7). Reduction of SHP2 activity suppresses tumour cell growth and is a potential target of cancer therapy(8,9). Here we report the discovery of a highly potent (IC50 = 0.071 mu M), selective and orally bioavailable small-molecule SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation. SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism. SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumour xenograft models. Together, these data demonstrate that pharmacological inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.	[Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.] Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA	Novartis	Sellers, WR; Stams, T; Fortin, PD (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	william.sellers@novartis.com; travis.stams@novartis.com; pafortin@gmail.com	Shakya, Subarna/AAD-1059-2019; Stams, Travis/R-5730-2019	Price, Edmund/0000-0001-6495-4725; Grunenfelder, Denise/0000-0002-0334-2167; Acker, Michael/0000-0002-3565-9601; Fortin, Pascal/0000-0001-9796-791X; Dobson, Jason/0000-0002-2306-2250; Kato, Mitsunori/0000-0002-8426-2504	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number DE-AC02-06CH11357.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Bricogne G, 2009, BUSTER VERSION 2 8 0; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Clare JJ, 2000, DRUG DISCOV TODAY, V5, P506, DOI 10.1016/S1359-6446(00)01570-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/nchembio.1427, 10.1038/NCHEMBIO.1427]; Grosskopf S, 2015, CHEMMEDCHEM, V10, P815, DOI 10.1002/cmdc.201500015; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; He RJ, 2015, ACS MED CHEM LETT, V6, P782, DOI 10.1021/acsmedchemlett.5b00118; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Schneeberger VE, 2015, ONCOTARGET, V6, P6191, DOI 10.18632/oncotarget.3356; Scott LM, 2011, BIOORG MED CHEM LETT, V21, P730, DOI 10.1016/j.bmcl.2010.11.117; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Szczepankiewicz BG, 2003, J AM CHEM SOC, V125, P4087, DOI 10.1021/ja0296733; Weisberg E, 2015, MOL CANCER THER, V14, P2249, DOI 10.1158/1535-7163.MCT-15-0429; Zeng LF, 2014, J MED CHEM, V57, P6594, DOI 10.1021/jm5006176; Zhao HY, 2004, BIOORG MED CHEM LETT, V14, P5543, DOI 10.1016/j.bmcl.2004.08.063	29	452	470	13	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					148	+		10.1038/nature18621	http://dx.doi.org/10.1038/nature18621			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362227				2022-12-28	WOS:000379015600042
J	Neves, J; Zhu, J; Sousa-Victor, P; Konjikusic, M; Riley, R; Chew, S; Qi, YY; Jasper, H; Lamba, DA				Neves, Joana; Zhu, Jie; Sousa-Victor, Pedro; Konjikusic, Mia; Riley, Rebeccah; Chew, Shereen; Qi, Yanyan; Jasper, Heinrich; Lamba, Deepak A.			Immune modulation by MANF promotes tissue repair and regenerative success in the retina	SCIENCE			English	Article							NEUROTROPHIC FACTOR; MICROGLIAL ACTIVATION; BLOOD-CELLS; DROSOPHILA; DEGENERATION; MACROPHAGES; MOUSE; SURVIVAL; DNA; DIFFERENTIATION	Regenerative therapies are limited by unfavorable environments in aging and diseased tissues. A promising strategy to improve success is to balance inflammatory and anti-inflammatory signals and enhance endogenous tissue repair mechanisms. Here, we identified a conserved immune modulatory mechanism that governs the interaction between damaged retinal cells and immune cells to promote tissue repair. In damaged retina of flies and mice, platelet-derived growth factor (PDGF)-like signaling induced mesencephalic astrocyte-derived neurotrophic factor (MANF) in innate immune cells. MANF promoted alternative activation of innate immune cells, enhanced neuroprotection and tissue repair, and improved the success of photoreceptor replacement therapies. Thus, immune modulation is required during tissue repair and regeneration. This approach may improve the efficacy of stem-cell-based regenerative therapies.	[Neves, Joana; Zhu, Jie; Sousa-Victor, Pedro; Konjikusic, Mia; Riley, Rebeccah; Chew, Shereen; Qi, Yanyan; Jasper, Heinrich; Lamba, Deepak A.] Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA	Buck Institute for Research on Aging	Jasper, H; Lamba, DA (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	hjasper@buckinstitute.org; dlamba@buckinstitute.org	Sousa-Victor, Pedro/AER-5744-2022	Mendes Neves, Joana/0000-0002-1027-3489; Chew, Shereen/0000-0002-7285-6604	NIH [EY018177, EY025779]; Amarantus Biosciences Inc.; Foundation for Retinal Research; Glenn Foundation for Medical Research; NATIONAL EYE INSTITUTE [R01EY018177, R01EY025779] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amarantus Biosciences Inc.; Foundation for Retinal Research; Glenn Foundation for Medical Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We acknowledge Amarantus Biosciences Inc. for kindly supplying the hrMANF protein used in these studies. Work in H.J.'s laboratory is supported by NIH grant EY018177, and some of the fly work was supported by Amarantus Biosciences Inc. Work in D.A.L.'s laboratory is supported by NIH grant EY025779 and the Foundation for Retinal Research. J.N. is supported by the Glenn Foundation for Medical Research. The full RNA-seq data set is provided as supplementary materials. J.N., H.J., and D.A.L. are the inventors and the Buck Institute for Research on Aging is the applicant for an international patent application for the use of MANF as an enhancer of cell replacement therapies.	Abrams EW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077618; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Babcock DT, 2008, P NATL ACAD SCI USA, V105, P10017, DOI 10.1073/pnas.0709951105; Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110; Belacortu Y, 2011, DEV DYNAM, V240, P2379, DOI 10.1002/dvdy.22753; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Cao XG, 2011, PATHOL INT, V61, P528, DOI 10.1111/j.1440-1827.2011.02695.x; Chen LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08133; Chen M, 2013, INVEST OPHTH VIS SCI, V54, P682, DOI 10.1167/iovs.12-10888; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; DOHERTY TM, 1993, J IMMUNOL, V151, P7151; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; DZIENNIS S, 1995, BLOOD, V85, P319; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Gust J, 2011, INVEST OPHTH VIS SCI, V52, P5266, DOI 10.1167/iovs.10-6329; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Jassim OW, 2003, EMBO J, V22, P5622, DOI 10.1093/emboj/cdg543; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Karpac J, 2011, DEV CELL, V20, P841, DOI 10.1016/j.devcel.2011.05.011; KEELER C, 1966, J HERED, V57, P47, DOI 10.1093/oxfordjournals.jhered.a107462; Kelsey EM, 2012, J CELL SCI, V125, P1393, DOI 10.1242/jcs.095323; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Luo X, 2007, EMBO J, V26, P380, DOI 10.1038/sj.emboj.7601484; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Nadella R, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0209-0; Neves J, 2015, DEV CELL, V32, P9, DOI 10.1016/j.devcel.2014.11.028; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Pearson RA, 2014, VISUAL NEUROSCI, V31, P333, DOI 10.1017/S0952523814000200; Peng B, 2014, J NEUROSCI, V34, P8139, DOI 10.1523/JNEUROSCI.5200-13.2014; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; PITTLER SJ, 1993, P NATL ACAD SCI USA, V90, P9616, DOI 10.1073/pnas.90.20.9616; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Razzell W, 2011, DIS MODEL MECH, V4, P569, DOI 10.1242/dmm.006825; Reynolds J, 2014, EXP EYE RES, V123, P151, DOI 10.1016/j.exer.2013.07.010; Samson ML, 2000, J BIOL CHEM, V275, P31107, DOI 10.1074/jbc.M001346200; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Sinenko SA, 2004, ONCOGENE, V23, P9120, DOI 10.1038/sj.onc.1208156; Song ZW, 2000, MOL CELL BIOL, V20, P2907, DOI 10.1128/MCB.20.8.2907-2914.2000; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; Stratoulias V, 2015, CELL MOL LIFE SCI, V72, P1989, DOI 10.1007/s00018-014-1789-7; Tang ZS, 2010, J EXP MED, V207, P867, DOI 10.1084/jem.20091704; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Wang LH, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00113; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; West EL, 2010, STEM CELLS, V28, P1997, DOI 10.1002/stem.520; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384; Yang S, 2014, NEURON, V81, P349, DOI 10.1016/j.neuron.2013.12.002; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhang C, 2005, MOL VIS, V11, P887; Zhao H, 2016, MOL NEUROBIOL, V53, P187, DOI 10.1007/s12035-014-9000-6	78	140	146	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294							aaf3646	10.1126/science.aaf3646	http://dx.doi.org/10.1126/science.aaf3646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365452	Green Accepted			2022-12-28	WOS:000378816200029
J	Boutron, I; Dechartres, A; Baron, G; Li, J; Ravaud, P				Boutron, Isabelle; Dechartres, Agnes; Baron, Gabriel; Li, Jacques; Ravaud, Philippe			Sharing of Data From Industry-Funded Registered Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Boutron, Isabelle; Dechartres, Agnes; Baron, Gabriel; Ravaud, Philippe] Paris Descartes Univ, INSERM, UMR 1153, Paris, France; [Li, Jacques] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, Aile A2 1er Etage,1,Pl Parvis Notre Dame, F-75181 Paris 4, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Boutron, I (corresponding author), Hop Hotel Dieu, Ctr Epidemiol Clin, Aile A2 1er Etage,1,Pl Parvis Notre Dame, F-75181 Paris 4, France.	isabelle.boutron@htd.aphp.fr	ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241				Bauchner H, 2016, JAMA-J AM MED ASSOC, V315, P1237, DOI 10.1001/jama.2016.2420; Ebrahim S, 2014, JAMA-J AM MED ASSOC, V312, P1024, DOI 10.1001/jama.2014.9646; Mayo-Wilson E, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4169; Navar AM, 2016, JAMA-J AM MED ASSOC, V315, P1283, DOI 10.1001/jama.2016.2374; Ross JS, 2013, JAMA-J AM MED ASSOC, V309, P1355, DOI 10.1001/jama.2013.1299; Taichman DB, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001950	6	13	14	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2729	2730		10.1001/jama.2016.6310	http://dx.doi.org/10.1001/jama.2016.6310			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27367768	Bronze			2022-12-28	WOS:000378709300025
J	Clement, A; Cane, MA; Murphy, LN; Bellomo, K; Mauritsen, T; Stevens, B				Clement, Amy; Cane, Mark A.; Murphy, Lisa N.; Bellomo, Katinka; Mauritsen, Thorsten; Stevens, Bjorn			Response to Comment on "The Atlantic Multidecadal Oscillation without a role for ocean circulation"	SCIENCE			English	Editorial Material								Zhang et al. interpret the mixed- layer energy budget in models as showing that "ocean dynamics play a central role in the AMO." Here, we show that their diagnostics cannot reveal the causes of the Atlantic Multidecadal Oscillation (AMO) and that their results can be explained with minimal ocean influence. Hence, we reaffirm our findings that the AMO in models can be understood primarily as the upper-ocean thermal response to stochastic atmospheric forcing.	[Clement, Amy; Murphy, Lisa N.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Cane, Mark A.; Bellomo, Katinka] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Mauritsen, Thorsten; Stevens, Bjorn] Max Planck Inst Meteorol, Bundesstr 55, D-20146 Hamburg, Germany	University of Miami; Columbia University; Max Planck Society	Clement, A (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	aclement@rsmas.miami.edu	Kushnir, Yochanan/B-4472-2013; Mauritsen, Thorsten/G-5880-2013; Murphy, Lisa/B-8547-2013; Stevens, Bjorn/A-1757-2013	Mauritsen, Thorsten/0000-0003-1418-4077; Murphy, Lisa/0000-0003-4343-8005; Stevens, Bjorn/0000-0003-3795-0475				Buckley MW, 2016, REV GEOPHYS, V54, P5, DOI 10.1002/2015RG000493; Clement A, 2015, SCIENCE, V350, P320, DOI 10.1126/science.aab3980; Park S, 2005, J CLIMATE, V18, P4582, DOI 10.1175/JCLI3521.1; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Zhang R, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1660	5	34	35	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293								10.1126/science.aaf2575	http://dx.doi.org/10.1126/science.aaf2575			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339977				2022-12-28	WOS:000378346500031
J	Burns, J				Burns, Janis			What will junior doctors earn under their new contract?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Burns, Janis] Northwest London Deanery, London, England		Burns, J (corresponding author), Northwest London Deanery, London, England.	Janis.burns@cantab.net							0	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2016	353								i3453	10.1136/bmj.i3453	http://dx.doi.org/10.1136/bmj.i3453			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BX	27339697				2022-12-28	WOS:000378724000003
J	Martinez, EA; Muschik, CA; Schindler, P; Nigg, D; Erhard, A; Heyl, M; Hauke, P; Dalmonte, M; Monz, T; Zoller, P; Blatt, R				Martinez, Esteban A.; Muschik, Christine A.; Schindler, Philipp; Nigg, Daniel; Erhard, Alexander; Heyl, Markus; Hauke, Philipp; Dalmonte, Marcello; Monz, Thomas; Zoller, Peter; Blatt, Rainer			Real-time dynamics of lattice gauge theories with a few-qubit quantum computer	NATURE			English	Article							SIMULATION; INVARIANCE	Gauge theories are fundamental to our understanding of interactions between the elementary constituents of matter as mediated by gauge bosons(1,2). However, computing the real-time dynamics in gauge theories is a notorious challenge for classical computational methods. This has recently stimulated theoretical effort, using Feynman's idea of a quantum simulator(3,4), to devise schemes for simulating such theories on engineered quantum-mechanical devices, with the difficulty that gauge invariance and the associated local conservation laws (Gauss laws) need to be implemented(5-7). Here we report the experimental demonstration of a digital quantum simulation of a lattice gauge theory, by realizing (1 + 1)-dimensional quantum electrodynamics (the Schwinger model(8,9)) on a few-qubit trapped-ion quantum computer. We are interested in the real-time evolution of the Schwinger mechanism(10,11), describing the instability of the bare vacuum due to quantum fluctuations, which manifests itself in the spontaneous creation of electron-positron pairs. To make efficient use of our quantum resources, we map the original problem to a spin model by eliminating the gauge fields(12) in favour of exotic long-range interactions, which can be directly and efficiently implemented on an ion trap architecture(13). We explore the Schwinger mechanism of particle-antiparticle generation by monitoring the mass production and the vacuum persistence amplitude. Moreover, we track the real-time evolution of entanglement in the system, which illustrates how particle creation and entanglement generation are directly related. Our work represents a first step towards quantum simulation of high-energy theories using atomic physics experiments-the long-term intention is to extend this approach to real-time quantum simulations of non-Abelian lattice gauge theories.	[Martinez, Esteban A.; Schindler, Philipp; Nigg, Daniel; Erhard, Alexander; Monz, Thomas; Blatt, Rainer] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Muschik, Christine A.; Heyl, Markus; Hauke, Philipp; Dalmonte, Marcello; Zoller, Peter; Blatt, Rainer] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-6020 Innsbruck, Austria; [Muschik, Christine A.; Hauke, Philipp; Dalmonte, Marcello; Zoller, Peter] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Heyl, Markus] Tech Univ Munich, Dept Phys, D-85747 Garching, Germany	University of Innsbruck; Austrian Academy of Sciences; University of Innsbruck; Technical University of Munich	Martinez, EA (corresponding author), Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria.; Muschik, CA (corresponding author), Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-6020 Innsbruck, Austria.; Muschik, CA (corresponding author), Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria.	esteban.martinez@uibk.ac.at; christine.muschik@oeaw.ac.at	Muschik, Christine A/D-1477-2013; Schindler, Philipp/AAB-4803-2019; Blatt, Rainer/H-9527-2014; Hauke, Philipp/H-5304-2015; Schindler, Philipp/E-1485-2017; Monz, Thomas/E-1285-2017; Zoller, Peter/O-1639-2014	Muschik, Christine A/0000-0002-4599-5107; Schindler, Philipp/0000-0002-9461-9650; Hauke, Philipp/0000-0002-0414-1754; Schindler, Philipp/0000-0002-9461-9650; Zoller, Peter/0000-0003-4014-1505; dalmonte, marcello/0000-0001-5338-4181; Martinez, Esteban/0000-0002-0803-4024; Heyl, Markus/0000-0002-7126-1836; Monz, Thomas/0000-0001-7410-4804	Austrian Science Fund (FWF) through the SFB FoQuS (FWF) [F4002-N16, F4016-N23]; European Commission; ERC synergy grant UQUAM; Deutsche Akademie der Naturforscher Leopoldina [LPDS 2013-07, LPDR 2015-01]; Institut fur Quantenoptik und Quanteninformation GmbH; Austrian Academy of Sciences; Austrian Science Foundation (FWF) Erwin Schrodinger Stipendium [3600-N27]; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) through the Army Research Office [W911NF-10-1-0284]; Austrian Science Fund (FWF) [J 3600] Funding Source: researchfish	Austrian Science Fund (FWF) through the SFB FoQuS (FWF)(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); ERC synergy grant UQUAM; Deutsche Akademie der Naturforscher Leopoldina; Institut fur Quantenoptik und Quanteninformation GmbH; Austrian Academy of Sciences; Austrian Science Foundation (FWF) Erwin Schrodinger Stipendium(Austrian Science Fund (FWF)); Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) through the Army Research Office; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We acknowledge discussions with C. Hempel, E. R. Ortega and U. J. Wiese. Financial support was provided by the Austrian Science Fund (FWF), through the SFB FoQuS (FWF project nos F4002-N16 and F4016-N23), by the European Commission via the integrated project SIQS and the ERC synergy grant UQUAM, by the Deutsche Akademie der Naturforscher Leopoldina (grant nos LPDS 2013-07 and LPDR 2015-01), as well as the Institut fur Quantenoptik und Quanteninformation GmbH. E.A.M. is a recipient of a DOC fellowship from the Austrian Academy of Sciences. P.S. was supported by the Austrian Science Foundation (FWF) Erwin Schrodinger Stipendium 3600-N27. This research was funded by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office grant W911NF-10-1-0284. All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI, or the US Government.	BANKS T, 1976, PHYS REV D, V13, P1043, DOI 10.1103/PhysRevD.13.1043; Banuls MC, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2013)158; Banuls MC, 2013, P SCI LATTICE, P332; Barends R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8654; Calzetta EA, 2008, CAM M MATH, P1, DOI 10.1017/CBO9780511535123; Casanova J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.260501; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Gattringer C, 2010, LECT NOTES PHYS, V788, P1, DOI 10.1007/978-3-642-01850-3; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Gorin T, 2006, PHYS REP, V435, P33, DOI 10.1016/j.physrep.2006.09.003; Grass T, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.063612; Hamer CJ, 1997, PHYS REV D, V56, P55, DOI 10.1103/PhysRevD.56.55; Hauke P, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041018; Hebenstreit F, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.201601; Heyl M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135704; Kasper V., 2015, SCHWINGER PAIR PRODU; KOGUT J, 1975, PHYS REV D, V11, P395, DOI 10.1103/PhysRevD.11.395; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Lanyon BP, 2011, SCIENCE, V334, P57, DOI 10.1126/science.1208001; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Monroe C, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.022317; Narozhny NB, 2014, EUR PHYS J-SPEC TOP, V223, P1083, DOI 10.1140/epjst/e2014-02159-1; Plenio MB, 2007, QUANTUM INF COMPUT, V7, P1; Salathe Y, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021027; Schindler P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/123012; SCHWINGER J, 1951, PHYS REV, V82, P664, DOI 10.1103/PhysRev.82.664; SCHWINGER J, 1962, PHYS REV, V128, P2425, DOI 10.1103/PhysRev.128.2425; Tagliacozzo L, 2013, ANN PHYS-NEW YORK, V330, P160, DOI 10.1016/j.aop.2012.11.009	36	381	381	5	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					516	+		10.1038/nature18318	http://dx.doi.org/10.1038/nature18318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27337339	Green Submitted			2022-12-28	WOS:000378270300046
J	Gladwin, MT				Gladwin, Mark T.			Cardiovascular complications and risk of death in sickle-cell disease	LANCET			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; NATRIURETIC PEPTIDE LEVELS; ACUTE CHEST SYNDROME; PULMONARY-HYPERTENSION; MYOCARDIAL-INFARCTION; CLINICAL-MANIFESTATIONS; SYSTOLIC PRESSURE; FREE HEMOGLOBIN; HEMOLYSIS; ANEMIA	In sickle-cell disease, a point mutation in the beta-globin chain causes haemoglobin to polymerise within erythrocytes during deoxygenation, altering red blood cell rheology and causing haemolysis. Improvements in health infrastructure, preventive care, and clinical treatments have reduced the morbidity and mortality of sickle-cell disease in developed countries. However, as these patients live longer, the chronic effects of sustained haemolytic anaemia and episodic vaso-occlusive events drive the development of end-organ complications. Cardiopulmonary organ dysfunction and chronic kidney injury have a large effect on morbidity and premature mortality, and typically accelerate in the second decade of life. These processes culminate in the development of pulmonary hypertension, left ventricular diastolic heart disease, dysrhythmia, and sudden death. In this Series paper, we review the mechanisms, clinical features, and epidemiology of major cardiovascular complications in patients with sickle-cell disease and discuss how screening and intervention could reduce their incidence.	[Gladwin, Mark T.] Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Gladwin, Mark T.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gladwin, MT (corresponding author), Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA 15260 USA.	gladwinmt@upmc.edu			National Institutes of Health [2R01HL098032, 1R01HL125886-01, P01HL103455, T32 HL110849, T32 HL007563]; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103455, R01HL125886, T32HL110849, T32HL007563, R01HL098032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	I receive research support from the National Institutes of Health (grants 2R01HL098032, 1R01HL125886-01, and P01HL103455, T32 HL110849, and T32 HL007563), the Institute for Transfusion Medicine, and the Hemophilia Center of Western Pennsylvania.	Acar P, 2003, ARCH MAL COEUR VAISS, V96, P507; Akgul F, 2007, ACTA HAEMATOL-BASEL, V118, P1, DOI 10.1159/000100929; Aliyu ZY, 2008, AM J HEMATOL, V83, P485, DOI 10.1002/ajh.21162; Aliyu ZY, 2010, BRIT J HAEMATOL, V150, P102, DOI 10.1111/j.1365-2141.2010.08195.x; Almeida CB, 2015, BLOOD, V126, P711, DOI 10.1182/blood-2014-12-616250; Anthi A, 2007, AM J RESP CRIT CARE, V175, P1272, DOI 10.1164/rccm.200610-1498OC; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Ataga KI, 2009, HAEMATOL-HEMATOL J, V94, P1481, DOI 10.3324/haematol.2009.013672; Bartolucci P, 2012, BLOOD, V120, P3136, DOI 10.1182/blood-2012-04-424184; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Berra L, 2014, AM J RESP CRIT CARE, V190, P800, DOI 10.1164/rccm.201405-0850OC; Bode-Thomas F, 2011, ANN TROP PAEDIATR, V31, P67, DOI 10.1179/1465328110Y.0000000006; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Caldas MC, 2008, J AM SOC ECHOCARDIOG, V21, P1163, DOI 10.1016/j.echo.2007.06.001; Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420; Castro O, 2003, BLOOD, V101, P1257, DOI 10.1182/blood-2002-03-0948; Caughey MC, 2015, BRIT J HAEMATOL, V170, P416, DOI 10.1111/bjh.13447; Connes P, 2014, BRIT J HAEMATOL, V165, P564, DOI 10.1111/bjh.12786; Dang NC, 2005, AM J HEMATOL, V80, P133, DOI 10.1002/ajh.20385; Day TG, 2012, HAEMATOL-HEMATOL J, V97, P201, DOI 10.3324/haematol.2011.050336; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; de Montalembert M, 2004, ARCH DIS CHILD, V89, P359, DOI 10.1136/adc.2003.027326; DeBaun MR, 2012, BLOOD, V119, P4587, DOI 10.1182/blood-2011-02-272682; Dessap AM, 2008, AM J RESP CRIT CARE, V177, P646, DOI 10.1164/rccm.200710-1606OC; Detterich JA, 2015, BLOOD, V126, P703, DOI 10.1182/blood-2014-12-614370; Deymann AJ, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.2.e183; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Dosunmu Adedoyin O, 2014, Niger Med J, V55, P161, DOI 10.4103/0300-1652.129661; Fitzhugh CD, 2010, AM J HEMATOL, V85, P36, DOI 10.1002/ajh.21569; Fonseca GHH, 2012, EUR RESPIR J, V39, P112, DOI 10.1183/09031936.00134410; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Ghosh S, 2013, J CLIN INVEST, V123, P4809, DOI 10.1172/JCI64578; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Gladwin MT, 2015, BLOOD, V126, P695, DOI 10.1182/blood-2015-06-649491; Gladwin MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099489; Gladwin MT, 2014, BLOOD, V123, P3689, DOI 10.1182/blood-2014-03-563874; Gladwin MT, 2012, J AM COLL CARDIOL, V59, P1123, DOI 10.1016/j.jacc.2011.10.900; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; GRAY A, 1991, J CLIN PATHOL, V44, P459, DOI 10.1136/jcp.44.6.459; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Hankins JS, 2010, PEDIATR BLOOD CANCER, V55, P495, DOI 10.1002/pbc.22587; Haque AK, 2002, HUM PATHOL, V33, P1037, DOI 10.1053/hupa.2002.128059; Helms CC, 2013, J THROMB HAEMOST, V11, P2148, DOI 10.1111/jth.12422; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Hoffman JIE, 2011, NEW ENGL J MED, V365, P1647, DOI 10.1056/NEJMc1109130; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Johnson MC, 2010, BLOOD, V116, P16, DOI 10.1182/blood-2009-06-227447; Johnson WH, 1999, PEDIATR CARDIOL, V20, P221, DOI 10.1007/s002469900447; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kato GJ, 2008, JAMA-J AM MED ASSOC, V300, P2638, DOI 10.1001/jama.2008.598; Kaul DK, 2000, AM J PHYSIOL-HEART C, V278, pH1799, DOI 10.1152/ajpheart.2000.278.6.H1799; Khalique Z, 2010, AM J HEMATOL, V85, P91, DOI 10.1002/ajh.21546; Klings ES, 2014, AM J RESP CRIT CARE, V189, P727, DOI 10.1164/rccm.201401-0065ST; Lai YC, 2014, CIRC RES, V115, P115, DOI 10.1161/CIRCRESAHA.115.301146; Lorch D, 2011, ACTA HAEMATOL-BASEL, V125, P225, DOI 10.1159/000323464; Machado RF, 2006, JAMA-J AM MED ASSOC, V296, P310, DOI 10.1001/jama.296.3.310; Machado RF, 2011, BLOOD, V118, P855, DOI 10.1182/blood-2010-09-306167; Machado RF, 2011, BRIT J HAEMATOL, V154, P512, DOI 10.1111/j.1365-2141.2011.08777.x; MAISEL A, 1983, CLIN CARDIOL, V6, P339, DOI 10.1002/clc.4960060707; Manci EA, 2003, BRIT J HAEMATOL, V123, P359, DOI 10.1046/j.1365-2141.2003.04594.x; Marouf R, 2014, MED PRIN PRACT, V23, P212, DOI 10.1159/000362126; Mehari A, 2013, AM J RESP CRIT CARE, V187, P840, DOI 10.1164/rccm.201207-1222OC; Mehari A, 2012, JAMA-J AM MED ASSOC, V307, P1254, DOI 10.1001/jama.2012.358; Milton JN, 2013, BRIT J HAEMATOL, V161, P270, DOI 10.1111/bjh.12245; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Naik RP, 2014, J THROMB HAEMOST, V12, P2010, DOI 10.1111/jth.12744; NORRIS S, 1991, J NATL MED ASSOC, V83, P209; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Novelli EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114309; Ohene-Frempong K, 1998, BLOOD, V91, P288; Osarogiagbon UR, 2000, BLOOD, V96, P314, DOI 10.1182/blood.V96.1.314.013k39_314_320; Pannu Rajmony, 2008, Crit Pathw Cardiol, V7, P133, DOI 10.1097/HPC.0b013e3181668ac3; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Pavlu J, 2007, LANCET, V369, P246, DOI 10.1016/S0140-6736(07)60114-7; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Poludasu S, 2013, J CARD FAIL, V19, P333, DOI 10.1016/j.cardfail.2013.03.009; POWARS DR, 1991, ANN INTERN MED, V115, P614, DOI 10.7326/0003-4819-115-8-614; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Robard I, 2015, INT J CARDIOL, V180, P120, DOI 10.1016/j.ijcard.2014.11.165; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; ROY SB, 1963, CIRCULATION, V28, P346, DOI 10.1161/01.CIR.28.3.346; Sachdev V, 2007, J AM COLL CARDIOL, V49, P472, DOI 10.1016/j.jacc.2006.09.038; Sachdev V, 2011, CIRCULATION, V124, P1452, DOI 10.1161/CIRCULATIONAHA.111.032920; Saraf SL, 2014, BRIT J HAEMATOL, V164, P729, DOI 10.1111/bjh.12690; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Tanner M A, 2006, Br J Haematol, V134, P2, DOI 10.1111/j.1365-2141.2006.06116.x; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; Upadhya B, 2013, EUR J HAEMATOL, V91, P170, DOI 10.1111/ejh.12127; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Yuditskaya S, 2009, BLOOD, V113, P1122, DOI 10.1182/blood-2008-03-142604; Yung GL, 1998, AM J RESP CRIT CARE, V157, P1690, DOI 10.1164/ajrccm.157.5.9710032	97	80	83	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2565	2574		10.1016/S0140-6736(16)00647-4	http://dx.doi.org/10.1016/S0140-6736(16)00647-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27353687				2022-12-28	WOS:000377947200033
J	Sotgiu, G; Tiberi, S; D'Ambrosio, L; Centis, R; Zumla, A; Migliori, GB				Sotgiu, Giovanni; Tiberi, Simon; D'Ambrosio, Lia; Centis, Rosella; Zumla, Alimuddin; Migliori, Giovanni Battista			WHO recommendations on shorter treatment of multidrug-resistant tuberculosis	LANCET			English	Editorial Material							HOST-DIRECTED THERAPIES; REGIMENS; DRUGS		[Sotgiu, Giovanni] Univ Sassari, Clin Epidemiol & Med Stat Unit, Dept Biomed Sci, Res Med Educ & Profess Dev Unit,AOU Sassari, I-07100 Sassari, Italy; [Tiberi, Simon] Barts Hlth NHS Trust, Div Infect, London, England; [D'Ambrosio, Lia; Centis, Rosella; Migliori, Giovanni Battista] IRCCS, Fdn S Maugeri, Care & Res Inst, I-21049 Tradate, Italy; [D'Ambrosio, Lia] Publ Hlth Consulting Grp, Lugano, Switzerland; [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England; [Zumla, Alimuddin] UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England	University of Sassari; Barts Health NHS Trust; Istituti Clinici Scientifici Maugeri IRCCS; University of London; University College London; University of London; University College London	Migliori, GB (corresponding author), IRCCS, Fdn S Maugeri, Care & Res Inst, I-21049 Tradate, Italy.	giovannibattista.migliori@fsm.it	ZUMLA, Alimuddin/ABA-8208-2020; Tiberi, Simon/I-2552-2019; Migliori, Giovanni Battista/AAB-8589-2020; Centis, Rosella/E-8882-2018; Sotgiu, Giovanni/N-1032-2017	ZUMLA, Alimuddin/0000-0002-5111-5735; Tiberi, Simon/0000-0001-9424-6551; Migliori, Giovanni Battista/0000-0002-2597-574X; Centis, Rosella/0000-0002-8551-3598; Sotgiu, Giovanni/0000-0002-1600-4474				Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Caminero JA, 2015, EUR RESPIR J, V46, P887, DOI 10.1183/13993003.00432-2015; Ghimire S, 2016, EUR RESPIR J, V47, P1867, DOI 10.1183/13993003.00040-2016; Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312; Piubello A, 2014, INT J TUBERC LUNG D, V18, P1188, DOI 10.5588/ijtld.13.0075; Tiberi S, 2016, EUR RESPIR J, V47, P1758, DOI 10.1183/13993003.00214-2016; Tiberi S, 2016, EUR RESPIR J, V47, P1235, DOI 10.1183/13993003.02146-2015; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Wallis RS, 2016, LANCET INFECT DIS, V16, pE34, DOI 10.1016/S1473-3099(16)00070-0; WHO, 2016, TREATM GUID DRUG RES; World Health Organization, 2016, GLOB TUB REP 2015; World Health Organization (WHO), 2015, MULT RES TUB MDR TB; Zumla A, 2016, LANCET INFECT DIS, V16, pE47, DOI 10.1016/S1473-3099(16)00078-5; [No title captured]	14	37	42	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2486	2487		10.1016/S0140-6736(16)30729-2	http://dx.doi.org/10.1016/S0140-6736(16)30729-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27353670	Green Submitted			2022-12-28	WOS:000377947200007
J	Sullenger, BA; Nair, S				Sullenger, Bruce A.; Nair, Smita			From the RNA world to the clinic	SCIENCE			English	Review							DENDRITIC CELL VACCINES; MESSENGER-RNA; HIV-1-INFECTED PATIENTS; TUMOR; IMMUNOTHERAPY; THERAPEUTICS; INTERFERENCE; RECEPTOR; CANCER; ELECTROPORATION	The study of RNA has continually emphasized the structural and functional versatility of RNA molecules. This versatility has inspired translational and clinical researchers to explore the utility of RNA-based therapeutic agents for a wide variety of medical applications. Several RNA therapeutics, with diverse modes of action, are being evaluated in large late-stage clinical trials, and many more are in early clinical development. Hundreds of patients are enrolled in large trials testing messenger RNAs to combat cancer, small interfering RNAs to treat renal and hepatic disorders, and aptamers to combat ocular and cardiovascular disease. Results from these studies are generating considerable interest among the biomedical community and the public and will be important for the future development of this emerging class of therapeutic agents.	[Sullenger, Bruce A.] Duke Univ, Med Ctr, Duke Translat Res Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University; Duke University	Sullenger, BA (corresponding author), Duke Univ, Med Ctr, Duke Translat Res Inst, Durham, NC 27710 USA.	bruce.sullenger@duke.edu	Nair, Smita/GYR-2993-2022; Nair Jain, Smita/M-2765-2018	Nair, Smita/0000-0001-5615-7056; Nair Jain, Smita/0000-0002-1542-9913	NHLBI NIH HHS [R01 HL065222] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065222] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allard SD, 2012, CLIN IMMUNOL, V142, P252, DOI 10.1016/j.clim.2011.10.010; Amin A, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0055-3; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Benteyn D, 2015, EXPERT REV VACCINES, V14, P161, DOI 10.1586/14760584.2014.957684; Bobbin ML, 2016, ANNU REV PHARMACOL, V56, P103, DOI 10.1146/annurev-pharmtox-010715-103633; Bringmann A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/623687; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Drolet DW, 2016, NUCLEIC ACID THER, V26, P127, DOI 10.1089/nat.2015.0573; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Ganson NJ, 2016, J ALLERGY CLIN IMMUN, V137, P1610, DOI 10.1016/j.jaci.2015.10.034; Garba AO, 2010, OPHTHALMOL EYE DIS, V2, P75, DOI 10.4137/OED.S4878; Granstein RD, 2000, J INVEST DERMATOL, V114, P632, DOI 10.1046/j.1523-1747.2000.00929.x; Hanna Mazen, 2014, Curr Heart Fail Rep, V11, P50, DOI 10.1007/s11897-013-0182-4; Hoerr I, 2000, EUR J IMMUNOL, V30, P1; Kim YH, 2016, THERANOSTICS, V6, P357, DOI 10.7150/thno.13621; Lan N, 1998, SCIENCE, V280, P1593, DOI 10.1126/science.280.5369.1593; Lee J, 2008, IMMUNOLOGY, V125, P229, DOI 10.1111/j.1365-2567.2008.02833.x; Lincoff AM, 2016, LANCET, V387, P349, DOI 10.1016/S0140-6736(15)00515-2; McClorey G, 2015, CURR OPIN PHARMACOL, V24, P52, DOI 10.1016/j.coph.2015.07.005; Mehan MR, 2013, ADV EXP MED BIOL, V735, P283, DOI 10.1007/978-1-4614-4118-2_20; Mitchell DA, 2015, NATURE, V519, P366, DOI 10.1038/nature14320; Nair S., 2011, CANC VACCINES RES CL, P217; Nemunaitis J, 2014, ONCOLOGY-BASEL, V87, P21, DOI 10.1159/000360993; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ramos AM, 2015, EXPERT OPIN DRUG DIS, V10, P541, DOI 10.1517/17460441.2015.1033394; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Suhr OB, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0326-6; SULLENGER BA, 1990, CELL, V63, P601, DOI 10.1016/0092-8674(90)90455-N; Van Gulck E, 2012, AIDS, V26, pF1, DOI 10.1097/QAD.0b013e32834f33e8; Van Lint S, 2015, EXPERT REV VACCINES, V14, P235, DOI 10.1586/14760584.2015.957685; Van Nuffel AMT, 2012, CANCER IMMUNOL IMMUN, V61, P1033, DOI 10.1007/s00262-011-1176-2; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Vigneswara V, 2014, BRAIN, V137, P1656, DOI 10.1093/brain/awu037; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yoon SH, 2009, CANCER GENE THER, V16, P489, DOI 10.1038/cgt.2008.98; Zhao YB, 2010, CANCER RES, V70, P9053, DOI 10.1158/0008-5472.CAN-10-2880	40	169	183	7	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1417	1420		10.1126/science.aad8709	http://dx.doi.org/10.1126/science.aad8709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313039	Green Accepted			2022-12-28	WOS:000377975400039
J	Ueno, N				Ueno, Nobuo			Tuning organic band structures with Coulomb interactions The smooth change of band gaps in blends of organic semiconductors arises from long-range electronic interactions	SCIENCE			English	Editorial Material									[Ueno, Nobuo] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba 2638522, Japan	Chiba University	Ueno, N (corresponding author), Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba 2638522, Japan.	uenon@faculty.chiba-u.jp	Ueno, Nobuo/F-4358-2014	Ueno, Nobuo/0000-0003-2051-1492				Bounds B. J., 1981, CHEM PHYS, V59, P41; Hains AW, 2010, CHEM REV, V110, P6689, DOI 10.1021/cr9002984; Heeger AJ, 2014, ADV MATER, V26, P10, DOI 10.1002/adma.201304373; Mendez H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9560; Olthof S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.176601; Salzmann I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.035502; Schwarze M, 2016, SCIENCE, V352, P1446, DOI 10.1126/science.aaf0590; Sueyoshi T, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3332577; Topham BJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165405; Ueno N, 2015, SPRINGER SER MATER S, V209, P3, DOI 10.1007/978-4-431-55206-2_1; Walzer K, 2007, CHEM REV, V107, P1233, DOI 10.1021/cr050156n; Yoshida H, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.075145	12	16	16	0	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1395	1396		10.1126/science.aaf8937	http://dx.doi.org/10.1126/science.aaf8937			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO7PV	27313026				2022-12-28	WOS:000377975400023
J	Hrvatin, S; Nagy, MA; Greenberg, ME				Hrvatin, Sinisa; Nagy, M. Aurel; Greenberg, Michael E.			Catching the Brain in the Act	CELL			English	Editorial Material							NEURONS	Understanding how genes within cells, and cells within circuits, function together to produce the extraordinary repertoire of animal behaviors is arguably one of the most challenging undertakings in neuroscience. Two papers in this issue move toward this goal via 3D imaging of active neurons across the entire mouse brain.	[Hrvatin, Sinisa; Nagy, M. Aurel; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu		Hrvatin, Sinisa/0000-0001-7303-4218	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; Mardinly AR, 2016, NATURE, V531, P371, DOI 10.1038/nature17187; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Renier N, 2016, CELL, V165, P1789, DOI 10.1016/j.cell.2016.05.007; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Ye L, 2016, CELL, V165, P1776, DOI 10.1016/j.cell.2016.05.010	8	0	0	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1570	1571		10.1016/j.cell.2016.06.008	http://dx.doi.org/10.1016/j.cell.2016.06.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315474	Bronze			2022-12-28	WOS:000378062000009
J	Di Nisio, M; van Es, N; Buller, HR				Di Nisio, Marcello; van Es, Nick; Bueller, Harry R.			Deep vein thrombosis and pulmonary embolism	LANCET			English	Review							RECURRENT VENOUS THROMBOEMBOLISM; D-DIMER CUTOFF; CATHETER-DIRECTED THROMBOLYSIS; CLINICAL-PREDICTION RULES; OUT CRITERIA PERC; VENA-CAVA FILTERS; DIAGNOSTIC MANAGEMENT; 1ST EPISODE; COMPRESSION ULTRASONOGRAPHY; POSTTHROMBOTIC SYNDROME	Deep vein thrombosis and pulmonary embolism, collectively referred to as venous thromboembolism, constitute a major global burden of disease. The diagnostic work-up of suspected deep vein thrombosis or pulmonary embolism includes the sequential application of a clinical decision rule and D-dimer testing. Imaging and anticoagulation can be safely withheld in patients who are unlikely to have venous thromboembolism and have a normal D-dimer. All other patients should undergo ultrasonography in case of suspected deep vein thrombosis and CT in case of suspected pulmonary embolism. Direct oral anticoagulants are first-line treatment options for venous thromboembolism because they are associated with a lower risk of bleeding than vitamin K antagonists and are easier to use. Use of thrombolysis should be limited to pulmonary embolism associated with haemodynamic instability. Anticoagulant treatment should be continued for at least 3 months to prevent early recurrences. When venous thromboembolism is unprovoked or secondary to persistent risk factors, extended treatment beyond this period should be considered when the risk of recurrence outweighs the risk of major bleeding.	[Di Nisio, Marcello] Gabriele DAnnunzio Univ, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Di Nisio, Marcello; van Es, Nick; Bueller, Harry R.] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands	G d'Annunzio University of Chieti-Pescara; University of Amsterdam; Academic Medical Center Amsterdam	Di Nisio, M (corresponding author), Gabriele DAnnunzio Univ, Dept Med Oral & Biotechnol Sci, Chieti, Italy.	mdinisio@unich.it		van Es, Nick/0000-0001-5256-6346	Bayer Health Care; Grifols; Daiichi Sankyo; Sanofi-Aventis; Bristol-Myers Squibb; GlaxoSmithKline; Pfizer; Roche; ISIS Medical; Thrombogenics; Boehringer Ingelheim	Bayer Health Care(Bayer AGBayer Healthcare Pharmaceuticals); Grifols; Daiichi Sankyo(Daiichi Sankyo Company Limited); Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Roche(Roche Holding); ISIS Medical; Thrombogenics; Boehringer Ingelheim(Boehringer Ingelheim)	MDN has received fees for consultancy from Bayer Health Care, Grifols, and Daiichi Sankyo outside the present work. HRB reports grants and personal fees from Sanofi-Aventis, Bayer HealthCare, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Pfizer, Roche, ISIS Medical, Thrombogenics, and Boehringer Ingelheim, outside the submitted work. NvE declares no competing interests.	Ageno W, 2013, J THROMB HAEMOST, V11, P1597, DOI 10.1111/jth.12301; Ageno W, 2016, LANCET HAEMATOL, V3, pE12, DOI 10.1016/S2352-3026(15)00257-4; Ageno W, 2015, LANCET HAEMATOL, V2, pE474, DOI 10.1016/S2352-3026(15)00190-8; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Akl EA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006650.pub4; Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Andreozzi GM, 2015, CIRCULATION, V132, P1891, DOI 10.1161/CIRCULATIONAHA.115.016930; Ansell JE, 2014, NEW ENGL J MED, V371, P2141, DOI 10.1056/NEJMc1411800; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Baglin T, 2012, J THROMB HAEMOST, V10, P1702, DOI [10.1111/j.1538-7836.2012.04806.x, 10.1111/j.1538-7836.2012.04662.x]; Baglin T, 2010, J THROMB HAEMOST, V8, P2436, DOI 10.1111/j.1538-7836.2010.04022.x; Bashir R, 2014, JAMA INTERN MED, V174, P1494, DOI 10.1001/jamainternmed.2014.3415; Bates SM, 2012, CHEST, V141, pE351S, DOI 10.1378/chest.11-2299; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Bell EJ, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.10.014; Bernardi E, 2008, JAMA-J AM MED ASSOC, V300, P1653, DOI 10.1001/jama.300.14.1653; Beyer-Westendorf J, 2014, THROMB HAEMOSTASIS, V113, P1; Beyer-Westendorf J, 2014, BLOOD, V124, P955, DOI 10.1182/blood-2014-03-563577; Birdwell BG, 1998, ANN INTERN MED, V128, P1, DOI 10.7326/0003-4819-128-1-199801010-00001; Boutitie F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3036; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Buller HR, 2009, ANN INTERN MED, V150, P229, DOI 10.7326/0003-4819-150-4-200902170-00003; Caldeira D, 2015, HEART, V101, P1204, DOI 10.1136/heartjnl-2015-307489; Camporese G, 2012, J THROMB HAEMOST, V10, P2605, DOI 10.1111/jth.12015; Carrier M, 2012, J THROMB HAEMOST, V10, P1486, DOI 10.1111/j.1538-7836.2012.04804.x; Carrier M, 2011, J THROMB HAEMOST, V9, P1119, DOI 10.1111/j.1538-7836.2011.04254.x; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; Castellucci LA, 2014, JAMA-J AM MED ASSOC, V312, P1122, DOI 10.1001/jama.2014.10538; Castellucci LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5133; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Chan WS, 2009, ANN INTERN MED, V151, P85, DOI 10.7326/0003-4819-151-2-200907210-00004; Cogo A, 1998, BRIT MED J, V316, P17, DOI 10.1136/bmj.316.7124.17; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Cosmi B, 2010, BLOOD, V115, P481, DOI 10.1182/blood-2009-08-237354; Couturaud F, 2015, JAMA-J AM MED ASSOC, V314, P31, DOI 10.1001/jama.2015.7046; Deitelzweig SB, 2011, J THROMB THROMBOLYS, V31, P133, DOI 10.1007/s11239-010-0503-3; den Exter PL, 2015, THROMB HAEMOSTASIS, V114, P26, DOI 10.1160/TH14-10-0842; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Di Nisio M, 2016, THROMB HAEMOSTASIS, V115, P424, DOI 10.1160/TH15-06-0474; Douma RA, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00002; Douma RA, 2010, THROMB HAEMOSTASIS, V104, P831, DOI 10.1160/TH10-02-0093; Douma RA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1475; Eerenberg ES, 2015, J THROMB HAEMOST, V13, P1590, DOI 10.1111/jth.13051; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Elias A, 2003, THROMB HAEMOSTASIS, V89, P221; Enden T, 2012, LANCET, V379, P31, DOI 10.1016/S0140-6736(11)61753-4; Erkens PMG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001100.pub3; Geersing GJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1340; Geersing GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2990; Gibson NS, 2008, THROMB HAEMOSTASIS, V99, P229, DOI 10.1160/TH07-05-0321; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Grosse SD, 2016, THROMB RES, V137, P3, DOI 10.1016/j.thromres.2015.11.033; Haig Y, 2016, LANCET HAEMATOL, V3, pE64, DOI 10.1016/S2352-3026(15)00248-3; Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309; Heit JA, 2015, NAT REV CARDIOL, V12, P464, DOI 10.1038/nrcardio.2015.83; Hoeper MM, 2014, LANCET RESP MED, V2, P573, DOI 10.1016/S2213-2600(14)70089-X; Huang W, 2014, AM J MED, V127, P829, DOI 10.1016/j.amjmed.2014.03.041; Hugli O, 2011, J THROMB HAEMOST, V9, P300, DOI 10.1111/j.1538-7836.2010.04147.x; Huisman MV, 2012, J THROMB HAEMOST, V10, P741, DOI 10.1111/j.1538-7836.2012.04678.x; Huisman MV, 2009, J THROMB HAEMOST, V7, P312, DOI 10.1111/j.1538-7836.2009.03386.x; Iorio A, 2010, ARCH INTERN MED, V170, P1710, DOI 10.1001/archinternmed.2010.367; Januel JM, 2012, JAMA-J AM MED ASSOC, V307, P294, DOI 10.1001/jama.2011.2029; Jensvoll H, 2015, CLIN EPIDEMIOL, V7, P401, DOI 10.2147/CLEP.S84279; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Johnson SA, 2010, JAMA-J AM MED ASSOC, V303, P438, DOI 10.1001/jama.2010.43; Kahn SR, 2013, LANCET, V6736, P1; Kahn SR, 2014, CIRCULATION, V130, P1636, DOI 10.1161/CIR.0000000000000130; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Kearon C, 2016, J THROMB HAEMOST, V14, P1480, DOI 10.1111/jth.13336; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Kearon C, 2010, J THROMB HAEMOST, V8, P2313, DOI 10.1111/j.1538-7836.2010.03991.x; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Kearon C, 2015, ANN INTERN MED, V162, P27, DOI 10.7326/M14-1275; Klok FA, 2008, ARCH INTERN MED, V168, P2131, DOI 10.1001/archinte.168.19.2131; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Kraaijenhagen RA, 2002, ARCH INTERN MED, V162, P907, DOI 10.1001/archinte.162.8.907; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Lee AYY, 2015, JAMA-J AM MED ASSOC, V314, P677, DOI 10.1001/jama.2015.9243; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Linkins LA, 2006, THROMB RES, V117, P241, DOI 10.1016/j.thromres.2005.02.011; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Linkins LA, 2012, CHEST, V141, pE495S, DOI 10.1378/chest.11-2303; Liu D, 2015, CAN MED ASSOC J, V187, P1288, DOI 10.1503/cmaj.141614; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; MacCallum P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4387; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Mismetti P, 2015, JAMA-J AM MED ASSOC, V313, P1627, DOI 10.1001/jama.2015.3780; Moores LK, 2004, ANN INTERN MED, V141, P866, DOI 10.7326/0003-4819-141-11-200412070-00011; Morange PE, 2015, THROMB HAEMOSTASIS, V114, P910, DOI 10.1160/TH15-05-0410; Mos ICM, 2014, THROMB RES, V133, P1039, DOI 10.1016/j.thromres.2014.03.050; Oo TH, 2014, J THROMB HAEMOST, V12, P115, DOI 10.1111/jth.12434; Ost D, 2005, JAMA-J AM MED ASSOC, V294, P706, DOI 10.1001/jama.294.6.706; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Palareti G, 2014, BLOOD, V124, P196, DOI 10.1182/blood-2014-01-548065; Palareti G, 2014, BLOOD, V123, P1802, DOI 10.1182/blood-2013-10-512616; Penaloza A, 2012, J THROMB HAEMOST, V10, P1291, DOI 10.1111/j.1538-7836.2012.04769.x; Perrier A, 2003, AM J RESP CRIT CARE, V167, P39, DOI 10.1164/rccm.2106128; Pollack CV, 2011, J AM COLL CARDIOL, V57, P700, DOI 10.1016/j.jacc.2010.05.071; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Raja AS, 2015, ANN INTERN MED, V163, P701, DOI 10.7326/M14-1772; Raskob GE, 2014, ARTERIOSCL THROM VAS, V34, P2363, DOI 10.1161/ATVBAHA.114.304488; Raskob G, 2016, LANCET HAEMATOL, V3, pE228, DOI [10.1016/s2352-3026(16)00023-5, 10.1016/S2352-3026(16)00023-5]; Righini M, 2006, THROMB HAEMOSTASIS, V95, P56, DOI 10.1160/TH05-08-0588; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Riva N, 2014, THROMB HAEMOSTASIS, V112, P511, DOI 10.1160/TH14-01-0081; Roach REJ, 2014, CIRCULATION, V129, P51, DOI 10.1161/CIRCULATIONAHA.113.004768; Rodger M, 2010, BLOOD REV, V24, P171, DOI 10.1016/j.blre.2010.06.001; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Runyon MS, 2007, ACAD EMERG MED, V14, P53, DOI 10.1197/j.aem.2006.07.032; Sarosiek S, 2013, JAMA INTERN MED, V173, P513, DOI 10.1001/jamainternmed.2013.343; Schellong SM, 2003, THROMB HAEMOSTASIS, V89, P228; Schmidt M, 2014, J THROMB HAEMOST, V12, P1207, DOI 10.1111/jth.12604; Schouten HJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2492; Schulman S, 2014, CIRCULATION, V129, P764, DOI 10.1161/CIRCULATIONAHA.113.004450; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Schwarz T, 2002, CLIN APPL THROMB-HEM, V8, P45, DOI 10.1177/107602960200800106; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Silveira PC, 2015, JAMA INTERN MED, V175, P1112, DOI 10.1001/jamainternmed.2015.1687; Simes J, 2014, CIRCULATION, V130, P1062, DOI 10.1161/CIRCULATIONAHA.114.008828; Singh B, 2013, EMERG MED J, V30, P701, DOI 10.1136/emermed-2012-201730; Sogaard KK, 2014, CIRCULATION, V130, P829, DOI 10.1161/CIRCULATIONAHA.114.009107; Spencer FA, 2010, ARCH INTERN MED, V170, P1456, DOI 10.1001/archinternmed.2010.272; Squizzato A, 2012, J THROMB HAEMOST, V10, P1276, DOI 10.1111/j.1538-7836.2012.04739.x; Stein PD, 2012, THROMB RES, V130, P841, DOI 10.1016/j.thromres.2012.07.011; Stein PD, 2011, AM J MED, V124, P655, DOI 10.1016/j.amjmed.2011.02.021; Stein PD, 2010, AM J MED, V123, P426, DOI 10.1016/j.amjmed.2009.09.037; Stein PD, 2010, ANN INTERN MED, V152, P434, DOI 10.7326/0003-4819-152-7-201004060-00008; Stein PD, 2009, J NUCL MED, V50, P1999, DOI 10.2967/jnumed.109.063958; Tan M, 2014, BLOOD, V124, P623, DOI 10.1182/blood-2014-04-566380; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; Tosetto A, 2012, J THROMB HAEMOST, V10, P1019, DOI 10.1111/j.1538-7836.2012.04735.x; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; van Es N, 2016, ANN INTERN MED, V165, P253, DOI 10.7326/M16-0031; van Es N, 2014, BLOOD, V124, P1968, DOI [10.1182/blood-2014-04571232, 10.1182/blood-2014-04-571232]; Verhovsek M, 2008, ANN INTERN MED, V149, P481, DOI 10.7326/0003-4819-149-7-200810070-00008; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wells PS, 2014, JAMA-J AM MED ASSOC, V311, P717, DOI 10.1001/jama.2014.65; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 2006, JAMA-J AM MED ASSOC, V295, P199, DOI 10.1001/jama.295.2.199; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Zondag W, 2011, J THROMB HAEMOST, V9, P1500, DOI 10.1111/j.1538-7836.2011.04388.x	156	363	371	25	123	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					3060	3073		10.1016/S0140-6736(16)30514-1	http://dx.doi.org/10.1016/S0140-6736(16)30514-1			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1VF	27375038				2022-12-28	WOS:000390112300038
J	Devlin, MJ				Devlin, Michael J.			Binge-Eating Disorder Comes of Age	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Devlin, Michael J.] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA; [Devlin, Michael J.] New York State Psychiat Inst & Hosp, Unit 116,1051 Riverside Dr, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Devlin, MJ (corresponding author), New York State Psychiat Inst & Hosp, Unit 116,1051 Riverside Dr, New York, NY 10032 USA.	mjd5@cumc.columbia.edu						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Berge JM, 2015, PEDIATRICS, V136, pE591, DOI 10.1542/peds.2015-0326; Brownley KA, 2016, ANN INTERN MED, V165, P409, DOI 10.7326/M15-2455; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Goldschmidt AB, 2016, HEALTH PSYCHOL, V35, P245, DOI 10.1037/hea0000283; Mitchell JE, 2016, INT J EAT DISORDER, V49, P319, DOI 10.1002/eat.22452; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; STUNKARD AJ, 1959, PSYCHIAT QUART, V33, P284, DOI 10.1007/BF01575455; Volkow ND, 2013, BIOL PSYCHIAT, V73, P811, DOI 10.1016/j.biopsych.2012.12.020; Zylke JW, 2016, JAMA-J AM MED ASSOC, V315, P2277, DOI 10.1001/jama.2016.6190	10	2	2	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2016	165	6					445	446		10.7326/M16-1398	http://dx.doi.org/10.7326/M16-1398			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DW9FR	27366876				2022-12-28	WOS:000383962000022
J	Lo, S; Horton, R				Lo, Selina; Horton, Richard			Transgender health: an opportunity for global health equity	LANCET			English	Editorial Material									[Lo, Selina; Horton, Richard] The Lancet, London EC2Y 5AS, England		Lo, S (corresponding author), The Lancet, London EC2Y 5AS, England.							Global Action for Trans* Equality, 2013, ENGL TRANSL ARG GEND; Grinberg E, 2016, CNN             0530; Lo S, 2015, LANCET, V386, P1313, DOI 10.1016/S0140-6736(15)60305-1; Reisner SL, 2016, LANCET; Smith D., 2016, GUARDIAN; United Nations, UNIVERSAL DECLARATIO; Winter S, 2016, LANCET; Wylie K, 2016, LANCET	8	25	25	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					316	318		10.1016/S0140-6736(16)30675-4	http://dx.doi.org/10.1016/S0140-6736(16)30675-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR6MV	27323923				2022-12-28	WOS:000380016900008
J	Thackeray, SJ; Henrys, PA; Hemming, D; Bell, JR; Botham, MS; Burthe, S; Helaouet, P; Johns, DG; Jones, ID; Leech, DI; Mackay, EB; Massimino, D; Atkinson, S; Bacon, PJ; Brereton, TM; Carvalho, L; Clutton-Brock, TH; Duck, C; Edwards, M; Elliott, JM; Hall, SJG; Harrington, R; Pearce-Higgins, JW; Hoye, TT; Kruuk, LEB; Pemberton, JM; Sparks, TH; Thompson, PM; White, I; Winfield, IJ; Wanless, S				Thackeray, Stephen J.; Henrys, Peter A.; Hemming, Deborah; Bell, James R.; Botham, Marc S.; Burthe, Sarah; Helaouet, Pierre; Johns, David G.; Jones, Ian D.; Leech, David I.; Mackay, Eleanor B.; Massimino, Dario; Atkinson, Sian; Bacon, Philip J.; Brereton, Tom M.; Carvalho, Laurence; Clutton-Brock, Tim H.; Duck, Callan; Edwards, Martin; Elliott, J. Malcolm; Hall, Stephen J. G.; Harrington, Richard; Pearce-Higgins, James W.; Hoye, Toke T.; Kruuk, Loeske E. B.; Pemberton, Josephine M.; Sparks, Tim H.; Thompson, Paul M.; White, Ian; Winfield, Ian J.; Wanless, Sarah			Phenological sensitivity to climate across taxa and trophic levels	NATURE			English	Article							FRESH-WATER; SPRING PHYTOPLANKTON; RESPONSES; CONSTRAINTS; MISMATCH; TRENDS; STREAM; SHIFTS; BIRD	Differences in phenological responses to climate change among species can desynchronise ecological interactions and thereby threaten ecosystem function. To assess these threats, we must quantify the relative impact of climate change on species at different trophic levels. Here, we apply a Climate Sensitivity Profile approach to 10,003 terrestrial and aquatic phenological data sets, spatially matched to temperature and precipitation data, to quantify variation in climate sensitivity. The direction, magnitude and timing of climate sensitivity varied markedly among organisms within taxonomic and trophic groups. Despite this variability, we detected systematic variation in the direction and magnitude of phenological climate sensitivity. Secondary consumers showed consistently lower climate sensitivity than other groups. We used mid-century climate change projections to estimate that the timing of phenological events could change more for primary consumers than for species in other trophic levels (6.2 versus 2.5-2.9 days earlier on average), with substantial taxonomic variation (1.1-14.8 days earlier on average).	[Thackeray, Stephen J.; Henrys, Peter A.; Jones, Ian D.; Mackay, Eleanor B.; Winfield, Ian J.] Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lib Ave, Lancaster LA1 4AP, England; [Hemming, Deborah] Met Off, FitzRoy Rd, Exeter EX1 3PB, Devon, England; [Bell, James R.; Harrington, Richard] Rothamsted Res, Harpenden AL5 2JQ, Herts, England; [Botham, Marc S.] Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England; [Burthe, Sarah; Carvalho, Laurence; Wanless, Sarah] Ctr Ecol & Hydrol, Bush Estate, Penicuik EH26 0QB, Midlothian, Scotland; [Helaouet, Pierre; Johns, David G.; Edwards, Martin] Sir Alister Hardy Fdn Ocean Sci, The Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England; [Leech, David I.; Massimino, Dario; Pearce-Higgins, James W.] British Trust Ornithol, The Nunnery, Thetford IP24 2PU, Norfolk, England; [Atkinson, Sian] Woodland Trust, Kempton Way, Grantham NG31 6LL, Lincolnshire, England; [Bacon, Philip J.] Futtie Pk, Aberdeen AB31 4RX, Scotland; [Brereton, Tom M.] Butterfly Conservat, Wareham BH20 5QP, Dorset, England; [Clutton-Brock, Tim H.] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England; [Duck, Callan] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews KY16 8LB, Fife, Scotland; [Elliott, J. Malcolm] Freshwater Biol Assoc, Ambleside LA22 0LP, Cumbria, England; [Hall, Stephen J. G.] Lincoln Univ, Riseholme Hall,Riseholme Pk, Lincoln LN2 2LG, Lincolnshire, England; [Hoye, Toke T.] Aarhus Univ, Aarhus Inst Adv Studies, Dept Biosci, Hoegh Guldbergs Gade 6B, Aarhus, Denmark; [Hoye, Toke T.] Aarhus Univ, Arctic Res Ctr, Hoegh Guldbergs Gade 6B, DK-8000 Aarhus C, Denmark; [Kruuk, Loeske E. B.; Pemberton, Josephine M.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland; [Kruuk, Loeske E. B.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2612, Australia; [Sparks, Tim H.] Coventry Univ, Fac Engn & Comp, Priory St, Coventry CV1 5FB, W Midlands, England; [Sparks, Tim H.] Poznan Univ Life Sci, Inst Zool, Wojska Polskiego 71C, PL-60625 Poznan, Poland; [Thompson, Paul M.] Univ Aberdeen, George St, Cromarty IV11 8YJ, Ross Shire, Scotland; [White, Ian] Peoples Trust Endangered Species, 15 Cloisters House,8 Battersea Pk Rd, London SW8 4BG, England	Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); Met Office - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH); British Trust for Ornithology; University of Cambridge; University of St Andrews; Freshwater Biological Association (FBA); University of Lincoln; Aarhus University; Aarhus University; University of Edinburgh; Australian National University; Coventry University; Poznan University of Life Sciences; University of Aberdeen	Thackeray, SJ (corresponding author), Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lib Ave, Lancaster LA1 4AP, England.	sjtr@ceh.ac.uk	Kruuk, Loeske/AAB-8714-2019; Hoye, Toke T./ABF-7808-2020; Thackeray, Stephen J/D-2415-2013; Høye, Toke Thomas/A-7701-2008; Kruuk, Loeske E. B./J-3295-2012; Mackay, Eleanor/AAP-5437-2020; Massimino, Dario/A-8113-2010; Thompson, Paul M/B-6742-2009; Pemberton, Josephine M/F-3100-2010; Winfield, Ian J/I-6085-2012; Mackay, Eleanor B/F-5490-2013; Jones, Ian/E-5507-2015; Carvalho, Laurence/D-3276-2009; Bell, James/C-2247-2009; Burthe, Sarah J/Q-9505-2016; Henrys, Peter/K-3321-2012	Kruuk, Loeske/0000-0001-8588-1123; Hoye, Toke T./0000-0001-5387-3284; Thackeray, Stephen J/0000-0003-3274-2706; Høye, Toke Thomas/0000-0001-5387-3284; Kruuk, Loeske E. B./0000-0001-8588-1123; Mackay, Eleanor/0000-0001-5697-7062; Massimino, Dario/0000-0002-5855-4060; Thompson, Paul M/0000-0001-6195-3284; Winfield, Ian J/0000-0001-9296-5114; Mackay, Eleanor B/0000-0001-5697-7062; Jones, Ian/0000-0002-6898-1429; Carvalho, Laurence/0000-0002-9768-9902; Bell, James/0000-0003-1640-6120; Burthe, Sarah J/0000-0001-8871-3432; Henrys, Peter/0000-0003-4758-1482; Helaouet, Pierre/0000-0001-6102-7379; Sparks, Tim/0000-0003-4382-7051; Hall, Stephen/0000-0003-2666-1715; Johns, David/0000-0003-3270-6764	Natural Environment Research Council (NERC) [NE/J02080X/1]; BBSRC; BBSRC [BBS/E/C/00005195, BBS/E/C/00005191] Funding Source: UKRI; NERC [SAH01001, NE/J02080X/1, NE/J020362/1, NE/J020451/1, NE/I024925/1, ceh020002, NE/M003035/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005195, BBS/E/C/00005191] Funding Source: researchfish; Natural Environment Research Council [NE/J020451/1, NE/I030062/1, SAH01001, NE/J020362/1, smru10001, NE/J02080X/1, NE/M003035/1, ceh020002, NE/I024925/1, NE/L00688X/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Natural Environment Research Council (NERC) grant NE/J02080X/1. We thank O. Mountford for assigning species traits for plants, H. Feuchtmayr for extracting plankton data for analysis and N. Dodd for air and water temperature data from the Tarland Burn. We also thank P Vender, the staff and many volunteers and contributors, including Science and Advice for Scottish Agriculture, to the Rothamsted Insect Survey (RIS) over the last half century. The RIS is a National Capability strategically funded by BBSRC. The consortium represented by the authorship list hold long-term data that represent a considerable investment in scientific endeavour. Whilst we are committed to sharing these data for scientific research, users are requested to collaborate before publication of these data to ensure accurate biological interpretation.	Amano T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3017; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Burthe S, 2012, MAR ECOL PROG SER, V454, P119, DOI 10.3354/meps09520; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Doi H, 2008, CLIM RES, V36, P181, DOI 10.3354/cr00741; ELLIOTT JM, 1984, J ANIM ECOL, V53, P327, DOI 10.2307/4360; Feuchtmayr H, 2012, FRESHWATER BIOL, V57, P331, DOI 10.1111/j.1365-2427.2011.02671.x; IPCC, 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; Jones ID, 2008, FRESHWATER BIOL, V53, P393, DOI 10.1111/j.1365-2427.2007.01902.x; Jonsson T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6992; Miller-Rushing AJ, 2010, PHILOS T R SOC B, V365, P3177, DOI 10.1098/rstb.2010.0148; Mohseni O, 1998, WATER RESOUR RES, V34, P2685, DOI 10.1029/98WR01877; Nakazawa T, 2012, OIKOS, V121, P489, DOI 10.1111/j.1600-0706.2011.20171.x; Nussey DH, 2005, BIOL LETT-UK, V1, P457, DOI 10.1098/rsbl.2005.0352; Ohlberger J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0938; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perry M, 2005, INT J CLIMATOL, V25, P1041, DOI 10.1002/joc.1161; Phillimore AB, 2012, P NATL ACAD SCI USA, V109, DOI 10.1073/pnas.1203538109; Phillimore AB, 2010, P NATL ACAD SCI USA, V107, P8292, DOI 10.1073/pnas.0913792107; Pope KS, 2013, GLOBAL CHANGE BIOL, V19, P1518, DOI 10.1111/gcb.12130; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reed TE, 2013, SCIENCE, V340, P488, DOI 10.1126/science.1232870; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Scheffer M, 2015, SCIENCE, V347, P1317, DOI 10.1126/science.aaa3769; Thackeray SJ, 2008, J ECOL, V96, P523, DOI 10.1111/j.1365-2745.2008.01355.x; Thackeray SJ, 2012, FRESHWATER BIOL, V57, P345, DOI 10.1111/j.1365-2427.2011.02614.x; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; van de Pol M, 2011, AM NAT, V177, P698, DOI 10.1086/659101; van Emden H.F., 2007, APHIDS CROP PESTS, P717; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980	41	472	488	23	499	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					241	U94		10.1038/nature18608	http://dx.doi.org/10.1038/nature18608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27362222	Green Submitted, Green Accepted			2022-12-28	WOS:000379912600048
J	Ding, HY; Smith, RG; Poleg-Polsky, A; Diamond, JS; Briggman, KL				Ding, Huayu; Smith, Robert G.; Poleg-Polsky, Alon; Diamond, Jeffrey S.; Briggman, Kevin L.			Species-specific wiring for direction selectivity in the mammalian retina	NATURE			English	Article							STARBURST AMACRINE CELLS; RABBIT RETINA; MOUSE RETINA; GANGLION-CELLS; NEURAL COMPUTATION; SYNAPTIC INPUT; AXIAL LENGTH; DENDRITES; CIRCUIT; MOTION	Directionally tuned signalling in starburst amacrine cell (SAC) dendrites lies at the heart of the circuit that detects the direction of moving stimuli in the mammalian retina. The relative contributions of intrinsic cellular properties and network connectivity to SAC direction selectivity remain unclear. Here we present a detailed connectomic reconstruction of SAC circuitry in mouse retina and describe two previously unknown features of synapse distributions along SAC dendrites: input and output synapses are segregated, with inputs restricted to proximal dendrites; and the distribution of inhibitory inputs is fundamentally different from that observed in rabbit retina. An anatomically constrained SAC network model suggests that SAC-SAC wiring differences between mouse and rabbit retina underlie distinct contributions of synaptic inhibition to velocity and contrast tuning and receptive field structure. In particular, the model indicates that mouse connectivity enables SACs to encode lower linear velocities that account for smaller eye diameter, thereby conserving angular velocity tuning. These predictions are confirmed with calcium imaging of mouse SAC dendrites responding to directional stimuli.	[Ding, Huayu; Poleg-Polsky, Alon; Diamond, Jeffrey S.] NINDS, Synapt Physiol Sect, Bethesda, MD 20892 USA; [Smith, Robert G.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Briggman, Kevin L.] Max Planck Inst Med Res, Dept Biomed Opt, Jahnstr 29, D-69120 Heidelberg, Germany; [Briggman, Kevin L.] NINDS, Circuit Dynam & Connect Unit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Pennsylvania; Max Planck Society; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Briggman, KL (corresponding author), Max Planck Inst Med Res, Dept Biomed Opt, Jahnstr 29, D-69120 Heidelberg, Germany.; Briggman, KL (corresponding author), NINDS, Circuit Dynam & Connect Unit, Bethesda, MD 20892 USA.	kevin.briggman@nih.gov	Diamond, Jeffrey/C-1835-2015	Diamond, Jeffrey/0000-0002-1770-2629	NIH [EY016607, EY022070]; NINDS [NS003145, NS003133]; Max-Planck Society; Pew Charitable Trusts; NATIONAL EYE INSTITUTE [R01EY016607, R01EY022070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003145, ZIANS003133] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Max-Planck Society(Max Planck Society); Pew Charitable Trusts; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Denk for supporting the collection of the serial block-face scanning electron microscopy data in his laboratory. This work was supported by NIH grants EY016607 and EY022070 (RGS), by the NINDS Intramural Research Program (NS003145; J.S.D.) and (NS003133; K.L.B.), the Max-Planck Society (K.L.B.), and the Pew Charitable Trusts (K.L.B.).	Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Borghuis BG, 2013, J NEUROSCI, V33, P10972, DOI 10.1523/JNEUROSCI.1241-13.2013; Bozkir G, 1997, ACTA MED OKAYAMA, V51, P9; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; Chen MG, 2014, J NEUROPHYSIOL, V112, P1950, DOI 10.1152/jn.00283.2014; Dacheux RF, 2003, J COMP NEUROL, V456, P267, DOI 10.1002/cne.10521; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Enciso G, 2010, J COMPUT NEUROSCI, V28, P567, DOI 10.1007/s10827-010-0238-3; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Greene MJ, 2016, CELL REP, V14, P1892, DOI 10.1016/j.celrep.2016.02.001; Grzywacz NM, 2007, VISUAL NEUROSCI, V24, P647, DOI 10.1017/S0952523807070666; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hoggarth A, 2015, NEURON, V86, P276, DOI 10.1016/j.neuron.2015.02.035; Ichinose T, 2014, J NEUROSCI, V34, P8761, DOI 10.1523/JNEUROSCI.3965-13.2014; Ishii T, 2014, J PHYSIOL-LONDON, V592, P4235, DOI 10.1113/jphysiol.2014.271148; Keeley PW, 2007, J COMP NEUROL, V505, P539, DOI 10.1002/cne.21518; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Kostadinov D, 2015, ELIFE, V4, DOI 10.7554/eLife.08964; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; MILLAR TJ, 1987, NEUROSCI LETT, V74, P281, DOI 10.1016/0304-3940(87)90310-7; Morgan JL, 2013, NAT METHODS, V10, P494, DOI 10.1038/nmeth.2480; Muller LPD, 2007, J COMP NEUROL, V505, P177, DOI 10.1002/cne.21487; Munch TA, 2006, J NEUROPHYSIOL, V96, P471, DOI 10.1152/jn.00628.2005; Oesch NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012447; Park HN, 2012, OPTOMETRY VISION SCI, V89, P296, DOI 10.1097/OPX.0b013e31824529e5; Park SJH, 2014, J NEUROSCI, V34, P3976, DOI 10.1523/JNEUROSCI.5017-13.2014; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Schachter MJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000899; SMITH RG, 1992, J NEUROSCI METH, V43, P83, DOI 10.1016/0165-0270(92)90019-A; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Taylor WR, 2012, VISUAL NEUROSCI, V29, P73, DOI 10.1017/S0952523811000393; Tukker JJ, 2004, VISUAL NEUROSCI, V21, P611, DOI 10.1017/S0952523804214109; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; VANEY DI, 1989, NEUROBIOLOGY INNER R, P157; Vlasits AL, 2016, NEURON, V89, P1317, DOI 10.1016/j.neuron.2016.02.020; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Yonehara K, 2013, NEURON, V79, P1078, DOI 10.1016/j.neuron.2013.08.005	47	98	99	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					105	+		10.1038/nature18609	http://dx.doi.org/10.1038/nature18609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27350241	Green Accepted			2022-12-28	WOS:000379015600033
J	Haukoos, JS; Sasson, C				Haukoos, Jason S.; Sasson, Comilla			Is Prehospital Advanced Life Support Harmful? RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Haukoos, Jason S.] Denver Hlth Med Ctr, Denver, CO 80204 USA; [Sasson, Comilla] Univ Colorado, Sch Med, Aurora, CO USA	Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Haukoos, JS (corresponding author), Denver Hlth Med Ctr, Denver, CO 80204 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS021749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106057] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Sanghavi P, 2015, ANN INTERN MED, V163, P681, DOI 10.7326/M15-0557; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stiell IG, 2007, NEW ENGL J MED, V356, P2156, DOI 10.1056/NEJMoa060334; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517	6	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					71	71		10.7326/L16-5011	http://dx.doi.org/10.7326/L16-5011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380291				2022-12-28	WOS:000379215800021
J	Usha, L; Dewdney, SB; Buckingham, LE				Usha, Lydia; Dewdney, Summer B.; Buckingham, Lela E.			Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ENDOMETRIAL CANCER; COLORECTAL-CANCER		[Usha, Lydia] Rush Univ, Med Ctr, Div Hematol Oncol & Stem Cell Transplant, Dept Med, Chicago, IL 60612 USA; [Dewdney, Summer B.] Rush Univ, Med Ctr, Div Gynecol Oncol, Dept Obstet & Gynecol, Chicago, IL 60612 USA; [Buckingham, Lela E.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA	Rush University; Rush University; Rush University	Usha, L (corresponding author), Rush Univ, Med Ctr, Div Hematol Oncol & Stem Cell Transplant, 1725 W Harrison St,Ste 809, Chicago, IL 60612 USA.	lydia_usha@rush.edu						Buchanan DD, 2014, J CLIN ONCOL, V32, P90, DOI 10.1200/JCO.2013.51.2129; Lancaster JM, 2015, GYNECOL ONCOL, V136, P3, DOI 10.1016/j.ygyno.2014.09.009; Mills AM, 2014, AM J SURG PATHOL, V38, P1501, DOI 10.1097/PAS.0000000000000321; Moline J, 2013, GYNECOL ONCOL, V130, P121, DOI 10.1016/j.ygyno.2013.04.022; Moreira L, 2012, JAMA-J AM MED ASSOC, V308, P1555, DOI 10.1001/jama.2012.13088; Palomaki GE, 2009, GENET MED, V11, P42, DOI 10.1097/GIM.0b013e31818fa2db; Vilar E, 2014, CANCER GENET-NY, V207, P495, DOI 10.1016/j.cancergen.2014.10.002	7	4	5	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					93	94		10.1001/jama.2016.8286	http://dx.doi.org/10.1001/jama.2016.8286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2MY	27380347				2022-12-28	WOS:000379037600023
J	Stahl, PL; Salmen, F; Vickovic, S; Lundmark, A; Navarro, JF; Magnusson, J; Giacomello, S; Asp, M; Westholm, JO; Huss, M; Mollbrink, A; Linnarsson, S; Codeluppi, S; Borg, A; Ponten, F; Costea, PI; Sahlen, P; Mulder, J; Bergmann, O; Lundeberg, J; Frisen, J				Stahl, Patrik L.; Salmen, Fredrik; Vickovic, Sanja; Lundmark, Anna; Navarro, Jose Fernandez; Magnusson, Jens; Giacomello, Stefania; Asp, Michaela; Westholm, Jakub O.; Huss, Mikael; Mollbrink, Annelie; Linnarsson, Sten; Codeluppi, Simone; Borg, Ake; Ponten, Fredrik; Costea, Paul Igor; Sahlen, Pelin; Mulder, Jan; Bergmann, Olaf; Lundeberg, Joakim; Frisen, Jonas			Visualization and analysis of gene expression in tissue sections by spatial transcriptomics	SCIENCE			English	Article							CELL RNA-SEQ; ORGANIZATION	Analysis of the pattern of proteins or messenger RNAs (mRNAs) in histological tissue sections is a cornerstone in biomedical research and diagnostics. This typically involves the visualization of a few proteins or expressed genes at a time. We have devised a strategy, which we call "spatial transcriptomics," that allows visualization and quantitative analysis of the transcriptome with spatial resolution in individual tissue sections. By positioning histological sections on arrayed reverse transcription primers with unique positional barcodes, we demonstrate high-quality RNA-sequencing data with maintained two-dimensional positional information from the mouse brain and human breast cancer. Spatial transcriptomics provides quantitative gene expression data and visualization of the distribution of mRNAs within tissue sections and enables novel types of bioinformatics analyses, valuable in research and diagnostics.	[Stahl, Patrik L.; Navarro, Jose Fernandez; Magnusson, Jens; Bergmann, Olaf; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Stahl, Patrik L.; Salmen, Fredrik; Vickovic, Sanja; Lundmark, Anna; Navarro, Jose Fernandez; Giacomello, Stefania; Asp, Michaela; Mollbrink, Annelie; Costea, Paul Igor; Sahlen, Pelin; Lundeberg, Joakim] KTH Royal Inst Technol, Div Gene Technol, Sci Life Lab, SE-10691 Stockholm, Sweden; [Lundmark, Anna] Karolinska Inst, Div Periodontol, Dept Dent Med, SE-14104 Huddinge, Sweden; [Westholm, Jakub O.; Huss, Mikael] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Box 1031, SE-17121 Solna, Sweden; [Linnarsson, Sten; Codeluppi, Simone] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurosci, SE-17177 Stockholm, Sweden; [Codeluppi, Simone] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Borg, Ake] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, SE-22381 Lund, Sweden; [Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Mulder, Jan] Karolinska Inst, Dept Neurosci, Sci Life Lab, SE-17177 Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology; Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska Institutet; Lund University; Uppsala University; Karolinska Institutet	Lundeberg, J (corresponding author), KTH Royal Inst Technol, Div Gene Technol, Sci Life Lab, SE-10691 Stockholm, Sweden.	joakim.lundeberg@scilifelab.se	Sahlen, Pelin/AAJ-1824-2021; Bergmann, Olaf/A-5706-2009; Linnarsson, Sten/HCH-3909-2022; Mulder, Jan/G-3909-2011; Vickovic, Sanja/AAD-6473-2022; Mulder, Jan/AAG-9761-2021; huang, dezhi/ABC-6566-2021; Salmen, Fredrik/J-6899-2016	Bergmann, Olaf/0000-0003-1065-4107; Mulder, Jan/0000-0003-3717-5018; Vickovic, Sanja/0000-0003-0985-9885; Giacomello, Stefania/0000-0003-0738-1574; Salmen, Fredrik/0000-0001-8728-3709; Magnusson, Jens/0000-0002-3928-8959; Huss, Mikael/0000-0003-0839-2451; Costea, Paul Igor/0000-0003-1645-3947; Fernandez Navarro, Jose/0000-0002-4035-5258; Westholm, Jakub/0000-0002-6849-6220	Knut och Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; Swedish Research Council; Swedish Cancer Society; Karolinska Institute; Tobias Stiftelsen; Torsten Soderbergs Stiftelse; Ragnar Soderbergs Stiftelse; StratRegen; Ake Wiberg Foundation; Jeansson Foundations; BioProject [PRJNA316587]	Knut och Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; Torsten Soderbergs Stiftelse; Ragnar Soderbergs Stiftelse; StratRegen; Ake Wiberg Foundation; Jeansson Foundations; BioProject	We thank K. Meletis and M. Nilsson for discussions. This study was supported by Knut och Alice Wallenberg Foundation, the Swedish Foundation for Strategic Research, the Swedish Research Council, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, Torsten Soderbergs Stiftelse, Ragnar Soderbergs Stiftelse, StratRegen, Ake Wiberg Foundation, and the Jeansson Foundations. P.L.S. was supported by a postdoctoral fellowship from the Swedish Research Council. We thank the Swedish National Genomics Infrastructure hosted at SciLifeLab, as well as the Swedish National Infrastructure for Computing-Uppsala Multidisciplinary Center for Advanced Computational Science and Bioinformatics Long-Term Support for providing sequencing and computational assistance and infrastructure. The sequencing data are deposited at the National Center for Biotechnology Information, NIH, with BioProject ID PRJNA316587. Gene counts and scripts can be downloaded from www.spatialtranscriptomicsresearch.org. P.L.S., F.S., J.L., and J.F. are authors on patents applied for by Spatial Transcriptomics AB covering the technology.	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Combs PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071820; Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Grun D, 2015, CELL, V163, P799, DOI 10.1016/j.cell.2015.10.039; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Kittaneh Muaiad, 2013, Biomark Cancer, V5, P61, DOI 10.4137/BIC.S9455; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mahfouz A, 2015, METHODS, V73, P79, DOI 10.1016/j.ymeth.2014.10.004; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zechel S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0486-z	16	902	950	68	392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					78	82		10.1126/science.aaf2403	http://dx.doi.org/10.1126/science.aaf2403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365449				2022-12-28	WOS:000378816200040
J	Chandesris, MO; Damaj, G; Canioni, D; Brouzes, C; Lhermitte, L; Hanssens, K; Frenzel, L; Cherquaoui, Z; Durieu, I; Durupt, S; Gyan, E; Beyne-Rauzy, O; Launay, D; Faure, C; Hamidou, M; Besnard, S; Diouf, M; Schiffmann, A; Niault, M; Jeandel, PY; Ranta, D; Gressin, R; Chantepie, S; Barete, S; Dubreuil, P; Bourget, P; Lortholary, O; Hermine, O				Chandesris, Marie-Olivia; Damaj, Gandhi; Canioni, Danielle; Brouzes, Chantal; Lhermitte, Ludovic; Hanssens, Katia; Frenzel, Laurent; Cherquaoui, Zoubair; Durieu, Isabelle; Durupt, Stephane; Gyan, Emmanuel; Beyne-Rauzy, Odille; Launay, David; Faure, Cyril; Hamidou, Mohamed; Besnard, Sophie; Diouf, Momar; Schiffmann, Aurelie; Niault, Mathilde; Jeandel, Pierre-Yves; Ranta, Dana; Gressin, Remi; Chantepie, Sylvain; Barete, Stephane; Dubreuil, Patrice; Bourget, Philippe; Lortholary, Olivier; Hermine, Olivier		Ceremast Study Grp	Midostaurin in Advanced Systemic Mastocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Chandesris, Marie-Olivia] French Natl Reference Ctr Mastocytosis CERE MAST, Paris, France; [Damaj, Gandhi; Chantepie, Sylvain] Univ Lower Normandy, Sch Med, Caen, France; [Canioni, Danielle; Brouzes, Chantal; Lhermitte, Ludovic; Frenzel, Laurent; Cherquaoui, Zoubair; Bourget, Philippe; Lortholary, Olivier] Necker Univ Hosp, Paris, France; [Hanssens, Katia; Dubreuil, Patrice] Paoli Calmettes Inst, Marseille, France; [Durieu, Isabelle; Durupt, Stephane] Lyon Sud Univ Hosp, Lyon, France; [Gyan, Emmanuel] Tours Univ Hosp, Tours, France; [Beyne-Rauzy, Odille] Purpan Univ Hosp, Toulouse, France; [Launay, David] Lille Univ Hosp, Lille, France; [Faure, Cyril] Vesoul Reg Univ Hosp, Vesoul, France; [Hamidou, Mohamed] Hotel Dieu Univ Hosp, Nantes, France; [Besnard, Sophie] Rennes Univ Hosp, Rennes, France; [Diouf, Momar] Amiens Univ Hosp, Amiens, France; [Schiffmann, Aurelie] St Eloi Univ Hosp, Montpellier, France; [Niault, Mathilde] Bretagne Sud Reg Hosp, Lorient, France; [Jeandel, Pierre-Yves] Archet 1 Univ Hosp, Nice, France; [Ranta, Dana] Nancy Univ Hosp, Nancy, France; [Gressin, Remi] Grenoble Univ Hosp, Grenoble, France; [Barete, Stephane] Tenon Univ Hosp, Paris, France; [Hermine, Olivier] Imagine Inst, Paris, France	Universite de Caen Normandie; Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut Paoli-Calmette (IPC); CHU Lyon; CHU Tours; CHU de Toulouse; Universite de Lille - ISITE; CHU Lille; Nantes Universite; CHU de Nantes; CHU Rennes; Universite de Rennes; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite de Montpellier; CHU de Montpellier; CHU Nice; CHU de Nancy; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Hermine, O (corresponding author), Imagine Inst, Paris, France.	ohermine@gmail.com	Launay, David/H-1674-2016; Launay, David/A-5270-2018; Hermine, Olivier/Q-7072-2018; Remy, GRESSIN/G-7303-2014; Jeandel, Pierre-Yves/ABD-6658-2020; Dubreuil, Patrice/V-4816-2019; dubreuil, patrice/F-5346-2011	Launay, David/0000-0003-1840-1817; Launay, David/0000-0003-1840-1817; Remy, GRESSIN/0000-0002-9188-3501; Dubreuil, Patrice/0000-0003-1155-1150; dubreuil, patrice/0000-0003-1155-1150; Hermine, Olivier/0000-0003-2574-3874; GYAN, Emmanuel/0000-0002-7651-9189; CHANDESRIS, Marie-Olivia/0000-0002-9795-1085; Chantepie, Sylvain P/0000-0003-0457-2252				Gotlib J, 2013, BLOOD, V121, P2393, DOI 10.1182/blood-2012-09-458521; Growney JD, 2005, BLOOD, V106, P721, DOI 10.1182/blood-2004-12-4617; Horny AC, 2008, WHO CLASSIFICATION T, P53; Lim KH, 2009, BLOOD, V113, P5727, DOI 10.1182/blood-2009-02-205237	4	41	42	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2605	2607		10.1056/NEJMc1515403	http://dx.doi.org/10.1056/NEJMc1515403			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8DD	27355555				2022-12-28	WOS:000378727200029
J	Meckler, N				Meckler, Nele			EARTH SCIENCE An extended yardstick for climate variability	NATURE			English	Editorial Material							MONSOON		[Meckler, Nele] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; [Meckler, Nele] Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway	University of Bergen; Bjerknes Centre for Climate Research; University of Bergen	Meckler, N (corresponding author), Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway.; Meckler, N (corresponding author), Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway.	nele.meckler@uib.no	Meckler, Anna Nele/AAC-2490-2020	Meckler, Anna Nele/0000-0002-7225-8276				Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Barker S, 2011, SCIENCE, V334, P347, DOI 10.1126/science.1203580; Cheng H, 2016, NATURE, V534, P640, DOI 10.1038/nature18591; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; DANSGAARD W, 1964, TELLUS, V16, P436; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Huybers P, 2011, NATURE, V480, P229, DOI 10.1038/nature10626; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Ruddiman W., 2013, EARTHSCLIMATE FUTURE; Stocker TF, 1998, SCIENCE, V282, P61, DOI 10.1126/science.282.5386.61; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618	12	1	3	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					626	628		10.1038/534626a	http://dx.doi.org/10.1038/534626a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357790				2022-12-28	WOS:000378676000024
J	Wise, J				Wise, Jacqui			Significant numbers of consultant obstetricians and gynaecologists report bullying	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Shabazz T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011462	1	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2016	353								i3576	10.1136/bmj.i3576	http://dx.doi.org/10.1136/bmj.i3576			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FG	27352921				2022-12-28	WOS:000379017000008
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Our messy divorce from the EU	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				European Union, FOUND PRINC UN; Kirk A, 2016, DAILY TELEGRAPH; McCann K, 2016, DAILY TELEGRAPH; Vote Leave Take Control, VOT REM IS RISK OP	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2016	353								i3551	10.1136/bmj.i3551	http://dx.doi.org/10.1136/bmj.i3551			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8CA	27343264	Bronze, Green Published			2022-12-28	WOS:000378724300003
J	Verba, KA; Wang, RYR; Arakawa, A; Liu, YX; Shirouzu, M; Yokoyama, S; Agard, DA				Verba, Kliment A.; Wang, Ray Yu-Ruei; Arakawa, Akihiko; Liu, Yanxin; Shirouzu, Mikako; Yokoyama, Shigeyuki; Agard, David A.			STRUCTURAL BIOLOGY Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase	SCIENCE			English	Article							EUKARYOTIC PROTEIN-KINASES; MOLECULAR CHAPERONE HSP90; CRYSTAL-STRUCTURE; COMPLEX; BINDING; CDC37; CLIENT; DOMAIN; TRANSITIONS; ACTIVATION	The Hsp90 molecular chaperone and its Cdc37 cochaperone help stabilize and activate more than half of the human kinome. However, both the mechanism by which these chaperones assist their "client" kinases and the reason why some kinases are addicted to Hsp90 while closely related family members are independent are unknown. Our structural understanding of these interactions is lacking, as no full-length structures of human Hsp90, Cdc37, or either of these proteins with a kinase have been elucidated. Here we report a 3.9 angstrom cryo-electron microscopy structure of the Hsp90-Cdc37-Cdk4 kinase complex. Surprisingly, the two lobes of Cdk4 are completely separated with the beta 4-beta 5 sheet unfolded. Cdc37 mimics part of the kinase N lobe, stabilizing an open kinase conformation by wedging itself between the two lobes. Finally, Hsp90 clamps around the unfolded kinase beta 5 strand and interacts with exposed N- and C-lobe interfaces, protecting the kinase in a trapped unfolded state. On the basis of this structure and an extensive amount of previously collected data, we propose unifying conceptual and mechanistic models of chaperone-kinase interactions.	[Verba, Kliment A.; Wang, Ray Yu-Ruei; Liu, Yanxin; Agard, David A.] Univ Calif San Francisco, HHMI, San Francisco, CA 94158 USA; [Verba, Kliment A.; Wang, Ray Yu-Ruei; Liu, Yanxin; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Arakawa, Akihiko; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; RIKEN	Agard, DA (corresponding author), Univ Calif San Francisco, HHMI, San Francisco, CA 94158 USA.; Agard, DA (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu	Yokoyama, Shigeyuki/N-6911-2015; Liu, Yanxin/D-8633-2011; Shirouzu, Mikako/A-6521-2016	Yokoyama, Shigeyuki/0000-0003-3133-7338; Liu, Yanxin/0000-0002-2253-3698; 	Protein Structure Initiative-Biology grant [U01 GM098254]; American Association for Cancer Research-Breast Cancer Research Foundation grant [218084]; HHMI Helen Hay Whitney Foundation; HHMI International Student Research Fellowship; HHMI; NIH National Institute of General Medical Sciences [9 P41 GM103310]; NSF [ACI-1053575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, U01GM098254] Funding Source: NIH RePORTER	Protein Structure Initiative-Biology grant; American Association for Cancer Research-Breast Cancer Research Foundation grant; HHMI Helen Hay Whitney Foundation; HHMI International Student Research Fellowship; HHMI(Howard Hughes Medical Institute); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of NRAMM-Scripps for help with collecting data; Y. Fan for the yeast expression vector; N. Ohbayashi and M. Niino (RIKEN Center for Life Science Technologies) for help with Sf9 protein expression; N. F. Rebbe (University of North Carolina at Chapel Hill) and E. Laue (University of Cambridge) for the plasmids encoding human HSP90b and Cdc37, respectively; D.A.A.'s lab members for helpful discussions; and N. Jura for reading the manuscript. Support for this work was provided by Protein Structure Initiative-Biology grant U01 GM098254 (to D. A. A.), American Association for Cancer Research-Breast Cancer Research Foundation grant 218084 for Translational Breast Cancer Research (to D. A. A.), a gift from the Cabala family (to D. A. A.), an HHMI Helen Hay Whitney Foundation Fellowship (to Y.L.), an HHMI International Student Research Fellowship (to K.A.V.), and the HHMI (to D. A. A.). Some of the work presented here was conducted at NRAMM, which is supported by a grant from the NIH National Institute of General Medical Sciences (9 P41 GM103310). Some of the work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by NSF grant ACI-1053575.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Boczek EE, 2015, P NATL ACAD SCI USA, V112, pE3189, DOI 10.1073/pnas.1424342112; BRUGGE J, 1983, MOL CELL BIOL, V3, P9, DOI 10.1128/MCB.3.1.9; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Eckl JM, 2015, J BIOL CHEM, V290, P30843, DOI 10.1074/jbc.M115.693150; Eckl JM, 2013, J BIOL CHEM, V288, P16032, DOI 10.1074/jbc.M112.439257; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Hartson SD, 1999, BIOCHEMISTRY-US, V38, P3837, DOI 10.1021/bi983027s; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lachowiec J, 2015, MOL BIOL EVOL, V32, P91, DOI 10.1093/molbev/msu270; Lavery LA, 2014, MOL CELL, V53, P330, DOI 10.1016/j.molcel.2013.12.023; Liu WJ, 2015, BIOCHEMISTRY-US, V54, P1493, DOI 10.1021/bi501129g; Mayer MP, 2015, MOL CELL, V58, P8, DOI 10.1016/j.molcel.2015.02.022; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Tsutsumi S, 2012, P NATL ACAD SCI USA, V109, P2937, DOI 10.1073/pnas.1114414109; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	34	243	247	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1542	1547		10.1126/science.aaf5023	http://dx.doi.org/10.1126/science.aaf5023			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339980	Green Accepted, Green Submitted			2022-12-28	WOS:000378346500035
J	Riley, RD; Ensor, J; Snell, KIE; Debray, TPA; Altman, DG; Moons, KGM; Collins, GS				Riley, Richard D.; Ensor, Joie; Snell, Kym I. E.; Debray, Thomas P. A.; Altman, Doug G.; Moons, Karel G. M.; Collins, Gary S.			External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDIVIDUAL PARTICIPANT DATA; DEEP-VEIN THROMBOSIS; PROGNOSTIC MODEL; INTERNAL VALIDATION; CARDIOVASCULAR RISK; DIAGNOSIS TRIPOD; WELLS RULE; BIAS; PROBABILITY; PERFORMANCE	Access to big datasets from e-health records and individual participant data (IPD) meta-analysis is signalling a new advent of external validation studies for clinical prediction models. In this article, the authors illustrate novel opportunities for external validation in big, combined datasets, while drawing attention to methodological challenges and reporting issues.	[Riley, Richard D.; Ensor, Joie] Keele Univ, Res Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England; [Snell, Kym I. E.] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Debray, Thomas P. A.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Debray, Thomas P. A.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Cochrane Netherlands, Utrecht, Netherlands; [Altman, Doug G.; Collins, Gary S.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England	Keele University; University of Birmingham; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Oxford	Riley, RD (corresponding author), Keele Univ, Res Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England.	r.riley@keele.ac.uk	Debray, Thomas/J-7413-2012; Ensor, Joie/AAE-9109-2019; Riley, Richard David/ABE-5877-2020; Snell, Kym/L-1918-2015; Collins, Gary Stephen/A-2258-2014	Debray, Thomas/0000-0002-1790-2719; Ensor, Joie/0000-0001-7481-0282; Riley, Richard David/0000-0001-8699-0735; Snell, Kym/0000-0001-9373-6591; Collins, Gary Stephen/0000-0002-2772-2316	Medical Research Council (MRC) [G0902393]; MRC [MR/J013595/1, G1100513]; Netherlands Organisation for Scientific Research [9120.8004, 918.10.015]; MRC [G0902393] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [G0902393, G1100513, MR/J013595/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10131] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	RDR and DGA received funding from a Medical Research Council (MRC) partnership grant for the PROGnosis RESearch Strategy (PROGRESS) group (grant reference no G0902393). RDR also received funding from an MRC methodology research grant (grant reference no MR/J013595/1). KGMM receives finding from the Netherlands Organisation for Scientific Research (project 9120.8004 and 918.10.015). GSC and DGA have received MRC funding (grant no G1100513)	Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Ahmed Ikhlaaq, 2012, BMJ, V344, pd7762, DOI 10.1136/bmj.d7762; Ahmed I, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-3; Altman DG, 2007, STAT IND TECHNOL, P3, DOI 10.1007/978-0-8176-4542-7_1; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 2012, BRIT MED J, DOI DOI 10.1136/BMJ.E4181; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Collins GS, 2016, STAT MED, V35, P214, DOI 10.1002/sim.6787; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Collins GS, 2012, CURR OSTEOPOROS REP, V10, P199, DOI 10.1007/s11914-012-0108-1; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Cook JA, 2015, BRIT J SURG, V102, pE93, DOI 10.1002/bjs.9723; Dalton ARH, 2014, ETHNIC HEALTH, V19, P367, DOI 10.1080/13557858.2013.797568; Debray TPA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001886; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; Debray TPA, 2013, STAT MED, V32, P3158, DOI 10.1002/sim.5732; Debray TPA, 2012, STAT MED, V31, P2697, DOI 10.1002/sim.5412; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Geersing GJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1340; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Hingorani AD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5793; Hippisley-Cox J., 2014, VALIDATION QRISK2 20; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Jinks RC, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0078-y; Jolani S, 2015, STAT MED, V34, P1841, DOI 10.1002/sim.6451; Knottnerus JA, 2002, J CLIN EPIDEMIOL, V55, P1201, DOI 10.1016/S0895-4356(02)00528-0; Krumholz HM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h599; Leeflang MMG, 2013, CAN MED ASSOC J, V185, pE537, DOI 10.1503/cmaj.121286; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-21; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Ogundimu Emmanuel O, 2016, J Clin Epidemiol, V76, P175, DOI 10.1016/j.jclinepi.2016.02.031; Oudega R, 2005, ANN INTERN MED, V143, P100, DOI 10.7326/0003-4819-143-2-200507190-00008; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pennells L, 2014, AM J EPIDEMIOL, V179, P621, DOI 10.1093/aje/kwt298; Qin GS, 2008, STAT METHODS MED RES, V17, P207, DOI 10.1177/0962280207087173; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Resche-Rigon M, 2013, STAT MED, V32, P4890, DOI 10.1002/sim.5894; Riley RD, 2015, STAT MED, V34, P2081, DOI 10.1002/sim.6471; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Royston P, 2004, STAT MED, V23, P907, DOI 10.1002/sim.1691; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Sauerbrei W, 2005, ADV OTO-RHINO-LARYNG, V62, P184; Schuetz P, 2008, EPIDEMIOL INFECT, V136, P1628, DOI 10.1017/S0950268808000435; Snell KIE, 2016, J CLIN EPIDEMIOL, V69, P40, DOI 10.1016/j.jclinepi.2015.05.009; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tierney JF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001855; Tillin T, 2014, HEART, V100, P437, DOI 10.1136/heartjnl-2013-305333; Vale CL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1088; Van Calster B, 2016, J CLIN EPIDEMIOL, V74, P167, DOI 10.1016/j.jclinepi.2015.12.005; van Klaveren D, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-5; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Willis BH, 2014, J CLIN EPIDEMIOL, V67, P538, DOI 10.1016/j.jclinepi.2013.10.016; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539; Wynants L, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-128	81	225	226	6	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i3140	10.1136/bmj.i3140	http://dx.doi.org/10.1136/bmj.i3140			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27334381	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000378723500006
J	Eaton, CB				Eaton, Charles B.			Review: Providing genetic-based risk estimates for disease does not affect risk-reducing behaviors in adults Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTERVENTIONS; METAANALYSIS		[Eaton, Charles B.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA	Brown University	Eaton, CB (corresponding author), Brown Univ, Alpert Med Sch, Providence, RI 02912 USA.							Lara J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0177-3; O'Brien N, 2015, HEALTH PSYCHOL REV, V9, P417, DOI 10.1080/17437199.2015.1012177; Patnode CD, 2015, ANN INTERN MED, V163, P608, DOI 10.7326/M15-0171	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					JC65	JC65		10.7326/ACPJC-2016-164-12-065	http://dx.doi.org/10.7326/ACPJC-2016-164-12-065			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323261				2022-12-28	WOS:000379343000004
J	Le, P; Rothberg, MB				Phuc Le; Rothberg, Michael B.			Zoster Vaccination for Persons Aged 50 to 59 Years RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							HERPES-ZOSTER; POSTHERPETIC NEURALGIA; EFFICACY		[Phuc Le; Rothberg, Michael B.] Cleveland Clin, Inst Med, Ctr Value Based Care Res, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Le, P (corresponding author), Cleveland Clin, Inst Med, Ctr Value Based Care Res, Cleveland, OH 44106 USA.							Drolet M, 2012, VACCINE, V30, P2047, DOI 10.1016/j.vaccine.2012.01.045; Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184; Li XM, 2015, VACCINE, V33, P1499, DOI 10.1016/j.vaccine.2014.10.039; Morrison VA, 2015, CLIN INFECT DIS, V60, P900, DOI 10.1093/cid/ciu918; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Preaud E, 2015, HUM VACC IMMUNOTHER, V11, P884, DOI 10.1080/21645515.2015.1011561	6	0	0	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					850	851		10.7326/L15-0587	http://dx.doi.org/10.7326/L15-0587			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323254				2022-12-28	WOS:000379343000021
J	Choi, E; Zhang, XL; Xing, C; Yu, HT				Choi, Eunhee; Zhang, Xiangli; Xing, Chao; Yu, Hongtao			Mitotic Checkpoint Regulators Control Insulin Signaling and Metabolic Homeostasis	CELL			English	Article							MAD2; RECEPTOR; PROTEIN; CDC20; RESISTANCE; KINETOCHORES; ANEUPLOIDY; INHIBITOR; LONGEVITY; GENE	Insulin signaling regulates many facets of animal physiology. Its dysregulation causes diabetes and other metabolic disorders. The spindle checkpoint proteins MAD2 and BUBR1 prevent precocious chromosome segregation and suppress aneuploidy. The MAD2 inhibitory protein p31(comet) promotes checkpoint inactivation and timely chromosome segregation. Here, we show that whole-body p31(comet) knockout mice die soon after birth and have reduced hepatic glycogen. Liver-specific ablation of p31(comet) causes insulin resistance, hyperinsulinemia, glucose intolerance, and hyperglycemia and diminishes the plasma membrane localization of the insulin receptor (IR) in hepatocytes. MAD2 directly binds to IR and facilitates BUBR1-dependent recruitment of the clathrin adaptor AP2 to IR. p31(comet) blocks the MAD2-BUBR1 interaction and prevents spontaneous clathrin-mediated IR endocytosis. BUBR1 deficiency enhances insulin sensitivity in mice. BUBR1 depletion in hepatocytes or the expression of MAD2-binding-deficient IR suppresses the metabolic phenotypes of p31(comet) ablation. Our findings establish a major IR regulatory mechanism and link guardians of chromosome stability to nutrient metabolism.	[Choi, Eunhee; Yu, Hongtao] Univ Texas Southwestern Med Ctr, Howard Hughes Med Inst, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Zhang, Xiangli; Xing, Chao] Univ Texas Southwestern Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Bioinformat Core, 6001 Forest Pk Rd, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, HT (corresponding author), Univ Texas Southwestern Med Ctr, Howard Hughes Med Inst, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu	Choi, Eunhee/AAM-2772-2020	Choi, Eunhee/0000-0003-3286-6477; Xing, Chao/0000-0002-1838-0502	Clayton Foundation; NIH [UL1TR001105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	Clayton Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank Xuemin Zhang for assistance with generating the p31<SUP>F/F</SUP> mice, Jan van Deursen for providing the Bub1b<SUP>H/H</SUP> mice and other reagents, Mayuko Hara for performing ITC, Bing Li for preparing BUBR1N, Min Kim for advice on adenovirus production, Ralph DeBerardinis for providing 293FT and HepG2 cells, Vanessa Schmid and Rachel Bruce for single-cell sequencing, John Shelton and James Richardson for advice on histological analysis, and Xuelian Luo for advice on protein purification. We are grateful to anonymous reviewers for suggesting the genetic suppression experiments. This work is supported, in part, by grants from the Clayton Foundation (to H.Y.) and the NIH (UL1TR001105 to C.X.). H.Y. is an HHMI Investigator.	Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Boucher J, 2014, COLD SPRING HARB PER, V6; Cayrol C, 2002, BIOCHEM BIOPH RES CO, V298, P720, DOI 10.1016/S0006-291X(02)02522-6; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Girard J, 1998, BIOCHEM SOC T, V26, P69, DOI 10.1042/bst0260069; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Izawa D, 2015, NATURE, V517, P631, DOI 10.1038/nature13911; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Knouse KA, 2014, P NATL ACAD SCI USA, V111, P13409, DOI 10.1073/pnas.1415287111; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Malureanu L, 2010, J CELL BIOL, V191, P313, DOI 10.1083/jcb.201003090; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nelson KK, 1999, BIOCHEM J, V343, P673, DOI 10.1042/0264-6021:3430673; ONeill TJ, 1997, J BIOL CHEM, V272, P10035; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048	36	62	63	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					567	581		10.1016/j.cell.2016.05.074	http://dx.doi.org/10.1016/j.cell.2016.05.074			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27374329	Green Accepted, Bronze			2022-12-28	WOS:000380546500010
J	Reed, T				Reed, Terry			GIRES: e-learning for transgender health training	LANCET			English	Editorial Material									[Reed, Terry] GIRES, London, England		Reed, T (corresponding author), GIRES, London, England.	info@gires.org.uk							0	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					333	333		10.1016/S0140-6736(16)30838-8	http://dx.doi.org/10.1016/S0140-6736(16)30838-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR6MV	27323917				2022-12-28	WOS:000380016900023
J	Scialdone, A; Tanaka, Y; Jawaid, W; Moignard, V; Wilson, NK; Macaulay, IC; Marioni, JC; Gottgens, B				Scialdone, Antonio; Tanaka, Yosuke; Jawaid, Wajid; Moignard, Victoria; Wilson, Nicola K.; Macaulay, Iain C.; Marioni, John C.; Gottgens, Berthold			Resolving early mesoderm diversification through single-cell expression profiling	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION; PRIMITIVE STREAK; MOUSE EMBRYOS; RNA-SEQ; HEMOGENIC ENDOTHELIUM; CLONAL ANALYSIS; EPIBLAST CELLS; GERM LAYER; BLOOD	In mammals, specification of the three major germ layers occurs during gastrulation, when cells ingressing through the primitive streak differentiate into the precursor cells of major organ systems. However, the molecular mechanisms underlying this process remain unclear, as numbers of gastrulating cells are very limited. In the mouse embryo at embryonic day 6.5, cells located at the junction between the extra-embryonic region and the epiblast on the posterior side of the embryo undergo an epithelial-to-mesenchymal transition and ingress through the primitive streak. Subsequently, cells migrate, either surrounding the prospective ectoderm contributing to the embryo proper, or into the extra-embryonic region to form the yolk sac, umbilical cord and placenta. Fate mapping has shown that mature tissues such as blood and heart originate from specific regions of the-pre-gastrula epiblast(1), but the plasticity of cells within the embryo and the function of key cell-type-specific transcription factors remain unclear. Here we analyse 1,205 cells from the epiblast and nascent Flk1(+) mesoderm of gastrulating mouse embryos using single-cell RNA sequencing, representing the first transcriptome-wide in vivo view of early mesoderm formation during mammalian gastrulation. Additionally, using knockout mice, we study the function of Tal1, a key haematopoietic transcription factor, and demonstrate, contrary to previous studies performed using retrospective assays(2,3), that Tal1 knockout does not immediately bias precursor cells towards a cardiac fate.	[Scialdone, Antonio; Marioni, John C.] EMBL European Bioinformat Inst EMBL EBI, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Scialdone, Antonio; Macaulay, Iain C.; Marioni, John C.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Tanaka, Yosuke; Jawaid, Wajid; Moignard, Victoria; Wilson, Nicola K.; Gottgens, Berthold] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Tanaka, Yosuke; Jawaid, Wajid; Moignard, Victoria; Wilson, Nicola K.; Gottgens, Berthold] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge, England; [Marioni, John C.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Tanaka, Yosuke] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Tokyo	Marioni, JC (corresponding author), EMBL European Bioinformat Inst EMBL EBI, Wellcome Genome Campus, Cambridge CB10 1SD, England.; Marioni, JC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.; Gottgens, B (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England.; Gottgens, B (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge, England.; Marioni, JC (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England.	marioni@ebi.ac.uk; bg200@cam.ac.uk	Jawaid, Wajid/L-3625-2016	Jawaid, Wajid/0000-0002-4861-6694; Marioni, John/0000-0001-9092-0852; Macaulay, Iain/0000-0002-6761-757X; Scialdone, Antonio/0000-0002-4956-2843; Gottgens, Berthold/0000-0001-6302-5705	Medical Research Council; Cancer Research UK; Biotechnology and Biological Sciences Research Council; Bloodwise; Leukemia and Lymphoma Society; Sanger-EBI Single Cell Centre; Wellcome Trust [105031/D/14/Z]; European Molecular Biology Laboratory; Japan Society for the Promotion of Science; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [MR/M008975/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [22231, 12765] Funding Source: researchfish; Medical Research Council [MC_PC_12009, MR/M008975/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bloodwise; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Sanger-EBI Single Cell Centre; Wellcome Trust(Wellcome Trust); European Molecular Biology Laboratory; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. de Bruijn, A. Martinez-Arias J. Nichols and C. Mulas for discussion, the Cambridge Institute for Medical Research Flow Cytometry facility for their expertise in single-cell index sorting, and S. Lorenz from the Sanger Single Cell Genomics Core for supervising purification of Tal1<SUP>-/-</SUP> sequencing libraries. ChIP-seq reads were processed by R. Hannah. Research in the authors laboratories is supported by the Medical Research Council, Cancer Research UK, the Biotechnology and Biological Sciences Research Council, Bloodwise, the Leukemia and Lymphoma Society, and the Sanger-EBI Single Cell Centre, and by core support grants from the Wellcome Trust to the Cambridge Institute for Medical Research and Wellcome Trust - MRC Cambridge Stem Cell Institute and by core funding from Cancer Research UK and the European Molecular Biology Laboratory. Y.T. was supported by a fellowship from the Japan Society for the Promotion of Science. W.J. is a Wellcome Trust Clinical Research Fellow. A.S. is supported by the Sanger-EBI Single Cell Centre. This work was funded as part of Wellcome Trust Strategic Award 105031/D/14/Z 'Tracing early mammalian lineage decisions by single-cell genomics' awarded to W. Reik, S. Teichmann. J. Nichols, B. Simons, T. Voet, S. Srinivas, L. Vanier, B. Gottgens and J. Marioni.	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angerer P., 2015, BIORXIV; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Batta K, 2014, CELL REP, V9, P1871, DOI 10.1016/j.celrep.2014.11.002; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bheda P, 2014, TRENDS CELL BIOL, V24, P712, DOI 10.1016/j.tcb.2014.08.010; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Brown CB, 2004, DEV BIOL, V267, P190, DOI 10.1016/j.ydbio.2003.10.024; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Burnham K. P., 2002, MODEL SELECTION MULT; Burtscher I, 2009, DEVELOPMENT, V136, P1029, DOI 10.1242/dev.028415; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Chintala S, 2007, BLOOD, V109, P1533, DOI 10.1182/blood-2006-08-040196; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Downs KM, 2004, DEVELOPMENT, V131, P37, DOI 10.1242/dev.00906; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Du JG, 2010, DEV BIOL, V346, P25, DOI 10.1016/j.ydbio.2010.07.008; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Ema M, 2006, BLOOD, V108, P4018, DOI 10.1182/blood-2006-03-012872; Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Goode DK, 2016, DEV CELL, V36, P572, DOI 10.1016/j.devcel.2016.01.024; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Henke C, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0138-8; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Isern J, 2011, BLOOD, V117, P4924, DOI 10.1182/blood-2010-10-313676; Joshi A, 2013, EXP HEMATOL, V41, P354, DOI 10.1016/j.exphem.2012.11.008; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kingsley PD, 2004, BLOOD, V104, P19, DOI 10.1182/blood-2003-12-4162; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lania G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138525; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitsunaga K, 2004, MECH DEVELOP, V121, P237, DOI 10.1016/j.mod.2004.01.006; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Naiche LA, 2011, DEV DYNAM, V240, P2290, DOI 10.1002/dvdy.22731; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; North T, 1999, DEVELOPMENT, V126, P2563; Oginuma M, 2008, DEVELOPMENT, V135, P2555, DOI 10.1242/dev.019877; Org T, 2015, EMBO J, V34, P759, DOI 10.15252/embj.201490542; Padron-Barthe L, 2014, BLOOD, V124, P2523, DOI 10.1182/blood-2013-12-545939; PALIS J, 1995, BLOOD, V86, P156, DOI 10.1182/blood.V86.1.156.bloodjournal861156; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Perea-Gomez A, 1999, DEVELOPMENT, V126, P4499; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Robertson EJ, 2014, SEMIN CELL DEV BIOL, V32, P73, DOI 10.1016/j.semcdb.2014.03.028; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rozbicki E, 2015, NAT CELL BIOL, V17, P397, DOI 10.1038/ncb3138; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 2007, DEV DYNAM, V236, P1450, DOI 10.1002/dvdy.21143; Sanchez-Castillo M, 2015, NUCLEIC ACIDS RES, V43, pD1117, DOI 10.1093/nar/gku895; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Silver L, 1997, BLOOD, V89, P1154, DOI 10.1182/blood.V89.4.1154; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Southwood CM, 1996, DEV DYNAM, V206, P248, DOI 10.1002/(SICI)1097-0177(199607)206:3<248::AID-AJA3>3.0.CO;2-I; Sroczynska Patrycja, 2009, V538, P317, DOI 10.1007/978-1-59745-418-6_16; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tamplin OJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-511; Tanaka Y, 2014, CELL REP, V8, P31, DOI 10.1016/j.celrep.2014.05.055; Tanaka Y, 2012, DEV BIOL, V366, P404, DOI 10.1016/j.ydbio.2012.03.024; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; van der Maaten L., 2013, PREPRINT; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; van Nes J, 2006, DEVELOPMENT, V133, P419, DOI 10.1242/dev.02216; Vincent SD, 2014, HUM MOL GENET, V23, P5087, DOI 10.1093/hmg/ddu232; Weidgang CE, 2013, STEM CELL REP, V1, P248, DOI 10.1016/j.stemcr.2013.08.002; Wilkinson AC, 2013, BIOL OPEN, V2, P1229, DOI 10.1242/bio.20136296; Wilkinson D. G., 1999, SITU HYBRIDIZATION; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089694; YANG JT, 1995, DEVELOPMENT, V121, P549; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596; Zhang HL, 2014, STEM CELLS, V32, P191, DOI 10.1002/stem.1536; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zwart W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-232	105	183	185	1	63	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					289	+		10.1038/nature18633	http://dx.doi.org/10.1038/nature18633			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27383781	Green Accepted			2022-12-28	WOS:000379912600058
J	Kim, K; Lee, T; Kwon, Y; Seo, Y; Song, J; Park, JK; Lee, H; Park, JY; Ihee, H; Cho, SJ; Ryoo, R				Kim, Kyoungsoo; Lee, Taekyoung; Kwon, Yonghyun; Seo, Yongbeom; Song, Jongchan; Park, Jung Ki; Lee, Hyunsoo; Park, Jeong Young; Ihee, Hyotcherl; Cho, Sung June; Ryoo, Ryong			Lanthanum-catalysed synthesis of microporous 3D graphene-like carbons in a zeolite template	NATURE			English	Article							HYDROGEN STORAGE; REPLICAS	Three-dimensional graphene architectures with periodic nanopores-reminiscent of zeolite frameworks-are of topical interest because of the possibility of combining the characteristics of graphene with a three-dimensional porous structure(1-6). Lately, the synthesis of such carbons has been approached by using zeolites as templates and small hydrocarbon molecules that can enter the narrow pore apertures(7-15). However, pyrolytic carbonization of the hydrocarbons (a necessary step in generating pure carbon) requires high temperatures and results in non-selective carbon deposition outside the pores. Here, we demonstrate that lanthanum ions embedded in zeolite pores can lower the temperature required for the carbonization of ethylene or acetylene. In this way, a graphene-like carbon structure can be selectively formed inside the zeolite template, without carbon being deposited at the external surfaces. X-ray diffraction data from zeolite single crystals after carbonization indicate that electron densities corresponding to carbon atoms are generated along the walls of the zeolite pores. After the zeolite template is removed, the carbon framework exhibits an electrical conductivity that is two orders of magnitude higher than that of amorphous mesoporous carbon. Lanthanum catalysis allows a carbon framework to form in zeolite pores with diameters of less than 1 nanometre; as such, microporous carbon nanostructures can be reproduced with various topologies corresponding to different zeolite pore sizes and shapes. We demonstrate carbon synthesis for large-pore zeolites (FAU, EMT and beta), a one-dimensional medium-pore zeolite (LTL), and even small-pore zeolites (MFI and LTA). The catalytic effect is a common feature of lanthanum, yttrium and calcium, which are all carbide-forming metal elements. We also show that the synthesis can be readily scaled up, which will be important for practical applications such as the production of lithium-ion batteries and zeolite-like catalyst supports.	[Kim, Kyoungsoo; Lee, Taekyoung; Kwon, Yonghyun; Seo, Yongbeom; Lee, Hyunsoo; Park, Jeong Young; Ihee, Hyotcherl; Ryoo, Ryong] Inst for Basic Sci Korea, Ctr Nanomat & Chem React, Daejeon 305701, South Korea; [Lee, Taekyoung; Kwon, Yonghyun; Ihee, Hyotcherl; Ryoo, Ryong] Korea Adv Inst Sci & Technol, Dept Chem, Daejeon 34141, South Korea; [Song, Jongchan; Park, Jung Ki] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Daejeon 34141, South Korea; [Park, Jeong Young] Korea Adv Inst Sci & Technol, Grad Sch EEWS, Daejeon 34141, South Korea; [Cho, Sung June] Chonnam Natl Univ, Clean Energy Technol Lab, Gwangju 61186, South Korea; [Cho, Sung June] Chonnam Natl Univ, Dept Chem Engn, Gwangju 61186, South Korea	Institute for Basic Science - Korea (IBS); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Chonnam National University; Chonnam National University	Ryoo, R (corresponding author), Inst for Basic Sci Korea, Ctr Nanomat & Chem React, Daejeon 305701, South Korea.; Ryoo, R (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Daejeon 34141, South Korea.	rryoo@kaist.ac.kr	Park, Jung-Ki/C-1966-2011; Park, Jeong Young/A-2999-2008; Ryoo, Ryong/B-1090-2009; Ihee, Hyotcherl/C-1614-2011	Park, Jeong Young/0000-0002-8132-3076; Ryoo, Ryong/0000-0003-0047-3329; Cho, Sung June/0000-0002-0030-9409	IBS-R004-D1	IBS-R004-D1	This work was supported by IBS-R004-D1. The authors thank D. Ahn at the Pohang Accelerator Laboratory (PLS) for discussions on powder XRD measurements. X-ray crystallography was carried out with help from D. Moon at PLS and H. J. Lee at Korea Basic Science Institute.	[Anonymous], 2014, APEX2 SAINT; Biener J, 2012, ADV MATER, V24, P5083, DOI 10.1002/adma.201202289; Breck D. W., 1974, ZEOLITE MOL SIEVES; Cao XH, 2014, ENERG ENVIRON SCI, V7, P1850, DOI 10.1039/c4ee00050a; Chakraborty B, 2012, J PHYS CHEM C, V116, P22502, DOI 10.1021/jp3036296; Corma A, 2003, J CATAL, V216, P298, DOI 10.1016/S0021-9517(02)00132-X; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; DAVIS ME, 1992, CHEM MATER, V4, P756, DOI 10.1021/cm00022a005; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; DELPRATO F, 1990, ZEOLITES, V10, P546, DOI 10.1016/S0144-2449(05)80310-0; Deschamps M, 2013, NAT MATER, V12, P351, DOI [10.1038/nmat3567, 10.1038/NMAT3567]; Ferchiche S, 2001, INT J INORG MATER, V3, P773, DOI 10.1016/S1466-6049(01)00046-0; Guisnet M, 2001, APPL CATAL A-GEN, V212, P83, DOI 10.1016/S0926-860X(00)00845-0; Han S, 2014, ADV MATER, V26, P849, DOI 10.1002/adma.201303115; Jiang LL, 2014, NANOSCALE, V6, P1922, DOI 10.1039/c3nr04555b; Johnson SA, 1997, CHEM MATER, V9, P2448, DOI 10.1021/cm9703278; Jun S, 2000, J AM CHEM SOC, V122, P10712, DOI 10.1021/ja002261e; Kyotani T, 2003, CARBON, V41, P1451, DOI 10.1016/S0008-6223(03)00090-3; Kyotani T, 1997, CHEM MATER, V9, P609, DOI 10.1021/cm960430h; LENOSKY T, 1992, NATURE, V355, P333, DOI 10.1038/355333a0; Liu XF, 2014, SMALL, V10, P193, DOI 10.1002/smll.201300812; Ma ZX, 2000, CHEM COMMUN, P2365, DOI 10.1039/b006295m; Ma ZX, 2001, CHEM MATER, V13, P4413, DOI 10.1021/crm0107301; MACKAY AL, 1991, NATURE, V352, P762, DOI 10.1038/352762a0; McCusker LB, 1999, J APPL CRYSTALLOGR, V32, P36, DOI 10.1107/S0021889898009856; Ning GQ, 2011, CHEM COMMUN, V47, P5976, DOI 10.1039/c1cc11159k; Nishihara H, 2009, CARBON, V47, P1220, DOI 10.1016/j.carbon.2008.12.040; Nueangnoraj K, 2013, CARBON, V62, P455, DOI 10.1016/j.carbon.2013.06.033; Odkhuu D, 2014, CARBON, V66, P39, DOI 10.1016/j.carbon.2013.08.033; Palatinus L, 2008, J APPL CRYSTALLOGR, V41, P975, DOI 10.1107/S0021889808028185; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; Parmentier J, 2014, LANGMUIR, V30, P297, DOI 10.1021/la402762v; Petricek V, 2014, Z KRIST-CRYST MATER, V229, P345, DOI 10.1515/zkri-2014-1737; Sheldrick G.M., 2008, SADABS; VANDERBILT D, 1992, PHYS REV LETT, V68, P511, DOI 10.1103/PhysRevLett.68.511; Xie D, 2011, J AM CHEM SOC, V133, P20604, DOI 10.1021/ja209220a; Yang ZX, 2007, J AM CHEM SOC, V129, P1673, DOI 10.1021/ja067149g; Yang ZX, 2006, J PHYS CHEM B, V110, P18424, DOI 10.1021/jp0639849; Yoon M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206806; Zhai YL, 2015, CHEMCATCHEM, V7, P2806, DOI 10.1002/cctc.201500323; Zhou J, 2013, ELECTROCHIM ACTA, V89, P763, DOI 10.1016/j.electacta.2012.11.068	41	200	206	28	836	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					131	+		10.1038/nature18284	http://dx.doi.org/10.1038/nature18284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362224				2022-12-28	WOS:000379015600038
J	Zhao, YG; Ren, JS; Harlos, K; Jones, DM; Zeltina, A; Bowden, TA; Padilla-Parra, S; Fry, EE; Stuart, DI				Zhao, Yuguang; Ren, Jingshan; Harlos, Karl; Jones, Daniel M.; Zeltina, Antra; Bowden, Thomas A.; Padilla-Parra, Sergi; Fry, Elizabeth E.; Stuart, David I.			Toremifene interacts with and destabilizes the Ebola virus glycoprotein	NATURE			English	Article							NIEMANN-PICK C1; SMALL-MOLECULE INHIBITORS; HIV-1 VIRION FUSION; CRYSTAL-STRUCTURE; ENTRY; INFECTION; ANTIBODY; RECEPTOR; CHOLESTEROL; SYSTEM	Ebola viruses (EBOVs) are responsible for repeated outbreaks of fatal infections, including the recent deadly epidemic in West Africa. There are currently no approved therapeutic drugs or vaccines for the disease. EBOV has a membrane envelope decorated by trimers of a glycoprotein (GP, cleaved by furin to form GP1 and GP2 subunits), which is solely responsible for host cell attachment, endosomal entry and membrane fusion(1-7). GP is thus a primary target for the development of antiviral drugs. Here we report the first, to our knowledge, unliganded structure of EBOV GP, and high-resolution complexes of GP with the anticancer drug toremifene and the painkiller ibuprofen. The high-resolution apo structure gives a more complete and accurate picture of the molecule, and allows conformational changes introduced by antibody and receptor binding to be deciphered(8-10). Unexpectedly, both toremifene and ibuprofen bind in a cavity between the attachment (GP1) and fusion (GP2) subunits at the entrance to a large tunnel that links with equivalent tunnels from the other monomers of the trimer at the three-fold axis. Protein-drug interactions with both GP1 and GP2 are predominately hydrophobic. Residues lining the binding site are highly conserved among filoviruses except Marburg virus (MARV), suggesting that MARV may not bind these drugs. Thermal shift assays show up to a 14 degrees C decrease in the protein melting temperature after toremifene binding, while ibuprofen has only a marginal effect and is a less potent inhibitor. These results suggest that inhibitor binding destabilizes GP and triggers premature release of GP2, thereby preventing fusion between the viral and endosome membranes. Thus, these complex structures reveal the mechanism of inhibition and may guide the development of more powerful anti-EBOV drugs.	[Zhao, Yuguang; Ren, Jingshan; Harlos, Karl; Jones, Daniel M.; Zeltina, Antra; Bowden, Thomas A.; Padilla-Parra, Sergi; Fry, Elizabeth E.; Stuart, David I.] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Padilla-Parra, Sergi] Univ Oxford, Cellular Imaging Core, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Stuart, David I.] Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; Diamond Light Source	Stuart, DI (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.; Stuart, DI (corresponding author), Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England.	dave@strubi.ox.ac.uk	Ren, Jingshan/AAT-7729-2021; Padilla-Parra, Sergi/N-8725-2019; Padilla-Parra, Sergi/S-3017-2018	Ren, Jingshan/0000-0003-4015-1404; Padilla-Parra, Sergi/0000-0002-8010-9481; Zeltina, Antra/0000-0002-5485-5480; Stuart, David/0000-0002-3426-4210; Fry, Elizabeth/0000-0001-9754-5303	Biostruct-X project by the EU seventh Framework Programme (FP7) [283570]; Wellcome Trust; UK Medical Research Council [MR/N00065X/1]; Wellcome Trust [090532/Z/09/Z]; Marie Curie Fellowship [658363]; MRC [MR/L009528/1]; Nuffield Department of Medicine Leadership Fellowship; MRC [G1000099, MR/N00065X/1] Funding Source: UKRI; Medical Research Council [MR/N00065X/1, MR/L009528/1, G1000099, G1100525] Funding Source: researchfish	Biostruct-X project by the EU seventh Framework Programme (FP7); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Fellowship(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nuffield Department of Medicine Leadership Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Diamond scientists at I02 and I03 for assistance with data collection, T.S. Walter for help with crystallization and thermal-shift essay. Y.Z. was supported by the Biostruct-X project (283570) funded by the EU seventh Framework Programme (FP7), J.R. by the Wellcome Trust, and D.I.S., E.E.F. and K.H. by the UK Medical Research Council (MR/N00065X/1). This is a contribution from the UK Instruct Centre. The Wellcome Trust Centre for Human Genetics is supported by the Wellcome Trust (grant 090532/Z/09/Z). A.Z. is supported by a Marie Curie Fellowship (658363), T.A.B. is supported by the MRC (MR/L009528/1). SP-P is funded by a Nuffield Department of Medicine Leadership Fellowship. D.I.S. is a Jenner Investigator.	Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326; Brecher M, 2012, J VIROL, V86, P364, DOI 10.1128/JVI.05708-11; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cheng H, 2015, J VIROL, V89, P9932, DOI 10.1128/JVI.01337-15; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Edwards MR, 2015, ACS INFECT DIS, V1, P380, DOI 10.1021/acsinfecdis.5b00053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022; Gregory SM, 2011, P NATL ACAD SCI USA, V108, P11211, DOI 10.1073/pnas.1104760108; Hacke M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8688; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597; Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471; Jones DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13449; Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88; Lea WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036219; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Veljkovic Veljko, 2015, F1000Res, V4, P104, DOI 10.12688/f1000research.6436.1; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; World Health Organisation, 2016, EB SIT REP 30 MARCH; Zhao YG, 2016, FEBS LETT, V590, P605, DOI 10.1002/1873-3468.12089; Zhao YG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5321	41	154	160	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					169	+		10.1038/nature18615	http://dx.doi.org/10.1038/nature18615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362232	Green Submitted, Green Accepted			2022-12-28	WOS:000379015600046
J	Altman, DG				Altman, Douglas G.			Moderate Alcohol Intake and Cardiometabolic Risk in Adults With Type 2 Diabetes	ANNALS OF INTERNAL MEDICINE			English	Letter									[Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of Oxford	Altman, DG (corresponding author), Univ Oxford, Ctr Stat Med, Oxford, England.				Cancer Research UK [16895] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		ARMITAGE P, 1966, ARCH INTERN MED, V118, P270; Gepner Y, 2015, ANN INTERN MED, V163, P569, DOI 10.7326/M14-1650	2	1	1	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					67	+		10.7326/L16-5013	http://dx.doi.org/10.7326/L16-5013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380289				2022-12-28	WOS:000379215800015
J	Iacobucci, G				Iacobucci, Gareth			NHS funding at serious risk from Brexit, think tank warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2016, OSBORNE ABANDONS 202; IACOBUCCI G, 2016, BMJ-BRIT MED J, V353; Iacobucci G, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3604; Perraudin F., 2016, IAIN DUNCAN SMITH BA; Stone J., 2016, INDEPENDENT; The Health Foundation, 2016, BRIEF NHS FIN OUTS E	6	1	1	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2016	354								i3731	10.1136/bmj.i3731	http://dx.doi.org/10.1136/bmj.i3731			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EG	27380770				2022-12-28	WOS:000379580200011
J	Welk, B; McArthur, E; Morrow, SA; MacDonald, P; Hayward, J; Leung, A; Lum, A				Welk, Blayne; McArthur, Eric; Morrow, Sarah A.; MacDonald, Penny; Hayward, Jade; Leung, Andrew; Lum, Andrea			Association Between Gadolinium Contrast Exposure and the Risk of Parkinsonism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Welk, Blayne] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [McArthur, Eric; Hayward, Jade] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Morrow, Sarah A.; MacDonald, Penny] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Leung, Andrew; Lum, Andrea] Univ Western Ontario, Dept Med Imaging, London, ON, Canada	Western University (University of Western Ontario); University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario)	Welk, B (corresponding author), Univ Western Ontario, Dept Surg Epidemiol & Biostat, Div Urol & Epidemiol & Biostat, St Josephs Hlth Care, Room B4-667,268 Grosvenor St, London, ON N6A 4V2, Canada.	bkwelk@gmail.com	Leung, Andrew/AAJ-6850-2020	Leung, Andrew/0000-0003-3349-1574				ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Butt DA, 2014, NEUROEPIDEMIOLOGY, V43, P28, DOI 10.1159/000365590; Errante Y, 2014, INVEST RADIOL, V49, P685, DOI 10.1097/RLI.0000000000000072; Munchau A, 2000, J NEUROL NEUROSUR PS, V69, P494, DOI 10.1136/jnnp.69.4.494; Ramalho J, 2015, AM J NEURORADIOL, DOI [10.3174/ajnr.A4615, DOI 10.3174/AJNR.A4615]; Welk B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5398	6	63	66	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					96	98		10.1001/jama.2016.8096	http://dx.doi.org/10.1001/jama.2016.8096			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2MY	27380348	Bronze			2022-12-28	WOS:000379037600024
J	Briggs, KJ; Koivunen, P; Cao, SG; Backus, KM; Olenchock, BA; Patel, H; Zhang, Q; Signoretti, S; Gerfen, GJ; Richardson, AL; Witkiewicz, AK; Cravatt, BF; Clardy, J; Kaelin, WG				Briggs, Kimberly J.; Koivunen, Peppi; Cao, Shugeng; Backus, Keriann M.; Olenchock, Benjamin A.; Patel, Hetalben; Zhang, Qing; Signoretti, Sabina; Gerfen, Gary J.; Richardson, Andrea L.; Witkiewicz, Agnieszka K.; Cravatt, Benjamin F.; Clardy, Jon; Kaelin, William G., Jr.			Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine	CELL			English	Article							HYDROXYLASE DOMAIN 2; HYPOXIA-INDUCIBLE FACTORS; THERAPEUTIC TARGET; GLUTATHIONE LEVELS; CYSTINE UPTAKE; CELL-DEATH; METASTASIS; EXPRESSION; RECEPTORS; PATHWAY	The HIF transcription factor promotes adaptation to hypoxia and stimulates the growth of certain cancers, including triple-negative breast cancer (TNBC). The HIF alpha subunit is usually prolyl-hydroxylated by EglN family members under normoxic conditions, causing its rapid degradation. We confirmed that TNBC cells secrete glutamate, which we found is both necessary and sufficient for the paracrine induction of HIF1 alpha in such cells under normoxic conditions. Glutamate inhibits the xCT glutamate-cystine antiporter, leading to intracellular cysteine depletion. EglN1, the main HIF alpha prolyl-hydroxylase, undergoes oxidative self-inactivation in the absence of cysteine both in biochemical assays and in cells, resulting in HIF1 alpha accumulation. Therefore, EglN1 senses both oxygen and cysteine.	[Briggs, Kimberly J.; Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Briggs, Kimberly J.; Kaelin, William G., Jr.] Brigham & Womens Hosp, Boston, MA 02215 USA; [Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Bioctr Oulu, FIN-90014 Oulu, Finland; [Cao, Shugeng; Clardy, Jon] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Backus, Keriann M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Olenchock, Benjamin A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Patel, Hetalben; Gerfen, Gary J.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Zhang, Qing] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Signoretti, Sabina; Richardson, Andrea L.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Witkiewicz, Agnieszka K.] Univ Texas Southwestern Med Ctr, Dept Pathol, Dallas, TX 75235 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Cao, Shugeng] Univ Hawaii, Daniel K Inouye Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA; [Richardson, Andrea L.] Johns Hopkins Med, Dept Pathol, 600 N Wolfe St, Baltimore, MD 21287 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of Oulu; Harvard University; Harvard Medical School; Scripps Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Hawaii System; University Hawaii Hilo; Johns Hopkins University; Johns Hopkins Medicine	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Kaelin, WG (corresponding author), Brigham & Womens Hosp, Boston, MA 02215 USA.; Kaelin, WG (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	william_kaelin@dfci.harvard.edu	ZHANG, QING/AGY-7972-2022	ZHANG, QING/0000-0002-6595-8995	NIH; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P50CA058223, R37CA087660, R01CA068490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Kaelin Laboratory for useful discussions, Gang Lu for multiple reagents and cloning advice, Jason Marineau for fractionation advice and reagents, Julie Losman for her FACS expertise, Amanda Silva for performing gavage, and Humayun Sharif and Michael Eck for generating Figure 6I. This work was supported by grants to W.G.K. from the NIH and the Breast Cancer Research Foundation and T32 and F32 NIH training grants to K.J.B. W.G.K. is an HHMI Investigator.	Anderson TMR, 2013, CANCER RES, V73, P5810, DOI 10.1158/0008-5472.CAN-13-0523; Andras IE, 2007, J CEREBR BLOOD F MET, V27, P1431, DOI 10.1038/sj.jcbfm.9600445; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Chowdhury R, 2011, J MOL BIOL, V410, P268, DOI 10.1016/j.jmb.2011.04.075; Chung HS, 2013, CIRC RES, V112, P382, DOI 10.1161/CIRCRESAHA.112.268680; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; ISHII T, 1981, J CELL PHYSIOL, V107, P283, DOI 10.1002/jcp.1041070215; Jacob C, 2011, BIOCHEM SOC T, V39, P1247, DOI 10.1042/BST0391247; JANJIC D, 1992, EUR J BIOCHEM, V210, P297, DOI 10.1111/j.1432-1033.1992.tb17421.x; JUVA K, 1966, ANAL BIOCHEM, V15, P77, DOI 10.1016/0003-2697(66)90249-1; Kaelin WG, 2005, CELL METAB, V1, P357, DOI 10.1016/j.cmet.2005.05.006; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Laurinavicius A, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-27; Lee G, 2016, SCI REP-UK, V6, DOI 10.1038/srep18928; Lu HQ, 2015, P NATL ACAD SCI USA, V112, pE4600, DOI 10.1073/pnas.1513433112; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; MAKOWSKE M, 1982, J BIOL CHEM, V257, P5663; Mecinovic J, 2009, ANAL BIOCHEM, V393, P215, DOI 10.1016/j.ab.2009.06.029; Mehta MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069851; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; MYLLYLA R, 1978, BIOCHEM BIOPH RES CO, V83, P441, DOI 10.1016/0006-291X(78)91010-0; Narang VS, 2007, CHEMOTHERAPY, V53, P210, DOI 10.1159/000100812; Narang VS, 2003, ANTICANCER RES, V23, P4571; North WG, 2010, BREAST CANCER RES TR, V122, P307, DOI 10.1007/s10549-009-0556-1; Nytko KJ, 2011, BLOOD, V117, P5485, DOI 10.1182/blood-2010-09-307637; Schito L, 2012, P NATL ACAD SCI USA, V109, pE2707, DOI 10.1073/pnas.1214019109; Seidlitz EP, 2009, CLIN EXP METASTAS, V26, P781, DOI 10.1007/s10585-009-9277-4; Semenza GL, 2012, TRENDS MOL MED, V18, P534, DOI 10.1016/j.molmed.2012.08.001; Sharma MK, 2010, BIOCHEM BIOPH RES CO, V391, P91, DOI 10.1016/j.bbrc.2009.10.168; Sims B, 2012, STEM CELL RES, V8, P285, DOI 10.1016/j.scr.2011.09.002; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Stepulak A, 2014, J NEURAL TRANSM, V121, P933, DOI 10.1007/s00702-014-1182-6; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Willard SS, 2013, INT J BIOL SCI, V9, P728, DOI 10.7150/ijbs.6475; Wong CCL, 2012, J MOL MED, V90, P803, DOI 10.1007/s00109-011-0855-y; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhong H, 1999, CANCER RES, V59, P5830	50	140	145	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					126	139		10.1016/j.cell.2016.05.042	http://dx.doi.org/10.1016/j.cell.2016.05.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368101	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000380254400016
J	Lee, SS; Tyler, JK				Lee, Siu Sylvia; Tyler, Jessica K.			PHYSIOLOGY Stressed-out chromatin promotes longevity	NATURE			English	Editorial Material							MITOCHONDRIA		[Lee, Siu Sylvia] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Tyler, Jessica K.] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA	Cornell University; Cornell University	Lee, SS (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	sylvia.lee@cornell.edu; jet2021@med.cornell.edu		Tyler, Jessica/0000-0001-9765-1659	NATIONAL CANCER INSTITUTE [R01CA095641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024425] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA095641] Funding Source: Medline; NIA NIH HHS [R01 AG024425] Funding Source: Medline; NIGMS NIH HHS [R01 GM064475] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chang HW, 2015, FREE RADICAL BIO MED, V78, P168, DOI 10.1016/j.freeradbiomed.2014.10.576; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Labbadia J, 2015, MOL CELL, V59, P639, DOI 10.1016/j.molcel.2015.06.027; Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011	10	1	1	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					625	626		10.1038/534625a	http://dx.doi.org/10.1038/534625a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357789	Green Accepted			2022-12-28	WOS:000378676000023
J	Blanton, LV; Barratt, MJ; Charbonneau, MR; Ahmed, T; Gordon, JI				Blanton, Laura V.; Barratt, Michael J.; Charbonneau, Mark R.; Ahmed, Tahmeed; Gordon, Jeffrey I.			MICROBIOTA Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics	SCIENCE			English	Review							SEVERE ACUTE MALNUTRITION; MODERATE ACUTE MALNUTRITION; ENVIRONMENTAL ENTEROPATHY; INTESTINAL INFLAMMATION; GROWTH; BIFIDOBACTERIA; DISCORDANT; RESPONSES; CHILDREN; INFANTS	Childhood undernutrition is a major global health challenge. Although current therapeutic approaches have reduced mortality in individuals with severe disease, they have had limited efficacy in ameliorating long-term sequelae, notably stunting, immune dysfunction, and neurocognitive deficits. Recent work is providing insights about the role of impaired development of the human gut microbiota in disease pathogenesis, leading to new concepts for treatment and prevention. These findings raise intriguing basic questions about the mechanisms that direct normal gut microbial community assembly and functional maturation. Designing and implementing new microbiota-directed therapeutics for undernutrition highlights the need to simultaneously consider a variety of features of human biology as well as broader societal issues.	[Blanton, Laura V.; Barratt, Michael J.; Charbonneau, Mark R.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Blanton, Laura V.; Barratt, Michael J.; Charbonneau, Mark R.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63110 USA; [Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka 1212, Bangladesh	Washington University (WUSTL); Washington University (WUSTL); International Centre for Diarrhoeal Disease Research (ICDDR)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA.; Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63110 USA.	jgordon@wustl.edu			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Work cited from the authors' laboratory was supported in part by a grant from the Bill & Melinda Gates Foundation. J.I.G. is cofounder of Matatu, a company characterizing the role of diet-by-microbiota interactions in animal health. Upon completion of his Ph.D., M.R.C. has joined Matatu as a research scientist.	Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Allen LH, 2012, ADV NUTR, V3, P362, DOI 10.3945/an.111.001172; Bartz S, 2014, J CLIN ENDOCR METAB, V99, P2128, DOI 10.1210/jc.2013-4018; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Brown EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8806; Casanova JL, 2015, P NATL ACAD SCI USA, V112, pE7128, DOI 10.1073/pnas.1521651112; Chang CY, 2013, J NUTR, V143, P215, DOI 10.3945/jn.112.168047; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Eddy SR, 2005, PLOS COMPUT BIOL, V1, P3, DOI 10.1371/journal.pcbi.0010006; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gough EK1, 2014, BMJ-BRIT MED J, V15, P348; Guo SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124549; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Horta BL., 2013, SHORT TERM EFFECTS B, V49; Hsiao A, 2014, NATURE, V515, P423, DOI 10.1038/nature13738; Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937; Isanaka S, 2016, NEW ENGL J MED, V374, P444, DOI 10.1056/NEJMoa1507024; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kerac M, 2009, LANCET, V374, P136, DOI 10.1016/S0140-6736(09)60884-9; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Kosek M, 2014, CLIN INFECT DIS, V59, pS239, DOI 10.1093/cid/ciu457; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Lenters LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S23; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Marginean CO, 2014, J PEDIATR GASTR NUTR, V59, P666, DOI 10.1097/MPG.0000000000000492; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; McKay S, 2010, INT HEALTH, V2, P172, DOI 10.1016/j.inhe.2010.07.006; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Naylor C, 2015, EBIOMEDICINE, V2, P1759, DOI 10.1016/j.ebiom.2015.09.036; PAPATHAKIS PC, 2016, MOL CELL ENDOCRINOL, V435, P40, DOI DOI 10.1016/j.mce.2016.01.024; Pfeiffer JK, 2016, SCIENCE, V351, DOI 10.1126/science.aad5872; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649; Reyesa A, 2015, P NATL ACAD SCI USA, V112, P11941, DOI 10.1073/pnas.1514285112; Salam RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S22; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Smilowitz JT, 2014, ANNU REV NUTR, V34, P143, DOI 10.1146/annurev-nutr-071813-105721; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; UNICEF, 2015, LEV TRENDS CHILD MOR, P1; Weng MQ, 2014, AM J PHYSIOL-GASTR L, V306, pG779, DOI 10.1152/ajpgi.00183.2013; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Wu M, 2015, SCIENCE, V350, DOI 10.1126/science.aac5992	50	142	145	3	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293							aad9359	10.1126/science.aad9359	http://dx.doi.org/10.1126/science.aad9359			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339978				2022-12-28	WOS:000378346500032
J	Colonna, M; Cervantes-Barragan, L				Colonna, Marco; Cervantes-Barragan, Luisa			Converting to adapt Gut microbiota affect T cell plasticity in the intestinal lining	SCIENCE			English	Editorial Material							DIFFERENTIATION; IMMUNITY		[Colonna, Marco; Cervantes-Barragan, Luisa] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO USA.	mcolonna@pathology.wustl.edu		Colonna, Marco/0000-0001-5222-4987				Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Cheroutre H, 2013, SEMIN IMMUNOL, V25, P273, DOI 10.1016/j.smim.2013.10.022; Cortez VS, 2014, J EXP MED, V211, P623, DOI 10.1084/jem.20130904; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jabri B, 2015, NAT REV IMMUNOL, V15, P771, DOI 10.1038/nri3919; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Takeuchi A, 2016, J EXP MED, V213, P123, DOI 10.1084/jem.20150519; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152	15	1	1	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1515	1516		10.1126/science.aag1719	http://dx.doi.org/10.1126/science.aag1719			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339967				2022-12-28	WOS:000378346500018
J	Ohto, U; Ishida, H; Krayukhina, E; Uchiyama, S; Inoue, N; Shimizu, T				Ohto, Umeharu; Ishida, Hanako; Krayukhina, Elena; Uchiyama, Susumu; Inoue, Naokazu; Shimizu, Toshiyuki			Structure of IZUMO1-JUNO reveals sperm-oocyte recognition during mammalian fertilization	NATURE			English	Article							CRYSTAL-STRUCTURE; PROTEIN IZUMO; EGG FUSION; ULTRACENTRIFUGATION; FOLATE; JUNO	Fertilization is a fundamental process in sexual reproduction, creating a new individual through the combination of male and female gametes(1-4). The IZUMO1 sperm membrane protein(5) and its counterpart oocyte receptor JUNO(6) have been identified as essential factors for sperm-oocyte interaction and fusion. However, the mechanism underlying their specific recognition remains poorly defined. Here, we show the crystal structures of human IZUMO1, JUNO and the IZUMO1-JUNO complex, establishing the structural basis for the IZUMO1-JUNO-mediated sperm-oocyte interaction. IZUMO1 exhibits an elongated rod-shaped structure comprised of a helical bundle IZUMO domain and an immunoglobulin-like domain that are each firmly anchored to an intervening beta-hairpin region through conserved disulfide bonds. The central beta-hairpin region of IZUMO1 provides the main platform for JUNO binding, while the surface located behind the putative JUNO ligand binding pocket is involved in IZUMO1 binding. Structure-based mutagenesis analysis confirms the biological importance of the IZUMO1-JUNO interaction. This structure provides a major step towards elucidating an essential phase of fertilization and it will contribute to the development of new therapeutic interventions for fertility, such as contraceptive agents.	[Ohto, Umeharu; Ishida, Hanako; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Krayukhina, Elena; Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Uchiyama, Susumu] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan; [Inoue, Naokazu] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan	University of Tokyo; Osaka University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Fukushima Medical University	Ohto, U; Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	umeji@mol.f.u-tokyo.ac.jp; shimizu@mol.f.u-tokyo.ac.jp	UCHIYAMA, Susumu/F-9590-2017	UCHIYAMA, Susumu/0000-0002-5181-179X; Inoue, Naokazu/0000-0002-6187-8293	Japan Agency for Medical Research and Development (AMED); Japanese Ministry of Education, Culture, Sports, Science, and Technology; CREST, JST; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research [26291052] Funding Source: KAKEN	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the beamline staff members at the Photon Factory and SPring-8 for their assistance with data collection. We thank Y. Yamada and D. Liebschner for assistance with S-SAD data collection at PF-1A. This research is supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED). This work was supported by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (U.O., S.U., N.I. and T.S.); CREST, JST (T.S.); the Takeda Science Foundation (U.O., N.I. and T.S.); the Mochida Memorial Foundation for Medical and Pharmaceutical Research (U.O.); and the Daiichi Sankyo Foundation of Life Science (U.O.).	Bianchi E, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0101; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Chen C, 2013, NATURE, V500, P486, DOI 10.1038/nature12327; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans JP, 2012, ANNU REV PHYSIOL, V74, P477, DOI 10.1146/annurev-physiol-020911-153339; Foster D L., 1994, PHYSL REPROD, V2; Han L, 2016, CURR BIOL, V26, pR100, DOI 10.1016/j.cub.2015.12.034; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9858; Inoue N, 2013, DEVELOPMENT, V140, P3221, DOI 10.1242/dev.094854; Inoue N, 2008, BIOCHEM BIOPH RES CO, V377, P910, DOI 10.1016/j.bbrc.2008.10.073; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klinovska K, 2014, INT J MOL SCI, V15, P10652, DOI 10.3390/ijms150610652; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okabe M, 2013, DEVELOPMENT, V140, P4471, DOI 10.1242/dev.090613; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wibowo AS, 2013, P NATL ACAD SCI USA, V110, P15180, DOI 10.1073/pnas.1308827110	29	74	80	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					566	+		10.1038/nature18596	http://dx.doi.org/10.1038/nature18596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309808				2022-12-28	WOS:000378270300057
J	Sipp, D; Pei, DQ				Sipp, Douglas; Pei, Duanqing			No wild east	NATURE			English	Editorial Material									[Sipp, Douglas] RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan; [Sipp, Douglas] Keio Univ, Sch Med, Tokyo, Japan; [Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China	RIKEN; Keio University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Sipp, D (corresponding author), RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan.; Sipp, D (corresponding author), Keio Univ, Sch Med, Tokyo, Japan.	sipp@cdb.riken.jp; duanqing@gibh.ac.cn	Sipp, Douglas/C-9218-2017	Sipp, Douglas/0000-0002-5979-0938				[Anonymous], 2003, GUID HUM EMBR STEM C; [Anonymous], 2001, GUID HUM ASS REPR TE; Chen Y, 2003, CELL RES, V13, P251, DOI 10.1038/sj.cr.7290170; Doring O, 2004, KENNEDY INST ETHIC J, V14, P39, DOI 10.1353/ken.2004.0014; Gao F., 2016, NATURE BIOTECHNOL; Jin X, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/934567; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kawakami M, 2010, CELL STEM CELL, V6, P415, DOI 10.1016/j.stem.2010.04.010; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Nachtigall RD, 2009, FERTIL STERIL, V92, P2094, DOI 10.1016/j.fertnstert.2009.06.027	10	9	9	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					465	467		10.1038/534465a	http://dx.doi.org/10.1038/534465a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27337327	Bronze			2022-12-28	WOS:000378270300028
J	Wise, J				Wise, Jacqui			Plant based treatments give modest improvement in menopausal symptoms, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Franco OH, 2016, JAMA-J AM MED ASSOC, V315, P2554, DOI 10.1001/jama.2016.8012	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i3474	10.1136/bmj.i3474	http://dx.doi.org/10.1136/bmj.i3474			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27335343				2022-12-28	WOS:000378723500017
J	Ersche, KD; Gillan, CM; Jones, PS; Williams, GB; Ward, LHE; Luijten, M; de Wit, S; Sahakian, BJ; Bullmore, ET; Robbins, TW				Ersche, Karen D.; Gillan, Claire M.; Jones, P. Simon; Williams, Guy B.; Ward, Laetitia H. E.; Luijten, Maartje; de Wit, Sanne; Sahakian, Barbara J.; Bullmore, Edward T.; Robbins, Trevor W.			Carrots and sticks fail to change behavior in cocaine addiction	SCIENCE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; DRUG-ADDICTION; REINFORCEMENT; HABITS; DOPAMINE; IMPULSIVITY; SEEKING	Cocaine addiction is a major public health problem that is particularly difficult to treat. Without medically proven pharmacological treatments, interventions to change the maladaptive behavior of addicted individuals mainly rely on psychosocial approaches. Here we report on impairments in cocaine-addicted patients to act purposefully toward a given goal and on the influence of extended training on their behavior. When patients were rewarded for their behavior, prolonged training improved their response rate toward the goal but simultaneously rendered them insensitive to the consequences of their actions. By contrast, overtraining of avoidance behavior had no effect on patient performance. Our findings illustrate the ineffectiveness of punitive approaches and highlight the potential for interventions that focus on improving goal-directed behavior and implementing more desirable habits to replace habitual drug-taking.	[Ersche, Karen D.; Gillan, Claire M.; Jones, P. Simon; Williams, Guy B.; Ward, Laetitia H. E.; Sahakian, Barbara J.; Bullmore, Edward T.; Robbins, Trevor W.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Ersche, Karen D.; Gillan, Claire M.; Jones, P. Simon; Williams, Guy B.; Ward, Laetitia H. E.; Sahakian, Barbara J.; Bullmore, Edward T.; Robbins, Trevor W.] Univ Cambridge, Dept Psychol, Cambridge, England; [Ersche, Karen D.; Gillan, Claire M.; Jones, P. Simon; Williams, Guy B.; Ward, Laetitia H. E.; Sahakian, Barbara J.; Bullmore, Edward T.; Robbins, Trevor W.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Ersche, Karen D.; Gillan, Claire M.; Jones, P. Simon; Williams, Guy B.; Ward, Laetitia H. E.; Sahakian, Barbara J.; Bullmore, Edward T.; Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Gillan, Claire M.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Luijten, Maartje] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [de Wit, Sanne] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Bullmore, Edward T.] Cambridgeshire & Peterborough Natl Hlth Serv Fdn, Cambridge, England; [Bullmore, Edward T.] GlaxoSmithKline R&D, Alternat Discovery & Dev Div, Immunopsychiat Discovery Performance Unit, Stevenage SG1 2NY, Herts, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; New York University; Radboud University Nijmegen; University of Amsterdam; GlaxoSmithKline	Ersche, KD (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.; Ersche, KD (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.; Ersche, KD (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.; Ersche, KD (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England.	ke220@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020; Robbins, Trevor W/A-7551-2008; Gillan, Claire/AAA-7348-2020; Bullmore, Ed/C-1706-2012	Sahakian, Barbara/0000-0001-7352-1745; Gillan, Claire/0000-0001-9065-403X; Bullmore, Ed/0000-0002-8955-8283; Williams, Guy/0000-0001-5223-6654; Robbins, Trevor/0000-0003-0642-5977; Ward, Laetitia/0000-0002-4707-3069; de Wit, Sanne/0000-0003-1438-7085	Sir Henry Wellcome Postdoctoral Fellowship [101521/Z/12/Z]; Medical Research Council [MR/J012084/1]; Wellcome Trust; MRC [MR/J012084/1, G1000183] Funding Source: UKRI; Medical Research Council [G1000183B, G1000183] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10051] Funding Source: researchfish	Sir Henry Wellcome Postdoctoral Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank all volunteers for their participation in this study, as well as the staff at the Mental Health Research Network and the Cambridge BioResource for their assistance with volunteer recruitment. We are especially grateful to N. Flake and S. Whittle for their exceptional commitment in this regard. We also thank the staff at the National Institute for Health Research (NIHR) Clinical Research Facility at Addenbrooke's Hospital for their support throughout this study. We are grateful to S. Abbott, R. Lumsden, Arlt C. Whitelock, I. Lee, and M. Pollard for their assistance. C.M.G. is supported by a Sir Henry Wellcome Postdoctoral Fellowship (101521/Z/12/Z). This work was funded by a grant from the Medical Research Council (MR/J012084/1) and was conducted within the NIHR Cambridge Biomedical Research Centre and the Behavioral and Clinical Neuroscience Institute which is jointly funded by the Medical Research Council and the Wellcome Trust. The data described in his paper are stored at the University of Cambridge's institutional repository, Apollo (http://dx.doi.org/10.17863/CAM.122).	Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Barker JM, 2014, NEUROSCI BIOBEHAV R, V47, P281, DOI 10.1016/j.neubiorev.2014.08.012; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; BENINGER RJ, 1980, J PHARMACOL EXP THER, V213, P623; Corbit LH, 2014, NEUROPSYCHOPHARMACOL, V39, P1893, DOI 10.1038/npp.2014.37; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; de Wit S, 2012, PSYCHOPHARMACOLOGY, V219, P621, DOI 10.1007/s00213-011-2563-2; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gillan CM, 2016, ELIFE, V5, DOI 10.7554/eLife.11305; Gillan CM, 2014, BIOL PSYCHIAT, V75, P631, DOI 10.1016/j.biopsych.2013.02.002; Gillan CM, 2011, AM J PSYCHIAT, V168, P718, DOI 10.1176/appi.ajp.2011.10071062; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Martinez D, 2009, AM J PSYCHIAT, V166, P1170, DOI 10.1176/appi.ajp.2009.08121801; Miles FJ, 2003, BEHAV NEUROSCI, V117, P927, DOI 10.1037/0735-7044.117.5.927; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; Sjoerds Z, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.107; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042	23	139	140	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1468	1471		10.1126/science.aaf3700	http://dx.doi.org/10.1126/science.aaf3700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313048	Green Accepted			2022-12-28	WOS:000377975400051
J	Walker, C				Walker, Cameron			Learn the local lingo to get ahead	NATURE			English	Editorial Material																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					425	427						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5XQ	27314140				2022-12-28	WOS:000377856800044
J	Li, N; Daie, K; Svoboda, K; Druckmann, S				Li, Nuo; Daie, Kayvon; Svoboda, Karel; Druckmann, Shaul			Robust neuronal dynamics in premotor cortex during motor planning (vol 532, pg 459, 2016)	NATURE			English	Correction																		Li N, 2016, NATURE, V532, P459, DOI 10.1038/nature17643	1	5	5	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					122	122		10.1038/nature18623	http://dx.doi.org/10.1038/nature18623			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27362233	Bronze			2022-12-28	WOS:000382426900052
J	Zhao, Y; Chen, SS; Yoshioka, C; Baconguis, I; Gouaux, E				Zhao, Yan; Chen, Shanshuang; Yoshioka, Craig; Baconguis, Isabelle; Gouaux, Eric			Architecture of fully occupied GluA2 AMPA receptor-TARP complex elucidated by cryo-EM	NATURE			English	Article							2 DISTINCT MECHANISMS; LIGAND-BINDING CORE; GLUTAMATE-RECEPTOR; AUXILIARY SUBUNITS; ACTIVATION; STARGAZIN; DESENSITIZATION; CHANNELS; STATES	Fast excitatory neurotransmission in the mammalian central nervous system is largely carried out by AMPA-sensitive ionotropic glutamate receptors(1). Localized within the postsynaptic density of glutamatergic spines, AMPA receptors are composed of heterotetrameric receptor assemblies associated with auxiliary subunits, the most common of which are transmembrane AMPA receptor regulatory proteins (TARPs). The association of TARPs with AMPA receptors modulates receptor trafficking and the kinetics of receptor gating and pharmacology(2). Here we report the cryo-electron microscopy (cryo-EM) structure of the homomeric rat GluA2 AMPA receptor saturated with TARP gamma 2 subunits, which shows how the TARPs are arranged with four-fold symmetry around the ion channel domain and make extensive interactions with the M1, M2 and M4 transmembrane helices. Poised like partially opened 'hands' underneath the two-fold symmetric ligand-binding domain (LBD) 'clamshells', one pair of TARPs is juxtaposed near the LBD dimer interface, whereas the other pair is near the LBD dimer-dimer interface. The extracellular 'domains' of TARP are positioned to not only modulate LBD clamshell closure, but also affect conformational rearrangements of the LBD layer associated with receptor activation and desensitization, while the TARP transmembrane domains buttress the ion channel pore.	[Zhao, Yan; Chen, Shanshuang; Baconguis, Isabelle; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Yoshioka, Craig] Oregon Hlth & Sci Univ, Dept Biomed Engn, 2730 SW Moody Ave, Portland, OR 97201 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Baconguis, Isabelle/AAH-3790-2021; Gouaux, Eric/Y-4370-2019; Chen, Shanshuang/N-6665-2019; Yoshioka, Craig/ABH-3720-2020	Baconguis, Isabelle/0000-0002-5440-2289; Gouaux, Eric/0000-0002-8549-2360; Chen, Shanshuang/0000-0003-2317-6589; 	American Heart Association [16POST27790099]; NIH [NS038631]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS038631, R01NS038631] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Nakagawa for providing the clone 10 cell line, Z. H. Yu, R. Huang and C. Hong (Janelia Campus) for assistance with microscope operation and data collection and the Advanced Computing Center (OHSU) for computational support. We are grateful to A. Goehring for help with cell culture, the Multiscale Microscopy Core (OHSU) for support with microscopy, L. Vaskalis for assistance with figures, H. Owen for help with proofreading and other Gouaux laboratory members for helpful discussions. S.C. is supported by an American Heart Association postdoctoral fellowship (16POST27790099). This work was supported by the NIH (E.G., NS038631). E.G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker ML, 2007, STRUCTURE, V15, P7, DOI 10.1016/j.str.2006.11.008; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Dawe GB, 2016, NEURON, V89, P1264, DOI 10.1016/j.neuron.2016.01.038; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Herguedas B, 2016, SCIENCE, V352, DOI 10.1126/science.aad3873; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kaae BH, 2007, CHEM BIOL, V14, P1294, DOI 10.1016/j.chembiol.2007.10.012; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; WL D, 2002, PYMOL MOL GRAPHICS S; Zhu SJ, 2016, CELL, V165, P704, DOI 10.1016/j.cell.2016.03.028	48	77	77	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					108	+		10.1038/nature18961	http://dx.doi.org/10.1038/nature18961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27368053	Green Submitted, Green Accepted			2022-12-28	WOS:000380999200040
J	Wolf, AJ; Reyes, CN; Liang, WB; Becker, C; Shimada, K; Wheeler, ML; Cho, HC; Popescu, NI; Coggeshall, KM; Arditi, M; Underhill, DM				Wolf, Andrea J.; Reyes, Christopher N.; Liang, Wenbin; Becker, Courtney; Shimada, Kenichi; Wheeler, Matthew L.; Cho, Hee Cheol; Popescu, Narcis I.; Coggeshall, K. Mark; Arditi, Moshe; Underhill, David M.			Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan	CELL			English	Article							NLRP3 INFLAMMASOME ACTIVATION; DEPENDENT ANION CHANNELS; ACETYL-D-GLUCOSAMINE; NALP3 INFLAMMASOME; BACILLUS-ANTHRACIS; MURAMYL DIPEPTIDE; PERMEABILITY TRANSITION; STAPHYLOCOCCUS-AUREUS; CASPASE-1 ACTIVATION; IL-1-BETA SECRETION	Degradation of Gram-positive bacterial cell wall peptidoglycan in macrophage and dendritic cell phagosomes leads to activation of the NLRP3 inflammasome, a cytosolic complex that regulates processing and secretion of interleukin (IL)-1 beta and IL-18. While many inflammatory responses to peptidoglycan are mediated by detection of its muramyl dipeptide component in the cytosol by NOD2, we report here that NLRP3 inflammasome activation is caused by release of N-acetylglucosamine that is detected in the cytosol by the glycolytic enzyme hexokinase. Inhibition of hexokinase by N-acetylglucosamine causes its dissociation from mitochondria outer membranes, and we found that this is sufficient to activate the NLRP3 inflammasome. In addition, we observed that glycolytic inhibitors and metabolic conditions affecting hexokinase function and localization induce inflammasome activation. While previous studies have demonstrated that signaling by pattern recognition receptors can regulate metabolic processes, this study shows that a metabolic enzyme can act as a pattern recognition receptor.	[Wolf, Andrea J.; Reyes, Christopher N.; Becker, Courtney; Wheeler, Matthew L.; Underhill, David M.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA; [Wolf, Andrea J.; Shimada, Kenichi; Wheeler, Matthew L.; Arditi, Moshe; Underhill, David M.] Cedars Sinai Med Ctr, Div Immunol, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Liang, Wenbin; Cho, Hee Cheol] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Shimada, Kenichi; Arditi, Moshe] Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA; [Popescu, Narcis I.; Coggeshall, K. Mark] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Liang, Wenbin] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Liang, Wenbin] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1Y 4W7, Canada; [Cho, Hee Cheol] Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA; [Cho, Hee Cheol] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Oklahoma Medical Research Foundation; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Emory University; Emory University	Underhill, DM (corresponding author), Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA.; Underhill, DM (corresponding author), Cedars Sinai Med Ctr, Div Immunol, Dept Biomed Sci, Los Angeles, CA 90048 USA.	david.underhill@csmc.edu	UNDERHILL, DAVID/ABE-2185-2021	Underhill, David/0000-0002-2989-658X; Popescu, Narcis/0000-0002-4809-9885	NIH [GM085796, T32AI089553, AI067995, AI062629]; Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at Cedars-Sinai Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067995, U19AI062629, T32AI089553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085796] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at Cedars-Sinai Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the NIH (GM085796 to D.M.U., T32AI089553 to A.J.W., AI067995 to M.A., and AI062629 to K.M.C.). Further support came from the Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at Cedars-Sinai Medical Center (D.M.U.). Thanks to the laboratory of Dr. Robin Shaw for use of their FemtoJet microinjection system.	Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Aleshin AE, 1998, STRUCTURE, V6, P39, DOI 10.1016/S0969-2126(98)00006-9; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Ferwerda G, 2008, EUR J IMMUNOL, V38, P184, DOI 10.1002/eji.200737103; GERBER G, 1974, EUR J BIOCHEM, V45, P39, DOI 10.1111/j.1432-1033.1974.tb03527.x; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Iyer JK, 2011, J IMMUNOL, V186, P3841, DOI 10.4049/jimmunol.1004058; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; JONAS AJ, 1990, BIOCHEM J, V268, P41, DOI 10.1042/bj2680041; JONAS AJ, 1989, J BIOL CHEM, V264, P4953; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Langer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003706; Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Muller S, 2015, CELL HOST MICROBE, V18, P604, DOI 10.1016/j.chom.2015.10.011; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nomura J, 2015, J IMMUNOL, V195, P5718, DOI 10.4049/jimmunol.1402512; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; SPIRO RG, 1958, J BIOL CHEM, V233, P546; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Tomasello F, 2009, CELL RES, V19, P1363, DOI 10.1038/cr.2009.98; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; WICK AN, 1957, J BIOL CHEM, V224, P963; Wilson MH, 2011, J CEREBR BLOOD F MET, V31, P2019, DOI 10.1038/jcbfm.2011.81; Wolf AJ, 2011, J IMMUNOL, V187, P6002, DOI 10.4049/jimmunol.1100232; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083	49	277	289	4	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					624	636		10.1016/j.cell.2016.05.076	http://dx.doi.org/10.1016/j.cell.2016.05.076			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27374331	Green Accepted, Bronze			2022-12-28	WOS:000380546500014
J	Zhang, H; Liu, T; Zhang, Z; Payne, SH; Zhang, B; McDermott, JE; Zhou, JY; Petyuk, VA; Chen, L; Ray, D; Sun, SS; Yang, F; Chen, LJ; Wang, J; Shah, P; Cha, SW; Aiyetan, P; Woo, S; Tian, Y; Gritsenko, MA; Clauss, TR; Choi, C; Monroe, ME; Thomas, S; Nie, S; Wu, CC; Moore, RJ; Yu, KH; Tabb, DL; Fenyo, D; Bafna, V; Wang, Y; Rodriguez, H; Boja, ES; Hiltke, T; Rivers, RC; Sokoll, L; Zhu, H; Shih, IM; Cope, L; Pandey, A; Zhang, B; Snyder, MP; Levine, DA; Smith, RD; Chan, DW; Rodland, KD				Zhang, Hui; Liu, Tao; Zhang, Zhen; Payne, Samuel H.; Zhang, Bai; McDermott, Jason E.; Zhou, Jian-Ying; Petyuk, Vladislav A.; Chen, Li; Ray, Debjit; Sun, Shisheng; Yang, Feng; Chen, Lijun; Wang, Jing; Shah, Punit; Cha, Seong Won; Aiyetan, Paul; Woo, Sunghee; Tian, Yuan; Gritsenko, Marina A.; Clauss, Therese R.; Choi, Caitlin; Monroe, Matthew E.; Thomas, Stefani; Nie, Song; Wu, Chaochao; Moore, Ronald J.; Yu, Kun-Hsing; Tabb, David L.; Fenyo, David; Bafna, Vineet; Wang, Yue; Rodriguez, Henry; Boja, Emily S.; Hiltke, Tara; Rivers, Robert C.; Sokoll, Lori; Zhu, Heng; Shih, Ie-Ming; Cope, Leslie; Pandey, Akhilesh; Zhang, Bing; Snyder, Michael P.; Levine, Douglas A.; Smith, Richard D.; Chan, Daniel W.; Rodland, Karin D.		CPTAC Investigators	Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer	CELL			English	Article							EPITHELIAL OVARIAN; PHASE-II; HISTONE DEACETYLASE; PROTEIN EXPRESSION; CARCINOMA; REPAIR; BELINOSTAT; STRATEGIES; MUTATIONS; ABUNDANCE	To provide a detailed analysis of the molecular components and underlying mechanisms associated with ovarian cancer, we performed a comprehensive mass-spectrometry-based proteomic characterization of 174 ovarian tumors previously analyzed by The Cancer Genome Atlas (TCGA), of which 169 were high-grade serous carcinomas (HGSCs). Integrating our proteomic measurements with the genomic data yielded a number of insights into disease, such as how different copy-number alternations influence the proteome, the proteins associated with chromosomal instability, the sets of signaling pathways that diverse genome rearrangements converge on, and the ones most associated with short overall survival. Specific protein acetylations associated with homologous recombination deficiency suggest a potential means for stratifying patients for therapy. In addition to providing a valuable resource, these findings provide a view of how the somatic genome drives the cancer proteome and associations between protein and post-translational modification levels and clinical outcomes in HGSC.	[Zhang, Hui; Zhang, Zhen; Zhang, Bai; Zhou, Jian-Ying; Chen, Li; Sun, Shisheng; Chen, Lijun; Shah, Punit; Aiyetan, Paul; Tian, Yuan; Choi, Caitlin; Thomas, Stefani; Sokoll, Lori; Zhu, Heng; Chan, Daniel W.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA; [Liu, Tao; Payne, Samuel H.; McDermott, Jason E.; Petyuk, Vladislav A.; Ray, Debjit; Yang, Feng; Gritsenko, Marina A.; Clauss, Therese R.; Monroe, Matthew E.; Nie, Song; Wu, Chaochao; Moore, Ronald J.; Smith, Richard D.; Rodland, Karin D.] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Wang, Jing; Tabb, David L.; Zhang, Bing] Vanderbilt Univ, Dept Biomed Informat, Sch Med, Nashville, TN 37203 USA; [Cha, Seong Won; Woo, Sunghee] Univ Calif San Diego, Dept Elect & Comp Engn, San Diego, CA 92093 USA; [Yu, Kun-Hsing] Stanford Univ, Biomed Informat Training Program, Sch Med, Stanford, CA 94305 USA; [Yu, Kun-Hsing; Snyder, Michael P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Fenyo, David] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Fenyo, David] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Bafna, Vineet] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92093 USA; [Wang, Yue] Virginia Polytech Inst & State Univ, Bradley Dept Elect & Comp Engn, Arlington, VA 22203 USA; [Rodriguez, Henry; Boja, Emily S.; Hiltke, Tara; Rivers, Robert C.] NCI, Off Canc Clin Prote Res, Bethesda, MD 20892 USA; [Shih, Ie-Ming] Johns Hopkins Med Inst, Dept Gynecol & Obstet, Baltimore, MD 21231 USA; [Cope, Leslie] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21231 USA; [Pandey, Akhilesh] Johns Hopkins Med Inst, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; [Levine, Douglas A.] NYU, Laura & Isaac Perlmutter Canc Ctr, Dept Gynecol Oncol, Langone Med Ctr, New York, NY 10016 USA	Johns Hopkins University; Johns Hopkins Medicine; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Vanderbilt University; University of California System; University of California San Diego; Stanford University; Stanford University; New York University; New York University; University of California System; University of California San Diego; Virginia Polytechnic Institute & State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; New York University; NYU Langone Medical Center	Chan, DW (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA.; Rodland, KD (corresponding author), Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	dchan@jhmi.edu; karin.rodland@pnnl.gov	Pandey, Akhilesh/CAI-9458-2022; Monroe, Matthew/L-1157-2019; Rodland, Karin/R-6186-2019; Payne, Samuel/AAC-6388-2021; Bafna, Vineet/AAY-8111-2020; Thomas, Stefani/AAF-4212-2021; Yu, Kun-Hsing/J-3300-2019; Sun, Shisheng/P-5027-2019; Smith, Richard D/J-3664-2012; sdsd, shihieih/ABE-6190-2020; Ray, Debjit/J-9302-2016	Pandey, Akhilesh/0000-0001-9943-6127; Payne, Samuel/0000-0002-8351-1994; Bafna, Vineet/0000-0002-5810-6241; Thomas, Stefani/0000-0003-1679-5453; Yu, Kun-Hsing/0000-0001-9892-8218; Smith, Richard D/0000-0002-2381-2349; Ray, Debjit/0000-0002-7192-9859; Mani, D. R./0000-0003-3914-133X; Wang, Pei/0000-0002-6890-6453; Aiyetan, Paul/0000-0001-9031-000X; Sun, Shisheng/0000-0002-7242-7164; Tabb, David/0000-0001-7223-578X; Fenyo, David/0000-0001-5049-3825; Wang, Jing/0000-0003-1580-1356; Snyder, Michael/0000-0003-0784-7987; Levine, Douglas/0000-0003-1038-8232; McDermott, Jason/0000-0003-2961-2572; Oberti, Mauricio/0000-0001-7107-2616; McGarvey, Peter/0000-0002-8312-6017; White, Forest/0000-0002-1545-1651; Davies, Sherri/0000-0002-7141-8354	National Cancer Institute (NCI) [U24CA160019, U24CA160036]; NIH [P41GM103493]; DOE [DE-AC05-76RL01830]; NATIONAL CANCER INSTITUTE [U24CA160019, U24CA160036, U24CA160035, U24CA160034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114362, P41GM103493, P41GM103484] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute (NCI) CPTAC awards U24CA160019 and U24CA160036 and by NIH grant P41GM103493. The PNNL proteomics work described herein was performed in the Environmental Molecular Sciences Laboratory, a U.S. Department of Energy (DOE) National Scientific User Facility located at PNNL in Richland, WA. PNNL is a multi-program national laboratory operated by the Battelle Memorial Institute for the DOE under contract DE-AC05-76RL01830. Genomics data for this study were generated by the TCGA Pilot Project, established by the NCI and the National Human Genome Research Institute.	Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cai RL, 2000, J BIOL CHEM, V275, P27909; Collins BC, 2013, NAT METHODS, V10, P1246, DOI [10.1038/NMETH.2703, 10.1038/nmeth.2703]; Cope L, 2013, GYNECOL ONCOL, V128, P500, DOI 10.1016/j.ygyno.2012.11.031; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Dizon DS, 2012, INT J GYNECOL CANCER, V22, P979, DOI 10.1097/IGC.0b013e31825736fd; Fanjul-Fernandez M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3531; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gadducci A, 2015, CRIT REV ONCOL HEMAT, V96, P113, DOI 10.1016/j.critrevonc.2015.05.009; Gong FD, 2013, MUTAT RES-FUND MOL M, V750, P23, DOI 10.1016/j.mrfmmm.2013.07.002; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Koebel Martin, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800077X; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liu J, 2014, CLIN CANCER RES, V20, P5150, DOI 10.1158/1078-0432.CCR-14-1312; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mackay HJ, 2010, EUR J CANCER, V46, P1573, DOI 10.1016/j.ejca.2010.02.047; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Mielcarek M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00042; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Ruggles KV, 2016, MOL CELL PROTEOMICS, V15, P1060, DOI 10.1074/mcp.M115.056226; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Vang R, 2016, INT J GYNECOL PATHOL, V35, P48, DOI 10.1097/PGP.0000000000000207; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Woo S, 2014, PROTEOMICS, V14, P2719, DOI 10.1002/pmic.201400206; Woodbine L, 2014, DNA REPAIR, V16, P84, DOI 10.1016/j.dnarep.2014.02.011; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yang JY, 2013, J CLIN INVEST, V123, P3740, DOI 10.1172/JCI68509; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Yi B, 2015, ONCOL REP, V33, P1201, DOI 10.3892/or.2015.3707; Yu GQ, 2011, BIOINFORMATICS, V27, P1473, DOI 10.1093/bioinformatics/btr183; Zhang B, 2009, BIOINFORMATICS, V25, P526, DOI 10.1093/bioinformatics/btn660; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	44	526	535	8	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					755	765		10.1016/j.cell.2016.05.069	http://dx.doi.org/10.1016/j.cell.2016.05.069			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27372738	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-28	WOS:000380546500024
J	Winter, S; Settle, E; Wylie, K; Reisner, S; Cabral, M; Knudson, G; Baral, S				Winter, Sam; Settle, Edmund; Wylie, Kevan; Reisner, Sari; Cabral, Mauro; Knudson, Gail; Baral, Stefan			Synergies in health and human rights: a call to action to improve transgender health	LANCET			English	Editorial Material									[Winter, Sam] Curtin Univ, Sch Publ Hlth, Fac Hlth Sci, Bentley, WA 6102, Australia; [Settle, Edmund] UNDP Bangkok Reg Hub, United Nations Dev Programme, Bangkok, Thailand; [Wylie, Kevan] Porterbrook Clin, Sheffield, S Yorkshire, England; [Wylie, Kevan] Royal Hallamshire Hosp, Sheffield, S Yorkshire, England; [Wylie, Kevan] Univ Sheffield, Dept Neurosci, Sheffield, S Yorkshire, England; [Reisner, Sari] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Reisner, Sari] Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA; [Reisner, Sari] Harvard Med Sch, Boston, MA USA; [Reisner, Sari] Fenway Hlth, Fenway Inst, Boston, MA USA; [Cabral, Mauro] Global Act Trans Equal, Buenos Aires, DF, Argentina; [Cabral, Mauro] Global Act Trans Equal, New York, NY USA; [Knudson, Gail] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Baral, Stefan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Curtin University; University of Sheffield; University of Sheffield; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Fenway Health; University of British Columbia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Winter, S (corresponding author), Curtin Univ, Sch Publ Hlth, Fac Hlth Sci, Bentley, WA 6102, Australia.	sjwinter@hku.hk	Wylie, Kevan/C-5751-2011; Baral, Stefan/AAG-4818-2020	Wylie, Kevan/0000-0003-3805-105X; Baral, Stefan/0000-0002-5482-2419				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], ICD 11 BET DRAFT; Center of Excellence for Transgender Health, 2011, PRIM CAR PROT TRANSG; Drescher J, 2012, INT REV PSYCHIATR, V24, P568, DOI 10.3109/09540261.2012.741575; Health Policy Project Asia-Pacific Transgender Network and United Nations Development Program, 2015, BLUEPR PROV COMPR CA; Olson KR, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3223; Pan American Health Organization John Snow Inc World Professional Association for Transgender Health, 2014, BLUEPR PROV COMPR CA; Reisner SL, 2016, LANCET; UNDP IRGT, 2016, IMPL COMPR HIV STI P; Winter S, 2016, LANCET; Winter S., 2012, FOCUS, P69; World Professional Association on Transgender Health, 2012, STAND CAR HLTH TRANS; Wylie K, 2016, LANCET	13	53	54	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					318	321		10.1016/S0140-6736(16)30653-5	http://dx.doi.org/10.1016/S0140-6736(16)30653-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR6MV	27323921	Green Accepted			2022-12-28	WOS:000380016900009
J	Ellebrecht, CT; Bhoj, VG; Nace, A; Choi, EJ; Mao, XM; Cho, MJ; Di Zenzo, G; Lanzavecchia, A; Seykora, JT; Cotsarelis, G; Milone, MC; Payne, AS				Ellebrecht, Christoph T.; Bhoj, Vijay G.; Nace, Arben; Choi, Eun Jung; Mao, Xuming; Cho, Michael Jeffrey; Di Zenzo, Giovanni; Lanzavecchia, Antonio; Seykora, John T.; Cotsarelis, George; Milone, Michael C.; Payne, Aimee S.			Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease	SCIENCE			English	Article							B-CELL; PEMPHIGUS-VULGARIS; PERSISTENCE; ACTIVATION; 4-1BB; DESMOGLEIN-3; MALIGNANCIES; SEGREGATION; INTERFACE; LYMPHOMA	Ideally, therapy for autoimmune diseases should eliminate pathogenic autoimmune cells while sparing protective immunity, but feasible strategies for such an approach have been elusive. Here, we show that in the antibody-mediated autoimmune disease pemphigus vulgaris (PV), autoantigen-based chimeric immunoreceptors can direct T cells to kill autoreactive B lymphocytes through the specificity of the B cell receptor (BCR). We engineered human T cells to express a chimeric autoantibody receptor (CAAR), consisting of the PV autoantigen, desmoglein (Dsg) 3, fused to CD137-CD3 zeta signaling domains. Dsg3 CAAR-T cells exhibit specific cytotoxicity against cells expressing anti-Dsg3 BCRs in vitro and expand, persist, and specifically eliminate Dsg3-specific B cells in vivo. CAAR-T cells may provide an effective and universal strategy for specific targeting of autoreactive B cells in antibody-mediated autoimmune disease.	[Ellebrecht, Christoph T.; Nace, Arben; Choi, Eun Jung; Mao, Xuming; Cho, Michael Jeffrey; Seykora, John T.; Cotsarelis, George; Payne, Aimee S.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Bhoj, Vijay G.; Milone, Michael C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Di Zenzo, Giovanni] IDI IRCCS, Mol & Cellular Biol Lab, I-00167 Rome, Italy; [Lanzavecchia, Antonio] Inst Biomed Res, CH-6500 Bellinzona, Switzerland	University of Pennsylvania; University of Pennsylvania; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Universita della Svizzera Italiana	Payne, AS (corresponding author), Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA.; Milone, MC (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	milone@mail.med.upenn.edu; aimee.payne@uphs.upenn.edu	Di Zenzo, Giovanni/K-1943-2018	Di Zenzo, Giovanni/0000-0001-6106-599X	Penn Institute for Immunology; Dermatology Foundation Charles and Daneen Stiefel Scholar Award; National Institute of Arthritis and Musculoskeletal and Skin Diseases of NIH [R01-AR057001, R01-AR068288, T32-AR007465, F31-AR066456, R01-AR055309]; National Institute of Arthritis and Musculoskeletal and Skin Diseases of NIH (Skin Diseases Research Core grant) [P30-AR057217]; Deutsche Forschungsgemeinschaft [EL711/1-1]; National Cancer Institute of NIH [T32-CA009140]; National Heart, Lung, and Blood Institute of NIH [K12-HL087064]; Italian Ministry of Health [RF10-2309790]; NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007465, P30AR057217, R01AR057001, F30AR065870, F31AR066456, R01AR055309, R01AR068288] Funding Source: NIH RePORTER	Penn Institute for Immunology; Dermatology Foundation Charles and Daneen Stiefel Scholar Award; National Institute of Arthritis and Musculoskeletal and Skin Diseases of NIH; National Institute of Arthritis and Musculoskeletal and Skin Diseases of NIH (Skin Diseases Research Core grant); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Cancer Institute of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Margolis, S. Prouty, T. Dentchev, C.-Y. Tsai, and S. Nunez-Cruz for technical assistance and consultation on the studies and J. R. Stanley for helpful discussions. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. Constructs and cell lines are available from the corresponding authors under a Material Transfer Agreement with the University of Pennsylvania. C.T.E., V.G.B., M.C.M, and A.S.P. have filed patent PCT/US15/28872, 2015, which relates to compositions and methods of chimeric autoantibody receptor T cells. C.T.E. and A.S.P. have filed Provisional Patent Application 62/222,132, 2015, which relates to the VRC01 chimeric antigen receptor. Research reported in this publication was supported in part by the Penn Institute for Immunology (A.S.P. and M.C.M.); the Dermatology Foundation Charles and Daneen Stiefel Scholar Award (A.S.P.); the National Institute of Arthritis and Musculoskeletal and Skin Diseases of NIH (A.S.P., R01-AR057001 and R01-AR068288; M.J.C., T32-AR007465 and F31-AR066456; G.C., R01-AR055309; and Skin Diseases Research Core grant P30-AR057217); Deutsche Forschungsgemeinschaft (C.T.E., EL711/1-1); the National Cancer Institute of NIH (V.G.B., T32-CA009140); the National Heart, Lung, and Blood Institute of NIH (V.G.B., K12-HL087064); and the Italian Ministry of Health (G.D.Z., Ricerca Finalizzata RF10-2309790). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Cho MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5167; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Colliou N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005166; Cruz CRY, 2013, BLOOD, V122, P2965, DOI 10.1182/blood-2013-06-506741; Culton DA, 2015, J INVEST DERMATOL, V135, P1590, DOI 10.1038/jid.2015.54; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; Eming R, 2008, J INVEST DERMATOL, V128, P2850, DOI 10.1038/jid.2008.172; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hammers CM, 2015, J INVEST DERMATOL, V135, P742, DOI 10.1038/jid.2014.291; HENNECKE S, 1993, J BIOL CHEM, V268, P26607; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Lunardon L, 2012, ARCH DERMATOL, V148, P1031, DOI 10.1001/archdermatol.2012.1522; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Ohyama B, 2012, J INVEST DERMATOL, V132, P1158, DOI 10.1038/jid.2011.448; Payne A. S., 2012, DERMATOLOGY GEN MED; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Srivastava S, 2015, TRENDS IMMUNOL, V36, P494, DOI 10.1016/j.it.2015.06.004; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Watanabe K., 2014, BLOOD, V124, P4799, DOI [10.1182/blood.V124.21.4799.4799, DOI 10.1182/BLOOD.V124.21.4799.4799]; Yang SL, 2004, P NATL ACAD SCI USA, V101, P4990, DOI 10.1073/pnas.0400880101; Ye ZM, 2002, NAT MED, V8, P343, DOI 10.1038/nm0402-343; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	37	313	348	9	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					179	184		10.1126/science.aaf6756	http://dx.doi.org/10.1126/science.aaf6756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27365313	Green Accepted			2022-12-28	WOS:000379208400042
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Celebrating the expert generalist	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Baird B, 2016, UNDERSTANDING PRESSU; Blunt I, 2014, QUALITYWATCH FOCUS A; Cowling TE, 2014, J ROY SOC MED, V107, P432, DOI 10.1177/0141076814542669; Firth J, 2014, CLIN MED, V14, P354, DOI 10.7861/clinmedicine.14-4-354; King's Fund, 2012, CONT CAR OLD HOSP PA; Medical Schools Council, 2011, ROYAL COLL GEN PRACT; National Voices, 2013, NARR PERS CTR COORD; Oliver David, 2016, Future Hosp J, V3, P49, DOI 10.7861/futurehosp.3-1-49; Royal College of General Practitioners, 2012, MED GEN WHY EXP WHOL; Royal College of Physicians, 2016, 2014 15 CENS UK CONS; Royal College of Physicians of London, 2014, SPEC SPOTL AC INT ME; Royal College of Physicians of London, 2015, HOSP WORKF FIT FUT; Thomas R, 2015, HLTH SERV J	13	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2016	354								i3701	10.1136/bmj.i3701	http://dx.doi.org/10.1136/bmj.i3701			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EG	27381627	Green Published, Bronze			2022-12-28	WOS:000379580200008
J	Kirby, T				Kirby, Tony			Profile Tom Potokar-helping burns climb up the international agenda Obituary	LANCET			English	Biographical-Item														Potokar, Tom/0000-0001-9282-8128				POTOKAR T, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2595	2595		10.1016/S0140-6736(16)30852-2	http://dx.doi.org/10.1016/S0140-6736(16)30852-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27353813				2022-12-28	WOS:000378390500016
J	Dutta, A; Le Magnen, C; Mitrofanova, A; Ouyang, XS; Califano, A; Abate-Shen, C				Dutta, Aditya; Le Magnen, Clementine; Mitrofanova, Antonina; Ouyang, Xuesong; Califano, Andrea; Abate-Shen, Cory			Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation	SCIENCE			English	Article							METHYLTRANSFERASE G9A; LUNG ADENOCARCINOMA; CANCER; NKX3.1; NKX2-1; CELLS; ORIGIN; GENES; UTX	The NKX3.1 homeobox gene plays essential roles in prostate differentiation and prostate cancer. We show that loss of function of Nkx3.1 in mouse prostate results in down-regulation of genes that are essential for prostate differentiation, as well as up-regulation of genes that are not normally expressed in prostate. Conversely, gain of function of Nkx3.1 in an otherwise fully differentiated nonprostatic mouse epithelium (seminal vesicle) is sufficient for respecification to prostate in renal grafts in vivo. In human prostate cells, these activities require the interaction of NKX3.1 with the G9a histone methyltransferase via the homeodomain and are mediated by activation of target genes such as UTY (KDM6c), the male-specific paralog of UTX (KDM6a). We propose that an NKX3.1-G9a-UTY transcriptional regulatory network is essential for prostate differentiation, and we speculate that disruption of such a network predisposes to prostate cancer.	[Dutta, Aditya; Le Magnen, Clementine] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Med,Inst Canc Genet, New York, NY 10032 USA; [Dutta, Aditya; Le Magnen, Clementine] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Urol,Inst Canc Genet, New York, NY 10032 USA; [Mitrofanova, Antonina] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Ouyang, Xuesong] Columbia Univ, Med Ctr, Dept Urol, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Syst Biol,Herbert Irving Comprehens Canc Ctr, Ctr Computat Biol & Bioinformat,Inst Canc Genet, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Biomed Informat,Herbert Irving Comprehens Ca, Ctr Computat Biol & Bioinformat,Inst Canc Genet, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys,Herbert Irving Compreh, Ctr Computat Biol & Bioinformat,Inst Canc Genet, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Dept Urol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Dept Med, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Dept Syst Biol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA; [Mitrofanova, Antonina] Rutgers State Univ, Dept Hlth Informat, 65 Bergen St,Room 350B, Newark, NJ 07101 USA; [Ouyang, Xuesong] Crown Biosci Inc, 6 West Beijing Rd, Taicang 215400, Jiangsu, Peoples R China	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Rutgers State University Newark; Rutgers State University New Brunswick	Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Dept Urol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA.; Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Dept Med, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA.; Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Dept Syst Biol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA.; Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, Inst Canc Genet,Herbert Irving Comprehens Canc Ct, New York, NY 10032 USA.	cabateshen@columbia.edu	Le Magnen, Clementine/T-1164-2019; Dutta, Aditya/D-4825-2016	Dutta, Aditya/0000-0001-9007-4262; Califano, Andrea/0000-0003-4742-3679; Le Magnen, Clementine/0000-0002-6084-6054	JP Sulzberger Columbia Genome Center; Proteomics Shared Resource; NIH/NCI [P30 CA013696]; National Cancer Institute [CA154293]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000040]; Swiss National Science Foundation [PBBSP3_146959, P300P3_151158]; Prostate Cancer Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE [R01CA076501, R01CA173481, R01CA183929, P30CA013696, P01CA154293] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER	JP Sulzberger Columbia Genome Center; Proteomics Shared Resource; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Prostate Cancer Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We are grateful to A. Aytes, F. Constantini, E. Gelmann, D. Reinberg, and M. Shen for comments on the manuscript. We thank C. Bieberich (University of Maryland) for Nkx3.1 antisera. We acknowledge support from the JP Sulzberger Columbia Genome Center and the Proteomics Shared Resource, which are shared resources of the Herbert Irving Comprehensive Cancer Center at Columbia University, supported in part by NIH/NCI grant P30 CA013696. This research is supported by funding to C.A.-S. from the National Cancer Institute (CA154293). A. D. was supported in part by the National Center for Advancing Translational Sciences, National Institutes of Health, grant UL1 TR000040. C.L.M. was supported by the Swiss National Science Foundation (PBBSP3_146959 and P300P3_151158). A. M. is a recipient of a Prostate Cancer Foundation Young Investigator Award. C.A.-S. is an American Cancer Society Research Professor supported in part by a generous gift from the F.M. Kirby Foundation.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Burglin T. R., 2015, CHROMOSOMA, V2015, P1; Chaturvedi CP, 2009, P NATL ACAD SCI USA, V106, P18303, DOI 10.1073/pnas.0906769106; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Lau YFC, 2000, MOL CARCINOGEN, V27, P308, DOI 10.1002/(SICI)1098-2744(200004)27:4<308::AID-MC9>3.0.CO;2-R; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Lehnertz B, 2014, GENE DEV, V28, P317, DOI 10.1101/gad.236794.113; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; Li CMC, 2015, GENE DEV, V29, P1850, DOI 10.1101/gad.267393.115; OSTROWSKI MC, 1979, J BIOL CHEM, V254, P383; Ouyang X, 2005, CANCER RES, V65, P6773, DOI 10.1158/0008-5472.CAN-05-1948; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Shpargel K. B., 2012, GENET, V8; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037647; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2014, CELL REP, V8, P1339, DOI 10.1016/j.celrep.2014.08.002; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Zheng SL, 2006, CANCER RES, V66, P69, DOI 10.1158/0008-5472.CAN-05-1550	27	62	63	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1576	1580		10.1126/science.aad9512	http://dx.doi.org/10.1126/science.aad9512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339988	Green Accepted			2022-12-28	WOS:000378346500044
J	Iwasaki, S; Ingolia, NT				Iwasaki, Shintaro; Ingolia, Nicholas T.			Seeing translation Monitoring individual messenger RNAs as they make protein reveals the tricks of translation	SCIENCE			English	Editorial Material							DYNAMICS; CELLS		[Iwasaki, Shintaro; Ingolia, Nicholas T.] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr RNA Syst Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ingolia, NT (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr RNA Syst Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ingolia@berkeley.edu	Iwasaki, Shintaro/AAO-7743-2021; Iwasaki, Shintaro/D-1472-2017	Iwasaki, Shintaro/0000-0001-7724-3754; Iwasaki, Shintaro/0000-0001-7724-3754				Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Morisaki T, 2016, SCIENCE, V352, P1425, DOI 10.1126/science.aaf0899; Mukherjee C, 2012, CELL REP, V2, P674, DOI 10.1016/j.celrep.2012.07.011; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shieh YW, 2015, SCIENCE, V350, P678, DOI 10.1126/science.aac8171; Wang C, 2016, CELL, V165, P990, DOI 10.1016/j.cell.2016.04.040; Wu B, 2016, SCIENCE, V352, P1430, DOI 10.1126/science.aaf1084; Yan XW, 2016, CELL, V165, P976, DOI 10.1016/j.cell.2016.04.034	10	13	14	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1391	1392		10.1126/science.aag1039	http://dx.doi.org/10.1126/science.aag1039			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313023				2022-12-28	WOS:000377975400020
J	Atianand, MK; Hu, WQ; Satpathy, AT; Shen, Y; Ricci, EP; Alvarez-Dominguez, JR; Bhatta, A; Schattgen, SA; McGowan, JD; Blin, J; Braun, JE; Gandhi, P; Moore, MJ; Chang, HY; Lodish, HF; Caffrey, DR; Fitzgerald, KA				Atianand, Maninjay K.; Hu, Wenqian; Satpathy, Ansuman T.; Shen, Ying; Ricci, Emiliano P.; Alvarez-Dominguez, Juan R.; Bhatta, Ankit; Schattgen, Stefan A.; McGowan, Jason D.; Blin, Juliana; Braun, Joerg E.; Gandhi, Pallavi; Moore, Melissa J.; Chang, Howard Y.; Lodish, Harvey F.; Caffrey, Daniel R.; Fitzgerald, Katherine A.			A Long Noncoding RNA lincRNA-EPS Acts as a Transcriptional Brake to Restrain Inflammation	CELL			English	Article							CHROMATIN SITES; EXPRESSION; SUSCEPTIBILITY; ACTIVATION; REPRESSION; EVOLUTION; REVEALS; DISEASE; REGIONS; HNRNPL	Long intergenic noncoding RNAs (lincRNAs) are important regulators of gene expression. Although lincRNAs are expressed in immune cells, their functions in immunity are largely unexplored. Here, we identify an immunoregulatory lincRNA, lincRNA-EPS, that is precisely regulated in macrophages to control the expression of immune response genes (IRGs). Transcriptome analysis of macrophages from lincRNA-EPS-deficient mice, combined with gain-of-function and rescue experiments, revealed a specific role for this lincRNA in restraining IRG expression. Consistently, lincRNA-EPS-deficient mice manifest enhanced inflammation and lethality following endotoxin challenge in vivo. lincRNA-EPS localizes at regulatory regions of IRGs to control nucleosome positioning and repress transcription. Further, lincRNA-EPS mediates these effects by interacting with heterogeneous nuclear ribonucleoprotein L via a CANACA motif located in its 3' end. Together, these findings identify lincRNA-EPS as a repressor of inflammatory responses, highlighting the importance of lincRNAs in the immune system.	[Atianand, Maninjay K.; Bhatta, Ankit; Schattgen, Stefan A.; McGowan, Jason D.; Blin, Juliana; Gandhi, Pallavi; Caffrey, Daniel R.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Program Innate Immun, Worcester, MA 01605 USA; [Hu, Wenqian; Alvarez-Dominguez, Juan R.; Lodish, Harvey F.] MIT, Whitehead Inst, Cambridge, MA 02142 USA; [Satpathy, Ansuman T.; Shen, Ying; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Satpathy, Ansuman T.; Shen, Ying; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Ricci, Emiliano P.; Braun, Joerg E.; Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01655 USA; [Ricci, Emiliano P.; Braun, Joerg E.; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Biochem & Pharmacol, Worcester, MA 01655 USA; [Fitzgerald, Katherine A.] NTNU, Ctr Mol Inflammat Res, Dept Canc Res & Mol Med, N-7491 Trondheim, Norway; [Hu, Wenqian] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ricci, Emiliano P.] Univ Lyon, Ecole Normale Super Lyon, Ctr Int Rech Infectiol, F-69364 Lyon, France	University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Whitehead Institute; Stanford University; Stanford University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU); Mayo Clinic; Ecole Normale Superieure de Lyon (ENS de LYON)	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Program Innate Immun, Worcester, MA 01605 USA.; Fitzgerald, KA (corresponding author), NTNU, Ctr Mol Inflammat Res, Dept Canc Res & Mol Med, N-7491 Trondheim, Norway.	kate.fitzgerald@umassmed.edu	Atianand, Maninjay/AAF-7823-2019; Fitzgerald, Katherine/ABE-6317-2020; Braun, Joerg/G-2617-2012; Hu, Wenqian/H-6094-2019; Braun, Joerg/N-1277-2019; Ricci, Emiliano/G-7619-2012	Atianand, Maninjay/0000-0003-4135-2515; Braun, Joerg/0000-0002-8309-6401; Hu, Wenqian/0000-0003-3577-3604; Braun, Joerg/0000-0002-8309-6401; Ricci, Emiliano/0000-0002-9789-5837; Blin, Juliana/0000-0002-9628-8920; Schattgen, Stefan/0000-0002-6860-5079; Satpathy, Ansuman/0000-0002-5167-537X; Bhatta, Ankit/0000-0002-2420-8805; Fitzgerald, Kate/0000-0003-3175-609X	American Heart Association grant [14POST18930001]; NIH [P50-HG007735, DK068348, AI067497]; Kenneth Rainin Foundation; Lupus Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115448, R37AI067497, T32AI095213, R56AI067497, R01AI067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK068348, R01DK047618, R01DK068348] Funding Source: NIH RePORTER	American Heart Association grant(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kenneth Rainin Foundation; Lupus Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We sincerely thank Zhaozhao Jiang and Kelly Army for animal care and technical help, Mona Motwani and Shruti Sharma for help with flow cytometry, Alicia Schep for NucleoATAC analysis, Rui Li for help during initial stages of ATAC-seq library preparation, and all members of the Fitzgerald laboratory as well as Susan Carpenter (UCSC) for their insightful comments. We thank Michael Karin (UCSD) for providing RNA samples, and Scott Schaffer and John Leszyck (UMass, Worcester) for mass spectrometry. This study was supported by American Heart Association grant (14POST18930001) to M.K.A., by NIH grant (P50-HG007735) to H.Y.C., by NIH grant (DK068348) to H.F.L., and by grants from the Kenneth Rainin Foundation, Lupus Research Foundation, and NIH (AI067497) to K.A.F.	Atianand MK, 2014, TRENDS MOL MED, V20, P623, DOI 10.1016/j.molmed.2014.09.002; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Chan J, 2015, J IMMUNOL, V195, P1359, DOI 10.4049/jimmunol.1500264; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Girauda M, 2014, P NATL ACAD SCI USA, V111, P1491, DOI 10.1073/pnas.1323535111; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hacisuleyman E, 2014, NAT STRUCT MOL BIOL, V21, P198, DOI 10.1038/nsmb.2764; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Heyer EE, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1235; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Leary VB, 2015, CELL REP, V11, P474, DOI 10.1016/j.celrep.2015.03.043; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Smale ST, 2013, COLD SH Q B, V78, P61, DOI 10.1101/sqb.2013.78.020313; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012	32	289	311	0	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1672	1685		10.1016/j.cell.2016.05.075	http://dx.doi.org/10.1016/j.cell.2016.05.075			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315481	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000378062000018
J	Dey, S; Stowers, L				Dey, Sandeepa; Stowers, Lisa			Think You Know How Smell Works? Sniff Again	CELL			English	Editorial Material							CHEMOSENSORY RECEPTORS; PHEROMONES; FAMILY	The sense of smell is mediated by GPCRs in the odorant receptor (OR) family. Greer et al. report a new family of odor detectors, MS4As, that have similar cellular localization and chemodetection ability as ORs but are not GPCRs and follow a strikingly different logic of odor coding at the periphery.	[Dey, Sandeepa; Stowers, Lisa] Scripps Res Inst, Dept Mol & Cellular Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA	Scripps Research Institute	Stowers, L (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	stowers@scripps.edu		Stowers, Lisa/0000-0002-4403-1269				BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Greer PL, 2016, CELL, V165, P1734, DOI 10.1016/j.cell.2016.05.001; Kuek LE, 2016, IMMUNOL CELL BIOL, V94, P11, DOI 10.1038/icb.2015.48; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2014, ANNU REV PHYSIOL, V76, P151, DOI 10.1146/annurev-physiol-021113-170334; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Munger SD, 2010, CURR BIOL, V20, P1438, DOI 10.1016/j.cub.2010.06.021; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P274, DOI 10.1016/j.conb.2010.02.013; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209	9	1	1	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1566	1567		10.1016/j.cell.2016.06.006	http://dx.doi.org/10.1016/j.cell.2016.06.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315472	Bronze			2022-12-28	WOS:000378062000007
J	Edgren, G; Hjalgrim, H; Rostgaard, K; Lambert, P; Wikman, A; Norda, R; Titlestad, KE; Erikstrup, C; Ullum, H; Melbye, M; Busch, MP; Nyren, O				Edgren, Gustaf; Hjalgrim, Henrik; Rostgaard, Klaus; Lambert, Paul; Wikman, Agneta; Norda, Rut; Titlestad, Kjell-Einar; Erikstrup, Christian; Ullum, Henrik; Melbye, Mads; Busch, Michael P.; Nyren, Olof			Transmission of Neurodegenerative Disorders Through Blood Transfusion A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CREUTZFELDT-JAKOB-DISEASE; BETA-AMYLOIDOSIS; PROPAGATION; VARIANT; TAUOPATHIES; MECHANISMS; INDUCTION; DEMENTIA; PRIMATES; BRAIN	Background: The aggregation of misfolded proteins in the brain occurs in several neurodegenerative disorders. Aberrant protein aggregation is inducible in rodents and primates by intracerebral inoculation. Possible transfusion transmission of neurodegenerative diseases has important public health implications. Objective: To investigate possible transfusion transmission of neurodegenerative disorders. Design: Retrospective cohort study. Setting: Nationwide registers of transfusions in Sweden and Denmark. Participants: 1 465 845 patients who received transfusions between 1968 and 2012. Measurements: Multivariable Cox regression models were used to estimate hazard ratios for dementia of any type, Alzheimer disease, and Parkinson disease in patients receiving blood transfusions from donors who were later diagnosed with any of these diseases versus patients who received blood from healthy donors. Whether excess occurrence of neurodegenerative disease occurred among recipients of blood from a subset of donors was also investigated. As a positive control, transmission of chronic hepatitis before and after implementation of hepatitis C virus screening was assessed. Results: Among included patients, 2.9% received a transfusion from a donor diagnosed with one of the studied neurodegenerative diseases. No evidence of transmission of any of these diseases was found, regardless of approach. The hazard ratio for dementia in recipients of blood from donors with dementia versus recipients of blood from healthy donors was 1.04 (95% CI, 0.99 to 1.09). Corresponding estimates for Alzheimer disease and Parkinson disease were 0.99 (CI, 0.85 to 1.15) and 0.94 (CI, 0.78 to 1.14), respectively. Hepatitis transmission was detected before but not after implementation of hepatitis C virus screening. Limitation: Observational study design, underascertainment of the outcome, and possible insufficient statistical power. Conclusion: The data provide no evidence for the transmission of neurodegenerative diseases and suggest that if transmission does occur, it is rare.	[Edgren, Gustaf; Nyren, Olof] Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, SE-17177 Stockholm, Sweden; [Wikman, Agneta] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, C2 66 Huddinge, SE-17777 Stockholm, Sweden; [Hjalgrim, Henrik; Rostgaard, Klaus; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, 5 Artillerivej, DK-2300 Copenhagen S, Denmark; [Ullum, Henrik] Copenhagen Univ Hosp, Dept Clin Immunol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Lambert, Paul] Univ Leicester, Dept Hlth Sci, Adrian Bldg,Univ Rd, Leicester LE1 7RH, Leics, England; Uppsala Univ, Dept Immunol Genet & Pathol, Akad Sjukhuset, SE-75185 Uppsala, Sweden; [Titlestad, Kjell-Einar] Odense Univ Hosp, Dept Clin Immunol, Sondre Blvd 29, DK-5000 Odense, Denmark; [Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, Palle Juul Jensens Blvd 99, DK-8000 Aarhus, Denmark; Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Busch, Michael P.] Blood Syst Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA; Univ Calif San Francisco, San Francisco, CA USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Statens Serum Institut; University of Copenhagen; University of Leicester; Uppsala University; Uppsala University Hospital; University of Southern Denmark; Odense University Hospital; Aarhus University; Stanford University; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Edgren, G (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, SE-17177 Stockholm, Sweden.	gustaf.edgren@ki.se	Edgren, Gustaf/F-4013-2014; Hjalgrim, Henrik/AAG-4973-2021	Edgren, Gustaf/0000-0002-2198-4745; melbye, mads/0000-0001-8264-6785; Erikstrup, Christian/0000-0001-6551-6647; Ullum, Henrik/0000-0001-7306-9058; Wikman, Agneta/0000-0002-8810-7974; Lambert, Paul/0000-0002-5337-663X; Rostgaard, Klaus/0000-0001-6220-9414	Swedish Research Council [2011-30405, 2007-7469]; Swedish Heart-Lung Foundation [20090710]; Swedish Society for Medical Research; Danish Council for Independent Research [2009B026]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Society for Medical Research; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The assembly of the SCANDAT2 database and the conduct of this study were made possible through grants from the Swedish Research Council (2011-30405 and 2007-7469), the Swedish Heart-Lung Foundation (20090710), the Swedish Society for Medical Research (Dr. Edgren), and the Danish Council for Independent Research (2009B026).	BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Dorsey K, 2009, TRANSFUSION, V49, P977, DOI 10.1111/j.1537-2995.2008.02056.x; Douet JY, 2014, EMERG INFECT DIS, V20, P114, DOI 10.3201/eid2001.130353; Edgren G, 2007, LANCET, V369, P1724, DOI 10.1016/S0140-6736(07)60779-X; Edgren G, 2015, TRANSFUSION, V55, P1600, DOI 10.1111/trf.12986; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; GREENLAND S, 2008, MODERN EPIDEMIOLOGY, P358; Hinchliffe SR, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-13; Hjalgrim H, 2015, BLOOD, V126, P2059, DOI 10.1182/blood-2015-03-632844; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jin P, 2004, NEUROLOGY, V63, P739, DOI 10.1212/01.WNL.0000134604.48018.97; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kamper-Jorgensen M, 2009, TRANSFUSION, V49, P888, DOI 10.1111/j.1537-2995.2008.02081.x; Kim JS, 2010, SCIENCE, V330, P918, DOI 10.1126/science.1198314; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Phung TKT, 2007, DEMENT GERIATR COGN, V24, P220, DOI 10.1159/000107084; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; Rodriguez-Leyva I, 2015, NEUROLOGY S14, V83; Rodriguez-Leyva I, 2014, ANN CLIN TRANSL NEUR, V1, P471, DOI 10.1002/acn3.78; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	38	31	31	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					316	+		10.7326/M15-2421	http://dx.doi.org/10.7326/M15-2421			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27368068				2022-12-28	WOS:000382795000002
J	Franca, GVA; Schuler-Faccini, L; Oliveira, WK; Henriques, CMP; Carmo, EH; Pedi, VD; Nunes, ML; Castro, MC; Serruya, S; Silveira, MF; Barros, FC; Victora, CG				Franca, Giovanny V. A.; Schuler-Faccini, Lavinia; Oliveira, Wanderson K.; Henriques, Claudio M. P.; Carmo, Eduardo H.; Pedi, Vaneide D.; Nunes, Marilia L.; Castro, Marcia C.; Serruya, Suzanne; Silveira, Mariangela F.; Barros, Fernando C.; Victora, Cesar G.			Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation	LANCET			English	Article							INFECTION; OUTBREAK	Background In November, 2015, an epidemic of microcephaly was reported in Brazil, which was later attributed to congenital Zika virus infection. 7830 suspected cases had been reported to the Brazilian Ministry of Health by June 4, 2016, but little is known about their characteristics. We aimed to describe these newborn babies in terms of clinical findings, anthropometry, and survival. Methods We reviewed all 1501 liveborn infants for whom investigation by medical teams at State level had been completed as of Feb 27, 2016, and classified suspected cases into five categories based on neuroimaging and laboratory results for Zika virus and other relevant infections. Definite cases had laboratory evidence of Zika virus infection; highly probable cases presented specific neuroimaging findings, and negative laboratory results for other congenital infections; moderately probable cases had specific imaging findings but other infections could not be ruled out; somewhat probable cases had imaging findings, but these were not reported in detail by the local teams; all other newborn babies were classified as discarded cases. Head circumference by gestational age was assessed with InterGrowth standards. First week mortality and history of rash were provided by the State medical teams. Findings Between Nov 19, 2015, and Feb 27, 2015, investigations were completed for 1501 suspected cases reported to the Brazilian Ministry of Health, of whom 899 were discarded. Of the remainder 602 cases, 76 were definite, 54 highly probable, 181 moderately probable, and 291 somewhat probable of congenital Zika virus syndrome. Clinical, anthropometric, and survival differences were small among the four groups. Compared with these four groups, the 899 discarded cases had larger head circumferences (mean Z scores -1.54 vs -3.13, difference 1.58 [95% CI 1.45-1.72]); lower first-week mortality (14 per 1000 vs 51 per 1000; rate ratio 0.28 [95% CI 0.14-0.56]); and were less likely to have a history of rash during pregnancy (20.7% vs 61.4%, ratio 0.34 [95% CI 0.27-0.42]). Rashes in the third trimester of pregnancy were associated with brain abnormalities despite normal sized heads. One in five definite or probable cases presented head circumferences in the normal range (above -2 SD below the median of the InterGrowth standard) and for one third of definite and probable cases there was no history of a rash during pregnancy. The peak of the epidemic occurred in late November, 2015. Interpretation Zika virus congenital syndrome is a new teratogenic disease. Because many definite or probable cases present normal head circumference values and their mothers do not report having a rash, screening criteria must be revised in order to detect all affected newborn babies. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.	[Franca, Giovanny V. A.; Oliveira, Wanderson K.; Henriques, Claudio M. P.; Carmo, Eduardo H.; Pedi, Vaneide D.; Nunes, Marilia L.] Secretariat Hlth Surveillance Minist Hlth, Brasilia, DF, Brazil; [Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Castro, Marcia C.] Harvard T H Chan Sch Publ Hlth, Boston, MA USA; [Serruya, Suzanne] Latin Amer Ctr Perinatol Women & Reprod Hlth, Montevideo, Uruguay; [Silveira, Mariangela F.; Barros, Fernando C.; Victora, Cesar G.] Univ Fed Pelotas, Programa Posgrad Epidemiol, BR-96020220 Pelotas, RS, Brazil; [Barros, Fernando C.] Univ Catolica Pelotas, Pelotas, RS, Brazil	Universidade Federal do Rio Grande do Sul; Harvard University; Harvard T.H. Chan School of Public Health; Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas	Victora, CG (corresponding author), Univ Fed Pelotas, Programa Posgrad Epidemiol, BR-96020220 Pelotas, RS, Brazil.	cvictora@equidade.org	Henriques, Claudio/AAW-8044-2021; de França, Giovanny Vinícius Araújo/L-7385-2018; Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013; Oliveira, Wanderson/AAF-5182-2019; SCHULER-FACCINI, LAVINIA/C-8309-2013; Castro, Marcia/S-2681-2019	de França, Giovanny Vinícius Araújo/0000-0002-7530-2017; Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Oliveira, Wanderson/0000-0002-9662-1930; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Castro, Marcia/0000-0003-4606-2795; Barros, Fernando/0000-0001-5973-1746	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	CGV holds a Wellcome Trust Senior Investigator Award. We thank the Health Secretaries of the Brazilian states and municipalities; the state Central Laboratories Network National Reference Laboratories; the General Coordination of National Dengue Control Program (CGPNCD/MS); the General Coordination of Surveillance and Response (CGVR/MS); the General Coordination of Public Health Laboratories (CGLAB/MS); the General Coordination of Information and Epidemiological Analysis (CGIAE/MS); the Brazilian Society of Medical Genetics; the Latin American Center for Perinatology, Women and Reproductive Health (CLAP/WR-PAHO/WHO); and the Pan American Health Organization in Washington and the national office in Brazil. Pablo Duran and Andres de Francisco provided inputs in an earlier version of the manuscript; Jose Villar and Eric Ohuma provided advice on the calculations of head circumference Z scores; Dacio de Lyra Rabello Neto, Roberto Carlos Reyes Lecca, Marli Montenegro Silva, and Anthony Stevens carried out the linkage between the microcephaly surveillance system and the National Birth Registration System (SINASC); and Aluisio J D Barros provided statistical analysis advice. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Brazilian Ministry of Health or of the Pan American Health Organization.	Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.3201/eid2206.160062, 10.32032/eid2206.160062]; Brasil. Ministerio da Saude, 2016, REG EV SAUD PUBL RES; Brasil. Ministerio da Saude, 2016, PROT VIG RESP OC MIC, V2 2; Brasil Ministerio da Saude, 2016, INF EP 25; Brasil. Ministerio da Saude, 2016, INF EP 15; Brito C, 2015, ACTA MEDICA PORT, V28, P679; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Centers for Disease Control and Prevention (CDC), CDC CONCL ZIK CAUS M; [DATASUS Brasil. Ministerio da Saude], 2016, SIST NAC NASC VIV; [DATASUS Brasil. Ministerio da Saude], IND MORT TEX MORT NE; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617; Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2; Matijasevich A, 2013, EPIDEMIOL SERV SAUDE, V22, P557, DOI 10.5123/S1679-49742013000400002; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Organizacion Panamericana de la Salud, 2016, GUIA VIG ENF VIR ZIK; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901; Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7; Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; World Health Organization, 2016, ZIK VIR MICR GUILL B	26	384	392	1	67	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					891	897		10.1016/S0140-6736(16)30902-3	http://dx.doi.org/10.1016/S0140-6736(16)30902-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU0RI	27372398	hybrid			2022-12-28	WOS:000381911800027
J	Horton, R; Clark, S				Horton, Richard; Clark, Stephanie			The perils and possibilities of the private health sector	LANCET			English	Editorial Material									[Horton, Richard; Clark, Stephanie] The Lancet, London EC2Y 5AS, England		Horton, R (corresponding author), The Lancet, London EC2Y 5AS, England.							Mackintosh M, 2016, LANCET; McPake B, 2016, LANCET; Montagu D, 2016, LANCET; Morgan R, 2016, LANCET	4	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					540	541		10.1016/S0140-6736(16)30774-7	http://dx.doi.org/10.1016/S0140-6736(16)30774-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27358254				2022-12-28	WOS:000380756600007
J	Cinner, JE; Huchery, C; MacNeil, MA; Graham, NAJ; McClanahan, TR; Maina, J; Maire, E; Kittinger, JN; Hicks, CC; Mora, C; Allison, EH; D'Agata, S; Hoey, A; Feary, DA; Crowder, L; Williams, ID; Kulbicki, M; Vigliola, L; Wantiez, L; Edgar, G; Stuart-Smith, RD; Sandin, SA; Green, AL; Hardt, MJ; Beger, M; Friedlander, A; Campbell, SJ; Holmes, KE; Wilson, SK; Brokovich, E; Brooks, AJ; Cruz-Motta, JJ; Booth, DJ; Chabanet, P; Gough, C; Tupper, M; Ferse, SCA; Sumaila, UR; Mouillot, D				Cinner, Joshua E.; Huchery, Cindy; MacNeil, M. Aaron; Graham, Nicholas A. J.; McClanahan, Tim R.; Maina, Joseph; Maire, Eva; Kittinger, John N.; Hicks, Christina C.; Mora, Camilo; Allison, Edward H.; D'Agata, Stephanie; Hoey, Andrew; Feary, David A.; Crowder, Larry; Williams, Ivor D.; Kulbicki, Michel; Vigliola, Laurent; Wantiez, Laurent; Edgar, Graham; Stuart-Smith, Rick D.; Sandin, Stuart A.; Green, Alison L.; Hardt, Marah J.; Beger, Maria; Friedlander, Alan; Campbell, Stuart J.; Holmes, Katherine E.; Wilson, Shaun K.; Brokovich, Eran; Brooks, Andrew J.; Cruz-Motta, Juan J.; Booth, David J.; Chabanet, Pascale; Gough, Charlie; Tupper, Mark; Ferse, Sebastian C. A.; Sumaila, U. Rashid; Mouillot, David			Bright spots among the world's coral reefs	NATURE			English	Article							GRAVITY; MANAGEMENT; DISTANCE	Ongoing declines in the structure and function of the world's coral reefs(1,2) require novel approaches to sustain these ecosystems and the millions of people who depend on them(3). A presently unexplored approach that draws on theory and practice in human health and rural development(4,5) is to systematically identify and learn from the 'outliers'-places where ecosystems are substantially better ('bright spots') or worse ('dark spots') than expected, given the environmental conditions and socioeconomic drivers they are exposed to. Here we compile data from more than 2,500 reefs worldwide and develop a Bayesian hierarchical model to generate expectations of how standing stocks of reef fish biomass are related to 18 socioeconomic drivers and environmental conditions. We identify 15 bright spots and 35 dark spots among our global survey of coral reefs, defined as sites that have biomass levels more than two standard deviations from expectations. Importantly, bright spots are not simply comprised of remote areas with low fishing pressure; they include localities where human populations and use of ecosystem resources is high, potentially providing insights into how communities have successfully confronted strong drivers of change. Conversely, dark spots are not necessarily the sites with the lowest absolute biomass and even include some remote, uninhabited locations often considered near pristine(6). We surveyed local experts about social, institutional, and environmental conditions at these sites to reveal that bright spots are characterized by strong sociocultural institutions such as customary taboos and marine tenure, high levels of local engagement in management, high dependence on marine resources, and beneficial environmental conditions such as deep-water refuges. Alternatively, dark spots are characterized by intensive capture and storage technology and a recent history of environmental shocks. Our results suggest that investments in strengthening fisheries governance, particularly aspects such as participation and property rights, could facilitate innovative conservation actions that help communities defy expectations of global reef degradation.	[Cinner, Joshua E.; Huchery, Cindy; MacNeil, M. Aaron; Graham, Nicholas A. J.; Maire, Eva; Hicks, Christina C.; Hoey, Andrew; Mouillot, David] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [MacNeil, M. Aaron] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia; [MacNeil, M. Aaron] Dalhousie Univ, Dept Math & Stat, Halifax, NS B3H 3J5, Canada; [Graham, Nicholas A. J.; Hicks, Christina C.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [McClanahan, Tim R.; Maina, Joseph; D'Agata, Stephanie; Campbell, Stuart J.; Holmes, Katherine E.] Wildlife Conservat Soc, Global Marine Program, Bronx, NY 10460 USA; [Maina, Joseph; Beger, Maria] Univ Queensland, Ctr Biodivers & Conservat Sci, Australian Res Council Ctr Excellence Environm De, St Lucia, Qld 4074, Australia; [Maina, Joseph; D'Agata, Stephanie] Macquarie Univ, Dept Environm Sci, N Ryde, NSW 2109, Australia; [Maire, Eva; Mouillot, David] Univ Montpellier, IRD CNRS UM IFREMER, UMR 9190, MARBEC, F-34095 Montpellier, France; [Kittinger, John N.; Hicks, Christina C.; Crowder, Larry] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Kittinger, John N.] Conservat Int Hawaii Betty & Gordon Moore Ctr Sci, 7192 Kalaniana Ole Hwy,Suite G230, Honolulu, HI 96825 USA; [Mora, Camilo] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA; [Allison, Edward H.] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98102 USA; [D'Agata, Stephanie; Vigliola, Laurent] Inst Res Dev, UMR IRD UR CNRS ENTROPIE, Lab Excellence LABEX CORAIL, BP A5, Noumea 98848, New Caledonia; [Feary, David A.] Univ Nottingham, Sch Life Sci, Ecol & Evolut Grp, Univ Pk, Nottingham NG7 2RD, England; [Williams, Ivor D.] NOAA Pacific Islands Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI 96818 USA; [Kulbicki, Michel] Univ Perpignan, Labex Corail IRD, UMR Entropie, F-66000 Perpignan, France; [Wantiez, Laurent] Univ New Caledonia, LIVE EA4243, BPR4, Noumea 98851, New Caledonia; [Edgar, Graham; Stuart-Smith, Rick D.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Sandin, Stuart A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Green, Alison L.] Nature Conservancy, Brisbane, Qld 4101, Australia; [Hardt, Marah J.] Future Fish, 7315 Wisconsin Ave,Suite 1000W, Bethesda, MD 20814 USA; [Friedlander, Alan] Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Friedlander, Alan] Natl Geog Soc, Pristine Seas Program, 1145 17th St NW, Washington, DC 20036 USA; [Wilson, Shaun K.] Dept Pk & Wildlife, Perth, WA 6151, Australia; [Wilson, Shaun K.] Univ Western Australia, Oceans Inst, Crawley, WA 6009, Australia; [Brokovich, Eran] Israeli Soc Ecol & Environm Sci, Kehilat New York 19, Tel Aviv, Israel; [Brooks, Andrew J.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Cruz-Motta, Juan J.] Univ Puerto Rico, Recinto Univ Mayaguez, Dept Ciencias Marinas, San Juan, PR 00680 USA; [Booth, David J.] Univ Technol Sydney, Sch Life Sci, Sydney, NSW 2007, Australia; [Chabanet, Pascale] Inst Rech Dev, UMR ENTROPIE, Lab Excellence LABEX CORAIL, CS 41095, St Clothilde 97495, Reunion, France; [Gough, Charlie] Blue Ventures Conservat, 39-41 North Rd, London N7 9DP, England; [Tupper, Mark] Coastal Resources Assoc, St Joseph St, Surigao City 8400, Surigao Del Nor, Philippines; [Ferse, Sebastian C. A.] Leibniz Ctr Trop Marine Ecol ZMT, Fahrenheitstr 6, D-28359 Bremen, Germany; [Sumaila, U. Rashid] Univ British Columbia, Fisheries Econ Res Unit, 2202 Main Mall, Vancouver, BC V6T 1Z4, Canada	James Cook University; Australian Institute of Marine Science; Dalhousie University; Lancaster University; Wildlife Conservation Society; University of Queensland; Macquarie University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Montpellier; Stanford University; University of Hawaii System; University of Hawaii Manoa; University of Washington; University of Washington Seattle; University of Nottingham; Universite Perpignan Via Domitia; Universite Nouvelle Caledonie; University of Tasmania; University of California System; University of California San Diego; Scripps Institution of Oceanography; Nature Conservancy; University of Hawaii System; National Geographic Society; University of Western Australia; University of California System; University of California Santa Barbara; University of Puerto Rico; University of Technology Sydney; Institut de Recherche pour le Developpement (IRD); Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of British Columbia	Cinner, JE (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	Joshua.cinner@jcu.edu.au	Maire, Eva/T-1934-2019; Dagata, Stéphanie/ABC-7437-2020; Sumaila, U. Rashid/ABE-6475-2020; McClanahan, Tim/K-4998-2019; Allison, Edward Hugh/B-8615-2009; Graham, Nicholas AJ/C-8360-2014; Beger, Maria/F-9049-2013; Edgar, Graham/AAY-3797-2020; Stuart-Smith, Rick D/M-1829-2013; MacNeil, Aaron/E-8196-2017; Stephanie, D'Agata/AAN-3692-2020; Chabanet, Pascale/L-9470-2017; Beger, Maria/ABC-5975-2022; Vigliola, Laurent/J-7107-2016; Cinner, Joshua e/E-8966-2011; Stuart-Smith, Rick/I-5214-2019; Cinner, Joshua/AAA-6823-2021; Hoey, Andrew S/B-5457-2015; Ferse, Sebastian/AAH-8048-2021; MacNeil, M. Aaron/ABD-6444-2021; Wantiez, Laurent/L-3343-2013; Hicks, Christina/M-6182-2015	Maire, Eva/0000-0002-1032-3394; Graham, Nicholas AJ/0000-0002-0304-7467; Beger, Maria/0000-0003-1363-3571; Edgar, Graham/0000-0003-0833-9001; Stuart-Smith, Rick D/0000-0002-8874-0083; MacNeil, Aaron/0000-0001-8406-325X; Stephanie, D'Agata/0000-0001-6941-8489; Beger, Maria/0000-0003-1363-3571; Vigliola, Laurent/0000-0003-4715-7470; Cinner, Joshua e/0000-0003-2675-9317; Stuart-Smith, Rick/0000-0002-8874-0083; Ferse, Sebastian/0000-0003-0930-5356; MacNeil, M. Aaron/0000-0001-8406-325X; Wantiez, Laurent/0000-0001-5024-2057; Hicks, Christina/0000-0002-7399-4603; Cruz Motta, Juan Jose/0000-0001-6117-9014; Hoey, Andrew/0000-0002-4261-5594; Maina, Joseph/0000-0003-1268-6137; Booth, David/0000-0002-8256-1412; Williams, Ivor/0000-0002-9444-1020; Chabanet, Pascale/0000-0001-7600-943X; Tupper, Mark/0000-0002-6157-7714; Campbell, Stuart/0000-0002-1158-3200; Allison, Edward/0000-0003-4663-1396; Wilson, Shaun/0000-0002-4590-0948; huchery, cindy/0000-0002-5657-7584	ARC Centre of Excellence for Coral Reef Studies, Stanford University; University of Montpellier; J.E.C.'s Pew Fellowship in Marine Conservation; ARC Australian Research Fellowship; Natural Environment Research Council [ceh010010] Funding Source: researchfish	ARC Centre of Excellence for Coral Reef Studies, Stanford University(Australian Research Council); University of Montpellier; J.E.C.'s Pew Fellowship in Marine Conservation; ARC Australian Research Fellowship(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The ARC Centre of Excellence for Coral Reef Studies, Stanford University, and University of Montpellier funded working group meetings. This work was supported by J.E.C.'s Pew Fellowship in Marine Conservation and ARC Australian Research Fellowship. Thanks to M. Barnes for constructive comments.	Anderson J. E., 2010, THE GRAVITY MODEL; ANDERSON JE, 1979, AM ECON REV, V69, P106; Andrefouet S., 2006, P 10 INT COR REEF S, P1732; [Anonymous], 2021, LANG ENV STAT COMP; Bartholome E., 2002, GLC 2000 GLOBAL LAND; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BLACK WR, 1973, TRANSPORTATION, V2, P299; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Cinner JE, 2011, GLOBAL ENVIRON CHANG, V21, P835, DOI 10.1016/j.gloenvcha.2011.04.012; Cinner J, 2006, ECOL SOC, V11; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Cinner JE, 2016, REG ENVIRON CHANGE, V16, P1133, DOI 10.1007/s10113-015-0832-z; Devillers R, 2015, AQUAT CONSERV, V25, P480, DOI 10.1002/aqc.2445; Dijkstra EW., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dodd SC, 1950, AM SOCIOL REV, V15, P245, DOI 10.2307/2086789; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; Emran M. S., 2008, EXTENT MARKET STAGES, V4534; Falk A, 2013, SCIENCE, V340, P707, DOI 10.1126/science.1231566; Froese R., 2014, FISHBASE; Gelman A., 2014, BAYESIAN DATA ANAL, V2; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Hughes TP, 2013, CONSERV BIOL, V27, P261, DOI 10.1111/j.1523-1739.2012.01957.x; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Levinson FJ, 2007, FOOD NUTR BULL, V28, P259, DOI 10.1177/156482650702800301; Lindfield SJ, 2016, CORAL REEFS, V35, P125, DOI 10.1007/s00338-015-1386-8; LUKERMANN F, 1960, ANN ASSOC AM GEOGR, V50, P493, DOI 10.1111/j.1467-8306.1960.tb00364.x; MacNeil M. Aaron, 2015, P116; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; Maina J., 2011, SPATIAL BEHAV ARTISA; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Nelson A., 2008, TRAVEL TIME MAJOR CI; Noble A., 2005, BRIGHT SPOTS DEMONST, P7; O'Rourke D, 2014, SCIENCE, V344, P1124, DOI 10.1126/science.1248526; Ostrom E., 1990, GOVERNING COMMONS EV; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pascale R. T., 2005, HARVARD BUS REV, V83, P153; Patil A, 2010, J STAT SOFTW, V35, P1; Pressey RL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0280; Pretty JN, 2006, ENVIRON SCI TECHNOL, V40, P1114, DOI 10.1021/es051670d; Ravenstein E.G., 1885, J STAT SOC LONDON, V48, P167; Sampson GS, 2015, SCIENCE, V348, P504, DOI 10.1126/science.aaa4639; Sandel M.J, 2012, WHAT MONEY CANT BUY; Schmitt KM, 2009, ENVIRON CONSERV, V36, P289, DOI 10.1017/S0376892910000159; Sternin M, 1997, HEARTH NUTR MODEL AP, P49; Teh LSL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065397; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; York R, 2003, AM SOCIOL REV, V68, P279, DOI 10.2307/1519769	55	296	301	8	299	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					416	+		10.1038/nature18607	http://dx.doi.org/10.1038/nature18607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27309809	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000380344200039
J	Dev, J; Park, D; Fu, QS; Chen, J; Ha, HJ; Ghantous, F; Herrmann, T; Chang, WT; Liu, ZJ; Frey, G; Seaman, MS; Chen, B; Chou, JJ				Dev, Jyoti; Park, Donghyun; Fu, Qingshan; Chen, Jia; Ha, Heather Jiwon; Ghantous, Fadi; Herrmann, Tobias; Chang, Weiting; Liu, Zhijun; Frey, Gary; Seaman, Michael S.; Chen, Bing; Chou, James J.			Structural basis for membrane anchoring of HIV-1 envelope spike	SCIENCE			English	Article							SPANNING DOMAIN; GLYCOPROTEIN; FUSION; NEUTRALIZATION; RECOGNITION; EXPRESSION; MUTATIONS; MECHANISM; REGION; TRIMER	HIV-1 envelope spike (Env) is a type I membrane protein that mediates viral entry. We used nuclear magnetic resonance to determine an atomic structure of the transmembrane (TM) domain of HIV-1 Env reconstituted in bicelles that mimic a lipid bilayer. The TM forms a well-ordered trimer that protects a conserved membrane-embedded arginine. An aminoterminal coiled-coil and a carboxyl-terminal hydrophilic core stabilize the trimer. Individual mutations of conserved residues did not disrupt the TM trimer and minimally affected membrane fusion and infectivity. Major changes in the hydrophilic core, however, altered the antibody sensitivity of Env. These results show how a TM domain anchors, stabilizes, and modulates a viral envelope spike and suggest that its influence on Env conformation is an important consideration for HIV-1 immunogen design.	[Dev, Jyoti; Fu, Qingshan; Chou, James J.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 250 Longwood Ave, Boston, MA 02115 USA; [Dev, Jyoti; Chang, Weiting] Harvard Med Sch, Virol Program, 250 Longwood Ave, Boston, MA 02115 USA; [Park, Donghyun; Chen, Jia; Ha, Heather Jiwon; Chang, Weiting; Frey, Gary; Chen, Bing] Boston Childrens Hosp, Div Mol Med, 3 Blackfan St, Boston, MA 02115 USA; [Chen, Jia; Frey, Gary; Chen, Bing] Harvard Med Sch, Dept Pediat, 300 Longwood Ave, Boston, MA 02115 USA; [Ghantous, Fadi; Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, 330 Brookline Ave, Boston, MA 02215 USA; [Liu, Zhijun; Chou, James J.] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, B (corresponding author), Boston Childrens Hosp, Div Mol Med, 3 Blackfan St, Boston, MA 02115 USA.; Chen, B (corresponding author), Harvard Med Sch, Dept Pediat, 300 Longwood Ave, Boston, MA 02115 USA.	bchen@crystal.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013; Fu, Qingshan/E-1405-2015; Park, Donghyun/AAA-5338-2022	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344; Fu, Qingshan/0000-0002-7445-2355; Park, Donghyun/0000-0003-2048-6004	NIH [AI084794, GM083680, AI106488, HL103526, AI127193, P41 EB-002026]; Collaboration for AIDS Vaccine Discovery (CAVD) grant [OPP1040741]; Center for HIV/AIDS Vaccine Immunology-Immunogen Design [AI-100645]; Chinese Academy of Sciences [XDB08030301]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127193, R01AI084794, UM1AI100645, R01AI106488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083680] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaboration for AIDS Vaccine Discovery (CAVD) grant; Center for HIV/AIDS Vaccine Immunology-Immunogen Design; Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Harrison and S. Rits-Volloch for generous advice and assistance; D. Barouch, B. Haynes, and A. Carfi for critical reading of the manuscript; and the NIH AIDS Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, for reagents. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The atomic structure coordinate and structural constraints are deposited in the Protein Data Bank under the accession number 5JYN. The chemical-shift values are deposited in the Biological Magnetic Resonance Data Bank under the accession number 30090. This work was supported by NIH grants AI084794 (to B.C. and Dan H. Barouch), GM083680 (to B.C.), AI106488 (to B.C.), HL103526 (to J.J.C.), and AI127193 (to B.C. and J.J.C.), Collaboration for AIDS Vaccine Discovery (CAVD) grant OPP1040741 (to Dan H. Barouch from the Bill and Melinda Gates Foundation), and the Center for HIV/AIDS Vaccine Immunology-Immunogen Design AI-100645 (to Barton F. Haynes). The NMR data were collected at the NMR facility of National Center for Protein Science Shanghai (supported by Chinese Academy of Sciences grant XDB08030301) and Massachusetts Institute of Technology-Harvard Center for Magnetic Resonance (supported by NIH grant P41 EB-002026).	Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; HELSETH E, 1990, J VIROL, V64, P6314, DOI 10.1128/JVI.64.12.6314-6318.1990; Jeffs SA, 2004, VACCINE, V22, P1032, DOI 10.1016/j.vaccine.2003.08.042; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kovacs JM, 2014, P NATL ACAD SCI USA, V111, P18542, DOI 10.1073/pnas.1422269112; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; OWENS RJ, 1994, J VIROL, V68, P570, DOI 10.1128/JVI.68.1.570-574.1994; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROWELL JF, 1995, J IMMUNOL, V155, P473; SANDERS CR, 1992, BIOCHEMISTRY-US, V31, P8898, DOI 10.1021/bi00152a029; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Teese MG, 2015, BIOCHEMISTRY-US, V54, P5125, DOI 10.1021/acs.biochem.5b00495; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; West JT, 2001, J VIROL, V75, P9601, DOI 10.1128/JVI.75.20.9601-9612.2001; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Yue L, 2009, J VIROL, V83, P11588, DOI 10.1128/JVI.00914-09; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	32	139	143	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					172	175		10.1126/science.aaf7066	http://dx.doi.org/10.1126/science.aaf7066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27338706	Green Accepted			2022-12-28	WOS:000379208400040
J	Lenzer, J				Lenzer, Jeanne			PROFILE Robert Califf: controversial new head of the FDA	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jlenzer@bmj.com						[Anonymous], 2007, COMMUNICATION; Belluz J., 2016, VOX; Califf RM, 2016, FDA VOICE; Cohen D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6980; Duke Clinical Research Institute, 2015, ANN REP ANSW TOD QUE; FDA, 2013, JOINT M END MET DRUG; FDA panel affirms DCRI's review of RECORD, 2013, FDA PAN AFF DCRIS RE; Herper M., 2008, FORBES; Nissen SE, 2013, FORBES; Project on Government Oversight, 2016, NEW CLOUD CLIN TRIAL; Robb MA, 2016, JAMA-J AM MED ASSOC, V315, P1107, DOI 10.1001/jama.2016.2240; Young J., 2009, HILL	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2016	354								i3656	10.1136/bmj.i3656	http://dx.doi.org/10.1136/bmj.i3656			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EG	27381843				2022-12-28	WOS:000379580200005
J	Bromham, L; Dinnage, R; Hua, X				Bromham, Lindell; Dinnage, Russell; Hua, Xia			Interdisciplinary research has consistently lower funding success	NATURE			English	Article							SCIENCE; IMPACT; DIVERSITY; METRICS	Interdisciplinary research is widely considered a hothouse for innovation, and the only plausible approach to complex problems such as climate change(1,2). One barrier to interdisciplinary research is the widespread perception that interdisciplinary projects are less likely to be funded than those with a narrower focus(3,4). However, this commonly held belief has been difficult to evaluate objectively, partly because of lack of a comparable, quantitative measure of degree of interdisciplinarity that can be applied to funding application data(1). Here we compare the degree to which research proposals span disparate fields by using a biodiversity metric that captures the relative representation of different fields (balance) and their degree of difference (disparity). The Australian Research Council's Discovery Programme provides an ideal test case, because a single annual nationwide competitive grants scheme covers fundamental research in all disciplines, including arts, humanities and sciences. Using data on all 18,476 proposals submitted to the scheme over 5 consecutive years, including successful and unsuccessful applications, we show that the greater the degree of interdisciplinarity, the lower the probability of being funded. The negative impact of interdisciplinarity is significant even when number of collaborators, primary research field and type of institution are taken into account. This is the first broad-scale quantitative assessment of success rates of interdisciplinary research proposals. The interdisciplinary distance metric allows efficient evaluation of trends in research funding, and could be used to identify proposals that require assessment strategies appropriate to interdisciplinary research(5).	[Bromham, Lindell; Dinnage, Russell; Hua, Xia] Australian Natl Univ, Res Sch Biol, 116 Daley Rd, Canberra, ACT 0200, Australia	Australian National University	Bromham, L (corresponding author), Australian Natl Univ, Res Sch Biol, 116 Daley Rd, Canberra, ACT 0200, Australia.	lindell.bromham@anu.edu.au	Bromham, Lindell/D-1046-2009; Dinnage, Russell/H-9023-2019	Bromham, Lindell/0000-0003-2202-2609; Dinnage, Russell/0000-0003-0846-2819				Bammer Gabriele., 2012, STRENGTHENING INTERD; Bruun H., 2005, PROMOTING INTERDISCI; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Committee on Facilitating Interdisciplinary Research Committee on Science Engineering and Public Policy, 2004, FAC INT RES; Goring SJ, 2014, FRONT ECOL ENVIRON, V12, P39, DOI 10.1890/120370; Haythornthwaite C., 2006, NEW INFRASTRUCTURES, P143, DOI [10.4018/978-1-59140-717-1.ch007, DOI 10.4018/978-1-59140-717-1.CH007]; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Huutoniemi K, 2010, RES POLICY, V39, P79, DOI 10.1016/j.respol.2009.09.011; Langfeldt L, 2006, RES EVALUAT, V15, P31, DOI 10.3152/147154406781776039; Laudel G, 2006, RES EVALUAT, V15, P57, DOI 10.3152/147154406781776048; Ledford H, 2015, NATURE, V525, P308, DOI 10.1038/525308a; Lyall C, 2013, SCI PUBL POLICY, V40, P62, DOI 10.1093/scipol/scs121; Ma A, 2015, P NATL ACAD SCI USA, V112, P14760, DOI 10.1073/pnas.1513651112; Mansilla VB, 2006, RES EVALUAT, V15, P69; Nichols LG, 2014, SCIENTOMETRICS, V100, P741, DOI 10.1007/s11192-014-1319-2; Porter AL, 2006, RES EVALUAT, V15, P187, DOI 10.3152/147154406781775841; Porter AL, 2012, BIOSCIENCE, V62, P282, DOI 10.1525/bio.2012.62.3.9; Porter AL, 2009, SCIENTOMETRICS, V81, P719, DOI 10.1007/s11192-008-2197-2; Rylance R, 2015, NATURE, V525, P313, DOI 10.1038/525313a; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006547; Stirling A, 2007, J R SOC INTERFACE, V4, P707, DOI 10.1098/rsif.2007.0213; Uzzi B, 2013, SCIENCE, V342, P468, DOI 10.1126/science.1240474; Van Noorden R, 2015, NATURE, V525, P306, DOI 10.1038/525306a; Wagner CS, 2011, J INFORMETR, V5, P14, DOI 10.1016/j.joi.2010.06.004; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127298; Woelert P, 2013, HIGH EDUC, V66, P755, DOI 10.1007/s10734-013-9634-8; Yegros-Yegros A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135095	27	242	252	28	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					684	+		10.1038/nature18315	http://dx.doi.org/10.1038/nature18315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP7JV	27357795				2022-12-28	WOS:000378676000036
J	Faber, F; Tran, L; Byndloss, MX; Lopez, CA; Velazquez, EM; Kerrinnes, T; Nuccio, SP; Wangdi, T; Fiehn, O; Tsolis, RM; Baumler, AJ				Faber, Franziska; Tran, Lisa; Byndloss, Mariana X.; Lopez, Christopher A.; Velazquez, Eric M.; Kerrinnes, Tobias; Nuccio, Sean-Paul; Wangdi, Tamding; Fiehn, Oliver; Tsolis, Renee M.; Baumler, Andreas J.			Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion	NATURE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; NITRIC-OXIDE; RESISTANCE; GROWTH; MICROBIOTA; INFECTION	Changes in the gut microbiota may underpin many human diseases, but the mechanisms that are responsible for altering microbial communities remain poorly understood. Antibiotic usage elevates the risk of contracting gastroenteritis caused by Salmonella enterica serovars(1), increases the duration for which patients shed the pathogen in their faeces, and may on occasion produce a bacteriologic and symptomatic relapse(2,3). These antibiotic-induced changes in the gut microbiota can be studied in mice, in which the disruption of a balanced microbial community by treatment with the antibiotic streptomycin leads to an expansion of S. enterica serovars in the large bowel(4). However, the mechanisms by which streptomycin treatment drives an expansion of S. enterica serovars are not fully resolved. Here we show that host-mediated oxidation of galactose and glucose promotes post-antibiotic expansion of S. enterica serovar Typhimurium (S. Typhimurium). By elevating expression of the gene encoding inducible nitric oxide synthase (iNOS) in the caecal mucosa, streptomycin treatment increased post-antibiotic availability of the oxidation products galactarate and glucarate in the murine caecum. S. Typhimurium used galactarate and glucarate within the gut lumen of streptomycin pre-treated mice, and genetic ablation of the respective catabolic pathways reduced S. Typhimurium competitiveness. Our results identify host-mediated oxidation of carbohydrates in the gut as a mechanism for post-antibiotic pathogen expansion.	[Faber, Franziska; Tran, Lisa; Byndloss, Mariana X.; Lopez, Christopher A.; Velazquez, Eric M.; Kerrinnes, Tobias; Nuccio, Sean-Paul; Wangdi, Tamding; Tsolis, Renee M.; Baumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, One Shields Ave, Davis, CA 95616 USA; [Fiehn, Oliver] Univ Calif Davis, Genome Ctr, One Shields Ave, Davis, CA 95616 USA; [Fiehn, Oliver] King Abdulaziz Univ, Dept Biochem, Jeddah 21412, Saudi Arabia	University of California System; University of California Davis; University of California System; University of California Davis; King Abdulaziz University	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, One Shields Ave, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Byndloss, Mariana X/D-9890-2014; Faber, Franziska/B-5601-2017; Velazquez, Eric/AAU-3279-2020; Baumler, Andreas J/H-2301-2011; Byndloss, Mariana Xavier/ABD-5506-2021	Byndloss, Mariana X/0000-0002-2122-4156; Faber, Franziska/0000-0002-8700-6522; Baumler, Andreas J/0000-0001-9152-7809; Byndloss, Mariana Xavier/0000-0002-2122-4156; Tsolis, Renee/0000-0001-9131-6657; Tran, Lisa/0000-0002-0446-2777; Nuccio, Sean-Paul/0000-0002-9683-9278	Public Health Service [OD010931, AI060555, AI096528, AI09799, AI112241, AI112258, AI112445, U24 DK097154 (01), AI112949, AI114922]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060555, R01AI112949, R21AI114922, R21AI112258, R01AI096528, R01AI109799, R56AI112949, F31AI112241, R01AI112445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056765] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010956, T32OD010931] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Public Health Service grants OD010931 (E.M.V.), AI060555 (S.-P.N.), AI096528 (A.J.B.), AI09799 (R.M.T), AI112241 (C.A.L.), AI112258 (R.M.T), AI112445 (A.J.B.), U24 DK097154 (01), AI112949 (A.J.B.) and AI114922 (A.J.B.).	ASERKOFF B, 1969, NEW ENGL J MED, V281, P636, DOI 10.1056/NEJM196909182811202; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; de Souza MVN, 2004, QUIM NOVA, V27, P287, DOI 10.1590/S0100-40422004000200019; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Hwang I, 2015, FASEB J, V29, P2397, DOI 10.1096/fj.14-265983; Kelterborn E., 1989, KAUFFMANN WHITE SCHE, P1; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Lamichhane-Khadka R, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130146; Lamichhane-Khadka R, 2011, J BACTERIOL, V193, P5824, DOI 10.1128/JB.05456-11; LAWES M, 1995, J BACTERIOL, V177, P1383, DOI 10.1128/jb.177.5.1383-1387.1995; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; NELSON JD, 1980, PEDIATRICS, V65, P1125; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Nuccio SP, 2014, MBIO, V5, DOI 10.1128/mBio.00929-14; OZAWA A, 1964, J INFECT DIS, V114, P235, DOI 10.1093/infdis/114.3.235; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PAVIA AT, 1990, J INFECT DIS, V161, P255, DOI 10.1093/infdis/161.2.255; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rivera-Chavez F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003267; Sheldon RA, 2004, ADV SYNTH CATAL, V346, P1051, DOI 10.1002/adsc.200404110; Spees AM, 2013, MBIO, V4, DOI 10.1128/mBio.00430-13; STEFANOVICRACIC M, 1995, J RHEUMATOL, V22, P1922; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Tsolis RM, 1999, INFECT IMMUN, V67, P4879, DOI 10.1128/IAI.67.9.4879-4885.1999; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Winter SE, 2009, INFECT IMMUN, V77, P1904, DOI 10.1128/IAI.01341-08	30	105	109	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					697	+		10.1038/nature18597	http://dx.doi.org/10.1038/nature18597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27309805	Green Accepted			2022-12-28	WOS:000378676000039
J	Munch, C; Harper, JW				Munch, Christian; Harper, J. Wade			Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation	NATURE			English	Article							CANCER-CELL LINE; STRESS-RESPONSE; ACTIVATION; EXPRESSION; PATHWAYS; ELEGANS; ELEMENT; HSP90; UPR	The mitochondrial matrix is unique in that it must integrate the folding and assembly of proteins derived from the nuclear and mitochondrial genomes. In Caenorhabditis elegans, the mitochondrial unfolded protein response (UPRmt) senses matrix protein misfolding and induces a program of nuclear gene expression, including mitochondrial chaperonins, to promote mitochondrial proteostasis(1-3). While misfolded mitochondrial-matrix-localized ornithine transcarbamylase induces chaperonin expression(4-6), our understanding of mammalian UPRmt is rudimentary(7), reflecting a lack of acute triggers for UPRmt activation. This limitation has prevented analysis of the cellular responses to matrix protein misfolding and the effects of UPRmt on mitochondrial translation to control protein folding loads. Here we combine pharmacological inhibitors of matrix-localized HSP90/TRAP1 (ref. 8) or LON protease(9), which promote chaperonin expression, with global transcriptional and proteomic analysis to reveal an extensive and acute response of human cells to UPRmt. This response encompasses widespread induction of nuclear genes, including matrix-localized proteins involved in folding, pre-RNA processing and translation. Functional studies revealed rapid but reversible translation inhibition in mitochondria occurring concurrently with defects in pre-RNA processing caused by transcriptional repression and LON-dependent turnover of the mitochondrial pre-RNA processing nuclease MRPP3 (ref. 10). This study reveals that acute mitochondrial protein folding stress activates both increased chaperone availability within the matrix and reduced matrix-localized protein synthesis through translational inhibition, and provides a framework for further dissection of mammalian UPRmt.	[Munch, Christian; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Munch, Christian/AAW-7256-2020	Munch, Christian/0000-0003-3832-090X; Harper, Jeffrey/0000-0002-6944-7236	National Institutes of Health [R37NS083524]; Biogen, Inc.; EMBO Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS083524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biogen, Inc.(Biogen); EMBO Fellowship(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. C. Altieri for GTPP, J. Paulo and S. P. Gygi for assistance with mass spectrometry, and L. Pontano and S. H. Sui for assistance with RNA-seq. This work was supported by National Institutes of Health grant R37NS083524 and Biogen, Inc. (J.W.H.), and an EMBO Fellowship (C.M.).	Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Bernstein SH, 2012, BLOOD, V119, P3321, DOI 10.1182/blood-2011-02-340075; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Horibe T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000835; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Lamech LT, 2015, J CELL BIOL, V209, P781, DOI 10.1083/jcb.201503107; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Reinhard L, 2015, NUCLEIC ACIDS RES, V43, P5664, DOI 10.1093/nar/gkv481; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zajac M, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-44; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	28	155	162	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					710	+		10.1038/nature18302	http://dx.doi.org/10.1038/nature18302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27350246	Green Accepted			2022-12-28	WOS:000378676000042
J	Murray, SA				Murray, Scott A.			PERSONAL VIEW Set a low bar for starting palliative care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LUNG-CANCER; END		[Murray, Scott A.] Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Murray, SA (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH8 9AG, Midlothian, Scotland.	Scott.Murray@ed.ac.uk		Murray, Scott A/0000-0002-6649-9428				Carduff Emma, 2015, BMC Res Notes, V8, P142, DOI 10.1186/s13104-015-1107-y; Cavers D, 2012, CAN MED ASSOC J, V184, pE373, DOI 10.1503/cmaj.111622; Mackenbach JP, 2012, INT J PUBLIC HEALTH, V57, P915, DOI 10.1007/s00038-012-0381-x; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2008, BRIT MED J, V336, P958, DOI 10.1136/bmj.39535.491238.94; Murray SA, 2007, J PAIN SYMPTOM MANAG, V34, P393, DOI 10.1016/j.jpainsymman.2006.12.009; Murray SA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2581; Tapsfield J, 2016, BMJ SUPPORT PALLIAT; WHO,, 2020, WHO DEF PALL CAR	9	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3598	10.1136/bmj.i3598	http://dx.doi.org/10.1136/bmj.i3598			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27365045				2022-12-28	WOS:000379019700008
J	Appleby, J				Appleby, John			DATA BRIEFING I'm a healthy patient; get me out of here	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Appleby J, 2016, 19 KINGS FUND; Monitor, 2015, MONITOR Q REPORT PER; NHS England, 2016, BED AV OCC DAT OV; NHS England, 2016, DEL TRANSF CAR; NHS England, 2016, A E ATT EM ADM 2016; NHS Providers, 2015, RIGHT PLAC RIGHT TIM; Triggle N., 2016, BBC NEWS	7	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2016	353								i3585	10.1136/bmj.i3585	http://dx.doi.org/10.1136/bmj.i3585			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FV	27356943				2022-12-28	WOS:000379018700003
J	Backus, KM; Correia, BE; Lum, KM; Forli, S; Horning, BD; Gonzalez-Paez, GE; Chatterjee, S; Lanning, BR; Teijaro, JR; Olson, AJ; Wolan, DW; Cravatt, BF				Backus, Keriann M.; Correia, Bruno E.; Lum, Kenneth M.; Forli, Stefano; Horning, Benjamin D.; Gonzalez-Paez, Gonzalo E.; Chatterjee, Sandip; Lanning, Bryan R.; Teijaro, John R.; Olson, Arthur J.; Wolan, Dennis W.; Cravatt, Benjamin F.			Proteome-wide covalent ligand discovery in native biological systems	NATURE			English	Article							INHIBITORS; SITE; SELECTIVITY; DESIGN; DEATH	Small molecules are powerful tools for investigating protein function and can serve as leads for new therapeutics. Most human proteins, however, lack small-molecule ligands, and entire protein classes are considered 'undruggable'(1,2). Fragment-based ligand discovery can identify small-molecule probes for proteins that have proven difficult to target using high-throughput screening of complex compound libraries(1,3). Although reversibly binding ligands are commonly pursued, covalent fragments provide an alternative route to small-molecule probes(4-10), including those that can access regions of proteins that are difficult to target through binding affinity alone(5,10,11). Here we report a quantitative analysis of cysteine-reactive small-molecule fragments screened against thousands of proteins in human proteomes and cells. Covalent ligands were identified for >700 cysteines found in both druggable proteins and proteins deficient in chemical probes, including transcription factors, adaptor/scaffolding proteins, and uncharacterized proteins. Among the atypical ligand-protein interactions discovered were compounds that react preferentially with pro-(inactive) caspases. We used these ligands to distinguish extrinsic apoptosis pathways in human cell lines versus primary human T cells, showing that the former is largely mediated by caspase-8 while the latter depends on both caspase-8 and -10. Fragment-based covalent ligand discovery provides a greatly expanded portrait of the ligandable proteome and furnishes compounds that can illuminate protein functions in native biological systems.	[Backus, Keriann M.; Correia, Bruno E.; Lum, Kenneth M.; Horning, Benjamin D.; Lanning, Bryan R.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92307 USA; [Forli, Stefano; Olson, Arthur J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92307 USA; [Gonzalez-Paez, Gonzalo E.; Chatterjee, Sandip; Wolan, Dennis W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92307 USA; [Teijaro, John R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92307 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Backus, KM; Cravatt, BF (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92307 USA.	kbackus@scripps.edu; cravatt@scripps.edu	Forli, Stefano/AFR-7638-2022	Forli, Stefano/0000-0002-5964-7111; Wolan, Dennis/0000-0001-9879-8353; Gonzalez-Paez, Gonzalo/0000-0003-4708-5753	National Institutes of Health [CA087660, GM090294, GM108208, GM069832]; NATIONAL CANCER INSTITUTE [R37CA087660, R01CA087660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069832, R01GM090294, F32GM108208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (CA087660 (B.F.C.), GM090294 (B.F.C.), GM108208 (K.M.B.), GM069832 (S.F., A.J.O.)). We thank J. Cisar, K. Mowen, C. Wang, M. Suciu, M. Dix, G. Simon, M. Carrillo, and J. Hulce for experimental assistance, M. Lenardo, L. Zheng and R. Siegel for helpful suggestions, the Marletta and Vogt laboratories at The Scripps Research Institute for sharing instrumentation, and Iterative Threading ASSEmbly Refinement (I-TASSER) for the structural modelling of IMPDH2.	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cardoso R, 2012, PROTEIN SCI, V21, P1885, DOI 10.1002/pro.2172; DeLaBarre B, 2014, CHEM BIOL, V21, P1143, DOI 10.1016/j.chembiol.2014.08.007; DeLano W.L, PYMOL MOL GRAPHICS S; Edfeldt FNB, 2011, DRUG DISCOV TODAY, V16, P284, DOI 10.1016/j.drudis.2011.02.002; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Held JM, 2010, MOL CELL PROTEOMICS, V9, P1400, DOI 10.1074/mcp.M900643-MCP200; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Inloes JM, 2014, P NATL ACAD SCI USA, V111, P14924, DOI 10.1073/pnas.1413706111; Jost C, 2014, J MED CHEM, V57, P7590, DOI 10.1021/jm5006918; Kathman SG, 2014, J MED CHEM, V57, P4969, DOI 10.1021/jm500345q; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lafont E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013638; Lannine BR, 2014, NAT CHEM BIOL, V10, P760, DOI [10.1038/NCHEMBIO.1582, 10.1038/nchembio.1582]; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Lim SM, 2014, ANGEW CHEM INT EDIT, V53, P199, DOI 10.1002/anie.201307387; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; London N, 2014, NAT CHEM BIOL, V10, P1066, DOI 10.1038/nchembio.1666; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Miller RM, 2013, J AM CHEM SOC, V135, P5298, DOI 10.1021/ja401221b; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nonoo RH, 2012, CHEMMEDCHEM, V7, P2082, DOI 10.1002/cmdc.201200404; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; Vickers CJ, 2013, J AM CHEM SOC, V135, P12869, DOI 10.1021/ja406399r; Wachmann K, 2010, BIOCHEMISTRY-US, V49, P8307, DOI 10.1021/bi100968m; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Wissner A, 2003, J MED CHEM, V46, P49, DOI 10.1021/jm020241c; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	43	381	390	19	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					570	+		10.1038/nature18002	http://dx.doi.org/10.1038/nature18002			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309814	Green Accepted			2022-12-28	WOS:000378270300058
J	Melcher, K				Melcher, Karsten			STRUCTURAL BIOLOGY When sperm meets egg	NATURE			English	Editorial Material							MAMMALIAN FERTILIZATION; FOLATE RECEPTORS; RECOGNITION; IZUMO; JUNO	Sperm-egg binding is mediated by two cell-surface proteins. Structural analysis of these proteins, separately and in complex, provides insight into the recognition process and the subsequent sperm-egg fusion. SEE LETTERS p. 562 & p. 566	[Melcher, Karsten] Van Andel Res Inst, Grand Rapids, MI 49503 USA	Van Andel Institute	Melcher, K (corresponding author), Van Andel Res Inst, Grand Rapids, MI 49503 USA.	karsten.melcher@vai.org	Melcher, Karsten/AAZ-3861-2020	Melcher, Karsten/0000-0002-9125-4027				Aydin H, 2016, NATURE, V534, P562, DOI 10.1038/nature18595; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Chen C, 2013, NATURE, V500, P486, DOI 10.1038/nature12327; Han L, 2016, CURR BIOL, V26, pR100, DOI 10.1016/j.cub.2015.12.034; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9858; Kato K., 2016, NATURE COMMUN; Krauchunas AR, 2016, MOL REPROD DEV, V83, P376, DOI 10.1002/mrd.22634; Ohto U, 2016, NATURE, V534, P566, DOI 10.1038/nature18596; Okabe M, 2013, DEVELOPMENT, V140, P4471, DOI 10.1242/dev.090613; Wibowo AS, 2013, P NATL ACAD SCI USA, V110, P15180, DOI 10.1073/pnas.1308827110; YANAGIMACHI R, 1976, BIOL REPROD, V15, P471, DOI 10.1095/biolreprod15.4.471	12	3	4	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					484	485		10.1038/nature18448	http://dx.doi.org/10.1038/nature18448			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309810				2022-12-28	WOS:000378270300040
J	Arie, S				Arie, Sophie			EU REFERENDUM AND HEALTH What the leave campaign said about the NHS, and how the experts answered	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						Asthana A, 2016, GUARDIAN; BMA, 2016, EU REF; Dilnot A, 2016, UK CONTRIBUTIONS EUR; Gutteridge N, 2016, DAILY EXPRESS; Owen C., 1989, Thatcheria, V24, P1; Institute for Fiscal Studies, 2016, BREX WOULD NOT MAK; McKee M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2489; NHS Providers, 2016, 1 SURV SHOWS 75 FRON; Vote Leave, 350 MILL WE GIV EU E; Vote Leave, 1924, PAV ROAD ANK EU IMM	10	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2016	353								i3261	10.1136/bmj.i3261	http://dx.doi.org/10.1136/bmj.i3261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HJ	27312659				2022-12-28	WOS:000378240800002
J	Tanaka, EM				Tanaka, Elly M.			The Molecular and Cellular Choreography of Appendage Regeneration	CELL			English	Review							VERTEBRATE LIMB REGENERATION; WING BUD STUMPS; MOUSE DIGIT TIP; MUSCLE-CELLS; STEM-CELLS; PLANARIAN REGENERATION; ANTERIOR-POSTERIOR; URODELE AMPHIBIANS; PROGENITOR CELLS; XENOPUS-LAEVIS	Recent advances in limb regeneration are revealing the molecular events that integrate growth control, cell fate programming, and positional information to yield the exquisite replacement of the amputated limb. Parallel progress in several invertebrate and vertebrate models has provided a broader context for understanding the mechanisms and the evolution of regeneration. Together, these discoveries provide a foundation for describing the principles underlying regeneration of complex, multi-tissue structures. As such these findings should provide a wealth of ideas for engineers seeking to reconstitute regeneration fromconstituent parts or to elicit full regeneration from partial regeneration events.	[Tanaka, Elly M.] Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, Fetscherstr 105, D-01307 Dresden, Germany	Technische Universitat Dresden	Tanaka, EM (corresponding author), Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, Fetscherstr 105, D-01307 Dresden, Germany.	elly.tanaka@crt-dresden.de	Tanaka, Elly M/F-8572-2010	Tanaka, Elly/0000-0003-4240-2158	DFG; ERC; BMBF; MPG	DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); MPG(Max Planck Society)	I would like to thank Nadia Frobisch for discussions on evolution and comments from reviewers. Work in the author's lab was funded by the DFG, ERC, BMBF, and MPG.	Abraham Y, 2012, J R SOC INTERFACE, V9, P640, DOI 10.1098/rsif.2011.0395; Alvarado AS, 2000, BIOESSAYS, V22, P578, DOI 10.1002/(SICI)1521-1878(200006)22:6<578::AID-BIES11>3.0.CO;2-#; Antos CL, 2010, ADV EXP MED BIOL, V695, P184, DOI 10.1007/978-1-4419-7037-4_13; Blassberg RA, 2011, J CELL SCI, V124, P47, DOI 10.1242/jcs.076331; Blum N, 2012, DEVELOPMENT, V139, P107, DOI 10.1242/dev.065391; BROCKES JP, 1986, CELL, V45, P301, DOI 10.1016/0092-8674(86)90394-6; Brockes JP, 2001, J ANAT, V199, P3; BUTLER ELMER GRIMSHAW, 1955, J MORPH, V96, P265, DOI 10.1002/jmor.1050960204; CONANT EB, 1970, J EXP ZOOL, V174, P15, DOI 10.1002/jez.1401740103; Cuervo R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01886; Cuervo R, 2012, P NATL ACAD SCI USA, V109, P3838, DOI 10.1073/pnas.1006619109; Del Rio-Tsonis K, 2003, DEV DYNAM, V226, P211, DOI 10.1002/dvdy.10224; Dinsmore CE., 1991, HIST REGENERATION RE; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Fei J.F., 2016, NAT REGEN MED; Fei JF, 2014, STEM CELL REP, V3, P444, DOI 10.1016/j.stemcr.2014.06.018; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Frobisch NB, 2015, NATURE, V527, P231, DOI 10.1038/nature15397; Frobisch NB, 2011, DEV DYNAM, V240, P1087, DOI 10.1002/dvdy.22629; Galis F, 2003, EVOL DEV, V5, P208, DOI 10.1046/j.1525-142X.2003.03028.x; Garza-Garcia AA, 2010, INTEGR COMP BIOL, V50, P528, DOI 10.1093/icb/icq022; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Goss RJ., 1969, PRINCIPLES REGENERAT; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; Hesse RG, 2015, ELIFE, V4, DOI 10.7554/eLife.07702; ITEN LE, 1975, DEV BIOL, V44, P119, DOI 10.1016/0012-1606(75)90381-4; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kang JS, 2016, NATURE, V532, P201, DOI 10.1038/nature17644; Kang JS, 2013, DEV CELL, V27, P19, DOI 10.1016/j.devcel.2013.08.015; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Khattak S, 2013, STEM CELL REP, V1, P90, DOI 10.1016/j.stemcr.2013.03.002; Khattak S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-17; Knapp D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061352; Konstantinides N, 2014, SCIENCE, V343, P788, DOI 10.1126/science.1243529; Kostakopoulou K, 1996, MECH DEVELOP, V55, P119, DOI 10.1016/0925-4773(95)00492-0; Kostakopoulou K, 1997, INT J DEV BIOL, V41, P747; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Kumar A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9684; Kumar A, 2011, P NATL ACAD SCI USA, V108, P13588, DOI 10.1073/pnas.1108472108; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; LHEUREUX E, 1977, J EMBRYOL EXP MORPH, V38, P151; Lin GF, 2013, DEV CELL, V24, P41, DOI 10.1016/j.devcel.2012.11.017; Looso M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r16; Makanae A, 2014, DEV BIOL, V396, P57, DOI 10.1016/j.ydbio.2014.09.021; McClure KD, 2008, DEV BIOL, V319, P68, DOI 10.1016/j.ydbio.2008.04.004; McCusker C, 2014, REGENERATION, V1, P27, DOI 10.1002/reg2.10; MESCHER AL, 1984, J EXP ZOOL, V230, P485, DOI 10.1002/jez.1402300317; MESCHER AL, 1975, DEV BIOL, V44, P187, DOI 10.1016/0012-1606(75)90386-3; MOHANTYHEJMADI P, 1992, NATURE, V355, P352, DOI 10.1038/355352a0; Monaghan JR, 2012, DEV BIOL, V368, P63, DOI 10.1016/j.ydbio.2012.05.015; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Nacu E, 2013, DEVELOPMENT, V140, P513, DOI 10.1242/dev.081752; Nacu E, 2011, ANNU REV CELL DEV BI, V27, P409, DOI 10.1146/annurev-cellbio-092910-154115; Nacu E, 2016, NATURE, V533, P407, DOI 10.1038/nature17972; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Paliwal P, 2011, CHEM BIOL, V18, P1153, DOI 10.1016/j.chembiol.2011.07.012; PESCITELLI MJ, 1980, DEV BIOL, V79, P255, DOI 10.1016/0012-1606(80)90115-3; Raspopovic J, 2014, SCIENCE, V345, P566, DOI 10.1126/science.1252960; Reddien PW, 2013, DEVELOPMENT, V140, P951, DOI 10.1242/dev.080499; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Roensch K, 2013, SCIENCE, V342, P1375, DOI 10.1126/science.1241796; Rojas-Munoz A, 2009, DEV BIOL, V327, P177, DOI 10.1016/j.ydbio.2008.12.012; Rosello-Diez A, 2014, DEVELOPMENT, V141, P1534, DOI 10.1242/dev.106831; Saiz-Lopez P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9108; Sandoval-Guzman T, 2014, CELL STEM CELL, V14, P174, DOI 10.1016/j.stem.2013.11.007; SCHMID V, 1984, CELL, V38, P801, DOI 10.1016/0092-8674(84)90275-7; Shimizu-Nishikawa K, 2003, DEV DYNAM, V227, P563, DOI 10.1002/dvdy.10345; Simon A, 2013, NATURE, V500, P32, DOI 10.1038/nature12458; SINGER M, 1948, J EXP ZOOL, V108, P279, DOI 10.1002/jez.1401080207; Stewart R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002936; Stewart S, 2014, CELL REP, V6, P482, DOI 10.1016/j.celrep.2014.01.010; Stocum DL, 2011, EUR J NEUROSCI, V34, P908, DOI 10.1111/j.1460-9568.2011.07827.x; Sugiura T, 2016, NATURE, V531, P237, DOI 10.1038/nature16974; Sundaram M, 2004, BIOCHEM CELL BIOL, V82, P191, DOI 10.1139/o03-087; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tanaka HV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11069; Torok MA, 1999, J EXP ZOOL, V284, P197, DOI 10.1002/(SICI)1097-010X(19990701)284:2<197::AID-JEZ9>3.0.CO;2-F; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Villiard E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-180; Wang H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8916; Wang LS, 2000, J NEUROBIOL, V43, P150, DOI 10.1002/(SICI)1097-4695(200005)43:2<150::AID-NEU5>3.0.CO;2-G; Wehner D, 2014, CELL REP, V6, P467, DOI 10.1016/j.celrep.2013.12.036; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Whited JL, 2013, DEVELOPMENT, V140, P1137, DOI 10.1242/dev.087734; Witchley JN, 2013, CELL REP, V4, P633, DOI 10.1016/j.celrep.2013.07.022; Yakushiji N, 2009, DEV DYNAM, V238, P1887, DOI 10.1002/dvdy.22011; Yokoyama H, 2001, DEV BIOL, V233, P72, DOI 10.1006/dbio.2001.0180; Yokoyama H, 2000, DEV BIOL, V219, P18, DOI 10.1006/dbio.1999.9587; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Yun MH, 2015, ELIFE, V4, DOI 10.7554/eLife.05505; Yun MH, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.009; Yun MH, 2013, P NATL ACAD SCI USA, V110, P17392, DOI 10.1073/pnas.1310519110; Zhu W, 2012, DEV BIOL, V370, P42, DOI 10.1016/j.ydbio.2012.07.021	96	127	127	1	69	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1598	1608		10.1016/j.cell.2016.05.038	http://dx.doi.org/10.1016/j.cell.2016.05.038			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315477	Bronze			2022-12-28	WOS:000378062000012
J	Matyskiela, ME; Lu, G; Ito, T; Pagarigan, B; Lu, CC; Miller, K; Fang, W; Wang, NY; Nguyen, D; Houston, J; Carmel, G; Tran, T; Riley, M; Nosaka, L; Lander, GC; Gaidarova, S; Xu, SC; Ruchelman, AL; Handa, H; Carmichael, J; Daniel, TO; Cathers, BE; Lopez-Girona, A; Chamberlain, PP				Matyskiela, Mary E.; Lu, Gang; Ito, Takumi; Pagarigan, Barbra; Lu, Chin-Chun; Miller, Karen; Fang, Wei; Wang, Nai-Yu; Nguyen, Derek; Houston, Jack; Carmel, Gilles; Tran, Tam; Riley, Mariko; Nosaka, Lyn'Al; Lander, Gabriel C.; Gaidarova, Svetlana; Xu, Shuichan; Ruchelman, Alexander L.; Handa, Hiroshi; Carmichael, James; Daniel, Thomas O.; Cathers, Brian E.; Lopez-Girona, Antonia; Chamberlain, Philip P.			A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase	NATURE			English	Article							LENALIDOMIDE; TARGET; DEGRADATION; PROTEINS; COMPLEX; IKAROS; POMALIDOMIDE; RECOGNITION; THALIDOMIDE; HYDROXYPROLINE	Immunomodulatory drugs bind to cereblon (CRBN) to confer differentiated substrate specificity on the CRL4(CRBN) E3 ubiquitin ligase. Here we report the identification of a new cereblon modulator, CC-885, with potent anti-tumour activity. The anti-tumour activity of CC-885 is mediated through the cereblon-dependent ubiquitination and degradation of the translation termination factor GSPT1. Patient-derived acute myeloid leukaemia tumour cells exhibit high sensitivity to CC-885, indicating the clinical potential of this mechanism. Crystallographic studies of the CRBN-DDB1-CC-885-GSPT1 complex reveal that GSPT1 binds to cereblon through a surface turn containing a glycine residue at a key position, interacting with both CC-885 and a 'hotspot' on the cereblon surface. Although GSPT1 possesses no obvious structural, sequence or functional homology to previously known cereblon substrates, mutational analysis and modelling indicate that the cereblon substrate Ikaros uses a similar structural feature to bind cereblon, suggesting a common motif for substrate recruitment. These findings define a structural degron underlying cereblon 'neosubstrate' selectivity, and identify an anti-tumour target rendered druggable by cereblon modulation.	[Matyskiela, Mary E.; Lu, Gang; Pagarigan, Barbra; Lu, Chin-Chun; Miller, Karen; Fang, Wei; Wang, Nai-Yu; Nguyen, Derek; Houston, Jack; Carmel, Gilles; Tran, Tam; Riley, Mariko; Gaidarova, Svetlana; Xu, Shuichan; Ruchelman, Alexander L.; Carmichael, James; Daniel, Thomas O.; Cathers, Brian E.; Lopez-Girona, Antonia; Chamberlain, Philip P.] Celgene Corp, 10300 Campus Point Dr,Suite 100, San Diego, CA 92121 USA; [Ito, Takumi; Handa, Hiroshi] Tokyo Med Univ, Dept Nanoparticle Translat Res, Shinjuku Ku, Tokyo 1608402, Japan; [Nosaka, Lyn'Al; Lander, Gabriel C.] Scripps Res Inst, San Diego, CA 92121 USA	Bristol-Myers Squibb; Celgene Corporation; Tokyo Medical University; Scripps Research Institute	Lu, G; Chamberlain, PP (corresponding author), Celgene Corp, 10300 Campus Point Dr,Suite 100, San Diego, CA 92121 USA.	glu@celgene.com; pchamberlain@celgene.com		Cathers, Brian/0000-0003-2793-7533; Lander, Gabriel C./0000-0003-4921-1135; Ito, Takumi/0000-0002-9997-2664	National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23102002]; JST, PRESTO; MEXT [26750374]	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST, PRESTO(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Thanks to G. Reyes, C. Havens, P. Jackson and H. Hadjivassiliou for discussions relating to this manuscript, and P Jackson, J. Hansen, M. Correa, B. Fahr, M. Abbasian, E. Ambing, E. Rychak, D. Mendy and K. Hughes for technical assistance. We thank K. Motamedchaboki (Proteomics Core, Sanford Burnham Prebys Medical Discovery Institute) for mass spectrometry-based proteomic analysis. Thanks to J. Ballesteros and P Hernandez at Vivia for patient sample testing. Parts of this work were conducted at the Advanced Light Source. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract No. DE-AC02-05CH11231. This work was also supported by Grant-in-Aid for Scientific Research on Innovative Areas "Chemical Biology of Natural Products" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (23102002 to H.H.), by JST, PRESTO (T.I.) and by Grant-in-Aid for Young Scientists (B) from MEXT (26750374 to T.I).	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bennett TA, 2014, CL LYMPH MYELOM LEUK, V14, P305, DOI 10.1016/j.clml.2013.11.006; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chauvin C, 2007, MOL CELL BIOL, V27, P5619, DOI 10.1128/MCB.00035-07; Cheng Z, 2009, GENE DEV, V23, P1106, DOI 10.1101/gad.1770109; Deshaies RJ, 2015, NAT CHEM BIOL, V11, P634, DOI 10.1038/nchembio.1887; Dijon M, 2008, BLOOD, V111, P1138, DOI 10.1182/blood-2007-07-098202; Dimopoulos MA, 2015, NAT REV CLIN ONCOL, V12, P42, DOI 10.1038/nrclinonc.2014.200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; KIKUCHI Y, 1988, EMBO J, V7, P1175, DOI 10.1002/j.1460-2075.1988.tb02928.x; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Petzold G., 2016, NATURE, V532, P127, DOI DOI 10.1038/NATURE16979;PMID:26909574; Preis A, 2014, CELL REP, V8, P59, DOI 10.1016/j.celrep.2014.04.058; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	34	264	285	10	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					252	+		10.1038/nature18611	http://dx.doi.org/10.1038/nature18611			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27338790				2022-12-28	WOS:000379912600050
J	Meara, E; Horwitz, JR; Powell, W; McClelland, L; Zhou, WP; O'Malley, AJ; Morden, NE				Meara, Ellen; Horwitz, Jill R.; Powell, Wilson; McClelland, Lynn; Zhou, Weiping; O'Malley, A. James; Morden, Nancy E.			State Legal Restrictions and Prescription-Opioid Use among Disabled Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRESCRIBING PATTERNS; MONITORING PROGRAMS; DRUG OVERDOSE; UNITED-STATES; TRENDS; MORTALITY; LAWS; FLORIDA; DEATHS; IMPACT	BACKGROUND In response to rising rates of opioid abuse and overdose, U.S. states enacted laws to restrict the prescribing and dispensing of controlled substances. The effect of these laws on opioid use is unclear. METHODS We tested associations between prescription-opioid receipt and state controlled-substances laws. Using Medicare administrative data for fee-for-service disabled beneficiaries 21 to 64 years of age who were alive throughout the calendar year (8.7 million person-years from 2006 through 2012) and an original data set of laws (e.g., prescription-drug monitoring programs), we examined the annual prevalence of beneficiaries with four or more opioid prescribers, prescriptions yielding a daily morphine-equivalent dose (MED) of more than 120 mg, and treatment for nonfatal prescription-opioid overdose. We estimated how opioid outcomes varied according to eight types of laws. RESULTS From 2006 through 2012, states added 81 controlled-substance laws. Opioid receipt and potentially hazardous prescription patterns were common. In 2012 alone, 47% of beneficiaries filled opioid prescriptions (25% in one to three calendar quarters and 22% in every calendar quarter); 8% had four or more opioid prescribers; 5% had prescriptions yielding a daily MED of more than 120 mg in any calendar quarter; and 0.3% were treated for a nonfatal prescription-opioid overdose. We observed no significant associations between opioid outcomes and specific types of laws or the number of types enacted. For example, the percentage of beneficiaries with a prescription yielding a daily MED of more than 120 mg did not decline after adoption of a prescription-drug monitoring program (0.27 percentage points; 95% confidence interval, -0.05 to 0.59). CONCLUSIONS Adoption of controlled-substance laws was not associated with reductions in potentially hazardous use of opioids or overdose among disabled Medicare beneficiaries, a population particularly at risk.	[Meara, Ellen; Powell, Wilson; Zhou, Weiping; O'Malley, A. James; Morden, Nancy E.] Dartmouth Inst Hlth Policy & Clin Practice, WTRB Level 5,1 Med Ctr Dr, Lebanon, NH 03756 USA; [Meara, Ellen; Horwitz, Jill R.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Horwitz, Jill R.; McClelland, Lynn] Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90024 USA	Dartmouth College; National Bureau of Economic Research; University of California System; University of California Los Angeles	Meara, E (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, WTRB Level 5,1 Med Ctr Dr, Lebanon, NH 03756 USA.	ellen.r.meara@dartmouth.edu		Meara, Ellen/0000-0003-0211-1970	National Institute on Aging; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019783, U01AG046830] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institute on Aging and others.	[Anonymous], 2002, PRESCR DRUGS STAT MO; [Anonymous], 2014, OP PAINK PRESCR YOU; [Anonymous], 2016, PREV PRESCR DRUG OV; [Anonymous], 2014, 2014 NASCSA SURV CON; [Anonymous], 2012, 2006 2011 RXHCC MOD; Arlotta C. J., 2015, FORBES; Bachhuber MA, 2014, JAMA INTERN MED, V174, P1668, DOI 10.1001/jamainternmed.2014.4005; Baehren DF, 2010, ANN EMERG MED, V56, P19, DOI 10.1016/j.annemergmed.2009.12.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betses M, 2013, NEW ENGL J MED, V369, P989, DOI 10.1056/NEJMp1308222; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Bonito AJ, 2008, CREATION NEW RACE ET; Braden JB, 2010, ARCH INTERN MED, V170, P1425, DOI 10.1001/archinternmed.2010.273; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, 2012, PRESCR DRUG OV STAT; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; D'Onofrio G, 2015, JAMA-J AM MED ASSOC, V313, P1636, DOI 10.1001/jama.2015.3474; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Davis C. S., 2015, LEG INT RED OV MORT; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Franklin GM, 2005, AM J IND MED, V48, P91, DOI 10.1002/ajim.20191; Haegerich TM, 2014, DRUG ALCOHOL DEPEN, V145, P34, DOI 10.1016/j.drugalcdep.2014.10.001; Haffajee RL, 2015, JAMA-J AM MED ASSOC, V313, P891, DOI 10.1001/jama.2014.18514; Jena AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1393; Johnson H, 2014, MMWR-MORBID MORTAL W, V63, P569; Kilby A., 2015, OPIOIDS MASSES WELFA; Larrick AK, 2014, REQUEST COMMENTS ENH; McDonald JH, 2015, HDB BIOL STAT, P254; Morden NE, 2014, MED CARE, V52, P852, DOI 10.1097/MLR.0000000000000183; National Alliance for Model State Drug Laws, 2014, STAT REQ PRESCR DISP; National Center for Health Statistics; Centers for Disease Control and Prevention; U. S Department of Health and Human Services, 2015, MULT CAUS DEATH 1999; Pacula RL, 2015, J POLICY ANAL MANAG, V34, P7, DOI 10.1002/pam.21804; Panis C, 2000, SSA PROGRAM DATA USE; Paulozzi LJ, 2015, MMWR SURVEILL SUMM, V64, P1, DOI 10.15585/mmwr.ss6409a1; Prescription Drug Monitoring Program Center of Excellence, 2014, PRESCR DRUG MON PROG; Reifler LM, 2012, PAIN MED, V13, P434, DOI 10.1111/j.1526-4637.2012.01327.x; Robst J, 2007, HEALTH CARE FINANC R, V28, P15; Rutkow L, 2015, JAMA INTERN MED, V175, P1642, DOI 10.1001/jamainternmed.2015.3931	39	156	156	2	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2016	375	1					44	53		10.1056/NEJMsa1514387	http://dx.doi.org/10.1056/NEJMsa1514387			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ1ZP	27332619	Green Accepted, Bronze			2022-12-28	WOS:000379000200004
J	Nash, IS				Nash, Ira S.			Why Physicians Hate "Patient Satisfaction": The Real Reasons RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Nash, Ira S.] Northwell Hlth, Manhasset, NY 11030 USA	Northwell Health	Nash, IS (corresponding author), Northwell Hlth, Manhasset, NY 11030 USA.								0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					72	72		10.7326/L16-5009	http://dx.doi.org/10.7326/L16-5009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380292				2022-12-28	WOS:000379215800023
J	Antonovsky, N; Gleizer, S; Noor, E; Zohar, Y; Herz, E; Barenholz, U; Zelcbuch, L; Amram, S; Wides, A; Tepper, N; Davidi, D; Bar-On, Y; Bareia, T; Wernick, DG; Shani, I; Malitsky, S; Jona, G; Bar-Even, A; Milo, R				Antonovsky, Niv; Gleizer, Shmuel; Noor, Elad; Zohar, Yehudit; Herz, Elad; Barenholz, Uri; Zelcbuch, Lior; Amram, Shira; Wides, Aryeh; Tepper, Naama; Davidi, Dan; Bar-On, Yinon; Bareia, Tasneem; Wernick, David G.; Shani, Ido; Malitsky, Sergey; Jona, Ghil; Bar-Even, Arren; Milo, Ron			Sugar Synthesis from CO2 in Escherichia coli	CELL			English	Article							GENETIC SELECTION; RUBISCO; EVOLUTION; BIOLOGY; ADAPTATION; EXPRESSION; CONVERSION; MICROBES; PATHWAYS; FIXATION	Can a heterotrophic organism be evolved to synthesize biomass from CO2 directly? So far, non-native carbon fixation in which biomass precursors are synthesized solely from CO2 has remained an elusive grand challenge. Here, we demonstrate how a combination of rational metabolic rewiring, recombinant expression, and laboratory evolution has led to the biosynthesis of sugars and other major biomass constituents by a fully functional Calvin-Benson-Bassham (CBB) cycle in E. coli. In the evolved bacteria, carbon fixation is performed via a non-native CBB cycle, while reducing power and energy are obtained by oxidizing a supplied organic compound (e.g., pyruvate). Genome sequencing reveals that mutations in flux branchpoints, connecting the non-native CBB cycle to biosynthetic pathways, are essential for this phenotype. The successful evolution of a non-native carbon fixation pathway, though not yet resulting in net carbon gain, strikingly demonstrates the capacity for rapid trophic-mode evolution of metabolism applicable to biotechnology.	[Antonovsky, Niv; Gleizer, Shmuel; Noor, Elad; Zohar, Yehudit; Herz, Elad; Barenholz, Uri; Zelcbuch, Lior; Amram, Shira; Wides, Aryeh; Davidi, Dan; Bar-On, Yinon; Bareia, Tasneem; Wernick, David G.; Shani, Ido; Malitsky, Sergey; Bar-Even, Arren; Milo, Ron] Weizmann Inst Sci, Dept Plant & Environm Sci, IL-7610001 Rehovot, Israel; [Tepper, Naama] Technion, Dept Comp Sci, Israel Inst Technol, IL-3200003 Haifa, Israel; [Jona, Ghil] Weizmann Inst Sci, Dept Biol Serv, IL-7610001 Rehovot, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Weizmann Institute of Science	Milo, R (corresponding author), Weizmann Inst Sci, Dept Plant & Environm Sci, IL-7610001 Rehovot, Israel.	ron.milo@weizmann.ac.il	Malitsky, Sergey/ABC-2545-2020; Noor, Elad/AAN-9042-2020	Malitsky, Sergey/0000-0003-4619-7219; Noor, Elad/0000-0001-8776-4799; Gleizer, Shmuel/0000-0001-9774-0504; Milo, Ron/0000-0003-1641-2299; Bar-On, Yinon/0000-0001-8477-609X; Jona, Ghil/0000-0002-4526-6182; Bar-Even, Arren/0000-0002-1039-4328	European Research Council [SYMPAC 260392, NOVCARBFIX 646827]; Helmsley Charitable Foundation; Larson Charitable Foundation; Estate of David Arthur Barton; Anthony Stalbow Charitable Trust; Stella Gelerman, Canada; United States-Israel Education Foundation	European Research Council(European Research Council (ERC)European Commission); Helmsley Charitable Foundation; Larson Charitable Foundation; Estate of David Arthur Barton; Anthony Stalbow Charitable Trust; Stella Gelerman, Canada; United States-Israel Education Foundation	We thank Ichiro Matsumura for kindly supplying the prkA plasmid and Michal Shapira for kindly supplying the R. rubrum culture. We also thank Amir Aharoni, Asaph Aharoni, Uri Alon, Gil Amitai, Abdussalam Azem, Naama Barkai, Sima Benjamin, Sonjia Billerbeck, Dvora Biran, Elad Chomski, Ahuva Cooperstein, Daniel Dar, Michal Dayagi, Shani Doron, Noa Dvir, Avigdor Eldar, David Fell, Avi Flamholz, Shay Fleishon, Idan Frumkin, Shlomit Gilad, Pierre Goloubinoff, Michael Gurevitz, Jacob Hanna, Tami Hayon, Lee-Or Herzog, Keren Kahil, Miriam Kaltenbach, Mechael Kanovsky, Aaron Kaplan, Leeat Keren, Roy Kishony, Hagar Kroytoro, Rob Last, Paola Laurino, Tali Lavy, Ronen Levi, Ayelet Levin, Yishai Levin, Avi Levy, Hannes Link, Adar Lopez, Yehuda Marcus, Barak Marcus, Adi Millman, Uri Moran, Oliver Mueller-Cajar, Yotam Nadav, Amnon Naziri, Ravit Netzer, Gal Ofir, Nigel Orme, Rob Phillips, Uri Pick, Noa Rippel, Orel Rivni, Liat Rockah, Ilana Rogachev, Eliora Ron, Dave Savage, Alon Savidor, Efrat Schwartz, Lior Shachar, Tali Shalit, Tomer Shlomi, Rotem Sorek, Zvika Tamari, Dan Tawfik, Noam Vardi, Adi Volpert, Alon Wellner, Sagit Yahav, Dan Yakir, Oren Yishai, and Yonatan Zegman for support and feedback on this research. This work was funded by the European Research Council (projects SYMPAC 260392 and NOVCARBFIX 646827), Dana and Yossie Hollander, the Helmsley Charitable Foundation, the Larson Charitable Foundation, the Estate of David Arthur Barton, the Anthony Stalbow Charitable Trust, and Stella Gelerman, Canada. R.M. is the Charles and Louise Gartner professional chair and an EMBO young investigator program member. D.G.W. is supported by the United States-Israel Education Foundation.	Bar-Even A, 2010, P NATL ACAD SCI USA, V107, P8889, DOI 10.1073/pnas.0907176107; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; BASSHAM JA, 1954, J AM CHEM SOC, V76, P1760, DOI 10.1021/ja01636a012; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Church GM, 2014, NAT REV MOL CELL BIO, V15, P289, DOI 10.1038/nrm3767; Deatherage DE, 2014, METHODS MOL BIOL, V1151, P165, DOI 10.1007/978-1-4939-0554-6_12; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Durao P, 2015, NAT CHEM BIOL, V11, P148, DOI [10.1038/NCHEMBIO.1715, 10.1038/nchembio.1715]; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; Fast AG, 2015, CURR OPIN BIOTECH, V33, P60, DOI 10.1016/j.copbio.2014.11.014; Foster PL, 2015, P NATL ACAD SCI USA, V112, pE5990, DOI 10.1073/pnas.1512136112; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Gong FY, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0268-1; Grenier F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01038-14; Kleeb AC, 2007, P NATL ACAD SCI USA, V104, P13907, DOI 10.1073/pnas.0705379104; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Lovley DR, 2011, ENV MICROBIOL REP, V3, P27, DOI 10.1111/j.1758-2229.2010.00211.x; Maddamsetti R, 2015, GENETICS, V200, P619, DOI 10.1534/genetics.115.176677; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Muller JEN, 2015, METAB ENG, V28, P190, DOI 10.1016/j.ymben.2014.12.008; Mueller-Cajar O, 2008, BIOCHEM J, V414, P205, DOI 10.1042/BJ20080668; Neidhardt F.C., 1987, ESCHERICHIA COLI SAL, VI; NEIDHARDT FC, 1987, ESCHERICHIA COLI SAL, V2; Notley-McRobb L, 2003, P ROY SOC B-BIOL SCI, V270, P843, DOI 10.1098/rspb.2002.2295; NOVICK A, 1950, P NATL ACAD SCI USA, V36, P708, DOI 10.1073/pnas.36.12.708; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Parikh MR, 2006, PROTEIN ENG DES SEL, V19, P113, DOI 10.1093/protein/gzj010; Quandt EM, 2015, ELIFE, V4, DOI 10.7554/eLife.09696; Reznik E, 2010, J THEOR BIOL, V266, P536, DOI 10.1016/j.jtbi.2010.07.023; Sauer U, 2001, Adv Biochem Eng Biotechnol, V73, P129; Shih PM, 2014, J BIOL CHEM, V289, P9493, DOI 10.1074/jbc.C113.543132; Siegel JB, 2015, P NATL ACAD SCI USA, V112, P3704, DOI 10.1073/pnas.1500545112; Whitaker WB, 2015, CURR OPIN BIOTECH, V33, P165, DOI 10.1016/j.copbio.2015.01.007; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Zelcbuch L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt151; Zhuang ZY, 2013, BIORESOURCE TECHNOL, V150, P79, DOI 10.1016/j.biortech.2013.09.116	38	182	192	32	202	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					115	125		10.1016/j.cell.2016.05.064	http://dx.doi.org/10.1016/j.cell.2016.05.064			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27345370	Green Published, hybrid			2022-12-28	WOS:000380254400015
J	Olotu, A; Fegan, G; Wambua, J; Nyangweso, G; Leach, A; Lievens, M; Kaslow, DC; Njuguna, P; Marsh, K; Bejon, P				Olotu, Ally; Fegan, Gregory; Wambua, Juliana; Nyangweso, George; Leach, Amanda; Lievens, Marc; Kaslow, David C.; Njuguna, Patricia; Marsh, Kevin; Bejon, Philip			Seven-Year Efficacy of RTS, S/AS01 Malaria Vaccine among Young African Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RTS,S/AS01E	BACKGROUND The candidate malaria vaccine RTS, S/AS01 is being evaluated in order to inform a decision regarding its inclusion in routine vaccination schedules. METHODS We conducted 7 years of follow-up in children who had been randomly assigned, at 5 to 17 months of age, to receive three doses of either the RTS, S/AS01 vaccine or a rabies (control) vaccine. The end point was clinical malaria (temperature of >= 37.5 degrees C and infection with Plasmodium falciparum of >2500 parasites per cubic millimeter). In an analysis that was not prespecified, the malaria exposure of each child was estimated with the use of information on the prevalence of malaria among residents within a 1-km radius of the child's home. Vaccine efficacy was defined as 1 minus the hazard ratio or the incidence-rate ratio, multiplied by 100, in the RTS, S/AS01 group versus the control group. RESULTS Over 7 years of follow-up, we identified 1002 episodes of clinical malaria among 223 children randomly assigned to the RTS, S/AS01 group and 992 episodes among 224 children randomly assigned to the control group. The vaccine efficacy, as assessed by negative binomial regression, was 4.4% (95% confidence interval [CI], -17.0 to 21.9; P = 0.66) in the intention-to-treat analysis and 7.0% (95% CI, -14.5 to 24.6; P = 0.52) in the per-protocol analysis. Vaccine efficacy waned over time (P = 0.006 for the interaction between vaccination and time), including negative efficacy during the fifth year among children with higher-than-average exposure to malaria parasites (intention-to-treat analysis: -43.5%; 95% CI, -100.3 to -2.8 [P = 0.03]; per-protocol analysis: -56.8%; 95% CI, -118.7 to -12.3 [P = 0.008]). CONCLUSIONS A three-dose vaccination with RTS, S/AS01 was initially protective against clinical malaria, but this result was offset by rebound in later years in areas with higher-than-average exposure to malaria parasites.	[Olotu, Ally; Fegan, Gregory; Wambua, Juliana; Nyangweso, George; Njuguna, Patricia; Marsh, Kevin; Bejon, Philip] Kenya Med Res Inst KEMRI, Wellcome Trust Programme, Kilifi, Kenya; [Olotu, Ally] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Fegan, Gregory; Marsh, Kevin; Bejon, Philip] Univ Oxford, Nuffield Dept Med, Oxford, England; [Leach, Amanda; Lievens, Marc] GlaxoSmithKline Vaccines, Wavre, Belgium; [Kaslow, David C.] PATH, Seattle, WA USA	Kenya Medical Research Institute; Ifakara Health Institute; University of Oxford; GlaxoSmithKline	Bejon, P (corresponding author), KEMRI, Wellcome Trust Res Programme, POB 230, Kilifi, Kenya.	pbejon@kemri-wellcome.org	Fegan, Greg W/O-8079-2018; Leach, Amanda/AAS-1120-2020	Fegan, Greg W/0000-0002-2663-2765; Leach, Amanda/0000-0002-7114-9967; /0000-0001-9585-3820	PATH Malaria Vaccine Initiative; MRC [G1002624] Funding Source: UKRI; Medical Research Council [G1002624] Funding Source: researchfish	PATH Malaria Vaccine Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by the PATH Malaria Vaccine Initiative and others; ClinicalTrials.gov number, NCT00872963	Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2014, ELIFE, V3, DOI 10.7554/eLife.02130; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Campo JJ, 2015, MOL CELL PROTEOMICS, V14, P519, DOI 10.1074/mcp.M114.044677; Grobusch MP, 2009, J INFECT DIS, V200, P1658, DOI 10.1086/647990; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Odhiambo FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010016; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Oyediran A B, 1993, Afr J Med Med Sci, V22, P55; RTS,S Clinical Trials Partnership, 2014, PLoS Med, V11, pe1001685, DOI 10.1371/journal.pmed.1001685; Senn N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001195; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3	16	227	228	3	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2519	2529		10.1056/NEJMoa1515257	http://dx.doi.org/10.1056/NEJMoa1515257			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8DD	27355532	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000378727200004
J	Saredi, G; Huang, HD; Hammond, CM; Alabert, C; Bekker-Jensen, S; Forne, I; Reveron-Gomez, N; Foster, BM; Mlejnkova, L; Bartke, T; Cejka, P; Mailand, N; Imhof, A; Patel, DJ; Groth, A				Saredi, Giulia; Huang, Hongda; Hammond, Colin M.; Alabert, Constance; Bekker-Jensen, Simon; Forne, Ignasi; Reveron-Gomez, Nazaret; Foster, Benjamin M.; Mlejnkova, Lucie; Bartke, Till; Cejka, Petr; Mailand, Niels; Imhof, Axel; Patel, Dinshaw J.; Groth, Anja			H4K20me0 marks post-replicative chromatin and recruits the TONSL-MMS22L DNA repair complex	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; MMS22L-NFKBIL2 COMPLEX; MMS22L-TONSL COMPLEX; CELL-CYCLE; METHYLATION; CHAPERONE; BINDING; BARD1; STABILITY; PROTEINS	After DNA replication, chromosomal processes including DNA repair and transcription take place in the context of sister chromatids. While cell cycle regulation can guide these processes globally, mechanisms to distinguish pre- and post-replicative states locally remain unknown. Here we reveal that new histones incorporated during DNA replication provide a signature of post-replicative chromatin, read by the human TONSL-MMS22L(1-4) homologous recombination complex. We identify the TONSL ankyrin repeat domain (ARD) as a reader of histone H4 tails unmethylated at K20 (H4K20me0), which are specific to new histones incorporated during DNA replication and mark post-replicative chromatin until the G2/M phase of the cell cycle. Accordingly, TONSL-MMS22L binds new histones H3-H4 both before and after incorporation into nucleosomes, remaining on replicated chromatin until late G2/M. H4K20me0 recognition is required for TONSL-MMS22L binding to chromatin and accumulation at challenged replication forks and DNA lesions. Consequently, TONSL ARD mutants are toxic, compromising genome stability, cell viability and resistance to replication stress. Together, these data reveal a histone-reader-based mechanism for recognizing the post-replicative state, offering a new angle to understand DNA repair with the potential for targeted cancer therapy.	[Saredi, Giulia; Hammond, Colin M.; Alabert, Constance; Reveron-Gomez, Nazaret; Groth, Anja] Univ Copenhagen, BRIC, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Saredi, Giulia; Hammond, Colin M.; Alabert, Constance; Reveron-Gomez, Nazaret; Groth, Anja] Univ Copenhagen, Ctr Epigenet, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Huang, Hongda; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Bekker-Jensen, Simon; Mailand, Niels] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Forne, Ignasi; Imhof, Axel] Univ Munich, Dept Mol Biol, Biomed Ctr, D-80336 Munich, Germany; [Forne, Ignasi; Imhof, Axel] Univ Munich, Ctr Integrated Prot Sci Munich, D-80336 Munich, Germany; [Foster, Benjamin M.; Bartke, Till] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, CSC, Du Cane Rd, London W12 0NN, England; [Foster, Benjamin M.; Bartke, Till] Univ London Imperial Coll Sci Technol & Med, Fac Med, ICS, Du Cane Rd, London W12 0NN, England; [Mlejnkova, Lucie; Cejka, Petr] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland	University of Copenhagen; University of Copenhagen; Memorial Sloan Kettering Cancer Center; Novo Nordisk Foundation; University of Copenhagen; University of Munich; University of Munich; Imperial College London; Imperial College London; University of Zurich	Groth, A (corresponding author), Univ Copenhagen, BRIC, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark.; Groth, A (corresponding author), Univ Copenhagen, Ctr Epigenet, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark.; Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; anja.groth@bric.ku.dk	Imhof, Axel/AAU-5313-2021; Groth, Anja/AAH-5386-2019; Foster, Benjamin/AGK-6443-2022	Imhof, Axel/0000-0003-2993-8249; Groth, Anja/0000-0003-0577-1771; Foster, Benjamin/0000-0003-0670-2321; Saredi, Giulia/0000-0002-0798-0959; Cejka, Petr/0000-0002-9087-032X; Hammond, Colin/0000-0003-0571-5710; Reveron-Gomez, Nazaret/0000-0001-7347-781X; Mlejnkova, Lucie/0000-0002-7390-2123	European Commission; Leukemia and Lymphoma Society; STARR foundation; European Research Council (ERC) [281765]; Danish National Research Foundation to the Center for Epigenetics [DNRF82]; Danish Cancer Society; Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; European Commission [257082]; DFG Excellence Clusters CIPSM; SyNergy; DFG Collaborative Research Center [1064]; Medical Research Council and the European Research Council (ERC) [309952]; MRC [MC_UP_1102/2] Funding Source: UKRI; Medical Research Council [MC_UP_1102/2] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0012839] Funding Source: researchfish; The Danish Cancer Society [R124-A7922] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); STARR foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); Danish National Research Foundation to the Center for Epigenetics; Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre); DFG Excellence Clusters CIPSM(German Research Foundation (DFG)); SyNergy; DFG Collaborative Research Center(German Research Foundation (DFG)); Medical Research Council and the European Research Council (ERC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation Center for Protein Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the beam staff at the synchrotrons at the Argonne National Laboratory (NE-CAT) for technical assistance. We thank J. Rouse, D. Durocher, G. Legube and C. Storgaard Sorensen for reagents, G. Montoya for assistance with circular dichroism, C. B. Stromme, A. Strandsby, K. Nakamura, S.-b. Lee and M. Hodl for help with experiments, and Y. Antoku for assistance with microscopy. We thank J. Lukas for comments on the manuscript and Z. Jasencakova for illustrations. G.S. was supported by European Commission Marie Curie ITN FP7 'aDDRess'. D.J.P. was supported in part by grants from the Leukemia and Lymphoma Society and the STARR foundation. A. G. is an EMBO Young Investigator and her research is supported by the European Research Council (ERC StG, no. 281765), the Danish National Research Foundation to the Center for Epigenetics (DNRF82), the Danish Cancer Society, the Danish Medical Research Council, the Novo Nordisk Foundation and the Lundbeck Foundation. A. I. is supported by the European Commission FP7 Network of Excellence EpiGeneSys (project 257082), the DFG Excellence Clusters CIPSM and SyNergy, as well as the DFG Collaborative Research Center 1064 (projects A3 and Z3). T.B. is supported by the Medical Research Council and the European Research Council (ERC StG, no. 309952).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alabert C, 2015, GENE DEV, V29, P585, DOI 10.1101/gad.256354.114; Alabert C, 2014, NAT CELL BIOL, V16, P281, DOI 10.1038/ncb2918; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Bodor DL, 2013, MOL BIOL CELL, V24, P923, DOI 10.1091/mbc.E13-01-0034; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Campos EI, 2015, MOL CELL, V60, P697, DOI 10.1016/j.molcel.2015.08.005; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fox D, 2008, J BIOL CHEM, V283, P21179, DOI 10.1074/jbc.M802333200; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Huang HD, 2015, NAT STRUCT MOL BIOL, V22, P618, DOI 10.1038/nsmb.3055; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Ishitobi M, 2003, CANCER LETT, V200, P1, DOI 10.1016/S0304-3835(03)00387-2; Jakobsen JS, 2013, GENOME RES, V23, P592, DOI 10.1101/gr.146399.112; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kalashnikova AA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1022; Laufer M, 2007, J BIOL CHEM, V282, P34325, DOI 10.1074/jbc.M705198200; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; O'Connell BC, 2010, MOL CELL, V40, P645, DOI 10.1016/j.molcel.2010.10.022; O'Donnell L, 2010, MOL CELL, V40, P619, DOI 10.1016/j.molcel.2010.10.024; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Piwko W, 2010, EMBO J, V29, P4210, DOI 10.1038/emboj.2010.304; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Richet N, 2015, NUCLEIC ACIDS RES, V43, P1905, DOI 10.1093/nar/gkv021; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007	41	119	121	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					714	+		10.1038/nature18312	http://dx.doi.org/10.1038/nature18312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27338793	Green Accepted, Green Submitted			2022-12-28	WOS:000378676000043
J	Wehr, R; Munger, JW; McManus, JB; Nelson, DD; Zahniser, MS; Davidson, EA; Wofsy, SC; Saleska, SR				Wehr, R.; Munger, J. W.; McManus, J. B.; Nelson, D. D.; Zahniser, M. S.; Davidson, E. A.; Wofsy, S. C.; Saleska, S. R.			Seasonality of temperate forest photosynthesis and daytime respiration	NATURE			English	Article							GROSS PRIMARY PRODUCTION; ECOSYSTEM CARBON EXCHANGE; TERM EDDY COVARIANCE; WATER-USE EFFICIENCY; TERRESTRIAL ECOSYSTEMS; CO2; FLUORESCENCE; ASSIMILATION; VEGETATION; FLUXES	Terrestrial ecosystems currently offset one-quarter of anthropogenic carbon dioxide (CO2) emissions because of a slight imbalance between global terrestrial photosynthesis and respiration(1). Understanding what controls these two biological fluxes is therefore crucial to predicting climate change(2). Yet there is no way of directly measuring the photosynthesis or daytime respiration of a whole ecosystem of interacting organisms; instead, these fluxes are generally inferred from measurements of net ecosystem-atmosphere CO2 exchange (NEE), in a way that is based on assumed ecosystem-scale responses to the environment. The consequent view of temperate deciduous forests (an important CO2 sink) is that, first, ecosystem respiration is greater during the day than at night; and second, ecosystem photosynthetic light-use efficiency peaks after leaf expansion in spring and then declines(3), presumably because of leaf ageing or water stress. This view has underlain the development of terrestrial biosphere models used in climate prediction(4,5) and of remote sensing indices of global biosphere productivity(5,6). Here, we use new isotopic instrumentation(7) to determine ecosystem photosynthesis and daytime respiration(8) in a temperate deciduous forest over a three-year period. We find that ecosystem respiration is lower during the day than at night-the first robust evidence of the inhibition of leaf respiration by light(9-11) at the ecosystem scale. Because they do not capture this effect, standard approaches(12,13) overestimate ecosystem photosynthesis and daytime respiration in the first half of the growing season at our site, and inaccurately portray ecosystem photosynthetic light-use efficiency. These findings revise our understanding of forest-atmosphere carbon exchange, and provide a basis for investigating how leaf-level physiological dynamics manifest at the canopy scale in other ecosystems.	[Wehr, R.; Saleska, S. R.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Munger, J. W.; Wofsy, S. C.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Munger, J. W.; Wofsy, S. C.] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA; [McManus, J. B.; Nelson, D. D.; Zahniser, M. S.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Davidson, E. A.] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA	University of Arizona; Harvard University; Harvard University; Aerodyne Research; University System of Maryland; University of Maryland Center for Environmental Science	Wehr, R; Saleska, SR (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	rawehr@email.arizona.edu; saleska@email.arizona.edu	Munger, J William/H-4502-2013; Davidson, Eric A/K-4984-2013; Saleska, Scott R/K-1733-2016	Munger, J William/0000-0002-1042-8452; Davidson, Eric A/0000-0002-8525-8697; Saleska, Scott R/0000-0002-4974-3628; Wehr, Richard/0000-0002-0806-9390	US Department Of Energy (DOE), Office of Science, Terrestrial Ecosystem Science (TES) program [DE-SC0006741]; Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona; National Science Foundation (NSF); DOE TES program; NSF LTER program	US Department Of Energy (DOE), Office of Science, Terrestrial Ecosystem Science (TES) program(United States Department of Energy (DOE)); Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona; National Science Foundation (NSF)(National Science Foundation (NSF)); DOE TES program; NSF LTER program	This research was supported by the US Department Of Energy (DOE), Office of Science, Terrestrial Ecosystem Science (TES) program (award DE-SC0006741), and the Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona. Soil chamber data were acquired with the help of K. Savage at the Woods Hole Research Center, under the DOE award. The Harvard Forest Environmental Measurements Site infrastructure is a component of the Harvard Forest Long-Term Ecological Research (LTER) site, supported by the National Science Foundation (NSF), and is additionally supported by the DOE TES program. Below-canopy PAR, soil temperature and soil moisture data were provided by E. Nicoll at the Harvard Forest, supported by the NSF LTER program. OCS data and SIF data were provided by the authors of refs 40 and 41, respectively.	Bassow SL, 1998, ECOLOGY, V79, P2660, DOI 10.1890/0012-9658(1998)079[2660:HECACL]2.0.CO;2; Beer C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003233; Billmark Kaycie A., 2009, P143, DOI 10.1007/978-1-4419-0026-5_6; Bowling DR, 2001, GLOBAL CHANGE BIOL, V7, P127, DOI 10.1046/j.1365-2486.2001.00400.x; Commane R, 2015, P NATL ACAD SCI USA, V112, P14162, DOI 10.1073/pnas.1504131112; CONSTABLE GA, 1980, AUST J PLANT PHYSIOL, V7, P89, DOI 10.1071/PP9800089; dePury DGG, 1997, PLANT CELL ENVIRON, V20, P537, DOI 10.1111/j.1365-3040.1997.00094.x; Dillen SY, 2012, AGR FOREST METEOROL, V160, P60, DOI 10.1016/j.agrformet.2012.03.001; Falge E, 2002, AGR FOREST METEOROL, V113, P53, DOI 10.1016/S0168-1923(02)00102-8; Fassbinder JJ, 2012, AGR FOREST METEOROL, V153, P154, DOI 10.1016/j.agrformet.2011.09.020; GATZ DF, 1995, ATMOS ENVIRON, V29, P1185, DOI 10.1016/1352-2310(94)00210-C; Giasson MA, 2013, ECOSPHERE, V4, DOI 10.1890/ES13.00183.1; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; Grassi G, 2005, TREE PHYSIOL, V25, P349, DOI 10.1093/treephys/25.3.349; Heskel MA, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00120.1; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Keenan TF, 2014, ECOL APPL, V24, P1478, DOI 10.1890/13-0652.1; Knohl A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002301; Knohl A, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000663; KOK B, 1949, BIOCHIM BIOPHYS ACTA, V3, P625, DOI 10.1016/0006-3002(49)90136-5; Lai CT, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003369; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Ogee J, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001995; Ogee J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002166; Parazoo NC, 2014, GLOBAL CHANGE BIOL, V20, P3103, DOI 10.1111/gcb.12652; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Restrepo-Coupe N, 2013, AGR FOREST METEOROL, V182, P128, DOI 10.1016/j.agrformet.2013.04.031; Savage K, 2013, GLOBAL CHANGE BIOL, V19, P1151, DOI 10.1111/gcb.12108; Schimel D, 2015, GLOBAL CHANGE BIOL, V21, P1762, DOI 10.1111/gcb.12822; Stockli R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000562; Sun J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111744; Tang XG, 2014, SCI REP-UK, V4, DOI 10.1038/srep07483; Turner DP, 2003, REMOTE SENS ENVIRON, V88, P256, DOI 10.1016/j.rse.2003.06.005; van der Tol C, 2014, J GEOPHYS RES-BIOGEO, V119, P2312, DOI 10.1002/2014JG002713; Wehr R, 2015, AGR FOREST METEOROL, V214, P515, DOI 10.1016/j.agrformet.2015.09.009; Wehr R, 2013, AGR FOREST METEOROL, V181, P69, DOI 10.1016/j.agrformet.2013.07.002; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314; Wu J, 2016, SCIENCE, V351, P972, DOI 10.1126/science.aad5068; Yakir D, 1996, NATURE, V380, P515, DOI 10.1038/380515a0; Yang X, 2015, GEOPHYS RES LETT, V42, P2977, DOI 10.1002/2015GL063201; Yuan WP, 2014, AGR FOREST METEOROL, V192, P108, DOI 10.1016/j.agrformet.2014.03.007; Zhang J, 2006, PLANT CELL ENVIRON, V29, P483, DOI 10.1111/j.1365-3040.2005.01425.x; Zobitz JM, 2008, GLOBAL CHANGE BIOL, V14, P1785, DOI 10.1111/j.1365-2486.2008.01609.x	43	152	162	21	409	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					680	+		10.1038/nature17966	http://dx.doi.org/10.1038/nature17966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357794				2022-12-28	WOS:000378676000035
J	Liu, JJ; Jones, JS; Rao, PK				Liu, Jen-Jane; Jones, J. Stephen; Rao, Pravin K.			Urinalysis in the Evaluation of Hematuria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADULTS; DEFINITION; GUIDELINE; DIAGNOSIS		[Liu, Jen-Jane] Oregon Hlth & Sci Univ, Dept Urol, Portland, OR 97201 USA; [Jones, J. Stephen] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Rao, Pravin K.] Johns Hopkins Univ Hosp, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [Rao, Pravin K.] Mid Atlantic Permanente Med Grp, 1447 York Rd,Ste 100, Lutherville Timonium, MD 21043 USA	Oregon Health & Science University; Cleveland Clinic Foundation; Johns Hopkins University; Johns Hopkins Medicine; Permanente Medical Groups	Rao, PK (corresponding author), Mid Atlantic Permanente Med Grp, 1447 York Rd,Ste 100, Lutherville Timonium, MD 21043 USA.	prao@jhmi.edu						Barkan GA, 2015, ARCH PATHOL LAB MED, V139, P1009, DOI 10.5858/arpa.2014-0227-CP; Davis R, 2012, J UROLOGY, V188, P2473, DOI 10.1016/j.juro.2012.09.078; Grossfeld GD, 2001, UROLOGY, V57, P599, DOI 10.1016/S0090-4295(01)00919-0; Jocham D, 2008, EUR UROL, V53, P1138, DOI 10.1016/j.eururo.2007.11.048; Rao PK, 2010, J UROLOGY, V183, P560, DOI 10.1016/j.juro.2009.10.049; Shen L, 2014, EXPERT PANEL UROLOGI; SUTTON JM, 1990, JAMA-J AM MED ASSOC, V263, P2475, DOI 10.1001/jama.263.18.2475; Van der Molen AJ, 2008, EUR RADIOL, V18, P4, DOI 10.1007/s00330-007-0792-x	8	3	3	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2726	2727		10.1001/jama.2016.5050	http://dx.doi.org/10.1001/jama.2016.5050			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27357242				2022-12-28	WOS:000378709300024
J	Sarpatwari, A; Kesselheim, AS				Sarpatwari, Ameet; Kesselheim, Aaron S.			Navigating the Dermatological Drug Cost Curve	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE Physicians from many specialties as well as primary care prescribe dermatologic medications; as insurance formularies become increasingly restrictive and more patients are covered with high-deductible insurance plans, many patients are forced to pay high retail prices to obtain their medications. OBJECTIVES To determine the changes in the prices of commonly prescribed dermatologic medications since 2009 and to identify trends in price increases for different classes of drugs. DESIGN, SETTING, AND PARTICIPANTS Four national chain pharmacies received surveys requesting price data on commonly prescribed dermatologic drugs in 2009, 2011, 2014, and 2015. The initial survey requested information on 72 brand-name drugs. Subsequent surveys increased to eventually include 120 additional brand-name drugs and their generic alternatives when available. Owing to the frequency of prescription, diseases treated, or unusual price increases, 19 brand-name drugs surveyed in all 4 years were selected for final price trend analysis, which was conducted from August 1 to 15, 2015. MAIN OUTCOMES AND MEASURES Retail prices of topical and systemic drugs for the treatment of various dermatologic conditions. RESULTS Prices of surveyed brand-name drugs increased rapidly between 2009 and 2015. Of the 19 brand-name drugs analyzed, the retail prices of 7 drugs more than quadrupled during the study period. Among these 19 drugs, the mean price increase was 401% during the 6-year survey period, with the majority of the price increases occurring after 2011. Prices of topical antineoplastic drugs had the greatest mean absolute and percentage increase ($10 926.58 [1240%]). Prices of drugs in the antiinfective class had the smallest mean absolute increase ($333.99); prices of psoriasis medications had the smallest mean percentage increase (180%). Prices of acne and rosacea medications increased a mean of 195%, and prices of topical corticosteroids increased a mean of 290% during the study period. Selected generic drugs surveyed in 2011 and 2014 also increased a mean of 279% during the 3-year period. CONCLUSIONS AND RELEVANCE The price of prescription dermatologic drugs rose considerably from 2009 to 2015, with the vast majority of price increases occurring after 2011. Percent increases for multiple, frequently prescribed medications greatly outpaced inflation, national health expenditure growth, and increases in reimbursements for physician services.	Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sarpatwari, A (corresponding author), Brigham & Womens Hosp, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	asarpatwari@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Altman D., WASHINGTON POST; [Anonymous], PRESCR MED COST CONT; DiJulio B, KAISER HLTH TRACKING; Kirchoff SM, SPECIALTY DRUGS BACK; Peters JR, 2009, DERMATOL THER, V22, P229, DOI 10.1111/j.1529-8019.2009.01236.x; Rosenberg ME, 2016, JAMA DERMATOL, V152, P158, DOI 10.1001/jamadermatol.2015.3897; Shrank WH, 2011, AM J MED, V124, P309, DOI 10.1016/j.amjmed.2010.11.020; Silverman E., WALL STREET J; US Food & Drug Administration, OR BOOK APPR DRUG PR	9	0	0	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2724	2725		10.1001/jama.2016.3851	http://dx.doi.org/10.1001/jama.2016.3851			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27367767				2022-12-28	WOS:000378709300023
J	Inoue, AK; Tamura, Y; Matsuo, H; Mawatari, K; Shimizu, I; Shibuya, T; Ota, K; Yoshida, N; Zackrisson, E; Kashikawa, N; Kohno, K; Umehata, H; Hatsukade, B; Iye, M; Matsuda, Y; Okamoto, T; Yamaguchi, Y				Inoue, Akio K.; Tamura, Yoichi; Matsuo, Hiroshi; Mawatari, Ken; Shimizu, Ikkoh; Shibuya, Takatoshi; Ota, Kazuaki; Yoshida, Naoki; Zackrisson, Erik; Kashikawa, Nobunari; Kohno, Kotaro; Umehata, Hideki; Hatsukade, Bunyo; Iye, Masanori; Matsuda, Yuichi; Okamoto, Takashi; Yamaguchi, Yuki			DISTANT GALAXIES Detection of an oxygen emission line from a high-redshift galaxy in the reionization epoch	SCIENCE			English	Article							LY-ALPHA EMITTERS; STAR-FORMING GALAXIES; C II EMISSION; SIMILAR-TO 7; MU-M LINE; DUST CONTENT; ALMA; CONTINUUM; ORIGIN	The physical properties and elemental abundances of the interstellar medium in galaxies during cosmic reionization are important for understanding the role of galaxies in this process. We report the Atacama Large Millimeter/submillimeter Array detection of an oxygen emission line at a wavelength of 88 micrometers from a galaxy at an epoch about 700 million years after the Big Bang. The oxygen abundance of this galaxy is estimated at about one-tenth that of the Sun. The nondetection of far-infrared continuum emission indicates a deficiency of interstellar dust in the galaxy. A carbon emission line at a wavelength of 158 micrometers is also not detected, implying an unusually small amount of neutral gas. These properties might allow ionizing photons to escape into the intergalactic medium.	[Inoue, Akio K.; Mawatari, Ken] Osaka Sangyo Univ, Coll Gen Educ, 3-1-1 Nakagaito, Daito, Osaka 5748530, Japan; [Tamura, Yoichi; Kohno, Kotaro; Umehata, Hideki; Yamaguchi, Yuki] Univ Tokyo, Inst Astron, 2-21-1 Osawa, Mitaka, Tokyo 1810015, Japan; [Matsuo, Hiroshi; Kashikawa, Nobunari; Hatsukade, Bunyo; Iye, Masanori; Matsuda, Yuichi] Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan; [Matsuo, Hiroshi; Kashikawa, Nobunari; Matsuda, Yuichi] Grad Univ Adv Studies SOKENDAI, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan; [Shimizu, Ikkoh] Osaka Univ, Dept Earth & Space Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan; [Shibuya, Takatoshi] Univ Tokyo, Inst Cosm Ray Res, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778582, Japan; [Ota, Kazuaki] Univ Cambridge, Kavli Inst Cosmol, Cambridge CB3 0HA, England; [Ota, Kazuaki] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Yoshida, Naoki] Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Yoshida, Naoki] Univ Tokyo, Kavli IPMU, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778583, Japan; [Zackrisson, Erik] Uppsala Univ, Dept Phys & Astron, SE-75120 Uppsala, Sweden; [Umehata, Hideki] European So Observ, D-85748 Garching, Germany; [Okamoto, Takashi] Hokkaido Univ, Grad Sch Sci, Dept Cosmosci, Kita Ku, N10 W8, Sapporo, Hokkaido 0600810, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Graduate University for Advanced Studies - Japan; Osaka University; University of Tokyo; University of Cambridge; University of Cambridge; University of Tokyo; University of Tokyo; Uppsala University; European Southern Observatory; Hokkaido University	Inoue, AK (corresponding author), Osaka Sangyo Univ, Coll Gen Educ, 3-1-1 Nakagaito, Daito, Osaka 5748530, Japan.	akinoue@las.osaka-sandai.ac.jp	Inoue, Akio/ABG-1924-2020; Umehata, Hideki/GZB-1722-2022; Matsuo, Hiroshi/F-4807-2013; Tamura, Yoichi/W-1382-2019; YOSHIDA, NAOKI/G-4986-2014	Matsuo, Hiroshi/0000-0003-3278-2484; Tamura, Yoichi/0000-0003-4807-8117; Mawatari, Ken/0000-0003-4985-0201; Hatsukade, Bunyo/0000-0001-6469-8725; Okamoto, Takashi/0000-0003-0137-2490	JSPS [26287034, 26247022, 25287050, 24740112, 15H02073, 15K17616]; MEXT of Japan; Kavli Institute Fellowship (at Kavli Institute for Cosmology, University of Cambridge) - Kavli Foundation; Swedish Research Council [2011-5349]; Wenner-Gren Foundations;  [S08B-019];  [S08B-051];  [S09B-055];  [S331D]; Grants-in-Aid for Scientific Research [25287050] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kavli Institute Fellowship (at Kavli Institute for Cosmology, University of Cambridge) - Kavli Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundations; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This paper makes use of the following ALMA data: ADS/JAO. ALMA#2013.1.01010. S and 2012.1.00374. S, which are available at https://almascience.nao.ac.jp/alma-data/archive. ALMA is a partnership of the European Southern Observatory (ESO) (representing its member states), NSF (USA), and NINS (Japan), together with NRC (Canada), NSC and ASIAA (Taiwan), and KASI (Republic of Korea), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, the National Radio Astronomy Observatory/Associated Universities Inc., and the National Astronomical Observatory of Japan (NAOJ). Based in part on data collected at Subaru Telescope, which is operated by NAOJ; data are available at http://smoka.nao.ac.jp/ under project codes S08B-019, S08B-051, and S09B-055, and also at the W.M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA; data are available at www2.keck.hawaii.edu/koa/public/koa.php under the project code S331D. When some of the data reported here were acquired, UKIRT was operated by the Joint Astronomy Centre on behalf of the Science and Technology Facilities Council of the UK; UKIDSS data are available at http://wsa.roe.ac.uk//dr10plus_release.html. Based in part on archival data obtained with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA; data are available at www.cfa.harvard.edu/SEDS/data.html. Supported by JSPS KAKENHI grants 26287034 (A.K.I. and K.M.), 26247022 (I.S.), 25287050 (N.Y.), 24740112 (T.O.), 15H02073 (Y.T.), and 15K17616 (B.H.), and by a grant-in-aid for JSPS Fellows (H.U.), by a grant-in-aid for the Global COE Program "The Next Generation of Physics, Spun from Universality and Emergence" from MEXT of Japan (K.O.), the Kavli Institute Fellowship (at Kavli Institute for Cosmology, University of Cambridge) supported by the Kavli Foundation (K.O.), and the Swedish Research Council (project 2011-5349) and the Wenner-Gren Foundations (E.Z.).	Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Bouwens RJ, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/2/140; Brauher JR, 2008, ASTROPHYS J SUPPL S, V178, P280, DOI 10.1086/590249; Capak PL, 2015, NATURE, V522, P455, DOI 10.1038/nature14500; Cormier D, 2015, ASTRON ASTROPHYS, V578, DOI 10.1051/0004-6361/201425207; De Looze I, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201322489; Erb DK, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/1/33; Ferkinhoff C, 2010, ASTROPHYS J LETT, V714, pL147, DOI 10.1088/2041-8205/714/1/L147; Gullberg B, 2015, MON NOT R ASTRON SOC, V449, P2883, DOI 10.1093/mnras/stv372; Hashimoto T, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/2/157; Hashimoto T, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/70; Inoue AK, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L18; Inoue AK, 2011, EARTH PLANETS SPACE, V63, P1027, DOI 10.5047/eps.2011.02.013; Kawada M, 2011, PUBL ASTRON SOC JPN, V63, P903, DOI 10.1093/pasj/63.4.903; Madden SC, 2013, PUBL ASTRON SOC PAC, V125, P600, DOI 10.1086/671138; Maiolino R, 2015, MON NOT R ASTRON SOC, V452, P54, DOI 10.1093/mnras/stv1194; Ota K, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/34; Ouchi M, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/102; Shibuya T, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/74; Shibuya T, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/114; Stacey GJ, 2010, ASTROPHYS J, V724, P957, DOI 10.1088/0004-637X/724/2/957; Stark DP, 2015, MON NOT R ASTRON SOC, V454, P1393, DOI 10.1093/mnras/stv1907; Stark DP, 2015, MON NOT R ASTRON SOC, V450, P1846, DOI 10.1093/mnras/stv688; Vallini L, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/1/36; Valtchanov I, 2011, MON NOT R ASTRON SOC, V415, P3473, DOI 10.1111/j.1365-2966.2011.18959.x; Watson D, 2015, NATURE, V519, P327, DOI 10.1038/nature14164	26	136	138	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1559	1562		10.1126/science.aaf0714	http://dx.doi.org/10.1126/science.aaf0714			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27312046	Green Submitted			2022-12-28	WOS:000378346500039
J	Iwasaki, S; Floor, SN; Ingolia, NT				Iwasaki, Shintaro; Floor, Stephen N.; Ingolia, Nicholas T.			Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor	NATURE			English	Article							MESSENGER-RNA; NUCLEOTIDE RESOLUTION; INITIATION-FACTORS; IN-VIVO; HELICASE; BINDING; SILVESTROL; CANCER; ROLES; MODEL	Rocaglamide A (RocA) typifies a class of protein synthesis inhibitors that selectively kill aneuploid tumour cells and repress translation of specific messenger RNAs1-4. RocA targets eukaryotic initiation factor 4A (eIF4A), an ATP-dependent DEAD-box RNA helicase; its messenger RNA selectivity is proposed to reflect highly structured 5' untranslated regions that depend strongly on eIF4A-mediated unwinding(5). However, rocaglate treatment may not phenocopy the loss of eIF4A activity, as these drugs actually increase the affinity between eIF4A and RNA(1,2,6). Here we show that secondary structure in 5' untranslated regions is only a minor determinant for RocA selectivity and that RocA does not repress translation by reducing eIF4A availability. Rather, in vitro and in cells, RocA specifically clamps eIF4A onto polypurine sequences in an ATP-independent manner. This artificially clamped eIF4A blocks 43S scanning, leading to premature, upstream translation initiation and reducing protein expression from transcripts bearing the RocA-eIF4A target sequence. In elucidating the mechanism of selective translation repression by this lead anti-cancer compound, we provide an example of a drug stabilizing sequence-selective RNA-protein interactions.	[Iwasaki, Shintaro; Floor, Stephen N.; Ingolia, Nicholas T.] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr RNA Syst Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ingolia, NT (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr RNA Syst Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ingolia@berkeley.edu	Iwasaki, Shintaro/D-1472-2017; Iwasaki, Shintaro/AAO-7743-2021	Iwasaki, Shintaro/0000-0001-7724-3754; Iwasaki, Shintaro/0000-0001-7724-3754; Floor, Stephen/0000-0002-9965-9694	Damon Runyon Cancer Research Foundation [DRR-37-15]; Searle Scholars Program [11-SSP-229]; National Institute of General Medical Sciences of the National Institutes of Health [P50GM102706]; National Institutes of Health S10 Instrumentation Grants [S10RR029668, S10RR027303, OD018174]; Human Frontier Science Program long-term fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668, S10RR027303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018174] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Searle Scholars Program; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health S10 Instrumentation Grants; Human Frontier Science Program long-term fellowship(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to J. Tanaka for providing hippuristanol, to Y. Tomari for sharing DNA constructs, to H. Asahara and University of California, Berkeley DNA sequencing facility for help with the toeprinting assay, and to A. Pinder and F. Tan for support with deep sequencing analysis. We also thank the members of Ingolia, Lareau, and Tomari laboratories for discussion and technical support. N.T.I. is a Damon-Runyon-Rachleff Innovator supported in part by the Damon Runyon Cancer Research Foundation (DRR-37-15), the Searle Scholars Program (11-SSP-229), and the National Institute of General Medical Sciences of the National Institutes of Health (P50GM102706). This work used the Vincent J. Coates Genomics Sequencing Laboratory at University of California, Berkeley, supported by National Institutes of Health S10 Instrumentation Grants S10RR029668, S10RR027303, and OD018174. S.I. is a recipient of Human Frontier Science Program long-term fellowship. S.N.F. is a Howard Hughes Medical Institute Fellow of the Helen Hay Whitney Foundation.	ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arribere JA, 2013, GENOME RES, V23, P977, DOI 10.1101/gr.150342.112; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Dmitriev SE, 2003, FEBS LETT, V533, P99, DOI 10.1016/S0014-5793(02)03776-6; Galicia-Vazquez G, 2012, RNA, V18, P1373, DOI 10.1261/rna.033209.112; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Liu T, 2012, J MED CHEM, V55, P8859, DOI 10.1021/jm3011542; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Medenbach J, 2011, CELL, V145, P902, DOI 10.1016/j.cell.2011.05.005; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Sadlish H, 2013, ACS CHEM BIOL, V8, P1519, DOI 10.1021/cb400158t; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shirokikh NE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1025; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485	37	143	146	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					558	+		10.1038/nature17978	http://dx.doi.org/10.1038/nature17978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309803	Green Submitted, Green Accepted			2022-12-28	WOS:000378270300055
J	Joppi, R; Gerardi, C; Bertele, V; Garattini, S				Joppi, Roberta; Gerardi, Chiara; Bertele, Vittorio; Garattini, Silvio			Letting post-marketing bridge the evidence gap: the case of orphan drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PATENT DUCTUS-ARTERIOSUS; HIGH-GRADE DYSPLASIA; HAIRY-CELL LEUKEMIA; ESSENTIAL THROMBOCYTHEMIA; PHOTODYNAMIC THERAPY; ADRENOCORTICAL CARCINOMA; ORAL IBUPROFEN; BARRETTS-ESOPHAGUS; PRETERM INFANTS; ANAGRELIDE		[Joppi, Roberta; Gerardi, Chiara; Bertele, Vittorio; Garattini, Silvio] Ist Ric Farmacol Mario Negri, IRCCS, Milan, Italy; [Joppi, Roberta] Local Hlth Unit Verona, Pharmaceut Dept, Via Salvo DAcquisto 7, I-37122 Verona, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Joppi, R (corresponding author), Ist Ric Farmacol Mario Negri, IRCCS, Milan, Italy.; Joppi, R (corresponding author), Local Hlth Unit Verona, Pharmaceut Dept, Via Salvo DAcquisto 7, I-37122 Verona, Italy.	roberta.joppi@guest.marionegri.it	Bertele, Vittorio/AAA-6461-2020; Garattini, Silvio/AAA-6390-2020; Gerardi, Chiara/AAA-6718-2020	Bertele, Vittorio/0000-0002-0032-7033; Garattini, Silvio/0000-0003-0647-9297; Gerardi, Chiara/0000-0002-2459-4769				[Anonymous], 2015, ADAPTIVE LICENSING A; Bagnoli F, 2013, J MATERN-FETAL NEO M, V26, P423, DOI 10.3109/14767058.2012.733775; Banzi R, 2015, EUR J INTERN MED, V26, P572, DOI 10.1016/j.ejim.2015.08.008; Berruti A, 2005, ENDOCR-RELAT CANCER, V12, P657, DOI 10.1677/erc.1.01025; Besses C, 2013, LEUKEMIA RES, V37, P162, DOI 10.1016/j.leukres.2012.11.004; Brewer GJ, 2005, CNS DRUGS, V19, P185, DOI 10.2165/00023210-200519030-00001; Cacciola RR, 2007, ACTA HAEMATOL-BASEL, V118, P215, DOI 10.1159/000111776; Dang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077888; Dunn JM, 2013, LASER MED SCI, V28, P707, DOI 10.1007/s10103-012-1132-1; EMA, 2015, EUR MED AG ASS REP Z; EMA, 2015, EUR MED AG ASS REP M; EMA, 2015, EUR MED AG ASS REP P; EMA, 2015, EUR MED AG ASS REP A; EMA, 2015, EUR MED AG ASS REP I; EMA, 2015, EUR MED AG ASS REP C; Eras Z, 2013, AM J PERINAT, V30, P855, DOI 10.1055/s-0033-1333667; Fassnacht M, 2012, NEW ENGL J MED, V366, P2189, DOI 10.1056/NEJMoa1200966; Fassnacht M, 2010, J CLIN ENDOCR METAB, V95, P4925, DOI 10.1210/jc.2010-0803; Gisslinger H, 2013, BLOOD, V121, P1720, DOI 10.1182/blood-2012-07-443770; Harrison CN, 2005, NEW ENGL J MED, V353, P33, DOI 10.1056/NEJMoa043800; Joppi R, 2006, BRIT J CLIN PHARMACO, V61, P355, DOI 10.1111/j.1365-2125.2006.02579.x; Joppi R, 2013, EUR J CLIN PHARMACOL, V69, P1009, DOI 10.1007/s00228-012-1423-2; Lago P, 2014, NEONATOLOGY, V105, P46, DOI 10.1159/000355679; Lerario AM, 2014, HORM CANCER-US, V5, P232, DOI 10.1007/s12672-014-0182-1; Nava HR, 2011, LASER SURG MED, V43, P705, DOI 10.1002/lsm.21112; Neumann R, 2012, NEONATOLOGY, V102, P9, DOI 10.1159/000335332; Ohlsson A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003481.pub5; Oncel MY, 2014, J PEDIATR-US, V164, P510, DOI 10.1016/j.jpeds.2013.11.008; Overholt BF, 2005, GASTROINTEST ENDOSC, V62, P488, DOI 10.1016/j.gie.2005.06.047; Petrides PE, 2009, CLIN THER, V31, P386, DOI 10.1016/j.clinthera.2009.02.008; Ragunath K, 2005, SCAND J GASTROENTERO, V40, P750, DOI 10.1080/00365520510015737; Ravandi F, 2011, BLOOD, V118, P3818, DOI 10.1182/blood-2011-04-351502; Rey J, 2014, EUR J HAEMATOL, V92, P127, DOI 10.1111/ejh.12210; Robak T, 2007, BLOOD, V109, P3672, DOI 10.1182/blood-2006-08-042929; Schmitz S, 2010, ONKOLOGIE, V33, P39, DOI 10.1159/000264611; Steurer M, 2011, ONKOLOGIE, V34, P206; Waseem J, 2014, GASTROENTEROLOGY S1, V146, pS305; Yadav S, 2014, PEDIATR CARDIOL, V35, P824, DOI 10.1007/s00246-014-0861-2; Zenhausern R, 2009, LEUKEMIA LYMPHOMA, V50, P1501, DOI 10.1080/10428190903131755	39	19	20	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i2978	10.1136/bmj.i2978	http://dx.doi.org/10.1136/bmj.i2978			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27335134				2022-12-28	WOS:000378723500002
J	Ebbert, JO; Jacobson, RM				Ebbert, Jon O.; Jacobson, Robert M.			Reducing Childhood Tobacco Smoke Exposure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CESSATION; CHILDREN	IMPORTANCE Reducing child exposure to tobacco smoke is a public health priority. Guidelines recommend that health care professionals in child health settings should address tobacco smoke exposure (TSE) in children. OBJECTIVE To determine the effectiveness of interventions delivered by health care professionals who provide routine child health care in reducing TSE in children. DATA SOURCES A secondary analysis of 57 trials included in a 2014 Cochrane review and a subsequent extended searchwas performed. Controlled trials (published through June 2015) of interventions that focused on reducing child TSE, with no restrictions placed on who delivered the interventions, were identified. Secondary data extraction was performed in August 2015. STUDY SELECTION Controlled trials of routine child health care delivered by health care professionals (physicians, nurses, medical assistants, health educators, and dieticians) that addressed the outcomes of interest (TSE reduction in children and parental smoking behaviors) were eligible for inclusion in this review and meta-analysis. DATA EXTRACTION AND SYNTHESIS Study details and quality characteristics were independently extracted by 2 authors. If outcome measures were sufficiently similar, meta-analysis was performed using the random-effects model by Der Simonian and Laird. Otherwise, the results were described narratively. MAIN OUTCOMES AND MEASURES The primary outcome measure was reduction in child TSE. Secondary outcomes of interest were parental smoking cessation, parental smoking reduction, and maternal postpartum smoking relapse prevention. RESULTS Sixteen studies met the selection criteria. Narrative analysis of the 6 trials that measured child TSE indicated no intervention effects relative to comparison groups. Similarly, meta-analysis of 9 trials that measured parental smoking cessation demonstrated no overall intervention effect (n = 6399) (risk ratio, 1.05; 95% CI, 0.74-1.50; P = .78). Meta-analysis of the 3 trials that measured maternal postpartum smoking relapse prevention demonstrated a significant overall intervention effect (n = 1293) (risk ratio, 1.53; 95% CI, 1.10-2.14; P = .01). High levels of study heterogeneity likely resulted from variability in outcome measures, length of follow-up, intervention strategies, and unknown intervention fidelity. CONCLUSIONS AND RELEVANCE Interventions delivered by health care professionals who provide routine child health care may be effective in preventing maternal smoking relapse. Further research is required to improve the effectiveness of such interventions in reducing child TSE and increasing parental smoking cessation. The findings of this meta-analysis have policy and practice implications relating to interventions by routine pediatric health care professionals that aim to reduce child exposure to tobacco smoke.	[Ebbert, Jon O.; Jacobson, Robert M.] Mayo Clin, Rochester, MN USA	Mayo Clinic	Ebbert, JO (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	ebbert.jon@mayo.edu						Daly JB, 2016, JAMA PEDIATR, V170, P138, DOI 10.1001/jamapediatrics.2015.3342; Fang WL, 2004, J AM BOARD FAM PRACT, V17, P264, DOI 10.3122/jabfm.17.4.264; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Priest N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001746.pub2; Rosen LJ, 2012, PEDIATRICS, V129, P141, DOI 10.1542/peds.2010-3209	5	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2610	2611		10.1001/jama.2016.6751	http://dx.doi.org/10.1001/jama.2016.6751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27327803				2022-12-28	WOS:000378306700023
J	Constantinescu, AO; O'Reilly, JX; Behrens, TEJ				Constantinescu, Alexandra O.; O'Reilly, Jill X.; Behrens, Timothy E. J.			Organizing conceptual knowledge in humans with a gridlike code	SCIENCE			English	Article							MEMORY; REPRESENTATION; NAVIGATION; FUTURE; CELLS; MAP	It has been hypothesized that the brain organizes concepts into a mental map, allowing conceptual relationships to be navigated in a manner similar to that of space. Grid cells use a hexagonally symmetric code to organize spatial representations and are the likely source of a precise hexagonal symmetry in the functional magnetic resonance imaging signal. Humans navigating conceptual two-dimensional knowledge showed the same hexagonal signal in a set of brain regions markedly similar to those activated during spatial navigation. This gridlike signal is consistent across sessions acquired within an hour and more than a week apart. Our findings su::est that global relational codes may be used to organize nonspatial conceptual representations and that these codes may have a hexagonal gridlike pattern when conceptual knowledge is laid out in two continuous dimensions.	[Constantinescu, Alexandra O.; O'Reilly, Jill X.; Behrens, Timothy E. J.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, Oxford OX3 9DU, England; [O'Reilly, Jill X.] Univ Oxford, Dept Expt Psychol, 9 South Parks Rd, Oxford OX1 3UD, England; [O'Reilly, Jill X.] Radboud Univ Nijmegen, Donders Inst, NL-6525 ED Nijmegen, Netherlands; [Behrens, Timothy E. J.] UCL, Wellcome Trust Ctr Neuroimaging, 12 Queen Sq, London WC1N 3BG, England	University of Oxford; University of Oxford; Radboud University Nijmegen; University of London; University College London	Constantinescu, AO; Behrens, TEJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, Oxford OX3 9DU, England.; Behrens, TEJ (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, 12 Queen Sq, London WC1N 3BG, England.	alexandra.constantinescu@magd.ox.ac.uk; behrens@fmrib.ox.ac.uk		O'Reilly, Jill/0000-0002-6998-455X; Behrens, Timothy/0000-0003-0048-1177	Wellcome Trust [099715/Z/12/Z, WT104765MA]; Medical Research Council [MR/L019639/1]; James S. McDonnell Foundation [JSMF220020372]; MRC [MR/L019639/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); James S. McDonnell Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank N. Burgess, Z. Kurth-Nelson, H. Barron, L. Hunt, M. Garvert, and T. Muller for helpful discussions and comments on this manuscript as well as the anonymous peer reviewers who greatly improved the manuscript. We thank S. Jbabdi for help with data collection and analysis, as well as A. Winkler and L. Griffanti for guidance. We also thank all participants for Vainteering in this study. The study was supported by a Wellcome Trust 4-year Ph.D. studentship (099715/Z/12/Z) to A.O.C., a Medical Research Council Career Development Award (MR/L019639/1) to J.X.O.R., and a Wellcome Trust Senior Research Fellowship (WT104765MA) together with a James S. McDonnell Foundation Award (JSMF220020372) to T.E.J.B. The authors declare no conflicts of interest. At raw data are archived at the Oxford Centre for Functional MRI of the Brain.	[Anonymous], 2014, ADV NEURAL INFORM PR; Aronov D., 2016, P COMP SYST NEUR M T, VT-29, P41; Barron HC, 2013, NAT NEUROSCI, V16, P1492, DOI 10.1038/nn.3515; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Benoit RG, 2014, P NATL ACAD SCI USA, V111, P16550, DOI 10.1073/pnas.1419274111; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Clithero JA, 2014, SOC COGN AFFECT NEUR, V9, P1289, DOI 10.1093/scan/nst106; Davis T, 2014, CEREB CORTEX, V24, P1720, DOI 10.1093/cercor/bht014; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Dordek Y, 2016, ELIFE, V5, DOI 10.7554/eLife.10094; Eichenbaum H, 2014, NEURON, V83, P764, DOI 10.1016/j.neuron.2014.07.032; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Horner AJ, 2016, CURR BIOL, V26, P842, DOI 10.1016/j.cub.2016.01.042; Jacobs J, 2013, NAT NEUROSCI, V16, P1188, DOI 10.1038/nn.3466; Kraus BJ, 2015, NEURON, V88, P578, DOI 10.1016/j.neuron.2015.09.031; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; Kunz L, 2015, SCIENCE, V350, P430, DOI 10.1126/science.aac8128; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Stensola T, 2015, NATURE, V518, P207, DOI 10.1038/nature14151; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626	27	310	310	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1464	1468		10.1126/science.aaf0941	http://dx.doi.org/10.1126/science.aaf0941			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO7PV	27313047	Green Submitted, Green Accepted			2022-12-28	WOS:000377975400050
J	Muller, C; Remy, S				Mueller, Christina; Remy, Stefan			Slowly Building Excitement	CELL			English	Editorial Material							SODIUM-CHANNEL NA(V)1.7; NEURONS	While some neurons are tuned to integrate fast and precisely timed inputs, others set behavioral states on much slower timescales. In this issue of Cell, Branco et al. demonstrate that body weight is regulated by hypothalamic neurons using a highly effective form of slow synaptic integration, which is mediated by the voltage gated sodium channel Na(v)1.7.	[Mueller, Christina; Remy, Stefan] German Ctr Neurodegenerat Dis, Neuronal Networks Grp, Ludwig Erhard Allee 2, D-53175 Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Remy, S (corresponding author), German Ctr Neurodegenerat Dis, Neuronal Networks Grp, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	stefan.remy@dzne.de						Branco T, 2016, CELL, V165, P1749, DOI 10.1016/j.cell.2016.05.019; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.ph.58.030196.002025; Morinville A, 2007, J COMP NEUROL, V504, P680, DOI 10.1002/cne.21484; Prescott SA, 2005, J NEUROSCI, V25, P4743, DOI 10.1523/JNEUROSCI.0356-05.2005; Sheffield MEJ, 2011, NAT NEUROSCI, V14, P200, DOI 10.1038/nn.2728; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Yue CY, 2005, J NEUROSCI, V25, P9704, DOI 10.1523/JNEUROSCI.1621-05.2005	10	0	0	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1568	1569		10.1016/j.cell.2016.06.005	http://dx.doi.org/10.1016/j.cell.2016.06.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315473	Bronze			2022-12-28	WOS:000378062000008
J	Roberts, DJ; Frosch, MP				Roberts, Drucilla J.; Frosch, Matthew P.			Zika and histopathology in first trimester infections	LANCET			English	Editorial Material							CRANIOSYNOSTOSIS; INTERVILLOSITIS; PREGNANCY; PLACENTA; VIRUS		[Roberts, Drucilla J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA; [Frosch, Matthew P.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Roberts, DJ (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	djroberts@mgh.harvard.edu	Roberts, Drucilla/AAB-6379-2022; Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861				Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4; [Anonymous], 2016, LANCET; Boyd TK, 2000, HUM PATHOL, V31, P1389, DOI 10.1053/hupa.2000.19454; Cohen MM, 2006, BIRTH DEFECTS RES A, V76, P658, DOI 10.1002/bdra.20295; Flaherty K, 2016, WIRES DEV BIOL, V5, P429, DOI 10.1002/wdev.227; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617; Hyde SR, 1997, MODERN PATHOL, V10, P602; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Raam MS, 2010, AM J MED GENET C, V154C, P176, DOI 10.1002/ajmg.c.30234; Ribeiro CF, 2012, INT J INFECT DIS, V16, pE72, DOI 10.1016/j.ijid.2011.09.005; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; US Centers for Disease Control and Prevention, 2016, CDC CONCL ZIK CAUS M	15	7	7	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					847	849		10.1016/S0140-6736(16)30930-8	http://dx.doi.org/10.1016/S0140-6736(16)30930-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU0RI	27372399	Bronze			2022-12-28	WOS:000381911800007
J	MacLaren, RE				MacLaren, Robert E.			Benefits of gene therapy for both eyes	LANCET			English	Editorial Material							LEBERS CONGENITAL AMAUROSIS; DELIVERY		[MacLaren, Robert E.] Univ Oxford, Oxford Univ Hosp, Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England; [MacLaren, Robert E.] Moorfields Eye Hosp NHS Fdn Trusts, Oxford OX3 9DU, England; [MacLaren, Robert E.] NIHR Biomed Res Ctr, Oxford OX3 9DU, England	University of Oxford; University of Oxford	MacLaren, RE (corresponding author), Univ Oxford, Oxford Univ Hosp, Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England.; MacLaren, RE (corresponding author), Moorfields Eye Hosp NHS Fdn Trusts, Oxford OX3 9DU, England.; MacLaren, RE (corresponding author), NIHR Biomed Res Ctr, Oxford OX3 9DU, England.	enquiries@eye.ox.ac.uk		MacLaren, Robert/0000-0002-3096-4682	Department of Health [EME/12/66/35] Funding Source: Medline; National Institute for Health Research [NF-SI-0515-10047] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Barker SE, 2009, J GENE MED, V11, P486, DOI 10.1002/jgm.1327; Bennett J, 1996, HUM GENE THER, V7, P1763, DOI 10.1089/hum.1996.7.14-1763; Bennett J, 2016, LANCET; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Kotterman MA, 2015, GENE THER, V22, P116, DOI 10.1038/gt.2014.115; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Porto FBO, 2002, J GENE MED, V4, P390, DOI 10.1002/jgm.278	10	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					635	636		10.1016/S0140-6736(16)30783-8	http://dx.doi.org/10.1016/S0140-6736(16)30783-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UX	27375039				2022-12-28	WOS:000381268700004
J	Sankar, TS; Wastuwidyaningtyas, BD; Dong, YX; Lewis, SA; Wang, JD				Sankar, T. Sabari; Wastuwidyaningtyas, Brigitta D.; Dong, Yuexin; Lewis, Sarah A.; Wang, Jue D.			The nature of mutations induced by replication-transcription collisions	NATURE			English	Article							ESCHERICHIA-COLI PLASMIDS; BACILLUS-SUBTILIS; DNA-REPLICATION; RNA-POLYMERASE; MAXIMUM-LIKELIHOOD; GENOME INSTABILITY; STRUCTURAL BASIS; FORK MOVEMENT; E. COLI; GENE	The DNA replication and transcription machineries share a common DNA template and thus can collide with each other co-directionally or head-on(1,2). Replication-transcription collisions can cause replication fork arrest, premature transcription termination, DNA breaks, and recombination intermediates threatening genome integrity(1-10). Collisions may also trigger mutations, which are major contributors to genetic disease and evolution(5,7,11). However, the nature and mechanisms of collision-induced mutagenesis remain poorly understood. Here we reveal the genetic consequences of replication-transcription collisions in actively dividing bacteria to be two classes of mutations: duplications/deletions and base substitutions in promoters. Both signatures are highly deleterious but are distinct from the previously well-characterized base substitutions in the coding sequence. Duplications/deletions are probably caused by replication stalling events that are triggered by collisions; their distribution patterns are consistent with where the fork first encounters a transcription complex upon entering a transcription unit. Promoter substitutions result mostly from head-on collisions and frequently occur at a nucleotide that is conserved in promoters recognized by the major sigma factor in bacteria. This substitution is generated via adenine deamination on the template strand in the promoter open complex, as a consequence of head-on replication perturbing transcription initiation. We conclude that replication-transcription collisions induce distinct mutation signatures by antagonizing replication and transcription, not only in coding sequences but also in gene regulatory elements.	[Sankar, T. Sabari; Dong, Yuexin; Wang, Jue D.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Sankar, T. Sabari; Wastuwidyaningtyas, Brigitta D.; Lewis, Sarah A.; Wang, Jue D.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Wisconsin System; University of Wisconsin Madison; Baylor College of Medicine	Wang, JD (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Wang, JD (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	wang@bact.wisc.edu	Wang, Jue/GVU-0480-2022	Thirupathy, Sabari Sankar/0000-0003-0692-8769; Wang, Jue/0000-0003-1503-170X; Lewis, Sarah/0000-0002-5568-955X; Dong, Yuexin/0000-0002-7471-8053	National Institutes of Health Director's New Innovator Award [DP2OD004433]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084003] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004433] Funding Source: NIH RePORTER	National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Robleto, R. Yasbin and L. Simmons for strains, M. Cox, R. Gourse, C. Hittinger, R. Landick, K. Wasserman, C. Gross, M. Laub, S. Rosenberg, L. Simmons and the Wang laboratory for discussions and comments on the manuscript. This work was supported by the National Institutes of Health Director's New Innovator Award DP2OD004433 to J.D.W.	Aamodt RM, 2004, J BIOL CHEM, V279, P13601, DOI 10.1074/jbc.M314277200; Bruand C, 2001, MOL MICROBIOL, V39, P1248, DOI 10.1111/j.1365-2958.2001.02312.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fijalkowska IJ, 1998, P NATL ACAD SCI USA, V95, P10020, DOI 10.1073/pnas.95.17.10020; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Gao F, 2007, BIOINFORMATICS, V23, P1866, DOI 10.1093/bioinformatics/btm255; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kunkel TA, 2009, COLD SH Q B, V74, P91, DOI 10.1101/sqb.2009.74.027; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lippert MJ, 2011, P NATL ACAD SCI USA, V108, P698, DOI 10.1073/pnas.1012363108; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LU AL, 1983, P NATL ACAD SCI-BIOL, V80, P4639, DOI 10.1073/pnas.80.15.4639; Luria SE, 1943, GENETICS, V28, P491; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Million-Weaver S, 2015, P NATL ACAD SCI USA, V112, pE1096, DOI 10.1073/pnas.1416651112; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; Paul S, 2013, NATURE, V495, P512, DOI 10.1038/nature11989; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Reijns MAM, 2015, NATURE, V518, P502, DOI 10.1038/nature14183; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; SCHAAPER RM, 1986, J MOL BIOL, V189, P273, DOI 10.1016/0022-2836(86)90509-7; Schroeder JW, 2016, CURR BIOL, V26, P692, DOI 10.1016/j.cub.2016.01.016; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Ter Beek A, 2008, J BACTERIOL, V190, P1751, DOI 10.1128/JB.01516-07; VASANTHA N, 1980, J BACTERIOL, V144, P1119, DOI 10.1128/JB.144.3.1119-1125.1980; VILETTE D, 1992, EMBO J, V11, P3629, DOI 10.1002/j.1460-2075.1992.tb05447.x; VILETTE D, 1995, MOL MICROBIOL, V17, P493, DOI 10.1111/j.1365-2958.1995.mmi_17030493.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshiyama K, 2001, J MOL BIOL, V307, P1195, DOI 10.1006/jmbi.2001.4557; ZAMENHOF S, 1961, J BACTERIOL, V81, P111, DOI 10.1128/JB.81.1.111-117.1961; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	48	78	78	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					178	+		10.1038/nature18316	http://dx.doi.org/10.1038/nature18316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362223	Green Accepted			2022-12-28	WOS:000379015600048
J	Ardalan, ZS; Vasudevan, A; Testro, AG				Ardalan, Zaid S.; Vasudevan, Abhinav; Testro, Adam G.			Arthralgia and Fevers in a Patient With Autoimmune Hepatitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ERYTHEMA-NODOSUM; DISEASE		[Ardalan, Zaid S.; Vasudevan, Abhinav; Testro, Adam G.] Austin Hosp, Dept Gastroenterol & Liver Transplantat, Heidelberg, Vic 3084, Australia; [Testro, Adam G.] Univ Melbourne, Parkville, Vic 3052, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Ardalan, ZS (corresponding author), Austin Hosp, Gastroenterol & Liver Transplant Unit, Heidelberg, Vic 3084, Australia.	zaid.ardalan@gmail.com	Vasudevan, Abhinav/K-3758-2019	Vasudevan, Abhinav/0000-0001-5026-9014				Blake Tristan, 2014, Dermatol Online J, V20, P22376; CERVIA M, 1982, ARCH DERMATOL, V118, P878, DOI 10.1001/archderm.1982.01650230006009; Cribier B, 1998, INT J DERMATOL, V37, P667, DOI 10.1046/j.1365-4362.1998.00316.x; de Fonclare AL, 2007, ARCH DERMATOL, V143, P744, DOI 10.1001/archderm.143.6.744; Garcia-Porrua C, 2000, ARTHRITIS RHEUM, V43, P584, DOI 10.1002/1529-0131(200003)43:3<584::AID-ANR15>3.0.CO;2-6; Requena L, 2001, J AM ACAD DERMATOL, V45, P163, DOI 10.1067/mjd.2001.114736; Requena L, 2008, DERMATOL CLIN, V26, P425, DOI 10.1016/j.det.2008.05.014; Schwartz RA, 2007, AM FAM PHYSICIAN, V75, P695	8	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					91	92		10.1001/jama.2016.6818	http://dx.doi.org/10.1001/jama.2016.6818			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2MY	27380346				2022-12-28	WOS:000379037600022
J	Bonzi, M; Fiorelli, EM; Solbiati, M; Montano, N				Bonzi, Mattia; Fiorelli, Elisa Maria; Solbiati, Monica; Montano, Nicola			Accuracy of Peripheral Thermometers for Estimating Temperature	ANNALS OF INTERNAL MEDICINE			English	Letter									[Bonzi, Mattia; Fiorelli, Elisa Maria; Solbiati, Monica; Montano, Nicola] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Bonzi, M (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy.		fiorelli, elisa maria/AAB-3749-2019; Solbiati, Monica/K-4755-2016	Solbiati, Monica/0000-0003-1964-3770				Bur A, 2003, CRIT CARE MED, V31, P793, DOI 10.1097/01.CCM.0000053650.12025.1A; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Niven DJ, 2015, ANN INTERN MED, V163, P768, DOI 10.7326/M15-1150	3	5	5	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					73	73		10.7326/L16-0070	http://dx.doi.org/10.7326/L16-0070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380160				2022-12-28	WOS:000379215800024
J	Soumerai, SB				Soumerai, Stephen B.			Outcomes of Basic Versus Advanced Life Support for Out-of-Hospital Medical Emergencies	ANNALS OF INTERNAL MEDICINE			English	Letter									[Soumerai, Stephen B.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Soumerai, SB (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.							Effective Practice and Organisation of Care (EPOC), 2013, WHAT STUD DES SHOULD; Sanghavi P, 2015, ANN INTERN MED, V163, P681, DOI 10.7326/M15-0557; Soumerai SB, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150187	4	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					68	69		10.7326/L15-0627	http://dx.doi.org/10.7326/L15-0627			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380154				2022-12-28	WOS:000379215800017
J	Howard, AB; McDermott, P				Howard, Alexander B.; McDermott, Patrice			Reforms to improve US government accountability	SCIENCE			English	Editorial Material									[Howard, Alexander B.] Sunlight Fdn, Washington, DC 20036 USA; [McDermott, Patrice] OpenTheGovt Org, Washington, DC 20005 USA		McDermott, P (corresponding author), OpenTheGovt Org, Washington, DC 20005 USA.	pmcdermott@openthegovernment.org						Abel D, 2016, BOSTON GLOBE; [Anonymous], 2016, 18F FOIA HUB; [Anonymous], 2015, HUFFINGTON POST; Caramanica M. R., 2012, FEDERAL FOIA APPEALS; Gerstein J., 2014, POLITICO        0520; Howard A. B., 2014, DO NOTHING C POISED; Howard A. B., 2014, FEDERAL GOVT AGENCIE; Jones N., 2015, MOST AGENCIES FALLIN; Leopold J., 2016, VICENEWS        0309; Mullin B., 2015, OBAMA ADM SETS RECOR; O'Brien K. J., 2014, COLUMBIA JOURNALISM; Snyder J., 2012, BLOOMBERG NEWS	12	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					35	36		10.1126/science.aag2886	http://dx.doi.org/10.1126/science.aag2886			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP9KX	27365442				2022-12-28	WOS:000378816200025
J	[Anonymous]				[Anonymous]			Beyond the referendum	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													; Cullum, Nicky/F-2438-2011; Marmot, Michael/Y-3920-2019	Wessely, Simon Charles/0000-0002-6743-9929; Cullum, Nicky/0000-0003-2631-123X; Walshe, Kieran/0000-0002-0696-480X; Marmot, Michael/0000-0002-2431-6419					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3591	10.1136/bmj.i3591	http://dx.doi.org/10.1136/bmj.i3591			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27364154				2022-12-28	WOS:000379019700007
J	Bonnefon, JF; Shariff, A; Rahwan, I				Bonnefon, Jean-Francois; Shariff, Azim; Rahwan, Iyad			The social dilemma of autonomous vehicles	SCIENCE			English	Article							MACHINE ETHICS; LIFE	Autonomous vehicles (AVs) should reduce traffic accidents, but they will sometimes have to choose between two evils, such as running over pedestrians or sacrificing themselves and their passenger to save the pedestrians. Defining the algorithms that will help AVs make these moral decisions is a formidable challenge. We found that participants in six Amazon Mechanical Turk studies approved of utilitarian AVs (that is, AVs that sacrifice their passengers for the greater good) and would like others to buy them, but they would themselves prefer to ride in AVs that protect their passengers at all costs. The study participants disapprove of enforcing utilitarian regulations for AVs and would be less willing to buy such an AV. Accordingly, regulating for utilitarian algorithms may paradoxically increase casualties by postponing the adoption of a safer technology.	[Bonnefon, Jean-Francois] Univ Toulouse Capitole, CNRS, Inst Adv Study Toulouse, Toulouse Sch Econ,Ctr Res Management, Toulouse, France; [Shariff, Azim] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Rahwan, Iyad] MIT, Media Lab, Cambridge, MA 02139 USA; [Shariff, Azim] Univ Calif Irvine, Dept Psychol & Social Behav, Social & Behav Sci Gateway 4201, Irvine, CA 92697 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse 1 Capitole; Toulouse School of Economics; University of Oregon; Massachusetts Institute of Technology (MIT); University of California System; University of California Irvine	Rahwan, I (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	irahwan@mit.edu	Rahwan, Iyad/ABB-2422-2020	Rahwan, Iyad/0000-0002-1796-4303; Bonnefon, Jean-Francois/0000-0002-4959-188X; Shariff, Azim/0000-0003-4444-460X	Agence Nationale de la Recherche-Laboratoires d'Excellence Institute for Advanced Study in Toulouse; University of Oregon	Agence Nationale de la Recherche-Laboratoires d'Excellence Institute for Advanced Study in Toulouse(French National Research Agency (ANR)); University of Oregon	J.-F.B. gratefully acknowledges support through the Agence Nationale de la Recherche-Laboratoires d'Excellence Institute for Advanced Study in Toulouse. This research was supported by internal funds from the University of Oregon to A.S. I.R. is grateful for financial support from R. Hoffman. Data files have been uploaded as supplementary materials.	Cote S, 2013, J PERS SOC PSYCHOL, V104, P490, DOI 10.1037/a0030931; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Deng B, 2015, NATURE, V523, P24, DOI 10.1038/523024a; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Everett JAC, 2016, J EXP PSYCHOL GEN, V145, P772, DOI 10.1037/xge0000165; Gao P., 2014, MCKIN Q; Gold N, 2014, JUDGM DECIS MAK, V9, P65; Goodall NJ, 2014, LECT N MOBIL, P93, DOI 10.1007/978-3-319-05990-7_9; Gray K, 2012, PSYCHOL INQ, V23, P206, DOI 10.1080/1047840X.2012.686247; Greene J., 2014, MORAL TRIBES EMOTION; Haidt J., 2012, RIGHTEOUS MIND WHY G; Kass NE, 2001, AM J PUBLIC HEALTH, V91, P1776, DOI 10.2105/AJPH.91.11.1776; Montemerlo M, 2008, J FIELD ROBOT, V25, P569, DOI 10.1002/rob.20258; Posner EA, 2005, U CHICAGO LAW REV, V72, P537; Rosen F., 2005, CLASSICAL UTILITARIA; Spieser K, 2014, LECT N MOBIL, P229, DOI 10.1007/978-3-319-05990-7_20; Sunstein CR, 2005, STANFORD LAW REV, V58, P703; Urmson C, 2008, J FIELD ROBOT, V25, P425, DOI 10.1002/rob.20255; van Arem B, 2006, IEEE T INTELL TRANSP, V7, P429, DOI 10.1109/TITS.2006.884615; Van Lange PAM, 2013, ORGAN BEHAV HUM DEC, V120, P125, DOI 10.1016/j.obhdp.2012.11.003; Vladeck DC, 2014, WASH LAW REV, V89, P116; Waldrop MM, 2015, NATURE, V518, P20, DOI 10.1038/518020a	23	577	591	51	490	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1573	1576		10.1126/science.aaf2654	http://dx.doi.org/10.1126/science.aaf2654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP2TT	27339987	Green Submitted, Green Published			2022-12-28	WOS:000378346500043
J	Fankhauser, S				Fankhauser, Sarah			A winding path to satisfaction	SCIENCE			English	Editorial Material								When I speak with my students about their future careers, it is clear that many feel there is only one path to success and that any deviations will be catastrophic. My own academic path might seem to support this belief. On the surface, it appears quite linear: undergrad, grad student, postdoc, faculty member. But if you look deeper, you will see the series of roadblocks and revised plans that led me to where I am today. Using my own experience as an example, I try to convince students not to fear bends in the road. In fact, these deviations often help us develop, both as scientists and as people, and lead us to our true passions.	[Fankhauser, Sarah] Emory Univ, Oxford Coll, Biol, Atlanta, GA 30322 USA	Emory University	Fankhauser, S (corresponding author), Emory Univ, Oxford Coll, Biol, Atlanta, GA 30322 USA.	SciCareerEditor@aaas.org		Fankhauser, Sarah/0000-0001-5121-4509					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1606	1606		10.1126/science.352.6293.1606	http://dx.doi.org/10.1126/science.352.6293.1606			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP2TT	27339991				2022-12-28	WOS:000378346500049
J	Aydin, H; Sultana, A; Li, S; Thavalingam, A; Lee, JE				Aydin, Halil; Sultana, Azmiri; Li, Sheng; Thavalingam, Annoj; Lee, Jeffrey E.			Molecular architecture of the human sperm IZUMO1 and egg JUNO fertilization complex	NATURE			English	Article							STRUCTURE REFINEMENT; STRUCTURAL BASIS; FUSION; MASS; GLYCOPROTEIN; RESOLUTION; CRYSTALS; EXCHANGE; ADHESION; INSIGHTS	Fertilization is an essential biological process in sexual reproduction and comprises a series of molecular interactions between the sperm and egg(1,2). The fusion of the haploid spermatozoon and oocyte is the culminating event in mammalian fertilization, enabling the creation of a new, genetically distinct diploid organism(3,4). The merger of two gametes is achieved through a two-step mechanism in which the sperm protein IZUMO1 on the equatorial segment of the acrosome-reacted sperm recognizes its receptor, JUNO, on the egg surface(4-6). This recognition is followed by the fusion of the two plasma membranes. IZUMO1 and JUNO proteins are indispensable for fertilization, as constitutive knockdown of either protein results in mice that are healthy but infertile(5,6). Despite their central importance in reproductive medicine, the molecular architectures of these proteins and the details of their functional roles in fertilization are not known. Here we present the crystal structures of human IZUMO1 and JUNO in unbound and bound conformations. The human IZUMO1 structure exhibits a distinct boomerang shape and provides structural insights into the IZUMO family of proteins(7). Human IZUMO1 forms a high-affinity complex with JUNO and undergoes a major conformational change within its N-terminal domain upon binding to the egg-surface receptor. Our results provide insights into the molecular basis of sperm-egg recognition, cross-species fertilization, and the barrier to polyspermy, thereby promising benefits for the rational development of non-hormonal contraceptives and fertility treatments for humans and other mammals.	[Aydin, Halil; Sultana, Azmiri; Thavalingam, Annoj; Lee, Jeffrey E.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Toronto; University of California System; University of California San Diego	Lee, JE (corresponding author), Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada.	jeff.lee@utoronto.ca			CIHR [MOP-115066]; NSERC [RGPIN 435607-13]; Ontario Early Researcher Award [ER-13-09-116]; Canada Research Chair; NIH [1U19AI117905, R01 GM020501, R01 AI101436]; University of Toronto; Ontario Graduate Scholarships; NSERC USRA; NSERC; National Research Council of Canada; CIHR; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; US Department of Energy (Office of Basic Energy Sciences) through the Integrated Diffraction Analysis Technologies program [DE-AC02-05CH11231]; DOE Office of Biological and Environmental Research; NIH project MINOS [R01GM105404]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101436, U19AI117905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, R01GM105404] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Toronto(University of Toronto); Ontario Graduate Scholarships(Ontario Graduate Scholarship); NSERC USRA(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council of Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; US Department of Energy (Office of Basic Energy Sciences) through the Integrated Diffraction Analysis Technologies program(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH project MINOS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a CIHR Operating Grant (MOP-115066), an NSERC Discovery Grant (RGPIN 435607-13), an Ontario Early Researcher Award (ER-13-09-116), and a Canada Research Chair to J.E.L. S.L. is supported by grants from NIH (1U19AI117905, R01 GM020501 and R01 AI101436). Support for stipends was provided by University of Toronto and Ontario Graduate Scholarships to H.A. and an NSERC USRA to A.T. We thank W. Houry, T. Moraes and C. Spring for access to circular dichroism, SEC-MALS and SPR systems, respectively. This work is based upon X-ray data collected at beamline 08ID-1 at the Canadian Light Source (CLS) and Structural Genomics Consortium (SGC), and SAXS data acquired at the Advanced Light Source (ALS) SIBYLS beamline 12.3.1. The CLS is supported by NSERC, National Research Council of Canada, CIHR, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. The ALS is a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the US Department of Energy (Office of Basic Energy Sciences) through the Integrated Diffraction Analysis Technologies program (DE-AC02-05CH11231), supported by the DOE Office of Biological and Environmental Research; additional support comes from NIH project MINOS (R01GM105404). We thank F. Azimi, J. Cook, A. Dong and N. Ly for technical support, and E. Ollmann Saphire, A. S. Rocca and G. Bikopoulos for critical reading of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Chen C, 2013, NATURE, V500, P486, DOI 10.1038/nature12327; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Dauter Z, 2003, ACTA CRYSTALLOGR D, V59, P2004, DOI 10.1107/S0907444903021085; Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans JP, 2012, ANNU REV PHYSIOL, V74, P477, DOI 10.1146/annurev-physiol-020911-153339; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FISHER RG, 1980, ACTA CRYSTALLOGR A, V36, P755, DOI 10.1107/S0567739480001520; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Grayson Phil, 2012, Int J Evol Biol, V2012, P958164, DOI 10.1155/2012/958164; Gupta SK, 2012, CELL TISSUE RES, V349, P665, DOI 10.1007/s00441-011-1319-y; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Han L, 2016, CURR BIOL, V26, pR100, DOI 10.1016/j.cub.2015.12.034; Han L, 2010, CELL, V143, P404, DOI 10.1016/j.cell.2010.09.041; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9858; Inoue N, 2013, DEVELOPMENT, V140, P3221, DOI 10.1242/dev.094854; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim E, 2008, INT J DEV BIOL, V52, P677, DOI 10.1387/ijdb.072528ek; Klinovska K, 2014, INT J MOL SCI, V15, P10652, DOI 10.3390/ijms150610652; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; MARQUARDT T, 1992, J CELL BIOL, V117, P505, DOI 10.1083/jcb.117.3.505; Marsh JJ, 2013, BIOCHEMISTRY-US, V52, P5491, DOI 10.1021/bi4007995; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Sathiyamoorthy K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004309; Sheerin DJ, 2011, BIOCHEM J, V435, P629, DOI 10.1042/BJ20101941; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; Sultana A., 2015, CURR PROT PROTEIN SC, V79; Sutovsky P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001045; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wibowo AS, 2013, P NATL ACAD SCI USA, V110, P15180, DOI 10.1073/pnas.1308827110; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yanagimachi R., 1994, Zygote, V2, P371; YEATES TO, 1988, ACTA CRYSTALLOGR A, V44, P142, DOI 10.1107/S0108767387009632; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	54	77	83	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					562	+		10.1038/nature18595	http://dx.doi.org/10.1038/nature18595			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309818	Green Accepted			2022-12-28	WOS:000378270300056
J	Shepherd, MR; Dudek, JJ; Mitchell, RE				Shepherd, Matthew R.; Dudek, Jozef J.; Mitchell, Ryan E.			Searching for the rules that govern hadron construction	NATURE			English	Review							EXOTIC MESON PRODUCTION; LATTICE QCD; MODEL; RESONANCE; STATES	Just as quantum electrodynamics describes how electrons are bound in atoms by the electromagnetic force, mediated by the exchange of photons, quantum chromodynamics (QCD) describes how quarks are bound inside hadrons by the strong force, mediated by the exchange of gluons. QCD seems to allow hadrons constructed from increasingly many quarks to exist, just as atoms with increasing numbers of electrons exist, yet such complex constructions seemed, until recently, not to be present in nature. Here we describe advances in the spectroscopy of mesons that are refining our understanding of the rules for predicting hadron structure from QCD.	[Shepherd, Matthew R.; Mitchell, Ryan E.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Dudek, Jozef J.] Old Dominion Univ, Dept Phys, Norfolk, VA 23529 USA; [Dudek, Jozef J.] Jefferson Lab, Newport News, VA 23606 USA	Indiana University System; Indiana University Bloomington; Old Dominion University; United States Department of Energy (DOE); Jefferson National Accelerator	Shepherd, MR (corresponding author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.	mashephe@indiana.edu		Dudek, Jozef/0000-0003-4327-2121	US Department of Energy [DE-AC05-06OR23177, DE-SC0006765, DE-FG02-05ER41374]	US Department of Energy(United States Department of Energy (DOE))	J.J.D. acknowledges support provided by US Department of Energy contract DE-AC05-06OR23177, under which Jefferson Science Associates manages Jefferson Laboratory and the Early Career Award contract DE-SC0006765. M.R.S. and R.E.M. are supported by US Department of Energy contract DE-FG02-05ER41374. M.R.S. acknowledges the Jefferson Science Associates Sabbatical Leave Support Program. We thank L. Weinstein for comments on the initial draft of this manuscript.	Aaij R, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.072001; Aaij R, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.222002; Ablikim M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.242001; Ablikim M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.252001; Adams GS, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.112009; Alekseev MG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.241803; Aoki S, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.094506; Aoki S, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-2890-7; Aoki S, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.094505; AUBERT JJ, 1974, PHYS REV LETT, V33, P1404, DOI 10.1103/PhysRevLett.33.1404; AUGUSTIN JE, 1974, PHYS REV LETT, V33, P1406, DOI 10.1103/PhysRevLett.33.1406; Bai JZ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.101802; BARNES T, 1983, NUCL PHYS B, V224, P241, DOI 10.1016/0550-3213(83)90004-4; Bondar A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.122001; Bugg DV, 2008, J PHYS G NUCL PARTIC, V35, DOI 10.1088/0954-3899/35/7/075005; CHANOWITZ M, 1983, NUCL PHYS B, V228, P588; Chilikin K, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.112009; Chilikin K, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.074026; Christ NH, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.114506; Clark MA, 2010, COMPUT PHYS COMMUN, V181, P1517, DOI 10.1016/j.cpc.2010.05.002; Ding HT, 2015, INT J MOD PHYS E, V24, DOI 10.1142/S0218301315300076; Dudek JJ, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.094505; Dudek JJ, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.034505; Dudek JJ, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.074023; Dudek JJ, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.111502; Dudek JJ, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.034508; Dudek JJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.262001; Egri GI, 2007, COMPUT PHYS COMMUN, V177, P631, DOI 10.1016/j.cpc.2007.06.005; EICHTEN E, 1978, PHYS REV D, V17, P3090, DOI 10.1103/PhysRevD.17.3090; Feng X, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.094505; Fu ZW, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.074501; General IJ, 2007, EUR PHYS J C, V51, P347, DOI 10.1140/epjc/s10052-007-0298-3; GODFREY S, 1985, PHYS REV D, V32, P189, DOI 10.1103/PhysRevD.32.189; Guo FK, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.071502; Guo P, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.014501; Guo P, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.056003; He S, 2005, J HIGH ENERGY PHYS; HORN D, 1978, PHYS REV D, V17, P898, DOI 10.1103/PhysRevD.17.898; ISGUR N, 1985, PHYS REV D, V31, P2910, DOI 10.1103/PhysRevD.31.2910; Ivanov EI, 2001, PHYS REV LETT, V86, P3977, DOI 10.1103/PhysRevLett.86.3977; JAFFE RL, 1986, ANN PHYS-NEW YORK, V168, P344, DOI 10.1016/0003-4916(86)90035-7; Kronfeld AS, 2013, 100 YEARS OF SUBATOMIC PHYSICS, P493; Kronfeld AS, 2012, ANNU REV NUCL PART S, V62, P265, DOI 10.1146/annurev-nucl-102711-094942; Kuhn J, 2004, PHYS LETT B, V595, P109, DOI 10.1016/j.physletb.2004.05.032; Lang CB, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.054508; Lang CB, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.054503; Lees JP, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.111103; Lees JP, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.051102; Liu LM, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2012)126; Liu ZQ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.252002; LUSCHER M, 1991, NUCL PHYS B, V354, P531, DOI 10.1016/0550-3213(91)90366-6; Meyer CA, 2015, PROG PART NUCL PHYS, V82, P21, DOI 10.1016/j.ppnp.2015.03.001; Mizuk R, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.072004; Moir G, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2013)021; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Osterheld A., 1986, SLACPUB4160; Peardon M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.054506; Pelissier C, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.014503; Swanson ES, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.034009; Szczepaniak AP, 2015, PHYS LETT B, V747, P410, DOI 10.1016/j.physletb.2015.06.029; Wang Q, 2013, PHYS LETT B, V725, P106, DOI 10.1016/j.physletb.2013.06.049; Wang XL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.142002; Wilson DJ, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.094502; Xiao T, 2013, PHYS LETT B, V727, P366, DOI 10.1016/j.physletb.2013.10.041	68	22	22	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					487	493		10.1038/nature18011	http://dx.doi.org/10.1038/nature18011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27337337	Green Submitted			2022-12-28	WOS:000378270300041
J	Franco, OH; Chowdhury, R; Troup, J; Voortman, T; Kunutsor, S; Kavousi, M; Oliver-Williams, C; Muka, T				Franco, Oscar H.; Chowdhury, Rajiv; Troup, Jenna; Voortman, Trudy; Kunutsor, Setor; Kavousi, Maryam; Oliver-Williams, Clare; Muka, Taulant			Use of Plant-Based Therapies and Menopausal Symptoms A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED CROSSOVER TRIAL; STANDARDIZED SOY EXTRACT; DOUBLE-BLIND; POSTMENOPAUSAL WOMEN; HOT FLUSHES; VASOMOTOR SYMPTOMS; BLACK COHOSH	IMPORTANCE Between 40% and 50% of women in Western countries use complementary therapies to manage menopausal symptoms. OBJECTIVE To determine the association of plant-based therapies with menopausal symptoms, including hot flashes, night sweats, and vaginal dryness. DATA SOURCES The electronic databases Ovid MEDLINE, EMBASE, and Cochrane Central were systematically searched to identify eligible studies published before March 27, 2016. Reference lists of the included studies were searched for further identification of relevant studies. STUDY SELECTION Randomized clinical trials that assessed plant-based therapies and the presence of hot flashes, night sweats, and vaginal dryness. DATA EXTRACTION Data were extracted by 2 independent reviewers using a predesigned data collection form. MAIN OUTCOMES AND MEASURES Hot flashes, night sweats, and vaginal dryness. RESULTS In total, 62 studies were identified, including 6653 individual women. Use of phytoestrogens was associated with a decrease in the number of daily hot flashes (pooled mean difference of changes, -1.31 [95% CI, -2.02 to -0.61]) and vaginal dryness score (pooled mean difference of changes, -0.31 [95% CI, -0.52 to -0.10]) between the treatment groups but not in the number of night sweats (pooled mean difference of changes, -2.14 [95% CI, -5.57 to 1.29]). Individual phytoestrogen interventions such as dietary and supplemental soy isoflavones were associated with improvement in daily hot flashes (pooled mean difference of changes, -0.79 [-1.35 to -0.23]) and vaginal dryness score (pooled mean difference of changes, -0.26 [-0.48 to -0.04]). Several herbal remedies, but not Chinese medicinal herbs, were associated with an overall decrease in the frequency of vasomotor symptoms. There was substantial heterogeneity in quality across the available studies, and 46 (74%) of the included randomized clinical trials demonstrated a high risk of bias within 3 or more areas of study quality. CONCLUSIONS AND RELEVANCE This meta-analysis of clinical trials suggests that composite and specific phytoestrogen supplementations were associated with modest reductions in the frequency of hot flashes and vaginal dryness but no significant reduction in night sweats. However, because of general suboptimal quality and the heterogeneous nature of the current evidence, further rigorous studies are needed to determine the association of plant-based and natural therapies with menopausal health.	[Franco, Oscar H.; Troup, Jenna; Voortman, Trudy; Kavousi, Maryam; Muka, Taulant] Erasmus Univ, Med Ctr, Dept Epidemiol, POB 2040,Dr Molewaterpl 50,Off NA29-05, NL-3000 CA Rotterdam, Netherlands; [Chowdhury, Rajiv; Kunutsor, Setor; Oliver-Williams, Clare] Univ Cambridge, Cardiovasc Epidemiol Unit, Dept Publ Hlth & Primary Care, Cambridge, England; [Voortman, Trudy; Muka, Taulant] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; University of Cambridge; Harvard University; Harvard T.H. Chan School of Public Health	Muka, T (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, POB 2040,Dr Molewaterpl 50,Off NA29-05, NL-3000 CA Rotterdam, Netherlands.	t.muka@erasmusmc.nl	Kavousi, Maryam/F-1174-2018; Voortman, Trudy/C-2963-2015; Franco, Óscar H/ABE-2305-2020; Chowdhury, Rajiv/AHB-1253-2022; Kunutsor, Setor K/H-9807-2019	Kavousi, Maryam/0000-0001-5976-6519; Voortman, Trudy/0000-0003-2830-6813; Franco, Óscar H/0000-0002-4606-4929; Kunutsor, Setor K/0000-0002-2625-0273	Metagenics Inc.; British Heart Foundation [RG/13/13/30194, RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0800270, MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; MRC [G0800270, MR/L003120/1] Funding Source: UKRI	Metagenics Inc.; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was sponsored by Metagenics Inc.	Abdali K, 2010, MENOPAUSE, V17, P326, DOI 10.1097/gme.0b013e3181b8e02d; Albertazzi P, 2005, CLIMACTERIC, V8, P371, DOI 10.1080/13697130500345257; Albertazzi P, 1998, OBSTET GYNECOL, V91, P6, DOI 10.1016/S0029-7844(97)00597-8; Amsterdam JD, 2009, J CLIN PSYCHOPHARM, V29, P478, DOI 10.1097/JCP.0b013e3181b2abf2; Aso T, 2012, J WOMENS HEALTH, V21, P92, DOI 10.1089/jwh.2011.2753; Atkinson C, 2004, BREAST CANCER RES, V6, pR170, DOI 10.1186/bcr773; Baber R J, 1999, Climacteric, V2, P85, DOI 10.3109/13697139909025571; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Borud EK, 2009, MENOPAUSE, V16, P484, DOI 10.1097/gme.0b013e31818c02ad; Brzezinski A, 1997, MENOPAUSE, V4, P89; Burke GL, 2003, MENOPAUSE, V10, P147, DOI 10.1097/00042192-200310020-00006; Chen MN, 2015, CLIMACTERIC, V18, P260, DOI 10.3109/13697137.2014.966241; Cheng GJ, 2007, MENOPAUSE, V14, P468, DOI 10.1097/GME.0b013e31802cc7d0; Chung DJ, 2007, YONSEI MED J, V48, P289, DOI 10.3349/ymj.2007.48.2.289; Colacurci N, 2004, Minerva Ginecol, V56, P407; Colli MC, 2012, J MED FOOD, V15, P840, DOI 10.1089/jmf.2011.0228; Crisafulli A, 2004, MENOPAUSE, V11, P400, DOI 10.1097/01.GME.0000109314.11228.E5; D'Anna R, 2007, MENOPAUSE, V14, P648, DOI 10.1097/01.gme.0000248708.60698.98; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiBonaventura MD, 2013, INT J WOMENS HEALTH, V5, P261, DOI 10.2147/IJWH.S39027; Dodin S, 2005, J CLIN ENDOCR METAB, V90, P1390, DOI 10.1210/jc.2004-1148; Duffy R, 2003, PHARMACOL BIOCHEM BE, V75, P721, DOI 10.1016/S0091-3057(03)00116-3; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evans M, 2011, MATURITAS, V68, P189, DOI 10.1016/j.maturitas.2010.11.012; Farzaneh F, 2013, ARCH GYNECOL OBSTET, V288, P1075, DOI 10.1007/s00404-013-2852-6; Faure ED, 2002, MENOPAUSE, V9, P329, DOI 10.1097/00042192-200209000-00005; Ferrari A, 2009, J OBSTET GYNAECOL RE, V35, P1083, DOI 10.1111/j.1447-0756.2009.01058.x; Frei-Kleiner S, 2005, MATURITAS, V51, P397, DOI 10.1016/j.maturitas.2004.10.003; Fu SF, 2016, MENOPAUSE, V23, P311, DOI 10.1097/GME.0000000000000534; Garcia JT, 2010, MENOPAUSE, V17, P303, DOI 10.1097/gme.0b013e3181bf8e92; Geller SE, 2009, MENOPAUSE, V16, P1156, DOI 10.1097/gme.0b013e3181ace49b; Green R, 2009, WOMENS HEALTH, V5, P127, DOI 10.2217/17455057.5.2.127; Hachul H, 2013, CLIMACTERIC, V16, P36, DOI 10.3109/13697137.2012.698432; Hachul H, 2011, MENOPAUSE, V18, P178, DOI 10.1097/gme.0b013e3181ecf9b9; Haines CJ, 2008, CLIMACTERIC, V11, P244, DOI 10.1080/13697130802073029; Han KK, 2002, OBSTET GYNECOL, V99, P389, DOI 10.1016/S0029-7844(01)01744-6; Hasper I, 2009, MENOPAUSE, V16, P117, DOI [10.1097/GME.0b013e3181806446, 10.1097/gme.0b013e3181806446]; Heger M, 2006, MENOPAUSE, V13, P744, DOI 10.1097/01.gme.0000240632.08182.e4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Hsu CC, 2011, CLIMACTERIC, V14, P132, DOI 10.3109/13697137.2010.498594; Im EO, 2010, WESTERN J NURS RES, V32, P540, DOI 10.1177/0193945909354343; Jaspers L, 2015, MATURITAS, V81, P93, DOI 10.1016/j.maturitas.2015.02.010; Jeri AR, 2002, FEMALE PATIENT, V27, P35; Jiang K, 2015, CLIMACTERIC, V18, P559, DOI 10.3109/13697137.2015.1042450; Knight D C, 1999, Climacteric, V2, P79, DOI 10.3109/13697139909025570; Komesaroff P A, 2001, Climacteric, V4, P144; Kotsopoulos D, 2000, Climacteric, V3, P161, DOI 10.1080/13697130008500108; Kronenberg F, 2002, ANN INTERN MED, V137, P805, DOI 10.7326/0003-4819-137-10-200211190-00009; Kwee SH, 2007, MATURITAS, V58, P83, DOI 10.1016/j.maturitas.2007.06.005; Lee J, 2010, ARCH PHARM RES, V33, P523, DOI 10.1007/s12272-010-0405-0; Lewis JE, 2006, MENOPAUSE, V13, P631, DOI 10.1097/01.gme.0000191882.59799.67; Lipovac M, 2012, GYNECOL ENDOCRINOL, V28, P203, DOI 10.3109/09513590.2011.593671; Liu ZM, 2014, MENOPAUSE, V21, P653, DOI [10.1097/GME.0000000000000102, 10.1097/gme.0000000000000102]; Lontos S, 2003, MED J AUSTRALIA, V179, P390, DOI 10.5694/j.1326-5377.2003.tb05606.x; MacGregor CA, 2005, EUR J CANCER, V41, P708, DOI 10.1016/j.ejca.2005.01.005; Mohammad-Alizadeh-Charandabi S, 2013, CHIN MED-UK, V8, DOI 10.1186/1749-8546-8-20; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; MURKIES AL, 1995, MATURITAS, V21, P189, DOI 10.1016/0378-5122(95)00899-V; Nahas EAP, 2007, MATURITAS, V58, P249, DOI 10.1016/j.maturitas.2007.08.012; Nahas EP, 2004, MATURITAS, V48, P372, DOI 10.1016/j.maturitas.2003.09.026; Nedeljkovic M, 2014, MENOPAUSE, V21, P15, DOI [10.1097/GME.0b013e31829374e8, 10.1097/gme.0b013e31829374e8]; Newton KM, 2006, ANN INTERN MED, V145, P869, DOI 10.7326/0003-4819-145-12-200612190-00003; Nikander E, 2003, OBSTET GYNECOL, V101, P1213, DOI 10.1016/S0029-7844(03)00232-1; Penotti M, 2003, FERTIL STERIL, V79, P1112, DOI 10.1016/S0015-0282(03)00158-4; Pockaj BA, 2006, J CLIN ONCOL, V24, P2836, DOI 10.1200/JCO.2005.05.4296; Porzio G, 2002, TUMORI, V88, P128, DOI 10.1177/030089160208800209; Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068; Reed SD, 2013, MATURITAS, V75, P152, DOI 10.1016/j.maturitas.2013.03.003; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rotem C, 2007, GYNECOL ENDOCRINOL, V23, P117, DOI 10.1080/09513590701200900; Scambia G, 2000, MENOPAUSE, V7, P105, DOI 10.1097/00042192-200007020-00006; Shahnazi Mahnaz, 2013, J Caring Sci, V2, P105, DOI 10.5681/jcs.2013.013; Shakeri F, 2015, CLIMACTERIC, V18, P568, DOI 10.3109/13697137.2014.999660; Simbalista RL, 2010, J NUTR, V140, P293, DOI 10.3945/jn.109.113886; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tanmahasamut P, 2015, CLIMACTERIC, V18, P79, DOI 10.3109/13697137.2014.933410; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Tice JA, 2003, JAMA-J AM MED ASSOC, V290, P207, DOI 10.1001/jama.290.2.207; Unfer V, 2004, FERTIL STERIL, V82, P145, DOI 10.1016/j.fertnstert.2003.11.041; Upmalis DH, 2000, MENOPAUSE, V7, P236, DOI 10.1097/00042192-200007040-00005; van de Weijer PHM, 2002, MATURITAS, V42, P187, DOI 10.1016/S0378-5122(02)00080-4; van der Sluijs CP, 2009, MENOPAUSE, V16, P336, DOI 10.1097/gme.0b013e3181883dc1; van Die MD, 2009, MENOPAUSE, V16, P156, DOI 10.1097/gme.0b013e31817fa9e0; Van Patten CL, 2002, J CLIN ONCOL, V20, P1449, DOI 10.1200/JCO.20.6.1449; Vashisht A, 2001, Climacteric, V4, P250, DOI 10.1080/713605091; Verhoeven MO, 2005, MENOPAUSE, V12, P412, DOI 10.1097/01.gme.0000170603.63022.62; Winther K, 2005, CLIMACTERIC, V8, P162, DOI 10.1080/13697130500117987; Xia Y, 2012, MENOPAUSE, V19, P234, DOI 10.1097/gme.0b013e3182273177; Yang HM, 2007, ACTA OBSTET GYN SCAN, V86, P978, DOI 10.1080/00016340701446108	91	132	137	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2554	2563		10.1001/jama.2016.8012	http://dx.doi.org/10.1001/jama.2016.8012			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27327802	Bronze			2022-12-28	WOS:000378306700019
J	Rehm, CD; Penalvo, JL; Afshin, A; Mozaffarian, D				Rehm, Colin D.; Penalvo, Jose L.; Afshin, Ashkan; Mozaffarian, Dariush			Dietary Intake Among US Adults, 1999-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; UNITED-STATES; MEAT CONSUMPTION; RISK; TRENDS; OBESITY; METAANALYSIS; NUTRIENTS; REDUCTION; STROKE	IMPORTANCE Most studies of US dietary trends have evaluated major macronutrients or only a few dietary factors. Understanding trends in summary measures of diet quality for multiple individual foods and nutrients, and the corresponding disparities among population subgroups, is crucial to identify challenges and opportunities to improve dietary intake for all US adults. OBJECTIVE To characterize trends in overall diet quality and multiple dietary components related to major diseases among US adults, including by age, sex, race/ethnicity, education, and income. DESIGN, SETTING, AND PARTICIPANTS Repeated cross-sectional investigation using 24-hour dietary recalls in nationally representative samples including 33 932 noninstitutionalized US adults aged 20 years or older from 7 National Health and Nutrition Examination Survey (NHANES) cycles (1999-2012). The sample size per cycle ranged from 4237 to 5762. EXPOSURES Calendar year and population sociodemographic subgroups. MAIN OUTCOMES AND MEASURES Survey-weighted, energy-adjusted mean consumption and proportion meeting targets of the American Heart Association (AHA) 2020 continuous diet scores, AHA score components (primary: total fruits and vegetables, whole grains, fish and shellfish, sugar-sweetened beverages, and sodium; secondary: nuts, seeds, and legumes, processed meat, and saturated fat), and other individual food groups and nutrients. RESULTS Several overall dietary improvements were identified (P < .01 for trend for each). The AHA primary diet score (maximum of 50 points) improved from 19.0 to 21.2 (an improvement of 11.6%). The AHA secondary diet score (maximum of 80 points) improved from 35.1 to 38.5 (an improvement of 9.7%). Changes were attributable to increased consumption between 1999-2000 and 2011-2012 of whole grains (0.43 servings/d; 95% CI, 0.34-0.53 servings/d) and nuts or seeds (0.25 servings/d; 95% CI, 0.18-0.34 servings/d) (fish and shellfish intake also increased slightly) and to decreased consumption of sugar-sweetened beverages (0.49 servings/d; 95% CI, 0.28-0.70 servings/d). No significant trend was observed for other score components, including total fruits and vegetables, processed meat, saturated fat, or sodium. The estimated percentage of US adults with poor diets (defined as < 40% adherence to the primary AHA diet score components) declined from 55.9% to 45.6%, whereas the percentage with intermediate diets (defined as 40% to 79.9% adherence to the primary AHA diet score components) increased from 43.5% to 52.9%. Other dietary trends included increased consumption of whole fruit (0.15 servings/d; 95% CI, 0.05-0.26 servings/d) and decreased consumption of 100% fruit juice (0.11 servings/d; 95% CI, 0.04-0.18 servings/d). Disparities in diet quality were observed by race/ethnicity, education, and income level; for example, the estimated percentage of non-Hispanic white adults with a poor diet significantly declined (53.9% to 42.8%), whereas similar improvements were not observed for non-Hispanic black or Mexican American adults. There was little evidence of reductions in these disparities and some evidence of worsening by income level. CONCLUSIONS AND RELEVANCE In nationally representative US surveys conducted between 1999 and 2012, several improvements in self-reported dietary habits were identified, with additional findings suggesting persistent or worsening disparities based on race/ethnicity, education level, and income level. These findings may inform discussions on emerging successes, areas for greater attention, and corresponding opportunities to improve the diets of individuals living in the United States.	[Rehm, Colin D.] Montefiore Med Ctr, Off Community & Populat Hlth, 111 E 210th St, Bronx, NY 10467 USA; [Rehm, Colin D.; Penalvo, Jose L.; Afshin, Ashkan; Mozaffarian, Dariush] Tufts Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA; [Afshin, Ashkan] Univ Washington, Dept Global Hlth, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), Tufts Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.	dariush.mozaffarian@tufts.edu	Penalvo, Jose L./AAA-9210-2020; REHM, COLIN D./J-1215-2019; Mozaffarian, Dariush/ABC-2822-2020	Penalvo, Jose L./0000-0003-0096-6238; REHM, COLIN D./0000-0002-7644-0040; 	National Heart, Lung, and Blood Institute [5R01HL115189]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115189] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant 5R01HL115189 from the National Heart, Lung, and Blood Institute.	Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; Aune D, 2013, EUR J EPIDEMIOL, V28, P845, DOI 10.1007/s10654-013-9852-5; Bowman S. A., USDA FOOD PATTERNS E; Bowman SA., MYPYRAMID EQUIVALENT; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cho SS, 2013, AM J CLIN NUTR, V98, P594, DOI 10.3945/ajcn.113.067629; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Ford ES, 2013, AM J CLIN NUTR, V97, P848, DOI 10.3945/ajcn.112.052662; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; Kipnis V, 2009, BIOMETRICS, V65, P1003, DOI 10.1111/j.1541-0420.2009.01223.x; Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943; Kuklina Elena V, 2013, NCHS Data Brief, P1; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Slining MM, 2013, J ACAD NUTR DIET, V113, P1683, DOI 10.1016/j.jand.2013.06.001; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; USDA, DIET GUID AM 2015 20; Wang DD, 2014, JAMA INTERN MED, V174, P1587, DOI 10.1001/jamainternmed.2014.3422; Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366; Willett W., 2013, MONOGRAPHS EPIDEMIOL, V3rd	34	384	391	8	73	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2542	2553		10.1001/jama.2016.7491	http://dx.doi.org/10.1001/jama.2016.7491			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27327801	Green Accepted, Bronze			2022-12-28	WOS:000378306700018
J	Lee, N				Lee, Naomi			The Lancet Technology: pharming blood	LANCET			English	Editorial Material												naomi.lee@lancet.com							0	1	1	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2496	2496		10.1016/S0140-6736(16)30800-5	http://dx.doi.org/10.1016/S0140-6736(16)30800-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27353675				2022-12-28	WOS:000377947200014
J	Guarente, L				Guarente, Leonard			The resurgence of NAD(+) Restoring a mitochondrial metabolite slows stem cell loss and aging	SCIENCE			English	Editorial Material							LONGEVITY; MICE		[Guarente, Leonard] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu						Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693	11	20	20	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1396	1397		10.1126/science.aag1718	http://dx.doi.org/10.1126/science.aag1718			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313027				2022-12-28	WOS:000377975400024
J	Johnson, NF; Zheng, M; Vorobyeva, Y; Gabriel, A; Qi, H; Velasquez, N; Manrique, P; Johnson, D; Restrepo, E; Song, C; Wuchty, S				Johnson, N. F.; Zheng, M.; Vorobyeva, Y.; Gabriel, A.; Qi, H.; Velasquez, N.; Manrique, P.; Johnson, D.; Restrepo, E.; Song, C.; Wuchty, S.			New online ecology of adversarial aggregates: ISIS and beyond	SCIENCE			English	Article							LEADERSHIP; NETWORKS	Support for an extremist entity such as Islamic State (ISIS) somehow manages to survive globally online despite considerable external pressure and may ultimately inspire acts by individuals having no history of extremism, membership in a terrorist faction, or direct links to leadership. Examining longitudinal records of online activity, we uncovered an ecology evolving on a daily time scale that drives online support, and we provide a mathematical theory that describes it. The ecology features self-organized aggregates (ad hoc groups formed via linkage to a Facebook page or analog) that proliferate preceding the onset of recent real-world campaigns and adopt novel adaptive mechanisms to enhance their survival. One of the predictions is that development of large, potentially potent pro-ISIS aggregates can be thwarted by targeting smaller ones.	[Johnson, N. F.; Zheng, M.; Gabriel, A.; Qi, H.; Manrique, P.; Song, C.] Univ Miami, Dept Phys, Coral Gables, FL 33126 USA; [Vorobyeva, Y.; Velasquez, N.] Univ Miami, Dept Int Studies, Coral Gables, FL 33126 USA; [Johnson, D.] Harvard Univ, Dept Govt, Cambridge, MA 02138 USA; [Restrepo, E.] Univ Miami, Dept Geog & Reg Studies, Coral Gables, FL 33126 USA; [Wuchty, S.] Univ Miami, Dept Comp Sci, Coral Gables, FL 33126 USA; [Wuchty, S.] Univ Miami, Ctr Computat Sci, Coral Gables, FL 33126 USA	University of Miami; University of Miami; Harvard University; University of Miami; University of Miami; University of Miami	Wuchty, S (corresponding author), Univ Miami, Dept Comp Sci, Coral Gables, FL 33126 USA.; Wuchty, S (corresponding author), Univ Miami, Ctr Computat Sci, Coral Gables, FL 33126 USA.	wuchtys@cs.miami.edu	Zheng, Minzhang/AAD-2861-2019	Zheng, Minzhang/0000-0003-2689-9539	Intelligence Advanced Research Projects Activity (IARPA) [D12PC00285]; National Science Foundation (NSF) [CNS1500250]; Air Force (AFOSR) grant [16RT0367]	Intelligence Advanced Research Projects Activity (IARPA); National Science Foundation (NSF)(National Science Foundation (NSF)); Air Force (AFOSR) grant	N.F.J. gratefully acknowledges partial support for preliminary work from Intelligence Advanced Research Projects Activity (IARPA) under grant D12PC00285 and recent funding under National Science Foundation (NSF) grant CNS1500250 and Air Force (AFOSR) grant 16RT0367. The views and conclusions contained herein are solely those of Me authors and do not represent official policies or endorsements by any of the entities named in this paper. Data described are presentee in an Excel file available in the supplementary materials, and code is provided in the SM document.	[Anonymous], 2020, CRIMINAL JUSTICE REV, DOI DOI 10.1177/0734016815626970; [Anonymous], 2015, BBC NEWS; Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; Berger J. M., 2016, ISLAMIC STATES DIMIN; Cadena J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128879; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Gill P, 2015, POLITICAL VIOLENCE, P1; Gill P, 2014, INT INTERACT, V40, P52, DOI 10.1080/03050629.2013.863190; Johnson N. F., 2003, FINANCIAL MARKET COM; Johnson N, 2011, SCIENCE, V333, P81, DOI 10.1126/science.1205068; Karimi F., 2015, CNN NEWS; Kenney M, 2013, APPL ERGON, V44, P739, DOI 10.1016/j.apergo.2012.05.005; King G, 2014, SCIENCE, V345, P891, DOI 10.1126/science.1251722; Koutra D., 2015, VLDB 2015; Manrique P, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS: BIG DATA, EMERGENT THREATS, AND DECISION-MAKING IN SECURITY INFORMATICS, P169, DOI 10.1109/ISI.2013.6578812; Matheny J., 2013, TEST EVALUATION ACE; Morgenstern AP, 2013, AM J PHYS, V81, P805, DOI 10.1119/1.4820892; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Perra N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.238701; Ruszczycki B, 2009, EUR PHYS J B, V72, P289, DOI 10.1140/epjb/e2009-00354-5; Shapiro J.N., 2013, TERRORISTS DILEMMA M; Smith JE, 2016, TRENDS ECOL EVOL, V31, P54, DOI 10.1016/j.tree.2015.09.013; Stanton A., 2015, ARXIV150801192V1; Subrahmanian V.S., 2013, COMPUTATIONAL ANAL T, P34; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Weiss, 2015, ISIS INSIDE ARMY TER; Wrangham RW, 2012, HUM NATURE-INT BIOS, V23, P5, DOI 10.1007/s12110-012-9132-1; Zhao Q., 2015, ACM SIGKDD INT C KNO; Zhao ZY, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056107	29	61	66	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1459	1463		10.1126/science.aaf0675	http://dx.doi.org/10.1126/science.aaf0675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313046	Green Submitted			2022-12-28	WOS:000377975400049
J	Landau, S				Landau, Susan			The real security issues of the iPhone case Law enforcement needs 21st-century investigative savvy	SCIENCE			English	Editorial Material									[Landau, Susan] Worcester Polytech Inst, Worcester, MA 01690 USA	Worcester Polytechnic Institute	Landau, S (corresponding author), Worcester Polytech Inst, Worcester, MA 01690 USA.	susan.landau@privacyink.org						Abelson H, 2015, J CYBERSECURITY, V1, P69, DOI 10.1093/cybsec/tyv009; [Anonymous], 2016, ENCR PRIV AR LARG IS; Apuzzo M., 2016, NY TIMES, pB1; Bellovin S. M., 2014, NW J TECH INTELL PRO, V12, P1; Comey J. B., 2014, GOING DARK ARE TECHN; Cross T., 2010, BLACK HAT DC 2010; Daniels M., 2014, HEARTBLEED UNDERSTAN; Department of Homeland Security, 2016, AL IR AL H 16 056 01; Duo Security, 2016, FAC SEC PHIL DUO HEL; Federal Bureau of Investigation, 2016, FY 2017 BUDG REQ GLA; Hayden M., 2016, GEN M HAYDEN APPL FB; Hersh Seymour, 1999, NEW YORKER; Joyce Robert, 2016, COMMUNICATION; Landau S., 2013, J TELECOMMUNICATIONS, V11, P1; McConnell M, 2015, WASHINGTON POST; Nakashima E., 2016, WASHINGTON POST; Perez S., 2015, TECHCRUNCH; Prevelakis V, 2007, IEEE SPECTRUM, V44, P26, DOI 10.1109/MSPEC.2007.376605; Thompson II R. M., 2016, R44407 C RES SERV; Vijayakumar, 2016, WORLDWIDE SURVEY ENC; Zdziarski J., 2016, COMMUNICATION	21	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1398	1399		10.1126/science.aaf7708	http://dx.doi.org/10.1126/science.aaf7708			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO7PV	27313028				2022-12-28	WOS:000377975400025
J	Dalton, J; Proops, DW				Dalton, J.; Proops, D. W.			George Allen Dalton OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		DALTON GA, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2016	353								i3331	10.1136/bmj.i3331	http://dx.doi.org/10.1136/bmj.i3331			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HJ	27311584				2022-12-28	WOS:000378240800006
J	Snippert, HJ				Snippert, Hugo J.			Colonic Crypts: Safe Haven from Microbial Products	CELL			English	Editorial Material							HOMEOSTASIS; INTESTINE	The notion that the colon's deep crypt pockets provide a protected location that shields stem cells from potentially toxic substances is widely accepted. In this issue of Cell, Kaiko et al. reveal how a metabolite abundantly produced by the gut microbiota can inhibit stem cell proliferation but is blocked from doing so by crypt architecture.	[Snippert, Hugo J.] Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Snippert, HJ (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, NL-3584 CX Utrecht, Netherlands.	h.j.g.snippert@umcutrecht.nl						ALAM M, 1994, SCAND J GASTROENTERO, V29, P445, DOI 10.3109/00365529409096836; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; FRANKEL WL, 1994, GASTROENTEROLOGY, V106, P375, DOI 10.1016/0016-5085(94)90595-9; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Vermeulen L, 2014, NAT REV CANCER, V14, P468, DOI 10.1038/nrc3744	8	3	3	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1564	1566		10.1016/j.cell.2016.06.003	http://dx.doi.org/10.1016/j.cell.2016.06.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315471	Bronze			2022-12-28	WOS:000378062000006
J	Larocca, RA; Abbink, P; Peron, JPS; Zanotto, PMD; Iampietro, MJ; Badamchi-Zadeh, A; Boyd, M; Ng'ang'a, D; Kirilova, M; Nityanandam, R; Mercado, NB; Li, ZF; Moseley, ET; Bricault, CA; Borducchi, EN; Giglio, PB; Jetton, D; Neubauer, G; Nkolola, JP; Maxfield, LF; De La Barrera, RA; Jarman, RG; Eckels, KH; Michael, NL; Thomas, SJ; Barouch, DH				Larocca, Rafael A.; Abbink, Peter; Peron, Jean Pierre S.; Zanotto, Paolo M. de A.; Iampietro, M. Justin; Badamchi-Zadeh, Alexander; Boyd, Michael; Ng'ang'a, David; Kirilova, Marinela; Nityanandam, Ramya; Mercado, Noe B.; Li, Zhenfeng; Moseley, Edward T.; Bricault, Christine A.; Borducchi, Erica N.; Giglio, Patricia B.; Jetton, David; Neubauer, George; Nkolola, Joseph P.; Maxfield, Lori F.; De La Barrera, Rafael A.; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.; Barouch, Dan H.			Vaccine protection against Zika virus from Brazil	NATURE			English	Article							NEUTRALIZING ANTIBODY; HEALTHY-ADULTS; CHALLENGE; IMMUNOGENICITY; INFECTION; AMERICA; SAFETY; MODEL; MICE	Zika virus (ZIKV) is a flavivirus that is responsible for the current epidemic in Brazil and the Americas(1,2). ZIKV has been causally associated with fetal microcephaly, intrauterine growth restriction, and other birth defects in both humans(3-8) and mice(9-11). The rapid development of a safe and effective ZIKV vaccine is a global health priority(1,2), but very little is currently known about ZIKV immunology and mechanisms of immune protection. Here we show that a single immunization with a plasmid DNA vaccine or a purified inactivated virus vaccine provides complete protection in susceptible mice against challenge with a strain of ZIKV involved in the outbreak in northeast Brazil. This ZIKV strain has recently been shown to cross the placenta and to induce fetal microcephaly and other congenital malformations in mice(11). We produced DNA vaccines expressing ZIKV pre-membrane and envelope (prM-Env), as well as a series of deletion mutants. The prM-Env DNA vaccine, but not the deletion mutants, afforded complete protection against ZIKV, as measured by absence of detectable viraemia following challenge, and protective efficacy correlated with Env-specific antibody titers. Adoptive transfer of purified IgG from vaccinated mice conferred passive protection, and depletion of CD4 and CD8 T lymphocytes in vaccinated mice did not abrogate this protection. These data demonstrate that protection against ZIKV challenge can be achieved by single-shot subunit and inactivated virus vaccines in mice and that Env-specific antibody titers represent key immunologic correlates of protection. Our findings suggest that the development of a ZIKV vaccine for humans is likely to be achievable.	[Larocca, Rafael A.; Abbink, Peter; Iampietro, M. Justin; Badamchi-Zadeh, Alexander; Boyd, Michael; Ng'ang'a, David; Kirilova, Marinela; Nityanandam, Ramya; Mercado, Noe B.; Li, Zhenfeng; Moseley, Edward T.; Bricault, Christine A.; Borducchi, Erica N.; Giglio, Patricia B.; Jetton, David; Neubauer, George; Nkolola, Joseph P.; Maxfield, Lori F.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Peron, Jean Pierre S.; Zanotto, Paolo M. de A.] Univ Sao Paulo, BR-05508000 Sao Paulo, Brazil; [De La Barrera, Rafael A.; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade de Sao Paulo; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	dbarouch@bidmc.harvard.edu	Peron, Jean Pierre S/F-9248-2012; de A. Zanotto, Paolo M./B-9286-2019; Barouch, Dan/Y-3918-2019; Mercado, Noe/ABE-8247-2020	de A. Zanotto, Paolo M./0000-0002-8167-0625; Jetton, David/0000-0002-1615-9986; Maxfield, Lori/0000-0002-7595-6205; Thomas, Stephen/0000-0002-8368-7682; Mercado, Noe/0000-0001-7769-7326; Peron, Jean Pierre/0000-0003-1638-8866	Ragon Institute of MGH, MIT, and Harvard; National Institutes of Health [AI095985, AI096040, AI100663, AI124377]; Sao Paulo Research Foundation [FAPESP 2011/18703-2, 2014/17766-9]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, UM1AI124377, U19AI095985, U19AI096040] Funding Source: NIH RePORTER	Ragon Institute of MGH, MIT, and Harvard; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Vasconcelos, K. Modjarrad, R. Olson, K. Kabra, C. Kannadka, C. Springer, G. Ballarini, G. Alter, K. Stephenson, F. Stephens, B. Lee, J. Jimenez, A. Chandrashekar, P. Penaloza and C. Cabral for generous advice, assistance and reagents. We acknowledge support from the Ragon Institute of MGH, MIT, and Harvard, the National Institutes of Health (AI095985, AI096040, AI100663, AI124377), and the Sao Paulo Research Foundation (FAPESP 2011/18703-2, 2014/17766-9). The views expressed in this manuscript are those of the authors and do not represent the official views of the Department of the Army or the Department of Defense.	Brasil P., 2016, N ENGL J MED; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; DEMICHELI V, 2000, COCHRANE DB SYST REV; Demicheli V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000977.pub2; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650; Martinez LJ, 2015, AM J TROP MED HYG, V93, P454, DOI 10.4269/ajtmh.14-0819; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Tartaglia LJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005431; Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361	30	371	417	0	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					474	+		10.1038/nature18952	http://dx.doi.org/10.1038/nature18952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27355570	Green Submitted, Green Accepted			2022-12-28	WOS:000382646600045
J	Bland, SE; Crowley, JS; Gostin, LO				Bland, Sean E.; Crowley, Jeffrey S.; Gostin, Lawrence O.			Strategies for Health System Innovation After Gobeille v LibertyMutual Insurance Company	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bland, Sean E.; Crowley, Jeffrey S.; Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				BROWN EF, 2016, HLTH AFFAIRS BLOG; Claxton G, 2015, HEALTH AFFAIR, V34, P1779, DOI 10.1377/hlthaff.2015.0885; Wilson J., 2012, OPTUM INSIGHT, V1, P1	3	6	6	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					581	582		10.1001/jama.2016.8293	http://dx.doi.org/10.1001/jama.2016.8293			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27367856				2022-12-28	WOS:000380985600007
J	Balchin, D; Hayer-Hartl, M; Hartl, FU				Balchin, David; Hayer-Hartl, Manajit; Hartl, F. Ulrich			In vivo aspects of protein folding and quality control	SCIENCE			English	Review							EUKARYOTIC CHAPERONIN TRIC/CCT; HSP90 MOLECULAR CHAPERONE; REAL-TIME OBSERVATION; HSP70 CHAPERONE; TRIGGER FACTOR; NEURODEGENERATIVE DISEASES; CONFORMATIONAL DYNAMICS; SUBSTRATE RECOGNITION; MISFOLDED PROTEINS; NASCENT CHAIN	Most proteins must fold into unique three-dimensional structures to perform their biological functions. In the crowded cellular environment, newly synthesized proteins are at risk of misfolding and forming toxic aggregate species. To ensure efficient folding, different classes of molecular chaperones receive the nascent protein chain emerging from the ribosome and guide it along a productive folding pathway. Because proteins are structurally dynamic, constant surveillance of the proteome by an integrated network of chaperones and protein degradation machineries is required to maintain protein homeostasis (proteostasis). The capacity of this proteostasis network declines during aging, facilitating neurodegeneration and other chronic diseases associated with protein aggregation. Understanding the proteostasis network holds the promise of identifying targets for pharmacological intervention in these pathologies.	[Balchin, David; Hayer-Hartl, Manajit; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany	Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742; Balchin, David/0000-0002-5000-0995	European Molecular Biology Organization long-term fellowship [ALTF 1116-2014]; European Research Council Advanced Grant; Center for Integrated Protein Science Munich (CiPSM); Munich Cluster for Systems Neurology (SyNergy); Minerva Foundation; Proteostasis Therapeutics, Inc.	European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); European Research Council Advanced Grant(European Research Council (ERC)); Center for Integrated Protein Science Munich (CiPSM); Munich Cluster for Systems Neurology (SyNergy); Minerva Foundation; Proteostasis Therapeutics, Inc.	This Review focuses mainly on original publications of the last 15 years. We apologize to all colleagues whose work could not be cited owing to space limitations. We thank G. Jayaraj for bioinformatics analyses and members of the group for critically reading the manuscript. Work in the authors' laboratory was supported by a European Molecular Biology Organization long-term fellowship to D.B. (ALTF 1116-2014), a European Research Council Advanced Grant (to F.U.H.), the Center for Integrated Protein Science Munich (CiPSM), and the Munich Cluster for Systems Neurology (SyNergy). M.H.-H. acknowledges funding by the Minerva Foundation. F.U.H. holds stock options in, receives consulting fees from, and is the chair of the scientific advisory board of Proteostasis Therapeutics, Inc.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baranczak A, 2016, CURR OPIN CHEM BIOL, V32, P10, DOI 10.1016/j.cbpa.2016.01.009; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Boczek EE, 2015, P NATL ACAD SCI USA, V112, pE3189, DOI 10.1073/pnas.1424342112; Borgia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9861; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Brandt F, 2010, MOL CELL, V39, P560, DOI 10.1016/j.molcel.2010.08.003; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Breydo L, 2015, FEBS LETT, V589, P2640, DOI 10.1016/j.febslet.2015.07.013; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Cabrita LD, 2016, NAT STRUCT MOL BIOL, V23, P278, DOI 10.1038/nsmb.3182; Calabretta S, 2015, TRENDS BIOCHEM SCI, V40, P662, DOI 10.1016/j.tibs.2015.08.012; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chari A, 2010, TRENDS BIOCHEM SCI, V35, P676, DOI 10.1016/j.tibs.2010.07.006; Chiabudini M, 2012, MOL CELL BIOL, V32, P4769, DOI 10.1128/MCB.00809-12; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choe YJ, 2016, NATURE, V531, P191, DOI 10.1038/nature16973; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cooley CB, 2014, P NATL ACAD SCI USA, V111, P13046, DOI 10.1073/pnas.1406050111; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; De Los Rios P, 2014, ELIFE, V3, DOI 10.7554/eLife.02218; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Falsone SF, 2012, CELL REP, V2, P358, DOI 10.1016/j.celrep.2012.06.012; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Gamerdinger M, 2015, SCIENCE, V348, P201, DOI 10.1126/science.aaa5335; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Georgescauld F, 2014, CELL, V157, P922, DOI 10.1016/j.cell.2014.03.038; Gershenson A, 2014, NAT CHEM BIOL, V10, P884, DOI 10.1038/nchembio.1670; Gruber R, 2016, CHEM REV, V116, P6588, DOI 10.1021/acs.chemrev.5b00556; Gupta AJ, 2014, J MOL BIOL, V426, P2739, DOI 10.1016/j.jmb.2014.04.018; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hauser T, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.65, 10.1038/nplants.2015.65]; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Hill SM, 2014, SCIENCE, V344, P1389, DOI 10.1126/science.1252634; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Holtkamp W, 2015, SCIENCE, V350, P1104, DOI 10.1126/science.aad0344; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Joachimiak LA, 2014, CELL, V159, P1042, DOI 10.1016/j.cell.2014.10.042; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kakkar V, 2016, MOL CELL, V62, P272, DOI 10.1016/j.molcel.2016.03.017; Kalisman N, 2013, STRUCTURE, V21, P540, DOI 10.1016/j.str.2013.01.017; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kosolapov A, 2009, NAT STRUCT MOL BIOL, V16, P405, DOI 10.1038/nsmb.1571; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee JH, 2015, P NATL ACAD SCI USA, V112, pE4206, DOI 10.1073/pnas.1505173112; Leitman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090803; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li J, 2011, NAT STRUCT MOL BIOL, V18, P61, DOI 10.1038/nsmb.1965; Li X., 2016, CURR TOP MED CHEM; Li Z, 2013, NAT STRUCT MOL BIOL, V20, P929, DOI 10.1038/nsmb.2608; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lindquist S, 2009, COLD SH Q B, V74, P103, DOI 10.1101/sqb.2009.74.043; Lopez T, 2015, J MOL BIOL, V427, P2919, DOI 10.1016/j.jmb.2015.04.013; Mallam AL, 2012, NAT CHEM BIOL, V8, P147, DOI 10.1038/nchembio.742; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Mendez AS, 2015, ELIFE, V4, DOI 10.7554/eLife.05434; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Mogk A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00022; Mohammad F, 2016, CELL REP, V14, P686, DOI 10.1016/j.celrep.2015.12.073; Morgner N, 2015, CELL REP, V11, P759, DOI 10.1016/j.celrep.2015.03.063; Nagy M, 2016, P NATL ACAD SCI USA, V113, P5424, DOI 10.1073/pnas.1604885113; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884; Nilsson OB, 2016, J MOL BIOL, V428, P1356, DOI 10.1016/j.jmb.2016.02.014; Nilsson OB, 2015, CELL REP, V12, P1533, DOI 10.1016/j.celrep.2015.07.065; Nunes JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7307; O'Brien EP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3988; O'Brien EP, 2011, J AM CHEM SOC, V133, P513, DOI 10.1021/ja107863z; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Oromendia AB, 2014, DIS MODEL MECH, V7, P15, DOI 10.1242/dmm.013391; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Plimpton RL, 2015, P NATL ACAD SCI USA, V112, P2413, DOI 10.1073/pnas.1419595112; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Pratt WB, 2015, ANNU REV PHARMACOL, V55, P353, DOI 10.1146/annurev-pharmtox-010814-124332; Preissler S, 2015, EMBO J, V34, P1905, DOI 10.15252/embj.201490194; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Reissmann S, 2012, CELL REP, V2, P866, DOI 10.1016/j.celrep.2012.08.036; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Rivenzon-Segal D, 2005, NAT STRUCT MOL BIOL, V12, P233, DOI 10.1038/nsmb901; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Rubinsztein DC, 2015, J EXP MED, V212, P979, DOI 10.1084/jem.20150956; Russmann F, 2012, P NATL ACAD SCI USA, V109, P21208, DOI 10.1073/pnas.1218836109; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Schinzel R, 2015, CURR OPIN CELL BIOL, V33, P102, DOI 10.1016/j.ceb.2015.01.006; Scholl ZN, 2014, J BIOL CHEM, V289, P28607, DOI 10.1074/jbc.M114.582049; Schulz AM, 2015, BBA-BIOENERGETICS, V1847, P1448, DOI 10.1016/j.bbabio.2015.03.008; Sekhar A, 2016, P NATL ACAD SCI USA, V113, pE2794, DOI 10.1073/pnas.1601846113; Sekhar A, 2015, P NATL ACAD SCI USA, V112, P10395, DOI 10.1073/pnas.1508504112; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Shieh YW, 2015, SCIENCE, V350, P678, DOI 10.1126/science.aac8171; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Sikor M, 2013, EMBO J, V32, P1639, DOI 10.1038/emboj.2013.89; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Street TO, 2014, J MOL BIOL, V426, P2393, DOI 10.1016/j.jmb.2014.04.001; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Taguchi H, 2015, J MOL BIOL, V427, P2912, DOI 10.1016/j.jmb.2015.04.007; Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Weaver J, 2014, J BIOL CHEM, V289, P23219, DOI 10.1074/jbc.M114.577205; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Yonashiro R, 2016, ELIFE, V5, DOI 10.7554/eLife.11794; Zhang HQ, 2015, STRUCTURE, V23, P472, DOI 10.1016/j.str.2015.01.003; Zhang Y, 2012, MOL BIOL CELL, V23, P3027, DOI 10.1091/mbc.E12-02-0112; Zhang YX, 2014, NAT STRUCT MOL BIOL, V21, P1042, DOI 10.1038/nsmb.2908; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; Zhuravleva A, 2015, P NATL ACAD SCI USA, V112, pE2865, DOI 10.1073/pnas.1506692112	187	739	749	23	510	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294							aac4354	10.1126/science.aac4354	http://dx.doi.org/10.1126/science.aac4354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365453	Green Submitted			2022-12-28	WOS:000378816200028
J	Cappell, SD; Chung, MY; Jaimovich, A; Spencer, SL; Meyer, T				Cappell, Steven D.; Chung, Mingyu; Jaimovich, Ariel; Spencer, Sabrina L.; Meyer, Tobias			Irreversible APC(Cdh1) Inactivation Underlies the Point of No Return for Cell-Cycle Entry	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; RESTRICTION POINT; PHASE; PROLIFERATION; DEGRADATION; QUIESCENCE; DYNAMICS; DECISION; SPINDLE; KINASE	Proliferating cells must cross a point of no return before they replicate their DNA and divide. This commitment decision plays a fundamental role in cancer and degenerative diseases and has been proposed to be mediated by phosphorylation of retinoblastoma (Rb) protein. Here, we show that inactivation of the anaphase-promoting complex/cyclosome (APC(Cdh1)) has the necessary characteristics to be the point of no return for cell-cycle entry. Our study shows that APC(Cdh1) inactivation is a rapid, bistable switch initiated shortly before the start of DNA replication by cyclin E/Cdk2 and made irreversible by Emi1. Exposure to stress between Rb phosphorylation and APC(Cdh1) inactivation, but not after APC(Cdh1) inactivation, reverted cells to a mitogen-sensitive quiescent state, from which they can later re-enter the cell cycle. Thus, APC(Cdh1) inactivation is the commitment point when cells lose the ability to return to quiescence and decide to progress through the cell cycle.	[Cappell, Steven D.; Chung, Mingyu; Jaimovich, Ariel; Spencer, Sabrina L.; Meyer, Tobias] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Spencer, Sabrina L.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Stanford University; University of Colorado System; University of Colorado Boulder	Cappell, SD; Meyer, T (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	scappell@stanford.edu; tobias1@stanford.edu	Cappell, Steven/O-4072-2018	Cappell, Steven/0000-0002-2885-7327; Chung, Mingyu/0000-0003-1718-6203; Meyer, Tobias/0000-0003-4339-3804; SPENCER, SABRINA/0000-0002-5798-3007	Damon Runyon Cancer Research Foundation [DRG-2141-12, DRG-2043-10]; American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship [PF-13-304-01-CCG]; NIH [GM118377, GM030179, P50GM107615]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118377, P50GM107615, R01GM030179] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Hee Wong Yang, Jia-yun Chen, Sean Collins, Feng-Chiao Tsai, Sam Bandara, Nalin Ratnayeke, Roy Wollman, Karlene Cimprich, James Ferrell, and Charles Sherr for helpful discussions, Philipp Kaldis for supplying the Cdk2<SUP>-/-</SUP> MEFs, and the Stanford Shared FACS Facility for cell sorting. S.D.C. and S.L.S. were supported by the Damon Runyon Cancer Research Foundation (DRG-2141-12 and DRG-2043-10). S.L.S. was also supported by an American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship (PF-13-304-01-CCG). T.M. was supported by NIH grants GM118377, GM030179, and P50GM107615.	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Borel F, 2002, J CELL SCI, V115, P2829; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Eguren M, 2011, SEMIN CELL DEV BIOL, V22, P572, DOI 10.1016/j.semcdb.2011.03.010; Erol A, 2011, CELL CYCLE, V10, P3239, DOI 10.4161/cc.10.19.17460; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Floyd S, 2008, CURR BIOL, V18, P1649, DOI 10.1016/j.cub.2008.09.058; Fukushima H, 2013, CELL REP, V4, P803, DOI 10.1016/j.celrep.2013.07.031; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; PlanasSilva MD, 1997, CURR OPIN CELL BIOL, V9, P768, DOI 10.1016/S0955-0674(97)80076-2; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sigl R, 2009, J CELL SCI, V122, P4208, DOI 10.1242/jcs.054197; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Walker A, 2008, J CELL SCI, V121, P2319, DOI 10.1242/jcs.031591; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xu LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034616; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yuan X, 2014, MOL BIOL CELL, V25, P441, DOI 10.1091/mbc.E13-08-0480; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	37	119	120	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					167	180		10.1016/j.cell.2016.05.077	http://dx.doi.org/10.1016/j.cell.2016.05.077			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368103	Bronze, Green Accepted			2022-12-28	WOS:000380254400019
J	Gauntlett, J				Gauntlett, Jerome			Thomas Kibble (1932-2016) Theoretical physicist and Higgs-boson pioneer. OBITUARY	NATURE			English	Biographical-Item									[Gauntlett, Jerome] Univ London Imperial Coll Sci Technol & Med, Theoret Phys, London SW7 2AZ, England	Imperial College London	Gauntlett, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Theoret Phys, London SW7 2AZ, England.	j.gauntlett@imperial.ac.uk		Gauntlett, Jerome/0000-0001-6622-7812	STFC [ST/L00044X/1] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		KIBBLE TWB, PUBLICATION LIST	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					622	622		10.1038/534622a	http://dx.doi.org/10.1038/534622a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357788				2022-12-28	WOS:000378676000021
J	Rogelj, J; den Elzen, M; Hohne, N; Fransen, T; Fekete, H; Winkler, H; Chaeffer, RS; Ha, F; Riahi, K; Meinshausen, M				Rogelj, Joeri; den Elzen, Michel; Hoehne, Niklas; Fransen, Taryn; Fekete, Hanna; Winkler, Harald; Chaeffer, Roberto S.; Ha, Fus; Riahi, Keywan; Meinshausen, Malte			Paris Agreement climate proposals need a boost to keep warming well below 2 degrees C	NATURE			English	Article							GREENHOUSE-GAS EMISSIONS; CO2 EMISSIONS; TARGETS; TECHNOLOGY; SCENARIOS	The Paris climate agreement aims at holding global warming to well below 2 degrees Celsius and to "pursue efforts" to limit it to 1.5 degrees Celsius. To accomplish this, countries have submitted Intended Nationally Determined Contributions (INDCs) outlining their post-2020 climate action. Here we assess the effect of current INDCs on reducing aggregate greenhouse gas emissions, its implications for achieving the temperature objective of the Paris climate agreement, and potential options for overachievement. The INDCs collectively lower greenhouse gas emissions compared to where current policies stand, but still imply a median warming of 2.6-3.1 degrees Celsius by 2100. More can be achieved, because the agreement stipulates that targets for reducing greenhouse gas emissions are strengthened over time, both in ambition and scope. Substantial enhancement or over-delivery on current INDCs by additional national, sub-national and non-state actions is required to maintain a reasonable chance of meeting the target of keeping warming well below 2 degrees Celsius.	[Rogelj, Joeri; Riahi, Keywan] Int Inst Appl Syst Anal, ENE Program, A-2361 Laxenburg, Austria; [Rogelj, Joeri] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland; [den Elzen, Michel] PBL Netherlands Environm Assessment Agcy, Bilthoven, Netherlands; [Hoehne, Niklas; Fekete, Hanna] NewClimate Inst, Cologne, Germany; [Hoehne, Niklas] Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands; [Fransen, Taryn] World Resources Inst, Washington, DC 20006 USA; [Winkler, Harald] Univ Cape Town, Energy Res Ctr, ZA-7925 Cape Town, South Africa; [Chaeffer, Roberto S.] Univ Fed Rio de Janeiro COPPE UFRJ, Rio De Janeiro, Brazil; [Ha, Fus] Natl Ctr Climate Change Strategy & Int Cooperat, Beijing, Peoples R China; [Riahi, Keywan] Graz Univ Technol, A-8010 Graz, Austria; [Meinshausen, Malte] Univ Melbourne, Australian German Climate & Energy Coll, Sch Earth Sci, Melbourne, Vic, Australia; [Meinshausen, Malte] Potsdam Inst Climate Impact Res PIK, PRIMAP Grp, Potsdam, Germany	International Institute for Applied Systems Analysis (IIASA); Swiss Federal Institutes of Technology Domain; ETH Zurich; Wageningen University & Research; University of Cape Town; Graz University of Technology; University of Melbourne; Potsdam Institut fur Klimafolgenforschung	den Elzen, M (corresponding author), PBL Netherlands Environm Assessment Agcy, Bilthoven, Netherlands.; Hohne, N (corresponding author), NewClimate Inst, Cologne, Germany.; Hohne, N (corresponding author), Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands.	Michel.denElzen@pbl.nl; n.hoehne@newclimate.org	Riahi, Keywan/B-6426-2011; Höhne, Niklas/AAZ-2422-2020; Höhne, Niklas/L-8971-2013; Meinshausen, Malte/A-7037-2011; Elzen, Michel den/AAM-8272-2021; Winkler, Harald/AAF-6226-2020; Rogelj, Joeri/I-7108-2012; Schaeffer, Roberto/F-9262-2012; Schaeffer, Roberto/AAY-4357-2020; Meinshausen, Malte/AAG-7985-2019; Meinshausen, Malte/AAG-6505-2019; Elzen, Michel den/M-2779-2016	Riahi, Keywan/0000-0001-7193-3498; Höhne, Niklas/0000-0001-9246-8759; Meinshausen, Malte/0000-0003-4048-3521; Elzen, Michel den/0000-0002-5128-8150; Rogelj, Joeri/0000-0003-2056-9061; Schaeffer, Roberto/0000-0002-3709-7323; Meinshausen, Malte/0000-0003-4048-3521; Elzen, Michel den/0000-0002-5128-8150; Fekete, Hanna/0000-0002-5273-9347; fu, sha/0000-0002-8061-0348; Winkler, Harald/0000-0002-5826-4071	European Union [642147]; Australian Research Council (ARC) [FT130100809]	European Union(European Commission); Australian Research Council (ARC)(Australian Research Council)	We thank all involved in the UNEP Emissions Gap Report, in particular J. McGlade, J. Alcamo and B. Metz, the members of the steering committee, all its authors, and the secretariat at UNEP-DTU, in particular A. Olhoff and J. Christensen. We acknowledge and are grateful for the data contributions of, and discussion with, all the global and national modelling groups, in particular M. Rocha, B. Hare, M. Schaeffer (Climate Analytics, Germany, Climate Action Tracker), L. Jeffery (PIK, Germany, Climate Action Tracker), P van Breevoort (Ecofys, The Netherlands, Climate Action Tracker), A. Admiraal, M. Roelfsema, H. van Soest (PBL, The Netherlands), N. Forsell (IIASA, Austria), L. Cozzi, F. Kesicke (IEA, France), J. Cranston Turner, R. Boyd (LSE, UK), S. Dockweiler (DEA, Denmark), L. Siegel, E. Sawin (Climate Interactive, USA), A. Kitous, K. Keramidas, G. Grassi (JRC, European Commission). G. Iyer (PNNL, USA), and the UNFCCC Secretariat. Without their contributions, this Perspective would have had a much more limited data basis, We thank S. Sterl (NewClimate Institute, Germany) and M. Roelfsema (PBL, The Netherlands) for assistance with data analysis, M. Strubegger (IIASA, Austria) for providing load factor estimates, V. Krey and O. Fricko (IIASA, Austria) for providing capture efficiencies for negative emissions technologies, and J. Cook for critical feedback on the manuscript and figures. We acknowledge and thank the International Institute for Applied Systems Analysis (IIASA) for hosting and maintaining the IPCC AR5 Scenario Database. J.R., N.H. and K.R. received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No, 642147 (CD-LINKS). M.M. is the recipient of an Australian Research Council (ARC) Future Fellowship (grant number FT130100809).	Admiraal A., 2015, 1879 PBL; Armstrong J. S., 2012, FORECASTING DICT; Blanco G, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P351; Blok K, 2012, NAT CLIM CHANGE, V2, P471, DOI 10.1038/nclimate1602; Boden T. A., 2013, GLOBAL REGIONAL NATL, DOI [10.3334/CDIAC/00001_V2013, DOI 10.3334/CDIAC/00001_V2013]; Boyd R., 2015, INTENDED NATL DETERM; Cames M., 2015, DIR GEN INT POLICIES; Clarke L, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P413; Climate Analytics Ecofys NewClimate Institute & PIK, 2015, CLIM PLEDG WILL BRIN; Climate Interactive, 2015, CLIM SCOR; Coelho ST, 2012, GLOBAL ENERGY ASSESS, P1459, DOI DOI 10.1017/CB09780511793677.026; Creutzig F, 2015, GCB BIOENERGY, V7, P916, DOI 10.1111/gcbb.12205; Cronin C., 2015, FASTER CLEANER DECAR; Damassa T., 2015, WORKING PAPER; Day T., 2015, PREPARATION INTENDED; DEA, 2015, AN 2030 EM GAP; den Elzen M., 2015, 1631 PBL; den Elzen M, 2016, ENERG POLICY, V89, P224, DOI 10.1016/j.enpol.2015.11.030; Eom J, 2015, TECHNOL FORECAST SOC, V90, P73, DOI 10.1016/j.techfore.2013.09.017; Fawcett AA, 2015, SCIENCE, V350, P1168, DOI 10.1126/science.aad5761; Fekete H., 2015, IMPACT GOOD PRACTICE; Friedlingstein P, 2014, NAT GEOSCI, V7, P709, DOI [10.1038/NGEO2248, 10.1038/ngeo2248]; Global Wind Energy Council, 2015, GLOB STAT; Grassi G, 2015, 27561 EUR, DOI 10.2788/096422; Hsu A, 2015, NAT CLIM CHANGE, V5, P501, DOI 10.1038/nclimate2594; ICAO, 2014, 10022 ICAO; IEA, 2014, WORLD EN OUTL 2014; IEA-International Energy Agency, 2015, WORLD EN OUTL 2015; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; IPCC, 2014, CONTRIBUTION WORKING; IPCC, 2005, IPCC SPECIAL REPORT; IPCC, 2011, SPEC REP REN EN SOUR; IPCC, 2013, CLIMATE CHANGE 2022; Iyer GC, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125002; Iyer GC, 2015, NAT CLIM CHANGE, V5, P436, DOI [10.1038/NCLIMATE2553, 10.1038/nclimate2553]; JRC/PBL, 2014, EDGAR VERS 4 2FT2012; Kitous A., 2015, ANAL SCENARIOS INTEG, P1; Knutti R, 2016, NAT GEOSCI, V9, P13, DOI 10.1038/NGEO2595; Knutti R, 2015, CLIMATIC CHANGE, V133, P361, DOI 10.1007/s10584-015-1340-3; Kriegler E, 2015, TECHNOL FORECAST SOC, V90, P24, DOI 10.1016/j.techfore.2013.09.021; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P349, DOI 10.5194/essd-7-349-2015; Luderer G, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034033; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Meinshausen M., 2015, INDC FACTSHEETS; Meinshausen M, 2015, NAT CLIM CHANGE, V5, P1098, DOI [10.1038/NCLIMATE2826, 10.1038/nclimate2826]; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Obersteiner M, 2001, SCIENCE, V294, P786; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Randalls S, 2010, WIRES CLIM CHANGE, V1, P598, DOI 10.1002/wcc.62; Riahi K, 2015, TECHNOL FORECAST SOC, V90, P8, DOI 10.1016/j.techfore.2013.09.016; Roehrl RA, 2000, TECHNOL FORECAST SOC, V63, P231, DOI 10.1016/S0040-1625(99)00112-2; Roelfsema M., 2015, 1188 PBL; Rogelj J, 2016, NAT GEOSCI, V9, P187, DOI 10.1038/ngeo2668; Rogelj J, 2016, NAT CLIM CHANGE, V6, P245, DOI 10.1038/NCLIMATE2868; Rogelj J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/10/105007; Rogelj J, 2015, NAT CLIM CHANGE, V5, P519, DOI 10.1038/nclimate2572; Rogelj J, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/031003; Rogelj J, 2013, NAT CLIM CHANGE, V3, P405, DOI [10.1038/nclimate1758, 10.1038/NCLIMATE1758]; Rogelj J, 2013, NATURE, V493, P79, DOI 10.1038/nature11787; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Rogelj J, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024002; Scott V, 2015, NAT CLIM CHANGE, V5, P419, DOI 10.1038/NCLIMATE2578; Sha F, 2015, ANAL CHINAS INDC; Smith P, 2016, NAT CLIM CHANGE, V6, P42, DOI [10.1038/NCLIMATE2870, 10.1038/nclimate2870]; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; SolarPower Europe, 2015, GLOB MARK OUTL SOL P; UNEP, 2015, DEW1917NA UNEP; UNEP, 2015, EM GAP REP 2015; UNFCCC, 2015, FCCCCP20157; UNFCCC, 2015, INDCS COMM PART; UNFCCC, 2015, ADOPTION PARIS AGREE; UNFCCC, 1992, FCCCINFORMAL84; UNFCCC, 2002, FCCCCP20028, P7; Upham P, 2011, INT J GREENH GAS CON, V5, P1359, DOI 10.1016/j.ijggc.2011.06.005; Weischer Lutz, 2012, REV EUROPEAN COMMUNI, V21, P177, DOI DOI 10.1111/REEL.12007; World Resources Institute, 2015, PAR CONTR MAP	78	1614	1672	132	1011	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					631	639		10.1038/nature18307	http://dx.doi.org/10.1038/nature18307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357792	Green Accepted			2022-12-28	WOS:000378676000026
J	Cole, TB				Cole, Thomas B.			The Bright Side Winslow Homer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2650	2651		10.1001/jama.2015.14333	http://dx.doi.org/10.1001/jama.2015.14333			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27367757				2022-12-28	WOS:000378709300001
J	Greene, JD				Greene, Joshua D.			Our driverless dilemma When should your car be willing to kill you?	SCIENCE			English	Editorial Material									[Greene, Joshua D.] Harvard Univ, Dept Psychol, Ctr Brain Sci, 33 Kirkland St, Cambridge, MA 02138 USA	Harvard University	Greene, JD (corresponding author), Harvard Univ, Dept Psychol, Ctr Brain Sci, 33 Kirkland St, Cambridge, MA 02138 USA.	jgreene@wjh.harvard.edu						[Anonymous], 2010, MORAL MACHINES TEACH; Asimov I., 2004, I ROBOT; Bonnefon JF, 2016, SCIENCE, V352, P1573, DOI 10.1126/science.aaf2654; Chapman S, 2006, INJURY PREV, V12, P365, DOI 10.1136/ip.2006.013714; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; Lin P, 2012, INTELL ROBOT AUTON, P1; Neil D., 2015, WALL STREET J; Russel H, 2014, MCKIN Q	8	44	47	8	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1514	1515		10.1126/science.aaf9534	http://dx.doi.org/10.1126/science.aaf9534			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339966				2022-12-28	WOS:000378346500017
J	Mayor, S				Mayor, Susan			Asthma patients in England with easier access to primary care have fewer hospital admissions	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Fleetcroft R, 2016, BRIT J GEN PRACT, V66, pE640, DOI 10.3399/bjgp16X686089	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2016	353								i3508	10.1136/bmj.i3508	http://dx.doi.org/10.1136/bmj.i3508			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BX	27338873				2022-12-28	WOS:000378724000008
J	Zhao, WD; Hamid, E; Shin, W; Wen, PJ; Krystofiak, ES; Villarreal, SA; Chiang, HC; Kachar, B; Wu, LG				Zhao, Wei-Dong; Hamid, Edaeni; Shin, Wonchul; Wen, Peter J.; Krystofiak, Evan S.; Villarreal, Seth A.; Chiang, Hsueh-Cheng; Kachar, Bechara; Wu, Ling-Gang			Hemi-fused structure mediates and controls fusion and fission in live cells	NATURE			English	Article							MEMBRANE FISSION; CHROMAFFIN CELLS; CA2+-TRIGGERED EXOCYTOSIS; SNARE COMPLEX; PORES; VESICLES; ENDOCYTOSIS; TOMOGRAPHY; PROTEINS; INTERMEDIATE	Membrane fusion and fission are vital for eukaryotic life(1-5). For three decades, it has been proposed that fusion is mediated by fusion between the proximal leaflets of two bilayers (hemi-fusion) to produce a hemi-fused structure, followed by fusion between the distal leaflets, whereas fission is via hemi-fission, which also produces a hemi-fused structure, followed by full fission(1,4,6-10). This hypothesis remained unsupported owing to the lack of observation of hemi-fusion or hemi-fission in live cells. A competing fusion hypothesis involving protein-lined pore formation has also been proposed(2,11-15). Here we report the observation of a hemi-fused Omega-shaped structure in live neuroendocrine chromaffin cells and pancreatic beta-cells, visualized using confocal and super-resolution stimulated emission depletion microscopy. This structure is generated from fusion pore opening or closure (fission) at the plasma membrane. Unexpectedly, the transition to full fusion or fission is determined by competition between fusion and calcium/dynamin-dependent fission mechanisms, and is notably slow (seconds to tens of seconds) in a substantial fraction of the events. These results provide key missing evidence in support of the hemi-fusion and hemi-fission hypothesis in live cells, and reveal the hemi-fused intermediate as a key structure controlling fusion and fission, as fusion and fission mechanisms compete to determine the transition to fusion or fission.	[Zhao, Wei-Dong; Hamid, Edaeni; Shin, Wonchul; Wen, Peter J.; Villarreal, Seth A.; Chiang, Hsueh-Cheng; Wu, Ling-Gang] NINDS, 35 Convent Dr,Room 2B-1012, Bethesda, MD 20892 USA; [Krystofiak, Evan S.; Kachar, Bechara] NIDCD, 35A Convent Dr,Room 3D-824, Bethesda, MD 20892 USA; [Chiang, Hsueh-Cheng] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, 1 Univ Rd, Tainan 701, Taiwan	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Cheng Kung University	Wu, LG (corresponding author), NINDS, 35 Convent Dr,Room 2B-1012, Bethesda, MD 20892 USA.	wul@ninds.nih.gov		Zhao, Wei-Dong/0000-0003-0029-4400	National Institute of Neurological Disorders and Stroke Intramural Research Program [ZIA NS003009-13, ZIA NS003105-08]; National Institute on Deafness and Other Communication Disorders (NIDCD) Intramural Research Program [Z01-DC000002]; National Institute on Deafness and Other Communication Disorders (NIDCD) Intramural Research Program (NIDCD Advanced Imaging Core ZIC) [DC000081]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003105, ZIANS003009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000002, ZIADC000009, ZICDC000081, ZIADC000002] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Deafness and Other Communication Disorders (NIDCD) Intramural Research Program; National Institute on Deafness and Other Communication Disorders (NIDCD) Intramural Research Program (NIDCD Advanced Imaging Core ZIC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank T. Balla, G. Miesenbock, and D.-S. Wang for providing the construct containing the GFP-fused PH domain of PLC delta 1, the VAMP2-pHluorin construct, and dynamin siRNA, respectively; C. Smith for technical support with STED microscopy; and S. Cheng and V. Crocker for their electron microscopy technical support. This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Research Program (ZIA NS003009-13 and ZIA NS003105-08) and National Institute on Deafness and Other Communication Disorders (NIDCD) Intramural Research Program (Z01-DC000002 and NIDCD Advanced Imaging Core ZIC DC000081).	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Chang CW, 2015, J NEUROSCI, V35, P5772, DOI 10.1523/JNEUROSCI.3983-14.2015; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chiang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4356; Diao JJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00109; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; Gao JH, 2009, AM J TRANSL RES, V1, P312; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Han X, 2005, BIOPHYS J, V88, pL20, DOI 10.1529/biophysj.104.056739; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Jackson MB, 2010, J MEMBRANE BIOL, V235, P89, DOI 10.1007/s00232-010-9258-1; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jung JH, 2016, P NATL ACAD SCI USA, V113, pE1098, DOI 10.1073/pnas.1523054113; KOZLOV MM, 1983, BIOFIZIKA+, V28, P242; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lomasney JW, 1996, J BIOL CHEM, V271, P25316, DOI 10.1074/jbc.271.41.25316; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Pinto da Silva P., 1977, J CELL BIOL, V73, P161; Revelo NH, 2014, J CELL BIOL, V205, P591, DOI 10.1083/jcb.201402066; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Vardjan N, 2007, J NEUROSCI, V27, P4737, DOI 10.1523/JNEUROSCI.0351-07.2007; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; Wong JL, 2007, DEV CELL, V12, P653, DOI 10.1016/j.devcel.2007.02.007; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Zampighi GA, 2006, BIOPHYS J, V91, P2910, DOI 10.1529/biophysj.106.084814	34	80	81	4	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					548	+		10.1038/nature18598	http://dx.doi.org/10.1038/nature18598			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309816	Green Accepted			2022-12-28	WOS:000378270300053
J	[Anonymous]				[Anonymous]			Science in China	NATURE			English	Editorial Material																			0	2	2	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					451	451		10.1038/534451a	http://dx.doi.org/10.1038/534451a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP1SS	27337323	Bronze			2022-12-28	WOS:000378270300015
J	Pannill, FC				Pannill, Fitzhugh C.			In older hospitalized patients, adding transitional care to in-hospital geriatric assessment did not improve ADL Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Pannill, Fitzhugh C.] Southbury Med Associates, Southbury, CT 06488 USA; [Pannill, Fitzhugh C.] Univ Connecticut, Sch Med, Farmington, CT 06032 USA	University of Connecticut	Pannill, FC (corresponding author), Southbury Med Associates, Southbury, CT 06488 USA.; Pannill, FC (corresponding author), Univ Connecticut, Sch Med, Farmington, CT 06032 USA.							Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Hesselink G, 2012, ANN INTERN MED, V157, P417, DOI 10.7326/0003-4819-157-6-201209180-00006; Sinsky CA, 2016, ANN INTERN MED, V164, P370, DOI 10.7326/M16-0008	4	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					JC63	JC63		10.7326/ACPJC-2016-164-12-063	http://dx.doi.org/10.7326/ACPJC-2016-164-12-063			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323259				2022-12-28	WOS:000379343000002
J	Pisetsky, DS				Pisetsky, David S.			Modified Framingham Risk Score predicted 10-y CAD better than the original score in patients with lupus Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Pisetsky, David S.] Duke Univ, Med Ctr, Durham, NC 27708 USA	Duke University	Pisetsky, DS (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.							Costenbader KH, 2005, ARTHRIT RHEUM-ARTHR, V53, P718, DOI 10.1002/art.21441; Parker B, 2013, LUPUS, V22, P1259, DOI 10.1177/0961203313502570; Yazdany J, 2014, ARTHRIT CARE RES, V66, P617, DOI 10.1002/acr.22182	3	1	1	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					JC71	JC71		10.7326/ACPJC-2016-164-12-071	http://dx.doi.org/10.7326/ACPJC-2016-164-12-071			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323267				2022-12-28	WOS:000379343000010
J	Barnett, R				Barnett, Richard			Case histories Malaria	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	0	0	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2495	2495		10.1016/S0140-6736(16)30799-1	http://dx.doi.org/10.1016/S0140-6736(16)30799-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27358983				2022-12-28	WOS:000377947200013
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Misinformation in the EU debate	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mgtmmccartney@gmail.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Full Fact, 2016, EU FACTS CLAIMS MEMB; Ipsos MORI, 2016, PER PERC EU; Medecins Sans Frontieres, 2016, MED MIGR; UK Statistics Authority, 2016, UK STAT AUTH STAT US	4	0	0	4	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2016	353								i3297	10.1136/bmj.i3297	http://dx.doi.org/10.1136/bmj.i3297			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HJ	27312483	Bronze, Green Published			2022-12-28	WOS:000378240800003
J	Richardson, R				Richardson, Ruth			A J Cronin's Citadel	LANCET			English	Editorial Material									[Richardson, Ruth] The Lancet, London EC2Y 5AS, England		Richardson, R (corresponding author), The Lancet, London EC2Y 5AS, England.								0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2284	2285		10.1016/S0140-6736(16)30696-1	http://dx.doi.org/10.1016/S0140-6736(16)30696-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27308677				2022-12-28	WOS:000376969100017
J	Berwick, DM; Downey, AS; Cornett, EA				Berwick, Donald M.; Downey, Autumn S.; Cornett, Elizabeth A.			A National Trauma Care System to Achieve Zero Preventable Deaths After Injury Recommendations From a National Academies of Sciences, Engineering, and Medicine Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Berwick, Donald M.] Inst Healthcare Improvement, Cambridge, MA USA; [Downey, Autumn S.; Cornett, Elizabeth A.] Natl Acad Sci Engn & Med, Washington, DC USA	Institute for Healthcare Improvement; National Academies of Sciences, Engineering & Medicine	Berwick, DM (corresponding author), Inst Healthcare Improvement, Editorial Affairs, 20 Univ Rd,Seventh Floor, Cambridge, MA 02138 USA.	donberwick@gmail.com						Blackbourne LH, 2013, J TRAUMA ACUTE CARE, V74, P705, DOI 10.1097/TA.0b013e31828174f3; Blackbourne LH, 2013, J TRAUMA ACUTE CARE, V74, P347, DOI 10.1097/01.ta.0000426020.38942.d4; Blackbourne LH, 2012, J TRAUMA ACUTE CARE, V73, pS372, DOI 10.1097/TA.0b013e3182755662; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Ireland MW, 1921, J AMER MED ASSOC, V76, P763; Kwon AM, 2014, EUR J TRAUMA EMERG S, V40, P279, DOI 10.1007/s00068-013-0364-5; National Academies of Sciences Engineering and Medicine, 2016, NAT TRAUM CAR SYST I; Rasmussen Todd E, 2015, J Trauma Acute Care Surg, V79, pS61, DOI 10.1097/TA.0000000000000795; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Smith M., 2013, BUSINESS MODELS RESP	10	37	44	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					927	928		10.1001/jama.2016.8524	http://dx.doi.org/10.1001/jama.2016.8524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27315351				2022-12-28	WOS:000382460200013
J	Regenstein, M; Nocella, K; Jewers, MM; Mullan, F				Regenstein, Marsha; Nocella, Kiki; Jewers, Mariellen Malloy; Mullan, Fitzhugh			The Cost of Residency Training in Teaching Health Centers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Regenstein, Marsha; Jewers, Mariellen Malloy; Mullan, Fitzhugh] George Washington Univ, Dept Hlth Policy & Management, Milken Inst, Sch Publ Hlth, Washington, DC USA; [Nocella, Kiki] KCN Consulting, Valencia, CA USA; [Nocella, Kiki] Educ Hlth Ctr Initiat, Seattle, WA USA	George Washington University	Regenstein, M (corresponding author), George Washington Univ, Dept Hlth Policy & Management, Milken Inst, Sch Publ Hlth, Washington, DC USA.							Chen C, 2012, ACAD MED, V87, P1752, DOI 10.1097/ACM.0b013e3182720f4d; Evaluation and initial assessment of HRSA teaching health centers, 2015, OMB CONTR NUMB 0906; Phillips RL, 2013, ACAD MED, V88, P1934, DOI 10.1097/ACM.0000000000000025	3	27	29	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					612	614		10.1056/NEJMp1607866	http://dx.doi.org/10.1056/NEJMp1607866			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT4VF	27376580				2022-12-28	WOS:000381478600002
J	Walley, AY; Green, TC				Walley, Alexander Y.; Green, Traci C.			Mainstreaming Naloxone Through Coprescription to Patients Receiving Long-Term Opioid Therapy for Chronic Pain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OVERDOSE EDUCATION; INTERVENTIONS; STAFF		[Walley, Alexander Y.] Boston Univ, Sch Med, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA; [Walley, Alexander Y.] Boston Med Ctr, Clin Addict Res & Educ Unit, Sect Gen Internal Med, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA; [Green, Traci C.] Boston Univ, Sch Med, 1 Boston Med Ctr Pl, Boston, MA 02118 USA; [Green, Traci C.] Boston Med Ctr, Injury Prevent Ctr, Dept Emergency Med, 1 Boston Med Ctr Pl, Boston, MA 02118 USA	Boston University; Boston Medical Center; Boston Medical Center; Boston University; Boston Medical Center	Walley, AY (corresponding author), Boston Univ, Sch Med, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA.; Walley, AY (corresponding author), Boston Med Ctr, Clin Addict Res & Educ Unit, Sect Gen Internal Med, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA.	awalley@bu.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS024021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA013582, R01DA038082, R01DA037768] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baehren DF, 2010, ANN EMERG MED, V56, P19, DOI 10.1016/j.annemergmed.2009.12.011; Binswanger IA, 2015, J GEN INTERN MED, V30, P1837, DOI 10.1007/s11606-015-3394-3; Caudarella A, 2016, DRUG ALCOHOL DEPEN, V162, P51, DOI 10.1016/j.drugalcdep.2016.02.024; Coffin PO, 2016, ANN INTERN MED, V165, P245, DOI 10.7326/M15-2771; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Haegerich TM, 2014, DRUG ALCOHOL DEPEN, V145, P34, DOI 10.1016/j.drugalcdep.2014.10.001; Jones CM, 2016, AM J PUBLIC HEALTH, V106, P689, DOI 10.2105/AJPH.2016.303062; Oliva EM, 2016, SUBST ABUS, V37, P118, DOI 10.1080/08897077.2015.1129528; Walley AY, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f174; Zaller ND, 2013, SUBST USE MISUSE, V48, P590, DOI 10.3109/10826084.2013.793355	10	5	5	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					292	+		10.7326/M16-1348	http://dx.doi.org/10.7326/M16-1348			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UI	27367047				2022-12-28	WOS:000381267200022
J	Chaudhry, HJ; Hengerer, AS; Snyder, GB				Chaudhry, Humayun J.; Hengerer, Arthur S.; Snyder, Gregory B.			Medical Board Expectations for Physicians Recommending Marijuana	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chaudhry, Humayun J.; Snyder, Gregory B.] Federat State Med Boards, 400 Fuller Wiser Rd,Ste 300, Euless, TX 76039 USA; [Hengerer, Arthur S.] Univ Rochester, Dept Otolaryngol Head & Neck Surg, Rochester, NY USA	University of Rochester	Chaudhry, HJ (corresponding author), Federat State Med Boards, 400 Fuller Wiser Rd,Ste 300, Euless, TX 76039 USA.	hchaudhry@fsmb.org						Chaudhry HJ, 2015, JAMA-J AM MED ASSOC, V313, P1791, DOI 10.1001/jama.2015.4017; Hasin DS, 2015, JAMA PSYCHIAT, V72, P1235, DOI 10.1001/jamapsychiatry.2015.1858; Hill KP, 2015, JAMA-J AM MED ASSOC, V313, P2474, DOI 10.1001/jama.2015.6199	3	16	16	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					577	578		10.1001/jama.2016.7741	http://dx.doi.org/10.1001/jama.2016.7741			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27308872				2022-12-28	WOS:000380985600005
J	McPake, B; Hanson, K				McPake, Barbara; Hanson, Kara			Managing the public-private mix to achieve universal health coverage	LANCET			English	Article							CARE; SERVICES; MANAGEMENT; CONTRACT; QUALITY	The private sector has a large and growing role in health systems in low-income and middle-income countries. The goal of universal health coverage provides a renewed focus on taking a system perspective in designing policies to manage the private sector. This perspective requires choosing policies that will contribute to the performance of the system as a whole, rather than of any sector individually. Here we draw and extrapolate main messages from the papers in this Series and additional sources to inform policy and research agendas in the context of global and country level efforts to secure universal health coverage in low-income and middle-income countries. Recognising that private providers are highly heterogeneous in terms of their size, objectives, and quality, we explore the types of policy that might respond appropriately to the challenges and opportunities created by four stylised private provider types: the low-quality, underqualified sector that serves poor people in many countries; not-for-profit providers that operate on a range of scales; formally registered small-to-medium private practices; and the corporate commercial hospital sector, which is growing rapidly and about which little is known.	[McPake, Barbara] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [McPake, Barbara] Univ Edinburgh, Inst Global Hlth & Dev, Edinburgh, Midlothian, Scotland; [Hanson, Kara] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England	University of Melbourne; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Hanson, K (corresponding author), London Sch Hyg & Trop Med, London WC1H 9SH, England.	kara.hanson@lshtm.ac.uk	McPake, Barbara/AAE-8655-2021	McPake, Barbara/0000-0002-9904-1077				Agarwala SK, 2008, MICROECONOMIC THEO 1; [Anonymous], 2004, BUCK TREND SRI LANK; Arur A, 2010, HEALTH POLICY PLANN, V25, P135, DOI 10.1093/heapol/czp045; Bryant J, 2001, Asia Pac J Public Health, V13, P91, DOI 10.1177/101053950101300206; Burger R, 2011, 811 CREDIT U NOTT; Corby N, 2012, ADDRESSING NEED LESS; Crone RK, 2008, ACAD MED, V83, P117, DOI 10.1097/ACM.0b013e318160965c; Ellis RP, 2000, ECON POLIT WEEKLY, V35, P207; FRANK RG, 1994, J ECON PERSPECT, V8, P129, DOI 10.1257/jep.8.4.129; Grindle MS, 1995, PUBLIC ADMIN DEVELOP, V15, P441, DOI 10.1002/pad.4230150502; Gunatilleke G, 1999, SOCIAL DEV PUBLIC PO, P139; Heard A, 2013, TROP MED INT HEALTH, V18, P861, DOI 10.1111/tmi.12113; Hildebrand GM, 1994, BUILDING SUSTAINABLE; Hodgins S, 2013, GLOB HEALTH-SCI PRAC, V1, P328, DOI 10.9745/GHSP-D-13-00023; Hunter BM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3012; Kela M, 1998, STUDY WASTE MANAGEME; Khanna Umesh, 2009, Indian J Nephrol, V19, P1, DOI 10.4103/0971-4065.50671; Leonard DK, 2013, WORLD DEV, V48, P71, DOI 10.1016/j.worlddev.2013.04.003; Mackintosh M, 2002, J DEV STUD, V39, P1; Mackintosh M., 2008, PROMOTING INNOVATION; Mackintosh M, 2016, LANCET, V388, P596, DOI 10.1016/S0140-6736(16)00342-1; Manjunath U., 2007, TQM MAG, V19, P129; Mcintyre D, 2014, 5 CHATH HOUS WORK GR; Mills A, 1998, HEALTH POLICY PLANN, V13, P32, DOI 10.1093/heapol/13.1.32; Montagu D, 2016, LANCET; Morgan R, 2016, LANCET, V388, P606, DOI 10.1016/S0140-6736(16)00343-3; Oxfam, 2014, DANG DIV WILL IFCS F; Paris V., 2010, HLTH SYSTEMS I CHARA; Patcharanarumol W, 2011, GOOD HLTH LOW COST 2; Rannan-Eliya R, 2008, GOOD PRACTICES HLTH; Rao PH, 2008, WASTE MANAGE RES, V26, P297, DOI 10.1177/0734242X08088693; RESYST, 2014, WHAT IS STRAT PURCH; Sheikh K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001073; Sloan FA, 2001, J HEALTH ECON, V20, P1, DOI 10.1016/S0167-6296(00)00066-7; Soeters R, 2003, HEALTH POLICY PLANN, V18, P74, DOI 10.1093/heapol/18.1.74; Tangcharoensathien V, 2015, HEALTH POLICY PLANN, V30, P1152, DOI 10.1093/heapol/czu120; Wagstaff A., 2013, WHAT EXACTLY IS PUBL; Watch E, 2014, JAKARTA POST, V2014, P14; Witter S, 2007, REPROD HEALTH MATTER, V15, P61, DOI 10.1016/S0968-8080(07)30325-X; Witvliet MI., WORLD HLTH SURVEY US; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Zere E, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-27	43	67	67	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					622	630		10.1016/S0140-6736(16)00344-5	http://dx.doi.org/10.1016/S0140-6736(16)00344-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27358252				2022-12-28	WOS:000380756600035
J	Montagu, D; Goodman, C				Montagu, Dominic; Goodman, Catherine			Prohibit, constrain, encourage, or purchase: how should we engage with the private health-care sector?	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; COMPETITIVE VOUCHER PROGRAM; INSECTICIDE-TREATED NETS; OF-THE-LITERATURE; CONCEPTUAL-FRAMEWORK; HOSPITAL OWNERSHIP; MALARIA TREATMENT; SERVICE-DELIVERY; CONTRACTING-OUT; QUALITY	The private for-profit sector's prominence in health-care delivery, and concern about its failures to deliver social benefit, has driven a search for interventions to improve the sector's functioning. We review evidence for the effectiveness and limitations of such private sector interventions in low-income and middle-income countries. Few robust assessments are available, but some conclusions are possible. Prohibiting the private sector is very unlikely to succeed, and regulatory approaches face persistent challenges in many low-income and middle-income countries. Attention is therefore turning to interventions that encourage private providers to improve quality and coverage (while advancing their financial interests) such as social marketing, social franchising, vouchers, and contracting. However, evidence about the effect on clinical quality, coverage, equity, and cost-effectiveness is inadequate. Other challenges concern scalability and scope, indicating the limitations of such interventions as a basis for universal health coverage, though interventions can address focused problems on a restricted scale.	[Montagu, Dominic] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Goodman, Catherine] London Sch Hyg & Trop Med, London, England	University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine	Montagu, D (corresponding author), Univ Calif San Francisco, Epidemiol & Biostat, San Francisco, CA 94105 USA.	dominic.montagu@ucsf.edu		Goodman, Catherine/0000-0002-2241-3485				Alkhenizan A, 2011, ANN SAUDI MED, V31, P407, DOI 10.4103/0256-4947.83204; [Anonymous], 2012, IND EV PHAS 1 AFF ME; Attanayake N, 2003, INQUIRY REGULATION P; Bank W, WORLD BANK RESP NEW; Barnett C, 2013, APPROACHES REGULATIN; Basak S. C., 2010, Southern Med Review, V3, P27; Bellows BW, 2013, J HEALTH POPUL NUTR, V31, P106; Bellows NM, 2011, TROP MED INT HEALTH, V16, P84, DOI 10.1111/j.1365-3156.2010.02667.x; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Beyeler N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060669; Bharaswadkar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097993; Bhat R, 1996, INT J HEALTH PLAN M, V11, P253; Bhat R, 2009, J HEALTH POPUL NUTR, V27, P249, DOI 10.3329/jhpn.v27i2.3367; Bishai DM, 2008, HARVARD HLTH POLICY, V9, P184; Bloom G, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-53; Borghi J, 2005, HEALTH POLICY PLANN, V20, P222, DOI 10.1093/heapol/czi026; Bukonda N, 2002, INT J QUAL HEALTH C, V14, P7; Chakraborty S, 2000, HEALTH POLICY PLANN, V15, P400, DOI 10.1093/heapol/15.4.400; Chalker J, 2005, SOC SCI MED, V60, P131, DOI 10.1016/j.socscimed.2004.04.019; Chapman S, 2003, EFFECTIVENESS EFFICI; Chuc NTK, 1999, EUR J CLIN PHARMACOL, V55, P325, DOI 10.1007/s002280050636; Chuc NTK, 2002, J CLIN EPIDEMIOL, V55, P1148, DOI 10.1016/S0895-4356(02)00458-4; Chuc NTK, 2001, ANN PHARMACOTHER, V35, P1283, DOI 10.1345/aph.10313; Coelho CF, 2009, BREAKING NEW GROUND; Conteh L, 2003, SOC SCI MED, V57, P1147, DOI 10.1016/S0277-9536(02)00491-4; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; De Allegri M, 2010, HEALTH POLICY PLANN, V25, P28, DOI 10.1093/heapol/czp031; Eggleston K, 2008, HEALTH ECON, V17, P1345, DOI 10.1002/hec.1333; Ensor T, 2004, INT J HEALTH PLAN M, V19, P267, DOI 10.1002/hpm.762; Ensor T, 2007, SOC SCI MED, V65, P355, DOI 10.1016/j.socscimed.2007.03.021; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Gopalan SS, 2014, SOC SCI MED, V100, P72, DOI 10.1016/j.socscimed.2013.10.030; Gostin L O, 2013, COUNTERING PROBLEM F; Greer G, 2004, IMPROVING MANAGEMENT; Hanson K, 2001, HEALTH POLICY PLANN, V16, P125, DOI 10.1093/heapol/16.2.125; Hanson K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2434; Healy J, 2006, MED J AUSTRALIA, V184, pS56; Hinchcliff R, 2012, BMJ QUAL SAF, V21, P979, DOI 10.1136/bmjqs-2012-000852; Jacobs B, 2010, HEALTH POLICY PLANN, V25, P197, DOI 10.1093/heapol/czp049; Khatib RA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-98; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Kumaranayake I, 2000, HEALTH POLICY PLANN, V15, P357, DOI 10.1093/heapol/15.4.357; Liu XZ, 2008, HEALTH POLICY PLANN, V23, P1, DOI 10.1093/heapol/czm042; Liu XZ, 2007, HEALTH POLICY, V82, P200, DOI 10.1016/j.healthpol.2006.09.012; Llumpo A, 2015, HEALTHCARE PUBLIC PR, V2; Loevinsohn B, 2005, LANCET, V366, P676, DOI 10.1016/S0140-6736(05)67140-1; Lowe RF., 2009, S MED REV, V2, P35; Marchant T, 2010, CAN MED ASSOC J, V182, P152, DOI 10.1503/cmaj.090268; Marriott G, 2019, CHALLENGING SAFETY Q; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; MCPAKE B, 1995, SOC SCI MED, V41, P13, DOI 10.1016/0277-9536(94)00303-B; MERCK for mothers, 2014, PROGR REP MERCK MOTH; Meuwissen LE, 2006, INT J QUAL HEALTH C, V18, P35, DOI 10.1093/intqhc/mzi073; Meuwissen LE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-204; Meuwissen Liesbeth E, 2006, J Adolesc Health, V38, P56; Meyer C, 2011, IMPACT VOUCHERS USE; Mills A, 1998, MACROECONOMICS HLTH, V33; Montagu D, 2002, HEALTH POLICY PLANN, V17, P121, DOI 10.1093/heapol/17.2.121; Montagu D, HARDING MONTAGU PREK; Montagu D., 2011, PRIVATE VERSUS PUBLI; Montagu D, 2003, ACCREDITATION OTHER; Montagu D, 2016, HEALTH POLICY PLANN, V31, P1117, DOI 10.1093/heapol/czw018; Montagu Dominic, 2012, World Hosp Health Serv, V48, P15; Morgan R, 2014, INT J HEALTH PLAN MA, V31, P49; Mulligan JA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-32; Murray SF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-30; National Pharmaceutical Pricing Authority, 2014, PRIC NOT; Nijmeijer KJ, 2014, HEALTH POLICY PLANN, V29, P164, DOI 10.1093/heapol/czt001; Palmer N, 2000, B WORLD HEALTH ORGAN, V78, P821; Patouillard Edith, 2007, Int J Equity Health, V6, P17, DOI 10.1186/1475-9276-6-17; Peters DH, 2008, SOC SCI MED, V66, P2133, DOI 10.1016/j.socscimed.2008.01.037; Rutta E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-22; Santa-Ana-Tellez Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075550; Sax S, 2014, HEALTH POLICY PLANN, V29, P1021, DOI 10.1093/heapol/czt084; Schlein K, 2011, CLIN SOCIAL FRANCHIS; Shah NM, 2011, HEALTH POLICY PLANN, V26, P275, DOI 10.1093/heapol/czq074; Shaw CD, 2013, INT J QUAL HEALTH C, V25, P222, DOI 10.1093/intqhc/mzt011; Sheikh K, 2015, HEALTH POLICY PLANN, V30, P39, DOI 10.1093/heapol/czt095; Singh Gurminder, 2014, Indian J Dent, V5, P146, DOI 10.4103/0975-962X.140831; SINGH Susheela, 2009, ABORTION WORLDWIDE D; Sloan FA, 2001, J HEALTH ECON, V20, P1, DOI 10.1016/S0167-6296(00)00066-7; Spreng C., 2011, HLTH PARTNERSHIPS GO; Stenson B, 1997, HEALTH POLICY PLANN, V12, P329, DOI 10.1093/heapol/12.4.329; Sun XY, 2007, J NUTR EDUC BEHAV, V39, P302, DOI 10.1016/j.jneb.2007.03.090; Teerawattananon Y, 2003, HEALTH POLICY, V63, P323, DOI 10.1016/S0168-8510(02)00140-9; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; Viswanathan R, 2014, CLIN SOCIAL FRANCHIS; Wafulaa'b' F, 2013, SOC SCI MED, V97, P220, DOI 10.1016/j.socscimed.2013.08.020; WHO, GLOB HLTH EXP DAT TA	90	65	65	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					613	621		10.1016/S0140-6736(16)30242-2	http://dx.doi.org/10.1016/S0140-6736(16)30242-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27358250	Green Accepted			2022-12-28	WOS:000380756600034
J	Banani, SF; Rice, AM; Peeples, WB; Lin, Y; Jain, S; Parker, R; Rosen, MK				Banani, Salman F.; Rice, Allyson M.; Peeples, William B.; Lin, Yuan; Jain, Saumya; Parker, Roy; Rosen, Michael K.			Compositional Control of Phase-Separated Cellular Bodies	CELL			English	Article							PML NUCLEAR-BODIES; STRESS GRANULES; LIQUID DROPLETS; RNA; PROTEIN; BINDING; PHOSPHORYLATION; TRANSITION; DYNAMICS; DAXX	Cellular bodies such as P bodies and PML nuclear bodies (PML NBs) appear to be phase-separated liquids organized by multivalent interactions among proteins and RNA molecules. Although many components of various cellular bodies are known, general principles that define body composition are lacking. We modeled cellular bodies using several engineered multivalent proteins and RNA. In vitro and in cells, these scaffold molecules form phase-separated liquids that concentrate low valency client proteins. Clients partition differently depending on the ratio of scaffolds, with a sharp switch across the phase diagram diagonal. Composition can switch rapidly through changes in scaffold concentration or valency. Natural PML NBs and P bodies show analogous partitioning behavior, suggesting how their compositions could be controlled by levels of PML SUMOylation or cellular mRNA concentration, respectively. The data suggest a conceptual framework for considering the composition and control thereof of cellular bodies assembled through heterotypic multivalent interactions.	[Banani, Salman F.; Rice, Allyson M.; Peeples, William B.; Lin, Yuan; Rosen, Michael K.] UT Southwestern Med Ctr, Dept Biophys, Dallas, TX 75390 USA; [Banani, Salman F.; Rice, Allyson M.; Peeples, William B.; Lin, Yuan; Rosen, Michael K.] UT Southwestern Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Jain, Saumya; Parker, Roy] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Rosen, MK (corresponding author), UT Southwestern Med Ctr, Dept Biophys, Dallas, TX 75390 USA.; Rosen, MK (corresponding author), UT Southwestern Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu		Rice, Allyson/0000-0002-2781-0439	Howard Hughes Medical Institute; HCIA program of HHMI; NIH [R01-GM56322]; Welch Foundation [I-1544]; Sara and Frank McKnight Graduate Fellowship; NSF [1000196079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322, R01GM045443] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); HCIA program of HHMI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Sara and Frank McKnight Graduate Fellowship; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Louie Kerr, Kate Luby-Phelps, and Abhijit Bugde for assistance with imaging; Chad Brautigam and Thomas Scheuermann for assistance with ITC; Mark Kittisopikul for helpful discussions regarding image analysis, numerical fitting, and statistical testing; Pier Paolo Scaglioni for providing PML<SUP>-/-</SUP> cells; Rama Ranganathan for critical reading of the manuscript; and members of the Rosen lab for helpful discussions. This work was supported by the Howard Hughes Medical Institute, the HCIA program of HHMI, grants from the NIH (R01-GM56322) and Welch Foundation (I-1544), a Sara and Frank McKnight Graduate Fellowship (to S.F.B.), and the NSF (1000196079; to A.M.R.).	Antolini F, 2003, PROTEIN EXPRES PURIF, V29, P94, DOI 10.1016/S1046-5928(03)00004-4; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Brand Peter, 2010, PMC Biophys, V3, P3, DOI 10.1186/1757-5036-3-3; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cappadocia L, 2015, STRUCTURE, V23, P126, DOI 10.1016/j.str.2014.10.015; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Chalupnikova K, 2008, J BIOL CHEM, V283, P35186, DOI 10.1074/jbc.M804857200; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chen YCM, 2008, MOL BIOL CELL, V19, P3147, DOI 10.1091/mbc.E08-01-0035; Chung I, 2011, J CELL SCI, V124, P3603, DOI 10.1242/jcs.084681; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Dellaire G, 2006, J CELL SCI, V119, P1034, DOI 10.1242/jcs.02817; Dundr M, 2004, J CELL BIOL, V164, P831, DOI 10.1083/jcb.200311121; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Everett RD, 1999, J CELL SCI, V112, P4581; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Fong KW, 2013, J CELL BIOL, V203, P149, DOI 10.1083/jcb.201303145; Fromm SA, 2014, ANGEW CHEM INT EDIT, V53, P7354, DOI 10.1002/anie.201402885; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; Handwerger KE, 2005, MOL BIOL CELL, V16, P202, DOI 10.1091/mbc.E04-08-0742; Hattersley N, 2011, MOL BIOL CELL, V22, P78, DOI 10.1091/mbc.E10-06-0504; He XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123882; Huang SY, 2014, J BIOMOL NMR, V60, P275, DOI 10.1007/s10858-014-9869-4; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; ISHOV AM, 1999, J CELL BIOL, V147, P221, DOI [10.1083/jcb.147.2.221, DOI 10.1083/JCB.147.2.221]; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jain S, 2013, ADV EXP MED BIOL, V768, P23, DOI 10.1007/978-1-4614-5107-5_3; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Mitrea DM, 2016, ELIFE, V5, DOI 10.7554/eLife.13571; Mohamad N, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-44; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Muller S, 1999, J VIROL, V73, P5137; Nisole S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00125; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Rojas-Fernandez A, 2014, MOL CELL, V53, P880, DOI 10.1016/j.molcel.2014.02.031; Sahin U, 2014, J CELL BIOL, V204, P931, DOI 10.1083/jcb.201305148; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	67	547	552	10	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					651	663		10.1016/j.cell.2016.06.010	http://dx.doi.org/10.1016/j.cell.2016.06.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27374333	Green Accepted, Bronze			2022-12-28	WOS:000380546500016
J	Watson, R				Watson, Rory			Health groups demand closure of Europe's coal fired power stations	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2016, EUROPES DARK CLOUD C; Vidal J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6885	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2016	354								i3752	10.1136/bmj.i3752	http://dx.doi.org/10.1136/bmj.i3752			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EG	27381196				2022-12-28	WOS:000379580200013
J	Zeitlin, J; Manktelow, BN; Piedvache, A; Cuttini, M; Boyle, E; van Heijst, A; Gadzinowski, J; Van Reempts, P; Huusom, L; Weber, T; Schmidt, S; Barros, H; Dillalo, D; Toome, L; Norman, M; Blondel, B; Bonet, M; Draper, ES; Maier, RF				Zeitlin, Jennifer; Manktelow, Bradley N.; Piedvache, Aurelie; Cuttini, Marina; Boyle, Elaine; van Heijst, Arno; Gadzinowski, Janusz; Van Reempts, Patrick; Huusom, Lene; Weber, Tom; Schmidt, Stephan; Barros, Henrique; Dillalo, Dominico; Toome, Liis; Norman, Mikael; Blondel, Beatrice; Bonet, Mercedes; Draper, Elisabeth S.; Maier, Rolf F.			Use of evidence based practices to improve survival without severe morbidity for very preterm infants: results from the EPICE population based cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; EUROPEAN CONSENSUS GUIDELINES; RESPIRATORY-DISTRESS-SYNDROME; CLINICAL-PRACTICE GUIDELINES; BRONCHOPULMONARY DYSPLASIA; ANTENATAL CORTICOSTEROIDS; CARE BUNDLE; MORTALITY; OUTCOMES; MANAGEMENT	OBJECTIVES To evaluate the implementation of four high evidence practices for the care of very preterm infants to assess their use and impact in routine clinical practice and whether they constitute a driver for reducing mortality and neonatal morbidity. DESIGN Prospective multinational population based observational study. SETTING 19 regions from 11 European countries covering 850 000 annual births participating in the EPICE (Effective Perinatal Intensive Care in Europe for very preterm births) project. PARTICIPANTS 7336 infants born between 24+0 and 31+6 weeks' gestation in 2011/12 without serious congenital anomalies and surviving to neonatal admission. MAIN OUTCOME MEASURES Combined use of four evidence based practices for infants born before 28 weeks' gestation using an "all or none" approach: delivery in a maternity unit with appropriate level of neonatal care; administration of antenatal corticosteroids; prevention of hypothermia (temperature on admission to neonatal unit >= 36 degrees C); surfactant used within two hours of birth or early nasal continuous positive airway pressure. Infant outcomes were in-hospital mortality, severe neonatal morbidity at discharge, and a composite measure of death or severe morbidity, or both. We modelled associations using risk ratios, with propensity score weighting to account for potential confounding bias. Analyses were adjusted for clustering within delivery hospital. RESULTS Only 58.3% (n=4275) of infants received all evidence based practices for which they were eligible. Infants with low gestational age, growth restriction, low Apgar scores, and who were born on the day of maternal admission to hospital were less likely to receive evidence based care. After adjustment, evidence based care was associated with lower in-hospital mortality (risk ratio 0.72, 95% confidence interval 0.60 to 0.87) and in-hospital mortality or severe morbidity, or both (0.82, 0.73 to 0.92), corresponding to an estimated 18% decrease in all deaths without an increase in severe morbidity if these interventions had been provided to all infants. CONCLUSIONS More comprehensive use of evidence based practices in perinatal medicine could result in considerable gains for very preterm infants, in terms of increased survival without severe morbidity.	[Zeitlin, Jennifer; Piedvache, Aurelie; Blondel, Beatrice; Bonet, Mercedes] Paris Descartes Univ, Ctr Epidemiol & Stat, Sorbonne Paris Cite,DHU Risks Pregnancy,UMR 1153, INSERM,Obstet Perinatal & Pediat Epidemiol Res Te, Paris, France; [Manktelow, Bradley N.; Boyle, Elaine; Draper, Elisabeth S.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Cuttini, Marina] Bambino Gesu Pediat Hosp, Clin Care & Management Innovat Res Area, Rome, Italy; [van Heijst, Arno] Radboud Univ Nijmegen, Med Ctr, Dept Neonatol, Nijmegen, Netherlands; [Gadzinowski, Janusz] Poznan Univ Med Sci, Dept Neonatol, Poznan, Poland; [Van Reempts, Patrick] Univ Antwerp Hosp, Dept Neonatol, Antwerp, Belgium; [Van Reempts, Patrick] Study Ctr Perinatal Epidemiol, Brussels, Belgium; [Huusom, Lene; Weber, Tom] Hvidovre Univ Hosp, Dept Obstet, Hvidovre, Denmark; [Schmidt, Stephan] Univ Marburg, Univ Hosp, Dept Obstet, Marburg, Germany; [Barros, Henrique] Univ Porto, EPIUnit, Inst Publ Hlth, Oporto, Portugal; [Dillalo, Dominico] Hlth Dept, Rome, Italy; [Toome, Liis] Tallinn Childrens Hosp, Unit Neonates & Infants, Tallinn, Estonia; [Toome, Liis] Univ Tartu, Tartu, Estonia; [Norman, Mikael] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Paediat, Stockholm, Sweden; [Norman, Mikael] Karolinska Univ Hosp, Dept Neonatal Med, Stockholm, Sweden; [Maier, Rolf F.] Univ Marburg, Univ Hosp, Childrens Hosp, Marburg, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Leicester; IRCCS Bambino Gesu; Radboud University Nijmegen; Poznan University of Medical Sciences; University of Antwerp; University of Copenhagen; Philipps University Marburg; Universidade do Porto; University of Tartu; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Philipps University Marburg	Zeitlin, J (corresponding author), Paris Descartes Univ, Ctr Epidemiol & Stat, Sorbonne Paris Cite,DHU Risks Pregnancy,UMR 1153, INSERM,Obstet Perinatal & Pediat Epidemiol Res Te, Paris, France.	Jennifer.zeitlin@inserm.fr	Draper, Elizabeth/S-6874-2019; Barros, Henrique/Q-8609-2019; Draper, Elizabeth S/I-6304-2018; Barros, Henrique/A-5488-2008; Zeitlin, Jennifer/G-4973-2017; Blondel, Beatrice/G-5011-2017; Boyle, Elaine M/I-6298-2018; Cuttini, Marina/AAI-1987-2019; van Heijst, Arno/P-8527-2014; Manktelow, Bradley/G-2794-2011	Draper, Elizabeth/0000-0001-9340-8176; Barros, Henrique/0000-0003-4699-6571; Draper, Elizabeth S/0000-0001-9340-8176; Zeitlin, Jennifer/0000-0002-9568-2969; Boyle, Elaine M/0000-0002-5038-3148; Cuttini, Marina/0000-0002-3284-6874; van Heijst, Arno/0000-0003-2276-0177; Diegues Rodrigues, Carina Eduarda/0000-0003-1720-2808; Norman, Mikael/0000-0003-4191-3781; Gadzinowski, Janusz/0000-0001-8397-6989; PIEDVACHE, AURELIE/0000-0002-2737-0461; Manktelow, Bradley/0000-0002-3264-0323	European Union [259882]; France (French Institute of Public Health Research/Institute of Public Health); France (French Health Ministry); France (National Institute of Health and Medical Research); France (National Institute of Cancer); France (National Solidarity Fund for Autonomy); France (National Research Agency through the French Equipex Program of Investments in the Future) [ANR-11-EQPX-0038]; France (PremUp Foundation); Poland (Polish Ministry of Science and Higher Education); Sweden (Stockholm County Council); Sweden (Karolinska Institutet); Sweden (Department of Neonatal Medicine, Karolinska University Hospital)	European Union(European Commission); France (French Institute of Public Health Research/Institute of Public Health); France (French Health Ministry); France (National Institute of Health and Medical Research); France (National Institute of Cancer); France (National Solidarity Fund for Autonomy); France (National Research Agency through the French Equipex Program of Investments in the Future); France (PremUp Foundation); Poland (Polish Ministry of Science and Higher Education); Sweden (Stockholm County Council); Sweden (Karolinska Institutet); Sweden (Department of Neonatal Medicine, Karolinska University Hospital)	The research leading to these results received funding from the European Union's Seventh Framework Programme ([FP7/2007-2013]) under grant agreement No 259882. Additional funding is acknowledged from the following regions: France (French Institute of Public Health Research/Institute of Public Health and its partners the French Health Ministry, the National Institute of Health and Medical Research, the National Institute of Cancer, and the National Solidarity Fund for Autonomy; grant ANR-11-EQPX-0038 from the National Research Agency through the French Equipex Program of Investments in the Future; and the PremUp Foundation); Poland (2012-2015 allocation of funds for international projects from the Polish Ministry of Science and Higher Education); Sweden (funding by a regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, and by the Department of Neonatal Medicine, Karolinska University Hospital); UK (funding for the neonatal survey from Neonatal Networks for East Midlands and Yorkshire and Humber regions). The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Alleman BW, 2013, PEDIATRICS, V132, pE175, DOI 10.1542/peds.2012-3707; Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; Bahadue FL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001456.pub2; Battersby C, 2014, ARCH DIS CHILD-FETAL, V99, pF395, DOI 10.1136/archdischild-2013-305475; Benitz WE, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3730; Berenholtz Sean, 2003, Curr Opin Crit Care, V9, P321, DOI 10.1097/00075198-200308000-00012; de Almeida MFB, 2014, J PEDIATR-US, V164, P271, DOI 10.1016/j.jpeds.2013.09.049; Brok J, 2008, ARCH DIS CHILD-FETAL, V93, pF225, DOI 10.1136/adc.2007.118000; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chien LY, 2002, OBSTET GYNECOL, V99, P401, DOI 10.1016/S0029-7844(01)01732-X; Draper ES, 2009, ARCH DIS CHILD-FETAL, V94, pF158, DOI 10.1136/adc.2008.141531; Empana JP, 2004, ACTA PAEDIATR, V93, P1318, DOI 10.1080/08035250410030054; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Guillen U, 2015, PEDIATRICS, V136, P343, DOI 10.1542/peds.2015-0542; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Hayter MA, 2005, J OBSTET GYNAECOL CA, V27, P25, DOI 10.1016/S1701-2163(16)30168-2; Kollee LAA, 2009, BJOG-INT J OBSTET GY, V116, P1481, DOI 10.1111/j.1471-0528.2009.02235.x; Lasswell SM, 2010, JAMA-J AM MED ASSOC, V304, P992, DOI 10.1001/jama.2010.1226; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Lyu YY, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.0277; MacDorman Marian F, 2014, Natl Vital Stat Rep, V63, P1; McCall EM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004210.pub4; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Miller SS, 2011, J PERINATOL, V31, pS49, DOI 10.1038/jp.2010.177; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; Papiernik E, 2008, BJOG-INT J OBSTET GY, V115, P361, DOI 10.1111/j.1471-0528.2007.01611.x; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Payne NR, 2010, PEDIATRICS, V125, P437, DOI 10.1542/peds.2009-1272; Profit J, 2015, PEDIATRICS, V135, pE397, DOI 10.1542/peds.2014-2177; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rogowski JA, 2004, JAMA-J AM MED ASSOC, V291, P202, DOI 10.1001/jama.291.2.202; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Sasi A, 2014, HEART LUNG, V43, P347, DOI 10.1016/j.hrtlng.2014.04.014; Sharma A, 2007, ACTA PAEDIATR, V96, P1115, DOI 10.1111/j.1651-2227.2007.00388.x; Sterling KL, 2008, J EVID-INFORM SOC WO, V5, P295, DOI 10.1300/J394v05n01_11; Sweet DG, 2013, NEONATOLOGY, V103, P353, DOI 10.1159/000349928; Sweet DG, 2010, NEONATOLOGY, V97, P402, DOI 10.1159/000297773; Ting JY, 2013, CAN J INFECT DIS MED, V24, P185, DOI 10.1155/2013/781690; Truffert P, 2003, ACTA PAEDIATR, V92, P948, DOI 10.1080/08035250310002579; Turner M, 2015, STROKE, V46, P1065, DOI 10.1161/STROKEAHA.114.007608; Van Reempts P, 2007, PEDIATRICS, V120, pe815, DOI 10.1542/peds.2006-3122; Wandersman A, 2008, AM J COMMUN PSYCHOL, V41, P171, DOI 10.1007/s10464-008-9174-z; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Rojas-Reyes MX, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000510.pub2; Zeitlin J, 2008, PEDIATRICS, V121, pE936, DOI 10.1542/peds.2007-1620; Zou GY, 2013, STAT METHODS MED RES, V22, P661, DOI 10.1177/0962280211427759	50	106	111	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2016	354								i2976	10.1136/bmj.i2976	http://dx.doi.org/10.1136/bmj.i2976			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EG	27381936	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000379580200001
J	Mayor, S				Mayor, Susan			GPs should have direct access to wider range of tests for suspected cancer, says NICE	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, 2015, SUSP CANC REC REF NG; National Institute for Health and Care Excellence, 2016, SUSP CANC QUAL STAND	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2016	354								i3686	10.1136/bmj.i3686	http://dx.doi.org/10.1136/bmj.i3686			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EA	27378684				2022-12-28	WOS:000379579600003
J	Golden, SA; Heshmati, M; Flanigan, M; Christoffel, DJ; Guise, K; Pfau, ML; Aleyasin, H; Menard, C; Zhang, HX; Hodes, GE; Bregman, D; Khibnik, L; Tai, J; Rebusi, N; Krawitz, B; Chaudhury, D; Walsh, JJ; Han, MH; Shapiro, ML; Russo, SJ				Golden, Sam A.; Heshmati, Mitra; Flanigan, Meghan; Christoffel, Daniel J.; Guise, Kevin; Pfau, Madeline L.; Aleyasin, Hossein; Menard, Caroline; Zhang, Hongxing; Hodes, Georgia E.; Bregman, Dana; Khibnik, Lena; Tai, Jonathan; Rebusi, Nicole; Krawitz, Brian; Chaudhury, Dipesh; Walsh, Jessica J.; Han, Ming-Hu; Shapiro, Matt L.; Russo, Scott J.			Basal forebrain projections to the lateral habenula modulate aggression reward	NATURE			English	Article							DEEP BRAIN-STIMULATION; OPTOGENETIC INHIBITION; SOCIAL DEFEAT; NEURONS; DEPRESSION; NUCLEUS; STRESS; BEHAVIOR; ACTIVATION; EXPERIENCE	Maladaptive aggressive behaviour is associated with a number of neuropsychiatric disorders(1) and is thought to result partly from the inappropriate activation of brain reward systems in response to aggressive or violent social stimuli(2). Nuclei within the ventromedial hypothalamus(3-5), extended amygdala(6) and limbic(7) circuits are known to encode initiation of aggression; however, little is known about the neural mechanisms that directly modulate the motivational component of aggressive behaviour(8). Here we established a mouse model to measure the valence of aggressive inter-male social interaction with a smaller subordinate intruder as reinforcement for the development of conditioned place preference (CPP). Aggressors develop a CPP, whereas non-aggressors develop a conditioned place aversion to the intruder-paired context. Furthermore, we identify a functional GABAergic projection from the basal forebrain (BF) to the lateral habenula (lHb) that bi-directionally controls the valence of aggressive interactions. Circuit-specific silencing of GABAergic BF-lHb terminals of aggressors with halorhodopsin (NpHR3.0) increases lHb neuronal firing and abolishes CPP to the intruder-paired context. Activation of GABAergic BF-lHb terminals of non-aggressors with channelrhodopsin (ChR2) decreases lHb neuronal firing and promotes CPP to the intruder-paired context. Finally, we show that altering inhibitory transmission at BF-lHb terminals does not control the initiation of aggressive behaviour. These results demonstrate that the BF-lHb circuit has a critical role in regulating the valence of inter-male aggressive behaviour and provide novel mechanistic insight into the neural circuits modulating aggression reward processing.	[Golden, Sam A.; Heshmati, Mitra; Flanigan, Meghan; Guise, Kevin; Pfau, Madeline L.; Aleyasin, Hossein; Menard, Caroline; Hodes, Georgia E.; Bregman, Dana; Khibnik, Lena; Tai, Jonathan; Rebusi, Nicole; Krawitz, Brian; Han, Ming-Hu; Shapiro, Matt L.; Russo, Scott J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Golden, Sam A.; Heshmati, Mitra; Flanigan, Meghan; Guise, Kevin; Pfau, Madeline L.; Aleyasin, Hossein; Menard, Caroline; Hodes, Georgia E.; Bregman, Dana; Khibnik, Lena; Tai, Jonathan; Rebusi, Nicole; Krawitz, Brian; Han, Ming-Hu; Shapiro, Matt L.; Russo, Scott J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Golden, Sam A.; Heshmati, Mitra; Flanigan, Meghan; Guise, Kevin; Pfau, Madeline L.; Krawitz, Brian] Icahn Sch Med Mt Sinai, Grad Program Neurosci, New York, NY 10029 USA; [Christoffel, Daniel J.; Walsh, Jessica J.] Stanford Univ, Med Ctr, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA; [Zhang, Hongxing; Chaudhury, Dipesh; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Zhang, Hongxing; Chaudhury, Dipesh; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Inst Syst Biomed, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stanford University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Russo, SJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.; Russo, SJ (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.	scott.russo@mssm.edu	Menard, Caroline/AAV-4017-2020; Core, Vector/CAF-4832-2022; Han, Ming-Hu/G-8836-2012; Russo, Scott/R-7107-2019; Hodes, Georgia/L-8022-2016	Menard, Caroline/0000-0001-8202-7378; Russo, Scott/0000-0002-6470-1805; Hodes, Georgia/0000-0002-1551-2178; Christoffel, Dan/0000-0002-6303-5134; Flanigan, Meghan/0000-0002-3185-7459; Golden, Sam/0000-0002-2104-2272; Walsh, Jessica/0000-0001-8466-8451	US National Institutes of Health [R01 MH090264, P50 MH096890, P50 AT008661-01, R01 MH092306, T32 MH087004, T32 MH096678, F30 MH100835, F31 MH105217]; National Institute of General Medical Sciences [1FI2GM117583-01]; Natural National Science Foundation of China [81200862]; National Center for Complementary & Integrative Health [P50AT008661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [FI2GM117583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092306, T32MH096678, R01MH073689, R01MH090264, F30MH100835, P50MH096890, T32MH087004, R01MH104559, F31MH105217, R21MH112081] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by US National Institutes of Health grants R01 MH090264, P50 MH096890 and P50 AT008661-01 (S.J.R.), R01 MH092306 (M.H.H.), T32 MH087004 (M.L.P., M.H. and M.F.), T32 MH096678 (M.L.P.), F30 MH100835 (M.H.), F31 MH105217 (M.L.P.), National Institute of General Medical Sciences 1FI2GM117583-01 (S.A.G.) and the Natural National Science Foundation of China 81200862 (H.Z.). We would like to thank K. Miczek and Y. Shaham for their input.	Anderson DJ, 2012, BIOL PSYCHIAT, V71, P1081, DOI 10.1016/j.biopsych.2011.11.012; Aquili L, 2014, LEARN MEMORY, V21, P223, DOI 10.1101/lm.034199.113; Beck Anne, 2014, Curr Top Behav Neurosci, V17, P443, DOI 10.1007/7854_2013_258; Bewernick BH, 2012, NEUROPSYCHOPHARMACOL, V37, P1975, DOI 10.1038/npp.2012.44; Callaway EM, 2015, J NEUROSCI, V35, P8979, DOI 10.1523/JNEUROSCI.0409-15.2015; Chandra R, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00013; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Felton TM, 1999, NEUROREPORT, V10, P883, DOI 10.1097/00001756-199903170-00039; Friedman AK, 2014, SCIENCE, V344, P313, DOI 10.1126/science.1249240; Glenn AL, 2012, BIOL PSYCHIAT, V72, P817, DOI 10.1016/j.biopsych.2012.04.027; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Golden SA, 2013, NAT MED, V19, P337, DOI 10.1038/nm.3090; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kudryavtseva NN, 2002, BEHAV BRAIN RES, V133, P83, DOI 10.1016/S0166-4328(01)00443-0; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lecca S, 2014, EUR J NEUROSCI, V39, P1170, DOI 10.1111/ejn.12480; LEE EHY, 1988, BEHAV BRAIN RES, V30, P265, DOI 10.1016/0166-4328(88)90169-6; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lobo MK, 2013, J NEUROSCI, V33, P18381, DOI 10.1523/JNEUROSCI.1875-13.2013; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Maroteaux M, 2012, J NEUROSCI, V32, P12641, DOI 10.1523/JNEUROSCI.2405-12.2012; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; Miczek K A, 1984, Prog Clin Biol Res, V167, P1; Quina LA, 2015, J COMP NEUROL, V523, P32, DOI 10.1002/cne.23662; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; Shelton L, 2012, J NEUROPHYSIOL, V107, P2633, DOI 10.1152/jn.00012.2012; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; TAKAHASHI A, 2013, CURR TOP BEHAV NEURO, V17, P3, DOI DOI 10.1007/7854_2013_263; Unger EK, 2015, CELL REP, V10, P453, DOI 10.1016/j.celrep.2014.12.040; WASMAN M, 1962, ARCH NEUROL-CHICAGO, V6, P220, DOI 10.1001/archneur.1962.00450210048005; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yetnikoff L, 2015, J COMP NEUROL, V523, P2426, DOI 10.1002/cne.23797; Yu Q, 2014, MOL PSYCHIATR, V19, P635, DOI 10.1038/mp.2014.45; Zahm DS, 2013, J COMP NEUROL, V521, P50, DOI 10.1002/cne.23157	44	120	120	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					688	+		10.1038/nature18601	http://dx.doi.org/10.1038/nature18601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357796	Green Accepted			2022-12-28	WOS:000378676000037
J	Kleinman, A				Kleinman, Arthur			The art of medicine Caring for memories	LANCET			English	Editorial Material									[Kleinman, Arthur] Harvard Univ, Asia Ctr, Cambridge, MA 02138 USA; [Kleinman, Arthur] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Kleinman, Arthur] Harvard Univ, Dept Global Hlth & Social Med, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Kleinman, A (corresponding author), Harvard Univ, Asia Ctr, Cambridge, MA 02138 USA.; Kleinman, A (corresponding author), Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA.; Kleinman, A (corresponding author), Harvard Univ, Dept Global Hlth & Social Med, Cambridge, MA 02138 USA.	kleinman@fas.harvard.edu							0	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2596	2597		10.1016/S0140-6736(16)30853-4	http://dx.doi.org/10.1016/S0140-6736(16)30853-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP3JX	27358988				2022-12-28	WOS:000378390500017
J	Armstrong, S				Armstrong, Stephen			What happens to data gathered by health and wellness apps?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						[Anonymous], 2014, FITB DAT NOW BEING U; Blenner SR, 2016, JAMA-J AM MED ASSOC, V315, P1051, DOI 10.1001/jama.2015.19426; Campbell D, 2016, GUARDIAN; Capgemini, WEAR DEV THEIR APPL; European Union, ANN HLTH DAT APPS DE; Gershman J, 2016, WALL STREET J; Health IMS, 2015, IMS HLTH STUD PAT OP; Huckvale K, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0444-y; Information Commissioner's Office, 2015, ACT WEV TAK PHARMACY; Mamiit A, 2016, TECH TIMES      0402; National Information Board, PERS HLTH CAR 2020 W; National Information Board, 2015, HLTH SECR OUTL VIS U; Open Effect, 2016, EV STEP YOU FAK; Pai A, 2015, MOBI HLTH NEWS  1105; Vitality, WALK WALK WEAR DEV	15	15	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2016	353								i3406	10.1136/bmj.i3406	http://dx.doi.org/10.1136/bmj.i3406			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BX	27338775				2022-12-28	WOS:000378724000002
J	Pan, YD; Schimel, D				Pan, Yude; Schimel, David			BIOGEOCHEMISTRY Synergy of a warm spring and dry summer	NATURE			English	Editorial Material								An analysis suggests that high carbon uptake by US land ecosystems during the warm spring of 2012 offset the carbon loss that resulted from severe drought over the summer - and hints that the warm spring could have worsened the drought.	[Pan, Yude] US Forest Serv, Res Unit Climate Fire & Carbon Cycle Sci, USDA, Newtown Sq, PA 19073 USA; [Schimel, David] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA	United States Department of Agriculture (USDA); United States Forest Service; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Pan, YD (corresponding author), US Forest Serv, Res Unit Climate Fire & Carbon Cycle Sci, USDA, Newtown Sq, PA 19073 USA.	ypan@fs.fed.us						Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Hu J, 2010, GLOBAL CHANGE BIOL, V16, P771, DOI 10.1111/j.1365-2486.2009.01967.x; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; Melillo J.M., 2014, 3 NATL COMMUNICATION; Rippey BR, 2015, WEATHER CLIM EXTREME, V10, P57, DOI 10.1016/j.wace.2015.10.004; Wolf S, 2016, P NATL ACAD SCI USA, V113, P5880, DOI 10.1073/pnas.1519620113	6	6	6	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					483	484		10.1038/nature18450	http://dx.doi.org/10.1038/nature18450			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309806				2022-12-28	WOS:000378270300039
J	Tilg, H				Tilg, Herbert			A Gut Feeling about Thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ATHEROSCLEROSIS; RISK		[Tilg, Herbert] Med Univ Innsbruck, Dept Internal Med Gastroenterol Endocrinol & Meta, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Tilg, H (corresponding author), Med Univ Innsbruck, Dept Internal Med Gastroenterol Endocrinol & Meta, A-6020 Innsbruck, Austria.							Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Warrier M, 2015, CELL REP; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	5	37	46	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2494	2496		10.1056/NEJMcibr1604458	http://dx.doi.org/10.1056/NEJMcibr1604458			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1TG	27332910				2022-12-28	WOS:000378271700015
J	Ganz, P; Heidecker, B; Hveem, K; Jonasson, C; Kato, S; Segal, MR; Sterling, DG; Williams, SA				Ganz, Peter; Heidecker, Bettina; Hveem, Kristian; Jonasson, Christian; Kato, Shintaro; Segal, Mark R.; Sterling, David G.; Williams, Stephen A.			Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENETIC RISK; STATIN THERAPY; EVENTS; ASSOCIATION; PREVENTION; SELECTION; HEALTH; MODEL; LASSO	IMPORTANCE Precise stratification of cardiovascular risk in patients with coronary heart disease (CHD) is needed to inform treatment decisions. OBJECTIVE To derive and validate a score to predict risk of cardiovascular outcomes among patients with CHD, using large-scale analysis of circulating proteins. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of participants with stable CHD. For the derivation cohort (Heart and Soul study), outpatients from San Francisco were enrolled from 2000 through 2002 and followed up through November 2011 (<= 11.1 years). For the validation cohort (HUNT3, a Norwegian population-based study), participants were enrolled from 2006 through 2008 and followed up through April 2012 (5.6 years). EXPOSURES Using modified aptamers, 1130 proteins were measured in plasma samples. MAIN OUTCOMES AND MEASURES A 9-protein risk score was derived and validated for 4-year probability of myocardial infarction, stroke, heart failure, and all-cause death. Tests, including the C statistic, were used to assess performance of the 9-protein risk score, which was compared with the Framingham secondary event model, refit to the cohorts in this study. Within-person change in the 9-protein risk score was evaluated in the Heart and Soul study from paired samples collected 4.8 years apart. RESULTS From the derivation cohort, 938 samples were analyzed, participants' median age at enrollment was 67.0 years, and 82% were men. From the validation cohort, 971 samples were analyzed, participants' median age at enrollment was 70.2 years, and 72% were men. In the derivation cohort, C statistics were 0.66 for refit Framingham, 0.74 for 9-protein, and 0.75 for refit Framingham plus 9-protein models. In the validation cohort, C statistics were 0.64 for refit Framingham, 0.70 for 9-protein, and 0.71 for refit Framingham plus 9-protein models. Adding the 9-protein risk score to the refit Framingham model increased the C statistic by 0.09 (95% CI, 0.06-0.12) in the derivation cohort, and in the validation cohort, the C statistic was increased by 0.05 (95% CI, 0.02-0.09). Compared with the refit Framingham model, the integrated discrimination index for the 9-protein model was 0.12 (95% CI, 0.08-0.16) in the derivation cohort and 0.08 (95% CI, 0.05-0.10) in the validation cohort. In analysis of paired samples among 139 participants with cardiovascular events after the second sample, absolute within-person annualized risk increased more for the 9-protein model (median, 1.86%[95% CI, 1.15%-2.54%]) than for the refit Framingham model (median, 1.00% [95% CI, 0.87%-1.19%]) (P = .002), while among 375 participants without cardiovascular events, both scores changed less and similarly (P = .30). CONCLUSIONS AND RELEVANCE Among patients with stable CHD, a risk score based on 9 proteins performed better than the refit Framingham secondary event risk score in predicting cardiovascular events, but still provided only modest discriminative accuracy. Further research is needed to assess whether the score is more accurate in a lower-risk population.	[Ganz, Peter; Heidecker, Bettina] Univ Calif San Francisco, Dept Med, 1001 Potrero Ave,Room 5G1, San Francisco, CA 94110 USA; [Ganz, Peter] San Francisco Gen Hosp, Div Cardiol, San Francisco, CA USA; [Heidecker, Bettina] Univ Zurich, Div Cardiol, Zurich, Switzerland; [Hveem, Kristian; Jonasson, Christian] NTNU, Dept Publ Hlth, HUNT Res Ctr, Levanger, Norway; [Kato, Shintaro] N Amer Philips Lighting Corp, Irving, TX USA; [Segal, Mark R.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Sterling, David G.; Williams, Stephen A.] SomaLogic, Boulder, CO USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of Zurich; Norwegian University of Science & Technology (NTNU); Philips; University of California System; University of California San Francisco	Ganz, P (corresponding author), Univ Calif San Francisco, Dept Med, 1001 Potrero Ave,Room 5G1, San Francisco, CA 94110 USA.	peter.ganz@ucsf.edu	Hveem, Kristian/AFV-4683-2022	Ganz, Peter/0000-0002-0437-8882; Heidecker, Bettina/0000-0002-3811-7920; Jonasson, Christian/0000-0002-7694-6025	Department of Veterans Affairs; National Heart, Lung, and Blood Institute [R01 HL079235]; American Federation for Aging Research; Robert Wood Johnson Foundation; Ischemia Research and Education Foundation; Norwegian Ministry of Health; Norges Teknisk-Naturvitenskapelige University; Norwegian Research Council; Central Norway Regional Health Authority; Nord-Trondelag County Council; Norwegian Institute of Public Health; SomaLogic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Federation for Aging Research; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Ischemia Research and Education Foundation; Norwegian Ministry of Health; Norges Teknisk-Naturvitenskapelige University; Norwegian Research Council(Research Council of NorwayEuropean Commission); Central Norway Regional Health Authority; Nord-Trondelag County Council; Norwegian Institute of Public Health; SomaLogic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Heart and Soul cohort was supported by the Department of Veterans Affairs; the National Heart, Lung, and Blood Institute (R01 HL079235); the American Federation for Aging Research; the Robert Wood Johnson Foundation; and the Ischemia Research and Education Foundation. The HUNT3 cohort was funded by the Norwegian Ministry of Health, Norges Teknisk-Naturvitenskapelige University, the Norwegian Research Council, Central Norway Regional Health Authority, the Nord-Trondelag County Council, and the Norwegian Institute of Public Health. Measurement of all proteins in both cohorts was funded by SomaLogic.	Beatty AL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001646; Brody E, 2012, J MOL BIOL, V422, P595, DOI 10.1016/j.jmb.2012.06.021; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; Dadu RT, 2014, NAT REV CARDIOL, V11, P563, DOI 10.1038/nrcardio.2014.84; Eagle KA, 2010, CIRCULATION, V121, P1447, DOI 10.1161/CIRCULATIONAHA.109.904029; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Kraemer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026332; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Lindsey ML, 2015, CIRCULATION, V132, P852, DOI 10.1161/CIR.0000000000000226; Marcus GM, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.05.019; McClelland RL, 2015, J AM COLL CARDIOL, V66, P1643, DOI 10.1016/j.jacc.2015.08.035; McShane LM, 2013, NATURE, V502, P317, DOI 10.1038/nature12564; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; Mehan MR, 2013, ADV EXP MED BIOL, V735, P283, DOI 10.1007/978-1-4614-4118-2_20; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Olson KA, 2015, EUR HEART J, V36, P3426, DOI 10.1093/eurheartj/ehv385; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pencina MJ, 2012, STAT MED, V31, P1543, DOI 10.1002/sim.4508; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pepe MS, UW BIOSTATISTICS WOR, V384; R Core Team RFfSC, 2013, AUSTR R LANG ENV STA; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Wilson PWF, 2012, AM J MED, V125, P695, DOI 10.1016/j.amjmed.2012.01.014	34	174	178	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2532	2541		10.1001/jama.2016.5951	http://dx.doi.org/10.1001/jama.2016.5951			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27327800	Bronze			2022-12-28	WOS:000378306700017
J	Frisbie, CD				Frisbie, C. Daniel			Designing a robust single-molecule switch A single-molecule switch works at room temperature	SCIENCE			English	Editorial Material							JUNCTIONS		[Frisbie, C. Daniel] Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Frisbie, CD (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	frisbie@umn.edu						Baldea I, 2015, NANOSCALE, V7, P10465, DOI 10.1039/c5nr02225h; Bergren AJ, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/9/094011; Jia CC, 2016, SCIENCE, V352, P1443, DOI 10.1126/science.aaf6298; Katsonis N, 2006, ADV MATER, V18, P1397, DOI 10.1002/adma.200600210; Kim Y, 2014, NAT NANOTECHNOL, V9, P881, DOI [10.1038/nnano.2014.209, 10.1038/NNANO.2014.209]; Manrique DZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7389; Meng FB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4023; Schmaus S, 2011, NAT NANOTECHNOL, V6, P185, DOI [10.1038/nnano.2011.11, 10.1038/NNANO.2011.11]; Song H, 2009, NATURE, V462, P1039, DOI 10.1038/nature08639; Su TA, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.2; Xiang LM, 2015, NAT CHEM, V7, P221, DOI [10.1038/NCHEM.2183, 10.1038/nchem.2183]; Yuan L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7324; Zhang XY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11118	13	18	18	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1394	1395		10.1126/science.aag0827	http://dx.doi.org/10.1126/science.aag0827			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313025				2022-12-28	WOS:000377975400022
J	Mora, S; Ames, JM; Manson, JE				Mora, Samia; Ames, Jeffrey M.; Manson, JoAnn E.			Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease Shared Decision Making in Clinical Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mora, Samia; Manson, JoAnn E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Mora, Samia; Manson, JoAnn E.] Harvard Med Sch, Boston, MA USA; [Mora, Samia] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Ames, Jeffrey M.] Software & Mobile Applicat Dev, Boston, MA USA; [Manson, JoAnn E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Manson, JE (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, 900 Commonwealth Ave,Third Floor, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu		Mora, Samia/0000-0001-6283-0980	NCI NIH HHS [CA138962] Funding Source: Medline; NHLBI NIH HHS [HL117861, R01 HL034594, HL034594] Funding Source: Medline; PHS HHS [HHSN268201100001C] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA138962, U01CA138962] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117861, R01HL034594] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS60, DOI 10.2337/dc16-S011; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; De Berardis G, 2012, JAMA-J AM MED ASSOC, V307, P2286, DOI 10.1001/jama.2012.5034; Guirguis-Blake JM, 2016, ANN INTERN MED, V164, P804, DOI 10.7326/M15-2113; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Mainous AG, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000989; Mora S, JAMA INTERN MED, DOI [10.1001/jamainternmed.2016.2648, DOI 10.1001/JAMAINTERNMED.2016]; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Whitlock EP, 2015, AHRQ PUBLICATION, V132; Whitlock EP, 2016, ANN INTERN MED, V164, P826, DOI 10.7326/M15-2112	10	30	35	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					709	710		10.1001/jama.2016.8362	http://dx.doi.org/10.1001/jama.2016.8362			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27323335				2022-12-28	WOS:000381514800012
J	Winter, S; Diamond, M; Green, J; Karasic, D; Reed, T; Whittle, S; Wylie, K				Winter, Sam; Diamond, Milton; Green, Jamison; Karasic, Dan; Reed, Terry; Whittle, Stephen; Wylie, Kevan			Transgender people: health at the margins of society	LANCET			English	Article							SEX HORMONAL TREATMENT.; QUALITY-OF-LIFE; GENDER IDENTITY; MENTAL-HEALTH; FEMALE TRANSSEXUALS; WHITE-MATTER; REASSIGNMENT; BRAIN; RISK; DIFFERENCE	In this paper we examine the social and legal conditions in which many transgender people (often called trans people) live, and the medical perspectives that frame the provision of health care for transgender people across much of the world. Modern research shows much higher numbers of transgender people than were apparent in earlier clinic-based studies, as well as biological factors associated with gender incongruence. We examine research showing that many transgender people live on the margins of society, facing stigma, discrimination, exclusion, violence, and poor health. They often experience difficulties accessing appropriate health care, whether specific to their gender needs or more general in nature. Some governments are taking steps to address human rights issues and provide better legal protection for transgender people, but this action is by no means universal. The mental illness perspective that currently frames health-care provision for transgender people across much of the world is under scrutiny. The WHO diagnostic manual may soon abandon its current classification of transgender people as mentally disordered. Debate exists as to whether there should be a diagnosis of any sort for transgender children below the age of puberty.	[Winter, Sam] Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA 6102, Australia; [Diamond, Milton] Univ Hawaii, John A Burns Sch Med, Pacific Ctr Sex & Soc, Manoa, HI USA; [Green, Jamison] Calif Inst Integral Studies, San Francisco, CA USA; [Karasic, Dan] Univ Calif & San Francisco, Dept Psychiat, San Francisco, CA USA; [Reed, Terry] Gender Ident Res & Educ Soc, Ashtead, England; [Whittle, Stephen] Manchester Metropolitan Univ, Sch Law, Manchester, Lancs, England; [Wylie, Kevan] Porterbrook Clin, Sheffield, S Yorkshire, England; [Wylie, Kevan] Royal Hallamshire Hosp, Sheffield, S Yorkshire, England	Curtin University; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California San Francisco; Manchester Metropolitan University; University of Sheffield	Winter, S (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA 6102, Australia.	sam.winter@curtin.edu.au	Wylie, Kevan/C-5751-2011	Wylie, Kevan/0000-0003-3805-105X	United Nations Development Programme	United Nations Development Programme	The United Nations Development Programme funded a developmental review meeting for this Series.	Alston P, 2007, YOGYAKARTA PRINCIPLE; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; AmFAR, 2014, T POP HIV TIM END NE; Amnesty International, 2014, FJR; [Anonymous], 2014, AMA CALLS MOD BIRTH; [Anonymous], 2015, STAT GEND INC CHILDH; [Anonymous], 2011, J SEX MED, DOI DOI 10.1111/j.1743-6109.2011.02449.x; Aristegui I, 2014, 20 INT AIDS C MELB; Balzer C., 2012, TRANSRESPECT VERSUS; Bao AM, 2011, FRONT NEUROENDOCRIN, V32, P214, DOI 10.1016/j.yfrne.2011.02.007; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bauer GR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1867-2; Berglund H, 2008, CEREB CORTEX, V18, P1900, DOI 10.1093/cercor/bhm216; Bockting WO, 2013, AM J PUBLIC HEALTH, V103, P943, DOI 10.2105/AJPH.2013.301241; Bradley SJ, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e9; Burke SM, 2014, ARCH SEX BEHAV, V43, P1515, DOI 10.1007/s10508-014-0278-2; Byrne, 2013, DISCUSSION PAPER TRA; Byrne J., 2014, LICENSE BE YOURSELF; Clark TC, 2014, J ADOLESCENT HEALTH, V55, P93, DOI 10.1016/j.jadohealth.2013.11.008; Clements-Nolle K, 2006, J HOMOSEXUAL, V51, P53, DOI 10.1300/J082v51n03_04; Cochran SD, 2014, B WORLD HEALTH ORGAN, V92, P672, DOI 10.2471/BLT.14.135541; Conron KJ, 2012, AM J PUBLIC HEALTH, V102, P118, DOI 10.2105/AJPH.2011.300315; de Vries ALC, 2014, PEDIATRICS, V134, P696, DOI 10.1542/peds.2013-2958; Dessens AB, 2005, ARCH SEX BEHAV, V34, P389, DOI 10.1007/s10508-005-4338-5; Dessens AB, 1999, ARCH SEX BEHAV, V28, P31, DOI 10.1023/A:1018789521375; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Dhejne C, 2014, ARCH SEX BEHAV, V43, P1535, DOI 10.1007/s10508-014-0300-8; Dhejne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016885; Diamond M, 2004, CHILD ADOL PSYCH CL, V13, P623, DOI 10.1016/j.chc.2004.02.015; Diamond M, 1997, ARCH PEDIAT ADOL MED, V151, P298, DOI 10.1001/archpedi.1997.02170400084015; Diamond M, 2013, INT J TRANSGENDERISM, V14, P24, DOI 10.1080/15532739.2013.750222; Diamond M, 2009, ARCH SEX BEHAV, V38, P172, DOI 10.1007/s10508-008-9438-6; Drescher J, 2016, LANCET PSYCHIAT, V3, P297, DOI 10.1016/S2215-0366(15)00586-6; Drescher J, 2012, INT REV PSYCHIATR, V24, P568, DOI 10.3109/09540261.2012.741575; Drew N, 2011, LANCET, V378, P1664, DOI 10.1016/S0140-6736(11)61458-X; Fraser L, 2010, INT J TRANSGENDERISM, V12, P80, DOI 10.1080/15532739.2010.509202; Garcia-Falgueras A, 2008, BRAIN, V131, P3132, DOI 10.1093/brain/awn276; Glen F, 2012, TECHNICAL NOTE MEASU; Global Action for Trans* Equality, 2013, ENGL TRANSL ARG GEND; Global Action for Trans* Equality, 2011, GATE EXP M HAG NOV 1; Global Action for Trans* Equality Civil Society Expert Working Group, 2013, WORK GROUP M BUEN AI; Gooren LJ, 2013, ASIAN J ANDROL, V15, P280, DOI 10.1038/aja.2012.139; Gorin-Lazard A, 2012, J SEX MED, V9, P531, DOI 10.1111/j.1743-6109.2011.02564.x; Government of Malta, 2015, GEND EXPR SEC CHAR A; Govier E, 2010, INT J TRANSGENDERISM, V12, P144, DOI 10.1080/15532739.2010.514219; Grant J, 2011, INJUSTICE EVERY TURN, P3; Green R, 2000, ARCH SEX BEHAV, V29, P499, DOI 10.1023/A:1001947920872; Green R, 2001, ARCH SEX BEHAV, V30, P565, DOI 10.1023/A:1011908532367; Greenfield C., 2014, ATLANTIC; Haas A. P., 2014, SUICIDE ATTEMPTS TRA; Hancock K, 2012, AM PSYCHOL, V67, P10, DOI 10.1037/a0024659; Hare L, 2009, BIOL PSYCHIAT, V65, P93, DOI 10.1016/j.biopsych.2008.08.033; Henningsson S, 2005, PSYCHONEUROENDOCRINO, V30, P657, DOI 10.1016/j.psyneuen.2005.02.006; Home Affairs, 2014, REP SIT FUND RIGHTS; Hyde Z., 2014, 1 AUSTR NATL T MENTA; ILGA-EUROPE, 2015, RAINB MAP IND; Jim Collins Foundation, GEND CONF SURG GRANT; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Keo-Meier CL, 2015, J CONSULT CLIN PSYCH, V83, P143, DOI 10.1037/a0037599; Kerry SC, 2014, INT J TRANSGENDERISM, V15, P173, DOI 10.1080/15532739.2014.995262; Kipnis K, 1998, J CLIN ETHIC, V9, P398; Kohler R, 2013, LEGAL GENDER RECOGNI; Kruijver FPM, 2000, J CLIN ENDOCR METAB, V85, P2034, DOI 10.1210/jc.85.5.2034; Kuyper L, 2014, ARCH SEX BEHAV, V43, P377, DOI 10.1007/s10508-013-0140-y; Liao LM, 2012, J PEDIATR UROL, V8, P597, DOI 10.1016/j.jpurol.2012.09.009; Luders E, 2009, NEUROIMAGE, V46, P904, DOI 10.1016/j.neuroimage.2009.03.048; McNeil J, 2014, SPEAKING MARGINS T M; Murad MH, 2010, CLIN ENDOCRINOL, V72, P214, DOI 10.1111/j.1365-2265.2009.03625.x; Nadal KL, 2014, J TRAUMA DISSOCIATIO, V15, P169, DOI 10.1080/15299732.2014.867572; Nuttbrock L, 2010, J SEX RES, V47, P12, DOI 10.1080/00224490903062258; Ochoa B, 1996, J UROLOGY, V160, P1116; Perez-Brumer A, 2015, BEHAV MED, V41, P164, DOI 10.1080/08964289.2015.1028322; Poompruek P, 2014, INT J DRUG POLICY, V25, P798, DOI 10.1016/j.drugpo.2014.06.015; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Rametti G, 2011, J PSYCHIATR RES, V45, P949, DOI 10.1016/j.jpsychires.2010.11.007; Rametti G, 2011, J PSYCHIATR RES, V45, P199, DOI 10.1016/j.jpsychires.2010.05.006; Reed GM, 2011, WORLD PSYCHIATRY, V10, P118; Riggs D, 2013, GENDER IDENTITY AUST; Savic I, 2011, CEREB CORTEX, V21, P2525, DOI 10.1093/cercor/bhr032; SNAITH RP, 1991, LANCET, V337, P557, DOI 10.1016/0140-6736(91)91348-X; Stevens M, 2002, PARENT-SCI PRACT, V2, P47, DOI 10.1207/S15327922PAR0201_3; Transgender Europe, 2016, IDAHOT 2016 T MURD M; Transgender Europe, 2016, T RIGHTS EUR 2016 MA; UNCHR UN Women UNAIDS UNDP UNFPA UNICEF WHO., 2014, EL FORC COERC OTH IN; Van Caenegem E, 2015, ARCH SEX BEHAV, V44, P1281, DOI 10.1007/s10508-014-0452-6; Whittle S, 2008, EUROSTUDY LEGAL SURV; WHO Western Pacific Region, 2013, REG ASS HIV STI OTH; Winter S, 2016, GENDER INCONGRUENCE; Winter S., 2012, FOCUS, P69; Winter S, 2009, INT J SEX HEALTH, V21, P35, DOI 10.1080/19317610802554141; Winter S, 2009, INT J SEX HEALTH, V21, P96, DOI 10.1080/19317610902922537; World Health Organization, 2018, INT CLASSIFICATION D; World Medical Assocation, STAT FORC COERC STER; World Professional Association for Transgender Health, 2013, WPATH ICD 11 CONS M; World Professional Association for Transgender Health, 2015, STAT LEG REC GEND ID; World Professional Association for Transgender Health, 2010, ID REC STAT; World Professional Association for Transgender Health, 2015, ICD11 WORLD PROF ASS; World Professional Association on Transgender Health, 2012, STAND CAR HLTH TRANS; Wylie K, 2016, LANCET; Xavier J., 2007, HLTH HLTH RELATED NE; Yadegarfard M, 2014, J LGBT YOUTH, V11, P347, DOI 10.1080/19361653.2014.910483; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0; Zucker KJ, 2001, J CHILD PSYCHOL PSYC, V42, P767, DOI 10.1111/1469-7610.00773; Zucker KJ., 1992, GENDER IDENTITY DISO, V3, P73, DOI [10.1080/10532528.1992.10559876, DOI 10.1080/10532528.1992.10559876]	104	442	449	11	135	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					390	400		10.1016/S0140-6736(16)00683-8	http://dx.doi.org/10.1016/S0140-6736(16)00683-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR6MV	27323925	Green Accepted			2022-12-28	WOS:000380016900042
J	Chapman, S; Alpers, P; Jones, M				Chapman, Simon; Alpers, Philip; Jones, Michael			Association Between Gun Law Reforms and Intentional Firearm Deaths in Australia, 1979-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Rapid-fire weapons are often used by perpetrators in mass shooting incidents. In 1996 Australia introduced major gun law reforms that included a ban on semiautomatic rifles and pump-action shotguns and rifles and also initiated a program for buyback of firearms. OBJECTIVE To determine whether enactment of the 1996 gun laws and buyback program were followed by changes in the incidence of mass firearm homicides and total firearm deaths. DESIGN Observational study using Australian government statistics on deaths caused by firearms (1979-2013) and news reports of mass shootings in Australia (1979-May 2016). Changes in intentional firearm death rates were analyzed with negative binomial regression, and data on firearm-related mass killings were compared. EXPOSURES Implementation of major national gun law reforms. MAIN OUTCOMES AND MEASURES Changes in mass fatal shooting incidents (defined as >= 5 victims, not including the perpetrator) and in trends of rates of total firearm deaths, firearm homicides and suicides, and total homicides and suicides per 100 000 population. RESULTS From 1979-1996 (before gun law reforms), 13 fatal mass shootings occurred in Australia, whereas from 1997 through May 2016 (after gun law reforms), no fatal mass shootings occurred. There was also significant change in the preexisting downward trends for rates of total firearm deaths prior to vs after gun law reform. From 1979-1996, the mean rate of total firearm deaths was 3.6 (95% CI, 3.3-3.9) per 100 000 population (average decline of 3% per year; annual trend, 0.970; 95% CI, 0.963-0.976), whereas from 1997-2013 (after gun law reforms), the mean rate of total firearm deaths was 1.2 (95% CI, 1.0-1.4) per 100 000 population (average decline of 4.9% per year; annual trend, 0.951; 95% CI, 0.940-0.962), with a ratio of trends in annual death rates of 0.981 (95% CI, 0.968-0.993). There was a statistically significant acceleration in the preexisting downward trend for firearm suicide (ratio of trends, 0.981; 95% CI, 0.970-0.993), but this was not statistically significant for firearm homicide (ratio of trends, 0.975; 95% CI, 0.949-1.001). From 1979-1996, the mean annual rate of total nonfirearm suicide and homicide deaths was 10.6 (95% CI, 10.0-11.2) per 100 000 population (average increase of 2.1% per year; annual trend, 1.021; 95% CI, 1.016-1.026), whereas from 1997-2013, the mean annual rate was 11.8 (95% CI, 11.3-12.3) per 100 000 (average decline of 1.4% per year; annual trend, 0.986; 95% CI, 0.980-0.993), with a ratio of trends of 0.966 (95% CI, 0.958-0.973). There was no evidence of substitution of other lethal methods for suicides or homicides. CONCLUSIONS AND RELEVANCE Following enactment of gun law reforms in Australia in 1996, there were no mass firearm killings through May 2016. There was a more rapid decline in firearm deaths between 1997 and 2013 compared with before 1997 but also a decline in total nonfirearm suicide and homicide deaths of a greater magnitude. Because of this, it is not possible to determine whether the change in firearm deaths can be attributed to the gun law reforms.	[Chapman, Simon; Alpers, Philip] Univ Sydney, Sch Publ Hlth, Edward Ford Bldg A27, Sydney, NSW 2006, Australia; [Jones, Michael] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia	University of Sydney; Macquarie University	Chapman, S (corresponding author), Univ Sydney, Sch Publ Hlth, Edward Ford Bldg A27, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009; Jones, Michael/A-9013-2013	Jones, Michael/0000-0003-0565-4938				Alpers P., AUSTR CIVILIAN GUN I; Alpers P, AUSTR PROPORTION HOU; Alpers P, AUSTR FIREARM AMNEST; Alpers Philip, 2013, REDUCING GUN VIOLENC, V205; Beaman V, 2000, ANN EMERG MED, V35, P258, DOI 10.1016/S0196-0644(00)70077-1; Bricknell S., FIREARM TRAFFICKING; Chapman S, 2006, INJURY PREV, V12, P365, DOI 10.1136/ip.2006.013714; Chapman S, 1998, ACCIDENT ANAL PREV, V30, P815, DOI 10.1016/S0001-4575(98)00034-7; Chapman S., 2013, OUR DEAD BODIES PORT, P117; Clark David E, 2014, Inj Epidemiol, V1, P24; Duwe G, 2004, JUSTICE Q, V21, P729, DOI 10.1080/07418820400095971; Harrison J, INJURY DEATHS DATA A; Hudson P., 2004, THE AGE         0808; Morton RJ, SERIAL MURDER MULTID; Peters R., 2013, REDUCING GUN VIOLENC, P195; Reuter P., 2003, EVALUATING GUN POLIC, P121; Spittal MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044565	17	70	70	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2016	316	3					291	299		10.1001/jama.2016.8752	http://dx.doi.org/10.1001/jama.2016.8752			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR3LN	27332876	Bronze			2022-12-28	WOS:000379804800017
J	Nieto, MA; Huang, RYJ; Jackson, RA; Thiery, JP				Angela Nieto, M.; Huang, Ruby Yun-Ju; Jackson, Rebecca A.; Thiery, Jean Paul			EMT: 2016	CELL			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM-CELLS; CIRCULATING TUMOR-CELLS; NEURAL CREST CELLS; METASTATIC BREAST-CANCER; HEPATIC STELLATE CELLS; E-CADHERIN REPRESSION; SRC-KINASE INHIBITOR; HEAT-SHOCK PROTEINS; GROWTH-FACTOR-BETA	The significant parallels between cell plasticity during embryonic development and carcinoma progression have helped us understand the importance of the epithelial-mesenchymal transition (EMT) in human disease. Our expanding knowledge of EMT has led to a clarification of the EMT program as a set of multiple and dynamic transitional states between the epithelial and mesenchymal phenotypes, as opposed to a process involving a single binary decision. EMT and its intermediate states have recently been identified as crucial drivers of organ fibrosis and tumor progression, although there is some need for caution when interpreting its contribution to metastatic colonization. Here, we discuss the current state-of-the-art and latest findings regarding the concept of cellular plasticity and heterogeneity in EMT. We raise some of the questions pending and identify the challenges faced in this fast-moving field.	[Angela Nieto, M.] Inst Neurociencias CSIC UMH, Avda Ramon y Cajal S-N, Alacant 03550, Spain; [Huang, Ruby Yun-Ju] Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 119228, Singapore; [Huang, Ruby Yun-Ju; Thiery, Jean Paul] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Jackson, Rebecca A.; Thiery, Jean Paul] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117596, Singapore; [Thiery, Jean Paul] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Nieto, MA (corresponding author), Inst Neurociencias CSIC UMH, Avda Ramon y Cajal S-N, Alacant 03550, Spain.; Thiery, JP (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore.; Thiery, JP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117596, Singapore.; Thiery, JP (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore.	anieto@umh.es; bchtjp@nus.edu.sg	Thiery, Jean Paul/M-9387-2019; Nieto, M. Angela/A-6531-2008; Huang, Ruby Yun-Ju/AAE-8854-2019; Thiery, Jean Paul/H-1550-2011	Nieto, M. Angela/0000-0002-3538-840X; Huang, Ruby Yun-Ju/0000-0001-6376-3185; Thiery, Jean Paul/0000-0003-0478-5020	Spanish Ministry of Economy and Competitiveness [MINECO-BFU2014-53128-R]; Generalitat Valenciana [II/2013/002, ISIC 2012/010]; European Research Council [ERC AdG322694]; Department of Biochemistry and Cancer Science Institute National University of Singapore and Institute of Molecular Cell Biology A*STAR Singapore	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Research Council(European Research Council (ERC)European Commission); Department of Biochemistry and Cancer Science Institute National University of Singapore and Institute of Molecular Cell Biology A*STAR Singapore(National University of Singapore)	We sincerely apologize to colleagues whose work has been omitted from this review owing to space limitations. We thank Stuart Ingham from the Instituto de Neurociencias for his help with the figures. This work has been supported by grants from the Spanish Ministry of Economy and Competitiveness (MINECO-BFU2014-53128-R), the Generalitat Valenciana (Prometeo II/2013/002 and ISIC 2012/010), and the European Research Council (ERC AdG322694) to M.A.N. and from Department of Biochemistry and Cancer Science Institute National University of Singapore and Institute of Molecular Cell Biology A*STAR Singapore to J.P.T. The Instituto de Neurociencias is a Centre of Excellence Severo Ochoa. This review is dedicated to the late Professor Gerald Maurice Edelman who was very influential on the research carried out by J.P.T. and to Mr. Angel Nieto who passed away recently and always was a role model for M.A.N.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; Akalay I, 2013, CANCER RES, V73, P2418, DOI 10.1158/0008-5472.CAN-12-2432; Alderton GK, 2013, NAT REV CANCER, V13, P3, DOI 10.1038/nrc3428; Alix-Panabieres C, 2014, LAB CHIP, V14, P57, DOI 10.1039/c3lc50644d; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Antoniou A, 2013, CELL CYCLE, V12, P3743, DOI 10.4161/cc.27305; Aref AR, 2013, INTEGR BIOL-UK, V5, P381, DOI 10.1039/c2ib20209c; Ariza L, 2016, DEV DYNAM, V245, P307, DOI 10.1002/dvdy.24373; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Au SH, 2016, P NATL ACAD SCI USA, V113, P4947, DOI 10.1073/pnas.1524448113; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Baek ST, 2012, DEVELOPMENT, V139, P2040, DOI 10.1242/dev.074054; Baggiolini A, 2015, CELL STEM CELL, V16, P314, DOI 10.1016/j.stem.2015.02.017; Bahri S, 2010, DEVELOPMENT, V137, P2023, DOI 10.1242/dev.045088; Bai J, 2015, ONCOTARGET, V6, P36603, DOI 10.18632/oncotarget.5464; Bai J, 2015, ONCOTARGET, V6, P25295, DOI 10.18632/oncotarget.4716; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Beck B, 2015, CELL STEM CELL, V16, P67, DOI 10.1016/j.stem.2014.12.002; Bedi U, 2014, ONCOTARGET, V5, P2016, DOI 10.18632/oncotarget.1875; Beerling E, 2016, CELL REP, V14, P2281, DOI 10.1016/j.celrep.2016.02.034; Bellaye PS, 2014, PHARMACOL THERAPEUT, V143, P119, DOI 10.1016/j.pharmthera.2014.02.009; Beug H, 2009, CELL, V138, P623, DOI 10.1016/j.cell.2009.08.007; Bidard FC, 2008, CLIN CANCER RES, V14, P3306, DOI 10.1158/1078-0432.CCR-07-4749; Bidard FC, 2014, LANCET ONCOL, V15, P406, DOI 10.1016/S1470-2045(14)70069-5; Blanco MJ, 2007, DEVELOPMENT, V134, P4073, DOI 10.1242/dev.006858; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Bonomi S, 2013, NUCLEIC ACIDS RES, V41, P8665, DOI 10.1093/nar/gkt579; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; BOUCAUT JC, 1984, NATURE, V307, P364, DOI 10.1038/307364a0; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Braeutigam C, 2014, ONCOGENE, V33, P1082, DOI 10.1038/onc.2013.50; Brockhausen J, 2015, LIVER INT, V35, P240, DOI 10.1111/liv.12517; Bronnum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056280; Buitrago-Delgado E, 2015, SCIENCE, V348, P1332, DOI 10.1126/science.aaa3655; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cano E, 2016, P NATL ACAD SCI USA, V113, P656, DOI 10.1073/pnas.1509834113; Carmody LC, 2012, J BIOMOL SCREEN, V17, P1204, DOI 10.1177/1087057112458317; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Chan YS, 2013, STEM CELLS, V31, P682, DOI 10.1002/stem.1307; Chang CC, 2013, CANCER RES, V73, P4147, DOI 10.1158/0008-5472.CAN-12-4085; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen A, 2015, ONCOTARGET, V6, P862, DOI 10.18632/oncotarget.2696; Chen YL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.154; Cheng SZD, 1998, ANNU REV MATER SCI, V28, P533, DOI 10.1146/annurev.matsci.28.1.533; Chouaib S, 2014, CRIT REV IMMUNOL, V34, P91, DOI 10.1615/CritRevImmunol.2014010183; Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206; Chua KN, 2011, ADV DRUG DELIVER REV, V63, P558, DOI 10.1016/j.addr.2011.02.003; Chung VY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19943; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Clay MR, 2014, DEVELOPMENT, V141, P2506, DOI 10.1242/dev.105551; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Darido Charbel, 2010, Small GTPases, V1, P104, DOI 10.4161/sgtp.1.2.13620; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Deng HJ, 2014, EXP MOL PATHOL, V97, P176, DOI 10.1016/j.yexmp.2014.07.003; Diaz VM, 2016, SEMIN CANCER BIOL, V36, P71, DOI 10.1016/j.semcancer.2015.10.003; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Dong C, 2013, ONCOGENE, V32, P1351, DOI 10.1038/onc.2012.169; Drasin DJ, 2015, CANCER RES, V75, P1908, DOI 10.1158/0008-5472.CAN-14-2394; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; EDELMAN GM, 1983, P NATL ACAD SCI-BIOL, V80, P4384, DOI 10.1073/pnas.80.14.4384; Engl W, 2015, RESIST TARGET ANTI-C, V7, P267, DOI 10.1007/978-3-319-17807-3_12; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Futterman MA, 2011, DEV DYNAM, V240, P1502, DOI 10.1002/dvdy.22607; Gaeta X, 2013, NAT CELL BIOL, V15, P725, DOI 10.1038/ncb2800; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Grigore AD, 2016, J CLIN MED, V5, P51, DOI 10.3390/jcm5050051; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hamilton DH, 2013, ONCOTARGET, V4, P1777, DOI 10.18632/oncotarget.1295; Harney AS, 2015, CANCER DISCOV, V5, P932, DOI 10.1158/2159-8290.CD-15-0012; Hay ED, 1995, ACTA ANAT, V154, P8; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hlubek F, 2001, J BIOCHEM-TOKYO, V129, P635, DOI 10.1093/oxfordjournals.jbchem.a002901; Holzel M, 2013, NAT REV CANCER, V13, P365, DOI 10.1038/nrc3498; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Hong T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004569; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Hu N, 2014, DEV BIOL, V396, P159, DOI 10.1016/j.ydbio.2014.09.034; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Huang RYJ, 2012, J CELL SCI, V125, P4417, DOI 10.1242/jcs.099697; Hudson LG, 2009, J DERMATOL SCI, V56, P19, DOI 10.1016/j.jdermsci.2009.06.009; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Huleihel L, 2014, AM J PHYSIOL-LUNG C, V306, pL534, DOI 10.1152/ajplung.00149.2013; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hutchinson J, 2015, EUR RESPIR J, V46, P795, DOI 10.1183/09031936.00185114; Hwang WL, 2014, NAT CELL BIOL, V16, P268, DOI 10.1038/ncb2910; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Infante JR, 2012, J CLIN ONCOL, V30, P1527, DOI 10.1200/JCO.2011.38.9346; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Javaid S, 2013, CELL REP, V5, P1679, DOI 10.1016/j.celrep.2013.11.034; Jiang L, 2015, ONCOGENE, V34, P3908, DOI 10.1038/onc.2014.321; Jolly MK, 2016, ONCOTARGET, DOI 10.18632/oncotarget.8166; Jolly MK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00155; Jordan NV, 2011, CELL CYCLE, V10, P2865, DOI 10.4161/cc.10.17.17188; Jung HY, 2015, CELL STEM CELL, V16, P1, DOI 10.1016/j.stem.2014.12.005; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Khoo BL, 2015, ONCOTARGET, V6, P15578; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kitazawa K, 2016, CELL REP, V15, P1359, DOI 10.1016/j.celrep.2016.04.020; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Kurley SJ, 2012, DEVELOPMENT, V139, P1754, DOI 10.1242/dev.072769; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lamouille S, 2013, CURR OPIN CELL BIOL, V25, P200, DOI 10.1016/j.ceb.2013.01.008; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee B, 2014, DEV CELL, V29, P47, DOI 10.1016/j.devcel.2014.03.005; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee RTH, 2013, DEVELOPMENT, V140, P4890, DOI 10.1242/dev.094680; Leopold PL, 2012, SEMIN CANCER BIOL, V22, P471, DOI 10.1016/j.semcancer.2012.07.003; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li WY, 2016, TRENDS CANCER, V2, P65, DOI 10.1016/j.trecan.2016.01.001; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; Lin YW, 2014, CURR PHARM DESIGN, V20, P1698, DOI 10.2174/13816128113199990512; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Lomeli Hilda, 2009, BMC Res Notes, V2, P22, DOI 10.1186/1756-0500-2-22; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lu M, 2013, P NATL ACAD SCI USA, V110, P18144, DOI 10.1073/pnas.1318192110; Luxan G, 2016, CIRC RES, V118, pE1, DOI 10.1161/CIRCRESAHA.115.305350; Maheswaran S, 2015, NATURE, V527, P452, DOI 10.1038/nature16313; Manhire-Heath R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3790; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mingot JM, 2013, CELL REP, V5, P727, DOI 10.1016/j.celrep.2013.09.030; Perez-Pomares JM, 2011, CIRC RES, V109, P1429, DOI 10.1161/CIRCRESAHA.111.245589; Martin YD, 2015, CELL REP, V13, P2456, DOI 10.1016/j.celrep.2015.11.025; Mathow D, 2015, EMBO REP, V16, P321, DOI 10.15252/embr.201439333; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Mehal WZ, 2011, NAT MED, V17, P552, DOI 10.1038/nm0511-552; Meidhof S, 2015, EMBO MOL MED, V7, P831, DOI 10.15252/emmm.201404396; Millanes-Romero A, 2013, MOL CELL, V52, P746, DOI 10.1016/j.molcel.2013.10.015; Mingot JM, 2009, J CELL SCI, V122, P1452, DOI 10.1242/jcs.041749; Montgomery RL, 2014, EMBO MOL MED, V6, P1347, DOI 10.15252/emmm.201303604; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morizane R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04578; Moskowitz IP, 2011, P NATL ACAD SCI USA, V108, P4006, DOI 10.1073/pnas.1019025108; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; NAVARRO P, 1993, J CELL SCI, V105, P923; Nielsen SR, 2016, NAT CELL BIOL, V18, P549, DOI 10.1038/ncb3340; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nunan R, 2015, CELL REP, V13, P1380, DOI 10.1016/j.celrep.2015.09.085; Oba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013614; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Palumbo-Zerr K, 2015, NAT MED, V21, P150, DOI 10.1038/nm.3777; Pandian V, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0002-8; Park JH, 2015, BIOCHIMIE, V113, P26, DOI 10.1016/j.biochi.2015.03.015; Park KS, 2010, DEVELOPMENT, V137, P2691, DOI 10.1242/dev.050096; Pattabiraman DR, 2016, SCIENCE, V351, P1042, DOI 10.1126/science.aad3680; Pedroza M, 2016, FASEB J, V30, P129, DOI 10.1096/fj.15-273953; Peinado H, 2005, CELL CYCLE, V4, P1749, DOI 10.4161/cc.4.12.2224; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Polydorou C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2646; Pottier N, 2014, TRENDS PHARMACOL SCI, V35, P119, DOI 10.1016/j.tips.2014.01.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Puls LN, 2011, ONCOLOGIST, V16, P566, DOI 10.1634/theoncologist.2010-0408; Qi Q, 2015, P NATL ACAD SCI USA, V112, P7255, DOI 10.1073/pnas.1505917112; Qian BZ, 2015, J EXP MED, V212, P1433, DOI 10.1084/jem.20141555; Qian LW, 2016, WOUND REPAIR REGEN, V24, P26, DOI 10.1111/wrr.12381; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rembold M, 2014, GENE DEV, V28, P167, DOI 10.1101/gad.230953.113; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Rodon J, 2015, CLIN CANCER RES, V21, P553, DOI 10.1158/1078-0432.CCR-14-1380; Rosano L, 2006, EXP BIOL MED, V231, P1128; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Russell R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8677; Saitoh M, 2016, ONCOGENE, V35, P1049, DOI 10.1038/onc.2015.161; Sakabe M, 2012, DEVELOPMENT, V139, P385, DOI 10.1242/dev.067058; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Saunders LR, 2014, DEVELOPMENT, V141, P1503, DOI 10.1242/dev.101436; Scarpa E, 2015, DEV CELL, V34, P421, DOI 10.1016/j.devcel.2015.06.012; Schiffmacher AT, 2014, MOL BIOL CELL, V25, P41, DOI 10.1091/mbc.E13-08-0459; Schmidt JM, 2015, CELL REP, V10, P131, DOI 10.1016/j.celrep.2014.12.032; Scholten D, 2010, GASTROENTEROLOGY, V139, P987, DOI 10.1053/j.gastro.2010.05.005; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shamir ER, 2015, CURR TOP DEV BIOL, V112, P353, DOI 10.1016/bs.ctdb.2014.12.001; Shamir ER, 2014, J CELL BIOL, V204, P839, DOI 10.1083/jcb.201306088; Shaul YD, 2014, CELL, V158, P1094, DOI 10.1016/j.cell.2014.07.032; Shaw TJ, 2016, CURR OPIN CELL BIOL, V42, P29, DOI 10.1016/j.ceb.2016.04.001; Sheridan C, 2013, NAT BIOTECHNOL, V31, P775, DOI 10.1038/nbt0913-775a; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sosa MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7170; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Stankic M, 2013, CELL REP, V5, P1228, DOI 10.1016/j.celrep.2013.11.014; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; Tang O, 2013, AM J PHYSIOL-RENAL, V304, pF1266, DOI 10.1152/ajprenal.00302.2012; Tang Q, 2014, EUR J PHARMACOL, V741, P97, DOI 10.1016/j.ejphar.2014.07.051; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Theveneau E, 2011, CELL ADHES MIGR, V5, P490, DOI 10.4161/cam.5.6.18623; Thiery JP, 2013, CANCER CELL, V23, P272, DOI 10.1016/j.ccr.2013.03.004; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tian XJ, 2013, BIOPHYS J, V105, P1079, DOI 10.1016/j.bpj.2013.07.011; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran HD, 2014, CANCER RES, V74, P6330, DOI 10.1158/0008-5472.CAN-14-0923; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; Vaughan AE, 2013, BBA-MOL BASIS DIS, V1832, P922, DOI 10.1016/j.bbadis.2012.11.020; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Voon DCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070427; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070725, 10.1371/journal.pone.0060462, 10.1371/journal.pone.0077273, 10.1371/journal.pone.0081882]; Wang JM, 2015, ONCOTARGET, V6, P27427, DOI 10.18632/oncotarget.4861; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Watanabe K, 2014, DEV CELL, V29, P59, DOI 10.1016/j.devcel.2014.03.006; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Weston JA, 2015, DEV BIOL, V401, P37, DOI 10.1016/j.ydbio.2014.12.035; Wettstein G, 2013, FASEB J, V27, P1549, DOI 10.1096/fj.12-220053; Wu CY, 2012, TRENDS GENET, V28, P454, DOI 10.1016/j.tig.2012.05.005; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xiao W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08362; Yang FY, 2010, J PATHOL, V221, P390, DOI 10.1002/path.2721; Yang H, 2015, ONCOTARGET, V6, P6310, DOI 10.18632/oncotarget.3355; Yang MC, 2014, AM J CANCER RES, V4, P751; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2009, GENE DEV, V23, P1737, DOI 10.1101/gad.1809309; Zadran S, 2014, P NATL ACAD SCI USA, V111, P13235, DOI 10.1073/pnas.1414714111; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357; Zhang Y, 2012, CANCER LETT, V322, P70, DOI 10.1016/j.canlet.2012.02.010; Zhao SH, 2015, J CELL PHYSIOL, V230, P2706, DOI 10.1002/jcp.24995; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou FF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4388	293	2591	2697	23	495	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					21	45		10.1016/j.cell.2016.06.028	http://dx.doi.org/10.1016/j.cell.2016.06.028			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368099	Bronze			2022-12-28	WOS:000380254400009
J	Durbin, AP				Durbin, Anna P.			A Dengue Vaccine	CELL			English	Editorial Material									[Durbin, Anna P.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Durbin, AP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	adurbin1@jhu.edu							0	14	16	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					1	1		10.1016/j.cell.2016.06.036	http://dx.doi.org/10.1016/j.cell.2016.06.036			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368091	Bronze			2022-12-28	WOS:000380254400001
J	Belczynski, K; Holz, DE; Bulik, T; O'Shaughnessy, R				Belczynski, Krzysztof; Holz, Daniel E.; Bulik, Tomasz; O'Shaughnessy, Richard			The first gravitational-wave source from the isolated evolution of two stars in the 40-100 solar mass range	NATURE			English	Article							BLACK-HOLES; STELLAR EVOLUTION; COMMON ENVELOPE; NEUTRON-STARS; MERGER RATES; COMPACT; POPULATION; PROSPECTS; BINARIES; METALLICITY	The merger of two massive (about 30 solar masses) black holes has been detected in gravitational waves(1). This discovery validates recent predictions(2-4) that massive binary black holes would constitute the first detection. Previous calculations, however, have not sampled the relevant binary-black-hole progenitors-massive, low-metallicity binary stars-with sufficient accuracy nor included sufficiently realistic physics to enable robust predictions to better than several orders of magnitude(5-10). Here we report high-precision numerical simulations of the formation of binary black holes via the evolution of isolated binary stars, providing a framework within which to interpret the first gravitational-wave source, GW150914, and to predict the properties of subsequent binary-black-hole gravitational-wave events. Our models imply that these events form in an environment in which the metallicity is less than ten per cent of solar metallicity, and involve stars with initial masses of 40-100 solar masses that interact through mass transfer and a common-envelope phase. These progenitor stars probably formed either about 2 billion years or, with a smaller probability, 11 billion years after the Big Bang. Most binary black holes form without supernova explosions, and their spins are nearly unchanged since birth, but do not have to be parallel. The classical field formation of binary black holes we propose, with low natal kicks (the velocity of the black hole at birth) and restricted common-envelope evolution, produces approximately 40 times more binary-black-holes mergers than do dynamical formation channels involving globular clusters(11); our predicted detection rate of these mergers is comparable to that from homogeneous evolution channels(12-15). Our calculations predict detections of about 1,000 black-hole mergers per year with total masses of 20-80 solar masses once second-generation ground-based gravitational-wave observatories reach full sensitivity.	[Belczynski, Krzysztof; Bulik, Tomasz] Warsaw Univ, Astron Observ, Ujazdowskie 4, PL-00478 Warsaw, Poland; [Holz, Daniel E.] Univ Chicago, Enrico Fermi Inst, Dept Phys, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Holz, Daniel E.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [O'Shaughnessy, Richard] Rochester Inst Technol, Ctr Computat Relat & Gravitat, Rochester, NY 14623 USA	University of Warsaw; University of Chicago; University of Chicago; Rochester Institute of Technology	Belczynski, K (corresponding author), Warsaw Univ, Astron Observ, Ujazdowskie 4, PL-00478 Warsaw, Poland.	chrisbelczynski@gmail.com	Bulik, Tomasz/AAJ-6742-2020; O'Shaughnessy, Richard/AAA-3625-2021	O'Shaughnessy, Richard/0000-0001-5832-8517; Bulik, Tomasz/0000-0003-2045-4803	NCN [DEC-2012/07/E/ST9/01360]; NSF CAREER grant [PHY-1151836]; Kavli Institute for Cosmological Physics at the University of Chicago through NSF [PHY-1125897]; Kavli Foundation; NCN grant Harmonia 6 [UMO-2014/14/M/ST9/00707]; NSF [PHY-1505629]; Direct For Mathematical & Physical Scien [1151836] Funding Source: National Science Foundation	NCN; NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); Kavli Institute for Cosmological Physics at the University of Chicago through NSF(National Science Foundation (NSF)); Kavli Foundation; NCN grant Harmonia 6; NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are indebted to G. Wiktorowicz, W. Gladysz and K. Piszczek for their help with population synthesis calculations, and to H.-Y. Chen and Z. Doctor for their help with our LIGO/Virgo rate calculations. We thank the thousands of Universe@home users that have provided their personal computers for our simulations. We also thank the Hannover GW group for letting us use their ATLAS supercomputer. K.B. acknowledges support from the NCN grant Sonata Bis 2 (DEC-2012/07/E/ST9/01360). D.E.H. was supported by NSF CAREER grant PHY-1151836. D.E.H. also acknowledges support from the Kavli Institute for Cosmological Physics at the University of Chicago through NSF grant PHY-1125897 as well as an endowment from the Kavli Foundation. T.B. acknowledges support from the NCN grant Harmonia 6 (UMO-2014/14/M/ST9/00707). R.O'S. was supported by NSF grant PHY-1505629.	Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.061102; Abbott BP, 2016, ASTROPHYS J LETT, V818, DOI 10.3847/2041-8205/818/2/L22; Abbott BP, 2016, LIVING REV RELATIV, V19, DOI 10.1007/lrr-2016-1; Abbott B. P., 2016, RATE BINARY BLACK HO; Albrecht S, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/83; Almeida LA, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/2/102; Bastian N, 2010, ANNU REV ASTRON ASTR, V48, P339, DOI 10.1146/annurev-astro-082708-101642; Belczynski K, 2002, ASTROPHYS J, V572, P407, DOI 10.1086/340304; Belczynski K, 2008, ASTROPHYS J SUPPL S, V174, P223, DOI 10.1086/521026; Belczynski K, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/2/108; Belczynski K, 2010, ASTROPHYS J LETT, V715, pL138, DOI 10.1088/2041-8205/715/2/L138; Bulik T, 2004, MON NOT R ASTRON SOC, V352, P1372, DOI 10.1111/j.1365-2966.2004.08028.x; Bulik T, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/140; de Mink SE, 2015, ASTROPHYS J, V814, DOI 10.1088/0004-637X/814/1/58; de Mink S. E., 2016, MON NOT R ASTRON SOC; Dominik M, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/263; Dominik M, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/72; Dominik M, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/52; Duchene G, 2013, ANNU REV ASTRON ASTR, V51, P269, DOI 10.1146/annurev-astro-081710-102602; Dvorkin I, 2015, MON NOT R ASTRON SOC, V452, pL36, DOI 10.1093/mnrasl/slv085; Eldridge J. J., 2016, BPASS PREDICTIONS BI; Eldridge JJ, 2013, MON NOT R ASTRON SOC, V436, P774, DOI 10.1093/mnras/stt1612; Fryer CL, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/91; Gerke JR, 2015, MON NOT R ASTRON SOC, V450, P3289, DOI 10.1093/mnras/stv776; Hirschauer AS, 2016, ASTROPHYS J, V822, DOI 10.3847/0004-637X/822/2/108; Hurley JR, 2000, MON NOT R ASTRON SOC, V315, P543, DOI 10.1046/j.1365-8711.2000.03426.x; Husa S, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.044006; Ivanova N, 2013, ASTRON ASTROPHYS REV, V21, DOI 10.1007/s00159-013-0059-2; Khan S, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.044007; MacLeod M, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/41; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; Marchant P, 2016, ASTRON ASTROPHYS, V588, DOI 10.1051/0004-6361/201628133; Mennekens N, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322198; Nelemans G, 2001, ASTRON ASTROPHYS, V375, P890, DOI 10.1051/0004-6361:20010683; O'Shaughnessy R, 2007, ASTROPHYS J, V667, P1048, DOI 10.1086/520756; Pavlovskii K, 2015, MON NOT R ASTRON SOC, V449, P4415, DOI 10.1093/mnras/stv619; PODSIADLOWSKI P, 1992, ASTROPHYS J, V391, P246, DOI 10.1086/171341; Ricker PM, 2008, ASTROPHYS J LETT, V672, pL41, DOI 10.1086/526343; Rodriguez CL, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.084029; Rogers TM, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/21; Sana H, 2012, SCIENCE, V337, P444, DOI 10.1126/science.1223344; Spera M, 2015, MON NOT R ASTRON SOC, V451, P4086, DOI 10.1093/mnras/stv1161; Szecsi D, 2015, ASTRON ASTROPHYS, V581, DOI 10.1051/0004-6361/201526617; TUTUKOV AV, 1993, MON NOT R ASTRON SOC, V260, P675, DOI 10.1093/mnras/260.3.675; Vangioni E, 2015, MON NOT R ASTRON SOC, V447, P2575, DOI 10.1093/mnras/stu2600; Villante FL, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/13; Vink JS, 2011, ASTROPHYS SPACE SCI, V336, P163, DOI 10.1007/s10509-011-0636-7; Voss R, 2003, MON NOT R ASTRON SOC, V342, P1169, DOI 10.1046/j.1365-8711.2003.06616.x; Woosley S. E., 2016, PROGENITOR GW150914; Xu XJ, 2010, ASTROPHYS J, V722, P1985, DOI 10.1088/0004-637X/722/2/1985	55	548	553	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					512	+		10.1038/nature18322	http://dx.doi.org/10.1038/nature18322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27337338	Green Submitted			2022-12-28	WOS:000378270300045
J	Eldridge, JJ				Eldridge, J. J.			ASTROPHYSICS Recipe for a black-hole merger	NATURE			English	Editorial Material							SUPERNOVAE	The detection of a gravitational wave was a historic event that heralded a new phase of astronomy. A numerical model of the Universe now allows researchers to tell the story of the black-hole system that caused the wave. SEE LETTER p.512	[Eldridge, J. J.] Univ Auckland, Dept Phys, Private Bag 92019, Auckland, New Zealand	University of Auckland	Eldridge, JJ (corresponding author), Univ Auckland, Dept Phys, Private Bag 92019, Auckland, New Zealand.	j.eldridge@auckland.ac.nz		Eldridge, Jan/0000-0002-1722-6343				Belczynski K, 2016, NATURE, V534, P512, DOI 10.1038/nature18322; de Mink S. E., 2016, MON NOT R ASTRON SOC; Gerke JR, 2015, MON NOT R ASTRON SOC, V450, P3289, DOI 10.1093/mnras/stv776; Hartwig T, 2016, MON NOT R ASTRON SOC, V460, pL74, DOI 10.1093/mnrasl/slw074; Ivanova N, 2013, ASTRON ASTROPHYS REV, V21, DOI 10.1007/s00159-013-0059-2; Smartt SJ, 2015, PUBL ASTRON SOC AUST, V32, DOI 10.1017/pasa.2015.17; Sukhbold T, 2016, ASTROPHYS J, V821, DOI 10.3847/0004-637X/821/1/38	7	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					478	479		10.1038/534478a	http://dx.doi.org/10.1038/534478a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27337335				2022-12-28	WOS:000378270300035
J	Tay, A				Tay, Andy			Show us the money	SCIENCE			English	Editorial Material									[Tay, Andy] Univ Calif Los Angeles, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Tay, A (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90024 USA.								0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1486	1486		10.1126/science.352.6292.1486	http://dx.doi.org/10.1126/science.352.6292.1486			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO7PV	27313050				2022-12-28	WOS:000377975400054
J	Wu, J; Belmonte, JCI				Wu, Jun; Belmonte, Juan Carlos Izpisua			Stem Cells: A Renaissance in Human Biology Research	CELL			English	Review							PRIMORDIAL GERM-CELLS; IN-VITRO; SELF-ORGANIZATION; LINEAGE SEGREGATION; HUMAN BLASTOCYST; HUMAN EMBRYOS; MOUSE; NAIVE; EPIBLAST; PLURIPOTENCY	The understanding of human biology and how it relates to that of other species represents an ancient quest. Limited access to human material, particularly during early development, has restricted researchers to only scratching the surface of this inherently challenging subject. Recent technological innovations, such as single cell "omics'' and human stem cell derivation, have now greatly accelerated our ability to gain insights into uniquely human biology. The opportunities afforded to delve molecularly into scarce material and to model human embryogenesis and pathophysiological processes are leading to new insights of human development and are changing our understanding of disease and choice of therapy options.	[Wu, Jun; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Wu, Jun] Univ Catolica San Antonio Murcia UCAM, Campus Jeronimos 135, Murcia 30107, Spain	Salk Institute; Universidad Catolica de Murcia	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Wu, Jun/AAF-1830-2019	Wu, Jun/0000-0001-9863-1668	G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Moxie Foundation; McKnight Foundation; Universidad Catolica San Antonio de Murcia (UCAM); Fundacion Dr. Pedro Guillen	G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Moxie Foundation; McKnight Foundation; Universidad Catolica San Antonio de Murcia (UCAM); Fundacion Dr. Pedro Guillen	We would like to thank Dr. Jose Maria Campistol for his encouragement and discussions on the importance of thinking on the patients while working with Petri dishes, Dr. Pedro Guillen for his continuous encouragement to bring basic biology discoveries to the patient's bedside, and all members from the J.C.I.B laboratory for their experimental and conceptual contributions, which led to some of the ideas presented in this review. We would like to thank May Schwarz and Peter Schwarz for their critical reading of the manuscript. Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, the Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002), the Moxie Foundation, the McKnight Foundation, the Universidad Catolica San Antonio de Murcia (UCAM), and Fundacion Dr. Pedro Guillen.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brehm MA, 2014, J IMMUNOL METHODS, V410, P3, DOI 10.1016/j.jim.2014.02.011; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carter AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0070; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chenoweth JG, 2010, DEV GROWTH DIFFER, V52, P293, DOI 10.1111/j.1440-169X.2010.01171.x; Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; De Paepe C, 2014, MOL HUM REPROD, V20, P599, DOI 10.1093/molehr/gau027; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Finkbeiner SR, 2015, STEM CELL REP, V4, P1140, DOI 10.1016/j.stemcr.2015.04.010; Franchini LF, 2015, DEVELOPMENT, V142, P3100, DOI 10.1242/dev.120048; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Graham SJL, 2016, CURR TOP DEV BIOL, V117, P671, DOI 10.1016/bs.ctdb.2015.11.021; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Guye P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10243; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hara K, 2009, DEV BIOL, V330, P427, DOI 10.1016/j.ydbio.2009.04.012; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; Huang K, 2014, CELL STEM CELL, V15, P410, DOI 10.1016/j.stem.2014.09.014; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Krivega M, 2015, MOL HUM REPROD, V21, P711, DOI 10.1093/molehr/gav036; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Kunath T, 2014, PLACENTA, V35, P1079, DOI 10.1016/j.placenta.2014.09.008; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mascetti VL, 2016, CELL STEM CELL, V18, P67, DOI 10.1016/j.stem.2015.11.017; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Morizane R, 2015, NAT BIOTECHNOL, V33, P1193, DOI 10.1038/nbt.3392; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Noguchi TK, 2015, NAT CELL BIOL, V17, P984, DOI 10.1038/ncb3200; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Passier R, 2016, CELL STEM CELL, V18, P309, DOI [10.1016/j.stem.2016.02.011, 10.1016/j.stem.2016.02.013]; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Pollina EA, 2011, ONCOGENE, V30, P3105, DOI 10.1038/onc.2011.45; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Rossant J, 2016, NATURE, V533, P182, DOI 10.1038/nature17894; Rossant J, 2015, DEVELOPMENT, V142, P9, DOI 10.1242/dev.115451; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schlaermann P, 2016, GUT, V65, P202, DOI 10.1136/gutjnl-2014-307949; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Sperber H, 2015, NAT CELL BIOL, V17, P1523, DOI 10.1038/ncb3264; Surani MA, 2015, STEM CELL REP, V4, P955, DOI 10.1016/j.stemcr.2015.04.014; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tam PPL, 2003, DEVELOPMENT, V130, P6155, DOI 10.1242/dev.00893; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tesar PJ, 2005, P NATL ACAD SCI USA, V102, P8239, DOI 10.1073/pnas.0503231102; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van den Berg CW, 2015, DEVELOPMENT, V142, P3231, DOI 10.1242/dev.123810; Van der Jeught M, 2014, HUM REPROD, V29, P41, DOI 10.1093/humrep/det400; Van der Jeught M, 2013, STEM CELLS DEV, V22, P296, DOI 10.1089/scd.2012.0256; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; von Meyenn F, 2015, CELL, V161, P1248, DOI 10.1016/j.cell.2015.05.039; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Wang P, 2011, CELL STEM CELL, V8, P335, DOI 10.1016/j.stem.2011.01.017; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Weinberger L, 2016, NAT REV MOL CELL BIO, V17, P155, DOI 10.1038/nrm.2015.28; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu J., 2016, TRANSGENIC RES; Wu J, 2016, CELL, V165, P13, DOI 10.1016/j.cell.2016.03.005; Wu J, 2015, NAT CELL BIOL, V17, P1519, DOI 10.1038/ncb3269; Wu J, 2015, CELL STEM CELL, V17, P509, DOI 10.1016/j.stem.2015.10.009; Wu J, 2015, NATURE, V521, P316, DOI 10.1038/nature14413; Wu J, 2014, NATURE, V516, P172, DOI 10.1038/516172a; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yanger K, 2011, DEV DYNAM, V240, P521, DOI 10.1002/dvdy.22561; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhou Q, 2016, CELL STEM CELL, V18, P330, DOI 10.1016/j.stem.2016.01.017	139	64	66	2	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1572	1585		10.1016/j.cell.2016.05.043	http://dx.doi.org/10.1016/j.cell.2016.05.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315475	Bronze			2022-12-28	WOS:000378062000010
J	Oestergaard, LB; Christiansen, MN; Schmiegelow, MD; Skov, RL; Andersen, PS; Petersen, A; Aasbjerg, K; Gerds, TA; Andersen, PK; Torp-Pedersen, C				Oestergaard, Louise B.; Christiansen, Mia N.; Schmiegelow, Michelle D.; Skov, Robert L.; Andersen, Paal S.; Petersen, Andreas; Aasbjerg, Kristian; Gerds, Thomas A.; Andersen, Per K.; Torp-Pedersen, Christian			Familial Clustering of Staphylococcus aureus Bacteremia in First-Degree Relatives A Danish Nationwide Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PYOGENIC BACTERIAL-INFECTIONS; POPULATION-BASED COHORT; ENVIRONMENTAL-INFLUENCES; METHICILLIN RESISTANCE; 30-DAY MORTALITY; BINDING LECTIN; RISK-FACTORS; DISEASE; EPIDEMIOLOGY; SUSCEPTIBILITY	Background: A genetic predisposition to Staphylococcus aureus bacteremia has been demonstrated in animals, suggesting that genetic differences might influence susceptibility to S aureus in humans. Objective: To determine whether a history of S aureus bacteremia in first-degree relatives increases the rate of the disease, and whether this rate is affected by the type of family relationship (that is, parent or sibling) or by how the relative acquired the infection. Design: Register-based nationwide cohort study (1992 to 2011). Setting: Denmark. Participants: First-degree relatives (children or siblings) of patients previously hospitalized with S aureus bacteremia. Measurements: Poisson regression models were used to calculate standardized incidence ratios (SIRs) of S aureus bacteremia, with the incidence rate in the population as a reference. Results: 34 774 individuals (the exposed cohort) with a firstdegree relative (index case patient) previously hospitalized with S aureus bacteremia were followed up for a median of 7.8 years (interquartile range, 3.6 to 13.0). A higher rate of S aureus bacteremia was observed among these first-degree relatives (SIR, 2.49 [95% CI, 1.95 to 3.19]) than in the background population. The estimate was significantly higher if the index case patient was a sibling (SIR, 5.01 [CI, 3.30 to 7.62]) than a parent (SIR, 1.96 [CI, 1.45 to 2.67]; interaction P < 0.0001). No interaction was observed regarding the sex of the first-degree relative (interaction P for parents = 0.85; interaction P for siblings = 0.92). Stratifying by disease acquisition revealed the highest rates in individuals exposed to index case patients with non-hospital-acquired infection. Few were infected with genetically identical bacteremia isolates. Limitation: The rarity of the outcome limited the number of variables in the multiple regression analysis, and whether nonsignificant interactions were true or caused by insufficient statistical power remains uncertain. Conclusion: A significant familial clustering of S aureus bacteremia was found, with the greatest relative rate of disease observed in individuals exposed to siblings with a history of the disease.	Aalborg Univ, Aalborg, Denmark; [Oestergaard, Louise B.] Copenhagen Univ Hosp Herlev Gentofte, Dept Cardiol, Kildegaardsvej 28,Post 635, DK-2900 Hellerup, Denmark; [Skov, Robert L.] Statens Serum Inst, Microbiol & Infect Control, Artillerivej 5, DK-2300 Copenhagen S, Denmark; [Andersen, Paal S.] Statens Serum Inst, Microbiol & Infect Control, 5 Artillerivej,47-217, DK-2300 Copenhagen S, Denmark; [Petersen, Andreas] Statens Serum Inst, Microbiol & Infect Control, 5 Artillerivej,46-104, DK-2300 Copenhagen S, Denmark; [Christiansen, Mia N.] Rigshosp, Afd 944, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Aasbjerg, Kristian] Aalborg Univ Hosp, Dept Ophthalmol, Hobrovej 18-22,POB365, DK-9000 Aalborg, Denmark; [Gerds, Thomas A.; Andersen, Per K.] Biostat Sect, Farimagsgade 5 Opg B,POB 2099, DK-1014 Copenhagen K, Denmark; [Torp-Pedersen, Christian] Dept Hlth Sci & Technol, Niels Jernes Vej 12,Room A5-208, DK-9220 Aalborg O, Denmark	Aalborg University; Statens Serum Institut; Statens Serum Institut; Statens Serum Institut; Rigshospitalet; University of Copenhagen; Aalborg University; Aalborg University Hospital	Oestergaard, LB (corresponding author), Copenhagen Univ Hosp Herlev Gentofte, Dept Cardiol, Kildegaardsvej 28,Post 635, DK-2900 Hellerup, Denmark.	l_bruun@hotmail.com	Andersen, Paal S/H-2087-2015; Skov, Robert/ABB-3105-2020	Andersen, Paal S/0000-0001-5656-0427; Skov, Robert/0000-0002-6079-5381; Gerds, Thomas Alexander/0000-0002-5955-816X; Petersen, Andreas/0000-0002-6864-0624	Danish Heart Foundation [R99-A6001]; Christian Larsen and Judge Ellen Larsen Foundation	Danish Heart Foundation; Christian Larsen and Judge Ellen Larsen Foundation	By grant R99-A6001 from the Danish Heart Foundation and a scholarship from the Christian Larsen and Judge Ellen Larsen Foundation, a minor fund supporting research in the fields of infectious diseases and cancer.; The Danish Heart Foundation and the Christian Larsen and Judge Ellen Larsen Foundation.	Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Bassetti M, 2012, CLIN MICROBIOL INFEC, V18, P862, DOI 10.1111/j.1469-0691.2011.03679.x; Bellis MA, 2005, J EPIDEMIOL COMMUN H, V59, P749, DOI 10.1136/jech.2005.036517; Ben-Ari J, 2012, EXPERT REV ANTI-INFE, V10, P881, DOI [10.1586/ERI.12.77, 10.1586/eri.12.77]; Blenstrup LT, 2011, SCAND J PUBLIC HEALT, V39, P79, DOI 10.1177/1403494811399957; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Clayton D., 2013, STAT MODELS EPIDEMIO; de Kraker MEA, 2013, CLIN MICROBIOL INFEC, V19, P860, DOI 10.1111/1469-0691.12028; EMBIL J, 1994, INFECT CONT HOSP EP, V15, P646; FINE PEM, 1981, INT J LEPROSY, V49, P437; Gaist D, 1997, DAN MED BULL, V44, P445; Haralambous E, 2003, EPIDEMIOL INFECT, V130, P413, DOI 10.1017/S0950268803008513; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; Hjuler T, 2008, AM J EPIDEMIOL, V167, P814, DOI 10.1093/aje/kwm376; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Johnson NV, 2012, G3-GENES GENOM GENET, V2, P693, DOI 10.1534/g3.112.002501; Keynan Y, 2013, CRIT CARE CLIN, V29, P547, DOI 10.1016/j.ccc.2013.03.008; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Lesens O, 2005, INFECT CONT HOSP EP, V26, P204, DOI 10.1086/502527; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maguire GP, 1998, J HOSP INFECT, V38, P273, DOI 10.1016/S0195-6701(98)90076-7; MALATY HM, 1994, ANN INTERN MED, V120, P982, DOI 10.7326/0003-4819-120-12-199406150-00002; Mejer N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-260; Melzer M, 2013, J HOSP INFECT, V84, P143, DOI 10.1016/j.jhin.2012.12.013; Nelson CL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-83; Nielsen LH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0740-8; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Regev-Yochay G, 2009, PEDIATR INFECT DIS J, V28, P960, DOI 10.1097/INF.0b013e3181a90883; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Smit J, 2016, EUR J ENDOCRINOL, V174, P631, DOI 10.1530/EJE-16-0023; Sogaard M, 2011, CLIN INFECT DIS, V52, P61, DOI 10.1093/cid/ciq069; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Statens Serum Institut, 2013, STAPH AUR BACT CAS D; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Tran CT, 2007, CLIN EXP IMMUNOL, V148, P101, DOI 10.1111/j.1365-2249.2007.03324.x; Turnidge JD, 2009, MED J AUSTRALIA, V191, P368, DOI 10.5694/j.1326-5377.2009.tb02841.x; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Yan Q, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004149; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	45	10	10	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2016	165	6					390	+		10.7326/M15-2762	http://dx.doi.org/10.7326/M15-2762			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW9FR	27379577				2022-12-28	WOS:000383962000014
J	Dyer, C				Dyer, Clare			Nurofen advertisement was misleading, says watchdog	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Coopes A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6852	1	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3669	10.1136/bmj.i3669	http://dx.doi.org/10.1136/bmj.i3669			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27363717				2022-12-28	WOS:000379019700022
J	Jongsma, MLM; Berlin, I; Wijdeven, RHM; Janssen, L; Janssen, GMC; Garstka, MA; Janssen, H; Mensink, M; van Veelen, PA; Spaapen, RM; Neefjes, J				Jongsma, Marlieke L. M.; Berlin, Ilana; Wijdeven, Ruud H. M.; Janssen, Lennert; Janssen, George M. C.; Garstka, Malgorzata A.; Janssen, Hans; Mensink, Mark; van Veelen, Peter A.; Spaapen, Robbert M.; Neefjes, Jacques			An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport	CELL			English	Article							CHOLESTEROL; TRAFFICKING; RECRUITMENT; CONTACTS; BINDING; DYNEIN; GLUT4; T6BP; RILP	Through a network of progressively maturing vesicles, the endosomal system connects the cell's interior with extracellular space. Intriguingly, this network exhibits a bilateral architecture, comprised of a relatively immobile perinuclear vesicle "cloud" and a highly dynamic peripheral contingent. How this spatiotemporal organization is achieved and what function(s) it curates is unclear. Here, we reveal the endoplasmic reticulum (ER)-located ubiquitin ligase Ring finger protein 26 (RNF26) as the global architect of the entire endosomal system, including the trans-Golgi network (TGN). To specify perinuclear vesicle coordinates, catalytically competent RNF26 recruits and ubiquitinates the scaffold p62/sequestosome 1 (p62/SQSTM1), in turn attracting ubiquitin-binding domains (UBDs) of various vesicle adaptors. Consequently, RNF26 restrains fast transport of diverse vesicles through a common molecular mechanism operating at the ER membrane, until the deubiquitinating enzyme USP15 opposes RNF26 activity to allow vesicle release into the cell's periphery. By drawing the endosomal system's architecture, RNF26 orchestrates endosomal maturation and trafficking of cargoes, including signaling receptors, in space and time.	[Jongsma, Marlieke L. M.; Berlin, Ilana; Wijdeven, Ruud H. M.; Janssen, Lennert; Garstka, Malgorzata A.; Janssen, Hans; Mensink, Mark; Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Janssen, George M. C.; van Veelen, Peter A.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, POB 9600, NL-2300 RC Leiden, Netherlands; [Jongsma, Marlieke L. M.; Spaapen, Robbert M.] Sanquin Res & Landsteiner Lab AMC UvA, Dept Immunopathol, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands; [Neefjes, Jacques] Leiden Univ, Med Ctr, Dept Chem Immunol, POB 9600, NL-2300 RC Leiden, Netherlands	Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Berlin, I; Neefjes, J (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.; Neefjes, J (corresponding author), Leiden Univ, Med Ctr, Dept Chem Immunol, POB 9600, NL-2300 RC Leiden, Netherlands.	i.berlin@nki.nl; j.neefjes@nki.nl	Spaapen, Robbert/AAF-9105-2021; Garstka, Malgorzata A./AAU-4401-2020; Neefjes, Jacques J.C./H-8780-2017	Garstka, Malgorzata A./0000-0003-2896-7275; Neefjes, Jacques J.C./0000-0001-6763-2211; Spaapen, Robbert/0000-0002-1329-8606; Janssen, Lennert/0000-0001-9705-0204; Mensink, Mark/0000-0002-2470-6919; van Veelen, Peter/0000-0002-7898-9408	ICI; NWO Gravitation project - Ministry of Education, Culture and Science of the Netherlands; ERC Advanced Grant; long-term EMBO fellowships	ICI; NWO Gravitation project - Ministry of Education, Culture and Science of the Netherlands; ERC Advanced Grant(European Research Council (ERC)); long-term EMBO fellowships	We thank J. Borst for valuable discussions and critical reading of the manuscript and B. van den Broek for help with the Cell Profiler software. We also thank the NKI Protein Production Facility and L. Oomen and L. Brocks for Microscopy Facility support, and particularly L. Oomen for advice on TrackMate software. This work was supported by the ICI, an NWO Gravitation project funded by the Ministry of Education, Culture and Science of the Netherlands and an ERC Advanced Grant awarded to J.N. I.B. and M.G. were recipients of long-term EMBO fellowships.	Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Ling L, 2000, P NATL ACAD SCI USA, V97, P9567, DOI 10.1073/pnas.170279097; Lippai M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832704; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Morriswood B, 2007, J CELL SCI, V120, P2574, DOI 10.1242/jcs.007005; Paul P, 2011, CELL, V145, P268, DOI 10.1016/j.cell.2011.03.023; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Pulido IR, 2011, TRAFFIC, V12, P1371, DOI 10.1111/j.1600-0854.2011.01248.x; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Sadacca LA, 2013, MOL BIOL CELL, V24, P2544, DOI 10.1091/mbc.E13-02-0103; Schroeder CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03351; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sorkin A, 2007, MOL CELL, V26, P771, DOI 10.1016/j.molcel.2007.06.003; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; Valderrama F, 1998, EUR J CELL BIOL, V76, P9, DOI 10.1016/S0171-9335(98)80012-5; van der Kant R, 2014, J CELL SCI, V127, P929, DOI 10.1242/jcs.137539; van der Kant R, 2013, J CELL SCI, V126, P3462, DOI 10.1242/jcs.129270; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Watts C, 2012, BBA-PROTEINS PROTEOM, V1824, P14, DOI 10.1016/j.bbapap.2011.07.006; Wubbolts R, 1999, J CELL SCI, V112, P785; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	32	129	130	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					152	166		10.1016/j.cell.2016.05.078	http://dx.doi.org/10.1016/j.cell.2016.05.078			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368102	hybrid, Green Published			2022-12-28	WOS:000380254400018
J	Gulland, A				Gulland, Anne			BRIEFING UK science and health outside the EU	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Economist Intelligence Unit, 2016, OUT MAPP IMP BREX; London School of Economics and Political Science, 2016, WILL NHS BE AFF LEAV	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2016	353								i3595	10.1136/bmj.i3595	http://dx.doi.org/10.1136/bmj.i3595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FV	27358270				2022-12-28	WOS:000379018700004
J	Collin, J; Casswell, S				Collin, Jeff; Casswell, Sally			Alcohol and the Sustainable Development Goals	LANCET			English	Editorial Material							GLOBAL HEALTH; TOBACCO; POLICY		[Collin, Jeff] Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Social Policy, Edinburgh EH8 9LD, Midlothian, Scotland; [Collin, Jeff; Casswell, Sally] Massey Univ, Coll Hlth, SHORE, Auckland, New Zealand; [Collin, Jeff; Casswell, Sally] Massey Univ, Coll Hlth, Whariki Res Ctr, Auckland, New Zealand	University of Edinburgh; Massey University; Massey University	Collin, J (corresponding author), Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Social Policy, Edinburgh EH8 9LD, Midlothian, Scotland.; Collin, J (corresponding author), Massey Univ, Coll Hlth, SHORE, Auckland, New Zealand.; Collin, J (corresponding author), Massey Univ, Coll Hlth, Whariki Res Ctr, Auckland, New Zealand.	jeff.collin@ed.ac.uk		Casswell, Sally/0000-0002-2211-7096	ESRC [ES/L001284/1] Funding Source: UKRI; Economic and Social Research Council [ES/L001284/1, ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: Medline	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Buse K, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0098-8; Collin J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6087; Collin J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3648; Collin J, 2012, TOB CONTROL, V21, P274, DOI 10.1136/tobaccocontrol-2011-050418; Friel S, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-46; Hawkes C, 2015, 1 UN STAND COMM NUTR; International Alliance for Responsible Drinking, BUILD PARTN TOOLK; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; SABMiller, PROSP UN GLOB GOALS; United Nations, SUST DEV GOALS; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2010, GLOB STRAT RED HARMF	13	37	37	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2582	2583		10.1016/S0140-6736(16)30827-3	http://dx.doi.org/10.1016/S0140-6736(16)30827-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP3JX	27353807				2022-12-28	WOS:000378390500008
J	Lake, BB; Ai, R; Kaeser, GE; Salathia, NS; Yung, YC; Liu, R; Wildberg, A; Gao, D; Fung, HL; Chen, S; Vijayaraghavan, R; Wong, JL; Chen, A; Sheng, XY; Kaper, F; Shen, R; Ronaghi, M; Fan, JB; Wang, W; Chun, J; Zhang, K				Lake, Blue B.; Ai, Rizi; Kaeser, Gwendolyn E.; Salathia, Neeraj S.; Yung, Yun C.; Liu, Rui; Wildberg, Andre; Gao, Derek; Fung, Ho-Lim; Chen, Song; Vijayaraghavan, Raakhee; Wong, Julian; Chen, Allison; Sheng, Xiaoyan; Kaper, Fiona; Shen, Richard; Ronaghi, Mostafa; Fan, Jian-Bing; Wang, Wei; Chun, Jerold; Zhang, Kun			Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain	SCIENCE			English	Article							ADULT HUMAN BRAIN; TRANSCRIPTOME; CELLS; SEQ; SIGNATURES	The human brain has enormously complex cellular diversity and connectivities fundamental to our neural functions, yet difficulties in interrogating individual neurons has impeded understanding of the underlying transcriptional landscape. We developed a scalable approach to sequence and quantify RNA molecules in isolated neuronal nuclei from a postmortem brain, generating 3227 sets of single-neuron data from six distinct regions of the cerebral cortex. Using an iterative clustering and classification approach, we identified 16 neuronal subtypes that were further annotated on the basis of known markers and cortical cytoarchitecture. These data demonstrate a robust and scalable method for identifying and categorizing single nuclear transcriptomes, revealing shared genes sufficient to distinguish previously unknown and orthologous neuronal subtypes as well as regional identity and transcriptomic heterogeneity within the human brain.	[Lake, Blue B.; Liu, Rui; Gao, Derek; Fung, Ho-Lim; Chen, Song; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Ai, Rizi; Wildberg, Andre; Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Kaeser, Gwendolyn E.; Yung, Yun C.; Wong, Julian; Chen, Allison; Sheng, Xiaoyan; Chun, Jerold] Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Kaeser, Gwendolyn E.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Salathia, Neeraj S.; Vijayaraghavan, Raakhee; Kaper, Fiona; Shen, Richard; Ronaghi, Mostafa; Fan, Jian-Bing] Illumina, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego; Illumina	Zhang, K (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.; Wang, W (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Chun, J (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.; Fan, JB (corresponding author), Illumina, San Diego, CA USA.	jianbing_fan@yahoo.com; wei-wang@ucsd.edu; jchun@scripps.edu; kzhang@bioeng.ucsd.edu	Zhang, Kun/ABE-6349-2020; Kaeser, Gwendolyn/AAY-6841-2020; Chun, Jerold/Y-4670-2019	Zhang, Kun/0000-0002-7596-5224; Salathia, Neeraj/0000-0002-1235-2439; Lake, Blue/0000-0002-8637-9044	NIH Common Fund Single Cell Analysis Program [1U01MH098977]; Neuroplasticity of Aging Training Grant [5T32AG000216-24]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH098977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000216] Funding Source: NIH RePORTER	NIH Common Fund Single Cell Analysis Program; Neuroplasticity of Aging Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Flow cytometry was performed both at the University of California, San Diego (UCSD) Human Embryonic Stem Cell Core and The Scripps Research Institute Flow Cytometry Core. Initial C1 runs were performed at the UCSD Stem Cell Genomics Core. The data tables accompanying this work are provided as Excel files in the supplementary materials. Clustering-and-Classification code used to identify neuronal subtypes and instructions (Readme.txt) for its operation in R are provided as supplementary files. We thank Fluidigm (M. Ray, R. C. Jones, and P. Steinberg) for instrument support and technical advice in adaptation of the C1 protocol for nuclei. Sequencing data has been deposited with dbGaP (accession phs000833.v3.p1), curated by the NIH Single Cell Analysis Program-Transcriptome (SCAP-T) Project (www.scap-t.org), and annotated in the supplementary materials (table S2). We thank G. Kennedy for help with RNAscope. Funding support was from the NIH Common Fund Single Cell Analysis Program (1U01MH098977). G.E.K. was additionally supported by a Neuroplasticity of Aging Training Grant (5T32AG000216-24).	Bushman DM, 2015, ELIFE, V4, DOI 10.7554/eLife.05116; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Gaidatzis D, 2015, NAT BIOTECHNOL, V33, P722, DOI 10.1038/nbt.3269; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Graf A, 2014, P NATL ACAD SCI USA, V111, P4139, DOI 10.1073/pnas.1321569111; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Grindberg RV, 2013, P NATL ACAD SCI USA, V110, P19802, DOI 10.1073/pnas.1319700110; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Krishnaswami SR, 2016, NAT PROTOC, V11, P499, DOI 10.1038/nprot.2016.015; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Westra JW, 2010, J COMP NEUROL, V518, P3981, DOI 10.1002/cne.22436; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	22	460	466	3	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1586	1590		10.1126/science.aaf1204	http://dx.doi.org/10.1126/science.aaf1204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339989	Green Accepted			2022-12-28	WOS:000378346500046
J	Tate, G				Tate, Gregory			The art of medicine John Keats: science and sympathy	LANCET			English	Editorial Material									[Tate, Gregory] Univ St Andrews, Sch English, St Andrews KY16 9AL, Fife, Scotland	University of St Andrews	Tate, G (corresponding author), Univ St Andrews, Sch English, St Andrews KY16 9AL, Fife, Scotland.	gpt4@st-andrews.ac.uk		Tate, Gregory/0000-0002-5930-8187				AEsculapius, 1818, HOSP PUP GUID BEING; Keats J, 2002, SELECTED LETT; Keats John, 1988, COMPLETE POEMS, V3rd; Roe Nicholas, 2012, J KEATS NEW LIFE; White RS, 2010, LIT LIVES, P1, DOI 10.1057/9780230281448	5	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2498	2499		10.1016/S0140-6736(16)30802-9	http://dx.doi.org/10.1016/S0140-6736(16)30802-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO7FG	27358984				2022-12-28	WOS:000377947200015
J	Watts, G				Watts, Geoff			Robert Charles Strunk Obituary	LANCET			English	Biographical-Item																		STRUNK RC, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2500	2500		10.1016/S0140-6736(16)30803-0	http://dx.doi.org/10.1016/S0140-6736(16)30803-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27358985	Bronze			2022-12-28	WOS:000377947200016
J	Dening, T				Dening, Tom			Robert George (Rob) Jones OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item													Dening, Tom/E-1335-2013	Dening, Tom/0000-0003-3387-4241				JONES R, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2016	353								i3388	10.1136/bmj.i3388	http://dx.doi.org/10.1136/bmj.i3388			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HJ	27312084				2022-12-28	WOS:000378240800016
J	Green, DR				Green, Douglas R.			A BH3 Mimetic for Killing Cancer Cells	CELL			English	Editorial Material									[Green, Douglas R.] St Jude Childrens Res Inst, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Green, DR (corresponding author), St Jude Childrens Res Inst, Dept Immunol, Memphis, TN 38105 USA.	douglas.green@stjude.org	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096208] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM096208] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	63	65	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1560	1560		10.1016/j.cell.2016.05.080	http://dx.doi.org/10.1016/j.cell.2016.05.080			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315468	Bronze			2022-12-28	WOS:000378062000003
J	Rich, EC				Rich, Eugene C.			Advanced Practice Clinicians and Physicians in Primary Care: Still More Questions than Answers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NURSE-PRACTITIONERS; COSTS		[Rich, Eugene C.] Math Policy Res, Ctr Hlth Care Effectiveness, 1100 First St Northeast, Washington, DC 20002 USA	Mathematica	Rich, EC (corresponding author), Math Policy Res, Ctr Hlth Care Effectiveness, 1100 First St Northeast, Washington, DC 20002 USA.	ERich@mathematica-mpr.com						Balogh EP, 2015, IMPROVING DIAGNOSIS; Bazemore A, 2015, ANN FAM MED, V13, P206, DOI 10.1370/afm.1787; Donelan K, 2013, NEW ENGL J MED, V368, P1898, DOI 10.1056/NEJMsa1212938; Hughes DR, 2015, JAMA INTERN MED, V175, P101, DOI 10.1001/jamainternmed.2014.6349; Kuo YF, 2015, J AM GERIATR SOC, V63, P1980, DOI 10.1111/jgs.13662; Lin HC, 2008, J GEN INTERN MED, V23, P304, DOI 10.1007/s11606-007-0462-3; Mafi JN, 2016, ANN INTERN MED, V165, P237, DOI 10.7326/M15-2152; O'Malley AS, 2015, J GEN INTERN MED, V30, P576, DOI 10.1007/s11606-015-3311-9; O'Malley AS, 2015, J GEN INTERN MED, V30, P568, DOI 10.1007/s11606-015-3300-z; Reschovsky JD, 2015, J GEN INTERN MED, V30, P555, DOI 10.1007/s11606-015-3366-7	10	8	8	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					290	291		10.7326/M16-1326	http://dx.doi.org/10.7326/M16-1326			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27322738				2022-12-28	WOS:000381267200021
J	Sierink, JC; Treskes, K; Edwards, MJR; Beuker, JA; den Hartog, D; Hohmann, J; Dijkgraaf, MGW; Luitse, JSK; Beenen, LFM; Hollmann, MW; Goslings, JC				Sierink, Joanne C.; Treskes, Kaij; Edwards, Michael J. R.; Beuker, J. A.; den Hartog, Dennis; Hohmann, Joachim; Dijkgraaf, Marcel G. W.; Luitse, Jan S. K.; Beenen, Ludo F. M.; Hollmann, Markus W.; Goslings, J. Carel		REACT-2 Study Grp	Immediate total-body CT scanning versus conventional imaging and selective CT scanning in patients with severe trauma (REACT-2): a randomised controlled trial	LANCET			English	Article							MULTISLICE COMPUTED-TOMOGRAPHY; EMERGENCY-ROOM MANAGEMENT; SEVERE BLUNT TRAUMA; MAJOR TRAUMA; INCIDENTAL FINDINGS; INJURED PATIENTS; MULTIPLE TRAUMA; METAANALYSIS; MORTALITY; SURVIVAL	Background Published work suggests a survival benefit for patients with trauma who undergo total-body CT scanning during the initial trauma assessment; however, level 1 evidence is absent. We aimed to assess the effect of total-body CT scanning compared with the standard work-up on in-hospital mortality in patients with trauma. Methods We undertook an international, multicentre, randomised controlled trial at four hospitals in the Netherlands and one in Switzerland. Patients aged 18 years or older with trauma with compromised vital parameters, clinical suspicion of life-threatening injuries, or severe injury were randomly assigned (1:1) by ALEA randomisation to immediate total-body CT scanning or to a standard work-up with conventional imaging supplemented with selective CT scanning. Neither doctors nor patients were masked to treatment allocation. The primary endpoint was in-hospital mortality, analysed in the intention-to-treat population and in subgroups of patients with polytrauma and those with traumatic brain injury. The. chi(2) test was used to assess differences in mortality. This trial is registered with ClinicalTrials.gov, number NCT01523626. Findings Between April 22, 2011, and Jan 1, 2014, 5475 patients were assessed for eligibility, 1403 of whom were randomly assigned:702 to immediate total-body CT scanning and 701 to the standard work-up. 541 patients in the immediate total-body CT scanning group and 542 in the standard work-up group were included in the primary analysis. In-hospital mortality did not differ between groups (total-body CT 86 [16%] of 541 vs standard work-up 85 [16%] of 542; p=0.92). In-hospital mortality also did not differ between groups in subgroup analyses in patients with polytrauma (total-body CT 81 [22%] of 362 vs standard work-up 82 [25%] of 331; p=0.46) and traumatic brain injury (68 [38%] of 178 vs 66 [44%] of 151; p=0.31). Three serious adverse events were reported in patients in the total-body CT group (1%), one in the standard work-up group (<1%), and one in a patient who was excluded after random allocation. All five patients died. Interpretation Diagnosing patients with an immediate total-body CT scan does not reduce in-hospital mortality compared with the standard radiological work-up. Because of the increased radiation dose, future research should focus on the selection of patients who will benefit from immediate total-body CT.	[Sierink, Joanne C.; Treskes, Kaij; Luitse, Jan S. K.; Goslings, J. Carel] Acad Med Ctr, Dept Surg, Trauma Unit, NL-1105 AZ Amsterdam, Netherlands; [Dijkgraaf, Marcel G. W.] Acad Med Ctr, Clin Res Unit, Amsterdam, Netherlands; [Beenen, Ludo F. M.] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Hollmann, Markus W.] Acad Med Ctr, Dept Anaesthesiol, Amsterdam, Netherlands; [Edwards, Michael J. R.] Radboud Univ Nijmegen, Med Ctr, Dept Surg, Trauma Unit, Nijmegen, Netherlands; [Beuker, J. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Trauma Unit, Groningen, Netherlands; [den Hartog, Dennis] Univ Med Ctr Rotterdam, Erasmus MC, Dept Surg, Trauma Res Unit, Rotterdam, Netherlands; [Hohmann, Joachim] Univ Basel Hosp, Dept Radiol & Nucl Med, Basel, Switzerland	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Basel	Goslings, JC (corresponding author), Acad Med Ctr, Dept Surg, Trauma Unit, NL-1105 AZ Amsterdam, Netherlands.	j.c.goslings@amc.nl	Edwards, M.J.R./H-8026-2014; Beenen, Ludo F/AAA-3114-2021; Brink, Monique/P-6085-2015; Hohmann, Joachim/B-4483-2014; Treskes, Kaij/AAI-4686-2021; Tromp, Tjarda N/A-6583-2016	Beenen, Ludo F/0000-0001-9204-1026; Brink, Monique/0000-0002-4146-1052; Hohmann, Joachim/0000-0003-2895-8774; Treskes, Kaij/0000-0002-9462-5372; Tromp, Tjarda/0000-0003-2037-8388; Klimek, Markus/0000-0002-0122-9929	ZonMw, the Netherlands Organisation for Health Research and Development	ZonMw, the Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	ZonMw, the Netherlands Organisation for Health Research and Development.	American College of Surgeons Committee on Trauma, 2012, STUDENT COURSE MANUA; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Barrett TW, 2009, AM J EMERG MED, V27, P428, DOI 10.1016/j.ajem.2008.03.025; Beenen LFM, 2015, ACTA RADIOL, V56, P873, DOI 10.1177/0284185114539319; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Bruns B, 2008, J TRAUMA, V65, P1217, DOI 10.1097/TA.0b013e318184ee63; Caputo ND, 2014, J TRAUMA ACUTE CARE, V77, P534, DOI 10.1097/TA.0000000000000414; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Healy DA, 2014, EMERG MED J, V31, P101, DOI 10.1136/emermed-2012-201892; Hilbert P, 2007, INJURY, V38, P552, DOI 10.1016/j.injury.2006.12.023; Hoffstetter P, 2008, ROFO-FORTSCHR RONTG, V180, P120, DOI 10.1055/s-2007-963594; Huber-Wagner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068880; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Hutter M, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-73; Jiang LB, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0054-2; Kanz Karl-Georg, 2010, J Trauma Manag Outcomes, V4, P4, DOI 10.1186/1752-2897-4-4; Kimura A, 2013, J TRAUMA ACUTE CARE, V75, P202, DOI 10.1097/TA.0b013e3182905ef7; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Sedlic A, 2013, EMERG RADIOL, V20, P401, DOI 10.1007/s10140-013-1139-3; Sierink JC, 2014, INJURY, V45, P840, DOI 10.1016/j.injury.2013.10.009; Sierink JC, 2013, EMERG RADIOL, V20, P507, DOI 10.1007/s10140-013-1147-3; Sierink JC, 2012, BRIT J SURG, V99, P52, DOI 10.1002/bjs.7760; Sierink JC, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-4; Statline, CONS PRIC PRIC IND 2; Surendran A, 2014, J TRAUMA ACUTE CARE, V76, P1122, DOI 10.1097/TA.0000000000000178; van Vugt R, 2012, J TRAUMA ACUTE CARE, V72, P553, DOI 10.1097/TA.0b013e31822dd93b; Venugopal K, 2012, EUR J EMERG MED, V19, P193, DOI 10.1097/MEJ.0b013e32834ada14; Wada D, 2013, CRIT CARE, V17, DOI 10.1186/cc12861; Weninger P, 2007, J TRAUMA, V62, P584, DOI 10.1097/01.ta.0000221797.46249.ee; Wurmb TE, 2011, EMERG MED J, V28, P300, DOI 10.1136/emj.2009.082164; Wurmb TE, 2009, J TRAUMA, V66, P658, DOI 10.1097/TA.0b013e31817de3f4; Yeguiayan JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11375; 1996, GUIDELINE GOOD CLIN	36	146	149	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					673	683		10.1016/S0140-6736(16)30932-1	http://dx.doi.org/10.1016/S0140-6736(16)30932-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UX	27371185				2022-12-28	WOS:000381268700027
J	Powers, JT; Tsanov, KM; Pearson, DS; Roels, F; Spina, CS; Ebright, R; Seligson, M; de Soysa, Y; Cahan, P; Theissen, J; Tu, HC; Han, A; Kurek, KC; LaPier, GS; Osborne, JK; Ross, SJ; Cesana, M; Collins, JJ; Berthold, F; Daley, GQ				Powers, John T.; Tsanov, Kaloyan M.; Pearson, Daniel S.; Roels, Frederik; Spina, Catherine S.; Ebright, Richard; Seligson, Marc; de Soysa, Yvanka; Cahan, Patrick; Theissen, Jessica; Tu, Ho-Chou; Han, Areum; Kurek, Kyle C.; LaPier, Grace S.; Osborne, Jihan K.; Ross, Samantha J.; Cesana, Marcella; Collins, James J.; Berthold, Frank; Daley, George Q.			Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COMPETITIVE ENDOGENOUS RNA; GENE-EXPRESSION; N-MYC; CANCER; TUMOR; LIN28B; CELLS; MIRNA; AMPLIFICATION	Poor prognosis in neuroblastoma is associated with genetic amplification of MYCN. MYCN is itself a target of let-7, a tumour suppressor family of microRNAs implicated in numerous cancers. LIN28B, an inhibitor of let-7 biogenesis, is overexpressed in neuroblastoma and has been reported to regulate MYCN. Here we show, however, that LIN28B is dispensable in MYCN-amplified neuroblastoma cell lines, despite de-repression of let-7. We further demonstrate that MYCN messenger RNA levels in amplified disease are exceptionally high and sufficient to sponge let-7, which reconciles the dispensability of LIN28B. We found that genetic loss of let-7 is common in neuroblastoma, inversely associated with MYCN amplification, and independently associated with poor outcomes, providing a rationale for chromosomal loss patterns in neuroblastoma. We propose that let-7 disruption by LIN28B, MYCN sponging, or genetic loss is a unifying mechanism of neuroblastoma development with broad implications for cancer pathogenesis.	[Powers, John T.; Tsanov, Kaloyan M.; Pearson, Daniel S.; Ebright, Richard; Seligson, Marc; de Soysa, Yvanka; Cahan, Patrick; Tu, Ho-Chou; Han, Areum; LaPier, Grace S.; Osborne, Jihan K.; Ross, Samantha J.; Cesana, Marcella; Daley, George Q.] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Roels, Frederik; Theissen, Jessica; Berthold, Frank] Univ Hosp Koln, Dept Pediat Oncol, D-50937 Cologne, Germany; [Spina, Catherine S.; Collins, James J.] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Kurek, Kyle C.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02215 USA; [Collins, James J.] Broad Inst MIT & Harvard, MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Daley, George Q.] Dana Farber Canc Inst, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Daley, George Q.] Boston Childrens Hosp, Boston, MA 02115 USA; [Daley, George Q.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; University of Cologne; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Daley, GQ (corresponding author), Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Dana Farber Canc Inst, Stem Cell Transplantat Program, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	george.daley@childrens.harvard.edu	/AAD-2039-2020; Powers, John/AAO-1018-2020; Cesana, Marcella/AAC-2697-2022; Tsanov, Kaloyan M/J-6852-2012	/0000-0001-9007-4844; Cesana, Marcella/0000-0002-9099-8681; Cahan, Patrick/0000-0003-3652-2540; DE SOYSA, TARJA/0000-0003-1394-3086; Spina, Catherine/0000-0001-6067-5024	National Institutes of Health [R01GM107536]; Alex's Lemonade Stand Foundation; Ellison Medical Foundation; National Institute of General Medical Sciences [T32GM007753]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107536, T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G.Q.D. is supported by National Institutes of Health grant R01GM107536, Alex's Lemonade Stand Foundation, and the Ellison Medical Foundation. G.Q.D. is an affiliate member of the Broad Institute, and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. J.T.P. was supported by Alex's Lemonade Stand Foundation. K.M.T. was supported as a Howard Hughes Medical Institute International Student Research Fellow and as a Herchel Smith Graduate Fellow. D.S.P. and R.E. were supported by award number T32GM007753 from the National Institute of General Medical Sciences.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Baeyens KJ, 1996, P NATL ACAD SCI USA, V93, P12851, DOI 10.1073/pnas.93.23.12851; Barone G, 2013, CLIN CANCER RES, V19, P5814, DOI 10.1158/1078-0432.CCR-13-0680; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beckers A, 2015, ONCOTARGET, V6, P5204, DOI 10.18632/oncotarget.2477; Blandino G, 2014, FEBS LETT, V588, P2639, DOI 10.1016/j.febslet.2014.03.033; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; Breen CJ, 2000, CANCER GENET CYTOGEN, V120, P44, DOI 10.1016/S0165-4608(99)00252-6; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cesana M, 2013, P NATL ACAD SCI USA, V110, P7112, DOI 10.1073/pnas.1305322110; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Ejeskar K, 1998, BRIT J CANCER, V77, P1787, DOI 10.1038/bjc.1998.297; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hackett CS, 2003, CANCER RES, V63, P5266; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Iwakawa R, 2013, GENE CHROMOSOME CANC, V52, P802, DOI 10.1002/gcc.22076; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Madison BB, 2013, GENE DEV, V27, P2233, DOI 10.1101/gad.224659.113; Maris JM, 2001, MED PEDIATR ONCOL, V36, P24, DOI 10.1002/1096-911X(20010101)36:1<24::AID-MPO1007>3.0.CO;2-7; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nguyen LH, 2014, CANCER CELL, V26, P248, DOI 10.1016/j.ccr.2014.06.018; Patro R, 2015, BIORXIV; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pugh TJ, 2014, ONCOGENE, V33, P5295, DOI 10.1038/onc.2014.150; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rakheja D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5802; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Spitz R, 2006, GENE CHROMOSOME CANC, V45, P1130, DOI 10.1002/gcc.20376; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Theissen J, 2014, GENE CHROMOSOME CANC, V53, P639, DOI 10.1002/gcc.22174; Theriault BL, 2014, CLIN EXP OPHTHALMOL, V42, P33, DOI 10.1111/ceo.12132; Tu HC, 2015, GENE DEV, V29, P1074, DOI 10.1101/gad.256693.114; Urbach A, 2014, GENE DEV, V28, P971, DOI 10.1101/gad.237149.113; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392	58	134	143	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					246	U112		10.1038/nature18632	http://dx.doi.org/10.1038/nature18632			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27383785	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000379912600049
J	Saitz, R; Naimi, T				Saitz, Richard; Naimi, Timothy			Moderate Alcohol Intake and Cardiometabolic Risk in Adults With Type 2 Diabetes	ANNALS OF INTERNAL MEDICINE			English	Letter									[Saitz, Richard] Boston Univ, Sch Med, Sch Publ Hlth, Boston, MA 02118 USA; Boston Med Ctr, Boston, MA USA	Boston University; Boston Medical Center	Saitz, R (corresponding author), Boston Univ, Sch Med, Sch Publ Hlth, Boston, MA 02118 USA.			/0000-0002-2535-1427				Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Gepner Y, 2015, ANN INTERN MED, V163, P569, DOI 10.7326/M14-1650; International Agency for Research on Cancer, 2015, AG CLASS IARC MON, V1- 109; Saitz R, 2015, ADDICTION, V110, P1228, DOI 10.1111/add.12979	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					67	67		10.7326/L16-5012	http://dx.doi.org/10.7326/L16-5012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380288				2022-12-28	WOS:000379215800014
J	Sanghavi, P; Jena, AB; Newhouse, JP; Zaslavsky, AM				Sanghavi, Prachi; Jena, Anupam B.; Newhouse, Joseph P.; Zaslavsky, Alan M.			Outcomes of Basic Versus Advanced Life Support for Out-of-Hospital Medical Emergencies RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Sanghavi, Prachi] Univ Chicago, Chicago, IL 60637 USA; [Jena, Anupam B.; Newhouse, Joseph P.; Zaslavsky, Alan M.] Harvard Med Sch, Boston, MA USA	University of Chicago; Harvard University; Harvard Medical School	Sanghavi, P (corresponding author), Univ Chicago, Chicago, IL 60637 USA.		Newhouse, Joseph/AAD-9763-2019; Newhouse, Joseph/AGJ-5632-2022		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R36HS022798] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Li F, ARXIV14041785V2STATM	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					69	70		10.7326/L15-0628	http://dx.doi.org/10.7326/L15-0628			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380156				2022-12-28	WOS:000379215800019
J	Etterson, JR; Mazer, SJ				Etterson, Julie R.; Mazer, Susan J.			How climate change affects plants' sex lives	SCIENCE			English	Editorial Material							EVOLUTION; DISPERSAL; SELECTION; SIZE; TIME		[Etterson, Julie R.] Univ Minnesota, Dept Biol, 207A Swenson Sci Bldg, Duluth, MN 55812 USA; [Mazer, Susan J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of Minnesota System; University of Minnesota Duluth; University of California System; University of California Santa Barbara	Etterson, JR (corresponding author), Univ Minnesota, Dept Biol, 207A Swenson Sci Bldg, Duluth, MN 55812 USA.	jetterso@d.umn.edu; mazer@lifesci.ucsb.edu		Etterson, Julie/0000-0001-6657-0610				Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Dempewolf H, 2014, AGROECOL SUST FOOD, V38, P369, DOI 10.1080/21683565.2013.870629; Dudley LS, 2007, J EVOLUTION BIOL, V20, P2200, DOI 10.1111/j.1420-9101.2007.01421.x; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; Etterson JR, 2016, AM J BOT, V103, P164, DOI 10.3732/ajb.1500313; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Galen C, 2000, AM NAT, V156, P72, DOI 10.1086/303373; Hargreaves AL, 2014, FUNCT ECOL, V28, P5, DOI 10.1111/1365-2435.12170; LLOYD DG, 1979, AM NAT, V113, P67, DOI 10.1086/283365; Nevo E, 2012, P NATL ACAD SCI USA, V109, P3412, DOI 10.1073/pnas.1121411109; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; PEASE CM, 1989, ECOLOGY, V70, P1657, DOI 10.2307/1938100; Petry WK, 2016, SCIENCE, V353, P69, DOI 10.1126/science.aaf2588; Shaw RG, 2012, NEW PHYTOL, V195, P752, DOI 10.1111/j.1469-8137.2012.04230.x; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249	15	13	14	5	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					32	33		10.1126/science.aag1624	http://dx.doi.org/10.1126/science.aag1624			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365440	Green Published			2022-12-28	WOS:000378816200023
J	Schroeder, LF; Guarner, J; Elbireer, A; Castle, PE; Amukele, TK				Schroeder, Lee F.; Guarner, Jeannette; Elbireer, Ali; Castle, Philip E.; Amukele, Timothy K.			Time for a Model List of Essential Diagnostics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERVENTION		[Schroeder, Lee F.] Univ Michigan, Ann Arbor, MI 48109 USA; [Guarner, Jeannette] Emory Univ, Atlanta, GA 30322 USA; [Elbireer, Ali; Amukele, Timothy K.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Castle, Philip E.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Castle, Philip E.] Global Coalit Cerv Canc, Arlington, VA USA; [Elbireer, Ali; Amukele, Timothy K.] Johns Hopkins Univ, Makerere Univ, Clin Core Lab, Infect Dis Inst, Kampala, Uganda	University of Michigan System; University of Michigan; Emory University; Johns Hopkins University; Yeshiva University; Albert Einstein College of Medicine; Makerere University	Schroeder, LF (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.		Castle, Philip/AAP-6395-2020; Guarner, Jeannette/B-8273-2013	Castle, Philip/0000-0003-1082-6554; Guarner, Jeannette/0000-0001-5610-3541; Elbireer, Ali/0000-0002-2513-3497				Mbonye AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129545; Schroeder LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134578; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Vreeman Daniel J, 2007, AMIA Annu Symp Proc, P771; Windus DW, 2007, CLIN CHEM, V53, P1954, DOI 10.1373/clinchem.2007.095067	5	33	33	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2511	2514		10.1056/NEJMp1602825	http://dx.doi.org/10.1056/NEJMp1602825			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8DD	27355530				2022-12-28	WOS:000378727200002
J	Vinogradova, Y; Coupland, C; Brindle, P; Hippisley-Cox, J				Vinogradova, Yana; Coupland, Carol; Brindle, Peter; Hippisley-Cox, Julia			Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DANISH POPULATION; HEART-DISEASE; LOW-RISK; ADHERENCE; THERAPY; NONADHERENCE; INEQUALITIES; CHOLESTEROL; PREDICTORS; PREVENTION	OBJECTIVES To estimate rates of discontinuation and restarting of statins, and to identify patient characteristics associated with either discontinuation or restarting. DESIGN Prospective open cohort study. SETTING 664 general practices contributing to the Clinical Practice Research Datalink in the United Kingdom. Data extracted in October 2014. PARTICIPANTS Incident statin users aged 25-84 years identified between January 2002 and September 2013. Patients with statin prescriptions divided into two groups: primary prevention and secondary prevention (those already diagnosed with cardiovascular disease). Patients with statin prescriptions in the 12 months before study entry were excluded. MAIN OUTCOME MEASURES Discontinuation of statin treatment (first 90 day gap after the estimated end date of a statin prescription), and restarting statin treatment for those who discontinued (defined as any subsequent prescription between discontinuation and study end). RESULTS Of 431 023 patients prescribed statins as primary prevention with a median follow-up time of 137 weeks, 47% (n = 204 622) discontinued treatment and 72% (n = 147 305) of those who discontinued restarted. Of 139 314 patients prescribed statins as secondary prevention with median follow-up time of 182 weeks, 41% (n = 57 791) discontinued treatment and 75% (43 211) of those who discontinued restarted. Younger patients (aged = 50 years), older patients (>= 75 years), women, and patients with chronic liver disease were more likely to discontinue statins and less likely to restart. However, patients in ethnic minority groups, current smokers, and patients with type 1 diabetes were more likely to discontinue treatment but then were more likely to restart, whereas patients with hypertension and type 2 diabetes were less likely to discontinue treatment and more likely to restart if they did discontinue. These results were mainly consistent in the primary prevention and secondary prevention groups. CONCLUSIONS Although a large proportion of statin users discontinue, many of them restart. For many patient groups previously considered as "stoppers," the problem of statin treatment " stopping" could be part of the wider issue of poor adherence. Identification of patient groups associated with completely stopping or stop-starting behaviour has positive implications for patients and doctors as well as suggesting areas for future research.	[Vinogradova, Yana; Coupland, Carol; Hippisley-Cox, Julia] Univ Nottingham, Div Primary Care, Univ Pk, Nottingham NG2 7RD, England; [Brindle, Peter] Bristol Clin Commissioning Grp, Avon Primary Care Res Collaborat, Bristol, Avon, England; [Brindle, Peter] Univ Bristol, Bristol, Avon, England	University of Nottingham; University of Bristol	Vinogradova, Y (corresponding author), Univ Nottingham, Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	Yana.Vinogradova@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306; Vinogradova, Yana/0000-0002-3030-5257	ClinRisk	ClinRisk	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any additional organisation for the submitted work; JH-C is a professor of clinical epidemiology at the University of Nottingham and unpaid director of QResearch, a not-for-profit organisation that is a joint partnership between the University of Nottingham and EMIS (Egton Medical Information System; commercial IT supplier for 60% of general practices in the UK); JH-C is also a paid director of ClinRisk, which produces open and closed source software to ensure the reliable and updatable implementation of clinical risk algorithms (including QRISK2) within clinical computer systems to help improve patient care; no other relationships or activities that could appear to have influenced the submitted work.	Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Caspard H, 2005, CLIN THER, V27, P1639, DOI 10.1016/j.clinthera.2005.10.005; Casula M, 2012, PATIENT PREFER ADHER, V6, P805, DOI 10.2147/PPA.S29092; Daskalopoulou SS, 2008, EUR HEART J, V29, P2083, DOI 10.1093/eurheartj/ehn346; Ferrajolo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112037; Granger BB, 2013, EUR J CARDIOVASC NUR, V12, P276, DOI 10.1177/1474515112447734; Halava H, 2014, CAN MED ASSOC J, V186, pE449, DOI 10.1503/cmaj.131807; Hippisley-Cox J, 2001, BMJ-BRIT MED J, V322, P832, DOI 10.1136/bmj.322.7290.832; Hippisley-Cox J, 2007, HEART, V93, P1256, DOI 10.1136/hrt.2006.110171; Hippisley-Cox Julia, 2010, BMJ, V340, pc2197, DOI 10.1136/bmj.c2197; Ingebrigtsen TS, 2015, THORAX, V70, P33, DOI 10.1136/thoraxjnl-2014-205795; Jensen MT, 2016, DIABETES RES CLIN PR, V111, P51, DOI 10.1016/j.diabres.2015.10.022; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Larsen J, 2002, BRIT J CLIN PHARMACO, V53, P375, DOI 10.1046/j.1365-2125.2002.01563.x; Lemstra M, 2012, CAN J CARDIOL, V28, P574, DOI 10.1016/j.cjca.2012.05.007; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Mancini GBJ, 2013, CAN J CARDIOL, V29, P1553, DOI 10.1016/j.cjca.2013.09.023; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; Mauskop Alexander, 2011, Curr Cardiol Rep, V13, P553, DOI 10.1007/s11886-011-0221-2; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; National Institute for Health and Care Excellence, 2014, LIP MOD CARD RISK AS; National Institute for Health and Care Excellence, 2008, LIP MOD CARD RISK AS; Nielsen SF, 2016, EUR HEART J, V37, P908, DOI 10.1093/eurheartj/ehv641; Pastori D, 2015, DIGEST LIVER DIS, V47, P4, DOI 10.1016/j.dld.2014.07.170; Prasad V, 2014, ANN INTERN MED, V160, P867, DOI 10.7326/M13-2974; Rosenbaum D, 2013, NUTR METAB CARDIOVAS, V23, P871, DOI 10.1016/j.numecd.2012.04.012; Royal Pharmaceutical Society of Great Britain British Medical Association, 2013, BRIT NAT FORM 66; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Schedlbauer A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004371.pub3; Smeeth L, 2003, QJM-INT J MED, V96, P337, DOI 10.1093/qjmed/hcg064; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Svensson E, 2015, CLIN EPIDEMIOL, V7, P213, DOI 10.2147/CLEP.S78145; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Trusler D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4350; Vinogradova Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008701; Warren JR, 2013, PHARMACOEPIDEM DR S, V22, P1298, DOI 10.1002/pds.3526; Young RP, 2009, EUR RESPIR REV, V18, P222, DOI 10.1183/09059180.00005309; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	41	77	77	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2016	353								i3305	10.1136/bmj.i3305	http://dx.doi.org/10.1136/bmj.i3305			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FP	27353261	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000379018000003
J	Gulland, A				Gulland, Anne			France's air pollution causes 48 000 deaths a year	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Sante Public France, 2016, IMP EXP CHRON PART F	1	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2016	353								i3523	10.1136/bmj.i3523	http://dx.doi.org/10.1136/bmj.i3523			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BX	27337979				2022-12-28	WOS:000378724000010
J	Soykan, T; Haucke, V				Soykan, Tolga; Haucke, Volker			CELL BIOLOGY Membrane kiss mediates hormone secretion	NATURE			English	Editorial Material							CA2+-TRIGGERED EXOCYTOSIS; FUSION; SNARE; INTERMEDIATE; HEMIFUSION	Communication between cells relies on hormone release from secretory granules, but how these vesicles fuse with cell membranes is unclear. An imaging study provides in vivo evidence for a stable intermediate fusion step. SEE LETTER p. 548	[Soykan, Tolga; Haucke, Volker] Leibniz Inst Mol Pharmacol, Dept Mol Pharmacol & Cell Biol, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Soykan, T (corresponding author), Leibniz Inst Mol Pharmacol, Dept Mol Pharmacol & Cell Biol, D-13125 Berlin, Germany.	soykan@fmp-berlin.de; haucke@fmp-berlin.de						Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chiang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4356; Diao JJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00109; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Mattila JP, 2015, NATURE, V524, P109, DOI 10.1038/nature14509; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Zhao WD, 2016, NATURE, V534, P548, DOI 10.1038/nature18598	13	2	2	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					479	480		10.1038/nature18446	http://dx.doi.org/10.1038/nature18446			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309811				2022-12-28	WOS:000378270300036
J	Elmore, JG; Tosteson, ANA; Pepe, MS; Longton, GM; Nelson, HD; Geller, B; Carney, PA; Onega, T; Allison, KH; Jackson, SL; Weaver, DL				Elmore, Joann G.; Tosteson, Anna N. A.; Pepe, Margaret S.; Longton, Gary M.; Nelson, Heidi D.; Geller, Berta; Carney, Patricia A.; Onega, Tracy; Allison, Kimberly H.; Jackson, Sara L.; Weaver, Donald L.			Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGICAL PATHOLOGY; VARIABILITY; REVIEWS; LESIONS; SLIDES	OBJECTIVE To evaluate the potential effect of second opinions on improving the accuracy of diagnostic interpretation of breast histopathology. DESIGN Simulation study. SETTING 12 different strategies for acquiring independent second opinions. PARTICIPANTS Interpretations of 240 breast biopsy specimens by 115 pathologists, one slide for each case, compared with reference diagnoses derived by expert consensus. MAIN OUTCOME MEASURES Misclassification rates for individual pathologists and for 12 simulated strategies for second opinions. Simulations compared accuracy of diagnoses from single pathologists with that of diagnoses based on pairing interpretations from first and second independent pathologists, where resolution of disagreements was by an independent third pathologist. 12 strategies were evaluated in which acquisition of second opinions depended on initial diagnoses, assessment of case difficulty or borderline characteristics, pathologists' clinical volumes, or whether a second opinion was required by policy or desired by the pathologists. The 240 cases included benign without atypia (10% non-proliferative, 20% proliferative without atypia), atypia (30%), ductal carcinoma in situ (DCIS, 30%), and invasive cancer (10%). Overall misclassification rates and agreement statistics depended on the composition of the test set, which included a higher prevalence of difficult cases than in typical practice. RESULTS Misclassification rates significantly decreased (P<0.001) with all second opinion strategies except for the strategy limiting second opinions only to cases of invasive cancer. The overall misclassification rate decreased from 24.7% to 18.1% when all cases received second opinions (P<0.001). Obtaining both first and second opinions from pathologists with a high volume (>= 10 breast biopsy specimens weekly) resulted in the lowest misclassification rate in this test set (14.3%, 95% confidence interval 10.9% to 18.0%). Obtaining second opinions only for cases with initial interpretations of atypia, DCIS, or invasive cancer decreased the over-interpretation of benign cases without atypia from 12.9% to 6.0%. Atypia cases had the highest misclassification rate after single interpretation (52.2%), remaining at more than 34% in all second opinion scenarios. CONCLUSION Second opinions can statistically significantly improve diagnostic agreement for pathologists' interpretations of breast biopsy specimens; however, variability in diagnosis will not be completely eliminated, especially for breast specimens with atypia.	[Elmore, Joann G.; Jackson, Sara L.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Pepe, Margaret S.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Longton, Gary M.] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, 1124 Columbia St, Seattle, WA 98104 USA; [Nelson, Heidi D.] Providence Hlth & Serv Oregon, Providence Canc Ctr, Portland, OR USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Dept Med Informat, Portland, OR 97201 USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Dept Clin Epidemiol & Med, Portland, OR 97201 USA; [Geller, Berta] Univ Vermont, Dept Family Med, Burlington, VT USA; [Carney, Patricia A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Onega, Tracy] Geisel Sch Med Dartmouth, Community & Family Med, Lebanon, NH USA; [Allison, Kimberly H.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Weaver, Donald L.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Weaver, Donald L.] Univ Vermont, UVM Canc Ctr, Burlington, VT USA	University of Washington; University of Washington Seattle; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Oregon Health & Science University; Oregon Health & Science University; University of Vermont; Oregon Health & Science University; Dartmouth College; Stanford University; University of Vermont; University of Vermont	Elmore, JG (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.	jelmore@uw.edu			National Cancer Institute [R01 CA140560, R01 CA172343, K05 CA104699]; National Cancer Institute funded Breast Cancer Surveillance Consortium [HHSN261201100031C]; NATIONAL CANCER INSTITUTE [R01CA172343, P30CA023108] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute funded Breast Cancer Surveillance Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (R01 CA140560, R01 CA172343, and K05 CA104699) and by the National Cancer Institute funded Breast Cancer Surveillance Consortium (HHSN261201100031C). The content is solely the responsibility of the authors and does not necessarily represent the vices of the National Cancer Institute or the National Institutes of Hearth.	Allison KH, 2014, HISTOPATHOLOGY, V65, P240, DOI 10.1111/his.12387; [Anonymous], 2015, IMPR DIAGN HLTH CAR; [Anonymous], 2000, ERR IS HUMAN BUILDIN; Bleiweiss IJ, 2012, J CLIN ONCOL, V30, P2175, DOI 10.1200/JCO.2012.42.1255; Davidson NE, 2015, JAMA-J AM MED ASSOC, V313, P1109, DOI 10.1001/jama.2015.1945; Dinnes J, 2001, BREAST, V10, P455, DOI 10.1054/brst.2001.0350; Elmore JG, 2016, ANN INTERN MED, V164, P649, DOI 10.7326/M15-0964; Elmore JG, 2015, JAMA-J AM MED ASSOC, V314, P83, DOI 10.1001/jama.2015.6239; Elmore JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI 10.1001/jama.2015.1405; Frable WJ, 2006, ARCH PATHOL LAB MED, V130, P620; Geller BM, 2014, J CLIN PATHOL, V67, P955, DOI 10.1136/jclinpath-2014-202290; Helmer O., 1964, SYSTEMATIC USE EXPER; Hofvind S, 2009, RADIOLOGY, V253, P652, DOI 10.1148/radiol.2533090210; Kennecke HF, 2012, J CLIN ONCOL, V30, P2227, DOI 10.1200/JCO.2011.38.9247; Khazai L, 2015, J SURG ONCOL, V111, P192, DOI 10.1002/jso.23788; Kronz JD, 1999, CANCER, V86, P2426, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2426::AID-CNCR34>3.0.CO;2-3; Manion E, 2008, AM J SURG PATHOL, V32, P732, DOI 10.1097/PAS.0b013e31815a04f5; Marco V, 2014, BREAST J, V20, P295, DOI 10.1111/tbj.12252; Middleton LP, 2014, J ONCOL PRACT, V10, P275, DOI 10.1200/JOP.2013.001204; Nakhleh RE, 2010, ARCH PATHOL LAB MED, V134, P740, DOI 10.1043/1543-2165-134.5.740; Newman EA, 2006, CANCER, V107, P2346, DOI 10.1002/cncr.22266; Onega T, 2014, J DIGIT IMAGING, V27, P642, DOI 10.1007/s10278-014-9683-2; Oster NV, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-3; Romanoff AM, 2014, ANN SURG ONCOL, V21, P3504, DOI 10.1245/s10434-014-3792-5; ROSAI J, 1991, AM J SURG PATHOL, V15, P209, DOI 10.1097/00000478-199103000-00001; SCHNITT SJ, 1992, AM J SURG PATHOL, V16, P1133, DOI 10.1097/00000478-199212000-00001; Silverstein M, 2009, J AM COLL SURGEONS, V208, P78, DOI 10.1016/j.jamcollsurg.2008.09.022; Silverstein Melvin J, 2009, J Am Coll Surg, V209, P504, DOI 10.1016/j.jamcollsurg.2009.07.006; Staradub VL, 2002, ANN SURG ONCOL, V9, P982, DOI 10.1245/ASO.2002.03.056; Tomaszewski JE, 2000, AM J CLIN PATHOL, V114, P329, DOI 10.1093/ajcp/114.3.329; Tsung JSH, 2004, AM J SURG PATHOL, V28, P399, DOI 10.1097/00000478-200403000-00015	31	20	20	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i3069	10.1136/bmj.i3069	http://dx.doi.org/10.1136/bmj.i3069			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27334105	Green Published, hybrid			2022-12-28	WOS:000378723500004
J	Mantilla, LL; Montori, VM				Mantilla, Laura Larrea; Montori, Victor M.			Review: In diabetes, benefits of lowering BP depend on baseline BP being 140 mm Hg or more Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Mantilla, Laura Larrea; Montori, Victor M.] Mayo Clin, Rochester, MN USA	Mayo Clinic	Mantilla, LL (corresponding author), Mayo Clin, Rochester, MN USA.			Montori, Victor/0000-0003-0595-2898				Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					JC62	JC62		10.7326/ACPJC-2016-164-12-062	http://dx.doi.org/10.7326/ACPJC-2016-164-12-062			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323258				2022-12-28	WOS:000379343000001
J	Buganim, Y				Buganim, Yosef			Back to basics Refined nuclear reprogramming techniques yield higher-quality stem cells	SCIENCE			English	Editorial Material									[Buganim, Yosef] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Buganim, Yosef] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel	Massachusetts Institute of Technology (MIT); Whitehead Institute; Hebrew University of Jerusalem	Buganim, Y (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA.; Buganim, Y (corresponding author), Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel.							Benchetrit H, 2015, CELL STEM CELL, V17, P543, DOI 10.1016/j.stem.2015.08.006; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Sebban S, 2016, TRENDS CELL BIOL, V26, P65, DOI 10.1016/j.tcb.2015.08.006	4	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1401	1401		10.1126/science.aag1215	http://dx.doi.org/10.1126/science.aag1215			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313030				2022-12-28	WOS:000377975400027
J	Montefiori, DC				Montefiori, David C.			Bispecific Antibodies Against HIV	CELL			English	Editorial Material							INFECTION	Synergistic bispecific antibodies against HIV exhibit extraordinary potency and breadth of neutralization as promising candidates for treatment and prevention.	[Montefiori, David C.] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27710 USA	Duke University	Montefiori, DC (corresponding author), Duke Univ, Dept Surg, Med Ctr, Durham, NC 27710 USA.	david.montefiori@duke.edu						Bournazos S, 2016, CELL, V165, P1609, DOI 10.1016/j.cell.2016.04.050; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Deal CE, 2015, CURR OPIN HIV AIDS, V10, P190, DOI 10.1097/COH.0000000000000145; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Huang YX, 2016, CELL, V165, P1621, DOI 10.1016/j.cell.2016.05.024; Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612; Lynch RM, 2015, SCI TRANSL MED, V7; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Wagh K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005520	9	10	10	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1563	1564		10.1016/j.cell.2016.06.004	http://dx.doi.org/10.1016/j.cell.2016.06.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315470	Bronze			2022-12-28	WOS:000378062000005
J	Wootten, D; Reynolds, CA; Smith, KJ; Mobarec, JC; Koole, C; Savage, EE; Pabreja, K; Simms, J; Sridhar, R; Furness, SGB; Liu, MJ; Thompson, PE; Miller, LJ; Christopoulos, A; Sexton, PM				Wootten, Denise; Reynolds, Christopher A.; Smith, Kevin J.; Mobarec, Juan C.; Koole, Cassandra; Savage, Emilia E.; Pabreja, Kavita; Simms, John; Sridhar, Rohan; Furness, Sebastian G. B.; Liu, Mengjie; Thompson, Philip E.; Miller, Laurence J.; Christopoulos, Arthur; Sexton, Patrick M.			The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism	CELL			English	Article							GLUCAGON-LIKE PEPTIDE-1; PROTEIN-COUPLED RECEPTOR; CLASS-B GPCR; BINDING; ACTIVATION; LIGANDS; REGIONS; LOOPS	Ligand-directed signal bias offers opportunities for sculpting molecular events, with the promise of better, safer therapeutics. Critical to the exploitation of signal bias is an understanding of the molecular events coupling ligand binding to intracellular signaling. Activation of class B G protein-coupled receptors is driven by interaction of the peptide N terminus with the receptor core. To understand how this drives signaling, we have used advanced analytical methods that enable separation of effects on pathway-specific signaling from those that modify agonist affinity and mapped the functional consequence of receptor modification onto three-dimensional models of a receptor-ligand complex. This yields molecular insights into the initiation of receptor activation and the mechanistic basis for biased agonism. Our data reveal that peptide agonists can engage different elements of the receptor extracellular face to achieve effector coupling and biased signaling providing a foundation for rational design of biased agonists.	[Wootten, Denise; Koole, Cassandra; Savage, Emilia E.; Pabreja, Kavita; Sridhar, Rohan; Furness, Sebastian G. B.; Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Liu, Mengjie; Thompson, Philip E.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Reynolds, Christopher A.; Smith, Kevin J.; Mobarec, Juan C.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Koole, Cassandra] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave, New York, NY 10065 USA; [Simms, John] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Miller, Laurence J.] Mayo Clin Scottsdale, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Monash University; Monash University; University of Essex; Rockefeller University; Aston University; Mayo Clinic; Mayo Clinic Phoenix	Wootten, D; Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia.	denise.wootten@monash.edu; patrick.sexton@monash.edu	Furness, Sebastian/Q-9068-2018; Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; Wootten, Denise/ABD-5703-2021; Reynolds, Christopher/G-1036-2010	Furness, Sebastian/0000-0001-8655-8221; Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Wootten, Denise/0000-0003-4563-1642; Simms, John/0000-0002-4675-0902; Thompson, Philip/0000-0002-5910-7625; Reynolds, Christopher/0000-0001-9267-5141; Liu, Mengjie (Oscar)/0000-0003-1944-5301; Mobarec, Juan Carlos/0000-0001-9482-4294	National Health and Medical Research Council of Australia (NHMRC) project [1061044, 1065410]; NHMRC program [1055134]; Biotechnology and Biological Sciences Research Council of the United Kingdom project [BB/M006883/1]; Medical Research Council (UK) Research Leader Fellowship [G1001812]; BBSRC [BB/M007529/1, BB/G000719/1, BB/M006883/1] Funding Source: UKRI; MRC [G1001812] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M006883/1, BB/G000719/1, BB/M007529/1] Funding Source: researchfish; Medical Research Council [G1001812] Funding Source: researchfish	National Health and Medical Research Council of Australia (NHMRC) project(National Health and Medical Research Council (NHMRC) of Australia); NHMRC program(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council of the United Kingdom project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK) Research Leader Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) project grants (1061044 and 1065410) and NHMRC program grant (1055134); Biotechnology and Biological Sciences Research Council of the United Kingdom project grant (BB/M006883/1); and Medical Research Council (UK) Research Leader Fellowship (G1001812) (C.A.R.). D.W. is a NHMRC Career Development Fellow. P.M.S. is a NHMRC Principal Research Fellow, and A.C. is a NHMRC Senior Principal Research Fellow. C.K. is a NHMRC CJ Martin Postdoctoral Fellow.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barwell J, 2011, BBA-MOL CELL RES, V1813, P1906, DOI 10.1016/j.bbamcr.2011.06.005; Bergwitz C, 1997, J BIOL CHEM, V272, P28861, DOI 10.1074/jbc.272.46.28861; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; Coopman K, 2010, J PHARMACOL EXP THER, V334, P795, DOI 10.1124/jpet.110.166009; Couvineau A, 2012, CURR DRUG TARGETS, V13, P103, DOI 10.2174/138945012798868434; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Dong MQ, 2012, FASEB J, V26, P5092, DOI 10.1096/fj.12-212399; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Reid TS., 2013, CLIN DIABETES, V31, P148, DOI DOI 10.2337/DIACLIN.31.4.148; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Wootten D, 2013, MOL PHARMACOL, V83, P822, DOI 10.1124/mol.112.084525; Zhang HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9918	25	99	99	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1632	1643		10.1016/j.cell.2016.05.023	http://dx.doi.org/10.1016/j.cell.2016.05.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315480	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000378062000015
J	Neogi, T				Neogi, Tuhina			Gout	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OF-RHEUMATOLOGY GUIDELINES; CHRONIC KIDNEY-DISEASE; US GENERAL-POPULATION; CASE-CROSSOVER GOUT; PURINE-RICH FOODS; URIC-ACID LEVEL; INCIDENT GOUT; AMERICAN-COLLEGE; SERUM URATE; CLASSIFICATION CRITERIA						Neogi, Tuhina/AAM-1110-2020	Neogi, Tuhina/0000-0002-9515-1711	NIAMS NIH HHS [P60 AR047785] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aggarwal R, 2015, ARTHRIT CARE RES, V67, P891, DOI 10.1002/acr.22583; Becker MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2978; Bhole V, 2010, ARTHRITIS RHEUM-US, V62, P1069, DOI 10.1002/art.27338; Borstad GC, 2004, J RHEUMATOL, V31, P2429; Bruderer S, 2014, ARTHRITIS RHEUMATOL, V66, P185, DOI 10.1002/art.38203; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2008, BMJ-BRIT MED J, V336, P309, DOI 10.1136/bmj.39449.819271.BE; Choi HK, 2007, ARTHRITIS RHEUM, V56, P2049, DOI 10.1002/art.22712; Choi HK, 2015, ARTHRITIS RHEUMATOL, V67, P555, DOI 10.1002/art.38917; Choi HK, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8190; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; Choi HK, 2010, AM J CLIN NUTR, V92, P922, DOI 10.3945/ajcn.2010.29565; Choi HK, 2009, ARCH INTERN MED, V169, P502, DOI 10.1001/archinternmed.2008.606; Dalbeth N, 2006, J RHEUMATOL, V33, P1646; Dalbeth N, 2010, ARTHRITIS RHEUM-US, V62, P1549, DOI 10.1002/art.27356; Doherty M, 2012, ANN RHEUM DIS, V71, P1765, DOI 10.1136/annrheumdis-2012-201687; FELSON DT, 1989, J RHEUMATOL, V16, P1241; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hunter DJ, 2006, J RHEUMATOL, V33, P1341; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Lindsay K, 2011, JCR-J CLIN RHEUMATOL, V17, P1, DOI 10.1097/RHU.0b013e318204a8f9; McQueen FM, 2014, RHEUM DIS CLIN N AM, V40, P231, DOI 10.1016/j.rdc.2014.01.004; McQueen FM, 2014, RHEUMATOLOGY, V53, P95, DOI 10.1093/rheumatology/ket329; Merriman TR, 2014, RHEUM DIS CLIN N AM, V40, P279, DOI 10.1016/j.rdc.2014.01.009; Neogi T, 2006, J RHEUMATOL, V33, P104; Neogi T, 2015, ANN RHEUM DIS, V74, P1789, DOI 10.1136/annrheumdis-2015-208237; Neogi T, 2015, ARTHRITIS RHEUMATOL, V67, P2557, DOI 10.1002/art.39254; Neogi T, 2014, AM J MED, V127, P311, DOI 10.1016/j.amjmed.2013.12.019; Neogi T, 2012, ARTHRITIS RHEUM-US, V64, P327, DOI 10.1002/art.33369; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Ogdie A, 2015, ANN RHEUM DIS, V74, P1868, DOI 10.1136/annrheumdis-2014-205431; Perez-Ruiz F, 2006, ARTHRIT RHEUM-ARTHR, V55, P786, DOI 10.1002/art.22232; Schlesinger N, 2009, J RHEUMATOL, V36, P1287, DOI 10.3899/jrheum.080938; Singh JA, 2007, ARTHRIT RHEUM-ARTHR, V57, P822, DOI 10.1002/art.22767; Sircar D, 2015, AM J KIDNEY DIS, V66, P945, DOI 10.1053/j.ajkd.2015.05.017; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Stamp LK, 2011, ARTHRITIS RHEUM-US, V63, P412, DOI 10.1002/art.30119; Taylor W, 2015, ARTHRITIS CARE RES H; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; Wu EQ, 2009, J RHEUMATOL, V36, P1032, DOI 10.3899/jrheum.080487; Zhang Y, 2008, ARTHRITIS RHEUM-US, V58, pS916; Zhang YQ, 2012, ARTHRITIS RHEUM-US, V64, P4004, DOI 10.1002/art.34677; Zhang YQ, 2012, ANN RHEUM DIS, V71, P1448, DOI 10.1136/annrheumdis-2011-201215; Zhu YY, 2012, AM J MED, V125, P679, DOI 10.1016/j.amjmed.2011.09.033; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520; Zhu YY, 2010, RHEUMATOLOGY, V49, P2391, DOI 10.1093/rheumatology/keq256	52	22	23	1	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					ITC1	ITC15		10.7326/AITC201607050	http://dx.doi.org/10.7326/AITC201607050			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380294				2022-12-28	WOS:000379215800001
J	Lapotre, MGA; Ewing, RC; Lamb, MP; Fischer, WW; Grotzinger, JP; Rubin, DM; Lewis, KW; Ballard, MJ; Day, M; Gupta, S; Banham, SG; Bridges, NT; Des Marais, DJ; Fraeman, AA; Grant, JA; Herkenhoff, KE; Ming, DW; Mischna, MA; Rice, MS; Sumner, DA; Vasavada, AR; Yingst, RA				Lapotre, M. G. A.; Ewing, R. C.; Lamb, M. P.; Fischer, W. W.; Grotzinger, J. P.; Rubin, D. M.; Lewis, K. W.; Ballard, M. J.; Day, M.; Gupta, S.; Banham, S. G.; Bridges, N. T.; Des Marais, D. J.; Fraeman, A. A.; Grant, J. A.; Herkenhoff, K. E.; Ming, D. W.; Mischna, M. A.; Rice, M. S.; Sumner, D. A.; Vasavada, A. R.; Yingst, R. A.			Large wind ripples on Mars: A record of atmospheric evolution	SCIENCE			English	Article							MERIDIANI-PLANUM; SAND RIPPLES; BEDFORMS; CRATER; DUNES; WATER; MODEL	Wind blowing over sand on Earth produces decimeter-wavelength ripples and hundred-meter-to kilometer-wavelength dunes: bedforms of two distinct size modes. Observations from the Mars Science Laboratory Curiosity rover and the Mars Reconnaissance Orbiter reveal that Mars hosts a third stable wind-driven bedform, with meter-scale wavelengths. These bedforms are spatially uniform in size and typically have asymmetric profiles with angle-of-repose lee slopes and sinuous crest lines, making them unlike terrestrial wind ripples. Rather, these structures resemble fluid-drag ripples, which on Earth include water-worked current ripples, but on Mars instead form by wind because of the higher kinematic viscosity of the low-density atmosphere. A reevaluation of the wind-deposited strata in the Burns formation (about 3.7 billion years old or younger) identifies potential wind-drag ripple stratification formed under a thin atmosphere.	[Lapotre, M. G. A.; Lamb, M. P.; Fischer, W. W.; Grotzinger, J. P.; Fraeman, A. A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Ewing, R. C.; Ballard, M. J.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; [Rubin, D. M.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Lewis, K. W.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Day, M.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Gupta, S.; Banham, S. G.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Bridges, N. T.] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Des Marais, D. J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Fraeman, A. A.; Mischna, M. A.; Vasavada, A. R.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Grant, J. A.] Smithsonian Inst, Natl Air & Space Museum, Washington, DC 20560 USA; [Herkenhoff, K. E.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Ming, D. W.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Rice, M. S.] Western Washington Univ, Dept Geol, Bellingham, WA 98225 USA; [Sumner, D. A.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Yingst, R. A.] Planetary Sci Inst, Tucson, AZ 85719 USA	California Institute of Technology; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Santa Cruz; Johns Hopkins University; University of Texas System; University of Texas Austin; Imperial College London; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Smithsonian Institution; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Western Washington University; University of California System; University of California Davis	Lapotre, MGA (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	mlapotre@caltech.edu	Mischna, Michael/AAF-3861-2020; Banham, Steven G./J-3327-2019; Lapotre, Mathieu/L-4910-2018	Mischna, Michael/0000-0002-8022-5319; Banham, Steven G./0000-0003-1206-1639; Grant, John/0000-0001-8276-1281; Rubin, David/0000-0003-1169-1452; Gupta, Sanjeev/0000-0001-6415-1332; Rice, Melissa/0000-0002-8370-4139; Ewing, Ryan/0000-0001-6337-610X; Day, Mackenzie/0000-0003-3998-7749; Fraeman, Abigail/0000-0003-4017-5158; Lapotre, Mathieu/0000-0001-9941-1552	NASA; UK Space Agency; NASA MSL Participating Scientist program; KISS Prize Postdoctoral Fellowship; Caltech GPS Division Texaco Prize Postdoctoral Fellowship; UK Space Agency [ST/J005169/1, ST/N000579/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); UK Space Agency; NASA MSL Participating Scientist program; KISS Prize Postdoctoral Fellowship; Caltech GPS Division Texaco Prize Postdoctoral Fellowship; UK Space Agency	We thank the MSL engineering and science teams; the Mastcam team; Malin Space Science Systems, who made the rover observations possible; and B. Ehlmann and K. Edgett for insightful comments. Data presented in this paper are archived in the Planetary Data System (https://pds.nasa.gov/), and our compilation is available in the supplementary materials (data tables S1 and S2). Part of this research was carried out at the Propultion Laboutatory-Caltech, under a contract with NASA. Work in the United Kingdom was funded by the UK Space Agency. D.M.R. was funded by the NASA MSL Participating Scientist program, and A.A.F. by a KISS Prize Postdoctoral Fellowship and a Caltech GPS Division Texaco Prize Postdoctoral Fellowship.	Andreotti B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028001; [Anonymous], 2013, COMP CLIMATOLOGY TER, DOI DOI 10.2458/AZU_UAPRESS_9780816530595-CH18; BAGNOLD RA, 1941, PHYS BLOWN SAND DESE, V10; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Blake DF, 2013, SCIENCE, V341, DOI 10.1126/science.1239505; Bridges NT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031445; Bridges NT, 2012, GEOLOGY, V40, P31, DOI 10.1130/G32373.1; de Silva SL, 2013, GEOL SOC AM BULL, V125, P1912, DOI 10.1130/B30916.1; Duran O, 2014, P NATL ACAD SCI USA, V111, P15665, DOI 10.1073/pnas.1413058111; Grazer R, 1982, EXPT STUDY CURRENT R; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; Grotzinger JP, 2005, EARTH PLANET SC LETT, V240, P11, DOI 10.1016/j.epsl.2005.09.039; Hayes AG, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003688; Hu RY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10003; HUNTER RE, 1977, SEDIMENTOLOGY, V24, P361, DOI 10.1111/j.1365-3091.1977.tb00128.x; Jerolmack DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002544; Kok JF, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/106901; Lamb MP, 2012, SOC SEDIMENT GEOL SP, V102, P139; Lorenz RD, 2014, ICARUS, V230, P77, DOI 10.1016/j.icarus.2013.10.026; Mahaffy PR, 2015, SCIENCE, V347, P412, DOI 10.1126/science.1260291; MCEWEN AS, 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; Middleton G.V., 1984, SEPM SHORT COURSE 3, P401; Ojha L, 2015, NAT GEOSCI, V8, P829, DOI [10.1038/ngeo2546, 10.1038/NGEO2546]; Rubin D.M., 2005, 20051272 US GEOL SUR; Rubin DM, 2012, EARTH-SCI REV, V113, P176, DOI 10.1016/j.earscirev.2012.03.010; RUBIN DM, 1980, SEDIMENT GEOL, V26, P207, DOI 10.1016/0037-0738(80)90012-3; Silvestro S, 2013, GEOLOGY, V41, P483, DOI 10.1130/G34162.1; SOUTHARD JB, 1990, J SEDIMENT PETROL, V60, P658, DOI 10.1306/212F9241-2B24-11D7-8648000102C1865D; Sullivan R, 2005, NATURE, V436, P58, DOI 10.1038/nature03641; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Tosca NJ, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003700; Tosca NJ, 2005, EARTH PLANET SC LETT, V240, P122, DOI 10.1016/j.epsl.2005.09.042; WERNER BT, 1986, GEOLOGY, V14, P743, DOI 10.1130/0091-7613(1986)14<743:MOESRC>2.0.CO;2; WILSON IG, 1972, SEDIMENTOLOGY, V19, P173, DOI 10.1111/j.1365-3091.1972.tb00020.x; Withers P, 2006, ICARUS, V185, P133, DOI 10.1016/j.icarus.2006.06.013; YALIN MS, 1985, J HYDRAUL ENG-ASCE, V111, P1148, DOI 10.1061/(ASCE)0733-9429(1985)111:8(1148); Yizhaq H, 2014, ICARUS, V230, P143, DOI 10.1016/j.icarus.2013.08.006	38	120	123	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					55	58		10.1126/science.aaf3206	http://dx.doi.org/10.1126/science.aaf3206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365444	Green Submitted, Green Accepted			2022-12-28	WOS:000378816200033
J	Donati, JF; Moutou, C; Malo, L; Baruteau, C; Yu, L; Hebrard, E; Hussain, G; Alencar, S; Menard, F; Bouvier, J; Petit, P; Takami, M; Doyon, R; Cameron, AC				Donati, J. F.; Moutou, C.; Malo, L.; Baruteau, C.; Yu, L.; Hebrard, E.; Hussain, G.; Alencar, S.; Menard, F.; Bouvier, J.; Petit, P.; Takami, M.; Doyon, R.; Cameron, A. Collier			A hot Jupiter orbiting a 2-million-year-old solar-mass T Tauri star	NATURE			English	Article							SPECTROPOLARIMETRIC OBSERVATIONS; DIFFERENTIAL ROTATION; MAGNETIC-FIELD; ACTIVE STARS; YOUNG SUNS; PLANET; SYSTEM; DISK; VARIABILITY; EVOLUTION	Hot Jupiters are giant Jupiter-like exoplanets that orbit their host stars 100 times more closely than Jupiter orbits the Sun. These planets presumably form in the outer part of the primordial disk from which both the central star and surrounding planets are born, then migrate inwards and yet avoid falling into their host star(1). It is, however, unclear whether this occurs early in the lives of hot Jupiters, when they are still embedded within protoplanetary disks(2), or later, once multiple planets are formed and interact(3). Although numerous hot Jupiters have been detected around mature Sun-like stars, their existence has not yet been firmly demonstrated for young stars(4-6), whose magnetic activity is so intense that it overshadows the radial velocity signal that close-in giant planets can induce. Here we report that the radial velocities of the young star V830 Tau exhibit a sine wave of period 4.93 days and semi-amplitude 75 metres per second, detected with a false-alarm probability of less than 0.03 per cent, after filtering out the magnetic activity plaguing the spectra. We find that this signal is unrelated to the 2.741-day rotation period of V830 Tau and we attribute it to the presence of a planet of mass 0.77 times that of Jupiter, orbiting at a distance of 0.057 astronomical units from the host star. Our result demonstrates that hot Jupiters can migrate inwards in less than two million years, probably as a result of planet-disk interactions(2).	[Donati, J. F.; Baruteau, C.; Yu, L.; Petit, P.] Univ Toulouse, UPS OMP, IRAP, 14 Ave Belin, F-31400 Toulouse, France; [Donati, J. F.; Baruteau, C.; Yu, L.; Petit, P.] CNRS, IRAP, UMR 5277, 14 Ave Belin, F-31400 Toulouse, France; [Moutou, C.; Malo, L.] Canada France Hawaii Telescope CFHT Corp, 65-1238 Mamalahoa Highway, Kamuela, HI 96743 USA; [Hebrard, E.] York Univ, Dept Phys & Astron, Toronto, ON L3T 3R1, Canada; [Hussain, G.] ESO, Karl Schwarzschild Str 2, D-85748 Garching, Germany; [Alencar, S.] Univ Fed Minas Gerais, Dept Fis, ICEx, Ave Antonio Carlos 6627, BR-30270901 Belo Horizonte, MG, Brazil; [Menard, F.; Bouvier, J.] Univ Grenoble Alpes, IPAG, BP 53, F-38041 Grenoble 09, France; [Menard, F.; Bouvier, J.] CNRS, IPAG, UMR 5274, BP 53, F-38041 Grenoble 09, France; [Takami, M.] Acad Sinica, Inst Astron & Astrophys, POB 23-141, Taipei 106, Taiwan; [Doyon, R.] Univ Montreal, Dept Phys, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Cameron, A. Collier] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Canada France Hawaii Telescope; York University - Canada; Universidade Federal de Minas Gerais; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Academia Sinica - Taiwan; Universite de Montreal; University of St Andrews	Donati, JF (corresponding author), Univ Toulouse, UPS OMP, IRAP, 14 Ave Belin, F-31400 Toulouse, France.; Donati, JF (corresponding author), CNRS, IRAP, UMR 5277, 14 Ave Belin, F-31400 Toulouse, France.	jean-francois.donati@irap.omp.eu	Alencar, Silvia H. P./C-2803-2013; Baruteau, Clément/AAI-8229-2021; Bouvier, Jerome/AAJ-2299-2020; Takami, Michihiro/ABA-7396-2020; Petit, Pascal/ABD-8648-2020; Petit, Pascal/C-5842-2011	Alencar, Silvia H. P./0000-0002-5171-8376; Baruteau, Clément/0000-0002-2672-3456; Takami, Michihiro/0000-0001-9248-7546; Petit, Pascal/0000-0001-7624-9222; Cameron, Andrew/0000-0002-8863-7828; Hussain, Gaitee/0000-0003-3547-3783	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig); STFC [ST/M001296/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/M001296/1] Funding Source: researchfish	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This paper is based on observations obtained at the CFHT Corporation (operated by the National Research Council of Canada, the Institut National des Sciences de l'Univers of the Centre National de la Recherche Scientifique (INSU/CNRS) of France and the University of Hawaii), at the Telescope Bernard Lyot (TBL) (operated by the Observatoire Midi-Pyrenees and by INSU/CNRS), and at the Gemini Observatory (operated by the Association of Universities for Research in Astronomy under a cooperative agreement with the National Science Foundation (NSF) on behalf of the Gemini partnership: the NSF of the United States, the National Research Council of Canada, CONICyT of Chile, the Ministerio de Ciencia, Tecnologia e Innovation Productiva of Argentina, and the Ministerio da Ciencia, Tecnologia e Inovacao of Brazil). We thank the Queue Service Observing teams of CFHT TBL and the Gemini Observatory, without whom this study would not have been possible. We also thank the IDEX initiative of Universite Fedetale Toulouse Midi-Pyrenees for awarding a 'Chaire d'Attractivite' to G.H., in the framework of which this work was done. S.A. acknowledges financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig).	Baruteau C., 2014, PROTOSTARS PLANETS, V914, P667; Chene A.-N., 2014, P SPIE, V9151, P47, DOI [10.1117/12.2057417, DOI 10.1117/12.2057417]; Collier Cameron A, 2001, LECT NOTE PHYS, V573, P183; Donati JF, 2015, MON NOT R ASTRON SOC, V453, P3706, DOI 10.1093/mnras/stv1837; Donati JF, 2014, MON NOT R ASTRON SOC, V444, P3220, DOI 10.1093/mnras/stu1679; Donati JF, 2012, MON NOT R ASTRON SOC, V425, P2948, DOI 10.1111/j.1365-2966.2012.21482.x; Donati JF, 2011, MON NOT R ASTRON SOC, V417, P472, DOI 10.1111/j.1365-2966.2011.19288.x; Donati JF, 2003, ASTR SOC P, V307, P41; Donati JF, 2003, MON NOT R ASTRON SOC, V345, P1187, DOI 10.1046/j.1365-2966.2003.07101.x; Donati JF, 1997, MON NOT R ASTRON SOC, V291, P1; Donati JF, 1997, MON NOT R ASTRON SOC, V291, P658, DOI 10.1093/mnras/291.4.658; GOLDREICH P, 1966, ICARUS, V5, P375, DOI 10.1016/0019-1035(66)90051-0; Grankin KN, 2008, ASTRON ASTROPHYS, V479, P827, DOI 10.1051/0004-6361:20078476; Haywood RD, 2016, MON NOT R ASTRON SOC, V457, P3637, DOI 10.1093/mnras/stw187; Huelamo N, 2008, ASTRON ASTROPHYS, V489, pL9, DOI 10.1051/0004-6361:200810596; Kraus AL, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/19; Kraus AL, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/5; Kurucz R., 1993, ATLAS9 ATMOSPHERIC M; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; LUCY LB, 1971, ASTRON J, V76, P544, DOI 10.1086/111159; Mahmud NI, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/123; Mayor M., 2011, HARPS SEARCH SO EXTR; Morin J, 2008, MON NOT R ASTRON SOC, V384, P77, DOI 10.1111/j.1365-2966.2007.12709.x; Morin J, 2012, EAS PUBLICATIONS, V57, P165, DOI 10.1051/eas/1257005; Mortier A, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201424908; Moutou C, 2007, ASTRON ASTROPHYS, V473, P651, DOI 10.1051/0004-6361:20077795; Petit P, 2015, ASTRON ASTROPHYS, V584, DOI 10.1051/0004-6361/201525993; Sallum S, 2015, NATURE, V527, P342, DOI 10.1038/nature15761; Setiawan J, 2008, NATURE, V451, P38, DOI 10.1038/nature06426; Siess L, 2000, ASTRON ASTROPHYS, V358, P593; van Eyken JC, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/42; VOGT SS, 1987, ASTROPHYS J, V321, P496, DOI 10.1086/165647; Winn JN, 2015, ANNU REV ASTRON ASTR, V53, P409, DOI 10.1146/annurev-astro-082214-122246; Wright JT, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/160	36	90	90	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					662	+		10.1038/nature18305	http://dx.doi.org/10.1038/nature18305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27324847	Green Submitted, Green Accepted			2022-12-28	WOS:000378676000031
J	Manchado, E; Weissmueller, S; Morris, JP; Chen, CC; Wullenkord, R; Lujambio, A; de Stanchina, E; Poirier, JT; Gainor, JF; Corcoran, RB; Engelman, JA; Rudin, CM; Rosen, N; Lowe, SW				Manchado, Eusebio; Weissmueller, Susann; Morris, John P.; Chen, Chi-Chao; Wullenkord, Ramona; Lujambio, Amaia; de Stanchina, Elisa; Poirier, John T.; Gainor, Justin F.; Corcoran, Ryan B.; Engelman, Jeffrey A.; Rudin, Charles M.; Rosen, Neal; Lowe, Scott W.			A combinatorial strategy for treating KRAS-mutant lung cancer	NATURE			English	Article							MEK INHIBITION; MEDIATED REACTIVATION; SELECTIVE INHIBITOR; FEEDBACK ACTIVATION; ACQUIRED-RESISTANCE; COLON-CANCER; RAS; POTENT; BRAF; DISCOVERY	Therapeutic targeting of KRAS-mutant lung adenocarcinoma represents a major goal of clinical oncology. KRAS itself has proved difficult to inhibit, and the effectiveness of agents that target key KRAS effectors has been thwarted by activation of compensatory or parallel pathways that limit their efficacy as single agents. Here we take a systematic approach towards identifying combination targets for trametinib, a MEK inhibitor approved by the US Food and Drug Administration, which acts downstream of KRAS to suppress signalling through the mitogen-activated protein kinase (MAPK) cascade. Informed by a short-hairpin RNA screen, we show that trametinib provokes a compensatory response involving the fibroblast growth factor receptor 1 (FGFR1) that leads to signalling rebound and adaptive drug resistance. As a consequence, genetic or pharmacological inhibition of FGFR1 in combination with trametinib enhances tumour cell death in vitro and in vivo. This compensatory response shows distinct specificities: it is dominated by FGFR1 in KRAS-mutant lung and pancreatic cancer cells, but is not activated or involves other mechanisms in KRAS wild-type lung and KRAS-mutant colon cancer cells. Importantly, KRAS-mutant lung cancer cells and patients' tumours treated with trametinib show an increase in FRS2 phosphorylation, a biomarker of FGFR activation; this increase is abolished by FGFR1 inhibition and correlates with sensitivity to trametinib and FGFR inhibitor combinations. These results demonstrate that FGFR1 can mediate adaptive resistance to trametinib and validate a combinatorial approach for treating KRAS-mutant lung cancer.	[Manchado, Eusebio; Weissmueller, Susann; Morris, John P.; Chen, Chi-Chao; Wullenkord, Ramona; Lujambio, Amaia; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Weissmueller, Susann] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Chen, Chi-Chao] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Lujambio, Amaia] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Liver Canc Program, Tisch Canc Inst, New York, NY 10029 USA; [de Stanchina, Elisa; Poirier, John T.; Rudin, Charles M.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA; [Poirier, John T.; Rudin, Charles M.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Gainor, Justin F.; Corcoran, Ryan B.; Engelman, Jeffrey A.] Massachusetts Gen Hosp, Dept Med, Ctr Canc, Boston, MA 02114 USA; [Gainor, Justin F.; Corcoran, Ryan B.; Engelman, Jeffrey A.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA.; Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA.; Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.; Lowe, SW (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	rosenn@mskcc.org; lowes@mskcc.org	Gainor, Justin/T-5411-2019; Rosen, Neal/ABF-2677-2020; Rudin, Charles/R-2530-2019	Rudin, Charles/0000-0001-5204-3465; Poirier, John/0000-0001-9795-5644; Lujambio, Amaia/0000-0002-2798-1481	National Cancer Institute; Center of Experimental Therapeutics; Stand Up To Cancer grant from the American Association for Cancer Research; Cancer Center Support grant; Jane Coffin Childs Memorial Fund for Medical Research; National Institutes of Health/National Cancer Institute [K99/R00]; Watson School of Biological Sciences; Bayer Foundation; EMBO Long-Term fellowship; Geoffrey Beene Cancer Research Center; NATIONAL CANCER INSTITUTE [P30CA008748, P50CA127003, P01CA129243, R01CA169351] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center of Experimental Therapeutics; Stand Up To Cancer grant from the American Association for Cancer Research; Cancer Center Support grant; Jane Coffin Childs Memorial Fund for Medical Research; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Watson School of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bayer Foundation(Bayer AG); EMBO Long-Term fellowship(European Molecular Biology Organization (EMBO)); Geoffrey Beene Cancer Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Sanchez-Cespedes, R. Somwar, and H. Varmus for sharing cell lines; S. Tian, J. Ahn, M. Taylor, A. Shroff, and J. Plevy for technical assistance; C. J. Sherr, L. E. Dow, P Lito, T Kastenhuber, and J. Leibold for advice on experimental design and/or for editing the manuscript: and other members of the Lowe laboratory for advice and discussions. This work was supported by a program project grant from the National Cancer Institute (S.W.L.. N.R.). a grant from the Center of Experimental Therapeutics (S.W.L., N.R.), a Stand Up To Cancer grant from the American Association for Cancer Research (N.R., J.A.E., C.R.), and a Cancer Center Support grant to MSKCC. E.M. was supported by The Jane Coffin Childs Memorial Fund for Medical Research and a K99/R00 grant from the National Institutes of Health/National Cancer Institute. S.W. was supported by the Annette Kade Fellowship from the Watson School of Biological Sciences. R.W. was supported by a Carl-Duisberg Fellowship from the Bayer Foundation. A.L. was supported by an EMBO Long-Term fellowship. E.d.S. received support through the Geoffrey Beene Cancer Research Center. S.W.L. is the Geoffrey Beene Chair of Cancer Biology and a Howard Hughes Medical Institute investigator.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Li F, 2015, CANCER DISCOV, V5, P438, DOI 10.1158/2159-8290.CD-14-0763; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Poirier JT, 2015, ONCOGENE, V34, P5869, DOI 10.1038/onc.2015.38; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Saborowski M, 2014, GENE DEV, V28, P85, DOI 10.1101/gad.232082.113; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Taylor James, 2007, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s19; Traer E, 2014, BLOOD, V123, P1516, DOI 10.1182/blood-2013-07-518381; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	36	265	270	0	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					647	+		10.1038/nature18600	http://dx.doi.org/10.1038/nature18600			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27338794	Green Accepted, Green Submitted			2022-12-28	WOS:000378676000028
J	Mohamed, M; Phillips, J				Mohamed, Muhajir; Phillips, Jehan			EASILY MISSED Hereditary haemochromatosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LONG-TERM SURVIVAL; IRON-OVERLOAD; EPIDEMIOLOGY; HOMOZYGOTES; MANAGEMENT; DIAGNOSIS; DISEASE; DEATH; RISK		[Mohamed, Muhajir] Launceston Gen Hosp, Dept Med, Launceston, Tas, Australia; [Mohamed, Muhajir] Univ Tasmania, Launceston Clin Sch, Launceston, Tas, Australia; [Phillips, Jehan] First Point Healthcare, Launceston, Tas, Australia	University of Tasmania	Mohamed, M (corresponding author), Launceston Gen Hosp, Dept Med, Launceston, Tas, Australia.; Mohamed, M (corresponding author), Univ Tasmania, Launceston Clin Sch, Launceston, Tas, Australia.	muhajirbm@yahoo.com						Adams PC, 2010, BLOOD, V116, P317, DOI 10.1182/blood-2010-01-261875; Adams PC, 2000, MOL GENET METAB, V71, P81, DOI 10.1006/mgme.2000.3037; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Alexander Jacob, 2005, Ann Hepatol, V4, P240; Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; BACON BR, 1990, HEPATOLOGY, V11, P127, DOI 10.1002/hep.1840110122; Bacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330; Beutler E, 2006, ANNU REV MED, V57, P331, DOI 10.1146/annurev.med.57.121304.131310; BOMFORD A, 1976, Q J MED, V45, P611; Bulaj ZJ, 1996, NEW ENGL J MED, V335, P1799, DOI 10.1056/NEJM199612123352403; EDWARDS CQ, 1983, ARCH INTERN MED, V143, P1890, DOI 10.1001/archinte.143.10.1890; Elmberg M, 2003, GASTROENTEROLOGY, V125, P1733, DOI 10.1053/j.gastro.2003.09.035; Fleming Robert E, 2004, Clin Liver Dis, V8, P755, DOI 10.1016/j.cld.2004.06.004; Milman N, 2001, ANN HEMATOL, V80, P737, DOI 10.1007/s002770100371; Morrison ED, 2003, ANN INTERN MED, V138, P627, DOI 10.7326/0003-4819-138-8-200304150-00008; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004; NIEDERAU C, 1994, ADV EXP MED BIOL, V356, P293; Osborne NJ, 2010, HEPATOLOGY, V51, P1311, DOI 10.1002/hep.23448; Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001; Ryan E, 2002, GUT, V51, P108, DOI 10.1136/gut.51.1.108; Salgia RJ, 2015, CLIN LIVER DIS, V19, P187, DOI 10.1016/j.cld.2014.09.011; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009; Yang QH, 1998, ANN INTERN MED, V129, P946, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00005	24	2	3	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3128	10.1136/bmj.i3128	http://dx.doi.org/10.1136/bmj.i3128			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27365180				2022-12-28	WOS:000379019700003
J	Torjesen, I				Torjesen, Ingrid			Doctors give patients potentially harmful procedures at end of life, global review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cardona-Morrell M, 2016, INT J QUAL HEALTH C, V28, P456, DOI 10.1093/intqhc/mzw060	1	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2016	353								i3613	10.1136/bmj.i3613	http://dx.doi.org/10.1136/bmj.i3613			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ2FV	27357962				2022-12-28	WOS:000379018700007
J	Torjesen, I				Torjesen, Ingrid			Raised inflammatory markers may indicate poorer quality of life in advanced cancer	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Laird BJA, 2016, J CLIN ONCOL, V34, P2769, DOI 10.1200/JCO.2015.65.7742	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2016	353								i3582	10.1136/bmj.i3582	http://dx.doi.org/10.1136/bmj.i3582			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FP	27353272				2022-12-28	WOS:000379018000016
J	Birchenough, GMH; Nystrom, EEL; Johansson, MEV; Hansson, GC				Birchenough, George M. H.; Nystrom, Elisabeth E. L.; Johansson, Malin E. V.; Hansson, Gunnar C.			INNATE IMMUNITY A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion	SCIENCE			English	Article							ACTIVATION	Innate immune signaling pathways contribute to the protection of host tissue when bacterially challenged. Colonic goblet cells are responsible for generating the two mucus layers that physically separate the luminalmicrobiota from the host epithelium. Analysis of colonic tissues from multiple mouse strains allowed us to identify a "sentinel" goblet cell (senGC) localized to the colonic crypt entrance. This cell nonspecifically endocytoses and reacts to the TLR2/1, TLR4, and TLR5 ligands by activating the Nlrp6 inflammasome downstream of TLR-and MyD88-dependent Nox/Duox reactive oxygen species synthesis. This triggers calcium ion-dependent compound exocytosis ofMuc2 mucin fromthe senGC and generates an intercellular gap junction signal; in turn, this signal induces Muc2 secretion from adjacent goblet cells in the upper crypt, which expels bacteria. Thus, senGCs guard and protect the colonic crypt from bacterial intruders that have penetrated the inner mucus layer.	[Birchenough, George M. H.; Nystrom, Elisabeth E. L.; Johansson, Malin E. V.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, S-40530 Gothenburg, Sweden	University of Gothenburg	Hansson, GC (corresponding author), Univ Gothenburg, Dept Med Biochem, S-40530 Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Johansson, Malin E. V./HCH-7451-2022; Hansson, Gunnar C/A-1236-2009; Hansson, Gunnar C./AAF-7324-2019	Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869; Johansson, Malin E. V./0000-0002-4237-6677	Swedish Research Council; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; Lundberg Foundation; Sahlgren's University Hospital (ALF); Torsten Soderbergs Stiftelse; National Institute of Allergy and Infectious Diseases [U01AI095473]; Swedish Foundation for Strategic Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lundberg Foundation(European Commission); Sahlgren's University Hospital (ALF); Torsten Soderbergs Stiftelse; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Swedish Research Council, Swedish Cancer Foundation, Knut and Alice Wallenberg Foundation, Lundberg Foundation, Sahlgren's University Hospital (ALF), Torsten Soderbergs Stiftelse, National Institute of Allergy and Infectious Diseases grant U01AI095473, and Swedish Foundation for Strategic Research. We thank the Gothenburg Centre for Cellular Imaging for technical help, F. Svensson for generating the RedMUC2<SUP>98trTg</SUP> mice, and W.-D. Hardt and the Mucosal Immunobiology and Vaccine Center at the University of Gothenburg for mouse strains.	Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; COLONY PC, 1987, ANAT REC, V218, P365, DOI 10.1002/ar.1092180403; Demon D, 2014, MUCOSAL IMMUNOL, V7, P1480, DOI 10.1038/mi.2014.36; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Halm DR, 1999, AM J PHYSIOL-CELL PH, V277, pC501, DOI 10.1152/ajpcell.1999.277.3.C501; Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Johansson MEV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041009; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Knoop KA, 2015, MUCOSAL IMMUNOL, V8, P198, DOI 10.1038/mi.2014.58; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Panday A, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.89; Patel KK, 2013, EMBO J, V32, P3130, DOI 10.1038/emboj.2013.233; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; SPECIAN RD, 1980, J CELL BIOL, V85, P626, DOI 10.1083/jcb.85.3.626; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	26	298	312	9	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1535	1542		10.1126/science.aaf7419	http://dx.doi.org/10.1126/science.aaf7419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339979	Green Accepted			2022-12-28	WOS:000378346500034
J	Chick, JM; Munger, SC; Simecek, P; Huttlin, EL; Choi, K; Gatti, DM; Raghupathy, N; Svenson, KL; Churchill, GA; Gygi, SP				Chick, Joel M.; Munger, Steven C.; Simecek, Petr; Huttlin, Edward L.; Choi, Kwangbom; Gatti, Daniel M.; Raghupathy, Narayanan; Svenson, Karen L.; Churchill, Gary A.; Gygi, Steven P.			Defining the consequences of genetic variation on a proteome-wide scale	NATURE			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; COLLABORATIVE CROSS; ABUNDANCE; MOUSE; EXPRESSION; RESOURCE; QUANTIFICATION; DISSECTION	Genetic variation modulates protein expression through both transcriptional and post-transcriptional mechanisms. To characterize the consequences of natural genetic diversity on the proteome, here we combine a multiplexed, mass spectrometry-based method for protein quantification with an emerging outbred mouse model containing extensive genetic variation from eight inbred founder strains. By measuring genome-wide transcript and protein expression in livers from 192 Diversity outbred mice, we identify 2,866 protein quantitative trait loci (pQTL) with twice as many local as distant genetic variants. These data support distinct transcriptional and post-transcriptional models underlying the observed pQTL effects. Using a sensitive approach to mediation analysis, we often identified a second protein or transcript as the causal mediator of distant pQTL. Our analysis reveals an extensive network of direct protein-protein interactions. Finally, we show that local genotype can provide accurate predictions of protein abundance in an independent cohort of collaborative cross mice.	[Chick, Joel M.; Huttlin, Edward L.; Gygi, Steven P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Munger, Steven C.; Simecek, Petr; Choi, Kwangbom; Gatti, Daniel M.; Raghupathy, Narayanan; Svenson, Karen L.; Churchill, Gary A.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	Harvard University; Harvard Medical School; Jackson Laboratory	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.; Churchill, GA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	gary.churchill@jax.org; steven_gygi@hms.harvard.edu	Simecek, Petr/ABG-4683-2021; Churchill, Gary/AAY-7496-2020; Simecek, Petr/R-3449-2019	Churchill, Gary/0000-0001-9190-9284; Simecek, Petr/0000-0002-2922-7183; Huttlin, Edward/0000-0002-1822-1173; Choi, Kwangbom/0000-0002-4637-4249; Raghupathy, Narayanan/0000-0002-2275-3674	Harvard Medical School; Jackson Laboratory; National Institutes of Health (NIH) [P50GM076468, F32HD074299, GM67945, U41HG006673]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD074299] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070683, R01GM067945, P50GM076468] Funding Source: NIH RePORTER	Harvard Medical School; Jackson Laboratory; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Somes and M. Strobel for breeding the mice; S. Ciciotte, S. Daigle, J. Pereira, C. Snow, R. Lynch and H. Munger for extracting RNA and performing RNA-seq experiments; and A. Manichaikul for discussion on mediation analysis. Collaborative Cross strains used in this study were imported to JAX from the Systems Genetics Core Facility at the University of North Carolina (USA)<SUP>38</SUP>. Previous to their relocation to UNC, CC lines CC001, CC003 and CC017 were generated and bred at Oak Ridge National Laboratory (USA)<SUP>39</SUP>; CC line CC004 was generated and bred at Tel Aviv University (Israel)<SUP>40</SUP>. Research reported here was supported by Harvard Medical School, The Jackson Laboratory, and National Institutes of Health (NIH) grants under awards P50GM076468 (to G.A.C.), F32HD074299 (to S. C. M.), GM67945 (to S.P.G.) and U41HG006673 (to S.P.G. and E.L.H).	Albert FW, 2014, NATURE, V506, P494, DOI 10.1038/nature12904; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2012, G3-GENES GENOM GENET, V2, P199, DOI 10.1534/g3.111.001818; Cheng R, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-66; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; DAMERVAL C, 1994, GENETICS, V137, P289; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Gatti DM, 2014, G3-GENES GENOM GENET, V4, P1623, DOI 10.1534/g3.114.013748; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iraqi FA, 2008, MAMM GENOME, V19, P379, DOI 10.1007/s00335-008-9113-1; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Khan Z, 2009, P NATL ACAD SCI USA, V106, P15544, DOI 10.1073/pnas.0904100106; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; Liu YT, 1998, J BIOL CHEM, V273, P7920, DOI 10.1074/jbc.273.14.7920; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Munger SC, 2014, GENETICS, V198, P59, DOI 10.1534/genetics.114.165886; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Skelly DA, 2013, GENOME RES, V23, P1496, DOI 10.1101/gr.155762.113; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Threadgill DW, 2012, GENETICS, V190, P291, DOI 10.1534/genetics.111.138032; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; van Weering JRT, 2012, EMBO J, V31, P4466, DOI 10.1038/emboj.2012.283; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Welsh CE, 2012, MAMM GENOME, V23, P706, DOI 10.1007/s00335-012-9410-6; Welsh CE, 2012, G3-GENES GENOM GENET, V2, P191, DOI 10.1534/g3.111.001784; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Wu YB, 2014, CELL, V158, P1415, DOI 10.1016/j.cell.2014.07.039; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	58	194	195	3	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					500	+		10.1038/nature18270	http://dx.doi.org/10.1038/nature18270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309819	Green Accepted			2022-12-28	WOS:000378270300043
J	Gulland, A				Gulland, Anne			Adrian Marston Pioneering vascular surgeon and prolific writer Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		MARSTON A, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2016	353								i3503	10.1136/bmj.i3503	http://dx.doi.org/10.1136/bmj.i3503			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BX	27339424				2022-12-28	WOS:000378724000006
J	Mulay, SR; Anders, HJ				Mulay, Shrikant R.; Anders, Hans-Joachim			Crystallopathies	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							URIC-ACID CRYSTALS; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; CHOLESTEROL CRYSTALS; ALZHEIMERS-DISEASE; GOUTY-ARTHRITIS; DOUBLE-BLIND; CELL-DEATH; ACTIVATION; NANOPARTICLES		[Mulay, Shrikant R.; Anders, Hans-Joachim] Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany	University of Munich	Anders, HJ (corresponding author), Klinikum Univ Munchen, Med Klin & Poliklin 4, Ziemssenstr 1, D-80336 Munich, Germany.	hjanders@med.uni-muenchen.de	Anders, Hans-Joachim/ABD-6247-2021; Mulay, Shrikant R./AAZ-2641-2021	Mulay, Shrikant R./0000-0003-4261-445X; Anders, Hans-Joachim/0000-0003-2434-2956				Abderrazak A, 2015, CIRCULATION, V131, P1061, DOI 10.1161/CIRCULATIONAHA.114.013730; Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Allen KC, 2015, DRUG SAFETY, V38, P183, DOI 10.1007/s40264-014-0255-7; Aouba A, 2015, MEDIAT INFLAMM, V2015, P1, DOI 10.1155/2015/792173; Asselman M, 2003, J AM SOC NEPHROL, V14, P3155, DOI 10.1097/01.ASN.0000099380.18995.F7; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Baron L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.576; Cheuk DK, 2010, COCHRANE DB SYST REV, V6; Cochat P, 2013, NEW ENGL J MED, V369, P649, DOI 10.1056/NEJMra1301564; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Darisipudi MN, 2012, J AM SOC NEPHROL, V23, P1783, DOI 10.1681/ASN.2012040338; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Desai J, 2016, EUR J IMMUNOL, V46, P223, DOI 10.1002/eji.201545605; Diamantopoulos AP, 2012, JCR-J CLIN RHEUMATOL, V18, P310, DOI 10.1097/RHU.0b013e31826149a2; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ea HK, 2011, P NATL ACAD SCI USA, V108, pE1361, DOI 10.1073/pnas.1114968108; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Franklin BS, 2016, ANNU REV IMMUNOL, V34, P173, DOI 10.1146/annurev-immunol-041015-055539; Gagne V, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4250; Garneau AP, 2015, NEW ENGL J MED, V373, P2691, DOI 10.1056/NEJMc1507547; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hari A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07281; Harris Bradley J, 2012, Front Biosci (Schol Ed), V4, P1344; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang DT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14361; Hutcheson JD, 2015, SEMIN CELL DEV BIOL, V46, P68, DOI 10.1016/j.semcdb.2015.09.004; Janoudi A, 2015, EUR HEART J     1224; Joosten LAB, 2016, ANN RHEUM DIS, V75, P1219, DOI 10.1136/annrheumdis-2014-206966; Kalantari P, 2014, CELL REP, V6, P196, DOI 10.1016/j.celrep.2013.12.014; Karaolanis G, 2014, TRANSPLANT REV-ORLAN, V28, P182, DOI 10.1016/j.trre.2014.05.004; Kearney CJ, 2014, FEBS J, V281, P4921, DOI 10.1111/febs.13034; Kiyotake R, 2015, J BIOL CHEM, V290, P25322, DOI 10.1074/jbc.M115.645234; Komada T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10901; Kzhyshkowska J, 2015, J LEUKOCYTE BIOL, V98, P953, DOI 10.1189/jlb.5VMR0415-166R; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Linkermann A, 2014, NAT REV IMMUNOL, V14, P759, DOI 10.1038/nri3743; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu G, 2013, ANNU REV PATHOL-MECH, V8, P161, DOI 10.1146/annurev-pathol-020712-163942; Liu ZM, 2014, J MATER CHEM B, V2, P3480, DOI 10.1039/c4tb00056k; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Moitra S, 2015, CURR OPIN PULM MED, V21, P114, DOI 10.1097/MCP.0000000000000136; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Mulay SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10274; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Neumann K, 2014, IMMUNITY, V40, P389, DOI 10.1016/j.immuni.2013.12.015; Parry Traci L, 2015, Front Cardiovasc Med, V2, P25, DOI 10.3389/fcvm.2015.00025; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Prencipe G, 2014, J AM SOC NEPHROL, V25, P1163, DOI 10.1681/ASN.2013060653; Quinones A, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0315-y; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Saemann MD, 2005, J CLIN INVEST, V115, P468, DOI 10.1172/JCI200522720; Samstad EO, 2014, J IMMUNOL, V192, P2837, DOI 10.4049/jimmunol.1302484; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Schlesinger N, 2012, ANN RHEUM DIS, V71, P1839, DOI 10.1136/annrheumdis-2011-200908; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Shi FS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-73; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; SLATER AFG, 1992, NATURE, V355, P167, DOI 10.1038/355167a0; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Syed F, 2015, NEW ENGL J MED, V372, P1377, DOI 10.1056/NEJMc1414481; Unno H, 2014, AM J RESP CELL MOL, V51, P344, DOI 10.1165/rcmb.2013-0281OC; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Worcester EM, 2010, NEW ENGL J MED, V363, P954, DOI 10.1056/NEJMcp1001011; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zimmer S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6100	77	79	79	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2465	2476		10.1056/NEJMra1601611	http://dx.doi.org/10.1056/NEJMra1601611			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1TG	27332905				2022-12-28	WOS:000378271700010
J	Yang, W				Yang, Wei			Boost basic research in China	NATURE			English	Editorial Material									[Yang, Wei] Zhejiang Univ, Engn Mech, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Wei] Natl Nat Sci Fdn China, Beijing, Peoples R China	Zhejiang University; National Natural Science Foundation of China (NSFC)	Yang, W (corresponding author), Zhejiang Univ, Engn Mech, Hangzhou 310003, Zhejiang, Peoples R China.; Yang, W (corresponding author), Natl Nat Sci Fdn China, Beijing, Peoples R China.	yangwei@nsfc.gov.cn	Yang, Wei/HIA-0360-2022; Yang, Wei/GWV-4107-2022					[Anonymous], 2012, NATURE, V481, P134; Frankel MS, 2016, HANDBOOK OF ACADEMIC INTEGRITY, P847, DOI 10.1007/978-981-287-098-8_65; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Qiu J, 2010, NATURE, V463, P142, DOI 10.1038/463142a; Shi YG, 2010, SCIENCE, V329, P1128, DOI 10.1126/science.1196916; Yang W, 2013, SCIENCE, V342, P1019, DOI 10.1126/science.1247700; 2012, NATURE, V481, P420, DOI DOI 10.1126/SCIENCE.1196916; 2012, NATURE, V481, P134, DOI DOI 10.1126/SCIENCE.1247700; 2012, NATURE, V481, P420	9	21	27	6	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					467	469		10.1038/534467a	http://dx.doi.org/10.1038/534467a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP1SS	27337328	Bronze			2022-12-28	WOS:000378270300029
J	Kumar, V; Kessler, J; Cohen, EJ				Kumar, Vivek; Kessler, Jason; Cohen, Elisabeth J.			Zoster Vaccination for Persons Aged 50 to 59 Years	ANNALS OF INTERNAL MEDICINE			English	Letter							HERPES-ZOSTER; COST-EFFECTIVENESS		[Kumar, Vivek] NYU, Sch Med, New York, NY USA; NYU, Langone Med Ctr, New York, NY USA	New York University; New York University; NYU Langone Medical Center	Kumar, V (corresponding author), NYU, Sch Med, New York, NY USA.							Drolet M, 2010, CLIN J PAIN, V26, P656, DOI 10.1097/AJP.0b013e3181eef686; Li XM, 2015, VACCINE, V33, P1499, DOI 10.1016/j.vaccine.2014.10.039; Maclntyre R, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0125025, DOI 10.1371/JOURNAL.PONE.0125025]; Le P, 2015, ANN INTERN MED, V163, P489, DOI 10.7326/M15-0093; Preaud E, 2015, HUM VACC IMMUNOTHER, V11, P884, DOI 10.1080/21645515.2015.1011561; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341	6	1	1	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					850	850		10.7326/L15-0586	http://dx.doi.org/10.7326/L15-0586			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323253				2022-12-28	WOS:000379343000020
J	Zusi, K				Zusi, Karen			Breaking Out of the Academic Pipeline	CELL			English	Editorial Material								For many graduate students, the academic path may not be the best fit, and with limited faculty positions available, many students are now looking to other career possibilities. University programs are helping students to explore and pursue alternative careers.											0	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1557	1559		10.1016/j.cell.2016.06.007	http://dx.doi.org/10.1016/j.cell.2016.06.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315467	Bronze			2022-12-28	WOS:000378062000002
J	Rubin, R				Rubin, Rita			Profile: Johns Hopkins Bloomberg School of Public Health at 100	LANCET			English	Editorial Material													Rubin, Rita/AAD-1259-2020						0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2370	2370		10.1016/S0140-6736(16)30786-3	http://dx.doi.org/10.1016/S0140-6736(16)30786-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1ST	27312295				2022-12-28	WOS:000377560100015
J	Brownley, KA; Berkman, ND; Peat, CM; Lohr, KN; Cullen, KE; Bann, CM; Bulik, CM				Brownley, Kimberly A.; Berkman, Nancy D.; Peat, Christine M.; Lohr, Kathleen N.; Cullen, Katherine E.; Bann, Carla M.; Bulik, Cynthia M.			Binge-Eating Disorder in Adults A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							COGNITIVE-BEHAVIORAL THERAPY; GUIDED SELF-HELP; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; OBSESSIVE-COMPULSIVE SCALE; DOUBLE-BLIND; BULIMIA-NERVOSA; INTERPERSONAL PSYCHOTHERAPY; DEPRESSIVE SYMPTOMATOLOGY; PRIMARY-CARE	Background: The best treatment options for binge-eating disorder are unclear. Purpose: To summarize evidence about the benefits and harms of psychological and pharmacologic therapies for adults with binge-eating disorder. Data Sources: English-language publications in EMBASE, the Cochrane Library, Academic OneFile, CINAHL, and ClinicalTrials.gov through 18 November 2015, and in MEDLINE through 12 May 2016. Study Selection: 9 waitlist-controlled psychological trials and 25 placebo-controlled trials that evaluated pharmacologic (n = 19) or combination (n = 6) treatment. All were randomized trials with low or medium risk of bias. Data Extraction: 2 reviewers independently extracted trial data, assessed risk of bias, and graded strength of evidence. Data Synthesis: Therapist-led cognitive behavioral therapy, lisdexamfetamine, and second-generation antidepressants (SGAs) decreased binge-eating frequency and increased binge-eating abstinence (relative risk, 4.95 [95% CI, 3.06 to 8.00], 2.61 [CI, 2.04 to 3.33], and 1.67 [CI, 1.24 to 2.26], respectively). Lisdexamfetamine (mean difference [MD], -6.50 [CI, -8.82 to -4.18]) and SGAs (MD, -3.84 [CI, -6.55 to -1.13]) reduced bingeeating-related obsessions and compulsions, and SGAs reduced symptoms of depression (MD, -1.97 [ CI, -3.67 to -0.28]). Headache, gastrointestinal upset, sleep disturbance, and sympathetic nervous system arousal occurred more frequently with lisdexamfetamine than placebo (relative risk range, 1.63 to 4.28). Other forms of cognitive behavioral therapy and topiramate also increased abstinence and reduced binge-eating frequency and related psychopathology. Topiramate reduced weight and increased sympathetic nervous system arousal, and lisdexamfetamine reduced weight and appetite. Limitations: Most study participants were overweight or obese white women aged 20 to 40 years. Many treatments were examined only in single studies. Outcomes were measured inconsistently across trials and rarely assessed beyond end of treatment. Conclusion: Cognitive behavioral therapy, lisdexamfetamine, SGAs, and topiramate reduced binge eating and related psychopathology, and lisdexamfetamine and topiramate reduced weight in adults with binge-eating disorder.	[Brownley, Kimberly A.] Univ N Carolina, Dept Psychiat, CB 7175, Chapel Hill, NC 27599 USA; [Berkman, Nancy D.; Lohr, Kathleen N.; Cullen, Katherine E.; Bann, Carla M.] RTI Int, POB 12194, Res Triangle Pk, NC 27709 USA; [Peat, Christine M.; Bulik, Cynthia M.] Univ N Carolina, Dept Psychiat, CB 7160, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill	Brownley, KA (corresponding author), Univ N Carolina, Dept Psychiat, CB 7175, Chapel Hill, NC 27599 USA.	kbrownle@med.unc.edu		Lohr, Kathleen/0000-0002-3825-0713; Berkman, Nancy/0000-0003-3617-1082; Bann, Carla/0000-0001-9305-8305; Brownley, Kim/0000-0002-5635-9229	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Primary Funding Source: Agency for Healthcare Research and Quality.	Alegria M, 2007, INT J EAT DISORDER, V40, pS15, DOI 10.1002/eat.20406; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Amianto F, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0445-6; Arnold LM, 2002, J CLIN PSYCHIAT, V63, P1028, DOI 10.4088/JCP.v63n1113; Bacon L., 2010, HLTH EVERY SIZE SURP; Berkman Nancy D, 2006, Evid Rep Technol Assess (Full Rep), P1; Berkman ND, 2015, J CLIN EPIDEMIOL, V68, P1312, DOI 10.1016/j.jclinepi.2014.11.023; Berkman ND, 2013, 290200710056I AG HEA; Brownley KA, 2007, INT J EAT DISORDER, V40, P337, DOI 10.1002/eat.20370; Brownley KA, 2013, J PSYCHOSOM RES, V75, P36, DOI 10.1016/j.jpsychores.2013.03.092; Bruce B, 1996, J AM DIET ASSOC, V96, P58, DOI 10.1016/S0002-8223(96)00016-8; Carrard I, 2011, BEHAV RES THER, V49, P482, DOI 10.1016/j.brat.2011.05.004; Carter JC, 1998, J CONSULT CLIN PSYCH, V66, P616, DOI 10.1037/0022-006X.66.4.616; Claudino AM, 2007, J CLIN PSYCHIAT, V68, P1324, DOI 10.4088/JCP.v68n0901; Colles SL, 2008, OBESITY, V16, P608, DOI 10.1038/oby.2007.99; COOPER Z, 1989, BRIT J PSYCHIAT, V154, P807, DOI 10.1192/bjp.154.6.807; Davidson MK, 2003, CANADIAN J DIABETES, V27, P62; de Jonge P, 2014, DIABETOLOGIA, V57, P699, DOI 10.1007/s00125-013-3157-9; de Zwaan M, 2010, SURG OBES RELAT DIS, V6, P79, DOI 10.1016/j.soard.2009.08.011; Devlin MJ, 2005, OBES RES, V13, P1077, DOI 10.1038/oby.2005.126; Dingemans AE, 2007, BEHAV RES THER, V45, P2551, DOI 10.1016/j.brat.2007.06.003; Eldredge KL, 1997, INT J EAT DISORDER, V21, P347, DOI 10.1002/(SICI)1098-108X(1997)21:4<347::AID-EAT7>3.0.CO;2-O; Elran-Barak R, 2015, EAT BEHAV, V18, P192, DOI 10.1016/j.eatbeh.2015.05.012; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fairburn CG., 1995, OVERCOMING BINGE EAT; Fairburn Christopher G., 1993, P361; Gagnon C, 2012, DIABETES EDUCATOR, V38, P537, DOI 10.1177/0145721712446203; Golay A, 2005, OBES RES, V13, P1701, DOI 10.1038/oby.2005.208; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Goracci A, 2015, J ADDICT MED, V9, P1, DOI 10.1097/ADM.0000000000000089; Grilo CM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0696-z; Grilo CM, 2013, BEHAV RES THER, V51, P855, DOI 10.1016/j.brat.2013.10.002; Grilo CM, 2013, BEHAV RES THER, V51, P167, DOI 10.1016/j.brat.2013.01.002; Grilo CM, 2005, BIOL PSYCHIAT, V57, P301, DOI 10.1016/j.biopsych.2004.11.002; Grilo CM, 2005, BIOL PSYCHIAT, V57, P1193, DOI 10.1016/j.biopsych.2005.03.001; Grucza RA, 2007, COMPR PSYCHIAT, V48, P124, DOI 10.1016/j.comppsych.2006.08.002; Guerdjikova AI, 2008, HUM PSYCHOPHARM CLIN, V23, P1, DOI 10.1002/hup.899; Guerdjikova AI, 2012, INT J EAT DISORDER, V45, P905, DOI 10.1002/eat.22028; Guerdjikova AI, 2012, INT J EAT DISORDER, V45, P281, DOI 10.1002/eat.20946; Guerdjikova AI, 2009, INT CLIN PSYCHOPHARM, V24, P150, DOI 10.1097/YIC.0b013e328329c7b5; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harvey K, 2011, INT J EAT DISORDER, V44, P447, DOI 10.1002/eat.20839; Hasnain M, 2012, POSTGRAD MED, V124, P154, DOI 10.3810/pgm.2012.07.2577; Hay Phillipa Pj, 2009, Cochrane Database Syst Rev, pCD000562, DOI 10.1002/14651858.CD000562.pub3; Herpertz S, 1998, DIABETES CARE, V21, P1110, DOI 10.2337/diacare.21.7.1110; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Hudson JI, 2010, AM J CLIN NUTR, V91, P1568, DOI 10.3945/ajcn.2010.29203; Hudson JI, 1998, AM J PSYCHIAT, V155, P1756, DOI 10.1176/ajp.155.12.1756; Javaras KN, 2008, J CLIN PSYCHIAT, V69, P266, DOI 10.4088/JCP.v69n0213; Kenardy J, 2001, Eat Behav, V2, P183, DOI 10.1016/S1471-0153(01)00028-9; Kessler RC, 2014, EPIDEMIOL PSYCH SCI, V23, P27, DOI 10.1017/S2045796013000516; Kessler RC, 2013, BIOL PSYCHIAT, V73, P904, DOI 10.1016/j.biopsych.2012.11.020; Kramer CK, 2011, OBES REV, V12, pe338, DOI 10.1111/j.1467-789X.2010.00846.x; Kristeller Jean L, 2011, Eat Disord, V19, P49, DOI 10.1080/10640266.2011.533605; Laederach-Hofmann K, 1999, INT J EAT DISORDER, V26, P231, DOI 10.1002/(SICI)1098-108X(199911)26:3&lt;231::AID-EAT1&gt;3.0.CO;2-6; Maneeton B, 2015, DRUG DES DEV THER, V9, P1927, DOI 10.2147/DDDT.S79071; Marek RJ, 2014, INT J EAT DISORDER, V47, P553, DOI 10.1002/eat.22268; Masson PC, 2013, BEHAV RES THER, V51, P723, DOI 10.1016/j.brat.2013.08.001; McElroy SL, 2003, AM J PSYCHIAT, V160, P255, DOI 10.1176/appi.ajp.160.2.255; McElroy SL, 2003, J CLIN PSYCHIAT, V64, P807, DOI 10.4088/JCP.v64n0711; McElroy SL, 2000, AM J PSYCHIAT, V157, P1004, DOI 10.1176/appi.ajp.157.6.1004; McElroy SL, 2007, BIOL PSYCHIAT, V61, P1039, DOI 10.1016/j.biopsych.2006.08.008; McElroy SL, 2007, J CLIN PSYCHIAT, V68, P390, DOI 10.4088/JCP.v68n0306; McElroy SL, 2016, NEUROPSYCHOPHARMACOL, V41, P1251, DOI 10.1038/npp.2015.275; McElroy SL, 2015, CNS SPECTRUMS, V20, P546, DOI 10.1017/S1092852915000759; McElroy SL, 2015, INT CLIN PSYCHOPHARM, V30, P209, DOI 10.1097/YIC.0000000000000079; McElroy SL, 2015, JAMA PSYCHIAT, V72, P235, DOI 10.1001/jamapsychiatry.2014.2162; McElroy SL, 2013, INT J EAT DISORDER, V46, P239, DOI 10.1002/eat.22114; McElroy SL, 2011, INT J EAT DISORDER, V44, P81, DOI 10.1002/eat.20876; Meneghini LF, 2006, DIABETES CARE, V29, P2760, DOI 10.2337/dc06-1364; MITCHELL JE, 1993, INT J EAT DISORDER, V14, P277, DOI 10.1002/1098-108X(199311)14:3&lt;277::AID-EAT2260140306&gt;3.0.CO;2-8; National Institute for Health and Care Excellence (NICE), EAT DIS 8S MAN GUID; Nicdao EG, 2007, INT J EAT DISORDER, V40, pS22, DOI 10.1002/eat.20450; North Carolina Division of Health and Human Services Division of Medical Assistance, 2015, SURG CLIN SEV MORB O; Pearlstein T, 2003, Arch Womens Ment Health, V6, P147; Perkins SJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004191.pub2; Peterson CB, 2009, AM J PSYCHIAT, V166, P1347, DOI 10.1176/appi.ajp.2009.09030345; Peterson CB, 2001, INT J EAT DISORDER, V30, P363, DOI 10.1002/eat.1098; Peterson CB, 1998, INT J EAT DISORDER, V24, P125, DOI 10.1002/(SICI)1098-108X(199809)24:2<125::AID-EAT2>3.0.CO;2-G; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raevuori A, 2015, INT J EAT DISORDER, V48, P555, DOI 10.1002/eat.22334; Reas DL, 2008, OBESITY, V16, P2024, DOI 10.1038/oby.2008.333; Rotella F, 2012, ACTA DIABETOL, V49, pS179, DOI 10.1007/s00592-012-0403-4; RTI International-University of North Carolina Evidence-Based Practice Center, 2015, MAN OUTC BING EAT DI; RUSH AJ, 1986, PSYCHIAT RES, V18, P65; SPITZER RL, 1993, INT J EAT DISORDER, V13, P137, DOI 10.1002/1098-108X(199303)13:2&lt;161::AID-EAT2260130204&gt;3.0.CO;2-R; Stefano Sergio Carlos, 2008, Eat Behav, V9, P129, DOI 10.1016/j.eatbeh.2007.03.006; Stein RI, 2007, INT J EAT DISORDER, V40, P195, DOI 10.1002/eat.20352; Stice E, 2013, J ABNORM PSYCHOL, V122, P445, DOI 10.1037/a0030679; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Tasca GA, 2006, PSYCHOTHER RES, V16, P106, DOI 10.1080/10503300500090928; Tasca GA, 2012, INT J GROUP PSYCHOTH, V62, P197, DOI 10.1521/ijgp.2012.62.2.197; TELCH CF, 1990, J CONSULT CLIN PSYCH, V58, P629, DOI 10.1037/0022-006X.58.5.629; Trace SE, 2012, INT J EAT DISORDER, V45, P531, DOI 10.1002/eat.20955; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Vocks S, 2010, INT J EAT DISORDER, V43, P205, DOI 10.1002/eat.20696; Welch E, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0840-7; Whisman MA, 2012, INT J EAT DISORDER, V45, P385, DOI 10.1002/eat.20935; White MA, 2013, J CLIN PSYCHIAT, V74, P400, DOI 10.4088/JCP.12m08071; White MA, 2010, J CLIN PSYCHIAT, V71, P175, DOI 10.4088/JCP.08m04328blu; Wilfley DE, 2002, ARCH GEN PSYCHIAT, V59, P713, DOI 10.1001/archpsyc.59.8.713; Wilson GT, 2010, ARCH GEN PSYCHIAT, V67, P94, DOI 10.1001/archgenpsychiatry.2009.170; Yager J, 2012, GUIDELINE WATCH AUGU, P1; Yager J., 2006, PRACTICE GUIDELINES, P1; Yanovski SZ, 2000, ARCH INTERN MED, V160, P2581, DOI 10.1001/archinte.160.17.2581	106	136	142	2	69	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2016	165	6					409	U95		10.7326/M15-2455	http://dx.doi.org/10.7326/M15-2455			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DW9FR	27367316	Green Accepted			2022-12-28	WOS:000383962000016
J	Solomon, S; Ivy, DJ; Kinnison, D; Mills, MJ; Neely, RR; Schmidt, A				Solomon, Susan; Ivy, Diane J.; Kinnison, Doug; Mills, Michael J.; Neely, Ryan R., III; Schmidt, Anja			Emergence of healing in the Antarctic ozone layer	SCIENCE			English	Article							BREWER-DOBSON CIRCULATION; STRATOSPHERIC OZONE; DATA SETS; VARIABILITY; DEPLETION; RECOVERY; TRENDS; SIMULATIONS; CLIMATE; SULFUR	Industrial chlorofluorocarbons that cause ozone depletion have been phased out under the Montreal Protocol. A chemically driven increase in polar ozone (or "healing") is expected in response to this historic agreement. Observations and model calculations together indicate that healing of the Antarctic ozone layer has now begun to occur during the month of September. Fingerprints of September healing since 2000 include (i) increases in ozone column amounts, (ii) changes in the vertical profile of ozone concentration, and (iii) decreases in the areal extent of the ozone hole. Along with chemistry, dynamical and temperature changes have contributed to the healing but could represent feedbacks to chemistry. Volcanic eruptions have episodically interfered with healing, particularly during 2015, when a record October ozone hole occurred after the Calbuco eruption.	[Solomon, Susan; Ivy, Diane J.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Kinnison, Doug; Mills, Michael J.] Natl Ctr Atmospher Res, Atmospher Chem Observat & Modeling Lab, POB 3000, Boulder, CO 80305 USA; [Neely, Ryan R., III; Schmidt, Anja] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Neely, Ryan R., III] Univ Leeds, Natl Ctr Atmospher Sci, Leeds, W Yorkshire, England	Massachusetts Institute of Technology (MIT); National Center Atmospheric Research (NCAR) - USA; University of Leeds; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Leeds	Solomon, S (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	solos@mit.edu	Schmidt, Anja/ABD-7113-2021; Mills, Michael/B-5068-2010; Neely, Ryan/F-8702-2010; Schmidt, Anja/C-9617-2012	Schmidt, Anja/0000-0001-8759-2843; Mills, Michael/0000-0002-8054-1346; Neely, Ryan/0000-0003-4560-4812; 	NSF Frontiers in Earth System Dynamics grant [OCE-1338814]; NSF Atmospheric Chemistry grant [AGS-1539972]; University of Leeds; NCAR visiting scientist grant; Natural Environment Research Council [NE/N006038/1]; NSF; Office of Science of the U.S. Department of Energy; Div Atmospheric & Geospace Sciences [1539972] Funding Source: National Science Foundation; Natural Environment Research Council [ncas10003] Funding Source: researchfish; NERC [ncas10003, NE/N006038/1] Funding Source: UKRI	NSF Frontiers in Earth System Dynamics grant; NSF Atmospheric Chemistry grant; University of Leeds; NCAR visiting scientist grant; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Tilmes (NCAR) for help with the MERRA (Modern-Era Retrospective Analysis for Research and Applications) data. D.K. and S. S. were partially supported by NSF Frontiers in Earth System Dynamics grant OCE-1338814, and D.J.I. was supported by NSF Atmospheric Chemistry grant AGS-1539972. A. S. was supported by an Academic Research Fellowship from the University of Leeds, an NCAR visiting scientist grant, and Natural Environment Research Council grant NE/N006038/1. NCAR is sponsored by NSF. WACCM is a component of CESM, which is supported by NSF and the Office of Science of the U.S. Department of Energy. We are grateful to D. Fahey, B. Hassler, W. D. McKenna, and the anonymous reviewers for helpful comments. Instructions for access to data reported in this paper are given in the supplementary materials.	Arfeuille F, 2013, ATMOS CHEM PHYS, V13, P11221, DOI 10.5194/acp-13-11221-2013; Braesicke P, 2013, ATMOS CHEM PHYS, V13, P10677, DOI 10.5194/acp-13-10677-2013; Bruhl C, 2015, J GEOPHYS RES-ATMOS, V120, P2103, DOI 10.1002/2014JD022430; Butchart N, 2014, REV GEOPHYS, V52, P157, DOI 10.1002/2013RG000448; Chehade W, 2014, ATMOS CHEM PHYS, V14, P7059, DOI 10.5194/acp-14-7059-2014; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Forster PMD, 1997, CLIM DYNAM, V13, P547, DOI 10.1007/s003820050182; Harris NRP, 2015, ATMOS CHEM PHYS, V15, P9965, DOI 10.5194/acp-15-9965-2015; Hassler B, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045542; Hopfner M, 2015, ATMOS CHEM PHYS, V15, P7017, DOI 10.5194/acp-15-7017-2015; Hofmann DJ, 1997, J GEOPHYS RES-ATMOS, V102, P8931, DOI 10.1029/96JD03749; HOFMANN DJ, 1993, J GEOPHYS RES-ATMOS, V98, P18555, DOI 10.1029/93JD02092; Kunz A, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016686; Kuttippurath J, 2015, ATMOS CHEM PHYS, V15, P10385, DOI 10.5194/acp-15-10385-2015; Kuttippurath J, 2013, ATMOS CHEM PHYS, V13, P1625, DOI 10.5194/acp-13-1625-2013; Li F, 2008, J CLIMATE, V21, P40, DOI 10.1175/2007JCLI1663.1; Livesey NJ, 2015, ATMOS CHEM PHYS, V15, P9945, DOI 10.5194/acp-15-9945-2015; Marsh DR, 2013, J CLIMATE, V26, P7372, DOI 10.1175/JCLI-D-12-00558.1; McLandress C, 2009, J CLIMATE, V22, P1516, DOI 10.1175/2008JCLI2679.1; McPeters RD, 2013, J GEOPHYS RES-ATMOS, V118, P8032, DOI 10.1002/jgrd.50597; Meul S, 2015, ATMOS CHEM PHYS, V15, P6897, DOI 10.5194/acp-15-6897-2015; Mills MJ, 2016, J GEOPHYS RES-ATMOS, V121, P2332, DOI 10.1002/2015JD024290; Newchurch MJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003471; Newman PA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025232; Portmann RW, 1996, J GEOPHYS RES-ATMOS, V101, P22991, DOI 10.1029/96JD02608; Salby M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047266; Scaife AA, 2005, J ATMOS SCI, V62, P629, DOI 10.1175/JAS-3334.1; Shepherd TG, 2014, NAT GEOSCI, V7, P443, DOI [10.1038/ngeo2155, 10.1038/NGEO2155]; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; Solomon S, 2015, J GEOPHYS RES-ATMOS, V120, P7958, DOI 10.1002/2015JD023365; Tabazadeh A, 2002, P NATL ACAD SCI USA, V99, P2609, DOI 10.1073/pnas.052518199; Tummon F, 2015, ATMOS CHEM PHYS, V15, P3021, DOI 10.5194/acp-15-3021-2015; Vernier JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047563; WMO, 2015, WMO ANT OZ B 2015; World Meteorological Organization/United Nations Environment Programme (WMO/UNEP), 2014, 55 WMOUNEP; Yang ES, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009675	36	328	332	41	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2016	353	6296					269	274		10.1126/science.aae0061	http://dx.doi.org/10.1126/science.aae0061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0EM	27365314	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000379580800044
J	Hsia, Y; Bale, JB; Gonen, S; Shi, D; Sheffler, W; Fong, KK; Nattermann, U; Xu, CF; Huang, PS; Ravichandran, R; Yi, S; Davis, TN; Gonen, T; King, NP; Baker, D				Hsia, Yang; Bale, Jacob B.; Gonen, Shane; Shi, Dan; Sheffler, William; Fong, Kimberly K.; Nattermann, Una; Xu, Chunfu; Huang, Po-Ssu; Ravichandran, Rashmi; Yi, Sue; Davis, Trisha N.; Gonen, Tamir; King, Neil P.; Baker, David			Design of a hyperstable 60-subunit protein icosahedron	NATURE			English	Article							VIRUS-LIKE PARTICLES; ELECTRON-MICROSCOPY; IMAGE-ANALYSIS; GENERATION; VISUALIZATION; NANOMATERIALS; RESOLUTION; SYMMETRY; ALDOLASE; SYSTEM	The icosahedron is the largest of the Platonic solids, and icosahedral protein structures are widely used in biological systems for packaging and transport(1,2). There has been considerable interest in repurposing such structures(3-5) for applications ranging from targeted delivery to multivalent immunogen presentation. The ability to design proteins that self-assemble into precisely specified, highly ordered icosahedral structures would open the door to a new generation of protein containers with properties custom-tailored to specific applications. Here we describe the computational design of a 25-nanometre icosahedral nanocage that self-assembles from trimeric protein building blocks. The designed protein was produced in Escherichia coli, and found by electron microscopy to assemble into a homogenous population of icosahedral particles nearly identical to the design model. The particles are stable in 6.7 molar guanidine hydrochloride at up to 80 degrees Celsius, and undergo extremely abrupt, but reversible, disassembly between 2 molar and 2.25 molar guanidinium thiocyanate. The icosahedron is robust to genetic fusions: one or two copies of green fluorescent protein (GFP) can be fused to each of the 60 subunits to create highly fluorescent 'standard candles' for use in light microscopy, and a designed protein pentamer can be placed in the centre of each of the 20 pentameric faces to modulate the size of the entrance/exit channels of the cage. Such robust and customizable nanocages should have considerable utility in targeted drug delivery(6), vaccine design(7) and synthetic biology(8).	[Hsia, Yang; Bale, Jacob B.; Gonen, Shane; Sheffler, William; Fong, Kimberly K.; Nattermann, Una; Xu, Chunfu; Huang, Po-Ssu; Ravichandran, Rashmi; Yi, Sue; Davis, Trisha N.; King, Neil P.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Hsia, Yang; Bale, Jacob B.; Gonen, Shane; Sheffler, William; Nattermann, Una; Xu, Chunfu; Huang, Po-Ssu; Ravichandran, Rashmi; Yi, Sue; King, Neil P.; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Hsia, Yang; Gonen, Shane; Nattermann, Una] Univ Washington, Grad Program Biol Phys Struct & Design, Seattle, WA 98195 USA; [Bale, Jacob B.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Gonen, Shane; Shi, Dan; Gonen, Tamir] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	dabaker@uw.edu	Davis, Trisha/F-8584-2010; Baker, David/K-8941-2012; Xu, Chunfu/B-5963-2012	Baker, David/0000-0001-7896-6217; Huang, Possu/0000-0002-7948-2895; Bale, Jacob/0000-0003-2444-5875; Gonen, Shane/0000-0002-4829-3151; Xu, Chunfu/0000-0002-8668-0566	Howard Hughes Medical Institute; JRC; National Science Foundation [CHE-1332907]; UW/Hutch CCSG Pilot Award NCI [5 P30 CA015704-41]; Takeda Pharmaceutical Company; Bill and Melinda Gates Foundation [OPP1120319]; National Institutes of Health (NIH) [P41 GM103533]; Defense Advanced Research Projects Agency [W911NF-14-1-0162]; Air Force Office of Scientific Research (AFOSR) [AFOSR FA950-12-10112]; NIH [T32GM008268]; PHS National Research Service Award from NIGMS [T32GM007270]; NSF Graduate Research Fellowship [DGE-0718124]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533, T32GM007270, T32GM008268, R01GM040506, P01GM105537] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JRC; National Science Foundation(National Science Foundation (NSF)); UW/Hutch CCSG Pilot Award NCI; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS National Research Service Award from NIGMS; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (D.B. and T.G.), the JRC visitor programme (S.G.), the National Science Foundation CHE-1332907 (D.B.), a UW/Hutch CCSG Pilot Award NCI 5 P30 CA015704-41 (D.B. and N.P.K.), Takeda Pharmaceutical Company (N.P.K.), the Bill and Melinda Gates Foundation OPP1120319 (D.B. and N.P.K.), the National Institutes of Health (NIH) P41 GM103533 (T.N.D.), the Defense Advanced Research Projects Agency (D.B. and N.P.K., grant no. W911NF-14-1-0162) and the Air Force Office of Scientific Research (AFOSR) AFOSR FA950-12-10112 (D.B.). Y.H. was supported in part by a NIH Molecular Biology Training Grant (T32GM008268). U.N. was supported in part by a PHS National Research Service Award (T32GM007270) from NIGMS. J.B.B. was supported in part by an NSF Graduate Research Fellowship (DGE-0718124). We thank the Janelia Research Campus Cryo-EM Facility and J. de la Cruz for their assistance with the Titan Krios.	Andrews BT, 2007, J MOL BIOL, V373, P476, DOI 10.1016/j.jmb.2007.07.071; Baalousha M, 2013, NAT NANOTECHNOL, V8, P308, DOI 10.1038/nnano.2013.78; Bauler P, 2010, J PHYS CHEM LETT, V1, P1332, DOI 10.1021/jz1002007; Boyle AL, 2012, J AM CHEM SOC, V134, P15457, DOI 10.1021/ja3053943; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Cortese K, 2009, J HISTOCHEM CYTOCHEM, V57, P1103, DOI 10.1369/jhc.2009.954214; Der BS, 2012, J AM CHEM SOC, V134, P375, DOI 10.1021/ja208015j; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Effio CL, 2015, BIOTECHNOL J, V10, P715, DOI 10.1002/biot.201400392; Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fullerton SWB, 2006, BIOORGAN MED CHEM, V14, P3002, DOI 10.1016/j.bmc.2005.12.022; Griffiths JS, 2002, BIOORGAN MED CHEM, V10, P545, DOI 10.1016/S0968-0896(01)00307-8; Howorka S, 2011, CURR OPIN BIOTECH, V22, P485, DOI 10.1016/j.copbio.2011.05.003; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Lai YT, 2014, NAT CHEM, V6, P1065, DOI [10.1038/NCHEM.2107, 10.1038/nchem.2107]; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ma YJ, 2012, ADV DRUG DELIVER REV, V64, P811, DOI 10.1016/j.addr.2012.01.005; Muller EGD, 2005, MOL BIOL CELL, V16, P3341, DOI 10.1091/mbc.E05-03-0214; Nannenga B. L., 2013, CURRENT PROTOCOLS PR; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perlmutter JD, 2015, ANNU REV PHYS CHEM, V66, P217, DOI 10.1146/annurev-physchem-040214-121637; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raman S., 2009, OPEN NANOMED J, V2, P15, DOI DOI 10.2174/1875933500902010015; Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007; RITSERT K, 1995, J MOL BIOL, V253, P151, DOI 10.1006/jmbi.1995.0542; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimogawa MM, 2010, CELL CYCLE, V9, P3619, DOI 10.4161/cc.9.17.12907; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Smith ML, 2006, VIROLOGY, V348, P475, DOI 10.1016/j.virol.2005.12.039; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Usui K, 2009, PROTEIN SCI, V18, P960, DOI 10.1002/pro.106; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Zandi R, 2004, P NATL ACAD SCI USA, V101, P15556, DOI 10.1073/pnas.0405844101; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k; ZULAUF M, 1992, J CRYST GROWTH, V122, P102, DOI 10.1016/0022-0248(92)90232-8	43	231	239	5	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					136	+		10.1038/nature18010	http://dx.doi.org/10.1038/nature18010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27309817	Green Accepted			2022-12-28	WOS:000379015600039
J	Bovensiepen, U; Ligges, M				Bovensiepen, Uwe; Ligges, Manuel			Timing photoemission-Final state matters	SCIENCE			English	Editorial Material							ATTOSECOND; WAVE		[Bovensiepen, Uwe; Ligges, Manuel] Univ Duisburg Essen, Fac Phys, D-47048 Duisburg, Germany	University of Duisburg Essen	Bovensiepen, U (corresponding author), Univ Duisburg Essen, Fac Phys, D-47048 Duisburg, Germany.	uwe.bovensiepen@uni-due.de	Bovensiepen, Uwe/E-7435-2017; Bovensiepen, Uwe/AGE-9200-2022	Bovensiepen, Uwe/0000-0002-1506-4491; Bovensiepen, Uwe/0000-0002-1506-4491				Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Fadley CS, 2013, J ELECTRON SPECTROSC, V190, P165, DOI 10.1016/j.elspec.2013.06.008; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Kazansky AK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.177401; Klunder K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.143002; Krasovskii EE, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195106; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Lemell C, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.062901; Leone SR, 2014, NAT PHOTONICS, V8, P162, DOI 10.1038/nphoton.2014.48; Liao Q, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.023602; Locher R, 2015, OPTICA, V2, P405, DOI 10.1364/OPTICA.2.000405; Lucchini M, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.137401; Neppl S, 2015, NATURE, V517, P342, DOI 10.1038/nature14094; Neppl S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.087401; Rettig L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10459; Tao ZS, 2016, SCIENCE, V353, P62, DOI 10.1126/science.aaf6793	17	2	2	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					28	29		10.1126/science.aag1090	http://dx.doi.org/10.1126/science.aag1090			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365437				2022-12-28	WOS:000378816200020
J	Twomey, EC; Yelshanskaya, MV; Grassucci, RA; Frank, J; Sobolevsky, AI				Twomey, Edward C.; Yelshanskaya, Maria V.; Grassucci, Robert A.; Frank, Joachim; Sobolevsky, Alexander I.			Elucidation of AMPA receptor-stargazin complexes by cryo-electron microscopy	SCIENCE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; AUXILIARY SUBUNITS; ACTIVATION; DESENSITIZATION; STOICHIOMETRY; TRAFFICKING; MECHANISM; TARPS; ARCHITECTURE; PROTEINS	AMPA-subtype ionotropic glutamate receptors (AMPARs) mediate fast excitatory neurotransmission and contribute to high cognitive processes such as learning and memory. In the brain, AMPAR trafficking, gating, and pharmacology is tightly controlled by transmembrane AMPAR regulatory proteins (TARPs). Here, we used cryo-electron microscopy to elucidate the structural basis of AMPAR regulation by one of these auxiliary proteins, TARP gamma 2, or stargazin (STZ). Our structures illuminate the variable interaction stoichiometry of the AMPAR-TARP complex, with one or two TARP molecules binding one tetrameric AMPAR. Analysis of the AMPAR-STZ binding interfaces suggests that electrostatic interactions between the extracellular domains of AMPAR and STZ play an important role in modulating AMPAR function through contact surfaces that are conserved across AMPARs and TARPs. We propose a model explaining how TARPs stabilize the activated state of AMPARs and how the interactions between AMPARs and their auxiliary proteins control fast excitatory synaptic transmission.	[Twomey, Edward C.; Yelshanskaya, Maria V.; Grassucci, Robert A.; Frank, Joachim; Sobolevsky, Alexander I.] Columbia Univ, Dept Biochem & Mol Biophys, 650 West 168th St, New York, NY 10032 USA; [Twomey, Edward C.] Columbia Univ, Integrated Program Cellular Mol & Biomed Studies, 650 West 168th St, New York, NY 10032 USA; [Frank, Joachim] Columbia Univ, Dept Biol Sci, 650 West 168th St, New York, NY 10032 USA; [Frank, Joachim] Howard Hughes Med Inst, 650 West 168th St, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Frank, J; Sobolevsky, AI (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 West 168th St, New York, NY 10032 USA.; Frank, J (corresponding author), Columbia Univ, Dept Biol Sci, 650 West 168th St, New York, NY 10032 USA.; Frank, J (corresponding author), Howard Hughes Med Inst, 650 West 168th St, New York, NY 10032 USA.	jf2192@cumc.columbia.edu; as4005@cumc.columbia.edu		Twomey, Edward/0000-0002-1855-1586	NIH [T32 GM008224, GM008281, R01 NS083660, R01 GM029169]; Pew Scholar Award in Biomedical Sciences; Schaefer Research Scholar Award; Klingenstein Fellowship Award in the Neurosciences; Irma T. Hirschl Career Scientist Award; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281, R01GM029169, T32GM008224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083660, F31NS093838] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Award in Biomedical Sciences; Schaefer Research Scholar Award; Klingenstein Fellowship Award in the Neurosciences(Klingenstein Philanthropies); Irma T. Hirschl Career Scientist Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Z. H. Yu, C. Hong, and R. Huang for assistance with data collection at the Howard Hughes Medical Institute Janelia Research Campus, M. Fislage (J.F. laboratory) for assistance with the initial cryo-EM preparation and critical reading of the manuscript, and H. Kao (J.F. laboratory) for computational support. We are grateful for manuscript edits and comments provided by K. Saotome and A. K. Singh (A.I.S. laboratory) and advice on image processing provided by I.S. Fernandez (Columbia), Z. Liu (J.F. laboratory), O.B. Clarke (Hendrickson laboratory, Columbia), A. des Georges (City University of New York), and members of J.F.'s laboratory. E.C.T. was supported by NIH training grants T32 GM008224 and GM008281. A.I.S. was supported by NIH (R01 NS083660), the Pew Scholar Award in Biomedical Sciences, the Schaefer Research Scholar Award, the Klingenstein Fellowship Award in the Neurosciences, and the Irma T. Hirschl Career Scientist Award. J.F. was supported by the Howard Hughes Medical Institute and NIH (R01 GM029169). Cryo-EM density maps have been deposited in the EM Data Bank under accession numbers EMD-8229 (GluA2-0xSTZ), EMD-8230 (GluA2-1xSTZ), EMD-8231 (GluA2-2xSTZ), and EMD-8232 (GluA2). Model coordinates have been deposited in the Protein Data Bank under accession numbers 5KBS (GluA2-0xSTZ), 5KBT (GluA2-1xSTZ), 5KBU (GluA2-2xSTZ), and 5KBV (GluA2).	Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carbone AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10178; Chapman AG, 2000, J NUTR, V130, p1043S, DOI 10.1093/jn/130.4.1043S; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Dawe GB, 2016, NEURON, V89, P1264, DOI 10.1016/j.neuron.2016.01.038; Dong H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1362; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Hastie P, 2013, P NATL ACAD SCI USA, V110, P5163, DOI 10.1073/pnas.1218765110; Howe JR, 2015, J PHYSIOL-LONDON, V593, P61, DOI 10.1113/jphysiol.2014.273904; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2010, TRENDS NEUROSCI, V33, P241, DOI 10.1016/j.tins.2010.02.004; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; MacLean DM, 2014, J GEN PHYSIOL, V144, P503, DOI 10.1085/jgp.201411287; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Morrell CN, 2008, J EXP MED, V205, P575, DOI 10.1084/jem.20071474; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rogawski MA, 2013, ACTA NEUROL SCAND, V127, P9, DOI 10.1111/ane.12099; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; Sobolevsky AI, 2015, J PHYSIOL-LONDON, V593, P29, DOI 10.1113/jphysiol.2013.264911; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uzunova G, 2014, CURR NEUROPHARMACOL, V12, P71, DOI 10.2174/1570159X113116660046; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Yelshanskaya MV, 2014, SCIENCE, V345, P1070, DOI 10.1126/science.1256508; Zhang F, 2013, STROKE, V44, P170, DOI 10.1161/STROKEAHA.112.667253; Zhang W, 2014, EUR J NEUROSCI, V39, P1138, DOI 10.1111/ejn.12519	36	87	87	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					83	86		10.1126/science.aaf8411	http://dx.doi.org/10.1126/science.aaf8411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365450	Green Accepted			2022-12-28	WOS:000378816200041
J	Ungar, PS; Hlusko, LJ				Ungar, P. S.; Hlusko, L. J.			The evolutionary path of least resistance	SCIENCE			English	Editorial Material							ENAMEL THICKNESS; BOISEI		[Ungar, P. S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA; [Hlusko, L. J.] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA	University of Arkansas System; University of Arkansas Fayetteville; University of California System; University of California Berkeley	Ungar, PS (corresponding author), Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA.	pungar@uark.edu		Hlusko, Leslea/0000-0003-0189-6390				Hlusko LJ, 2011, J EXP ZOOL PART B, V316B, P21, DOI 10.1002/jez.b.21378; Hlusko LJ, 2004, AM J PHYS ANTHROPOL, V124, P223, DOI 10.1002/ajpa.10353; Horvath JE, 2014, J HUM EVOL, V73, P75, DOI 10.1016/j.jhevol.2014.01.005; Kato A, 2014, AM J PHYS ANTHROPOL, V155, P447, DOI 10.1002/ajpa.22593; Lucas P., 2004, DENT FUNCTIONAL MORP; Pampush JD, 2013, J HUM EVOL, V64, P216, DOI 10.1016/j.jhevol.2013.01.009; Salazar-Ciudad I, 2012, CURR OPIN GENET DEV, V22, P585, DOI 10.1016/j.gde.2012.10.006; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Smith AL, 2015, ANAT REC, V298, P145, DOI 10.1002/ar.23073; Ungar PS, 2011, SCIENCE, V334, P190, DOI 10.1126/science.1207701; WALKER A, 1986, NATURE, V322, P517, DOI 10.1038/322517a0	11	24	25	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					29	30		10.1126/science.aaf8398	http://dx.doi.org/10.1126/science.aaf8398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365438				2022-12-28	WOS:000378816200021
J	Rashid, RS; Shim, TN				Rashid, Rabia Sofia; Shim, Tang Ngee			CLINICAL UPDATES Contact dermatitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC HAND ECZEMA; QUALITY-OF-LIFE; DIFFERENT MOISTURIZERS; ATOPIC-DERMATITIS; LONG-TERM; CHILDREN; CARE; TACROLIMUS; MANAGEMENT; GUIDELINE		[Rashid, Rabia Sofia; Shim, Tang Ngee] Univ Hosp, Dept Dermatol, Coventry CV2 2DX, W Midlands, England	University of Warwick	Shim, TN (corresponding author), Univ Hosp, Dept Dermatol, Coventry CV2 2DX, W Midlands, England.	tangngee.shim@uhcw.nhs.uk						Adisesh A, 2013, BRIT J DERMATOL, V168, P1167, DOI 10.1111/bjd.12256; Admani S, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0421-0; Aerts O, 2014, CONTACT DERMATITIS, V71, P41, DOI 10.1111/cod.12249; Aquino M, 2014, J ALLER CL IMM-PRACT, V2, P382, DOI 10.1016/j.jaip.2014.05.004; Ashcroft DM, 2005, BMJ-BRIT MED J, V330, P516, DOI 10.1136/bmj.38376.439653.D3; Basketter DA, 2012, CONTACT DERMATITIS, V67, P1, DOI 10.1111/j.1600-0536.2012.02131.x; Bauer A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004414.pub2; Beltrani VS, 2006, ANN ALLERG ASTHMA IM, V97, pS1, DOI 10.1016/S1081-1206(10)60811-3; Boehm D, 2012, CONTACT DERMATITIS, V67, P184, DOI 10.1111/j.1600-0536.2012.02062.x; Bourke J, 2009, BRIT J DERMATOL, V160, P946, DOI 10.1111/j.1365-2133.2009.09106.x; Burkemper Nicole M, 2015, Mo Med, V112, P296; Cohen David E, 2004, Dermatol Ther, V17, P334, DOI 10.1111/j.1396-0296.2004.04031.x; de Waard-van der Spek FB, 2013, PEDIAT ALLERG IMM-UK, V24, P321, DOI 10.1111/pai.12043; Diepgen TL, 2016, BRIT J DERMATOL, V174, P319, DOI 10.1111/bjd.14167; Diepgen Thomas L, 2015, J Dtsch Dermatol Ges, V13, pe1; DOOMSGOOSSENS A, 1992, CONTACT DERMATITIS, V26, P182, DOI 10.1111/j.1600-0536.1992.tb00290.x; English J, 2009, CLIN EXP DERMATOL, V34, P761, DOI 10.1111/j.1365-2230.2009.03649.x; Fonacier L, 2015, J ALLER CL IMM-PRACT, V3, pS1, DOI 10.1016/j.jaip.2015.02.009; Fonacier LS, 2014, ANN ALLERG ASTHMA IM, V113, P9, DOI 10.1016/j.anai.2014.03.018; Goldenberg A, 2015, DERMATITIS, V26, P216, DOI 10.1097/DER.0000000000000130; Hammonds LM, 2009, INT J DERMATOL, V48, P271, DOI 10.1111/j.1365-4632.2009.03890.x; HANNUKSELA M, 1986, CONTACT DERMATITIS, V14, P221, DOI 10.1111/j.1600-0536.1986.tb01229.x; Health and Safety Executive, WORK RELATED SKIN DI; Held E, 2001, CONTACT DERMATITIS, V44, P229, DOI 10.1034/j.1600-0536.2001.044004229.x; Higgins E, 2013, DERMATITIS, V24, P237, DOI 10.1097/DER.0b013e31829cb0d1; Holness DL, 2013, DERMATITIS, V24, P131, DOI 10.1097/DER.0b013e3182910416; Jacob SE, 2008, PEDIATR DERMATOL, V25, P81, DOI 10.1111/j.1525-1470.2007.00589.x; Jakasa I, 2007, J INVEST DERMATOL, V127, P129, DOI 10.1038/sj.jid.5700582; Johansen JD, 2015, CONTACT DERMATITIS, V73, P195, DOI 10.1111/cod.12432; Johansen JD, 2011, CONTACT DERMATITIS, V65, P13, DOI 10.1111/j.1600-0536.2011.01911.x; Jonker MJ, 2003, CONTACT DERMATITIS, V49, P114, DOI 10.1111/j.0105-1873.2003.0128m.x; Kadyk DL, 2003, J AM ACAD DERMATOL, V49, P1037, DOI 10.1016/S0190-9622(03)02112-1; KALISH RS, 1991, ARCH DERMATOL, V127, P1558, DOI 10.1001/archderm.127.10.1558; Kasemsarn P, 2016, CURR PROBL DERMATOL, V49, P135, DOI 10.1159/000441589; Katsarou A, 2012, EUR J DERMATOL, V22, P192, DOI 10.1684/ejd.2011.1615; Kohl L, 2002, DERMATOLOGY, V204, P334, DOI 10.1159/000063379; Lurati AR, 2015, WORKPLACE HEALTH SAF, V63, P81, DOI 10.1177/2165079914565351; Malik M, 2015, OCCUP MED-OXFORD, V65, P474, DOI 10.1093/occmed/kqv067; Malkonen T, 2010, BRIT J DERMATOL, V163, P999, DOI 10.1111/j.1365-2133.2010.09987.x; McFadden JP, 2013, BRIT J DERMATOL, V168, P692, DOI 10.1111/bjd.12145; MOLLER H, 1983, CURR MED RES OPIN, V8, P640, DOI 10.1185/03007998309109812; Moustafa M, 2011, CONTACT DERMATITIS, V65, P208, DOI 10.1111/j.1600-0536.2011.01900.x; National Institute for Health and Clinical Excellence, 2004, TACR PIM AT ECZ; National Institute for Health and Clinical Excellence, 2009, AL TREATM SEV CHRON; NETHERCOTT JR, 1989, J AM ACAD DERMATOL, V21, P568, DOI 10.1016/S0190-9622(89)80228-2; Pigatto PD, 2015, EUR ANN ALLERGY CLIN, V47, P188; Rajagopalan R, 1997, Am J Contact Dermat, V8, P215, DOI 10.1016/S1046-199X(97)90072-5; SHEHADE S A, 1991, Contact Dermatitis, V24, P119, DOI 10.1111/j.1600-0536.1991.tb01663.x; Tan CH, 2014, CLIN DERMATOL, V32, P116, DOI 10.1016/j.clindermatol.2013.05.033; Thyssen JP, 2010, CONTACT DERMATITIS, V62, P279, DOI 10.1111/j.1600-0536.2010.01709.x; Thyssen JP, 2010, CONTACT DERMATITIS, V62, P75, DOI 10.1111/j.1600-0536.2009.01669.x; Veien NK, 1999, BRIT J DERMATOL, V140, P882, DOI 10.1046/j.1365-2133.1999.02819.x; Warshaw EM, 2015, DERMATITIS, V26, P49, DOI 10.1097/DER.0000000000000097; White JML, 2012, CLIN EXP ALLERGY, V42, P180, DOI 10.1111/j.1365-2222.2011.03862.x; Williams C, 2010, BRIT J DERMATOL, V162, P1088, DOI 10.1111/j.1365-2133.2010.09643.x	55	24	25	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3299	10.1136/bmj.i3299	http://dx.doi.org/10.1136/bmj.i3299			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27364956				2022-12-28	WOS:000379019700004
J	Tsu, V; Jeronimo, J				Tsu, Vivien; Jeronimo, Jose			Saving the World's Women from Cervical Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tsu, Vivien; Jeronimo, Jose] PATH, Seattle, WA USA		Tsu, V (corresponding author), PATH, Seattle, WA USA.							Bloom DE, 2011, GLOBAL EC BURDEN NON; Campos NG, 2015, PAPILLOMAVIRUS RES, V1, P38, DOI 10.1016/j.pvr.2015.05.003; GLOBOCAN, 2013, GLOBOCAN 2012 ESTIMA; Markowitz LE, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1968; Schiffman M, 2016, J LOW GENIT TRACT DI, V20, P1, DOI 10.1097/LGT.0000000000000170	5	48	56	2	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2509	2511		10.1056/NEJMp1604113	http://dx.doi.org/10.1056/NEJMp1604113			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP8DD	27355529	Bronze			2022-12-28	WOS:000378727200001
J	Chalela, JG; Aguilar, L				Guillermo Chalela, Juan; Aguilar, Laura			Iododerma from Contrast Material	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Guillermo Chalela, Juan; Aguilar, Laura] Hosp Univ Fdn Santa Fe Bogota, Bogota, Colombia		Chalela, JG (corresponding author), Hosp Univ Fdn Santa Fe Bogota, Bogota, Colombia.	juanguibucaro@gmail.com							0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2477	2477		10.1056/NEJMicm1512512	http://dx.doi.org/10.1056/NEJMicm1512512			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1TG	27332906				2022-12-28	WOS:000378271700011
J	Glen, J; Constanti, M; Brohi, K				Glen, Jessica; Constanti, Margaret; Brohi, Karim		Guideline Development Grp	Assessment and initial management of major trauma: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Glen, Jessica; Constanti, Margaret] Royal Coll Physicians, Natl Guideline Ctr, London NW1 4LE, England; [Brohi, Karim] Queen Mary Univ London, Barts & London Sch Med, Ctr Trauma Sci, London, England	Royal College of Physicians; University of London; Queen Mary University London	Brohi, K (corresponding author), Queen Mary Univ London, Barts & London Sch Med, Ctr Trauma Sci, London, England.	k.brohi@qmul.ac.uk						[Anonymous], 2012, ADV TRAUM LIF SUPP A; National Audit Office, 2010, MAJ TRAUM CAR ENGL, P2009; National Institute for Health and Care Excellence, 2016, MAJ TRAUM SERV DEL; National Institute for Health and Care Excellence, 2016, FRACT COMPL ASS MAN; National Institute for Health and Care Excellence, 2016, MAJ TRAUM ASS IN MAN; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; National Institute for Health and Care Excellence, 2016, SPIN INJ ASS IN MAN; Stanworth SJ, 2016, BRIT J SURG, V103, P357, DOI 10.1002/bjs.10052	8	29	31	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2016	353								i3051	10.1136/bmj.i3051	http://dx.doi.org/10.1136/bmj.i3051			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BS	27333868				2022-12-28	WOS:000378723500003
J	Lettre, G; Bauer, DE				Lettre, Guillaume; Bauer, Daniel E.			Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies	LANCET			English	Article							QUANTITATIVE-TRAIT LOCUS; GAMMA-GLOBIN GENE; GENOME-WIDE ASSOCIATION; ADULT ERYTHROID-CELLS; FACTOR KLF1 CAUSES; RISK-FACTORS; BETA-THALASSEMIA; CHROMOSOME 6Q23; DNA METHYLATION; LYMPHOID DEVELOPMENT	Sickle-cell disease affects millions of individuals worldwide, but the global incidence is concentrated in Africa. The burden of sickle-cell disease is expected to continue to rise over the coming decades, adding to stress on the health infrastructures of many countries. Although the molecular cause of sickle-cell disease has been known for more than half a century, treatment options remain greatly limited. Allogeneic haemopoietic stem-cell transplantation is the only existing cure but is limited to specialised clinical centres and remains inaccessible for most patients. Induction of fetal haemoglobin production is a promising strategy for the treatment of sickle-cell disease. In this Series paper, we review scientific breakthroughs in epidemiology, genetics, and molecular biology that have brought reactivation of fetal haemoglobin to the forefront of sickle-cell disease research. Improved knowledge of the regulation of fetal haemoglobin production in human beings and the development of genome editing technology now support the design of innovative therapies for sickle-cell disease that are based on fetal haemoglobin.	[Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Bauer, Daniel E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston Childrens Hosp, 44 Binney St, Boston, MA 02115 USA; [Bauer, Daniel E.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Universite de Montreal; Universite de Montreal; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University	Lettre, G (corresponding author), Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada.; Lettre, G (corresponding author), Univ Montreal, Montreal, PQ H1T 1C8, Canada.; Bauer, DE (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston Childrens Hosp, 44 Binney St, Boston, MA 02115 USA.; Bauer, DE (corresponding author), Harvard Stem Cell Inst, Boston, MA 02115 USA.	guillaume.lettre@umontreal.ca; daniel.bauer@childrens.harvard.edu			Canadian Institute of Health Research (MOP) [123382]; Canada Research Chair Program, National Institute of Diabetes and Digestive and Kidney Diseases [K08DK093705]; Doris Duke Charitable Foundation; Charles H Hood Foundation; Cooley's Anemia Foundation; Biogen; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK093705] Funding Source: NIH RePORTER	Canadian Institute of Health Research (MOP); Canada Research Chair Program, National Institute of Diabetes and Digestive and Kidney Diseases; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Charles H Hood Foundation; Cooley's Anemia Foundation; Biogen(Biogen); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Carlo Brugnara (Boston Children's Hospital, Harvard Medical School, Boston, MA, USA) and Frederic Galacteros (Red Cell Genetic Disease Unit, Hopital Henri-Mondor, Creteil, France) for providing access to the GENMOD data used in figure 2, and H Franklin Bunn (Brigham and Women's Hospital, Harvard Medical School, Boston), William A Eaton (National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MA, USA), Russell E Ware (Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA), and Stuart H Orkin (Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Howard Hughes Medical Institute, Boston) for providing comments and suggestions on an earlier version of this paper. Diane D Chen (Boston Children's Hospital) helped with figure preparation. This work is supported by grants from the Canadian Institute of Health Research (MOP #123382), the Canada Research Chair Program, National Institute of Diabetes and Digestive and Kidney Diseases (K08DK093705), the Doris Duke Charitable Foundation, the Charles H Hood Foundation, Biogen, and the Cooley's Anemia Foundation.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Alsultan A, 2014, BRIT J HAEMATOL, V164, P597, DOI 10.1111/bjh.12650; ALTER BP, 1976, BLOOD, V48, P843; Amaya M, 2013, BLOOD, V121, P3493, DOI 10.1182/blood-2012-11-466227; Arnaud L, 2010, AM J HUM GENET, V87, P721, DOI 10.1016/j.ajhg.2010.10.010; Auer PL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0138-2; BAILEY K, 1992, ARCH DIS CHILD, V67, P517, DOI 10.1136/adc.67.4.517; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Basak A, 2015, J CLIN INVEST, V125, P2363, DOI 10.1172/JCI81163; Bauer DE, 2015, CURR OPIN GENET DEV, V33, P62, DOI 10.1016/j.gde.2015.08.001; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Benitez CM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004645; Bhatnagar P, 2013, PEDIATR BLOOD CANCER, V60, pE125, DOI 10.1002/pbc.24588; Bhatnagar P, 2011, J HUM GENET, V56, P316, DOI 10.1038/jhg.2011.12; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; CASTRO O, 1994, BLOOD, V84, P643, DOI 10.1182/blood.V84.2.643.643; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; CHARACHE S, 1992, BLOOD, V79, P2555; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; CHARACHE S, 1983, P NATL ACAD SCI-BIOL, V80, P4842, DOI 10.1073/pnas.80.15.4842; Chaturvedi CP, 2009, P NATL ACAD SCI USA, V106, P18303, DOI 10.1073/pnas.0906769106; Close J, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-33; Cui SY, 2015, BLOOD, V126, P386, DOI 10.1182/blood-2015-02-626259; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; DOVER GJ, 1992, BLOOD, V80, P816; Esteghamat F, 2013, BLOOD, V121, P2553, DOI 10.1182/blood-2012-06-434530; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Funnell APW, 2015, BLOOD, V126, P89, DOI 10.1182/blood-2015-04-638528; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Garner C, 2004, BLOOD, V104, P2184, DOI 10.1182/blood-2004-02-0527; Garner C, 1998, AM J HUM GENET, V62, P1468, DOI 10.1086/301859; Garner C, 2000, BLOOD, V95, P342; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; GOLDBERG MA, 1977, J BIOL CHEM, V252, P3414; Guda S, 2015, MOL THER, V23, P1465, DOI 10.1038/mt.2015.113; Hankins JS, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000215; Hennemann H, 2015, EUR J MED CHEM, V94, P489, DOI 10.1016/j.ejmech.2014.10.038; Herrick James B., 2001, Yale Journal of Biology and Medicine, V74, P179; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Huang JW, 2015, EUR J HUM GENET, V23, P1341, DOI 10.1038/ejhg.2014.291; HUISMAN THJ, 1979, AM J HEMATOL, V6, P173, DOI 10.1002/ajh.2830060210; Ippolito GC, 2014, P NATL ACAD SCI USA, V111, pE998, DOI 10.1073/pnas.1319228111; Jastaniah W, 2011, ANN SAUDI MED, V31, P289, DOI 10.4103/0256-4947.81540; John A, 2012, DEVELOPMENT, V139, P1831, DOI 10.1242/dev.072850; KAR BC, 1986, LANCET, V2, P1198; Kinney TR, 1999, BLOOD, V94, P1550; Krivega I, 2015, BLOOD, V126, P665, DOI 10.1182/blood-2015-02-629972; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; LABIE D, 1985, BLOOD, V66, P1463; Lee YT, 2013, BLOOD, V122, P1034, DOI 10.1182/blood-2012-12-472308; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Lessard S, 2015, GENOME MED, V7, DOI 10.1186/s13073-014-0122-2; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; Little JA, 2009, EUR J HAEMATOL, V82, P315, DOI 10.1111/j.1600-0609.2009.01210.x; Liu D, 2014, BLOOD, V124, P803, DOI 10.1182/blood-2014-03-561779; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mabaera R, 2007, BLOOD, V110, P1343, DOI 10.1182/blood-2007-01-068635; Magor GW, 2015, BLOOD, V125, P2405, DOI 10.1182/blood-2014-08-590968; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Meiler SE, 2011, BLOOD, V118, P1109, DOI 10.1182/blood-2010-11-319137; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; MILNER PF, 1991, NEW ENGL J MED, V325, P1476, DOI 10.1056/NEJM199111213252104; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Mtatiro SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111464; NAGEL RL, 1979, P NATL ACAD SCI USA, V76, P670, DOI 10.1073/pnas.76.2.670; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Obaro SK, 2015, LANCET GLOB HEALTH, V3, pE124, DOI 10.1016/S2214-109X(14)70371-7; Ohene-Frempong K, 1998, BLOOD, V91, P288; Okam MM, 2015, BLOOD, V125, P3668, DOI 10.1182/blood-2015-03-635391; PERRINE RP, 1972, LANCET, V2, P1163; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Reid ME, 2014, AM J HEMATOL, V89, P709, DOI 10.1002/ajh.23725; Renneville A, 2015, BLOOD, V126, P1930, DOI 10.1182/blood-2015-06-649087; Rivers A, 2015, EXP HEMATOL, V43, P546, DOI 10.1016/j.exphem.2015.04.005; Ruiz MA, 2015, EPIGENETICS-US, V10, P397, DOI 10.1080/15592294.2015.1039220; Sankaran VG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011643; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Sankaran VG, 2011, P NATL ACAD SCI USA, V108, P1519, DOI 10.1073/pnas.1018384108; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; SHERIDAN BL, 1976, BRIT J HAEMATOL, V32, P487, DOI 10.1111/j.1365-2141.1976.tb00952.x; Shi LH, 2013, NAT MED, V19, P291, DOI 10.1038/nm.3101; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; STEVENS MCG, 1981, J PEDIATR-US, V98, P37, DOI 10.1016/S0022-3476(81)80529-X; SUNSHINE HR, 1978, NATURE, V275, P238, DOI 10.1038/275238a0; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Thornburg CD, 2012, BLOOD, V120, P4304, DOI 10.1182/blood-2012-03-419879; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; VANDERPLOEG LHT, 1980, CELL, V19, P947, DOI 10.1016/0092-8674(80)90086-0; Verhelle D, 2008, J CLIN INVEST, V118, P248; Viprakasit V, 2014, BLOOD, V123, P1586, DOI 10.1182/blood-2013-09-526087; Voskaridou E, 2010, BLOOD, V115, P2354, DOI 10.1182/blood-2009-05-221333; WATSON J, 1948, AM J MED SCI, V215, P419, DOI 10.1097/00000441-194804000-00008; Wiegreffe C, 2015, NEURON, V87, P311, DOI 10.1016/j.neuron.2015.06.023; Wilber A, 2011, BLOOD, V117, P2817, DOI 10.1182/blood-2010-08-300723; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; WISHNER BC, 1975, J MOL BIOL, V98, P179, DOI 10.1016/S0022-2836(75)80108-2; Wonkam A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092506; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	122	54	57	1	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2554	2564		10.1016/S0140-6736(15)01341-0	http://dx.doi.org/10.1016/S0140-6736(15)01341-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27353686				2022-12-28	WOS:000377947200032
J	Watts, G				Watts, Geoff			Elizabeth Stanfield Bell Wilson	LANCET			English	Biographical-Item																		WILSON EO, PUBLICATION LIST	1	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2376	2376		10.1016/S0140-6736(16)30744-9	http://dx.doi.org/10.1016/S0140-6736(16)30744-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1ST	27312299	Bronze			2022-12-28	WOS:000377560100019
J	Stevens, GA; Alkema, L; Black, RE; Boerma, JT; Collins, GS; Ezzati, M; Grove, JT; Hogan, DR; Hogan, MC; Horton, R; Lawn, JE; Marusic, A; Mathers, CD; Murray, CJL; Rudan, I; Salomon, JA; Simpson, PJ; Vos, T; Welch, V				Stevens, Gretchen A.; Alkema, Leontine; Black, Robert E.; Boerma, J. Ties; Collins, Gary S.; Ezzati, Majid; Grove, John T.; Hogan, Daniel R.; Hogan, Margaret C.; Horton, Richard; Lawn, Joy E.; Marusic, Ana; Mathers, Colin D.; Murray, Christopher J. L.; Rudan, Igor; Salomon, Joshua A.; Simpson, Paul J.; Vos, Theo; Welch, Vivian		Gather Working Grp	Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement	LANCET			English	Article							REDUCING WASTE; STATISTICS	Measurements of health indicators are rarely available for every population and period of interest, and available data may not be comparable. The Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) defi ne best reporting practices for studies that calculate health estimates for multiple populations (in time or space) using multiple information sources. Health estimates that fall within the scope of GATHER include all quantitative population- level estimates (including global, regional, national, or subnational estimates) of health indicators, including indicators of health status, incidence and prevalence of diseases, injuries, and disability and functioning; and indicators of health determinants, including health behaviours and health exposures. GATHER comprises a checklist of 18 items that are essential for best reporting practice. A more detailed explanation and elaboration document, describing the interpretation and rationale of each reporting item along with examples of good reporting, is available on the GATHER website.	[Stevens, Gretchen A.; Boerma, J. Ties; Hogan, Daniel R.; Mathers, Colin D.] WHO, Dept Informat Evidence & Res, Geneva, Switzerland; [Alkema, Leontine] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Collins, Gary S.] Univ Oxford, NDORMS, Oxford, England; [Ezzati, Majid] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Grove, John T.] Bill & Melinda Gates Fdn, Global Dev Program, Seattle, WA USA; [Horton, Richard] The Lancet, London, England; [Lawn, Joy E.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Marusic, Ana] Univ Split, Sch Med, Dept Res Biomed & Hlth, Split, Croatia; [Marusic, Ana] Univ Split, Sch Med, Cochrane Croatia, Split, Croatia; [Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Rudan, Igor] Univ Edinburgh, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Salomon, Joshua A.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Simpson, Paul J.] PLOS Med, Cambridge, England; [Welch, Vivian] Bruyere Res Inst, Ottawa, ON, Canada; [Welch, Vivian] Univ Ottawa, Ctr Global Hlth, Ottawa, ON, Canada	World Health Organization; University of Massachusetts System; University of Massachusetts Amherst; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford; Imperial College London; Bill & Melinda Gates Foundation; University of London; London School of Hygiene & Tropical Medicine; University of Split; University of Split; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Edinburgh; Harvard University; Harvard T.H. Chan School of Public Health; University of Ottawa; University of Ottawa	Stevens, GA (corresponding author), WHO, Geneva, Switzerland.	stevensg@who.int	Collins, Gary Stephen/A-2258-2014; Salomon, Joshua A/D-3898-2009; Lawn, Joy/ABE-6382-2020; Welch, Vivian Andrea/AAD-9338-2020; Rudan, Igor/I-1467-2012; Marusic, Ana/E-7683-2013; Salomon, Joshua/S-1929-2019	Collins, Gary Stephen/0000-0002-2772-2316; Salomon, Joshua A/0000-0003-3929-5515; Lawn, Joy/0000-0002-4573-1443; Welch, Vivian Andrea/0000-0002-5238-7097; Rudan, Igor/0000-0001-6993-6884; Marusic, Ana/0000-0001-6272-0917; Salomon, Joshua/0000-0003-3929-5515; Mathers, Colin/0000-0002-0617-6731	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	We received financial support from the Bill & Melinda Gates Foundation. JTG is employed by the Bill & Melinda Gates Foundation. We acknowledge the thoughtful comments provided by 118 anonymous survey respondents; by the participants at WHO's meeting on country use of health estimates, in June, 2015, in Glion sur Montreux; and by Monika Bloessner, Mia Cokljat, Shah Ebrahim, Simon I Hay, Susan Norris, Shefali Oza, Christopher Paciorek, Juan Pablo Pena Rosas, and Iveta Simera.	Altman DG, 2008, LANCET, V371, P1149, DOI 10.1016/S0140-6736(08)60505-X; Atun R, 2014, LANCET, V384, P937, DOI 10.1016/S0140-6736(14)61062-X; Bill & Melinda Gates Foundation, 2015, BILL M GAT FDN OP AC; Bloom T, 2013, DATA ACCESS OPEN ACC; Boerma JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000373; Boerma T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0286-7; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001006; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Graham WJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001003; Hambleton IR, 2015, LANCET GLOB HEALTH, V3, pE593, DOI 10.1016/S2214-109X(15)00082-0; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Lang TA, 2013, SCI EDITORS HDB; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; Nature Publishing Group, 2014, AV DAT MAT METH; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Walker N, 2007, LANCET, V369, P956, DOI 10.1016/S0140-6736(07)60454-1; Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9; World Health Organization, 2014, GLOB REF LIST 100 CO; World Health Organization, 2013, TECHN M WHO GEN FEB	27	298	298	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					E19	E23		10.1016/S0140-6736(16)30388-9	http://dx.doi.org/10.1016/S0140-6736(16)30388-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE5FU	27371184	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000389631700001
J	Barba-Spaeth, G; Dejnirattisai, W; Rouvinski, A; Vaney, MC; Medits, I; Sharma, A; Simon-Loriere, E; Sakuntabhai, A; Cao-Lormeau, VM; Haouz, A; England, P; Stiasny, K; Mongkolsapaya, J; Heinz, FX; Screaton, GR; Rey, FA				Barba-Spaeth, Giovanna; Dejnirattisai, Wanwisa; Rouvinski, Alexander; Vaney, Marie-Christine; Medits, Iris; Sharma, Arvind; Simon-Loriere, Etienne; Sakuntabhai, Anavaj; Cao-Lormeau, Van-Mai; Haouz, Ahmed; England, Patrick; Stiasny, Karin; Mongkolsapaya, Juthathip; Heinz, Franz X.; Screaton, Gavin R.; Rey, Felix A.			Structural basis of potent Zika-dengue virus antibody cross-neutralization	NATURE			English	Article							REACTIVE ANTIBODIES; FUSION-LOOP; IN-VIVO; FLAVIVIRUSES; MATURATION; INFECTION; ENHANCEMENT; RECOGNITION; DYNAMICS; RECEPTOR	Zika virus is a member of the Flavivirus genus that had not been associated with severe disease in humans until the recent outbreaks, when it was linked to microcephaly in newborns in Brazil and to Guillain-Barre syndrome in adults in French Polynesia. Zika virus is related to dengue virus, and here we report that a subset of antibodies targeting a conformational epitope isolated from patients with dengue virus also potently neutralize Zika virus. The crystal structure of two of these antibodies in complex with the envelope protein of Zika virus reveals the details of a conserved epitope, which is also the site of interaction of the envelope protein dimer with the precursor membrane (prM) protein during virus maturation. Comparison of the Zika and dengue virus immunocomplexes provides a lead for rational, epitope-focused design of a universal vaccine capable of eliciting potent cross-neutralizing antibodies to protect simultaneously against both Zika and dengue virus infections.	[Barba-Spaeth, Giovanna; Rouvinski, Alexander; Vaney, Marie-Christine; Sharma, Arvind; Rey, Felix A.] Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris 15, France; [Barba-Spaeth, Giovanna; Rouvinski, Alexander; Vaney, Marie-Christine; Sharma, Arvind; Rey, Felix A.] CNRS, UMR Virol 3569, F-75724 Paris 15, France; [Dejnirattisai, Wanwisa; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London W12 0NN, England; [Medits, Iris; Stiasny, Karin; Heinz, Franz X.] Med Univ Vienna, Dept Virol, Kinderspitalgasse 15, A-1095 Vienna, Austria; [Simon-Loriere, Etienne; Sakuntabhai, Anavaj] Inst Pasteur, Unite Genet Fonct Malad Infect, Dept Genomes & Genet, F-75724 Paris 15, France; [Simon-Loriere, Etienne; Sakuntabhai, Anavaj] CNRS, URA 3012, F-75724 Paris 15, France; [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, F-98713 Papeete, Tahiti, France; [Haouz, Ahmed] Inst Pasteur, Plateforme Cristallog CiTech, Dept Biol Struct & Chim, F-75724 Paris 15, France; [Haouz, Ahmed; England, Patrick] CNRS, UMR 3528, F-75724 Paris 15, France; [England, Patrick] Inst Pasteur, Plateforme Biophys Macromol & Leurs Interact, CiTech, Dept Biol Struct & Chim, F-75724 Paris 15, France; [Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok 10700, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Imperial College London; Medical University of Vienna; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University	Rey, FA (corresponding author), Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris 15, France.; Rey, FA (corresponding author), CNRS, UMR Virol 3569, F-75724 Paris 15, France.; Screaton, GR (corresponding author), Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London W12 0NN, England.; Heinz, FX (corresponding author), Med Univ Vienna, Dept Virol, Kinderspitalgasse 15, A-1095 Vienna, Austria.	franz.x.heinz@meduniwien.ac.at; g.screaton@imperial.ac.uk; felix.rey@pasteur.fr	Cao-Lormeau, Van-Mai/H-4879-2018; de Villers, Thierry/AAF-3646-2021; Sharma, Arvind/ABG-2614-2021; Rey, Felix/B-6497-2012	Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Sharma, Arvind/0000-0002-7029-9867; Screaton, Gavin/0000-0002-3549-4309; Medits, Iris/0000-0003-3891-7335; Barba Spaeth, Giovanna/0000-0003-2069-9501; ENGLAND, Patrick/0000-0001-6410-5918; HAOUZ, Ahmed/0000-0003-1196-1635; , Etienne/0000-0001-8420-7743; Rey, Felix/0000-0002-9953-7988; Stiasny, Karin/0000-0002-1902-8674	European Commission [282 378FP7]; "Integrative Biology of Emerging Infectious Diseases" Labex (Laboratoire d'Excellence (French Government's "Investissements d'Avenir" program) [ANR-10-LABX-62-IBEID]; transnational ANR/FWF grant [FlaviStem/I1378]; Medical Research Council, UK; National Institute for Health Research Biomedical Research Centre, Funding Scheme, UK; NEUTRAVIR grant from Region ile-de-France (DIM-Maladies Infectieuses); MRC [G0801508, G0400720] Funding Source: UKRI; Austrian Science Fund (FWF) [I 1378] Funding Source: researchfish; Medical Research Council [G0400720, G0801508] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); "Integrative Biology of Emerging Infectious Diseases" Labex (Laboratoire d'Excellence (French Government's "Investissements d'Avenir" program)(French National Research Agency (ANR)); transnational ANR/FWF grant(French National Research Agency (ANR)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre, Funding Scheme, UK; NEUTRAVIR grant from Region ile-de-France (DIM-Maladies Infectieuses); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. van Kerkhove, the 'working group ZIKA' and our colleagues in the Unite de Virologie Structurale at Institut Pasteur for help and discussions; the staff at the crystallogenesis platform and the recombinant proteins platform of the Institut Pasteur; P. Sylvestre and the Risk Prevention Unit of the Institut Pasteur for their biosafety expertise; W. Shepard and P. Legrand for help during data collection and for discussions; the staff at beamlines PX1 and PX2 at SOLEIL synchrotron (Saclay, France), at beamline ID23-2 of the European Synchrotron Radiation Facility (Grenoble, France) and at beamline PX1 of the Swiss Light Source synchrotron (Villigen, Switzerland); G. Bricogne for suggestions on processing anisotropic diffraction data; A. Reiter and H. Prechler for help in recombinant sE production. G.R.S. is a Wellcome Trust Senior Investigator. We acknowledge support from the European Commission FP7 Programme for the DENFREE project under Grant Agreement number 282 378FP7 (F.A.R., J.M., G.R.S. and A. Sa.); the "Integrative Biology of Emerging Infectious Diseases" Labex (Laboratoire d'Excellence) grant number ANR-10-LABX-62-IBEID (French Government's "Investissements d'Avenir" program) (F.A.R.); the transnational ANR/FWF grant FlaviStem/I1378 (F.A.R. and K.S.), the Medical Research Council, UK (J.M.); the National Institute for Health Research Biomedical Research Centre, Funding Scheme, UK (G.R.S.); and the NEUTRAVIR grant from Region ile-de-France (DIM-Maladies Infectieuses) (P.E., A. H. and F.A.R.)	Backovic M, 2010, PROTEIN ENG DES SEL, V23, P169, DOI 10.1093/protein/gzp088; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bricogne G., 2016, BUSTER VERSION 2 10; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Dejnirattisai W., 2016, NAT IMMUNOL; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gilmartin AA, 2012, PROTEIN ENG DES SEL, V25, P59, DOI 10.1093/protein/gzr058; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindenbach B., 2013, FLAVIVIRIDAE VIRUSES, V1, P1101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11; Vratskikh O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003458; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang W, 2013, J STRUCT BIOL, V183, P86, DOI 10.1016/j.jsb.2013.04.005; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463	45	352	369	5	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					48	+		10.1038/nature18938	http://dx.doi.org/10.1038/nature18938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27338953	Green Submitted, Bronze			2022-12-28	WOS:000380999200027
J	Verdegaal, EME; de Miranda, NFCC; Visser, M; Harryvan, T; van Buuren, MM; Andersen, RS; Hadrup, SR; van der Minne, CE; Schotte, R; Spits, H; Haanen, JBAG; Kapiteijn, EHW; Schumacher, TN; van der Burg, SH				Verdegaal, Els M. E.; de Miranda, Noel F. C. C.; Visser, Marten; Harryvan, Tom; van Buuren, Marit M.; Andersen, Rikke S.; Hadrup, Sine R.; van der Minne, Caroline E.; Schotte, Remko; Spits, Hergen; Haanen, John B. A. G.; Kapiteijn, Ellen H. W.; Schumacher, Ton N.; van der Burg, Sjoerd H.			Neoantigen landscape dynamics during human melanoma-T cell interactions	NATURE			English	Article							EXOME ANALYSIS REVEALS; METASTATIC MELANOMA; CANCER-IMMUNOTHERAPY; PD-1 BLOCKADE; ANTIGENS; THERAPY; LYMPHOCYTES; RESPONSES; TUMORS; RECOGNITION	Recognition of neoantigens that are formed as a consequence of DNA damage is likely to form a major driving force behind the clinical activity of cancer immunotherapies such as T-cell checkpoint blockade and adoptive T-cell therapy(1-7). Therefore, strategies to selectively enhance T-cell reactivity against genetically defined neoantigens(1,8-11) are currently under development. In mouse models, T-cell pressure can sculpt the antigenicity of tumours, resulting in the emergence of tumours that lack defined mutant antigens(12,13). However, whether the T-cell-recognized neoantigen repertoire in human cancers is constant over time is unclear. Here we analyse the stability of neoantigen-specific T-cell responses and the antigens they recognize in two patients with stage IV melanoma treated by adoptive T-cell transfer. The T-cell-recognized neoantigens can be selectively lost from the tumour cell population, either by overall reduced expression of the genes or loss of the mutant alleles. Notably, loss of expression of T-cell-recognized neoantigens was accompanied by development of neoantigen-specific T-cell reactivity in tumour-infiltrating lymphocytes. These data demonstrate the dynamic interactions between cancer cells and T cells, which suggest that T cells mediate neoantigen immunoediting, and indicate that the therapeutic induction of broad neoantigen-specific T-cell responses should be used to avoid tumour resistance.	[Verdegaal, Els M. E.; Visser, Marten; Harryvan, Tom; van der Minne, Caroline E.; Haanen, John B. A. G.; Kapiteijn, Ellen H. W.; van der Burg, Sjoerd H.] Leiden Univ, Med Ctr, Dept Med Oncol, NL-2300 RC Leiden, Netherlands; [de Miranda, Noel F. C. C.] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [van Buuren, Marit M.; Haanen, John B. A. G.; Schumacher, Ton N.] Netherlands Canc Inst, Dept Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Andersen, Rikke S.; Hadrup, Sine R.] Herlev Univ Hosp, Dept Hematol, Ctr Canc Immune Therapy, DK-2730 Herlev, Denmark; [Schotte, Remko; Spits, Hergen] AIMM Therapeut, NL-1105 BA Amsterdam, Netherlands; [Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [van Buuren, Marit M.] Neon Therapeut, Cambridge, MA 02142 USA; [Andersen, Rikke S.] Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat Res, DK-5000 Odense, Denmark; [Hadrup, Sine R.] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, DK-1870 Copenhagen, Denmark	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; University of Copenhagen; Herlev & Gentofte Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Southern Denmark; Technical University of Denmark	Verdegaal, EME (corresponding author), Leiden Univ, Med Ctr, Dept Med Oncol, NL-2300 RC Leiden, Netherlands.	E.Verdegaal@lumc.nl	Haanen, John/AAD-8534-2022; Kapiteijn, Ellen/AAK-6065-2020; Schumacher, Ton/Y-2432-2019; de Miranda, NFCC/I-2520-2015; Verdegaal, Elizabeth/Y-2597-2018; Haanen, John/AAD-8578-2022; Spits, Hergen/N-2581-2019; van der Burg, Sjoerd H/T-1875-2017; Hadrup, Sine Reker/P-3388-2014; Andersen, Rikke/GRS-3064-2022	Haanen, John/0000-0001-5884-7704; Kapiteijn, Ellen/0000-0002-4814-6426; Schumacher, Ton/0000-0003-0517-8804; de Miranda, NFCC/0000-0001-6122-1024; Verdegaal, Elizabeth/0000-0002-4449-8707; Spits, Hergen/0000-0003-3269-8338; van der Burg, Sjoerd H/0000-0002-6556-0354; Hadrup, Sine Reker/0000-0002-5937-4344; 	Dutch Cancer Society [UL 2012-5544, NKI 2012-5463, UVA 2010-4822]; Anticancer Fund; Dutch Cancer Society Queen Wilhelmina Award NKI [2013-6122]; Fight Colorectal Cancer-Michael's Mission-AACR Fellowship; Alpe d'HuZes/KWF Bas Mulder Award	Dutch Cancer Society(KWF Kankerbestrijding); Anticancer Fund; Dutch Cancer Society Queen Wilhelmina Award NKI; Fight Colorectal Cancer-Michael's Mission-AACR Fellowship; Alpe d'HuZes/KWF Bas Mulder Award	We are grateful to G. J. Liefers for handling of patient material, and T. van Wezel and D. Ruano for the setup of the M13-amplicon sequencing technology. This work was supported by Dutch Cancer Society grant UL 2012-5544 (to E.M.E.V., S.H.v.d.B. and J.B.A.G.H), the Anticancer Fund (to E.M.E.V. and S.H.v.d.B.), Dutch Cancer Society grant NKI 2012-5463 (to T.N.S, J.B.A.G.H. and S.H.v.d.B), the Dutch Cancer Society Queen Wilhelmina Award NKI 2013-6122 (T.N.S), Dutch Cancer Society grant UVA 2010-4822 (to H.S.), Fight Colorectal Cancer-Michael's Mission-AACR Fellowship (2015) and Alpe d'HuZes/KWF Bas Mulder Award (to N.F.C.C.d.M.).	Andersen RS, 2012, CANCER RES, V72, P1642, DOI 10.1158/0008-5472.CAN-11-2614; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Ellebaek E, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-169; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Kawakami Y, 2000, J IMMUNOTHER, V23, P17, DOI 10.1097/00002371-200001000-00004; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lu YC, 2014, CLIN CANCER RES, V20, P3401, DOI 10.1158/1078-0432.CCR-14-0433; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Timm J, 2015, MED MICROBIOL IMMUN, V204, P29, DOI 10.1007/s00430-014-0372-z; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Verdegaal EME, 2011, CANCER IMMUNOL IMMUN, V60, P953, DOI 10.1007/s00262-011-1004-8; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	29	277	288	6	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					91	+		10.1038/nature18945	http://dx.doi.org/10.1038/nature18945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27350335				2022-12-28	WOS:000380999200036
J	Wylie, K; Knudson, G; Khan, SI; Bonierbale, M; Watanyusakul, S; Baral, S				Wylie, Kevan; Knudson, Gail; Khan, Sharful Islam; Bonierbale, Mireille; Watanyusakul, Suporn; Baral, Stefan			Serving transgender people: clinical care considerations and service delivery models in transgender health	LANCET			English	Article							TERM-FOLLOW-UP; GENDER IDENTITY DISORDER; SEX REASSIGNMENT SURGERY; QUALITY-OF-LIFE; PUBERTY SUPPRESSION; ENDOCRINE TREATMENT; MALE-TRANSSEXUALS; HORMONAL-THERAPY; MENTAL-HEALTH; HUMAN-RIGHTS	The World Professional Association for Transgender Health (WPATH) standards of care for transsexual, transgender, and gender non-conforming people (version 7) represent international normative standards for clinical care for these populations. Standards for optimal individual clinical care are consistent around the world, although the implementation of services for transgender populations will depend on health system infrastructure and sociocultural contexts. Some clinical services for transgender people, including gender-affirming surgery, are best delivered in the context of more specialised facilities; however, the majority of health-care needs can be delivered by a primary care practitioner. Across high-income and low-income settings alike, there often remains a dearth of educational programming for health-care professionals in transgender health, although the best evidence supports introducing modules on transgender health early during clinical education of clinicians and allied health professionals. While these challenges remain, we review the increasing evidence and examples of the defined roles of the mental health professional in transgender health-care decisions, effective models of health service provision, and available surgical interventions for transgender people.	[Wylie, Kevan] Univ Sheffield, Sheffield, S Yorkshire, England; [Wylie, Kevan] Porterbrook Clin, Sheffield S11 9BF, S Yorkshire, England; [Knudson, Gail] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Khan, Sharful Islam] Icddr B, Div Infect Dis, Program HIV & AIDS, Dhaka, Bangladesh; [Baral, Stefan] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Bonierbale, Mireille] Univ Hosp Concept, Gender Dysphoria & Sexol Dept, Marseille, France; [Watanyusakul, Suporn] Aikchol Hosp, Div Plast Surg, Suporn Clin, Chon Buri, Thailand	University of Sheffield; University of British Columbia; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; UDICE-French Research Universities; Aix-Marseille Universite	Wylie, K (corresponding author), Porterbrook Clin, Sheffield S11 9BF, S Yorkshire, England.	k.r.wylie@sheffield.ac.uk	Wylie, Kevan/C-5751-2011; Baral, Stefan/AAG-4818-2020	Wylie, Kevan/0000-0003-3805-105X; Baral, Stefan/0000-0002-5482-2419; Khan, MBBS, MHSS, PhD, Sharful Islam/0000-0002-7319-1333	United Nations Development Programme	United Nations Development Programme	The United Nations Development Programme funded a developmental review meeting for this Series.	[Anonymous], 2014, IMPL CURR I CLIM CHA; Asscheman H, 2011, EUR J ENDOCRINOL, V164, P635, DOI 10.1530/EJE-10-1038; Bauer GR, 2009, J ASSOC NURSE AIDS C, V20, P348, DOI 10.1016/j.jana.2009.07.004; BLANCHARD R, 1989, CAN J PSYCHIAT, V34, P43, DOI 10.1177/070674378903400111; Bockting WO, 2008, SEXOLOGIES, V17, P211, DOI 10.1016/j.sexol.2008.08.001; Bodlund O, 1996, ARCH SEX BEHAV, V25, P303, DOI 10.1007/BF02438167; Bonierbale M, 2005, SEXOLOGIES, V15, P39; Brett MA, 2007, J SEX MED, V4, P946, DOI 10.1111/j.1743-6109.2007.00522.x; Byne William, 2012, Am J Psychiatry, V169, P875, DOI 10.1176/appi.ajp.2012.169.8.875; Campo JA, 2003, AM J PSYCHIAT, V160, P1332, DOI 10.1176/appi.ajp.160.7.1332; Chin J., 2015, HUFFINGTON POSTCANAD; Chokrungvaranont P, 2014, SCI WORLD J, DOI 10.1155/2014/182981; Cohen-Kettenis PT, 2008, J SEX MED, V5, P1892, DOI 10.1111/j.1743-6109.2008.00870.x; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; Connell R.W., 2002, GENDER; Dahl M., 2015, ENDOCRINE THERAPY TR; De Cuypere G, 2006, SEXOLOGIES, V15, P126, DOI 10.1016/j.sexol.2006.04.002; de Vries ALC, 2014, PEDIATRICS, V134, P696, DOI 10.1542/peds.2013-2958; de Vries ALC, 2011, J SEX MED, V8, P2276, DOI 10.1111/j.1743-6109.2010.01943.x; de Vries Annelou L C, 2007, Pediatr Endocrinol Rev, V4, P343; Dhejne C, 2016, INT REV PSYCHIATR, V28, P44, DOI 10.3109/09540261.2015.1115753; Dhejne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016885; Doussantousse S, 2011, CULT HEALTH SEX, V13, pS279, DOI 10.1080/13691058.2011.584633; Dowshen N, 2014, AM J PUBLIC HEALTH, V104, pE5, DOI 10.2105/AJPH.2014.301978; Drummond KD, 2008, DEV PSYCHOL, V44, P34, DOI 10.1037/0012-1649.44.1.34; de Antonio EI, 2013, CURR OPIN ENDOCRINOL, V20, P585, DOI 10.1097/01.med.0000436182.42966.31; FANG RH, 1992, PLAST RECONSTR SURG, V89, P679, DOI 10.1097/00006534-199204000-00015; GILBERT DA, 1987, ANN PLAS SURG, V18, P128, DOI 10.1097/00000637-198702000-00006; Gillott S, 2008, SEXOLOGIES, V17, P238, DOI 10.1016/j.sexol.2008.06.004; Gomez-Gil E, 2012, PSYCHONEUROENDOCRINO, V37, P662, DOI 10.1016/j.psyneuen.2011.08.010; Gooren LJ, 2011, NEW ENGL J MED, V364, P1251, DOI 10.1056/NEJMcp1008161; Gorin-Lazard A, 2008, SEXOLOGIES, V17, P225, DOI 10.1016/j.sexol.2008.06.003; Gorin-Lazard A, 2013, J NERV MENT DIS, V201, P996, DOI 10.1097/NMD.0000000000000046; Gorin-Lazard A, 2012, J SEX MED, V9, P531, DOI 10.1111/j.1743-6109.2011.02564.x; Guadamuz TE, 2011, AIDS BEHAV, V15, P650, DOI 10.1007/s10461-010-9850-5; Hage JJ, 1997, PLAST RECONSTR SURG, V99, P1799, DOI 10.1097/00006534-199706000-00001; HAGE JJ, 1993, J UROLOGY, V149, P1463, DOI 10.1016/S0022-5347(17)36416-9; Hakeem A., 2012, ADV PSYCHIAT TREATME, V18, P17, DOI [10.1192/apt.bp.111.009431, DOI 10.1192/APT.BP.111.009431]; Hardacker CT, 2014, J NURS MANAGE, V22, P257, DOI 10.1111/jonm.12125; Health Policy Project Asia Pacific Transgender Network United Nations Development Programme, 2015, BLUEPR PROV COMPR CA; Hedjazi A, 2013, N Am J Med Sci, V5, P224, DOI 10.4103/1947-2714.109198; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Hines S., 2007, TRANSFORMING GENDER; Johansson A, 2010, ARCH SEX BEHAV, V39, P1429, DOI 10.1007/s10508-009-9551-1; Karim M, 2013, DHAKA TRIBUNE; Karim RB, 1996, ANN PLAS SURG, V37, P669; Khan Sharful Islam, 2008, J LGBT Health Res, V4, P127; Khan SI, 2009, J HEALTH POPUL NUTR, V27, P441, DOI 10.3329/jhpn.v27i4.3388; Klotzbaugh R, 2014, J NURS ADMIN, V44, P481, DOI 10.1097/NNA.0000000000000103; Kuiper AJ, 1998, INT J TRANSGENDERISM, V2; Landen M, 1998, ACTA PSYCHIAT SCAND, V97, P284, DOI 10.1111/j.1600-0447.1998.tb10001.x; Laurent E, 2005, J HOMOSEXUAL, V48, P163, DOI 10.1300/J082v48n03_09; Lawrence AA, 2003, ARCH SEX BEHAV, V32, P299, DOI 10.1023/A:1024086814364; LINDEMALM G, 1986, ARCH SEX BEHAV, V15, P187, DOI 10.1007/BF01542412; LUNDSTROM B, 1984, ACTA PSYCHIAT SCAND, V70, P289, DOI 10.1111/j.1600-0447.1984.tb01211.x; Mahapatra D, 2014, TIMES OF INDIA; Master V, 2003, UROLOGY, V62, DOI 10.1016/j.urology.2003.08.005; Masumori N, 2012, INT J UROL, V19, P402, DOI 10.1111/j.1442-2042.2012.02975.x; McCann E, 2013, AGING MENT HEALTH, V17, P358, DOI 10.1080/13607863.2012.751583; MCCAULEY E, 1984, J NERV MENT DIS, V172, P353, DOI 10.1097/00005053-198406000-00006; Melayu B., 2015, HUMAN RIGHTS WATCH; Michel A, 2002, EUR PSYCHIAT, V17, P353, DOI 10.1016/S0924-9338(02)00703-4; Moll J, 2014, ACAD EMERG MED, V21, P608, DOI 10.1111/acem.12368; Monro S, 2007, SOCIOL RES ONLINE, V12, DOI 10.5153/sro.1514; Monstrey Stan J, 2011, Semin Plast Surg, V25, P229, DOI 10.1055/s-0031-1281493; NANDA S, 1985, J HOMOSEXUAL, V11, P35; Nanda S, 1990, NEITHER MAN WOMAN; Nandi J., 2013, GUARDIAN; Neto RR, 2012, INT BRAZ J UROL, V38, P97, DOI 10.1590/S1677-55382012000100014; Offord B, 2001, J HOMOSEXUAL, V40, P233, DOI 10.1300/J082v40n03_12; OUSTERHOUT DK, 1987, PLAST RECONSTR SURG, V79, P701, DOI 10.1097/00006534-198705000-00003; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Parker AJ, 2008, SEXOLOGIES, V17, P277, DOI 10.1016/j.sexol.2008.08.006; PAULY IB, 1981, AUST NZ J PSYCHIAT, V15, P45, DOI 10.3109/00048678109159409; Perovic SV, 2003, BJU INT, V92, P981, DOI 10.1111/j.1464-410X.2003.04524.x; Pew Research Center, 2013, GLOB DIV HOM GREAT A; Pfaffin F, 1998, SEX REASSIGNMENT 30; Pfafflin Friedemann, 1993, J PSYCHOL HUMAN SEXU, V5, P69, DOI DOI 10.1300/J056V05N04_05; Reed Harold Morgan, 2011, Semin Plast Surg, V25, P163, DOI 10.1055/s-0031-1281486; Reisner SL, 2015, J URBAN HEALTH, V92, P584, DOI 10.1007/s11524-015-9947-2; Rice ME, 2011, PSYCHOL PUBLIC POL L, V17, P315, DOI 10.1037/a0022318; Safer JD, 2013, ENDOCR PRACT, V19, P633, DOI 10.4158/EP13014.OR; Sam H., 2010, TRANSGENDER REPRESEN; Sengezer M, 2004, PLAST RECONSTR SURG, V114, P439, DOI 10.1097/01.PRS.0000131883.27191.86; Shreshtha S, 2011, EXPLORING CONSEQUENC; Smith YLS, 2005, PSYCHOL MED, V35, P89, DOI 10.1017/S0033291704002776; Steensma TD, 2013, J AM ACAD CHILD PSY, V52, P582, DOI 10.1016/j.jaac.2013.03.016; Thornhill L, 2010, J ASSOC NURSE AIDS C, V21, P230, DOI 10.1016/j.jana.2009.11.007; Thornton J, 2008, SEXOLOGIES, V17, P271, DOI 10.1016/j.sexol.2008.08.003; Vale K, 2010, INT J TRANSGENDERISM, V12, P40, DOI 10.1080/15532731003749095; van de Ven BFML, 2008, SEXOLOGIES, V17, P291, DOI 10.1016/j.sexol.2008.08.008; Vidal-Ortiz S, 2008, SOCIOL COMPASS, V2, P433, DOI 10.1111/j.1751-9020.2007.00086.x; Wallien MSC, 2008, J AM ACAD CHILD PSY, V47, P1413, DOI 10.1097/CHI.0b013e31818956b9; Wassersug RJ, 2007, PERSPECT BIOL MED, V50, P544, DOI 10.1353/pbm.2007.0058; Watanyusakul S, 2004, 9 INT C OR SOC AESTH; Watanyusakul S, 2002, THAI J SURG, V23, P104; Weinand JD, 2015, J CLIN TRANSL ENDOCR, V2, P55, DOI 10.1016/j.jcte.2015.02.003; Weyers S, 2009, J SEX MED, V6, P752, DOI 10.1111/j.1743-6109.2008.01082.x; Wierckx K, 2011, J SEX MED, V8, P3379, DOI 10.1111/j.1743-6109.2011.02348.x; Winter S, 2009, INT J SEX HEALTH, V21, P35, DOI 10.1080/19317610802554141; Wirth JH, 2009, PSYCHOL SCI, V20, P169, DOI 10.1111/j.1467-9280.2009.02282.x; Worathamrong S, 2004, 9 INT C OR SOC AESTH; Wylie K, 2014, SEX RELATSH THER, V29, P154, DOI 10.1080/14681994.2014.883353; Wylie KR, 2009, SEX RELATSH THER, V24, P175, DOI 10.1080/14681990903023306; Zuzelo PR, 2014, JOGNN-J OBST GYN NEO, V43, P520, DOI 10.1111/1552-6909.12477	105	157	158	1	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					401	411		10.1016/S0140-6736(16)00682-6	http://dx.doi.org/10.1016/S0140-6736(16)00682-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR6MV	27323926				2022-12-28	WOS:000380016900043
J	Torjesen, I				Torjesen, Ingrid			Nursery policies on conjunctivitis may encourage GPs to prescribe antibiotics	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Finnikin S, 2016, BRIT J GEN PRACT, V66, pE674, DOI 10.3399/bjgp16X686125	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2016	354								i3754	10.1136/bmj.i3754	http://dx.doi.org/10.1136/bmj.i3754			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EP	27382983				2022-12-28	WOS:000379581100022
J	Krzywinska, E; Dennison, NJ; Lycett, GJ; Krzywinski, J				Krzywinska, Elzbieta; Dennison, Nathan J.; Lycett, Gareth J.; Krzywinski, Jaroslaw			A maleness gene in the malaria mosquito Anopheles gambiae	SCIENCE			English	Article							LUCILIA-CUPRINA DIPTERA; DOSAGE COMPENSATION; SEX DETERMINATION; Y-CHROMOSOME; X-CHROMOSOME; DETERMINING REGION; TRANSFORMER GENE; AEDES-AEGYPTI; DROSOPHILA; RATIO	The molecular pathways controlling gender are highly variable and have been identified in only a few nonmammalian model species. In many insects, maleness is conferred by a Ychromosome-linked M factor of unknown nature. We have isolated and characterized a gene, Yob, for the M factor in the malaria mosquito Anopheles gambiae. Yob, activated at the beginning of zygotic transcription and expressed throughout a male's life, controls male-specific splicing of the doublesex gene. Silencing embryonic Yob expression is male-lethal, whereas ectopic embryonic delivery of Yob transcripts yields male-only broods. This female-killing property may be an invaluable tool for creation of conditional male-only transgenic Anopheles strains for malaria control programs.	[Krzywinska, Elzbieta; Krzywinski, Jaroslaw] Pirbright Inst, Ash Rd, Pirbright GU24 0NF, Surrey, England; [Dennison, Nathan J.; Lycett, Gareth J.; Krzywinski, Jaroslaw] Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Pembroke Pl, Liverpool L3 5QA, Merseyside, England; [Dennison, Nathan J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Liverpool School of Tropical Medicine; University of Liverpool; Imperial College London	Krzywinski, J (corresponding author), Pirbright Inst, Ash Rd, Pirbright GU24 0NF, Surrey, England.; Krzywinski, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	jaroslaw.krzywinski@pirbright.ac.uk		Lycett, Gareth/0000-0002-2422-053X	Liverpool School of Tropical Medicine (LSTM); MRC-LSTM Research Studentship; Wellcome Trust [089045/Z/09/Z]; Pirbright Institute; Biotechnology and Biological Sciences Research Council [BB/F021933/1]; NIH [CRSC120816JKUND, HHSN272200900039C]; BBSRC [BBS/E/I/00001854, BB/F021933/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001854] Funding Source: researchfish	Liverpool School of Tropical Medicine (LSTM); MRC-LSTM Research Studentship; Wellcome Trust(Wellcome TrustEuropean Commission); Pirbright Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank H. Ranson, A. Wilson, and anonymous reviewers for comments and L. Revuelta for technical assistance. This study was supported by funds from the Liverpool School of Tropical Medicine (LSTM), an MRC-LSTM Research Studentship, Wellcome Trust grant 089045/Z/09/Z (J.K. and G.J.L.), and funds from the Pirbright Institute (J.K.). Transgenic mosquitoes used for sexing were developed with Biotechnology and Biological Sciences Research Council grant BB/F021933/1 (G.J.L.). J.K. was partly supported by a subcontract CRSC120816JKUND of the NIH contract HHSN272200900039C. The RNA-sequencing data have been deposited in the Sequence Read Archive repository under the accession numbers SRR953486.1 and SRR953487.1.	Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; BAKER RH, 1979, J HERED, V70, P345, DOI 10.1093/oxfordjournals.jhered.a109271; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; BEDO DG, 1985, CHROMOSOMA, V92, P344, DOI 10.1007/BF00327465; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Concha C, 2009, GENETICS, V182, P785, DOI 10.1534/genetics.109.100982; Criscione F, 2013, INSECT MOL BIOL, V22, P433, DOI 10.1111/imb.12034; Erickson JW, 2007, PLOS BIOL, V5, P2821, DOI 10.1371/journal.pbio.0050332; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; GERGEN JP, 1987, GENETICS, V117, P477; Hall AB, 2016, P NATL ACAD SCI USA, V113, pE2114, DOI 10.1073/pnas.1525164113; Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850; Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Hilfiker A, 1995, DEVELOPMENT, V121, P4017; HIROYOSHI T, 1964, GENETICS, V50, P373; Juhn J, 2006, INSECT MOL BIOL, V15, P363, DOI 10.1111/j.1365-2583.2006.00655.x; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902; Krzywinski J, 2004, GENETICS, V166, P1291, DOI 10.1534/genetics.166.3.1291; Li W.-H., 1997, MOL EVOLUTION, P177; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; LUCCHESI JC, 1981, CHROMOSOMA, V82, P217, DOI 10.1007/BF00286106; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Pane A, 2002, DEVELOPMENT, V129, P3715; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Pritchard DK, 1996, GENE DEV, V10, P1131, DOI 10.1101/gad.10.9.1131; Rose G, 2016, GENOME BIOL EVOL, V8, P411, DOI 10.1093/gbe/evw004; Scali C, 2005, J EXP BIOL, V208, P3701, DOI 10.1242/jeb.01819; Shukla JN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00602; STUART JJ, 1995, GENOME, V38, P673, DOI 10.1139/g95-085; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; WILKINS AS, 1995, BIOESSAYS, V17, P71, DOI 10.1002/bies.950170113; Willhoeft U, 1996, GENETICS, V144, P737	37	69	75	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					67	69		10.1126/science.aaf5605	http://dx.doi.org/10.1126/science.aaf5605			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365445	Green Accepted			2022-12-28	WOS:000378816200036
J	Flajnik, MF				Flajnik, Martin F.			Evidence of GOD's Miracle: Unearthing a RAG Transposon	CELL			English	Editorial Material							V(D)J RECOMBINATION; EVOLUTION; DNA	Diversity of antibodies and T cell receptors is generated by gene rearrangement dependent on RAG1 and RAG2, enzymes predicted to have been derived from a transposable element (TE) that invaded an immunoglobulin superfamily gene early in the evolution of jawed vertebrates. Now, Huang et al. report the discovery of ProtoRAG in the lower chordate Amphioxus, the long-anticipated TE related to the RAG transposon.	[Flajnik, Martin F.] Univ Maryland, Dept Microbiol & Immunol, 685 West Baltimore St,Suite 380, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Flajnik, MF (corresponding author), Univ Maryland, Dept Microbiol & Immunol, 685 West Baltimore St,Suite 380, Baltimore, MD 21201 USA.	mflajnik@som.umaryland.edu			NIH HHS [R01 OD010549] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010549] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; Carmona LM, 2016, GENE DEV, V30, P909, DOI 10.1101/gad.278432.116; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Hsu E, 2011, CURR OPIN IMMUNOL, V23, P156, DOI 10.1016/j.coi.2010.12.007; Huang SF, 2016, CELL, V166, P102, DOI 10.1016/j.cell.2016.05.032; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; THOMPSON CB, 1995, IMMUNITY, V3, P531, DOI 10.1016/1074-7613(95)90124-8; Zhang YN, 2014, P NATL ACAD SCI USA, V111, P397, DOI 10.1073/pnas.1318843111	10	5	6	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					11	12		10.1016/j.cell.2016.06.021	http://dx.doi.org/10.1016/j.cell.2016.06.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368095	Bronze, Green Accepted			2022-12-28	WOS:000380254400005
J	Khan, M; Rao, PK; Rao, RC				Khan, Mehnaz; Rao, P. Kumar; Rao, Rajesh C.			CASE REVIEW A brushfire in the eye	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNE-DEFICIENCY SYNDROME; CYTOMEGALOVIRUS-RETINITIS; RETINAL-DETACHMENT; CMV RETINITIS; AIDS; ERA; GANCICLOVIR; RISK; MANAGEMENT		[Khan, Mehnaz] Cleveland Clin, Cole Eye Inst, Cleveland, OH USA; [Rao, P. Kumar] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO USA; [Rao, Rajesh C.] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Rao, Rajesh C.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	Cleveland Clinic Foundation; Washington University (WUSTL); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rao, RC (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA.; Rao, RC (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	rajeshr@med.umich.edu	Rao, Rajesh C./N-1107-2017	Rao, Rajesh C./0000-0002-5776-8366				Butler NJ, 2012, CURR OPIN OPHTHALMOL, V23, P517, DOI 10.1097/ICU.0b013e328358ba85; CHUANG EL, 1992, EYE, V6, P28, DOI 10.1038/eye.1992.4; Cochereau I, 2000, J FR OPHTALMOL, V23, P123; Crosson Jason N, 2015, Retin Cases Brief Rep, V9, P162, DOI 10.1097/ICB.0000000000000126; DAMICO DJ, 1986, ARCH OPHTHALMOL-CHIC, V104, P1788; FREEMAN WR, 1993, AM J OPHTHALMOL, V116, P713, DOI 10.1016/S0002-9394(14)73471-3; FREEMAN WR, 1984, AM J OPHTHALMOL, V97, P133, DOI 10.1016/S0002-9394(14)76082-9; Friedberg DN, 1997, J ACQ IMMUN DEF SYND, V14, pS1, DOI 10.1097/00042560-199700001-00002; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Holland GN, 2008, AM J OPHTHALMOL, V145, P12, DOI 10.1016/j.ajo.2007.09.040; Holland GN, 2008, AM J OPHTHALMOL, V145, P5, DOI 10.1016/j.ajo.2007.09.023; HOLLAND GN, 1983, OPHTHALMOLOGY, V90, P859; JABS DA, 1991, ARCH OPHTHALMOL-CHIC, V109, P794, DOI 10.1001/archopht.1991.01080060058024; Jabs DA, 2004, OPHTHALMOLOGY, V111, P2224, DOI 10.1016/j.ophtha.2004.05.031; Jabs DA, 1997, AM J OPHTHALMOL, V124, P61; Jabs DA, 2010, OPHTHALMOLOGY, V117, P2, DOI [10.1016/j.ophtha.2010.03.031, DOI 10.1016/J.0PHTHA.2010.03.031]; Jabs DA, 2013, OPHTHALMOLOGY, V120, P1262, DOI 10.1016/j.ophtha.2012.11.023; Jabs DA, 2011, AM J OPHTHALMOL, V151, P198, DOI 10.1016/j.ajo.2010.10.018; Kempen JH, 2001, ARCH OPHTHALMOL-CHIC, V119, P33; Maningding E, 2015, JAIDS-J ACQ IMM DEF, V69, pe115, DOI 10.1097/QAI.0000000000000629; Martin DF, 1999, NEW ENGL J MED, V340, P1063, DOI 10.1056/NEJM199904083401402; Musch DC, 1997, NEW ENGL J MED, V337, P83, DOI 10.1056/NEJM199707103370203; PAVESIO CE, 1995, EYE, V9, P271, DOI 10.1038/eye.1995.53; PEPOSE JS, 1984, OPHTHALMOLOGY, V91, P1669; PERTEL P, 1992, J ACQ IMMUN DEF SYND, V5, P1069; Schmitz K, 1991, Fortschr Ophthalmol, V88, P698; Stewart MW, 2010, CLIN OPHTHALMOL, V4, P285; Thorne JE, 2006, OPHTHALMOLOGY, V113, P1441, DOI 10.1016/j.ophtha.2006.03.022	28	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3075	10.1136/bmj.i3075	http://dx.doi.org/10.1136/bmj.i3075			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27363427				2022-12-28	WOS:000379019700002
J	Angermann, CE; Gelbrich, G; Stork, S; Gunold, H; Edelmann, F; Wachter, R; Schunkert, H; Graf, T; Kindermann, I; Haass, M; Blankenberg, S; Pankuweit, S; Prettin, C; Gottwik, M; Bohm, M; Faller, H; Deckert, J; Ertl, G				Angermann, Christiane E.; Gelbrich, Goetz; Stoerk, Stefan; Gunold, Hilka; Edelmann, Frank; Wachter, Rolf; Schunkert, Heribert; Graf, Tobias; Kindermann, Ingrid; Haass, Markus; Blankenberg, Stephan; Pankuweit, Sabine; Prettin, Christiane; Gottwik, Martin; Boehm, Michael; Faller, Hermann; Deckert, Juergen; Ertl, Georg		MOOD-HF Study Investigators Comm	Effect of Escitalopramon All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression The MOOD-HF Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLLABORATIVE DISEASE MANAGEMENT; QUALITY-OF-LIFE; MYOCARDIAL-INFARCTION; INTERDISCIPLINARY NETWORK; MORBIDITY; METAANALYSIS; SYMPTOMS; EVENTS; CARE; REHOSPITALIZATION	IMPORTANCE Depression is frequent in patients with heart failure and is associated with adverse clinical outcomes. Long-term efficacy and safety of selective serotonin reuptake inhibitors in these patients are unknown. OBJECTIVE To determine whether 24 months of treatment with escitalopram improves mortality, morbidity, and mood in patients with chronic systolic heart failure and depression. DESIGN, SETTING, AND PARTICIPANTS The Effects of Selective Serotonin Re-Uptake Inhibition on Morbidity, Mortality, and Mood in Depressed Heart Failure Patients (MOOD-HF) studywas a double-blind, placebo-controlled randomized clinical trial conducted at 16 tertiary medical centers in Germany. Between March 2009 and February 2014, patients at outpatient clinics with New York Heart Association class II-IV heart failure and reduced left ventricular ejection fraction (<45%) were screened for depression using the 9-item Patient Health Questionnaire. Patients with suspected depression were then invited to undergo a Structured Clinical Interview based on the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) to establish the diagnosis. INTERVENTIONS Patients were randomized 1:1 to receive escitalopram (10-20 mg) or matching placebo in addition to optimal heart failure therapy. Study duration was 24 months. MAIN OUTCOMES AND MEASURES The composite primary outcome was time to all-cause death or hospitalization. Prespecified secondary outcomes included safety and depression severity at 12 weeks of treatment (including the titration period), which were determined using the 10-item Montgomery-angstrom sberg Depression Rating Scale (total possible score, 0 to 60; higher scores indicate more severe depression). RESULTS A total of 372 patients (mean age, 62 years; 24% female) were randomized and had taken at least 1 dose of study medication when the data and safety monitoring committee recommended the trial be stopped early. During a median participation time of 18.4 months (n = 185) for the escitalopram group and 18.7 months (n = 187) for the placebo group, the primary outcome of death or hospitalization occurred in 116 (63%) patients and 119 (64%) patients, respectively (hazard ratio, 0.99 [95% CI, 0.76 to 1.27]; P = .92). The mean Montgomery-angstrom sberg Depression Rating Scale sum score changed from 20.2 at baseline to 11.2 at 12weeks in the escitalopram group and from 21.4 to 12.5 in the placebo group (between-group difference, -0.9 [95% CI,-2.6 to 0.7]; P = .26). Safety parameters were comparable between groups. CONCLUSIONS AND RELEVANCE In patients with chronic heart failure with reduced ejection fraction and depression, 18 months of treatment with escitalopram compared with placebo did not significantly reduce all-cause mortality or hospitalization, and there was no significant improvement in depression. These findings do not support the use of escitalopram in patients with chronic systolic heart failure and depression.	[Angermann, Christiane E.; Stoerk, Stefan; Ertl, Georg] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, D-97078 Wurzburg, Germany; [Angermann, Christiane E.; Stoerk, Stefan; Ertl, Georg] Univ Hosp Wurzburg, Dept Med 1, D-97078 Wurzburg, Germany; [Gelbrich, Goetz] Univ Wurzburg, Inst Clin Epidemiol & Biometry, D-97078 Wurzburg, Germany; [Gelbrich, Goetz] Univ Hosp Wurzburg, Clin Trial Ctr Wurzburg, D-97078 Wurzburg, Germany; [Gunold, Hilka] Univ Hosp Leipzig, Dept Med & Cardiol, Leipzig, Germany; [Gunold, Hilka] Univ Hosp Leipzig, Ctr Heart, Leipzig, Germany; [Edelmann, Frank] Univ Hosp Gottingen, Dept Cardiol, Gottingen, Germany; [Edelmann, Frank] Univ Med Berlin, Charite Campus Virchow Klinikum, Dept Internal Med, Cardiol, Berlin, Germany; [Wachter, Rolf] Univ Hosp Gottingen, Dept Cardiol, Gottingen, Germany; [Schunkert, Heribert] Tech Univ Munich, German Heart Ctr Munich, D-80290 Munich, Germany; [Graf, Tobias] Univ Hosp Lubeck, Dept Med 2, Lubeck, Germany; [Kindermann, Ingrid; Boehm, Michael] Saarland Univ Hosp, Dept Med 3, Homburg, Saar, Germany; [Haass, Markus] Heidelberg Univ, Acad Teaching Hosp, Theresienkrankenhaus, Dept Cardiol, Heidelberg, Germany; [Blankenberg, Stephan] Univ Heart Ctr Hamburg, Hamburg, Germany; [Pankuweit, Sabine] Univ Hosp Marburg, Dept Cardiol, Marburg, Germany; [Prettin, Christiane] Univ Leipzig, Clin Trial Ctr Leipzig, D-04109 Leipzig, Germany; [Gottwik, Martin] Klinikum Nurnberg, Univ Hosp Nurnberg, Dept Cardiol, Nurnberg, Germany; [Faller, Hermann] Univ Wurzburg, Ctr Mental Hlth, Dept Med Psychol Med Sociol & Rehabil Sci, D-97078 Wurzburg, Germany; [Deckert, Juergen] Univ Hosp Wurzburg, Ctr Mental Hlth, Dept Psychiat Psychosomat Med & Psychotherapy, D-97078 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Leipzig University; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gottingen; German Heart Centre Munich; Technical University of Munich; University of Lubeck; Universitatsklinikum des Saarlandes; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University Hospital of Giessen & Marburg; Leipzig University; Klinikum Nurnberg Nord; University of Erlangen Nuremberg; University of Wurzburg; University of Wurzburg	Angermann, CE (corresponding author), Univ Wurzburg, Med & Cardiol, Straubmuhlweg 2a, D-97078 Wurzburg, Germany.; Angermann, CE (corresponding author), Univ Hosp Wurzburg, Dept Med 1, Cardiol, Straubmuhlweg 2a, D-97078 Wurzburg, Germany.; Angermann, CE (corresponding author), Comprehens Heart Failure Ctr Wurzburg, Straubmuhlweg 2a, D-97078 Wurzburg, Germany.	angermann_c@ukw.de	Hurlemann, Rene/G-4164-2012; Kindermann, Ingrid/AAQ-3805-2020; Stork, Stefan/AAR-4182-2020; Böhm, Michael/C-3638-2011; Hurlemann, Rene/AAL-5515-2020; Wachter, Rolf/AAA-4037-2020	Hurlemann, Rene/0000-0003-2628-565X; Stork, Stefan/0000-0002-1771-7249; Hurlemann, Rene/0000-0003-2628-565X; Edelmann, Frank/0000-0003-4401-5936; Graf, Tobias/0000-0003-4038-147X; Wachter, Rolf/0000-0003-2231-2200	German Ministry of Education and Research; Lundbeck AS Denmark	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Lundbeck AS Denmark	The study was funded by the German Ministry of Education and Research and Lundbeck AS Denmark. The Departments of Cardiology, to which investigators enrolling patients in the Effects of Selective Serotonin Re-Uptake Inhibition on Morbidity, Mortality, and Mood in Depressed Heart Failure Patients (MOOD-HF) were affiliated received case payment from the German Ministry of Education and Research and cofunding from Lundbeck AS Denmark, which was distributed by the Administrative Office of the Wurzburg University Hospital. Case payments were calculated ex ante based on the expected net costs for 24 months of study participation per patient and data entry into the central data base. Case payments included funds for performing the Structured Clinical Interview based on the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) for the diagnosis of depression and for psychiatric emergency interventions, which were transferred to the partnering Departments of Psychiatry or Psychosomatic Medicine. The Institute of Clinical Epidemiology and Biometry, University of Wurzburg, and the Clinical Trial Centre, University of Leipzig, received funding for biometry, statistical analyses, and study management.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Angermann CE, 2007, EUR J HEART FAIL, V9, P1212, DOI 10.1016/j.ejheart.2007.10.005; Angermann CE, 2012, CIRC-HEART FAIL, V5, P25, DOI 10.1161/CIRCHEARTFAILURE.111.962969; Bekelman DB, 2015, JAMA INTERN MED, V175, P725, DOI 10.1001/jamainternmed.2015.0315; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Blumenthal JA, 2012, JAMA-J AM MED ASSOC, V308, P465, DOI 10.1001/jama.2012.8720; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; European Medicines Agency, ICHE6R1 EUR MED AG; Faller H, 2005, PSYCHOTHER PSYCH MED, V55, P200, DOI 10.1055/s-2004-834597; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedland KE, 2015, JAMA INTERN MED, V175, P1773, DOI 10.1001/jamainternmed.2015.5220; Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508; Gelbrich G, 2014, EUR J HEART FAIL, V16, P1133, DOI 10.1002/ejhf.150; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Guder G, 2015, EUR J HEART FAIL, V17, P442, DOI 10.1002/ejhf.252; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Hawley CJ, 2002, J AFFECT DISORDERS, V72, P177, DOI 10.1016/S0165-0327(01)00451-7; Herrmann N, 1998, STROKE, V29, P618, DOI 10.1161/01.STR.29.3.618; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Huffman JC, 2014, JAMA INTERN MED, V174, P927, DOI 10.1001/jamainternmed.2014.739; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Kramer DG, 2010, J AM COLL CARDIOL, V56, P392, DOI 10.1016/j.jacc.2010.05.011; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367; Mastenbroek MH, 2014, EUR J HEART FAIL, V16, P384, DOI 10.1002/ejhf.55; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moraska AR, 2013, CIRC-HEART FAIL, V6, P387, DOI 10.1161/CIRCHEARTFAILURE.112.000118; O'Connor CM, 2010, J AM COLL CARDIOL, V56, P692, DOI 10.1016/j.jacc.2010.03.068; Oremus M, 2014, HEART FAIL REV, V19, P471, DOI 10.1007/s10741-014-9439-6; Piepenburg SM, 2015, CIRC-HEART FAIL, V8, P464, DOI 10.1161/CIRCHEARTFAILURE.114.001488; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; World Medical Association, 2002, J Postgrad Med, V48, P206	40	166	174	4	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2683	2693		10.1001/jama.2016.7635	http://dx.doi.org/10.1001/jama.2016.7635			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27367876	Bronze			2022-12-28	WOS:000378709300019
J	Stott, P				Stott, Peter			How climate change affects extreme weather events Research can increasingly determine the contribution of climate change to extreme events such as droughts	SCIENCE			English	Editorial Material							ATTRIBUTION		[Stott, Peter] Met Off Hadley Ctr, Fitzroy Rd, Exeter EX1 3PB, Devon, England; [Stott, Peter] Univ Exeter, Dept Math, Exeter EX4 4QF, Devon, England	Met Office - UK; Hadley Centre; University of Exeter	Stott, P (corresponding author), Met Off Hadley Ctr, Fitzroy Rd, Exeter EX1 3PB, Devon, England.; Stott, P (corresponding author), Univ Exeter, Dept Math, Exeter EX4 4QF, Devon, England.	peter.stott@metoffice.gov.uk	Stott, Peter/N-1228-2016	Stott, Peter/0000-0003-4853-7686				Bellprat O, 2016, GEOPHYS RES LETT, V43, P2158, DOI 10.1002/2015GL067189; Bindoff NL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P867; Herring SC, 2015, B AM METEOROL SOC, V96, DOI 10.1175/BAMS-EEE_2014_ch1.1; Lott FC, 2016, J CLIMATE, V29, P4565, DOI 10.1175/JCLI-D-15-0566.1; Natl. Acad. Sci. Eng. Med, 2016, ATTRIBUTION EXTREME; Otto FEL, 2016, NAT CLIM CHANGE, V6, P340; Peterson TC, 2012, B AM METEOROL SOC, V93, P1041, DOI 10.1175/BAMS-D-12-00021.1; Schaller N, 2014, B AM METEOROL SOC, V95, pS69; Shepherd TG, 2016, CURR CLIM CHANGE REP, V2, P28, DOI 10.1007/s40641-016-0033-y; Sippel S, 2015, WEATHER CLIM SOC, V7, P224, DOI 10.1175/WCAS-D-14-00045.1; Solow AR, 2015, SCIENCE, V349, P1444, DOI 10.1126/science.aad2132; Stott PA, 2016, WIRES CLIM CHANGE, V7, P23, DOI 10.1002/wcc.380; Sun Y, 2014, NAT CLIM CHANGE, V4, P1082, DOI 10.1038/NCLIMATE2410; Trenberth KE, 2015, NAT CLIM CHANGE, V5, P725, DOI 10.1038/NCLIMATE2657; Zhang XB, 2013, GEOPHYS RES LETT, V40, P5252, DOI 10.1002/grl.51010	15	279	292	82	403	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1517	1518		10.1126/science.aaf7271	http://dx.doi.org/10.1126/science.aaf7271			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339968				2022-12-28	WOS:000378346500019
J	Johnson, P; Federico, M; Kirkwood, A; Fossa, A; Berkahn, L; Carella, A; d'Amore, F; Enblad, G; Franceschetto, A; Fulham, M; Luminari, S; O'Doherty, M; Patrick, P; Roberts, T; Sidra, G; Stevens, L; Smith, P; Trotman, J; Viney, Z; Radford, J; Barrington, S				Johnson, Peter; Federico, Massimo; Kirkwood, Amy; Fossa, Alexander; Berkahn, Leanne; Carella, Angelo; d'Amore, Francesco; Enblad, Gunilla; Franceschetto, Antonella; Fulham, Michael; Luminari, Stefano; O'Doherty, Michael; Patrick, Pip; Roberts, Thomas; Sidra, Gamal; Stevens, Lindsey; Smith, Paul; Trotman, Judith; Viney, Zaid; Radford, John; Barrington, Sally			Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NON-INFERIORITY TRIAL; OPEN-LABEL; ABVD; CHEMOTHERAPY; DISEASE; BLEOMYCIN; SURVIVAL; HYBRID; MOPP; TOMOGRAPHY	BACKGROUND We tested interim positron-emission tomography-computed tomography (PET-CT) as a measure of early response to chemotherapy in order to guide treatment for patients with advanced Hodgkin's lymphoma. METHODS Patients with newly diagnosed advanced classic Hodgkin's lymphoma underwent a baseline PET-CT scan, received two cycles of ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy, and then underwent an interim PET-CT scan. Images were centrally reviewed with the use of a 5-point scale for PET findings. Patients with negative PET findings after two cycles were randomly assigned to continue ABVD (ABVD group) or omit bleomycin (AVD group) in cycles 3 through 6. Those with positive PET findings after two cycles received BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone). Radiotherapy was not recommended for patients with negative findings on interim scans. The primary outcome was the difference in the 3-year progression-free survival rate between randomized groups, a noninferiority comparison to exclude a difference of 5 or more percentage points. RESULTS A total of 1214 patients were registered; 937 of the 1119 patients (83.7%) who underwent an interim PET-CT scan according to protocol had negative findings. With a median follow-up of 41 months, the 3-year progression-free survival rate and overall survival rate in the ABVD group were 85.7% (95% confidence interval [CI], 82.1 to 88.6) and 97.2% (95% CI, 95.1 to 98.4), respectively; the corresponding rates in the AVD group were 84.4% (95% CI, 80.7 to 87.5) and 97.6% (95% CI, 95.6 to 98.7). The absolute difference in the 3-year progression-free survival rate (ABVD minus AVD) was 1.6 percentage points (95% CI, -3.2 to 5.3). Respiratory adverse events were more severe in the ABVD group than in the AVD group. BEACOPP was given to the 172 patients with positive findings on the interim scan, and 74.4% had negative findings on a third PET-CT scan; the 3-year progression-free survival rate was 67.5% and the overall survival rate 87.8%. A total of 62 patients died during the trial (24 from Hodgkin's lymphoma), for a 3-year progression-free survival rate of 82.6% and an overall survival rate of 95.8%. CONCLUSIONS Although the results fall just short of the specified noninferiority margin, the omission of bleomycin from the ABVD regimen after negative findings on interim PET resulted in a lower incidence of pulmonary toxic effects than with continued ABVD but not significantly lower efficacy.	[Johnson, Peter] Univ Southampton, Canc Res UK Ctr, Southampton SO16 6YD, Hants, England; [Kirkwood, Amy; Patrick, Pip; Roberts, Thomas; Stevens, Lindsey; Smith, Paul] Canc Res UK, London, England; [Kirkwood, Amy; Patrick, Pip; Roberts, Thomas; Stevens, Lindsey; Smith, Paul] UCL, Canc Trials Ctr, London, England; [O'Doherty, Michael; Viney, Zaid; Barrington, Sally] Kings Coll London, Kings Hlth Partners, St Thomas Hosp, PET Imaging Ctr, London WC2R 2LS, England; [Sidra, Gamal] Lincoln Cty Hosp, Dept Haematol, Lincoln, England; [Radford, John] Christie Hosp, Dept Med Oncol, Manchester, Lancs, England; [Federico, Massimo; Franceschetto, Antonella; Luminari, Stefano] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy; [Carella, Angelo] San Martino Univ Hosp, Dept Hematol, Genoa, Italy; [Luminari, Stefano] IRCCS, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; [Fossa, Alexander] Oslo Univ Hosp, Dept Med Oncol, Oslo, Norway; [Berkahn, Leanne] Auckland City Hosp, Dept Haematol, Auckland, New Zealand; [d'Amore, Francesco] Aarhus Univ Hosp, Dept Hematol, DK-8000 Aarhus, Denmark; [Enblad, Gunilla] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Fulham, Michael] Royal Prince Alfred Hosp, Dept Mol Imaging, Sydney, NSW, Australia; [Trotman, Judith] Univ Sydney, Concord Repatriat Gen Hosp, Sydney, NSW 2006, Australia	Cancer Research UK; University of Southampton; Cancer Research UK; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Christie NHS Foundation Trust; Christie Hospital; Universita di Modena e Reggio Emilia; University of Genoa; IRCCS AOU San Martino IST; IRCCS Arcispedale S. Maria Nuova; University of Oslo; Auckland City Hospital; Aarhus University; Uppsala University; University of Sydney; Concord Repatriation General Hospital; University of Sydney	Johnson, P (corresponding author), Univ Southampton, Southampton Gen Hosp, Canc Res UK Ctr, Somers Canc Res Bldg, Southampton SO16 6YD, Hants, England.	johnsonp@soton.ac.uk	Luminari, Stefano/J-5916-2014; Johnson, Peter/O-3529-2019; Federico, Massimo/A-6801-2012; Radford, John A/N-1331-2015; Johnson, Peter/L-2403-2018; Federico, Massimo/J-5984-2014	Luminari, Stefano/0000-0001-8446-2285; Johnson, Peter/0000-0003-2306-4974; Federico, Massimo/0000-0002-9889-3796; Radford, John A/0000-0001-7898-2786; Johnson, Peter/0000-0003-2306-4974; Federico, Massimo/0000-0002-5074-3262; Barrington, Sally/0000-0002-2516-5288; Fulham, Michael/0000-0003-0602-6319; Trotman, Judith/0000-0001-8009-4593	Cancer Research UK; Cancer Research UK [9619, 16463] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	Funded by Cancer Research UK and Others; ClinicalTrials.gov number, NCT00678327.	Barrington SF, 2011, ANN ONCOL, V22, P739, DOI 10.1093/annonc/mdq428; Barrington SF, 2014, J CLIN ONCOL, V32, P3048, DOI 10.1200/JCO.2013.53.5229; Barrington SF, 2010, EUR J NUCL MED MOL I, V37, P1824, DOI 10.1007/s00259-010-1490-5; Behringer K, 2015, LANCET, V385, P1418, DOI 10.1016/S0140-6736(14)61469-0; Behringer K, 2013, J CLIN ONCOL, V31, P231, DOI 10.1200/JCO.2012.44.3721; Boleti E, 2007, ANN ONCOL, V18, P376, DOI 10.1093/annonc/mdl397; BONADONNA G, 1975, CANCER, V36, P252, DOI 10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Duggan DB, 2003, J CLIN ONCOL, V21, P607, DOI 10.1200/JCO.2003.12.086; Eichenauer DA, 2014, BLOOD, V123, P1658, DOI 10.1182/blood-2013-07-512657; Engert A, 2012, LANCET, V379, P1791, DOI 10.1016/S0140-6736(11)61940-5; Engert A, 2009, J CLIN ONCOL, V27, P4548, DOI 10.1200/JCO.2008.19.8820; Evens AM, 2007, BRIT J HAEMATOL, V137, P545, DOI 10.1111/j.1365-2141.2007.06598.x; Gallamini A., 2015, HEMATOL ONCOL, V33, P163; Gallamini A, 2007, J CLIN ONCOL, V25, P3746, DOI 10.1200/JCO.2007.11.6525; Gordon LI, 2013, J CLIN ONCOL, V31, P684, DOI 10.1200/JCO.2012.43.4803; Hoskin PJ, 2009, J CLIN ONCOL, V27, P5390, DOI 10.1200/JCO.2009.23.3239; Hutchings M, 2014, J CLIN ONCOL, V32, P2705, DOI 10.1200/JCO.2013.53.2838; Johnson PWM, 2005, J CLIN ONCOL, V23, P9208, DOI 10.1200/JCO.2005.03.2151; Martin WG, 2005, J CLIN ONCOL, V23, P7614, DOI 10.1200/JCO.2005.02.7243; Mounier N, 2014, ANN ONCOL, V25, P1622, DOI 10.1093/annonc/mdu189; Press OW, 2016, J CLIN ONCOL; Scott DW, 2013, J CLIN ONCOL, V31, P692, DOI 10.1200/JCO.2012.43.4589; Skoetz N, 2013, LANCET ONCOL, V14, P943, DOI 10.1016/S1470-2045(13)70341-3; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Viviani S, 1996, J CLIN ONCOL, V14, P1421, DOI 10.1200/JCO.1996.14.5.1421; Viviani S, 2011, NEW ENGL J MED, V365, P203, DOI 10.1056/NEJMoa1100340	27	454	464	4	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2419	2429		10.1056/NEJMoa1510093	http://dx.doi.org/10.1056/NEJMoa1510093			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1TG	27332902	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000378271700006
J	Ainsworth, SB; McGuire, W				Ainsworth, Sean B.; McGuire, William			Peripherally Inserted Central Catheters vs Peripheral Cannulas for Delivering Parenteral Nutrition in Neonates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								CLINICAL QUESTION Is parenteral nutrition via peripherally inserted central catheters ( PICCs) associated with better delivery of nutrition and growth and fewer adverse events compared with short peripheral cannulas in neonates? BOTTOM LINE Compared with short peripheral cannulas, parenteral nutrition via PICCs is associated with better nutrient delivery and lower rates of subsequent catheters or cannulas placed and is not associated with increased rates of invasive infection.	[Ainsworth, Sean B.] Victoria Hosp, Natl Hlth Serv Fife, Neonatal Serv, Kirkcaldy, Scotland; [McGuire, William] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [McGuire, William] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England	University of Hull; University of York - UK; University of York - UK	Ainsworth, SB (corresponding author), Victoria Hosp, Neonatal Unit, Phase 3,Hayfield Rd, Kirkcaldy KY2 5AH, Fife, Scotland.	sean.ainsworth@nhs.net		McGuire, William/0000-0001-8572-3467	National Institute for Health Research [13/89/12] Funding Source: researchfish; Department of Health [13/89/12] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Ainsworth S, 2015, COCHRANE DB SYST REV, V10; Balain M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011078.pub2; Beardsall K, 2003, ARCH DIS CHILD-FETAL, V88, P292; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Trotter C W, 1996, Neonatal Netw, V15, P15; Vasudevan C, 2011, COCHRANE DB SYST REV, V8	6	12	13	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2612	2613		10.1001/jama.2016.7020	http://dx.doi.org/10.1001/jama.2016.7020			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27327804	Green Accepted			2022-12-28	WOS:000378306700024
J	Clevers, H				Clevers, Hans			Modeling Development and Disease with Organoids	CELL			English	Review							PLURIPOTENT STEM-CELLS; IN-VITRO EXPANSION; DUCTAL PANCREATIC-CANCER; EPITHELIAL-CELLS; CYSTIC-FIBROSIS; SMALL-INTESTINE; DIRECTED DIFFERENTIATION; ALVEOLAR CELLS; MAMMARY-GLAND; SINGLE LGR5	Recent advances in 3D culture technology allow embryonic and adult mammalian stem cells to exhibit their remarkable self-organizing properties, and the resulting organoids reflect key structural and functional properties of organs such as kidney, lung, gut, brain and retina. Organoid technology can therefore be used to model human organ development and various human pathologies 'n a dish.'' Additionally, patient-derived organoids hold promise to predict drug response in a personalized fashion. Organoids open up new avenues for regenerative medicine and, in combination with editing technology, for gene therapy. The many potential applications of this technology are only beginning to be explored.	[Clevers, Hans] Royal Netherlands Acad Arts & Sci, Princess Maxima Ctr, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Princess Maxima Ctr, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.; Clevers, H (corresponding author), Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu						Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Chen KG, 2014, CELL STEM CELL, V14, P13, DOI 10.1016/j.stem.2013.12.005; Cherry ABC, 2012, CELL, V148, P1110, DOI 10.1016/j.cell.2012.02.031; Chua CW, 2014, NAT CELL BIOL, V16, P951, DOI 10.1038/ncb3047; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Clevers H, 2015, SCIENCE, V350, P1319, DOI 10.1126/science.aad7016; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Dekkers F. e. a., 2016, SCI TRANSL IN PRESS; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; DeWard AD, 2014, CELL REP, V9, P701, DOI 10.1016/j.celrep.2014.09.027; Dorrell C, 2014, STEM CELL RES, V13, P275, DOI 10.1016/j.scr.2014.07.006; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Fukuda M, 2014, GENE DEV, V28, P1752, DOI 10.1101/gad.245233.114; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jain R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7727; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Kessler M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9989; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kurmann AA, 2015, CELL STEM CELL, V17, P527, DOI 10.1016/j.stem.2015.09.004; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; LINDBERG K, 1993, INVEST OPHTH VIS SCI, V34, P2672; Linnemann JR, 2015, DEVELOPMENT, V142, P3239, DOI 10.1242/dev.123554; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Ma RS, 2015, THYROID, V25, P455, DOI 10.1089/thy.2014.0537; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Maimets M, 2016, STEM CELL REP, V6, P150, DOI 10.1016/j.stemcr.2015.11.009; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051; Muguruma K, 2010, NAT NEUROSCI, V13, P1171, DOI 10.1038/nn.2638; Nadauld LD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0428-9; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nanduri LSY, 2014, STEM CELL REP, V3, P957, DOI 10.1016/j.stemcr.2014.09.015; Nantasanti S, 2015, STEM CELL REP, V5, P895, DOI 10.1016/j.stemcr.2015.09.002; OCONNOR NE, 1981, LANCET, V1, P75; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sinagoga KL, 2015, EMBO J, V34, P1149, DOI 10.15252/embj.201490686; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Tadokoro T, 2014, P NATL ACAD SCI USA, V111, pE3641, DOI 10.1073/pnas.1409781111; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Wang X, 2015, NATURE, V522, P173, DOI 10.1038/nature14484; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	91	1310	1361	84	630	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1586	1597		10.1016/j.cell.2016.05.082	http://dx.doi.org/10.1016/j.cell.2016.05.082			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315476	Bronze			2022-12-28	WOS:000378062000011
J	Irianto, J; Pfeifer, CR; Xia, YT; Discher, DE				Irianto, Jerome; Pfeifer, Charlotte R.; Xia, Yuntao; Discher, Dennis E.			SnapShot: Mechanosensing Matrix	CELL			English	Editorial Material							STIFFNESS		[Irianto, Jerome; Pfeifer, Charlotte R.; Xia, Yuntao; Discher, Dennis E.] Univ Penn, Mol & Cell Biophys Lab, Philadelphia, PA 19104 USA	University of Pennsylvania	Irianto, J (corresponding author), Univ Penn, Mol & Cell Biophys Lab, Philadelphia, PA 19104 USA.		Xia, Yuntao/S-3936-2018	Xia, Yuntao/0000-0002-3011-5859; Irianto, Jerome/0000-0002-4804-7225	NCI NIH HHS [U54 CA193417] Funding Source: Medline; NHLBI NIH HHS [R21 HL128187, R01 HL124106] Funding Source: Medline; NIDDK NIH HHS [P01 DK032094] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA193417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124106, R21HL128187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Majkut S, 2013, CURR BIOL, V23, P2434, DOI 10.1016/j.cub.2013.10.057; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104	10	38	38	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1820	+		10.1016/j.cell.2016.06.002	http://dx.doi.org/10.1016/j.cell.2016.06.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315485	Bronze, Green Accepted			2022-12-28	WOS:000378062000030
J	Gamble, CE; Brule, CE; Dean, KM; Fields, S; Grayhack, EJ				Gamble, Caitlin E.; Brule, Christina E.; Dean, Kimberly M.; Fields, Stanley; Grayhack, Elizabeth J.			Adjacent Codons Act in Concert to Modulate Translation Efficiency in Yeast	CELL			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; QUALITY-CONTROL; IN-VIVO; PROTEIN TRANSLATION; GENE-EXPRESSION; BIAS; RIBOSOME; ELONGATION; GENOME	Translation elongation efficiency is largely thought of as the sum of decoding efficiencies for individual codons. Here, we find that adjacent codon pairs modulate translation efficiency. Deploying an approach in Saccharomyces cerevisiae that scored the expression of over 35,000 GFP variants in which three adjacent codons were randomized, we have identified 17 pairs of adjacent codons associated with reduced expression. For many pairs, codon order is obligatory for inhibition, implying a more complex interaction than a simple additive effect. Inhibition mediated by adjacent codons occurs during translation itself as GFP expression is restored by increased tRNA levels or by non-native tRNAs with exact-matching anticodons. Inhibition operates in endogenous genes, based on analysis of ribosome profiling data. Our findings suggest translation efficiency is modulated by an interplay between tRNAs at adjacent sites in the ribosome and that this concerted effect needs to be considered in predicting the functional consequences of codon choice.	[Gamble, Caitlin E.; Fields, Stanley] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Gamble, Caitlin E.; Fields, Stanley] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Gamble, Caitlin E.] Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Brule, Christina E.; Dean, Kimberly M.; Grayhack, Elizabeth J.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Brule, Christina E.; Dean, Kimberly M.; Grayhack, Elizabeth J.] Univ Rochester, Ctr RNA Biol, Rochester, NY 14642 USA; [Fields, Stanley] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Dean, Kimberly M.] BD Biosci, 2350 Qume Dr, San Jose, CA 95131 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Rochester; University of Rochester; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fields, S (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Fields, S (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.; Grayhack, EJ (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.; Grayhack, EJ (corresponding author), Univ Rochester, Ctr RNA Biol, Rochester, NY 14642 USA.; Fields, S (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	fields@uw.edu; elizabeth_grayhack@urmc.rochester.edu	Grayhack, Elizabeth J/G-4386-2012	Grayhack, Elizabeth J/0000-0003-2400-5490	NSF [MCB-1329545]; NIH [1P41 GM103533]; NIH T32 Training Grant [GM068411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, P41GM103533] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1329545] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Eric Phizicky, Andrew Wolf, Scott Butler, Gloria Culver, Adam Geballe, David Mathews, David Morris, and Yi-Tao Yu for discussions and comments on the manuscript, Jeffrey Hussman for assistance with ribosome profiling data, Josh Hatfield, Shannon Schmitt, Blake Bentley, and Erin Eidschun for assistance with experiments, XiaoJu Zhang and David Mathews for initial help analyzing codon use in the yeast genome, the URMC Flow Cytometry Resource and NCCR (1S10RR0292299-01) for technical support. This work was supported by an NSF grant (MCB-1329545) (to E.J.G.) and an NIH grant (1P41 GM103533) (to S.F.). C.E.B. was also supported by an NIH T32 Training Grant (GM068411), and C.E.G. was supported by an NSF Fellowship. S.F. is an investigator of the Howard Hughes Medical Institute.	Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; BEGGS JD, 1978, NATURE, V275, P104, DOI 10.1038/275104a0; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Chevance FFV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004392; Chu D, 2014, EMBO J, V33, P21, DOI 10.1002/embj.201385651; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Dean KM, 2012, RNA, V18, P2335, DOI 10.1261/rna.035907.112; Demeshkina N, 2010, CURR OPIN STRUC BIOL, V20, P325, DOI 10.1016/j.sbi.2010.03.002; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; Fedorov A, 2002, NUCLEIC ACIDS RES, V30, P1192, DOI 10.1093/nar/30.5.1192; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Hussmann JA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005732; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lareau LF, 2014, ELIFE, V3, DOI 10.7554/eLife.01257; Letzring DP, 2013, RNA, V19, P1208, DOI 10.1261/rna.039446.113; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Moura G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r28; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; PEDERSEN S, 1984, EMBO J, V3, P2895, DOI 10.1002/j.1460-2075.1984.tb02227.x; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Stadler M, 2011, RNA, V17, P2063, DOI 10.1261/rna.02890211; Subramaniam AR, 2014, CELL, V159, P1200, DOI 10.1016/j.cell.2014.10.043; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Weatheritt RJ, 2013, SCIENCE, V342, P1325, DOI 10.1126/science.1248425; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Wolf AS, 2015, RNA, V21, P935, DOI 10.1261/rna.049080.114; Xu Y, 2013, NATURE, V495, P116, DOI 10.1038/nature11942; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	52	111	113	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					679	690		10.1016/j.cell.2016.05.070	http://dx.doi.org/10.1016/j.cell.2016.05.070			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27374328	Green Accepted, Bronze			2022-12-28	WOS:000380546500018
J	Denny, SK; Yang, D; Chuang, CH; Brady, JJ; Lim, JS; Gruner, BM; Chiou, SH; Schep, AN; Baral, J; Hamard, C; Antoine, M; Wislez, M; Kong, CS; Connolly, AJ; Park, KS; Sage, J; Greenleaf, WJ; Winslow, MM				Denny, Sarah K.; Yang, Dian; Chuang, Chen-Hua; Brady, Jennifer J.; Lim, Jing Shan; Gruner, Barbara M.; Chiou, Shin-Heng; Schep, Alicia N.; Baral, Jessika; Hamard, Cecile; Antoine, Martine; Wislez, Marie; Kong, Christina S.; Connolly, Andrew J.; Park, Kwon-Sik; Sage, Julien; Greenleaf, William J.; Winslow, Monte M.			Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility	CELL			English	Article							CELL LUNG-CANCER; TRANSCRIPTION FACTORS; NUCLEAR FACTOR-1; TUMOR-CELLS; GENE; DYNAMICS; ACTIVATION; MIGRATION; ONCOGENE; SURVIVAL	Metastases are the main cause of cancer deaths, but the mechanisms underlying metastatic progression remain poorly understood. We isolated pure populations of cancer cells from primary tumors and metastases from a genetically engineered mouse model of human small cell lung cancer ( SCLC) to investigate the mechanisms that drive the metastatic spread of this lethal cancer. Genome-wide characterization of chromatin accessibility revealed the opening of large numbers of distal regulatory elements across the genome during metastatic progression. These changes correlate with copy number amplification of the Nfib locus, and differentially accessible sites were highly enriched for Nfib transcription factor binding sites. Nfib is necessary and sufficient to increase chromatin accessibility at a large subset of the intergenic regions. Nfib promotes pro-metastatic neuronal gene expression programs and drives the metastatic ability of SCLC cells. The identification of widespread chromatin changes during SCLC progression reveals an unexpected global reprogramming during metastatic progression.	[Denny, Sarah K.; Greenleaf, William J.] Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA; [Yang, Dian; Lim, Jing Shan; Sage, Julien; Winslow, Monte M.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Chuang, Chen-Hua; Brady, Jennifer J.; Gruner, Barbara M.; Chiou, Shin-Heng; Schep, Alicia N.; Baral, Jessika; Sage, Julien; Greenleaf, William J.; Winslow, Monte M.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Kong, Christina S.; Connolly, Andrew J.; Winslow, Monte M.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Sage, Julien; Winslow, Monte M.] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Sage, Julien] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Hamard, Cecile; Antoine, Martine; Wislez, Marie] Univ Paris 06, Hop Tenon, APHP, Serv Pneumol, F-75020 Paris, France; [Park, Kwon-Sik] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Virginia; Stanford University	Greenleaf, WJ (corresponding author), Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA.; Winslow, MM (corresponding author), Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA.; Greenleaf, WJ; Winslow, MM (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Winslow, MM (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Winslow, MM (corresponding author), Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA.; Greenleaf, WJ (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	wjg@stanford.edu; mwinslow@stanford.edu	Grüner, Barbara M/T-1298-2018; Grüner, Barbara/AAB-9246-2020	Grüner, Barbara M/0000-0003-0974-4826; Grüner, Barbara/0000-0003-0974-4826; Park, Kwon-Sik/0000-0003-3346-9086; Denny, Sarah/0000-0001-8753-6040; wislez, marie/0000-0001-7518-7859	Stanford Cancer Institute Cancer Biology Seed Grant; Stanford Cancer Institute [NIH P30-CA124435]; NIH [P50HG007735, R01CA206540, F32-CA189659]; Baxter Foundation Faculty Scholar Grant; Rita Allen Foundation; Human Frontier Science Program; Stanford Biophysics training grant [T32 GM008294]; NSF GRFP; Stanford Graduate Fellowship; TRDRP Dissertation Award [24DT-0001]; American Lung Association Fellowship; Hope Funds for Cancer Research [HFCR-15-06-07]; NATIONAL CANCER INSTITUTE [P30CA124435, R01CA206540, F32CA189659] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790, T32GM008294] Funding Source: NIH RePORTER	Stanford Cancer Institute Cancer Biology Seed Grant; Stanford Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter Foundation Faculty Scholar Grant; Rita Allen Foundation; Human Frontier Science Program(Human Frontier Science Program); Stanford Biophysics training grant; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Stanford Graduate Fellowship(Stanford University); TRDRP Dissertation Award; American Lung Association Fellowship; Hope Funds for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Pauline Chu for technical assistance, Sean Dolan and Alexandra Orantes for administrative support, David Feldser, Nadine Jahchan, Youcef Ouadah, Mark Krasnow, Gerald Crabtree, Namita Bisaria, and members of the M.M.W., W.J.G., and J.S. laboratories for helpful comments. We thank the Stanford Shared FACS Facility. This work was supported by a Stanford Cancer Institute Cancer Biology Seed Grant (to M.M.W., W.J.G., and J.S.) and, in part, by a Stanford Cancer Institute support grant (NIH P30-CA124435), NIH grants (P50HG007735 and R01CA206540), a Baxter Foundation Faculty Scholar Grant, the Rita Allen Foundation, and the Human Frontier Science Program. S.K.D. was supported by a Stanford Biophysics training grant (T32 GM008294) and by the NSF GRFP. D.Y. was supported by a Stanford Graduate Fellowship and by a TRDRP Dissertation Award (24DT-0001). C.-H.C. was funded by an American Lung Association Fellowship. J.J.B. was supported by an NIH grant (F32-CA189659). B.M.G. was supported by a fellowship from the Hope Funds for Cancer Research (HFCR-15-06-07). J.S. is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases. W.J.G. is the scientific co-founder of Epinomics.	Alevizopoulos A, 1995, GENE DEV, V9, P3051, DOI 10.1101/gad.9.24.3051; Augustyn A, 2014, P NATL ACAD SCI USA, V111, P14788, DOI 10.1073/pnas.1410419111; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Betancourt J, 2014, J COMP NEUROL, V522, P6, DOI 10.1002/cne.23373; Blomquist P, 1996, J BIOL CHEM, V271, P153, DOI 10.1074/jbc.271.1.153; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Chen J, 2012, ADV CANCER RES, V114, P1, DOI 10.1016/B978-0-12-386503-8.00001-6; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Foley K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5823; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Grabowska MM, 2014, MOL ENDOCRINOL, V28, P949, DOI 10.1210/me.2013-1213; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Harris L, 2015, DEV DYNAM, V244, P227, DOI 10.1002/dvdy.24182; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Kalemkerian GP, 2013, J NATL COMPR CANC NE, V11, P78, DOI 10.6004/jnccn.2013.0011; Ko SY, 2014, CANCER METAST REV, V33, P101, DOI 10.1007/s10555-013-9459-z; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakazawa K, 2012, ONCOL LETT, V4, P617, DOI 10.3892/ol.2012.792; Osborne JK, 2013, P NATL ACAD SCI USA, V110, P6524, DOI 10.1073/pnas.1303932110; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Sung MH, 2016, NAT METHODS, V13, P222, DOI 10.1038/nmeth.3766; Sung MH, 2014, MOL CELL, V56, P275, DOI 10.1016/j.molcel.2014.08.016; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zaret KS, 2016, CURR OPIN GENET DEV, V37, P76, DOI 10.1016/j.gde.2015.12.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou WJ, 2011, CELL RES, V21, P609, DOI 10.1038/cr.2011.17; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	49	206	211	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					328	342		10.1016/j.cell.2016.05.052	http://dx.doi.org/10.1016/j.cell.2016.05.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27374332	Green Accepted, Bronze			2022-12-28	WOS:000380255400012
J	Moll, PJW; Nair, NL; Helm, T; Potter, AC; Kimchi, I; Vishwanath, A; Analytis, JG				Moll, Philip J. W.; Nair, Nityan L.; Helm, Toni; Potter, Andrew C.; Kimchi, Itamar; Vishwanath, Ashvin; Analytis, James G.			Transport evidence for Fermi-arc-mediated chirality transfer in the Dirac semimetal Cd3As2	NATURE			English	Article							SURFACE-STATE; WEYL; OSCILLATIONS	The dispersion of charge carriers in a metal is distinctly different from that of free electrons owing to their interactions with the crystal lattice. These interactions may lead to quasiparticles mimicking the massless relativistic dynamics of high-energy particle physics(1-3), and they can twist the quantum phase of electrons into topologically non-trivial knots-producing protected surface states with anomalous electromagnetic properties(4-9). These effects intertwine in materials known as Weyl semimetals, and in their crystal-symmetry-protected analogues, Dirac semimetals(10). The latter show a linear electronic dispersion in three dimensions described by two copies of the Weyl equation (a theoretical description of massless relativistic fermions). At the surface of a crystal, the broken translational symmetry creates topological surface states, so-called Fermi arcs(11), which have no counterparts in high-energy physics or conventional condensed matter systems. Here we present Shubnikov-de Haas oscillations in focused-ion-beam-prepared microstructures of Cd3As2 that are consistent with the theoretically predicted 'Weyl orbits', a kind of cyclotron motion that weaves together Fermi-arc and chiral bulk states(12). In contrast to conventional cyclotron orbits, this motion is driven by the transfer of chirality from one Weyl node to another, rather than momentum transfer of the Lorentz force. Our observations provide evidence for direct access to the topological properties of charge in a transport experiment, a first step towards their potential application.	[Moll, Philip J. W.; Nair, Nityan L.; Helm, Toni; Potter, Andrew C.; Kimchi, Itamar; Vishwanath, Ashvin; Analytis, James G.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Moll, Philip J. W.; Nair, Nityan L.] Max Planck Inst Chem Phys Solids, Noethnitzer Str 40, D-01187 Dresden, Germany; [Analytis, James G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Max Planck Society; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Moll, PJW; Analytis, JG (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.; Moll, PJW (corresponding author), Max Planck Inst Chem Phys Solids, Noethnitzer Str 40, D-01187 Dresden, Germany.	philip.moll@cpfs.mpg.de; analytis@berkeley.edu	Vishwanath, Ashvin/AAO-6878-2020; McCoy, Tina/P-3402-2019; analytis, james/ABE-6100-2020; Helm, Toni/K-7515-2018; Potter, Andrew/AAM-1480-2020	analytis, james/0000-0002-7657-7688; Helm, Toni/0000-0002-0938-8537; Potter, Andrew/0000-0001-5048-1269	SCOPE-M centre for electron microscopy at ETH Zurich; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4307, GBMF4374]; Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the US Department of Energy [DE-AC02-05CH11231]; University of California, Berkeley; Quantum Materials FWP, US Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02- 05CH11231]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]	SCOPE-M centre for electron microscopy at ETH Zurich; Gordon and Betty Moore Foundation's EPiQS Initiative; Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the US Department of Energy(United States Department of Energy (DOE)); University of California, Berkeley(University of California System); Quantum Materials FWP, US Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE))	The FIB work was supported by the SCOPE-M centre for electron microscopy at ETH Zurich. We thank P Gasser, J. Reuteler and B. Batlogg for FIB support, and M. Bachmann for performing magnetoresistance measurements. A.C.P. was supported by the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF4307. We also thank S. Teat and K. Gagnon for their help in conducting X-ray diffraction measurements at the Advanced Light Source (ALS) beam line 11.3.1, and N. Tamura for micro-diffraction on beam line 12.3.2. N.T. and the ALS are supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the US Department of Energy under contract no. DE-AC02-05CH11231 at Lawrence Berkeley National Laboratory and the University of California, Berkeley. Transport experiments, material synthesis and FIB microstructuring were supported by the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF4374. Single-crystal X-ray refinements (T.H.) and theoretical support (A.V. and I.K.) were funded by the Quantum Materials FWP, US Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, under contract no. DE-AC02- 05CH11231. Work at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231.	ADLER SL, 1969, PHYS REV, V177, P2426, DOI 10.1103/PhysRev.177.2426; Ali MN, 2014, INORG CHEM, V53, P4062, DOI 10.1021/ic403163d; Analytis JG, 2010, NAT PHYS, V6, P960, DOI 10.1038/NPHYS1861; BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1; BELL JS, 1969, NUOVO CIMENTO A, V60, P47, DOI 10.1007/BF02823296; Borisenko S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.027603; DEJONG MJM, 1995, PHYS REV B, V51, P13389, DOI 10.1103/PhysRevB.51.13389; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Haldane F. D. M., 2014, PREPRINT; He LP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.246402; Jaroszynski J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.174523; Jeon S, 2014, NAT MATER, V13, P851, DOI 10.1038/nmat4023; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; Liang T, 2014, NAT MATER, V4, P3; Liu ZK, 2014, NAT MATER, V13, P677, DOI [10.1038/NMAT3990, 10.1038/nmat3990]; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; Moll PJW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7663; Moll PJW, 2014, NAT PHYS, V10, P644, DOI [10.1038/nphys3034, 10.1038/NPHYS3034]; Moll PJW, 2013, NAT MATER, V12, P134, DOI [10.1038/NMAT3489, 10.1038/nmat3489]; Moll PJW, 2010, NAT MATER, V9, P628, DOI [10.1038/NMAT2795, 10.1038/nmat2795]; Neupane M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4786; NIELSEN HB, 1983, PHYS LETT B, V130, P389, DOI 10.1016/0370-2693(83)91529-0; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Ooi S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.247002; Pan ZH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.257004; Park SR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.046805; Potter AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6161; ROSENBERG AJ, 1959, J APPL PHYS, V30, P1621, DOI 10.1063/1.1735019; Roushan P, 2009, NATURE, V460, P1106, DOI 10.1038/nature08308; Shoenberg D., 1984, MAGNETIC OSCILLATION; THORNTON TJ, 1989, PHYS REV LETT, V63, P2128, DOI 10.1103/PhysRevLett.63.2128; TOKUMOTO M, 1990, J PHYS SOC JPN, V59, P2324, DOI 10.1143/JPSJ.59.2324; Vafek O, 2014, ANNU REV CONDEN MA P, V5, P83, DOI 10.1146/annurev-conmatphys-031113-133841; WALLACE PR, 1979, PHYS STATUS SOLIDI B, V92, P49, DOI 10.1002/pssb.2220920106; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wang ZJ, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125427; Wang ZJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195320; Wray LA, 2011, NAT PHYS, V7, P32, DOI 10.1038/NPHYS1838; Yi HM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06106; Young SM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140405; Zhang T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266803; Ziegler JF, 2004, NUCL INSTRUM METH B, V219, P1027, DOI 10.1016/j.nimb.2004.01.208	43	238	239	11	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					266	+		10.1038/nature18276	http://dx.doi.org/10.1038/nature18276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27376477	Green Submitted			2022-12-28	WOS:000379912600053
J	Barlow, J; Lennox, GD; Ferreira, J; Berenguer, E; Lees, AC; Mac Nally, R; Thomson, JR; Ferraz, SFD; Louzada, J; Oliveira, VHF; Parry, L; Solar, RRD; Vieira, ICG; Aragao, LEOC; Begotti, RA; Braga, RF; Cardoso, TM; de Oliveira, RC; Souza, CM; Moura, NG; Nunes, SS; Siqueira, JV; Pardini, R; Silveira, JM; Vaz-de-Mello, FZ; Veiga, RCS; Venturieri, A; Gardner, TA				Barlow, Jos; Lennox, Gareth D.; Ferreira, Joice; Berenguer, Erika; Lees, Alexander C.; Mac Nally, Ralph; Thomson, James R.; de Barros Ferraz, Silvio Frosini; Louzada, Julio; Fonseca Oliveira, Victor Hugo; Parry, Luke; de Castro Solar, Ricardo Ribeiro; Vieira, Ima C. G.; Aragao, Luiz E. O. C.; Begotti, Rodrigo Anzolin; Braga, Rodrigo F.; Cardoso, Thiago Moreira; de Oliveira, Raimundo Cosme, Jr.; Souza, Carlos M., Jr.; Moura, Nargila G.; Nunes, Samia Serra; Siqueira, Joao Victor; Pardini, Renata; Silveira, Juliana M.; Vaz-de-Mello, Fernando Z.; Stulpen Veiga, Ruan Carlo; Venturieri, Adriano; Gardner, Toby A.			Anthropogenic disturbance in tropical forests can double biodiversity loss from deforestation	NATURE			English	Article							CONSERVATION; DEGRADATION; EXTINCTION; RESPONSES; RISK; FIRE	Concerted political attention has focused on reducing deforestation(1-3), and this remains the cornerstone of most biodiversity conservation strategies(4-6). However, maintaining forest cover may not reduce anthropogenic forest disturbances, which are rarely considered in conservation programmes(6). These disturbances occur both within forests, including selective logging and wildfires(7,8), and at the landscape level, through edge, area and isolation effects(9). Until now, the combined effect of anthropogenic disturbance on the conservation value of remnant primary forests has remained unknown, making it impossible to assess the relative importance of forest disturbance and forest loss. Here we address these knowledge gaps using a large data set of plants, birds and dung beetles (1,538, 460 and 156 species, respectively) sampled in 36 catchments in the Brazilian state of Para. Catchments retaining more than 69-80% forest cover lost more conservation value from disturbance than from forest loss. For example, a 20% loss of primary forest, the maximum level of deforestation allowed on Amazonian properties under Brazil's Forest Code(5), resulted in a 39-54% loss of conservation value: 96-171% more than expected without considering disturbance effects. We extrapolated the disturbance-mediated loss of conservation value throughout Para, which covers 25% of the Brazilian Amazon. Although disturbed forests retained considerable conservation value compared with deforested areas, the toll of disturbance outside Para's strictly protected areas is equivalent to the loss of 92,000-139,000 km(2) of primary forest. Even this lowest estimate is greater than the area deforested across the entire Brazilian Amazon between 2006 and 2015 (ref. 10). Species distribution models showed that both landscape and within-forest disturbances contributed to biodiversity loss, with the greatest negative effects on species of high conservation and functional value. These results demonstrate an urgent need for policy interventions that go beyond the maintenance of forest cover to safeguard the hyper-diversity of tropical forest ecosystems.	[Barlow, Jos; Lennox, Gareth D.; Berenguer, Erika; Louzada, Julio; Fonseca Oliveira, Victor Hugo; Parry, Luke; Silveira, Juliana M.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Barlow, Jos; Lees, Alexander C.; Vieira, Ima C. G.; Moura, Nargila G.] MCTI Museu Paraense Emilio Goeldi, CP 399, BR-66040170 Belem, Para, Brazil; [Barlow, Jos; Louzada, Julio; Fonseca Oliveira, Victor Hugo; Braga, Rodrigo F.; Silveira, Juliana M.] Univ Fed Lavras, Setor Ecologia Conservacao, BR-37200000 Lavras, MG, Brazil; [Ferreira, Joice; Cardoso, Thiago Moreira; de Oliveira, Raimundo Cosme, Jr.; Venturieri, Adriano] EMBRAPA Amazonia Oriental, BR-66095100 Belem, Para, Brazil; [Lees, Alexander C.; Moura, Nargila G.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; [Mac Nally, Ralph; Thomson, James R.] Univ Canberra, Inst Appl Ecol, Bruce, ACT 2617, Australia; [Thomson, James R.] Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, 123 Brown St, Heidelberg, Vic 3084, Australia; [de Barros Ferraz, Silvio Frosini; Begotti, Rodrigo Anzolin] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Esalq USP, Ave Padua Dias 11, BR-13418900 Piracicaba, SP, Brazil; [Parry, Luke] Univ Fed Para UFPA, NAEA, Av Perimetral 1, BR-66075750 Belem, Para, Brazil; [de Castro Solar, Ricardo Ribeiro] Univ Fed Vicosa, Dept Biol Geral, Av PH Rolfs S-N, BR-36570900 Vicosa, MG, Brazil; [Aragao, Luiz E. O. C.] Natl Inst Space Res INPE, Remote Sensing Div, Trop Ecosyst & Environm Sci Grp TREES, Ave Astronautas,1-758 Jd Granja, BR-12227010 Sao Jose Dos Campos, SP, Brazil; [Aragao, Luiz E. O. C.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4RJ, Devon, England; [Souza, Carlos M., Jr.; Nunes, Samia Serra; Siqueira, Joao Victor] IMAZON, Rua Dom Romualdo Seixas 1698, BR-66055200 Belem, Para, Brazil; [Pardini, Renata] Univ Sao Paulo, Inst Biociencias, Rua Matao,Travessa 14,101, BR-05508090 Sao Paulo, Brazil; [Vaz-de-Mello, Fernando Z.] Univ Fed Mato Grosso, Inst Biociencias, Dept Biol & Zool, Av Fernando Correa da Costa 2367, BR-78060900 Cuiaba, MT, Brazil; [Stulpen Veiga, Ruan Carlo] ISASM, Estrada Ribeirao das Voltas S-N, BR-28616010 Lumiar, Nova Friburgo, Brazil; [Gardner, Toby A.] Stockholm Environm Inst, Linnegatan 87D,Box 24218, S-10451 Stockholm, Sweden; [Gardner, Toby A.] Int Inst Sustainabil, Estrada Dona Castorina 124, BR-22460320 Rio De Janeiro, Brazil	Lancaster University; Museu Paraense Emilio Goeldi; Universidade Federal de Lavras; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Cornell University; University of Canberra; Arthur Rylah Institute for Environmental Research (ARI); Universidade de Sao Paulo; Universidade Federal do Para; Universidade Federal de Vicosa; University of Exeter; Universidade de Sao Paulo; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul; Stockholm Environment Institute	Barlow, J (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England.; Barlow, J (corresponding author), MCTI Museu Paraense Emilio Goeldi, CP 399, BR-66040170 Belem, Para, Brazil.; Barlow, J (corresponding author), Univ Fed Lavras, Setor Ecologia Conservacao, BR-37200000 Lavras, MG, Brazil.	josbarlow@gmail.com	Souza, CARLOS/AAK-8207-2021; Parry, Luke/ABD-4194-2021; Barlow, Jos/HGE-9486-2022; de Castro Solar, Ricardo Ribeiro/F-2043-2010; Pardini, Renata/C-4095-2012; Oliveira, Victor/C-2719-2015; Thomson, Jim/W-2950-2019; Ferraz, Silvio FB/C-8851-2012; Barlow, Jos/E-7861-2014; Fonseca Oliveira, Victor Hugo/ABE-9099-2021; Louzada, Julio/F-1265-2010; Lees, Alexander Charles/S-2443-2019; Vieira, Ima C.G./H-6897-2012; Vaz-de-Mello, Fernando Z/A-1023-2009; Begotti, Rodrigo Anzolin/Y-9269-2019; aragao, luiz eoc/G-8387-2012	Souza, CARLOS/0000-0002-0205-6134; Parry, Luke/0000-0003-0330-9516; de Castro Solar, Ricardo Ribeiro/0000-0001-5627-4017; Pardini, Renata/0000-0002-3769-8401; Oliveira, Victor/0000-0002-0553-0268; Ferraz, Silvio FB/0000-0003-1808-5420; Fonseca Oliveira, Victor Hugo/0000-0002-0553-0268; Louzada, Julio/0000-0002-1481-3112; Lees, Alexander Charles/0000-0001-7603-9081; Vieira, Ima C.G./0000-0003-1233-318X; Vaz-de-Mello, Fernando Z/0000-0001-9697-320X; Begotti, Rodrigo Anzolin/0000-0001-5363-8743; aragao, luiz eoc/0000-0002-4134-6708; Mac Nally, Ralph/0000-0002-4473-1636; Nunes, Samia/0000-0002-5460-3312	Brazil (CNPq) [574008/2008-0, 458022/2013-6, 400640/2012-0]; Brazil (Embrapa) [SEG:02.08.06.005.00]; Brazil (Nature Conservancy - Brasil); Brazil (CAPES); UK (Darwin Initiative) [17-023, NE/F01614X/1, NE/G000816/1, NE/F015356/2, NE/l018123/1, NE/K016431/1]; Formas [2013-1571]; Australian Research Council [DP120100797]; NERC [NE/K016385/1, NE/G000816/1, NE/F015356/2, NE/K016431/1] Funding Source: UKRI; Natural Environment Research Council [NE/K016431/1, NE/K016385/1, NE/F015356/2, NE/G000816/1, ceh010010] Funding Source: researchfish	Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazil (Embrapa)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Brazil (Nature Conservancy - Brasil); Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UK (Darwin Initiative); Formas(Swedish Research Council Formas); Australian Research Council(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by grants from Brazil (CNPq 574008/2008-0, 458022/2013-6, and 400640/2012-0; Embrapa SEG:02.08.06.005.00; The Nature Conservancy - Brasil; CAPES scholarships) the UK (Darwin Initiative 17-023; NE/F01614X/1; NE/G000816/1; NE/F015356/2; NE/l018123/1; NE/K016431/1), Formas 2013-1571, and Australian Research Council grant DP120100797. Institutional support was provided by the Herbario IAN in Belem, LBA in Santarem and FAPEMAT. R.M. and J.R.T. were supported by Australian Research Council grant DP120100797. This is paper no. 49 in the Sustainable Amazon Network series.	Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Banks-Leite C, 2014, J APPL ECOL, V51, P849, DOI 10.1111/1365-2664.12272; Barlow J, 2004, ECOL APPL, V14, P1358, DOI 10.1890/03-5077; Barrio Javier, 2011, Rev. peru biol., V18, P225; Berenguer E, 2014, GLOBAL CHANGE BIOL, V20, P3713, DOI 10.1111/gcb.12627; Boucher D., 2014, DEFORESTATION SUCCES; Burivalova Z, 2014, CURR BIOL, V24, P1893, DOI 10.1016/j.cub.2014.06.065; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chen Y, 2011, SCIENCE, V334, P787, DOI 10.1126/science.1209472; Convention on Biological Diversity, 2015, STRAT PLAN BIOD 2011; Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x; Da Silva JMC, 2005, CONSERV BIOL, V19, P689, DOI 10.1111/j.1523-1739.2005.00705.x; Ferraz SFD, 2009, FOREST ECOL MANAG, V257, P1586, DOI 10.1016/j.foreco.2009.01.013; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Gardner TA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0166; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Instituto Nacional de Pesquisas Espaciais (INPE), 2015, PROJ PROD AM DEF DAT; Instituto Nacional de Pesquisas Espaciais (INPE), 2013, TERR DAT 2010; Lees AC, 2013, REV BRAS ORNITOL, V21, P16; Lees AC, 2012, REV BRAS ORNITOL, V20, P93; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Malhi Y, 2014, ANNU REV ENV RESOUR, V39, P125, DOI 10.1146/annurev-environ-030713-155141; Manne LL, 1999, NATURE, V399, P258, DOI 10.1038/20436; Morton DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0163; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Panfil SN, 2016, CONSERV LETT, V9, P143, DOI 10.1111/conl.12188; Parrotta J. A., 2012, UNDERSTANDING RELATI; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Sloan S, 2015, FOREST ECOL MANAG, V352, P134, DOI 10.1016/j.foreco.2015.06.013; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Souza CM, 2013, REMOTE SENS-BASEL, V5, P5493, DOI 10.3390/rs5115493; Zanne A.E., 2009, DRYAD DATA REPOS, DOI [10.5061/dryad.234, DOI 10.5061/DRYAD.234]	37	524	536	39	710	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					144	+		10.1038/nature18326	http://dx.doi.org/10.1038/nature18326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362236	Green Accepted, Green Published			2022-12-28	WOS:000379015600041
J	Edwards, DP				Edwards, David P.			CONSERVATION The rainforest's 'do not disturb' signs	NATURE			English	Editorial Material							AMAZONIAN FORESTS; TROPICAL FORESTS; DEFORESTATION; BIODIVERSITY		[Edwards, David P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Edwards, DP (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	david.edwards@sheffield.ac.uk	Edwards, David/AAC-5091-2019	Edwards, David/0000-0001-8562-3853				Barlow J, 2004, ECOL APPL, V14, P1358, DOI 10.1890/03-5077; Barlow J, 2016, NATURE, V535, P144, DOI 10.1038/nature18326; Edwards DP, 2014, TRENDS ECOL EVOL, V29, P511, DOI 10.1016/j.tree.2014.07.003; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2016, P NATL ACAD SCI USA, V113, P892, DOI 10.1073/pnas.1516525113; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005	11	6	6	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					44	45		10.1038/nature18901	http://dx.doi.org/10.1038/nature18901			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362235				2022-12-28	WOS:000379015600024
J	Groninger, H; Kelemen, A; Ruiz, G				Groninger, Hunter; Kelemen, Anne; Ruiz, George			"Vote for Me"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Groninger, Hunter; Kelemen, Anne] MedStar Washington Hosp Ctr, Dept Med, Sect Palliat Care, Washington, DC USA; [Ruiz, George] MedStar Heart & Vasc Inst, Sect Heart Failure, Washington, DC USA	MedStar Washington Hospital Center	Groninger, H (corresponding author), MedStar Washington Hosp Ctr, Dept Med, Sect Palliat Care, Washington, DC USA.	hunter.groninger@medstar.net						FARRIOR J B, 1954, Trans Am Laryngol Rhinol Otol Soc, V4, P80; Fine RL, 2007, J PALLIAT MED, V10, P1239, DOI 10.1089/jpm.2007.0114; Osler W, 1904, AEQUANIMITAS, P187; Parles K, 2004, ONCOLOGIST, V9, P719, DOI 10.1634/theoncologist.9-6-719; Schofield PE, 2003, ANN ONCOL, V14, P48, DOI 10.1093/annonc/mdg010	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					31	32		10.1001/jama.2016.3713	http://dx.doi.org/10.1001/jama.2016.3713			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2MY	27380338				2022-12-28	WOS:000379037600013
J	Cameron, EG; Goldberg, JL				Cameron, Evan G.; Goldberg, Jeffrey L.			Promoting CNS repair	SCIENCE			English	Editorial Material							ASTROCYTES; CELLS; INJURY		[Cameron, Evan G.; Goldberg, Jeffrey L.] Stanford Univ, Dept Ophthalmol, Stanford, CA 94303 USA	Stanford University	Cameron, EG (corresponding author), Stanford Univ, Dept Ophthalmol, Stanford, CA 94303 USA.	ecamer1@stanford.edu		Goldberg, Jeffrey/0000-0002-1390-7360	NATIONAL EYE INSTITUTE [F32EY025915, R01EY026766] Funding Source: NIH RePORTER; NEI NIH HHS [EY025915, EY026766, F32 EY025915] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Benowitz LI, 2017, EXP NEUROL, V287, P365, DOI 10.1016/j.expneurol.2015.12.015; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Neves J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3646; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304	15	2	3	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					30	31		10.1126/science.aag3327	http://dx.doi.org/10.1126/science.aag3327			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365439				2022-12-28	WOS:000378816200022
J	Huey, RB; Deutsch, C				Huey, Raymond B.; Deutsch, Curtis			How frigate birds soar around the doldrums	SCIENCE			English	Editorial Material									[Huey, Raymond B.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Deutsch, Curtis] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Huey, RB (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	hueyrb@uw.edu	Huey, Raymond/F-1597-2010					Almgren R, 2015, OPTIM CONTR APPL MET, V36, P475, DOI 10.1002/oca.2122; Coleridge S. T., 1798, LYRICAL BALLAD FEW O; Dodge S, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-3; Dunn O., 1989, DIARIO C COLUMBUSS 1; Horvitz N, 2014, ECOL LETT, V17, P670, DOI 10.1111/ele.12268; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Kaplan DM, 2014, ICES J MAR SCI, V71, P1728, DOI 10.1093/icesjms/fst233; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Liechti F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3554; Nicoll MAC, 2017, GLOBAL CHANGE BIOL, V23, P550, DOI 10.1111/gcb.13324; Rattenborg NC, 2008, BIOL LETTERS, V4, P402, DOI 10.1098/rsbl.2008.0203; Roxy MK, 2016, GEOPHYS RES LETT, V43, P826, DOI 10.1002/2015GL066979; Sapir N, 2011, BEHAV ECOL SOCIOBIOL, V65, P1353, DOI 10.1007/s00265-011-1146-x; Weimerskirch H, 2004, MAR ECOL PROG SER, V275, P297, DOI 10.3354/meps275297; Weimerskirch H, 2016, SCIENCE, V353, P74, DOI 10.1126/science.aaf4374	15	2	2	11	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					26	27		10.1126/science.aag1865	http://dx.doi.org/10.1126/science.aag1865			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365436				2022-12-28	WOS:000378816200019
J	Mayor, S				Mayor, Susan			New bone turnover measure is more accurate predictor of postmenopausal bone loss	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Shieh A, 2016, J CLIN ENDOCR METAB, V101, P2802, DOI 10.1210/jc.2015-4262	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2016	353								i3552	10.1136/bmj.i3552	http://dx.doi.org/10.1136/bmj.i3552			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FG	27354724				2022-12-28	WOS:000379017000004
J	McKinnon, WB; Nimmo, F; Wong, T; Schenk, PM; White, OL; Roberts, JH; Moore, JM; Spencer, JR; Howard, AD; Umurhan, OM; Stern, SA; Weaver, HA; Olkin, CB; Young, LA; Smith, KE				McKinnon, William B.; Nimmo, Francis; Wong, Teresa; Schenk, Paul M.; White, Oliver L.; Roberts, J. H.; Moore, J. M.; Spencer, J. R.; Howard, A. D.; Umurhan, O. M.; Stern, S. A.; Weaver, H. A.; Olkin, C. B.; Young, L. A.; Smith, K. E.		New Horizons Geology; Geophysics & Imaging Theme Team	Convection in a volatile nitrogen-ice-rich layer drives Pluto's geological vigour (vol 534, pg 82, 2016)	NATURE			English	Correction													Olkin, Catherine/AAF-5160-2019; Roberts, James/AAI-3283-2020; Weaver, Harold A/D-9188-2016; Roberts, James H/I-9030-2012	Olkin, Catherine/0000-0002-5846-716X; Roberts, James/0000-0002-2671-3207; Weaver, Harold A/0000-0003-0951-7762; Roberts, James H/0000-0003-1766-6127				McKinnon WB, 2016, NATURE, V534, P82, DOI 10.1038/nature18289	1	0	0	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					122	122		10.1038/nature18937	http://dx.doi.org/10.1038/nature18937			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27383784				2022-12-28	WOS:000382426900053
J	Kara, E; Miller, JM; Reynolds, C; Dai, LX				Kara, Erin; Miller, Jon M.; Reynolds, Chris; Dai, Lixin			Relativistic reverberation in the accretion flow of a tidal disruption event	NATURE			English	Article							X-RAY REVERBERATION; ACTIVE GALACTIC NUCLEI; BROAD-LINE REGION; BLACK-HOLE MASS; RADIUS-LUMINOSITY RELATIONSHIP; K-ALPHA REVERBERATION; NARROW-LINE; XMM-NEWTON; IRON K; TIME LAGS	Our current understanding of the curved space-time around supermassive black holes is based on actively accreting black holes, which make up only ten per cent or less of the overall population. X-ray observations of that small fraction reveal strong gravitational redshifts that indicate that many of these black holes are rapidly rotating(1); however, selection biases suggest that these results are not necessarily reflective of the majority of black holes in the Universe(2). Tidal disruption events, where a star orbiting an otherwise dormant black hole gets tidally shredded and accreted onto the black hole(3), can provide a short, unbiased glimpse at the space-time around the other ninety per cent of black holes. Observations of tidal disruptions have hitherto revealed the formation of an accretion disk and the onset of an accretion-powered jet(4-8), but have failed to reveal emission from the inner accretion flow, which enables the measurement of black hole spin. Here we report observations of reverberation(9-12) arising from gravitationally redshifted iron Ka photons reflected off the inner accretion flow in the tidal disruption event Swift J1644+57. From the reverberation timescale, we estimate the mass of the black hole to be a few million solar masses, suggesting an accretion rate of 100 times the Eddington limit or more(13). The detection of reverberation from the relativistic depths of this rare super-Eddington event demonstrates that the X-rays do not arise from the relativistically moving regions of a jet, as previously thought(5,14).	[Kara, Erin; Reynolds, Chris] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Kara, Erin] NASA, Xray Astrophys Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Kara, Erin; Reynolds, Chris; Dai, Lixin] Univ Maryland, Joint Space Sci Inst, College Pk, MD 20742 USA; [Miller, Jon M.] Univ Michigan, Dept Astron, Ann Arbor, MI 48103 USA; [Dai, Lixin] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland College Park	Kara, E (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.; Kara, E (corresponding author), NASA, Xray Astrophys Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.; Kara, E (corresponding author), Univ Maryland, Joint Space Sci Inst, College Pk, MD 20742 USA.	ekara@astro.umd.edu		Reynolds, Christopher/0000-0002-1510-4860; Miller, Jon/0000-0003-2869-7682; Dai, Lixin/0000-0002-9589-5235	Hubble Fellowship Program from Space Telescope Science Institute [HST-HF2-51360.001-A]; NASA [NAS5-26555, NNX14AF86G]; NASA/NSF/TCAN [NNX14AB46G]; NSF/XSEDE/TACC [TG-PHY120005]; NASA/Pleiades [SMD-14-5451]; ESA member states; US (NASA); Suzaku satellite; Division Of Astronomical Sciences [1333514] Funding Source: National Science Foundation	Hubble Fellowship Program from Space Telescope Science Institute; NASA(National Aeronautics & Space Administration (NASA)); NASA/NSF/TCAN(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NSF/XSEDE/TACC; NASA/Pleiades; ESA member states(European Space Agency); US (NASA)(National Aeronautics & Space Administration (NASA)); Suzaku satellite; Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	E.K. thanks A. Zoghbi, M. C. Miller, F. Tombesi, E. Miller and L. Denby for discussions. E. K. also thanks the Hubble Fellowship Program for support under grant number HST-HF2-51360.001-A from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Incorporated, under NASA contract NAS5-26555. J.M.M. acknowledges N. Schartel and XMM-Newton for executing target-of-opportunity observations of Swift J1644+57. C.R. acknowledges support from NASA under grant number NNX14AF86G. L.D. thanks J. McKinney for discussions. L.D. acknowledges support from NASA/NSF/TCAN (NNX14AB46G), NSF/XSEDE/TACC (TG-PHY120005) and NASA/Pleiades (SMD-14-5451). This work is based on observations made with XMM-Newton, a European Space Agency (ESA) science mission with instruments and contributions directly funded by ESA member states and the US (NASA) and the Suzaku satellite, a collaborative mission between the space agencies of Japan (JAXA) and the US (NASA).	Abramowicz MA, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201014467; ABRAMOWICZ MA, 1988, ASTROPHYS J, V332, P646, DOI 10.1086/166683; Alston WN, 2015, MON NOT R ASTRON SOC, V449, P467, DOI 10.1093/mnras/stv351; Alston WN, 2013, MON NOT R ASTRON SOC, V435, P1511, DOI 10.1093/mnras/stt1391; Bentz MC, 2006, ASTROPHYS J, V651, P775, DOI 10.1086/507417; Bentz MC, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/149; Bentz MC, 2009, ASTROPHYS J, V697, P160, DOI 10.1088/0004-637X/697/1/160; Bian W, 2003, MON NOT R ASTRON SOC, V343, P164, DOI 10.1046/j.1365-8711.2003.06650.x; Bloom JS, 2011, SCIENCE, V333, P203, DOI 10.1126/science.1207150; Burrows DN, 2011, NATURE, V476, P421, DOI 10.1038/nature10374; Cackett EM, 2014, MON NOT R ASTRON SOC, V438, P2980, DOI 10.1093/mnras/stt2424; Coughlin ER, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/82; Dai LX, 2015, ASTROPHYS J LETT, V812, DOI 10.1088/2041-8205/812/2/L39; De Marco B, 2013, MON NOT R ASTRON SOC, V431, P2441, DOI 10.1093/mnras/stt339; Denney KD, 2009, ASTROPHYS J, V702, P1353, DOI 10.1088/0004-637X/702/2/1353; EVANS CR, 1989, ASTROPHYS J, V346, pL13, DOI 10.1086/185567; Fabian AC, 2009, NATURE, V459, P540, DOI 10.1038/nature08007; Grier CJ, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/90; Grier CJ, 2012, ASTROPHYS J LETT, V744, DOI 10.1088/2041-8205/744/1/L4; Guillochon J., 2015, PREPRINT; Jaasen F, 2001, ASTRON ASTROPHYS, V365, pL1, DOI 10.1051/0004-6361:20000036; Jiang YF, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/106; Jin CC, 2013, MON NOT R ASTRON SOC, V436, P3173, DOI 10.1093/mnras/stt1801; Kara E, 2015, MON NOT R ASTRON SOC, V446, P737, DOI 10.1093/mnras/stu2136; Kara E, 2014, MON NOT R ASTRON SOC, V439, pL26, DOI 10.1093/mnrasl/slt173; Kara E, 2013, MON NOT R ASTRON SOC, V434, P1129, DOI 10.1093/mnras/stt1055; Kara E, 2013, MON NOT R ASTRON SOC, V430, P1408, DOI 10.1093/mnras/stt024; Kara E, 2013, MON NOT R ASTRON SOC, V428, P2795, DOI 10.1093/mnras/sts155; Kaspi S, 2000, ASTROPHYS J, V533, P631, DOI 10.1086/308704; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Komossa S, 2015, J HIGH ENERGY ASTROP, V7, P148, DOI 10.1016/j.jheap.2015.04.006; Krolik JH, 2002, ASTROPHYS J, V573, P754, DOI 10.1086/340760; Levan AJ, 2011, SCIENCE, V333, P199, DOI 10.1126/science.1207143; Malizia A, 2008, MON NOT R ASTRON SOC, V389, P1360, DOI 10.1111/j.1365-2966.2008.13657.x; Marinucci A, 2014, MON NOT R ASTRON SOC, V440, P2347, DOI 10.1093/mnras/stu404; McKinney Jonathan C., 2015, Monthly Notices of the Royal Astronomical Society: Letters, V454, pL6, DOI 10.1093/mnrasl/slv115; Miller JM, 2015, NATURE, V526, P542, DOI 10.1038/nature15708; Nowak MA, 1999, ASTROPHYS J, V510, P874, DOI 10.1086/306610; Protassov R, 2002, ASTROPHYS J, V571, P545, DOI 10.1086/339856; Ravasio M, 2004, ASTRON ASTROPHYS, V424, P841, DOI 10.1051/0004-6361:20034545; REES MJ, 1988, NATURE, V333, P523, DOI 10.1038/333523a0; Reis RC, 2012, SCIENCE, V337, P949, DOI 10.1126/science.1223940; Reynolds CS, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/24/244004; Sadowski A, 2015, MON NOT R ASTRON SOC, V453, P3213, DOI 10.1093/mnras/stv1802; Saxton CJ, 2012, MON NOT R ASTRON SOC, V422, P1625, DOI 10.1111/j.1365-2966.2012.20739.x; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Shiokawa H, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/2/85; Simien F, 2002, ASTRON ASTROPHYS, V384, P371, DOI 10.1051/0004-6361:20020071; Struder L, 2001, ASTRON ASTROPHYS, V365, pL18, DOI 10.1051/0004-6361:20000066; Tchekhovskoy A, 2014, MON NOT R ASTRON SOC, V437, P2744, DOI 10.1093/mnras/stt2085; TIMMER J, 1995, ASTRON ASTROPHYS, V300, P707; Uttley P, 2014, ASTRON ASTROPHYS REV, V22, DOI 10.1007/s00159-014-0072-0; Vasudevan RV, 2016, MON NOT R ASTRON SOC, V458, P2012, DOI 10.1093/mnras/stw363; Zauderer BA, 2011, NATURE, V476, P425, DOI 10.1038/nature10366; Zhang EP, 2006, ASTROPHYS J, V653, P137, DOI 10.1086/506515; Zhou XL, 2005, ASTROPHYS J, V618, pL83, DOI 10.1086/427871; Zoghbi A, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/56; Zoghbi A, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/24; Zoghbi A, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/121; Zoghbi A, 2012, MON NOT R ASTRON SOC, V422, P129, DOI 10.1111/j.1365-2966.2012.20587.x; Zoghbi A, 2011, MON NOT R ASTRON SOC, V418, P2642, DOI 10.1111/j.1365-2966.2011.19655.x	61	47	47	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2016	535	7612					388	+		10.1038/nature18007	http://dx.doi.org/10.1038/nature18007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS1GQ	27338795	Green Submitted			2022-12-28	WOS:000380344200033
J	Baldridge, RD; Rapoport, TA				Baldridge, Ryan D.; Rapoport, Tom A.			Autoubiquitination of the Hrd1 Ligase Triggers Protein Retrotranslocation in ERAD	CELL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; QUALITY-CONTROL; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; UBIQUITIN; DISLOCATION; COMPLEX; MECHANISMS	Misfolded proteins of the ER are retrotranslocated to the cytosol, where they are polyubiquitinated, extracted from the membrane, and degraded by the proteasome. To investigate how the ER-associated Degradation ( ERAD) machinery can accomplish retrotranslocation of a misfolded luminal protein domain across a lipid bilayer, we have reconstituted retrotranslocation with purified S. cerevisiae proteins, using proteoliposomes containing the multispanning ubiquitin ligase Hrd1. Retrotranslocation of the luminal domain of a membrane-spanning substrate is triggered by autoubiquitination of Hrd1. Substrate ubiquitination is a subsequent event, and the Cdc48 ATPase that completes substrate extraction from the membrane is not required for retrotranslocation. Ubiquitination of lysines in Hrd1's RING-finger domain is required for substrate retrotranslocation in vitro and for ERAD in vivo. Our results suggest that Hrd1 forms a ubiquitin-gated protein-conducting channel.	[Baldridge, Ryan D.; Rapoport, Tom A.] Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA; [Baldridge, Ryan D.; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Baldridge, RD; Rapoport, TA (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.; Baldridge, RD; Rapoport, TA (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	ryan_baldridge@hms.harvard.edu; tom_rapoport@hms.harvard.edu		Baldridge, Ryan/0000-0001-7158-7812	NIH/NIGMS [R01GM052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Nicholas Bodnar, Stefan Schoebel, and Alexander Stein for help with some in vitro experiments and Neil Blok, Stefan Schoebel, Alexander Stein, and Xudong Wu for their critical reading of the manuscript. We also thank the ICCB-Longwood Screening Facility at Harvard Medical School for access to the M5 plate reader. This work is supported by the NIH/NIGMS Award R01GM052586. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. R.D.B. is the Fraternal Order of Eagles Fellow of the Damon Runyon Cancer Research Foundation, DRG-2184-14. T.A.R. is a Howard Hughes Medical Institute Investigator.	Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Collinson I., 2015, PHILOS T R SOC LON B, P370; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Khmelinskii A, 2014, NATURE, V516, P410, DOI 10.1038/nature14096; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Mehnert M, 2014, NAT CELL BIOL, V16, P77, DOI 10.1038/ncb2882; Morris LL, 2014, J BIOL CHEM, V289, P19053, DOI 10.1074/jbc.M114.576652; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wang GL, 1999, MOL CELL BIOL, V19, P342; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2013, J BIOL CHEM, V288, P23295, DOI 10.1074/jbc.M113.482018; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852	43	119	120	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					394	407		10.1016/j.cell.2016.05.048	http://dx.doi.org/10.1016/j.cell.2016.05.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27321670	Green Accepted, Bronze			2022-12-28	WOS:000380255400017
J	Schlindwein, V; Schmid, F				Schlindwein, Vera; Schmid, Florian			Mid-ocean-ridge seismicity reveals extreme types of ocean lithosphere	NATURE			English	Article							SOUTHWEST INDIAN RIDGE; SPREADING GAKKEL RIDGE; SEA-FLOOR GENERATION; CRUSTAL THICKNESS; MIDOCEAN RIDGES; ATLANTIC RIDGE; 69-DEGREES-E; PERIDOTITES; EXHUMATION; TECTONICS	Along ultraslow-spreading ridges, where oceanic tectonic plates drift very slowly apart, conductive cooling is thought to limit mantle melting(1) and melt production has been inferred to be highly discontinuous(2-4). Along such spreading centres, long ridge sections without any igneous crust alternate with magmatic sections that host massive volcanoes capable of strong earthquakes(5). Hence melt supply, lithospheric composition and tectonic structure seem to vary considerably along the axis of the slowest-spreading ridges(6). However, owing to the lack of seismic data, the lithospheric structure of ultraslow ridges is poorly constrained. Here we describe the structure and accretion modes of two end-member types of oceanic lithosphere using a detailed seismicity survey along 390 kilometres of ultraslow-spreading ridge axis. We observe that a magmatic sections lack shallow seismicity in the upper 15 kilometres of the lithosphere, but unusually contain earthquakes down to depths of 35 kilometres. This observation implies a cold, thick lithosphere, with an upper aseismic zone that probably reflects substantial serpentinization. We find that regions of magmatic lithosphere thin dramatically under volcanic centres, and infer that the resulting topography of the lithosphere-asthenosphere boundary could allow along-axis melt flow, explaining the uneven crustal production at ultraslow-spreading ridges. The seismicity data indicate that alteration in ocean lithosphere may reach far deeper than previously thought, with important implications towards seafloor deformation and fluid circulation.	[Schlindwein, Vera; Schmid, Florian] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Alten Hafen 26, D-27568 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Schlindwein, V (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Alten Hafen 26, D-27568 Bremerhaven, Germany.	Vera.Schlindwein@awi.de		Schlindwein, Vera/0000-0001-5570-2753; Schmid, Florian/0000-0001-9921-7397	German Science Foundation [SCHL853/1-1, SCHL853/3-1]	German Science Foundation(German Research Foundation (DFG))	This study was enabled by grants SCHL853/1-1 and SCHL853/3-1 of the German Science Foundation to V.S. Instruments were borrowed from the DEPAS pool. We acknowledge the efforts of the crews of RV Polarstern cruises ANT-XXIX/2+8 and ARK-XXIV/3, RV Meteor cruise M101 and RV Marion Dufresne.	ANDERSON DL, 1995, REV GEOPHYS, V33, P125, DOI 10.1029/94RG02785; BOWN JW, 1994, EARTH PLANET SC LETT, V121, P435, DOI 10.1016/0012-821X(94)90082-5; Cannat M, 1999, J GEOPHYS RES-SOL EA, V104, P22825, DOI 10.1029/1999JB900195; CANNAT M, 1993, J GEOPHYS RES-SOL EA, V98, P4163, DOI 10.1029/92JB02221; Cannat M, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000480; Cannat M, 1996, J GEOPHYS RES-SOL EA, V101, P2847, DOI 10.1029/95JB03116; Cannat M, 2006, GEOLOGY, V34, P605, DOI 10.1130/G22486.1; Cannat M, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001676; CHEN WP, 1983, J GEOPHYS RES, V88, P4183, DOI 10.1029/JB088iB05p04183; CHEN YS, 1990, J GEOPHYS RES-SOLID, V95, P17583, DOI 10.1029/JB095iB11p17583; deMartin BJ, 2007, GEOLOGY, V35, P711, DOI 10.1130/G23718A.1; Dick HJB, 2003, NATURE, V426, P405, DOI 10.1038/nature02128; Dusunur D, 2009, MAR GEOPHYS RES, V30, P105, DOI 10.1007/s11001-009-9071-3; Edmonds HN, 2003, NATURE, V421, P252, DOI 10.1038/nature01351; Escartin J, 2008, NATURE, V455, P790, DOI 10.1038/nature07333; Escartin J, 2001, GEOLOGY, V29, P1023, DOI 10.1130/0091-7613(2001)029<1023:SOSSPI>2.0.CO;2; Jokat W, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051199; KISSLING E, 1994, J GEOPHYS RES-SOL EA, V99, P19635, DOI 10.1029/93JB03138; Maus S, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002471; McKenzie D, 2005, EARTH PLANET SC LETT, V233, P337, DOI 10.1016/j.epsl.2005.02.005; Michael PJ, 2003, NATURE, V423, P956, DOI 10.1038/nature01704; Minshull TA, 2006, GEOPHYS J INT, V166, P135, DOI 10.1111/j.1365-246X.2006.03001.x; Montesi LGJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031067; Montesi LGJ, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008259; Niu XW, 2015, GEOCHEM GEOPHY GEOSY, V16, P468, DOI 10.1002/2014GC005645; Roumejon S, 2014, GEOCHEM GEOPHY GEOSY, V15, P2354, DOI 10.1002/2013GC005148; Sauter D, 2013, NAT GEOSCI, V6, P314, DOI [10.1038/ngeo1771, 10.1038/NGEO1771]; Sauter D, 2010, GEOPHYS MONOGR SER, V188, P153, DOI 10.1029/2008GM000843; Sauter D, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001764; Schlindwein V, 2012, GEOPHYS J INT, V190, P442, DOI 10.1111/j.1365-246X.2012.05502.x; Schlindwein V, 2014, REP POLAR MARINE RES, V672, P14; Schlindwein V, 2013, GEOPHYS RES LETT, V40, P1703, DOI 10.1002/grl.50329; Schwartz S, 2013, LITHOS, V178, P197, DOI 10.1016/j.lithos.2012.11.023; Schweitzer J, 2001, PURE APPL GEOPHYS, V158, P277, DOI 10.1007/PL00001160; Simao N, 2010, GEOPHYS J INT, V183, P1559, DOI 10.1111/j.1365-246X.2010.04815.x; Sleep NH, 2014, GEOCHEM GEOPHY GEOSY, V15, P3161, DOI 10.1002/2014GC005423; Standish JJ, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001959; WHITE RS, 1992, J GEOPHYS RES-SOL EA, V97, P19683, DOI 10.1029/92JB01749	39	81	88	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					276	U185		10.1038/nature18277	http://dx.doi.org/10.1038/nature18277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27362231				2022-12-28	WOS:000379912600055
J	Herzlinger, RE				Herzlinger, Regina E.			Health Insurance Stores and Health Hubs Innovations That Get Close to the Customer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Herzlinger, Regina E.] Harvard Univ, Sch Business, 10 Soldiers Field Rd,Baker Lib 171, Boston, MA 02163 USA	Harvard University	Herzlinger, RE (corresponding author), Harvard Univ, Sch Business, 10 Soldiers Field Rd,Baker Lib 171, Boston, MA 02163 USA.	rherzlinger@hbs.edu						Bluestein AD, KAISER PERMANENTE DE; Fangmeier JO, HAS AFFORDABLE CARE; Madigan NI, HLTH CARE EXPANSION	3	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					25	26		10.1001/jama.2016.6493	http://dx.doi.org/10.1001/jama.2016.6493			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2MY	27380337				2022-12-28	WOS:000379037600010
J	Nelson, EC; Dixon-Woods, M; Batalden, PB; Homa, K; Van Citters, AD; Morgan, TS; Eftimovska, E; Fisher, ES; Ovretveit, J; Harrison, W; Lind, C; Lindblad, S				Nelson, Eugene C.; Dixon-Woods, Mary; Batalden, Paul B.; Homa, Karen; Van Citters, Aricca D.; Morgan, Tamara S.; Eftimovska, Elena; Fisher, Elliott S.; Ovretveit, John; Harrison, Wade; Lind, Cristin; Lindblad, Staffan			Patient focused registries can improve health, care, and science	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE; OUTCOMES		[Nelson, Eugene C.; Batalden, Paul B.; Van Citters, Aricca D.; Morgan, Tamara S.; Fisher, Elliott S.; Harrison, Wade] Dartmouth Coll, Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, 1 Med Ctr Dr, Lebanon, NH 03766 USA; [Dixon-Woods, Mary] Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Cambridge, England; [Homa, Karen] Dartmouth Hitchcock Hlth, Lebanon, NH USA; [Eftimovska, Elena; Ovretveit, John; Lindblad, Staffan] Karolinska Inst, Med Management Ctr, Stockholm, Sweden; [Lind, Cristin; Lindblad, Staffan] Karolinska Inst, Qual Register Ctr Stockholm, Stockholm, Sweden; [Lind, Cristin; Lindblad, Staffan] Stockholm Cty Council, Stockholm, Sweden	Dartmouth College; University of Cambridge; Karolinska Institutet; Karolinska Institutet; Stockholm County Council	Morgan, TS (corresponding author), Dartmouth Coll, Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, 1 Med Ctr Dr, Lebanon, NH 03766 USA.	tamara.s.morgan@dartmouth.edu	Van Citters, Aricca/AAK-6492-2020	Van Citters, Aricca/0000-0002-2961-5661; Harrison, Wade/0000-0001-5597-3115; ovretveit, john/0000-0002-5177-6613	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR062799] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aisner D, 2006, LEARNING HEALTHCARE; [Anonymous], 2013, SVENSK REUM KVAL ARS; Batalden M, 2016, BMJ QUAL SAF, V25, P509, DOI 10.1136/bmjqs-2015-004315; Black N, 2013, BMJ-BRIT MED J, V346, pf167, DOI [DOI 10.1136/BMJ.F167, 10.1136/bmj.f167]; Bloem BR, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1838; Carter P, 2015, J MED ETHICS, V41, P404, DOI 10.1136/medethics-2014-102374; Christensen CM, 2008, THE INNOVATORS PRESC; Cloud G, 2013, CLIN MED, V13, P444, DOI 10.7861/clinmedicine.13-5-444; Cornish JA, 2011, SURG ONCOL, V20, pE72, DOI 10.1016/j.suronc.2010.10.005; Crandall W, 2011, INFLAMM BOWEL DIS, V17, P450, DOI 10.1002/ibd.21394; Eriksson JK, 2014, CLIN EXP RHEUMATOL, V32, pS147; Forrest CB, 2014, HEALTH AFFAIR, V33, P1171, DOI 10.1377/hlthaff.2014.0127; Forsberg HH, 2015, J AMBUL CARE MANAG, V38, P188, DOI 10.1097/JAC.0000000000000052; Fredriksson C, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000184; Gale CP, 2012, HEART, V98, P1040, DOI 10.1136/heartjnl-2012-302469; Gliklich RE., 2014, REGISTRIES EVALUATIN, V3; Healthcare Quality Improvement Partnership, 2016, NHS ENGL QUAL ACC LI; Ieva F, 2014, EXPERT REV CARDIOVAS, V12, P1383, DOI 10.1586/14779072.2015.982096; Institute of Medicine, 2011, IOM; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Laurie G, 2015, INT J MED INFORM, V84, P933, DOI 10.1016/j.ijmedinf.2015.08.011; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Lupton D, 2015, HEALTH PROMOT INT, V30, P174, DOI 10.1093/heapro/dau091; Margolis PA, 2013, PEDIATRICS, V131, pS219, DOI 10.1542/peds.2012-3786J; McNeil JJ, 2010, MED J AUSTRALIA, V192, P244, DOI 10.5694/j.1326-5377.2010.tb03499.x; Mintzberg H, 2005, STRATEGY SAFARI GUID; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; Richardson D, 2014, OVERVIEW; Seid M, 2014, JAMA PEDIATR, V168, P201, DOI 10.1001/jamapediatrics.2013.5063; Shneiderman B, 2008, SCIENCE, V319, P1349, DOI 10.1126/science.1153539; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Smith R., 2015, FILL VOID EVIDENCE E; Wagner E H, 2001, Jt Comm J Qual Improv, V27, P63; Wolfe F, 2011, RHEUMATOLOGY, V50, P16, DOI 10.1093/rheumatology/keq155	35	93	93	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2016	353								i3319	10.1136/bmj.i3319	http://dx.doi.org/10.1136/bmj.i3319			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ2GK	27370543	Green Published, hybrid			2022-12-28	WOS:000379020300001
J	Dyer, O				Dyer, Owen			Medical data of 655 000 Americans put up for sale by hacker	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1876	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3664	10.1136/bmj.i3664	http://dx.doi.org/10.1136/bmj.i3664			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27365497				2022-12-28	WOS:000379019700020
J	Kissig, M; Shapira, SN; Seale, P				Kissig, Megan; Shapira, Suzanne N.; Seale, Patrick			SnapShot: Brown and Beige Adipose Thermogenesis	CELL			English	Editorial Material							FAT		[Kissig, Megan] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Kissig, M (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.				NIDDK NIH HHS [R01 DK103008] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103008] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Shao ML, 2016, CELL METAB, V23, P1167, DOI 10.1016/j.cmet.2016.04.023	4	29	36	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					258	U296		10.1016/j.cell.2016.06.038	http://dx.doi.org/10.1016/j.cell.2016.06.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368105	Green Accepted, Bronze			2022-12-28	WOS:000380254400026
J	Metzger, MJ; Villalba, A; Carballal, MJ; Iglesias, D; Sherry, J; Reinisch, C; Muttray, AF; Baldwin, SA; Goff, SP				Metzger, Michael J.; Villalba, Antonio; Carballal, Maria J.; Iglesias, David; Sherry, James; Reinisch, Carol; Muttray, Annette F.; Baldwin, Susan A.; Goff, Stephen P.			Widespread transmission of independent cancer lineages within multiple bivalve species	NATURE			English	Article							HEMIC NEOPLASIA; CERASTODERMA-EDULE; MYTILUS-TROSSULUS; EVOLUTION; POPULATIONS; VENERIDAE; SEQUENCE; DISEASES; MUSSELS; CELLS	Most cancers arise from oncogenic changes in the genomes of somatic cells, and while the cells may migrate by metastasis, they remain within that single individual. Natural transmission of cancer cells from one individual to another has been observed in two distinct cases in mammals (Tasmanian devils(1) and dogs(2,3)), but these are generally considered to be rare exceptions in nature. The discovery of transmissible cancer in soft-shell clams (Mya arenaria)(4) suggested that this phenomenon might be more widespread. Here we analyse disseminated neoplasia in mussels (Mytilus trossulus), cockles (Cerastoderma edule), and golden carpet shell clams (Polititapes aureus) and find that neoplasias in all three species are attributable to independent transmissible cancer lineages. In mussels and cockles, the cancer lineages are derived from their respective host species; however, unexpectedly, cancer cells in P. aureus are all derived from Venerupis corrugata, a different species living in the same geographical area. No cases of disseminated neoplasia have thus far been found in V. corrugata from the same region. These findings show that transmission of cancer cells in the marine environment is common in multiple species, that it has originated many times, and that while most transmissible cancers are found spreading within the species of origin, cross-species transmission of cancer cells can occur.	[Metzger, Michael J.; Goff, Stephen P.] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA; [Metzger, Michael J.; Goff, Stephen P.] Howard Hughes Med Inst, New York, NY 10032 USA; [Villalba, Antonio; Carballal, Maria J.; Iglesias, David] Conselleria Mar, Ctr Invest Marinas, Xunta De Galicia 36620, Vilanova De Aro, Spain; [Villalba, Antonio] Univ Alcala de Henares, Dept Life Sci, E-28871 Alcala De Henares, Spain; [Sherry, James; Reinisch, Carol] Environm Canada, Water Sci & Technol Directorate, Burlington, ON L7R 4A6, Canada; [Muttray, Annette F.; Baldwin, Susan A.] Univ British Columbia, Chem & Biol Engn, Vancouver, BC V6T 1Z3, Canada; [Muttray, Annette F.] SLR Consulting Canada Ltd, Vancouver, BC V6J 1V4, Canada; [Goff, Stephen P.] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Universidad de Alcala; Environment & Climate Change Canada; University of British Columbia; Columbia University	Goff, SP (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.; Goff, SP (corresponding author), Howard Hughes Med Inst, New York, NY 10032 USA.; Goff, SP (corresponding author), Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA.	spg1@cumc.columbia.edu	Goff, Stephen P/K-6337-2014; Iglesias, David/F-9123-2013; Metzger, Michael/AAA-3635-2022; Villalba, Antonio/E-3621-2013	Goff, Stephen P/0000-0003-0693-5547; Iglesias, David/0000-0003-2127-7757; Metzger, Michael/0000-0001-7855-1388; Villalba, Antonio/0000-0001-8049-0502	Howard Hughes Medical Institute and Training Grant [T32 CA009503]; Conselleria do Mar da Xunta de Galicia, through the project PGIDIT-CIMA [13/03]; NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER	Howard Hughes Medical Institute and Training Grant; Conselleria do Mar da Xunta de Galicia, through the project PGIDIT-CIMA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M.J.M. and S.P.G. were supported by the Howard Hughes Medical Institute and Training Grant T32 CA009503. D.I., M.J.C., and A.V. were supported by the Conselleria do Mar da Xunta de Galicia, through the project PGIDIT-CIMA 13/03. We thank J. Ausio for help in collection of M. trossulus from Vancouver Island.	Arriagada G, 2014, P NATL ACAD SCI USA, V111, P14175, DOI 10.1073/pnas.1409945111; Barber BJ, 2004, AQUAT LIVING RESOUR, V17, P449, DOI 10.1051/alr:2004052; Canapa A, 2003, MAR BIOL, V142, P1125, DOI 10.1007/s00227-003-1048-1; Carballal MJ, 2013, J INVERTEBR PATHOL, V112, P16, DOI 10.1016/j.jip.2012.10.003; Carballal ML, 2015, J INVERTEBR PATHOL, V131, P83, DOI 10.1016/j.jip.2015.06.004; Carballal MJ, 2001, J INVERTEBR PATHOL, V78, P87, DOI 10.1006/jipa.2001.5049; COCKRILL JM, 1979, AM J VET RES, V40, P409; Diaz S, 2010, DIS AQUAT ORGAN, V90, P215, DOI 10.3354/dao02231; Diaz S., 2016, J FISH DIS; Dungern V., 1912, MUNCHEN MED WOCHEN, P238; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Howard D., 2004, NOAA TECHNICAL MEMOR, V5; Iglesias D., 2006, THESIS; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; KENT ML, 1991, J INVERTEBR PATHOL, V57, P435, DOI 10.1016/0022-2011(91)90148-J; Martinez L, 2009, CONSERV GENET RESOUR, V1, P107, DOI 10.1007/s12686-009-9026-7; Mateo D. R., 2015, J FISH DIS; Metzger MJ, 2015, CELL, V161, P255, DOI 10.1016/j.cell.2015.02.042; MOORE JD, 1991, J INVERTEBR PATHOL, V58, P231, DOI 10.1016/0022-2011(91)90067-Z; Muehlenbachs A, 2015, NEW ENGL J MED, V373, P1845, DOI 10.1056/NEJMoa1505892; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Muttray AF, 2008, MAR ENVIRON RES, V66, P412, DOI 10.1016/j.marenvres.2008.06.004; Oliverio M, 2001, J MOLLUS STUD, V67, P243, DOI 10.1093/mollus/67.2.243; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pye RJ, 2016, P NATL ACAD SCI USA, V113, P374, DOI 10.1073/pnas.1519691113; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Rodzen JA, 2002, GENOME, V45, P1064, DOI [10.1139/g02-083, 10.1139/G02-083]; Salvi D, 2012, MOL PHYLOGENET EVOL, V65, P792, DOI 10.1016/j.ympev.2012.07.017; Samso A., 1965, THESIS; Sticker A., 1906, Z KREBSFORSCH, V4, P227; Strakova A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0168-9; Vassilenko E, 2014, J INVERTEBR PATHOL, V117, P68, DOI 10.1016/j.jip.2014.02.002; Vassilenko EI, 2010, MUTAT RES-GEN TOX EN, V701, P145, DOI 10.1016/j.mrgentox.2010.06.001; Villalba A, 2001, DIS AQUAT ORGAN, V46, P213, DOI 10.3354/dao046213; Wade H, 1908, J PATHOL BACTERIOL, V12, P384, DOI 10.1002/path.1700120221	36	111	115	4	127	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					705	+		10.1038/nature18599	http://dx.doi.org/10.1038/nature18599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27338791	Green Accepted			2022-12-28	WOS:000378676000041
J	Mustafa, OM; Aduriz-Lorenzo, PM				Mustafa, Osama M.; Aduriz-Lorenzo, Patricio M.			Hypopyon and Klebsiella Sepsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mustafa, Osama M.] Alfaisal Univ, Riyadh, Saudi Arabia; [Aduriz-Lorenzo, Patricio M.] Dubai Hosp, Dubai, U Arab Emirates	Alfaisal University; Dubai Hospital	Mustafa, OM (corresponding author), Alfaisal Univ, Riyadh, Saudi Arabia.	omustafa@alfaisal.edu							0	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					E33	E33		10.1056/NEJMicm1509932	http://dx.doi.org/10.1056/NEJMicm1509932			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8DD	27355556				2022-12-28	WOS:000378727200011
J	Shigeoka, T; Jung, H; Jung, J; Turner-Bridger, B; Ohk, J; Lin, JLQJ; Amieux, PS; Holt, CE				Shigeoka, Toshiaki; Jung, Hosung; Jung, Jane; Turner-Bridger, Benita; Ohk, Jiyeon; Lin, Julie Qiaojin; Amieux, Paul S.; Holt, Christine E.			Dynamic Axonal Translation in Developing and Mature Visual Circuits	CELL			English	Article							LOCAL PROTEIN-SYNTHESIS; MESSENGER-RNA LOCALIZATION; RETINAL GROWTH CONES; INTRAAXONAL TRANSLATION; CHEMOTROPIC RESPONSES; SYMPATHETIC NEURONS; SYNAPTIC PLASTICITY; BINDING PROTEIN; REVEALS; SIGNAL	Local mRNA translation mediates the adaptive responses of axons to extrinsic signals, but direct evidence that it occurs in mammalian CNS axons in vivo is scant. We developed an axon-TRAP-RiboTag approach in mouse that allows deep-sequencing analysis of ribosome-bound mRNAs in the retinal ganglion cell axons of the developing and adult retinotectal projection in vivo. The embryonic-to-postnatal axonal translatome comprises an evolving subset of enriched genes with axon-specific roles, suggesting distinct steps in axon wiring, such as elongation, pruning, and synaptogenesis. Adult axons, remarkably, have a complex translatome with strong links to axon survival, neurotransmission, and neurodegenerative disease. Translationally coregulated mRNA subsets share common upstream regulators, and sequence elements generated by alternative splicing promote axonal mRNA translation. Our results indicate that intricate regulation of compartment-specific mRNA translation in mammalian CNS axons supports the formation and maintenance of neural circuits in vivo.	[Shigeoka, Toshiaki; Turner-Bridger, Benita; Lin, Julie Qiaojin; Holt, Christine E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England; [Jung, Hosung; Jung, Jane; Ohk, Jiyeon] Yonsei Univ, Coll Med, Brain Res Inst, Dept Anat, Seoul 03722, South Korea; [Jung, Hosung; Jung, Jane; Ohk, Jiyeon] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea; [Amieux, Paul S.] Bastyr Univ, Res Inst, Kenmore, WA 98028 USA	University of Cambridge; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Holt, CE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.; Jung, H (corresponding author), Yonsei Univ, Coll Med, Brain Res Inst, Dept Anat, Seoul 03722, South Korea.; Jung, H (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea.	hosungjung@yonsei.ac.kr; ceh33@cam.ac.uk	Jung, Hosung/A-4401-2012; Amieux, Paul/AAG-4102-2021; Lin, Julie Qiaojin/AAY-5309-2020; Lin, Qiaojin/ABA-3382-2020	Jung, Hosung/0000-0002-5059-8050; Lin, Julie Qiaojin/0000-0002-2669-6478; Lin, Qiaojin/0000-0002-2669-6478; Holt, Christine Elizabeth/0000-0003-2829-121X; Turner-Bridger, Benita/0000-0003-3718-3632	Wellcome Trust Programme Grant [085314/Z/08/Z]; European Research Council Advanced Grant [322817]; Cambridge Wellcome Trust PhD programme in Developmental Biology; Gates Cambridge Scholarship; Basic Science Research Program [NRF-2013R1A1A1009625, NRF-2014K2A7A1036305]; Biomedical Technology Development Program [NRF-2013M3A9D5072551]; Brain Research Program through the NRF by the Korean government (MSIP) [NRF-2015M3C7A1028396]; Yonsei University Future-Leading Research Initiative [2015-22-0095]; faculty research grant from Yonsei University College of Medicine [6-2013-0064-2-1]	Wellcome Trust Programme Grant(Wellcome Trust); European Research Council Advanced Grant(European Research Council (ERC)); Cambridge Wellcome Trust PhD programme in Developmental Biology; Gates Cambridge Scholarship; Basic Science Research Program; Biomedical Technology Development Program; Brain Research Program through the NRF by the Korean government (MSIP); Yonsei University Future-Leading Research Initiative; faculty research grant from Yonsei University College of Medicine	We apologize to authors of key papers, which we could not cite due to space limitations. We thank W. Harris for many valuable discussions and critical reading of the manuscript. We thank A. Riccio for myr-d2EGFP; J. Skepper for EM; Gihoon Son for advice on IPA; M. Minett for advice on mouse genetics; and K. Mooslehner, A. Dwivedy, and Jeeun Song for technical assistance. This work was supported by Wellcome Trust Programme Grant (085314/Z/08/Z), European Research Council Advanced Grant (322817) to C.E.H., Cambridge Wellcome Trust PhD programme in Developmental Biology (to B.T.-B.), Gates Cambridge Scholarship (to J.Q.L.), Basic Science Research Program (NRF-2013R1A1A1009625 and NRF-2014K2A7A1036305), Biomedical Technology Development Program (NRF-2013M3A9D5072551), Brain Research Program (NRF-2015M3C7A1028396) funded through the NRF by the Korean government (MSIP), Yonsei University Future-Leading Research Initiative of 2015 (2015-22-0095), and a faculty research grant from Yonsei University College of Medicine for 2013 (6-2013-0064-2-1) to H.J.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Andreassi C, 2010, NAT NEUROSCI, V13, P291, DOI 10.1038/nn.2486; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Baleriola J, 2014, CELL, V158, P1159, DOI 10.1016/j.cell.2014.07.001; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Campbell DS, 2013, J CELL BIOL, V203, P657, DOI 10.1083/jcb.201303072; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Cosker KE, 2016, NAT NEUROSCI, V19, P690, DOI 10.1038/nn.4280; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Darnell JC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012344; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Ellis JM, 2013, MOL CELL BIOL, V33, P1869, DOI 10.1128/MCB.01548-12; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Graber TE, 2013, P NATL ACAD SCI USA, V110, P16205, DOI 10.1073/pnas.1307747110; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hillefors M, 2007, CELL MOL NEUROBIOL, V27, P701, DOI 10.1007/s10571-007-9148-y; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ji SJ, 2012, NEURON, V74, P95, DOI 10.1016/j.neuron.2012.02.022; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim E, 2015, BMB REP, V48, P139, DOI 10.5483/BMBRep.2015.48.3.010; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; Kun A, 2007, J NEUROSCI RES, V85, P2087, DOI 10.1002/jnr.21340; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Preitner N, 2014, CELL, V158, P368, DOI 10.1016/j.cell.2014.05.042; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Sasaki Y, 2014, DEV NEUROBIOL, V74, P397, DOI 10.1002/dneu.22113; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Spillane M, 2013, CELL REP, V5, P1564, DOI 10.1016/j.celrep.2013.11.022; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Verheijen MHG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087255; Walker BA, 2012, GENE THER, V19, P947, DOI 10.1038/gt.2011.217; Yoon BC, 2012, CELL, V148, P752, DOI 10.1016/j.cell.2011.11.064; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhang KX, 2016, CELL REP, V14, P1258, DOI 10.1016/j.celrep.2015.12.102; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	53	246	247	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					181	192		10.1016/j.cell.2016.05.029	http://dx.doi.org/10.1016/j.cell.2016.05.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27321671	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000380254400020
J	Hu, JC; Laviana, A; Sedrakyan, A				Hu, Jim C.; Laviana, Aaron; Sedrakyan, Art			High-Intensity Focused Ultrasound for Prostate Cancer Novelty or Innovation?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THERAPY		[Hu, Jim C.] Weill Cornell Med, Dept Urol, 525 E 68th St,Starr 946, New York, NY 10065 USA; [Laviana, Aaron] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Sedrakyan, Art] Weill Cornell Med, Dept Healthcare Policy & Res, 525 E 68th St,Starr 946, New York, NY 10065 USA	Cornell University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University	Hu, JC (corresponding author), Weill Cornell Med, Dept Urol, 525 E 68th St,Starr 946, New York, NY 10065 USA.	jch9011@med.cornell.edu			FDA HHS [U01 FD005478] Funding Source: Medline; FOOD AND DRUG ADMINISTRATION [U01FD005478] Funding Source: NIH RePORTER	FDA HHS; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)		Ahmed HU, 2015, EUR UROL, V68, P927, DOI 10.1016/j.eururo.2015.01.030; Cooperberg MR, 2015, JAMA-J AM MED ASSOC, V314, P80, DOI 10.1001/jama.2015.6036; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Laviana AA, 2016, CANCER-AM CANCER SOC, V122, P447, DOI 10.1002/cncr.29743; Lee SM, 2014, DOCTORS PAY UNAPPROV; Rewcastle JC, 2014, IMAGE GUIDED PROSTAT, P255; Sinnott M, 2012, PROSTATE, V72, P1179, DOI 10.1002/pros.22467; US Food and Drug Administration (FDA), 2015, PUBL WORKSH AUA FDA; Warmuth M, 2010, EUR UROL, V58, P803, DOI 10.1016/j.eururo.2010.09.009	9	7	8	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2659	2660		10.1001/jama.2016.5002	http://dx.doi.org/10.1001/jama.2016.5002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27367874				2022-12-28	WOS:000378709300011
J	Green, A				Green, Andrew			Anne Deborah Atai-Omoruto	LANCET			English	Biographical-Item																		ATAIOMORUTO AD, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2598	2598		10.1016/S0140-6736(16)30854-6	http://dx.doi.org/10.1016/S0140-6736(16)30854-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27358989	Bronze			2022-12-28	WOS:000378390500018
J	Simoes-Costa, M; Bronner, ME				Simoes-Costa, Marcos; Bronner, Marianne E.			Reprogramming of avian neural crest axial identity and cell fate	SCIENCE			English	Article							EVOLUTION; REVEALS; NEURONS	Neural crest populations along the embryonic body axis of vertebrates differ in developmental potential and fate, so that only the cranial neural crest can contribute to the craniofacial skeleton in vivo. We explored the regulatory program that imbues the cranial crest with its specialized features. Using axial-level specific enhancers to isolate and perform genome-wide profiling of the cranial versus trunk neural crest in chick embryos, we identified and characterized regulatory relationships between a set of cranial-specific transcription factors. Introducing components of this circuit into neural crest cells of the trunk alters their identity and endows these cells with the ability to give rise to chondroblasts in vivo. Our results demonstrate that gene regulatory circuits that support the formation of particular neural crest derivatives may be used to reprogram specific neural crest-derived cell types.	[Simoes-Costa, Marcos; Bronner, Marianne E.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Simoes-Costa, Marcos] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	California Institute of Technology; Cornell University	Bronner, ME (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mbronner@caltech.edu	Simoes-Costa, Marcos/AAX-4780-2020	Bronner, Marianne/0000-0003-4274-1862	NIH [DE024157, HD037105, K99DE024232]; Pew Fellows Program in Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024157, K99DE024232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Fellows Program in Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Tan-Cabugao, M. Stone, B. Jun, and D. S. E. Koo for technical assistance. The Caltech Millard and Muriel Jacobs Genetics and Genomics Laboratory provided sequencing and bioinformatics support. We are indebted to D. Perez, K. Beadle, and R. Diamond for cell- sorting assistance at the Caltech Flow Cytometry Cell Sorting Facility. We also thank M. Barembaum for the Sox8 and Tfap2b expression constructs. This work was supported by NIH grants DE024157 and HD037105 to M. E. B. M. S.-C. was funded by a fellowship from the Pew Fellows Program in Biomedical Sciences and by NIH grant K99DE024232. The supplementary materials contain additional data.	Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Dyachuk V, 2014, SCIENCE, V345, P82, DOI 10.1126/science.1253281; Green SA, 2015, NATURE, V520, P474, DOI 10.1038/nature14436; Le Douarin N.M., 1982, NEURAL CREST; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; LELIEVRE CS, 1980, DEV BIOL, V77, P362, DOI 10.1016/0012-1606(80)90481-9; Lwigale PY, 2004, DEVELOPMENT, V131, P1979, DOI 10.1242/dev.01106; Simoes-Costa M, 2015, DEV CELL, V34, P544, DOI 10.1016/j.devcel.2015.06.024; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Simoes-Costa M, 2014, GENOME RES, V24, P281, DOI 10.1101/gr.161182.113; Simoes-Costa M, 2013, GENOME RES, V23, P1069, DOI 10.1101/gr.157586.113; Simoes-Costa MS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003142; Uesaka T, 2015, J NEUROSCI, V35, P9879, DOI 10.1523/JNEUROSCI.1239-15.2015	13	88	88	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1570	1573		10.1126/science.aaf2729	http://dx.doi.org/10.1126/science.aaf2729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339986	Green Accepted			2022-12-28	WOS:000378346500042
J	Zhang, R; Sutton, R; Danabasoglu, G; Delworth, TL; Kim, WM; Robson, J; Yeager, SG				Zhang, Rong; Sutton, Rowan; Danabasoglu, Gokhan; Delworth, Thomas L.; Kim, Who M.; Robson, Jon; Yeager, Stephen G.			Comment on "The Atlantic Multidecadal Oscillation without a role for ocean circulation"	SCIENCE			English	Editorial Material							VARIABILITY	Clement et al. (Reports, 16 October 2015, p. 320) claim that the Atlantic Multidecadal Oscillation (AMO) is a thermodynamic response of the ocean mixed layer to stochastic atmospheric forcing and that ocean circulation changes have no role in causing the AMO. These claims are not justified. We show that ocean dynamics play a central role in the AMO.	[Zhang, Rong; Delworth, Thomas L.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA; [Sutton, Rowan; Robson, Jon] Univ Reading, Dept Meteorol, Natl Ctr Atmospher Sci, Reading, Berks, England; [Danabasoglu, Gokhan; Kim, Who M.; Yeager, Stephen G.] Natl Ctr Atmospher Res, Climate & Global Dynam Lab, POB 3000, Boulder, CO 80307 USA	National Oceanic Atmospheric Admin (NOAA) - USA; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Reading; National Center Atmospheric Research (NCAR) - USA	Zhang, R (corresponding author), NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA.	rong.zhang@noaa.gov	Zhang, Rong/D-9767-2014; Delworth, Thomas L/C-5191-2014; Kim, Who Myung/F-5348-2018; Robson, Jon/A-7677-2012	Zhang, Rong/0000-0002-8493-6556; Delworth, Thomas L/0000-0003-4865-5391; Kim, Who Myung/0000-0001-5754-9852; Robson, Jon/0000-0002-3467-018X; Sutton, Rowan/0000-0001-8345-8583; Danabasoglu, Gokhan/0000-0003-4676-2732	Natural Environment Research Council [ncas10009] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Clement A, 2015, SCIENCE, V350, P320, DOI 10.1126/science.aab3980; Dunstone NJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047949; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Gulev SK, 2013, NATURE, V499, P464, DOI 10.1038/nature12268; Hodson DLR, 2014, J CLIMATE, V27, P8229, DOI 10.1175/JCLI-D-14-00301.1; Msadek R, 2014, J CLIMATE, V27, P6472, DOI 10.1175/JCLI-D-13-00476.1; Robson JI, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053370; Robson J, 2012, J CLIMATE, V25, P4116, DOI 10.1175/JCLI-D-11-00443.1; Ruiz-Barradas A, 2013, CLIM DYNAM, V41, P3301, DOI 10.1007/s00382-013-1810-0; Wang CZ, 2013, J CLIMATE, V26, P6137, DOI 10.1175/JCLI-D-12-00721.1; Wang CZ, 2010, CLIM DYNAM, V34, P953, DOI 10.1007/s00382-009-0560-5; Yeager S, 2012, J CLIMATE, V25, P5173, DOI 10.1175/JCLI-D-11-00595.1; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030225; Zhang R, 2013, J ATMOS SCI, V70, P1135, DOI 10.1175/JAS-D-12-0331.1; Zhang R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035463	15	95	96	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293								10.1126/science.aaf1660	http://dx.doi.org/10.1126/science.aaf1660			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339976				2022-12-28	WOS:000378346500030
J	Watson, J				Watson, James			Bring climate change back from the future	NATURE			English	Editorial Material									[Watson, James] Univ Queensland, Brisbane, Qld, Australia; [Watson, James] Soc Conservat Biol, Brisbane, Qld, Australia; [Watson, James] Wildlife Conservat Soc, Sci & Res Initiat, Brisbane, Qld, Australia	University of Queensland	Watson, J (corresponding author), Univ Queensland, Brisbane, Qld, Australia.; Watson, J (corresponding author), Soc Conservat Biol, Brisbane, Qld, Australia.; Watson, J (corresponding author), Wildlife Conservat Soc, Sci & Res Initiat, Brisbane, Qld, Australia.	jwatson@wcs.org	Watson, James Edward Maxwell/D-8779-2013	Watson, James Edward Maxwell/0000-0003-4942-1984					0	17	17	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					437	437		10.1038/534437a	http://dx.doi.org/10.1038/534437a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP1SS	27337304	Bronze			2022-12-28	WOS:000378270300005
J	Cambronne, XA; Stewart, ML; Kim, D; Jones-Brunette, AM; Morgan, RK; Farrens, DL; Cohen, MS; Goodman, RH				Cambronne, Xiaolu A.; Stewart, Melissa L.; Kim, DongHo; Jones-Brunette, Amber M.; Morgan, Rory K.; Farrens, David L.; Cohen, Michael S.; Goodman, Richard H.			Biosensor reveals multiple sources for mitochondrial NAD(+)	SCIENCE			English	Article							NICOTINAMIDE; COMPARTMENTATION; TRANSPORTER; METABOLISM	Nicotinamide adenine dinucleotide (NAD(+)) is an essential substrate for sirtuins and poly(adenosine diphosphate-ribose) polymerases (PARPs), which are NAD(+)-consuming enzymes localized in the nucleus, cytosol, and mitochondria. Fluctuations in NAD(+) concentrations within these subcellular compartments are thought to regulate the activity of NAD(+)-consuming enzymes; however, the challenge in measuring compartmentalized NAD(+) in cells has precluded direct evidence for this type of regulation. We describe the development of a genetically encoded fluorescent biosensor for directly monitoring free NAD(+) concentrations in subcellular compartments. We found that the concentrations of free NAD(+) in the nucleus, cytoplasm, and mitochondria approximate the Michaelis constants for sirtuins and PARPs in their respective compartments. Systematic depletion of enzymes that catalyze the final step of NAD(+) biosynthesis revealed cell-specific mechanisms for maintaining mitochondria! NAD(+) concentrations.	[Cambronne, Xiaolu A.; Stewart, Melissa L.; Kim, DongHo; Goodman, Richard H.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Jones-Brunette, Amber M.; Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Morgan, Rory K.; Cohen, Michael S.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Cambronne, XA (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.; Cohen, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA.	ang@ohsu.edu; cohenmic@ohsu.edu	Cambronne, Xiaolu Ang/GRY-7149-2022	Cambronne, Xiaolu Ang/0000-0002-3547-448X; Morgan, Rory/0000-0003-0194-0304	Pew Charitable Trust; NIH [NS088629, UL1TR000128, P30NS061800, P30CA069533]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088629, P30NS061800] Funding Source: NIH RePORTER	Pew Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NAD<SUP>+</SUP> sensors are available from Oregon Health & Science University (OHSU) under a material transfer agreement with the authors. We thank D. Piston for guidance and the cpVenus construct: C. Brenner and M. Michaud for NR, E. Cambronne for the Enterococcus fecalis isolate, J. Wiedrick and S. Markwardt for statistical help G. Mandel for critical reading of the manuscript, and P. Brehm, J. and C. Galbraith, H. Zhang, and R. Hanson for helpful discussions. Imaging, flow cytometry: and high-performance liquid chromatography were supported by OHSU core facilities. This work was supported by the Pew Charitable Trust and the NIH (grants NS088629, UL1TR000128, P30NS061800, and P30CA069533). X.A.C., M.L.S., M.S.C. and R.H.G. are inventors on pawns PCT/US15/62003 for the NAD<SUP>+</SUP> sensor. Materials and methods are described in the supplementary materials.	Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; Gajiwala KS, 2004, STRUCTURE, V12, P1449, DOI 10.1016/j.str.2004.05.017; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hicks AN, 2013, NEUROUROL URODYNAM, V32, P1130, DOI 10.1002/nau.22372; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Tantama M, 2012, PROG BRAIN RES, V196, P235, DOI 10.1016/B978-0-444-59426-6.00012-4; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200	16	223	229	12	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1474	1477		10.1126/science.aad5168	http://dx.doi.org/10.1126/science.aad5168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313049	Green Accepted			2022-12-28	WOS:000377975400053
J	Morisaki, T; Lyon, K; DeLuca, KF; DeLuca, JG; English, BP; Zhang, ZJ; Lavis, LD; Grimm, JB; Viswanathan, S; Looger, LL; Lionnet, T; Stasevich, TJ				Morisaki, Tatsuya; Lyon, Kenneth; DeLuca, Keith F.; DeLuca, Jennifer G.; English, Brian P.; Zhang, Zhengjian; Lavis, Luke D.; Grimm, Jonathan B.; Viswanathan, Sarada; Looger, Loren L.; Lionnet, Timothee; Stasevich, Timothy J.			Real-time quantification of single RNA translation dynamics in living cells	SCIENCE			English	Article							GENE-EXPRESSION; TRANSCRIPTION; MICROSCOPY; INITIATION; POLYSOMES; MOLECULE; YEAST	Although messenger RNA (mRNA) translation is a fundamental biological process, it has never been imaged in real time in vivo with single-molecule precision. To achieve this, we developed nascent chain tracking (NCT), a technique that uses multi-epitope tags and antibody-based fluorescent probes to quantify protein synthesis dynamics at the single-mRNA level. NCT reveals an elongation rate of similar to 10 amino acids per second, with initiation occurring stochastically every similar to 30 seconds. Polysomes contain similar to 1 ribosome every 200 to 900 nucleotides and are globular rather than elongated in shape. By developing multicolor probes, we showed that most polysomes act independently; however, a small fraction (similar to 5%) form complexes in which two distinct mRNAs can be translated simultaneously. The sensitivity and versatility of NCT make it a powerful new tool for quantifying mRNA translation kinetics.	[Morisaki, Tatsuya; Lyon, Kenneth; DeLuca, Keith F.; DeLuca, Jennifer G.; Stasevich, Timothy J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [English, Brian P.; Zhang, Zhengjian; Lavis, Luke D.; Grimm, Jonathan B.; Viswanathan, Sarada; Looger, Loren L.; Lionnet, Timothee] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA	Colorado State University; Howard Hughes Medical Institute	Stasevich, TJ (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	tim.stasevich@colostate.edu	English, Brian P/O-8156-2016	English, Brian P/0000-0002-4037-6294; Morisaki, Tatsuya/0000-0001-7401-4673; Lionnet, Timothee/0000-0003-1508-0202	Colorado State University	Colorado State University	This work was supported by start-up funds from Colorado State University. We thank R. Cohen, F. Scavone, H. Kimura, S. DiPietro, A. Ambrosio, L Stargell, A. Thurston, and J. Chao for help with experiments. We thank Wu et al. (25) for sharing their preliminary data and. the Transcription Imaging Consortium at the Janelia Research Campus of the Howard Hughes Medical Institute for creating the environment that made our interactions and discussions possible. T.M. and T.J.S. planned, analyzed, and carried out all experiments except for microinjections. T.J.S., I.M. and K.L. wrote the manuscript. K.L. helped with plasmid costruction and transfections cell culture analysis, Western blotting and figures. K.F.D. and J.G.D. performed microinjections. B.P.E. provided guidance to the multicolor single-molecule microscopy. Z.Z. purified Halo-MCP. L.L.L. and S.V. provided HA and FLAG SM constructs. L.D.L. and J.B.G. provided fluorophores. T.L. provided help with experimental design.	Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; Chao J. A., 2012, COLD SPRING HARB PER, V4; Christensen AK, 1999, ANAT REC, V255, P116, DOI 10.1002/(SICI)1097-0185(19990601)255:2<116::AID-AR2>3.0.CO;2-O; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Halstead JM, 2015, SCIENCE, V347, P1367, DOI 10.1126/science.aaa3380; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson R, 2015, RNA, V21, P652, DOI 10.1261/rna.049908.115; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Mueller F, 2012, BIOPHYS J, V102, P1656, DOI 10.1016/j.bpj.2012.02.029; PALMITER RD, 1975, CELL, V4, P189, DOI 10.1016/0092-8674(75)90167-1; Shieh YW, 2015, SCIENCE, V350, P678, DOI 10.1126/science.aac8171; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Viero G, 2015, J CELL BIOL, V208, P581, DOI 10.1083/jcb.201406040; Viswanathan S, 2015, NAT METHODS, V12, P568, DOI 10.1038/nmeth.3365; WARNER JR, 1962, SCIENCE, V138, P1399, DOI 10.1126/science.138.3548.1399; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Wu B, 2016, SCIENCE, V352, P1430, DOI 10.1126/science.aaf1084; Yang JR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001910; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	26	210	215	4	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1425	1429		10.1126/science.aaf0899	http://dx.doi.org/10.1126/science.aaf0899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313040				2022-12-28	WOS:000377975400041
J	Clark, A				Clark, Anthony			John Ernest Tebbett OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		TEBBETT JE, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2016	353								i3329	10.1136/bmj.i3329	http://dx.doi.org/10.1136/bmj.i3329			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HJ	27311485				2022-12-28	WOS:000378240800005
J	Freiman, JM; Tran, TM; Schumacher, SG; White, LF; Ongarello, S; Cohn, J; Easterbrook, PJ; Linas, BP; Denkinger, CM				Freiman, J. Morgan; Tran, Trang M.; Schumacher, Samuel G.; White, Laura F.; Ongarello, Stefano; Cohn, Jennifer; Easterbrook, Philippa J.; Linas, Benjamin P.; Denkinger, Claudia M.			Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							HCV RNA; CLINICAL-USEFULNESS; SERUM-LEVELS; VIRAL LOAD; ASSAY; PERFORMANCE; GENOTYPE; UTILITY; SENSITIVITY; PREVALENCE	Background: Diagnosis of chronic hepatitis C virus (HCV) infection requires both a positive HCV antibody screen and confirmatory nucleic acid testing (NAT). Testing for hepatitis C virus core antigen (HCVcAg) is a potential alternative to NAT. Purpose: To evaluate the accuracy of diagnosis of active HCV infection among adults and children for 5 HCVcAg tests compared with NAT. Data Sources: EMBASE, PubMed, Web of Science, Scopus, and Cochrane Database of Systematic Reviews from 1990 through 31 March 2016. Study Selection: Case-control, cross-sectional, cohort, or randomized trials that compared any of 5 HCVcAg tests with an NAT reference standard. Data Extraction: 2 independent reviewers extracted data and assessed quality using an adapted QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies 2) tool. Data Synthesis: 44 studies evaluated 5 index tests. Studies for the Abbott ARCHITECT HCV Ag assay had the highest quality, whereas those for the Ortho HCV Ag enzyme-linked immunosorbent assay (ELISA) had the lowest quality. From bivariate analyses, the sensitivity and specificity of the assays were as follows: Abbott ARCHITECT, 93.4% (95% CI, 90.1% to 96.4%) and 98.8% (CI, 97.4% to 99.5%); Ortho ELISA, 93.2% (CI, 81.6% to 97.7%) and 99.2% (CI, 87.9% to 100%); and Hunan Jynda Bioengineering Group HCV Ag ELISA, 59.5% (CI, 46.0% to 71.7%) and 82.9% (CI, 58.6% to 94.3%). Insufficient data were available for a meta-analysis about the Fujirebio Lumipulse Ortho HCV Ag and Eiken Lumispot HCV Ag assays. In 3 quantitative studies using Abbott ARCHITECT, HCVcAg correlated closely with HCV RNA levels greater than 3000 IU/mL. Limitations: Insufficient data were available on covariates, such as HIV or hepatitis B virus status, for subgroup analyses. Few studies reported genotypes of isolates, and data for genotypes 4, 5, and 6 were scant. Most studies were conducted in high-resource settings and reference laboratories. Conclusion: The HCVcAg assays with signal amplification have high sensitivity, high specificity, and good correlation with HCV RNA levels greater than 3000 IU/mL and have the potential to replace NAT in settings with high HCV prevalence.	Boston Univ, Sch Publ Hlth, Boston Med Ctr, Boston, MA USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; WHO, Med Sans Frontieres Access Campaign, Geneva, Switzerland; Fdn Innovat New Diagnost, Geneva, Switzerland; Univ Penn, Philadelphia, PA 19104 USA; [Freiman, J. Morgan] One Boston Med Ctr Pl,Dowling 3 North, Boston, MA 02118 USA; [Tran, Trang M.; Cohn, Jennifer] Med Sans Frontieres Access Campaign, Rue Lausanne 78,Box 116, CH-1211 Geneva 21, Switzerland; [Schumacher, Samuel G.; Ongarello, Stefano; Denkinger, Claudia M.] Campus Biotech, Chemin Mines 9, CH-1202 Geneva, Switzerland; [White, Laura F.] Boston Univ, Sch Publ Hlth, Dept Biostat, Crosstown Bldg,801 Massachusetts Ave,3rd Floor, Boston, MA 02118 USA; [Easterbrook, Philippa J.] WHO, Dept 20, HIV AIDS Dept, Ave Appia, CH-1211 Geneva 27, Switzerland; [Linas, Benjamin P.] Boston Univ, Sch Med, Infect Dis Sect, Crosstown Bldg,801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA	Boston Medical Center; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Doctors Without Borders; World Health Organization; Foundation For Innovative New Diagnostics; University of Pennsylvania; Doctors Without Borders; Boston University; World Health Organization; Boston University	Freiman, JM (corresponding author), One Boston Med Ctr Pl,Dowling 3 North, Boston, MA 02118 USA.	j.morgan.freiman@bmc.org	Tran, Trang/GRY-7016-2022	Schumacher, Samuel G/0000-0002-6136-206X; White, Laura F/0000-0002-0588-8235; Easterbrook, Philippa/0000-0002-2603-5418	National Institutes of Health [5T32AI052074-10, 5R01DA031059-04, 1P30DA040500-01, 5P30AI042853-18]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052074, P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031059, P30DA040500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By the National Institutes of Health (grants 5T32AI052074-10, 5R01DA031059-04, 1P30DA040500-01, and 5P30AI042853-18).	Agha S, 2004, J MED VIROL, V73, P216, DOI 10.1002/jmv.20078; Burkner PC, 2014, STAT MED, V33, P3061, DOI 10.1002/sim.6177; Buket CA, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.7; Chevaliez S, 2014, J CLIN VIROL, V61, P145, DOI [10.1016/j.jcv.2014.05.014, 10.1016/j.jcv.2014.15.014]; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cohn J, 2015, CURR OPIN HIV AIDS, V10, P369, DOI 10.1097/COH.0000000000000180; Cresswell FV, 2015, CLIN INFECT DIS, V60, P263, DOI 10.1093/cid/ciu782; Descamps V, 2012, J CLIN MICROBIOL, V50, P465, DOI 10.1128/JCM.06503-11; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Durante-Mangoni E, 2013, J MED VIROL, V85, P1913, DOI 10.1002/jmv.23672; Eden J, 2011, FINDING WHAT WORKS IN HEALTH CARE: STANDARDS FOR SYSTEMATIC REVIEWS, P1; el-Sayed Zaki Maysaa, 2004, Egypt J Immunol, V11, P123; Ergunay K, 2011, DIAGN MICR INFEC DIS, V70, P486, DOI 10.1016/j.diagmicrobio.2011.04.011; Florea D, 2014, J GASTROINTEST LIVER, V23, P393, DOI 10.15403/jgld.2014.1121.234.chcv; Forum for Collaborative HIV Research Foundation for Innovative New Diagnostics, 2015, HIGH PRIOR TARG PROD; Garbuglia AR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-222; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gu Jin-lian, 2014, Chinese Journal of Biologicals, V27, P1181; Gu SJ, 2012, MOL BIOL REP, V39, P8197, DOI 10.1007/s11033-012-1667-z; Hadziyannis E, 2013, ANN GASTROENTEROL, V26, P146; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; Heidrich B, 2014, J VIRAL HEPATITIS, V21, P769, DOI 10.1111/jvh.12204; Kadkhoda K, 2014, CLIN LAB, V60, P677, DOI 10.7754/Clin.Lab.2013.130634; Kamal SM, 2015, ALIMENT PHARM THER, V42, P307, DOI 10.1111/apt.13261; Kamal SM, 2008, AM J GASTROENTEROL, V103, P1283, DOI 10.1111/j.1572-0241.2008.01825.x; Kesli R, 2011, J CLIN MICROBIOL, V49, P4089, DOI 10.1128/JCM.05292-11; Kooglu M, 2012, AFR J MICROBIOL RES, V6, P809, DOI 10.5897/AJMR11.1130; Kuo YH, 2012, J CLIN MICROBIOL, V50, P1989, DOI 10.1128/JCM.05175-11; Letowska M, 2004, TRANSFUSION, V44, P1067, DOI 10.1111/j.1537-2995.2004.03340.x; Li Cavoli Gioacchino, 2012, Hepat Res Treat, V2012, P832021, DOI 10.1155/2012/832021; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Linas BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097317; Lu Ye-cheng, 2007, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V23, P635; Medecins Sans Frontieres, 2015, PUTTING HIV AND HCV; Mederacke I, 2009, J HEPATOL, V50, pS129, DOI 10.1016/S0168-8278(09)60335-4; Mederacke I, 2012, J CLIN VIROL, V53, P110, DOI 10.1016/j.jcv.2011.11.009; Medici MC, 2016, J CLIN VIROL, V77, P92, DOI 10.1016/j.jcv.2016.02.017; Medici MC, 2011, J CLIN VIROL, V51, P260, DOI 10.1016/j.jcv.2011.05.003; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Miedouge M, 2010, J CLIN VIROL, V48, P18, DOI 10.1016/j.jcv.2010.02.012; Mixson-Hayden T, 2015, J CLIN VIROL, V66, P15, DOI 10.1016/j.jcv.2015.02.015; Murayama A, 2012, J CLIN MICROBIOL, V50, P1943, DOI 10.1128/JCM.00487-12; Nubling CM, 2002, TRANSFUSION, V42, P1037, DOI 10.1046/j.1537-2995.2002.00166.x; Ohta Hirotoshi, 2004, Rinsho Byori, V52, P813; Okazaki Kazuyuki, 2008, Rinsho Byori, V56, P95; Ottiger C, 2013, J CLIN VIROL, V58, P535, DOI 10.1016/j.jcv.2013.08.028; Ouyang Yi, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P894; Pai M, 2004, NATL MED J INDIA, V17, P86; Palmer TM, 2008, STATA J, V8, P242, DOI 10.1177/1536867X0800800206; Park Y, 2010, J CLIN MICROBIOL, V48, P2253, DOI 10.1128/JCM.01856-09; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Reyes-Mendez MA, 2014, ANN HEPATOL, V13, P337, DOI 10.1016/S1665-2681(19)30862-2; Rongey CA, 2009, AM J PREV MED, V36, P235, DOI 10.1016/j.amepre.2008.10.013; Rouet F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116975; Russi S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4513; Saito R, 2003, J VIROL METHODS, V112, P93, DOI 10.1016/S0166-0934(03)00195-2; Sidharthan S, 2015, CLIN INFECT DIS, V60, P1743, DOI 10.1093/cid/civ170; Tanaka E, 1996, HEPATOLOGY, V23, P1330, DOI 10.1002/hep.510230606; Tedder RS, 2013, J VIRAL HEPATITIS, V20, P65, DOI 10.1111/j.1365-2893.2012.01630.x; Thong VD, 2015, INTERVIROLOGY, V58, P73, DOI 10.1159/000370070; van Helden J, 2014, Z GASTROENTEROL, V52, P1164, DOI 10.1055/s-0034-1366618; Vanhommerig JW, 2015, J VIROL METHODS, V213, P147, DOI 10.1016/j.jviromet.2014.11.026; VERMEHREN J, 2012, J HEPATOL S2, V56, pS461; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Ward JW, 2015, NEW ENGL J MED, V373, P2678, DOI 10.1056/NEJMe1513245; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; World Health Organization, 2015, HEP C; Zhang HQ, 2007, WORLD J GASTROENTERO, V13, P2738, DOI 10.3748/wjg.v13.i19.2738; Zhu Hong, 2010, Journal of Dalian Medical University, V32, P211	71	115	116	0	78	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					345	+		10.7326/M16-0065	http://dx.doi.org/10.7326/M16-0065			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27322622	Green Accepted			2022-12-28	WOS:000382795000004
J	Matcovitch-Natan, O; Winter, DR; Giladi, A; Aguilar, SV; Spinrad, A; Sarrazin, S; Ben-Yehuda, H; David, E; Gonzalez, FZ; Perrin, P; Keren-Shaul, H; Gury, M; Lara-Astaiso, D; Thaiss, CA; Cohen, M; Halpern, KB; Baruch, K; Deczkowska, A; Lorenzo-Vivas, E; Itzkovitz, S; Elinav, E; Sieweke, MH; Schwartz, M; Amit, I				Matcovitch-Natan, Orit; Winter, Deborah R.; Giladi, Amir; Aguilar, Stephanie Vargas; Spinrad, Amit; Sarrazin, Sandrine; Ben-Yehuda, Hila; David, Eyal; Gonzalez, Fabiola Zelada; Perrin, Pierre; Keren-Shaul, Hadas; Gury, Meital; Lara-Astaiso, David; Thaiss, Christoph A.; Cohen, Merav; Halpern, Keren Bahar; Baruch, Kuti; Deczkowska, Aleksandra; Lorenzo-Vivas, Erika; Itzkovitz, Shalev; Elinav, Eran; Sieweke, Michael H.; Schwartz, Michal; Amit, Ido			Microglia development follows a stepwise program to regulate brain homeostasis	SCIENCE			English	Article							TISSUE-RESIDENT MACROPHAGES; HEMATOPOIETIC STEM-CELLS; HUMAN GENOME; MYELOID PROGENITORS; IMMUNE INVOLVEMENT; LANGERHANS CELLS; GENE-EXPRESSION; CHOROID-PLEXUS; SELF-RENEWAL; ADULT LIFE	Microglia, the resident myeloid cells of the central nervous system, play important roles in life-long brain maintenance and in pathology. Despite their importance, their regulatory dynamics during brain development have not been fully elucidated. Using genome-wide chromatin and expression profiling coupled with single-cell transcriptomic analysis throughout development, we found that microglia undergo three temporal stages of development in synchrony with the brain-early, pre-, and adult microglia-which are under distinct regulatory circuits. Knockout of the gene encoding the adult microglia transcription factor MAFB and environmental perturbations, such as those affecting the microbiome or prenatal immune activation, led to disruption of developmental genes and immune response pathways. Together, our work identifies a stepwise microglia developmental program integrating immune response pathways that may be associated with several neurodevelopmental disorders.	[Matcovitch-Natan, Orit; Winter, Deborah R.; Giladi, Amir; Spinrad, Amit; David, Eyal; Keren-Shaul, Hadas; Gury, Meital; Lara-Astaiso, David; Thaiss, Christoph A.; Lorenzo-Vivas, Erika; Elinav, Eran; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Matcovitch-Natan, Orit; Spinrad, Amit; Ben-Yehuda, Hila; Cohen, Merav; Baruch, Kuti; Deczkowska, Aleksandra; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [Aguilar, Stephanie Vargas; Sarrazin, Sandrine; Gonzalez, Fabiola Zelada; Perrin, Pierre; Sieweke, Michael H.] Univ Aix Marseille, CIML, UM2, Campus Luminy, Marseille, France; [Aguilar, Stephanie Vargas; Sarrazin, Sandrine; Gonzalez, Fabiola Zelada; Perrin, Pierre; Sieweke, Michael H.] INSERM, U1104, Marseille, France; [Aguilar, Stephanie Vargas; Sarrazin, Sandrine; Gonzalez, Fabiola Zelada; Perrin, Pierre; Sieweke, Michael H.] CNRS, UMR7280, Marseille, France; [Aguilar, Stephanie Vargas; Sieweke, Michael H.] Helmholt Gemeinschaft MDC, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Halpern, Keren Bahar; Itzkovitz, Shalev] Weizmann Inst Sci, Dept Cell Biol, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Weizmann Institute of Science	Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.; Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel.; Sieweke, MH (corresponding author), Univ Aix Marseille, CIML, UM2, Campus Luminy, Marseille, France.; Sieweke, MH (corresponding author), INSERM, U1104, Marseille, France.; Sieweke, MH (corresponding author), CNRS, UMR7280, Marseille, France.; Sieweke, MH (corresponding author), Helmholt Gemeinschaft MDC, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	sieweke@ciml.univ-mrs.fr; michal.schwartz@weizmann.ac.il; ido.amit@weizmann.ac.il	Winter, Deborah R./AAQ-9253-2020; Sieweke, Michael/AAR-7515-2020; Elinav, Eran/ABE-8881-2020	Winter, Deborah R./0000-0003-1806-673X; Sieweke, Michael/0000-0002-3228-9537; Elinav, Eran/0000-0002-5775-2110; Spinrad, Amit/0000-0003-0158-6464; Lorenzo Vivas, Erika/0000-0002-8150-5902; Vargas Aguilar, Stephanie/0000-0002-6584-0209	European Research Council [309788]; Israeli Science Foundation [1782/11]; European Commission Seventh Framework Programme (EC FP7) BLUEPRINT consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; Israeli Ministry of Science, Technology and Space; David and Fela Shapell Family Foundation; National Human Genome Research Institute Center for Excellence in Genome Science [1P50HG006193]; Alan and Laraine Fischer Career Development Chair; Advanced European Research Council [232835]; EC FP7 HEALTH-2011 program [279017]; Agence Nationale de la Recherche [ANR BLAN07-1_205752, ANR-11-BSV3-026-01]; Fondation pour la Recherche Medicale [DEq. 20071210559, DEq. 20110421320]; InCA (French National Cancer Institute) [13-10/405/AB-LC-HS]; European Molecular Biology Organization (EMBO) [ALT766-2014]; EC FP7 (Marie Curie Actions) [GA-2012-600394]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Israeli Science Foundation(Israel Science Foundation); European Commission Seventh Framework Programme (EC FP7) BLUEPRINT consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; Israeli Ministry of Science, Technology and Space(Ministry of Science, Technology and Space (MOST), Israel); David and Fela Shapell Family Foundation; National Human Genome Research Institute Center for Excellence in Genome Science; Alan and Laraine Fischer Career Development Chair; Advanced European Research Council(European Research Council (ERC)); EC FP7 HEALTH-2011 program; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); InCA (French National Cancer Institute)(Institut National du Cancer (INCA) France); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); EC FP7 (Marie Curie Actions); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the I. A. and M.S. laboratories for discussions, T. Wiesel for artwork, M. Barad from the CIML flow cytometry platform for assistance with microglia sorting, and M. Azoulay and O. Rozenberg for animal handling. Research in the I. A. laboratory is supported by the European Research Council (grant 309788); the Israeli Science Foundation (grant 1782/11); the European Commission Seventh Framework Programme (EC FP7) BLUEPRINT consortium; the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; a Minerva Stiftung research grant; the Israeli Ministry of Science, Technology and Space; the David and Fela Shapell Family Foundation; and the National Human Genome Research Institute Center for Excellence in Genome Science (grant 1P50HG006193). I.A. holds the Alan and Laraine Fischer Career Development Chair. Research in the M.S. laboratory is supported by the Advanced European Research Council (grant 232835) and by the EC FP7 HEALTH-2011 program (grant 279017). M.S. holds the Maurice and Ilse Katz Professorial Chair in Neuroimmunology. M.H.S. was supported by grants from the Agence Nationale de la Recherche (grants ANR BLAN07-1_205752 and ANR-11-BSV3-026-01), the Fondation pour la Recherche Medicale (DEq. 20071210559 and DEq. 20110421320), and InCA (French National Cancer Institute; grant 13-10/405/AB-LC-HS). M.H.S. is a Berlin Institute of Health Einstein fellow and an INSERM-Helmholtz group leader. D.R.W. is supported by the European Molecular Biology Organization (EMBO; ALT766-2014) and the EC FP7 (Marie Curie Actions, EMBOCOFUND2012, GA-2012-600394). ATAC-seq, ChIP-seq, bulk RNA-seq, and single-cell RNA-seq data are deposited in the Genome Expression Omnibus under accession number GSE79819.	AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; BRADY G, 1995, CURR BIOL, V5, P909, DOI 10.1016/S0960-9822(95)00181-3; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Calaminus SDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051361; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24; Gate D, 2010, J NEURAL TRANSM, V117, P961, DOI 10.1007/s00702-010-0422-7; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Giovanoli S, 2016, BRAIN BEHAV IMMUN, V55, P25, DOI 10.1016/j.bbi.2015.09.015; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Halpern KB, 2015, MOL CELL, V58, P147, DOI 10.1016/j.molcel.2015.01.027; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim H, 2010, NAT IMMUNOL, V11, P743, DOI 10.1038/ni.1897; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2008, NEUROPSYCHOPHARMACOL, V33, P441, DOI 10.1038/sj.npp.1301413; Meyer U, 2006, BRAIN BEHAV IMMUN, V20, P378, DOI 10.1016/j.bbi.2005.11.003; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nirschl CJ, 2013, CLIN CANCER RES, V19, P4917, DOI 10.1158/1078-0432.CCR-12-1972; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Winter DR, 2014, IMMUNOL REV, V261, P9, DOI 10.1111/imr.12200; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	82	627	635	9	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2016	353	6301							aad8670	10.1126/science.aad8670	http://dx.doi.org/10.1126/science.aad8670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZE	27338705				2022-12-28	WOS:000381561400037
J	Coffin, PO; Behar, E; Rowe, C; Santos, GM; Coffa, D; Bald, M; Vittinghoff, E				Coffin, Phillip O.; Behar, Emily; Rowe, Christopher; Santos, Glenn-Milo; Coffa, Diana; Bald, Matthew; Vittinghoff, Eric			Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; HEROIN USERS; OVERDOSE PREVENTION	Background: Unintentional overdose involving opioid analgesics is a leading cause of injury-related death in the United States. Objective: To evaluate the feasibility and effect of implementing naloxone prescription to patients prescribed opioids for chronic pain. Design: 2-year nonrandomized intervention study. Setting: 6 safety-net primary care clinics in San Francisco, California. Participants: 1985 adults receiving long-term opioid therapy for pain. Intervention: Providers and clinic staff were trained and supported in naloxone prescribing. Measurements: Outcomes were proportion of patients prescribed naloxone, opioid-related emergency department (ED) visits, and prescribed opioid dose based on chart review. Results: 38.2% of 1985 patients receiving long-term opioids were prescribed naloxone. Patients prescribed higher doses of opioids and with an opioid-related ED visit in the past 12 months were independently more likely to be prescribed naloxone. Patients who received a naloxone prescription had 47% fewer opioid-related ED visits per month in the 6 months after receipt of the prescription (incidence rate ratio [IRR], 0.53 [95% CI, 0.34 to 0.83]; P = 0.005) and 63% fewer visits after 1 year (IRR, 0.37 [CI, 0.22 to 0.64]; P < 0.001) compared with patients who did not receive naloxone. There was no net change over time in opioid dose among those who received naloxone and those who did not (IRR, 1.03 [CI, 0.91 to 1.27]; P = 0.61). Limitation: Results are observational and may not be generalizable beyond safety-net settings. Conclusion: Naloxone can be coprescribed to primary care patients prescribed opioids for pain. When advised to offer naloxone to all patients receiving opioids, providers may prioritize those with established risk factors. Providing naloxone in primary care settings may have ancillary benefits, such as reducing opioid-related adverse events.	[Coffin, Phillip O.; Behar, Emily; Rowe, Christopher; Santos, Glenn-Milo] San Francisco Dept Publ Hlth, 25 Van Ness Ave,Suite 500, San Francisco, CA 94102 USA; [Vittinghoff, Eric] Univ Calif San Francisco, 550 16th St, San Francisco, CA 94158 USA; [Coffa, Diana] Univ Calif San Francisco, Sch Med, 1001 Potrero Ave,SFGH 80, San Francisco, CA 94110 USA; [Bald, Matthew] Kaiser Permanente San Francisco, 2425 Geary Blvd,M160, San Francisco, CA 94115 USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente	Coffin, PO (corresponding author), San Francisco Dept Publ Hlth, 25 Van Ness Ave,Suite 500, San Francisco, CA 94102 USA.	phillip.coffin@ucsf.edu	Coffin, Phillip O/G-3286-2012	Coffin, Phillip O/0000-0002-3891-6570; Santos, Glenn-Milo/0000-0003-1009-5317	National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA036776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health.	Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; [Anonymous], 2016, MED LETT DRUGS THER, V58, P1; Bartoszek M, 2012, OPERATION OPIOIDSAFE; Coffin PO, 2013, ANN INTERN MED, V158, P1, DOI 10.7326/0003-4819-158-1-201301010-00003; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Giglio Rebecca E, 2015, Inj Epidemiol, V2, P10; Greenland S, 2003, EPIDEMIOLOGY, V14, P300, DOI 10.1097/00001648-200305000-00009; Hirsch A, 2014, PAIN MED, V15, P1187, DOI 10.1111/pme.12391; Jones CM, 2015, MMWR-MORBID MORTAL W, V64, P719; Khalid L, 2015, PAIN MED, V16, P480, DOI 10.1111/pme.12602; Maxwell S, 2006, J ADDICT DIS, V25, P89, DOI 10.1300/J069v25n03_11; National Services Scotland, 2014, NAT NAL PROGR SCOTL; Paone D, 2010, ILLICIT DRUG USE NY, P1; Rudd RA, 2014, MMWR-MORBID MORTAL W, V63, P849; Seal KH, 2005, J URBAN HEALTH, V82, P303, DOI 10.1093/jurban/jti053; Substance Abuse and Mental Health Services Administration: Office of Applied Studies, 2009, DRUG AB WARN NETW EM, P178; Svendsen K, 2011, PALLIATIVE MED, V25, P725, DOI 10.1177/0269216311398300; Visconti AJ, 2015, J URBAN HEALTH, V92, P758, DOI 10.1007/s11524-015-9967-y; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Walley A.Y., 2012, BYSTANDER OVERDOSE E; Walley AY, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f174; Wheeler E, 2015, MMWR-MORBID MORTAL W, V64, P631	22	117	118	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					245	+		10.7326/M15-2771	http://dx.doi.org/10.7326/M15-2771			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27366987	Green Accepted			2022-12-28	WOS:000381267200013
J	Euler, T; Baden, T				Euler, Thomas; Baden, Tom			COMPUTATIONAL NEUROSCIENCE Species-specific motion detectors	NATURE			English	Editorial Material							STARBURST AMACRINE CELLS; DIRECTION-SELECTIVITY; WIRING SPECIFICITY; RABBIT RETINA		[Euler, Thomas; Baden, Tom] Univ Tubingen, Inst Ophthalm Res, D-72076 Tubingen, Germany; [Euler, Thomas] Univ Tubingen, Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Baden, Tom] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Sussex	Euler, T (corresponding author), Univ Tubingen, Inst Ophthalm Res, D-72076 Tubingen, Germany.	thomas@eulerlab.de; tom@badenlab.org		Euler, Thomas/0000-0002-4567-6966				Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Ding HY, 2016, NATURE, V535, P105, DOI 10.1038/nature18609; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Gebhardt C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00111; Grzywacz NM, 2007, VISUAL NEUROSCI, V24, P647, DOI 10.1017/S0952523807070666; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; RODIECK RW, 1989, J COMP NEUROL, V285, P18, DOI 10.1002/cne.902850104; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165	11	9	9	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					45	46		10.1038/nature18454	http://dx.doi.org/10.1038/nature18454			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27350240				2022-12-28	WOS:000379015600025
J	Harrison, P; Hogan, BJ; Floros, L; Davies, E				Harrison, P.; Hogan, B. J.; Floros, L.; Davies, E.		Guideline Dev Grp	GUIDELINES Assessment and management of cirrhosis in people older than 16 years: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harrison, P.] Kings Coll Hosp London, London SE5 9RS, England; [Hogan, B. J.] Guyss & St Thomas Hosp NHS Fdn Trust, Intens Care Med & Hepatol, London, England; [Floros, L.; Davies, E.] Royal Coll Physicians, Natl Guideline Ctr, London NW1 4LE, England	King's College Hospital NHS Foundation Trust; King's College Hospital; Royal College of Physicians	Davies, E (corresponding author), Royal Coll Physicians, Natl Guideline Ctr, London NW1 4LE, England.	Emily.Davies@rcplondon.ac.uk		Hogan, Brian/0000-0002-6902-4380				[Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; National Institute for Health and Care Excellence, 2016, ASS MAN CIRRH CLIN G; National Institute for Health and Care Excellence, 2016, NON FATT LIV DIS NAF; RightCare, 2013, NHS ATL VAR HEALTHC; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9	6	10	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2016	354								i2850	10.1136/bmj.i2850	http://dx.doi.org/10.1136/bmj.i2850			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EP	27383758				2022-12-28	WOS:000379581100002
J	David, TJ; Hillenbrand, LA; Petigura, EA; Carpenter, JM; Crossfield, IJM; Hinkley, S; Ciardi, DR; Howard, AW; Isaacson, HT; Cody, AM; Schlieder, JE; Beichman, CA; Barenfeld, SA				David, Trevor J.; Hillenbrand, Lynne A.; Petigura, Erik A.; Carpenter, John M.; Crossfield, Ian J. M.; Hinkley, Sasha; Ciardi, David R.; Howard, Andrew W.; Isaacson, Howard T.; Cody, Ann Marie; Schlieder, Joshua E.; Beichman, Charles A.; Barenfeld, Scott A.			A Neptune-sized transiting planet closely orbiting a 5-10-million-year-old star	NATURE			English	Article							LOW-MASS STARS; PRE-MAIN-SEQUENCE; UPPER-SCORPIUS; GIANT PLANETS; M DWARFS; MEMBERS; I.; KEPLER; MODEL; MULTIPLICITY	Theories of the formation and early evolution of planetary systems postulate that planets are born in circumstellar disks, and undergo radial migration during and after dissipation of the dust and gas disk from which they formed(1,2). The precise ages of meteorites indicate that planetesimals-the building blocks of planets-are produced within the first million years of a star's life(3). Fully formed planets are frequently detected on short orbital periods around mature stars. Some theories suggest that the in situ formation of planets close to their host stars is unlikely and that the existence of such planets is therefore evidence of large-scale migration(4,5). Other theories posit that planet assembly at small orbital separations may be common(6-8). Here we report a newly born, transiting planet orbiting its star with a period of 5.4 days. The planet is 50 per cent larger than Neptune, and its mass is less than 3.6 times that of Jupiter (at 99.7 per cent confidence), with a true mass likely to be similar to that of Neptune. The star is 5-10 million years old and has a tenuous dust disk extending outward from about twice the Earth-Sun separation, in addition to the fully formed planet located at less than one-twentieth of the Earth-Sun separation.	[David, Trevor J.; Hillenbrand, Lynne A.; Barenfeld, Scott A.] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA; [Petigura, Erik A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Carpenter, John M.] Joint ALMA Observ, Ave Alonso de Cordova 3107, Santiago, Chile; [Crossfield, Ian J. M.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Hinkley, Sasha] Univ Exeter, Dept Phys, Stocker Rd, Exeter EX4 4QL, Devon, England; [Ciardi, David R.; Beichman, Charles A.] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Howard, Andrew W.] Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA; [Isaacson, Howard T.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Cody, Ann Marie; Schlieder, Joshua E.] NASA Ames Res Ctr, Mountain View, CA 94035 USA	California Institute of Technology; California Institute of Technology; University of Arizona; University of Exeter; California Institute of Technology; National Aeronautics & Space Administration (NASA); University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	David, TJ (corresponding author), CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA.	tjd@astro.caltech.edu	Petigura, Erik/GZL-2909-2022	Petigura, Erik/0000-0003-0967-2893; David, Trevor/0000-0001-6534-6246; Ciardi, David/0000-0002-5741-3047; Carpenter, John/0000-0003-2251-0602	NSF [DGE1144469]; Hubble Fellowship; Sagan Fellowship; NASA [NNX16AE75G, 1541779]; NASA Science Mission directorate; STFC [ST/M00127X/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); Hubble Fellowship; Sagan Fellowship; NASA(National Aeronautics & Space Administration (NASA)); NASA Science Mission directorate(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank S. Metchev, K Batygin, B. Benneke, K Deck, J. Fuller and A. Shporer for discussions, M. Ireland for software used in the aperture masking analysis, and A. Kraus for contributing to the 2011 Keck/NIRC2 data acquisition. T.J.D. is supported by an NSF Graduate Research Fellowship under Grant DGE1144469. E.A.P. is supported through a Hubble Fellowship. I.J.M.C. is supported through a Sagan Fellowship. A.W.H. acknowledges funding from NASA grant NNX16AE75G and NASA Research Support Agreement 1541779. This paper includes data collected by the Kepler mission, funded by the NASA Science Mission directorate. Some data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and NASA We acknowledge the important cultural role and reverence that the summit of Mauna Kea has always had within the indigenous Hawaiian community and we are fortunate to be able to conduct observations from this mountain.	Allen PR, 2003, ASTROPHYS J, V595, P1222, DOI 10.1086/377436; [Anonymous], 2008, NEAREST OB ASS SCORP; Armitage PJ, 2011, ANNU REV ASTRON ASTR, V49, P195, DOI 10.1146/annurev-astro-081710-102521; BALDWIN JE, 1986, NATURE, V320, P595, DOI 10.1038/320595a0; Baraffe I, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425481; Barenfeld S., ASTROPHYS J IN PRESS; BLAAUW A, 1991, NATO ADV SCI I C-MAT, V342, P125; Boley AC, 2016, ASTROPHYS J LETT, V817, DOI 10.3847/2041-8205/817/2/L17; Bouy H, 2009, ASTRON ASTROPHYS, V504, P981, DOI 10.1051/0004-6361/200811088; Bowler BP, 2015, ASTROPHYS J SUPPL S, V216, DOI 10.1088/0067-0049/216/1/7; Brand J., 1985, ASSL, V120, P95; Chen CH, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/122; Claret A, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219849; Crossfield IJM, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/10; David T. J., 2015, ASTROPHYS J, V816, P21; David TJ, 2016, ASTRON J, V151, DOI 10.3847/0004-6256/151/5/112; de Bruijne JHJ, 1999, MON NOT R ASTRON SOC, V310, P585, DOI 10.1046/j.1365-8711.1999.02953.x; de Zeeuw PT, 1999, ASTRON J, V117, P354, DOI 10.1086/300682; DEGEUS EJ, 1989, ASTRON ASTROPHYS, V216, P44; Dieterich SB, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/2/64; Dressing CD, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/45; Dressing CD, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/95; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Frink S., 1999, THESIS; Girardi L, 2005, ASTRON ASTROPHYS, V436, P895, DOI 10.1051/0004-6361:20042352; Girardi L, 2012, ASTROPHYSICS SPACE, P165, DOI 10.1007/978-3-642-18418-5_17; Hansen BMS, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/158; Herczeg GJ, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/1/23; Hinkley S, 2015, ASTROPHYS J LETT, V806, DOI 10.1088/2041-8205/806/1/L9; Howell SB, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/123; Huelamo N, 2008, ASTRON ASTROPHYS, V489, pL9, DOI 10.1051/0004-6361:200810596; Jackson RJ, 2014, MON NOT R ASTRON SOC, V441, P2111, DOI 10.1093/mnras/stu651; Kolbl R., 2014, ASTRON J, V149, P18, DOI DOI 10.1088/0004-6256/149/1/18; Kraus AL, 2007, ASTROPHYS J, V662, P413, DOI 10.1086/516835; Kraus AL, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/3; Kraus AL, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/141; Kraus AL, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/8; Kreidberg L, 2015, PUBL ASTRON SOC PAC, V127, P1161, DOI 10.1086/683602; Kurosawa R, 2006, MON NOT R ASTRON SOC, V372, P1879, DOI 10.1111/j.1365-2966.2006.11005.x; Lepine S, 2009, ASTRON J, V137, P3632, DOI 10.1088/0004-6256/137/3/3632; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Lodieu N, 2015, ASTRON ASTROPHYS, V584, DOI 10.1051/0004-6361/201527464; Lodieu N, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201014992; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Malavolta L, 2016, ASTRON ASTROPHYS, V588, DOI 10.1051/0004-6361/201527933; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Mann AW, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/1/46; Martin EL, 1998, ASTRON J, V115, P351, DOI 10.1086/300168; McQuillan A, 2013, MON NOT R ASTRON SOC, V432, P1203, DOI 10.1093/mnras/stt536; Montet BT, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/28; Morton T. D., 2015, ASTROPHYS SOURCE COD; Nidever DL, 2002, ASTROPHYS J SUPPL S, V141, P503, DOI 10.1086/340570; Pecaut MJ, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/9; Pecaut MJ, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/154; Petigura EA, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/2/102; Preibisch T, 1999, ASTRON J, V117, P2381, DOI 10.1086/300842; Preibisch T, 2002, ASTRON J, V124, P404, DOI 10.1086/341174; Preibisch T, 2001, ASTRON J, V121, P1040, DOI 10.1086/318774; Rafikov RR, 2006, ASTROPHYS J, V648, P666, DOI 10.1086/505695; READHEAD ACS, 1988, ASTRON J, V95, P1278, DOI 10.1086/114724; Rucinski SM, 2008, MON NOT R ASTRON SOC, V391, P1913, DOI 10.1111/j.1365-2966.2008.14014.x; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Trilling DE, 2008, ASTROPHYS J, V674, P1086, DOI 10.1086/525514; Tuthill PG, 2000, PUBL ASTRON SOC PAC, V112, P555, DOI 10.1086/316550; Vanderburg A, 2016, ASTROPHYS J SUPPL S, V222, DOI 10.3847/0067-0049/222/1/14; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; Wyatt MC, 2008, ANNU REV ASTRON ASTR, V46, P339, DOI 10.1146/annurev.astro.45.051806.110525; Yu L, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/48	78	121	121	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					658	+		10.1038/nature18293	http://dx.doi.org/10.1038/nature18293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27324846	Green Submitted, Green Accepted			2022-12-28	WOS:000378676000030
J	O'Connor, DH; Osorio, JE; Tanuri, A; Kallas, EG				O'Connor, David H.; Osorio, Jorge E.; Tanuri, Amilcar; Kallas, Esper G.			Forging Collaborative Relationships in Brazil: From AIDS to ZIKV	CELL			English	Editorial Material								The Zika virus (ZIKV) outbreak has stimulated collaborations between Brazilians, researchers from other South American countries, and scientists from around the world. The Brazilian response to the HIV/AIDS epidemic demonstrates capabilities that can be applied to the study of ZIKV and provides lessons for developing effective international infectious disease research collaborations.	[O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA; [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53705 USA; [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, BR-2194190 Rio De Janeiro, Brazil; [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, BR-01246903 Sao Paulo, Brazil; [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Dept Infect Dis, BR-01246903 Sao Paulo, Brazil	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade de Sao Paulo	O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.; Kallas, EG (corresponding author), Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, BR-01246903 Sao Paulo, Brazil.; Kallas, EG (corresponding author), Univ Sao Paulo, Sch Med, Dept Infect Dis, BR-01246903 Sao Paulo, Brazil.	dhoconno@wisc.edu; esper.kallas@usp.br	Tanuri, Amilcar/AAM-8601-2021	Kallas, Esper/0000-0003-2026-6925				Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502; Central Intelligence Agency, 2016, WORLD FACTBOOK; Gao GF, 2014, SCIENCE, V346, P666, DOI 10.1126/science.346.6209.666; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Merson MH, 2014, NEW ENGL J MED, V370, P1676, DOI 10.1056/NEJMp1401124; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Office of the United Nations Special Envoy on Ebola, 2016, RES RES 5; Scimago Journal & Country Rank, 2016, COUNTR RANK; Sistema Unico de Saude, 2016, PORT DA SAUD; The World Bank, 2016, WORLD DEV IND REPR H; World Bank, 2016, COUNTR LEND GROUPS; World Bank, 2020, RES DEV EXP GDP; World Health Organization, 2016, SIT REP ZIK VIR DIS; World Health Organization, 2016, WORLD HLTH ORG COUNT	14	1	1	0	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					2	4		10.1016/j.cell.2016.06.023	http://dx.doi.org/10.1016/j.cell.2016.06.023			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368092	Bronze			2022-12-28	WOS:000380254400002
J	von der Ecken, J; Heissler, SM; Pathan-Chhatbar, S; Manstein, DJ; Raunser, S				von der Ecken, Julian; Heissler, Sarah M.; Pathan-Chhatbar, Salma; Manstein, Dietmar J.; Raunser, Stefan			Cryo-EM structure of a human cytoplasmic actomyosin complex at near-atomic resolution	NATURE			English	Article							HEAVY-CHAIN GENE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; DICTYOSTELIUM MYOSIN-II; ACTIN-BINDING SITE; BETA-MYOSIN; FUNCTIONAL-CHARACTERIZATION; DILATED CARDIOMYOPATHY; MUSCLE-CONTRACTION; MISSENSE MUTATION; ATPASE ACTIVITY	The interaction of myosin with actin filaments is the central feature of muscle contraction(1) and cargo movement along actin filaments of the cytoskeleton(2). The energy for these movements is generated during a complex mechanochemical reaction cycle(3,4). Crystal structures of myosin in different states have provided important structural insights into the myosin motor cycle when myosin is detached from F-actin(5-7). The difficulty of obtaining diffracting crystals, however, has prevented structure determination by crystallography of actomyosin complexes. Thus, although structural models exist of F-actin in complex with various myosins(8-11), a high-resolution structure of the F-actin-myosin complex is missing. Here, using electron cryomicroscopy, we present the structure of a human rigor actomyosin complex at an average resolution of 3.9 angstrom. The structure reveals details of the actomyosin interface, which is mainly stabilized by hydrophobic interactions. The negatively charged amino (N) terminus of actin interacts with a conserved basic motif in loop 2 of myosin, promoting cleft closure in myosin. Surprisingly, the overall structure of myosin is similar to rigor-like myosin structures in the absence of F-actin, indicating that F-actin binding induces only minimal conformational changes in myosin. A comparison with pre-powerstroke and intermediate (P-i-release)(7) states of myosin allows us to discuss the general mechanism of myosin binding to F-actin. Our results serve as a strong foundation for the molecular understanding of cytoskeletal diseases, such as autosomal dominant hearing loss and diseases affecting skeletal and cardiac muscles, in particular nemaline myopathy and hypertrophic cardiomyopathy.	[von der Ecken, Julian; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany; [Heissler, Sarah M.; Pathan-Chhatbar, Salma; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Manstein, Dietmar J.] Hannover Med Sch, Div Struct Anal, D-30625 Hannover, Germany; [Heissler, Sarah M.] NHLBI, Lab Mol Physiol, NIH, Bldg 10, Bethesda, MD 20892 USA	Max Planck Society; Hannover Medical School; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Raunser, S (corresponding author), Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany.	stefan.raunser@mpi-dortmund.mpg.de	Raunser, Stefan/AHE-1573-2022; Manstein, Dietmar J./AAG-2640-2019; Manstein, Dietmar J. J/M-1034-2013	Manstein, Dietmar J./0000-0003-0763-0147; Manstein, Dietmar J. J/0000-0003-0763-0147; von der Ecken, Julian/0000-0001-8526-2656; Raunser, Stefan/0000-0001-9373-3016	Max Planck Society; European Research Council under the European Union [615984]; Behrens-Weise foundation; German Research Foundation (DFG) [MA 1081/21-1]	Max Planck Society(Max Planck Society); European Research Council under the European Union(European Research Council (ERC)); Behrens-Weise foundation; German Research Foundation (DFG)(German Research Foundation (DFG))	We thank O. Hofnagel for assistance in cryo sample preparation. We acknowledge R. Matadeen and S. de Carlo for image acquisition at the Netherlands Centre for Nanoscopy in Leiden. We thank R. S. Goody for reading the manuscript. This work was supported by the Max Planck Society, the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013) (grant number 615984) (to S.R.), the Behrens-Weise foundation (to S. R.) and German Research Foundation (DFG) grant MA 1081/21-1 (to D.J.M.). J.v.d.E. is a fellow of Studienstiftung des deutschen Volkes.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Blanchard E, 1999, CIRC RES, V84, P475, DOI 10.1161/01.RES.84.4.475; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COOK RK, 1993, J BIOL CHEM, V268, P2410; Coulton A, 2006, BIOCHEMISTRY-US, V45, P12853, DOI 10.1021/bi0613224; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; CUDA G, 1993, J CLIN INVEST, V91, P2861, DOI 10.1172/JCI116530; Daehmlow S, 2002, BIOCHEM BIOPH RES CO, V298, P116, DOI 10.1016/S0006-291X(02)02374-4; DAUSSE E, 1993, J CLIN INVEST, V92, P2807, DOI 10.1172/JCI116900; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EPSTEIN ND, 1992, CIRCULATION, V86, P345, DOI 10.1161/01.CIR.86.2.345; Erdmann J, 2003, CLIN GENET, V64, P339, DOI 10.1034/j.1399-0004.2003.00151.x; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Greber-Platzer S, 2001, J MOL CELL CARDIOL, V33, P141, DOI 10.1006/jmcc.2000.1287; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Klein JC, 2008, P NATL ACAD SCI USA, V105, P12867, DOI 10.1073/pnas.0802286105; Kojima S, 2001, BIOCHEMISTRY-US, V40, P657, DOI 10.1021/bi0011328; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LANKFORD EB, 1995, J CLIN INVEST, V95, P1409, DOI 10.1172/JCI117795; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Llinas P, 2015, DEV CELL, V33, P401, DOI 10.1016/j.devcel.2015.03.025; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; MILLIGAN RA, 1990, NATURE, V348, P217, DOI 10.1038/348217a0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mohiddin SA, 2003, GENET TEST, V7, P21, DOI 10.1089/109065703321560895; MOOLMAN JC, 1993, HUM MOL GENET, V2, P1731, DOI 10.1093/hmg/2.10.1731; Moolman-Smook JC, 1999, AM J HUM GENET, V65, P1308, DOI 10.1086/302623; Muller M, 2012, CELL MOL LIFE SCI, V69, P3457, DOI 10.1007/s00018-012-1030-5; Munnich S, 2014, FEBS LETT, V588, P4754, DOI 10.1016/j.febslet.2014.11.007; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Murphy CT, 1999, BIOCHEMISTRY-US, V38, P3785, DOI 10.1021/bi9826815; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Ohki T, 2009, BIOCHEM BIOPH RES CO, V383, P146, DOI 10.1016/j.bbrc.2009.03.144; Onishi H, 2006, P NATL ACAD SCI USA, V103, P6136, DOI 10.1073/pnas.0601595103; Perrot A, 2005, J MOL MED-JMM, V83, P468, DOI 10.1007/s00109-005-0635-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Lopez-Blanco JR, 2013, J STRUCT BIOL, V184, P261, DOI 10.1016/j.jsb.2013.08.010; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasaki N, 1999, J BIOL CHEM, V274, P37840, DOI 10.1074/jbc.274.53.37840; Sasaki N, 2000, J BIOL CHEM, V275, P38705, DOI 10.1074/jbc.M001966200; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; UYEDA TQP, 1994, NATURE, V368, P567, DOI 10.1038/368567a0; Van Dijk J, 1999, BIOCHEMISTRY-US, V38, P15078, DOI 10.1021/bi991595h; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P602, DOI 10.1016/j.jacc.2004.04.039; Varkuti BH, 2015, J BIOL CHEM, V290, P1679, DOI 10.1074/jbc.M114.606665; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Villard E, 2005, EUR HEART J, V26, P794, DOI 10.1093/eurheartj/ehi193; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woo A, 2003, HEART, V89, P1179, DOI 10.1136/heart.89.10.1179; Yu B, 2005, J CLIN PATHOL, V58, P479, DOI 10.1136/jcp.2004.021642	78	132	132	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					724	+		10.1038/nature18295	http://dx.doi.org/10.1038/nature18295			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27324845				2022-12-28	WOS:000378676000045
J	Hankey, GJ				Hankey, Graeme J.			The ABC-stroke risk score was superior to the CHA(2)DS(2)-VASc score for predicting stroke in atrial fibrillation Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANTICOAGULATION; BIOMARKERS		[Hankey, Graeme J.] Univ Western Australia, Perth, WA, Australia	University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Perth, WA, Australia.		Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Aspberg S., 2016, EUR HEART J; Hijazi Z, 2016, HEART, V102, P508, DOI 10.1136/heartjnl-2015-308887; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128	4	0	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					JC69	JC69		10.7326/ACPJC-2016-164-12-069	http://dx.doi.org/10.7326/ACPJC-2016-164-12-069			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323265				2022-12-28	WOS:000379343000008
J	Young-Wolff, KC; Kotz, K; Mccaw, B				Young-Wolff, Kelly C.; Kotz, Krista; Mccaw, Brigid			Transforming the Health Care Response to Intimate Partner Violence Addressing "Wicked Problems"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEMS; TRIAL		[Young-Wolff, Kelly C.] Kaiser Permanente No Calif, Div Res, 2000 Broadway, Oakland, CA 94162 USA; [Kotz, Krista; Mccaw, Brigid] Kaiser Permanente No Calif, Family Violence Prevent Program, 2000 Broadway, Oakland, CA 94162 USA	Kaiser Permanente; Kaiser Permanente	Young-Wolff, KC (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway, Oakland, CA 94162 USA.	kelly.c.young-wolff@kp.org						Adler NE, 2015, SCIENCE, V350, P257, DOI 10.1126/science.aad5923; Bair-Merritt MH, 2014, AM J PREV MED, V46, P188, DOI 10.1016/j.amepre.2013.10.001; Bauer Mark S, 2015, BMC Psychol, V3, P32, DOI 10.1186/s40359-015-0089-9; Decker MR, 2012, J WOMENS HEALTH, V21, P1222, DOI 10.1089/jwh.2012.4058; Klevens J, 2012, JAMA-J AM MED ASSOC, V308, P681, DOI 10.1001/jama.2012.6434; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; McCaw B, 2011, USING SYSTEMS MODEL, P169; Miller E, 2015, J WOMENS HEALTH, V24, P92, DOI 10.1089/jwh.2014.4870; Moyer VA, 2013, ANN INTERN MED, V158, P478, DOI 10.7326/0003-4819-158-6-201303190-00588; Periyakoil VS, 2007, J PALLIAT MED, V10, P658, DOI 10.1089/jpm.2007.9955	10	26	26	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2517	2518		10.1001/jama.2016.4837	http://dx.doi.org/10.1001/jama.2016.4837			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27327796				2022-12-28	WOS:000378306700010
J	Jia, CC; Migliore, A; Xin, N; Huang, SY; Wang, JY; Yang, Q; Wang, SP; Chen, HL; Wang, DM; Feng, BY; Liu, ZR; Zhang, GY; Qu, DH; Tian, H; Ratner, MA; Xu, HQ; Nitzan, A; Guo, XF				Jia, Chuancheng; Migliore, Agostino; Xin, Na; Huang, Shaoyun; Wang, Jinying; Yang, Qi; Wang, Shuopei; Chen, Hongliang; Wang, Duoming; Feng, Boyong; Liu, Zhirong; Zhang, Guangyu; Qu, Da-Hui; Tian, He; Ratner, Mark A.; Xu, H. Q.; Nitzan, Abraham; Guo, Xuefeng			Covalently bonded single-molecule junctions with stable and reversible photoswitched conductivity	SCIENCE			English	Article							ELECTRONIC DEVICES; SWITCHES; HYSTERESIS; CELLS	Through molecular engineering, single diarylethenes were covalently sandwiched between graphene electrodes to form stable molecular conduction junctions. Our experimental and theoretical studies of these junctions consistently show and interpret reversible conductance photoswitching at room temperature and stochastic switching between different conductive states at low temperature at a single-molecule level. We demonstrate a fully reversible, two-mode, single-molecule electrical switch with unprecedented levels of accuracy (on/off ratio of similar to 100), stability (over a year), and reproducibility (46 devices with more than 100 cycles for photoswitching and similar to 10(5) to 10(6) cycles for stochastic switching).	[Jia, Chuancheng; Xin, Na; Wang, Jinying; Chen, Hongliang; Liu, Zhirong; Guo, Xuefeng] Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Beijing Natl Lab Mol Sci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Migliore, Agostino] Duke Univ, Dept Chem, Durham, NC 27708 USA; [Huang, Shaoyun; Yang, Qi; Feng, Boyong; Xu, H. Q.] Peking Univ, Dept Elect, Beijing 100871, Peoples R China; [Huang, Shaoyun; Yang, Qi; Feng, Boyong; Xu, H. Q.] Peking Univ, Key Lab Phys & Chem Nanodevices, Beijing 100871, Peoples R China; [Wang, Shuopei; Wang, Duoming; Zhang, Guangyu] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Qu, Da-Hui; Tian, He] E China Univ Sci & Technol, Key Lab Adv Mat, Shanghai 200237, Peoples R China; [Qu, Da-Hui; Tian, He] E China Univ Sci & Technol, Inst Fine Chem, Shanghai 200237, Peoples R China; [Ratner, Mark A.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Nitzan, Abraham] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Nitzan, Abraham] Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel; [Guo, Xuefeng] Peking Univ, Dept Mat Sci & Engn, Coll Engn, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Duke University; Peking University; Peking University; Chinese Academy of Sciences; Institute of Physics, CAS; East China University of Science & Technology; East China University of Science & Technology; Northwestern University; University of Pennsylvania; Tel Aviv University; Peking University	Guo, XF (corresponding author), Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Beijing Natl Lab Mol Sci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.; Xu, HQ (corresponding author), Peking Univ, Dept Elect, Beijing 100871, Peoples R China.; Xu, HQ (corresponding author), Peking Univ, Key Lab Phys & Chem Nanodevices, Beijing 100871, Peoples R China.; Nitzan, A (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.; Nitzan, A (corresponding author), Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel.; Guo, XF (corresponding author), Peking Univ, Dept Mat Sci & Engn, Coll Engn, Beijing 100871, Peoples R China.	hqxu@pku.edu.cn; anitzan@sas.upenn.edu; guoxf@pku.edu.cn	Zhang, Guangyu/G-7892-2011; Qu, Da-Hui/P-5148-2014; Tian, He/ABD-5758-2021; Jia, Chuancheng/U-8066-2019; Liu, Zhirong/K-8703-2012; HUANG, SHAOYUN/B-5018-2012; Chen, Hongliang/N-9529-2019; Migliore, Agostino/B-6656-2018; Xu, Hongqi/D-4248-2017	Qu, Da-Hui/0000-0002-2039-3564; Tian, He/0000-0003-3547-7485; HUANG, SHAOYUN/0000-0002-2222-3999; Chen, Hongliang/0000-0002-4442-7984; Migliore, Agostino/0000-0001-7780-2296; Xu, Hongqi/0000-0001-6434-2569; , Jia/0000-0002-1513-8497	National Basic Research Program of China [2012CB921404, 2012CB932703]; National Natural Science Foundation of China [21225311, 91333102, 21373014, 21190033, 91221202, 61321001]; Israel Science Foundation; U.S.-Israel Bi-national Science Foundation; University of Pennsylvania	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Israel Science Foundation(Israel Science Foundation); U.S.-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); University of Pennsylvania	We acknowledge Z. Liu, N. Kang, J. Bergfield, and C. Van Dyck for insightful discussions. This work was supported by the National Basic Research Program of China (2012CB921404 and 2012CB932703) (K.G. and H.Q.X.), the National Natural Science Foundation of China (21225311, 91333102, 21373014, 21190033, 91221202, and 61321001) (X.G., D.-H.Q., and H.Q.X.), the Israel Science Foundation (A.N. and A.M.), the U.S.-Israel Bi-national Science Foundation (A.N.), and the University of Pennsylvania (A.N.).	[Anonymous], 2013, NAT NANOTECHNOL, V8, P377, DOI DOI 10.1038/NNANO.2013.116; Baldea I, 2015, NANOSCALE, V7, P10465, DOI 10.1039/c5nr02225h; Cao Y, 2012, ANGEW CHEM INT EDIT, V51, P12228, DOI 10.1002/anie.201205607; Dulic D, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.207402; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; Galperin M, 2005, NANO LETT, V5, P125, DOI 10.1021/nl048216c; Guo XF, 2006, SCIENCE, V311, P356, DOI 10.1126/science.1120986; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Jia CC, 2013, ANGEW CHEM INT EDIT, V52, P8666, DOI 10.1002/anie.201304301; Jia CC, 2013, CHEM SOC REV, V42, P5642, DOI 10.1039/c3cs35527f; Mathapa BG, 2014, BIOMATER SCI-UK, V2, P212, DOI 10.1039/c3bm60162e; Meredith MT, 2012, ANNU REV ANAL CHEM, V5, P157, DOI 10.1146/annurev-anchem-062011-143049; Migliore A, 2015, P NATL ACAD SCI USA, V112, pE2419, DOI 10.1073/pnas.1502000112; Migliore A, 2013, J AM CHEM SOC, V135, P9420, DOI 10.1021/ja401336u; Migliore A, 2011, ACS NANO, V5, P6669, DOI 10.1021/nn202206e; Naaman R, 2011, PHYS CHEM CHEM PHYS, V13, P13153, DOI 10.1039/c1cp21106d; Pathem BK, 2013, ANNU REV PHYS CHEM, V64, P605, DOI 10.1146/annurev-physchem-040412-110045; Rochat S, 2013, ACS APPL MATER INTER, V5, P4488, DOI 10.1021/am400939w; Schwarz F, 2016, NAT NANOTECHNOL, V11, P170, DOI [10.1038/NNANO.2015.255, 10.1038/nnano.2015.255]; Sendler T, 2015, ADV SCI, V2, DOI 10.1002/advs.201500017; Tatikonda AK, 2013, BIOSENS BIOELECTRON, V45, P201, DOI 10.1016/j.bios.2013.01.040; Whalley AC, 2007, J AM CHEM SOC, V129, P12590, DOI 10.1021/ja073127y; Zhang JL, 2015, CHEM SOC REV, V44, P2998, DOI 10.1039/c4cs00377b	23	511	529	45	714	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1443	1445		10.1126/science.aaf6298	http://dx.doi.org/10.1126/science.aaf6298			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313042				2022-12-28	WOS:000377975400044
J	Rockstrom, J; Stordalen, GA; Horton, R				Rockstrom, Johan; Stordalen, Gunhild Anker; Horton, Richard			Acting in the Anthropocene: the EAT-Lancet Commission	LANCET			English	Editorial Material									[Rockstrom, Johan] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Stordalen, Gunhild Anker] EAT Fdn, NO-0153 Oslo, Norway; [Horton, Richard] The Lancet, London, England	Stockholm University	Stordalen, GA (corresponding author), EAT Fdn, NO-0153 Oslo, Norway.	gunhild@eatforum.org		Rockstrom, Johan/0000-0001-8988-2983				Bloom DE, 2011, GLOBAL EC BURDEN NON; Erb KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11382; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Garnett T., 2014, WHAT IS SUSTAINABLE, P31; Krausmann F, 2013, P NATL ACAD SCI USA, V110, P10324, DOI 10.1073/pnas.1211349110; Ranganathan J., 2016, WORKING PAPER, DOI DOI 10.1007/s10584-006-9122-6; Springmann M, 2016, P NATL ACAD SCI USA, V113, P4146, DOI 10.1073/pnas.1523119113; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Waters CN, 2016, SCIENCE, V351, P137, DOI 10.1126/science.aad2622; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; WHO, 2001, WORLD HLTH REPORT 20; World Health Organization,, 2015, OB OV; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS	13	28	30	1	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2364	2365		10.1016/S0140-6736(16)30681-X	http://dx.doi.org/10.1016/S0140-6736(16)30681-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1ST	27312291				2022-12-28	WOS:000377560100011
J	Richardson, TT; Harran, O; Murray, H				Richardson, Tomas T.; Harran, Omar; Murray, Heath			The bacterial DnaA-trio replication origin element specifies single-stranded DNA initiator binding (vol 534, pg 412, 2016)	NATURE			English	Correction																		Richardson TT, 2016, NATURE, V534, P412, DOI 10.1038/nature17962	1	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617								10.1038/nature18932	http://dx.doi.org/10.1038/nature18932			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27362230	Bronze			2022-12-28	WOS:000382646600049
J	Garg, A; Boynton-Jarrett, R; Dworkin, PH				Garg, Arvin; Boynton-Jarrett, Renee; Dworkin, Paul H.			Avoiding the Unintended Consequences of Screening for Social Determinants of Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Garg, Arvin; Boynton-Jarrett, Renee] Boston Univ, Sch Med, Boston Med Ctr, Dept Pediat, 88 E Newton St, Boston, MA 02118 USA; [Dworkin, Paul H.] Univ Connecticut, Sch Med, Dept Pediat, Farmington, CT 06032 USA; [Dworkin, Paul H.] Childrens Med Ctr, Off Community Child Hlth, Hartford, CT USA	Boston Medical Center; Boston University; University of Connecticut; Connecticut Children's Medical Center	Garg, A (corresponding author), Boston Univ, Sch Med, Boston Med Ctr, Div Gen Pediat,Dept Pediat, 88 E Newton St, Boston, MA 02118 USA.	arvin.garg@bmc.org		Boynton-Jarrett, Renee/0000-0002-5392-6443; Garg, Arvin/0000-0003-0839-2611				Alley DE, 2016, NEW ENGL J MED, V374, P8, DOI 10.1056/NEJMp1512532; Bottino C, 2013, ANN M PED AC SOC WAS; Duffee JH, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0339; Fierman AH, 2016, ACAD PEDIATR, V16, pS136, DOI 10.1016/j.acap.2016.01.004; Garg A, 2012, J PEDIATR-US, V160, P535, DOI 10.1016/j.jpeds.2012.01.001; Hughes M, 2016, INFANT YOUNG CHILD, V29, P116, DOI 10.1097/IYC.0000000000000059; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Perrin EC, 1998, J DEV BEHAV PEDIATR, V19, P350, DOI 10.1097/00004703-199810000-00006	8	193	193	2	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					813	814		10.1001/jama.2016.9282	http://dx.doi.org/10.1001/jama.2016.9282			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT8JL	27367226				2022-12-28	WOS:000381736200006
J	Raman, AS; White, KI; Ranganathan, R				Raman, Arjun S.; White, K. Ian; Ranganathan, Rama			Origins of Allostery and Evolvability in Proteins: A Case Study	CELL			English	Article							PDZ DOMAINS; EVOLUTION; ROBUSTNESS; SUBSTRATE; BINDING; RECOGNITION; SPECIFICITY; TRYPSIN; SYSTEM	Proteins display the capacity for adaptation to new functions, a property critical for evolvability. But what structural principles underlie the capacity for adaptation? Here, we show that adaptation to a physiologically distinct class of ligand specificity in a PSD95, DLG1, ZO-1 ( PDZ) domain preferentially occurs through class-bridging intermediate mutations located distant from the ligand-binding site. These mutations provide a functional link between ligand classes and demonstrate the principle of "conditional neutrality'' in mediating evolutionary adaptation. Structures show that class-bridging mutations work allosterically to open up conformational plasticity at the active site, permitting novel functions while retaining existing function. More generally, the class-bridging phenotype arises from mutations in an evolutionarily conserved network of coevolving amino acids in the PDZ family ( the sector) that connects the active site to distant surface sites. These findings introduce the concept that allostery in proteins could have its origins not in protein function but in the capacity to adapt.	[Raman, Arjun S.; White, K. Ian; Ranganathan, Rama] Univ Texas Southwestern Med Ctr, Green Ctr Syst Biol, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Ranganathan, Rama] Univ Texas Southwestern Med Ctr, Dept Biophys, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Ranganathan, Rama] Univ Texas Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas Southwestern Med Ctr, Green Ctr Syst Biol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.; Ranganathan, R (corresponding author), Univ Texas Southwestern Med Ctr, Dept Biophys, 6001 Forest Pk Rd, Dallas, TX 75390 USA.; Ranganathan, R (corresponding author), Univ Texas Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu	White, Kristopher Ian/ABA-4166-2021	White, Kristopher Ian/0000-0001-8182-3655	NIH [RO1EY018720-05]; Robert A. Welch Foundation [I-1366]; Green Center for Systems Biology at UT Southwestern Medical Center; NIGMS [T32 GM008203]; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Green Center for Systems Biology at UT Southwestern Medical Center; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the R.R. lab for critical review of the manuscript; M.A. Socolich, F.J. Poelwijk, and S. Subramanian for technical help; and K.A. Reynolds for discussions. We also thank the UT Southwestern Genomics Core for assistance with sequencing and the High Performance Computing Group (Bio-HPC) at UT Southwestern for facilitating the computational simulations. This work was supported by NIH Grant RO1EY018720-05 (to R.R.), Robert A. Welch Foundation Grant I-1366 (to R.R.), and the Green Center for Systems Biology at UT Southwestern Medical Center. A.S.R. and K.I.W. were supported in part through pre-doctoral fellowships (NIGMS T32 GM008203).	Aakre CD, 2015, CELL, V163, P594, DOI 10.1016/j.cell.2015.09.055; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; DeLano W.L, PYMOL MOL GRAPHICS S; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Draghi JA, 2011, NATURE, V474, P45, DOI 10.1038/474045a; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Harris BZ, 2001, J CELL SCI, V114, P3219; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; HEDSTROM L, 1994, BIOCHEMISTRY-US, V33, P8757, DOI 10.1021/bi00195a017; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lukacs CM, 2000, NAT STRUCT BIOL, V7, P134; Luria SE, 1943, GENETICS, V28, P491; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Morgan RD, 2009, NUCLEIC ACIDS RES, V37, P5222, DOI 10.1093/nar/gkp535; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; Poelwijk FJ, 2011, CELL, V146, P462, DOI 10.1016/j.cell.2011.06.035; Reynolds KA, 2013, METHOD ENZYMOL, V523, P213, DOI 10.1016/B978-0-12-394292-0.00010-2; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Salverda MLM, 2010, FEMS MICROBIOL REV, V34, P1015, DOI 10.1111/j.1574-6976.2010.00222.x; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stiffler MA, 2015, CELL, V160, P882, DOI 10.1016/j.cell.2015.01.035; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665	47	82	83	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					468	480		10.1016/j.cell.2016.05.047	http://dx.doi.org/10.1016/j.cell.2016.05.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27321669	Bronze			2022-12-28	WOS:000380255400022
J	DeVree, BT; Mahoney, JP; Velez-Ruiz, GA; Rasmussen, SGF; Kuszak, AJ; Edwald, E; Fung, JJ; Manglik, A; Masureel, M; Du, Y; Matt, RA; Pardon, E; Steyaert, J; Kobilka, BK; Sunahara, RK				DeVree, Brian T.; Mahoney, Jacob P.; Velez-Ruiz, Gisselle A.; Rasmussen, Soren G. F.; Kuszak, Adam J.; Edwald, Elin; Fung, Juan-Jose; Manglik, Aashish; Masureel, Matthieu; Du, Yang; Matt, Rachel A.; Pardon, Els; Steyaert, Jan; Kobilka, Brian K.; Sunahara, Roger K.			Allosteric coupling from G protein to the agonist-binding pocket in GPCRs	NATURE			English	Article							BETA-ADRENERGIC-RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; TERNARY COMPLEX MODEL; NEUROTENSIN RECEPTOR; GUANINE-NUCLEOTIDES; ANTAGONIST BINDING; ADENYLATE-CYCLASE; CRYSTAL-STRUCTURE; ACTIVATION; AFFINITY	G-protein-coupled receptors (GPCRs) remain the primary conduit by which cells detect environmental stimuli and communicate with each other(1). Upon activation by extracellular agonists, these seven-transmembrane-domain-containing receptors interact with heterotrimeric G proteins to regulate downstream second messenger and/or protein kinase cascades(1). Crystallographic evidence from a prototypic GPCR, the beta(2)-adrenergic receptor (beta(2)AR), in complex with its cognate G protein, Gs, has provided a model for how agonist binding promotes conformational changes that propagate through the GPCR and into the nucleotide-binding pocket of the G protein a-subunit to catalyse GDP release, the key step required for GTP binding and activation of G proteins(2). The structure also offers hints about how G-protein binding may, in turn, allosterically influence ligand binding. Here we provide functional evidence that G-protein coupling to the beta(2)AR stabilizes a 'closed' receptor conformation characterized by restricted access to and egress from the hormone-binding site. Surprisingly, the effects of G protein on the hormone-binding site can be observed in the absence of a bound agonist, where G-protein coupling driven by basal receptor activity impedes the association of agonists, partial agonists, antagonists and inverse agonists. The ability of bound ligands to dissociate from the receptor is also hindered, providing a structural explanation for the G-protein-mediated enhancement of agonist affinity, which has been observed for many GPCR-G-protein pairs. Our data also indicate that, in contrast to agonist binding alone, coupling of a G protein in the absence of an agonist stabilizes large structural changes in a GPCR. The effects of nucleotide-free G protein on ligand-binding kinetics are shared by other members of the superfamily of GPCRs, suggesting that a common mechanism may underlie G-protein-mediated enhancement of agonist affinity.	[DeVree, Brian T.; Mahoney, Jacob P.; Velez-Ruiz, Gisselle A.; Kuszak, Adam J.; Edwald, Elin; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Rasmussen, Soren G. F.; Fung, Juan-Jose; Manglik, Aashish; Masureel, Matthieu; Du, Yang; Matt, Rachel A.; Kobilka, Brian K.] Stanford Univ, Dept Cellular & Mol Physiol, Palo Alto, CA 94305 USA; [Pardon, Els] VUB, Struct Biol Res Ctr, VIB, Pl Laan 2, B-1050 Brussels, Belgium; [Steyaert, Jan] VUB, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium; [Sunahara, Roger K.] Univ Calif San Diego, Dept Pharmacol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; Stanford University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; University of California System; University of California San Diego	Sunahara, RK (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.; Sunahara, RK (corresponding author), Univ Calif San Diego, Dept Pharmacol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rsunahara@ucsd.edu	Sunahara, Roger/AAJ-8667-2020; DeVree, Brian T/F-6205-2011; Steyaert, Jan/H-4662-2011; steyaert, jan/GQP-7811-2022	Steyaert, Jan/0000-0002-3825-874X; DeVree, Brian/0000-0003-0582-8125; Kobilka, Brian/0000-0001-5958-3990; Kuszak, Adam/0000-0001-8719-145X; Rasmussen, Soren/0000-0002-1853-1841; Matt, Rachel/0000-0002-9944-8897; Pardon, Els/0000-0002-2466-0172	Lundbeck Foundation; Fund for Scientific Research of Flanders (FWO-Vlaanderen); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); National Institute of Neural Disorders and Stroke [RO1-NS28471]; Mather Charitable Foundation; National Institute of General Medical Sciences [RO1-GM083118, U19-GM106990, RO1-GM068603]; National Institutes of Drug Abuse [R21-031418]; Michigan Diabetes Research and Training Center; National Institute of Diabetes and Digestive and Kidney Diseases [P60DK-20572]; University of Michigan Biological Sciences Scholars Program; Rackham School of Graduate Studies; Molecular Biophysics Training Grant [T32GM008270]; Cell and Molecular Biology Training Grant [T32GM007315]; Pharmacological Sciences Training Program [T32GM007767]; AHA Midwest Affiliate Predoctoral Fellowship [13PRE17110027]; Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118, T32GM008270, T32GM007767, R01GM068603, U19GM106990, T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031418] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); National Institute of Neural Disorders and Stroke; Mather Charitable Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Michigan Diabetes Research and Training Center; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Michigan Biological Sciences Scholars Program(University of Michigan System); Rackham School of Graduate Studies; Molecular Biophysics Training Grant; Cell and Molecular Biology Training Grant; Pharmacological Sciences Training Program; AHA Midwest Affiliate Predoctoral Fellowship; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. S. Kobilka for preparation of affinity chromatography reagents and F. S. Thian for help with cell culture. We thank J. Traynor and J. Tesmer for their support and use of their laboratory space for J.P.M. This work was supported by the Lundbeck Foundation (Junior Group Leader Fellowship to S.G.F.R.); Fund for Scientific Research of Flanders (FWO-Vlaanderen) and the Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB) (E.P. and J.S.); National Institute of Neural Disorders and Stroke grant RO1-NS28471 (B.K.K.); the Mather Charitable Foundation (B.K.K.); National Institute of General Medical Sciences grants RO1-GM083118 and U19-GM106990 (B.K.K. and R.K.S.) and RO1-GM068603 (R.K.S.); National Institutes of Drug Abuse R21-031418 (B.K.K. and R.K.S.); Michigan Diabetes Research and Training Center Grant, National Institute of Diabetes and Digestive and Kidney Diseases, P60DK-20572 (R.K.S.); University of Michigan Biological Sciences Scholars Program (R.K.S.) and the Rackham School of Graduate Studies (B.T.D.); Molecular Biophysics Training Grant T32GM008270 (B.T.D.); Cell and Molecular Biology Training Grant T32GM007315 (G.A.V.-R.) and Pharmacological Sciences Training Program T32GM007767 (J.P.M.); and AHA Midwest Affiliate Predoctoral Fellowship 13PRE17110027 (J.P.M.).	Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; BURGISSER E, 1982, P NATL ACAD SCI-BIOL, V79, P1732, DOI 10.1073/pnas.79.6.1732; Bylund DB, 2001, J NEUROSCI METH, V105, P159, DOI 10.1016/S0165-0270(00)00358-7; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Kikkawa H, 1998, MOL PHARMACOL, V53, P128, DOI 10.1124/mol.53.1.128; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Krumm BE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8895; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; LEFKOWITZ RJ, 1977, P NATL ACAD SCI USA, V74, P515, DOI 10.1073/pnas.74.2.515; MAGUIRE ME, 1976, MOL PHARMACOL, V12, P335; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PRATER MR, 1992, MOL PHARMACOL, V42, P765; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; ROSS EM, 1977, J BIOL CHEM, V252, P5761; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Weiss JM, 1996, J THEOR BIOL, V178, P151, DOI 10.1006/jtbi.1996.0014; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	34	158	161	3	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					182	+		10.1038/nature18324	http://dx.doi.org/10.1038/nature18324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362234	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000379015600049
J	D'Silva, J				D'Silva, Jeetha			BMJ AWARDS SOUTH ASIA 2016 BMJ Awards South Asia 2016: Nominate a healthcare champion today	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.dsilva@gmail.com						D'Silva J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5911; Hurley R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4540; Shivalli S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137735	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2016	353								i3652	10.1136/bmj.i3652	http://dx.doi.org/10.1136/bmj.i3652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2GE	27364354				2022-12-28	WOS:000379019700014
J	Alonso-Coello, P; Schunemann, HJ; Moberg, J; Brignardello-Petersen, R; Akl, EA; Davoli, M; Treweek, S; Mustafa, RA; Rada, G; Rosenbaum, S; Morelli, A; Guyatt, GH; Oxman, AD				Alonso-Coello, Pablo; Schunemann, Holger J.; Moberg, Jenny; Brignardello-Petersen, Romina; Akl, Elie A.; Davoli, Marina; Treweek, Shaun; Mustafa, Reem A.; Rada, Gabriel; Rosenbaum, Sarah; Morelli, Angela; Guyatt, Gordon H.; Oxman, Andrew D.		GRADE Working Grp	GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-PRACTICE GUIDELINES; INTERNATIONAL NETWORK; TECHNOLOGY-ASSESSMENT; COVERAGE DECISIONS; MULTIPLE CRITERIA; QUALITY; RECOMMENDATIONS; AUSTRALIA; STANDARDS; CONFLICT		[Alonso-Coello, Pablo] CIBERESP IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain; [Alonso-Coello, Pablo; Schunemann, Holger J.; Brignardello-Petersen, Romina; Akl, Elie A.; Mustafa, Reem A.; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Schunemann, Holger J.; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Moberg, Jenny; Rosenbaum, Sarah; Morelli, Angela; Oxman, Andrew D.] Norwegian Inst Publ Hlth, Oslo, Norway; [Brignardello-Petersen, Romina] Univ Chile, Evidence Based Dent Unit, Fac Dent, Santiago, Chile; [Akl, Elie A.] Amer Univ Beirut, Dept Internal Med, Clin Epidemiol Unit, Med Ctr, Beirut 2020, Lebanon; [Davoli, Marina] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Treweek, Shaun] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Mustafa, Reem A.] Univ Missouri, Dept Med, Kansas City, MO 64110 USA; [Rada, Gabriel] Pontificia Univ Catolica Chile, Fac Med, Evidence Based Hlth Care Program, Santiago, Chile; [Rada, Gabriel] Pontificia Univ Catolica Chile, Fac Med, Dept Internal Med, Santiago, Chile; [Rada, Gabriel] Epistemonikos Fdn, Santiago, Chile	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; McMaster University; McMaster University; Norwegian Institute of Public Health (NIPH); Universidad de Chile; American University of Beirut; University of Aberdeen; University of Missouri System; University of Missouri Kansas City; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Oxman, AD (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.	oxman@online.no	Akl, Elie A/R-2079-2016; Oxman, Andrew/Y-3004-2019; Akl, Elie/K-5269-2019; Davoli, Marina/K-1975-2016; Treweek, Shaun/AAE-8006-2019; Meerpohl, Joerg J/J-4224-2013; Parmelli, Elena/J-8622-2016; Glenton, Claire/GSE-3606-2022	Akl, Elie A/0000-0002-3444-8618; Oxman, Andrew/0000-0002-5608-5061; Davoli, Marina/0000-0003-4521-032X; Treweek, Shaun/0000-0002-7239-7241; Meerpohl, Joerg J/0000-0002-1333-5403; Parmelli, Elena/0000-0002-3730-8530; Alonso-Coello, Pablo/0000-0002-8001-8504; Glenton, Claire/0000-0002-7558-7737; von Elm, Erik/0000-0002-7412-0406	Chief Scientist Office [HSRU2] Funding Source: researchfish	Chief Scientist Office		Aaserud Morten, 2002, Tidsskr Nor Laegeforen, V122, P2619; Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; ALONSOCOELLO P, 2016, BMJ-BRIT MED J, V353, P2089, DOI [DOI 10.1136/BMJ.I2089, 10.1136/bmj.i2089]; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], 2013, EUNETHTA JOINT ACTIO; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Boyd Elizabeth A, 2006, Health Res Policy Syst, V4, P16, DOI 10.1186/1478-4505-4-16; Brunetti M, 2013, J CLIN EPIDEMIOL, V66, P140, DOI 10.1016/j.jclinepi.2012.04.012; Chambers JD, 2012, MED CARE, V50, P249, DOI 10.1097/MLR.0b013e318241eb40; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Fischer KE, 2012, HEALTH POLICY, V107, P218, DOI 10.1016/j.healthpol.2012.07.005; Goetghebeur MM, 2012, MED DECIS MAKING, V32, P376, DOI 10.1177/0272989X11416870; Guindo Lalla Aida, 2012, Cost Eff Resour Alloc, V10, P9, DOI 10.1186/1478-7547-10-9; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hailey D, 2003, INT J TECHNOL ASSESS, V19, P1, DOI 10.1017/S0266462303000011; Harris AH, 2008, MED DECIS MAKING, V28, P713, DOI 10.1177/0272989X08315247; Hsu J, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-62; Hutton J, 2007, INT J TECHNOL ASSESS, V23, P425, DOI 10.1017/S0266462307070651; Kristiansen A, 2015, CHEST, V147, P754, DOI 10.1378/chest.14-1366; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Oxman AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2530; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Richardson WS, 1995, ACP J CLUB, V123, pA12, DOI DOI 10.7326/ACPJC-1995-123-3-A12; Schunemann HJ, 2009, AM J RESP CRIT CARE, V180, P564, DOI 10.1164/rccm.200901-0126ST; Schunemann HJ, 2015, ANN INTERN MED, V163, P548, DOI 10.7326/M14-1885; Thokala P, 2012, VALUE HEALTH, V15, P1172, DOI 10.1016/j.jval.2012.06.015; Treweek S, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-6; Tromp Noor, 2012, BMC Health Serv Res, V12, P454, DOI 10.1186/1472-6963-12-454; Verkerk K, 2006, INT J QUAL HEALTH C, V18, P365, DOI 10.1093/intqhc/mzl040; Vogel JP, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-19; WHO, 2013, US BED TREATM MULT R	39	550	571	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2016	353								i2016	10.1136/bmj.i2016	http://dx.doi.org/10.1136/bmj.i2016			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ2FP	27353417	Bronze, Green Published			2022-12-28	WOS:000379018000001
J	McCulloch, I; Salleo, A; Chabinyc, M				McCulloch, Iain; Salleo, Alberto; Chabinyc, Michael			Avoid the kinks when measuring mobility Transistor measurements can overstate organic semiconductor charge carrier mobility	SCIENCE			English	Editorial Material							FIELD-EFFECT TRANSISTORS		[McCulloch, Iain] King Abdullah Univ Sci & Technol, KSC, Thuwal 239556900, Saudi Arabia; [McCulloch, Iain] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England; [McCulloch, Iain] Univ London Imperial Coll Sci Technol & Med, Ctr Plast Elect, London SW7 2AZ, England; [Salleo, Alberto] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Chabinyc, Michael] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	King Abdullah University of Science & Technology; Imperial College London; Imperial College London; Stanford University; University of California System; University of California Santa Barbara	McCulloch, I (corresponding author), King Abdullah Univ Sci & Technol, KSC, Thuwal 239556900, Saudi Arabia.; McCulloch, I (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.; McCulloch, I (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Plast Elect, London SW7 2AZ, England.	i.mcculloch@imperial.ac.uk	McCulloch, Iain/G-1486-2015	McCulloch, Iain/0000-0002-6340-7217				Arias AC, 2010, CHEM REV, V110, P3, DOI 10.1021/cr900150b; Bittle EG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10908; Chen ZY, 2012, ADV MATER, V24, P647, DOI 10.1002/adma.201102786; Facchetti A, 2011, CHEM MATER, V23, P733, DOI 10.1021/cm102419z; Li J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00754; Mott N.F., 1979, ELECT PROCESSES NONC, Vsecond; Nielsen CB, 2013, ADV MATER, V25, P1859, DOI 10.1002/adma.201201795; Okachi T, 2015, PROC SPIE, V9568, DOI 10.1117/12.2187572; Reese C, 2009, J APPL PHYS, V105, DOI 10.1063/1.3029587; Sirringhaus H, 2014, ADV MATER, V26, P1319, DOI 10.1002/adma.201304346; Tseng HR, 2014, ADV MATER, V26, P2993, DOI 10.1002/adma.201305084; Uemura T, 2016, ADV MATER, V28, P151, DOI 10.1002/adma.201503133; Yi HT, 2011, ADV MATER, V23, P5807, DOI 10.1002/adma.201103305	13	185	185	3	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1521	1522		10.1126/science.aaf9062	http://dx.doi.org/10.1126/science.aaf9062			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339971				2022-12-28	WOS:000378346500022
J	Pokorney, SD; Navar, AM				Pokorney, Sean D.; Navar, Ann Marie			In patients with MI, new-onset or existing AF increased risk forCVevents at 90 days Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Pokorney, Sean D.; Navar, Ann Marie] Duke Clin Res Inst, Durham, NC 27705 USA	Duke University	Pokorney, SD (corresponding author), Duke Clin Res Inst, Durham, NC 27705 USA.							Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Boehringer Ingelheim, 2016, EV DUAL THER DAB VS; Bristol-Myers Squibb, 2016, STUD AP PAT ATR FIBR; Janssen Scientific Affairs LLC, 2016, STUD EXPL 2 STRAT RI; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	7	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					JC66	JC66		10.7326/ACPJC-2016-164-12-066	http://dx.doi.org/10.7326/ACPJC-2016-164-12-066			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27323262				2022-12-28	WOS:000379343000005
J	D'Orangeville, L; Duchesne, L; Houle, D; Kneeshaw, D; Cote, B; Pederson, N				D'Orangeville, L.; Duchesne, L.; Houle, D.; Kneeshaw, D.; Cote, B.; Pederson, N.			Northeastern North America as a potential refugium for boreal forests in a warming climate	SCIENCE			English	Article							BLACK SPRUCE FORESTS; NET PRIMARY PRODUCTION; EASTERN CANADA; DROUGHT STRESS; TREE GROWTH; CARBON; IMPACTS; PRODUCTIVITY; TEMPERATURES; 20TH-CENTURY	High precipitation in boreal northeastern North America could help forests withstand the expected temperature-driven increase in evaporative demand, but definitive evidence is lacking. Using a network of tree-ring collections from 16,450 stands across 583,000 km(2) of boreal forests in Quebec, Canada, we observe a latitudinal shift in the correlation of black spruce growth with temperature and reduced precipitation, from negative south of 49 degrees N to largely positive to the north of that latitude. Our results su: zest that the positive effect of a warmer climate on growth rates and growing season length north of 49 degrees N outweighs the potential negative effect of lower water availability. Unlike the central and western portions of the continent's boreal forest, northeastern North America may act as a climatic refugium in a warmer climate.	[D'Orangeville, L.; Kneeshaw, D.] Univ Quebec, Ctr Etude Foret, Case Postale 8888,Succursale Ctr Ville, Montreal, PQ H3C 3P8, Canada; [D'Orangeville, L.] Indiana Univ, Dept Biol, 1001 East 3rd St,Jordan Hall 142, Bloomington, IN 47405 USA; [Duchesne, L.; Houle, D.] Minist Forets Faune & Parcs Quebec, Direct Rech Forestiere, 2700 Einstein, Quebec City, PQ G1P 3W8, Canada; [Houle, D.] Consortium Climatol Reg & Adaptat Changements Cli, 550 Sherbrooke W, Montreal, PQ H3A 1B9, Canada; [Cote, B.] McGill Univ, Dept Nat Resource Sci, 21 111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Pederson, N.] Harvard Forest, 324 North Main St, Petersham, MA 01366 USA	University of Quebec; University of Quebec Montreal; Indiana University System; Indiana University Bloomington; Ouranos Consortium; McGill University; Harvard University	D'Orangeville, L (corresponding author), Univ Quebec, Ctr Etude Foret, Case Postale 8888,Succursale Ctr Ville, Montreal, PQ H3C 3P8, Canada.; D'Orangeville, L (corresponding author), Indiana Univ, Dept Biol, 1001 East 3rd St,Jordan Hall 142, Bloomington, IN 47405 USA.	loicdorangeville@gmail.com		D'Orangeville, Loic/0000-0001-7841-7082	NASA Astrobiology Institute Early Career Collaboration Award; National Radio Astronomy Observatory Jansky Postdoctoral Fellowshiip; National Science Foundation; NASA Astrobiology Institute through the Goddard Team [NNX09AH63A, NNX15A133A (NNX09AH63A)]; NSF Astronomy and Astrophysics [AST-1109857]; Australian government;  [AGBT06B-006]	NASA Astrobiology Institute Early Career Collaboration Award; National Radio Astronomy Observatory Jansky Postdoctoral Fellowshiip; National Science Foundation(National Science Foundation (NSF)); NASA Astrobiology Institute through the Goddard Team; NSF Astronomy and Astrophysics; Australian government(Australian GovernmentCGIAR); 	We thank the PRIMOS team, GBT, and Parkes staff for their ongoing support in acquiring the GBT and Parkes data and S. Breen, S. Mader, and J. Reynolds for assistance with Parkes data eduction. acknowledge the support of L. Snyder, J. M. Hollis, and F. Lovas. B.A.M. thanks J. Mangum and J. Corby for helpful discussions. P.B.C. and B.A.M. acknowledge We support of a NASA Astrobiology Institute Early Career Collaboration Award. B.A.M. is funded by a National Radio Astronomy Observatory Jansky Postdoctoral Fellowshiip. R.A.L and I.A.F. are funded by a National Science Foundation Graduate Research Fellowship. P.B.C., I.A.F., and G.A.B. acknowledge support from the NASA Astrobiology Institute through the Goddard Team (M. J. Mumma, PI) under Cooperative Research Agreements NNX09AH63A and NNX15A133A (NNX09AH63A), and the NSF Astronomy and Astrophysics (AST-1109857)grant program. Access to the entire PRIMOS data set, specifics on the observing strategy, and overall frequency coverage information is available at www.cv.nrao.edu/PRIMOS/. The spectra obtained with Parkes are available through this website as well. Data from project AGBT06B-006 are available in the NRAO Archive at https://science.nrao.edu/observing/data-archive. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. The Australia Telescope Compact Array (Parkes Radio Telescope/Mopra Radio Telescope/Long Baseline Array)) is part of the Australia Telescope National Facility, which a funded by the Australian government for operation as a National Facility managed by the Commonwealth Scientific and Industrial Research Organisation (CSIRO).	Babst F, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045705; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Beaudoin A, 2014, CAN J FOREST RES, V44, P521, DOI 10.1139/cjfr-2013-0401; Beck PSA, 2011, ECOL LETT, V14, P373, DOI 10.1111/j.1461-0248.2011.01598.x; Bergeron O, 2007, GLOBAL CHANGE BIOL, V13, P89, DOI 10.1111/j.1365-2486.2006.01281.x; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; D'Orangeville L, 2013, TREE PHYSIOL, V33, P516, DOI 10.1093/treephys/tpt027; de Jong R, 2012, GLOBAL CHANGE BIOL, V18, P642, DOI 10.1111/j.1365-2486.2011.02578.x; Dietze MC, 2014, ANNU REV PLANT BIOL, V65, P667, DOI 10.1146/annurev-arplant-050213-040054; Gamache I, 2004, J ECOL, V92, P835, DOI 10.1111/j.0022-0477.2004.00913.x; Gauthier S, 2015, SCIENCE, V349, P819, DOI 10.1126/science.aaa9092; Girard F, 2011, ECOSCIENCE, V18, P279, DOI 10.2980/18-3-3438; Girardin MP, 2016, GLOBAL CHANGE BIOL, V22, P627, DOI 10.1111/gcb.13072; Girardin MP, 2005, CAN J FOREST RES, V35, P48, DOI 10.1139/X04-144; Havranek W., 1995, ECOPHYSIOLOGY CONIFE, P95, DOI DOI 10.1016/B978-0-08-092593-6.50010-4; Huang JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056758; Huang JG, 2010, GLOBAL CHANGE BIOL, V16, P711, DOI 10.1111/j.1365-2486.2009.01990.x; Kauppi PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111340; Lloyd AH, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045013; Myhre G., 2013, CONTRIBUTION WORKING; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pederson Neil, 2004, Dendrochronologia, V22, P7, DOI 10.1016/j.dendro.2004.09.005; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Schaphoff S, 2016, FOREST ECOL MANAG, V361, P432, DOI 10.1016/j.foreco.2015.11.043; Sevanto S, 2006, TREE PHYSIOL, V26, P749, DOI 10.1093/treephys/26.6.749; Steele SJ, 1997, TREE PHYSIOL, V17, P577; Thrasher B, 2012, HYDROL EARTH SYST SC, V16, P3309, DOI 10.5194/hess-16-3309-2012; Trabucco A., 2009, CGIAR CONSORTIUMFOR; Turcotte A, 2009, AGR FOREST METEOROL, V149, P1403, DOI 10.1016/j.agrformet.2009.03.010; Vaganov EA, 1999, NATURE, V400, P149, DOI 10.1038/22087; Walker XJ, 2015, GLOBAL CHANGE BIOL, V21, P3102, DOI 10.1111/gcb.12893; Wolken JM, 2011, CAN J FOREST RES, V41, P2292, DOI [10.1139/x11-136, 10.1139/X11-136]; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	34	93	94	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1452	1455		10.1126/science.aaf4951	http://dx.doi.org/10.1126/science.aaf4951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313044				2022-12-28	WOS:000377975400047
J	Wu, B; Eliscovich, C; Yoon, YJ; Singer, RH				Wu, Bin; Eliscovich, Carolina; Yoon, Young J.; Singer, Robert H.			Translation dynamics of single mRNAs in live cells and neurons	SCIENCE			English	Article							IN-VIVO; LOCAL TRANSLATION; GENE-EXPRESSION; ENDOPLASMIC-RETICULUM; HIPPOCAMPAL-NEURONS; PROTEIN; FLUORESCENT; SYSTEM; VISUALIZATION; LOCALIZATION	Translation is the fundamental biological process converting mRNA information into proteins. Single-molecule imaging in live cells has illuminated the dynamics of RNA transcription; however, it is not yet applicable to translation. Here, we report single-molecule imaging of nascent peptides (SINAPS) to assess translation in live cells. The approach provides direct readout of initiation, elongation, and location of translation. We show that mRNAs coding for endoplasmic reticulum (ER) proteins are translated when they encounter the ER membrane. Single-molecule fluorescence recovery after photobleaching provides direct measurement of elongation speed (5 amino acids per second). In primary neurons, mRNAs are translated in proximal dendrites but repressed in distal dendrites and display "bursting" translation. This technology provides a tool with which to address the spatiotemporal translation mechanism of single mRNAs in living cells.	[Wu, Bin; Eliscovich, Carolina; Yoon, Young J.; Singer, Robert H.] Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Wu, Bin; Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Yoon, Young J.; Singer, Robert H.] Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Singer, Robert H.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Singer, RH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.; Singer, RH (corresponding author), Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA.; Singer, RH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.; Singer, RH (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	robert.singer@einstein.yu.edu			NIH [NS083085]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank X. Meng for cloning some of the constructs and Western dotting, E. L. Snapp for providing the oxBFP plasmic, and the sequence of CytERM, E. Tutucci for constructive discussion and suggestions, and L Levis for providing JF dyes Halotag. The authors thank I. Morisaki eta). for sharing their preliminary data and the Transcription Imaging Consortium at the Janelia Research Campus of the HHMI for creating the environment for our interactions and discussions. This work was supported by NIH grant NS083085 to R.H.S.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Butko MT, 2012, NAT NEUROSCI, V15, P1742, DOI 10.1038/nn.3246; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Costantini LM, 2012, TRAFFIC, V13, P643, DOI 10.1111/j.1600-0854.2012.01336.x; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; Halstead JM, 2015, SCIENCE, V347, P1367, DOI 10.1126/science.aaa3380; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jan CH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8299; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Morisaki T, 2016, SCIENCE, V352, P1425, DOI 10.1126/science.aaf0899; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Reid DW, 2015, SCIENCE, V348, DOI 10.1126/science.aaa7257; Reid DW, 2015, NAT REV MOL CELL BIO, V16, P221, DOI 10.1038/nrm3958; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Starck SR, 2004, CHEM BIOL, V11, P999, DOI 10.1016/j.chembiol.2004.05.011; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795; Wu B, 2015, CELL, V162, P211, DOI 10.1016/j.cell.2015.05.054; Wu B, 2015, GENE DEV, V29, P876, DOI 10.1101/gad.259358.115; Wu B, 2012, BIOPHYS J, V102, P2936, DOI 10.1016/j.bpj.2012.05.017	38	256	264	6	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1430	1435		10.1126/science.aaf1084	http://dx.doi.org/10.1126/science.aaf1084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313041	Green Accepted			2022-12-28	WOS:000377975400042
J	Huang, YX; Yu, J; Lanzi, A; Yao, X; Andrews, CD; Tsai, L; Gajjar, MR; Sun, M; Seaman, MS; Padte, NN; Ho, DD				Huang, Yaoxing; Yu, Jian; Lanzi, Anastasia; Yao, Xin; Andrews, Chasity D.; Tsai, Lily; Gajjar, Mili R.; Sun, Ming; Seaman, Michael S.; Padte, Neal N.; Ho, David D.			Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity	CELL			English	Article							ANTI-CD4 MONOCLONAL-ANTIBODY; BROADLY NEUTRALIZING ANTIBODIES; IMMUNODEFICIENCY-VIRUS TYPE-1; HUMANIZED MICE; RATIONAL DESIGN; HIV-ANTIBODIES; DISULFIDE REDUCTION; DEPENDENT EPITOPE; RHESUS-MONKEYS; POTENT	While the search for an efficacious HIV-1 vaccine remains elusive, emergence of a new generation of virus-neutralizing monoclonal antibodies (mAbs) has re-ignited the field of passive immunization for HIV-1 prevention. However, the plasticity of HIV-1 demands additional improvements to these mAbs to better ensure their clinical utility. Here, we report engineered bispecific antibodies that are the most potent and broad HIV-neutralizing antibodies to date. One bispecific antibody, 10E8(V2.0)/iMab, neutralized 118 HIV-1 pseudotyped viruses tested with a mean 50% inhibitory concentration (IC50) of 0.002 mu g/mL. 10E8(V2.0)/iMab also potently neutralized 99% of viruses in a second panel of 200 HIV-1 isolates belonging to clade C, the dominant subtype accounting for similar to 50% of new infections worldwide. Importantly, 10E8(V2.0)/iMab reduced virus load substantially in HIV-1-infected humanized mice and also provided complete protection when administered prior to virus challenge. These bispecific antibodies hold promise as novel prophylactic and/or therapeutic agents in the fight against HIV-1.	[Huang, Yaoxing; Yu, Jian; Lanzi, Anastasia; Yao, Xin; Andrews, Chasity D.; Tsai, Lily; Gajjar, Mili R.; Sun, Ming; Padte, Neal N.; Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 First Ave, New York, NY 10016 USA; [Seaman, Michael S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ho, DD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 First Ave, New York, NY 10016 USA.	dho@adarc.org			Bill and Melinda Gates Foundation [OPP50714, OPP1040732, 1032144]; National Institutes of Health [DP1DA033263]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA033263] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Faye Yu, Mar Boente-Carrera, and Natanya Gettie for technical assistance; Brian T. Chait and Paul Dominic B. Olinares for native mass spectroscopy analyses on 10E8 and 10E8/P140; Wendy Chen for assistance with figure preparation; Michel Nussenzweig for providing neutralization data for 3BNC117; Mark Louder and John Mascola for providing neutralization data for the combination of 3BNC117, PG9, 10-1074 and 10E8; and members of the Ho laboratory for helpful discussions. D.D.H. was supported by the Bill and Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery (Grants OPP50714 and OPP1040732) and by the National Institutes of Health (Grant DP1DA033263). M.S.S. was supported by the Bill and Melinda Gates Foundation's Comprehensive Ab Vaccine Immune Monitoring Consortium (Grant 1032144). D.D.H. is the scientific founder of TaiMed Biologics, Inc., which owns the commercial rights to ibalizumab. In this capacity, D.D.H. hold less than 1% equity in the company and has a financial conflict of interest. Y.H., J.Y., and D.D.H. are inventors on a patent describing HIV CrossMAbs, including 10E8/iMab and 10E8/P140 and their variants, for HIV-1 prevention and therapy. If the technology were to be licensed, the inventors would benefit financially.	Andrews CD, 2014, SCIENCE, V343, P1151, DOI 10.1126/science.1248707; Baeten JM, 2013, JAIDS-J ACQ IMM DEF, V63, pS122, DOI 10.1097/QAI.0b013e3182986f69; Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; BURKLY LC, 1992, J IMMUNOL, V149, P1779; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Georgiev IS, 2014, J IMMUNOL, V192, P1100, DOI 10.4049/jimmunol.1302515; Goetze AM, 2010, MABS-AUSTIN, V2, P500, DOI 10.4161/mabs.2.5.12897; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Haverick M, 2014, MABS-AUSTIN, V6, P852, DOI 10.4161/mabs.28693; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Hutterer KM, 2013, MABS-AUSTIN, V5, P608, DOI 10.4161/mabs.24725; Jacobson JM, 2009, ANTIMICROB AGENTS CH, V53, P450, DOI 10.1128/AAC.00942-08; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14; Koterba KL, 2012, J BIOTECHNOL, V157, P261, DOI 10.1016/j.jbiotec.2011.11.009; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Lowe D, 2011, ADV PROTEIN CHEM STR, V84, P41, DOI 10.1016/B978-0-12-386483-3.00004-5; Luo XM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001225; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mouquet H, 2012, P NATL ACAD SCI USA, V109, P875, DOI 10.1073/pnas.1120059109; Mullan B., 2011, BMC P S8, V5, P110; Olson W.C., 2003, US patent, Patent No. [US7122185 B2, 7122185]; Pace CS, 2013, P NATL ACAD SCI USA, V110, P13540, DOI 10.1073/pnas.1304985110; Pace CS, 2013, JAIDS-J ACQ IMM DEF, V62, P1, DOI 10.1097/QAI.0b013e3182732746; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reimann KA, 1997, AIDS RES HUM RETROV, V13, P933, DOI 10.1089/aid.1997.13.933; Rosati S, 2014, NAT PROTOC, V9, P967, DOI 10.1038/nprot.2014.057; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Salinas BA, 2010, J PHARM SCI-US, V99, P2962, DOI 10.1002/jps.22056; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Song RJ, 2010, J VIROL, V84, P6935, DOI 10.1128/JVI.00453-10; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun M, 2014, JAIDS-J ACQ IMM DEF, V66, P473, DOI 10.1097/QAI.0000000000000218; Tenorio Allan R, 2011, Curr HIV/AIDS Rep, V8, P1, DOI 10.1007/s11904-010-0068-y; Toma J, 2011, J VIROL, V85, P3872, DOI 10.1128/JVI.02237-10; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110	53	125	132	2	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1621	1631		10.1016/j.cell.2016.05.024	http://dx.doi.org/10.1016/j.cell.2016.05.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315479	Green Accepted, Bronze			2022-12-28	WOS:000378062000014
J	Cusi, K; Orsak, B; Bril, F; Lomonaco, R; Hecht, J; Ortiz-Lopez, C; Tio, F; Hardies, J; Darland, C; Musi, N; Webb, A; Portillo-Sanchez, P				Cusi, Kenneth; Orsak, Beverly; Bril, Fernando; Lomonaco, Romina; Hecht, Joan; Ortiz-Lopez, Carolina; Tio, Fermin; Hardies, Jean; Darland, Celia; Musi, Nicolas; Webb, Amy; Portillo-Sanchez, Paola			Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							FATTY LIVER-DISEASE; PLACEBO-CONTROLLED TRIAL; INSULIN-RESISTANCE; BLADDER-CANCER; AMINOTRANSFERASE LEVELS; HEPATIC STEATOSIS; NATURAL-HISTORY; RISK; PREVALENCE; NAFLD	Background: The metabolic defects of nonalcoholic steatohepatitis (NASH) and prediabetes or type 2 diabetes mellitus (T2DM) seem to be specifically targeted by pioglitazone. However, information about its long-term use in this population is limited. Objective: To determine the efficacy and safety of long-term pioglitazone treatment in patients with NASH and prediabetes or T2DM. Design: Randomized, double-blind, placebo-controlled trial. (ClinicalTrials. gov: NCT00994682) Setting: University hospital. Participants: Patients (n = 101) with prediabetes or T2DM and biopsy-proven NASH were recruited from the general population and outpatient clinics. Intervention: All patients were prescribed a hypocaloric diet (500-kcal/d deficit from weight-maintaining caloric intake) and then randomly assigned to pioglitazone, 45 mg/d, or placebo for 18 months, followed by an 18-month open-label phase with pioglitazone treatment. Measurements: The primary outcome was a reduction of at least 2 points in the nonalcoholic fatty liver disease activity score in 2 histologic categories without worsening of fibrosis. Secondary outcomes included other histologic outcomes, hepatic triglyceride content measured by magnetic resonance and proton spectroscopy, and metabolic parameters. Results: Among patients randomly assigned to pioglitazone, 58% achieved the primary outcome (treatment difference, 41 percentage points [95% CI, 23 to 59 percentage points]) and 51% had resolution of NASH (treatment difference, 32 percentage points [CI, 13 to 51 percentage points]) (P < 0.001 for each). Pioglitazone treatment also was associated with improvement in individual histologic scores, including the fibrosis score (treatment difference, -0.5 [CI, -0.9 to 0.0]; P = 0.039); reduced hepatic triglyceride content from 19% to 7% (treatment difference, -7 percentage points [CI, -10 to -4 percentage points]; P < 0.001); and improved adipose tissue, hepatic, and muscle insulin sensitivity (P < 0.001 vs. placebo for all). All 18-month metabolic and histologic improvements persisted over 36 months of therapy. The overall rate of adverse events did not differ between groups, although weight gain was greater with pioglitazone (2.5 kg vs. placebo). Limitation: Single-center study. Conclusion: Long-term pioglitazone treatment is safe and effective in patients with prediabetes or T2DM and NASH.	[Cusi, Kenneth; Bril, Fernando; Lomonaco, Romina; Portillo-Sanchez, Paola] Univ Florida, 1600 SW Archer Rd,Room H-2, Gainesville, FL 32610 USA; Malcom Randall Vet Affairs Med Ctr, Gainesville, FL USA; [Orsak, Beverly; Hecht, Joan; Ortiz-Lopez, Carolina; Tio, Fermin; Hardies, Jean; Darland, Celia; Musi, Nicolas; Webb, Amy] Univ Texas Hlth Sci Ctr San Antonio, 7703 Floyd Curl Dr,DTL Room 3-380S, San Antonio, TX 78229 USA; Audie L Murphy Vet Adm Med Ctr, San Antonio, TX USA	State University System of Florida; University of Florida; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Cusi, K (corresponding author), Univ Florida, 1600 SW Archer Rd,Room H-2, Gainesville, FL 32610 USA.; Cusi, K (corresponding author), Univ Florida, Div Endocrinol Diabet & Metab, Med, 1600 SW Archer Rd,Room H-2, Gainesville, FL 32610 USA.	Kenneth.Cusi@medicine.ufl.edu	Bril, Fernando/E-3430-2017	Bril, Fernando/0000-0001-5570-4396	Burroughs Wellcome Fund [1006762.01]; American Diabetes Association [1-08-CR-08]; National Center for Research Resources [MO1-RR-01346]; UTHSCSA Clinical Research Center and Research Imaging Center; Veterans Affairs Medical Research Fund	Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Diabetes Association(American Diabetes Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UTHSCSA Clinical Research Center and Research Imaging Center; Veterans Affairs Medical Research Fund(US Department of Veterans Affairs)	By the Burroughs Wellcome Fund (1006762.01 [Dr. Cusi]) and the American Diabetes Association (1-08-CR-08 [Dr. Cusi]). Additional support was provided by the National Center for Research Resources (MO1-RR-01346), the UTHSCSA Clinical Research Center and Research Imaging Center, and the Veterans Affairs Medical Research Fund.	Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Bril F, 2016, J CLIN ENDOCR METAB, V101, P644, DOI 10.1210/jc.2015-3111; Bril F, 2015, DIABETES, V64, pA337; Bril F, 2015, LIVER INT, V35, P2139, DOI 10.1111/liv.12840; Bugianesi Elisabetta, 2007, Curr Diab Rep, V7, P175, DOI 10.1007/s11892-007-0029-z; Caldwell SH, 2004, J HEPATOL, V40, P578, DOI 10.1016/j.jhep.2004.02.013; Caldwell SH, 2001, AM J GASTROENTEROL, V96, P519; Caldwell S, 2010, DIGEST DIS, V28, P162, DOI 10.1159/000282081; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cusi K, 2014, J HEPATOL, V60, P167, DOI 10.1016/j.jhep.2013.07.042; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Dall TM, 2014, DIABETES CARE, V37, P3172, DOI 10.2337/dc14-1036; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038; Fan JG, 2007, J GASTROEN HEPATOL, V22, P1086, DOI 10.1111/j.1440-1746.2006.04781.x; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Gastaldelli A, 2010, ALIMENT PHARM THER, V32, P769, DOI 10.1111/j.1365-2036.2010.04405.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koliaki C, 2013, MOL CELL ENDOCRINOL, V379, P35, DOI 10.1016/j.mce.2013.06.002; Kotronen A, 2008, DIABETES CARE, V31, P165, DOI 10.2337/dc07-1463; Leite NC, 2011, LIVER INT, V31, P700, DOI 10.1111/j.1478-3231.2011.02482.x; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Levin D, 2015, DIABETOLOGIA, V58, P493, DOI 10.1007/s00125-014-3456-9; Lewis JD, 2015, JAMA-J AM MED ASSOC, V314, P265, DOI 10.1001/jama.2015.7996; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Lomonaco R, 2016, DIABETES CARE, DOI 26861926; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Lutchman G, 2007, HEPATOLOGY, V46, P424, DOI 10.1002/hep.21661; Maximos M, 2015, HEPATOLOGY, V61, P153, DOI 10.1002/hep.27395; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V38, P1008, DOI 10.1053/jhep.2003.50420; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Neuschwander-Tetri BA, 2014, NAT REV GASTRO HEPAT, V11, P274, DOI 10.1038/nrgastro.2014.51; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Ortiz-Lopez C, 2012, DIABETES CARE, V35, P873, DOI 10.2337/dc11-1849; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Portillo P., 2014, CURR HEPATOL REP, V13, P159, DOI DOI 10.1007/s11901-014-0229-3; Portillo-Sanchez P, 2015, J CLIN ENDOCR METAB, V100, P2231, DOI 10.1210/jc.2015-1966; Promrat K, 2004, HEPATOLOGY, V39, P188, DOI 10.1002/hep.20012; Ratziu V, 2008, GASTROENTEROLOGY, V135, P100, DOI 10.1053/j.gastro.2008.03.078; Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038; Ratziu V, 2010, HEPATOLOGY, V52, P2206, DOI 10.1002/hep.24042; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Soccio RE, 2014, CELL METAB, V20, P573, DOI 10.1016/j.cmet.2014.08.005; Stepanova M, 2013, DIGEST DIS SCI, V58, P3017, DOI 10.1007/s10620-013-2743-5; Targher G, 2008, J AM SOC NEPHROL, V19, P1564, DOI 10.1681/ASN.2007101155; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Williamson RM, 2011, DIABETES CARE, V34, P1139, DOI 10.2337/dc10-2229; Yau H, 2013, CURR DIABETES REP, V13, P329, DOI 10.1007/s11892-013-0378-8; Younossi ZM, 2004, CLIN GASTROENTEROL H, V2, P262, DOI 10.1016/S1542-3565(04)00014-X; Zein CO, 2011, HEPATOLOGY, V54, P1610, DOI 10.1002/hep.24544	56	498	517	5	54	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					305	+		10.7326/M15-1774	http://dx.doi.org/10.7326/M15-1774			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27322798				2022-12-28	WOS:000382795000001
J	Morgan, R; Ensor, T; Waters, H				Morgan, Rosemary; Ensor, Tim; Waters, Hugh			Performance of private sector health care: implications for universal health coverage	LANCET			English	Article							LOW-INCOME; MARKETS; FACILITIES; HOSPITALS; QUALITY; SEEKING; ACCESS; KERALA	Although the private sector is an important health-care provider in many low-income and middle-income countries, its role in progress towards universal health coverage varies. Studies of the performance of the private sector have focused on three main dimensions: quality, equity of access, and efficiency. The characteristics of patients, the structures of both the public and private sectors, and the regulation of the sector influence the types of health services delivered, and outcomes. Combined with characteristics of private providers-including their size, objectives, and technical competence-the interaction of these factors affects how the sector performs in different contexts. Changing the performance of the private sector will require interventions that target the sector as a whole, rather than individual providers alone. In particular, the performance of the private sector seems to be intrinsically linked to the structure and performance of the public sector, which suggests that deriving population benefit from the private health-care sector requires a regulatory response focused on the health-care sector as a whole.	[Morgan, Rosemary] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Ensor, Tim] Univ Leeds, Inst Hlth Sci, Leeds, W Yorkshire, England; [Waters, Hugh] Univ North Carolina Chapel Hill, Sch Nursing, Chapel Hill, NC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Leeds; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Morgan, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	rosemary.morgan@jhu.edu	Ensor, Tim/ABD-5899-2020	Ensor, Tim/0000-0003-0279-9576; Morgan, Rosemary/0000-0001-5009-8470				Ahmed SM, 2005, B WORLD HEALTH ORGAN, V83, P109; Ahmed SM, 2007, HEALTH POLICY, V84, P332, DOI 10.1016/j.healthpol.2007.05.011; Akhtar A, 2011, HLTH CARE REGULATION; Barber SL, 2007, HEALTH AFFAIR, V26, pW352, DOI 10.1377/hlthaff.26.3.w352; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Bennett S, 2005, WORKING NONSTATE SEC; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Bhatia J, 2004, HEALTH POLICY PLANN, V19, P402, DOI 10.1093/heapol/czh055; Bloom G, 2011, HEALTH POLICY PLANN, V26, pi45, DOI 10.1093/heapol/czr025; Borah BJ, 2006, HEALTH ECON, V15, P915, DOI 10.1002/hec.1166; Brugha R, 2003, B WORLD HEALTH ORGAN, V81, P616; Brugha R, 2003, BRIT MED J, V326, P1382, DOI 10.1136/bmj.326.7403.1382; Chatterjee S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002844; Cheng ZH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007267; Das J, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.2.93; Das J, 2007, J DEV ECON, V83, P1, DOI 10.1016/j.jdeveco.2006.05.004; Dilip TR, 2010, HEALTH POLICY PLANN, V25, P437, DOI 10.1093/heapol/czq012; Eggleston K, 2006, HEALTH POLICY, V78, P157, DOI 10.1016/j.healthpol.2005.09.007; Eggleston K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-76; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Ensor T, 2013, LABOR MARKET HLTH WO; Ensor T, 2009, OVERSIGHT REGULATION; Gbotosho GO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-313; Gupta S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-227; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hsu J., 2010, RELATIVE EFFICIENCY; Kutty VR, 2000, HEALTH POLICY PLANN, V15, P103, DOI 10.1093/heapol/15.1.103; Leonard KL, 2007, J HUM RESOUR, V42, P682; Leonard KL, 2002, INT REV LAW ECON, V22, P61, DOI 10.1016/S0144-8188(02)00069-8; Liyanage IK, 2013, STUDY QUALITY CARE P; Mackintosh M, 2016, LANCET, V388, P596, DOI 10.1016/S0140-6736(16)00342-1; Macq J, 2001, HUM RESOUR HEALTH, V5, P17; McPake B, 2016, LANCET, V388, P622, DOI 10.1016/S0140-6736(16)00344-5; McPake B, 2016, B WORLD HEALTH ORGAN, V94, P142, DOI 10.2471/BLT.14.151894; Mikkelsen-Lopez I, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-444; Mills A, 2002, B WORLD HEALTH ORGAN, V80, P325; Montagu D, 2016, LANCET; Morgan R, 2016, INT J HEALTH PLAN M, V31, P49, DOI 10.1002/hpm.2257; Northbridge Capital, 2010, HOSP SECT; Nyazema N. Z., 2000, Central African Journal of Medicine, V46, P89; Posnett J., 2002, HOSP CHANGING EUROPE; Prata N, 2005, B WORLD HEALTH ORGAN, V83, P274; Preker AS., 2003, PRIVATE PARTICIPATIO; Rannan-Eliya RP, 2003, HLTH POLICY RES S AS; Rao P., 2012, ASCI J MANAGE, V41, P14; Russo G, 2010, HEALTH POLICY PLANN, V25, P70, DOI 10.1093/heapol/czp042; Socha KZ, 2011, HEALTH POLICY, V102, P1, DOI 10.1016/j.healthpol.2010.10.017; Sriratanaban Jiruth, 2004, Jt Comm J Qual Saf, V30, P246; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; World Bank, 2005, COMP ADV PUBL PRIV H	51	72	72	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					606	612		10.1016/S0140-6736(16)00343-3	http://dx.doi.org/10.1016/S0140-6736(16)00343-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27358251	Green Accepted			2022-12-28	WOS:000380756600033
J	De Sanctis, MC; Raponi, A; Ammannito, E; Ciarniello, M; Toplis, MJ; McSween, HY; Castillo-Rogez, JC; Ehlmann, BL; Carrozzo, FG; Marchi, S; Tosi, F; Zambon, F; Capaccioni, F; Capria, MT; Fonte, S; Formisano, M; Frigeri, A; Giardino, M; Longobardo, A; Magni, G; Palomba, E; McFadden, LA; Pieters, CM; Jaumann, R; Schenk, P; Mugnuolo, R; Raymond, CA; Russell, CT				De Sanctis, M. C.; Raponi, A.; Ammannito, E.; Ciarniello, M.; Toplis, M. J.; McSween, H. Y.; Castillo-Rogez, J. C.; Ehlmann, B. L.; Carrozzo, F. G.; Marchi, S.; Tosi, F.; Zambon, F.; Capaccioni, F.; Capria, M. T.; Fonte, S.; Formisano, M.; Frigeri, A.; Giardino, M.; Longobardo, A.; Magni, G.; Palomba, E.; McFadden, L. A.; Pieters, C. M.; Jaumann, R.; Schenk, P.; Mugnuolo, R.; Raymond, C. A.; Russell, C. T.			Bright carbonate deposits as evidence of aqueous alteration on (1) Ceres	NATURE			English	Article							AMMONIUM-BEARING MINERALS; OPTICAL-CONSTANTS; WATER ICE; REFLECTANCE SPECTROSCOPY; CRYSTALLINE H2O-ICE; SURFACE-COMPOSITION; MU-M; PHYLLOSILICATES; CHONDRITES; RELEVANT	The typically dark surface of the dwarf planet Ceres is punctuated by areas of much higher albedo, most prominently in the Occator crater(1). These small bright areas have been tentatively interpreted as containing a large amount of hydrated magnesium sulfate(1), in contrast to the average surface, which is a mixture of lowalbedo materials and magnesium phyllosilicates, ammoniated phyllosilicates and carbonates(2-4). Here we report high spatial and spectral resolution near-infrared observations of the bright areas in the Occator crater on Ceres. Spectra of these bright areas are consistent with a large amount of sodium carbonate, constituting the most concentrated known extraterrestrial occurrence of carbonate on kilometre-wide scales in the Solar System. The carbonates are mixed with a dark component and small amounts of phyllosilicates, as well as ammonium carbonate or ammonium chloride. Some of these compounds have also been detected in the plume of Saturn's sixth-largest moon Enceladus(5). The compounds are endogenous and we propose that they are the solid residue of crystallization of brines and entrained altered solids that reached the surface from below. The heat source may have been transient (triggered by impact heating). Alternatively, internal temperatures may be above the eutectic temperature of subsurface brines, in which case fluids may exist at depth on Ceres today.	[De Sanctis, M. C.; Raponi, A.; Ammannito, E.; Ciarniello, M.; Carrozzo, F. G.; Marchi, S.; Tosi, F.; Zambon, F.; Capaccioni, F.; Capria, M. T.; Fonte, S.; Formisano, M.; Frigeri, A.; Giardino, M.; Longobardo, A.; Magni, G.; Palomba, E.] Ist Nazl Astrofis INAF, Ist Astrofis & Planetol Spaziali, Via Fosso del Cavaliere 100, I-00133 Rome, Italy; [Ammannito, E.; Russell, C. T.] Univ Calif Los Angeles, Earth Planetary & Space Sci, Los Angeles, CA USA; [Toplis, M. J.] Univ Toulouse 3, Univ Toulouse, CNRS, Inst Rech Astrophys & Planetol, Toulouse, France; [McSween, H. Y.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Castillo-Rogez, J. C.; Ehlmann, B. L.; Raymond, C. A.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Ehlmann, B. L.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Marchi, S.] SRI, Solar Syst Explorat Res Virtual Inst, 1050 Walnut St, Boulder, CO 80302 USA; [McFadden, L. A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Pieters, C. M.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Jaumann, R.] German Aerosp Ctr DLR, Inst Planetary Res, Rutherfordstr 2, D-12489 Berlin, Germany; [Schenk, P.] Lunar & Planetary Inst, 3600 Bay Area Blvd, Houston, TX 77058 USA; [Mugnuolo, R.] Agenzia Spaziale Italiana, Via Politecn, I-00133 Rome, Italy	Istituto Nazionale Astrofisica (INAF); University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Tennessee System; University of Tennessee Knoxville; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Brown University; Helmholtz Association; German Aerospace Centre (DLR); Agenzia Spaziale Italiana (ASI)	De Sanctis, MC (corresponding author), Ist Nazl Astrofis INAF, Ist Astrofis & Planetol Spaziali, Via Fosso del Cavaliere 100, I-00133 Rome, Italy.	mariacristina.desanctis@iaps.inaf.it	Tosi, Federico/F-2321-2018; Zambon, Francesca/J-2855-2018; Formisano, Michelangelo/AAJ-2719-2020; Palomba, Ernesto/E-8287-2017; mugnuolo, raffaele/X-7642-2018; Russell, Christopher T/E-7745-2012; Jaumann, Ralf/N-1001-2018; Frigeri, Alessandro/K-9679-2019; McFadden, Lucy/I-4902-2013; De Sanctis, Maria Cristina/G-5232-2013	Tosi, Federico/0000-0003-4002-2434; Zambon, Francesca/0000-0002-4190-6592; Formisano, Michelangelo/0000-0003-3236-1604; Palomba, Ernesto/0000-0002-9101-6774; mugnuolo, raffaele/0000-0002-7334-6585; Russell, Christopher T/0000-0003-1639-8298; Jaumann, Ralf/0000-0002-9759-6597; Frigeri, Alessandro/0000-0002-9140-3977; Raponi, Andrea/0000-0003-4996-0099; Ciarniello, Mauro/0000-0002-7498-5207; Capaccioni, Fabrizio/0000-0003-1631-4314; McFadden, Lucy/0000-0002-0537-9975; Longobardo, Andrea/0000-0002-1797-2741; Carrozzo, Filippo Giacomo/0000-0002-0391-6407; Giardino, Marco/0000-0002-6983-6346; De Sanctis, Maria Cristina/0000-0002-3463-4437	Italian Space Agency; National Aeronautics and Space Administration (NASA, USA); Deutsches Zentrum fur Luft- und Raumfahrt (DLR, Germany)	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); National Aeronautics and Space Administration (NASA, USA)(National Aeronautics & Space Administration (NASA)); Deutsches Zentrum fur Luft- und Raumfahrt (DLR, Germany)	We thank the following institutions and agencies which supported this work: the Italian Space Agency, the National Aeronautics and Space Administration (NASA, USA) and the Deutsches Zentrum fur Luft- und Raumfahrt (DLR, Germany). The VIR was funded and coordinated by the Italian Space Agency and built by SELEX ES, with the scientific leadership of the Institute for Space Astrophysics and Planetology and the Italian National Institute for Astrophysics, and is operated by the Institute for Space Astrophysics and Planetology, Italy. A portion of this work was carried out at the Jet Propulsion Laboratory, California Institute of Technology, USA, under contract to NASA. We also thank the Dawn Mission Operations team and the Framing Camera team.	Ammannito E., SCIENCE IN PRESS; Beran A, 2002, REV MINERAL GEOCHEM, V46, P351, DOI 10.2138/rmg.2002.46.07; Berg BL, 2016, ICARUS, V265, P218, DOI 10.1016/j.icarus.2015.10.028; Bishop JL, 2008, CLAY MINER, V43, P35, DOI 10.1180/claymin.2008.043.1.03; Bowling T. J, 2016, 47 LUN PLAN SCI C, V47, P2268; Brearley A.J., 2006, METEORITES EARLY SOL, P587; Buczkowski D., SCIENCE IN PRESS; Carli C, 2014, ICARUS, V235, P207, DOI 10.1016/j.icarus.2014.03.022; Castillo-Rogez JC, 2010, ICARUS, V205, P443, DOI 10.1016/j.icarus.2009.04.008; Clark R. N., 2007, DIGITAL DATA SERIES, V231; Clark RN, 2012, ICARUS, V218, P831, DOI 10.1016/j.icarus.2012.01.008; de Leuw S, 2010, METEORIT PLANET SCI, V45, P513, DOI 10.1111/j.1945-5100.2010.01037.x; De Sanctis MC, 2015, NATURE, V525, P500, DOI 10.1038/nature14869; De Sanctis MC, 2011, SPACE SCI REV, V163, P329, DOI 10.1007/s11214-010-9668-5; Filacchione G, 2016, NATURE, V529, P368, DOI 10.1038/nature16190; Hapke B., 2012, THEORY REFLECTANCE E; Harner PL, 2015, ICARUS, V250, P204, DOI 10.1016/j.icarus.2014.11.037; Hunt G. R., 1971, Modern Geology, V2, P23; JOHNSON CA, 1993, GEOCHIM COSMOCHIM AC, V57, P2843, DOI 10.1016/0016-7037(93)90393-B; Kiefer D. M., 2002, TODAYS CHEM WORK, V11, P90; Kiefer D. M., 2002, TODAYS CHEM WORK, V11, P87; KING TVV, 1992, SCIENCE, V255, P1551, DOI 10.1126/science.255.5051.1551; Mastrapa RM, 2008, ICARUS, V197, P307, DOI 10.1016/j.icarus.2008.04.008; Mastrapa RM, 2009, ASTROPHYS J, V701, P1347, DOI 10.1088/0004-637X/701/2/1347; Milliken RE, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002534; Moore MH, 2007, ICARUS, V190, P260, DOI 10.1016/j.icarus.2007.02.020; Moore MH, 2003, EARTH MOON PLANETS, V92, P291, DOI 10.1023/B:MOON.0000031946.53696.f6; Nathues A, 2015, NATURE, V528, P237, DOI 10.1038/nature15754; Postberg F, 2011, NATURE, V474, P620, DOI 10.1038/nature10175; Postberg F, 2009, NATURE, V459, P1098, DOI 10.1038/nature08046; Raponi A., 2015, THESIS; Rivkin AS, 2006, ICARUS, V185, P563, DOI 10.1016/j.icarus.2006.08.022; Takir D, 2013, METEORIT PLANET SCI, V48, P1618, DOI 10.1111/maps.12171; Waite JH, 2009, NATURE, V460, P487, DOI 10.1038/nature08153; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206; Zolotov MY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031234; Zolotov MY, 2012, ICARUS, V220, P713, DOI 10.1016/j.icarus.2012.05.036	38	194	194	4	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					54	+		10.1038/nature18290	http://dx.doi.org/10.1038/nature18290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27362221				2022-12-28	WOS:000380999200028
J	Lane, R				Lane, Richard			Sam Winter and Kevan Wylie: pioneers in transgender health	LANCET			English	Biographical-Item													Wylie, Kevan/C-5751-2011	Wylie, Kevan/0000-0003-3805-105X				WINTER S, PUBLICATION LIST	1	2	2	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					331	331		10.1016/S0140-6736(16)30841-8	http://dx.doi.org/10.1016/S0140-6736(16)30841-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR6MV	27323924				2022-12-28	WOS:000380016900021
J	Long, JZ; Svensson, KJ; Bateman, LA; Lin, H; Kamenecka, T; Lokurkar, IA; Lou, J; Rao, RR; Chang, MR; Jedrychowski, MP; Paulo, JA; Gygi, SP; Griffin, PR; Nomura, DK; Spiegelman, BM				Long, Jonathan Z.; Svensson, Katrin J.; Bateman, Leslie A.; Lin, Hua; Kamenecka, Theodore; Lokurkar, Isha A.; Lou, Jesse; Rao, Rajesh R.; Chang, Mi Ra; Jedrychowski, Mark P.; Paulo, Joao A.; Gygi, Steven P.; Griffin, Patrick R.; Nomura, Daniel K.; Spiegelman, Bruce M.			The Secreted Enzyme PM20D1 Regulates Lipidated Amino Acid Uncouplers of Mitochondria	CELL			English	Article							BROWN ADIPOSE-TISSUE; BEIGE FAT; THERMOGENESIS; MICE; ABLATION; IDENTIFICATION; DIPEPTIDASE; PROTEINS; OBESITY; PRDM16	Brown and beige adipocytes are specialized cells that express uncoupling protein 1 ( UCP1) and dissipate chemical energy as heat. These cells likely possess alternative UCP1-independent thermogenic mechanisms. Here, we identify a secreted enzyme, peptidase M20 domain containing 1 ( PM20D1), that is enriched in UCP1(+) versus UCP1(-) adipocytes. We demonstrate that PM20D1 is a bidirectional enzyme in vitro, catalyzing both the condensation of fatty acids and amino acids to generate N-acyl amino acids and also the reverse hydrolytic reaction. N-acyl amino acids directly bind mitochondria and function as endogenous uncouplers of UCP1-independent respiration. Mice with increased circulating PM20D1 have augmented respiration and increased N-acyl amino acids in blood. Lastly, administration of N-acyl amino acids to mice improves glucose homeostasis and increases energy expenditure. These data identify an enzymatic node and a family of metabolites that regulate energy homeostasis. This pathway might be useful for treating obesity and associated disorders.	[Long, Jonathan Z.; Svensson, Katrin J.; Lokurkar, Isha A.; Lou, Jesse; Rao, Rajesh R.; Jedrychowski, Mark P.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Long, Jonathan Z.; Svensson, Katrin J.; Rao, Rajesh R.; Jedrychowski, Mark P.; Paulo, Joao A.; Gygi, Steven P.; Spiegelman, Bruce M.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Bateman, Leslie A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bateman, Leslie A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Bateman, Leslie A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Lin, Hua; Kamenecka, Theodore; Chang, Mi Ra; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Rao, Rajesh R.] Novartis Res Fdn GNF, Genom Inst, San Diego, CA 92121 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Scripps Research Institute; Novartis	Spiegelman, BM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.; Spiegelman, BM (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Nomura, DK (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Nomura, DK (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Nomura, DK (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	dnomura@berkeley.edu; bruce_spiegelman@dfci.harvard.edu	Svensson, Katrin J./AAA-4770-2021; Lin, Hua/U-1529-2019; Paulo, Joao/AAO-3981-2020	Svensson, Katrin J./0000-0001-5376-5128; Paulo, Joao/0000-0002-4291-413X; Long, Jonathan/0000-0003-2631-7463; Lin, Hua/0000-0002-0840-6553	NIH [DK105203, DK098285, R01CA172667, DK5447, DK31405]; Swedish Research Council [PE2013/613]; American Cancer Society [RSG14-242-01-TBE]; JPB Foundation; NATIONAL CANCER INSTITUTE [R01CA172667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054477, R01DK031405, K01DK098285, K99DK105203, R37DK031405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); American Cancer Society(American Cancer Society); JPB Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Marc Kirschner for many critical discussions as well as members of the B.M.S., D.K.N., and P.R.G. labs for helpful comments. We are grateful to Julie J. Johnson and Arbansjit Sandhu at the University of Pennsylvania Vector Core for AAV production. This work was supported by grants to J.Z.L. (NIH DK105203), K.J.S. (Swedish Research Council Postdoctoral Fellowship PE2013/613), J.A.P. (NIH DK098285), D.K.N. (American Cancer Society Research Scholar Award RSG14-242-01-TBE and NIH R01CA172667), and B.M.S. (NIH DK5447, DK31405 and the JPB Foundation). B.M.S. is a consultant for Calico Life Sciences, LLC.	Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; FUKUI T, 1961, J BIOL CHEM, V236, P811; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Katayama K, 1999, BBA-MOL CELL BIOL L, V1440, P205, DOI 10.1016/S1388-1981(99)00124-9; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Nicholls D G, 1978, Experientia Suppl, V32, P89; Niphakis MJ, 2015, CELL, V161, P1668, DOI 10.1016/j.cell.2015.05.045; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; STEGINK LD, 1991, AM J CLIN NUTR, V53, P670, DOI 10.1093/ajcn/53.3.670; Svensson KJ, 2016, CELL METAB, V23, P454, DOI 10.1016/j.cmet.2016.01.008; Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Van Coster RN, 2005, BIOCHEM BIOPH RES CO, V338, P1322, DOI 10.1016/j.bbrc.2005.10.126; Veiga-da-Cunha M, 2014, J BIOL CHEM, V289, P19726, DOI 10.1074/jbc.M114.576579; Wang GX, 2014, NAT MED, V20, P1436, DOI 10.1038/nm.3713; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	30	152	154	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					424	435		10.1016/j.cell.2016.05.071	http://dx.doi.org/10.1016/j.cell.2016.05.071			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27374330	Green Accepted, Bronze			2022-12-28	WOS:000380255400019
J	Mallard, C; Coltice, N; Seton, M; Muller, RD; Tackley, PJ				Mallard, Claire; Coltice, Nicolas; Seton, Maria; Muller, R. Dietmar; Tackley, Paul J.			Subduction controls the distribution and fragmentation of Earth's tectonic plates	NATURE			English	Article							MANTLE CONVECTION; MODELS; PACIFIC; RECONSTRUCTIONS; REORGANIZATION; PARAMETERS; BEHAVIOR; BASIN; FLOW; MA	The theory of plate tectonics describes how the surface of Earth is split into an organized jigsaw of seven large plates(1) of similar sizes and a population of smaller plates whose areas follow a fractal distribution(2,3). The reconstruction of global tectonics during the past 200 million years(4) suggests that this layout is probably a long-term feature of Earth, but the forces governing it are unknown. Previous studies(3,5,6), primarily based on the statistical properties of plate distributions, were unable to resolve how the size of the plates is determined by the properties of the lithosphere and the underlying mantle convection. Here we demonstrate that the plate layout of Earth is produced by a dynamic feedback between mantle convection and the strength of the lithosphere. Using three-dimensional spherical models of mantle convection that self-consistently produce the plate size-frequency distribution observed for Earth, we show that subduction geometry drives the tectonic fragmentation that generates plates. The spacing between the slabs controls the layout of large plates, and the stresses caused by the bending of trenches break plates into smaller fragments. Our results explain why the fast evolution in small back-arc plates(7,8) reflects the marked changes in plate motions during times of major reorganizations. Our study opens the way to using convection simulations with plate-like behaviour to unravel how global tectonics and mantle convection are dynamically connected.	[Mallard, Claire; Coltice, Nicolas] Univ Lyon 1, CNRS, UMR 5276, Lab Geol Lyon,Ecole Normale Super, F-69622 Villeurbanne, France; [Coltice, Nicolas] Inst Univ France, 103 Blvd St Michel, F-75005 Paris, France; [Seton, Maria; Muller, R. Dietmar] Univ Sydney, Sch Geosci, EarthByte Grp, Madsen Bldg F09, Sydney, NSW 2006, Australia; [Tackley, Paul J.] ETH, Dept Earth Sci, Inst Geophys, Sonneggstr 5, CH-8092 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Universitaire de France; University of Sydney; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mallard, C (corresponding author), Univ Lyon 1, CNRS, UMR 5276, Lab Geol Lyon,Ecole Normale Super, F-69622 Villeurbanne, France.	claire.mallard@univ-lyon1.fr	Tackley, Paul J/D-8155-2016; Seton, Maria/H-8272-2013; Müller, Dietmar/L-1200-2019	Tackley, Paul J/0000-0003-4878-621X; Seton, Maria/0000-0001-8541-1367; Müller, Dietmar/0000-0002-3334-5764; Mallard, Claire A./0000-0003-2595-2414; Coltice, Nicolas/0000-0001-5444-414X	European Research Council under ERC [617588]; Institut Universitaire de France; ARC [DP130101946, FT130101564]	European Research Council under ERC(European Research Council (ERC)); Institut Universitaire de France; ARC(Australian Research Council)	The research leading to these results was funded by the European Research Council within the framework of the SP2-Ideas Programme ERC-2013-CoG under ERC grant agreement 617588. We thank S. Durant and E. Debayle for helping to make Fig. 1e, i and E. J. Garnero for his inputs. Calculations were performed on the AUGURY supercomputer at P2CHPD Lyon. N.C. was supported by the Institut Universitaire de France. R.D.M and M.S are supported by ARC grants DP130101946 and FT130101564.	Amante C., 2009, ETOPO1 1 ARC MINUTE; Barckhausen U, 2008, GEOLOGY, V36, P767, DOI 10.1130/G25056A.1; Becker TW, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000168; Bello L, 2014, GEOCHEM GEOPHY GEOSY, V15, P2319, DOI 10.1002/2014GC005254; Bird P, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000252; CLOETINGH S, 1990, J GEOL SOC LONDON, V147, P495, DOI 10.1144/gsjgs.147.3.0495; Coltice N, 2013, EARTH PLANET SC LETT, V383, P92, DOI 10.1016/j.epsl.2013.09.032; French SW, 2015, NATURE, V525, P95, DOI 10.1038/nature14876; Gordon R. G., 2000, GEOPHYS MONOGR SER, V121, P143; Goudarzi MA, 2014, GPS SOLUT, V18, P153, DOI 10.1007/s10291-013-0354-4; HARBERT W, 1991, TECTONICS, V10, P1, DOI 10.1029/90TC02093; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; LEPICHON X, 1968, J GEOPHYS RES, V73, P3661, DOI 10.1029/JB073i012p03661; Matthews KJ, 2012, EARTH PLANET SC LETT, V355, P283, DOI 10.1016/j.epsl.2012.08.023; Mitrovica JX, 1996, J GEOPHYS RES-SOL EA, V101, P555, DOI 10.1029/95JB03208; Moresi L, 1998, GEOPHYS J INT, V133, P669, DOI 10.1046/j.1365-246X.1998.00521.x; Morra G, 2013, EARTH PLANET SC LETT, V373, P93, DOI 10.1016/j.epsl.2013.04.020; Petterson MG, 1999, TECTONOPHYSICS, V301, P35, DOI 10.1016/S0040-1951(98)00214-5; RICARD Y, 1993, J GEOPHYS RES-SOL EA, V98, P21895, DOI 10.1029/93JB02216; Ricard Y, 2001, J GEOPHYS RES-SOL EA, V106, P8907, DOI 10.1029/2000JB900431; Sdrolias M, 2004, TECTONOPHYSICS, V394, P69, DOI 10.1016/j.tecto.2004.07.061; Seton M, 2012, EARTH-SCI REV, V113, P212, DOI 10.1016/j.earscirev.2012.03.002; Sornette D, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015043; Stegman DR, 2010, TECTONOPHYSICS, V483, P46, DOI 10.1016/j.tecto.2009.08.026; Stein C, 2004, PHYS EARTH PLANET IN, V142, P225, DOI 10.1016/j.pepi.2004.01.006; Tackley P. J., 2000, GEOCHEM GEOPHY GEOSY, V1, P1, DOI [10.1029/2000GC000036, DOI 10.1029/2000GC000036, 10.1029/200GC000036, 10.1029/2000GC000043]; Tackley PJ, 2008, PHYS EARTH PLANET IN, V171, P7, DOI 10.1016/j.pepi.2008.08.005; Taylor B, 1996, EARTH PLANET SC LETT, V144, P35, DOI 10.1016/0012-821X(96)00148-3; Tebbens SF, 1997, J GEOPHYS RES-SOL EA, V102, P12061, DOI 10.1029/96JB02582; Tosi N, 2015, GEOCHEM GEOPHY GEOSY, V16, P2175, DOI 10.1002/2015GC005807; Trompert R, 1998, NATURE, V395, P686, DOI 10.1038/27185; Vallianatos F, 2010, PHYSICA A, V389, P4989, DOI 10.1016/j.physa.2010.06.056; van der Meer DG, 2012, NAT GEOSCI, V5, P215, DOI [10.1038/NGEO1401, 10.1038/ngeo1401]; van Heck HJ, 2011, EARTH PLANET SC LETT, V310, P252, DOI 10.1016/j.epsl.2011.07.029; van Heck HJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035190; Williams S.E., 2012, GSA TODAY, V22, P4, DOI [10.1130/GSATG139A.1, DOI 10.1130/GSATG139A.1, 10.1016/j.earscirev.2012.03.002]; Zhong SJ, 1998, J GEOPHYS RES-SOL EA, V103, P15255, DOI 10.1029/98JB00605	37	63	68	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					140	+		10.1038/nature17992	http://dx.doi.org/10.1038/nature17992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27309815	Green Submitted			2022-12-28	WOS:000379015600040
J	Cheng, CM; DeLizza, C				Cheng, Christine M.; DeLizza, Colleen			Content, Consistency, and Quality of Black Box Warnings	ANNALS OF INTERNAL MEDICINE			English	Letter									[Cheng, Christine M.; DeLizza, Colleen] First Databank, San Francisco, CA 94080 USA		Cheng, CM (corresponding author), First Databank, San Francisco, CA 94080 USA.							Elraiyah T, 2015, ANN INTERN MED, V163, P875, DOI 10.7326/M15-1097; Sousa-Pinto B, 2015, J ALLERGY CLIN IMMUN, V136, P1092, DOI 10.1016/j.jaci.2015.03.019; U.S. Food and Drug Administration, 2011, GUID IND WARN PREC C	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					74	74		10.7326/L16-0072	http://dx.doi.org/10.7326/L16-0072			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380161				2022-12-28	WOS:000379215800026
J	Walter, S; Mejia-Guevara, I; Estrada, K; Liu, SY; Glymour, MM				Walter, Stefan; Mejia-Guevara, Ivan; Estrada, Karol; Liu, Sze Y.; Glymour, M. Maria			Association of a Genetic Risk Score With Body Mass Index Across Different Birth Cohorts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUGAR-SWEETENED BEVERAGES; PHYSICAL-ACTIVITY; US ADULTS; OBESITY; TRENDS; PREVALENCE; INDIVIDUALS; RACE; FTO	IMPORTANCE Many genetic variants are associated with body mass index (BMI). Associations may have changed with the 20th century obesity epidemic and may differ for black vs white individuals. OBJECTIVE Using birth cohort as an indicator for exposure to obesogenic environment, to evaluate whether genetic predisposition to higher BMI has a larger magnitude of association among adults from more recent birth cohorts, who were exposed to the obesity epidemic at younger ages. DESIGN, SETTING, AND PARTICIPANTS Observational study of 8788 adults in the US national Health and Retirement Study who were aged 50 years and older, born between 1900 and 1958, with as many as 12 BMI assessments from 1992 to 2014. EXPOSURES A multilocus genetic risk score for BMI (GRS-BMI), calculated as the weighted sum of alleles of 29 single nucleotide polymorphisms associated with BMI, with weights equal to the published per-allele effects. The GRS-BMI represents how much each person's BMI is expected to differ, based on genetic background (with respect to these 29 loci), from the BMI of a sample member with median genetic risk. The median-centered GRS-BMI ranged from -1.68 to 2.01. MAIN OUTCOMES AND MEASURES BMI based on self-reported height and weight. RESULTS GRS-BMI was significantly associated with BMI among white participants (n = 7482; mean age at first assessment, 59 years; 3373 [45%] were men; P < .001) and among black participants (n = 1306; mean age at first assessment, 57 years; 505 [39%] were men; P < .001) but accounted for 0.99% of variation in BMI among white participants and 1.37% among black participants. In multilevel models accounting for age, the magnitude of associations of GRS-BMI with BMI were larger for more recent birth cohorts. For example, among white participants, each unit higher GRS-BMI was associated with a difference in BMI of 1.37 (95% CI, 0.93 to 1.80) if born after 1943, and 0.17 (95% CI, -0.55 to 0.89) if born before 1924 (P = .006). For black participants, each unit higher GRS-BMI was associated with a difference in BMI of 3.70 (95% CI, 2.42 to 4.97) if born after 1943, and 1.44 (95% CI, -1.40 to 4.29) if born before 1924. CONCLUSIONS AND RELEVANCE For participants born between 1900 and 1958, the magnitude of association between BMI and a genetic risk score for BMI was larger among persons born in later cohorts. This suggests that associations of known genetic variants with BMI may be modified by obesogenic environments.	[Walter, Stefan; Glymour, M. Maria] Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St,Mission Hall,Second Floor, San Francisco, CA 94132 USA; [Mejia-Guevara, Ivan; Liu, Sze Y.] Harvard Univ, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Estrada, Karol] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA	University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Glymour, MM (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St,Mission Hall,Second Floor, San Francisco, CA 94132 USA.	mglymour@psg.ucsf.edu	Liu, Sze/ABB-4170-2021	Walter, Stefan/0000-0002-6010-7550; Liu, Sze Yan/0000-0002-7148-356X	National Institute on Aging [U01AG009740, RC2AG036495, RC4AG039029]; NATIONAL INSTITUTE ON AGING [U01AG009740, RC2AG036495, RC4AG039029] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Health and Retirement Study genetic data collection was sponsored by the National Institute on Aging (U01AG009740, RC2AG036495, and RC4AG039029).	Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Crimmins E, 2008, DOCUMENTATION BIOMAR; Demerath EW, 2013, HUM HERED, V75, P175, DOI 10.1159/000351742; Ervin R Bethene, 2013, NCHS Data Brief, P1; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Guo G, 2015, DEMOGRAPHY, V52, P1651, DOI 10.1007/s13524-015-0421-2; Heeringa S.G., 1995, TECHNICAL DESCRIPTIO; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Kutty Nandinee, 2008, SEGREGATION RISING C, P197; Liu SY, 2015, SOC SCI MED, V127, P150, DOI 10.1016/j.socscimed.2014.09.009; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450; Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005; Nielsen SJ, 2002, OBES RES, V10, P370, DOI 10.1038/oby.2002.51; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Rasbash J., 2000, USERS GUIDE MLWIN; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027135; Rosenquist JN, 2015, P NATL ACAD SCI USA, V112, P354, DOI 10.1073/pnas.1411893111; Sallis JF, 2012, CIRCULATION, V125, P729, DOI 10.1161/CIRCULATIONAHA.110.969022; Sha HB, 2007, PHYSIOL GENOMICS, V31, P252, DOI 10.1152/physiolgenomics.00093.2007; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Suemoto CK, 2015, INT J OBESITY, V39, P1383, DOI 10.1038/ijo.2015.83; Weir D., 2012, QUALITY CONTROL REPO; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Wright Jacqueline D, 2010, NCHS Data Brief, P1; Wyatt ID, 2006, MON LABOR REV, V129, P35; Yang Y., 2013, AGE PERIOD COHORT AN	36	83	83	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					63	69		10.1001/jama.2016.8729	http://dx.doi.org/10.1001/jama.2016.8729			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ2MY	27380344	Bronze			2022-12-28	WOS:000379037600019
J	Jee, J; Rasouly, A; Shamovsky, I; Akivis, Y; Steinman, SR; Mishra, B; Nudler, E				Jee, Justin; Rasouly, Aviram; Shamovsky, Ilya; Akivis, Yonatan; Steinman, Susan R.; Mishra, Bud; Nudler, Evgeny			Rates and mechanisms of bacterial mutagenesis from maximum-depth sequencing	NATURE			English	Article							ESCHERICHIA-COLI; MUTATION-RATE; RARE MUTATIONS; ANTIBIOTICS; SENSITIVITY; SELECTION; GENE	In 1943, Luria and Delbruck used a phage-resistance assay to establish spontaneous mutation as a driving force of microbial diversity(1). Mutation rates are still studied using such assays, but these can only be used to examine the small minority of mutations conferring survival in a particular condition. Newer approaches, such as long-term evolution followed by whole-genome sequencing(2,3), may be skewed by mutational 'hot' or 'cold' spots(3,4). Both approaches are affected by numerous caveats(5-7). Here we devise a method, maximum-depth sequencing (MDS), to detect extremely rare variants in a population of cells through error-corrected, high-throughput sequencing. We directly measure locus-specific mutation rates in Escherichia coli and show that they vary across the genome by at least an order of magnitude. Our data suggest that certain types of nucleotide misincorporation occur 10(4)-fold more frequently than the basal rate of mutations, but are repaired in vivo. Our data also suggest specific mechanisms of antibiotic-induced mutagenesis, including downregulation of mismatch repair via oxidative stress, transcription-replication conflicts, and, in the case of fluoroquinolones, direct damage to DNA.	[Jee, Justin; Rasouly, Aviram; Shamovsky, Ilya; Akivis, Yonatan; Steinman, Susan R.; Nudler, Evgeny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Jee, Justin; Mishra, Bud] NYU, Courant Inst Math Sci, New York, NY 10016 USA; [Rasouly, Aviram; Nudler, Evgeny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; New York University; Howard Hughes Medical Institute; New York University	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.; Mishra, B (corresponding author), NYU, Courant Inst Math Sci, New York, NY 10016 USA.; Nudler, E (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	mishra@nyu.edu; evgeny.nudler@nyumc.org		Nudler, Evgeny/0000-0002-8811-3071; Rasouly, Aviram/0000-0003-2857-6151	Cancer Center Support Grant [P30CA016087]; NIH [R01GM107329]; HHMI; NCI PSOC grant [U54 CA193313]; NYU Medical Scientist Training Program; National Defense Science and Engineering Graduate Fellowship; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308, R01GM107329] Funding Source: NIH RePORTER	Cancer Center Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NCI PSOC grant; NYU Medical Scientist Training Program; National Defense Science and Engineering Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Heguy and the NYU Genome Technology Center, which is partially supported by the Cancer Center Support Grant, P30CA016087, at the Laura and Isaac Perlmutter Cancer Center. This work used computing resources at the High Performance Computing Facility of the Center for Health Informatics and Bioinformatics at the NYU Langone Medical Center. We thank D. Dwyer and K. Shankarling for materials, and T Artemyev for his contribution. This work was supported by NIH grant R01GM107329 and HHMI (E.N.) and NCI PSOC grant U54 CA193313 (B.M.). J.J. was supported by the NYU Medical Scientist Training Program and a National Defense Science and Engineering Graduate Fellowship.	Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Chen XZ, 2013, MOL BIOL EVOL, V30, P1559, DOI 10.1093/molbev/mst060; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Drake JW, 2012, G3-GENES GENOM GENET, V2, P483, DOI 10.1534/g3.111.001842; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; LENSKI RE, 1989, P NATL ACAD SCI USA, V86, P2775, DOI 10.1073/pnas.86.8.2775; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Luria SE, 1943, GENETICS, V28, P491; Martincorena I, 2012, NATURE, V485, P95, DOI 10.1038/nature10995; McDonald MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000622; Merrikh H, 2012, NAT REV MICROBIOL, V10, P449, DOI 10.1038/nrmicro2800; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Pohlhaus JR, 2005, MOL MICROBIOL, V56, P1416, DOI 10.1111/j.1365-2958.2005.04638.x; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Sangurdekar DP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r32; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; Schmitt MW, 2015, NAT METHODS, V12, P423, DOI [10.1038/nmeth.3351, 10.1038/NMETH.3351]; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wielgoss S, 2013, P NATL ACAD SCI USA, V110, P222, DOI 10.1073/pnas.1219574110; Wielgoss S, 2011, G3-GENES GENOM GENET, V1, P183, DOI 10.1534/g3.111.000406; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Zhu LC, 2009, MOL BIOL EVOL, V26, P2353, DOI 10.1093/molbev/msp144	34	69	72	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					693	+		10.1038/nature18313	http://dx.doi.org/10.1038/nature18313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27338792	Green Accepted			2022-12-28	WOS:000378676000038
J	[Anonymous]				[Anonymous]			The Centennial of the Stethoscope (Reprinted from JAMA vol 66, pg 1928-1929, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1916, JAMA, V66, P1928	1	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24								10.1001/jama.2015.17091	http://dx.doi.org/10.1001/jama.2015.17091			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9YE	27367779				2022-12-28	WOS:000394975200001
J	Elwyn, G; Wieringa, S; Greenhalgh, T				Elwyn, Glyn; Wieringa, Siestse; Greenhalgh, Trisha			Clinical encounters in the post-guidelines era	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SHARED DECISION-MAKING; OF-INTEREST; PUBLICATION; MINDLINES; KNOWLEDGE; BIAS; AIDS		[Elwyn, Glyn] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA; [Wieringa, Siestse] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Greenhalgh, Trisha] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	Dartmouth College; University of Oslo; University of Oxford	Elwyn, G (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA.	glynelwyn@gmail.com	Elwyn, Glyn/B-4798-2009; Greenhalgh, Trisha/B-1825-2015	Elwyn, Glyn/0000-0002-0917-6286; Greenhalgh, Trisha/0000-0003-2369-8088; Wieringa, Sietse/0000-0002-7758-8493	National Institute for Health Research [NF-SI-0512-10031] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Agoritsas T, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7624; Akl EA, 2014, J CLIN EPIDEMIOL, V67, P1222, DOI 10.1016/j.jclinepi.2014.05.006; Allen D, 2005, LANCET, V365, P1768, DOI 10.1016/S0140-6736(05)66578-6; Berg M, 1999, INT J MED INFORM, V55, P87, DOI 10.1016/S1386-5056(99)00011-8; Croskerry P, 2013, NEW ENGL J MED, V368, P2445, DOI 10.1056/NEJMp1303712; Durand MA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010008; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Elwyn G, 2016, PATIENT EDUC COUNS, V99, P571, DOI 10.1016/j.pec.2015.10.011; Elwyn G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0436-y; Elwyn G, 2014, PATIENT EDUC COUNS, V97, P158, DOI 10.1016/j.pec.2014.07.027; Fay M, 2016, PATIENT EDUC COUNS, V99, P236, DOI 10.1016/j.pec.2015.08.025; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Gabbay J, 2011, PRACTICE-BASED EVIDENCE FOR HEALTHCARE: CLINICAL MINDLINES, P1; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Greenhalgh T., CLIN UNCERTAINTY PRI, P23; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Kruglanski AW, 2011, PSYCHOL REV, V118, P97, DOI 10.1037/a0020762; Laine C, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00011; Lindblom C, 1964, SCI MUDDING; May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281; Montgomery K., 2005, DOCTORS THINK CLIN J; National Institute for Health and Care Excellence, 2012, TYP 2 DIAB PREV PEOP; National Institute for Health and Care Excellence, 2013, CLINICAL GUIDELINE 1; National Institute for Health and Care Excellence, 2009, LOW BACK PAIN AD EAR; National Institute for Health and Care Excellence, 2009, DEPR AD REC MAN; National Institute for Health and Care Excellence, 2012, PSOR ASS MAN; National Institute for Health and Clinical Excellence, 2010, CLIN MAN PRIM HYP AD; National Institute for Health and Clinical Excellence, 2008, SAT OBS BEN SCI SOC; Schei E, 2006, PERSPECT BIOL MED, V49, P393, DOI 10.1353/pbm.2006.0048; Tiedje K, 2013, PATIENT EDUC COUNS, V93, P86, DOI 10.1016/j.pec.2013.03.013; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Van de Ven AH, 2006, ACAD MANAGE REV, V31, P802, DOI [10.2307/20159252, 10.5465/AMR.2006.22527385]; van der Weijden T, 2013, BMJ QUAL SAF, V22, P855, DOI 10.1136/bmjqs-2012-001502; Vandvik PO, 2013, CHEST, V144, P381, DOI 10.1378/chest.13-0746; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Wieringa S, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0229-x; Wyatt KD, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-26	39	24	24	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2016	353								i3200	10.1136/bmj.i3200	http://dx.doi.org/10.1136/bmj.i3200			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ2FG	27352795				2022-12-28	WOS:000379017000001
J	Donald, PR; Van Toorn, R				Donald, Peter Roderick; Van Toorn, Ronald			Use of corticosteroids in tuberculous meningitis	LANCET			English	Editorial Material							THERAPY		[Donald, Peter Roderick; Van Toorn, Ronald] Univ Stellenbosch, Paediat & Child Hlth, Fac Med & Hlth Sci, ZA-8000 Cape Town, South Africa	Stellenbosch University	Donald, PR (corresponding author), Univ Stellenbosch, Paediat & Child Hlth, Fac Med & Hlth Sci, ZA-8000 Cape Town, South Africa.	prd@sun.ac.za	van Toorn, Ronald/AAR-9157-2021	van Toorn, Ronald/0000-0002-2689-065X				Bekker LG, 1998, J INFECT DIS, V178, P580, DOI 10.1086/517479; Datta M, 2015, P NATL ACAD SCI USA, V112, P1827, DOI 10.1073/pnas.1424563112; FITZPATRICK MJ, 1954, AM REV TUBERC PULM, V69, P370; Lammie GA, 2009, J INFECTION, V20, P1; Orme IM, 2014, TUBERCULOSIS, V94, P8, DOI 10.1016/j.tube.2013.07.004; PRASAD K, 2000, COCHRANE DB SYST REV, V3; Prasad K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub4; Schoeman JF, 2004, J CHILD NEUROL, V19, P250, DOI 10.1177/088307380401900402; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2013, LANCET NEUROL, V12, P999, DOI 10.1016/S1474-4422(13)70168-6; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tsenova L, 2002, ANTIMICROB AGENTS CH, V46, P1887, DOI 10.1128/AAC.46.6.1887-1895.2002; Zumla A, 2015, J INTERN MED, V277, P373, DOI 10.1111/joim.12256	13	9	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2585	2587		10.1016/S0140-6736(16)30770-X	http://dx.doi.org/10.1016/S0140-6736(16)30770-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27353808				2022-12-28	WOS:000378390500010
J	Guglani, S				Guglani, Sam			The Notes Glamour	LANCET			English	Editorial Material									[Guglani, Sam] Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Guglani, S (corresponding author), Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England.	sam@medicineunboxed.org							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2593	2593		10.1016/S0140-6736(16)30850-9	http://dx.doi.org/10.1016/S0140-6736(16)30850-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27358990				2022-12-28	WOS:000378390500015
J	Chen, PC; Liu, XL; Hedrick, JL; Xie, Z; Wang, SZ; Lin, QY; Hersam, MC; Dravid, VP; Mirkin, CA				Chen, Peng-Cheng; Liu, Xiaolong; Hedrick, James L.; Xie, Zhuang; Wang, Shunzhi; Lin, Qing-Yuan; Hersam, Mark C.; Dravid, Vinayak P.; Mirkin, Chad A.			Polyelemental nanoparticle libraries	SCIENCE			English	Article							DIRECTED SYNTHESIS; HYBRID; PARTICLES; GROWTH; ALLOY; JANUS	Multimetallic nanoparticles are useful in many fields, yet there are no effective strategies for synthesizing libraries of such structures, in which architectures can be explored in a systematic and site-specific manner. The absence of these capabilities precludes the possibility of comprehensively exploring such systems. We present systematic studies of individual polyelemental particle systems, in which composition and size can be independently controlled and structure formation (alloy versus phase-separated state) can be understood. We made libraries consisting of every combination of five metallic elements (Au, Ag, Co, Cu, and Ni) through polymer nanoreactor-mediated synthesis. Important insight into the factors that lead to alloy formation and phase segregation at the nanoscale were obtained, and routes to libraries of nanostructures that cannot be made by conventional methods were developed.	[Chen, Peng-Cheng; Lin, Qing-Yuan; Hersam, Mark C.; Dravid, Vinayak P.; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Chen, Peng-Cheng; Hedrick, James L.; Xie, Zhuang; Wang, Shunzhi; Lin, Qing-Yuan; Dravid, Vinayak P.; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Liu, Xiaolong; Hersam, Mark C.] Northwestern Univ, Appl Phys Grad Program, Evanston, IL 60208 USA; [Hedrick, James L.; Mirkin, Chad A.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Xie, Zhuang; Wang, Shunzhi; Hersam, Mark C.; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.; Mirkin, CA (corresponding author), Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA.; Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.; Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Hersam, Mark/B-6739-2009; XIE, Zhuang/F-4236-2010; Mirkin, Chad A/E-3911-2010; Liu, Xiaolong/P-6477-2019; Dravid, Vinayak/B-6688-2009; Chen, Peng-Cheng/B-7085-2016	XIE, Zhuang/0000-0002-2211-7141; Liu, Xiaolong/0000-0002-6186-5257; Chen, Peng-Cheng/0000-0002-0411-9549; Wang, Shunzhi/0000-0001-5033-7478; Mirkin, Chad/0000-0002-6634-7627	GlaxoSmithKline; Air Force Office of Scientific Research [FA9550-12-1-0141]; Asian Office of Aerospace RD [FA2386-13-1-4124]; Ryan Fellowship; Northwestern University International Institute for Nanotechnology; Materials Research Science and Engineering Center of Northwestern University [NSF DMR-1121262]; Air Force Research Laboratory; National Science Foundation under the Ceramics program; U.S. Department of Defense through the National Defense Science & Engineering Graduate Fellowship Program; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource [NSF NNCI-1542205]	GlaxoSmithKline(GlaxoSmithKline); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Asian Office of Aerospace RD; Ryan Fellowship; Northwestern University International Institute for Nanotechnology; Materials Research Science and Engineering Center of Northwestern University(National Science Foundation (NSF)); Air Force Research Laboratory; National Science Foundation under the Ceramics program; U.S. Department of Defense through the National Defense Science & Engineering Graduate Fellowship Program; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource	This material is based on work supported by GlaxoSmithKline, the Air Force Office of Scientific Research (award FA9550-12-1-0141), and the Asian Office of Aerospace R&D (award FA2386-13-1-4124). The authors thank B. R. Meckes for helpful discussion. P.-C.C., S.W., and Q.-Y.L. gratefully acknowledge support from the Ryan Fellowship and the Northwestern University International Institute for Nanotechnology. X.L. and M.C.H. acknowledge support from the Materials Research Science and Engineering Center of Northwestern University (grant NSF DMR-1121262). V.P.D. acknowledges support by the Air Force Research Laboratory and the National Science Foundation under the Ceramics program. J.L.H. acknowledges support from the U.S. Department of Defense through the National Defense Science & Engineering Graduate Fellowship Program. This work made use of the EPIC facility of the NUANCE Center at Northwestern University, which has received support from the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF NNCI-1542205). A patent has been issued on this work: C. A. Mirkin, G. Liu, D. J. Eichelsdoerfer, K. A. Brown, "Method for synthesizing nanoparticles on surfaces" World Intellectual Property Organization Patent 2014039821-A1.	Buck MR, 2013, ANGEW CHEM INT EDIT, V52, P6154, DOI 10.1002/anie.201207240; Buck MR, 2012, NAT CHEM, V4, P37, DOI 10.1038/nchem.1195; Calvo F, 2015, PHYS CHEM CHEM PHYS, V17, P27922, DOI 10.1039/c5cp00274e; Chai JA, 2010, P NATL ACAD SCI USA, V107, P20202, DOI 10.1073/pnas.1014892107; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Chen GX, 2014, SCIENCE, V344, P495, DOI 10.1126/science.1252553; Chen PC, 2015, J AM CHEM SOC, V137, P9167, DOI 10.1021/jacs.5b05139; Cortie MB, 2011, CHEM REV, V111, P3713, DOI 10.1021/cr1002529; Demortiere A, 2014, J AM CHEM SOC, V136, P2342, DOI 10.1021/ja4092616; Gan L, 2014, SCIENCE, V346, P1502, DOI 10.1126/science.1261212; Ganguli AK, 2010, CHEM SOC REV, V39, P474, DOI 10.1039/b814613f; George C, 2013, NANO LETT, V13, P752, DOI 10.1021/nl304448p; Giam LR, 2012, NANO LETT, V12, P1022, DOI 10.1021/nl204233r; Guisbiers G, 2014, NANO LETT, V14, P6718, DOI 10.1021/nl503584q; Hill JC, 2015, NAT MATER, V14, P1150, DOI [10.1038/NMAT4408, 10.1038/nmat4408]; Huang XQ, 2015, SCIENCE, V348, P1230, DOI 10.1126/science.aaa8765; Huo FW, 2008, SCIENCE, V321, P1658, DOI 10.1126/science.1162193; Kwon SG, 2015, NAT MATER, V14, P215, DOI [10.1038/NMAT4115, 10.1038/nmat4115]; Liu GL, 2013, P NATL ACAD SCI USA, V110, P887, DOI 10.1073/pnas.1220689110; Mokari T, 2004, SCIENCE, V304, P1787, DOI 10.1126/science.1097830; Nie ZH, 2006, J AM CHEM SOC, V128, P9408, DOI 10.1021/ja060882n; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Read CG, 2015, J AM CHEM SOC, V137, P12514, DOI 10.1021/jacs.5b08850; Reddington E, 1998, SCIENCE, V280, P1735, DOI 10.1126/science.280.5370.1735; Rodriguez-Fernandez D, 2015, CHEM MATER, V27, P2540, DOI 10.1021/acs.chemmater.5b00128; Sang W, 2014, NANO LETT, V14, P6666, DOI 10.1021/nl503343n; Sankar M, 2012, CHEM SOC REV, V41, P8099, DOI 10.1039/c2cs35296f; Schick I, 2014, J AM CHEM SOC, V136, P2473, DOI 10.1021/ja410787u; Villars P., 2006, ASM ALLOY PHASE DIAG; Xu CJ, 2009, J AM CHEM SOC, V131, P4216, DOI 10.1021/ja900790v; Yu H, 2005, NANO LETT, V5, P379, DOI 10.1021/nl047955q; Zhang L, 2015, SCIENCE, V349, P412, DOI 10.1126/science.aab0801	32	252	257	24	434	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1565	1569		10.1126/science.aaf8402	http://dx.doi.org/10.1126/science.aaf8402			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339985				2022-12-28	WOS:000378346500041
J	Xu, JW; Gui, M; Wang, DH; Xiang, Y				Xu, Jingwei; Gui, Miao; Wang, Dianhong; Xiang, Ye			The bacteriophage phi 29 tail possesses a pore-forming loop for cell membrane penetration	NATURE			English	Article							VIRUS; RELEASE; PEPTIDE; SYSTEM; ENTRY	Most bacteriophages are tailed bacteriophages with an isometric or a prolate head attached to a long contractile, long non-contractile, or short non-contractile tail(1). The tail is a complex machine that plays a central role in host cell recognition and attachment, cell wall and membrane penetration, and viral genome ejection. The mechanisms involved in the penetration of the inner host cell membrane by bacteriophage tails are not well understood. Here we describe structural and functional studies of the bacteriophage phi 29 tail knob protein gene product 9 (gp9). The 2.0 angstrom crystal structure of gp9 shows that six gp9 molecules form a hexameric tube structure with six flexible hydrophobic loops blocking one end of the tube before DNA ejection. Sequence and structural analyses suggest that the loops in the tube could be membrane active. Further biochemical assays and electron microscopy structural analyses show that the six hydrophobic loops in the tube exit upon DNA ejection and form a channel that spans the lipid bilayer of the membrane and allows the release of the bacteriophage genomic DNA, suggesting that cell membrane penetration involves a pore-forming mechanism similar to that of certain non-enveloped eukaryotic viruses(2-4). A search of other phage tail proteins identified similar hydrophobic loops, which indicates that a common mechanism might be used for membrane penetration by prokaryotic viruses. These findings suggest that although prokaryotic and eukaryotic viruses use apparently very different mechanisms for infection, they have evolved similar mechanisms for breaching the cell membrane.	[Xu, Jingwei; Gui, Miao; Wang, Dianhong; Xiang, Ye] Tsinghua Univ, Ctr Infect Dis Res, Collaborat Innovat Ctr Diag & Treatment Infect Di, Dept Basic Med Sci,Sch Med,Beijing Adv Innovat Ct, Beijing 100084, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University	Xiang, Y (corresponding author), Tsinghua Univ, Ctr Infect Dis Res, Collaborat Innovat Ctr Diag & Treatment Infect Di, Dept Basic Med Sci,Sch Med,Beijing Adv Innovat Ct, Beijing 100084, Peoples R China.	yxiang@mail.tsinghua.edu.cn	Gui, Miao/AAU-6300-2021	Xiang, Ye/0000-0003-0230-9522; Gui, Miao/0000-0001-9113-8029; Xu, Jingwei/0000-0003-1833-1513	973 program [2015CB910102]; National Natural Science Foundation of China [31470721, 81550001]; Junior Thousand Talents Program of China [20131770418]; Beijing Advanced Innovation Center for Structural Biology	973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Junior Thousand Talents Program of China; Beijing Advanced Innovation Center for Structural Biology	We thank L. Q. Zhang, N. Yan, H. T. Li, S. L. Fan, N. Gao, C. Z. Zhou, D. L. Anderson and M. G. Rossmann for support; the Tsinghua University Branch of the China National Center for Protein Sciences for the facility support; and the staff at the Shanghai Synchrotron Research Facility beam line BL17U for assistance with data collection. This work was supported by funds from the 973 program (2015CB910102), the National Natural Science Foundation of China (31470721 and 81550001), the Junior Thousand Talents Program of China (20131770418) and the Beijing Advanced Innovation Center for Structural Biology to Y.X.	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson Dwight, 1993, P859; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cardarelli L, 2010, P NATL ACAD SCI USA, V107, P14384, DOI 10.1073/pnas.1005822107; Cohen DN, 2008, J MOL BIOL, V378, P804, DOI 10.1016/j.jmb.2008.02.068; Cohen DN, 2009, J MOL BIOL, V387, P607, DOI 10.1016/j.jmb.2009.02.001; Cowtan K. D., 2000, INT TABLES CRYSTALLO, VF, P507; Doan T, 2013, GENE DEV, V27, P322, DOI 10.1101/gad.209049.112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galloux M, 2010, J BIOL CHEM, V285, P19409, DOI 10.1074/jbc.M109.076083; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jarmer H, 2002, FEMS MICROBIOL LETT, V206, P197, DOI 10.1016/S0378-1097(01)00525-0; Johnson John E, 2010, Curr Top Microbiol Immunol, V343, pv; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Llaguno MC, 2014, J STRUCT BIOL, V185, P405, DOI 10.1016/j.jsb.2014.01.006; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Meijer WJJ, 2001, MICROBIOL MOL BIOL R, V65, P261, DOI 10.1128/MMBR.65.2.261-287.2001; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjwani A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004294; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shukla A, 2014, J VIROL, V88, P12409, DOI 10.1128/JVI.01896-14; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Tang JH, 2008, STRUCTURE, V16, P935, DOI 10.1016/j.str.2008.02.024; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xiang Y, 2008, P NATL ACAD SCI USA, V105, P9552, DOI 10.1073/pnas.0803787105; Xiang Y, 2006, EMBO J, V25, P5229, DOI 10.1038/sj.emboj.7601386; Xiang Y, 2011, P NATL ACAD SCI USA, V108, P4806, DOI 10.1073/pnas.1018097108; Xiang Y, 2009, MOL CELL, V34, P375, DOI 10.1016/j.molcel.2009.04.009	37	19	20	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					544	+		10.1038/nature18017	http://dx.doi.org/10.1038/nature18017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27309813				2022-12-28	WOS:000378270300052
J	Parekh, N				Parekh, Nikesh			The most vulnerable refugees are not in Europe	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Parekh, Nikesh] Brighton & Sussex Med Sch, Dept Med, Audrey Emerton Bldg, Brighton BN2 5BE, E Sussex, England	University of Brighton; University of Sussex	Parekh, N (corresponding author), Brighton & Sussex Med Sch, Dept Med, Audrey Emerton Bldg, Brighton BN2 5BE, E Sussex, England.	n.parekh@bsms.ac.uk						[Anonymous], 2016, LEB TOT PERS CONC; Syria Regional Refugee Response, 2016, REG OV; UK Government, UK GOV IS RESP EB; UN Refugee Agency, 2016, LEB OP UPD	4	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2016	353								i3432	10.1136/bmj.i3432	http://dx.doi.org/10.1136/bmj.i3432			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BP	27330030				2022-12-28	WOS:000378723200003
J	Wise, J				Wise, Jacqui			Pioglitazone seems safe and effective for patients with fatty liver disease and diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cusi K, 2016, ANN INTERN MED, V165, P305, DOI 10.7326/M15-1774; Vilar-Gomez E, 2016, ANN INTERN MED, V165, P373, DOI 10.7326/M16-1303	2	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2016	353								i3435	10.1136/bmj.i3435	http://dx.doi.org/10.1136/bmj.i3435			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8BP	27330009				2022-12-28	WOS:000378723200004
J	Hinnebusch, AG; Ivanov, IP; Sonenberg, N				Hinnebusch, Alan G.; Ivanov, Ivaylo P.; Sonenberg, Nahum			Translational control by 5 '-untranslated regions of eukaryotic mRNAs	SCIENCE			English	Review							OPEN READING FRAMES; START CODON SELECTION; CAP-INDEPENDENT TRANSLATION; INTEGRATED STRESS-RESPONSE; GENOME-WIDE ANALYSIS; SECONDARY STRUCTURE; 5' UTR; MODULATES AUTOREGULATION; NUCLEOTIDE RESOLUTION; INITIATION-FACTORS	The eukaryotic 5' untranslated region (UTR) is critical for ribosome recruitment to the messenger RNA (mRNA) and start codon choice and plays a major role in the control of translation efficiency and shaping the cellular proteome. The ribosomal initiation complex is assembled on the mRNA via a cap-dependent or cap-independent mechanism. We describe various mechanisms controlling ribosome scanning and initiation codon selection by 5' upstream open reading frames, translation initiation factors, and primary and secondary structures of the 5' UTR, including particular sequence motifs. We also discuss translational control via phosphorylation of eukaryotic initiation factor 2, which is implicated in learning and memory, neurodegenerative diseases, and cancer.	[Hinnebusch, Alan G.; Ivanov, Ivaylo P.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Grp Cell Regulat & Dev, NIH, Bethesda, MD USA; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Sonenberg, Nahum] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); McGill University; McGill University	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.; Sonenberg, N (corresponding author), McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada.	nahum.sonenberg@mcgill.ca		Ivanov, Ivaylo/0000-0002-4793-5466; Ivanov, Ivaylo/0000-0002-6008-3261	Intramural NIH HHS [Z01 HD001004] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abaeva IS, 2011, EMBO J, V30, P115, DOI 10.1038/emboj.2010.302; Agalarov SC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04438; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Arribere JA, 2013, GENOME RES, V23, P977, DOI 10.1101/gr.150342.112; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P9488, DOI 10.1073/pnas.0603597103; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; DONAHUE TF, 1988, CELL, V54, P621, DOI 10.1016/S0092-8674(88)80006-0; Gaba A, 2005, MOL CELL, V20, P449, DOI 10.1016/j.molcel.2005.09.019; Gandin V, 2016, GENOME RES, V26, P636, DOI 10.1101/gr.197566.115; Gerashchenko MV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku671; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Hentze MW, 2007, TRANSLATIONAL CONTRO, P269; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov IP, 2010, P NATL ACAD SCI USA, V107, P18056, DOI 10.1073/pnas.1009269107; Ivanov IP, 2010, NUCLEIC ACIDS RES, V38, P353, DOI 10.1093/nar/gkp1037; Jackson RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011569; Johnstone TG, 2016, EMBO J, V35, P706, DOI 10.15252/embj.201592759; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Loughran G, 2012, NUCLEIC ACIDS RES, V40, P2898, DOI 10.1093/nar/gkr1192; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; Medenbach J, 2011, CELL, V145, P902, DOI 10.1016/j.cell.2011.05.005; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Park HS, 2001, CELL, V106, P723, DOI 10.1016/S0092-8674(01)00487-1; PELLETIER J, 1985, MOL CELL BIOL, V5, P3222, DOI 10.1128/MCB.5.11.3222; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Raney A, 2002, J BIOL CHEM, V277, P5988, DOI 10.1074/jbc.M108375200; Roy B, 2010, RNA, V16, P748, DOI 10.1261/rna.2056010; Rubio CA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0476-1; Schleich S, 2014, NATURE, V512, P208, DOI 10.1038/nature13401; SEDMAN SA, 1990, J VIROL, V64, P453, DOI 10.1128/JVI.64.1.453-457.1990; Sen ND, 2015, GENOME RES, V25, P1196, DOI 10.1101/gr.191601.115; Shirokikh NE, 2008, P NATL ACAD SCI USA, V105, P10738, DOI 10.1073/pnas.0804940105; Sinvani H, 2015, CELL METAB, V21, P479, DOI 10.1016/j.cmet.2015.02.010; Somers J, 2015, GENE DEV, V29, P1891, DOI 10.1101/gad.261867.115; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Svitkin YV, 2001, RNA, V7, P1743; Szamecz B, 2008, GENE DEV, V22, P2414, DOI 10.1101/gad.480508; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; Vanderperre B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070698; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wei JJ, 2012, MOL CELL BIOL, V32, P2396, DOI 10.1128/MCB.00136-12; Weingarten-Gabbay S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4939; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Young SK, 2015, J BIOL CHEM, V290, P28257, DOI 10.1074/jbc.M115.693184; Zhang F, 2011, NUCLEIC ACIDS RES, V39, P3128, DOI 10.1093/nar/gkq1251; Zinoviev A, 2015, MOL CELL, V57, P1059, DOI 10.1016/j.molcel.2015.01.039	60	515	529	23	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1413	1416		10.1126/science.aad9868	http://dx.doi.org/10.1126/science.aad9868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313038	Green Accepted, Green Published			2022-12-28	WOS:000377975400038
J	Olive, JA; Behn, MD; Ito, G; Buck, WR; Escartin, J; Howell, S				Olive, J. -A.; Behn, M. D.; Ito, G.; Buck, W. R.; Escartin, J.; Howell, S.			Response to Comment on "Sensitivity of seafloor bathymetry to climate-driven fluctuations in mid-ocean ridge magma supply"	SCIENCE			English	Editorial Material							STOCHASTIC-ANALYSIS	Huybers et al. present new bathymetric spectra from an intermediate-spreading ridge as evidence for a primary contribution of sea level cycles to the morphology of the seafloor. Although we acknowledge the possibility that sea level-modulated magmatic constructions may be superimposed on a first-order tectonic fabric, we emphasize the difficulty of deciphering these different contributions in the frequency domain alone.	[Olive, J. -A.; Buck, W. R.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Behn, M. D.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Ito, G.; Howell, S.] Univ Hawaii, Honolulu, HI 96822 USA; [Escartin, J.] Univ Paris Diderot, Inst Phys Globe Paris, CNRS, Paris, France	Columbia University; Woods Hole Oceanographic Institution; University of Hawaii System; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Olive, JA (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA.	jaolive@ldeo.columbia.edu	ESCARTIN, Javier/A-1043-2010; Behn, Mark D/F-5813-2012; Howell, Samuel/AAI-2549-2020; Escartin, Javier/B-3344-2008; Olive, Jean-Arthur/ABE-1290-2021	ESCARTIN, Javier/0000-0002-3416-6856; Behn, Mark D/0000-0002-2001-1335; Howell, Samuel/0000-0002-5126-3228; 	Directorate For Geosciences [1155098, 1009839] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Behn MD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001965; Buck WR, 1997, GEOLOGY, V25, P935; CARBOTTE SM, 1994, J GEOPHYS RES-SOL EA, V99, P13609, DOI 10.1029/93JB02971; Crowley JW, 2015, SCIENCE, V347, P1237, DOI 10.1126/science.1261508; GOFF JA, 1991, J GEOPHYS RES-SOL EA, V96, P21713, DOI 10.1029/91JB02275; Goff JA, 1997, J GEOPHYS RES-SOL EA, V102, P15521, DOI 10.1029/97JB00781; Goff JA, 2015, SCIENCE, V349, DOI 10.1126/science.aab2350; Huybers P, 2016, SCIENCE, V352, DOI 10.1126/science.aae0451; Karsten J., 1999, INTERRIDGE NEWS, V8, P15; Macdonald KC, 1996, NATURE, V380, P125, DOI 10.1038/380125a0; Olive JA, 2015, SCIENCE, V350, P310, DOI 10.1126/science.aad0715; SEARLE R, 1984, TECTONOPHYSICS, V101, P319, DOI 10.1016/0040-1951(84)90119-7; SEARLE RC, 1977, J GEOPHYS RES, V82, P5313, DOI 10.1029/JB082i033p05313	13	9	9	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292								10.1126/science.aaf2021	http://dx.doi.org/10.1126/science.aaf2021			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313035				2022-12-28	WOS:000377975400035
J	Larsen, TB; Skjoth, F; Nielsen, PB; Kjaeldgaard, JN; Lip, GYH				Larsen, Torben Bjerregaard; Skjoth, Flemming; Nielsen, Peter Bronnum; Kjaeldgaard, Jette Nordstrom; Lip, Gregory Y. H.			Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STROKE PREVENTION; METAANALYSIS; RIVAROXABAN; EDOXABAN; DRUG	OBJECTIVE To study the effectiveness and safety of the non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants, NOACs) dabigatran, rivaroxaban, and apixaban compared with warfarin in anticoagulant naive patients with atrial fibrillation. DESIGN Observational nationwide cohort study. SETTING Three Danish nationwide databases, August 2011 to October 2015. PARTICIPANTS 61 678 patients with non-valvular atrial fibrillation who were naive to oral anticoagulants and had no previous indication for valvular atrial fibrillation or venous thromboembolism. The study population was distributed according to treatment type: warfarin (n=35 436, 57%), dabigatran 150 mg (n=12 701, 21%), rivaroxaban 20 mg (n=7192, 12%), and apixaban 5 mg (n=6349, 10%). MAIN OUTCOME MEASURES Effectiveness outcomes defined a priori were ischaemic stroke; a composite of ischaemic stroke or systemic embolism; death; and a composite of ischaemic stroke, systemic embolism, or death. Safety outcomes were any bleeding, intracranial bleeding, and major bleeding. RESULTS When the analysis was restricted to ischaemic stroke, NOACs were not significantly different from warfarin. During one year follow-up, rivaroxaban was associated with lower annual rates of ischaemic stroke or systemic embolism (3.0% v 3.3%, respectively) compared with warfarin: hazard ratio 0.83 (95% confidence interval 0.69 to 0.99). The hazard ratios for dabigatran and apixaban (2.8% and 4.9% annually, respectively) were non-significant compared with warfarin. The annual risk of death was significantly lower with apixaban (5.2%) and dabigatran (2.7%) (0.65, 0.56 to 0.75 and 0.63, 0.48 to 0.82, respectively) compared with warfarin (8.5%), but not with rivaroxaban (7.7%). For the combined endpoint of any bleeding, annual rates for apixaban (3.3%) and dabigatran (2.4%) were significantly lower than for warfarin (5.0%) (0.62, 0.51 to 0.74). Warfarin and rivaroxaban had comparable annual bleeding rates (5.3%). CONCLUSION All NOACs seem to be safe and effective alternatives to warfarin in a routine care setting. No significant difference was found between NOACs and warfarin for ischaemic stroke. The risks of death, any bleeding, or major bleeding were significantly lower for apixaban and dabigatran compared with warfarin.	[Larsen, Torben Bjerregaard] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Larsen, Torben Bjerregaard; Skjoth, Flemming; Nielsen, Peter Bronnum; Kjaeldgaard, Jette Nordstrom; Lip, Gregory Y. H.] Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Skjoth, Flemming] Aalborg Univ Hosp, Unit Clin Biostat & Bioinformat, Aalborg, Denmark; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Inst Cardiovasc Sci, Birmingham, W Midlands, England	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital; University of Birmingham	Larsen, TB (corresponding author), Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.; Larsen, TB (corresponding author), Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark.	tobl@rn.dk	Skjøth, Flemming/AAI-9954-2020	Skjoth, Flemming/0000-0003-2975-647X; Nielsen, Peter Bronnum/0000-0003-2922-6970	Obel Family Foundation	Obel Family Foundation	The Obel Family Foundation partly funded this research by an unrestricted grant. The sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The study was entirely free from industry sponsorships.	Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Camm AJ, 2012, EUR HEART J, V33; Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948; Cohen D, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i575; Connolly SJ, 2009, N ENGL J MED, V361, P1139, DOI [10.1056/NEJMoa0905561, DOI 10.1056/NEJM0A0905561]; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Diener HC, 2017, EUR HEART J, V38, P852, DOI 10.1093/eurheartj/ehv643; Diener HC, 2017, EUR HEART J, V38, P860, DOI 10.1093/eurheartj/ehw069; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Lee SI, 2015, INT J CLIN PRACT, V69, P1341, DOI 10.1111/ijcp.12712; Lip GYH, 2010, AM J MED, V123, P785, DOI 10.1016/j.amjmed.2010.01.031; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; Olesen JB, 2015, EUROPACE, V17, P187, DOI 10.1093/europace/euu225; Patel MR, 2016, NEW ENGL J MED, V374, P785, DOI 10.1056/NEJMc1515842; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Ruff CT, 2010, AM HEART J, V160, P635, DOI 10.1016/j.ahj.2010.06.042; Schneeweiss S, 2011, CLIN PHARMACOL THER, V90, P777, DOI 10.1038/clpt.2011.235; Shields AM, 2015, J INTERN MED, V278, P1, DOI 10.1111/joim.12360; Sturmer T, 2014, J INTERN MED, V275, P570, DOI 10.1111/joim.12197; Wang KL, 2015, STROKE, V46, P2555, DOI 10.1161/STROKEAHA.115.009947	31	318	325	3	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2016	353								i3189	10.1136/bmj.i3189	http://dx.doi.org/10.1136/bmj.i3189			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HJ	27312796	Green Published, hybrid			2022-12-28	WOS:000378240800001
J	Lu, C				Lu, Cindy			Curb Your Inflammation	CELL			English	Editorial Material																		Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Rialdi A, 2016, SCIENCE, V352, DOI 10.1126/science.aad7993; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252	4	1	1	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1553	1555						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27315466	Bronze			2022-12-28	WOS:000378062000001
J	Wurmb, TE; Bernhard, M				Wurmb, Thomas Erik; Bernhard, Michael			Total-body CT for initial diagnosis of severe trauma	LANCET			English	Editorial Material							MULTISLICE COMPUTED-TOMOGRAPHY; EMERGENCY-ROOM MANAGEMENT; BLUNT TRAUMA; MAJOR TRAUMA; TOOL; ALGORITHM; SURVIVAL; TIME; CARE		[Wurmb, Thomas Erik] Univ Hosp Wuerzburg, Sect Emergency Med, Dept Anaesthesiol, D-97080 Wurzburg, Germany; [Bernhard, Michael] Univ Hosp Leipzig, Emergency Dept, D-04105 Leipzig, Germany	University of Wurzburg; Leipzig University	Wurmb, TE (corresponding author), Univ Hosp Wuerzburg, Sect Emergency Med, Dept Anaesthesiol, D-97080 Wurzburg, Germany.	wurmb_t@ukw.de						Bernhard M, 2007, RESUSCITATION, V73, P362, DOI 10.1016/j.resuscitation.2006.09.014; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Davies RM, 2016, INJURY, V47, P43, DOI 10.1016/j.injury.2015.08.036; Hilbert P, 2007, INJURY, V38, P552, DOI 10.1016/j.injury.2006.12.023; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Rieger M, 2002, ANAESTHESIST, V51, P835, DOI 10.1007/s00101-002-0369-7; Sierink JC, 2016, LANCET, P30932; Wada D, 2013, CRIT CARE, V17, DOI 10.1186/cc12861; Weninger P, 2007, J TRAUMA, V62, P584, DOI 10.1097/01.ta.0000221797.46249.ee; Wurmb TE, 2011, EMERG MED J, V28, P300, DOI 10.1136/emj.2009.082164; Wurmb TE, 2007, AM J EMERG MED, V25, P1057, DOI 10.1016/j.ajem.2007.03.016; Wurmb TE, 2009, J TRAUMA, V66, P658, DOI 10.1097/TA.0b013e31817de3f4	12	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					636	638		10.1016/S0140-6736(16)30933-3	http://dx.doi.org/10.1016/S0140-6736(16)30933-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UX	27371186				2022-12-28	WOS:000381268700005
J	Hermine, O; Hoster, E; Walewski, J; Bosly, A; Stilgenbauer, S; Thieblemont, C; Szymczyk, M; Bouabdallah, R; Kneba, M; Hallek, M; Salles, G; Feugier, P; Ribrag, V; Birkmann, J; Forstpointner, R; Haioun, C; Hanel, M; Casasnovas, RO; Finke, J; Peter, N; Bouabdallah, K; Sebban, C; Fischer, T; Duhrsen, U; Metzner, B; Maschmeyer, G; Kanz, L; Schmidt, C; Delarue, R; Brousse, N; Klapper, W; Macintyre, E; Delfau-Larue, MH; Pott, C; Hiddemann, W; Unterhalt, M; Dreyling, M				Hermine, Olivier; Hoster, Eva; Walewski, Jan; Bosly, Andre; Stilgenbauer, Stephan; Thieblemont, Catherine; Szymczyk, Michal; Bouabdallah, Reda; Kneba, Michael; Hallek, Michael; Salles, Gilles; Feugier, Pierre; Ribrag, Vincent; Birkmann, Josef; Forstpointner, Roswitha; Haioun, Corinne; Haenel, Mathias; Casasnovas, Rene Olivier; Finke, Juergen; Peter, Norma; Bouabdallah, Kamal; Sebban, Catherine; Fischer, Thomas; Duehrsen, Ulrich; Metzner, Bernd; Maschmeyer, Georg; Kanz, Lothar; Schmidt, Christian; Delarue, Richard; Brousse, Nicole; Klapper, Wolfram; Macintyre, Elizabeth; Delfau-Larue, Marie-Helene; Pott, Christiane; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin		European Mantle Cell Lymphoma	Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network	LANCET			English	Article							1ST-LINE TREATMENT; RESPONSE CRITERIA; PLUS RITUXIMAB; FREE SURVIVAL; FOLLOW-UP; THERAPY; CHOP; INDOLENT; TEMSIROLIMUS; MULTICENTER	Background Mantle cell lymphoma is characterised by a poor long-term prognosis. The European Mantle Cell Lymphoma Network aimed to investigate whether the introduction of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation (ASCT) improves outcome. Methods This randomised, open-label, parallel-group, phase 3 trial was done in 128 haemato-oncological hospital departments or private practices in Germany, France, Belgium, and Poland. Patients aged 65 years or younger with untreated stage II IV mantle cell lymphoma were centrally randomised (1:1), with computer-assisted random block selection, to receive either six courses of R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) followed by myeloablative radiochemotherapy and AS CT (control group), or six courses of alternating R-CHOP or R-DHAP (rituximab plus dexamethasone, high-dose cytarabine, and cisplatin) followed by a high-dose cytarabine-containing conditioning regimen and AS CT (cytarabine group). Patients were stratified by study group and international prognostic index. The primary outcome was time to treatment failure from randomisation to stable disease after at least four induction cycles, progression, or death from any cause. Patients with stage II IV mantle cell lymphoma were included in the primary analysis if treatment was started according to randomisation. For safety analyses, patients were assessed according to the treatment actually started. This study is registered with ClinicalTrials.gov, number NCT00209222. Findings Of 497 patients (median age 55 years [IQR 49-60]) randomised from July 20,2004, to March 18,2010,234 of 249 in the control group and 232 of 248 in the cytarabine group were included in the primary analysis. After a median follow-up of 6.1 years (95% CI 5.4-6.4), time to treatment failure was significantly longer in the cytarabine group (median 9.1 years [95% CI 6.3 not reached], 5 year rate 65% [95% CI 57-71]) than in the control group (3 " 9 years [3.2-4 " 4], 40% [33-46]; hazard ratio 0.56; p=0.038). During induction immunochemotherapy, patients who received high-dose cytarabine had increased grade 3 or 4 haematological toxicity (haemoglobin 71 [29%] of 241 vs 19 [8%] of 227 controls; platelets 176 [73%] of 240 vs 21 [9%] of 225), grade 3 or 4 febrile neutropenia (39 [17%] of 230 vs 19 [8%] of 224), and grade 1 or 2 renal toxicity (creatinine 102 [43%] of 236 vs 22 [10%] of 224). The number of AS CT-related deaths was similar (eight [3.4%]) in both groups. Interpretation Immunochemotherapy containing high-dose cytarabine followed by ASCT should be considered standard of care in patients aged 65 years or younger with mantle cell lymphoma.	[Hermine, Olivier; Delarue, Richard] Univ Paris 05, Hop Necker, AP HP, Dept Hematol, Paris, France; [Brousse, Nicole] Univ Paris 05, Hop Necker, AP HP, Dept Pathol, Paris, France; [Macintyre, Elizabeth] Univ Paris 05, Hop Necker, AP HP, Dept Biol Hematol, Paris, France; [Hermine, Olivier] Univ Sorbonne Paris Cite, INSERM U1163, Paris, France; [Hermine, Olivier] Univ Sorbonne Paris Cite, CNRS 8254, Imagine Inst, Paris, France; [Hoster, Eva; Forstpointner, Roswitha; Schmidt, Christian; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin] Ludwig Maximilians Univ Hosp Munich, Dept Internal Med 3, D-81377 Munich, Germany; [Hoster, Eva] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Walewski, Jan; Szymczyk, Michal] Maria Skiodowska Curie Mem Canc Ctr, Dept Lymphoid Malignancies, Warsaw, Poland; [Walewski, Jan; Szymczyk, Michal] Inst Oncol, Warsaw, Poland; [Bosly, Andre] Louvain Catholic Univ, Namur Univ Hosp, Namur, Belgium; [Stilgenbauer, Stephan] Univ Ulm, Dept Internal Med, Ulm, Germany; [Thieblemont, Catherine] St Louis Hosp, AP HP, Hematooncol Dept, Paris, France; [Bouabdallah, Reda] Inst Paoli Calmettes, Dept Hematol, Marseille, France; [Kneba, Michael; Pott, Christiane] Univ Hosp Schleswig Holstein, Dept Med 2, Kiel, Germany; [Hallek, Michael] Univ Cologne, Dept Internal Med, Cologne, Germany; [Salles, Gilles] Univ Claude Bernard, Ctr Hosp Lyon Sud, Hosp Civils Lyon, Pierre Benite, France; [Feugier, Pierre] Nancy Univ Hosp, Dept Hematol, Nancy, France; [Ribrag, Vincent] Inst Gustave Roussy, Villejuif, France; [Birkmann, Josef] Paracelsus Med Univ, Dept Oncol, Nurnberg, Germany; [Haioun, Corinne] Hosp Henri Mondor, Lymphoid Malignancies Unit, Creteil, France; [Haenel, Mathias] Klinikum Chemnitz, Dept Internal Med 3, Chemnitz, Germany; [Casasnovas, Rene Olivier] CHU Dijon, Hematol Clin, Dijon, France; [Finke, Juergen] Univ Hosp Freiburg, Dept Hematol & Oncol, Freiburg, Germany; [Peter, Norma] Carl Thiem Klinikum Cottbus, Dept Med 2, Cottbus, Germany; [Bouabdallah, Kamal] Univ Hosp Bordeaux, Dept Hematol & Cell Therapy, Pessac, France; [Sebban, Catherine] Ctr Leon Berard, Dept Haematol, Lyon, France; [Fischer, Thomas] Univ Hosp Magdeburg, Dept Hematol & Oncol, Magdeburg, Germany; [Duehrsen, Ulrich] Univ Hosp Essen, Dept Hematol, Essen, Germany; [Metzner, Bernd] Univ Hosp Oldenburg, Dept Hematol & Oncol, Oldenburg, Germany; [Maschmeyer, Georg] Ernst von Bergmann Hospital, Dept Hematol Oncol & Palliat Med, Potsdam, Germany; [Kanz, Lothar] Univ Tubingen, Dept Med 2, Tubingen, Germany; [Klapper, Wolfram] Univ Kiel, Hematopathol Sect, Dept Pathol, Kiel, Germany; [Klapper, Wolfram] Univ Kiel, Lymph Node Registry, Kiel, Germany; [Delfau-Larue, Marie-Helene] UPEC Univ, Dept Biol Hematol & Immunol, Henri Mondor Hosp, AP HP,INSERM U9SS, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Munich; University of Munich; Maria Sklodowska-Curie National Research Institute of Oncology; Ulm University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut Paoli-Calmette (IPC); University of Kiel; Schleswig Holstein University Hospital; University of Cologne; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU de Nancy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Chemnitz Clinic; CHU Dijon Bourgogne; University of Freiburg; CHU Bordeaux; UNICANCER; Centre Leon Berard; University Hospital Magdeburg; University of Duisburg Essen; Klinikum Ernst von Bergmann; Eberhard Karls University of Tubingen; University of Kiel; University of Kiel; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Dreyling, M (corresponding author), Ludwig Maximilians Univ Hosp Munich, Dept Internal Med 3, D-81377 Munich, Germany.	Martin.Dreyling@med.uni-muenchen.de	Salles, Gilles/Z-2336-2019; Metzner, Bernd/AAM-4054-2021; Stilgenbauer, Stephan/ABE-6609-2020; Hoster, Eva/M-2795-2019; Hallek, Michael/Y-3191-2019; Haenel, Mathias Hänel/AAF-2220-2021; Walewski, Jan/ABC-9523-2020; Thieblemont, Catherine/AAZ-8423-2020; Hermine, Olivier/Q-7072-2018; Klapper, Wolfram/S-6314-2016	Salles, Gilles/0000-0002-9541-8666; Metzner, Bernd/0000-0002-1496-1377; Hoster, Eva/0000-0002-0749-1389; Hallek, Michael/0000-0002-7425-4455; Thieblemont, Catherine/0000-0002-9941-2448; Hermine, Olivier/0000-0003-2574-3874; Walewski, Jan/0000-0003-4247-2674; Macintyre-Davi, Elizabeth Anne/0000-0003-0520-0493; Casasnovas, Rene-Olivier/0000-0002-1156-8983	European Commission [LSHC-CT-2004-503351]; Lymphoma Research Foundation; Roche	European Commission(European CommissionEuropean Commission Joint Research Centre); Lymphoma Research Foundation; Roche(Roche Holding)	The trial was partly funded by the European Commission (LSHC-CT-2004-503351), the Lymphoma Research Foundation, and Roche.	[Anonymous], 1992, DESIGN ANAL SEQUENTI; Bernstein SH, 2013, ANN ONCOL, V24, P1587, DOI 10.1093/annonc/mdt070; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Damon LE, 2009, J CLIN ONCOL, V27, P6101, DOI 10.1200/JCO.2009.22.2554; Delarue R, 2013, BLOOD, V121, P48, DOI 10.1182/blood-2011-09-370320; Determann O, 2008, BLOOD, V111, P2385, DOI 10.1182/blood-2007-10-117010; Dreyling M, 2005, BLOOD, V105, P2677, DOI 10.1182/blood-2004-10-3883; Dreyling M, 2014, ANN ONCOL, V25, P83, DOI 10.1093/annonc/mdu264; Dreyling M, 2016, LANCET, V387, P770, DOI 10.1016/S0140-6736(15)00667-4; Flinn IW, 2014, BLOOD, V123, P2944, DOI 10.1182/blood-2013-11-531327; Geisler CH, 2012, BRIT J HAEMATOL, V158, P355, DOI 10.1111/j.1365-2141.2012.09174.x; Herrmann A, 2009, J CLIN ONCOL, V27, P511, DOI 10.1200/JCO.2008.16.8435; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Hoster E, 2009, 51 AM SOC HEM ANN M, P880; Hoster E, 2014, BLOOD, V124, P1752; Hoster E, 2008, BLOOD, V111, P558, DOI 10.1182/blood-2007-06-095331; Klapper Wolfram, 2009, J Hematop, V2, P103, DOI 10.1007/s12308-009-0036-x; Kluin-Nelemans HC, 2012, NEW ENGL J MED, V367, P520, DOI 10.1056/NEJMoa1200920; Le Gouill S, 2014, 56 AM SOC HEM ANN M, P124; Lefrere F, 2002, LEUKEMIA, V16, P587, DOI 10.1038/sj.leu.2402406; Lenz G, 2005, J CLIN ONCOL, V23, P1984, DOI 10.1200/JCO.2005.08.133; Merli F, 2012, BRIT J HAEMATOL, V156, P346, DOI 10.1111/j.1365-2141.2011.08958.x; Pott C, 2006, BLOOD, V107, P2271, DOI 10.1182/blood-2005-07-2845; Pott C, 2011, ANN ONCOL, V22, P161; Robak T, 2015, NEW ENGL J MED, V372, P944, DOI 10.1056/NEJMoa1412096; Romaguera JE, 2005, J CLIN ONCOL, V23, P7013, DOI 10.1200/JCO.2005.01.1825; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Schulz H, 2007, JNCI-J NATL CANCER I, V99, P706, DOI 10.1093/jnci/djk152; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Swerdlow SH, 2008, WHO CLASSIFICATION T; Trneny M, 2014, 56 AM SOC HEM ANN M, P124; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220	33	241	251	2	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					565	575		10.1016/S0140-6736(16)00739-X	http://dx.doi.org/10.1016/S0140-6736(16)00739-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS4NA	27313086				2022-12-28	WOS:000380756600029
J	Martin, P				Martin, Peter			Mantle cell lymphoma treatment: plus ca change ...	LANCET			English	Editorial Material							PROSPECTIVE RANDOMIZED-TRIAL; STUDY-GROUP GLSG; INVESTIGATORS CHOICE; OPEN-LABEL; RITUXIMAB; CYCLOPHOSPHAMIDE; FLUDARABINE; SURVIVAL; THERAPY; TEMSIROLIMUS		[Martin, Peter] Weill Cornell Med Coll, 525 East 68th St, New York, NY 10065 USA	Cornell University	Martin, P (corresponding author), Weill Cornell Med Coll, 525 East 68th St, New York, NY 10065 USA.	pem9019@med.cornell.edu						Abrahamsson A, 2014, BLOOD, V124, P1288, DOI 10.1182/blood-2014-03-559930; Dreyling M, 2005, BLOOD, V105, P2677, DOI 10.1182/blood-2004-10-3883; Dreyling M, 2016, LANCET, V387, P770, DOI 10.1016/S0140-6736(15)00667-4; Forstpointner R, 2004, BLOOD, V104, P3064, DOI 10.1182/blood-2004-04-1323; Forstpointner R, 2006, BLOOD, V108, P4003, DOI 10.1182/blood-2006-04-016725; Hermine O, 2016, LANCET; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Kluin-Nelemans HC, 2012, NEW ENGL J MED, V367, P520, DOI 10.1056/NEJMoa1200920; Lenz G, 2005, J CLIN ONCOL, V23, P1984, DOI 10.1200/JCO.2005.08.133; Robak T, 2015, NEW ENGL J MED, V372, P944, DOI 10.1056/NEJMoa1412096; Rule S, 2016, HAEMATOLOGICA, V101, P235, DOI 10.3324/haematol.2015.128710; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Trneny M, 2016, LANCET ONCOL, V17, P319, DOI 10.1016/S1470-2045(15)00559-8	13	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					535	536		10.1016/S0140-6736(16)30451-2	http://dx.doi.org/10.1016/S0140-6736(16)30451-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS4NA	27313085				2022-12-28	WOS:000380756600004
J	Henry, LG; McManus, JF; Curry, WB; Roberts, NL; Piotrowski, AM; Keigwin, LD				Henry, L. G.; McManus, J. F.; Curry, W. B.; Roberts, N. L.; Piotrowski, A. M.; Keigwin, L. D.			North Atlantic ocean circulation and abrupt climate change during the last glaciation	SCIENCE			English	Article							ATMOSPHERIC CO2; DEEP-WATER; OVERTURNING CIRCULATION; HEINRICH EVENTS; VARIABILITY; DELTA-C-13; PATTERNS; COLLAPSE; RISE; FLOW	The most recent ice age was characterized by rapid and hemispherically asynchronous climate oscillations, whose origin remains unresolved. Variations in oceanic meridional heat transport may contribute to these repeated climate changes, which were most pronounced during marine isotope stage 3, the glacial interval 25 thousand to 60 thousand years ago. We examined climate and ocean circulation proxies throughout this interval at high resolution in a deep North Atlantic sediment core, combining the kinematic tracer protactinium/thorium (Pa/Th) with the deep water-mass tracer, epibenthic delta C-13. These indicators suggest reduced Atlantic overturning circulation during every cool northern stadial, with the greatest reductions during episodic Hudson Strait iceberg discharges, while sharp northern warming followed reinvigorated overturning. These results provide direct evidence for the ocean's persistent, central role in abrupt glacial climate change.	[Henry, L. G.; McManus, J. F.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Curry, W. B.; Keigwin, L. D.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Curry, W. B.] Bermuda Inst Ocean Sci, St Georges, Bermuda; [Roberts, N. L.; Piotrowski, A. M.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	Columbia University; Woods Hole Oceanographic Institution; Bermuda Institute of Ocean Sciences; University of Cambridge	Henry, LG (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	lhenry@ldeo.columbia.edu			NSF Graduate Research Fellowship; Comer Science and Education Foundation; NSF [ATM-0936496, ATM-0836472, AGS-1548160]; LDEO Climate Center; Natural Environment Research Council [NE/K005235/1, NE/F006047/1] Funding Source: researchfish; NERC [NE/K005235/1] Funding Source: UKRI	NSF Graduate Research Fellowship(National Science Foundation (NSF)); Comer Science and Education Foundation; NSF(National Science Foundation (NSF)); LDEO Climate Center; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Data are available at www.ncdc.noaa.gov/paleo/study/20248. This research was supported in part by a NSF Graduate Research Fellowship to L.G.H., by awards from the Comer Science and Education Foundation and NSF grant ATM-0936496 to J.F.M., and an award from the LDEO Climate Center to L.G.H. and J.F.M. L.D.K. and W.B.C. were supported by NSF grant ATM-0836472, and L.D.K. was supported by NSF grant AGS-1548160. We thank M. Jeglinski and K. Rose for technical support. The authors thank R. Anderson, S. Hemming, and C. Hayes for constructive discussion leading to improvement of the manuscript; R. Anderson for unpublished data included in the Fig. 1 map; and M. Fleisher for analytical support.	Adkins JF, 2013, PALEOCEANOGRAPHY, V28, P539, DOI 10.1002/palo.20046; Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; Alley RB, 1999, GEOPH MONOG SERIES, V112, P385; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barker S, 2015, NATURE, V520, P333, DOI 10.1038/nature14330; Bohm E, 2015, NATURE, V517, P73, DOI 10.1038/nature14059; Boyle EA, 1997, P NATL ACAD SCI USA, V94, P8300, DOI 10.1073/pnas.94.16.8300; Broecker W, 1992, CLIM DYNAM, V6, P265, DOI 10.1007/BF00193540; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Buizert C, 2015, NATURE, V520, P661, DOI 10.1038/nature14401; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Gherardi JM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001696; Gottschalk J, 2015, NAT GEOSCI, V8, P950, DOI [10.1038/ngeo2558, 10.1038/NGEO2558]; Hayes CT, 2015, MAR CHEM, V170, P49, DOI 10.1016/j.marchem.2015.01.006; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Henderson GM, 2003, REV MINERAL GEOCHEM, V52, P493, DOI 10.2113/0520493; Henderson GM, 1999, DEEP-SEA RES PT I, V46, P1861, DOI 10.1016/S0967-0637(99)00030-8; Keigwin LD, 1999, PALEOCEANOGRAPHY, V14, P164, DOI 10.1029/1998PA900026; Lippold J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038068; Lynch-Stieglitz J, 2014, NAT GEOSCI, V7, P144, DOI [10.1038/ngeo2045, 10.1038/NGEO2045]; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; McManus JF, 1998, EARTH PLANET SC LETT, V155, P29, DOI 10.1016/S0012-821X(97)00201-X; Menviel L, 2014, CLIM PAST, V10, P63, DOI 10.5194/cp-10-63-2014; Negre C, 2010, NATURE, V468, P84, DOI 10.1038/nature09508; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Sachs JP, 1999, SCIENCE, V286, P756, DOI 10.1126/science.286.5440.756; Schmittner A, 2015, CLIM PAST, V11, P135, DOI 10.5194/cp-11-135-2015; Schmittner A, 2008, NATURE, V456, P373, DOI 10.1038/nature07531; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Yasuhara M, 2008, P NATL ACAD SCI USA, V105, P1556, DOI 10.1073/pnas.0705486105; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0; Zahn R, 2002, EARTH PLANET SC LETT, V200, P191, DOI 10.1016/S0012-821X(02)00613-1; Zhang X, 2014, NATURE, V512, P290, DOI 10.1038/nature13592	35	183	190	6	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					470	474		10.1126/science.aaf5529	http://dx.doi.org/10.1126/science.aaf5529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27365315	Green Submitted			2022-12-28	WOS:000380583600036
J	Cuylen, S; Blaukopf, C; Politi, AZ; Muller-Reichert, T; Neumann, B; Poser, I; Ellenberg, J; Hyman, AA; Gerlich, DW				Cuylen, Sara; Blaukopf, Claudia; Politi, Antonio Z.; Mueller-Reichert, Thomas; Neumann, Beate; Poser, Ina; Ellenberg, Jan; Hyman, Anthony A.; Gerlich, Daniel W.			Ki-67 acts as a biological surfactant to disperse mitotic chromosomes	NATURE			English	Article							CELL-PROLIFERATION; PROTEIN; ANTIGEN; ORGANIZATION; MICROSCOPY; ANAPHASE; GENOME; DOMAIN; GENES	Eukaryotic genomes are partitioned into chromosomes that form compact and spatially well-separated mechanical bodies during mitosis(1-3). This enables chromosomes to move independently of each other for segregation of precisely one copy of the genome to each of the nascent daughter cells. Despite insights into the spatial organization of mitotic chromosomes(4) and the discovery of proteins at the chromosome surface(3,5,6), the molecular and biophysical bases of mitotic chromosome structural individuality have remained unclear. Here we report that the proliferation marker protein Ki-67 (encoded by the MKI67 gene), a component of the mitotic chromosome periphery, prevents chromosomes from collapsing into a single chromatin mass after nuclear envelope disassembly, thus enabling independent chromosome motility and efficient interactions with the mitotic spindle. The chromosome separation function of human Ki-67 is not confined within a specific protein domain, but correlates with size and net charge of truncation mutants that apparently lack secondary structure. This suggests that Ki-67 forms a steric and electrostatic charge barrier, similar to surface-active agents (surfactants) that disperse particles or phase-separated liquid droplets in solvents. Fluorescence correlation spectroscopy showed a high surface density of Ki-67 and dual-colour labelling of both protein termini revealed an extended molecular conformation, indicating brush-like arrangements that are characteristic of polymeric surfactants. Our study thus elucidates a biomechanical role of the mitotic chromosome periphery in mammalian cells and suggests that natural proteins can function as surfactants in intracellular compartmentalization.	[Cuylen, Sara; Blaukopf, Claudia; Gerlich, Daniel W.] Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria; [Politi, Antonio Z.; Ellenberg, Jan] EMBL, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Mueller-Reichert, Thomas] Tech Univ Dresden, Med Fac Carl Gustav Carus, Expt Ctr, Fetscherstr 74, D-01307 Dresden, Germany; [Neumann, Beate] EMBL, Adv Light Microscopy Facil, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Poser, Ina; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); European Molecular Biology Laboratory (EMBL); Technische Universitat Dresden; Carl Gustav Carus University Hospital; European Molecular Biology Laboratory (EMBL); Max Planck Society	Cuylen, S (corresponding author), Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.		Gerlich, Daniel Wolfram W/A-6991-2016; Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Ellenberg, Jan/I-4688-2014	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Hyman, Anthony A/0000-0003-3664-154X; Ellenberg, Jan/0000-0001-5909-701X; Politi, Antonio/0000-0003-4788-0933; Neumann, Beate/0000-0002-6899-502X	European Community [241548, 258068, 330114]; ERC [281198]; Austrian Science Fund (FWF) project [SFB F34-06]; Human Frontier Science Program Long-Term Postdoctoral Fellowship; Deutsche Forschungsgemeinschaft (DFG) [MU 1423/3-2, MU 1423/8-1]	European Community(European Commission); ERC(European Research Council (ERC)European Commission); Austrian Science Fund (FWF) project(Austrian Science Fund (FWF)); Human Frontier Science Program Long-Term Postdoctoral Fellowship(Human Frontier Science Program); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank the IMBA/IMP BioOptics microscopy facility and Molecular Biology Service, J. Meissner, and M. J. Hossain for technical support, H. Liu and S. Tietscher for generation of plasmids, C. Haering, M. Samwer, W. H. Gerlich, and O. Wueseke for comments on the manuscript, Life Science Editors for editing assistance, and U. Kutay for LAP2 beta-GFP/H2B-mRFP-expressing cells. D.W.G., A.A.H. and J.E. have received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no. 241548 (MitoSys), and A.Z.P., D.W.G. and J.E. under grant agreement no. 258068 (Systems Microscopy). D.G. has received funding from an ERC Starting Grant under agreement no. 281198 (DIVIMAGE), and from the Austrian Science Fund (FWF) project no. SFB F34-06 (Chromosome Dynamics). S.C. has received funding from a Human Frontier Science Program Long-Term Postdoctoral Fellowship and the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no. 330114 (IFF). T.M.R. was supported by Deutsche Forschungsgemeinschaft (DFG): SPP1384 'Mechanisms of Genome Haploidization MU 1423/3-2 and grant MU 1423/8-1.	Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Booth DG, 2014, ELIFE, V3, DOI 10.7554/eLife.01641; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Cidado J, 2016, ONCOTARGET, V7, P6281, DOI 10.18632/oncotarget.7057; Erfle H, 2008, J BIOMOL SCREEN, V13, P575, DOI 10.1177/1087057108320133; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Heriche JK, 2014, MOL BIOL CELL, V25, P2522, DOI 10.1091/mbc.E13-04-0221; Hirano T, 2016, CELL, V164, P847, DOI 10.1016/j.cell.2016.01.033; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Kschonsak M, 2015, BIOESSAYS, V37, P755, DOI 10.1002/bies.201500020; Lukinavicius G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9497; MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Ohta S, 2011, CURR OPIN CELL BIOL, V23, P114, DOI 10.1016/j.ceb.2010.09.009; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rosen MJ, 2012, SURFACTANTS AND INTERFACIAL PHENOMENA, 4TH EDITION, P1, DOI 10.1002/9781118228920; Saiwaki T, 2005, EXP CELL RES, V308, P123, DOI 10.1016/j.yexcr.2005.04.010; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Schmitz MHA, 2009, METHODS MOL BIOL, V545, P113, DOI 10.1007/978-1-60327-993-2_7; Sobecki M, 2016, ELIFE, V5, DOI 10.7554/eLife.13722; Takagi M, 1999, J CELL SCI, V112, P2463; Takagi M, 2001, J BIOL CHEM, V276, P25386, DOI 10.1074/jbc.M102227200; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Vanneste D, 2009, CURR BIOL, V19, P1712, DOI 10.1016/j.cub.2009.09.019; VERHEIJEN R, 1989, J CELL SCI, V92, P531; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zwicker D, 2014, P NATL ACAD SCI USA, V111, pE2636, DOI 10.1073/pnas.1404855111	33	281	287	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					308	+		10.1038/nature18610	http://dx.doi.org/10.1038/nature18610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR4ZN	27362226	Green Accepted			2022-12-28	WOS:000379912600062
J	Avgousti, DC; Herrmann, C; Kulej, K; Pancholi, NJ; Sekulic, N; Petrescu, J; Molden, RC; Blumenthal, D; Paris, AJ; Reyes, ED; Ostapchuk, P; Hearing, P; Seeholzer, SH; Worthen, GS; Black, BE; Garcia, BA; Weitzman, MD				Avgousti, Daphne C.; Herrmann, Christin; Kulej, Katarzyna; Pancholi, Neha J.; Sekulic, Nikolina; Petrescu, Joana; Molden, Rosalynn C.; Blumenthal, Daniel; Paris, Andrew J.; Reyes, Emigdio D.; Ostapchuk, Philomena; Hearing, Patrick; Seeholzer, Steven H.; Worthen, G. Scott; Black, Ben E.; Garcia, Benjamin A.; Weitzman, Matthew D.			A core viral protein binds host nucleosomes to sequester immune danger signals	NATURE			English	Article							TEMPLATE-ACTIVATING FACTOR; CENP-A NUCLEOSOMES; ACUTE LUNG INJURY; ADENOVIRUS CHROMATIN; MASS-SPECTROMETRY; VIRUS-INFECTION; DNA; MOBILITY; CELLS; HMGB1	Viral proteins mimic host protein structure and function to redirect cellular processes and subvert innate defenses(1). Small basic proteins compact and regulate both viral and cellular DNA genomes. Nucleosomes are the repeating units of cellular chromatin and play an important part in innate immune responses(2). Viralen-coded core basic proteins compact viral genomes, but their impact on host chromatin structure and function remains unexplored. Adenoviruses encode a highly basic protein called protein VII that resembles cellular histones(3). Although protein VII binds viral DNA and is incorporated with viral genomes into virus particles(4,5), it is unknown whether protein VII affects cellular chromatin. Here we show that protein VII alters cellular chromatin, leading us to hypothesize that this has an impact on antiviral responses during adenovirus infection in human cells. We find that protein VII forms complexes with nucleosomes and limits DNA accessibility. We identified post-translational modifications on protein VII that are responsible for chromatin localization. Furthermore, proteomic analysis demonstrated that protein VII is sufficient to alter the protein composition of host chromatin. We found that protein VII is necessary and sufficient for retention in the chromatin of members of the high-mobility-group protein B family (HMGB1, HMGB2 and HMGB3). HMGB1 is actively released in response to inflammatory stimuli and functions as a danger signal to activate immune responses(6,7). We showed that protein VII can directly bind HMGB1 in vitro and further demonstrated that protein VII expression in mouse lungs is sufficient to decrease inflammation-induced HMGB1 content and neutrophil recruitment in the bronchoalveolar lavage fluid. Together, our in vitro and in vivo results show that protein VII sequesters HMGB1 and can prevent its release. This study uncovers a viral strategy in which nucleosome binding is exploited to control extracellular immune signalling.	[Avgousti, Daphne C.; Kulej, Katarzyna; Reyes, Emigdio D.; Weitzman, Matthew D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Avgousti, Daphne C.; Herrmann, Christin; Kulej, Katarzyna; Pancholi, Neha J.; Petrescu, Joana; Reyes, Emigdio D.; Weitzman, Matthew D.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Canc Pathobiol, Philadelphia, PA 19104 USA; [Herrmann, Christin; Pancholi, Neha J.] Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Sekulic, Nikolina; Black, Ben E.; Garcia, Benjamin A.] Univ Penn, Dept Biochem Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sekulic, Nikolina; Molden, Rosalynn C.; Black, Ben E.; Garcia, Benjamin A.] Univ Penn, Epigenet Program, Perelman Sch Med, Philadelphia, PA 19104 USA; [Petrescu, Joana] Villanova Univ, Villanova, PA 19085 USA; [Blumenthal, Daniel] Childrens Hosp Philadelphia, Div Cell Pathol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Paris, Andrew J.] Hosp Univ Penn, Div Pulm Allergy & Crit Care Med, 3400 Spruce St, Philadelphia, PA 19104 USA; [Paris, Andrew J.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ostapchuk, Philomena; Hearing, Patrick] SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Seeholzer, Steven H.] Childrens Hosp Philadelphia, Prot & Prote Core, Philadelphia, PA 19104 USA; [Worthen, G. Scott] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Worthen, G. Scott] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sekulic, Nikolina] Univ Oslo, Biotechnol Ctr Oslo, N-0316 Oslo, Norway; [Sekulic, Nikolina] Univ Oslo, Dept Chem, N-0316 Oslo, Norway	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Villanova University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Oslo; University of Oslo	Weitzman, MD (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; Weitzman, MD (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Canc Pathobiol, Philadelphia, PA 19104 USA.	weitzmanm@email.chop.edu	Sekulic, Nikolina/N-5550-2016	Sekulic, Nikolina/0000-0001-7555-3222; Blumenthal, Daniel/0000-0002-9207-5848; Petrescu, Joana/0000-0002-5436-7639; Paris, Andrew/0000-0002-9808-071X; Herrmann, Christin/0000-0003-4885-1384	American Cancer Society; National Institutes of Health [CA097093, AI102577, CA122677, AI118891, GM110174, GM082989]; Institute for Immunology of the University of Pennsylvania; Children's Hospital of Philadelphia;  [T32 CA115299];  [F32 GM112414];  [T32 NS007180]; NATIONAL CANCER INSTITUTE [T32CA115299, R01CA122677, R01CA097093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891, R01AI099479, R21AI102577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082989, F32GM112414, R01GM110174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007180] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Immunology of the University of Pennsylvania; Children's Hospital of Philadelphia; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Weitzman laboratory for insightful discussions and input, especially R. Dilley and B. Simpson for generating reagents. We also thank R. Panetierri and C. Koziol-White for providing precision-cut lung slices. We are grateful to D. Curiel for sharing recombinant protein-VII-GFP vectors and L. Gerace for anti-protein-VII antibodies. We thank the Penn Vector Core for assistance in purifying recombinant vectors, the Penn CDB Microscopy Core for imaging and FRAP assistance, and the CHOP Pathology core for immunostaining of mouse lungs. We thank members of the Black, Garcia and Worthen laboratories for technical help. We thank C. Bassing, I. Brodsky, J. Henao-Mejia, R. Kohli, C. Lopez, A. Resnick, S. Shin, K. Spindler and J. Weitzman for advice and critical reading of the manuscript. D.C.A. was supported in part by T32 CA115299 and F32 GM112414. N.J.P. was supported in part by T32 NS007180. N.S. was supported in part by funding from the American Cancer Society. Research was supported by grants from the National Institutes of Health (CA097093 to M.D.W., AI102577 and CA122677 to P.H., AI118891 and GM110174 to B.A.G., and GM082989 to B.E.B.), the Institute for Immunology of the University of Pennsylvania, and funds from the Children's Hospital of Philadelphia (M.D.W.).	Blumenthal D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11655; CHATTERJEE PK, 1986, EMBO J, V5, P1633, DOI 10.1002/j.1460-2075.1986.tb04406.x; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Das S, 2013, JOVE-J VIS EXP, DOI 10.3791/50318; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Falk SJ, 2015, SCIENCE, V348, P699, DOI 10.1126/science.1259308; FEDOR MJ, 1980, J VIROL, V35, P637, DOI 10.1128/JVI.35.3.637-643.1980; Ferrari R, 2014, CELL HOST MICROBE, V16, P663, DOI 10.1016/j.chom.2014.10.004; Ferrari R, 2009, NAT REV GENET, V10, P290, DOI 10.1038/nrg2539; Gyurcsik B, 2006, BIOCHEMISTRY-US, V45, P303, DOI 10.1021/bi051248+; Haruki H, 2006, J VIROL, V80, P794, DOI 10.1128/JVI.80.2.794-801.2006; Hasson D, 2013, NAT STRUCT MOL BIOL, V20, P687, DOI 10.1038/nsmb.2562; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; Johnson JS, 2004, J VIROL, V78, P6459, DOI 10.1128/JVI.78.12.6459-6468.2004; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Karen KA, 2011, J VIROL, V85, P4135, DOI 10.1128/JVI.02540-10; Khandelia P, 2011, P NATL ACAD SCI USA, V108, P12799, DOI 10.1073/pnas.1103532108; Knipe DM, 2013, VIROLOGY, V435, P141, DOI 10.1016/j.virol.2012.09.023; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kozarsky KF, 1996, NAT GENET, V13, P54, DOI 10.1038/ng0596-54; Koziol-White CJ, 2011, EXPERT REV RESP MED, V5, P767, DOI [10.1586/ERS.11.77, 10.1586/ers.11.77]; Kulej K, 2015, METHODS, V90, P8, DOI 10.1016/j.ymeth.2015.06.008; Le LP, 2006, VIROLOGY, V351, P291, DOI 10.1016/j.virol.2006.03.042; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; LISCHWE MA, 1977, NATURE, V267, P552, DOI 10.1038/267552a0; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; Orazio NI, 2011, J VIROL, V85, P1887, DOI 10.1128/JVI.02134-10; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; REICH NC, 1983, VIROLOGY, V128, P480, DOI 10.1016/0042-6822(83)90274-X; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Sapojnikova N, 2005, BBA-GENE STRUCT EXPR, V1729, P57, DOI 10.1016/j.bbaexp.2005.03.002; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Teves SS, 2012, METHODS MOL BIOL, V833, P421, DOI 10.1007/978-1-61779-477-3_25; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; VAYDA ME, 1983, NUCLEIC ACIDS RES, V11, P441, DOI 10.1093/nar/11.2.441; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; White AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19122; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zaret K., 2005, CURR PROTOC MOL BIOL, V21, P21, DOI 10.1002/0471142727.mb2101s69	51	82	86	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					173	+		10.1038/nature18317	http://dx.doi.org/10.1038/nature18317			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27362237	Green Accepted			2022-12-28	WOS:000379015600047
J	Niven, DJ; Laupland, KB; Stelfox, HT				Niven, Daniel J.; Laupland, Kevin B.; Stelfox, Henry Thomas			Accuracy of Peripheral Thermometers for Estimating Temperature RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							INFECTION		[Niven, Daniel J.; Stelfox, Henry Thomas] Univ Calgary, Calgary, AB, Canada; [Laupland, Kevin B.] Royal Inland Hosp, Kamloops, BC, Canada	University of Calgary	Niven, DJ (corresponding author), Univ Calgary, Calgary, AB, Canada.		Laupland, Kevin/AAG-3656-2020; Laupland, kevin/AAJ-6339-2020	Laupland, kevin/0000-0002-1205-5354; Stelfox, Henry/0000-0003-1231-1490				Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6; YOUNG PJ, 2012, INTENSIVE CARE MED	4	1	1	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					73	74		10.7326/L16-0069	http://dx.doi.org/10.7326/L16-0069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27380159				2022-12-28	WOS:000379215800025
J	Gulliford, MC; Moore, MV; Little, P; Hay, AD; Fox, R; Prevost, AT; Juszczyk, D; Charlton, J; Ashworth, M				Gulliford, Martin C.; Moore, Michael V.; Little, Paul; Hay, Alastair D.; Fox, Robin; Prevost, A. Toby; Juszczyk, Dorota; Charlton, Judith; Ashworth, Mark			Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLUSTER RANDOMIZED-TRIAL; SORE THROAT; COMPLICATIONS; STRATEGIES; PNEUMONIA; ILLNESS; RATES	OBJECTIVE To determine whether the incidence of pneumonia, peritonsillar abscess, mastoiditis, empyema, meningitis, intracranial abscess, and Lemierre's syndrome is higher in general practices that prescribe fewer antibiotics for self limiting respiratory tract infections (RTIs). DESIGN Cohort study. SETTING 610 UK general practices from the UK Clinical Practice Research Datalink. PARTICIPANTS Registered patients with 45.5 million person years of follow-up from 2005 to 2014. EXPOSURES Standardised proportion of RTI consultations with antibiotics prescribed for each general practice, and rate of antibiotic prescriptions for RTIs per 1000 registered patients. MAIN OUTCOME MEASURES Incidence of pneumonia, peritonsillar abscess, mastoiditis, empyema, meningitis, intracranial abscess, and Lemierre's syndrome, adjusting for age group, sex, region, deprivation fifth, RTI consultation rate, and general practice. Results From 2005 to 2014 the proportion of RTI consultations with antibiotics prescribed decreased from 53.9% to 50.5% in men and from 54.5% to 51.5% in women. From 2005 to 2014, new episodes of meningitis, mastoiditis, and peritonsillar abscess decreased annually by 5.3%, 4.6%, and 1.0%, respectively, whereas new episodes of pneumonia increased by 0.4%. Age and sex standardised incidences for pneumonia and peritonsillar abscess were higher for practices in the lowest fourth of antibiotic prescribing compared with the highest fourth. The adjusted relative risk increases for a 10% reduction in antibiotic prescribing were 12.8% (95% confidence interval 7.8% to 17.5%, P<0.001) for pneumonia and 9.9% (5.6% to 14.0%, P<0.001) for peritonsillar abscess. If a general practice with an average list size of 7000 patients reduces the proportion of RTI consultations with antibiotics prescribed by 10%, then it might observe 1.1 (95% confidence interval 0.6 to 1.5) more cases of pneumonia each year and 0.9 (0.5 to 1.3) more cases of peritonsillar abscess each decade. Mastoiditis, empyema, meningitis, intracranial abscess, and Lemierre's syndrome were similar in frequency at low prescribing and high prescribing practices. Conclusions General practices that adopt a policy to reduce antibiotic prescribing for RTIs might expect a slight increase in the incidence of treatable pneumonia and peritonsillar abscess. No increase is likely in mastoiditis, empyema, bacterial meningitis, intracranial abscess, or Lemierre's syndrome. Even a substantial reduction in antibiotic prescribing was predicted to be associated with only a small increase in numbers of cases observed overall, but caution might be required in subgroups at higher risk of pneumonia.	[Gulliford, Martin C.; Prevost, A. Toby; Juszczyk, Dorota; Charlton, Judith; Ashworth, Mark] Kings Coll London, Dept Primary Care & Publ Hlth Sci, Guys Campus, London SE1 1UL, England; [Moore, Michael V.; Little, Paul] Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton, Hants, England; [Hay, Alastair D.] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England; [Fox, Robin] Ctr Hlth, Oxford, England	University of London; King's College London; University of Southampton; University of Bristol	Gulliford, MC (corresponding author), Kings Coll London, Dept Primary Care & Publ Hlth Sci, Guys Campus, London SE1 1UL, England.	martin.gulliford@kcl.ac.uk	Hay, Alastair/L-1818-2019; Moore, Michael/C-3447-2011; Gulliford, Martin C/I-8606-2018	Moore, Michael/0000-0002-5127-4509; Gulliford, Martin C/0000-0003-1898-9075; Ashworth, Mark/0000-0001-6514-9904; Hay, Alastair/0000-0003-3012-375X; Juszczyk, Dorota/0000-0003-2187-8085; Prevost, A. Toby/0000-0003-1723-0796; Little, Paul/0000-0003-3664-1873	UK National Institute for Health Research Health Technology Assessment programme initiative on antimicrobial drug resistance; National Institute of Health Research (NIHR) Biomedical Research Centre at Guy's Hospital; National Institute of Health Research (NIHR) Biomedical Research Centre at St Thomas' Hospital; National Institute for Health Research [RP-PG-0608-10018, CDF-2009-02-10, NIHR-RP-02-12-012] Funding Source: researchfish	UK National Institute for Health Research Health Technology Assessment programme initiative on antimicrobial drug resistance; National Institute of Health Research (NIHR) Biomedical Research Centre at Guy's Hospital; National Institute of Health Research (NIHR) Biomedical Research Centre at St Thomas' Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	The research was supported by the UK National Institute for Health Research Health Technology Assessment programme initiative on antimicrobial drug resistance. The funders did not engage in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, and approval of the manuscript. MCG and ATP were also supported by the National Institute of Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' Hospitals. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health. This study is based in part on data from the Clinical Practice Research Datalink obtained under licence from the UK Medicines and Healthcare products Regulatory Agency. However, the interpretation and conclusions contained in this report are those of the authors alone.	Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; Ashworth M, 2004, J PUBLIC HEALTH-UK, V26, P268, DOI 10.1093/pubmed/fdh160; Bjork H, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0975-z; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Centor RM, 2015, ANN INTERN MED, V162, P241, DOI 10.7326/M14-1305; Chief Medical Officer, 2001, UNUSUAL DISEASE DIAG; Chief Medical Officer, 2011, ANNUAL REPORT OF THE, V2; Coxeter P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010907.pub2; Gonzales R, 2013, JAMA INTERN MED, V173, P267, DOI 10.1001/jamainternmed.2013.1589; Gordon M, 2016, ADVANCED FOREST PLOT; Gulliford M, 2009, J PUBLIC HEALTH-UK, V31, P512, DOI 10.1093/pubmed/fdp081; Gulliford MC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006245; Gulliford MC, 2014, ANN FAM MED, V12, P344, DOI 10.1370/afm.1659; Health and Social Care Information Centre, 2016, NHS UK READ CODES CL; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Howie J G, 1971, J R Coll Gen Pract, V21, P657; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Little P, 1997, BRIT MED J, V315, P350; Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5806; Little P, 2014, LANCET INFECT DIS, V14, P213, DOI 10.1016/S1473-3099(13)70294-9; Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6867; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Lucas PJ, 2015, SCAND J PRIM HEALTH, V33, P11, DOI 10.3109/02813432.2015.1001942; Maes N., 2015, DAILY MAIL; National Institute for Health and Care Excellence, 2008, PRESCRIBING OF ANTIB; Okike IO, 2014, LANCET INFECT DIS, V14, P301, DOI 10.1016/S1473-3099(13)70332-3; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Quan TP, 2016, THORAX, V71, P535, DOI 10.1136/thoraxjnl-2015-207688; R Development Core Team, 2009, R LANG ENV STAT COMP; Ronnegard L, 2010, R J, V2, P20; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; SINAVE CP, 1989, MEDICINE, V68, P85, DOI 10.1097/00005792-198903000-00002; Spinks Anneliese, 2013, Cochrane Database Syst Rev, pCD000023, DOI 10.1002/14651858.CD000023.pub4; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub3; Stocks N, 2002, FAM PRACT, V19, P375, DOI 10.1093/fampra/19.4.375; Trotter CL, 2008, EMERG INFECT DIS, V14, P727, DOI 10.3201/eid1405.071011; van den Broek d'Obrenan J, 2014, J ANTIMICROB CHEMOTH, V69, P1701, DOI 10.1093/jac/dku005; Van den Bruel A, 2016, ARCH DIS CHILD, V101, P382, DOI 10.1136/archdischild-2015-309228; Venekamp RP, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000219.pub4, 10.1002/14651858.CD000219.pub3]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	42	84	83	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2016	354								i3410	10.1136/bmj.i3410	http://dx.doi.org/10.1136/bmj.i3410			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR0EA	27378578	hybrid, Green Published			2022-12-28	WOS:000379579600001
J	Weimerskirch, H; Bishop, C; Jeanniard-du-Dot, T; Prudor, A; Sachs, G				Weimerskirch, Henri; Bishop, Charles; Jeanniard-du-Dot, Tiphaine; Prudor, Aurelien; Sachs, Gottfried			Frigate birds track atmospheric conditions over months-long transoceanic flights	SCIENCE			English	Article							STRATEGY	Understanding how animals respond to atmospheric conditions across space is critical for understanding the evolution of flight strategies and long-distance migrations. We studied the three-dimensional movements and energetics of great frigate birds (Fregata minor) and showed that they can stay aloft for months during transoceanic flights. To do this, birds track the edge of the doldrums to take advantage of favorable winds and strong convection. Locally, they use a roller-coaster flight, relying on thermals and wind to soar within a 50- to 600-meter altitude band under cumulus clouds and then glide over kilometers at low energy costs. To deal with the local scarcity of clouds and gain longer gliding distances, birds regularly soar inside cumulus clouds to use their strong updraft, and they can reach altitudes of 4000 meters, where freezing conditions occur.	[Weimerskirch, Henri; Prudor, Aurelien] CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France; [Weimerskirch, Henri; Prudor, Aurelien] Univ Reunion, UMR ENTROPIE 9220, St Denis, Reunion, France; [Bishop, Charles] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Jeanniard-du-Dot, Tiphaine] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Sachs, Gottfried] Tech Univ Munich, Inst Flight Syst Dynam, Garching, Germany	Centre National de la Recherche Scientifique (CNRS); University of La Reunion; Bangor University; University of British Columbia; Technical University of Munich	Weimerskirch, H (corresponding author), CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France.; Weimerskirch, H (corresponding author), Univ Reunion, UMR ENTROPIE 9220, St Denis, Reunion, France.	henriw@cebc.cnrs.fr	Weimerskirch, Henri/F-5562-2013; Jeanniard, Tiphaine/ABF-8836-2020; Weimerskirch, Henri/K-7306-2019	Jeanniard, Tiphaine/0000-0003-1985-8325; Weimerskirch, Henri/0000-0002-0457-586X	European Research Council under the European Community [ERC-2012-ADG_20120314]	European Research Council under the European Community(European Research Council (ERC))	The tracking data presented in the paper are available from the Dryad Digital Repository. We thank the Forces Armees de la Zone Sud de l'Ocean Indien for transport and logistical support on Europa Island and the TAAF Administration for allowing us to work on Europa Island. We thank the fieldworkers involved in the study on Europa, in particular J. B. Pons and R. Weimerskirch; R. Spivey for help with preparing the electrocardiogram and acceleration tags and for the data processing of the heart rate recording; and A. Corbeau for help with data analyses. The study is a contribution to the Program EARLYLIFE funded by a European Research Council Advanced Grant under the European Community's Seven Framework Program FP7/2007-2013 (grant agreement ERC-2012-ADG_20120314 to H.W.). We thank Y. Ropert-Coudert, Y. Cherel, and two anonymous reviewers for helpful comments on earlier versions of the manuscript.	Alerstam T., 1990, P331; Alerstam T, 1993, BIRD MIGRATION; Bishop CM, 2015, SCIENCE, V347, P250, DOI 10.1126/science.1258732; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Jonker HJJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032606; Kranstauber B, 2015, ECOL LETT, V18, P1338, DOI 10.1111/ele.12528; Laing A., 2011, INTRO TROPICAL METEO, V2nd; Lesku JA, 2012, SCIENCE, V337, P1654, DOI 10.1126/science.1220939; Liechti F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3554; MALKUS JS, 1954, J METEOROL, V11, P220; Mohanty U. C, 2014, MONITORING PREDICTIO; Nair US, 1998, J GEOPHYS RES-ATMOS, V103, P11363, DOI 10.1029/98JD00088; NELSON J B, 1975, Living Bird, V14, P113; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PENNYCUICK CJ, 1983, J EXP BIOL, V102, P307; Rattenborg NC, 2006, NATURWISSENSCHAFTEN, V93, P413, DOI 10.1007/s00114-006-0120-3; Rayner J.M.V., 1990, P283; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weimerskirch H, 2004, MAR ECOL PROG SER, V275, P297, DOI 10.3354/meps275297; Weimerskirch H, 2003, NATURE, V421, P333, DOI 10.1038/421333a; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270	23	79	83	20	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					74	78		10.1126/science.aaf4374	http://dx.doi.org/10.1126/science.aaf4374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27365448	Green Submitted			2022-12-28	WOS:000378816200039
J	Gotlib, J; Kluin-Nelemans, HC; George, TI; Akin, C; Sotlar, K; Hermine, O; Awan, FT; Hexner, E; Mauro, MJ; Sternberg, DW; Villeneuve, M; Labed, AH; Stanek, EJ; Hartmann, K; Horny, HP; Valent, P; Reiter, A				Gotlib, Jason; Kluin-Nelemans, Hanneke C.; George, Tracy I.; Akin, Cem; Sotlar, Karl; Hermine, Olivier; Awan, Farrukh T.; Hexner, Elizabeth; Mauro, Michael J.; Sternberg, David W.; Villeneuve, Matthieu; Labed, Alice Huntsman; Stanek, Eric J.; Hartmann, Karin; Horny, Hans-Peter; Valent, Peter; Reiter, Andreas			Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL WORKING GROUP; MAST-CELL DISORDERS; RESPONSE CRITERIA; KINASE INHIBITOR; INTERFERON-ALPHA; THERAPY; PKC412; ADULTS; CLASSIFICATION; ACTIVATION	BACKGROUND Advanced systemic mastocytosis comprises rare hematologic neoplasms that are associated with a poor prognosis and lack effective treatment options. The multikinase inhibitor midostaurin inhibits KIT D816V, a primary driver of disease pathogenesis. METHODS We conducted an open-label study of oral midostaurin at a dose of 100 mg twice daily in 116 patients, of whom 89 with mastocytosis-related organ damage were eligible for inclusion in the primary efficacy population; 16 had aggressive systemic mastocytosis, 57 had systemic mastocytosis with an associated hematologic neoplasm, and 16 had mast-cell leukemia. The primary outcome was the best overall response. RESULTS The overall response rate was 60% (95% confidence interval [CI], 49 to 70); 45% of the patients had a major response, which was defined as complete resolution of at least one type of mastocytosis-related organ damage. Response rates were similar regardless of the subtype of advanced systemic mastocytosis, KIT mutation status, or exposure to previous therapy. The median best percentage changes in bone marrow mast-cell burden and serum tryptase level were -59% and -58%, respectively. The median overall survival was 28.7 months, and the median progression-free survival was 14.1 months. Among the 16 patients with mast-cell leukemia, the median overall survival was 9.4 months (95% CI, 7.5 to not estimated). Dose reduction owing to toxic effects occurred in 56% of the patients; re-escalation to the starting dose was feasible in 32% of those patients. The most frequent adverse events were low-grade nausea, vomiting, and diarrhea. New or worsening grade 3 or 4 neutropenia, anemia, and thrombocytopenia occurred in 24%, 41%, and 29% of the patients, respectively, mostly in those with preexisting cytopenias. CONCLUSIONS In this open-label study, midostaurin showed efficacy in patients with advanced systemic mastocytosis, including the highly fatal variant mast-cell leukemia.	[Gotlib, Jason] Stanford Univ, Sch Med, Stanford Canc Inst, Div Hematol, Stanford, CA 94305 USA; [Kluin-Nelemans, Hanneke C.] Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Groningen, Netherlands; [George, Tracy I.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Akin, Cem] Brigham & Womens Hosp, Mastocytosis Ctr, 75 Francis St, Boston, MA 02115 USA; [Sotlar, Karl] Univ Munich, Inst Pathol, Thalkirchner Str 36, D-80539 Munich, Germany; [Hartmann, Karin] Univ Cologne, Dept Dermatol & Venereol, D-50931 Cologne, Germany; [Hartmann, Karin] Univ Lubeck, Lubeck, Germany; [Reiter, Andreas] Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany; [Hermine, Olivier] Univ Paris 05, INSERM, Inst Imagine, U1163, Paris, France; [Hermine, Olivier] CNRS, ERL8654, Ctr Reference Mastocytoses, Paris, France; [Awan, Farrukh T.] Ohio State Univ, Comprehens Canc Ctr, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Hexner, Elizabeth] Univ Penn, Abramson Canc Ctr, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Mauro, Michael J.] Mem Sloan Kettering Canc Ctr, Myeloproliferat Neoplasms Program, 1275 York Ave, New York, NY 10021 USA; [Sternberg, David W.; Stanek, Eric J.] Novartis Pharmaceut, E Hanover, NJ USA; [Villeneuve, Matthieu; Labed, Alice Huntsman] Novartis Pharmaceut, Basel, Switzerland; [Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Valent, Peter] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria	Stanford Cancer Institute; Stanford University; University of Groningen; University of New Mexico; Harvard University; Brigham & Women's Hospital; University of Munich; University of Cologne; University of Lubeck; Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center; Novartis; Novartis; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna	Gotlib, J (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Div Hematol, Stanford, CA 94305 USA.; Gotlib, J (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, 875 Blake Wilbur Dr,Rm 2324, Stanford, CA 94305 USA.	jason.gotlib@stanford.edu	George, Tracy I./GRY-0951-2022; Test, Test/Y-7921-2019; Valent, Peter/B-8533-2016; Gamperl, Susi/V-2715-2019; Test, PV/U-9451-2019; Hexner, Elizabeth/AAC-1442-2020; Hermine, Olivier/Q-7072-2018; Kluin-Nelemans, Johanna C/F-8658-2018; Hartmann, Karin/N-4865-2015	Valent, Peter/0000-0003-0456-5095; Gamperl, Susi/0000-0003-0456-5095; Hexner, Elizabeth/0000-0002-1125-4060; Kluin-Nelemans, Johanna C/0000-0003-2617-9427; Hartmann, Karin/0000-0002-4595-8226; Hermine, Olivier/0000-0003-2574-3874; Akin, Cem/0000-0001-6301-4520; George, Tracy/0000-0001-5478-7847	Novartis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL093366] Funding Source: NIH RePORTER	Novartis Pharmaceuticals(Novartis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by Novartis Pharmaceuticals and others; ClinicalTrials.gov number, NCT00782067.	[Anonymous], 2015, IM GLEEV; Barete S, 2015, BLOOD, V126, P1009, DOI 10.1182/blood-2014-12-614743; Cheson BD, 2000, BLOOD, V96, P3671; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Cohen SS, 2014, BRIT J HAEMATOL, V166, P521, DOI 10.1111/bjh.12916; DELAPORTE E, 1995, BRIT J DERMATOL, V132, P479, DOI 10.1111/j.1365-2133.1995.tb08689.x; Fabbro D, 2000, ANTI-CANCER DRUG DES, V15, P17; Fuller SJ, 2012, HEMATOL ONCOL CLIN N, V26, P1143, DOI 10.1016/j.hoc.2012.08.008; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Georgin-Lavialle S, 2013, BLOOD, V121, P1285, DOI 10.1182/blood-2012-07-442400; Gotlib J, 2005, BLOOD, V106, P2865, DOI 10.1182/blood-2005-04-1568; Gotlib J, 2010, 52 AM SOC HEM ANN M; Gotlib J, 2013, BLOOD, V121, P2393, DOI 10.1182/blood-2012-09-458521; Growney JD, 2005, BLOOD, V106, P721, DOI 10.1182/blood-2004-12-4617; Hauswirth AW, 2004, LEUKEMIA RES, V28, P249, DOI 10.1016/S0145-2126(03)00259-5; Horny HP, 2008, WHO CLASSIFICATION T, P54; Jawhar M, 2015, LEUKEMIA, V29, P1115, DOI 10.1038/leu.2015.4; Kluin-Nelemans HC, 2003, BLOOD, V102, P4270, DOI 10.1182/blood-2003-05-1699; Krauth MT, 2009, CLIN EXP ALLERGY, V39, P1711, DOI 10.1111/j.1365-2222.2009.03353.x; Kristensen T, 2011, J MOL DIAGN, V13, P180, DOI 10.1016/j.jmoldx.2010.10.004; Lim KH, 2009, AM J HEMATOL, V84, P790, DOI 10.1002/ajh.21561; Lim KH, 2009, BLOOD, V113, P5727, DOI 10.1182/blood-2009-02-205237; Pardanani A, 2004, LEUKEMIA RES, V28, P127, DOI 10.1016/S0145-2126(03)00185-1; Pardanani A, 2015, AM J HEMATOL, V90, P251, DOI 10.1002/ajh.23931; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Schwaab J, 2013, BLOOD, V122, P2460, DOI 10.1182/blood-2013-04-496448; Sotlar Karl, 2013, Methods Mol Biol, V999, P59, DOI 10.1007/978-1-62703-357-2_4; Sotlar K, 2010, J PATHOL, V220, P586, DOI 10.1002/path.2677; Tefferi A, 2001, NEW ENGL J MED, V344, P307, DOI 10.1056/NEJM200101253440415; Ustun C, 2014, J CLIN ONCOL, V32, P3264, DOI 10.1200/JCO.2014.55.2018; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Valent P, 2003, LEUKEMIA RES, V27, P635, DOI 10.1016/S0145-2126(02)00168-6; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE., 2010, USERS MANUAL SF 12V2, V2	37	264	272	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2530	2541		10.1056/NEJMoa1513098	http://dx.doi.org/10.1056/NEJMoa1513098			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8DD	27355533	Bronze			2022-12-28	WOS:000378727200005
J	Wolfe, MS; Yankner, BA				Wolfe, Michael S.; Yankner, Bruce A.			Sorting Out Presenilins in Alzheimer's Disease	CELL			English	Editorial Material							GAMMA-SECRETASE; A-BETA	Mutations in the presenilins that cause familial Alzheimer's disease alter the activity of these proteases to increase generation of an aggregation-prone isoform of the amyloid beta-peptide (A beta). How these mutations do so has been unclear. Sannerudet al. now show that regulation of subcellular localization plays a central role, advancing our understanding of the cell biology of Alzheimer's disease.	[Wolfe, Michael S.] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA; [Yankner, Bruce A.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wolfe, MS (corresponding author), Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.; Yankner, BA (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	mswolfe@partners.org; bruce_yankner@hms.harvard.edu			NATIONAL INSTITUTE ON AGING [DP1AG044161] Funding Source: NIH RePORTER; NIA NIH HHS [DP1 AG044161] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Fernandez MA, 2014, J BIOL CHEM, V289, P31043, DOI 10.1074/jbc.M114.581165; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197	9	7	8	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					13	15		10.1016/j.cell.2016.06.034	http://dx.doi.org/10.1016/j.cell.2016.06.034			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27368096	Bronze			2022-12-28	WOS:000380254400006
J	Mayor, S				Mayor, Susan			Threshold for surgery to reduce ovarian cancer risk should be lowered, suggests study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Manchanda R, 2016, J MED GENET, V53, P591, DOI 10.1136/jmedgenet-2016-103800	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2016	353								i3559	10.1136/bmj.i3559	http://dx.doi.org/10.1136/bmj.i3559			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2FP	27353314				2022-12-28	WOS:000379018000015
J	Sharp, P; Jacks, T; Hockfield, S				Sharp, Phillip; Jacks, Tyler; Hockfield, Susan			Capitalizing on convergence for health care Integrate physical sciences, engineering, and biomedicine	SCIENCE			English	Editorial Material									[Sharp, Phillip; Jacks, Tyler; Hockfield, Susan] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hockfield, S (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hockfield@mit.edu						AAAS, 2016, GUID PRES BUDG RES D; Jacks, 2016, CONV FUT HLTH; National Institutes of Health, REPORTER DAT; NBIB, 2016, BUDG; Sharp PA, 2011, SCIENCE, V333, P527, DOI 10.1126/science.1205008; The White House, 2013, BRAIN IN; The White House, 2016, NAT MICR IN; White House, 2015, PRES OB PREC MED IN	8	12	14	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1522	1523		10.1126/science.aag2350	http://dx.doi.org/10.1126/science.aag2350			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP2TT	27339972				2022-12-28	WOS:000378346500023
J	Bagnall, RD; Weintraub, RG; Ingles, J; Duflou, J; Yeates, L; Lam, L; Davis, AM; Thompson, T; Connell, V; Wallace, J; Naylor, C; Crawford, J; Love, DR; Hallam, L; White, J; Lawrence, C; Lynch, M; Morgan, N; James, P; du Sart, D; Puranik, R; Langlois, N; Vohra, J; Winship, I; Atherton, J; McGaughran, J; Skinner, JR; Semsarian, C				Bagnall, R. D.; Weintraub, R. G.; Ingles, J.; Duflou, J.; Yeates, L.; Lam, L.; Davis, A. M.; Thompson, T.; Connell, V.; Wallace, J.; Naylor, C.; Crawford, J.; Love, D. R.; Hallam, L.; White, J.; Lawrence, C.; Lynch, M.; Morgan, N.; James, P.; du Sart, D.; Puranik, R.; Langlois, N.; Vohra, J.; Winship, I.; Atherton, J.; McGaughran, J.; Skinner, J. R.; Semsarian, C.			A Prospective Study of Sudden Cardiac Death among Children and Young Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNEXPLAINED DEATH; MOLECULAR AUTOPSY; LONG-QT; SURVIVING RELATIVES; UNEXPECTED DEATH; CHANNELOPATHIES; PREVALENCE; PREVENTION; ETIOLOGY; DISEASE	BACKGROUND Sudden cardiac death among children and young adults is a devastating event. We performed a prospective, population-based, clinical and genetic study of sudden cardiac death among children and young adults. METHODS We prospectively collected clinical, demographic, and autopsy information on all cases of sudden cardiac death among children and young adults 1 to 35 years of age in Australia and New Zealand from 2010 through 2012. In cases that had no cause identified after a comprehensive autopsy that included toxicologic and histologic studies (unexplained sudden cardiac death), at least 59 cardiac genes were analyzed for a clinically relevant cardiac gene mutation. RESULTS A total of 490 cases of sudden cardiac death were identified. The annual incidence was 1.3 cases per 100,000 persons 1 to 35 years of age; 72% of the cases involved boys or young men. Persons 31 to 35 years of age had the highest incidence of sudden cardiac death (3.2 cases per 100,000 persons per year), and persons 16 to 20 years of age had the highest incidence of unexplained sudden cardiac death (0.8 cases per 100,000 persons per year). The most common explained causes of sudden cardiac death were coronary artery disease (24% of cases) and inherited cardiomyopathies (16% of cases). Unexplained sudden cardiac death (40% of cases) was the predominant finding among persons in all age groups, except for those 31 to 35 years of age, for whom coronary artery disease was the most common finding. Younger age and death at night were independently associated with unexplained sudden cardiac death as compared with explained sudden cardiac death. A clinically relevant cardiac gene mutation was identified in 31 of 113 cases (27%) of unexplained sudden cardiac death in which genetic testing was performed. During follow-up, a clinical diagnosis of an inherited cardiovascular disease was identified in 13% of the families in which an unexplained sudden cardiac death occurred. CONCLUSIONS The addition of genetic testing to autopsy investigation substantially increased the identification of a possible cause of sudden cardiac death among children and young adults.	[Bagnall, R. D.; Ingles, J.; Yeates, L.; Lam, L.; Semsarian, C.] Univ Sydney, Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Locked Bag 6, Newtown, NSW 2042, Australia; [Bagnall, R. D.; Ingles, J.; Duflou, J.; Puranik, R.; Semsarian, C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Duflou, J.] Royal Prince Alfred Hosp, Dept Forens Med, NSW Hlth Pathol, Sydney, NSW, Australia; [Ingles, J.; Yeates, L.; Puranik, R.; Semsarian, C.] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Weintraub, R. G.; Davis, A. M.; Connell, V.; du Sart, D.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Cardiol, Melbourne, Vic, Australia; [Weintraub, R. G.; Davis, A. M.; Connell, V.; du Sart, D.] Univ Melbourne, Melbourne, Vic, Australia; [Davis, A. M.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [James, P.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Thompson, T.; James, P.; Vohra, J.; Winship, I.] Univ Melbourne, Royal Melbourne Hosp, Genet Med, Melbourne, Vic, Australia; [Vohra, J.; Winship, I.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Lynch, M.; Morgan, N.] Victorian Inst Forens Med, Melbourne, Vic, Australia; [Wallace, J.; Naylor, C.] Forens & Sci Serv, Archerlield, QL, Australia; [Naylor, C.; White, J.] Univ Queensland, Brisbane, Qld, Australia; [Atherton, J.; McGaughran, J.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; PathWest, Dept Forens Pathol, Fremantle, WA, Australia; [Hallam, L.] Canberra Hosp, ACT Pathol, Canberra, ACT, Australia; [Lawrence, C.] Univ Tasmania, Royal Hobart Hosp, Hobart, Tas, Australia; [Langlois, N.] Univ Adelaide, Attorney Gen Dept, Adelaide, SA, Australia; [Crawford, J.; Skinner, J. R.] Starship Childrens Hosp, Green Lane Pediat & Congenital Cardiac Serv, Auckland, New Zealand; [Love, D. R.] Auckland City Hosp, LabPLUS, Auckland, New Zealand; [Skinner, J. R.] Univ Auckland, Dept Child Hlth, Auckland 1, New Zealand	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; University of Sydney; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Queensland; Royal Brisbane & Women's Hospital; University of Western Australia; Australian National University; Canberra Hospital; Royal Hobart Hospital; University of Tasmania; University of Adelaide; Starship Children's Hospital; Auckland City Hospital; University of Auckland	Semsarian, C (corresponding author), Univ Sydney, Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Locked Bag 6, Newtown, NSW 2042, Australia.	c.semsarian@centenary.org.au	Ingles, Jodie/J-3113-2019; Winship, Ingrid M/D-7204-2016; McGaughran, Julie/A-2563-2012; Duflou, Johan/AAK-2331-2020; Atherton, John J/B-9994-2011	Ingles, Jodie/0000-0002-4846-7676; Atherton, John J/0000-0003-2271-578X; Duflou, Johan/0000-0001-5863-635X; Bagnall, Richard/0000-0002-2476-9864; Love, Donald/0000-0003-4669-8769; Winship, Ingrid/0000-0001-8535-6003; James, Paul/0000-0002-4361-4657; Davis, Andrew/0000-0003-2826-8562; Skinner, Jonathan Robert/0000-0002-3653-0412; McGaughran, Julie/0000-0002-0926-7858	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funded by the National Health and Medical Research Council of Australia and others.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; Adabag AS, 2010, AM HEART J, V159, P33, DOI 10.1016/j.ahj.2009.10.019; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Bagnall RD, 2014, HEART RHYTHM, V11, P655, DOI 10.1016/j.hrthm.2014.01.017; Bagnall RD, 2010, INT J CARDIOL, V145, P150, DOI 10.1016/j.ijcard.2009.07.009; Behr ER, 2008, EUR HEART J, V29, P1670, DOI 10.1093/eurheartj/ehn219; Corrado D, 2003, CIRCULATION, V108, P3084, DOI 10.1161/01.CIR.0000103130.33451.D2; Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1; de Noronha SV, 2009, HEART, V95, P1409, DOI 10.1136/hrt.2009.168369; Doolan A, 2004, MED J AUSTRALIA, V180, P110, DOI 10.5694/j.1326-5377.2004.tb05830.x; Eckart RE, 2011, J AM COLL CARDIOL, V58, P1254, DOI 10.1016/j.jacc.2011.01.049; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Kumar S, 2013, HEART RHYTHM, V10, P1653, DOI 10.1016/j.hrthm.2013.08.022; Maron BJ, 2007, JAMA-J AM MED ASSOC, V298, P405, DOI 10.1001/jama.298.4.405; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Mellor G, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1078, DOI 10.1161/CIRCEP.114.001854; Napolitano C, 2012, CIRCULATION, V125, P2027, DOI 10.1161/CIRCULATIONAHA.111.055947; Papadakis M, 2013, CIRC-ARRHYTHMIA ELEC, V6, P588, DOI 10.1161/CIRCEP.113.000111; Papadakis M, 2009, EUROPACE, V11, P1353, DOI 10.1093/europace/eup229; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Puranik R, 2005, HEART RHYTHM, V2, P1277, DOI 10.1016/j.hrthm.2005.09.008; Semsarian C, 2015, EUR HEART J, V36, P1290, DOI 10.1093/eurheartj/ehv063; Semsarian C, 2012, HEART RHYTHM, V9, P145, DOI 10.1016/j.hrthm.2011.07.034; Skinner JR, 2008, MED J AUSTRALIA, V189, P539, DOI 10.5694/j.1326-5377.2008.tb02173.x; Skinner JR, 2011, HEART RHYTHM, V8, P412, DOI 10.1016/j.hrthm.2010.11.016; Sweeting J, 2014, PAEDIATR RESPIR REV, V15, P301, DOI 10.1016/j.prrv.2014.09.006; Tan HL, 2005, CIRCULATION, V112, P207, DOI 10.1161/CIRCULATIONAHA.104.522581; Tester DJ, 2007, J AM COLL CARDIOL, V49, P240, DOI 10.1016/j.jacc.2006.10.010; Tester DJ, 2005, CARDIOVASC RES, V67, P388, DOI 10.1016/j.cardiores.2005.02.013; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Tu E, 2011, BRAIN PATHOL, V21, P201, DOI 10.1111/j.1750-3639.2010.00438.x; van Rijsingen IAW, 2012, J AM COLL CARDIOL, V59, P493, DOI 10.1016/j.jacc.2011.08.078; Wilde AAM, 2013, NAT REV CARDIOL, V10, P571, DOI 10.1038/nrcardio.2013.108; Winkel BG, 2012, J CARDIOVASC ELECTR, V23, P1092, DOI 10.1111/j.1540-8167.2012.02371.x; Winkel BG, 2011, EUR HEART J, V32, P983, DOI 10.1093/eurheartj/ehq428	36	424	435	6	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2441	2452		10.1056/NEJMoa1510687	http://dx.doi.org/10.1056/NEJMoa1510687			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1TG	27332903	Bronze			2022-12-28	WOS:000378271700008
J	Butt, CA				Butt, Carrie A.			Taimyr Victor Vasarely	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2502	2503		10.1001/jama.2015.14320	http://dx.doi.org/10.1001/jama.2015.14320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27327787				2022-12-28	WOS:000378306700001
J	Bynum, B; Bynum, H				Bynum, Bill; Bynum, Helen			Chisholm chloroform inhaler	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2281	2281		10.1016/S0140-6736(16)30693-6	http://dx.doi.org/10.1016/S0140-6736(16)30693-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27308676				2022-12-28	WOS:000376969100014
J	Craske, MG; Stein, MB				Craske, Michelle G.; Stein, Murray B.			Anxiety	LANCET			English	Review							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; ONE-SESSION TREATMENT; GENOME-WIDE ASSOCIATION; QUALITY-OF-LIFE; GENERALIZED ANXIETY; PANIC DISORDER; SOCIAL ANXIETY; DOUBLE-BLIND; PHARMACOLOGICAL-TREATMENT	Anxiety disorders (separation anxiety disorder, selective mutism, specific phobias, social anxiety disorder, panic disorder, agoraphobia, and generalised anxiety disorder) are common and disabling conditions that mostly begin during childhood, adolescence, and early adulthood. They differ from developmentally normative or stress- induced transient anxiety by being marked (ie, out of proportion to the actual threat present) and persistent, and by impairing daily functioning. Most anxiety disorders affect almost twice as many women as men. They often co- occur with major depression, alcohol and other substance- use disorders, and personality disorders. Differential diagnosis from physical conditions- including thyroid, cardiac, and respiratory disorders, and substance intoxication and withdrawal- is imperative. If untreated, anxiety disorders tend to recur chronically. Psychological treatments, particularly cognitive behavioural therapy, and pharmacological treatments, particularly selective serotonin- reuptake inhibitors and serotonin- noradrenaline- reuptake inhibitors, are effective, and their combination could be more effective than is treatment with either individually. More research is needed to increase access to and to develop personalised treatments.	[Craske, Michelle G.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Craske, Michelle G.] Univ Calif Los Angles, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Craske, MG (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	craske@psych.ucla.edu			Behaviour Research and Psychological Bulletin; Janssen; Pfizer; Actelion; Resilience Therapeutics; UpToDate	Behaviour Research and Psychological Bulletin; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Actelion; Resilience Therapeutics; UpToDate	MGC receives book royalties from Oxford University Press, the American Psychological Association, and UpToDate Books, and editorial fees from Behaviour Research and Psychological Bulletin. MBS receives editorial fees and royalties from UpToDate, editorial compensation from Biological Psychiatry, and consulting fees from Janssen, Pfizer, Actelion, and Resilience Therapeutics.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Andrews G, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0533-1; Baldwin DS, 2015, J PSYCHOPHARMACOL, V29, P1047, DOI 10.1177/0269881115598411; Baldwin DS, 2014, J PSYCHOPHARMACOL, V28, P403, DOI 10.1177/0269881114525674; Bandelow B, 2012, INT J PSYCHIAT CLIN, V16, P77, DOI 10.3109/13651501.2012.667114; Bartley CA, 2013, PROG NEURO-PSYCHOPH, V45, P34, DOI 10.1016/j.pnpbp.2013.04.016; Baxter AJ, 2014, PSYCHOL MED, V44, P2363, DOI 10.1017/S0033291713003243; Baxter AJ, 2013, PSYCHOL MED, V43, P897, DOI 10.1017/S003329171200147X; Beesdo-Baum K, 2012, CHILD ADOL PSYCH CL, V21, P457, DOI 10.1016/j.chc.2012.05.001; Bergman RL, 2013, BEHAV RES THER, V51, P680, DOI 10.1016/j.brat.2013.07.003; Bergman RL, 2002, J AM ACAD CHILD PSY, V41, P938, DOI 10.1097/00004583-200208000-00012; Bogels SM, 2013, CLIN PSYCHOL REV, V33, P663, DOI 10.1016/j.cpr.2013.03.006; Bogels SM, 2010, DEPRESS ANXIETY, V27, P168, DOI 10.1002/da.20670; Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179; Burstein M, 2012, DEPRESS ANXIETY, V29, P1072, DOI 10.1002/da.22008; Campbell-Sills L, 2009, J AFFECT DISORDERS, V112, P92, DOI 10.1016/j.jad.2008.03.014; CHAMBLESS DL, 1985, BEHAV RES THER, V23, P35, DOI 10.1016/0005-7967(85)90140-8; Christensen H, 2014, CURR OPIN PSYCHIATR, V27, P7, DOI 10.1097/YCO.0000000000000019; Clauss JA, 2012, J AM ACAD CHILD PSY, V51, P1066, DOI 10.1016/j.jaac.2012.08.002; Connor KM, 2000, BRIT J PSYCHIAT, V176, P379, DOI 10.1192/bjp.176.4.379; Craske M.G., 2010, COGNITIVE BEHAV THER; Craske MG, 2006, BEHAV THER, V37, P112, DOI 10.1016/j.beth.2005.05.003; Craske MG, 2009, DEPRESS ANXIETY, V26, P1066, DOI 10.1002/da.20633; Cristea IA, 2015, BRIT J PSYCHIAT, V206, P7, DOI 10.1192/bjp.bp.114.146761; Cuijpers P, 2016, AM J PSYCHIAT, V173, P680, DOI 10.1176/appi.ajp.2015.15091141; Cuijpers P, 2014, WORLD PSYCHIATRY, V13, P56, DOI 10.1002/wps.20089; Cuijpers P, 2013, WORLD PSYCHIATRY, V12, P137, DOI 10.1002/wps.20038; de Gage SB, 2015, EXPERT OPIN DRUG SAF, V14, P733, DOI 10.1517/14740338.2015.1014796; de Moor MHM, 2015, JAMA PSYCHIAT, V72, P642, DOI 10.1001/jamapsychiatry.2015.0554; Duits P, 2015, DEPRESS ANXIETY, V32, P239, DOI 10.1002/da.22353; Dunsmoor JE, 2015, BIOL PSYCHIAT, V78, P336, DOI 10.1016/j.biopsych.2015.04.010; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; Fonzo GA, 2016, PSYCHOL MED, V46, P1037, DOI 10.1017/S0033291715002603; Fonzo GA, 2015, BRIT J PSYCHIAT, V206, P206, DOI 10.1192/bjp.bp.114.149880; Ginsburg GS, 2014, JAMA PSYCHIAT, V71, P310, DOI 10.1001/jamapsychiatry.2013.4186; Ginsburg GS, 2009, J CONSULT CLIN PSYCH, V77, P580, DOI 10.1037/a0014486; Glenn DE, 2014, BIOL PSYCHIAT, V75, P847, DOI 10.1016/j.biopsych.2013.09.022; Gommoll C, 2015, INT CLIN PSYCHOPHARM, V30, P297, DOI 10.1097/YIC.0000000000000096; Gommoll C, 2015, DEPRESS ANXIETY, V32, P451, DOI 10.1002/da.22365; Goodwin RD, 2005, EUR NEUROPSYCHOPHARM, V15, P435, DOI 10.1016/j.euroneuro.2005.04.006; Gould RL, 2012, J AM GERIATR SOC, V60, P218, DOI 10.1111/j.1532-5415.2011.03824.x; Gray SL, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i90; Hallion LS, 2011, PSYCHOL BULL, V137, P940, DOI 10.1037/a0024355; Hardwicke TE, 2016, P NATL ACAD SCI USA, V113, P5206, DOI 10.1073/pnas.1601440113; Heeren A, 2015, CLIN PSYCHOL REV, V40, P76, DOI 10.1016/j.cpr.2015.06.001; Heldt E, 2011, REV BRAS PSIQUIATR, V33, P23, DOI 10.1590/S1516-44462010005000005; Hettema JM, 2015, PSYCHOL MED, V45, P3075, DOI 10.1017/S0033291715001038; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hofmann SG, 2014, J CONSULT CLIN PSYCH, V82, P375, DOI 10.1037/a0035491; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Insel TR, 2015, SCIENCE, V348, P499, DOI 10.1126/science.aab2358; Ishak WW, 2014, DEPRESS ANXIETY, V31, P707, DOI 10.1002/da.22152; James AC, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004690.pub3, 10.1002/14651858.CD004690.pub4]; Kalisch R, 2009, CEREB CORTEX, V19, P187, DOI 10.1093/cercor/bhn076; Kaouane N, 2012, SCIENCE, V335, P1510, DOI 10.1126/science.1207615; Katzman MA, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-S1-S1; Keeley JW, 2016, AM PSYCHOL, V71, P3, DOI 10.1037/a0039972; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kessler RC, 2010, CURR TOP BEHAV NEURO, V2, P21, DOI 10.1007/7854_2009_9; Kilgore MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103223; Kindt M, 2014, BEHAV RES THER, V62, P24, DOI 10.1016/j.brat.2014.08.012; Kreys TJM, 2015, PHARMACOTHERAPY, V35, P175, DOI 10.1002/phar.1529; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Krystal JH, 2015, JAMA PSYCHIAT, V72, P734, DOI 10.1001/jamapsychiatry.2015.0351; Lamers F, 2011, J CLIN PSYCHIAT, V72, P341, DOI 10.4088/JCP.10m06176blu; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Levitan MN, 2015, NEUROPSYCH DIS TREAT, V11, P1149, DOI 10.2147/NDT.S67470; Loerinc AG, 2015, CLIN PSYCHOL REV, V42, P72, DOI 10.1016/j.cpr.2015.08.004; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Milad MR, 2014, BEHAV RES THER, V62, P17, DOI 10.1016/j.brat.2014.08.006; Minor TR, 1997, BIOL PSYCHIAT, V42, P324, DOI 10.1016/S0006-3223(96)00467-2; Monga S, 2015, J AM ACAD CHILD PSY, V54, P138, DOI 10.1016/j.jaac.2014.10.008; Moreno-Peral P, 2014, J AFFECT DISORDERS, V168, P337, DOI 10.1016/j.jad.2014.06.021; Muris P, 2000, J CLIN CHILD PSYCHOL, V29, P43, DOI 10.1207/S15374424jccp2901_5; Nail JE, 2015, CHILD YOUTH CARE FOR, V44, P327, DOI 10.1007/s10566-014-9290-x; National Institute of Health and Care Excellence, 2014, ANXIETY DISORDERS; Newman MG, 2002, BEHAV THER, V33, P215, DOI 10.1016/S0005-7894(02)80026-0; Oerbeck B, 2014, CHILD ADOL MENT H-UK, V19, P192, DOI 10.1111/camh.12045; Olfson M, 2015, JAMA PSYCHIAT, V72, P136, DOI 10.1001/jamapsychiatry.2014.1763; Ollendick TH, 2015, BEHAV THER, V46, P141, DOI 10.1016/j.beth.2014.09.004; Ollendick TH, 2013, COGN BEHAV THERAPY, V42, P275, DOI 10.1080/16506073.2013.773062; Olofsdotter S, 2016, ASSESSMENT, V23, P744, DOI 10.1177/1073191115583858; Olthuis JV, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011565; Ori R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007803.pub2; Ost LG, 2001, J CONSULT CLIN PSYCH, V69, P814, DOI 10.1037/0022-006X.69.5.814; Otowa T, 2016, MOL PSYCHIATR, V21, P1391, DOI 10.1038/mp.2015.197; Pollack MH, 2014, AM J PSYCHIAT, V171, P44, DOI 10.1176/appi.ajp.2013.12101353; Porter E, 2015, CLIN PSYCHOL REV, V42, P179, DOI 10.1016/j.cpr.2015.09.004; RAPEE RM, 1994, ANXIETY, V1, P114; Rapee RM, 2010, AM J PSYCHIAT, V167, P1518, DOI 10.1176/appi.ajp.2010.09111619; Rapee RM, 2009, ANNU REV CLIN PSYCHO, V5, P311, DOI 10.1146/annurev.clinpsy.032408.153628; Ravindran LN, 2009, KAPLAN SADOCK COMPRE, P1906; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Roy-Byrne P, 2010, JAMA PSYCHIAT; Schneider RL, 2015, CLIN PSYCHOL REV, V38, P39, DOI 10.1016/j.cpr.2015.02.004; Schneider S, 2013, J CONSULT CLIN PSYCH, V81, P932, DOI 10.1037/a0032678; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shimada-Sugimoto M, 2015, PSYCHIAT CLIN NEUROS, V69, P388, DOI 10.1111/pcn.12291; Silove D, 2015, AM J PSYCHIAT, V172, P647, DOI 10.1176/appi.ajp.2015.1409118.5; Skapinakis P, 2011, EUR PSYCHIAT, V26, P354, DOI 10.1016/j.eurpsy.2010.06.004; Smith DJ, 2016, MOL PSYCHIATR, V21, P749, DOI 10.1038/mp.2016.49; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Stanley MA, 2014, DEPRESS ANXIETY, V31, P391, DOI 10.1002/da.22239; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Stein MB, 2015, NEW ENGL J MED, V373, P2059, DOI 10.1056/NEJMcp1502514; Stein MB, 2011, J CLIN PSYCHIAT, V72, P970, DOI 10.4088/JCP.09m05626blu; Strawn JR, 2015, DEPRESS ANXIETY, V32, P149, DOI 10.1002/da.22329; Tolin DF, 2010, CLIN PSYCHOL REV, V30, P710, DOI 10.1016/j.cpr.2010.05.003; Twenge JM, 2010, CLIN PSYCHOL REV, V30, P145, DOI 10.1016/j.cpr.2009.10.005; Vachon DD, 2015, JAMA PSYCHIAT, V72, P1135, DOI 10.1001/jamapsychiatry.2015.1792; van Apeldoorn FJ, 2010, J CLIN PSYCHIAT, V71, P574, DOI 10.4088/JCP.08m04681blu; Vollestad J, 2012, BRIT J CLIN PSYCHOL, V51, P239, DOI 10.1111/j.2044-8260.2011.02024.x; Vos SPF, 2012, PSYCHOL MED, V42, P2661, DOI 10.1017/S0033291712000876; Welander-Vatn A, 2016, J AFFECT DISORDERS, V190, P349, DOI 10.1016/j.jad.2015.09.038; White KS, 2013, J CONSULT CLIN PSYCH, V81, P47, DOI 10.1037/a0030666; Wilson H, 2015, CNS DRUGS, V29, P29, DOI 10.1007/s40263-014-0217-8; Wolpe J., 1969, FEAR SURVEY SCHEDULE; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Ye XB, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-313; Zelikowsky M, 2012, HIPPOCAMPUS, V22, P1096, DOI 10.1002/hipo.20954; Zhang XB, 2015, J AFFECT DISORDERS, V172, P24, DOI 10.1016/j.jad.2014.09.036	129	268	279	55	299	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					3048	3059		10.1016/S0140-6736(16)30381-6	http://dx.doi.org/10.1016/S0140-6736(16)30381-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1VF	27349358				2022-12-28	WOS:000390112300037
J	Kamat, AM; Hahn, NM; Efstathiou, JA; Lerner, SP; Malmstrom, PU; Choi, W; Guo, CC; Lotan, Y; Kassouf, W				Kamat, Ashish M.; Hahn, Noah M.; Efstathiou, Jason A.; Lerner, Seth P.; Malmstrom, Per-Uno; Choi, Woonyoung; Guo, Charles C.; Lotan, Yair; Kassouf, Wassim			Bladder cancer	LANCET			English	Review							TRANSITIONAL-CELL-CARCINOMA; BACILLUS-CALMETTE-GUERIN; LONG-TERM OUTCOMES; INVASIVE UROTHELIAL CARCINOMA; COMBINED-MODALITY THERAPY; PHASE-III TRIAL; PERIOPERATIVE BLOOD-TRANSFUSION; EAU INTERNATIONAL CONSULTATION; CISPLATIN-BASED CHEMOTHERAPY; GEMCITABINE PLUS CISPLATIN	Bladder cancer is a complex disease associated with high morbidity and mortality rates if not treated optimally. Awareness of haematuria as the major presenting symptom is paramount, and early diagnosis with individualised treatment and follow-up is the key to a successful outcome. For non-muscle-invasive bladder cancer, the mainstay of treatment is complete resection of the tumour followed by induction and maintenance immunotherapy with intravesical BCG vaccine or intravesical chemotherapy. For muscle-invasive bladder cancer, multimodal treatment involving radical cystectomy with neoadjuvant chemotherapy offers the best chance for cure. Selected patients with muscle-invasive tumours can be offered bladder-sparing trimodality treatment consisting of transurethral resection with chemoradiation. Advanced disease is best treated with systemic cisplatin-based chemotherapy; immunotherapy is emerging as a viable salvage treatment for patients in whom first-line chemotherapy cannot control the disease. Developments in the past 2 years have shed light on genetic subtypes of bladder cancer that might differ from one another in response to various treatments.	[Kamat, Ashish M.; Choi, Woonyoung] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Guo, Charles C.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hahn, Noah M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Hahn, Noah M.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; [Efstathiou, Jason A.] Harvard Med Sch, Dept Radiat Oncol, Massachusetts Gen Hosp, Boston, MA USA; [Lerner, Seth P.] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Malmstrom, Per-Uno] Uppsala Univ, Urol, Dept Urol Surg, Uppsala, Sweden; [Lotan, Yair] Univ Texas Southwestern, Dept Urol, Dallas, TX USA; [Kassouf, Wassim] McGill Univ, Dept Surg, Ctr Hlth, Montreal, PQ, Canada	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Baylor College of Medicine; Uppsala University; University of Texas System; University of Texas Southwestern Medical Center Dallas; McGill University	Kamat, AM (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	akamat@mdanderson.org			Theralase; Sanofi; Taris; Spectrum Pharmaceuticals; MDxHealth; Heat Biologics; Photocure; Telesta Therapeutics; Merck; Abbott Molecular; FKD; Pacific Edge; BioCancell; Vaxxion; UroGen; Telesta; Sitka; Neucleixx; Bladder Cancer Journal; Ferring; ENDO Pharmaceuticals; Viventia; Roche/Genentech; Genome DX; Abbott; Cepheid; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Theralase; Sanofi; Taris; Spectrum Pharmaceuticals; MDxHealth; Heat Biologics; Photocure; Telesta Therapeutics; Merck(Merck & Company); Abbott Molecular; FKD; Pacific Edge; BioCancell; Vaxxion; UroGen; Telesta; Sitka; Neucleixx; Bladder Cancer Journal; Ferring(Ferring Pharmaceuticals); ENDO Pharmaceuticals; Viventia; Roche/Genentech(Roche HoldingGenentech); Genome DX; Abbott(Abbott Laboratories); Cepheid; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AMK reports consulting fees from Theralase, Sanofi, Taris, Spectrum Pharmaceuticals, and MDxHealth; reports research support from Heat Biologics, Photocure, Telesta Therapeutics, Merck, Abbott Molecular, FKD, and Pacific Edge; and has a patent pending for cytokine assay for response to intravesical therapy (CYPRIT) for the University of Texas. NMH reports consulting for Merck, Oncogenex, and Bristol-Myers Squibb, and research funding to institution from Novartis, Genentech, Merck, Oncogenex, Mirati Therapeutics, and Acerta Pharma, outside the submitted work. JAE reports consulting for Medivation and Astellas. SPL reports consulting fees from BioCancell, Vaxxion, UroGen, Telesta, Sitka, Neucleixx, Taris, Bladder Cancer Journal, and Ferring and grants from ENDO Pharmaceuticals, FKD, Viventia, Roche/Genentech, and Genome DX, during the conduct of the study. P-UM reports speaker fees from Medac GmbH and scientific advisory from Photocure ASA, and APIM Therapeutics AS, outside the submitted work. WC has a patent pending for methods of characterising and treating molecular subset of muscle-invasive bladder cancer. YL reports grants from Abbott, Cepheid, and MDxHealth and grants and personal fees from Pacific Edge, during the conduct of the study; and grants from genomedx and grants and personal fees from photocure, outside the submitted work. CCG and WK declare no competing interests.	Abd el-Latif A, 2013, J UROLOGY, V189, P1263, DOI 10.1016/j.juro.2012.10.054; Advanced Bladder Cancer ( ABC), 2005, EUR UROL, V48, P202, DOI [DOI 10.1016/J.EURUR0.2005.04.006, DOI 10.1016/j.eururo.2005.04.006]; Aine M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10957; Allory Y, 2014, EUR UROL, V65, P360, DOI 10.1016/j.eururo.2013.08.052; American Cancer Society, 2015, CANC FACTS FIG 2015; Amin MB, 2013, EUR UROL, V63, P16, DOI 10.1016/j.eururo.2012.09.063; Amin MB, 2009, MODERN PATHOL, V22, pS96, DOI 10.1038/modpathol.2009.26; Apolo AB, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.2_suppl.367; Arends TJH, 2016, EUR UROL, V69, P1046, DOI 10.1016/j.eururo.2016.01.006; Aziz A, 2014, EUR UROL, V66, P156, DOI 10.1016/j.eururo.2013.12.018; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Balbas-Martinez C, 2013, NAT GENET, V45, P1464, DOI 10.1038/ng.2799; Bangma CH, 2013, EUR UROL, V64, P41, DOI 10.1016/j.eururo.2013.02.036; Baumann BC, 2013, INT J RADIAT ONCOL, V85, P363, DOI 10.1016/j.ijrobp.2012.03.061; Bellmunt J, 2009, J CLIN ONCOL, V27, P4454, DOI 10.1200/JCO.2008.20.5534; Biton A, 2014, CELL REP, V9, P1235, DOI 10.1016/j.celrep.2014.10.035; Blacks PC, 2009, UROL ONCOL-SEMIN ORI, V27, P3, DOI 10.1016/j.urolonc.2007.07.010; Bochner BH, 2015, EUR UROL, V67, P1042, DOI 10.1016/j.eururo.2014.11.043; Bochner BH, 2004, J UROLOGY, V172, P1286, DOI 10.1097/01.ju.0000137817.56888.d1; Bono AV, 2005, EUR UROL, V48, P189, DOI 10.1016/j.eururo.2005.04.005; Brausi M, 2014, EUR UROL, V65, P69, DOI 10.1016/j.eururo.2013.07.021; Burger M, 2008, EUR UROL, V54, P835, DOI 10.1016/j.eururo.2007.12.026; Burger M, 2013, EUR UROL, V64, P846, DOI 10.1016/j.eururo.2013.03.059; Cambier S, 2016, EUR UROL, V69, P60, DOI 10.1016/j.eururo.2015.06.045; CAREL RS, 1987, CLIN CHEM, V33, P2106; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Chamie K, 2012, CANCER-AM CANCER SOC, V118, P1412, DOI 10.1002/cncr.26402; Chen ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047199; Cheng L, 2012, HUM PATHOL, V43, P2097, DOI 10.1016/j.humpath.2012.01.008; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Chou R, 2015, ANN INTERN MED, V163, P922, DOI 10.7326/M15-0997; Choudhury A, 2011, J CLIN ONCOL, V29, P733, DOI 10.1200/JCO.2010.31.5721; Choudhury A, 2010, CANCER RES, V70, P7017, DOI 10.1158/0008-5472.CAN-10-1202; Choueiri TK, 2014, J CLIN ONCOL, V32, P1889, DOI 10.1200/JCO.2013.52.4785; Christodouleas JP, 2014, CANCER-AM CANCER SOC, V120, P1272, DOI 10.1002/cncr.28544; Clark PE, 2013, J NATL COMPR CANC NE, V11, P446, DOI 10.6004/jnccn.2013.0059; Comperat E, 2010, PATHOLOGY, V42, P650, DOI 10.3109/00313025.2010.522173; Culp SH, 2014, J UROLOGY, V191, P40, DOI 10.1016/j.juro.2013.07.061; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Daneshmand S, 2014, NAT REV UROL, V11, P589, DOI 10.1038/nrurol.2014.245; Dash A, 2008, CANCER-AM CANCER SOC, V113, P2471, DOI 10.1002/cncr.23848; Dayyani F, 2013, J UROLOGY, V189, P1656, DOI 10.1016/j.juro.2012.11.084; De Santis M, 2012, J CLIN ONCOL, V30, P191, DOI 10.1200/JCO.2011.37.3571; Dhar NB, 2008, J UROLOGY, V179, P873, DOI 10.1016/j.juro.2007.10.076; Di Stasi SM, 2006, LANCET ONCOL, V7, P43, DOI 10.1016/S1470-2045(05)70472-1; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Divrik RT, 2006, J UROLOGY, V175, P1641, DOI 10.1016/S0022-5347(05)01002-5; Donat SM, 2009, EUR UROL, V55, P177, DOI 10.1016/j.eururo.2008.07.018; Edge SB, 2010, AJCC CANC STAGING MA, P497; Efstathiou JA, 2015, BLADDER PRESERVATION; Efstathiou JA, 2012, EUR UROL, V61, P705, DOI 10.1016/j.eururo.2011.11.010; Efstathiou JA, 2009, J CLIN ONCOL, V27, P4055, DOI 10.1200/JCO.2008.19.5776; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Eswara JR, 2012, J UROLOGY, V187, P463, DOI 10.1016/j.juro.2011.09.159; Fritsche HM, 2012, VIRCHOWS ARCH, V461, P655, DOI 10.1007/s00428-012-1328-6; Gakis G, 2013, EUR UROL, V63, P45, DOI 10.1016/j.eururo.2012.08.009; Galsky MD, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.2_suppl.357; Gangkak G, 2015, J UROLOGY, V194, P852, DOI 10.1016/j.juro.2015.02.2950; Giacalone NJ, 2015, INT J RADIAT ONCOL, V93, pS22, DOI 10.1016/j.ijrobp.2015.07.058; Gogna NK, 2006, RADIOTHER ONCOL, V81, P9, DOI 10.1016/j.radonc.2006.09.001; Gontero P, 2015, EUR UROL, V67, P74, DOI 10.1016/j.eururo.2014.06.040; Gordetsky J, 2014, UROLOGY, V84, P619, DOI 10.1016/j.urology.2014.05.037; Gospodarowicz M K, 1991, Clin Oncol (R Coll Radiol), V3, P155, DOI 10.1016/S0936-6555(05)81190-2; Griffiths G, 2011, J CLIN ONCOL, V29, P2171, DOI 10.1200/JCO.2010.32.3139; Groenendijk FH, 2016, EUR UROL, V69, P384, DOI 10.1016/j.eururo.2015.01.014; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Guevara A, 2010, J UROLOGY, V183, P2161, DOI 10.1016/j.juro.2010.02.026; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; Hansel DE, 2013, UROLOGY, V81, P1123, DOI 10.1016/j.urology.2013.01.027; Hansel DE, 2013, EUR UROL, V63, P321, DOI 10.1016/j.eururo.2012.10.008; Harland SJ, 2007, J UROLOGY, V178, P807, DOI 10.1016/j.juro.2007.05.024; Helenius M, 2015, SCAND J UROL, V49, P377, DOI 10.3109/21681805.2015.1026937; Herr HW, 1999, J UROLOGY, V162, P74, DOI 10.1097/00005392-199907000-00018; Huncharek M, 2000, J CLIN EPIDEMIOL, V53, P676, DOI 10.1016/S0895-4356(99)00203-6; Hurst CD, 2014, EUR UROL, V65, P367, DOI 10.1016/j.eururo.2013.08.057; James ND, 2012, NEW ENGL J MED, V366, P1477, DOI 10.1056/NEJMoa1106106; Jancke G, 2011, SCAND J UROL NEPHROL, V45, P388, DOI 10.3109/00365599.2011.590995; Jani AB, 2015, HEMATOL ONCOL CLIN N, V29, P289, DOI 10.1016/j.hoc.2014.10.004; Jarow J, 2015, BLADDER CANCER, V1, P133, DOI 10.3233/BLC-150016; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; Kaasinen E, 2002, EUR UROL, V42, P167, DOI 10.1016/S0302-2838(02)00260-9; Kamat AM, 2007, CANCER, V110, P62, DOI 10.1002/cncr.22756; Kamat AM, 2016, J CLIN ONCOL, V34, P1935, DOI 10.1200/JCO.2015.64.4070; Kamat AM, 2016, BJU INT, V117, P754, DOI 10.1111/bju.13186; Kamat AM, 2016, EUR UROL, V69, P197, DOI 10.1016/j.eururo.2015.06.023; Kamat AM, 2015, NAT REV UROL, V12, P225, DOI 10.1038/nrurol.2015.58; Kamat AM, 2014, J UROLOGY, V192, P305, DOI 10.1016/j.juro.2014.02.2573; Kamat AM, 2014, EUR UROL, V65, P267, DOI 10.1016/j.eururo.2013.10.016; Kamat AM, 2012, J UROLOGY, V187, P862, DOI 10.1016/j.juro.2011.10.144; Kassouf W, 2008, J UROLOGY, V180, P164, DOI 10.1016/j.juro.2008.03.037; Kessler TM, 2005, UROL CLIN N AM, V32, P165, DOI 10.1016/j.ucl.2005.02.005; Khan MS, 2016, EUR UROL, V69, P613, DOI 10.1016/j.eururo.2015.07.038; Kim J, 2015, CLIN CANCER RES, V21, P4514, DOI 10.1158/1078-0432.CCR-14-1215; Krogsboll L T, 2015, COCHRANE DB SYST REV, V1; Kurpad R, 2015, J SURG ONCOL, V112, P728, DOI 10.1002/jso.24009; Lamm D, 2014, J UROLOGY, V191, P20, DOI 10.1016/j.juro.2013.07.102; Lee JY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1571-8; Leissner J, 2000, BJU INT, V85, P817, DOI 10.1046/j.1464-410x.2000.00614.x; Leow JJ, 2014, EUR UROL, V66, P42, DOI 10.1016/j.eururo.2013.08.033; Lerner SP, 2015, BLADDER CANCER, V1, P29, DOI 10.3233/BLC-159002; Li W, 2014, AM J CLIN PATHOL, V142, P864, DOI 10.1309/AJCP1J0JPJBPSUXF; Liang Y, 2014, HUM PATHOL, V45, P1466, DOI 10.1016/j.humpath.2014.02.023; Linder BJ, 2013, J UROLOGY, V189, P1670, DOI 10.1016/j.juro.2012.11.006; Linder BJ, 2013, EUR UROL, V63, P839, DOI 10.1016/j.eururo.2013.01.004; Beltran AL, 2014, VIRCHOWS ARCH, V465, P199, DOI 10.1007/s00428-014-1601-y; Lopez-Beltran A, 2006, HUM PATHOL, V37, P1371, DOI 10.1016/j.humpath.2006.05.009; Lopez-Beltran ASG, 2004, WHO CLASSIFICATION T, P89; LOPEZBELTRAN A, 1988, HISTOL HISTOPATHOL, V3, P63; Lotan TL, 2009, AM J SURG PATHOL, V33, P1037, DOI 10.1097/PAS.0b013e3181962dcd; Lotan Y, 2003, UROLOGY, V61, P109, DOI 10.1016/S0090-4295(02)02136-2; Lynch SP, 2013, EUR UROL, V64, P307, DOI 10.1016/j.eururo.2012.04.020; MacLennan GT, 2007, EUR UROL, V51, P889, DOI 10.1016/j.eururo.2006.10.037; Mak KS, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.7_suppl.319; Mak RH, 2014, J CLIN ONCOL, V32, P3801, DOI 10.1200/JCO.2014.57.5548; Malmstrom PU, 2009, EUR UROL, V56, P247, DOI 10.1016/j.eururo.2009.04.038; MANSSON A, 1993, SCAND J UROL NEPHROL, V27, P363, DOI 10.3109/00365599309180448; MARTIN JE, 1989, J CLIN PATHOL, V42, P250, DOI 10.1136/jcp.42.3.250; Martin-Doyle W, 2015, J CLIN ONCOL, V33, P643, DOI 10.1200/JCO.2014.57.6967; McConkey DJ, 2016, EUR UROL, V69, P855, DOI 10.1016/j.eururo.2015.08.034; McConkey DJ, 2015, HEMATOL ONCOL CLIN N, V29, P377, DOI 10.1016/j.hoc.2014.11.003; McConkey DJ, 2014, EUR UROL, V66, P609, DOI 10.1016/j.eururo.2014.05.006; Mitin T, 2013, LANCET ONCOL, V14, P863, DOI 10.1016/S1470-2045(13)70255-9; Miyamoto H, 2010, AM J SURG PATHOL, V34, P418, DOI 10.1097/PAS.0b013e3181ce5066; Moch H., 2016, WHO CLASSIFICATION T, P77; Morgan TM, 2013, UROL ONCOL-SEMIN ORI, V31, P871, DOI 10.1016/j.urolonc.2011.07.012; Mostofi FK, 1973, HISTOLOGICAL TYPING; Mostofi FK, 1999, WHO INT HISTOLOGICAL, P1; Murphy WM, 2002, J UROLOGY, V168, P968, DOI 10.1016/S0022-5347(05)64553-3; National Comprehensive Cancer Network, 2016, NAT COMPR CANC NETW; Paner GP, 2014, HUM PATHOL, V45, P1473, DOI 10.1016/j.humpath.2014.02.024; Paner GP, 2010, AM J SURG PATHOL, V34, P792, DOI 10.1097/PAS.0b013e3181da7650; Pesch B, 2011, BJU INT, V108, P546, DOI 10.1111/j.1464-410X.2010.09971.x; Pettus JA, 2008, EUR UROL, V53, P370, DOI 10.1016/j.eururo.2007.07.031; Plimack ER, 2015, EUR UROL, V68, P959, DOI 10.1016/j.eururo.2015.07.009; Plimack ER, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.4502; Plimack ER, 2014, J CLIN ONCOL, V32, P1895, DOI 10.1200/JCO.2013.53.2465; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; QUILTY PM, 1986, BRIT J UROL, V58, P147, DOI 10.1111/j.1464-410X.1986.tb09015.x; Rebouissou S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008970; Reuter VE, 2006, UROLOGY, V67, P11, DOI 10.1016/j.urology.2006.01.037; Ricardo-Gonzalez RR, 2012, J UROLOGY, V187, P852, DOI 10.1016/j.juro.2011.10.145; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Roth B, 2010, EUR UROL, V57, P205, DOI 10.1016/j.eururo.2009.10.026; Samaratunga H, 2002, UROLOGY, V60, P315, DOI 10.1016/S0090-4295(02)01705-3; Sanchez A, 2015, J UROLOGY, V193, pE298, DOI 10.1016/j.juro.2015.02.1134; Satkunasivam R, 2016, BJU INT, V117, P463, DOI 10.1111/bju.13081; Schlomer BJ, 2010, J UROLOGY, V183, P62, DOI 10.1016/j.juro.2009.08.157; Schmitz-Drager BJ, 2015, UROL INT, V94, P1, DOI 10.1159/000369357; Segal R, 2012, BJU INT, V109, P1026, DOI 10.1111/j.1464-410X.2011.10462.x; Sfakianos JP, 2014, J UROLOGY, V191, P341, DOI 10.1016/j.juro.2013.08.022; Shah RB, 2013, UROL ONCOL-SEMIN ORI, V31, P1650, DOI 10.1016/j.urolonc.2012.04.009; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shen SS, 2006, HUM PATHOL, V37, P726, DOI 10.1016/j.humpath.2006.01.027; Shin K, 2014, NAT CELL BIOL, V16, P469, DOI 10.1038/ncb2956; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Smith ND, 2015, BJU INT, V115, P198, DOI 10.1111/bju.12699; Solomon DA, 2013, NAT GENET, V45, P1428, DOI 10.1038/ng.2800; Steiner H, 2008, BJU INT, V102, P291, DOI 10.1111/j.1464-410X.2008.07596.x; Sternberg CN, 2001, J CLIN ONCOL, V19, P2638, DOI 10.1200/JCO.2001.19.10.2638; Sternberg CN, 2015, LANCET ONCOL, V16, P76, DOI 10.1016/S1470-2045(14)71160-X; Sylvester RJ, 2016, EUR UROL, V69, P231, DOI 10.1016/j.eururo.2015.05.050; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Sylvester RJ, 2005, J UROLOGY, V174, P86, DOI 10.1097/01.ju.0000162059.64886.1c; Theodorescu D, 2014, EUR UROL, V65, P370, DOI 10.1016/j.eururo.2013.10.019; Tuna B, 2011, VIRCHOWS ARCH, V458, P659, DOI 10.1007/s00428-011-1072-3; Van Allen EM, 2014, CANCER DISCOV, V4, P1140, DOI 10.1158/2159-8290.CD-14-0623; Van Batavia J, 2014, NAT CELL BIOL, V16, P982, DOI 10.1038/ncb3038; van Kessel KEM, 2015, NAT REV UROL, V12, P681, DOI 10.1038/nrurol.2015.231; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; von Rundstedt FC, 2015, J UROLOGY, V193, P58, DOI 10.1016/j.juro.2014.07.114; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Weiss C, 2006, J CLIN ONCOL, V24, P2318, DOI 10.1200/JCO.2006.05.8149; Willis D, 2015, HEMATOL ONCOL CLIN N, V29, P237, DOI 10.1016/j.hoc.2014.10.011; Willis DL, 2015, J UROLOGY, V193, P1129, DOI 10.1016/j.juro.2014.09.092; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Xylinas E, 2014, UROL ONCOL-SEMIN ORI, V32, P222, DOI 10.1016/j.urolonc.2013.06.001; Zheng CJ, 2012, BJU INT, V110, pE680, DOI 10.1111/j.1464-410X.2012.11500.x; Zietman AL, 2003, J UROLOGY, V170, P1772, DOI 10.1097/01.ju.0000093721.23249.c3	179	703	720	16	195	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2796	2810		10.1016/S0140-6736(16)30512-8	http://dx.doi.org/10.1016/S0140-6736(16)30512-8			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE5FB	27345655				2022-12-28	WOS:000389629800031
J	Vilar-Gomez, E; Adams, LA				Vilar-Gomez, Eduardo; Adams, Leon A.			Pioglitazone: An Addition to Our Toolbox for Patients With Diabetes and Nonalcoholic Steatohepatitis?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FATTY LIVER-DISEASE; LONG; FEATURES; PLACEBO; COHORT; TRIAL		[Vilar-Gomez, Eduardo] Univ Seville, Seville, Spain; [Adams, Leon A.] Univ Western Australia, Nedlands, WA, Australia; [Vilar-Gomez, Eduardo] Univ Seville, Inst Biomed, Virgen Macarena Virgen Rocio Univ Hosp, Unit Clin Management Digest Dis,Ciberehd, Manuel Siurot Ave,S-N, Seville, Spain; [Adams, Leon A.] Univ Western Australia, Sch Med & Pharmacol, M50, Nedlands, WA 6009, Australia	University of Sevilla; University of Western Australia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Western Australia	Vilar-Gomez, E (corresponding author), Univ Seville, Inst Biomed, Virgen Macarena Virgen Rocio Univ Hosp, Unit Clin Management Digest Dis,Ciberehd, Manuel Siurot Ave,S-N, Seville, Spain.	eduardovilar2000@yahoo.com	Vilar, Eduardo/H-8556-2019; IBIS, DIGESTIVAS/O-1913-2015	Vilar, Eduardo/0000-0003-1435-4013; 				Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Adams LA, 2010, AM J GASTROENTEROL, V105, P1567, DOI 10.1038/ajg.2010.18; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Cusi K, 2016, ANN INTERN MED, V165, P305, DOI 10.7326/M15-1774; Ratziu V, 2010, HEPATOLOGY, V51, P445, DOI 10.1002/hep.23270; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Semenkovich CF, 2016, NEW ENGL J MED, V374, P1378, DOI 10.1056/NEJMe1600962; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005	10	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					373	+		10.7326/M16-1303	http://dx.doi.org/10.7326/M16-1303			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27322890				2022-12-28	WOS:000382795000007
J	Tsai, HH; Nie, WY; Blancon, JC; Toumpos, CCS; Asadpour, R; Harutyunyan, B; Neukirch, AJ; Verduzco, R; Crochet, JJ; Tretiak, S; Pedesseau, L; Even, J; Alam, MA; Gupta, G; Lou, J; Ajayan, PM; Bedzyk, MJ; Kanatzidis, MG; Mohite, AD				Tsai, Hsinhan; Nie, Wanyi; Blancon, Jean-Christophe; Toumpos, Constantinos C. S.; Asadpour, Reza; Harutyunyan, Boris; Neukirch, Amanda J.; Verduzco, Rafael; Crochet, Jared J.; Tretiak, Sergei; Pedesseau, Laurent; Even, Jacky; Alam, Muhammad A.; Gupta, Gautam; Lou, Jun; Ajayan, Pulickel M.; Bedzyk, Michael J.; Kanatzidis, Mercouri G.; Mohite, Aditya D.			High-efficiency two-dimensional Ruddlesden-Popper perovskite solar cells	NATURE			English	Article							STABILITY; PERFORMANCE; HYSTERESIS; ABSORBER	Three-dimensional organic-inorganic perovskites have emerged as one of the most promising thin-film solar cell materials owing to their remarkable photophysical properties(1-5), which have led to power conversion efficiencies exceeding 20 per cent(6,7), with the prospect of further improvements towards the Shockley-Queisser limit for a single-junction solar cell (33.5 per cent) (8). Besides efficiency, another critical factor for photovoltaics and other optoelectronic applications is environmental stability and photostability under operating conditions(9-15). In contrast to their three-dimensional counterparts, Ruddlesden-Popper phases-layered two-dimensional perovskite films-have shown promising stability, but poor efficiency at only 4.73 per cent(13,16,17). This relatively poor efficiency is attributed to the inhibition of out-of-plane charge transport by the organic cations, which act like insulating spacing layers between the conducting inorganic slabs. Here we overcome this issue in layered perovskites by producing thin films of near-single-crystalline quality, in which the crystallographic planes of the inorganic perovskite component have a strongly preferential out-of-plane alignment with respect to the contacts in planar solar cells to facilitate efficient charge transport. We report a photovoltaic efficiency of 12.52 per cent with no hysteresis, and the devices exhibit greatly improved stability in comparison to their three-dimensional counterparts when subjected to light, humidity and heat stress tests. Unencapsulated two-dimensional perovskite devices retain over 60 per cent of their efficiency for over 2,250 hours under constant, standard (AM1.5G) illumination, and exhibit greater tolerance to 65 per cent relative humidity than do three-dimensional equivalents. When the devices are encapsulated, the layered devices do not show any degradation under constant AM1.5G illumination or humidity. We anticipate that these results will lead to the growth of single-crystalline, solution-processed, layered, hybrid, perovskite thin films, which are essential for high-performance opto-electronic devices with technologically relevant long-term stability.	[Tsai, Hsinhan; Nie, Wanyi; Blancon, Jean-Christophe; Neukirch, Amanda J.; Crochet, Jared J.; Tretiak, Sergei; Gupta, Gautam; Mohite, Aditya D.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Tsai, Hsinhan; Verduzco, Rafael; Lou, Jun; Ajayan, Pulickel M.] Rice Univ, Dept Mat Sci & Nanoengn, Houston, TX 77005 USA; [Toumpos, Constantinos C. S.; Kanatzidis, Mercouri G.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Toumpos, Constantinos C. S.; Harutyunyan, Boris; Bedzyk, Michael J.; Kanatzidis, Mercouri G.] Northwestern Univ, Dept Mat Sci, Evanston, IL 60208 USA; [Toumpos, Constantinos C. S.; Harutyunyan, Boris; Bedzyk, Michael J.; Kanatzidis, Mercouri G.] Northwestern Univ, Engn & Argonne Northwestern Solar Energy Res ANSE, Evanston, IL 60208 USA; [Asadpour, Reza; Alam, Muhammad A.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Verduzco, Rafael] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [Pedesseau, Laurent; Even, Jacky] INSA Rennes, CNRS, UMR 6082, Fonct Opt Technol Informat,FOTON, F-35708 Rennes, France	United States Department of Energy (DOE); Los Alamos National Laboratory; Rice University; Northwestern University; Northwestern University; Northwestern University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Rice University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National des Sciences Appliquees de Rennes	Mohite, AD (corresponding author), Los Alamos Natl Lab, Los Alamos, NM 87545 USA.	amohite@lanl.gov	Bedzyk, Michael J/B-7503-2009; Blancon, Jean-Christophe/Q-7950-2017; Jacky, EVEN/C-6212-2008; Nie, Wanyi/AAC-5354-2019; Tsai, Hsinhan/AAN-7850-2020; Stoumpos, Constantinos C./P-6677-2016; Pedesseau, Laurent/G-5198-2014; Mohite, Aditya D./AAF-2908-2019; Tretiak, Sergei/B-5556-2009; 添, 王/ABI-8105-2020	Blancon, Jean-Christophe/0000-0002-3833-5792; Jacky, EVEN/0000-0002-4607-3390; Stoumpos, Constantinos C./0000-0001-8396-9578; Pedesseau, Laurent/0000-0001-9414-8644; Tretiak, Sergei/0000-0001-5547-3647; MOHITE, ADITYA/0000-0001-8865-409X; Crochet, Jared/0000-0002-9570-2173; Lou, Jun/0000-0002-4351-9561	ANSER Center, an Energy Frontier Research Center - US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001059]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; French national centres (GENCI/CINES/IDRIS grant) [2015-c2012096724]; Cellule Energie du CNRS (SOLHYBTRANS Project); University of Rennes 1 (Action Incitative, Defis Scientifique Emergents); Fondation d'entreprises banque Populaire de l'Ouest; Bay Area PV Consortium (a Department of Energy project with Prime Award) [DE-EE0004946]; NSF [DMR-1352099]; Division Of Materials Research [1352099] Funding Source: National Science Foundation	ANSER Center, an Energy Frontier Research Center - US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); French national centres (GENCI/CINES/IDRIS grant); Cellule Energie du CNRS (SOLHYBTRANS Project); University of Rennes 1 (Action Incitative, Defis Scientifique Emergents); Fondation d'entreprises banque Populaire de l'Ouest; Bay Area PV Consortium (a Department of Energy project with Prime Award)(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work at LANL was LANL LDRD programme (A.D.M., G.G., J.-C.B. and S.T.). Work at Northwestern University was supported as part of the ANSER Center, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Award No. DE-SC0001059. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Work at INSA de Rennes was performed using high-performance computational resources from the French national centres (GENCI/CINES/IDRIS grant 2015-c2012096724), Cellule Energie du CNRS (SOLHYBTRANS Project) and the University of Rennes 1 (Action Incitative,Defis Scientifique Emergents 2015). J.E.'s work is also supported by the Fondation d'entreprises banque Populaire de l'Ouest (Grant PEROPHOT 2015). The work at Purdue University was supported by the Bay Area PV Consortium (a Department of Energy project with Prime Award number DE-EE0004946). This work at LANL was done in part at the Center for Nonlinear Studies (CNLS) and the Center for Integrated Nanotechnologies (CINT). R.V. acknowledges the support of the NSF DMR-1352099.	Brivio F, 2013, APL MATER, V1, DOI 10.1063/1.4824147; Cao DH, 2015, J AM CHEM SOC, V137, P7843, DOI 10.1021/jacs.5b03796; Chen W, 2015, SCIENCE, V350, P944, DOI 10.1126/science.aad1015; Decock K, 2011, J APPL PHYS, V110, DOI 10.1063/1.3641987; deQuilettes DW, 2015, SCIENCE, V348, P683, DOI 10.1126/science.aaa5333; Eisenbarth T, 2010, J APPL PHYS, V107, DOI 10.1063/1.3277043; Gelderman K, 2007, J CHEM EDUC, V84, P685, DOI 10.1021/ed084p685; Han Y, 2015, J MATER CHEM A, V3, P8139, DOI 10.1039/c5ta00358j; Hegedus SS, 2004, PROG PHOTOVOLTAICS, V12, P155, DOI 10.1002/pip.518; Jeon YJ, 2014, SCI REP-UK, V4, DOI [10.1038/srep06953, 10.1038/srep06668]; Kagan CR, 1999, SCIENCE, V286, P945, DOI 10.1126/science.286.5441.945; Kaltenbrunner M, 2015, NAT MATER, V14, P1032, DOI [10.1038/NMAT4388, 10.1038/nmat4388]; Leijtens T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3885; Li X, 2015, NAT CHEM, V7, P703, DOI [10.1038/nchem.2324, 10.1038/NCHEM.2324]; Liang PW, 2014, ADV MATER, V26, P3748, DOI 10.1002/adma.201400231; Mei AY, 2014, SCIENCE, V345, P295, DOI 10.1126/science.1254763; Nie WY, 2015, SCIENCE, V347, P522, DOI 10.1126/science.aaa0472; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Sadhanala A, 2014, J PHYS CHEM LETT, V5, P2501, DOI 10.1021/jz501332v; Saliba M, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.17; Schulz P, 2014, ENERG ENVIRON SCI, V7, P1377, DOI 10.1039/c4ee00168k; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Smith IC, 2014, ANGEW CHEM INT EDIT, V53, P11232, DOI 10.1002/anie.201406466; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Stoumpos CC, 2016, CHEM MATER, V28, P2852, DOI 10.1021/acs.chemmater.6b00847; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Tress W, 2015, ENERG ENVIRON SCI, V8, P995, DOI 10.1039/c4ee03664f; Trukhanov VA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.205318; Tsai HH, 2015, CHEM MATER, V27, P5570, DOI 10.1021/acs.chemmater.5b02378; Unger EL, 2014, ENERG ENVIRON SCI, V7, P3690, DOI 10.1039/c4ee02465f; Wang GM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500613; Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Yaffe O, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.045414; Yang WS, 2015, SCIENCE, V348, P1234, DOI 10.1126/science.aaa9272; Yin WJ, 2014, ADV MATER, V26, P4653, DOI 10.1002/adma.201306281; You JB, 2016, NAT NANOTECHNOL, V11, P75, DOI [10.1038/nnano.2015.230, 10.1038/NNANO.2015.230]	36	2219	2259	125	2514	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					312	+		10.1038/nature18306	http://dx.doi.org/10.1038/nature18306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27383783	Green Submitted			2022-12-28	WOS:000381804900031
J	Koller, CF				Koller, Christopher F.			United's Withdrawal from Exchanges - Much Ado about the Wrong Things?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Koller, Christopher F.] Milbank Mem Fund, New York, NY 10022 USA		Koller, CF (corresponding author), Milbank Mem Fund, New York, NY 10022 USA.							Association for Community Affiliated Plans, 2016, OV MED HLTH PLANS QH; Centers for Medicare and Medicaid Services Center for Consumer Information and Insurance Oversight, 2016, HHS OP RISK ADJ METH; Cox C, 2016, ANAL UNITED HLTH GRO; Levitt L., 2016, JAMA FORUM REPORTS O	4	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2016	375	4					303	305		10.1056/NEJMp1605841	http://dx.doi.org/10.1056/NEJMp1605841			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS0UV	27331933				2022-12-28	WOS:000380313200003
J	Reisner, SL; Poteat, T; Keatley, J; Cabral, M; Mothopeng, T; Dunham, E; Holland, CE; Max, R; Baral, SD				Reisner, Sari L.; Poteat, Tonia; Keatley, JoAnne; Cabral, Mauro; Mothopeng, Tampose; Dunham, Emilia; Holland, Claire E.; Max, Ryan; Baral, Stefan D.			Global health burden and needs of transgender populations: a review	LANCET			English	Review							SEXUAL RISK BEHAVIORS; AUTISM SPECTRUM DISORDERS; GENDER IDENTITY DISORDER; HIV-RELATED RISK; SUBSTANCE USE; MENTAL-HEALTH; TRANSMITTED INFECTIONS; SOCIAL SUPPORT; SAN-FRANCISCO; PUBLIC-HEALTH	Transgender people are a diverse population affected by a range of negative health indicators across high-income, middle-income, and low-income settings. Studies consistently document a high prevalence of adverse health outcomes in this population, including HIV and other sexually transmitted infections, mental health distress, and substance use and abuse. However, many other health areas remain understudied, population-based representative samples and longitudinal studies are few, and routine surveillance efforts for transgender population health are scarce. The absence of survey items with which to identify transgender respondents in general surveys often restricts the availability of data with which to estimate the magnitude of health inequities and characterise the population-level health of transgender people globally. Despite the limitations, there are sufficient data highlighting the unique biological, behavioural, social, and structural contextual factors surrounding health risks and resiliencies for transgender people. To mitigate these risks and foster resilience, a comprehensive approach is needed that includes gender affirmation as a public health framework, improved health systems and access to health care informed by high quality data, and effective partnerships with local transgender communities to ensure responsiveness of and cultural specificity in programming. Consideration of transgender health underscores the need to explicitly consider sex and gender pathways in epidemiological research and public health surveillance more broadly.	[Reisner, Sari L.] Harvard Med Sch, Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA; [Reisner, Sari L.] Harvard TH Chan Sch Publ, Dept Epidemiol, Boston, MA USA; [Reisner, Sari L.; Dunham, Emilia] Fenway Inst, Fenway Hlth, Boston, MA USA; [Poteat, Tonia; Holland, Claire E.; Max, Ryan; Baral, Stefan D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Poteat, Tonia] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Keatley, JoAnne] Univ Calif San Francisco, Ctr Excellence Transgender Hlth, San Francisco, CA 94143 USA; [Cabral, Mauro] Global Act Trans Equal, Buenos Aires, DF, Argentina; [Cabral, Mauro] Global Act Trans Equal, New York, NY USA; [Mothopeng, Tampose] MATRIX, Maseru, Lesotho; [Dunham, Emilia] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Fenway Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco; Brandeis University	Reisner, SL (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA.	sari.reisner@childrens.harvard.edu	Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419; Poteat, Tonia/0000-0001-6541-3787	NIH [P30AI094189]; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; NIGMS; NIDDK; OAR; United Nations Development Programme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OAR; United Nations Development Programme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the transgender community members worldwide who participate in these studies given substantial risks and limited personal benefits, and the community groups that make great personal and professional sacrifices to serve the unmet health and advocacy needs of those most marginalised in the HIV response. The research by SDB and TP was facilitated by the infrastructure and resources provided by the Johns Hopkins University Center for AIDS Research, an NIH funded programme (P30AI094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The United Nations Development Programme funded a developmental review meeting for this Series.	Aghabikloo A, 2012, INT J MED TOX FORENS, V2, P128, DOI [10.22037/ijmtfm.v2i4, DOI 10.22037/IJMTFM.V2I4]; Aguayo N, 2013, SEX TRANSM INFECT, V89, pA254, DOI 10.1136/sextrans-2013-051184.0788; Ahmadzad-Asl M., 2013, EUR PSYCHIAT, V28, P1, DOI [10.1016/S0924-9338(13)75780-8, DOI 10.1016/S0924-9338(13)75780-8]; Almeida A, 2014, SEX TRANSM INFECT, V90, P497, DOI 10.1136/sextrans-2014-051523; Alvarez-Wyssmann V, 2013, J INT AIDS SOC, V16, P14; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; Arora R, 2013, SEX TRANSM INFECT, V89, pA193, DOI 10.1136/sextrans-2013-051184.0604; Asscheman H, 2011, EUR J ENDOCRINOL, V164, P635, DOI 10.1530/EJE-10-1038; Auer MK, 2013, FERTIL STERIL, V100, P1103, DOI 10.1016/j.fertnstert.2013.05.047; Baral SD, 2011, HUMAN RIGHTS LAW HIV; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Delgado JB, 2014, SEX RES SOC POLICY, V11, P187, DOI 10.1007/s13178-014-0150-0; Bauer GR, 2013, INT J TRANSGENDERISM, V14, P66, DOI 10.1080/15532739.2013.791650; Bauer GR, 2014, ANN EMERG MED, V63, P713, DOI 10.1016/j.annemergmed.2013.09.027; Becerra-Fernandez A, 2014, ENDOCRINOL NUTR, V61, P351, DOI 10.1016/j.endonu.2014.01.010; Benotsch EG, 2013, DRUG ALCOHOL DEPEN, V132, P391, DOI 10.1016/j.drugalcdep.2013.02.027; Bhatta DN, 2014, INT J INFECT DIS, V22, P11, DOI 10.1016/j.ijid.2014.01.002; Blosnich JR, 2013, AM J PUBLIC HEALTH, V103, pE27, DOI 10.2105/AJPH.2013.301507; Bockting WO, 2008, SEXOLOGIES, V17, P211, DOI 10.1016/j.sexol.2008.08.001; Bockting WO, 2013, AM J PUBLIC HEALTH, V103, P943, DOI 10.2105/AJPH.2013.301241; Bockting WO, 2009, SEX RELATSH THER, V24, P103, DOI 10.1080/14681990903037660; Bowers JR, 2011, CULT HEALTH SEX, V13, P629, DOI 10.1080/13691058.2011.564301; Boza C, 2014, INT J TRANSGENDERISM, V15, P35, DOI 10.1080/15532739.2014.890558; Bradford J, 2013, AM J PUBLIC HEALTH, V103, P1820, DOI 10.2105/AJPH.2012.300796; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Braveman P, 2006, ANNU REV PUBL HEALTH, V27, P167, DOI 10.1146/annurev.publhealth.27.021405.102103; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; Brennan J, 2012, AM J PUBLIC HEALTH, V102, P1751, DOI 10.2105/AJPH.2011.300433; Buchbinder SP, 2014, LANCET INFECT DIS, V14, P468, DOI 10.1016/S1473-3099(14)70025-8; Budge SL, 2013, J CONSULT CLIN PSYCH, V81, P545, DOI 10.1037/a0031774; Burt R.S., 2005, BROKERAGE CLOSURE IN; Cahill S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107104; Callens N, 2013, J SEX MED, V10, P2890, DOI 10.1111/jsm.12298; Carobene M, 2014, J MED VIROL, V86, P64, DOI 10.1002/jmv.23805; Chemnasiri T, 2010, AIDS EDUC PREV, V22, P100, DOI 10.1521/aeap.2010.22.2.100; Claes L, 2015, J SEX MED, V12, P168, DOI 10.1111/jsm.12711; Clark TC, 2014, J ADOLESCENT HEALTH, V55, P93, DOI 10.1016/j.jadohealth.2013.11.008; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; Connell R., 2021, GENDER WORLD PERSPEC, V4; Connell R., 2013, GENDER POWER SOC PER; Council of Europe Commissioner for Human Rights, 2015, HUM RIGHTS INT PEOPL; Cruz TM, 2014, SOC SCI MED, V110, P65, DOI 10.1016/j.socscimed.2014.03.032; Daly J, 2007, J CLIN EPIDEMIOL, V60, P43, DOI 10.1016/j.jclinepi.2006.03.014; Dank M, 2014, J YOUTH ADOLESCENCE, V43, P846, DOI 10.1007/s10964-013-9975-8; Davey A, 2014, J SEX MED, V11, P2976, DOI 10.1111/jsm.12681; de Vries ALC, 2011, J CHILD PSYCHOL PSYC, V52, P1195, DOI 10.1111/j.1469-7610.2011.02426.x; de Vries ALC, 2010, J AUTISM DEV DISORD, V40, P930, DOI 10.1007/s10803-010-0935-9; Deutsch MB, 2013, J AM MED INFORM ASSN, V20, P700, DOI 10.1136/amiajnl-2012-001472; Dowshen N, 2011, J ADOLESCENT HEALTH, V48, P410, DOI 10.1016/j.jadohealth.2010.07.021; Doyal L, 2003, INT J HEALTH SERV, V33, P569, DOI 10.2190/CWK2-U7R6-VCE0-E47P; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; Effrig JC, 2011, J COLL COUNS, V14, P143, DOI 10.1002/j.2161-1882.2011.tb00269.x; Emmanuel F, 2013, SEX TRANSM INFECT S3, V89, piii28; Socias ME, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0081-7; Feldman J, 2014, J HOMOSEXUAL, V61, P1558, DOI 10.1080/00918369.2014.944048; Flentje A, 2014, ADDICT BEHAV, V39, P969, DOI 10.1016/j.addbeh.2014.01.011; Fletcher JB, 2014, ARCH SEX BEHAV, V43, P1651, DOI 10.1007/s10508-014-0368-1; FRA (European Union Agency for Fundamental Rights), 2015, FUND RIGHTS SIT INT; Fredriksen-Goldsen KI, 2014, GERONTOLOGIST, V54, P488, DOI 10.1093/geront/gnt021; Gamarel KE, 2014, J FAM PSYCHOL, V28, P437, DOI 10.1037/a0037171; Garofalo R, 2012, J URBAN HEALTH, V89, P419, DOI 10.1007/s11524-011-9638-6; Gates G, 2011, MANY PEOPLE ARE LESB; Global Action for Trans Equality, 2012, ENGL TRANSL ARG GEND; Rocha RMG, 2013, SAUDE SOC-SAO PAULO, V22, P554, DOI 10.1590/S0104-12902013000200024; Gooren LJ, 2015, CULT HEALTH SEX, V17, P92, DOI 10.1080/13691058.2014.950982; Gruskin S, 2010, J PUBLIC HEALTH POL, V31, P129, DOI 10.1057/jphp.2010.7; Guzman-Parra J, 2014, J DUAL DIAGN, V10, P162, DOI 10.1080/15504263.2014.930658; Harawa NT, 2010, J HEALTH CARE POOR U, V21, P1071, DOI 10.1353/hpu.0.0349; Hendricks ML, 2012, PROF PSYCHOL-RES PR, V43, P460, DOI 10.1037/a0029597; Heylens G, 2014, BRIT J PSYCHIAT, V204, P151, DOI 10.1192/bjp.bp.112.121954; Hill SC, 2011, INT J STD AIDS, V22, P686, DOI 10.1258/ijsa.2009.009491; Horbach SER, 2015, J SEX MED, V12, P1499, DOI 10.1111/jsm.12868; Horvath KJ, 2014, J HOMOSEXUAL, V61, P1117, DOI 10.1080/00918369.2014.872502; Hotton AL, 2013, AIDS EDUC PREV, V25, P62, DOI 10.1521/aeap.2013.25.1.62; House A. S., 2011, TRAUMATOLOGY, V17, P75, DOI [DOI 10.1177/1534765610395621, 10.1177/15347656, DOI 10.1177/15347656]; Hwahng SJ, 2014, J HOMOSEXUAL, V61, P691, DOI 10.1080/00918369.2014.870439; Imbimbo C, 2009, J SEX MED, V6, P2736, DOI 10.1111/j.1743-6109.2009.01379.x; Institute of Medicine, 2011, HLTH LESB GAY BISEX; International Commission of Jurists and International Service for Human Rights, 2007, YOG PRINC PRINC APPL; Irwin JA, 2014, J HOMOSEXUAL, V61, P1172, DOI 10.1080/00918369.2014.872521; Javaheri F, 2010, IRAN STUD-UK, V43, P365, DOI 10.1080/00210861003693893; Jefferson Kevin, 2013, Ethn Inequal Health Soc Care, V6, P121; Johnston LG, 2013, INT J STD AIDS, V24, P313, DOI 10.1177/0956462412472460; Judge C, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00087; Kalra G, 2013, INT J TRANSGENDERISM, V14, P171, DOI 10.1080/15532739.2013.876378; Kelly J, 2015, DRUG ALCOHOL REV, V34, P358, DOI 10.1111/dar.12158; Koken JA, 2009, J FAM PSYCHOL, V23, P853, DOI 10.1037/a0017198; Kosciw JG, 2009, J YOUTH ADOLESCENCE, V38, P976, DOI 10.1007/s10964-009-9412-1; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Lai MC, 2010, ARCH SEX BEHAV, V39, P1415, DOI 10.1007/s10508-009-9570-y; Leinung MC, 2013, ENDOCR PRACT, V19, P644, DOI 10.4158/EP12170.OR; Leung MW, 2004, INT J EPIDEMIOL, V33, P499, DOI 10.1093/ije/dyh010; Leys M, 2003, HEALTH POLICY, V65, P217, DOI 10.1016/S0168-8510(02)00209-9; Liao LM, 2014, PSYCHOL SEX, V5, P83, DOI 10.1080/19419899.2013.831217; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Link BG, 1996, AM J PUBLIC HEALTH, V86, P471, DOI 10.2105/AJPH.86.4.471; Lipsitz MC, 2014, INT J STD AIDS, V25, P325, DOI 10.1177/0956462413507443; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; Manieri C, 2014, INT J TRANSGENDERISM, V15, P53, DOI 10.1080/15532739.2014.899174; Marin G, 2015, INT J HEALTH PLAN M, V30, P276, DOI 10.1002/hpm.2234; McElroy J, 2012, EPIDEMIOLOGY, V23, p5S; McGuire JK, 2010, J YOUTH ADOLESCENCE, V39, P1175, DOI 10.1007/s10964-010-9540-7; Meier SC, 2013, ARCH SEX BEHAV, V42, P463, DOI 10.1007/s10508-012-0052-2; Melendez RM, 2007, CULT HEALTH SEX, V9, P233, DOI 10.1080/13691050601065909; Miller W, 2011, SEX TRANSM INFECT, V87, pA132, DOI 10.1136/sextrans-2011-050108.80; Mitchell KJ, 2014, CHILD ABUSE NEGLECT, V38, P280, DOI 10.1016/j.chiabu.2013.09.008; Moody C, 2013, ARCH SEX BEHAV, V42, P739, DOI 10.1007/s10508-013-0099-8; Mustanski B, 2013, ARCH SEX BEHAV, V42, P437, DOI 10.1007/s10508-012-0013-9; Nemoto T, 2014, AIDS CARE, V26, P434, DOI 10.1080/09540121.2013.841832; Nieuwenhoven L, 2010, J WOMENS HEALTH, V19, P313, DOI 10.1089/jwh.2008.1156; Nowatzki N, 2011, HEALTH CARE WOMEN IN, V32, P263, DOI 10.1080/07399332.2010.519838; Nuttbrock L, 2014, AM J PUBLIC HEALTH, V104, P2199, DOI 10.2105/AJPH.2014.302106; Nuttbrock L, 2014, AM J PUBLIC HEALTH, V104, P2191, DOI 10.2105/AJPH.2013.301545; Nuttbrock L, 2013, AM J PUBLIC HEALTH, V103, P300, DOI 10.2105/AJPH.2011.300568; Nuttbrock L, 2010, J SEX RES, V47, P12, DOI 10.1080/00224490903062258; Nuttbrock L, 2009, JAIDS-J ACQ IMM DEF, V52, P417, DOI 10.1097/QAI.0b013e3181ab6ed8; Nuttbrock LA, 2009, SEX RELATSH THER, V24, P108, DOI 10.1080/14681990902926764; O'Flaherty M, 2008, HUM RIGHTS LAW REV, V8, P207, DOI 10.1093/hrlr/ngn009; Open Society Foundations, 2013, TRANSF HLTH INT RIGH; Operario D, 2014, J COMMUNITY PSYCHOL, V42, P544, DOI 10.1002/jcop.21636; Operario D, 2011, AIDS BEHAV, V15, P674, DOI 10.1007/s10461-010-9795-8; Operario D, 2010, JAIDS-J ACQ IMM DEF, V55, pS91, DOI 10.1097/QAI.0b013e3181fbc9ec; Pan American Health Organization, 2008, GUID GEND BAS AN HLT; Pasterski V, 2014, ARCH SEX BEHAV, V43, P387, DOI 10.1007/s10508-013-0154-5; Pathela P, 2014, SEX TRANSM DIS, V41, pS118; Peitzmeier SM, 2014, J GEN INTERN MED, V29, P778, DOI 10.1007/s11606-013-2753-1; PELL C, 2011, J SEX MED, V8, P179; Pfeffer CA, 2008, J LESBIAN STUD, V12, P325, DOI 10.1080/10894160802278184; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; Pitts MK, 2009, FEM PSYCHOL, V19, P475, DOI 10.1177/0959353509342771; Prunas A, 2015, J INTERPERS VIOLENCE, V30, P2872, DOI 10.1177/0886260514554293; Ramakrishnan L, 2012, J INT AIDS SOC, V15, P154; Rapues J, 2013, AM J PUBLIC HEALTH, V103, P1485, DOI 10.2105/AJPH.2012.301109; Rath JM, 2013, NICOTINE TOB RES, V15, P1822, DOI 10.1093/ntr/ntt062; Reback CJ, 2014, AIDS BEHAV, V18, P1359, DOI 10.1007/s10461-013-0657-z; Rehan N, 2011, J PAK MED ASSOC, V61, P695; Reisner Sari L, 2014, Psychol Sex Orientat Gend Divers, V1, P63; Reisner SL, 2014, LGBT HEALTH, V1, P177, DOI 10.1089/lgbt.2014.0009; Reisner SL, 2015, J SEX RES, V52, P243, DOI 10.1080/00224499.2014.886321; Reisner SL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1224; Reisner SL, 2014, LGBT HEALTH, V1, P98, DOI 10.1089/lgbt.2013.0018; Reisner SL, 2014, WOMEN HEALTH, V54, P750, DOI 10.1080/03630242.2014.932891; Reisner SL, 2014, ARCH SEX BEHAV, V43, P1503, DOI 10.1007/s10508-014-0314-2; Reisner SL, 2014, AIDS CARE, V26, P857, DOI 10.1080/09540121.2013.855701; Reisner SL, 2013, J AM PSYCHIAT NURSES, V19, P293, DOI 10.1177/1078390313500693; Reisner SL, 2010, AIDS PATIENT CARE ST, V24, P501, DOI 10.1089/apc.2010.0059; Robinson BE, 2002, HEALTH EDUC RES, V17, P43, DOI 10.1093/her/17.1.43; Sanchez FJ, 2009, J COUNS PSYCHOL, V56, P202, DOI 10.1037/a0014573; Santos GM, 2014, DRUG ALCOHOL REV, V33, P287, DOI 10.1111/dar.12116; Sausa  L. A, 2009, POLICY RECOMMENDATIO; Sevelius J, 2009, J ASSOC NURSE AIDS C, V20, P398, DOI 10.1016/j.jana.2009.06.001; Sevelius JM, 2013, SEX ROLES, V68, P675, DOI 10.1007/s11199-012-0216-5; Sevelius JM, 2009, AIDS EDUC PREV, V21, P113, DOI 10.1521/aeap.2009.21.2.113; Shipherd JC, 2012, INT J SEX HEALTH, V24, P78, DOI 10.1080/19317611.2011.639440; Simons L, 2013, J ADOLESCENT HEALTH, V53, P791, DOI 10.1016/j.jadohealth.2013.07.019; Simons L, 2012, J ADOLESCENT HEALTH, V50, pS29, DOI 10.1016/j.jadohealth.2011.10.078; Skidmore W. C., 2011, TRAUMATOLOGY, DOI [10.1177/15347656, DOI 10.1177/1534765610395614, 10.1177/1534765610395614]; Swiss National Advisory Commission on Biomedical Ethics, 2012, MAN DIFF SEC DEV ETH; Tate CC, 2013, J SEX RES, V50, P767, DOI 10.1080/00224499.2012.690110; The GenIUSS Group, 2014, BEST PRACT ASK QUEST; The GenIUSS Group, 2014, BEST PRACTICES ASKIN; Toibaro JJ, 2009, MEDICINA-BUENOS AIRE, V69, P327; Turner R, 2014, HIV MED, V15, P38; United States Census Bureau, 2014, US WORLD POP CLOCK; vanKesteren PJ, 1996, ARCH SEX BEHAV, V25, P589, DOI 10.1007/BF02437841; Verre MC, 2014, AIDS BEHAV, V18, P2030, DOI 10.1007/s10461-014-0787-y; Vlassoff C, 2007, J HEALTH POPUL NUTR, V25, P47; Wallerstein NB, 2011, AM J PUBLIC HEALTH, V101, P822, DOI 10.2105/AJPH.2008.140988; WHO, 2013, HANDBOOK ON HEALTH INEQUALITY MONITORING: WITH A SPECIAL FOCUS ON LOW- AND MIDDLE-INCOME COUNTRIES, P1; WHO, 2014, EL FORC COERC OTH IN; WHO, 2015, TRANSG EOPL HIV POL; Wierckx K, 2013, EUR J ENDOCRINOL, V169, P471, DOI 10.1530/EJE-13-0493; Wilson E, 2014, J SEX MED, V11, P1717, DOI 10.1111/jsm.12558; Wilson EC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-430; Winter S, 2016, LANCET; World Health Organization, 2002, GEND AN HLTH REV SEL; World Health Organization, 2015, OPERATIONAL FRAMEWOR; World Professional Association on Transgender Health, 2012, STAND CAR HLTH TRANS; Yadegarfard M, 2013, CULT HEALTH SEX, V15, P726, DOI 10.1080/13691058.2013.784362; Ybarra ML, 2015, CHILD ABUSE NEGLECT, V39, P123, DOI 10.1016/j.chiabu.2014.08.006	183	560	570	11	134	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					412	436		10.1016/S0140-6736(16)00684-X	http://dx.doi.org/10.1016/S0140-6736(16)00684-X			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR6MV	27323919	Green Accepted			2022-12-28	WOS:000380016900044
J	Visser, ME				Visser, Marcel E.			Interactions of climate change and species	NATURE			English	Editorial Material								At what times of year are phenological events across species sensitive to climatic variables, and how sensitive are they? Answers to these questions emerge from the analysis of a wealth of long-term data sets. SEE ARTICLE P 241	[Visser, Marcel E.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Visser, ME (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	m.visser@nioo.knaw.nl	Visser, Marcel E/A-9151-2009; KNAW, NIOO-KNAW/A-4320-2012	Visser, Marcel E/0000-0002-1456-1939; KNAW, NIOO-KNAW/0000-0002-3835-159X				Gienapp P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1611; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Reed TE, 2013, SCIENCE, V340, P488, DOI 10.1126/science.1232870; Stevenson TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1453; Thackeray SJ, 2016, NATURE, V535, P241, DOI 10.1038/nature18608; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997	7	28	30	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2016	535	7611					236	237		10.1038/nature18905	http://dx.doi.org/10.1038/nature18905			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR4ZN	27362228				2022-12-28	WOS:000379912600044
J	Emanuel, EJ; Onwuteaka-Philipsen, BD; Urwin, JW; Cohen, J				Emanuel, Ezekiel J.; Onwuteaka-Philipsen, Bregje D.; Urwin, John W.; Cohen, Joachim			Attitudes and Practices of Euthanasia and Physician-Assisted Suicide in the United States, Canada, and Europe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE DECISIONS; CARE PROFESSIONALS; MEDICAL DECISIONS; POSTMORTEM SURVEY; CANCER-PATIENTS; OREGON DEATH; END; NETHERLANDS; EXPERIENCES; BELGIUM	IMPORTANCE The increasing legalization of euthanasia and physician-assisted suicide worldwide makes it important to understand related attitudes and practices. OBJECTIVE To review the legal status of euthanasia and physician-assisted suicide and the available data on attitudes and practices. EVIDENCE REVIEW Polling data and published surveys of the public and physicians, official state and country databases, interview studies with physicians, and death certificate studies (the Netherlands and Belgium) were reviewed for the period 1947 to 2016. FINDINGS Currently, euthanasia or physician-assisted suicide can be legally practiced in the Netherlands, Belgium, Luxembourg, Colombia, and Canada (Quebec since 2014, nationally as of June 2016). Physician-assisted suicide, excluding euthanasia, is legal in 5 US states (Oregon, Washington, Montana, Vermont, and California) and Switzerland. Public support for euthanasia and physician-assisted suicide in the United States has plateaued since the 1990s (range, 47%-69%). In Western Europe, an increasing and strong public support for euthanasia and physician-assisted suicide has been reported; in Central and Eastern Europe, support is decreasing. In the United States, less than 20% of physicians report having received requests for euthanasia or physician-assisted suicide, and 5% or less have complied. In Oregon and Washington state, less than 1% of licensed physicians write prescriptions for physician-assisted suicide per year. In the Netherlands and Belgium, about half or more of physicians reported ever having received a request; 60% of Dutch physicians have ever granted such requests. Between 0.3% to 4.6% of all deaths are reported as euthanasia or physician-assisted suicide in jurisdictions where they are legal. The frequency of these deaths increased after legalization. More than 70% of cases involved patients with cancer. Typical patients are older, white, and well-educated. Pain is mostly not reported as the primary motivation. A large portion of patients receiving physician-assisted suicide in Oregon and Washington reported being enrolled in hospice or palliative care, as did patients in Belgium. In no jurisdiction was there evidence that vulnerable patients have been receiving euthanasia or physician-assisted suicide at rates higher than those in the general population. CONCLUSIONS AND RELEVANCE Euthanasia and physician-assisted suicide are increasingly being legalized, remain relatively rare, and primarily involve patients with cancer. Existing data do not indicate widespread abuse of these practices.	[Emanuel, Ezekiel J.; Urwin, John W.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,11th & 14th Floors, Philadelphia, PA 19104 USA; [Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Amsterdam, Netherlands; [Cohen, Joachim] VUB, End Life Care Res Grp, Brussels, Belgium; [Cohen, Joachim] Univ Ghent, Brussels, Belgium	University of Pennsylvania; Pennsylvania Medicine; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Brussel; Ghent University	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,11th & 14th Floors, Philadelphia, PA 19104 USA.	MEHPchair@upenn.edu	Cohen, Joachim/B-6803-2008	Cohen, Joachim/0000-0002-7224-9476; Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248				[Anonymous], 2014, BBC; [Anonymous], 2005, TIJDSCHRIFT NATL RAA, V109, P7; [Anonymous], 2002, ETHICAL PERSPECT, V9, P182, DOI DOI 10.2143/EP.9.2.503856; [Anonymous], 2014, AM END EUTH AND LIF; [Anonymous], 2015, GEN SOC SURV 1972 20; [Anonymous], 2015, SBS; Bachman JG, 1996, NEW ENGL J MED, V334, P303, DOI 10.1056/NEJM199602013340506; Battin MP, 2007, J MED ETHICS, V33, P591, DOI 10.1136/jme.2007.022335; BATTIN MP, 1995, ACAD MED, V70, P583; Board of the Royal Dutch Medical Association, 1984, MED CONTACT, V39, P990; Bolt EE, 2015, J MED ETHICS, V41, P592, DOI 10.1136/medethics-2014-102150; Bosshard G, 2012, Praxis (Bern 1994), V101, P183, DOI 10.1024/1661-8157/a000828; Bosshard G, 2003, SWISS MED WKLY, V133, P310; Bosshard G, 2016, JAMA INTERN MED, V176, P555, DOI 10.1001/jamainternmed.2015.7676; Brauer S, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14142; Brinkman-Stoppelenburg A, 2015, SUPPORT CARE CANCER, V23, P2899, DOI 10.1007/s00520-015-2655-3; Buiting H, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-18; Chambaere K, 2015, NEW ENGL J MED, V372, P1179, DOI 10.1056/NEJMc1414527; Chambaere K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1055; Chambaere K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-299; Cohen J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-307; Cohen J, 2014, INT J PUBLIC HEALTH, V59, P143, DOI 10.1007/s00038-013-0461-6; Cohen J, 2013, EUR J PUBLIC HEALTH, V23, P378, DOI 10.1093/eurpub/cks186; COHEN JS, 1994, NEW ENGL J MED, V331, P89, DOI 10.1056/NEJM199407143310206; Colbert JA, 2013, NEW ENGL J MED, V368, pE12, DOI 10.1056/NEJMclde1301407; Deliens L, 2003, LANCET, V362, P1239, DOI 10.1016/S0140-6736(03)14520-5; Dierickx S, 2015, JAMA INTERN MED, V175, P1703, DOI 10.1001/jamainternmed.2015.3982; Dobscha Steven K, 2004, J Palliat Med, V7, P451, DOI 10.1089/1096621041349374; Drum CE, 2010, DISABIL HEALTH J, V3, P3, DOI 10.1016/j.dhjo.2009.10.001; Dutch Ministry of Security and Justice and the Dutch Ministry of Health Welfare and Sport, 2007, STAATSCOURANT, V51, P8; Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4481; EMANUEL EJ, 1994, ARCH INTERN MED, V154, P1890, DOI 10.1001/archinte.154.17.1890; Emanuel EJ, 2000, ANN INTERN MED, V133, P527, DOI 10.7326/0003-4819-133-7-200010030-00011; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; EMANUEL EJ, 1994, ANN INTERN MED, V121, P793, DOI 10.7326/0003-4819-121-10-199411150-00010; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; Espino DV, 2010, J AM GERIATR SOC, V58, P1370, DOI 10.1111/j.1532-5415.2010.02910.x; Federal Statistical Office, 2012, CAUS DEATH STAT 2009; Fischer S, 2009, SWISS MED WKLY, V139, P333, DOI smw-12614; Ganzini L, 2002, NEW ENGL J MED, V347, P582, DOI 10.1056/NEJMsa020562; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Gielen J, 2008, J PALLIAT CARE, V24, P173, DOI 10.1177/082585970802400307; Groenewoud JH, 2000, NEW ENGL J MED, V342, P551, DOI 10.1056/NEJM200002243420805; Hilden JM, 2001, J CLIN ONCOL, V19, P205, DOI 10.1200/JCO.2001.19.1.205; Hurst SA, 2003, BRIT MED J, V326, P271, DOI 10.1136/bmj.326.7383.271; Kane L., 2014, MEDSCAPE ETHICS RE 1; Kim SYH, 2016, JAMA PSYCHIAT, V73, P362, DOI 10.1001/jamapsychiatry.2015.2887; Kissane DW, 1998, LANCET, V352, P1097, DOI 10.1016/S0140-6736(98)05406-3; Kouwenhoven PSC, 2014, EUR J GEN PRACT, V20, P25, DOI 10.3109/13814788.2013.813014; Kouwenhoven PSC, 2013, PALLIATIVE MED, V27, P273, DOI 10.1177/0269216312448507; Kuhse H, 1997, MED J AUSTRALIA, V166, P191, DOI 10.5694/j.1326-5377.1997.tb140074.x; Lee W, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-2; Legemaate J, 2012, HAGUE ZONMW, V84; Legemaate J, 2013, EUR J HEALTH LAW, V20, P451, DOI 10.1163/15718093-12341298; Lerner BH, 2015, JAMA INTERN MED, V175, P1640, DOI 10.1001/jamainternmed.2015.4086; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; Loefmark R, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-4; Louhiala P, 2006, J MED ETHICS, V32, P627, DOI 10.1136/jme.2006.016246; Mason B., 2015, ALLOW ME DIE; McCarthy J., 2014, 7 10 AM BACK EUTHANA; McCormack R, 2012, PALLIATIVE MED, V26, P23, DOI 10.1177/0269216311397688; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Muller-Busch H C, 2004, Med Health Care Philos, V7, P333; Onwuteaka-Philipsen B, 2012, 2 EVALUATION EUTHANA; Onwuteaka-Philipsen BD, 2012, LANCET, V380, P908, DOI 10.1016/S0140-6736(12)61034-4; Oregon Public Health Division, 2016, OR RES DEATHS AG GRO; Parpa Efi, 2006, Am J Hosp Palliat Care, V23, P297, DOI 10.1177/1049909106290247; Parpa E, 2010, HEALTH POLICY, V97, P160, DOI 10.1016/j.healthpol.2010.04.008; Pennec S, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-25; Peretti-Watel P, 2003, J PALLIATIVE CARE, V19, P271, DOI 10.1177/082585970301900409; Pew Research Center, 2013, VIEWS END OF LIF MED; Pousset G, 2010, ARCH PEDIAT ADOL MED, V164, P547, DOI 10.1001/archpediatrics.2010.59; Regional Euthanasia Control Committees, 2015, ANN REP 2002 2015; Rich BA, 2002, PAIN MED, V3, P353, DOI 10.1046/j.1526-4637.2002.02056.x; Rich P., 2014, PHYS PERSPECTIVE END; Rietjens JAC, 2014, JAMA-J AM MED ASSOC, V312, P1258, DOI 10.1001/jama.2014.9876; Schaus Valerie, 2015, J Pharm Belg, P4; Schmidt TA, 1996, ACAD EMERG MED, V3, P938, DOI 10.1111/j.1553-2712.1996.tb03323.x; Seale C, 2009, PALLIATIVE MED, V23, P198, DOI 10.1177/0269216308102042; Smets T, 2011, J PAIN SYMPTOM MANAG, V41, P580, DOI 10.1016/j.jpainsymman.2010.05.015; Smets T, 2010, MED CARE, V48, P187, DOI 10.1097/MLR.0b013e3181bd4dde; Smith KA, 2015, J PAIN SYMPTOM MANAG, V49, P555, DOI 10.1016/j.jpainsymman.2014.06.010; Statistics Belgium, 2016, NUMB DEATHS BELG 200; Statistics Netherlands, 2016, DEC GEND AG; Steck N, 2014, INT J EPIDEMIOL, V43, P614, DOI 10.1093/ije/dyu010; Steck N, 2013, MED CARE, V51, P938, DOI 10.1097/MLR.0b013e3182a0f427; Suarez-Almazor ME, 2002, J CLIN ONCOL, V20, P2134, DOI 10.1200/JCO.2002.08.025; ten Cate K, 2015, J MED ETHICS, V41, P795, DOI 10.1136/medethics-2014-102562; Tomlinson E, 2015, INT J GERIATR PSYCH, V30, P10, DOI 10.1002/gps.4169; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; van der Lee ML, 2005, J CLIN ONCOL, V23, P6607, DOI 10.1200/JCO.2005.14.308; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; Van Wesemael Y, 2011, J PAIN SYMPTOM MANAG, V42, P721, DOI 10.1016/j.jpainsymman.2011.02.011; Van Wesemael Y, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-220; Van Wesemael Y, 2009, HEALTH SERV RES, V44, P2180, DOI 10.1111/j.1475-6773.2009.01042.x; Verhagen E, 2005, NEW ENGL J MED, V352, P959, DOI 10.1056/NEJMp058026; Vrakking AM, 2005, LANCET, V365, P1329, DOI 10.1016/S0140-6736(05)61030-6; Washington State Department of Health, 2016, VIT STAT DAT DEATH T; Weide MCJV, 2005, ARCH INTERN MED, V165, P1698, DOI 10.1001/archinte.165.15.1698; Willems DL, 2000, ARCH INTERN MED, V160, P63, DOI 10.1001/archinte.160.1.63; Yun YH, 2011, CAN MED ASSOC J, V183, pE673, DOI 10.1503/cmaj.110020; Ziegler S, 2007, BMJ-BRIT MED J, V334, P295, DOI 10.1136/bmj.39100.417072.BE	102	345	350	36	355	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					79	90		10.1001/jama.2016.8499	http://dx.doi.org/10.1001/jama.2016.8499			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ2MY	27380345				2022-12-28	WOS:000379037600021
J	Cheng, H; Edwards, RL; Sinha, A; Spotl, C; Yi, L; Chen, ST; Kelly, M; Kathayat, G; Wang, XF; Li, XL; Kong, XG; Wang, YJ; Ning, YF; Zhang, HW				Cheng, Hai; Edwards, R. Lawrence; Sinha, Ashish; Spotl, Christoph; Yi, Liang; Chen, Shitao; Kelly, Megan; Kathayat, Gayatri; Wang, Xianfeng; Li, Xianglei; Kong, Xinggong; Wang, Yongjin; Ning, Youfeng; Zhang, Haiwei			The Asian monsoon over the past 640,000 years and ice age terminations	NATURE			English	Article							MILLENNIAL-SCALE; CLIMATE VARIABILITY; HIGH-RESOLUTION; OCEAN CIRCULATION; NORTH-ATLANTIC; GLACIAL CYCLES; DONGGE CAVE; RECORD; HOLOCENE; TRANSITIONS	Oxygen isotope records from Chinese caves characterize changes in both the Asian monsoon and global climate. Here, using our new speleothem data, we extend the Chinese record to cover the full uranium/thorium dating range, that is, the past 640,000 years. The record's length and temporal precision allow us to test the idea that insolation changes caused by the Earth's precession drove the terminations of each of the last seven ice ages as well as the millennia-long intervals of reduced monsoon rainfall associated with each of the terminations. On the basis of our record's timing, the terminations are separated by four or five precession cycles, supporting the idea that the '100,000-year' ice age cycle is an average of discrete numbers of precession cycles. Furthermore, the suborbital component of monsoon rainfall variability exhibits power in both the precession and obliquity bands, and is nearly in anti-phase with summer boreal insolation. These observations indicate that insolation, in part, sets the pace of the occurrence of millennial-scale events, including those associated with terminations and 'unfinished terminations'.	[Cheng, Hai; Kathayat, Gayatri; Li, Xianglei; Ning, Youfeng; Zhang, Haiwei] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China; [Cheng, Hai; Edwards, R. Lawrence; Kelly, Megan] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA; [Sinha, Ashish] Calif State Univ Dominguez Hills, Dept Earth Sci, Carson, CA 90747 USA; [Spotl, Christoph] Univ Innsbruck, Inst Geol, A-6020 Innsbruck, Austria; [Yi, Liang] Tongji Univ, State Key Lab Marine Geol, Shanghai 200092, Peoples R China; [Chen, Shitao; Kong, Xinggong; Wang, Yongjin] Nanjing Normal Univ, Coll Geog Sci, Nanjing 210023, Peoples R China; [Wang, Xianfeng] Nanyang Technol Univ, Earth Observ Singapore, Singapore 639798, Singapore	Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities; California State University System; California State University Dominguez Hills; University of Innsbruck; Tongji University; Nanjing Normal University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Cheng, H (corresponding author), Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China.; Cheng, H; Edwards, RL (corresponding author), Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA.	cheng021@mail.xjtu.edu.cn; edwar001@umn.edu	Edwards, R. Lawrence/I-3124-2014; Wang, Xianfeng/F-1233-2014; CHENG, HAI/H-3413-2017; Yi, Liang/AAM-9737-2020	Edwards, R. Lawrence/0000-0002-7027-5881; Wang, Xianfeng/0000-0002-8614-5627; CHENG, HAI/0000-0002-5305-9458; Li, Xianglei/0000-0002-8464-9020; Zhang, Haiwei/0000-0002-0855-1283	China grant NBRP [2013CB955902]; China grant NSFC [41230524, 4157020432, 41561144003]; US NSF [0502535, 1103404, 0823554, 1003690, 1137693, 1317693]; Singapore grant [NRF-NRFF2011-08]; Directorate For Geosciences [1103403, 1337693] Funding Source: National Science Foundation	China grant NBRP; China grant NSFC(National Natural Science Foundation of China (NSFC)); US NSF(National Science Foundation (NSF)); Singapore grant; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by China grants NBRP 2013CB955902, NSFC 41230524, 4157020432 and 41561144003, US NSF grants 0502535, 1103404, 0823554, 1003690, 1137693 and 1317693 and Singapore grant NRF-NRFF2011-08. We thank M. Siddall for help with analysis of the millennial-scale variability of the Antarctic temperature record and A. P. Roberts for converting the ice core chronology.	Abe-Ouchi A, 2013, NATURE, V500, P190, DOI 10.1038/nature12374; Alonso-Garcia M, 2011, QUATERNARY SCI REV, V30, P3234, DOI 10.1016/j.quascirev.2011.08.005; Barker S, 2011, SCIENCE, V334, P347, DOI 10.1126/science.1203580; Bereiter B, 2015, GEOPHYS RES LETT, V42, P542, DOI 10.1002/2014GL061957; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; Candy I, 2014, EARTH-SCI REV, V128, P18, DOI 10.1016/j.earscirev.2013.09.006; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Cheng H, 2012, CLIM DYNAM, V39, P1045, DOI 10.1007/s00382-012-1363-7; Chiang JCH, 2015, QUATERNARY SCI REV, V108, P111, DOI 10.1016/j.quascirev.2014.11.009; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175, DOI 10.1016/0012-821X(87)90154-3; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Fudge TJ, 2013, NATURE, V500, P440, DOI 10.1038/nature12376; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; Holmgren K, 2003, QUATERNARY SCI REV, V22, P2311, DOI 10.1016/S0277-3791(03)00204-X; Hoogakker BAA, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002155; Howell P., 1997, ARAND TIME SERIES AN; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; Huybers P, 2011, NATURE, V480, P229, DOI 10.1038/nature10626; IMBRIE J, 1980, SCIENCE, V207, P943, DOI 10.1126/science.207.4434.943; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; JANSEN JHF, 1986, SCIENCE, V232, P619, DOI 10.1126/science.232.4750.619; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kelly MJ, 2006, PALAEOGEOGR PALAEOCL, V236, P20, DOI 10.1016/j.palaeo.2005.11.042; Kissel C, 2013, EARTH PLANET SC LETT, V369, P248, DOI 10.1016/j.epsl.2013.03.042; Kutzbach JE, 2008, CLIM DYNAM, V30, P567, DOI 10.1007/s00382-007-0308-z; Lambert F, 2008, NATURE, V452, P616, DOI 10.1038/nature06763; Landais A, 2010, QUATERNARY SCI REV, V29, P235, DOI 10.1016/j.quascirev.2009.07.005; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Liu ZY, 2014, QUATERNARY SCI REV, V83, P115, DOI 10.1016/j.quascirev.2013.10.021; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Maslin MA, 2005, GEOL SOC SPEC PUBL, V247, P19, DOI 10.1144/GSL.SP.2005.247.01.02; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Meckler AN, 2012, SCIENCE, V336, P1301, DOI 10.1126/science.1218340; Orland IJ, 2015, GEOLOGY, V43, P555, DOI 10.1130/G36612.1; Paillard D, 1998, NATURE, V391, P378, DOI 10.1038/34891; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Parrenin F, 2003, EARTH PLANET SC LETT, V214, P243, DOI 10.1016/S0012-821X(03)00363-7; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Raymo ME, 1998, SCIENCE, V281, P1467, DOI 10.1126/science.281.5382.1467; SALTZMAN B, 1984, J ATMOS SCI, V41, P3380, DOI 10.1175/1520-0469(1984)041<3380:TLQGAT>2.0.CO;2; Schaefer JM, 2015, QUATERNARY SCI REV, V114, P52, DOI 10.1016/j.quascirev.2015.02.009; Severinghaus JP, 2009, SCIENCE, V324, P1431, DOI 10.1126/science.1169473; Siddall M, 2010, CLIM PAST, V6, P295, DOI 10.5194/cp-6-295-2010; Spotl C, 2003, RAPID COMMUN MASS SP, V17, P1004, DOI 10.1002/rcm.1010; Spratt R.M., 2015, CLIM DISCUSS, V11, P3699; Toggweiler JR, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2006PA001405; van Breukelen MR, 2008, EARTH PLANET SC LETT, V275, P54, DOI 10.1016/j.epsl.2008.07.060; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013; Wolff EW, 2009, NAT GEOSCI, V2, P206, DOI 10.1038/NGEO442; Wright AK, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2002PA000782; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220	61	674	779	45	409	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					640	+		10.1038/nature18591	http://dx.doi.org/10.1038/nature18591			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27357793	Green Accepted			2022-12-28	WOS:000378676000027
J	Fleurbaey, M				Fleurbaey, Marc			Social-progress panel seeks public comment	NATURE			English	Editorial Material									[Fleurbaey, Marc] Princeton Univ, Econ & Humanistic Studies, Princeton, NJ 08544 USA; [Fleurbaey, Marc] Coll Etud Mondiales FMSH, Econ Well Being Programme, Paris, France	Princeton University	Fleurbaey, M (corresponding author), Princeton Univ, Econ & Humanistic Studies, Princeton, NJ 08544 USA.; Fleurbaey, M (corresponding author), Coll Etud Mondiales FMSH, Econ Well Being Programme, Paris, France.	mfleurba@princeton.edu	Fleurbaey, Marc/HHS-9231-2022	zhang, xiaobo/0000-0002-4981-9565				Dubash NK, 2014, SCIENCE, V345, P36, DOI 10.1126/science.1255734; Edenhofer O, 2014, SCIENCE, V345, P37, DOI 10.1126/science.1255998; IPCC, 2014, CONTRIBUTION WORKING; US National Academy of Sciences Engineering and Medicine, 2016, GEN ENG CROPS EXP PR	4	4	4	1	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					616	617		10.1038/534616a	http://dx.doi.org/10.1038/534616a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP7JV	27357779				2022-12-28	WOS:000378676000013
J	Wu, JY; Huang, B; Chen, H; Yin, QZ; Liu, Y; Xiang, YL; Zhang, BJ; Liu, BF; Wang, QJ; Xia, WK; Li, WZ; Li, YY; Ma, J; Peng, X; Zheng, H; Ming, J; Zhang, WH; Zhang, J; Tian, G; Xu, F; Chang, Z; Na, J; Yang, XR; Xie, W				Wu, Jingyi; Huang, Bo; Chen, He; Yin, Qiangzong; Liu, Yang; Xiang, Yunlong; Zhang, Bingjie; Liu, Bofeng; Wang, Qiujun; Xia, Weikun; Li, Wenzhi; Li, Yuanyuan; Ma, Jing; Peng, Xu; Zheng, Hui; Ming, Jia; Zhang, Wenhao; Zhang, Jing; Tian, Geng; Xu, Feng; Chang, Zai; Na, Jie; Yang, Xuerui; Xie, Wei			The landscape of accessible chromatin in mammalian preimplantation embryos	NATURE			English	Article							GENE-EXPRESSION; MOUSE EMBRYO; STEM-CELLS; RNA-SEQ; VISCERAL ENDODERM; TRANSCRIPTION; DIFFERENTIATION; DYNAMICS; REVEALS; GENOME	In mammals, extensive chromatin reorganization is essential for reprogramming terminally committed gametes to a totipotent state during preimplantation development. However, the global chromatin landscape and its dynamics in this period remain unexplored. Here we report a genome-wide map of accessible chromatin in mouse preimplantation embryos using an improved assay for transposase-accessible chromatin with high throughput sequencing (ATAC-seq) approach with CRISPR/Cas9-assisted mitochondrial DNA depletion. We show that despite extensive parental asymmetry in DNA methylomes, the chromatin accessibility between the parental genomes is globally comparable after major zygotic genome activation (ZGA). Accessible chromatin in early embryos is widely shaped by transposable elements and overlaps extensively with putative cis-regulatory sequences. Unexpectedly, accessible chromatin is also found near the transcription end sites of active genes. By integrating the maps of cis-regulatory elements and single-cell transcriptomes, we construct the regulatory network of early development, which helps to identify the key modulators for lineage specification. Finally, we find that the activities of cis-regulatory elements and their associated open chromatin diminished before major ZGA. Surprisingly, we observed many loci showing non-canonical, large open chromatin domains over the entire transcribed units in minor ZGA, supporting the presence of an unusually permissive chromatin state. Together, these data reveal a unique spatiotemporal chromatin configuration that accompanies early mammalian development.	[Wu, Jingyi; Yin, Qiangzong; Xiang, Yunlong; Zhang, Bingjie; Liu, Bofeng; Wang, Qiujun; Xia, Weikun; Li, Yuanyuan; Ma, Jing; Zheng, Hui; Zhang, Wenhao; Xie, Wei] Tsinghua Univ, MOE Key Lab Bioinformat, Ctr Stem Cell Biol & Regenerat Med, THU PKU Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China; [Wu, Jingyi; Liu, Yang; Yang, Xuerui; Xie, Wei] Tsinghua Univ, Sch Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing 100084, Peoples R China; [Huang, Bo] Peking Univ, Acad Adv Interdisciplinary Studies, PKU THU Ctr Life Sci, Beijing 100871, Peoples R China; [Chen, He] Peking Univ, Coll Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing 100871, Peoples R China; [Liu, Yang; Yang, Xuerui] Tsinghua Univ, MOE Key Lab Bioinformat, Ctr Synthet & Syst Biol, THU PKU Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China; [Li, Wenzhi; Ming, Jia; Na, Jie] Tsinghua Univ, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Beijing 100084, Peoples R China; [Peng, Xu; Xu, Feng] ASTAR, Singapore Inst Clin Sci, Singapore 117609, Singapore; [Zhang, Jing; Chang, Zai] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Tian, Geng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Xu, Feng] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore	Tsinghua University; National Institute of Biological Sciences, Beijing; Tsinghua University; Peking University; National Institute of Biological Sciences, Beijing; Peking University; Tsinghua University; Tsinghua University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Tsinghua University; Tsinghua University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Xie, W (corresponding author), Tsinghua Univ, MOE Key Lab Bioinformat, Ctr Stem Cell Biol & Regenerat Med, THU PKU Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China.; Xie, W (corresponding author), Tsinghua Univ, Sch Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing 100084, Peoples R China.	xiewei121@tsinghua.edu.cn	huang, bo/A-2690-2017; Xia, Weikun/GXG-7930-2022; Xie, Wei/J-1380-2017; Na, Jie/U-4518-2019; Wu, Jingyi/S-9658-2019; Zhang, Bingjie/FGK-6320-2022; Na, Jie/N-3522-2018	Xie, Wei/0000-0003-2126-3849; Na, Jie/0000-0003-1820-0548; Zhang, Bingjie/0000-0002-0535-0371; Na, Jie/0000-0003-1820-0548; Xu, Feng/0000-0003-2016-7521; Zhang, Wenhao/0000-0002-3739-0415; Chen, He/0000-0001-9644-8202; Liu, Yang/0000-0003-2108-3207; Yang, Xuerui/0000-0002-7731-2147	National Basic Research Program of China (973 program) [2015CB856201]; National Natural Science Foundation of China [31422031, 31171381, 81472855]; National Basic Research Program of China [2012CB966701]; Beijing Natural Science Foundation [5152014]; Tsinghua University Initiative Scientific Research Program [20131089278, 2014z21046]; THU-PKU Center for Life Sciences; Youth Thousand Scholar Program of China	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Tsinghua University Initiative Scientific Research Program; THU-PKU Center for Life Sciences; Youth Thousand Scholar Program of China	We appreciate B. Ren, D. Leung, H. Yang and the members of the Xie laboratory for comments during preparation of the manuscript. This work is supported by the funding provided by the National Basic Research Program of China (973 program) 2015CB856201 (W.Xie), the National Natural Science Foundation of China 31422031 (W.Xie). 31171381 (J.N.). 81472855 (X.Y.), the National Basic Research Program of China 2012CB966701 (J.N.), the Beijing Natural Science Foundation grant 5152014 (J.N.), Tsinghua University Initiative Scientific Research Program (20131089278, 2014z21046) (X.Y.). the funding from the THU-PKU Center for Life Sciences (W.Xie, X.Y.), and the Youth Thousand Scholar Program of China (W.Xie, X.Y.).	Abe K, 2015, EMBO J, V34, P1523, DOI 10.15252/embj.201490648; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burton A, 2014, NAT REV MOL CELL BIO, V15, P722, DOI 10.1038/nrm3885; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; De Braekeleer E, 2012, LEUKEMIA RES, V36, P945, DOI 10.1016/j.leukres.2012.04.010; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Jedrusik A, 2015, DEV BIOL, V398, P147, DOI 10.1016/j.ydbio.2014.12.004; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Labelle-Dumais C, 2006, DEV DYNAM, V235, P3359, DOI 10.1002/dvdy.20996; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Maza I, 2015, NAT BIOTECHNOL, V33, P769, DOI 10.1038/nbt.3270; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Peng X, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku818; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Randise-Hinchliff CE, 2012, DEV CELL, V23, P919, DOI 10.1016/j.devcel.2012.10.024; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Robbez-Masson L, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0173-5; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wicklow E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004618; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564	50	351	362	13	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					652	+		10.1038/nature18606	http://dx.doi.org/10.1038/nature18606			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27309802				2022-12-28	WOS:000378676000029
J	DuPont, HL				DuPont, Herbert L.			Persistent Diarrhea A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FECAL MICROBIOTA TRANSPLANTATION; CLOSTRIDIUM-DIFFICILE INFECTION; CRYPTOSPORIDIUM-PARVUM; REDUCED SUSCEPTIBILITY; ENTERIC INFECTIONS; TRAVELERS DIARRHEA; ESCHERICHIA-COLI; CELIAC-DISEASE; DOUBLE-BLIND; CHILDREN	IMPORTANCE Diarrheal disease is commonly encountered in clinical practice. Persistent diarrhea (>= 14 days) can be caused by pathogens that differ from those commonly seen in acute illness; proper etiologic diagnosis is important for appropriate therapeutic management. This review provides an overview of the epidemiology, etiology, diagnosis, and management of persistent diarrhea caused by infectious agents in immunocompetent individuals worldwide. OBSERVATIONS Much of the data on persistent diarrhea comes from studies of residents in or expatriates of developing countries and travelers to these regions where follow-up studies have been performed. Persistent diarrhea occurs in approximately 3% of individuals traveling to developing countries. Schistosoma mansoni (and rarely Schistosoma haematobium) intestinal infection is also not very common and is found only in endemic areas. The microbiologic causes of protracted diarrhea include detectable parasitic (eg, Giardia, Cryptosporidium) and bacterial (eg, enteroaggregative Escherichia coli, Shigella) pathogens. Available diagnostic tests include culture-dependent for bacterial pathogens and culture-independent methods for bacterial, viral, and protozoal infections (eg, polymerase chain reaction [PCR]), including multiplex PCR, as well as and microscopy for protozoal infections. Antimicrobial therapy can be given empirically to patients returning from the undeveloped to the developed world. Otherwise, antibiotics should be given based on the results of laboratory testing. CONCLUSIONS AND RELEVANCE Persistent diarrhea is a poorly recognized syndrome in all populations that requires proper assessment and diagnosis to ensure that affected individuals receive the treatment needed to experience improvement of clinical symptoms.	[DuPont, Herbert L.] Univ Texas Houston, Sch Publ Hlth, 1200 Herman Pressler St,E-733, Houston, TX 77030 USA; [DuPont, Herbert L.] Univ Texas Houston, Sch Med, 1200 Herman Pressler St,E-733, Houston, TX 77030 USA; [DuPont, Herbert L.] Kelsey Res Fdn, Houston, TX USA; [DuPont, Herbert L.] Baylor Coll Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	DuPont, HL (corresponding author), Univ Texas Houston, Sch Publ Hlth, 1200 Herman Pressler St,E-733, Houston, TX 77030 USA.; DuPont, HL (corresponding author), Univ Texas Houston, Sch Med, 1200 Herman Pressler St,E-733, Houston, TX 77030 USA.	Herbert.l.DuPont@uth.tmc.edu	DuPont, Herbert/AAH-6776-2021		Romark Laboratories	Romark Laboratories	Funding for this article was provided by Romark Laboratories.	Abba K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-24; Becker SL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-37; Bhutta ZA, 2008, J PEDIATR GASTR NUTR, V47, P260, DOI 10.1097/MPG.0b013e318181b334; Carcamo C, 2005, J INFECT DIS, V191, P11, DOI 10.1086/426508; Carter JD, 2009, RHEUM DIS CLIN N AM, V35, P21, DOI 10.1016/j.rdc.2009.03.010; Centers for Disease Control and Prevention, BRAIN DIARRH; Cohen SA, 2005, CURR MED RES OPIN, V21, P999, DOI 10.1185/030079905X50534; Connor BA, 2005, CLIN INFECT DIS, V41, pS577, DOI 10.1086/432956; Drekonja D, 2015, ANN INTERN MED, V162, P630, DOI 10.7326/M14-2693; DuPont HL, 2014, NEW ENGL J MED, V370, P1532, DOI 10.1056/NEJMra1301069; DuPont HL, 1996, CLIN INFECT DIS, V22, P124, DOI 10.1093/clinids/22.1.124; Fagundes-Neto Ulysses, 2013, Curr Gastroenterol Rep, V15, P345, DOI 10.1007/s11894-013-0345-1; Farthing M, 2013, J CLIN GASTROENTEROL, V47, P12, DOI 10.1097/MCG.0b013e31826df662; Glasziou P., OXFORD 2011 LEVELS E; Han JH, 2013, DIAGN MICR INFEC DIS, V76, P491, DOI 10.1016/j.diagmicrobio.2013.04.018; Harano Y, 2015, INT J GEN MED, V8, P97, DOI 10.2147/IJGM.S63771; Herwaldt BL, 2001, J CLIN MICROBIOL, V39, P34, DOI 10.1128/JCM.39.1.34-42.2001; Iwamoto M, 2015, MMWR-MORBID MORTAL W, V64, P252; Kantele A, 2015, CLIN INFECT DIS, V60, P837, DOI 10.1093/cid/ciu957; Karlsson MS, 2013, ANTIMICROB AGENTS CH, V57, P1559, DOI 10.1128/AAC.02360-12; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kermani N. A., 2010, Eastern Mediterranean Health Journal, V16, P831; Khare R, 2014, J CLIN MICROBIOL, V52, P3667, DOI 10.1128/JCM.01637-14; Koo HL, 2014, INFECT CONT HOSP EP, V35, P667, DOI 10.1086/676433; Langenberg MCC, 2014, TRAVEL MED INFECT DI, V12, P401, DOI 10.1016/j.tmaid.2014.05.001; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; Muhsen K, 2012, CLIN INFECT DIS, V55, pS271, DOI 10.1093/cid/cis762; Mukhopadhyay C., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P13; Nabarro LEB, 2015, CLIN MICROBIOL INFEC, V21, P791, DOI 10.1016/j.cmi.2015.04.019; Nair P, 2014, J TRAVEL MED, V21, P153, DOI 10.1111/jtm.12114; Oxford Centre for Evidence-Based Medicine, 2009, LEVELS EVIDENCE; Penny ME, 2004, AM J CLIN NUTR, V79, P457; Putnam SD, 2006, J TRAVEL MED, V13, P92, DOI 10.1111/j.1708-8305.2006.00020.x; Rees JR, 2004, CLIN INFECT DIS, V38, pS311, DOI 10.1086/381601; Ren ZZ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-412; Riddle MS, 2012, AM J GASTROENTEROL, V107, P1248, DOI 10.1038/ajg.2012.130; Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014; Rossignol JF, 2012, T ROY SOC TROP MED H, V106, P167, DOI 10.1016/j.trstmh.2011.11.007; Rossignol JF, 2001, J INFECT DIS, V184, P381, DOI 10.1086/322038; Rossignol JFA, 2001, J INFECT DIS, V184, P103, DOI 10.1086/321008; Saneian H, 2010, IRAN J PEDIATR, V20, P343; Schultsz C, 2000, J CLIN MICROBIOL, V38, P3550, DOI 10.1128/JCM.38.10.3550-3554.2000; Sekar Uma, 2013, Trop Parasitol, V3, P35, DOI 10.4103/2229-5070.113901; SHAHID NS, 1988, BRIT MED J, V297, P1036, DOI 10.1136/bmj.297.6655.1036; Slack A, 2012, AUST FAM PHYSICIAN, V41, P782; Soes LM, 2014, EUR J CLIN MICROBIOL, V33, P957, DOI 10.1007/s10096-013-2033-3; STEINHOFF MC, 1980, GASTROENTEROLOGY, V78, P1495; TAYLOR DN, 1988, JAMA-J AM MED ASSOC, V260, P1245, DOI 10.1001/jama.260.9.1245; Umamaheswari B, 2010, INDIAN J PEDIATR, V77, P885, DOI 10.1007/s12098-010-0125-y; UN, 2012, WORLD EC SIT PROSP 2; Utzinger J, 2015, CLIN MICROBIOL INFEC, V21, P529, DOI [10.1016/j.cmi.2015.02.016, 10.1016/j.cmi.2015.03.014]; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Vernacchio L, 2006, J PEDIATR GASTR NUTR, V43, P52, DOI 10.1097/01.mpg.0000228094.74207.39; Vila J, 2003, EMERG INFECT DIS, V9, P552, DOI 10.3201/eid0905.020451; Zulu I, 2005, ALIMENT PHARM THERAP, V21, P757, DOI 10.1111/j.1365-2036.2005.02394.x	55	55	59	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2712	2723		10.1001/jama.2016.7833	http://dx.doi.org/10.1001/jama.2016.7833			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27357241				2022-12-28	WOS:000378709300022
J	Ellefson, JW; Gollihar, J; Shroff, R; Shivram, H; Iyer, VR; Ellington, AD				Ellefson, Jared W.; Gollihar, Jimmy; Shroff, Raghav; Shivram, Haridha; Iyer, Vishwanath R.; Ellington, Andrew D.			Synthetic evolutionary origin of a proofreading reverse transcriptase	SCIENCE			English	Article							DEPENDENT DNA-POLYMERASE; 3RD BASE-PAIR; AMPLIFICATION; REPLICATION; FIDELITY; VIRIONS; SYSTEM; URACIL; VIRUS; ACID	Most reverse transcriptase (RT) enzymes belong to a single protein family of ancient evolutionary origin. These polymerases are inherently error prone, owing to their lack of a proofreading (3'-5' exonuclease) domain. To determine if the lack of proofreading is a historical coincidence or a functional limitation of reverse transcription, we attempted to evolve a high-fidelity, thermostable DNA polymerase to use RNA templates efficiently. The evolutionarily distinct reverse transcription xenopolymerase (RTX) actively proofreads on DNA and RNA templates, which greatly improves RT fidelity. In addition, RTX enables applications such as single-enzyme reverse transcription-polymerase chain reaction and direct RNA sequencing without complementary DNA isolation. The creation of RTX confirms that proofreading is compatible with reverse transcription.	[Ellefson, Jared W.; Gollihar, Jimmy; Shroff, Raghav; Shivram, Haridha; Iyer, Vishwanath R.; Ellington, Andrew D.] Univ Texas Austin, Dept Mol Biosci, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Ellefson, JW; Ellington, AD (corresponding author), Univ Texas Austin, Dept Mol Biosci, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA.	jaredwellefson@gmail.com; ellingtonlab@gmail.com		Gollihar, Jimmy/0000-0003-3957-2092	Defense Advanced Research Projects Agency [HR0011-12-2-0001]; National Security Science and Engineering Faculty Fellowship [FA9550-10-1-0169]; NASA [NNX15AF46G]; Welch foundation [F-1654]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Security Science and Engineering Faculty Fellowship; NASA(National Aeronautics & Space Administration (NASA)); Welch foundation(The Welch Foundation)	We thank the University of Texas Genomic Sequencing and Analysis Facility for DNA sequencing support. This work was supported by Defense Advanced Research Projects Agency (HR0011-12-2-0001), National Security Science and Engineering Faculty Fellowship (FA9550-10-1-0169), NASA (NNX15AF46G), and the Welch foundation (F-1654). J.W.E. conceived of the project. J.W.E., J.G., R.S. performed research with contributions from H.S and V.R.I. J.W.E, J.G., R.S., and A.D.E. wrote the manuscript. The authors declare competing financial interests. A.D.E. was a paid consultant for Enzymatics. A provisional patent has been filed on the sequence composition of the reverse transcriptase.	BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Boeke JD, 1997, RETROVIRUSES; Cozens C, 2012, P NATL ACAD SCI USA, V109, P8067, DOI 10.1073/pnas.1120964109; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; DARNELL JE, 1986, P NATL ACAD SCI USA, V83, P1271, DOI 10.1073/pnas.83.5.1271; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Ghadessy FJ, 2001, P NATL ACAD SCI USA, V98, P4552, DOI 10.1073/pnas.071052198; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; HUFF JW, 1964, BIOCHEMISTRY-US, V3, P501, DOI 10.1021/bi00892a006; Jozwiakowski SK, 2011, CHEMBIOCHEM, V12, P35, DOI 10.1002/cbic.201000640; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Malyshev DA, 2012, P NATL ACAD SCI USA, V109, P12005, DOI 10.1073/pnas.1205176109; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Moser MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038371; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Takagi M, 1997, APPL ENVIRON MICROB, V63, P4504, DOI 10.1128/AEM.63.11.4504-4510.1997; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; WANG AHJ, 1982, NATURE, V299, P601, DOI 10.1038/299601a0; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yamashige R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1068; Yang ZY, 2011, J AM CHEM SOC, V133, P15105, DOI 10.1021/ja204910n	27	80	87	8	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1590	1593		10.1126/science.aaf5409	http://dx.doi.org/10.1126/science.aaf5409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27339990				2022-12-28	WOS:000378346500047
J	Davis, MM; Gebremariam, A; Ayanian, JZ				Davis, Matthew M.; Gebremariam, Achamyeleh; Ayanian, John Z.			Changes in Insurance Coverage Among Hospitalized Nonelderly Adults After Medicaid Expansion in Michigan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Davis, Matthew M.; Ayanian, John Z.] Univ Michigan, Inst Healthcare Policy & Innovat, 300 NIB,6A18, Ann Arbor, MI 48109 USA; [Gebremariam, Achamyeleh] Univ Michigan Hlth Syst, Child Hlth Evaluat & Res Unit, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Davis, MM (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, 300 NIB,6A18, Ann Arbor, MI 48109 USA.	mattdav@med.umich.edu						Ayanian JZ, 2013, NEW ENGL J MED, V369, P1773, DOI 10.1056/NEJMp1310910; DeLeire T, IMPACT INSURANCE EXP; Deloitte Development, COMM KENT MED EXP RE; Nikpay S, 2016, HEALTH AFFAIR, V35, P106, DOI 10.1377/hlthaff.2015.1144; State Health Reform Assistance Network, IMP MED EXP UNC CAR	5	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2617	2618		10.1001/jama.2016.6303	http://dx.doi.org/10.1001/jama.2016.6303			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27327805	Bronze			2022-12-28	WOS:000378306700025
J	Ouyang, Z; Zheng, H; Xiao, Y; Polasky, S; Liu, J; Xu, W; Wang, Q; Zhang, L; Xiao, Y; Rao, EM; Jiang, L; Lu, F; Wang, XK; Yang, GB; Gong, SH; Wu, BF; Zeng, Y; Yang, W; Daily, GC				Ouyang, Zhiyun; Zheng, Hua; Xiao, Yi; Polasky, Stephen; Liu, Jianguo; Xu, Weihua; Wang, Qiao; Zhang, Lu; Xiao, Yang; Rao, Enming; Jiang, Ling; Lu, Fei; Wang, Xiaoke; Yang, Guangbin; Gong, Shihan; Wu, Bingfang; Zeng, Yuan; Yang, Wu; Daily, Gretchen C.			Improvements in ecosystem services from investments in natural capital	SCIENCE			English	Article							LAND-USE; CHINA; IMPACTS	In response to ecosystem degradation from rapid economic development, China began investing heavily in protecting and restoring natural capital starting in 2000. We report on China's first national ecosystem assessment (2000-2010), designed to quantify and help manage change in ecosystem services, including food production, carbon sequestration, soil retention, sandstorm prevention, water retention, flood mitigation, and provision of habitat for biodiversity. Overall, ecosystem services improved from 2000 to 2010, apart from habitat provision. China's national conservation policies contributed significantly to the increases in those ecosystem services.	[Ouyang, Zhiyun; Zheng, Hua; Xiao, Yi; Xu, Weihua; Zhang, Lu; Xiao, Yang; Rao, Enming; Jiang, Ling; Lu, Fei; Wang, Xiaoke; Gong, Shihan] Chinese Acad Sci, Res Ctr Eco Environm Sci, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China; [Polasky, Stephen] Univ Minnesota, Inst Environm, Dept Appl Econ, St Paul, MN 55108 USA; [Polasky, Stephen] Univ Minnesota, Inst Environm, Nat Capital Project, St Paul, MN 55108 USA; [Liu, Jianguo] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA; [Wang, Qiao] Minist Environm Protect, Satellite Environm Ctr, Beijing 100094, Peoples R China; [Yang, Guangbin] Guizhou Normal Univ, Sch Geog & Environm Sci, Guiyang 550001, Peoples R China; [Wu, Bingfang; Zeng, Yuan] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing 100101, Peoples R China; [Yang, Wu] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Daily, Gretchen C.] Stanford Univ, Dept Biol, Nat Capital Project, Stanford, CA 94305 USA; [Daily, Gretchen C.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Michigan State University; Guizhou Normal University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Zhejiang University; Stanford University; Stanford University	Ouyang, Z (corresponding author), Chinese Acad Sci, Res Ctr Eco Environm Sci, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China.; Daily, GC (corresponding author), Stanford Univ, Dept Biol, Nat Capital Project, Stanford, CA 94305 USA.; Daily, GC (corresponding author), Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA.	zyouyang@rcees.ac.cn; gdaily@stanford.edu	Wu, Bingfang/AAD-7223-2022; Liu, Jianguo/G-5211-2015; Xiao, Yang/ABC-7068-2020; Polasky, Stephen/AAC-5341-2019	Liu, Jianguo/0000-0001-6344-0087; Xiao, Yang/0000-0002-8355-5209; Zheng, Hua/0000-0002-2301-1744; wang, xiao ke/0000-0002-2421-3970	Ministry of Finance of China; international Natural Capital Project	Ministry of Finance of China; international Natural Capital Project	We thank the Ministry of Environmental Protection (MEP) of China and Chinese Academy of Sciences (CAS) for organizing the Project, and experts in 31 provinces for collecting the field data or statistics analysis on this manuscript. This work was supported by the Ministry of Finance of China through the MEP/CAS project "Survey and Assessment of National Ecosystem Changes Between, 2000 and 2010, China" and by the international Natural Capital Project. All the data are available at www.sciencedb.cn/dataSet/handle/73.	[Anonymous], 2005, EC HUM WELL BEING SY; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; China Council for International Cooperation on Environment and Development, 2014, REP I INN EC PROT RE; Ehrlich PR, 2012, NATURE, V486, P68, DOI 10.1038/nature11157; Folke C, 2010, ECOL SOC, V15, DOI 10.5751/es-03610-150420; Fu BJ, 2008, SCIENCE, V321, P611, DOI 10.1126/science.1162213; Hatfield-Dodds S, 2015, NATURE, V527, P49, DOI 10.1038/nature16065; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Liu J., 2013, ENCY BIODIVERSITY, P372, DOI DOI 10.1016/B978-0-12-384719-5.00335-X; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JG, 2010, CRIT REV ENV SCI TEC, V40, P823, DOI 10.1080/10643389.2010.502645; Ministry of Environmental Protection, 2015, NAT EC PROT REDL MIN; Ministry of Environmental Protection of China and Chinese Academy of Sciences, 2015, NAT EC SERV ZON CHIN; Ministry of Transport of China, 2013, NAT ROAD DEV PLANNNN; National Development Reform Commission, 2013, OP ACC CONSTR EC CIV; Sharp R., 2015, INVEST VERSION USERS; Tuanmu MN, 2016, CONSERV BIOL, V30, P827, DOI 10.1111/cobi.12669; UKNEA, 2011, UK NATL ECOSYSTEM AS; Vina A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500965; WAVES (Wealth Accounting and the Valuation of Ecosystem Services), 2015, WAVES ANN REP 2015; Ye Q., 2005, Mitigation and Adaptation Strategies for Global Change, V10, P159, DOI 10.1007/s11027-005-7838-7; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135	25	755	909	217	1652	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1455	1459		10.1126/science.aaf2295	http://dx.doi.org/10.1126/science.aaf2295			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27313045				2022-12-28	WOS:000377975400048
J	Watts, G				Watts, Geoff			Utako Okamoto Obituary	LANCET			English	Biographical-Item																			0	17	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2286	2286		10.1016/S0140-6736(16)30697-3	http://dx.doi.org/10.1016/S0140-6736(16)30697-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27308678	Bronze			2022-12-28	WOS:000376969100018
J	Watts, G				Watts, Geoff			John Walton Obituary	LANCET			English	Biographical-Item																		WALTON JK, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2194	2194		10.1016/S0140-6736(16)30618-3	http://dx.doi.org/10.1016/S0140-6736(16)30618-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	27308680	Bronze			2022-12-28	WOS:000376820800022
J	Tape, CJ; Ling, S; Dimitriadi, M; McMahon, KM; Worboys, JD; Leong, HS; Norrie, IC; Miller, CJ; Poulogiannis, G; Lauffenburger, DA; Jorgensen, C				Tape, Christopher J.; Ling, Stephanie; Dimitriadi, Maria; McMahon, Kelly M.; Worboys, Jonathan D.; Leong, Hui Sun; Norrie, Ida C.; Miller, Crispin J.; Poulogiannis, George; Lauffenburger, Douglas A.; Jorgensen, Claus			Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation (vol 165, pg 910, 2016)	CELL			English	Correction												claus.jorgensen@cruk.manchester.ac.uk	Poulogiannis, George/AAY-2210-2021; Poulogiannis, George/AAE-1966-2019	Poulogiannis, George/0000-0002-0529-8614; Tape, Christopher/0000-0003-4712-2737; Worboys, Jonathan/0000-0002-8242-4901; Jorgensen, Claus/0000-0002-7841-943X; Miller, Crispin/0000-0003-4341-1283	Medical Research Council [1102929] Funding Source: researchfish; Cancer Research UK [12905] Funding Source: Medline; NCI NIH HHS [U54 CA112967, R01 CA096504, P30 CA014051] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Tape CJ, 2016, CELL, V165, P910, DOI 10.1016/j.cell.2016.03.029	1	113	118	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1818	1818		10.1016/j.cell.2016.05.079	http://dx.doi.org/10.1016/j.cell.2016.05.079			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27087446	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000378062000029
